Citrus Sinensis ID: 039291
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 362 | 2.2.26 [Sep-21-2011] | |||||||
| O22040 | 666 | Mitogen-activated protein | no | no | 0.715 | 0.388 | 0.329 | 1e-35 | |
| Q9FZ36 | 651 | Mitogen-activated protein | no | no | 0.712 | 0.396 | 0.320 | 7e-35 | |
| Q10407 | 1116 | MAP kinase kinase kinase | yes | no | 0.723 | 0.234 | 0.351 | 1e-34 | |
| O22042 | 651 | Mitogen-activated protein | no | no | 0.707 | 0.393 | 0.304 | 3e-33 | |
| P28829 | 659 | Protein kinase byr2 OS=Sc | no | no | 0.723 | 0.397 | 0.350 | 5e-33 | |
| Q01389 | 1478 | Serine/threonine-protein | yes | no | 0.690 | 0.169 | 0.346 | 2e-32 | |
| Q54R82 | 942 | Mitogen-activated protein | yes | no | 0.698 | 0.268 | 0.309 | 7e-31 | |
| P25390 | 1331 | Serine/threonine-protein | no | no | 0.701 | 0.190 | 0.323 | 2e-30 | |
| E9Q3S4 | 1311 | Mitogen-activated protein | yes | no | 0.671 | 0.185 | 0.303 | 8e-28 | |
| Q39008 | 608 | Mitogen-activated protein | no | no | 0.690 | 0.411 | 0.330 | 1e-27 |
| >sp|O22040|ANP1_ARATH Mitogen-activated protein kinase kinase kinase ANP1 OS=Arabidopsis thaliana GN=ANP1 PE=1 SV=2 | Back alignment and function desciption |
|---|
Score = 150 bits (379), Expect = 1e-35, Method: Compositional matrix adjust.
Identities = 95/288 (32%), Positives = 155/288 (53%), Gaps = 29/288 (10%)
Query: 7 SWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVSAS-----------ASLQKEK 55
SW +G++IG+G+FG V++ + L+AVK ++A+ L++E
Sbjct: 68 SWRKGQLIGRGAFGTVYMGMNLDSGE----LLAVKQVLIAANFASKEKTQAHIQELEEEV 123
Query: 56 EVFDNLNGCPFVLECFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVR 115
++ NL+ P ++ G T+ E+ + N+LLE+ GG++ L+EK PE VR
Sbjct: 124 KLLKNLSH-PNIVRYLG---TVREDDTL--NILLEFVPGGSISSLLEKFGP--FPESVVR 175
Query: 116 HFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFD 175
+TR +L G+ ++H+ +H D+K NIL+ K K+AD G +K+
Sbjct: 176 TYTRQLLLGLEYLHNHAIMHRDIKGANILV----DNKGCIKLADFGASKQVAELATMTGA 231
Query: 176 PSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGD 235
SM+GTP ++APE ++Q +DIW++GC V+EM++G+ W ++ + +F IG
Sbjct: 232 KSMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMVTGKAPW-SQQYKEVAAIF-FIGT 289
Query: 236 EHSLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGVDEE 283
S P IP +S +A+DFL +C P R TA LL PFV G +E
Sbjct: 290 TKSHPPIPDTLSSDAKDFLLKCLQEVPNLRPTASELLKHPFVMGKHKE 337
|
May be involved in an oxidative stress-mediated signaling cascade that phosphorylates downstream MAP kinases MPK3 and MPK6. May suppress auxin signaling that promotes cell cycle. Functionally redundant to ANP2 and ANP3 in the positive regulation of cytokinesis. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 2EC: 5 |
| >sp|Q9FZ36|M3K2_ARATH Mitogen-activated protein kinase kinase kinase 2 OS=Arabidopsis thaliana GN=ANP2 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 148 bits (373), Expect = 7e-35, Method: Compositional matrix adjust.
Identities = 92/287 (32%), Positives = 155/287 (54%), Gaps = 29/287 (10%)
Query: 8 WFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVSASAS-----------LQKEKE 56
W +G++IG+G+FG V++ + L+AVK ++++ + L++E +
Sbjct: 68 WRKGQLIGRGAFGTVYMGMNLDSGE----LLAVKQVLITSNCASKEKTQAHIQELEEEVK 123
Query: 57 VFDNLNGCPFVLECFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRH 116
+ NL+ P ++ G T+ E+ + N+LLE+ GG++ L+EK PE VR
Sbjct: 124 LLKNLSH-PNIVRYLG---TVREDETL--NILLEFVPGGSISSLLEKFGA--FPESVVRT 175
Query: 117 FTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDP 176
+T +L G+ ++H+ +H D+K NIL+ + K+AD G +K+
Sbjct: 176 YTNQLLLGLEYLHNHAIMHRDIKGANILV----DNQGCIKLADFGASKQVAELATISGAK 231
Query: 177 SMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDE 236
SM+GTP ++APE ++Q +DIW++GC V+EM++G+ W ++ I +F IG
Sbjct: 232 SMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMVTGKAPW-SQQYKEIAAIFH-IGTT 289
Query: 237 HSLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGVDEE 283
S P IP +S +A DFL +C ++P R TA LL PFV G +E
Sbjct: 290 KSHPPIPDNISSDANDFLLKCLQQEPNLRPTASELLKHPFVTGKQKE 336
|
Involved in cortical microtubules organization and stabilization by regulating the phosphorylation state of microtubule-associated proteins such as MAP65-1. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 5 |
| >sp|Q10407|MKH1_SCHPO MAP kinase kinase kinase mkh1 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) GN=mkh1 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 147 bits (372), Expect = 1e-34, Method: Compositional matrix adjust.
Identities = 103/293 (35%), Positives = 157/293 (53%), Gaps = 31/293 (10%)
Query: 8 WFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVSASAS---LQKEKEVFDNLNGC 64
W +G +IG G++G VF+A + L+AVK E+ + + Q K++ D++N
Sbjct: 825 WMKGELIGNGTYGKVFLAMNINTGE----LIAVKQVEIPQTINGRHDQLRKDIVDSINAE 880
Query: 65 PFV---LECFGEEITMG-ENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLP--EKDVRHFT 118
+ L+ +G E E ++ LEY +GG++G +C N P E+ VR +
Sbjct: 881 ISMIADLDHLNIVQYLGFEKTETDISIFLEYVSGGSIG----RCLRNYGPFEEQLVRFVS 936
Query: 119 RCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSM 178
R +L G+ ++H G +H D+K DN+L+ V KI+D G++K S + + SM
Sbjct: 937 RQVLYGLSYLHSKGIIHRDLKADNLLI----DFDGVCKISDFGISKHSDNVYDNDANLSM 992
Query: 179 RGTPLYLAPETVVQHMQ--EAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDE 236
+G+ ++APE + Q A D+W+LGCVVLEML+GR+ W E +I +F +G E
Sbjct: 993 QGSIFWMAPEVIHNDHQGYSAKVDVWSLGCVVLEMLAGRRPWSTDE--AIQAMFK-LGTE 1049
Query: 237 HSLPEIP----SRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGVDEELS 285
P IP S+VS EA FL CF R TAE LL+ PF+K DEE +
Sbjct: 1050 KKAPPIPSELVSQVSPEAIQFLNACFTVNADVRPTAEELLNHPFMK-CDEEFN 1101
|
May regulate cell morphology, cell wall integrity, salt resistance, cell cycle reentry from stationary-phase arrest, and filamentous growth in response to stress. Activates the MAP kinase kinase skh1/pek1 by phosphorylation. Schizosaccharomyces pombe (strain 972 / ATCC 24843) (taxid: 284812) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 5 |
| >sp|O22042|M3K3_ARATH Mitogen-activated protein kinase kinase kinase 3 OS=Arabidopsis thaliana GN=ANP3 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 142 bits (359), Expect = 3e-33, Method: Compositional matrix adjust.
Identities = 88/289 (30%), Positives = 155/289 (53%), Gaps = 33/289 (11%)
Query: 8 WFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVSASAS-----------LQKEKE 56
W +G +IG G+FG V++ + L+A+K ++ S++ L++E +
Sbjct: 68 WRKGELIGCGAFGRVYMGMNLDSGE----LLAIKQVLIAPSSASKEKTQGHIRELEEEVQ 123
Query: 57 VFDNLNGCPFVLECFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRH 116
+ NL+ P ++ G T+ E+ + N+L+E+ GG++ L+EK PE +
Sbjct: 124 LLKNLSH-PNIVRYLG---TVRESDSL--NILMEFVPGGSISSLLEKFGS--FPEPVIIM 175
Query: 117 FTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDP 176
+T+ +L G+ ++H++G +H D+K NIL+ K ++AD G +K+
Sbjct: 176 YTKQLLLGLEYLHNNGIMHRDIKGANILV----DNKGCIRLADFGASKKVVELATVNGAK 231
Query: 177 SMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSI--IG 234
SM+GTP ++APE ++Q +DIW++GC V+EM +G+ W + Q ++ IG
Sbjct: 232 SMKGTPYWMAPEVILQTGHSFSADIWSVGCTVIEMATGKPPWSEQ----YQQFAAVLHIG 287
Query: 235 DEHSLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGVDEE 283
+ P IP +S EA+DFL +C ++P+ R +A LL PFV G +E
Sbjct: 288 RTKAHPPIPEDLSPEAKDFLMKCLHKEPSLRLSATELLQHPFVTGKRQE 336
|
Involved in cortical microtubules organization and stabilization by regulating the phosphorylation state of microtubule-associated proteins such as MAP65-1. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 5 |
| >sp|P28829|BYR2_SCHPO Protein kinase byr2 OS=Schizosaccharomyces pombe (strain 972 / ATCC 24843) GN=byr2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 142 bits (357), Expect = 5e-33, Method: Compositional matrix adjust.
Identities = 100/285 (35%), Positives = 144/285 (50%), Gaps = 23/285 (8%)
Query: 2 DSDGTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEV-SASASLQKEKEVFDN 60
D W RG +IG GSFG V++ S+ LMAVK + S S S + ++ D
Sbjct: 388 DDQSIKWIRGALIGSGSFGQVYLGMNASSGE----LMAVKQVILDSVSESKDRHAKLLDA 443
Query: 61 LNGCPFVLECFGEEIT---MGENGEMAY-NLLLEYAAGGTLGDLIEKCNGNGLPEKDVRH 116
L G +L+ E +G N + N+ LEY GG++ L+ E V++
Sbjct: 444 LAGEIALLQELSHEHIVQYLGSNLNSDHLNIFLEYVPGGSVAGLLTMYGS--FEETLVKN 501
Query: 117 FTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKR----SRHCKRQ 172
F + L+G+ ++H G VH D+K NIL+ GK KI+D G++K+ S K
Sbjct: 502 FIKQTLKGLEYLHSRGIVHRDIKGANILV--DNKGKI--KISDFGISKKLELNSTSTKTG 557
Query: 173 KFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSI 232
PS +G+ ++APE V Q M +DIW+LGC+V+EML+ + + +C Q
Sbjct: 558 GARPSFQGSSFWMAPEVVKQTMHTEKTDIWSLGCLVIEMLTSKHPY---PNCDQMQAIFR 614
Query: 233 IGDEHSLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFV 277
IG E+ LPE PS +S A DFL + F R TA LL PFV
Sbjct: 615 IG-ENILPEFPSNISSSAIDFLEKTFAIDCNLRPTASELLSHPFV 658
|
Serine/threonine protein kinase involved in conjugation and sporulation. It is thought that it phosphorylates the byr1 protein kinase which itself phosphorylate the spk1 kinase. Schizosaccharomyces pombe (strain 972 / ATCC 24843) (taxid: 284812) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 5 |
| >sp|Q01389|BCK1_YEAST Serine/threonine-protein kinase BCK1/SLK1/SSP31 OS=Saccharomyces cerevisiae (strain ATCC 204508 / S288c) GN=BCK1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 140 bits (352), Expect = 2e-32, Method: Composition-based stats.
Identities = 99/286 (34%), Positives = 147/286 (51%), Gaps = 36/286 (12%)
Query: 7 SWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEV-----------SASASLQKEK 55
+W +G +IG+GSFG V++ + +MAVK EV S +L+ E
Sbjct: 1174 AWMKGEMIGKGSFGAVYLCLNVTTGE----MMAVKQVEVPKYSSQNEAILSTVEALRSEV 1229
Query: 56 EVFDNLNGCPFVLECFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVR 115
+L+ V + EN Y+L LEY AGG++G LI + G E ++
Sbjct: 1230 STLKDLDHLNIV------QYLGFENKNNIYSLFLEYVAGGSVGSLI-RMYGR-FDEPLIK 1281
Query: 116 HFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFD 175
H T +L+G+ ++H G +H D+K DN+LL Q G + KI+D G++++S+ D
Sbjct: 1282 HLTTQVLKGLAYLHSKGILHRDMKADNLLL--DQDG--ICKISDFGISRKSKDIYSNS-D 1336
Query: 176 PSMRGTPLYLAPETV-VQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIG 234
+MRGT ++APE V + A DIW+LGC+VLEM +G++ W E + +F IG
Sbjct: 1337 MTMRGTVFWMAPEMVDTKQGYSAKVDIWSLGCIVLEMFAGKRPWSNLE--VVAAMFK-IG 1393
Query: 235 DEHSLPEIPSR----VSKEARDFLRRCFVRKPAFRFTAEMLLDDPF 276
S P IP +S+ R+FL CF P R TA LL PF
Sbjct: 1394 KSKSAPPIPEDTLPLISQIGRNFLDACFEINPEKRPTANELLSHPF 1439
|
Serine/threonine protein kinase involved in a signal transduction pathway that play a role in yeast cell morphogenesis and cell growth. This pathway seems to starts by SMP3; then involve the kinase PKC1 that may act on this kinase. BCK1 probably phosphorylates MKK1 and MKK2 which themselves phosphorylate the MPK1 kinase. Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (taxid: 559292) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q54R82|MKKA_DICDI Mitogen-activated protein kinase kinase kinase A OS=Dictyostelium discoideum GN=mkkA PE=1 SV=2 | Back alignment and function description |
|---|
Score = 134 bits (338), Expect = 7e-31, Method: Compositional matrix adjust.
Identities = 90/291 (30%), Positives = 147/291 (50%), Gaps = 38/291 (13%)
Query: 8 WFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEV----------SASASLQKEKEV 57
W +G+++G+G +G V++ K L AVK E+ + S KE EV
Sbjct: 170 WQKGQILGRGGYGSVYLGLNKDTGE----LFAVKQLEIVDINSDPKLKNMILSFSKEIEV 225
Query: 58 FDNLNGCPFVLECFGEEITMGENGEMAY-NLLLEYAAGGTLGDLIEKCNGNGLPEKDVRH 116
+L V +G + + ++ ++ LEY GG++ L+ K E ++
Sbjct: 226 MRSLRHDNIVR-------YLGTSLDQSFLSVFLEYIPGGSISSLLGKFGA--FSENVIKV 276
Query: 117 FTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDP 176
+T+ IL+G+ +H + +H D+K NIL+ K + K++D G +K Q
Sbjct: 277 YTKQILQGLSFLHANSIIHRDIKGANILI----DTKGIVKLSDFGCSKSFSGIVSQF--K 330
Query: 177 SMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSI---I 233
SM+GTP ++APE + Q SDIW+LGCV++EM + + W +I +L ++ I
Sbjct: 331 SMQGTPYWMAPEVIKQTGHGRSSDIWSLGCVIVEMATAQPPW-----SNITELAAVMYHI 385
Query: 234 GDEHSLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGVDEEL 284
+S+P IPS +S+EA DFL CF R P R A LL PF+ +D+ +
Sbjct: 386 ASSNSIPNIPSHMSQEAFDFLNLCFKRDPKERPDANQLLKHPFIMNLDDNI 436
|
Regulates cell-type differentiation and spatial patterning, required for the proper induction and maintenance of prespore cell differentiation. Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 5 |
| >sp|P25390|SSK22_YEAST Serine/threonine-protein kinase SSK22 OS=Saccharomyces cerevisiae (strain ATCC 204508 / S288c) GN=SSK22 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 133 bits (335), Expect = 2e-30, Method: Compositional matrix adjust.
Identities = 98/303 (32%), Positives = 155/303 (51%), Gaps = 49/303 (16%)
Query: 8 WFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVSASASLQK-------EKEVFDN 60
W + IG G+FG V+ A N L AVK ++ + +++K E V +
Sbjct: 1034 WQKRSFIGGGTFGQVYSAINLENGEIL----AVKEIKIHDTTTMKKIFPLIKEEMTVLEM 1089
Query: 61 LNGCPFVLECFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRC 120
LN P +++ +G E+ + N+ +EY GG+L L++ +G E + +T
Sbjct: 1090 LNH-PNIVQYYGVEVHRDK-----VNIFMEYCEGGSLASLLD--HGRIEDEMVTQVYTFE 1141
Query: 121 ILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAK-----RSRHCKR---Q 172
+LEG+ ++H SG VH D+KP+NILL K+V D G A+ R+R + Q
Sbjct: 1142 LLEGLAYLHQSGVVHRDIKPENILLDFNGIIKYV----DFGTARTVVGSRTRTVRNAAVQ 1197
Query: 173 KFD------PSMRGTPLYLAPETV---VQHMQEAPSDIWALGCVVLEMLSGRQAWVVKED 223
F M GTP+Y+APET+ + D+WALGCVVLEM +GR+ W
Sbjct: 1198 DFGVETKSLNEMMGTPMYMAPETISGSAVKGKLGADDVWALGCVVLEMATGRRPW----- 1252
Query: 224 CSIDQLFSIIGDEHS--LPEIPSR--VSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKG 279
++D ++I+ + +P++P+R ++ R FL RC V+ P R TA LL DP++
Sbjct: 1253 SNLDNEWAIMYHVAAGRIPQLPNRDEMTAAGRAFLERCLVQDPTMRATAVELLIDPWMIQ 1312
Query: 280 VDE 282
+ E
Sbjct: 1313 IRE 1315
|
Kinase involved in a signal transduction pathway that is activated by changes in the osmolarity of the extracellular environment. Activates the PBS2 MAP kinase kinase by phosphorylation. Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (taxid: 559292) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|E9Q3S4|M3K19_MOUSE Mitogen-activated protein kinase kinase kinase 19 OS=Mus musculus GN=Map3k19 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 124 bits (312), Expect = 8e-28, Method: Compositional matrix adjust.
Identities = 89/293 (30%), Positives = 143/293 (48%), Gaps = 50/293 (17%)
Query: 8 WFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVSASASLQKEKE----------- 56
W +G ++G+G++G V+ + L L+AVK + S L EKE
Sbjct: 1044 WTKGEILGRGAYGTVYCGL-----TSLGQLIAVKQVALDTSDKLATEKEYRKLQEEVDLL 1098
Query: 57 -VFDNLNGCPFVLECFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVR 115
++N ++ C EE T+ ++ +E+ GG++ +I + LPE
Sbjct: 1099 KALKHVNIVAYLGTCL-EENTL--------SIFMEFVPGGSISSIINRFGP--LPEMVFC 1147
Query: 116 HFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKR-------SRH 168
+TR IL+G+ ++HD+ VH D+K +N++L+ T + K+ D G AKR H
Sbjct: 1148 KYTRQILQGVAYLHDNCVVHRDIKGNNVMLMPTG----IIKLIDFGCAKRLAWAGLNGTH 1203
Query: 169 CKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQ 228
K SMRGTP ++APE + + SDIW++GC V EM +G+ S+D+
Sbjct: 1204 SDMLK---SMRGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLA-----SMDR 1255
Query: 229 ---LFSIIGDEHSLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVK 278
+F I +P +P+R S+ A DF+R C R R +A LL F+K
Sbjct: 1256 MAAMFYIGAHRGLMPPLPARFSEPAADFVRLCLTRDQHERPSALQLLKHSFLK 1308
|
Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q39008|M3K1_ARATH Mitogen-activated protein kinase kinase kinase 1 OS=Arabidopsis thaliana GN=MEKK1 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 124 bits (310), Expect = 1e-27, Method: Compositional matrix adjust.
Identities = 93/281 (33%), Positives = 146/281 (51%), Gaps = 31/281 (11%)
Query: 6 TSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVSASASLQKEKEVFDNLNGCP 65
TSW +G+++G+GSFG V+ F AVK EVS + +E L G
Sbjct: 331 TSWQKGQLLGRGSFGSVYEGISGDGDFF-----AVK--EVSLLDQGSQAQECIQQLEGEI 383
Query: 66 FVLECFGEEITM-----GENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRC 120
+L + + ++G Y + LE G+L L ++ L + V +TR
Sbjct: 384 KLLSQLQHQNIVRYRGTAKDGSNLY-IFLELVTQGSLLKLYQRYQ---LRDSVVSLYTRQ 439
Query: 121 ILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMRG 180
IL+G+ ++HD G++H D+K NIL+ A + K+AD G+AK S+ + S +G
Sbjct: 440 ILDGLKYLHDKGFIHRDIKCANILVDANGA----VKLADFGLAKVSKFNDIK----SCKG 491
Query: 181 TPLYLAPETVVQHMQE---APSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEH 237
TP ++APE + + + +P+DIW+LGC VLEM +G+ + E + LF I
Sbjct: 492 TPFWMAPEVINRKDSDGYGSPADIWSLGCTVLEMCTGQIPYSDLE--PVQALFRI--GRG 547
Query: 238 SLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVK 278
+LPE+P +S +AR F+ +C P R TA LL+ PFV+
Sbjct: 548 TLPEVPDTLSLDARLFILKCLKVNPEERPTAAELLNHPFVR 588
|
Involved in the innate immune MAP kinase signaling cascade (MEKK1, MKK4/MKK5 and MPK3/MPK6) downstream of bacterial flagellin receptor FLS2. May be involved in the cold and salinity stress-mediated MAP kinase signaling cascade (MEKK1, MEK1/MKK2 and MPK4/MPK6). Activates downstream MKK2, MKK4 and MKK5. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 2 EC: 5 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 362 | ||||||
| 224115824 | 282 | predicted protein [Populus trichocarpa] | 0.756 | 0.971 | 0.639 | 1e-100 | |
| 224072745 | 278 | predicted protein [Populus trichocarpa] | 0.751 | 0.978 | 0.611 | 4e-96 | |
| 255543367 | 369 | Mitogen-activated protein kinase kinase | 0.828 | 0.813 | 0.540 | 5e-93 | |
| 255543573 | 320 | ATP binding protein, putative [Ricinus c | 0.773 | 0.875 | 0.562 | 5e-87 | |
| 449436643 | 335 | PREDICTED: serine/threonine-protein kina | 0.756 | 0.817 | 0.515 | 8e-76 | |
| 449491205 | 335 | PREDICTED: serine/threonine-protein kina | 0.756 | 0.817 | 0.512 | 2e-75 | |
| 449436645 | 336 | PREDICTED: serine/threonine-protein kina | 0.762 | 0.821 | 0.501 | 2e-74 | |
| 449491207 | 336 | PREDICTED: protein kinase byr2-like [Cuc | 0.762 | 0.821 | 0.494 | 3e-73 | |
| 255543917 | 343 | ATP binding protein, putative [Ricinus c | 0.765 | 0.807 | 0.474 | 6e-72 | |
| 356504533 | 348 | PREDICTED: mitogen-activated protein kin | 0.726 | 0.755 | 0.487 | 3e-63 |
| >gi|224115824|ref|XP_002332066.1| predicted protein [Populus trichocarpa] gi|222831952|gb|EEE70429.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 372 bits (956), Expect = e-100, Method: Compositional matrix adjust.
Identities = 179/280 (63%), Positives = 224/280 (80%), Gaps = 6/280 (2%)
Query: 8 WFRGRVIGQGSFGCVFIAK---PKSNSSFLPPLMAVKSAEVSASASLQKEKEVFDNLNGC 64
W RG ++G+G FG V++A PKS + + PP+MAVKSAEVSAS SLQKEKEVF+ LNGC
Sbjct: 1 WSRGPLLGKGGFGSVYLASLKSPKSRNGYYPPVMAVKSAEVSASCSLQKEKEVFNCLNGC 60
Query: 65 PFVLECFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEG 124
PF+++CFGEE T GEM YN+LLEYA+GGTL LI+K +G GLPE DV+ +TR ILEG
Sbjct: 61 PFIIKCFGEETTRDGGGEMFYNVLLEYASGGTLAGLIKKSDGVGLPELDVKRYTRSILEG 120
Query: 125 IGHIHDSGYVHCDVKPDNILLV--ATQSGKFVAKIADLGVAKRS-RHCKRQKFDPSMRGT 181
I +IH GYVHCD+KP+NILLV +T++G+FVAKI D G+AK+S + K++K DP +RGT
Sbjct: 121 IHYIHSHGYVHCDLKPENILLVSSSTKAGEFVAKIGDFGLAKKSEKRNKKRKIDPYLRGT 180
Query: 182 PLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEHSLPE 241
LY+APETV H+QE P DIWALGCVVLEML+G+QAW VK D +I++L IGD + LP+
Sbjct: 181 TLYMAPETVANHVQEPPCDIWALGCVVLEMLTGKQAWDVKPDVTIEELKRKIGDGYELPK 240
Query: 242 IPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGVD 281
+PS VSK+A+DFL+RCFV P FRFTAEMLLD+PFV GVD
Sbjct: 241 MPSEVSKDAKDFLKRCFVANPMFRFTAEMLLDEPFVSGVD 280
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224072745|ref|XP_002303860.1| predicted protein [Populus trichocarpa] gi|222841292|gb|EEE78839.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 357 bits (917), Expect = 4e-96, Method: Compositional matrix adjust.
Identities = 170/278 (61%), Positives = 219/278 (78%), Gaps = 6/278 (2%)
Query: 6 TSWFRGRVIGQGSFGCVFIA---KPKSNSSFLPPLMAVKSAEVSASASLQKEKEVFDNLN 62
+W RG +IG+G FG V++A PKS + + PP+MAVKSAEVSAS SLQKEKEVF+ LN
Sbjct: 1 VAWSRGPLIGKGGFGSVYLASLKNPKSRNGYYPPVMAVKSAEVSASCSLQKEKEVFNCLN 60
Query: 63 GCPFVLECFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCIL 122
GCPF+++CFGEE T ++GEM YN+LLEYA+GG L LI+K +G GLPE DV+ +TR IL
Sbjct: 61 GCPFIIKCFGEETTSNKDGEMFYNVLLEYASGGNLACLIKKSDGVGLPELDVKRYTRSIL 120
Query: 123 EGIGHIHDSGYVHCDVKPDNILLVAT--QSGKFVAKIADLGVAKRS-RHCKRQKFDPSMR 179
EGI +IH GYVHCD+KP+NILLV+ ++G+FVAKI D G+AK+S + K+ K DP +R
Sbjct: 121 EGICYIHSRGYVHCDLKPENILLVSNRAKAGEFVAKIGDFGLAKKSEKRNKKMKIDPYLR 180
Query: 180 GTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEHSL 239
GT LY+APETV H+QE P DIWALGCVVLEML+G+ AW +K + ++L IGD + L
Sbjct: 181 GTALYMAPETVANHVQEPPCDIWALGCVVLEMLTGKPAWDLKPHVTTEELLRKIGDGYEL 240
Query: 240 PEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFV 277
P+IPS++SK+A+DFL+RCFV P FRFTAEMLLD+PF+
Sbjct: 241 PKIPSQISKDAKDFLKRCFVANPMFRFTAEMLLDEPFM 278
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255543367|ref|XP_002512746.1| Mitogen-activated protein kinase kinase kinase, putative [Ricinus communis] gi|223547757|gb|EEF49249.1| Mitogen-activated protein kinase kinase kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 347 bits (890), Expect = 5e-93, Method: Compositional matrix adjust.
Identities = 166/307 (54%), Positives = 227/307 (73%), Gaps = 7/307 (2%)
Query: 4 DGTSWFRGRVIGQGSFGCVFIAKPKSN---SSFLPPLMAVKSAEVSASASLQKEKEVFDN 60
DG SW+RG+++G+G F V++AK K N + PPLMAVKSAE S S SLQ EKEVF+N
Sbjct: 13 DGVSWWRGKLLGEGGFASVYLAKLKKNYCRNKVYPPLMAVKSAEFSESNSLQNEKEVFNN 72
Query: 61 LNGCPFVLECFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRC 120
L CP++L+C+GEE T +NG ++YN+LLEYA+GGTL LI++ G GLPE DV+ +TRC
Sbjct: 73 LCTCPYILKCYGEETTFDKNGYLSYNVLLEYASGGTLAALIKQSGGCGLPESDVKRYTRC 132
Query: 121 ILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRS-RHCKRQKF-DPSM 178
IL+GI +IH YVHCD+KP+N+LLVA ++ FV KIAD G+AK+ ++ KR+K D +
Sbjct: 133 ILQGIDYIHRHSYVHCDLKPENVLLVAIENDGFVPKIADFGLAKKVLKNNKRRKMTDSFI 192
Query: 179 RGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEHS 238
GT LY+APET++ H+QE+P DIWALGC+V EML+G++ W K + + ++L IGD
Sbjct: 193 GGTVLYMAPETLIDHIQESPCDIWALGCIVFEMLTGKRVWDSKPEAATEELIKRIGDRFE 252
Query: 239 LPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGVDEELSRELEGDYSQGEVT 298
LP IPS +S++ +DFL+RC V+KPAFRFT+EMLLD PF+ G+D+ S + + +G V
Sbjct: 253 LPVIPSEISQDGKDFLKRCLVKKPAFRFTSEMLLDHPFMSGLDDSKSSDFKDISDEGCV- 311
Query: 299 LSNADAE 305
SNAD E
Sbjct: 312 -SNADNE 317
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255543573|ref|XP_002512849.1| ATP binding protein, putative [Ricinus communis] gi|223547860|gb|EEF49352.1| ATP binding protein, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 327 bits (838), Expect = 5e-87, Method: Compositional matrix adjust.
Identities = 161/286 (56%), Positives = 214/286 (74%), Gaps = 6/286 (2%)
Query: 1 MDSDGTSWFRGRVIGQGSFGCVFIA---KPKSNSSFLPPLMAVKSAEVSASASLQKEKEV 57
M + G SW+RG +IG+G FG V++A +PKS + P +MAVKSAEVS SASLQKEKEV
Sbjct: 7 MHNHGVSWWRGPLIGKGGFGSVYLANLKEPKSRNRIYPSVMAVKSAEVSESASLQKEKEV 66
Query: 58 FDNLNGCPFVLECFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHF 117
FDNL CP++L+C+GEE T + G M Y++LLEYA+GGTL LI++ G GLPE DV+ +
Sbjct: 67 FDNLYDCPYILQCYGEETTTNKAGVMFYDVLLEYASGGTLASLIKQSGGCGLPELDVKRY 126
Query: 118 TRCILEGIGHIHDSGYVHCDVKPDNILLVAT--QSGKFVAKIADLGVAKRSRHCKRQKFD 175
TR IL+GI IH +GYVHCD+KPDNILLV+ GKFV KI D G+AK+ K++K
Sbjct: 127 TRSILQGINCIHSNGYVHCDLKPDNILLVSIGGSDGKFVPKIGDFGLAKKVVKSKKRKLG 186
Query: 176 PS-MRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIG 234
S + GT LY+APETV+ H+QEAPSDIWALGC+V EM +G++ W K D + ++L IG
Sbjct: 187 GSYIGGTTLYMAPETVIDHIQEAPSDIWALGCIVFEMFTGKKVWDSKPDMTTNELLEKIG 246
Query: 235 DEHSLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGV 280
+ + P++PS++SK+ +DFL+RC V+K AFRFTAEMLL+ PF+ G+
Sbjct: 247 ECYEPPKMPSQISKDGKDFLKRCLVKKSAFRFTAEMLLNHPFLSGL 292
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449436643|ref|XP_004136102.1| PREDICTED: serine/threonine-protein kinase BCK1/SLK1/SSP31-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 290 bits (742), Expect = 8e-76, Method: Compositional matrix adjust.
Identities = 150/291 (51%), Positives = 198/291 (68%), Gaps = 17/291 (5%)
Query: 3 SDGTSWFRGRVIGQGSFGCVFIAKPK---SNSSFLPPLMAVKSAEVSASASLQKEKEVFD 59
++G W +GR+IG+GSFG VF+A K + S PP+MAVKSAE+S S +LQKEK+ +D
Sbjct: 22 NNGIQWKQGRLIGKGSFGSVFLASLKPHFTKYSIFPPVMAVKSAEISVSETLQKEKQNYD 81
Query: 60 NLNGCPFVLECFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTR 119
NL GC +++CFGEEIT NG M YNLLLE A GGTL I+ G GL E VR++T+
Sbjct: 82 NLKGCNSLIQCFGEEITTDHNGHMIYNLLLEVATGGTLAHHIKNTGGKGLEENVVRNYTK 141
Query: 120 CILEGIGHIHDSGYVHCDVKPDNILLV----ATQSGKFVAKIADLGVAKRSRHCKRQKFD 175
I++G+ HIH S YVHCD+KP NILL+ T+ +F+AKIADLG+A+R+ + K
Sbjct: 142 SIIKGLIHIHRSQYVHCDLKPANILLLPKNNTTKDRQFIAKIADLGLARRT---SKTKAS 198
Query: 176 PSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSI--DQLFSII 233
+ GT Y+APET++ +QE+ SDIWALGCVVLEML+G +AW + I + + I
Sbjct: 199 YCLGGTFSYMAPETLIDGVQESASDIWALGCVVLEMLTGNRAWAATDKVGIVKEMTENFI 258
Query: 234 GDEHSLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFV-KGVDEE 283
G +P+IP +S EA FL+ C VRKP FRFTAEML++ PFV G D E
Sbjct: 259 G----MPKIPEGLSPEATGFLKNCLVRKPEFRFTAEMLMNVPFVAAGEDHE 305
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449491205|ref|XP_004158828.1| PREDICTED: serine/threonine-protein kinase BCK1/SLK1/SSP31-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 289 bits (739), Expect = 2e-75, Method: Compositional matrix adjust.
Identities = 149/291 (51%), Positives = 198/291 (68%), Gaps = 17/291 (5%)
Query: 3 SDGTSWFRGRVIGQGSFGCVFIAKPK---SNSSFLPPLMAVKSAEVSASASLQKEKEVFD 59
++G W +GR+IG+GSFG VF+A K + S PP+MAVKSAE+S S +LQKEK+ +D
Sbjct: 22 NNGIQWKQGRLIGKGSFGSVFLASLKPHFTKYSIFPPVMAVKSAEISVSETLQKEKQNYD 81
Query: 60 NLNGCPFVLECFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTR 119
NL GC +++CFGEEIT NG M YNLLLE A GGTL I+ G GL E VR++T+
Sbjct: 82 NLKGCNSLIQCFGEEITTDHNGHMIYNLLLEVATGGTLAHHIKNTGGKGLEENVVRNYTK 141
Query: 120 CILEGIGHIHDSGYVHCDVKPDNILLV----ATQSGKFVAKIADLGVAKRSRHCKRQKFD 175
I++G+ H+H S YVHCD+KP NILL+ T+ +F+AKIADLG+A+R+ + K
Sbjct: 142 SIIKGLIHMHRSQYVHCDLKPANILLLPKNNTTKDRQFIAKIADLGLARRT---SKTKAS 198
Query: 176 PSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSI--DQLFSII 233
+ GT Y+APET++ +QE+ SDIWALGCVVLEML+G +AW + I + + I
Sbjct: 199 YCLGGTFSYMAPETLIDGVQESASDIWALGCVVLEMLTGNRAWAATDKVGIVKEMTENFI 258
Query: 234 GDEHSLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFV-KGVDEE 283
G +P+IP +S EA FL+ C VRKP FRFTAEML++ PFV G D E
Sbjct: 259 G----MPKIPEGLSPEATGFLKNCLVRKPEFRFTAEMLMNVPFVAAGEDHE 305
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449436645|ref|XP_004136103.1| PREDICTED: serine/threonine-protein kinase BCK1/SLK1/SSP31-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 285 bits (730), Expect = 2e-74, Method: Compositional matrix adjust.
Identities = 145/289 (50%), Positives = 195/289 (67%), Gaps = 13/289 (4%)
Query: 3 SDGTSWFRGRVIGQGSFGCVFIAKPKSNSSF----LPPLMAVKSAEVSASASLQKEKEVF 58
++G W RGR+IG+GSFG VF+A K + + P +MAVKSAE+S S +LQKEK+ +
Sbjct: 22 NNGVQWKRGRLIGKGSFGSVFLASLKPHITIKYCTFPSVMAVKSAEISVSETLQKEKQNY 81
Query: 59 DNLNGCPFVLECFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFT 118
D+L GC +++CFGEEIT NG M YNLLLE A GGTL I+ G GL E VR++T
Sbjct: 82 DSLKGCNSLIKCFGEEITTDHNGHMIYNLLLEVATGGTLAHHIKNTGGKGLEENVVRNYT 141
Query: 119 RCILEGIGHIHDSGYVHCDVKPDNILLV----ATQSGKFVAKIADLGVAKRSRHCKRQKF 174
+ I++G+ HIH S YVHCD+KP NILL+ T+ +F+AKIADLG+A+R+ + K
Sbjct: 142 KSIIKGLIHIHRSQYVHCDLKPANILLLPKNNTTKDRQFIAKIADLGLARRT---SKTKA 198
Query: 175 DPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIG 234
+ GT Y+APET + +QE+ SDIWALGCVVLEML+G +AW I + +
Sbjct: 199 SYCLGGTFSYMAPETFIDGVQESASDIWALGCVVLEMLTGNRAWAATNKVGI--MKEMTE 256
Query: 235 DEHSLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGVDEE 283
+ +P+IP +S EA FL+ CFVRKP FRFTAEML+ PFV V+++
Sbjct: 257 NFLGMPKIPEGLSAEATMFLKNCFVRKPEFRFTAEMLMIVPFVAAVEDQ 305
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449491207|ref|XP_004158829.1| PREDICTED: protein kinase byr2-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 281 bits (720), Expect = 3e-73, Method: Compositional matrix adjust.
Identities = 143/289 (49%), Positives = 195/289 (67%), Gaps = 13/289 (4%)
Query: 3 SDGTSWFRGRVIGQGSFGCVFIAKPKSNSSF----LPPLMAVKSAEVSASASLQKEKEVF 58
++G W RGR+IG+GSFG VF+A K + + P +MAVKSAE+S S +LQKEK+ +
Sbjct: 22 NNGVQWKRGRLIGKGSFGSVFLASLKPHITIKYCTFPSVMAVKSAEISVSETLQKEKQNY 81
Query: 59 DNLNGCPFVLECFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFT 118
D+L GC +++CFGEEIT +G M YN LLE A GGTL I+ G GL E VR++T
Sbjct: 82 DSLKGCNSLIKCFGEEITTDHSGHMIYNSLLEVATGGTLAHHIKNTGGKGLEENVVRNYT 141
Query: 119 RCILEGIGHIHDSGYVHCDVKPDNILLV----ATQSGKFVAKIADLGVAKRSRHCKRQKF 174
+ I++G+ HIH S YVHCD+KP NILL+ T+ +F+AKIADLG+A+R+ + K
Sbjct: 142 KSIIKGLIHIHRSQYVHCDLKPANILLLPKNNTTKDRQFIAKIADLGLARRT---SKTKA 198
Query: 175 DPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIG 234
+ GT Y+APET + +QE+ SDIWALGCVVLEML+G +AW + I + +
Sbjct: 199 SYCLGGTFSYMAPETFIDGVQESASDIWALGCVVLEMLTGNRAWAATDKVGI--MKEMTE 256
Query: 235 DEHSLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGVDEE 283
+ +P+IP +S EA FL+ CFVRKP FRFTAEML+ PFV V+++
Sbjct: 257 NFLGMPKIPEGLSAEATKFLKNCFVRKPEFRFTAEMLMIVPFVAAVEDQ 305
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255543917|ref|XP_002513021.1| ATP binding protein, putative [Ricinus communis] gi|223548032|gb|EEF49524.1| ATP binding protein, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 277 bits (708), Expect = 6e-72, Method: Compositional matrix adjust.
Identities = 141/297 (47%), Positives = 202/297 (68%), Gaps = 20/297 (6%)
Query: 3 SDGTSWFRGRVIGQGSFGCVFIAK---PKSNSSFLPPLMAVKSAEVSASASLQKEKEVFD 59
++G +W R ++G+G FG V++AK P+S S PP+MAVKSAE+S S+SLQ+EKEVF+
Sbjct: 16 NNGRTWKREHLLGKGGFGSVYLAKLKRPESKSQIYPPVMAVKSAELSESSSLQQEKEVFN 75
Query: 60 NLNGCPFVLECFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTR 119
N+ GCPF+L+C+GEE T + G +LIE+ + GLPE DVR +TR
Sbjct: 76 NIYGCPFILQCYGEETT---------------STGIVRANLIERSDARGLPESDVRRYTR 120
Query: 120 CILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMR 179
CILEGI +IH GYVHCD+KP+N+LLV+T++G FV KIAD G+AK+ ++ D +
Sbjct: 121 CILEGIRYIHSRGYVHCDLKPENVLLVSTENGDFVPKIADFGLAKKVVKKRKVA-DSTAG 179
Query: 180 GTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEHSL 239
GT +Y+APETVV ++Q+ P DIWALGC+V EM +G W D + D+L IGD H L
Sbjct: 180 GTTMYMAPETVVDNVQDFPCDIWALGCIVFEMFTGSPLW-YDSDTTSDELIKSIGDRHQL 238
Query: 240 PEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGVDEELSRELEGDYSQGE 296
PEIP + ++ R FL++C V+ P FR TA+MLL++PFV G+ ++ ++ + +G+
Sbjct: 239 PEIPYDIPEDGRAFLKKCLVKNPMFRLTADMLLNEPFVSGLRDDKCSDIAENSVEGQ 295
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356504533|ref|XP_003521050.1| PREDICTED: mitogen-activated protein kinase kinase kinase 2-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 248 bits (633), Expect = 3e-63, Method: Compositional matrix adjust.
Identities = 133/273 (48%), Positives = 181/273 (66%), Gaps = 10/273 (3%)
Query: 7 SWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVSASASLQKEKEVFDNLNGCPF 66
+W RG +G GSF V IA P + S+ AVKS+ V S+ L+ EKE+ D L P+
Sbjct: 2 NWVRGESLGSGSFATVNIAIPTNTSTQFLSSTAVKSSHVQTSSMLKNEKEILDRLGASPY 61
Query: 67 VLECFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIG 126
V+ CFG++ T+ ENGE YN+ LEYAAGG+L D ++K +G LPE VR TR ++EG+
Sbjct: 62 VINCFGDDHTV-ENGEEYYNIFLEYAAGGSLADQVKK-HGGRLPESYVRRCTRSLVEGLK 119
Query: 127 HIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMRGTPLYLA 186
HIHD+GYVHCDVK NIL+ Q+G KIAD G+AK K K + RGTPL+++
Sbjct: 120 HIHDNGYVHCDVKLQNILVF--QNGD--VKIADFGLAKEKGE-KPGKLE--CRGTPLFMS 172
Query: 187 PETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEHSLPEIPSRV 246
PE+V + E+P+DIWALGC V+EM++G+ AW V+ +I L IG LP+IP +
Sbjct: 173 PESVNDNEYESPADIWALGCAVVEMVTGKPAWDVR-GSNIWSLLIRIGAGEELPKIPEEL 231
Query: 247 SKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKG 279
S+E +DFL +CFV+ P R++AEMLL+ PFV G
Sbjct: 232 SEEGKDFLLKCFVKDPMKRWSAEMLLNHPFVNG 264
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 362 | ||||||
| TAIR|locus:2155568 | 344 | MAPKKK19 "mitogen-activated pr | 0.812 | 0.854 | 0.429 | 8.4e-58 | |
| TAIR|locus:2074835 | 342 | MAPKKK20 "mitogen-activated pr | 0.806 | 0.853 | 0.424 | 7.5e-57 | |
| TAIR|locus:2114990 | 336 | MAPKKK21 "mitogen-activated pr | 0.745 | 0.803 | 0.447 | 9.6e-57 | |
| TAIR|locus:2085677 | 379 | AT3G45670 [Arabidopsis thalian | 0.756 | 0.722 | 0.369 | 5.6e-45 | |
| TAIR|locus:2161690 | 448 | MAPKKK15 "mitogen-activated pr | 0.704 | 0.569 | 0.371 | 1.9e-42 | |
| TAIR|locus:2075246 | 376 | AT3G46140 [Arabidopsis thalian | 0.740 | 0.712 | 0.365 | 3.2e-42 | |
| TAIR|locus:2102684 | 376 | AT3G45790 [Arabidopsis thalian | 0.698 | 0.672 | 0.370 | 4.6e-41 | |
| TAIR|locus:2060246 | 372 | MAPKKK17 "mitogen-activated pr | 0.704 | 0.685 | 0.367 | 6.8e-40 | |
| TAIR|locus:2007337 | 499 | MAPKKK13 "mitogen-activated pr | 0.720 | 0.523 | 0.353 | 4.8e-39 | |
| TAIR|locus:2064590 | 351 | AT2G41930 [Arabidopsis thalian | 0.762 | 0.786 | 0.343 | 7e-38 |
| TAIR|locus:2155568 MAPKKK19 "mitogen-activated protein kinase kinase kinase 19" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 594 (214.2 bits), Expect = 8.4e-58, P = 8.4e-58
Identities = 132/307 (42%), Positives = 176/307 (57%)
Query: 8 WFRGRVIGQGSFGCVFIAKPKSNSSF-LPPLMXXXXXXXXXXXXLQKEKEVFDNL-NGCP 65
W RG IG G+F V +A +N S PPLM L EK V DNL + C
Sbjct: 3 WIRGETIGYGTFSTVSLATRSNNDSGEFPPLMAVKSADSYGAASLANEKSVLDNLGDDCN 62
Query: 66 FVLECFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGI 125
++ CFGE+ T+ ENGE +NL LEYA+ G+L ++K G G+PE VR T +L G+
Sbjct: 63 EIVRCFGEDRTV-ENGEEMHNLFLEYASRGSLESYLKKLAGEGVPESTVRRHTGSVLRGL 121
Query: 126 GHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMRGTPLYL 185
HIH +G+ HCD+K NILL G KIAD G+AKR + +RGTPLY+
Sbjct: 122 RHIHANGFAHCDLKLGNILLF----GDGAVKIADFGLAKRIGDLTALNYGVQIRGTPLYM 177
Query: 186 APETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEHSLPEIPSR 245
APE+V + + D+WALGCVV+EM SG+ AW +KE + L IG +P IP
Sbjct: 178 APESVNDNEYGSEGDVWALGCVVVEMFSGKTAWSLKEGSNFMSLLLRIGVGDEVPMIPEE 237
Query: 246 VSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVK-GVDEELSRELEGDYSQGEVTLSNADA 304
+S++ RDFL +CFV+ P R+TAEMLL+ PFV VD ++ + E D+ V + D
Sbjct: 238 LSEQGRDFLSKCFVKDPKKRWTAEMLLNHPFVTVDVDHDVLVK-EEDFV---VNMKTEDV 293
Query: 305 ESCSPEC 311
S SP C
Sbjct: 294 -STSPRC 299
|
|
| TAIR|locus:2074835 MAPKKK20 "mitogen-activated protein kinase kinase kinase 20" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 585 (211.0 bits), Expect = 7.5e-57, P = 7.5e-57
Identities = 130/306 (42%), Positives = 171/306 (55%)
Query: 8 WFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMXXXXXXXXXXXXLQKEKEVFDNLNGCPFV 67
W RG IG G+F V A NS P L+ L EK V D+L CP +
Sbjct: 3 WVRGETIGFGTFSTVSTATKSRNSGDFPALIAVKSTDAYGAASLSNEKSVLDSLGDCPEI 62
Query: 68 LECFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGH 127
+ C+GE+ T+ ENGE +NLLLEYA+ G+L ++K G GLPE VR T +L G+ H
Sbjct: 63 IRCYGEDSTV-ENGEEMHNLLLEYASRGSLASYMKKLGGEGLPESTVRRHTGSVLRGLRH 121
Query: 128 IHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKR-SRHCKRQKFDPSMRGTPLYLA 186
IH G+ HCD+K NILL S KIAD G+A R + +RGTPLY+A
Sbjct: 122 IHAKGFAHCDIKLANILLFNDGS----VKIADFGLAMRVDGDLTALRKSVEIRGTPLYMA 177
Query: 187 PETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEHSLPEIPSRV 246
PE V + + +D+WALGC V+EM SG+ AW VKE L IG LP+IP +
Sbjct: 178 PECVNDNEYGSAADVWALGCAVVEMFSGKTAWSVKEGSHFMSLLIRIGVGDELPKIPEML 237
Query: 247 SKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGVDEELSRELEGDYSQGEVT-LSNADAE 305
S+E +DFL +CFV+ PA R+TAEMLL+ FV +D LE D+ + V + + D
Sbjct: 238 SEEGKDFLSKCFVKDPAKRWTAEMLLNHSFVT-ID------LEDDHRENFVVKVKDEDKV 290
Query: 306 SCSPEC 311
SP+C
Sbjct: 291 LMSPKC 296
|
|
| TAIR|locus:2114990 MAPKKK21 "mitogen-activated protein kinase kinase kinase 21" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 584 (210.6 bits), Expect = 9.6e-57, P = 9.6e-57
Identities = 128/286 (44%), Positives = 176/286 (61%)
Query: 8 WFRGRVIGQGSFGCVFIAKPKSNSS-FLPPLMXXXXXXXXXXXXLQKEKEVFDNLNGCPF 66
W R IG GSF V +A +SS P LM L+ E++V D+L C
Sbjct: 3 WIRRETIGHGSFSTVSLATTSGSSSKAFPSLMAVKSSGVVCSAALRNERDVLDDLGDCSE 62
Query: 67 VLECFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIG 126
++ CFGE T+ ENGE YNL LEYA+GG+L D I K +G LPE +VR FTR I++G+
Sbjct: 63 IVRCFGEGRTV-ENGEEIYNLFLEYASGGSLADRI-KSSGEALPEFEVRRFTRSIVKGLC 120
Query: 127 HIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMRGTPLYLA 186
HIH +G+ HCD+K +N+L+ G KI+D G+AKR + + +RGTPLY+A
Sbjct: 121 HIHGNGFTHCDIKLENVLVF----GDGDVKISDFGLAKR----RSGEVCVEIRGTPLYMA 172
Query: 187 PETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSI---IGDEHSLPEIP 243
PE+V E+P+DIWALGC V+EM SG+ AW + ED ++ + S+ IG +P IP
Sbjct: 173 PESVNHGEFESPADIWALGCSVVEMSSGKTAWCL-EDGVMNNVMSLLVRIGSGDEVPRIP 231
Query: 244 SRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGVDEELSRELE 289
+S+E +DF+ +CFV+ A R+TAEMLLD PF+ VD+E E E
Sbjct: 232 VELSEEGKDFVSKCFVKNAAERWTAEMLLDHPFL-AVDDESGEEDE 276
|
|
| TAIR|locus:2085677 AT3G45670 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 473 (171.6 bits), Expect = 5.6e-45, P = 5.6e-45
Identities = 105/284 (36%), Positives = 153/284 (53%)
Query: 6 TSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMXXXXXXXXXXXXLQKEKEVFDNLNGCP 65
+SW + R++G+G++GCV++A K + L E + +L P
Sbjct: 95 SSWVKSRLLGEGAYGCVYLATSKDD--IYKTERAIKSADVLKAWSLMHEGRILRSLQS-P 151
Query: 66 FVLECFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGI 125
FV+ C+G EI G YNL+LEY +G L D+IE N G+PE DV+ F +L G+
Sbjct: 152 FVIRCYGHEIAREGTGHQ-YNLILEYCSGQCLADMIED-NQGGIPEFDVKQFAIDVLSGL 209
Query: 126 GHIHDSGYVHCDVKPDNILLVAT----QSGKFVAKIADLGVAKRSRHCKRQKFDPSMRGT 181
+IH +HC++KPDN+LL +S F+ KIAD G++ + MRGT
Sbjct: 210 SYIHRRNIIHCEIKPDNLLLSPVDHRFRSNGFLTKIADFGLSMEKGSKEYGNGRGHMRGT 269
Query: 182 PLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEHSLPE 241
Y+APE + + + DI A GC VLEML+G++ W D + D +IG P+
Sbjct: 270 TRYMAPELIGGGLLDFAVDICAFGCSVLEMLTGKRVWGEYGDLAHDDWVDLIGHSDLTPQ 329
Query: 242 IPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGVDEELS 285
I R+S EA+DFL RC V++P R+T L+D PF+ DEE S
Sbjct: 330 ISIRLSAEAQDFLMRCLVKEPGSRWTIGELVDHPFLCS-DEEFS 372
|
|
| TAIR|locus:2161690 MAPKKK15 "mitogen-activated protein kinase kinase kinase 15" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 449 (163.1 bits), Expect = 1.9e-42, P = 1.9e-42
Identities = 103/277 (37%), Positives = 152/277 (54%)
Query: 7 SWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMXXXXXXXXXXXXLQKEKEVFDNLNGCPF 66
+W RG +IG+GS V + S F LQ+E+ + L+ P+
Sbjct: 5 NWIRGPIIGRGSTATVSLGITNSGDFF-----AVKSAEFSSSAFLQREQSILSKLSS-PY 58
Query: 67 VLECFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIG 126
+++ G +T EN ++ YNLL+EY +GG+L DLI K +G LPE +R +TR IL+G+
Sbjct: 59 IVKYIGSNVTK-ENDKLMYNLLMEYVSGGSLHDLI-KNSGGKLPEPLIRSYTRQILKGLM 116
Query: 127 HIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMRGTPLYLA 186
++HD G VHCDVK N+++ G +AKI DLG AK + +F GTP +++
Sbjct: 117 YLHDQGIVHCDVKSQNVMI-----GGEIAKIVDLGCAKTVEENENLEFS----GTPAFMS 167
Query: 187 PETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEHSLPEIPSRV 246
PE Q P+D+WALGC V+EM +G W D + ++ I G P IP +
Sbjct: 168 PEVARGEEQSFPADVWALGCTVIEMATGSSPWPELNDV-VAAIYKI-GFTGESPVIPVWL 225
Query: 247 SKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGVDEE 283
S++ +DFLR+C + P R+T E LL PF+ DEE
Sbjct: 226 SEKGQDFLRKCLRKDPKQRWTVEELLQHPFL---DEE 259
|
|
| TAIR|locus:2075246 AT3G46140 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 447 (162.4 bits), Expect = 3.2e-42, P = 3.2e-42
Identities = 103/282 (36%), Positives = 150/282 (53%)
Query: 6 TSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMXXXXXXXXXXXXLQKEKEVFDNLNGCP 65
+SW + +G+GS+G V++A K + M L E+ + L+ P
Sbjct: 94 SSWIKSEFLGRGSYGSVYLATSKKAKT--KTTMAIKSAEISRASSLMDEERILTRLSS-P 150
Query: 66 FVLECFGEEITMGEN---GEMA-YNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCI 121
F++ C+G EI E GE YNL+LEY +G +L DL+ N GL EKDV+ R I
Sbjct: 151 FIVRCYGHEIAREETLFGGERTNYNLILEYCSGKSLFDLVND-NLGGLSEKDVKLLARDI 209
Query: 122 LEGIGHIHDSGYVHCDVKPDNILLVATQS----GKFVAKIADLGVAKRSRHCKRQKFDPS 177
L G+ IH + +HCD+KP+NI L ++ +VAKI D G+A + +K
Sbjct: 210 LYGLDCIHRANIIHCDIKPENIFLTPVENRIRPSGYVAKIGDFGLALEKGSSEYEKASGH 269
Query: 178 MRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDC-SIDQLFSIIGDE 236
RGT Y++PE + + + D WA GC VLEML+G+Q W D S+D +IG
Sbjct: 270 RRGTTRYMSPELIRHGIVDYAVDTWAFGCTVLEMLTGQQVWGEHSDLGSVDWDI-LIGQS 328
Query: 237 HSLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVK 278
+P IP +S+EA+ FL RC R PA R+ LL+ PF++
Sbjct: 329 CYIPYIPDWLSEEAQHFLSRCLKRDPASRWGIGALLNHPFLQ 370
|
|
| TAIR|locus:2102684 AT3G45790 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 436 (158.5 bits), Expect = 4.6e-41, P = 4.6e-41
Identities = 99/267 (37%), Positives = 143/267 (53%)
Query: 6 TSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMXXXXXXXXXXXXLQKEKEVFDNLNGCP 65
+SW + +G+GS+G V++A K + M L E+ + L+ P
Sbjct: 94 SSWIKSEFLGRGSYGSVYLATSKKAKT--KTTMAIKSAEISRASSLMDEERILTRLSS-P 150
Query: 66 FVLECFGEEITMGEN---GEMA-YNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCI 121
F++ C+G EI E GE YNL+LEY +G +L DL+ N GL EKDV+ R I
Sbjct: 151 FIVRCYGHEIAREETLFGGERTNYNLILEYCSGKSLFDLVNS-NLGGLSEKDVKLLARDI 209
Query: 122 LEGIGHIHDSGYVHCDVKPDNILLVATQS----GKFVAKIADLGVAKRSRHCKRQKFDPS 177
L G+ +IH + +HCD+KP+NILL ++ +VAKI D G+A + +K
Sbjct: 210 LYGLDYIHRANIIHCDIKPENILLAPVENRIRPNGYVAKIGDFGLALEKGSSEYEKASGH 269
Query: 178 MRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDC-SIDQLFSIIGDE 236
RGT Y++PE + + + D WA GC VLEML+G+Q W D S+D +IG
Sbjct: 270 RRGTTRYMSPELIRHGIVDYAVDTWAFGCTVLEMLTGQQVWGEHSDLGSVDWDI-LIGQS 328
Query: 237 HSLPEIPSRVSKEARDFLRRCFVRKPA 263
+P IP +S+EA+ FL RC R PA
Sbjct: 329 CYIPYIPDWLSEEAQHFLSRCLKRDPA 355
|
|
| TAIR|locus:2060246 MAPKKK17 "mitogen-activated protein kinase kinase kinase 17" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 425 (154.7 bits), Expect = 6.8e-40, P = 6.8e-40
Identities = 100/272 (36%), Positives = 149/272 (54%)
Query: 8 WFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMXXXXXXXXXXXXLQKEKEVFDNLNGCPFV 67
W RGR++G+GS V+ A ++ L LQ+E ++ +L+ P+V
Sbjct: 3 WTRGRILGRGSTATVYAAAGHNSDEIL----AVKSSEVHRSEFLQREAKILSSLSS-PYV 57
Query: 68 LECFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGH 127
+ G E NG + YNLL+EYA GTL D K +G + E V +TR IL+G+ +
Sbjct: 58 IGYRGSETKRESNGVVMYNLLMEYAPYGTLTDAAAK-DGGRVDETRVVKYTRDILKGLEY 116
Query: 128 IHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMRGTPLYLAP 187
IH G VHCDVK N+++ ++ G+ AKIAD G AKR F+ + GTP ++AP
Sbjct: 117 IHSKGIVHCDVKGSNVVI--SEKGE--AKIADFGCAKRVDPV----FESPVMGTPAFMAP 168
Query: 188 ETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSI--IGDEHSLPEIPSR 245
E Q SDIWA+GC ++EM++G W K D D + + +G PE+P
Sbjct: 169 EVARGEKQGKESDIWAVGCTMIEMVTGSPPWT-KADSREDPVSVLYRVGYSSETPELPCL 227
Query: 246 VSKEARDFLRRCFVRKPAFRFTAEMLLDDPFV 277
+++EA+DFL +C R+ R+TA LL+ PF+
Sbjct: 228 LAEEAKDFLEKCLKREANERWTATQLLNHPFL 259
|
|
| TAIR|locus:2007337 MAPKKK13 "mitogen-activated protein kinase kinase kinase 13" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 417 (151.9 bits), Expect = 4.8e-39, P = 4.8e-39
Identities = 99/280 (35%), Positives = 148/280 (52%)
Query: 1 MDSDGTSWFRGRVIGQGSFGCVFIAKPKSNSS-FLPPLMXXXXXXXXXXXXLQKEKEVFD 59
+ S + W RG IG+G FG V A K+N F + L+ E VF
Sbjct: 16 LSSPSSFWVRGACIGRGCFGAVSTAISKTNGEVFAVKSVDLATSLPTQSESLENEISVFR 75
Query: 60 NLNGCPFVLECFGEEITMGENGEMAY-NLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFT 118
+L P++++ G+ ++ + G + NL LEY G + + G E ++ +T
Sbjct: 76 SLKPHPYIVKFLGDGVS--KEGTTTFRNLYLEYLPNGDVAS--HRAGGKIEDETLLQRYT 131
Query: 119 RCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSM 178
C++ + H+H G+VHCDVK NIL+ +QS + K+AD G A R H R P
Sbjct: 132 ACLVSALRHVHSQGFVHCDVKARNILV--SQSS--MVKLADFGSAFRI-HTPRALITP-- 184
Query: 179 RGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSI-IGDEH 237
RG+PL++APE + + Q SD+W+LGC ++EM +G+ AW ED ID L I DE
Sbjct: 185 RGSPLWMAPEVIRREYQGPESDVWSLGCTIIEMFTGKPAW---EDHGIDSLSRISFSDE- 240
Query: 238 SLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFV 277
LP PS++S+ RDFL +C R P R++ + LL PF+
Sbjct: 241 -LPVFPSKLSEIGRDFLEKCLKRDPNQRWSCDQLLQHPFL 279
|
|
| TAIR|locus:2064590 AT2G41930 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 406 (148.0 bits), Expect = 7.0e-38, P = 7.0e-38
Identities = 102/297 (34%), Positives = 159/297 (53%)
Query: 12 RVIGQGSFGCVFIAKPKSNSSFLPPLMXXXXXXXXXXXXLQKEKEVFDNLNGCPFVLECF 71
+V+G+G++G V + K N L + +E + L GCP +++
Sbjct: 9 KVLGKGTYGSVELFSHKQNDGSLL-YNAVKIMDSENYGSIDQEFRILSELRGCPCIVQLC 67
Query: 72 GEEITMGE--NGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIH 129
G + G NG+ Y + +EYAA GTL + I++ N L + ++ FTR IL+G+ IH
Sbjct: 68 GNSLVQGIDCNGKKVYMMSMEYAAAGTLTNFIKR-NRTKLSDSVIKDFTRMILQGLVSIH 126
Query: 130 DSGYVHCDVKPDNILLVA-----TQSGKFVAKIADLGVAKRSRH---CKRQKFDPSMRGT 181
+ GYVHCD+KPDNILL T + + KI+D G++ R+ C R D GT
Sbjct: 127 NHGYVHCDLKPDNILLFPLYDKDTWNCSYELKISDFGISTRAGDKSGCWR--VDEPWVGT 184
Query: 182 PLYLAPETVVQHMQ-EAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEHSLP 240
+Y++PE+V E D+W+LGC+VL+M +G++ W+ E + S++ ++ + P
Sbjct: 185 SIYMSPESVSDGTTVEKTLDLWSLGCIVLKMYTGKRPWLGFEK----DVKSLLLNQKA-P 239
Query: 241 EIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGVDEELSRELEGDYSQGEV 297
EIP + +AR FL +CF RKP R +A LL PF+ G DE+ + G G V
Sbjct: 240 EIPETLPCDARLFLEKCFSRKPEERGSASELLLHPFLTG-DEKKGSSVAGGERTGMV 295
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.737 |
| 3rd Layer | 2.7.11 | 0.691 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | gw1.208.6.1 | hypothetical protein (282 aa) | |||||||||
(Populus trichocarpa) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 362 | |||
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 4e-91 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 2e-61 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 3e-52 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 2e-50 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 6e-50 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 5e-49 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 3e-46 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 7e-44 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 1e-43 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 2e-42 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 3e-41 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 5e-39 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 7e-38 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 1e-37 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 3e-35 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 9e-35 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 2e-34 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 2e-33 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 5e-33 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 5e-32 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 2e-31 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 5e-31 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 1e-30 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 2e-30 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 2e-30 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 3e-29 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 4e-29 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 5e-29 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 6e-29 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 3e-28 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 9e-28 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 2e-27 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 3e-26 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 5e-26 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 2e-25 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 2e-25 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 3e-25 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 2e-24 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 3e-24 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 3e-24 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 3e-24 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 4e-24 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 1e-23 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 1e-23 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 1e-23 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 2e-23 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 2e-23 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 2e-23 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 6e-23 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 7e-23 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 1e-22 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 1e-22 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 2e-22 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 2e-22 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 2e-22 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 4e-22 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 8e-22 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 1e-21 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 3e-21 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 5e-21 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 9e-21 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 1e-20 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 1e-20 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 2e-20 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 3e-20 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 3e-20 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 5e-20 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 6e-20 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 8e-20 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 1e-19 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 1e-19 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 3e-19 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 5e-19 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 6e-19 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 6e-19 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 1e-18 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 1e-18 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 2e-18 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 4e-18 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 8e-18 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 8e-18 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 9e-18 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 1e-17 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 1e-17 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 1e-17 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 1e-17 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 1e-17 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 2e-17 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 5e-17 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 6e-17 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 9e-17 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 1e-16 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 2e-16 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 2e-16 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 2e-16 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 2e-16 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 2e-16 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 4e-16 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 7e-16 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 1e-15 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 1e-15 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 2e-15 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 2e-15 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 2e-15 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 2e-15 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 2e-15 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 2e-15 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 3e-15 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 3e-15 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 4e-15 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 8e-15 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 9e-15 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 1e-14 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 1e-14 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 1e-14 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 1e-14 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 2e-14 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 3e-14 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 3e-14 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 5e-14 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 6e-14 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 6e-14 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 6e-14 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 9e-14 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 9e-14 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 1e-13 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 1e-13 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 1e-13 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 2e-13 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 2e-13 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 2e-13 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 2e-13 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 3e-13 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 4e-13 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 5e-13 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 5e-13 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 6e-13 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 7e-13 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 7e-13 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 9e-13 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 1e-12 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 1e-12 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 1e-12 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 2e-12 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 2e-12 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 2e-12 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 2e-12 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 3e-12 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 3e-12 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 4e-12 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 5e-12 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 6e-12 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 1e-11 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 1e-11 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 1e-11 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 1e-11 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 1e-11 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 2e-11 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 2e-11 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 3e-11 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 3e-11 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 4e-11 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 5e-11 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 6e-11 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 7e-11 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 7e-11 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 8e-11 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 8e-11 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 1e-10 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 1e-10 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 2e-10 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 3e-10 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 3e-10 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 4e-10 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 4e-10 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 4e-10 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 4e-10 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 4e-10 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 5e-10 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 6e-10 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 9e-10 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 9e-10 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 1e-09 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 2e-09 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 2e-09 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 2e-09 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 2e-09 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 2e-09 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 3e-09 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 3e-09 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 4e-09 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 4e-09 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 4e-09 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 4e-09 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 4e-09 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 4e-09 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 8e-09 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 9e-09 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 1e-08 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 1e-08 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 1e-08 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 1e-08 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 1e-08 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 1e-08 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 2e-08 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 2e-08 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 3e-08 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 3e-08 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 3e-08 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 3e-08 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 4e-08 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 4e-08 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 5e-08 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 6e-08 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 7e-08 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 8e-08 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 1e-07 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 1e-07 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 1e-07 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 1e-07 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 2e-07 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 2e-07 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 2e-07 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 3e-07 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 3e-07 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 3e-07 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 4e-07 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 5e-07 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 5e-07 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 5e-07 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 5e-07 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 7e-07 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 7e-07 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 8e-07 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 8e-07 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 1e-06 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 1e-06 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 1e-06 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 1e-06 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 2e-06 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 2e-06 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 2e-06 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 2e-06 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 3e-06 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 5e-06 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 5e-06 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 7e-06 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 7e-06 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 8e-06 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 8e-06 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 8e-06 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 9e-06 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 9e-06 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 1e-05 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 1e-05 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 2e-05 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 2e-05 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 3e-05 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 4e-05 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 5e-05 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 6e-05 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 7e-05 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 7e-05 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 9e-05 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 1e-04 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 2e-04 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 3e-04 | |
| PHA02882 | 294 | PHA02882, PHA02882, putative serine/threonine kina | 3e-04 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 6e-04 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 8e-04 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 0.001 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 0.001 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 0.001 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 0.001 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 0.002 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 0.002 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 0.002 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 0.003 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 0.003 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 0.003 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 273 bits (700), Expect = 4e-91
Identities = 102/276 (36%), Positives = 151/276 (54%), Gaps = 21/276 (7%)
Query: 7 SWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVS-----ASASLQKEKEVFDNL 61
W RG ++G+GSFG V++A K MAVKS E+S +L++E + +L
Sbjct: 1 EWTRGELLGRGSFGSVYLALDKDTGEL----MAVKSVELSGDSEEELEALEREIRILSSL 56
Query: 62 NGCPFVLECFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCI 121
P ++ +G E + N+ LEY +GG+L L++K LPE +R +TR I
Sbjct: 57 Q-HPNIVRYYGSERD---EEKNTLNIFLEYVSGGSLSSLLKK--FGKLPEPVIRKYTRQI 110
Query: 122 LEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMRGT 181
LEG+ ++H +G VH D+K NIL+ V K+AD G AKR + + S+RGT
Sbjct: 111 LEGLAYLHSNGIVHRDIKGANILV----DSDGVVKLADFGCAKRLGDIETGEGTGSVRGT 166
Query: 182 PLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEHSLPE 241
P ++APE + +DIW+LGC V+EM +G+ W + + L+ I PE
Sbjct: 167 PYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGN-PMAALYKIGSSG-EPPE 224
Query: 242 IPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFV 277
IP +S+EA+DFLR+C R P R TA+ LL PF+
Sbjct: 225 IPEHLSEEAKDFLRKCLRRDPKKRPTADELLQHPFL 260
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 197 bits (503), Expect = 2e-61
Identities = 80/275 (29%), Positives = 131/275 (47%), Gaps = 26/275 (9%)
Query: 8 WFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVK----SAEVSASASLQKEKEVFDNLNG 63
+ +G+GSFG V++A+ K L+A+K + +E ++ L
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGK----LVAIKVIKKKKIKKDRERILREIKILKKLK- 55
Query: 64 CPFVLECFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILE 123
P ++ + + L++EY GG L DL++K L E + R + R IL
Sbjct: 56 HPNIVRLYDVFEDEDK-----LYLVMEYCEGGDLFDLLKKRGR--LSEDEARFYLRQILS 108
Query: 124 GIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMRGTPL 183
+ ++H G VH D+KP+NILL K+AD G+A++ ++ + GTP
Sbjct: 109 ALEYLHSKGIVHRDLKPENILL----DEDGHVKLADFGLARQLDPGEKLT---TFVGTPE 161
Query: 184 YLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEH-SLPEI 242
Y+APE ++ DIW+LG ++ E+L+G+ + D + +LF IG P
Sbjct: 162 YMAPEVLLGKGYGKAVDIWSLGVILYELLTGKPPF--PGDDQLLELFKKIGKPKPPFPPP 219
Query: 243 PSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFV 277
+S EA+D +R+ V+ P R TAE L PF
Sbjct: 220 EWDISPEAKDLIRKLLVKDPEKRLTAEEALQHPFF 254
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 173 bits (442), Expect = 3e-52
Identities = 79/277 (28%), Positives = 129/277 (46%), Gaps = 30/277 (10%)
Query: 11 GRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVSASASLQKEKEVFDNLN-----GCP 65
R +G GSFG V+ AK K ++AVK + S +K++ + P
Sbjct: 4 LRKLGSGSFGTVYKAKHKGTGK----IVAVKILKKR-SEKSKKDQTARREIRILRRLSHP 58
Query: 66 FVLECFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGI 125
++ + + L++EY GG L D + + G L E + + IL G+
Sbjct: 59 NIVRLID---AFEDKDHLY--LVMEYCEGGDLFDYLSR--GGPLSEDEAKKIALQILRGL 111
Query: 126 GHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMRGTPLYL 185
++H +G +H D+KP+NILL V KIAD G+AK + GTP Y+
Sbjct: 112 EYLHSNGIIHRDLKPENILL----DENGVVKIADFGLAK-KLLKSSSSLT-TFVGTPWYM 165
Query: 186 APETVVQH-MQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEHSLPEIP- 243
APE ++ D+W+LG ++ E+L+G+ + + +DQL I E
Sbjct: 166 APEVLLGGNGYGPKVDVWSLGVILYELLTGKPPF--SGENILDQLQLIRRILGPPLEFDE 223
Query: 244 ---SRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFV 277
S S+EA+D +++C + P+ R TAE +L P+
Sbjct: 224 PKWSSGSEEAKDLIKKCLNKDPSKRPTAEEILQHPWF 260
|
Length = 260 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 169 bits (430), Expect = 2e-50
Identities = 95/289 (32%), Positives = 149/289 (51%), Gaps = 40/289 (13%)
Query: 8 WFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVSAS-------------ASLQKE 54
W +G +IG+G++G V++A + +MAVK E+ A+ +L+ E
Sbjct: 3 WVKGELIGKGTYGRVYLALNVTTGE----MMAVKQVELPATIAGRHDSRQKDMVKALRSE 58
Query: 55 KEVFDNLNGCPFVLECFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDV 114
E +L+ +++ G E E ++ LEY GG++G + E+ V
Sbjct: 59 IETLKDLDH-LNIVQYLGFE-----TTEEYLSIFLEYVPGGSIGSCLR--TYGRFEEQLV 110
Query: 115 RHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKF 174
R FT +LEG+ ++H G +H D+K DN+L+ G + KI+D G++K+S
Sbjct: 111 RFFTEQVLEGLAYLHSKGILHRDLKADNLLV--DADG--ICKISDFGISKKSDDIYDNDQ 166
Query: 175 DPSMRGTPLYLAPETVVQHMQEAPS---DIWALGCVVLEMLSGRQAWVVKEDCSIDQLFS 231
+ SM+G+ ++APE V+ + S DIW+LGCVVLEM +GR+ W +E +I +F
Sbjct: 167 NMSMQGSVFWMAPE-VIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEE--AIAAMFK 223
Query: 232 IIGDEHSLPEIP----SRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPF 276
+G++ S P IP +S A DFL CF P R TA LL PF
Sbjct: 224 -LGNKRSAPPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQHPF 271
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 167 bits (425), Expect = 6e-50
Identities = 95/281 (33%), Positives = 133/281 (47%), Gaps = 33/281 (11%)
Query: 7 SWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVSASASLQKEKEVFDNLNG--- 63
W +G ++G GSFG V+ + F AVK EVS + Q +E L
Sbjct: 1 RWRKGELLGSGSFGSVYEGLNLDDGDFF----AVK--EVSLADDGQTGQEAVKQLEQEIA 54
Query: 64 ------CPFVLECFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHF 117
P +++ G E E + LE GG+L L++K PE +R +
Sbjct: 55 LLSKLQHPNIVQYLGTERE-----EDNLYIFLELVPGGSLAKLLKKYGS--FPEPVIRLY 107
Query: 118 TRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPS 177
TR IL G+ ++HD VH D+K NIL+ V K+AD G+AK F S
Sbjct: 108 TRQILLGLEYLHDRNTVHRDIKGANILVDTNG----VVKLADFGMAK---QVVEFSFAKS 160
Query: 178 MRGTPLYLAPETVV-QHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDE 236
+G+P ++APE + Q +DIW+LGC VLEM +G+ W IG
Sbjct: 161 FKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPW---SQLEGVAAVFKIGRS 217
Query: 237 HSLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFV 277
LP IP +S EA+DF+ +C R P+ R TA LL+ PFV
Sbjct: 218 KELPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLEHPFV 258
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 165 bits (420), Expect = 5e-49
Identities = 98/285 (34%), Positives = 142/285 (49%), Gaps = 37/285 (12%)
Query: 8 WFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKS-----AEVSASASLQKEKEVFDNLN 62
W RG IG G+FG V+ A LMAVK + + E +V + L
Sbjct: 2 WQRGNKIGGGTFGKVYTAVNLDTGE----LMAVKEIRIQDNDPKTIKEIADEMKVLELLK 57
Query: 63 GCPFVLECFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCIL 122
P +++ +G E+ ++ + +EY +GGTL +L+E +G L E +R +T +L
Sbjct: 58 H-PNLVKYYGVEV---HREKV--YIFMEYCSGGTLEELLE--HGRILDEHVIRVYTLQLL 109
Query: 123 EGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDP--SMRG 180
EG+ ++H G VH D+KP NI L +G V K+ D G A + ++ + S+ G
Sbjct: 110 EGLAYLHSHGIVHRDIKPANIFLDH--NG--VIKLGDFGCAVKLKNNTTTMGEEVQSLAG 165
Query: 181 TPLYLAPETVV---QHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSI---IG 234
TP Y+APE + +DIW+LGCVVLEM +G++ W +D F I +G
Sbjct: 166 TPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPW-----SELDNEFQIMFHVG 220
Query: 235 DEHSLPEIPSR--VSKEARDFLRRCFVRKPAFRFTAEMLLDDPFV 277
H P IP +S E +DFL RC P R TA LL PFV
Sbjct: 221 AGHK-PPIPDSLQLSPEGKDFLDRCLESDPKKRPTASELLQHPFV 264
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 158 bits (401), Expect = 3e-46
Identities = 102/282 (36%), Positives = 155/282 (54%), Gaps = 28/282 (9%)
Query: 8 WFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVSA--SASLQKEKEVFDNLNGCP 65
W +G +IG GSFG V++ S+ LMAVK E+ + ++S +++ + D L
Sbjct: 2 WIKGALIGSGSFGSVYLGMNASSGE----LMAVKQVELPSVSASSKDRKRSMLDALAREI 57
Query: 66 FVL-ECFGEEIT--MGENGEMAY-NLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCI 121
+L E E I +G + + + N+ LEY GG++ L+ N E VR+F R I
Sbjct: 58 ALLKELQHENIVQYLGSSLDADHLNIFLEYVPGGSVAALLN--NYGAFEETLVRNFVRQI 115
Query: 122 LEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKR----SRHCKRQKFDPS 177
L+G+ ++H+ G +H D+K NIL+ K KI+D G++K+ S K PS
Sbjct: 116 LKGLNYLHNRGIIHRDIKGANILV----DNKGGIKISDFGISKKLEANSLSTKTNGARPS 171
Query: 178 MRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSI--IGD 235
++G+ ++APE V Q +DIW+LGC+V+EML+G+ + DC QL +I IG
Sbjct: 172 LQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPF---PDC--TQLQAIFKIG- 225
Query: 236 EHSLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFV 277
E++ PEIPS +S EA DFL + F R TA LL PF+
Sbjct: 226 ENASPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLKHPFL 267
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 151 bits (384), Expect = 7e-44
Identities = 87/281 (30%), Positives = 136/281 (48%), Gaps = 45/281 (16%)
Query: 11 GRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEV-----SASASLQKEKEVFDNLNGCP 65
G +IG+G+FG V+ F+ A+K + A S+ +E ++ NL
Sbjct: 5 GDLIGRGAFGVVYKGLNLETGDFV----AIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60
Query: 66 FVLECFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGI 125
V + I E + + ++LEYA G+L +I+K PE V + +L+G+
Sbjct: 61 IV-----KYIGSIETSD-SLYIILEYAENGSLRQIIKKFGP--FPESLVAVYVYQVLQGL 112
Query: 126 GHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMRGTPLYL 185
++H+ G +H D+K NIL T+ G V K+AD GVA + + GTP ++
Sbjct: 113 AYLHEQGVIHRDIKAANILT--TKDG--VVKLADFGVATKLNDVSKDDASVV--GTPYWM 166
Query: 186 APETVVQHMQEAPSDIWALGCVVLEMLSGR---------QAWVVKEDCSIDQLFSIIGDE 236
APE + SDIW+LGC V+E+L+G A LF I+ D+
Sbjct: 167 APEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAA-----------LFRIVQDD 215
Query: 237 HSLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFV 277
H P +P +S E +DFL +CF + P R TA+ LL P++
Sbjct: 216 H--PPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLKHPWI 254
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 150 bits (382), Expect = 1e-43
Identities = 76/274 (27%), Positives = 135/274 (49%), Gaps = 27/274 (9%)
Query: 8 WFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVS---ASASLQKEKEVFDNLNGC 64
+ IG+G FG V+ A+ K +A+K ++ + E ++
Sbjct: 2 FEILEKIGKGGFGEVYKARHKRTGK----EVAIKVIKLESKEKKEKIINEIQILKKCKH- 56
Query: 65 PFVLECFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEG 124
P +++ +G + + E+ +++E+ +GG+L DL++ N L E + + + +L+G
Sbjct: 57 PNIVKYYGSYL---KKDELW--IVMEFCSGGSLKDLLKSTNQ-TLTESQIAYVCKELLKG 110
Query: 125 IGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKR-SRHCKRQKFDPSMRGTPL 183
+ ++H +G +H D+K NILL T G+ K+ D G++ + S R +M GTP
Sbjct: 111 LEYLHSNGIIHRDIKAANILL--TSDGE--VKLIDFGLSAQLSDTKARN----TMVGTPY 162
Query: 184 YLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSI-IGDEHSLPEI 242
++APE + + +DIW+LG +E+ G+ + E + LF I L
Sbjct: 163 WMAPEVINGKPYDYKADIWSLGITAIELAEGKPPY--SELPPMKALFKIATNGPPGLRN- 219
Query: 243 PSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPF 276
P + S E +DFL++C + P R TAE LL PF
Sbjct: 220 PEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKHPF 253
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 146 bits (371), Expect = 2e-42
Identities = 71/268 (26%), Positives = 118/268 (44%), Gaps = 59/268 (22%)
Query: 14 IGQGSFGCVFIAKPKSNSSFLPPLMAVK----SAEVSASASLQKEKEVFDNLNGCPFVLE 69
+G+G FG V++A+ K + A+K S L +E E+ LN P +++
Sbjct: 1 LGEGGFGTVYLARDKKTGKKV----AIKIIKKEDSSSLLEELLREIEILKKLN-HPNIVK 55
Query: 70 CFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIH 129
+G L++EY GG+L DL+++ N L E ++ ILEG+ ++H
Sbjct: 56 LYGVFEDENH-----LYLVMEYCEGGSLKDLLKE-NEGKLSEDEILRILLQILEGLEYLH 109
Query: 130 DSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMRGTPLYLAPET 189
+G +H D+KP+NILL S K+AD G++K K ++ GTP Y+APE
Sbjct: 110 SNGIIHRDLKPENILL---DSDNGKVKLADFGLSKLLTSDKSLLK--TIVGTPAYMAPE- 163
Query: 190 VVQHMQEAP--SDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEHSLPEIPSRVS 247
V+ SDIW+LG ++ E+
Sbjct: 164 VLLGKGYYSEKSDIWSLGVILYEL------------------------------------ 187
Query: 248 KEARDFLRRCFVRKPAFRFTAEMLLDDP 275
E +D +R+ + P R +A+ +L+
Sbjct: 188 PELKDLIRKMLQKDPEKRPSAKEILEHL 215
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 144 bits (367), Expect = 3e-41
Identities = 77/282 (27%), Positives = 136/282 (48%), Gaps = 45/282 (15%)
Query: 12 RVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVSASASLQKEKE-------VFDNLNGC 64
+ IG+GSFG V++ + KS+ +K E+ S +KE+E + LN
Sbjct: 6 KQIGKGSFGKVYLVRRKSDGKLY----VLK--EIDLSNMSEKEREDALNEVKILKKLN-H 58
Query: 65 PFVLECFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNG--LPEKDVRHFTRCIL 122
P +++ + E G++ +++EYA GG L I+K G PE+ + + +
Sbjct: 59 PNIIKYYESFE---EKGKL--CIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLC 113
Query: 123 EGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFD--PSMRG 180
+ ++H +H D+KP NI L T +G + K+ D G++K D ++ G
Sbjct: 114 LALKYLHSRKILHRDIKPQNIFL--TSNG--LVKLGDFGISK----VLSSTVDLAKTVVG 165
Query: 181 TPLYLAPETVVQHMQ-EAPSDIWALGCVVLEMLSGR---QAWVVKEDCSIDQLF-SIIGD 235
TP YL+PE + Q+ SDIW+LGCV+ E+ + + + ++ +L I+
Sbjct: 166 TPYYLSPE-LCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGE------NLLELALKILKG 218
Query: 236 EHSLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFV 277
++ P IPS+ S E R+ + + P R + +L PF+
Sbjct: 219 QY--PPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQSPFI 258
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 142 bits (358), Expect = 5e-39
Identities = 84/366 (22%), Positives = 141/366 (38%), Gaps = 30/366 (8%)
Query: 11 GRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVSASASLQKEKEVFDNLNGCPFV--L 68
R +G+GSFG V++A+ + + L L ++ +E ++ +LN P + L
Sbjct: 5 LRKLGEGSFGEVYLARDRKLVA-LKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKL 63
Query: 69 ECFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKC-NGNGLPEKDVRHFTRCILEGIGH 127
F ++ E + L++EY GG+L DL++K L E + IL + +
Sbjct: 64 YDFFQD-------EGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEY 116
Query: 128 IHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCK----RQKFDPSMRGTPL 183
+H G +H D+KP+NILL V K+ D G+AK + GTP
Sbjct: 117 LHSKGIIHRDIKPENILL---DRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPG 173
Query: 184 YLAPETVVQHMQEAP---SDIWALGCVVLEMLSGRQAWV-VKEDCSIDQLFSIIGDE--- 236
Y+APE ++ SDIW+LG + E+L+G + K + Q II +
Sbjct: 174 YMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTP 233
Query: 237 ----HSLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGVDEELSRELEGDY 292
P P +SK A D L++ + P R ++ L + + + S +
Sbjct: 234 SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHLKLKESDLSDLLK 293
Query: 293 SQGEVTLSNADAESCSPECISFIPLEANSSLSSWGSAQRTNEGSTITVKELSSNPTVFCR 352
L IS + A S ++ S + +
Sbjct: 294 PDDSAPLRL-SLPPSLEALISSLNSLAISGSDLKLDDSNFSKELAPNGVSSSPHNSSSLL 352
Query: 353 SFFAIP 358
A
Sbjct: 353 LSTASS 358
|
Length = 384 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 136 bits (344), Expect = 7e-38
Identities = 79/289 (27%), Positives = 133/289 (46%), Gaps = 44/289 (15%)
Query: 8 WFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVSASASLQKEKE----------- 56
W +G V+G+G++G V+ L+AVK E+ S L EKE
Sbjct: 2 WTKGEVLGKGAYGTVYCGLTNQGQ-----LIAVKQVELDTSNVLAAEKEYEKLQEEVDLL 56
Query: 57 -VFDNLNGCPFVLECFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVR 115
++N ++ C + ++ +E+ GG++ ++ + LPE
Sbjct: 57 KSLKHVNIVQYLGTCLDDNTI---------SIFMEFVPGGSISSILNRFGP--LPEPVFC 105
Query: 116 HFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKR----SRHCKR 171
+T+ IL+G+ ++H++ VH D+K +N++L+ + K+ D G A+R H
Sbjct: 106 KYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNG----IIKLIDFGCARRLAWVGLHGTH 161
Query: 172 QKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFS 231
SM GTP ++APE + + SDIW++GC V EM +G+ S+D+L +
Sbjct: 162 SNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPL-----ASMDRLAA 216
Query: 232 I--IGDEHSL-PEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFV 277
+ IG L P +P S A DF+ C R R +A LL F+
Sbjct: 217 MFYIGAHRGLMPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLRHDFL 265
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 135 bits (341), Expect = 1e-37
Identities = 90/284 (31%), Positives = 147/284 (51%), Gaps = 34/284 (11%)
Query: 6 TSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVK-----------SAEVSASASLQKE 54
T+W RG+++GQG+FG V++ L AVK EV+A L+ E
Sbjct: 2 TNWRRGKLLGQGAFGRVYLCYDVDTGREL----AVKQVPFDPDSPETKKEVNA---LECE 54
Query: 55 KEVFDNLNGCPFVLECFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDV 114
++ NL +++ +G + ++ ++ + +EY GG++ D + K G L E
Sbjct: 55 IQLLKNLQH-ERIVQYYG---CLRDDETLS--IFMEYMPGGSVKDQL-KAYG-ALTETVT 106
Query: 115 RHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRH-CKRQK 173
R +TR ILEG+ ++H + VH D+K NIL + + K+ D G +KR + C
Sbjct: 107 RKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGN----VKLGDFGASKRLQTICSSGT 162
Query: 174 FDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSII 233
S+ GTP +++PE + +D+W++GC V+EML+ + W E + +F I
Sbjct: 163 GMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAA--IFK-I 219
Query: 234 GDEHSLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFV 277
+ + P++PS VS +AR+FLRR FV R +AE LL FV
Sbjct: 220 ATQPTNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRHFFV 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 129 bits (327), Expect = 3e-35
Identities = 80/282 (28%), Positives = 132/282 (46%), Gaps = 31/282 (10%)
Query: 10 RGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVSASASLQKEKEVFDNL-----NGC 64
R +V+GQGS G V+ + K A+K ++ + K++ L
Sbjct: 5 RVKVLGQGSSGVVYKVRHKPTGKIY----ALK--KIHVDGDEEFRKQLLRELKTLRSCES 58
Query: 65 PFVLECFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEG 124
P+V++C+G + GE++ ++LEY GG+L DL++K +PE + + R IL+G
Sbjct: 59 PYVVKCYGAFY---KEGEIS--IVLEYMDGGSLADLLKKVGK--IPEPVLAYIARQILKG 111
Query: 125 IGHIH-DSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAK---RSRHCKRQKFDPSMRG 180
+ ++H +H D+KP N+L+ + K KIAD G++K + + G
Sbjct: 112 LDYLHTKRHIIHRDIKPSNLLI----NSKGEVKIADFGISKVLENTLDQCN-----TFVG 162
Query: 181 TPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEHSLP 240
T Y++PE + +DIW+LG +LE G+ ++ S +L I D
Sbjct: 163 TVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPS 222
Query: 241 EIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGVDE 282
S E RDF+ C + P R +A LL PF+K D
Sbjct: 223 LPAEEFSPEFRDFISACLQKDPKKRPSAAELLQHPFIKKADN 264
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 127 bits (322), Expect = 9e-35
Identities = 68/269 (25%), Positives = 130/269 (48%), Gaps = 26/269 (9%)
Query: 13 VIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEV-SASASLQKEKEVFDNLNGCPFVLECF 71
+G+GS+G V+ A K + A+K V + KE + + P++++ +
Sbjct: 10 KLGEGSYGSVYKAIHKETGQVV----AIKVVPVEEDLQEIIKEISILKQCD-SPYIVKYY 64
Query: 72 GEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDS 131
G + +++EY G++ D+++ N L E+++ L+G+ ++H +
Sbjct: 65 GSYFKNTD-----LWIVMEYCGAGSVSDIMKITN-KTLTEEEIAAILYQTLKGLEYLHSN 118
Query: 132 GYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMRGTPLYLAPETVV 191
+H D+K NILL + + AK+AD GV+ + ++ ++ GTP ++APE +
Sbjct: 119 KKIHRDIKAGNILL----NEEGQAKLADFGVSGQLTDTMAKR--NTVIGTPFWMAPEVIQ 172
Query: 192 QHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEHSLP---EIPSRVSK 248
+ +DIW+LG +EM G+ + + + +F I + P P + S
Sbjct: 173 EIGYNNKADIWSLGITAIEMAEGKPPY--SDIHPMRAIFMIP---NKPPPTLSDPEKWSP 227
Query: 249 EARDFLRRCFVRKPAFRFTAEMLLDDPFV 277
E DF+++C V+ P R +A LL PF+
Sbjct: 228 EFNDFVKKCLVKDPEERPSAIQLLQHPFI 256
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 127 bits (321), Expect = 2e-34
Identities = 80/294 (27%), Positives = 122/294 (41%), Gaps = 48/294 (16%)
Query: 11 GRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVSASASLQK------EKEVFDNLNGC 64
G++IG+GSF V +AK K + A+K + +K EKEV LNG
Sbjct: 6 GKIIGEGSFSTVVLAKEKETN----KEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGH 61
Query: 65 PFVLECFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEG 124
P +++ + T + + + +LEYA G L I K G+ L EK R + IL
Sbjct: 62 PGIIKLYY---TFQDEENLYF--VLEYAPNGELLQYIRK-YGS-LDEKCTRFYAAEILLA 114
Query: 125 IGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAK-----------RSRHCKRQK 173
+ ++H G +H D+KP+NILL KI D G AK +
Sbjct: 115 LEYLHSKGIIHRDLKPENILL----DKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDS 170
Query: 174 FDPSMR-------GTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSI 226
R GT Y++PE + + SD+WALGC++ +ML+G+ + +
Sbjct: 171 QIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPF---RGSNE 227
Query: 227 DQLFSIIGDEHSLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDD----PF 276
F I P +A+D + + V P R D+ PF
Sbjct: 228 YLTFQKI--LKLEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPF 279
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 124 bits (314), Expect = 2e-33
Identities = 75/277 (27%), Positives = 134/277 (48%), Gaps = 38/277 (13%)
Query: 12 RVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVSAS----ASLQKEKEVFDNLNGCPFV 67
IG+GSFG V+ A K + ++A+K ++ + +Q+E + P++
Sbjct: 7 ECIGKGSFGEVYKAIDKRTNQ----VVAIKVIDLEEAEDEIEDIQQEIQFLSQCR-SPYI 61
Query: 68 LECFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGH 127
+ +G + + ++ +++EY GG+ DL++ L E + R +L G+ +
Sbjct: 62 TKYYG---SFLKGSKLW--IIMEYCGGGSCLDLLKPG---KLDETYIAFILREVLLGLEY 113
Query: 128 IHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAK--RSRHCKRQKFDPSMRGTPLYL 185
+H+ G +H D+K NILL ++ G K+AD GV+ S KR F GTP ++
Sbjct: 114 LHEEGKIHRDIKAANILL--SEEGD--VKLADFGVSGQLTSTMSKRNTF----VGTPFWM 165
Query: 186 APETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQ---LFSIIGDEHSLPEI 242
APE + Q + +DIW+LG +E+ G + LF I +++ P +
Sbjct: 166 APEVIKQSGYDEKADIWSLGITAIELAKGEPPL-----SDLHPMRVLFLIP--KNNPPSL 218
Query: 243 P-SRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVK 278
++ SK +DF+ C + P R +A+ LL F+K
Sbjct: 219 EGNKFSKPFKDFVSLCLNKDPKERPSAKELLKHKFIK 255
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 123 bits (310), Expect = 5e-33
Identities = 88/280 (31%), Positives = 145/280 (51%), Gaps = 25/280 (8%)
Query: 7 SWFRGRVIGQGSFGCVFIA-------KPKSNSSFLPPLMAVKSAEVSASASLQKEKEVFD 59
+W RG+++GQG+FG V++ + + P S EVSA L+ E ++
Sbjct: 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSA---LECEIQLLK 59
Query: 60 NLNGCPFVLECFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTR 119
NL +++ +G + + E + +EY GG++ D + K G L E R +TR
Sbjct: 60 NLQH-ERIVQYYG---CLRDRAEKTLTIFMEYMPGGSVKDQL-KAYG-ALTESVTRKYTR 113
Query: 120 CILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRH-CKRQKFDPSM 178
ILEG+ ++H + VH D+K NIL + + K+ D G +KR + C S+
Sbjct: 114 QILEGMSYLHSNMIVHRDIKGANILRDSAGN----VKLGDFGASKRLQTICMSGTGIRSV 169
Query: 179 RGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEHS 238
GTP +++PE + +D+W+LGC V+EML+ + W E ++ +F I + +
Sbjct: 170 TGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYE--AMAAIFK-IATQPT 226
Query: 239 LPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVK 278
P++PS +S+ ARDFL FV + R +AE LL PF +
Sbjct: 227 NPQLPSHISEHARDFLGCIFV-EARHRPSAEELLRHPFAQ 265
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 120 bits (303), Expect = 5e-32
Identities = 75/279 (26%), Positives = 131/279 (46%), Gaps = 26/279 (9%)
Query: 8 WFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVK---------SAEVSASASLQKEKEVF 58
W +G+ +G G+F + A+ + LMAVK S + +L+KE +
Sbjct: 2 WLKGQQLGTGAFSSCYQARDVKTGT----LMAVKQVTYVRNTSSEQEEVVEALRKEIRLM 57
Query: 59 DNLNGCPFVLECFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFT 118
LN P ++ G +NL +E+ AGG++ L+ K E + ++T
Sbjct: 58 ARLNH-PHIIRMLGATCEDSH-----FNLFVEWMAGGSVSHLLSKYGA--FKEAVIINYT 109
Query: 119 RCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKR--SRHCKRQKFDP 176
+L G+ ++H++ +H DVK N+L+ +T G+ + +IAD G A R ++ +F
Sbjct: 110 EQLLRGLSYLHENQIIHRDVKGANLLIDST--GQRL-RIADFGAAARLAAKGTGAGEFQG 166
Query: 177 SMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDE 236
+ GT ++APE + D+W++GCV++EM + + W ++ + L I
Sbjct: 167 QLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASA 226
Query: 237 HSLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDP 275
+ P IP +S RD RC +P R + LL P
Sbjct: 227 TTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKHP 265
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 2e-31
Identities = 90/287 (31%), Positives = 142/287 (49%), Gaps = 55/287 (19%)
Query: 13 VIGQGSFGCVFIAK-------------PKSNSSFLPPLMAVKSAEVSASASLQKEKEVFD 59
V+G+G++G V+ A+ P+ +S ++ PL E++ + L K + +
Sbjct: 15 VLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHE----EIALHSYL-KHRNIVQ 69
Query: 60 NLNGCPFVLECFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKD----VR 115
L ENG + + +E GG+L L+ G P KD +
Sbjct: 70 YLGSD-------------SENG--FFKIFMEQVPGGSLSALLRSKWG---PLKDNEQTII 111
Query: 116 HFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFD 175
+T+ ILEG+ ++HD+ VH D+K DN+L V T SG V KI+D G +KR +
Sbjct: 112 FYTKQILEGLKYLHDNQIVHRDIKGDNVL-VNTYSG--VVKISDFGTSKR-----LAGIN 163
Query: 176 P---SMRGTPLYLAPETVVQHMQE--APSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLF 230
P + GT Y+APE + + + AP+DIW+LGC ++EM +G+ ++ E
Sbjct: 164 PCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFI--ELGEPQAAM 221
Query: 231 SIIGDEHSLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFV 277
+G PEIP +S EA++F+ RCF P R +A LL DPF+
Sbjct: 222 FKVGMFKIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQDPFL 268
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 117 bits (296), Expect = 5e-31
Identities = 68/270 (25%), Positives = 113/270 (41%), Gaps = 47/270 (17%)
Query: 14 IGQGSFGCVFIAKPKSNSSFLPPLMAVKS---AEVSASASLQ---KEKEVFDNLNGCPFV 67
+G+GSFG V + + K L A+K ++ ++ E+ + +N PF+
Sbjct: 1 LGKGSFGKVLLVRKKDTGK----LYAMKVLKKKKIIKRKEVEHTLTERNILSRIN-HPFI 55
Query: 68 LECFGEEITMGENGEMAY--------NLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTR 119
++ Y L+LEYA GG L + K E+ R +
Sbjct: 56 VKLH-------------YAFQTEEKLYLVLEYAPGGELFSHLSKEGR--FSEERARFYAA 100
Query: 120 CILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMR 179
I+ + ++H G ++ D+KP+NILL G K+ D G+AK +
Sbjct: 101 EIVLALEYLHSLGIIYRDLKPENILL--DADGH--IKLTDFGLAKEL--SSEGSRTNTFC 154
Query: 180 GTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLF-SIIGDEHS 238
GTP YLAPE ++ D W+LG ++ EML+G+ +++ I+ D
Sbjct: 155 GTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGK---PPFYAEDRKEIYEKILKDP-- 209
Query: 239 LPEIPSRVSKEARDFLRRCFVRKPAFRFTA 268
P +S EARD + + P R +
Sbjct: 210 -LRFPEFLSPEARDLISGLLQKDPTKRLGS 238
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 1e-30
Identities = 90/323 (27%), Positives = 129/323 (39%), Gaps = 103/323 (31%)
Query: 12 RVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSA--------------EVSASASLQ----- 52
+ +G G+FG V++A+ K L+A+K EV + L
Sbjct: 5 KQLGDGTFGSVYLARNKETG----ELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNI 60
Query: 53 -KEKEVF---DNLNGCPFVLECFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNG 108
K KEVF D L FV E M NL L++ G
Sbjct: 61 VKLKEVFRENDELY---FVFEY------------MEGNLY----------QLMKDRKGKP 95
Query: 109 LPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAK--RS 166
E +R IL+G+ HIH G+ H D+KP+N+L+ SG V KIAD G+A+ RS
Sbjct: 96 FSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLV----SGPEVVKIADFGLAREIRS 151
Query: 167 RHCKRQKFDP-----SMRGTPLYLAPETVVQHMQ-EAPSDIWALGCVVLEMLSGRQAWVV 220
R P S R Y APE +++ +P DIWALGC++ E+ + R +
Sbjct: 152 R-------PPYTDYVSTR---WYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPG 201
Query: 221 KEDCSIDQLF---SIIGD------------------------EHSLPEIPSRVSKEARDF 253
+ IDQL+ S++G SL ++ S EA D
Sbjct: 202 SSE--IDQLYKICSVLGTPTKQDWPEGYKLASKLGFRFPQFAPTSLHQLIPNASPEAIDL 259
Query: 254 LRRCFVRKPAFRFTAEMLLDDPF 276
++ P R TA L P+
Sbjct: 260 IKDMLRWDPKKRPTASQALQHPY 282
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 116 bits (293), Expect = 2e-30
Identities = 80/271 (29%), Positives = 128/271 (47%), Gaps = 25/271 (9%)
Query: 14 IGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVSASASLQKEKEVFDNLNGC--PFVLECF 71
+G G+FG V+ A+ K F A K ++ + L+ D L+ C P ++ +
Sbjct: 13 LGDGAFGKVYKAQHKETGLF----AAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLY 68
Query: 72 GEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDS 131
+ +L+E+ GG L ++ + GL E +R+ R +LE + +H
Sbjct: 69 EAYFYENK-----LWILIEFCDGGALDSIMLEL-ERGLTEPQIRYVCRQMLEALNFLHSH 122
Query: 132 GYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMRGTPLYLAPETVV 191
+H D+K NILL T G K+AD GV+ +++ QK D + GTP ++APE V
Sbjct: 123 KVIHRDLKAGNILL--TLDGD--VKLADFGVSAKNKS-TLQKRD-TFIGTPYWMAPEVVA 176
Query: 192 -QHMQEAP----SDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEHSLPEIPSRV 246
+ ++ P +DIW+LG ++E+ E + L I+ E + PS+
Sbjct: 177 CETFKDNPYDYKADIWSLGITLIELAQMEPPH--HELNPMRVLLKILKSEPPTLDQPSKW 234
Query: 247 SKEARDFLRRCFVRKPAFRFTAEMLLDDPFV 277
S DFL+ C V+ P R TA LL PFV
Sbjct: 235 SSSFNDFLKSCLVKDPDDRPTAAELLKHPFV 265
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 2e-30
Identities = 76/277 (27%), Positives = 130/277 (46%), Gaps = 31/277 (11%)
Query: 14 IGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVSAS--ASLQKEKEVFDNLNGCPFVLECF 71
I +G+FG V++AK +S + + KS ++ + +++ E+ + P+V + +
Sbjct: 4 ISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLY 63
Query: 72 GEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDS 131
++ + Y L++EY GG LI+ G LPE + + ++ G+ +H
Sbjct: 64 ----YSFQSKDYLY-LVMEYLNGGDCASLIKTLGG--LPEDWAKQYIAEVVLGVEDLHQR 116
Query: 132 GYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMRGTPLYLAPETVV 191
G +H D+KP+N+L+ Q+G K+ D G+++ K+ GTP YLAPET++
Sbjct: 117 GIIHRDIKPENLLI--DQTGHL--KLTDFGLSRNGLENKK------FVGTPDYLAPETIL 166
Query: 192 QHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEHSLPEIPSRV----S 247
+ SD W+LGCV+ E L G + + D +F I P V S
Sbjct: 167 GVGDDKMSDWWSLGCVIFEFLFGYPPF---HAETPDAVFDNI--LSRRINWPEEVKEFCS 221
Query: 248 KEARDFLRRCFVRKPAFRFTA---EMLLDDPFVKGVD 281
EA D + R PA R A + + PF K ++
Sbjct: 222 PEAVDLINRLLCMDPAKRLGANGYQEIKSHPFFKSIN 258
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 113 bits (283), Expect = 3e-29
Identities = 86/280 (30%), Positives = 142/280 (50%), Gaps = 25/280 (8%)
Query: 6 TSWFRGRVIGQGSFGCVFIAKPKSNSSFLP-------PLMAVKSAEVSASASLQKEKEVF 58
T+W G+++GQG+FG V++ L P S EV+A L+ E ++
Sbjct: 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNA---LECEIQLL 58
Query: 59 DNLNGCPFVLECFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFT 118
NL +++ +G + + E ++ +E+ GG++ D + K G L E R +T
Sbjct: 59 KNLLH-ERIVQYYG---CLRDPMERTLSIFMEHMPGGSIKDQL-KSYG-ALTENVTRKYT 112
Query: 119 RCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRH-CKRQKFDPS 177
R ILEG+ ++H + VH D+K NIL + + K+ D G +KR + C S
Sbjct: 113 RQILEGVSYLHSNMIVHRDIKGANILRDSVGN----VKLGDFGASKRLQTICLSGTGMKS 168
Query: 178 MRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEH 237
+ GTP +++PE + +DIW++GC V+EML+ + W E ++ +F I +
Sbjct: 169 VTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFE--AMAAIFK-IATQP 225
Query: 238 SLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFV 277
+ P +P VS RDFL+R FV + R +A+ LL FV
Sbjct: 226 TNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRHTFV 264
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 4e-29
Identities = 80/283 (28%), Positives = 131/283 (46%), Gaps = 34/283 (12%)
Query: 14 IGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVSASA---SLQKEKEVFDNLNGCPFVLEC 70
I +G++G VF+AK KS + +K A++ + E+++ P+V++
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYA-IKVIKKADMIRKNQVDQVLTERDILSQAQ-SPYVVKL 58
Query: 71 FGEEITMGENGEMAYNLLL--EYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHI 128
+ G+ NL L EY GG L L+E N L E R + I+ + ++
Sbjct: 59 Y--YSFQGKK-----NLYLVMEYLPGGDLASLLE--NVGSLDEDVARIYIAEIVLALEYL 109
Query: 129 HDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAK---RSRHCKRQKFDPSMR---GTP 182
H +G +H D+KPDNIL+ +G K+ D G++K R + + GTP
Sbjct: 110 HSNGIIHRDLKPDNILI--DSNGHL--KLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTP 165
Query: 183 LYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFS-IIGDEHSLPE 241
Y+APE ++ D W+LGC++ E L G + + +++F I+ + PE
Sbjct: 166 DYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFH---GETPEEIFQNILNGKIEWPE 222
Query: 242 IPSRVSKEARDFLRRCFVRKPAFRFTA---EMLLDDPFVKGVD 281
VS EA D + + V P R A E + + PF KG+D
Sbjct: 223 DVE-VSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPFFKGID 264
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 112 bits (283), Expect = 5e-29
Identities = 77/279 (27%), Positives = 120/279 (43%), Gaps = 34/279 (12%)
Query: 13 VIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVSASASLQKEKE-------VFDNLNGCP 65
IG+GSFG V + KS+ L K E+ +KEK+ + L P
Sbjct: 7 TIGKGSFGTVRKVRRKSDGKIL----VWK--EIDYGNMTEKEKQQLVSEVNILRELKH-P 59
Query: 66 FVLECFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNG--LPEKDVRHFTRCILE 123
++ + I N + +++EY GG L LI+KC + E+ + +L
Sbjct: 60 NIVRYYDRIIDR-SNQTL--YIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLL 116
Query: 124 GIGHIH---DSGYV--HCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSM 178
+ H D G H D+KP NI L A + K+ D G+AK H F +
Sbjct: 117 ALYECHNRSDPGNTVLHRDLKPANIFLDANNN----VKLGDFGLAKILGH--DSSFAKTY 170
Query: 179 RGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEHS 238
GTP Y++PE + + SDIW+LGC++ E+ + + + + QL S I +
Sbjct: 171 VGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTAR---NQLQLASKIKEGK- 226
Query: 239 LPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFV 277
IP R S E + ++ P R + E LL P +
Sbjct: 227 FRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQLPLI 265
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 6e-29
Identities = 76/275 (27%), Positives = 134/275 (48%), Gaps = 35/275 (12%)
Query: 13 VIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVSASASLQKEKEVFDN---LNGC--PFV 67
IG+G+ G V+ A ++ +A+K + Q ++ + + + C P +
Sbjct: 26 KIGEGASGEVYKATDRATGK----EVAIKKMRLRK----QNKELIINEILIMKDCKHPNI 77
Query: 68 LECFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGH 127
++ + + E +++EY GG+L D+I + + E + + R +L+G+ +
Sbjct: 78 VDYYDSYLVGDE-----LWVVMEYMDGGSLTDIITQNFVR-MNEPQIAYVCREVLQGLEY 131
Query: 128 IHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKR--SRHCKRQKFDPSMRGTPLYL 185
+H +H D+K DNILL ++ G K+AD G A + KR S+ GTP ++
Sbjct: 132 LHSQNVIHRDIKSDNILL--SKDG--SVKLADFGFAAQLTKEKSKRN----SVVGTPYWM 183
Query: 186 APETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEHSLPEI--P 243
APE + + DIW+LG + +EM G ++ + + LF I +P + P
Sbjct: 184 APEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYL--REPPLRALFLIT--TKGIPPLKNP 239
Query: 244 SRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVK 278
+ S E +DFL +C V+ P R +AE LL PF+K
Sbjct: 240 EKWSPEFKDFLNKCLVKDPEKRPSAEELLQHPFLK 274
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 3e-28
Identities = 68/269 (25%), Positives = 116/269 (43%), Gaps = 21/269 (7%)
Query: 12 RVIGQGSFGCVFIAKPKSNSSF--LPPLMAVKSAEVSASASLQKEKEVFDNLNGCPFVLE 69
RVIG+G+FG V I + + + + K E + ++ E+ + LN PF++
Sbjct: 6 RVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNH-PFLVN 64
Query: 70 CFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIH 129
+ ++ E Y L+++ GG L + + E+ V+ + I+ + ++H
Sbjct: 65 LWYS----FQDEENMY-LVVDLLLGGDLRYHLSQ--KVKFSEEQVKFWICEIVLALEYLH 117
Query: 130 DSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMRGTPLYLAPET 189
G +H D+KPDNILL + G I D +A S GTP Y+APE
Sbjct: 118 SKGIIHRDIKPDNILL--DEQGH--VHITDFNIA---TKVTPDTLTTSTSGTPGYMAPEV 170
Query: 190 VVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEHSLPEIPSRVSKE 249
+ + D W+LG E L G++ + DQ+ + E + P+ S E
Sbjct: 171 LCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQ--ETADVLYPATWSTE 228
Query: 250 ARDFLRRCFVRKPAFRF--TAEMLLDDPF 276
A D + + R P R + L + P+
Sbjct: 229 AIDAINKLLERDPQKRLGDNLKDLKNHPY 257
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 109 bits (273), Expect = 9e-28
Identities = 76/270 (28%), Positives = 122/270 (45%), Gaps = 31/270 (11%)
Query: 14 IGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVSASASLQK-----EKEVFDNLNGCPFVL 68
IG+GSFG VF K++ + A+K ++S ++ E V L+ +++
Sbjct: 8 IGKGSFGVVFKVVRKADKR----VYAMKQIDLSKMNRREREEAIDEARVLAKLDS-SYII 62
Query: 69 ---ECFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGI 125
E F ++ G++ N+++EYA G L L++ G LPE V F IL G+
Sbjct: 63 RYYESFLDK------GKL--NIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGL 114
Query: 126 GHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMRGTPLYL 185
H+H +H D+K N+ L A + KI DLGVAK F ++ GTP YL
Sbjct: 115 AHLHSKKILHRDIKSLNLFLDAYDN----VKIGDLGVAKLLS--DNTNFANTIVGTPYYL 168
Query: 186 APETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEHSLPEIPSR 245
+PE SD+WALG V+ E +G+ + ++ + II P +
Sbjct: 169 SPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGAL--ILKII--RGVFPPVSQM 224
Query: 246 VSKEARDFLRRCFVRKPAFRFTAEMLLDDP 275
S++ + +C + R LL +P
Sbjct: 225 YSQQLAQLIDQCLTKDYRQRPDTFQLLRNP 254
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 107 bits (270), Expect = 2e-27
Identities = 80/280 (28%), Positives = 130/280 (46%), Gaps = 47/280 (16%)
Query: 14 IGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVSASASLQKEKEVFDNLNGC--------P 65
+G+GS+G V+ K S++ F A+K ++ + + QKE+E D +N P
Sbjct: 8 LGKGSYGSVYKVKRLSDNQF----YALKEVDLGSMS--QKERE--DAVNEIRILASVNHP 59
Query: 66 FVLECFGEEITMGENGEMAYNLL---LEYAAGGTLGDLIEKCN--GNGLPEKDVRHFTRC 120
++ + E G N L +EYA G L I K +PE+++
Sbjct: 60 NII-SYKEAFLDG-------NKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQ 111
Query: 121 ILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAK--RSRHCKRQKFDPSM 178
+L G+ +H+ +H D+K NILLVA + KI DLG++K + K Q
Sbjct: 112 LLRGLQALHEQKILHRDLKSANILLVAND----LVKIGDLGISKVLKKNMAKTQI----- 162
Query: 179 RGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQL-FSIIGDEH 237
GTP Y+APE SDIW+LGC++ EM + + + S+ L + + ++
Sbjct: 163 -GTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEAR---SMQDLRYKVQRGKY 218
Query: 238 SLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFV 277
P IP S++ ++F+R KP R + +L P V
Sbjct: 219 --PPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILASPAV 256
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 3e-26
Identities = 75/279 (26%), Positives = 140/279 (50%), Gaps = 28/279 (10%)
Query: 12 RVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVSASASLQK----EKEVFDNLNGCPFV 67
+G G+ G V + MAVK+ + + ++QK E ++ N P++
Sbjct: 7 GELGAGNSGVVSKVLHRPTGKI----MAVKTIRLEINEAIQKQILRELDILHKCN-SPYI 61
Query: 68 LECFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGH 127
+ +G NG++ ++ +EY GG+L ++++ G +PE+ + +L+G+ +
Sbjct: 62 VGFYGAFYN---NGDI--SICMEYMDGGSLDKILKEVQG-RIPERILGKIAVAVLKGLTY 115
Query: 128 IHDS-GYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMRGTPLYLA 186
+H+ +H DVKP NIL+ G+ K+ D GV+ + + + F GT Y+A
Sbjct: 116 LHEKHKIIHRDVKPSNILV--NSRGQI--KLCDFGVSGQLVNSLAKTF----VGTSSYMA 167
Query: 187 PETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDC--SIDQLFSIIGDEHSLPEIPS 244
PE + + SDIW+LG ++E+ +GR + + D I +L I +E P +PS
Sbjct: 168 PERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPP-PRLPS 226
Query: 245 -RVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGVDE 282
+ S + +DF+ C ++ P R + + LL+ PF+K +
Sbjct: 227 GKFSPDFQDFVNLCLIKDPRERPSYKELLEHPFIKKYES 265
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 5e-26
Identities = 78/269 (28%), Positives = 127/269 (47%), Gaps = 17/269 (6%)
Query: 10 RGRVIGQGSFGCVFIAKPKSNSSF-LPPLMAVKSAEVSASASLQKEKEVFDNLNGCPFVL 68
+ RV+G+G+FG V + + K++ + + V+ + Q E +V L+ P ++
Sbjct: 4 KIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSH-PNII 62
Query: 69 ECFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHI 128
E + E + A +++EYA GGTL + I+K + L E + HF IL + H+
Sbjct: 63 EYY-ENFLE----DKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHV 117
Query: 129 HDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMRGTPLYLAPE 188
H +H D+K NILL K V KI D G++K K + + ++ GTP Y++PE
Sbjct: 118 HTKLILHRDLKTQNILL---DKHKMVVKIGDFGISK-ILSSKSKAY--TVVGTPCYISPE 171
Query: 189 TVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEHSLPEIPSRVSK 248
SDIWALGCV+ E+ S ++A+ E ++ L I P I R S
Sbjct: 172 LCEGKPYNQKSDIWALGCVLYELASLKRAF---EAANLPALVLKIMSGTFAP-ISDRYSP 227
Query: 249 EARDFLRRCFVRKPAFRFTAEMLLDDPFV 277
+ R + P+ R ++ P
Sbjct: 228 DLRQLILSMLNLDPSKRPQLSQIMAQPIC 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 2e-25
Identities = 59/263 (22%), Positives = 113/263 (42%), Gaps = 26/263 (9%)
Query: 11 GRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVSASAS----LQKEKEVFDNLNGCPF 66
G+ +G+G+FG V+ K +AVK+ + AS +E + L+ P
Sbjct: 4 GKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLD-HPN 62
Query: 67 VLECFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIG 126
+++ G + E M +++EY GG L D + K L D+ F I G+
Sbjct: 63 IVKLLG--VCTEEEPLM---IVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGME 117
Query: 127 HIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMRGTPL--- 183
++ ++H D+ N L+ V KI+D G+++ K ++G L
Sbjct: 118 YLESKNFIHRDLAARNCLV----GENLVVKISDFGLSRDLYDDDYYK----VKGGKLPIR 169
Query: 184 YLAPETVVQHMQEAPSDIWALGCVVLEMLS-GRQAWVVKEDCSIDQLFSIIGDEHSLPEI 242
++APE++ + + SD+W+ G ++ E+ + G + + S ++ + + LP
Sbjct: 170 WMAPESLKEGKFTSKSDVWSFGVLLWEIFTLGEEPY---PGMSNAEVLEYLKKGYRLP-K 225
Query: 243 PSRVSKEARDFLRRCFVRKPAFR 265
P E + +C+ P R
Sbjct: 226 PPNCPPELYKLMLQCWAEDPEDR 248
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 2e-25
Identities = 86/279 (30%), Positives = 127/279 (45%), Gaps = 32/279 (11%)
Query: 10 RGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVSASASLQKEKEVFDNLNGCPFVLE 69
R IG G+ G V+ + + + E + + +E E+ ++N P V++
Sbjct: 78 RVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNH-PNVVK 136
Query: 70 CFGEEITMGE-NGEMAYNLLLEYAAGGTL-GDLIEKCNGNGLPEKDVRHFTRCILEGIGH 127
C M + NGE+ +LLE+ GG+L G I E+ + R IL GI +
Sbjct: 137 CHD----MFDHNGEI--QVLLEFMDGGSLEGTHIAD-------EQFLADVARQILSGIAY 183
Query: 128 IHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDP--SMRGTPLYL 185
+H VH D+KP N+L+ S K V KIAD GV++ Q DP S GT Y+
Sbjct: 184 LHRRHIVHRDIKPSNLLI---NSAKNV-KIADFGVSR----ILAQTMDPCNSSVGTIAYM 235
Query: 186 APETVVQHMQEA-----PSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEHSLP 240
+PE + + DIW+LG +LE GR + V L I P
Sbjct: 236 SPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQP-P 294
Query: 241 EIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKG 279
E P+ S+E R F+ C R+PA R++A LL PF+
Sbjct: 295 EAPATASREFRHFISCCLQREPAKRWSAMQLLQHPFILR 333
|
Length = 353 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 3e-25
Identities = 85/279 (30%), Positives = 141/279 (50%), Gaps = 25/279 (8%)
Query: 7 SWFRGRVIGQGSFGCVFIAKPKSNSSFLP-------PLMAVKSAEVSASASLQKEKEVFD 59
+W G+++G+G+FG V++ L P S EV+A L+ E ++
Sbjct: 3 NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNA---LECEIQLLK 59
Query: 60 NLNGCPFVLECFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTR 119
NL +++ +G + + E ++ +EY GG++ D + K G L E R +TR
Sbjct: 60 NLRH-DRIVQYYG---CLRDPEEKKLSIFVEYMPGGSIKDQL-KAYG-ALTENVTRRYTR 113
Query: 120 CILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRH-CKRQKFDPSM 178
IL+G+ ++H + VH D+K NIL +G K+ D G +KR + C S+
Sbjct: 114 QILQGVSYLHSNMIVHRDIKGANIL--RDSAGN--VKLGDFGASKRIQTICMSGTGIKSV 169
Query: 179 RGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEHS 238
GTP +++PE + +D+W++ C V+EML+ + W E ++ +F I + +
Sbjct: 170 TGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYE--AMAAIFK-IATQPT 226
Query: 239 LPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFV 277
P +P VS RDFL++ FV + R TAE LL PFV
Sbjct: 227 KPMLPDGVSDACRDFLKQIFVEE-KRRPTAEFLLRHPFV 264
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 2e-24
Identities = 67/220 (30%), Positives = 97/220 (44%), Gaps = 39/220 (17%)
Query: 87 LLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLV 146
L+ EY TL +L+E + GLP VR + +L+ I + H +H D+KP+NIL+
Sbjct: 77 LVFEYV-ERTLLELLEA-SPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILV- 133
Query: 147 ATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPS-DIWALG 205
++SG V K+ D G A R+ + T Y APE +V D+WA+G
Sbjct: 134 -SESG--VLKLCDFGFA-RALRARPASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIG 189
Query: 206 CVVLEMLSGRQAWVVKEDCSIDQLFSI---IGD---EH-------------SLPEIPSRV 246
C++ E+L G + D IDQL+ I +G H + PE
Sbjct: 190 CIMAELLDGEPLF--PGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGVAFPEPSQPE 247
Query: 247 SKEAR----------DFLRRCFVRKPAFRFTAEMLLDDPF 276
S E R DFL+ C P R T + LL P+
Sbjct: 248 SLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPY 287
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 99.8 bits (249), Expect = 3e-24
Identities = 77/272 (28%), Positives = 125/272 (45%), Gaps = 29/272 (10%)
Query: 12 RVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVSASASLQKEKEVFDNLNGCPFVLECF 71
RV+G+G+FG + + + S L+ K ++ + EKE D LN +
Sbjct: 6 RVLGKGAFGEATLYRRTEDDS----LVVWKEVNLTRLS----EKERRDALNEIVILSLLQ 57
Query: 72 GEEITMGENGEMAYNLLL---EYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHI 128
I N M N LL EYA GGTL D I + G E+ V + I+ + +I
Sbjct: 58 HPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYI 117
Query: 129 HDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAK----RSRHCKRQKFDPSMRGTPLY 184
H +G +H D+K NI L T++G + K+ D G++K + ++ GTP Y
Sbjct: 118 HKAGILHRDIKTLNIFL--TKAG--LIKLGDFGISKILGSEYSMAE------TVVGTPYY 167
Query: 185 LAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEHSLPEIPS 244
++PE SDIWALGCV+ E+L+ ++ + ++ + I+ ++ + S
Sbjct: 168 MSPELCQGVKYNFKSDIWALGCVLYELLTLKRTF--DATNPLNLVVKIVQGNYTP--VVS 223
Query: 245 RVSKEARDFLRRCFVRKPAFRFTAEMLLDDPF 276
S E + + P R TA+ +LD P
Sbjct: 224 VYSSELISLVHSLLQQDPEKRPTADEVLDQPL 255
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 99.7 bits (248), Expect = 3e-24
Identities = 69/268 (25%), Positives = 131/268 (48%), Gaps = 18/268 (6%)
Query: 12 RVIGQGSFGCVFIAKPKSNS-SFLPPLMAVKSAEVSASASLQKEKEVFDNLNGCPFVLEC 70
RV+G+GS+G V + + +++ ++ + +++A + ++E ++ L V
Sbjct: 6 RVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAY- 64
Query: 71 FGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHD 130
E GE+G + Y +++ + GG L +++ G LPE V + I + ++H+
Sbjct: 65 --RESWEGEDG-LLY-IVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHE 120
Query: 131 SGYVHCDVKPDNILLVATQSGKFVAKIADLGVAK-RSRHCKRQKFDPSMRGTPLYLAPET 189
+H D+K N+ L T + K+ DLG+A+ C ++ GTP Y++PE
Sbjct: 121 KHILHRDLKTQNVFLTRTN----IIKVGDLGIARVLENQCDMAS---TLIGTPYYMSPEL 173
Query: 190 VVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEHSLPEIPSRVSKE 249
SD+WALGC V EM + + A+ K+ S+ ++ II E LP +P S E
Sbjct: 174 FSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSL--VYRII--EGKLPPMPKDYSPE 229
Query: 250 ARDFLRRCFVRKPAFRFTAEMLLDDPFV 277
+ + ++P R + + +L P++
Sbjct: 230 LGELIATMLSKRPEKRPSVKSILRQPYI 257
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 99.7 bits (249), Expect = 3e-24
Identities = 78/286 (27%), Positives = 130/286 (45%), Gaps = 57/286 (19%)
Query: 14 IGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVSAS---ASLQKEKEVFDNLNGC--PFVL 68
IG G++G V+ A+ + L+A+K ++ +Q+E + L C P ++
Sbjct: 11 IGSGTYGDVYKARDIATGE----LVAIKVIKLEPGDDFEIIQQEISM---LKECRHPNIV 63
Query: 69 ECFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHI 128
FG + + +++EY GG+L D+ + G L E + + R L+G+ ++
Sbjct: 64 AYFGSYLRRDK-----LWIVMEYCGGGSLQDIYQVTRGP-LSELQIAYVCRETLKGLAYL 117
Query: 129 HDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRH--CKRQKFDPSMRGTPLYLA 186
H++G +H D+K NILL T+ G K+AD GV+ + KR+ F GTP ++A
Sbjct: 118 HETGKIHRDIKGANILL--TEDGD--VKLADFGVSAQLTATIAKRKSF----IGTPYWMA 169
Query: 187 PETVVQHMQEAP----SDIWALGCVVLEMLSG---------RQAWVVKEDCSIDQLFSII 233
PE V ++ DIWALG +E+ +A LF +I
Sbjct: 170 PE-VAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRA-----------LF-LI 216
Query: 234 GDEHSLP---EIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPF 276
+ P + + S DF+++C + P R TA LL PF
Sbjct: 217 SKSNFPPPKLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQHPF 262
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 99 bits (250), Expect = 4e-24
Identities = 76/297 (25%), Positives = 134/297 (45%), Gaps = 41/297 (13%)
Query: 10 RGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVK---SAEVSASASLQ---KEKEVFDNLNG 63
+ +G GSFG V + + K + + A+K A++ ++ EK + ++
Sbjct: 5 FIKTLGTGSFGRVMLVRHKGSGKY----YALKILSKAKIVKLKQVEHVLNEKRILQSIR- 59
Query: 64 CPFVLECFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILE 123
PF++ +G + ++ + Y L++EY GG L + K PE R + ++
Sbjct: 60 HPFLVNLYG---SFQDDSNL-Y-LVMEYVPGGELFSHLRKSGR--FPEPVARFYAAQVVL 112
Query: 124 GIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMRGTPL 183
+ ++H V+ D+KP+N+LL G KI D G AKR + R ++ GTP
Sbjct: 113 ALEYLHSLDIVYRDLKPENLLL--DSDGYI--KITDFGFAKRVK--GRTY---TLCGTPE 163
Query: 184 YLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFS-IIGDEHSLPEI 242
YLAPE ++ D WALG ++ EML+G + D + Q++ I+ +
Sbjct: 164 YLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFF---DDNPIQIYEKILEGKV---RF 217
Query: 243 PSRVSKEARDFLRRCFVRKPAFRF-----TAEMLLDDPFVKGVDEE--LSRELEGDY 292
PS S +A+D +R R + + P+ G+D L R++E +
Sbjct: 218 PSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNHPWFAGIDWIALLQRKIEAPF 274
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 98.0 bits (245), Expect = 1e-23
Identities = 64/271 (23%), Positives = 119/271 (43%), Gaps = 27/271 (9%)
Query: 11 GRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVSASAS----LQKEKEVFDNLNGCPF 66
G+ +G+G+FG V+ K K +AVK+ + AS +E + L+ P
Sbjct: 4 GKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLD-HPN 62
Query: 67 VLECFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIG 126
V++ G + E +++EY GG L + K N L D+ F I G+
Sbjct: 63 VVKLLG--VCTEEEPLY---IVMEYMEGGDLLSYLRK-NRPKLSLSDLLSFALQIARGME 116
Query: 127 HIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMRGTPL--- 183
++ ++H D+ N L+ V KI+D G+++ + RG L
Sbjct: 117 YLESKNFIHRDLAARNCLV----GENLVVKISDFGLSRDLYDDDYYR----KRGGKLPIR 168
Query: 184 YLAPETVVQHMQEAPSDIWALGCVVLEMLS-GRQAWVVKEDCSIDQLFSIIGDEHSLPEI 242
++APE++ + + SD+W+ G ++ E+ + G Q + S +++ + + + LP
Sbjct: 169 WMAPESLKEGKFTSKSDVWSFGVLLWEIFTLGEQPY---PGMSNEEVLEYLKNGYRLP-Q 224
Query: 243 PSRVSKEARDFLRRCFVRKPAFRFTAEMLLD 273
P E D + +C+ P R T L++
Sbjct: 225 PPNCPPELYDLMLQCWAEDPEDRPTFSELVE 255
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 99.3 bits (248), Expect = 1e-23
Identities = 80/312 (25%), Positives = 130/312 (41%), Gaps = 48/312 (15%)
Query: 12 RVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVSASASLQK------EKEVFDNLNGCP 65
+++G+G G VF+ + K A+K + K E+E+ L+ P
Sbjct: 7 KLLGKGDVGRVFLVRLKGTGKLF----ALKVLDKKEMIKRNKVKRVLTEQEILATLDH-P 61
Query: 66 FVLECFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGI 125
F+ + T E L+++Y GG L L+++ G L E+ R + +L +
Sbjct: 62 FLPTLYASFQT-----ETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLAL 116
Query: 126 GHIHDSGYVHCDVKPDNILL------------VATQSGKF-VAKIADLGVAKRSRHCKRQ 172
++H G V+ D+KP+NILL ++ QS L R
Sbjct: 117 EYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSI 176
Query: 173 KFD-----PSMR-----GTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKE 222
+ PS R GT Y+APE + + D W LG ++ EML G +
Sbjct: 177 PSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGS- 235
Query: 223 DCSIDQLFS-IIGDEHSLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDD----PFV 277
+ D+ FS I+ E + P P VS ARD +R+ V+ P+ R ++ + PF
Sbjct: 236 --NRDETFSNILKKEVTFPGSP-PVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFF 292
Query: 278 KGVDEELSRELE 289
+GV+ L R
Sbjct: 293 RGVNWALIRHTT 304
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 98.7 bits (246), Expect = 1e-23
Identities = 81/274 (29%), Positives = 129/274 (47%), Gaps = 36/274 (13%)
Query: 14 IGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVSASASLQKEKEVFDNLNGC------PFV 67
IG+GS G V IA KS +AVK ++ Q+ +E+ N P +
Sbjct: 27 IGEGSTGIVCIATDKSTGR----QVAVKKMDLRK----QQRRELLFNEVVIMRDYQHPNI 78
Query: 68 LECFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGH 127
+E + + E +++E+ GG L D++ + E+ + +L+ +
Sbjct: 79 VEMYSSYLVGDE-----LWVVMEFLEGGALTDIVTHTR---MNEEQIATVCLAVLKALSF 130
Query: 128 IHDSGYVHCDVKPDNILLVATQSGKFVAKIADLG-VAKRSRHCKRQKFDPSMRGTPLYLA 186
+H G +H D+K D+ILL T G K++D G A+ S+ R+K S+ GTP ++A
Sbjct: 131 LHAQGVIHRDIKSDSILL--TSDG--RVKLSDFGFCAQVSKEVPRRK---SLVGTPYWMA 183
Query: 187 PETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEHSLPEI--PS 244
PE + + DIW+LG +V+EM+ G + + Q I D P++
Sbjct: 184 PEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPL---QAMKRIRDNLP-PKLKNLH 239
Query: 245 RVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVK 278
+VS R FL R VR PA R TA LL+ PF+
Sbjct: 240 KVSPRLRSFLDRMLVRDPAQRATAAELLNHPFLA 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 97.6 bits (243), Expect = 2e-23
Identities = 78/275 (28%), Positives = 119/275 (43%), Gaps = 37/275 (13%)
Query: 14 IGQGSFGCVFIAKPKSNS-SFLPPLMAVKSAEVSASASLQKEKEVFDNLNGCPFVL--EC 70
IG+GSFG + K K + ++ + + +KE V N+ V E
Sbjct: 8 IGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQES 67
Query: 71 FGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHD 130
F E NG + ++++Y GG L I G PE + + I + H+HD
Sbjct: 68 FEE------NGNLY--IVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHD 119
Query: 131 SGYVHCDVKPDNILLVATQSGKFVAKIADLGVAK-------RSRHCKRQKFDPSMRGTPL 183
+H D+K NI L T+ G K+ D G+A+ +R C GTP
Sbjct: 120 RKILHRDIKSQNIFL--TKDG--TIKLGDFGIARVLNSTVELARTCI---------GTPY 166
Query: 184 YLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQL-FSIIGDEHSLPEI 242
YL+PE SDIWALGCV+ EM + + A+ E ++ L II S P +
Sbjct: 167 YLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAF---EAGNMKNLVLKII--RGSYPPV 221
Query: 243 PSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFV 277
S S + R+ + + F R P R + +L+ F+
Sbjct: 222 SSHYSYDLRNLVSQLFKRNPRDRPSVNSILEKNFI 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 97.8 bits (243), Expect = 2e-23
Identities = 78/270 (28%), Positives = 134/270 (49%), Gaps = 31/270 (11%)
Query: 14 IGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVSASAS----LQKEKEVFDNLNGCPFVLE 69
IG+GSFG VF K + ++A+K ++ + +Q+E V + P+V +
Sbjct: 12 IGKGSFGEVF----KGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDS-PYVTK 66
Query: 70 CFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIH 129
+G + + +++EY GG+ DL+E L E + R IL+G+ ++H
Sbjct: 67 YYGSYLK-----DTKLWIIMEYLGGGSALDLLEP---GPLDETQIATILREILKGLDYLH 118
Query: 130 DSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKR--SRHCKRQKFDPSMRGTPLYLAP 187
+H D+K N+LL ++ G+ K+AD GVA + KR F GTP ++AP
Sbjct: 119 SEKKIHRDIKAANVLL--SEHGE--VKLADFGVAGQLTDTQIKRNTF----VGTPFWMAP 170
Query: 188 ETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEHSLPEIPSRVS 247
E + Q ++ +DIW+LG +E+ G E + LF I +++ P + S
Sbjct: 171 EVIKQSAYDSKADIWSLGITAIELAKGEPPH--SELHPMKVLFLI--PKNNPPTLEGNYS 226
Query: 248 KEARDFLRRCFVRKPAFRFTAEMLLDDPFV 277
K ++F+ C ++P+FR TA+ LL F+
Sbjct: 227 KPLKEFVEACLNKEPSFRPTAKELLKHKFI 256
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 97.8 bits (244), Expect = 2e-23
Identities = 70/221 (31%), Positives = 99/221 (44%), Gaps = 41/221 (18%)
Query: 86 NLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILL 145
+L+ EY L +L EK N G+PE ++ L+ + H +H DVKP+NIL+
Sbjct: 76 HLVFEYCDHTVLNEL-EK-NPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILI 133
Query: 146 VATQSGKFVAKIADLGVAKRSRHCKRQKFD-PSMRGTPLYLAPETVVQHMQEAPS-DIWA 203
T+ G K+ D G A R D T Y APE +V Q P D+WA
Sbjct: 134 --TKQG--QIKLCDFGFA---RILTGPGDDYTDYVATRWYRAPELLVGDTQYGPPVDVWA 186
Query: 204 LGCVVLEMLSGRQAWVVKEDCSIDQLFSII---GD---EH-------------SLPEIPS 244
+GCV E+L+G+ W K D +DQL+ I GD H S+PE +
Sbjct: 187 IGCVFAELLTGQPLWPGKSD--VDQLYLIRKTLGDLIPRHQQIFSTNQFFKGLSIPEPET 244
Query: 245 RVSKEAR---------DFLRRCFVRKPAFRFTAEMLLDDPF 276
R E++ FL+ C P R + E LL+ P+
Sbjct: 245 REPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPY 285
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 96.6 bits (240), Expect = 6e-23
Identities = 82/275 (29%), Positives = 132/275 (48%), Gaps = 27/275 (9%)
Query: 14 IGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVSASASLQKEKEVFDNLNGC--PFVLECF 71
+G G+FG V+ AK K + L A K E + L+ + L C P++++
Sbjct: 20 LGDGAFGKVYKAKNKETGA----LAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLL 75
Query: 72 GEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDS 131
G G+ +++E+ GG + ++ + + GL E ++ R +LE + ++H
Sbjct: 76 GAFYWDGK-----LWIMIEFCPGGAVDAIMLELD-RGLTEPQIQVICRQMLEALQYLHSM 129
Query: 132 GYVHCDVKPDNILLVATQSGKFVAKIADLGV-AKRSRHCKRQKFDPSMRGTPLYLAPETV 190
+H D+K N+LL T G K+AD GV AK + +R+ S GTP ++APE V
Sbjct: 130 KIIHRDLKAGNVLL--TLDGDI--KLADFGVSAKNVKTLQRRD---SFIGTPYWMAPEVV 182
Query: 191 V-QHMQEAP----SDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEHSLPEIPSR 245
+ + M++ P +DIW+LG ++EM E + L I E PS+
Sbjct: 183 MCETMKDTPYDYKADIWSLGITLIEMAQIEPPH--HELNPMRVLLKIAKSEPPTLSQPSK 240
Query: 246 VSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGV 280
S E RDFL+ + P R +A LL+ PFV V
Sbjct: 241 WSMEFRDFLKTALDKHPETRPSAAQLLEHPFVSSV 275
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 96.2 bits (240), Expect = 7e-23
Identities = 58/203 (28%), Positives = 86/203 (42%), Gaps = 48/203 (23%)
Query: 108 GLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSR 167
GLPE ++ + +L+G+ H G +H D+KP+N+L+ G V K+AD G+A+
Sbjct: 94 GLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLI--NTEG--VLKLADFGLAR--- 146
Query: 168 HCKRQKFDPSMR------GTPLYLAPETVVQHMQEAPS-DIWALGCVVLEMLSGRQAWVV 220
F +R T Y APE ++ + DIW++GC+ E+LS R +
Sbjct: 147 -----SFGSPVRPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPG 201
Query: 221 KEDCSIDQLFSIIG-----DEHSLPEIPSR----------------------VSKEARDF 253
K + IDQLF I D P+ S S +A D
Sbjct: 202 KSE--IDQLFKIFRTLGTPDPEVWPKFTSLARNYKFSFPKKAGMPLPKLFPNASPQALDL 259
Query: 254 LRRCFVRKPAFRFTAEMLLDDPF 276
L + P R TAE L P+
Sbjct: 260 LSQMLHYDPHKRITAEQALAHPY 282
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 96.0 bits (239), Expect = 1e-22
Identities = 76/297 (25%), Positives = 129/297 (43%), Gaps = 46/297 (15%)
Query: 14 IGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVSA------SASLQKEKEVFDNLNGCPFV 67
IG+G++G V+ A+ K+ L+A+K + +L +E + L+ ++
Sbjct: 9 IGEGTYGKVYKARDKNTGK----LVALKKTRLEMDEEGIPPTAL-REISLLQMLSESIYI 63
Query: 68 LECFGEEITMGENGEMAYNLLLEYAAGG--TLGDLIEKCNGNGLPEKDVRHFTRCILEGI 125
+ E +NG+ + L+ EY D + G LP K ++ F +L+G+
Sbjct: 64 VRLLDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGV 123
Query: 126 GHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMRGTPLYL 185
H H G +H D+KP N+L+ K + KIADLG+ R+ + + + T Y
Sbjct: 124 AHCHKHGVMHRDLKPQNLLV---DKQKGLLKIADLGLG-RAFSIPVKSYTHEIV-TLWYR 178
Query: 186 APETVVQHMQ-EAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSI---IG------- 234
APE ++ P DIW++GC+ EM R+ + D + QL I +G
Sbjct: 179 APEVLLGSTHYSTPVDIWSVGCIFAEMS--RKQPLFPGDSELQQLLHIFKLLGTPTEQVW 236
Query: 235 -------DEHSLPEIPSR--------VSKEARDFLRRCFVRKPAFRFTAEMLLDDPF 276
D H P+ + +S E D L++ PA R +A+ L P+
Sbjct: 237 PGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPY 293
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 96.3 bits (240), Expect = 1e-22
Identities = 82/316 (25%), Positives = 141/316 (44%), Gaps = 36/316 (11%)
Query: 12 RVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVSAS---ASLQKEKEVFDNLNGCPFVL 68
+V+G+GSFG V +A+ K + +K + EK V PF+
Sbjct: 1 KVLGKGSFGKVLLAELKGTDELYA-VKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLT 59
Query: 69 ECFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHI 128
+ T + + ++EY GG L I++ E R + I+ G+ +
Sbjct: 60 QLHSCFQTK----DRLF-FVMEYVNGGDLMFHIQRSGR--FDEPRARFYAAEIVLGLQFL 112
Query: 129 HDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMRGTPLYLAPE 188
H+ G ++ D+K DN+LL S + KIAD G+ K + GTP Y+APE
Sbjct: 113 HERGIIYRDLKLDNVLL---DSEGHI-KIADFGMCKEGI-LGGVT-TSTFCGTPDYIAPE 166
Query: 189 TVVQHMQEAPS-DIWALGCVVLEMLSGRQAWVVKEDCSIDQLF-SIIGDEHSLPEIPSRV 246
++ + P+ D WALG ++ EML+G+ + ++ D+LF SI+ DE P +
Sbjct: 167 -ILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDE---DELFQSILEDE---VRYPRWL 219
Query: 247 SKEARDFLRRCFVRKPAFRFTA-----EMLLDDPFVKGVDEEL--SRELEGDYS---QGE 296
SKEA+ L+ + P R + + PF + +D + +E++ + +G
Sbjct: 220 SKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGHPFFREIDWDKLERKEIKPPFKPKIKGR 279
Query: 297 VTLSNADAESCSPECI 312
+SN D E + +
Sbjct: 280 FDVSNFDDEFTKEKPV 295
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 95.2 bits (238), Expect = 2e-22
Identities = 55/207 (26%), Positives = 86/207 (41%), Gaps = 36/207 (17%)
Query: 97 LGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAK 156
L ++K G L ++ +L G+ + H +H D+KP NIL+ + V K
Sbjct: 84 LKKYLDKRPG-PLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILI----NRDGVLK 138
Query: 157 IADLGVAKRSRHCKRQKFDPSMRGTPLYLAPETVV-QHMQEAPSDIWALGCVVLEMLSGR 215
+AD G+A+ R + T Y APE ++ DIW++GC+ EM++G+
Sbjct: 139 LADFGLARAFGIPLRTYTHEVV--TLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGK 196
Query: 216 QAWVVKEDCSIDQL---FSIIG--DEHSLPEIPS---------------------RVSKE 249
+ D IDQL F I+G E S P + R+ E
Sbjct: 197 P--LFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPTFPKFPPKDLEKVLPRLDPE 254
Query: 250 ARDFLRRCFVRKPAFRFTAEMLLDDPF 276
D L + PA R +A+ L P+
Sbjct: 255 GIDLLSKMLQYNPAKRISAKEALKHPY 281
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 95.5 bits (237), Expect = 2e-22
Identities = 79/275 (28%), Positives = 134/275 (48%), Gaps = 40/275 (14%)
Query: 14 IGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVSASASLQKEKEVFDN----------LNG 63
IG+GS G V IA+ K + +AVK ++ Q+ +E+ N N
Sbjct: 29 IGEGSTGIVCIAREKHSGR----QVAVKMMDLRK----QQRRELLFNEVVIMRDYQHQN- 79
Query: 64 CPFVLECFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILE 123
V+E + + GE + +L+E+ GG L D++ + L E+ + +L+
Sbjct: 80 ---VVEMYKSYLV----GEELW-VLMEFLQGGALTDIVSQTR---LNEEQIATVCESVLQ 128
Query: 124 GIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLG-VAKRSRHCKRQKFDPSMRGTP 182
+ ++H G +H D+K D+ILL T G+ K++D G A+ S+ ++K S+ GTP
Sbjct: 129 ALCYLHSQGVIHRDIKSDSILL--TLDGR--VKLSDFGFCAQISKDVPKRK---SLVGTP 181
Query: 183 LYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEHSLPEI 242
++APE + + DIW+LG +V+EM+ G + D + + + +
Sbjct: 182 YWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYF--SDSPVQAMKRLRDSPPPKLKN 239
Query: 243 PSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFV 277
++S RDFL R R+P R TA+ LLD PF+
Sbjct: 240 AHKISPVLRDFLERMLTREPQERATAQELLDHPFL 274
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 95.0 bits (237), Expect = 2e-22
Identities = 75/301 (24%), Positives = 127/301 (42%), Gaps = 56/301 (18%)
Query: 11 GRVIGQGSFGCVFIAKPKSNSSFLP-PLMAVKSAEVSASASLQKEKEVFDNLNGCPFVLE 69
IG+G+ G VF AK + + +A++ E +E + P+V++
Sbjct: 5 LGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQ-HPYVVK 63
Query: 70 CFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIH 129
+ + +G L++EY L +++ LPE V+ + R +L+G+ ++H
Sbjct: 64 L----LDVFPHGSGFV-LVMEY-MPSDLSEVLRDEE-RPLPEAQVKSYMRMLLKGVAYMH 116
Query: 130 DSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMR------GTPL 183
+G +H D+KP N+L+ A V KIAD G+A R + R T
Sbjct: 117 ANGIMHRDLKPANLLISADG----VLKIADFGLA-------RLFSEEEPRLYSHQVATRW 165
Query: 184 YLAPETVVQHMQEAPS-DIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIG-----DEH 237
Y APE + + P D+WA+GC+ E+L+G + + D I+QL + +E
Sbjct: 166 YRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGEND--IEQLAIVFRTLGTPNEE 223
Query: 238 SLPEI---------------PSR-------VSKEARDFLRRCFVRKPAFRFTAEMLLDDP 275
+ P + P S EA D L+ V P+ R +A L P
Sbjct: 224 TWPGLTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHP 283
Query: 276 F 276
+
Sbjct: 284 Y 284
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 93.9 bits (233), Expect = 4e-22
Identities = 78/272 (28%), Positives = 128/272 (47%), Gaps = 26/272 (9%)
Query: 12 RVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVSASASLQKEKEVFDN------LNGCP 65
+ IG+GSFG +++AK KS+S +K E+ + KEKE P
Sbjct: 6 KKIGEGSFGKIYLAKAKSDSEHC----VIK--EIDLTKMPVKEKEASKKEVILLAKMKHP 59
Query: 66 FVLECFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGI 125
++ F + ENG + +++EY GG L I + G E + + I G+
Sbjct: 60 NIVTFFA---SFQENGRLF--IVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGL 114
Query: 126 GHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMRGTPLYL 185
HIHD +H D+K NI L +++G VAK+ D G+A++ + + GTP YL
Sbjct: 115 KHIHDRKILHRDIKSQNIFL--SKNGM-VAKLGDFGIARQLNDS--MELAYTCVGTPYYL 169
Query: 186 APETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEHSLPEIPSR 245
+PE +DIW+LGCV+ E+ + + + E ++ QL I + P P+
Sbjct: 170 SPEICQNRPYNNKTDIWSLGCVLYELCTLKHPF---EGNNLHQLVLKICQGYFAPISPN- 225
Query: 246 VSKEARDFLRRCFVRKPAFRFTAEMLLDDPFV 277
S++ R + + F P R + +L PF+
Sbjct: 226 FSRDLRSLISQLFKVSPRDRPSITSILKRPFL 257
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 93.1 bits (232), Expect = 8e-22
Identities = 69/263 (26%), Positives = 124/263 (47%), Gaps = 36/263 (13%)
Query: 14 IGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVSAS---ASLQKEKEVFDNLNGCPFVLEC 70
+G G FG V + K KS + L VK + + + EKE+ + N PF++
Sbjct: 1 LGVGGFGRVELVKVKS-KNRTFALKCVKKRHIVETGQQEHIFSEKEILEECN-HPFIV-K 57
Query: 71 F------GEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEG 124
+ I M L+EY GG L ++ G E R + C++
Sbjct: 58 LYRTFKDKKYIYM----------LMEYCLGGELWTILRD-RGL-FDEYTARFYIACVVLA 105
Query: 125 IGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMRGTPLY 184
++H+ G ++ D+KP+N+LL +G +V K+ D G AK+ + ++ + GTP Y
Sbjct: 106 FEYLHNRGIIYRDLKPENLLL--DSNG-YV-KLVDFGFAKKLKSGQKTW---TFCGTPEY 158
Query: 185 LAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQL--FSIIGDEHSLPEI 242
+APE ++ + D W+LG ++ E+L+GR + ++ D + ++ I + E
Sbjct: 159 VAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDE---DPMEIYNDILKGNGKLEF 215
Query: 243 PSRVSKEARDFLRRCFVRKPAFR 265
P+ + K A+D +++ R P R
Sbjct: 216 PNYIDKAAKDLIKQLLRRNPEER 238
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 94.0 bits (234), Expect = 1e-21
Identities = 93/320 (29%), Positives = 150/320 (46%), Gaps = 59/320 (18%)
Query: 13 VIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVSAS---ASLQKEKEVFDNLNGC--PFV 67
V+G+G FG V +A+ K L + A+K ++ A SL EK +F+ N PF+
Sbjct: 6 VLGRGHFGKVLLAEYKKTGE-LYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFL 64
Query: 68 LE---CFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEG 124
+ CF E + ++EYAAGG DL+ + + E + C++ G
Sbjct: 65 VNLFACFQTE-------DHVC-FVMEYAAGG---DLMMHIHTDVFSEPRAVFYAACVVLG 113
Query: 125 IGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKR--------SRHCKRQKFDP 176
+ ++H++ V+ D+K DN+LL G FV KIAD G+ K S C
Sbjct: 114 LQYLHENKIVYRDLKLDNLLL--DTEG-FV-KIADFGLCKEGMGFGDRTSTFC------- 162
Query: 177 SMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLF-SIIGD 235
GTP +LAPE + + D W LG ++ EML G + ++ +++F SI+ D
Sbjct: 163 ---GTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDE---EEVFDSIVND 216
Query: 236 EHSLPEIPSRVSKEARDFLRRCFVRKPAFRF-----TAEMLLDDPFVKGVDEE--LSREL 288
E P +S+EA +RR R P R AE + PF + ++ + L+R++
Sbjct: 217 E---VRYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQPFFRDINWDDLLARKI 273
Query: 289 EGDYS---QGEVTLSNADAE 305
+ + +G +SN D E
Sbjct: 274 KPPFVPTIKGPEDVSNFDEE 293
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 93.1 bits (232), Expect = 3e-21
Identities = 82/312 (26%), Positives = 133/312 (42%), Gaps = 58/312 (18%)
Query: 13 VIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVSA------SASLQKEKEVFDNLNGCPF 66
VIG+G+FG V++ + K + A+K S A ++ E+++ + + P+
Sbjct: 8 VIGRGAFGEVWLVRDKDTGQ----VYAMKVLRKSDMIKRNQIAHVRAERDILADAD-SPW 62
Query: 67 VLECFGEEITMGENGEMAYNLLLEYAAGGTL-GDLIEKCNGNGLPEKDVRHFTRCILEGI 125
+++ + E L++EY GG L LI K + PE+ R + ++ +
Sbjct: 63 IVKLY-----YSFQDEEHLYLVMEYMPGGDLMNLLIRK---DVFPEETARFYIAELVLAL 114
Query: 126 GHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMR------ 179
+H G++H D+KPDNIL+ G K+AD G+ K+ K +++ +
Sbjct: 115 DSVHKLGFIHRDIKPDNILI--DADGHI--KLADFGLCKKMNKAKDREYYLNDSHNLLFR 170
Query: 180 ---------------------GTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAW 218
GTP Y+APE + D W+LG ++ EML G +
Sbjct: 171 DNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPF 230
Query: 219 VVKEDCSIDQLFSIIGDEHSLPEIPS--RVSKEARDFLRRCFVRKPAFRFT-AEMLLDDP 275
D + II + SL P VS EA D + R + P R E + P
Sbjct: 231 Y--SDTLQETYNKIINWKESL-RFPPDPPVSPEAIDLICR-LLCDPEDRLGSFEEIKSHP 286
Query: 276 FVKGVDEELSRE 287
F KG+D E RE
Sbjct: 287 FFKGIDWENLRE 298
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 90.9 bits (226), Expect = 5e-21
Identities = 59/204 (28%), Positives = 96/204 (47%), Gaps = 27/204 (13%)
Query: 87 LLLEYAAGGTLGDLIE-KCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILL 145
L++ Y +GG+L D+++ GL E + + +L+G+ ++H +G +H D+K NILL
Sbjct: 76 LVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILL 135
Query: 146 VATQSGKFVAKIADLGVA----------KRSRHCKRQKFDPSMRGTPLYLAPETVVQ-HM 194
S KIAD GV+ ++ R + GTP ++APE + Q H
Sbjct: 136 GEDGS----VKIADFGVSASLADGGDRTRKVRK--------TFVGTPCWMAPEVMEQVHG 183
Query: 195 QEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEHSLPE--IPSRVSKEARD 252
+ +DIW+ G +E+ +G A K + ++ D SL + SK R
Sbjct: 184 YDFKADIWSFGITAIELATGA-APYSKYPPMKVLMLTLQNDPPSLETGADYKKYSKSFRK 242
Query: 253 FLRRCFVRKPAFRFTAEMLLDDPF 276
+ C + P+ R TAE LL F
Sbjct: 243 MISLCLQKDPSKRPTAEELLKHKF 266
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 90.5 bits (224), Expect = 9e-21
Identities = 76/270 (28%), Positives = 130/270 (48%), Gaps = 31/270 (11%)
Query: 14 IGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVSASAS----LQKEKEVFDNLNGCPFVLE 69
IG+GSFG V+ K + ++A+K ++ + +Q+E V + P++
Sbjct: 12 IGKGSFGEVY----KGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDS-PYITR 66
Query: 70 CFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIH 129
+G + G + +++EY GG+ DL++ L E + R IL+G+ ++H
Sbjct: 67 YYGSYL----KGTKLW-IIMEYLGGGSALDLLKP---GPLEETYIATILREILKGLDYLH 118
Query: 130 DSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKR--SRHCKRQKFDPSMRGTPLYLAP 187
+H D+K N+LL ++ G K+AD GVA + KR F GTP ++AP
Sbjct: 119 SERKIHRDIKAANVLL--SEQGD--VKLADFGVAGQLTDTQIKRNTF----VGTPFWMAP 170
Query: 188 ETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEHSLPEIPSRVS 247
E + Q + +DIW+LG +E+ G + LF I ++S P + + S
Sbjct: 171 EVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRV--LFLI--PKNSPPTLEGQYS 226
Query: 248 KEARDFLRRCFVRKPAFRFTAEMLLDDPFV 277
K ++F+ C + P FR TA+ LL F+
Sbjct: 227 KPFKEFVEACLNKDPRFRPTAKELLKHKFI 256
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 90.5 bits (224), Expect = 1e-20
Identities = 83/286 (29%), Positives = 131/286 (45%), Gaps = 33/286 (11%)
Query: 14 IGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVSASASLQKEKEVFDNLNGCPF-----VL 68
+G G+FG V+ A+ K L A K + + L+ D L C +L
Sbjct: 13 LGDGAFGKVYKAQNKETGV----LAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLL 68
Query: 69 ECFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHI 128
+ F E + +L+E+ AGG + ++ + L E +R + LE + ++
Sbjct: 69 DAFYYENNLW--------ILIEFCAGGAVDAVMLELE-RPLTEPQIRVVCKQTLEALNYL 119
Query: 129 HDSGYVHCDVKPDNILLVATQSGKFVAKIADLGV-AKRSRHCKRQKFDPSMRGTPLYLAP 187
H++ +H D+K NIL T G K+AD GV AK +R +R+ S GTP ++AP
Sbjct: 120 HENKIIHRDLKAGNILF--TLDGDI--KLADFGVSAKNTRTIQRRD---SFIGTPYWMAP 172
Query: 188 ETVV-QHMQEAP----SDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEHSLPEI 242
E V+ + ++ P +D+W+LG ++EM E + L I E
Sbjct: 173 EVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPH--HELNPMRVLLKIAKSEPPTLAQ 230
Query: 243 PSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGVDEELSREL 288
PSR S E +DFL++C + R+T LL PFV + REL
Sbjct: 231 PSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHPFVTVNSNKPIREL 276
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 90.1 bits (223), Expect = 1e-20
Identities = 85/281 (30%), Positives = 133/281 (47%), Gaps = 52/281 (18%)
Query: 14 IGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVSASASLQKEKEVFDNLNGCPFVLECFGE 73
IG+GS G V IA KS+ L+AVK ++ Q+ +E+ F E
Sbjct: 28 IGEGSTGIVCIATVKSSGK----LVAVKKMDLRK----QQRRELL------------FNE 67
Query: 74 EITM----GENGEMAYN---------LLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRC 120
+ M EN YN +++E+ GG L D++ N E+ +
Sbjct: 68 VVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMN---EEQIAAVCLA 124
Query: 121 ILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLG-VAKRSRHCKRQKFDPSMR 179
+L+ + +H G +H D+K D+ILL T G+ K++D G A+ S+ R+K S+
Sbjct: 125 VLKALSVLHAQGVIHRDIKSDSILL--THDGR--VKLSDFGFCAQVSKEVPRRK---SLV 177
Query: 180 GTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEHSL 239
GTP ++APE + + DIW+LG +V+EM+ G + + + +I D +L
Sbjct: 178 GTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL---KAMKMIRD--NL 232
Query: 240 P---EIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFV 277
P + +VS + FL R VR PA R TA LL PF+
Sbjct: 233 PPKLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFL 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 89.3 bits (221), Expect = 2e-20
Identities = 75/270 (27%), Positives = 131/270 (48%), Gaps = 31/270 (11%)
Query: 14 IGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVSASAS----LQKEKEVFDNLNGCPFVLE 69
IG+GSFG VF K + ++A+K ++ + +Q+E V + P+V +
Sbjct: 12 IGKGSFGEVF----KGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDS-PYVTK 66
Query: 70 CFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIH 129
+G + G + +++EY GG+ DL+ E + + IL+G+ ++H
Sbjct: 67 YYGSYL----KGTKLW-IIMEYLGGGSALDLLR---AGPFDEFQIATMLKEILKGLDYLH 118
Query: 130 DSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKR--SRHCKRQKFDPSMRGTPLYLAP 187
+H D+K N+LL ++ G K+AD GVA + KR F GTP ++AP
Sbjct: 119 SEKKIHRDIKAANVLL--SEQGD--VKLADFGVAGQLTDTQIKRNTF----VGTPFWMAP 170
Query: 188 ETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEHSLPEIPSRVS 247
E + Q ++ +DIW+LG +E+ G + + LF I +++ P + S
Sbjct: 171 EVIQQSAYDSKADIWSLGITAIELAKGEPP--NSDMHPMRVLFLI--PKNNPPTLTGEFS 226
Query: 248 KEARDFLRRCFVRKPAFRFTAEMLLDDPFV 277
K ++F+ C + P+FR TA+ LL F+
Sbjct: 227 KPFKEFIDACLNKDPSFRPTAKELLKHKFI 256
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 89.5 bits (222), Expect = 3e-20
Identities = 81/284 (28%), Positives = 127/284 (44%), Gaps = 25/284 (8%)
Query: 12 RVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVSASASLQK---EKEVFDNLNGCPFVL 68
+V+G+GSFG V +A+ K + F + A+K V ++ E+ V PF+
Sbjct: 1 KVLGKGSFGKVMLAELKGTNEFFA-IKALKKDVVLEDDDVECTMVERRVLALAWEHPFLT 59
Query: 69 ECFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHI 128
F T + + ++EY GG L I+ E R + I+ G+ +
Sbjct: 60 HLF---CTFQTKEHLFF--VMEYLNGGDLMFHIQSSGR--FDEARARFYAAEIICGLQFL 112
Query: 129 HDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMRGTPLYLAPE 188
H G ++ D+K DN+LL + G KIAD G+ K + + + GTP Y+APE
Sbjct: 113 HKKGIIYRDLKLDNVLL--DKDGHI--KIADFGMCKE--NMNGEGKASTFCGTPDYIAPE 166
Query: 189 TVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEHSLPEIPSRVSK 248
+ D W+ G ++ EML G+ + D+LF I + P P +SK
Sbjct: 167 ILKGQKYNESVDWWSFGVLLYEMLIGQSPF---HGEDEDELFDSI--LNDRPHFPRWISK 221
Query: 249 EARDFLRRCFVRKPAFRF-TAEMLLDDPFVKGVDEEL--SRELE 289
EA+D L + F R P R + PF +G+D E RE+
Sbjct: 222 EAKDCLSKLFERDPTKRLGVDGDIRQHPFFRGIDWERLEKREIP 265
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 89.6 bits (222), Expect = 3e-20
Identities = 87/300 (29%), Positives = 137/300 (45%), Gaps = 52/300 (17%)
Query: 12 RVIGQGSFGCVFIAKPKSNSSFLPPLMAVK---------SAEVSASASLQKEKEVFDNLN 62
RV+G+GSFG V +A+ K + L AVK +V + + EK +
Sbjct: 1 RVLGKGSFGKVMLARLKESGR----LYAVKVLKKDVILQDDDVECTMT---EKRILSLAR 53
Query: 63 GCPFVLE---CFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTR 119
PF+ + CF + + + ++E+ GG L I+K E R +
Sbjct: 54 NHPFLTQLYCCF-------QTPDRLF-FVMEFVNGGDLMFHIQKSRR--FDEARARFYAA 103
Query: 120 CILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMR 179
I + +HD G ++ D+K DN+LL G K+AD G+ K K +
Sbjct: 104 EITSALMFLHDKGIIYRDLKLDNVLL--DHEGH--CKLADFGMCKEGIF--NGKTTSTFC 157
Query: 180 GTPLYLAPETVVQHMQEAPS-DIWALGCVVLEMLSGRQAWVVKEDCSIDQLF-SIIGDEH 237
GTP Y+APE ++Q M PS D WA+G ++ EML G + + + D LF +I+ DE
Sbjct: 158 GTPDYIAPE-ILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENE---DDLFEAILNDEV 213
Query: 238 SLPEIPSRVSKEARDFLRRCFVRKPAFRFTA------EMLLDDPFVKGVDEEL--SRELE 289
P+ +S++A D L+ + P R + E +L PF K +D E R++E
Sbjct: 214 VY---PTWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRHPFFKELDWEKLNRRQIE 270
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 88.0 bits (219), Expect = 5e-20
Identities = 64/272 (23%), Positives = 113/272 (41%), Gaps = 39/272 (14%)
Query: 12 RVIGQGSFGCVF--IAKPKSNSSFLPPLMAVKSAEVSASASLQKEKEVFDNLN-----GC 64
+ +G+G+FG V+ K K + +AVK+ + AS ++ K+ G
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTT---EVAVKT--LKEDASEEERKDFLKEARVMKKLGH 55
Query: 65 PFVLECFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKC-------NGNGLPEKDVRHF 117
P V+ G + E L+LEY GG L D + K + L KD+ F
Sbjct: 56 PNVVRLLG--VCTEEEPLY---LVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSF 110
Query: 118 TRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPS 177
I +G+ ++ +VH D+ N L+ V KI+D G+ SR +
Sbjct: 111 AIQIAKGMEYLASKKFVHRDLAARNCLV----GEDLVVKISDFGL---SRDVYDDDYYRK 163
Query: 178 MRGTPL---YLAPETVVQHMQEAPSDIWALGCVVLEMLS-GRQAWVVKEDCSIDQLFSII 233
G L ++APE++ + + SD+W+ G ++ E+ + G + S +++ +
Sbjct: 164 KTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPY---PGLSNEEVLEYL 220
Query: 234 GDEHSLPEIPSRVSKEARDFLRRCFVRKPAFR 265
+ LP P E + + C+ P R
Sbjct: 221 RKGYRLP-KPEYCPDELYELMLSCWQLDPEDR 251
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 88.6 bits (219), Expect = 6e-20
Identities = 62/195 (31%), Positives = 96/195 (49%), Gaps = 17/195 (8%)
Query: 87 LLLEYAAGGTLGDLI-EKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILL 145
+++EY AGG+L D++ E C + E + R L+ + +H + +H D+K DNILL
Sbjct: 93 VVMEYLAGGSLTDVVTETC----MDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILL 148
Query: 146 VATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALG 205
S K+ D G ++ Q +M GTP ++APE V + DIW+LG
Sbjct: 149 GMDGS----VKLTDFGFC--AQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLG 202
Query: 206 CVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEHSLPEI--PSRVSKEARDFLRRCFVRKPA 263
+ +EM+ G ++ + L + G PE+ P R+S RDFL RC
Sbjct: 203 IMAIEMVEGEPPYLNENPLRALYLIATNGT----PELQNPERLSAVFRDFLNRCLEMDVD 258
Query: 264 FRFTAEMLLDDPFVK 278
R +A+ LL PF+K
Sbjct: 259 RRGSAKELLQHPFLK 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 88.1 bits (219), Expect = 8e-20
Identities = 76/304 (25%), Positives = 125/304 (41%), Gaps = 65/304 (21%)
Query: 14 IGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVSASA-----------SLQKEKEVFDNLN 62
IG+G++G V+ A+ + F+ A+K V S +L K+ E F+
Sbjct: 7 IGEGAYGTVYKARDLNTGRFV----ALKKVRVPLSEEGIPLSTLREIALLKQLESFE--- 59
Query: 63 GCPFVLECFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCIL 122
P ++ + E+ L+ E+ L + KC GLP + ++ R +L
Sbjct: 60 -HPNIVRLLDVCHGPRTDRELKLTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLL 117
Query: 123 EGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMRGTP 182
G+ +H VH D+KP NIL+ T G+ KIAD G+A+ + M T
Sbjct: 118 RGVDFLHSHRIVHRDLKPQNILV--TSDGQV--KIADFGLAR--------IYSFEMALTS 165
Query: 183 L-----YLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQL---FSIIG 234
+ Y APE ++Q P D+W++GC+ E+ R+ + + DQL F +IG
Sbjct: 166 VVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFR-RRP-LFRGTSEADQLDKIFDVIG 223
Query: 235 --DEHSLPE--------------------IPSRVSKEARDFLRRCFVRKPAFRFTAEMLL 272
E P +P + +E D L++ P R +A L
Sbjct: 224 LPSEEEWPRNVSLPRSSFPSYTPRSFKSFVPE-ICEEGLDLLKKMLTFNPHKRISAFEAL 282
Query: 273 DDPF 276
P+
Sbjct: 283 QHPY 286
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 87.4 bits (216), Expect = 1e-19
Identities = 82/284 (28%), Positives = 130/284 (45%), Gaps = 56/284 (19%)
Query: 14 IGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVSASASLQKEKEVFDNLNGCPFVLECFGE 73
IG+GS G V IA K +AVK ++ Q+ +E+ F E
Sbjct: 30 IGEGSTGIVCIATEKHTGK----QVAVKKMDLRK----QQRRELL------------FNE 69
Query: 74 EITM----GENGEMAYN---------LLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRC 120
+ M EN YN +++E+ GG L D++ N E+ +
Sbjct: 70 VVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMN---EEQIATVCLS 126
Query: 121 ILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLG-VAKRSRHCKRQKFDPSMR 179
+L + ++H+ G +H D+K D+ILL T G+ K++D G A+ S+ ++K S+
Sbjct: 127 VLRALSYLHNQGVIHRDIKSDSILL--TSDGRI--KLSDFGFCAQVSKEVPKRK---SLV 179
Query: 180 GTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSI-----DQLFSIIG 234
GTP ++APE + + DIW+LG +V+EM+ G + + D L +
Sbjct: 180 GTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPRVK 239
Query: 235 DEHSLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVK 278
D H +VS R FL VR+P+ R TA+ LL PF+K
Sbjct: 240 DSH-------KVSSVLRGFLDLMLVREPSQRATAQELLQHPFLK 276
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 87.2 bits (216), Expect = 1e-19
Identities = 56/206 (27%), Positives = 92/206 (44%), Gaps = 25/206 (12%)
Query: 87 LLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLV 146
L++ GG L I G PE + I+ G+ H+H V+ D+KP+N+LL
Sbjct: 70 LVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLL- 128
Query: 147 ATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGC 206
G +I+DLG+A K K GTP Y+APE + + + D +ALGC
Sbjct: 129 -DDHGN--VRISDLGLAV---ELKGGKKIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGC 182
Query: 207 VVLEMLSGRQAW------VVKEDCSIDQLFSIIGDEHSLPEIPSRVSKEARDFLRRCFVR 260
+ EM++GR + V KE+ + + + P+ + S EA+D +
Sbjct: 183 TLYEMIAGRSPFRQRKEKVEKEE--LKRR--TLEMAVEYPD---KFSPEAKDLCEALLQK 235
Query: 261 KPAFRF-----TAEMLLDDPFVKGVD 281
P R +A+ + + P K ++
Sbjct: 236 DPEKRLGCRGGSADEVREHPLFKDLN 261
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 85.8 bits (212), Expect = 3e-19
Identities = 69/271 (25%), Positives = 127/271 (46%), Gaps = 25/271 (9%)
Query: 14 IGQGSFGCVFIAKPKS--NSSFLPPLMAVKSAEVSASASLQ--KEKEVFDNLNGCPFVLE 69
+G+GSFG V++ K K L L + E++ + ++Q +E ++ L+ P +++
Sbjct: 8 LGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDH-PAIVK 66
Query: 70 CFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNG--LPEKDVRHFTRCILEGIGH 127
+ E A+ ++ EY G L +E+ G L E V + +L G+ +
Sbjct: 67 FHASFL---ERD--AFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHY 121
Query: 128 IHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAK-RSRHCKRQKFDPSMRGTPLYLA 186
+H +H D+K NI L + KI D GV++ C + GTP Y++
Sbjct: 122 MHQRRILHRDLKAKNIFL-----KNNLLKIGDFGVSRLLMGSCD---LATTFTGTPYYMS 173
Query: 187 PETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEHSLPEIPSRV 246
PE + ++ SDIW+LGC++ EM A+ + S+ + I+ E P +P
Sbjct: 174 PEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSV--VLRIV--EGPTPSLPETY 229
Query: 247 SKEARDFLRRCFVRKPAFRFTAEMLLDDPFV 277
S++ ++ + P+ R +A +L +PF+
Sbjct: 230 SRQLNSIMQSMLNKDPSLRPSAAEILRNPFI 260
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 85.5 bits (211), Expect = 5e-19
Identities = 62/200 (31%), Positives = 99/200 (49%), Gaps = 22/200 (11%)
Query: 87 LLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLV 146
L++E+ G++ DLI+ GN L E+ + + R IL G+ H+H +H D+K N+LL
Sbjct: 86 LVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLT 145
Query: 147 ATQSGKFVAKIADLGV-AKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAP------- 198
K+ D GV A+ R R+ + GTP ++APE + E P
Sbjct: 146 ENAE----VKLVDFGVSAQLDRTVGRRN---TFIGTPYWMAPEVIA--CDENPDATYDFK 196
Query: 199 SDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEHSLPEIPSRV-SKEARDFLRRC 257
SD+W+LG +EM G A + + + LF I + P + S+ SK+ + F+ C
Sbjct: 197 SDLWSLGITAIEMAEG--APPLCDMHPMRALFLI--PRNPAPRLKSKKWSKKFQSFIESC 252
Query: 258 FVRKPAFRFTAEMLLDDPFV 277
V+ + R T E L+ PF+
Sbjct: 253 LVKNHSQRPTTEQLMKHPFI 272
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 85.4 bits (211), Expect = 6e-19
Identities = 64/200 (32%), Positives = 98/200 (49%), Gaps = 22/200 (11%)
Query: 87 LLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLV 146
L++E+ G++ DL++ GN L E + + R IL G+ H+H +H D+K N+LL
Sbjct: 96 LVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLT 155
Query: 147 ATQSGKFVAKIADLGV-AKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAP------- 198
K V D GV A+ R R+ + GTP ++APE + E P
Sbjct: 156 ENAEVKLV----DFGVSAQLDRTVGRRN---TFIGTPYWMAPEVIA--CDENPDATYDYR 206
Query: 199 SDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEHSLPEIPSRV-SKEARDFLRRC 257
SDIW+LG +EM G A + + + LF I + P++ S+ SK+ DF+ C
Sbjct: 207 SDIWSLGITAIEMAEG--APPLCDMHPMRALFLI--PRNPPPKLKSKKWSKKFIDFIEGC 262
Query: 258 FVRKPAFRFTAEMLLDDPFV 277
V+ R + E LL PF+
Sbjct: 263 LVKNYLSRPSTEQLLKHPFI 282
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 85.5 bits (211), Expect = 6e-19
Identities = 60/195 (30%), Positives = 96/195 (49%), Gaps = 17/195 (8%)
Query: 87 LLLEYAAGGTLGDLI-EKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILL 145
+++EY AGG+L D++ E C + E + R L+ + +H + +H D+K DN+LL
Sbjct: 93 VVMEYLAGGSLTDVVTETC----MDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLL 148
Query: 146 VATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALG 205
S K+ D G ++ Q +M GTP ++APE V + DIW+LG
Sbjct: 149 GMDGS----VKLTDFGFC--AQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLG 202
Query: 206 CVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEHSLPEI--PSRVSKEARDFLRRCFVRKPA 263
+ +EM+ G ++ + L + G PE+ P ++S RDFL RC
Sbjct: 203 IMAIEMVEGEPPYLNENPLRALYLIATNGT----PELQNPEKLSPIFRDFLNRCLEMDVE 258
Query: 264 FRFTAEMLLDDPFVK 278
R +A+ LL PF+K
Sbjct: 259 KRGSAKELLQHPFLK 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 84.4 bits (209), Expect = 1e-18
Identities = 58/198 (29%), Positives = 95/198 (47%), Gaps = 23/198 (11%)
Query: 87 LLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLV 146
+++EYA GG++ L++ + EK + R +L + +IH G +H D+K NIL+
Sbjct: 79 IIMEYAEGGSVRTLMK---AGPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILV- 134
Query: 147 ATQSGKFVAKIADLGVAKR--SRHCKRQKFDPSMRGTPLYLAPETVVQ-HMQEAPSDIWA 203
T +G K+ D GVA KR F GTP ++APE + + + +DIW+
Sbjct: 135 -TNTGN--VKLCDFGVAALLNQNSSKRSTF----VGTPYWMAPEVITEGKYYDTKADIWS 187
Query: 204 LGCVVLEMLSGRQAWVVKEDCSIDQLFSI--IGDEHSLPEIPSR-VSKEARDFLRRCFVR 260
LG + EM +G + +D ++ I P + SK R+F+ C
Sbjct: 188 LGITIYEMATGNPPY-----SDVDAFRAMMLIPKSKP-PRLEDNGYSKLLREFVAACLDE 241
Query: 261 KPAFRFTAEMLLDDPFVK 278
+P R +AE LL ++K
Sbjct: 242 EPKERLSAEELLKSKWIK 259
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 84.6 bits (209), Expect = 1e-18
Identities = 77/281 (27%), Positives = 124/281 (44%), Gaps = 50/281 (17%)
Query: 14 IGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVSASASLQKEKEVFDNLNGCPFVLECFGE 73
IGQG+ G V+ A + +A+K + Q +KE+ N E
Sbjct: 27 IGQGASGTVYTAIDVATGQ----EVAIKQMNLQQ----QPKKELIIN------------E 66
Query: 74 EITMGEN--------------GEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTR 119
+ M EN G+ + +++EY AGG+L D++ + + E + R
Sbjct: 67 ILVMRENKHPNIVNYLDSYLVGDELW-VVMEYLAGGSLTDVVTETC---MDEGQIAAVCR 122
Query: 120 CILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMR 179
L+ + +H + +H D+K DNILL S K+ D G ++ Q +M
Sbjct: 123 ECLQALEFLHSNQVIHRDIKSDNILLGMDGS----VKLTDFGFC--AQITPEQSKRSTMV 176
Query: 180 GTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEHSL 239
GTP ++APE V + DIW+LG + +EM+ G ++ + L + G
Sbjct: 177 GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGT---- 232
Query: 240 PEI--PSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVK 278
PE+ P ++S RDFL RC R +A+ LL PF+K
Sbjct: 233 PELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHPFLK 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 84.0 bits (208), Expect = 2e-18
Identities = 70/281 (24%), Positives = 130/281 (46%), Gaps = 33/281 (11%)
Query: 14 IGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVSASASLQKE--KEV-FDNLNGCPFVLEC 70
+G+G+ G V + K+ + A+K+ + LQK+ +E+ + P++++
Sbjct: 9 LGEGAGGSVTKCRLKNTGM----IFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKY 64
Query: 71 FGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKC--NGNGLPEKDVRHFTRCILEGIGHI 128
+G + + + +EY GG+L + +K G + EK + +L+G+ ++
Sbjct: 65 YG---AFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYL 121
Query: 129 HDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMRGTPLYLAPE 188
H +H D+KP NILL T+ G K+ D GV+ + GT Y+APE
Sbjct: 122 HSRKIIHRDIKPSNILL--TRKG--QVKLCDFGVSGEL----VNSLAGTFTGTSFYMAPE 173
Query: 189 TVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCS---IDQLFSIIG-------DEHS 238
+ SD+W+LG +LE+ R + + + I+ L I+ DE
Sbjct: 174 RIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDE-- 231
Query: 239 LPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKG 279
P + S+E +DF+++C + P R T +L+ P++K
Sbjct: 232 -PGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKA 271
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 83.0 bits (205), Expect = 4e-18
Identities = 77/302 (25%), Positives = 135/302 (44%), Gaps = 54/302 (17%)
Query: 14 IGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVSASAS----LQKEKEVFDNLNGCPFVLE 69
+G+G++G V+ + MA+K + S + E ++ P++++
Sbjct: 9 LGKGNYGSVYKVLHRPTGV----TMAMKEIRLELDESKFNQIIMELDILHKAVS-PYIVD 63
Query: 70 CFGEEITMGENGEMAYNLLLEYAAGGTLGDLI-EKCNGNGLPEKDVRHFTRCILEGIGHI 128
+G E A + +EY G+L L G+PE +R T +++G+ +
Sbjct: 64 FYGAFFI-----EGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFL 118
Query: 129 HDS-GYVHCDVKPDNILLVATQSGKFVAKIADLGV--------AKRSRHCKRQKFDPSMR 179
+ +H DVKP N+L+ +G K+ D GV AK + C+
Sbjct: 119 KEEHNIIHRDVKPTNVLV----NGNGQVKLCDFGVSGNLVASLAKTNIGCQS-------- 166
Query: 180 GTPLYLAPETV-VQHMQEAP-----SDIWALGCVVLEMLSGRQAWVVKEDCSI-DQLFSI 232
Y+APE + + P SD+W+LG +LEM GR + + +I QL +I
Sbjct: 167 ----YMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAI 222
Query: 233 I-GDEHSLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFV---KGVDEELSREL 288
+ GD P +PS S +A+DF+ +C + P R T LL+ P++ K D +++ +
Sbjct: 223 VDGDP---PTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKYKNADVDMAEWV 279
Query: 289 EG 290
G
Sbjct: 280 TG 281
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 82.5 bits (203), Expect = 8e-18
Identities = 60/195 (30%), Positives = 95/195 (48%), Gaps = 17/195 (8%)
Query: 87 LLLEYAAGGTLGDLI-EKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILL 145
+++EY AGG+L D++ E C + E + R L+ + +H + +H D+K DNILL
Sbjct: 94 VVMEYLAGGSLTDVVTETC----MDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILL 149
Query: 146 VATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALG 205
S K+ D G ++ Q +M GTP ++APE V + DIW+LG
Sbjct: 150 GMDGS----VKLTDFGFC--AQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLG 203
Query: 206 CVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEHSLPEI--PSRVSKEARDFLRRCFVRKPA 263
+ +EM+ G ++ + L + G PE+ P ++S RDFL RC
Sbjct: 204 IMAIEMIEGEPPYLNENPLRALYLIATNGT----PELQNPEKLSAIFRDFLNRCLDMDVE 259
Query: 264 FRFTAEMLLDDPFVK 278
R +A+ LL F+K
Sbjct: 260 KRGSAKELLQHQFLK 274
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 82.9 bits (205), Expect = 8e-18
Identities = 89/323 (27%), Positives = 145/323 (44%), Gaps = 54/323 (16%)
Query: 12 RVIGQGSFGCVFIAKPKSNS-----SFLPPLMAVKSAEVSASASLQKEKEVFDNLNG-CP 65
+VIG+G+FG V + K K+ L +K AE A ++E++V +NG
Sbjct: 7 KVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAET---ACFREERDVL--VNGDRR 61
Query: 66 FVLE---CFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCIL 122
++ F +E + Y L+++Y GG L L+ K + LPE R + ++
Sbjct: 62 WITNLHYAFQDENNL-------Y-LVMDYYVGGDLLTLLSKF-EDRLPEDMARFYLAEMV 112
Query: 123 EGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMR--- 179
I +H GYVH D+KPDN+LL ++G ++AD G C R D +++
Sbjct: 113 LAIDSVHQLGYVHRDIKPDNVLL--DKNGHI--RLADFG------SCLRLLADGTVQSNV 162
Query: 180 --GTPLYLAPETVVQHMQEAPS------DIWALGCVVLEMLSGRQAWVVKEDCSIDQLFS 231
GTP Y++PE ++Q M++ D W+LG + EML G + + ++
Sbjct: 163 AVGTPDYISPE-ILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYA--ESLVETYGK 219
Query: 232 IIG--DEHSLPEIPSRVSKEARDFLRR--CFVRKPAFRFTAEMLLDDPFVKGVDEELSRE 287
I+ + P + VS+EA+D +RR C R + D PF +G+D + R
Sbjct: 220 IMNHKEHFQFPPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDHPFFEGIDWDNIRN 279
Query: 288 LEGDYS---QGEVTLSNADAESC 307
Y SN D +
Sbjct: 280 STAPYVPEVSSPTDTSNFDVDDD 302
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 82.7 bits (204), Expect = 9e-18
Identities = 85/304 (27%), Positives = 139/304 (45%), Gaps = 49/304 (16%)
Query: 12 RVIGQGSFGCVFIAKPKSNS-----SFLPPLMAVKSAEVSASASLQKEKEVFDNLNGCPF 66
+VIG+G+FG V + K K L +K AE +A ++E+ V N C +
Sbjct: 7 KVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAE---TACFREERNVLVN-GDCQW 62
Query: 67 VLECFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIG 126
+ + E L+++Y GG L L+ K + LPE R + ++ I
Sbjct: 63 I-----TTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFE-DRLPEDMARFYIAEMVLAIH 116
Query: 127 HIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMR-----GT 181
IH YVH D+KPDN+LL +G ++AD G C + D +++ GT
Sbjct: 117 SIHQLHYVHRDIKPDNVLL--DMNGHI--RLADFG------SCLKMNQDGTVQSSVAVGT 166
Query: 182 PLYLAPETVVQHMQEA------PSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGD 235
P Y++PE ++Q M++ D W+LG + EML G + + S+ + + I +
Sbjct: 167 PDYISPE-ILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAE---SLVETYGKIMN 222
Query: 236 EHSLPEIPSR---VSKEARDFLRRCFVRKPAFRFTAEMLLDD----PFVKGVDEELSREL 288
+ PS VS+EA+D ++R + R + ++D F +G+D E R L
Sbjct: 223 HEERFQFPSHITDVSEEAKDLIQRLICSRE--RRLGQNGIEDFKKHAFFEGIDWENIRNL 280
Query: 289 EGDY 292
E Y
Sbjct: 281 EAPY 284
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 81.9 bits (203), Expect = 1e-17
Identities = 72/283 (25%), Positives = 130/283 (45%), Gaps = 34/283 (12%)
Query: 11 GRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVSAS--ASLQKEKEVFDNLNGCPFVL 68
VIG+G++G V+ A+ K L+A+K ++ +++E + + P +
Sbjct: 11 VEVIGEGTYGKVYKARHKKTGQ----LVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNIA 66
Query: 69 ECFGEEITMG-ENGEMAYNLLLEYAAGGTLGDLIE--KCNGNGLPEKDVRHFTRCILEGI 125
+G I + L++E GG++ DL++ + G L E+ + + R L G+
Sbjct: 67 TFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGL 126
Query: 126 GHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVA---KRSRHCKRQKFDPSMRGTP 182
++H++ +H D+K NILL T++ + K+ D GV+ + +R F GTP
Sbjct: 127 AYLHENKVIHRDIKGQNILL--TKNAE--VKLVDFGVSAQLDSTLG-RRNTF----IGTP 177
Query: 183 LYLAPETVVQHMQEAP-----SDIWALGCVVLEMLSGRQAWVVKEDCSID---QLFSIIG 234
++APE + Q SD+W+LG +E+ G+ C + LF I
Sbjct: 178 YWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPL-----CDMHPMRALFKIPR 232
Query: 235 DEHSLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFV 277
+ + P SK+ DF+ C ++ R E LL+ PF+
Sbjct: 233 NPPPTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI 275
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 82.3 bits (203), Expect = 1e-17
Identities = 84/286 (29%), Positives = 136/286 (47%), Gaps = 29/286 (10%)
Query: 12 RVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVSASASLQ---KEKEVFDNLNGCPFVL 68
+++G+GSFG VF+A+ K + F + A+K V ++ EK V PF+
Sbjct: 1 KMLGKGSFGKVFLAELKGTNQFFA-IKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLT 59
Query: 69 ECFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHI 128
+ T + + ++EY GG L I+ C+ LP + I+ G+ +
Sbjct: 60 HLY---CTFQTKENLFF--VMEYLNGGDLMFHIQSCHKFDLPRATF--YAAEIICGLQFL 112
Query: 129 HDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSR--HCKRQKFDPSMRGTPLYLA 186
H G V+ D+K DNILL G KIAD G+ K + K F GTP Y+A
Sbjct: 113 HSKGIVYRDLKLDNILL--DTDGHI--KIADFGMCKENMLGDAKTCTF----CGTPDYIA 164
Query: 187 PETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEHSLPEIPSRV 246
PE ++ D W+ G ++ EML G+ + ++ ++LF I ++ P P +
Sbjct: 165 PEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDE---EELFQSIRMDN--PCYPRWL 219
Query: 247 SKEARDFLRRCFVRKPAFRFTAEM-LLDDPFVKGVD-EEL-SRELE 289
++EA+D L + FVR+P R + + PF + +D L RE+E
Sbjct: 220 TREAKDILVKLFVREPERRLGVKGDIRQHPFFREIDWSALEEREIE 265
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 81.7 bits (202), Expect = 1e-17
Identities = 69/219 (31%), Positives = 98/219 (44%), Gaps = 39/219 (17%)
Query: 87 LLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLV 146
L+ E+ L DL + NG L E VR + IL GI H +H D+KP+NIL+
Sbjct: 77 LVFEFVDHTVLDDLEKYPNG--LDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILV- 133
Query: 147 ATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEA-PSDIWALG 205
+QSG V K+ D G A R+ + + + T Y APE +V + DIWA+G
Sbjct: 134 -SQSG--VVKLCDFGFA-RTLAAPGEVYTDYV-ATRWYRAPELLVGDTKYGRAVDIWAVG 188
Query: 206 CVVLEMLSGRQAWVVKEDCSIDQLFSII---GD---EH-------------SLPEIPS-- 244
C+V EML+G + D IDQL+ II G+ H LPE+
Sbjct: 189 CLVTEMLTGEP--LFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGMRLPEVKEIE 246
Query: 245 -------RVSKEARDFLRRCFVRKPAFRFTAEMLLDDPF 276
++S D ++C P R ++ LL F
Sbjct: 247 PLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEF 285
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 82.2 bits (203), Expect = 1e-17
Identities = 71/264 (26%), Positives = 131/264 (49%), Gaps = 25/264 (9%)
Query: 12 RVIGQGSFGCVFIAK----PKSNSSFLPPLMAVKSAEVSASASLQKEKEVFDNLNGCPFV 67
+V+GQGSFG VF+ + P + + ++ + +V + E+++ +N PF+
Sbjct: 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNH-PFI 60
Query: 68 LECFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGL-PEKDVRHFTRCILEGIG 126
++ T G+ L+L++ GG DL + + + E+DV+ + + +
Sbjct: 61 VKLHYAFQTEGK-----LYLILDFLRGG---DLFTRLSKEVMFTEEDVKFYLAELALALD 112
Query: 127 HIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMRGTPLYLA 186
H+H G ++ D+KP+NILL + G K+ D G++K S +++ + S GT Y+A
Sbjct: 113 HLHSLGIIYRDLKPENILL--DEEGHI--KLTDFGLSKESIDHEKKAY--SFCGTVEYMA 166
Query: 187 PETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEHSLPEIPSRV 246
PE V + +D W+ G ++ EML+G + K+ + + I+ + +P+ +
Sbjct: 167 PEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKD--RKETMTMILKAKLGMPQF---L 221
Query: 247 SKEARDFLRRCFVRKPAFRFTAEM 270
S EA+ LR F R PA R A
Sbjct: 222 SPEAQSLLRALFKRNPANRLGAGP 245
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 1e-17
Identities = 65/279 (23%), Positives = 120/279 (43%), Gaps = 36/279 (12%)
Query: 14 IGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVSASASLQK----EKEVFDNLNGCPFVLE 69
+G G+ G V K + MA K + A +S++K E ++ P+++
Sbjct: 13 LGAGNGGSVSKVKHIPTGTV----MAKKVVHIGAKSSVRKQILRELQIMHECR-SPYIVS 67
Query: 70 CFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIH 129
+G + E + +E+ G+L D I K G +P + + ++EG+ +++
Sbjct: 68 FYGAFLN-----ENNICMCMEFMDCGSL-DRIYKKGGP-IPVEILGKIAVAVVEGLTYLY 120
Query: 130 DSGY-VHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMRGTPLYLAPE 188
+ +H D+KP NIL+ + + K+ D GV+ + F GT Y++PE
Sbjct: 121 NVHRIMHRDIKPSNILV----NSRGQIKLCDFGVSGELINSIADTF----VGTSTYMSPE 172
Query: 189 TVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSI--------IGDEHSLP 240
+ SD+W+LG ++E+ G+ + Q + I E P
Sbjct: 173 RIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPP-P 231
Query: 241 EIPS-RVSKEARDFLRRCFVRKPAFRFTAEMLLD-DPFV 277
+PS ++ RDF+ C ++ P R T + L PF+
Sbjct: 232 RLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFI 270
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 81.0 bits (201), Expect = 2e-17
Identities = 61/275 (22%), Positives = 114/275 (41%), Gaps = 50/275 (18%)
Query: 11 GRVIGQGSFGCVF--IAKPKSNSSFLPPLMAVKS----AEVSASASLQKEKEVFDNLNGC 64
G+ +G+G+FG V+ K + +AVK+ A +E + L+
Sbjct: 4 GKKLGEGAFGEVYKGTLKGDGEGTETK--VAVKTLKEGASEEEREEFLEEASIMKKLS-H 60
Query: 65 PFVLE----CFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRC 120
P ++ C E ++ EY GG L D + K +G L KD+
Sbjct: 61 PNIVRLLGVCTQGEPLY---------IVTEYMPGGDLLDFLRK-HGEKLTLKDLLQMALQ 110
Query: 121 ILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFD----P 176
I +G+ ++ +VH D+ N L+ + V KI+D G++ R ++
Sbjct: 111 IAKGMEYLESKNFVHRDLAARNCLV----TENLVVKISDFGLS-------RDIYEDDYYR 159
Query: 177 SMRGTPL---YLAPETVVQHMQ--EAPSDIWALGCVVLEMLS-GRQAWVVKEDCSIDQLF 230
G L ++APE ++ + SD+W+ G ++ E+ + G Q + S +++
Sbjct: 160 KRGGGKLPIKWMAPE-SLKDGKFTSK-SDVWSFGVLLWEIFTLGEQPY---PGMSNEEVL 214
Query: 231 SIIGDEHSLPEIPSRVSKEARDFLRRCFVRKPAFR 265
++ D + LP P E + + +C+ P R
Sbjct: 215 ELLEDGYRLP-RPENCPDELYELMLQCWAYDPEDR 248
|
Length = 258 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 5e-17
Identities = 74/267 (27%), Positives = 124/267 (46%), Gaps = 23/267 (8%)
Query: 14 IGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVSASASLQ---KEKEVFDNLNGCPFVLEC 70
IG+G F V+ A + + L V+ E+ + + Q KE ++ L+ P V++
Sbjct: 10 IGKGQFSVVYKAICLLDGRVVA-LKKVQIFEMMDAKARQDCLKEIDLLKQLDH-PNVIKY 67
Query: 71 FGEEITMGENGEMAYNLLLEYAAGGTLGDLIE--KCNGNGLPEKDVRHFTRCILEGIGHI 128
I EN E+ N++LE A G L +I+ K +PE+ + + + + H+
Sbjct: 68 LASFI---ENNEL--NIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHM 122
Query: 129 HDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMRGTPLYLAPE 188
H +H D+KP N+ + AT V K+ DLG+ + + S+ GTP Y++PE
Sbjct: 123 HSKRIMHRDIKPANVFITATG----VVKLGDLGLGR--FFSSKTTAAHSLVGTPYYMSPE 176
Query: 189 TVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSII--GDEHSLPEIPSRV 246
+ ++ SDIW+LGC++ EM + Q+ + ++ L I D LP
Sbjct: 177 RIHENGYNFKSDIWSLGCLLYEM-AALQSPFYGDKMNLYSLCKKIEKCDYPPLPA--DHY 233
Query: 247 SKEARDFLRRCFVRKPAFRFTAEMLLD 273
S+E RD + RC P R +L
Sbjct: 234 SEELRDLVSRCINPDPEKRPDISYVLQ 260
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 80.0 bits (197), Expect = 6e-17
Identities = 73/284 (25%), Positives = 129/284 (45%), Gaps = 27/284 (9%)
Query: 7 SWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAE--VSASASLQKEKEVFDNLNGC 64
+W IG+G++G V+ K + S L AVK + ++ E + +L
Sbjct: 23 TWEIIETIGKGTYGKVYKVTNKKDGS----LAAVKILDPISDVDEEIEAEYNILQSLPNH 78
Query: 65 PFVLECFGEEITMGENGEMAYNLLLEYAAGGTLGDLIE---KCNGNGLPEKDVRHFTRCI 121
P V++ +G + L+LE GG++ +L++ C G L E + +
Sbjct: 79 PNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLIC-GQRLDEAMISYILYGA 137
Query: 122 LEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKR--SRHCKRQKFDPSMR 179
L G+ H+H++ +H DVK +NILL T+ G K+ D GV+ + S +R +
Sbjct: 138 LLGLQHLHNNRIIHRDVKGNNILL-TTEGG---VKLVDFGVSAQLTSTRLRRN----TSV 189
Query: 180 GTPLYLAPETVVQHMQ-----EAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIG 234
GTP ++APE + Q +A D+W+LG +E+ G + + + LF I
Sbjct: 190 GTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPP--LFDMHPVKTLFKIPR 247
Query: 235 DEHSLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVK 278
+ P + + F+ +C ++ R + LL+ PF+K
Sbjct: 248 NPPPTLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK 291
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 79.5 bits (196), Expect = 9e-17
Identities = 82/279 (29%), Positives = 128/279 (45%), Gaps = 42/279 (15%)
Query: 12 RVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVSASASLQKE----KEV-FDNLNGCPF 66
R IG GSFG V+ A+ + ++A+K S S +K KEV F P
Sbjct: 21 REIGHGSFGAVYFARDVRTNE----VVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPN 76
Query: 67 VLE---CFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILE 123
+E C+ E T A+ L++EY G + D++E + L E ++ L+
Sbjct: 77 TIEYKGCYLREHT-------AW-LVMEYCLG-SASDILE-VHKKPLQEVEIAAICHGALQ 126
Query: 124 GIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMRGTPL 183
G+ ++H +H D+K NILL T+ G K+AD G A S F GTP
Sbjct: 127 GLAYLHSHERIHRDIKAGNILL--TEPG--TVKLADFGSA--SLVSPANSF----VGTPY 176
Query: 184 YLAPETVVQHMQEA----PSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSII-GDEHS 238
++APE V+ M E D+W+LG +E L+ R+ + + ++ L+ I D +
Sbjct: 177 WMAPE-VILAMDEGQYDGKVDVWSLGITCIE-LAERKPPLFNMN-AMSALYHIAQNDSPT 233
Query: 239 LPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFV 277
L + S R+F+ C + P R ++E LL FV
Sbjct: 234 LS--SNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHRFV 270
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 1e-16
Identities = 73/263 (27%), Positives = 116/263 (44%), Gaps = 20/263 (7%)
Query: 12 RVIGQGSFG-CVFIAKPKSNSSFLPPLMAVKSAEVSASASLQKEKE-VFDNLNGCPFVLE 69
RV+G+GSFG + + S+ + M S+SA KE V P ++
Sbjct: 6 RVVGEGSFGRALLVQHVNSDQKYA---MKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIV- 61
Query: 70 CFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIH 129
F E + +++EY GG L I+ G PE + + + G+ HIH
Sbjct: 62 AFKESF----EADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIH 117
Query: 130 DSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMRGTPLYLAPET 189
+ +H D+K NI L TQ+GK K+ D G A+ + + GTP Y+ PE
Sbjct: 118 EKRVLHRDIKSKNIFL--TQNGK--VKLGDFGSARLLTS--PGAYACTYVGTPYYVPPEI 171
Query: 190 VVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEHSLPEIPSRVSKE 249
SDIW+LGC++ E+ + + + + S L + + S +PS S E
Sbjct: 172 WENMPYNNKSDIWSLGCILYELCTLKHPF---QANSWKNLILKVC-QGSYKPLPSHYSYE 227
Query: 250 ARDFLRRCFVRKPAFRFTAEMLL 272
R +++ F R P R +A +L
Sbjct: 228 LRSLIKQMFKRNPRSRPSATTIL 250
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 2e-16
Identities = 76/289 (26%), Positives = 130/289 (44%), Gaps = 40/289 (13%)
Query: 12 RVIGQGSFGCVFIAKPKS--NSSFLPPLMAVKSAEVSASASLQK----EKEVFDNLNGCP 65
RV+G G++G VF+ + ++ L + +K A + A + E++V + + CP
Sbjct: 6 RVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCP 65
Query: 66 FVLECFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGI 125
F++ T + +L+L+Y GG L E +VR + I+ +
Sbjct: 66 FLVTLHYAFQT-----DTKLHLILDYVNGGEL--FTHLYQREHFTESEVRVYIAEIVLAL 118
Query: 126 GHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDP-------SM 178
H+H G ++ D+K +NILL G V + D G++K +F S
Sbjct: 119 DHLHQLGIIYRDIKLENILL--DSEGHVV--LTDFGLSK--------EFLAEEEERAYSF 166
Query: 179 RGTPLYLAPETVV--QHMQEAPSDIWALGCVVLEMLSGRQAWVVK-EDCSIDQLFSIIGD 235
GT Y+APE + + D W+LG + E+L+G + V E S ++ I
Sbjct: 167 CGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRI-- 224
Query: 236 EHSLPEIPSRVSKEARDFLRRCFVRKPAFRF---TAEMLLDDPFVKGVD 281
S P P +S EARDF+++ + P R A+ + + PF +G+D
Sbjct: 225 LKSKPPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQGID 273
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 2e-16
Identities = 77/284 (27%), Positives = 129/284 (45%), Gaps = 29/284 (10%)
Query: 7 SWFRGRVIGQGSFGCVFIAKPKSNSS-----FLPPLMAVKSAEVSASASLQKEKEVFDNL 61
+W IG+G++G VF K N S L P+ + ++ E + L
Sbjct: 19 TWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDE-------EIEAEYNILKAL 71
Query: 62 NGCPFVLECFGEEITMG-ENGEMAYNLLLEYAAGGTLGDLIEKC--NGNGLPEKDVRHFT 118
+ P V++ +G +NG+ + L+LE GG++ DL++ G + E + +
Sbjct: 72 SDHPNVVKFYGMYYKKDVKNGDQLW-LVLELCNGGSVTDLVKGFLKRGERMEEPIIAYIL 130
Query: 119 RCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSM 178
L G+ H+H + +H DVK +NILL T+ G K+ D GV+ + R + + S+
Sbjct: 131 HEALMGLQHLHVNKTIHRDVKGNNILL-TTEGG---VKLVDFGVSAQLTS-TRLRRNTSV 185
Query: 179 RGTPLYLAPETVVQHMQ-----EAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSII 233
GTP ++APE + Q +A D+W+LG +E+ G + + + LF I
Sbjct: 186 -GTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPP--LADLHPMRALFKIP 242
Query: 234 GDEHSLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFV 277
+ P S E DF+R+C + R T LL F+
Sbjct: 243 RNPPPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI 286
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 79.1 bits (195), Expect = 2e-16
Identities = 79/298 (26%), Positives = 141/298 (47%), Gaps = 46/298 (15%)
Query: 12 RVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVSASASLQK-------EKEVFDNLNGC 64
+V+G+G +G VF + K + + A+K + + QK E+ + + +
Sbjct: 2 KVLGKGGYGKVFQVR-KVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKH- 59
Query: 65 PFVLECFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRC-ILE 123
PF+++ I + G Y L+LEY +GG L +E+ G+ +D F I
Sbjct: 60 PFIVDL----IYAFQTGGKLY-LILEYLSGGELFMHLER---EGIFMEDTACFYLSEISL 111
Query: 124 GIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMR---- 179
+ H+H G ++ D+KP+NILL A K+ D G+ CK + ++
Sbjct: 112 ALEHLHQQGIIYRDLKPENILLDAQGH----VKLTDFGL------CKESIHEGTVTHTFC 161
Query: 180 GTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVK-EDCSIDQLFSIIGDEHS 238
GT Y+APE +++ D W+LG ++ +ML+G + + +ID+ I+ + +
Sbjct: 162 GTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDK---ILKGKLN 218
Query: 239 LPEIPSRVSKEARDFLRRCFVRKPAFRF-----TAEMLLDDPFVKGV--DEELSRELE 289
L P ++ EARD L++ R P+ R A + PF + V D+ L+R++E
Sbjct: 219 L---PPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSHPFFRHVNWDDLLARKVE 273
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 78.8 bits (194), Expect = 2e-16
Identities = 70/251 (27%), Positives = 109/251 (43%), Gaps = 49/251 (19%)
Query: 101 IEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADL 160
++K G+ L E V++ +L G+ +IH +G +H D+KP N L + + KI D
Sbjct: 106 LQKIMGHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGN--LAVNEDCEL--KILDF 161
Query: 161 GVAKRSRHCKRQKFDPSMRG---TPLYLAPETVVQHMQEAPS-DIWALGCVVLEMLSGRQ 216
G+A RH D M G T Y APE ++ M + DIW++GC++ EML+G+
Sbjct: 162 GLA---RHA-----DAEMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKT 213
Query: 217 AWVVKEDCSIDQLFSII------GDE--------------HSLPEIPS--------RVSK 248
+ K+ +DQL I+ G E SLP+ P + S
Sbjct: 214 LFKGKD--YLDQLTQILKVTGVPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASP 271
Query: 249 EARDFLRRCFVRKPAFRFTAEMLLDDPF---VKGVDEELSRELEGDYSQGEVTLSNADAE 305
+A D L + R TA L+ P+ + DEE ++ D + E + +
Sbjct: 272 QAVDLLEKMLELDVDKRLTATEALEHPYFDSFRDADEETEQQPYDDSLENEKLSVDEWKK 331
Query: 306 SCSPECISFIP 316
E SF P
Sbjct: 332 HIYKEVKSFSP 342
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 2e-16
Identities = 74/266 (27%), Positives = 116/266 (43%), Gaps = 31/266 (11%)
Query: 12 RVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVSASASL---QKEKEVFDNLNGCPFVL 68
RVIG+GS+ V + + K N + VK V + Q EK VF+ + PF++
Sbjct: 1 RVIGRGSYAKVLLVRLKKNDQIYA-MKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLV 59
Query: 69 ---ECFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGI 125
CF + L++EY GG L + LPE+ R + I +
Sbjct: 60 GLHSCFQTTSRL--------FLVIEYVNGGDL--MFHMQRQRKLPEEHARFYAAEICIAL 109
Query: 126 GHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMRGTPLYL 185
+H+ G ++ D+K DN+LL G K+ D G+ K + GTP Y+
Sbjct: 110 NFLHERGIIYRDLKLDNVLL--DADGHI--KLTDYGMCKEG--LGPGDTTSTFCGTPNYI 163
Query: 186 APETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKED----CSIDQLFSIIGDEHSLP- 240
APE + D WALG ++ EM++GR + + D + D LF +I ++ P
Sbjct: 164 APEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEK---PI 220
Query: 241 EIPSRVSKEARDFLRRCFVRKPAFRF 266
IP +S +A L+ + P R
Sbjct: 221 RIPRFLSVKASHVLKGFLNKDPKERL 246
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 4e-16
Identities = 73/261 (27%), Positives = 123/261 (47%), Gaps = 27/261 (10%)
Query: 14 IGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEV------SASASLQKEKEVFDNLNGCPFV 67
IG+G F V+ A + +A+K ++ A A KE ++ LN P V
Sbjct: 10 IGRGQFSEVYRATCLLDGV----PVALKKVQIFDLMDAKARADCIKEIDLLKQLNH-PNV 64
Query: 68 LECFGEEITMGENGEMAYNLLLEYAAGGTLGDLIE--KCNGNGLPEKDVRHFTRCILEGI 125
++ + I E+ E+ N++LE A G L +I+ K +PEK V + + +
Sbjct: 65 IKYYASFI---EDNEL--NIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSAL 119
Query: 126 GHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMRGTPLYL 185
H+H +H D+KP N+ + AT V K+ DLG+ + + S+ GTP Y+
Sbjct: 120 EHMHSRRVMHRDIKPANVFITATG----VVKLGDLGLGRF--FSSKTTAAHSLVGTPYYM 173
Query: 186 APETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEHSLPEIPS- 244
+PE + ++ SDIW+LGC++ EM + Q+ + ++ L I ++ P +PS
Sbjct: 174 SPERIHENGYNFKSDIWSLGCLLYEM-AALQSPFYGDKMNLYSLCKKI-EQCDYPPLPSD 231
Query: 245 RVSKEARDFLRRCFVRKPAFR 265
S+E R + C P R
Sbjct: 232 HYSEELRQLVNMCINPDPEKR 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 76.5 bits (188), Expect = 7e-16
Identities = 64/228 (28%), Positives = 102/228 (44%), Gaps = 25/228 (10%)
Query: 54 EKEVFDNLNGCPFVLECFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKD 113
EKE+ + +N PF++ + + L++ GG L I GL +
Sbjct: 43 EKEILEKVNS-PFIVN-----LAYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMER 96
Query: 114 VRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQK 173
V H++ I GI H+H V+ D+KP+N+LL G +++DLG+A K K
Sbjct: 97 VIHYSAQITCGILHLHSMDIVYRDMKPENVLL--DDQGN--CRLSDLGLAVE---LKDGK 149
Query: 174 FDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAW------VVKEDCSID 227
GT Y+APE + + P D +A+GC + EM++GR + V KE+
Sbjct: 150 TITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRR 209
Query: 228 QLFSIIGDEHSLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDP 275
L + EH ++E++D R +KP R + DDP
Sbjct: 210 TLEDEVKFEH------QNFTEESKDICRLFLAKKPEDRLGSREKNDDP 251
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 1e-15
Identities = 84/317 (26%), Positives = 136/317 (42%), Gaps = 42/317 (13%)
Query: 12 RVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVSASASL---QKEKEVFDNLNGCPFVL 68
RVIG+GS+ V + + K + VK V+ + Q EK VF+ + PF++
Sbjct: 1 RVIGRGSYAKVLLVRLKKTERIYA-MKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLV 59
Query: 69 ---ECFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGI 125
CF E + ++EY GG L + LPE+ R ++ I +
Sbjct: 60 GLHSCFQTESRL--------FFVIEYVNGGDL--MFHMQRQRKLPEEHARFYSAEISLAL 109
Query: 126 GHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMRGTPLYL 185
++H+ G ++ D+K DN+LL G K+ D G+ K + + GTP Y+
Sbjct: 110 NYLHERGIIYRDLKLDNVLL--DSEGHI--KLTDYGMCKEG--LRPGDTTSTFCGTPNYI 163
Query: 186 APETVVQHMQEAPSDIWALGCVVLEMLSGRQAW-VVKEDCSIDQ-----LFSIIGDEHSL 239
APE + D WALG ++ EM++GR + +V + DQ LF +I ++
Sbjct: 164 APEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQI- 222
Query: 240 PEIPSRVSKEARDFLRRCFVRKPAFRFTA------EMLLDDPFVKGVDEELSRELE---- 289
IP +S +A L+ + P R + PF + VD +L + +
Sbjct: 223 -RIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDLMEQKQVVPP 281
Query: 290 -GDYSQGEVTLSNADAE 305
GE L N DA+
Sbjct: 282 FKPNISGEFGLDNFDAQ 298
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 1e-15
Identities = 74/291 (25%), Positives = 127/291 (43%), Gaps = 37/291 (12%)
Query: 12 RVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVSASASL---QKEKEVFDNLNGCPFVL 68
RVIG+GS+ V + + K + +K V+ + Q EK VF+ + PF++
Sbjct: 1 RVIGRGSYAKVLLVELKKTRRIYA-MKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLV 59
Query: 69 ---ECFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGI 125
CF E + ++E+ +GG L + LPE+ R ++ I +
Sbjct: 60 GLHSCFQTESRL--------FFVIEFVSGGDL--MFHMQRQRKLPEEHARFYSAEISLAL 109
Query: 126 GHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMRGTPLYL 185
+H+ G ++ D+K DN+LL A G K+ D G+ K + + GTP Y+
Sbjct: 110 NFLHERGIIYRDLKLDNVLLDA--EGHI--KLTDYGMCKEG--IRPGDTTSTFCGTPNYI 163
Query: 186 APETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVV------KEDCSIDQLFSIIGDEHSL 239
APE + D WALG ++ EM++GR + + + + D LF +I ++
Sbjct: 164 APEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQI- 222
Query: 240 PEIPSRVSKEARDFLRRCFVRKPAFRFTAEM------LLDDPFVKGVDEEL 284
IP +S +A L+ + P R + PF + +D +L
Sbjct: 223 -RIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFRNIDWDL 272
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 75.6 bits (186), Expect = 2e-15
Identities = 61/219 (27%), Positives = 100/219 (45%), Gaps = 40/219 (18%)
Query: 87 LLLEYAAGGTLGDLIEKCNGNGLPEKDVR-HFTRCILEGIGHIHDSGYVHCDVKPDNILL 145
+++EY GG L++ N LP R +F +L + ++H+ G VH D+KPDN+L+
Sbjct: 78 MVMEYVEGGDCATLLK--NIGALPVDMARMYFAETVL-ALEYLHNYGIVHRDLKPDNLLI 134
Query: 146 VATQSGKFVAKIADLGVAK----------RSRHCK---RQKFDPSMRGTPLYLAPETVVQ 192
T G K+ D G++K H + R+ D + GTP Y+APE +++
Sbjct: 135 --TSMGHI--KLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILR 190
Query: 193 HMQEAPSDIWALGCVVLEMLSGRQAWVVKEDC------SIDQLFS-IIGDEHSLPEIPSR 245
P D WA+G ++ E L G C + ++LF +I D+ PE
Sbjct: 191 QGYGKPVDWWAMGIILYEFLVG---------CVPFFGDTPEELFGQVISDDIEWPEGDEA 241
Query: 246 VSKEARDFLRRCFVRKPAFRF---TAEMLLDDPFVKGVD 281
+ +A+D + R + P R A + F G+D
Sbjct: 242 LPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLGLD 280
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 2e-15
Identities = 70/251 (27%), Positives = 123/251 (49%), Gaps = 25/251 (9%)
Query: 12 RVIGQGSFGCVFIAKPKSNSSF--LPPLMAVKSAEVSASASLQKEKEVFDNLNGCPFVLE 69
+VIG+G+FG V + + KS + L + + S SA +E+++ N P+V++
Sbjct: 49 KVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANS-PWVVQ 107
Query: 70 CFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIH 129
F + +++EY GG DL+ + +PEK R +T ++ + IH
Sbjct: 108 LF-----YAFQDDRYLYMVMEYMPGG---DLVNLMSNYDVPEKWARFYTAEVVLALDAIH 159
Query: 130 DSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMRGTPLYLAPET 189
G++H DVKPDN+LL +SG K+AD G + + D ++ GTP Y++PE
Sbjct: 160 SMGFIHRDVKPDNMLL--DKSGHL--KLADFGTCMKMNKEGMVRCDTAV-GTPDYISPEV 214
Query: 190 VVQHMQEA----PSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEHSL--PEIP 243
+ + D W++G + EML G + D + I+ ++SL P+
Sbjct: 215 LKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYA--DSLVGTYSKIMNHKNSLTFPD-D 271
Query: 244 SRVSKEARDFL 254
+ +SKEA++ +
Sbjct: 272 NDISKEAKNLI 282
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 2e-15
Identities = 71/285 (24%), Positives = 137/285 (48%), Gaps = 31/285 (10%)
Query: 12 RVIGQGSFGCVFIAKPKS--NSSFLPPLMAVKSAEVSASASLQK----EKEVFDNLNGCP 65
+V+G G++G VF+ + + ++ L + ++ A + A + E+ V +++ P
Sbjct: 6 KVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSP 65
Query: 66 FVLECFGEEITMGENGEMAYNLLLEYAAGGTL-GDLIEKCNGNGLPEKDVRHFTRCILEG 124
F++ + E +L+L+Y +GG + L ++ N E +VR ++ I+
Sbjct: 66 FLVT-----LHYAFQTEAKLHLILDYVSGGEMFTHLYQRDN---FSEDEVRFYSGEIILA 117
Query: 125 IGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMRGTPLY 184
+ H+H G V+ D+K +NILL G V + D G++K ++++ S GT Y
Sbjct: 118 LEHLHKLGIVYRDIKLENILL--DSEGHVV--LTDFGLSKEFLSEEKER-TYSFCGTIEY 172
Query: 185 LAPETVVQHMQEAPS-DIWALGCVVLEMLSGRQAWVVKEDCSIDQLFS--IIGDEHSLPE 241
+APE + + D W+LG ++ E+L+G + ++ + + S I+ + P
Sbjct: 173 MAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCD---PP 229
Query: 242 IPSRVSKEARDFLRRCFVRKPAFRF-----TAEMLLDDPFVKGVD 281
PS + EA+D L + + P R A + + PF KG+D
Sbjct: 230 FPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGLD 274
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 75.6 bits (186), Expect = 2e-15
Identities = 77/292 (26%), Positives = 115/292 (39%), Gaps = 52/292 (17%)
Query: 13 VIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVSASASLQKEKEVFDNLNGCPFVLECFG 72
++G+G FG V + + K+ + A+K + S L +E F F
Sbjct: 8 LVGRGHFGEVQVVREKATGD----IYAMKV--MKKSVLLAQETVSF------------FE 49
Query: 73 EE--ITMGENGEMAYNLL------------LEYAAGGTLGDLIEKCNGNGLPEKDVRHFT 118
EE I N L +EY GG L L+ + E + +
Sbjct: 50 EERDILSISNSPWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQ-FDEDMAQFYL 108
Query: 119 RCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSM 178
++ I +H GYVH D+KP+N+L+ T K+AD G A R K
Sbjct: 109 AELVLAIHSVHQMGYVHRDIKPENVLIDRTGH----IKLADFGSAARLTANK-MVNSKLP 163
Query: 179 RGTPLYLAPETVVQHMQEAPS-------DIWALGCVVLEMLSGRQAWVVKEDCSIDQLFS 231
GTP Y+APE V+ M D W+LG + EM+ GR + E S +
Sbjct: 164 VGTPDYIAPE-VLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPF--HEGTSAKTYNN 220
Query: 232 IIGDEHSL--PEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGVD 281
I+ + L PE P +VS + D ++ + R E L PF +D
Sbjct: 221 IMNFQRFLKFPEDP-KVSSDFLDLIQS-LLCGQKERLGYEGLCCHPFFSKID 270
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.3 bits (186), Expect = 2e-15
Identities = 42/202 (20%), Positives = 82/202 (40%), Gaps = 50/202 (24%)
Query: 111 EKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCK 170
E ++ + + +LEG+ ++H +G +H D+K NIL+ + V K+AD G+A+
Sbjct: 99 ESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILI----NNDGVLKLADFGLAR------ 148
Query: 171 RQKFDPSMRG-------TPLYLAPETVVQHMQEAPS-DIWALGCVVLEMLSGRQAWVVKE 222
+ T Y PE ++ + P D+W++GC++ E+ G+ + +
Sbjct: 149 --PYTKRNSADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKP--IFQG 204
Query: 223 DCSIDQL---FSIIG--DEHSLPEI---------------PSRV--------SKEARDFL 254
++QL F + G + + P + R+ A D L
Sbjct: 205 STELEQLEKIFELCGSPTDENWPGVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLL 264
Query: 255 RRCFVRKPAFRFTAEMLLDDPF 276
+ P R +A+ L +
Sbjct: 265 DKLLTLDPKKRISADQALQHEY 286
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 2e-15
Identities = 69/235 (29%), Positives = 109/235 (46%), Gaps = 32/235 (13%)
Query: 14 IGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVSAS-----------ASLQKEKEVFDNLN 62
IG G++G V+ A+ + F+ A+KS V + +L K E FD+ N
Sbjct: 8 IGVGAYGTVYKARDPHSGHFV----ALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPN 63
Query: 63 GCPFVLECFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCIL 122
+ C T + E L+ E+ L ++K GLP + ++ R L
Sbjct: 64 IVRLMDVC----ATSRTDRETKVTLVFEHV-DQDLRTYLDKVPPPGLPAETIKDLMRQFL 118
Query: 123 EGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMRGTP 182
G+ +H + VH D+KP+NIL+ T G+ K+AD G+A R C+ P + T
Sbjct: 119 RGLDFLHANCIVHRDLKPENILV--TSGGQ--VKLADFGLA-RIYSCQ-MALTPVVV-TL 171
Query: 183 LYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQL---FSIIG 234
Y APE ++Q P D+W++GC+ EM R+ + + DQL F +IG
Sbjct: 172 WYRAPEVLLQSTYATPVDMWSVGCIFAEMF--RRKPLFCGNSEADQLGKIFDLIG 224
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 3e-15
Identities = 77/292 (26%), Positives = 125/292 (42%), Gaps = 40/292 (13%)
Query: 14 IGQGSFGCVFIAKPKSNSSFLPPL--MAVKSAEVSASASLQKEKEVFDNLNGC--PFVLE 69
IG+G++G VF A+ N L + V++ E S +E V +L P V+
Sbjct: 9 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 68
Query: 70 CFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIH 129
F + E L+ E+ L ++K G+P + ++ +L G+ +H
Sbjct: 69 LFDVCTVSRTDRETKLTLVFEHV-DQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH 127
Query: 130 DSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMRGTPLYLAPET 189
VH D+KP NIL+ T SG+ K+AD G+A R Q S+ T Y APE
Sbjct: 128 SHRVVHRDLKPQNILV--TSSGQI--KLADFGLA---RIYSFQMALTSVVVTLWYRAPEV 180
Query: 190 VVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQL---FSIIG--------DEHS 238
++Q P D+W++GC+ EM R+ + + +DQL +IG + +
Sbjct: 181 LLQSSYATPVDLWSVGCIFAEMF--RRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVA 238
Query: 239 LPE--------------IPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPF 276
LP + + + +D L +C PA R +A L P+
Sbjct: 239 LPRQAFHSKSAQPIEKFVTD-IDELGKDLLLKCLTFNPAKRISAYSALSHPY 289
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 74.7 bits (184), Expect = 3e-15
Identities = 69/285 (24%), Positives = 124/285 (43%), Gaps = 50/285 (17%)
Query: 14 IGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVSASASLQK----EKEVFDNLNGCPFVLE 69
IG G+ G V+ + K +MAVK + + K + +V + CP++++
Sbjct: 23 IGSGTCGQVYKMRFKKTGH----VMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVK 78
Query: 70 CFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIH 129
C+G IT ++ + T D + K +PE + T I++ + ++
Sbjct: 79 CYGYFIT-------DSDVFICMELMSTCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLK 131
Query: 130 DS-GYVHCDVKPDNILLVATQSGKFVAKIADLGVAKR---SRHCKRQKFDPSMRGTPLYL 185
+ G +H DVKP NILL A SG K+ D G++ R S+ R G Y+
Sbjct: 132 EKHGVIHRDVKPSNILLDA--SG--NVKLCDFGISGRLVDSKAKTRSA------GCAAYM 181
Query: 186 APETVVQHMQEAP---------SDIWALGCVVLEMLSGRQAWVVKEDCSID-QLFSIIGD 235
APE + + P +D+W+LG ++E+ +G+ + ++C + ++ + I
Sbjct: 182 APERI-----DPPDPNPKYDIRADVWSLGISLVELATGQFPY---KNCKTEFEVLTKILQ 233
Query: 236 EHSLPEIPSR--VSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVK 278
E P +P S + F+ C + R LL PF++
Sbjct: 234 E-EPPSLPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIR 277
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 4e-15
Identities = 74/277 (26%), Positives = 126/277 (45%), Gaps = 38/277 (13%)
Query: 12 RVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVSASASLQKEKEVFDNLNGC-----PF 66
R IG GSFG V+ A+ NS ++A+K S S +K +++ + P
Sbjct: 21 REIGHGSFGAVYFARDVRNSE----VVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 67 VLE---CFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILE 123
++ C+ E T L++EY G + DL+E + L E ++ T L+
Sbjct: 77 TIQYRGCYLREHTAW--------LVMEYCLG-SASDLLE-VHKKPLQEVEIAAVTHGALQ 126
Query: 124 GIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMRGTPL 183
G+ ++H +H DVK NILL ++ G K+ D G A GTP
Sbjct: 127 GLAYLHSHNMIHRDVKAGNILL--SEPGL--VKLGDFGSASIMAPAN------XFVGTPY 176
Query: 184 YLAPETVV---QHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEHSLP 240
++APE ++ + + D+W+LG +E L+ R+ + + ++ L+ I +E
Sbjct: 177 WMAPEVILAMDEGQYDGKVDVWSLGITCIE-LAERKPPLFNMN-AMSALYHIAQNESPAL 234
Query: 241 EIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFV 277
+ S+ R+F+ C + P R T+E+LL FV
Sbjct: 235 Q-SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFV 270
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 74.0 bits (181), Expect = 8e-15
Identities = 77/281 (27%), Positives = 128/281 (45%), Gaps = 46/281 (16%)
Query: 12 RVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVSASASLQKEKEVFDNLNGC-----PF 66
R IG GSFG V+ A+ + ++A+K S S +K +++ + P
Sbjct: 31 REIGHGSFGAVYFARDVRTNE----VVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86
Query: 67 VLE---CFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILE 123
+E C+ E T L++EY G + DL+E + L E ++ T L+
Sbjct: 87 SIEYKGCYLREHTAW--------LVMEYCLG-SASDLLE-VHKKPLQEVEIAAITHGALQ 136
Query: 124 GIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMRGTPL 183
G+ ++H +H D+K NILL T+ G+ K+AD G A + S GTP
Sbjct: 137 GLAYLHSHNMIHRDIKAGNILL--TEPGQ--VKLADFGSASIASPAN------SFVGTPY 186
Query: 184 YLAPETVV---QHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEHSLP 240
++APE ++ + + D+W+LG +E L+ R+ + + ++ L+ I +E
Sbjct: 187 WMAPEVILAMDEGQYDGKVDVWSLGITCIE-LAERKPPLFNMN-AMSALYHIAQNES--- 241
Query: 241 EIPSRVSKEARDFLRR----CFVRKPAFRFTAEMLLDDPFV 277
P+ S E D+ R C + P R T+E LL FV
Sbjct: 242 --PTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFV 280
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 73.8 bits (182), Expect = 9e-15
Identities = 59/225 (26%), Positives = 92/225 (40%), Gaps = 52/225 (23%)
Query: 86 NLLLEYAAGGTLGDLIEKCNGNG---LPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDN 142
NL+ E+ DL EK + L D++ + L G+ ++H + +H D+KP+N
Sbjct: 78 NLVFEFMET----DL-EKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNN 132
Query: 143 ILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMRGTP-----LYLAPETVVQHMQEA 197
+L+ + V K+AD G+A R P+ + T Y APE +
Sbjct: 133 LLI----ASDGVLKLADFGLA-------RSFGSPNRKMTHQVVTRWYRAPELLFGARHYG 181
Query: 198 PS-DIWALGCVVLEMLSGRQAWVVKEDCSIDQL---FSIIG--------DEHSLP----- 240
D+W++GC+ E+L + D IDQL F +G SLP
Sbjct: 182 VGVDMWSVGCIFAELLLRV--PFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDYVEF 239
Query: 241 ---------EIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPF 276
+I S +A D L+R P R TA L+ P+
Sbjct: 240 KPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPY 284
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 1e-14
Identities = 64/210 (30%), Positives = 98/210 (46%), Gaps = 25/210 (11%)
Query: 12 RVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVSASASLQKEKEVFDNLNGCPFVLECF 71
+VIG+GSFG V +AK K++ F AVK V ++ K+KE + +L+
Sbjct: 1 KVIGKGSFGKVLLAKHKADGKF----YAVK---VLQKKAILKKKEQKHIMAERNVLLKNV 53
Query: 72 GEEITMG-----ENGEMAYNLLLEYAAGGTLGDLI--EKCNGNGLPEKDVRHFTRCILEG 124
+G + + Y +L+Y GG L + E+ PE R + I
Sbjct: 54 KHPFLVGLHYSFQTADKLY-FVLDYVNGGELFFHLQRERS----FPEPRARFYAAEIASA 108
Query: 125 IGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMRGTPLY 184
+G++H ++ D+KP+NILL G V + D G+ K + K + GTP Y
Sbjct: 109 LGYLHSLNIIYRDLKPENILL--DSQGHVV--LTDFGLCKEG--IEHSKTTSTFCGTPEY 162
Query: 185 LAPETVVQHMQEAPSDIWALGCVVLEMLSG 214
LAPE + + + D W LG V+ EML G
Sbjct: 163 LAPEVLRKQPYDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 73.6 bits (180), Expect = 1e-14
Identities = 82/302 (27%), Positives = 137/302 (45%), Gaps = 45/302 (14%)
Query: 12 RVIGQGSFGCVFIAKPKSNSS-----FLPPLMAVKSAEVSASASLQKEKEVFDNLNGCPF 66
+VIG+G+FG V + K K+ L +K AE +A ++E++V +NG
Sbjct: 7 KVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAE---TACFREERDVL--VNGDNQ 61
Query: 67 VLECFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIG 126
+ N L+++Y GG L L+ K + LPE R + ++ I
Sbjct: 62 WITTLHYAFQDENN----LYLVMDYYVGGDLLTLLSKFE-DRLPEDMARFYLAEMVIAID 116
Query: 127 HIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMR-----GT 181
+H YVH D+KPDNIL+ +G ++AD G C + D +++ GT
Sbjct: 117 SVHQLHYVHRDIKPDNILM--DMNGHI--RLADFG------SCLKLMEDGTVQSSVAVGT 166
Query: 182 PLYLAPETVVQHMQEAPS------DIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGD 235
P Y++PE ++Q M++ D W+LG + EML G + + S+ + + I +
Sbjct: 167 PDYISPE-ILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAE---SLVETYGKIMN 222
Query: 236 EHSLPEIPSR---VSKEARDFLRR--CFVRKPAFRFTAEMLLDDPFVKGVDEELSRELEG 290
+ P++ VS++A+D +RR C + E PF G+D + R E
Sbjct: 223 HKERFQFPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQHPFFTGIDWDNIRNCEA 282
Query: 291 DY 292
Y
Sbjct: 283 PY 284
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 73.3 bits (180), Expect = 1e-14
Identities = 78/341 (22%), Positives = 146/341 (42%), Gaps = 46/341 (13%)
Query: 12 RVIGQGSFGCVFIAKPKSNSSF-----LPPLMAVKSAEVSASASLQKEKEVFDNLNGCPF 66
+++G+G+FG V + + K+ + L + + EV+ + + E V N PF
Sbjct: 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLT---ESRVLQNTRH-PF 56
Query: 67 VLECFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIG 126
+ + + + + + ++EYA GG L + + E R + I+ +G
Sbjct: 57 LTAL---KYSFQTHDRLCF--VMEYANGGELFFHLSRERV--FSEDRARFYGAEIVSALG 109
Query: 127 HIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQ-KFDPSMR---GTP 182
++H V+ D+K +N++L + G KI D G+ CK +M+ GTP
Sbjct: 110 YLHSCDVVYRDLKLENLML--DKDGHI--KITDFGL------CKEGISDGATMKTFCGTP 159
Query: 183 LYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEHSLPEI 242
YLAPE + + D W LG V+ EM+ GR + ++ ++LF +I E
Sbjct: 160 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH---EKLFELILMEEI--RF 214
Query: 243 PSRVSKEARDFLRRCFVRKPAFRF-----TAEMLLDDPFVKGVDEE--LSRELEGDYS-- 293
P +S EA+ L + P R A+ +++ F ++ + + ++LE +
Sbjct: 215 PRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEHRFFASINWQDVVQKKLEPPFKPQ 274
Query: 294 -QGEVTLSNADAESCSPECISFIPLEANSSLSSWGSAQRTN 333
E D E + + I+ P + SL +R +
Sbjct: 275 VTSETDTRYFDEEFTA-QSITITPPDRYDSLGLLQLEERPH 314
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 73.9 bits (181), Expect = 1e-14
Identities = 68/251 (27%), Positives = 120/251 (47%), Gaps = 25/251 (9%)
Query: 12 RVIGQGSFGCVFIAKPKSNSSF--LPPLMAVKSAEVSASASLQKEKEVFDNLNGCPFVLE 69
+VIG+G+FG V + + KS+ + L + + S SA +E+++ N P+V++
Sbjct: 49 KVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANS-PWVVQ 107
Query: 70 CFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIH 129
F + +++EY GG DL+ + +PEK + +T ++ + IH
Sbjct: 108 LF-----CAFQDDKYLYMVMEYMPGG---DLVNLMSNYDVPEKWAKFYTAEVVLALDAIH 159
Query: 130 DSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMRGTPLYLAPET 189
G +H DVKPDN+LL + G K+AD G + + D ++ GTP Y++PE
Sbjct: 160 SMGLIHRDVKPDNMLL--DKHGHL--KLADFGTCMKMDETGMVRCDTAV-GTPDYISPEV 214
Query: 190 VVQHMQEA----PSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEHSL--PEIP 243
+ + D W++G + EML G + D + I+ ++SL PE
Sbjct: 215 LKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYA--DSLVGTYSKIMDHKNSLNFPE-D 271
Query: 244 SRVSKEARDFL 254
+SK A++ +
Sbjct: 272 VEISKHAKNLI 282
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 2e-14
Identities = 58/202 (28%), Positives = 97/202 (48%), Gaps = 16/202 (7%)
Query: 14 IGQGSFGCVFIAKPKSNSS--FLPPLMAVKSAEVSASASLQKEKEVFDNLNGCPFVLECF 71
IG+G F V+ A + L + + + A KE ++ LN P V++
Sbjct: 10 IGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNH-PNVIKYL 68
Query: 72 GEEITMGENGEMAYNLLLEYAAGGTLGDLIE--KCNGNGLPEKDVRHFTRCILEGIGHIH 129
I E+ E+ N++LE A G L +I+ K +PE+ V + + + H+H
Sbjct: 69 DSFI---EDNEL--NIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMH 123
Query: 130 DSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMRGTPLYLAPET 189
+H D+KP N+ + AT V K+ DLG+ + + S+ GTP Y++PE
Sbjct: 124 SRRVMHRDIKPANVFITATG----VVKLGDLGLGRF--FSSKTTAAHSLVGTPYYMSPER 177
Query: 190 VVQHMQEAPSDIWALGCVVLEM 211
+ ++ SDIW+LGC++ EM
Sbjct: 178 IHENGYNFKSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 72.3 bits (178), Expect = 3e-14
Identities = 54/205 (26%), Positives = 82/205 (40%), Gaps = 43/205 (20%)
Query: 109 LPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRH 168
L E ++ + +LEGI ++H++ +H D+K NIL+ + + KIAD G+A+
Sbjct: 112 LTESQIKCYMLQLLEGINYLHENHILHRDIKAANILI----DNQGILKIADFGLARPYDG 167
Query: 169 CKRQKFDPSMRG----TPL-----YLAPETVVQHMQEAPS-DIWALGCVVLEMLSGRQAW 218
G T L Y PE ++ + + DIW +GCV EM + R
Sbjct: 168 PPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPIL 227
Query: 219 VVKEDCSIDQL---FSIIG--DEHSLPEIPS----------------------RVSKEAR 251
K D IDQL F + G E + P S ++ E
Sbjct: 228 QGKSD--IDQLHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGL 285
Query: 252 DFLRRCFVRKPAFRFTAEMLLDDPF 276
D L + P R TA L+ P+
Sbjct: 286 DLLSKLLSLDPYKRLTASDALEHPY 310
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 3e-14
Identities = 57/209 (27%), Positives = 91/209 (43%), Gaps = 31/209 (14%)
Query: 14 IGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVSASASL------QKEKEVFDNLNGCPFV 67
+G G+FG V + + + + + A+K + L EK V ++ PF+
Sbjct: 9 VGTGTFGRVHLVRDRISEHYY----ALKVMAIPEVIRLKQEQHVHNEKRVLKEVSH-PFI 63
Query: 68 LECFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGH 127
+ F E+ + +L+EY GG L + N + I+ + +
Sbjct: 64 IRLF-----WTEHDQRFLYMLMEYVPGGELFSYLR--NSGRFSNSTGLFYASEIVCALEY 116
Query: 128 IHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPS--MRGTPLYL 185
+H V+ D+KP+NILL + G K+ D G AK+ R D + + GTP YL
Sbjct: 117 LHSKEIVYRDLKPENILL--DKEGHI--KLTDFGFAKKLR-------DRTWTLCGTPEYL 165
Query: 186 APETVVQHMQEAPSDIWALGCVVLEMLSG 214
APE + D WALG ++ EML G
Sbjct: 166 APEVIQSKGHNKAVDWWALGILIYEMLVG 194
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 71.7 bits (176), Expect = 5e-14
Identities = 82/313 (26%), Positives = 132/313 (42%), Gaps = 66/313 (21%)
Query: 13 VIGQGSFGCVFIAKPKSNSSFLPPLMAVKSA--EVSASASLQ--KEKEVFDNLNGCPFVL 68
+G G+ G V K S L +MA K E+ + Q +E +V N P+++
Sbjct: 8 ELGAGNGGVVT--KVLHRPSGL--IMARKLIHLEIKPAIRNQIIRELKVLHECNS-PYIV 62
Query: 69 ECFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHI 128
+G +GE+ ++ +E+ GG+L D + K G +PE + + +L G+ ++
Sbjct: 63 GFYG---AFYSDGEI--SICMEHMDGGSL-DQVLKKAGR-IPENILGKISIAVLRGLTYL 115
Query: 129 HDS-GYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDP---SMRGTPLY 184
+ +H DVKP NIL+ G+ K+ D GV+ Q D S GT Y
Sbjct: 116 REKHKIMHRDVKPSNILV--NSRGEI--KLCDFGVSG-------QLIDSMANSFVGTRSY 164
Query: 185 LAPETVVQHMQEAPSDIWALGCVVLEMLSGR-------------------QAWVVKEDC- 224
++PE + SDIW+LG ++EM GR KE
Sbjct: 165 MSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHR 224
Query: 225 -------------SIDQLFSIIGDEHSLPEIPSRV-SKEARDFLRRCFVRKPAFRFTAEM 270
+I +L I +E P++PS S E +DF+ +C + P R +
Sbjct: 225 PVSGHPPDSPRPMAIFELLDYIVNEPP-PKLPSGAFSDEFQDFVDKCLKKNPKERADLKE 283
Query: 271 LLDDPFVKGVDEE 283
L PF+K + E
Sbjct: 284 LTKHPFIKRAELE 296
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 71.1 bits (174), Expect = 6e-14
Identities = 73/284 (25%), Positives = 130/284 (45%), Gaps = 44/284 (15%)
Query: 13 VIGQGSFGCVFIAKPKSNSSFLPP---LMAVKSAEVSASASLQK----EKEVFDNLNGC- 64
++G G+ G V+ A + ++AVK + + LQK E E+ L C
Sbjct: 8 ILGHGNGGTVYKA-------YHLLTRRILAVKVIPLDITVELQKQIMSELEI---LYKCD 57
Query: 65 -PFVLECFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILE 123
P+++ +G E ++ E+ GG+L D+ K +PE + +++
Sbjct: 58 SPYIIGFYGAFFV-----ENRISICTEFMDGGSL-DVYRK-----IPEHVLGRIAVAVVK 106
Query: 124 GIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMRGTPL 183
G+ ++ +H DVKP N+L V T+ K+ D GV+ + + + + GT
Sbjct: 107 GLTYLWSLKILHRDVKPSNML-VNTRGQ---VKLCDFGVSTQLVNSIAKTY----VGTNA 158
Query: 184 YLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAW--VVKEDCSID--QLFSIIGDEHSL 239
Y+APE + SD+W+LG +E+ GR + + K S+ QL I DE
Sbjct: 159 YMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDP- 217
Query: 240 PEIP-SRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGVDE 282
P +P + S++ F+ +C ++P R E L+D PF+ ++
Sbjct: 218 PVLPVGQFSEKFVHFITQCMRKQPKERPAPENLMDHPFIVQYND 261
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 6e-14
Identities = 63/211 (29%), Positives = 98/211 (46%), Gaps = 27/211 (12%)
Query: 12 RVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVSASASLQKEKEVFDNLNGC------P 65
+VIG+GSFG V +A+ K+ F AVK + A ++EK + N P
Sbjct: 1 KVIGKGSFGKVLLARHKAEEKF----YAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHP 56
Query: 66 FVLECFGEEITMGENGEMAYNLLLEYAAGGTLGDLI--EKCNGNGLPEKDVRHFTRCILE 123
F++ G + ++ + +L+Y GG L + E+C E R + I
Sbjct: 57 FLV---GLHFSFQTADKLYF--VLDYINGGELFYHLQRERC----FLEPRARFYAAEIAS 107
Query: 124 GIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMRGTPL 183
+G++H V+ D+KP+NILL G V + D G+ K + + + GTP
Sbjct: 108 ALGYLHSLNIVYRDLKPENILL--DSQGHIV--LTDFGLCKEN--IEHNGTTSTFCGTPE 161
Query: 184 YLAPETVVQHMQEAPSDIWALGCVVLEMLSG 214
YLAPE + + + D W LG V+ EML G
Sbjct: 162 YLAPEVLHKQPYDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 71.7 bits (176), Expect = 6e-14
Identities = 60/214 (28%), Positives = 105/214 (49%), Gaps = 30/214 (14%)
Query: 12 RVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEV--SASASLQKEKEVFDNLNGCPFVLE 69
+VIG+G+FG V + + KS+ + K + S SA +E+++ + N ++++
Sbjct: 49 KVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANS-EWIVQ 107
Query: 70 CFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIH 129
++ + Y +++EY GG DL+ + +PEK R +T ++ + IH
Sbjct: 108 LH----YAFQDDKYLY-MVMEYMPGG---DLVNLMSNYDIPEKWARFYTAEVVLALDAIH 159
Query: 130 DSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMR-----GTPLY 184
G++H DVKPDN+LL +SG K+AD G C + + +R GTP Y
Sbjct: 160 SMGFIHRDVKPDNMLL--DKSGHL--KLADFGT------CMKMDANGMVRCDTAVGTPDY 209
Query: 185 LAPETVVQHMQEA----PSDIWALGCVVLEMLSG 214
++PE + + D W++G + EML G
Sbjct: 210 ISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 243
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.9 bits (174), Expect = 9e-14
Identities = 58/205 (28%), Positives = 91/205 (44%), Gaps = 23/205 (11%)
Query: 14 IGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVSASASLQ--KEKEVFDNLNGCPFV--LE 69
+GQG +G VF+AK K + KS + E+++ V L
Sbjct: 9 VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLY 68
Query: 70 CFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIH 129
F ++ E Y L +EY GG L+ N L E R + + E + +H
Sbjct: 69 AF-------QDDEYLY-LAMEYVPGGDFRTLL--NNLGVLSEDHARFYMAEMFEAVDALH 118
Query: 130 DSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMRGTPLYLAPET 189
+ GY+H D+KP+N L+ SG K+ D G++K + S+ G+P Y+APE
Sbjct: 119 ELGYIHRDLKPENFLI--DASGHI--KLTDFGLSKGI-----VTYANSVVGSPDYMAPEV 169
Query: 190 VVQHMQEAPSDIWALGCVVLEMLSG 214
+ + D W+LGC++ E L G
Sbjct: 170 LRGKGYDFTVDYWSLGCMLYEFLCG 194
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 71.2 bits (175), Expect = 9e-14
Identities = 85/323 (26%), Positives = 130/323 (40%), Gaps = 67/323 (20%)
Query: 12 RVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSA--EVSASASLQKEKEVFDNLNGCPFVLE 69
+VIG+G+FG V + + K KS E A ++ E+++ + P+V
Sbjct: 7 KVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEAD-NPWV-- 63
Query: 70 CFGEEITMGENGEMAYNLLL--EYAAGG---TLGDLIEKCNGNGLPEKDVRHF-TRCILE 123
+ + + + L L EY GG TL L++K + E++ R + IL
Sbjct: 64 -----VKLYYSFQDENYLYLIMEYLPGGDMMTL--LMKK---DTFTEEETRFYIAETIL- 112
Query: 124 GIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFD-------- 175
I IH GY+H D+KPDN+LL G K++D G+ + R +F
Sbjct: 113 AIDSIHKLGYIHRDIKPDNLLL--DAKGHI--KLSDFGLCTGLKKSHRTEFYRILSHALP 168
Query: 176 -----------PSMR-----------------GTPLYLAPETVVQHMQEAPSDIWALGCV 207
S R GTP Y+APE +Q D W+LG +
Sbjct: 169 SNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVI 228
Query: 208 VLEMLSGRQAWVVKEDCSIDQLFSIIGDEHSLPEIPS-RVSKEARDFLRR--CFVRKPAF 264
+ EML G + D + II + +L +S EA+D ++R C +
Sbjct: 229 MYEMLVGYPPFC--SDNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCCEAERRLG 286
Query: 265 RFTAEMLLDDPFVKGVDEELSRE 287
+ PF KGVD E RE
Sbjct: 287 NNGVNEIKSHPFFKGVDWEHIRE 309
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 1e-13
Identities = 66/210 (31%), Positives = 100/210 (47%), Gaps = 25/210 (11%)
Query: 12 RVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVSASASLQKEKEVFDNLNGCPFVLECF 71
+VIG+GSFG V +AK KS+ SF AVK V ++ K+KE + +L+
Sbjct: 1 KVIGKGSFGKVLLAKRKSDGSF----YAVK---VLQKKTILKKKEQNHIMAERNVLLKNL 53
Query: 72 GEEITMG-----ENGEMAYNLLLEYAAGGTLGDLI--EKCNGNGLPEKDVRHFTRCILEG 124
+G + E Y +L+Y GG L + E+C E R + +
Sbjct: 54 KHPFLVGLHYSFQTAEKLY-FVLDYVNGGELFFHLQRERC----FLEPRARFYAAEVASA 108
Query: 125 IGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMRGTPLY 184
IG++H ++ D+KP+NILL G V + D G+ K + ++ + GTP Y
Sbjct: 109 IGYLHSLNIIYRDLKPENILL--DSQGHVV--LTDFGLCKEG--VEPEETTSTFCGTPEY 162
Query: 185 LAPETVVQHMQEAPSDIWALGCVVLEMLSG 214
LAPE + + + D W LG V+ EML G
Sbjct: 163 LAPEVLRKEPYDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 1e-13
Identities = 58/216 (26%), Positives = 92/216 (42%), Gaps = 48/216 (22%)
Query: 99 DLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIA 158
DL L E+ R F +L G+ +IH + +H D+KP N+ + V KI
Sbjct: 101 DLANVLEQGPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTED---LVLKIG 157
Query: 159 DLGVAKRSRHCKRQKFDP--SMRG-------TPLYLAPETVVQ--HMQEAPSDIWALGCV 207
D G+A+ DP S +G T Y +P ++ + +A D+WA GC+
Sbjct: 158 DFGLAR--------IVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKA-IDMWAAGCI 208
Query: 208 VLEMLSGRQAW-----------------VVKE---DCSIDQLFSIIGDEHSLPEIPSR-- 245
EML+G+ + VV+E + ++ + S + ++ P P R
Sbjct: 209 FAEMLTGKPLFAGAHELEQMQLILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDL 268
Query: 246 ---VSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVK 278
V+ EA DFL + P R TAE L P++
Sbjct: 269 LPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMS 304
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 1e-13
Identities = 59/210 (28%), Positives = 92/210 (43%), Gaps = 27/210 (12%)
Query: 11 GRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVSASASLQ---KEKEVFDNLNGCPFV 67
G +G GSFG V IAK K + + +K E+ +Q +EK + L+ PF+
Sbjct: 23 GETLGTGSFGRVRIAKHKGTGEYYA-IKCLKKREILKMKQVQHVAQEKSILMELSH-PFI 80
Query: 68 LECFGEEITM--GENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRC-ILEG 124
+ M E LLE+ GG L + K G DV F ++
Sbjct: 81 -------VNMMCSFQDENRVYFLLEFVVGGELFTHLRKA---GRFPNDVAKFYHAELVLA 130
Query: 125 IGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMRGTPLY 184
++H ++ D+KP+N+LL K K+ D G AK+ + F ++ GTP Y
Sbjct: 131 FEYLHSKDIIYRDLKPENLLL----DNKGHVKVTDFGFAKKVPD---RTF--TLCGTPEY 181
Query: 185 LAPETVVQHMQEAPSDIWALGCVVLEMLSG 214
LAPE + D W +G ++ E ++G
Sbjct: 182 LAPEVIQSKGHGKAVDWWTMGVLLYEFIAG 211
|
Length = 329 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 2e-13
Identities = 67/272 (24%), Positives = 120/272 (44%), Gaps = 30/272 (11%)
Query: 14 IGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVSASASLQKEKEVFDNLNGC--PFVLECF 71
IG G++G V+ A+ + L A+K ++ ++ + C ++ F
Sbjct: 17 IGSGTYGDVYKARNVNTGE----LAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYF 72
Query: 72 GEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDS 131
G + + + +E+ GG+L D+ L E + + +R L+G+ ++H
Sbjct: 73 GSYLRRDK-----LWICMEFCGGGSLQDIYHVTGP--LSESQIAYVSRETLQGLYYLHSK 125
Query: 132 GYVHCDVKPDNILLVATQSGKFVAKIADLGVAKR--SRHCKRQKFDPSMRGTPLYLAPET 189
G +H D+K NILL T +G K+AD GV+ + + KR+ F GTP ++APE
Sbjct: 126 GKMHRDIKGANILL--TDNGH--VKLADFGVSAQITATIAKRKSF----IGTPYWMAPEV 177
Query: 190 VVQHMQEAPS---DIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEHSLPEIPSRV 246
+ + DIWA+G +E+ + + + LF + P++ ++
Sbjct: 178 AAVERKGGYNQLCDIWAVGITAIELAELQPPMF--DLHPMRALFLMTKSNFQPPKLKDKM 235
Query: 247 --SKEARDFLRRCFVRKPAFRFTAEMLLDDPF 276
S F++ + P R TAE LL PF
Sbjct: 236 KWSNSFHHFVKMALTKNPKKRPTAEKLLQHPF 267
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 69.7 bits (170), Expect = 2e-13
Identities = 75/280 (26%), Positives = 127/280 (45%), Gaps = 46/280 (16%)
Query: 14 IGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVSASASLQKEKEVFDNLNGC-----PFVL 68
IG GSFG V+ A +S ++AVK S + +K +++ + P +
Sbjct: 29 IGHGSFGAVYFA----TNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTI 84
Query: 69 E---CFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGI 125
E C+ +E T L++EY G + DL+E + L E ++ T L+G+
Sbjct: 85 EYKGCYLKEHTAW--------LVMEYCLG-SASDLLE-VHKKPLQEVEIAAITHGALQGL 134
Query: 126 GHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMRGTPLYL 185
++H +H D+K NILL T+ G+ K+AD G A +S S GTP ++
Sbjct: 135 AYLHSHNMIHRDIKAGNILL--TEPGQ--VKLADFGSASKSSPAN------SFVGTPYWM 184
Query: 186 APETVV---QHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEHSLPEI 242
APE ++ + + D+W+LG +E L+ R+ + + ++ L+ I ++
Sbjct: 185 APEVILAMDEGQYDGKVDVWSLGITCIE-LAERKPPLFNMN-AMSALYHIAQNDS----- 237
Query: 243 PSRVSKEARDFLRR----CFVRKPAFRFTAEMLLDDPFVK 278
P+ S E D R C + P R + LL FV+
Sbjct: 238 PTLQSNEWTDSFRGFVDYCLQKIPQERPASAELLRHDFVR 277
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 2e-13
Identities = 79/296 (26%), Positives = 131/296 (44%), Gaps = 49/296 (16%)
Query: 12 RVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVSASASLQKEKEVFDNLNGCPFVLECF 71
+V+G+GSFG V +A+ K + AVK+ L+K+ + D+ C V +
Sbjct: 1 KVLGKGSFGKVLLAELKGKGEYF----AVKA--------LKKDVVLIDDDVECTMVEK-- 46
Query: 72 GEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGL----PEKDVRHFTRC------I 121
+ + +L + L ++E NG L +K R I
Sbjct: 47 -RVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEI 105
Query: 122 LEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMR-- 179
+ G+ +H G ++ D+K DN++L + G KIAD G+ CK F +
Sbjct: 106 VCGLQFLHSKGIIYRDLKLDNVML--DRDGHI--KIADFGM------CKENVFGDNRAST 155
Query: 180 --GTPLYLAPETVVQHMQEAPS-DIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDE 236
GTP Y+APE ++Q ++ S D W+ G ++ EML G+ + ++ D+LF I
Sbjct: 156 FCGTPDYIAPE-ILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDE---DELFESI--R 209
Query: 237 HSLPEIPSRVSKEARDFLRRCFVRKPAFRF-TAEMLLDDPFVKGVDEEL--SRELE 289
P P ++KE++D L + F R P R + PF K ++ REL+
Sbjct: 210 VDTPHYPRWITKESKDILEKLFERDPTRRLGVVGNIRGHPFFKTINWTALEKRELD 265
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 2e-13
Identities = 73/287 (25%), Positives = 118/287 (41%), Gaps = 41/287 (14%)
Query: 12 RVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVS------ASASLQKEKEVFDNLNGCP 65
RV+G+G FG V + ++ + A K E A EK++ + +N
Sbjct: 6 RVLGKGGFGEVCACQVRATGK----MYACKKLEKKRIKKRKGEAMALNEKQILEKVNS-R 60
Query: 66 FVLECFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGI 125
FV+ + + A L+L GG L I G E+ + I G+
Sbjct: 61 FVVS-----LAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGL 115
Query: 126 GHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMRGTPLYL 185
+H V+ D+KP+NILL G +I+DLG+A + + GT Y+
Sbjct: 116 EDLHRERIVYRDLKPENILL--DDYGHI--RISDLGLAVEIPEGETIR---GRVGTVGYM 168
Query: 186 APETVVQHMQEAPSDIWALGCVVLEMLSG------RQAWVVKEDCSIDQLFSIIGDEHSL 239
APE V D W LGC++ EM+ G R+ V +E+ +++ +E+S
Sbjct: 169 APEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREE--VERRVKEDQEEYS- 225
Query: 240 PEIPSRVSKEARDFLRRCFVRKPAFRF-----TAEMLLDDPFVKGVD 281
+ S+ AR R+ + P FR AE + PF + +
Sbjct: 226 ----EKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRTAN 268
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 3e-13
Identities = 66/275 (24%), Positives = 128/275 (46%), Gaps = 45/275 (16%)
Query: 12 RVIGQGSFGCVFIAKPKS--NSSFLPPLMAVKSAEVSASASL----QKEKEVFDNLNGCP 65
+V+G G++G VF+ + S +S L + +K A + A + E++V +++ P
Sbjct: 6 KVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSP 65
Query: 66 FVLECFGEEITMGENGEMAYNLLLEYAAGGTL-GDLIEKCNGNGLPEKDVRHFTRCILEG 124
F++ + + +L+L+Y GG L L ++ E++V+ ++ I+
Sbjct: 66 FLVT-----LHYAFQTDTKLHLILDYINGGELFTHLSQRER---FKEQEVQIYSGEIVLA 117
Query: 125 IGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMRGTPLY 184
+ H+H G ++ D+K +NILL +G V + D G++K H + S GT Y
Sbjct: 118 LEHLHKLGIIYRDIKLENILL--DSNGHVV--LTDFGLSKEF-HEDEVERAYSFCGTIEY 172
Query: 185 LAPETVV--QHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEHSLPEI 242
+AP+ V + D W++G ++ E+L+G F++ G+++S EI
Sbjct: 173 MAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASP------------FTVDGEKNSQAEI 220
Query: 243 PSRVSKE-----------ARDFLRRCFVRKPAFRF 266
R+ K A+D ++R ++ P R
Sbjct: 221 SRRILKSEPPYPQEMSALAKDIIQRLLMKDPKKRL 255
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 69.3 bits (170), Expect = 4e-13
Identities = 56/211 (26%), Positives = 88/211 (41%), Gaps = 44/211 (20%)
Query: 109 LPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAK--RS 166
L E+ +R+F +L G+ +IH + +H D+KP N+L+ + +I D G+A+ S
Sbjct: 104 LTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLV----NEDCELRIGDFGMARGLSS 159
Query: 167 RHCKRQKFDPSMRGTPLYLAPE---TVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKED 223
+ + F T Y APE ++ ++ D+W++GC+ EML RQ + K
Sbjct: 160 SPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAI--DMWSVGCIFAEMLGRRQLFPGKN- 216
Query: 224 CSIDQLFSI--------------IGDEH------SLPEIPSR--------VSKEARDFLR 255
+ QL I IG + +LP S EA D L
Sbjct: 217 -YVHQLKLILSVLGSPSEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLS 275
Query: 256 RCFVRKPAFRFTAEMLLDDPFVKG---VDEE 283
+ P R T E L PF+ D+E
Sbjct: 276 QMLQFDPEERITVEQALQHPFLAQYHDPDDE 306
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.5 bits (168), Expect = 5e-13
Identities = 84/341 (24%), Positives = 130/341 (38%), Gaps = 111/341 (32%)
Query: 14 IGQGSFGCVFIAKPKSNSSFLPPLMAVKSAE--------VSASA----SLQKE------- 54
IG+G++G V+ AK K+ A+K + +S SA +L +E
Sbjct: 8 IGRGTYGRVYKAKRKNGKD--GKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVV 65
Query: 55 --KEVFDNLNGCPFVLECFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCN------G 106
EVF + + + LL +YA DL +
Sbjct: 66 SLVEVFLE-------------------HADKSVYLLFDYAEH----DLWQIIKFHRQAKR 102
Query: 107 NGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRS 166
+P V+ IL G+ ++H + +H D+KP NIL++ + V KI DLG+A
Sbjct: 103 VSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLA--- 159
Query: 167 RHCKRQKFDPSMRGTPL-----YLAPETVV--QHMQEAPSDIWALGCVVLEMLS------ 213
R P P+ Y APE ++ +H +A DIWA+GC+ E+L+
Sbjct: 160 RLF-NAPLKPLADLDPVVVTIWYRAPELLLGARHYTKA-IDIWAIGCIFAELLTLEPIFK 217
Query: 214 GRQAWVVKEDCSI----DQL---FSIIG--------DEHSLPEIPS-------------- 244
GR+A K S DQL F ++G D +PE +
Sbjct: 218 GREA---KIKKSNPFQRDQLERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNS 274
Query: 245 ---------RVSKEARDFLRRCFVRKPAFRFTAEMLLDDPF 276
+ + D LR+ P R TAE L+ P+
Sbjct: 275 LAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEHPY 315
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 5e-13
Identities = 78/317 (24%), Positives = 135/317 (42%), Gaps = 58/317 (18%)
Query: 12 RVIGQGSFGCVFIAKPKSNSSFLPPLMAVKS--AEVSASASLQKEKEVFDNLNGCPFVLE 69
+VIG+G+FG V + + K + K+ E A ++ E+++ +G +V++
Sbjct: 7 KVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGA-WVVK 65
Query: 70 CFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIH 129
F + L++E+ GG + L+ K + L E+ + + + I IH
Sbjct: 66 MF-----YSFQDKRNLYLIMEFLPGGDMMTLLMK--KDTLSEEATQFYIAETVLAIDAIH 118
Query: 130 DSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKF------DP------- 176
G++H D+KPDN+LL A K K++D G+ + R +F +P
Sbjct: 119 QLGFIHRDIKPDNLLLDA----KGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQ 174
Query: 177 --------------------SMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQ 216
S GTP Y+APE +Q D W+LG ++ EML G
Sbjct: 175 NMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP 234
Query: 217 AWVVKEDCSIDQLFSIIGDEHSL---PEIPSRVSKEARDFLRRCFVRKPAFRF---TAEM 270
+ + + ++ + +L PE+P +S++A+D + R F R E
Sbjct: 235 PFC--SETPQETYRKVMNWKETLVFPPEVP--ISEKAKDLILR-FCTDSENRIGSNGVEE 289
Query: 271 LLDDPFVKGVDEELSRE 287
+ PF +GVD RE
Sbjct: 290 IKSHPFFEGVDWGHIRE 306
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 6e-13
Identities = 79/298 (26%), Positives = 125/298 (41%), Gaps = 59/298 (19%)
Query: 12 RVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVSASASLQKEKEVFDNLNGC------- 64
+V+G+GSFG V +A+ K + EV A L+K+ + D+ C
Sbjct: 1 KVLGKGSFGKVMLAELKG------------TDEVYAIKVLKKDVILQDDDVDCTMTEKRI 48
Query: 65 -------PFVLE---CFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDV 114
PF+ CF + + ++EY GG L I++ E
Sbjct: 49 LALAAKHPFLTALHCCFQTKDRL--------FFVMEYVNGGDLMFQIQR--SRKFDEPRS 98
Query: 115 RHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKF 174
R + + + +H G ++ D+K DNILL A K+AD G+ K
Sbjct: 99 RFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGH----CKLADFGMCKEG--ILNGVT 152
Query: 175 DPSMRGTPLYLAPETVVQHMQEAPS-DIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSII 233
+ GTP Y+APE ++Q ++ PS D WALG ++ EM++G+ + + D LF I
Sbjct: 153 TTTFCGTPDYIAPE-ILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNE---DDLFESI 208
Query: 234 GDEHSLPEIPSRVSKEARDFLRRCFVRKPAFRF-------TAEMLLDDPFVKGVDEEL 284
+ L P +SKEA L+ + P R + + PF K +D L
Sbjct: 209 LHDDVL--YPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQHPFFKEIDWVL 264
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 68.1 bits (167), Expect = 7e-13
Identities = 38/106 (35%), Positives = 57/106 (53%), Gaps = 9/106 (8%)
Query: 109 LPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRH 168
LPEK V+ + +L+ + H+H +G H D+KP+NIL+ + K+AD G R +
Sbjct: 97 LPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILI-----KDDILKLADFGSC-RGIY 150
Query: 169 CKRQKFDPSMRGTPLYLAPETVVQHMQEAPS-DIWALGCVVLEMLS 213
K + + T Y APE ++ P DIWA+GCV E+LS
Sbjct: 151 SK-PPYTEYI-STRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILS 194
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.7 bits (166), Expect = 7e-13
Identities = 55/213 (25%), Positives = 88/213 (41%), Gaps = 47/213 (22%)
Query: 97 LGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAK 156
L ++ GL ++ + +L+GI + H +H D+KP N+L+ K
Sbjct: 84 LKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREG----ALK 139
Query: 157 IADLGVAKRSRHCKRQKFDPSMRG------TPLYLAPETVV-QHMQEAPSDIWALGCVVL 209
+AD G+A+ F +R T Y APE ++ P DIW++GC+
Sbjct: 140 LADFGLAR--------AFGVPVRTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFA 191
Query: 210 EMLSGRQAWVVKEDCSIDQLFSI---IG--DEHSLPEIPS-------------------- 244
EM++ R + D IDQLF I +G DE P + S
Sbjct: 192 EMVNRRP--LFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKPTFPKWARQDLSKVV 249
Query: 245 -RVSKEARDFLRRCFVRKPAFRFTAEMLLDDPF 276
+ ++ D L + V PA R +A+ L P+
Sbjct: 250 PNLDEDGLDLLSKMLVYDPAKRISAKAALQHPY 282
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 67.8 bits (165), Expect = 9e-13
Identities = 57/214 (26%), Positives = 97/214 (45%), Gaps = 48/214 (22%)
Query: 109 LPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAK--RS 166
LP V+ IL+GI ++H + +H D+KP NIL++ + KIAD+G A+ S
Sbjct: 105 LPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNS 164
Query: 167 RHCKRQKFDPSMRGTPLYLAPETVV--QHMQEAPSDIWALGCVVLEMLSGRQAWVVKED- 223
DP + T Y APE ++ +H +A DIWA+GC+ E+L+ + +++
Sbjct: 165 PLKPLADLDPVVV-TFWYRAPELLLGARHYTKA-IDIWAIGCIFAELLTSEPIFHCRQED 222
Query: 224 ---------CSIDQLFSIIG--------DEHSLPEIPS---------------------- 244
+D++FS++G D +PE P+
Sbjct: 223 IKTSNPFHHDQLDRIFSVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKH 282
Query: 245 RVSKEARDF--LRRCFVRKPAFRFTAEMLLDDPF 276
+V +++ F L++ P R T+E L DP+
Sbjct: 283 KVKPDSKVFLLLQKLLTMDPTKRITSEQALQDPY 316
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 1e-12
Identities = 60/208 (28%), Positives = 95/208 (45%), Gaps = 21/208 (10%)
Query: 12 RVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVSASASLQKEKEVFDNLNGCPFVLECF 71
+VIG+GSFG V +AK K + AVK + + +++K + N +L+
Sbjct: 1 KVIGKGSFGKVLLAKRKLDGKC----YAVKVLQKKIVLNRKEQKHIMAERN---VLLKNV 53
Query: 72 GEEITMG-----ENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIG 126
+G + E Y +L++ GG L +++ PE R + I +G
Sbjct: 54 KHPFLVGLHYSFQTTEKLY-FVLDFVNGGELFFHLQR--ERSFPEPRARFYAAEIASALG 110
Query: 127 HIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMRGTPLYLA 186
++H V+ D+KP+NILL G V + D G+ K + + GTP YLA
Sbjct: 111 YLHSINIVYRDLKPENILL--DSQGHVV--LTDFGLCKEG--IAQSDTTTTFCGTPEYLA 164
Query: 187 PETVVQHMQEAPSDIWALGCVVLEMLSG 214
PE + + + D W LG V+ EML G
Sbjct: 165 PEVIRKQPYDNTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 1e-12
Identities = 85/297 (28%), Positives = 122/297 (41%), Gaps = 63/297 (21%)
Query: 13 VIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVSASASLQK--------------EKEVF 58
V+G+GSFG V +A+ K + E+ A L+K EK V
Sbjct: 7 VLGKGSFGKVMLAERKG------------TDELYAIKILKKDVIIQDDDVECTMVEKRVL 54
Query: 59 DNLNGCPFVLE---CFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVR 115
PF+ + CF TM + Y ++EY GG L I++ E
Sbjct: 55 ALPGKPPFLTQLHSCFQ---TM----DRLY-FVMEYVNGGDLMYHIQQVGK--FKEPHAV 104
Query: 116 HFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFD 175
+ I G+ +H G ++ D+K DN++L G KIAD G+ CK F
Sbjct: 105 FYAAEIAIGLFFLHSKGIIYRDLKLDNVML--DAEGHI--KIADFGM------CKENIFG 154
Query: 176 PSMR----GTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFS 231
GTP Y+APE + D WA G ++ EML+G Q ED D+LF
Sbjct: 155 GKTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAG-QPPFDGED--EDELFQ 211
Query: 232 IIGDEHSLPEIPSRVSKEARDFLRRCFVRKPAFRF----TAEM-LLDDPFVKGVDEE 283
I EH+ P +SKEA + + PA R T E + + F + +D E
Sbjct: 212 SI-MEHN-VSYPKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREHAFFRRIDWE 266
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 1e-12
Identities = 55/213 (25%), Positives = 90/213 (42%), Gaps = 47/213 (22%)
Query: 97 LGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAK 156
L ++ +G+P ++ + +L+G+ H +H D+KP N+L+ G K
Sbjct: 85 LKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLI--NTEGAI--K 140
Query: 157 IADLGVAKRSRHCKRQKFDPSMRG------TPLYLAPETVV-QHMQEAPSDIWALGCVVL 209
+AD G+A+ F +R T Y APE ++ DIW+LGC+
Sbjct: 141 LADFGLAR--------AFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFA 192
Query: 210 EMLSGRQAWVVKEDCSIDQLFSI---IG--DEHSLP---------------------EIP 243
EM++ R+A + D IDQLF I +G DE P ++
Sbjct: 193 EMVT-RRA-LFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKPSFPKWARQDFSKVV 250
Query: 244 SRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPF 276
+ ++ RD L + P R +A+ L PF
Sbjct: 251 PPLDEDGRDLLSQMLHYDPNKRISAKAALAHPF 283
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 67.4 bits (165), Expect = 2e-12
Identities = 75/304 (24%), Positives = 125/304 (41%), Gaps = 56/304 (18%)
Query: 14 IGQGSFGCVFIAKPKSNSSFLPPLMAVK------SAEVSASASLQKEKEVFDNLNGCPFV 67
+GQG++G V A+ S +A+K S ++ A +L +E ++ + G +
Sbjct: 8 LGQGAYGIVCSARNAETSEEET--VAIKKITNVFSKKILAKRAL-RELKLLRHFRGHKNI 64
Query: 68 LECFGEEITM--GENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGI 125
+ +I N Y L+E L +I +G L + + F IL G+
Sbjct: 65 TCLYDMDIVFPGNFNELYLYEELMEA----DLHQIIR--SGQPLTDAHFQSFIYQILCGL 118
Query: 126 GHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMRG---TP 182
+IH + +H D+KP N+L+ A + KI D G+A R + M T
Sbjct: 119 KYIHSANVLHRDLKPGNLLVNA--DCEL--KICDFGLA-RGFSENPGENAGFMTEYVATR 173
Query: 183 LYLAPETVVQHMQEAPS-DIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIG-----DE 236
Y APE ++ + D+W++GC++ E+L + V K +DQL I+ DE
Sbjct: 174 WYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKP--VFKGKDYVDQLNQILQVLGTPDE 231
Query: 237 ---------------HSLPEIPSR--------VSKEARDFLRRCFVRKPAFRFTAEMLLD 273
SLP IP + + A D L + P R + E L+
Sbjct: 232 ETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALE 291
Query: 274 DPFV 277
P++
Sbjct: 292 HPYL 295
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 2e-12
Identities = 54/195 (27%), Positives = 94/195 (48%), Gaps = 25/195 (12%)
Query: 98 GDLIEKCNGNGL-PEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAK 156
GDL + +G+ E ++R + I+ G+ H+H+ V+ D+KP NILL + G +
Sbjct: 82 GDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILL--DEHGH--VR 137
Query: 157 IADLGVAKRSRHCKRQKFDPSMR-GTPLYLAPETVVQHMQ-EAPSDIWALGCVVLEMLSG 214
I+DLG+A C K P GT Y+APE + + + ++ +D ++LGC++ ++L G
Sbjct: 138 ISDLGLA-----CDFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRG 192
Query: 215 R---QAWVVKEDCSIDQLFSIIGDEHSLPEIPSRVSKEARDFLRRCFVRKPAFRF----- 266
+ K+ ID++ + E+P S E R L R R
Sbjct: 193 HSPFRQHKTKDKHEIDRMTLTMA-----VELPDSFSPELRSLLEGLLQRDVNRRLGCLGR 247
Query: 267 TAEMLLDDPFVKGVD 281
A+ + + PF + +D
Sbjct: 248 GAQEVKEHPFFRSLD 262
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 67.2 bits (165), Expect = 2e-12
Identities = 52/209 (24%), Positives = 84/209 (40%), Gaps = 50/209 (23%)
Query: 109 LPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRH 168
L + +++F IL G+ ++H + +H D+KP NIL+ + KI D G+A
Sbjct: 100 LTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCD----LKICDFGLA----- 150
Query: 169 CKRQKFDPSMRGTPL--------YLAPETVVQHMQ-EAPSDIWALGCVVLEMLSGRQAWV 219
R L Y APE ++ + DIW++GC+ E+L+ + +
Sbjct: 151 --RGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFP 208
Query: 220 VKEDCSIDQL---FSIIG--DEHSLPEIPS-----------------------RVSKEAR 251
++ IDQL ++G E L I S S EA
Sbjct: 209 GRD--YIDQLNLIVEVLGTPSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAI 266
Query: 252 DFLRRCFVRKPAFRFTAEMLLDDPFVKGV 280
D L + V P R TA+ L P++ +
Sbjct: 267 DLLEKMLVFDPKKRITADEALAHPYLAQL 295
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 2e-12
Identities = 69/277 (24%), Positives = 125/277 (45%), Gaps = 32/277 (11%)
Query: 14 IGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVSASASLQK---EKEVFDNLNGCPFVLEC 70
IG+GSFG V + K ++ + L ++ A + + + + E+ V +N CPF++
Sbjct: 1 IGKGSFGKVMQVR-KRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVN-CPFIVPL 58
Query: 71 FGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHD 130
+ + ++ L+L + GG L +++ R +T +L + ++H
Sbjct: 59 ---KFSFQSPEKLY--LVLAFINGGELFHHLQR--EGRFDLSRARFYTAELLCALENLHK 111
Query: 131 SGYVHCDVKPDNILLVATQSGKFVAKIA--DLGVAKRSRHCKRQKFDPSMRGTPLYLAPE 188
++ D+KP+NILL + IA D G+ K + K + GTP YLAPE
Sbjct: 112 FNVIYRDLKPENILL------DYQGHIALCDFGLCKLNM--KDDDKTNTFCGTPEYLAPE 163
Query: 189 TVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEHSLP-EIPSRVS 247
++ H D W LG ++ EML+G + D ++++++ I E P P
Sbjct: 164 LLLGHGYTKAVDWWTLGVLLYEMLTGLPPFY---DENVNEMYRKILQE---PLRFPDGFD 217
Query: 248 KEARDFLRRCFVRKPAFRF---TAEMLLDDPFVKGVD 281
++A+D L R P R A+ + + PF +
Sbjct: 218 RDAKDLLIGLLSRDPTRRLGYNGAQEIKNHPFFSQLS 254
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 3e-12
Identities = 74/274 (27%), Positives = 118/274 (43%), Gaps = 34/274 (12%)
Query: 14 IGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVSASASLQK-EKEVFDNLNGCPFVLECFG 72
+G G++G V+ A+ L AVK ++ ++E+F V EC
Sbjct: 17 VGSGTYGDVYKARNLHTGE----LAAVKIIKLEPGDDFSLIQQEIF-------MVKECKH 65
Query: 73 EEITMGENGEMAYNLL---LEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIH 129
I ++ L +EY GG+L D I G L E + + R L+G+ ++H
Sbjct: 66 CNIVAYFGSYLSREKLWICMEYCGGGSLQD-IYHVTGP-LSELQIAYVCRETLQGLAYLH 123
Query: 130 DSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKR--SRHCKRQKFDPSMRGTPLYLAP 187
G +H D+K NILL T +G K+AD GVA + + KR+ F GTP ++AP
Sbjct: 124 SKGKMHRDIKGANILL--TDNGD--VKLADFGVAAKITATIAKRKSF----IGTPYWMAP 175
Query: 188 ETVVQHMQEAPS---DIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEHSLPEIPS 244
E + DIWA+G +E+ + + + LF + P++
Sbjct: 176 EVAAVEKNGGYNQLCDIWAVGITAIEL--AELQPPMFDLHPMRALFLMSKSNFQPPKLKD 233
Query: 245 RV--SKEARDFLRRCFVRKPAFRFTAEMLLDDPF 276
+ S +F++ + P R TAE LL F
Sbjct: 234 KTKWSSTFHNFVKISLTKNPKKRPTAERLLTHLF 267
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 3e-12
Identities = 66/263 (25%), Positives = 110/263 (41%), Gaps = 28/263 (10%)
Query: 12 RVIGQGSFGCVFIAKPKSNSSFLP--PLMAVKSAEVSASASLQKEKEVFDNLNGCPFVLE 69
RV+G+G FG V + ++ L + + + EK++ + +N V
Sbjct: 6 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSL 65
Query: 70 CFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIH 129
+ E + A L+L GG L I G E + I G+ +H
Sbjct: 66 AYAYET------KDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLH 119
Query: 130 DSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMRGTPLYLAPET 189
V+ D+KP+NILL G +I+DLG+A H + GT Y+APE
Sbjct: 120 QERIVYRDLKPENILL--DDHGHI--RISDLGLAV---HVPEGQTIKGRVGTVGYMAPEV 172
Query: 190 VVQHMQEAPSDIWALGCVVLEMLSG------RQAWVVKEDCSIDQLFSIIGDEHSLPEIP 243
V D WALGC++ EM++G R+ + +E+ +++L + +E+S
Sbjct: 173 VKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREE--VERLVKEVQEEYS----- 225
Query: 244 SRVSKEARDFLRRCFVRKPAFRF 266
+ S +AR + + P R
Sbjct: 226 EKFSPDARSLCKMLLCKDPKERL 248
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 4e-12
Identities = 77/320 (24%), Positives = 138/320 (43%), Gaps = 64/320 (20%)
Query: 12 RVIGQGSFGCVFIAKPKSNSSF--LPPLMAVKSAEVSASASLQKEKEVF---DNLNGCPF 66
+VIG+G+FG V + + K + L E ++ E+++ D+L +
Sbjct: 7 KVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSL----W 62
Query: 67 VLECFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIG 126
V++ F ++ L++E+ GG + L+ K + L E++ + + + I
Sbjct: 63 VVKMF-----YSFQDKLNLYLIMEFLPGGDMMTLLMK--KDTLTEEETQFYIAETVLAID 115
Query: 127 HIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMR------- 179
IH G++H D+KPDN+LL K K++D G+ + R +F ++
Sbjct: 116 SIHQLGFIHRDIKPDNLLL----DSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDF 171
Query: 180 --------------------------GTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLS 213
GTP Y+APE +Q D W+LG ++ EML
Sbjct: 172 TFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLI 231
Query: 214 GRQAWVVKEDCSIDQLFSIIGDEHSL---PEIPSRVSKEARDFLRRCFVRKPAFRFTA-- 268
G + + + ++ + +L PE+P +S++A+D + R F + R A
Sbjct: 232 GYPPFC--SETPQETYKKVMNWKETLIFPPEVP--ISEKAKDLILR-FCCEWEHRIGAPG 286
Query: 269 -EMLLDDPFVKGVDEELSRE 287
E + +PF +GVD E RE
Sbjct: 287 VEEIKTNPFFEGVDWEHIRE 306
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 65.3 bits (159), Expect = 5e-12
Identities = 66/290 (22%), Positives = 119/290 (41%), Gaps = 47/290 (16%)
Query: 10 RGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEV----SASASLQKEKEVFDNLNGCP 65
R R +G+G FG V + + +AVKS + + A L+KE E+ NL
Sbjct: 8 RIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNL---- 63
Query: 66 FVLECFGEEITM-----GENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRC 120
+ E I E+G L++E+ G+L + + + N N + K +
Sbjct: 64 -----YHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPR-NKNKINLKQQLKYAVQ 117
Query: 121 ILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMRG 180
I +G+ ++ YVH D+ N+L+ + KI D G+ K K
Sbjct: 118 ICKGMDYLGSRQYVHRDLAARNVLVESEH----QVKIGDFGLTKAIETDKEYYTVKDDLD 173
Query: 181 TPLY-LAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCS-------------- 225
+P++ APE ++Q SD+W+ G + E+L+ + S
Sbjct: 174 SPVFWYAPECLIQSKFYIASDVWSFGVTLYELLT-----YCDSESSPMTLFLKMIGPTHG 228
Query: 226 ---IDQLFSIIGDEHSLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLL 272
+ +L ++ + LP P +E +R+C+ +P+ R T + L+
Sbjct: 229 QMTVTRLVRVLEEGKRLP-RPPNCPEEVYQLMRKCWEFQPSKRTTFQNLI 277
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 6e-12
Identities = 80/336 (23%), Positives = 131/336 (38%), Gaps = 74/336 (22%)
Query: 12 RVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVSAS------ASLQKEKEVFDNLNGCP 65
+VIG+G+FG V + + K + A+K+ S A ++ E++V + P
Sbjct: 7 KVIGKGAFGEVRLVQKKDTGK----IYAMKTLLKSEMFKKDQLAHVKAERDVLAESDS-P 61
Query: 66 FVLECFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHF--TRCILE 123
+V+ + ++ + Y L++E+ GG L ++ K + +DV F C+L
Sbjct: 62 WVVSLY----YSFQDAQYLY-LIMEFLPGGDLMTMLIKYD---TFSEDVTRFYMAECVL- 112
Query: 124 GIGHIHDSGYVHCDVKPDNILLVATQSGK----------------------FVAKIADLG 161
I +H G++H D+KPDNIL+ K K
Sbjct: 113 AIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNR 172
Query: 162 VAKRSRHC-------------------KRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIW 202
+ R+ R+ S GTP Y+APE +Q D W
Sbjct: 173 IDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWW 232
Query: 203 ALGCVVLEMLSGRQAW--VVKEDCSIDQLFSIIGDEHSLPEIPS--RVSKEARDFLRR-- 256
+LG ++ E L G W E+ S + II +L P +S EA D +RR
Sbjct: 233 SLGAIMFECLIG---WPPFCSEN-SHETYRKIINWRETL-YFPDDIHLSVEAEDLIRRLI 287
Query: 257 CFVRKPAFRFTAEMLLDDPFVKGVDEELSRELEGDY 292
R A + PF +GVD + R++ +
Sbjct: 288 TNAENRLGRGGAHEIKSHPFFRGVDWDTIRQIRAPF 323
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 1e-11
Identities = 38/133 (28%), Positives = 60/133 (45%), Gaps = 8/133 (6%)
Query: 90 EYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQ 149
EY G TL +++ LP + +L+ + H+ G VH D+KP NI +V+
Sbjct: 59 EYVPGRTLREVLA--ADGALPAGETGRLMLQVLDALACAHNQGIVHRDLKPQNI-MVSQT 115
Query: 150 SGKFVAKIADLGVAK-----RSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWAL 204
+ AK+ D G+ R + GTP Y APE + SD++A
Sbjct: 116 GVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAW 175
Query: 205 GCVVLEMLSGRQA 217
G + LE L+G++
Sbjct: 176 GLIFLECLTGQRV 188
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 1e-11
Identities = 57/198 (28%), Positives = 87/198 (43%), Gaps = 48/198 (24%)
Query: 114 VRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQK 173
+++F IL G+ ++H +G VH D+KP NIL+ KI D G+A+
Sbjct: 110 IQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCD----LKICDFGLARIQ------- 158
Query: 174 FDPSMRG---TPLYLAPETVVQHMQ-EAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQL 229
DP M G T Y APE ++ + + DIW+ GC+ EML G+ + K+ ++Q
Sbjct: 159 -DPQMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKD--HVNQ- 214
Query: 230 FSIIGD---------------EHSLPEIPSRVSKE--------------ARDFLRRCFVR 260
FSII D E++L + S +E A D L + V
Sbjct: 215 FSIITDLLGTPPDDVINTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVF 274
Query: 261 KPAFRFTAEMLLDDPFVK 278
P R +A L P++
Sbjct: 275 DPQKRISAAEALAHPYLA 292
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 1e-11
Identities = 72/282 (25%), Positives = 121/282 (42%), Gaps = 30/282 (10%)
Query: 14 IGQGSFGCVFIAKPKSNSSF-----LPPLMAVKSAEVSASASLQKEKEVFDNLNGCPFVL 68
IG+G+FG V+ + K L V EV+ + ++ V L+ PF++
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIG-ERNILVRTLLDESPFIV 59
Query: 69 ECFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHI 128
G + + + ++ L+ +Y +GG L ++K G E + + ++ + H+
Sbjct: 60 ---GLKFSFQTDSDLY--LVTDYMSGGELFWHLQK-EGR-FSEDRAKFYIAELVLALEHL 112
Query: 129 HDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMRGTPLYLAPE 188
H V+ D+KP+NILL AT + D G++K + K + GT YLAPE
Sbjct: 113 HKYDIVYRDLKPENILLDATGH----IALCDFGLSKAN--LTDNKTTNTFCGTTEYLAPE 166
Query: 189 TVVQHMQEAPS-DIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEHSLPEIPSRV- 246
++ D W+LG +V EM G + ++ Q++ I P V
Sbjct: 167 VLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAED---TQQMYRNIA--FGKVRFPKNVL 221
Query: 247 SKEARDFLRRCFVRKPAFRF----TAEMLLDDPFVKGVDEEL 284
S E R F++ R P R A L + PF +D +L
Sbjct: 222 SDEGRQFVKGLLNRNPQHRLGAHRDAVELKEHPFFADIDWDL 263
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 1e-11
Identities = 71/265 (26%), Positives = 116/265 (43%), Gaps = 38/265 (14%)
Query: 13 VIGQGSFGCVFIAKPKSNSSF-----LPPLMAVKSAEVSASASLQKEKEVFDNLNGCPFV 67
V+G+GSFG V +A+ K L + ++ +V + EK V + PF+
Sbjct: 7 VLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMV---EKRVLALQDKPPFL 63
Query: 68 LE---CFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEG 124
+ CF + + Y ++EY GG L I++ E + I G
Sbjct: 64 TQLHSCF-------QTVDRLY-FVMEYVNGGDLMYHIQQVGK--FKEPQAVFYAAEISVG 113
Query: 125 IGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRH---CKRQKFDPSMRGT 181
+ +H G ++ D+K DN++L G KIAD G+ K R + GT
Sbjct: 114 LFFLHRRGIIYRDLKLDNVML--DSEGHI--KIADFGMCKEHMVDGVTTR-----TFCGT 164
Query: 182 PLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEHSLPE 241
P Y+APE + D WA G ++ EML+G+ + +++ D+LF I EH++
Sbjct: 165 PDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDE---DELFQSIM-EHNV-S 219
Query: 242 IPSRVSKEARDFLRRCFVRKPAFRF 266
P +SKEA + + P+ R
Sbjct: 220 YPKSLSKEAVSICKGLMTKHPSKRL 244
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 1e-11
Identities = 52/179 (29%), Positives = 92/179 (51%), Gaps = 24/179 (13%)
Query: 94 GGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKF 153
G LG L++ L E ++ +L+G+ +IH +G +H D+KP N L + +
Sbjct: 103 GTDLGKLMKH---EKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGN--LAVNEDCEL 157
Query: 154 VAKIADLGVAKRSRHCKRQKFDPSMRG---TPLYLAPETVVQHMQEAPS-DIWALGCVVL 209
KI D G+A+++ D M G T Y APE ++ M + DIW++GC++
Sbjct: 158 --KILDFGLARQT--------DSEMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMA 207
Query: 210 EMLSGRQAWVVKEDCSIDQLFSIIGDEHSLP-EIPSRV-SKEARDFLRRC-FVRKPAFR 265
EML+G+ + K +DQL I+ + E ++ S++A++++++ RK FR
Sbjct: 208 EMLTGKP--LFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSEDAKNYVKKLPRFRKKDFR 264
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 63.6 bits (155), Expect = 2e-11
Identities = 52/204 (25%), Positives = 86/204 (42%), Gaps = 47/204 (23%)
Query: 106 GNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKR 165
G + + V+ + IL+GI H +H D+KP N+L+ K V K+AD G+A+
Sbjct: 95 GQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLI----DNKGVIKLADFGLAR- 149
Query: 166 SRHCKRQKFDPSMRG------TPLYLAPETVVQHMQEA-PSDIWALGCVVLEMLSGRQAW 218
F +R T Y APE ++ + + P DIW++G + EM + +
Sbjct: 150 -------AFGIPVRVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKP-- 200
Query: 219 VVKEDCSIDQLFSII-----------GDEHSLPEIPS---------------RVSKEARD 252
+ D IDQLF I SLP+ + + ++ D
Sbjct: 201 LFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYKNTFPKWKKGSLRSAVKNLDEDGLD 260
Query: 253 FLRRCFVRKPAFRFTAEMLLDDPF 276
L + + PA R +A+ L+ P+
Sbjct: 261 LLEKMLIYDPAKRISAKKALNHPY 284
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 63.7 bits (156), Expect = 2e-11
Identities = 51/188 (27%), Positives = 82/188 (43%), Gaps = 34/188 (18%)
Query: 121 ILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMR- 179
+L+ + +IH +H D+KP NILL S V K+AD G+A+ + +P +
Sbjct: 116 LLKALKYIHSGNVIHRDLKPSNILL---NSDCRV-KLADFGLARSLSELEENPENPVLTD 171
Query: 180 --GTPLYLAPETVVQHMQEAPS-DIWALGCVVLEMLSGRQAW------------------ 218
T Y APE ++ + D+W++GC++ EML G+ +
Sbjct: 172 YVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGP 231
Query: 219 VVKEDC-SID-----QLFSIIGDEH--SLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEM 270
ED SI + + L E+ + S +A D L++ V P R TAE
Sbjct: 232 PSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEE 291
Query: 271 LLDDPFVK 278
L+ P+V
Sbjct: 292 ALEHPYVA 299
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 3e-11
Identities = 72/284 (25%), Positives = 130/284 (45%), Gaps = 37/284 (13%)
Query: 13 VIGQGSFGCVF-IAKPKSNSSFLPPLMAVKSAEVSASASLQKEKEVFDNL---NGCPFVL 68
+IG+G FG V+ K + + + K ++ +L + + +L CPF++
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60
Query: 69 ECFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGL-PEKDVRHFTRCILEGIGH 127
C +T + +L+ GG DL + +G+ EK++R + I+ G+ H
Sbjct: 61 -C----MTYAFHTPDKLCFILDLMNGG---DLHYHLSQHGVFSEKEMRFYATEIILGLEH 112
Query: 128 IHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMR-GTPLYLA 186
+H+ V+ D+KP NILL + G +I+DLG+A C K P GT Y+A
Sbjct: 113 MHNRFVVYRDLKPANILL--DEHGH--VRISDLGLA-----CDFSKKKPHASVGTHGYMA 163
Query: 187 PETVVQHMQ-EAPSDIWALGCVVLEMLSGRQAW---VVKEDCSIDQLFSIIGDEHSLPEI 242
PE + + ++ +D ++LGC++ ++L G + K+ ID++ + E+
Sbjct: 164 PEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVN-----VEL 218
Query: 243 PSRVSKEARDFLRRCFVRKPAFRF-----TAEMLLDDPFVKGVD 281
P S E + L R + R A+ + + F KG+D
Sbjct: 219 PDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHVFFKGID 262
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 63.5 bits (155), Expect = 3e-11
Identities = 48/144 (33%), Positives = 74/144 (51%), Gaps = 26/144 (18%)
Query: 121 ILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMRG 180
IL G+ +IH +G +H D+KP NI + + KI D G+A RH D M G
Sbjct: 127 ILRGLKYIHSAGIIHRDLKPSNIAV----NEDCELKILDFGLA---RHT-----DDEMTG 174
Query: 181 ---TPLYLAPETVVQHMQEAPS-DIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIG-- 234
T Y APE ++ M + DIW++GC++ E+L+G+ + IDQL I+
Sbjct: 175 YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKT--LFPGSDHIDQLKRIMNLV 232
Query: 235 ---DEHSLPEIPSRVSKEARDFLR 255
DE L +I S+ AR++++
Sbjct: 233 GTPDEELLQKIS---SESARNYIQ 253
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 4e-11
Identities = 53/196 (27%), Positives = 84/196 (42%), Gaps = 35/196 (17%)
Query: 108 GLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSR 167
L V+ FT +L+GI H++ +H D+KP N+L+ + G+ K+AD G+A R+
Sbjct: 96 ALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLI--NKRGEL--KLADFGLA-RAF 150
Query: 168 HCKRQKFDPSMRGTPLYLAPETVVQHMQEAPS-DIWALGCVVLEMLSGRQAWVVKEDCSI 226
F + T Y AP+ ++ + S DIW++GC++ EM++GR + +
Sbjct: 151 GIPVNTFSNEVV-TLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNE-- 207
Query: 227 DQL---FSIIG--DEHSLPEIPS---------------------RVSKEARDFLRRCFVR 260
DQL F I+G E + P I D L R
Sbjct: 208 DQLLKIFRIMGTPTESTWPGISQLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQL 267
Query: 261 KPAFRFTAEMLLDDPF 276
P R +A L P+
Sbjct: 268 NPELRISAHDALQHPW 283
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 5e-11
Identities = 71/266 (26%), Positives = 115/266 (43%), Gaps = 40/266 (15%)
Query: 13 VIGQGSFGCVFIAKPKSNSSF-----LPPLMAVKSAEVSASASLQKEKEVFDNLNGCPFV 67
V+G+GSFG V +A+ K L + ++ +V + EK V PF+
Sbjct: 7 VLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMV---EKRVLALSGKPPFL 63
Query: 68 LE---CFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEG 124
+ CF TM + Y ++EY GG L I++ E + I G
Sbjct: 64 TQLHSCFQ---TM----DRLY-FVMEYVNGGDLMYQIQQVGR--FKEPHAVFYAAEIAIG 113
Query: 125 IGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFD----PSMRG 180
+ +H G ++ D+K DN++L + KIAD G+ CK +D + G
Sbjct: 114 LFFLHSKGIIYRDLKLDNVMLDSEGH----IKIADFGM------CKENMWDGVTTKTFCG 163
Query: 181 TPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEHSLP 240
TP Y+APE + D WA G ++ EML+G+ + +++ D+LF I + +
Sbjct: 164 TPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE---DELFQSIMEHNV-- 218
Query: 241 EIPSRVSKEARDFLRRCFVRKPAFRF 266
P +SKEA + + P R
Sbjct: 219 AYPKSMSKEAVAICKGLMTKHPGKRL 244
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 63.6 bits (154), Expect = 6e-11
Identities = 61/229 (26%), Positives = 102/229 (44%), Gaps = 36/229 (15%)
Query: 14 IGQGSFGCVFIAKPKSNSSFLP-PLMAVKSAEVSASASLQKEKEVFDNLNGCPFV--LEC 70
IG G FG VF+ K K F ++ + + + L E V L V ++
Sbjct: 21 IGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDR 80
Query: 71 FGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNG--NGLPEKDVRHFTRCILEGIGHI 128
F + + + Y +L+E+ G L I+KC + E + TR +L + +
Sbjct: 81 F-----LNKANQKLY-ILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYC 134
Query: 129 HD-------SGYVHCDVKPDNILL---------VATQS----GKFVAKIADLGVAKRSRH 168
H+ +H D+KP NI L + Q+ G+ +AKI D G+ S++
Sbjct: 135 HNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGL---SKN 191
Query: 169 CKRQKFDPSMRGTPLYLAPETVVQHMQ--EAPSDIWALGCVVLEMLSGR 215
+ S GTP Y +PE ++ + + SD+WALGC++ E+ SG+
Sbjct: 192 IGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGK 240
|
Length = 1021 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 62.8 bits (153), Expect = 7e-11
Identities = 55/200 (27%), Positives = 87/200 (43%), Gaps = 45/200 (22%)
Query: 114 VRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQK 173
V+ F IL G+ ++H +G +H D+KP N+L+ + V KI D G+A + ++
Sbjct: 105 VKVFLYQILRGLKYLHSAGILHRDIKPGNLLV----NSNCVLKICDFGLA------RVEE 154
Query: 174 FDPSMRGTP-----LYLAPETVV--QHMQEAPSDIWALGCVVLEMLSGR-----QAWVVK 221
D S T Y APE ++ +H A DIW++GC+ E+L R Q+ + +
Sbjct: 155 PDESKHMTQEVVTQYYRAPEILMGSRHYTSA-VDIWSVGCIFAELLGRRILFQAQSPIQQ 213
Query: 222 EDCSIDQLFS----------------IIGDEHSLPEIP------SRVSKEARDFLRRCFV 259
D D L + I+ H P +P S+ + EA L R V
Sbjct: 214 LDLITDLLGTPSLEAMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLV 273
Query: 260 RKPAFRFTAEMLLDDPFVKG 279
P R +A L P++
Sbjct: 274 FDPDKRISAADALAHPYLDE 293
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 7e-11
Identities = 69/262 (26%), Positives = 121/262 (46%), Gaps = 38/262 (14%)
Query: 14 IGQGSFGCVFIAKPKSNSSFLPPLMAVKSA----EVSASASLQKEKEVFDNLNGCPFVLE 69
+G+G++ VF K S L+A+K E A + +E + NL V
Sbjct: 13 LGEGTYATVF----KGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIV-- 66
Query: 70 CFGEEITMGE--NGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGH 127
T+ + + E L+ EY L ++ C GN + +V+ F +L G+ +
Sbjct: 67 ------TLHDIIHTERCLTLVFEYL-DSDLKQYLDNC-GNLMSMHNVKIFMFQLLRGLSY 118
Query: 128 IHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMRGTPLYLAP 187
H +H D+KP N+L+ + G+ K+AD G+A R++ + + S L+ P
Sbjct: 119 CHKRKILHRDLKPQNLLI--NEKGEL--KLADFGLA-RAKSVPTKTY--SNEVVTLWYRP 171
Query: 188 ETVVQHMQE--APSDIWALGCVVLEMLSGRQAW---VVKEDCSIDQLFSIIG--DEHSLP 240
V+ E P D+W +GC++ EM +GR + VKE+ + +F ++G E + P
Sbjct: 172 PDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHL--IFRLLGTPTEETWP 229
Query: 241 EIPSRVSKEARDFLRRCFVRKP 262
I S ++E R +L + +P
Sbjct: 230 GITS--NEEFRSYLFPQYRAQP 249
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 62.3 bits (152), Expect = 8e-11
Identities = 52/202 (25%), Positives = 80/202 (39%), Gaps = 52/202 (25%)
Query: 114 VRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQK 173
+++F IL G+ +IH + +H D+KP N+LL KI D G+A+ +
Sbjct: 108 IQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCD----LKICDFGLARIA------- 156
Query: 174 FDPSMRG---------TPLYLAPETVVQHMQEAPS-DIWALGCVVLEMLSGRQAWVVKED 223
DP T Y APE ++ + DIW++GC++ EMLS R + K+
Sbjct: 157 -DPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKD- 214
Query: 224 CSIDQL---FSIIGDEH-----------------SLPEIP--------SRVSKEARDFLR 255
+ QL ++G SLP P +A D L
Sbjct: 215 -YLHQLNLILGVLGTPSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLD 273
Query: 256 RCFVRKPAFRFTAEMLLDDPFV 277
+ P R T E L P++
Sbjct: 274 KMLTFNPHKRITVEEALAHPYL 295
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 8e-11
Identities = 56/209 (26%), Positives = 96/209 (45%), Gaps = 37/209 (17%)
Query: 109 LPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAK--RS 166
LP V+ IL+GI ++H + +H D+KP NIL++ + KIAD+G A+ S
Sbjct: 105 LPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNS 164
Query: 167 RHCKRQKFDPSMRGTPLYLAPETVV--QHMQEAPSDIWALGCVVLEMLSGRQAWVVKED- 223
DP + T Y APE ++ +H +A DIWA+GC+ E+L+ + +++
Sbjct: 165 PLKPLADLDPVVV-TFWYRAPELLLGARHYTKA-IDIWAIGCIFAELLTSEPIFHCRQED 222
Query: 224 ---------CSIDQLFSIIG-----DEHSLPEIPSRVSKEARDFLRRCFVR--------- 260
+D++F+++G D + ++P S +DF R +
Sbjct: 223 IKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEH-STLMKDFRRNTYTNCSLIKYMEK 281
Query: 261 ---KP---AFRFTAEMLLDDPFVKGVDEE 283
KP AF ++L DP + E+
Sbjct: 282 HKVKPDSKAFHLLQKLLTMDPIKRITSEQ 310
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 61.1 bits (149), Expect = 1e-10
Identities = 50/191 (26%), Positives = 78/191 (40%), Gaps = 48/191 (25%)
Query: 121 ILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMRG 180
+L G+ H+HD+ +H D+K N+LL + + + KI D G+A R+ P
Sbjct: 115 LLSGVAHLHDNWILHRDLKTSNLLL----NNRGILKICDFGLA-------REYGSPLKPY 163
Query: 181 TPL-----YLAPETVV-QHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQL---FS 231
T L Y APE ++ D+W++GC+ E+L+ + + K + IDQL F
Sbjct: 164 TQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSE--IDQLNKIFK 221
Query: 232 IIG--DEHSLPEIPS------------------------RVSKEARDFLRRCFVRKPAFR 265
++G E P +S D L R PA R
Sbjct: 222 LLGTPTEKIWPGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKR 281
Query: 266 FTAEMLLDDPF 276
+AE L P+
Sbjct: 282 ISAEDALKHPY 292
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 1e-10
Identities = 65/247 (26%), Positives = 100/247 (40%), Gaps = 62/247 (25%)
Query: 88 LLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVA 147
L+ + G L +++ KC L + V+ IL G+ +IH + +H D+KP N L
Sbjct: 99 LVTHLMGADLNNIV-KCQK--LTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSN--LAV 153
Query: 148 TQSGKFVAKIADLGVAKRSRHCKRQKFDPSMRG---TPLYLAPETVVQHMQ-EAPSDIWA 203
+ + KI D G+A+ + D M G T Y APE ++ M DIW+
Sbjct: 154 NEDCEL--KILDFGLARHT--------DDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWS 203
Query: 204 LGCVVLEMLSGRQAWVVKEDCSIDQLFSII------GDE--------------HSLPEIP 243
+GC++ E+L+GR + + IDQL I+ G E SL ++P
Sbjct: 204 VGCIMAELLTGRTLFPGTD--HIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMP 261
Query: 244 SR--------VSKEARDFLRRCFVRKPAFRFTAEMLL------------DDPFVKGVDEE 283
+ A D L + V R TA L D+P D+
Sbjct: 262 KMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADPYDQS 321
Query: 284 L-SRELE 289
SR+L
Sbjct: 322 FESRDLL 328
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 2e-10
Identities = 66/312 (21%), Positives = 130/312 (41%), Gaps = 58/312 (18%)
Query: 14 IGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVSASASLQKEKEVFDNLNGCPFVLECFGE 73
+G G+ G VF K + + + + + + +E +V N P+++ +G
Sbjct: 13 LGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNS-PYIVGFYGA 71
Query: 74 EITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGY 133
+ GE ++ +E+ GG+L +++K +PE+ + + +++G+ ++ +
Sbjct: 72 FYSDGE-----ISICMEHMDGGSLDQVLKK--AGRIPEQILGKVSIAVIKGLTYLREKHK 124
Query: 134 V-HCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQ 192
+ H DVKP NIL+ + + K+ D GV+ + F GT Y++PE +
Sbjct: 125 IMHRDVKPSNILV----NSRGEIKLCDFGVSGQLIDSMANSF----VGTRSYMSPERLQG 176
Query: 193 HMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLF--SIIGDEHSL----------- 239
SDIW++G ++EM GR + ++ +F + GD
Sbjct: 177 THYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPPGR 236
Query: 240 ---------------------------PEIPSRV-SKEARDFLRRCFVRKPAFRFTAEML 271
P++PS V E +DF+ +C ++ PA R + L
Sbjct: 237 PLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQL 296
Query: 272 LDDPFVKGVDEE 283
+ F+K + E
Sbjct: 297 MVHAFIKRSEAE 308
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 59.9 bits (146), Expect = 3e-10
Identities = 44/172 (25%), Positives = 75/172 (43%), Gaps = 16/172 (9%)
Query: 87 LLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLV 146
L+++Y G L DL++K L E +V+ R ++E + +H +H D+K +N+L
Sbjct: 86 LIMDYIKDGDLFDLLKK--EGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYD 143
Query: 147 ATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGC 206
K + D G+ CK GT Y +PE + H + D WA+G
Sbjct: 144 ---RAKDRIYLCDYGL------CKIIGTPSCYDGTLDYFSPEKIKGHNYDVSFDWWAVGV 194
Query: 207 VVLEMLSGRQAWV--VKEDCSIDQLFSIIGDEHSLPEIPSRVSKEARDFLRR 256
+ E+L+G+ + E+ ++ L VSK A DF++
Sbjct: 195 LTYELLTGKHPFKEDEDEELDLESLLKRQ---QKKLPFIKNVSKNANDFVQS 243
|
Length = 267 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 3e-10
Identities = 52/211 (24%), Positives = 95/211 (45%), Gaps = 25/211 (11%)
Query: 14 IGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVSASA----SLQKEKEVFDNLNGCPFVLE 69
+G G+FGCV+ + K+N L+A+K V A +++K + D ++ + E
Sbjct: 8 LGSGAFGCVYKVRKKNNGQ---NLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKE 64
Query: 70 CFGEE------ITMGENGEMAYNLLLEYAAGGTLGDLIE--KCNGNGLPEKDVRHFTRCI 121
T EN + ++++ G LG+ K E+ + + +
Sbjct: 65 QLRHPNIVRYYKTFLENDRLY--IVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQM 122
Query: 122 LEGIGHIH-DSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMRG 180
+ + ++H + VH D+ P+NI+L + K I D G+AK+ + + S+ G
Sbjct: 123 VLALRYLHKEKRIVHRDLTPNNIML--GEDDKVT--ITDFGLAKQK---QPESKLTSVVG 175
Query: 181 TPLYLAPETVVQHMQEAPSDIWALGCVVLEM 211
T LY PE V +D+WA GC++ +M
Sbjct: 176 TILYSCPEIVKNEPYGEKADVWAFGCILYQM 206
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 4e-10
Identities = 54/196 (27%), Positives = 88/196 (44%), Gaps = 10/196 (5%)
Query: 87 LLLEYAAGGTLGDLIEKCNGNGLP--EKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNIL 144
L++EY +GG L I++ LP E +V I+ + +H +H D+K NI
Sbjct: 142 LIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIF 201
Query: 145 LVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWAL 204
L+ T + K+ D G +K+ S GTP YLAPE + +D+W+L
Sbjct: 202 LMPTG----IIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSL 257
Query: 205 GCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEHSLPEIPSRVSKEARDFLRRCFVRKPAF 264
G ++ E+L+ + + I Q ++ ++ P VS + L + PA
Sbjct: 258 GVILYELLTLHRPFKGPSQREIMQ--QVLYGKYD--PFPCPVSSGMKALLDPLLSKNPAL 313
Query: 265 RFTAEMLLDDPFVKGV 280
R T + LL F+K V
Sbjct: 314 RPTTQQLLHTEFLKYV 329
|
Length = 478 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 60.1 bits (145), Expect = 4e-10
Identities = 65/258 (25%), Positives = 116/258 (44%), Gaps = 28/258 (10%)
Query: 14 IGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVSASASLQKEKEVFDNLNGCPFVLECFGE 73
+G+GS+ V+ K K N + + E + +E + L VL +
Sbjct: 13 LGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVL--LHD 70
Query: 74 EITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGY 133
I E L+ EY L ++K G GL ++V+ F +L G+ +IH
Sbjct: 71 IIHTKET----LTLVFEYVHT-DLCQYMDKHPG-GLHPENVKLFLFQLLRGLSYIHQRYI 124
Query: 134 VHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQH 193
+H D+KP N+L+ + +G+ K+AD G+A R++ + S L+ P V+
Sbjct: 125 LHRDLKPQNLLI--SDTGEL--KLADFGLA-RAKSVPSHTY--SNEVVTLWYRPPDVLLG 177
Query: 194 MQEAPS--DIWALGCVVLEMLSGRQAWVVKEDC--SIDQLFSIIGDE--------HSLPE 241
E + D+W +GC+ +EM+ G A+ +D ++++F ++G HSLP
Sbjct: 178 STEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPH 237
Query: 242 I-PSRVSKEARDFLRRCF 258
P R + + LR+ +
Sbjct: 238 FKPERFTLYSPKNLRQAW 255
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 4e-10
Identities = 56/209 (26%), Positives = 90/209 (43%), Gaps = 21/209 (10%)
Query: 12 RVIGQGSFGCVFIAKPKSNSSFLP--PLMAVKSAEVSASASLQKEKEVFDNLNGCPFVLE 69
RV+G+G FG V + ++ L + + + EK++ + +N V
Sbjct: 6 RVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNL 65
Query: 70 CFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIH 129
+ E + A L+L GG L I G E+ + IL G+ +H
Sbjct: 66 AYAYET------KDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLH 119
Query: 130 DSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMR---GTPLYLA 186
V+ D+KP+NILL G +I+DLG+A + + S+R GT Y+A
Sbjct: 120 RENTVYRDLKPENILL--DDYGHI--RISDLGLAVKIPEGE------SIRGRVGTVGYMA 169
Query: 187 PETVVQHMQEAPSDIWALGCVVLEMLSGR 215
PE + D W LGC++ EM+ G+
Sbjct: 170 PEVLNNQRYTLSPDYWGLGCLIYEMIEGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 4e-10
Identities = 76/325 (23%), Positives = 144/325 (44%), Gaps = 78/325 (24%)
Query: 12 RVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEV---SASASLQKEKEVF---DNLNGCP 65
+ IG G+FG V + + K +++ L + ++ A+V + +A ++ E+++ DN
Sbjct: 7 KTIGIGAFGEVCLVR-KVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADN----E 61
Query: 66 FVLECFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILE-- 123
+V++ + ++ + Y +++Y GG + L+ + G+ E+D+ F I E
Sbjct: 62 WVVKLYYS----FQDKDNLY-FVMDYIPGGDMMSLLIRL---GIFEEDLARFY--IAELT 111
Query: 124 -GIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVA------------KRSRHCK 170
I +H G++H D+KPDNIL+ + G K+ D G+ ++ H +
Sbjct: 112 CAIESVHKMGFIHRDIKPDNILI--DRDGHI--KLTDFGLCTGFRWTHDSKYYQKGDHHR 167
Query: 171 RQKFDP-----------------------------SMRGTPLYLAPETVVQHMQEAPSDI 201
+ +P S+ GTP Y+APE +++ D
Sbjct: 168 QDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDW 227
Query: 202 WALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEHSLPEIPS--RVSKEARDFLRRCFV 259
W++G ++ EML G+ ++ D + +I E +L IPS ++S+EA D + R
Sbjct: 228 WSVGVILYEMLVGQPPFL--ADTPAETQLKVINWETTL-HIPSQAKLSREASDLILR-LC 283
Query: 260 RKPAFRFTAEMLLD---DPFVKGVD 281
R + PF KG+D
Sbjct: 284 CGAEDRLGKNGADEIKAHPFFKGID 308
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 4e-10
Identities = 47/189 (24%), Positives = 90/189 (47%), Gaps = 16/189 (8%)
Query: 87 LLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLV 146
++ E+ A G+L D ++ G+ P + F+ I EG+ I Y+H D++ NIL+
Sbjct: 77 IITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILV- 135
Query: 147 ATQSGKFVAKIADLGVAK---RSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWA 203
S V KIAD G+A+ + + R+ ++ T APE + SD+W+
Sbjct: 136 ---SASLVCKIADFGLARVIEDNEYTAREGAKFPIKWT----APEAINFGSFTIKSDVWS 188
Query: 204 LGCVVLEMLS-GRQAWVVKEDCSIDQLFSIIGDEHSLPEIPSRVSKEARDFLRRCFVRKP 262
G +++E+++ GR + S ++ + + +P + +E + + RC+ +P
Sbjct: 189 FGILLMEIVTYGRIPY---PGMSNPEVIRALERGYRMPRPEN-CPEELYNIMMRCWKNRP 244
Query: 263 AFRFTAEML 271
R T E +
Sbjct: 245 EERPTFEYI 253
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 60.1 bits (145), Expect = 5e-10
Identities = 68/247 (27%), Positives = 106/247 (42%), Gaps = 52/247 (21%)
Query: 76 TMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVH 135
T EN Y L+ G L +++ KC L ++ V+ +L G+ +IH +G +H
Sbjct: 87 TSIENFNEVY--LVTNLMGADLNNIV-KCQK--LSDEHVQFLIYQLLRGLKYIHSAGIIH 141
Query: 136 CDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMRG---TPLYLAPETVVQ 192
D+KP N+ + + +I D G+A+++ D M G T Y APE ++
Sbjct: 142 RDLKPSNVAV----NEDCELRILDFGLARQA--------DDEMTGYVATRWYRAPEIMLN 189
Query: 193 HMQEAPS-DIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSI--------------IGDEH 237
M + DIW++GC++ E+L G+ + + IDQL I I EH
Sbjct: 190 WMHYNQTVDIWSVGCIMAELLKGKA--LFPGNDYIDQLKRIMEVVGTPSPEVLKKISSEH 247
Query: 238 ------SLPEIPSRVSKE--------ARDFLRRCFVRKPAFRFTAEMLLDDP-FVKGVDE 282
SLP +P + K+ A D L + V R +A L P F + D
Sbjct: 248 ARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQYHDP 307
Query: 283 ELSRELE 289
E E E
Sbjct: 308 EDEPEAE 314
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 59.3 bits (143), Expect = 6e-10
Identities = 68/283 (24%), Positives = 120/283 (42%), Gaps = 38/283 (13%)
Query: 12 RVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVSAS----ASLQKEKEVFDNLNGCPFV 67
+++G+G+FG V + + K++ + M + EV + A E V N PF+
Sbjct: 1 KLLGKGTFGKVILVREKASGKYYA--MKILKKEVIIAKDEVAHTLTESRVLKNTRH-PFL 57
Query: 68 LECFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGH 127
+ + + + ++EY GG L E R + I+ + +
Sbjct: 58 TSL---KYSFQTKDRLCF--VMEYVNGGEL--FFHLSRERVFSEDRTRFYGAEIVSALDY 110
Query: 128 IHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMR----GTPL 183
+H V+ D+K +N++L + G KI D G+ CK D + GTP
Sbjct: 111 LHSGKIVYRDLKLENLML--DKDGHI--KITDFGL------CKEGITDAATMKTFCGTPE 160
Query: 184 YLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEHSLPEIP 243
YLAPE + + D W LG V+ EM+ GR + ++ ++LF +I E + P
Sbjct: 161 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH---EKLFELILMEDI--KFP 215
Query: 244 SRVSKEARDFLRRCFVRKPAFRF-----TAEMLLDDPFVKGVD 281
+S +A+ L ++ P R A+ ++ F GV+
Sbjct: 216 RTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRHSFFTGVN 258
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 9e-10
Identities = 52/198 (26%), Positives = 82/198 (41%), Gaps = 46/198 (23%)
Query: 114 VRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQK 173
++ + IL GI + H +H D+KP N+L+ + K+AD G+A+
Sbjct: 104 IKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTN---ALKLADFGLAR--------A 152
Query: 174 FDPSMRG------TPLYLAPETVV-QHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSI 226
F +R T Y APE ++ P DIW++GC+ EM++ + + D I
Sbjct: 153 FGIPVRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKP--LFPGDSEI 210
Query: 227 DQL---FSIIG--DEH------SLPEIPSRVSK---------------EARDFLRRCFVR 260
D+L F I+G +E SLP+ S K D L +
Sbjct: 211 DELFKIFRILGTPNEETWPGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRL 270
Query: 261 KPAFRFTAEMLLDDPFVK 278
P+ R TA L+ + K
Sbjct: 271 DPSKRITARAALEHEYFK 288
|
Length = 294 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 58.5 bits (142), Expect = 9e-10
Identities = 62/275 (22%), Positives = 111/275 (40%), Gaps = 36/275 (13%)
Query: 11 GRVIGQGSFGCVF--IAKP-KSNSSFLPPLMAVKSAEVSASAS----LQKEKEVFDNLNG 63
R +GQGSFG V+ +AK +A+K+ +AS E V N
Sbjct: 11 IRELGQGSFGMVYEGLAKGVVKGEPETR--VAIKTVNENASMRERIEFLNEASVMKEFN- 67
Query: 64 CPFVLECFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKC-----NGNGLPEKDVRHFT 118
C V+ G T G+ +++E A G L + N GL ++ F
Sbjct: 68 CHHVVRLLGVVST----GQPTL-VVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFI 122
Query: 119 RCILE---GIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFD 175
+ E G+ ++ +VH D+ N ++ + KI D G+ + +
Sbjct: 123 QMAAEIADGMAYLAAKKFVHRDLAARNCMV----AEDLTVKIGDFGMTRDIYE--TDYYR 176
Query: 176 PSMRGT-PL-YLAPETVVQHMQEAPSDIWALGCVVLEMLS-GRQAWVVKEDCSIDQLFSI 232
+G P+ ++APE++ + SD+W+ G V+ EM + Q + S +++
Sbjct: 177 KGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGL---SNEEVLKF 233
Query: 233 IGDEHSLPEIPSRVSKEARDFLRRCFVRKPAFRFT 267
+ D L ++P + + +R C+ P R T
Sbjct: 234 VIDGGHL-DLPENCPDKLLELMRMCWQYNPKMRPT 267
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 58.2 bits (141), Expect = 1e-09
Identities = 76/310 (24%), Positives = 127/310 (40%), Gaps = 67/310 (21%)
Query: 14 IGQGSFGCVFIAKPKSNSSFLP-------------PLMAVKSAEVSASASLQKEKEVFDN 60
IGQG+FG VF A+ K + P+ A++ E+ L+ E V N
Sbjct: 20 IGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALR--EIKILQLLKHENVV--N 75
Query: 61 LNGCPFVLECFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRC 120
L +E + T + ++ L+ E+ G L K L E ++ +
Sbjct: 76 L------IEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTLSE--IKKVMKM 127
Query: 121 ILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAK---RSRHCKRQKFDPS 177
+L G+ +IH + +H D+K NIL+ T+ G + K+AD G+A+ S++ K ++ +
Sbjct: 128 LLNGLYYIHRNKILHRDMKAANILI--TKDG--ILKLADFGLARAFSLSKNSKPNRY--T 181
Query: 178 MRGTPL-YLAPETVVQHMQEAPS-DIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIG- 234
R L Y PE ++ P D+W GC++ EM + R +++ + QL I
Sbjct: 182 NRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWT-RSP-IMQGNTEQHQLTLISQL 239
Query: 235 ------------------DEHSLPEIPSRVSKE----------ARDFLRRCFVRKPAFRF 266
+ LP+ R KE A D + + V PA R
Sbjct: 240 CGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRI 299
Query: 267 TAEMLLDDPF 276
A+ L+ F
Sbjct: 300 DADTALNHDF 309
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 2e-09
Identities = 66/260 (25%), Positives = 112/260 (43%), Gaps = 26/260 (10%)
Query: 12 RVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVSAS----ASLQKEKEVFDNLNGCPFV 67
+++G+G+FG V + K K+ + M + EV + A E V N + PF+
Sbjct: 1 KLLGKGTFGKVILVKEKATGRYYA--MKILKKEVIVAKDEVAHTLTENRVLQN-SRHPFL 57
Query: 68 LECFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGH 127
+ + + + + ++EYA GG L E R + I+ + +
Sbjct: 58 T---ALKYSFQTHDRLCF--VMEYANGGEL--FFHLSRERVFSEDRARFYGAEIVSALDY 110
Query: 128 IH-DSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMRGTPLYLA 186
+H + V+ D+K +N++L + G KI D G+ K K + GTP YLA
Sbjct: 111 LHSEKNVVYRDLKLENLML--DKDGHI--KITDFGLCKEG--IKDGATMKTFCGTPEYLA 164
Query: 187 PETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEHSLPEIPSRV 246
PE + + D W LG V+ EM+ GR + ++ ++LF +I E P +
Sbjct: 165 PEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH---EKLFELILMEEI--RFPRTL 219
Query: 247 SKEARDFLRRCFVRKPAFRF 266
S EA+ L + P R
Sbjct: 220 SPEAKSLLSGLLKKDPKQRL 239
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 57.4 bits (139), Expect = 2e-09
Identities = 58/279 (20%), Positives = 112/279 (40%), Gaps = 46/279 (16%)
Query: 10 RGRVIGQGSFGCVF----IAKPKSNSSFLPPLMAVKSAEVSASASLQKEKEV-------- 57
R +G G+FG V+ + + V + S S Q E +
Sbjct: 10 LLRALGHGAFGEVYEGLYRGRDGDAVE-----LQVAVKTLPESCSEQDESDFLMEALIMS 64
Query: 58 -FDNLNGCPFVLECFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKC-----NGNGLPE 111
F++ N ++ G + +LLE AGG L + + + L
Sbjct: 65 KFNHQN----IVRLIGVSFE-----RLPRFILLELMAGGDLKSFLRENRPRPERPSSLTM 115
Query: 112 KDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAK---RSRH 168
KD+ R + +G ++ ++ ++H D+ N LL G+ VAKIAD G+A+ R+ +
Sbjct: 116 KDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGR-VAKIADFGMARDIYRASY 174
Query: 169 CKRQKFDPSMRGTPL-YLAPETVVQHMQEAPSDIWALGCVVLEMLS-GRQAWVVKEDCSI 226
+ K +M P+ ++ PE + + + +D+W+ G ++ E+ S G + + + +
Sbjct: 175 YR--KGGRAM--LPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEV 230
Query: 227 DQLFSIIGDEHSLPEIPSRVSKEARDFLRRCFVRKPAFR 265
+ + G P V + + C+ P R
Sbjct: 231 MEFVTGGGRLDPPKGCPGPVYR----IMTDCWQHTPEDR 265
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 2e-09
Identities = 65/244 (26%), Positives = 105/244 (43%), Gaps = 56/244 (22%)
Query: 14 IGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVSASASLQKEKEVFDNLNGCPF------- 66
IG G FG V + + NS + P + VK E+ SAS+Q++ + + P+
Sbjct: 3 IGNGWFGKVILGE--VNSGYTPAQVVVK--ELRVSASVQEQMKFLEEAQ--PYRSLQHSN 56
Query: 67 VLECFGE--EITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILE- 123
+L+C G+ E+T Y L++E+ G L + C L D R E
Sbjct: 57 LLQCLGQCTEVT-------PYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEI 109
Query: 124 --GIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQK---FDPSM 178
G+ H+H + ++H D+ N LL A + KI D G++ H K ++ P
Sbjct: 110 ALGLLHLHKNNFIHSDLALRNCLLTADLT----VKIGDYGLS----HNKYKEDYYVTPDQ 161
Query: 179 RGTPL-YLAPETV-------VQHMQEAPSDIWALGCVVLEM----------LSGRQ--AW 218
PL ++APE V + Q S++W+LG + E+ LS Q +
Sbjct: 162 LWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTY 221
Query: 219 VVKE 222
V+E
Sbjct: 222 TVRE 225
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 2e-09
Identities = 57/275 (20%), Positives = 115/275 (41%), Gaps = 35/275 (12%)
Query: 12 RVIGQGSFGCVFIAK----PKSNSSFLPPLMAVKSAEVSASASLQKEKEVFDNLNGCPFV 67
R +G+G+FG VF+A+ + L + A+K ++A Q+E E+ NL +
Sbjct: 11 RELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQH-EHI 69
Query: 68 LECFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNG-------NGLPEK-------- 112
++ +G G+ + ++ EY G L + + +G +G P +
Sbjct: 70 VKFYG---VCGDGDPLI--MVFEYMKHGDLNKFL-RAHGPDAMILVDGQPRQAKGELGLS 123
Query: 113 DVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQ 172
+ H I G+ ++ +VH D+ N L+ + KI D G+++
Sbjct: 124 QMLHIASQIASGMVYLASQHFVHRDLATRNCLV----GANLLVKIGDFGMSRDVYSTDYY 179
Query: 173 KFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLS-GRQAWVVKEDCSIDQLFS 231
+ ++ PE+++ SD+W+ G ++ E+ + G+Q W + + + +
Sbjct: 180 RVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECIT 239
Query: 232 IIGDEHSLPEIPSRVSKEARDFLRRCFVRKPAFRF 266
+ + E P KE D + C+ R+P R
Sbjct: 240 ----QGRVLERPRVCPKEVYDIMLGCWQREPQQRL 270
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 2e-09
Identities = 70/291 (24%), Positives = 122/291 (41%), Gaps = 56/291 (19%)
Query: 12 RVIGQGSFGCVFIAKPKSNSSFLPPLM-AVKSAEVSASASLQKEKE-------VFDNLNG 63
R IGQG+FG VF A+ + P M AVK + ASA +Q + + FD+ N
Sbjct: 11 RDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNI 70
Query: 64 CPFVLEC-FGEEITMGENGEMAYNLLLEYAAGGTLGDLIE------------------KC 104
+ C G+ + + L EY A G L + + KC
Sbjct: 71 VKLLGVCAVGKPMCL----------LFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKC 120
Query: 105 NGNGLP--EKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGV 162
N LP + + + G+ ++ + +VH D+ N L+ V KIAD G+
Sbjct: 121 GLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLV----GENMVVKIADFGL 176
Query: 163 AKR---SRHCKRQKFDPSMRGTPL-YLAPETVVQHMQEAPSDIWALGCVVLEMLS-GRQA 217
++ + + K + D P+ ++ PE++ + SD+WA G V+ E+ S G Q
Sbjct: 177 SRNIYSADYYKASEND----AIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQP 232
Query: 218 WVVKEDCSIDQLFSIIGDEHSLPEIPSRVSKEARDFLRRCFVRKPAFRFTA 268
+ + +++ + D + L P E + +R C+ + P+ R +
Sbjct: 233 YY---GMAHEEVIYYVRDGNVL-SCPDNCPLELYNLMRLCWSKLPSDRPSF 279
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 57.0 bits (138), Expect = 3e-09
Identities = 44/167 (26%), Positives = 79/167 (47%), Gaps = 22/167 (13%)
Query: 121 ILEGIGHIHDSGYV-HCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMR 179
I++ + ++H V H DVKP N+L ++G+ K+ D G++ + D
Sbjct: 112 IVKALEYLHSKLSVIHRDVKPSNVL--INRNGQV--KLCDFGISGYLVDSVAKTIDA--- 164
Query: 180 GTPLYLAPETVVQHMQEA----PSDIWALGCVVLEMLSGR---QAWVVKEDCSIDQLFSI 232
G Y+APE + + + SD+W+LG ++E+ +GR +W QL +
Sbjct: 165 GCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSW----KTPFQQLKQV 220
Query: 233 IGDEHSLPEIPS-RVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVK 278
+ E P++P+ + S E +DF+ +C + R LL PF +
Sbjct: 221 V--EEPSPQLPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQHPFFE 265
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 56.8 bits (137), Expect = 3e-09
Identities = 59/216 (27%), Positives = 91/216 (42%), Gaps = 34/216 (15%)
Query: 14 IGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVSASASLQ----KEKEVFDNLNGCPFVLE 69
IG G FG V + + S + VK SA+ Q +E + + LN P VL+
Sbjct: 3 IGNGWFGKVLLGEAHRGMS--KARVVVKELRASATPDEQLLFLQEVQPYRELNH-PNVLQ 59
Query: 70 CFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNG--NGLPEKDVRHFTRC-ILEGIG 126
C G+ I + Y L+LE+ G L + + G + +KDV C + G+
Sbjct: 60 CLGQCIES-----IPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLL 114
Query: 127 HIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQK---FDPSMRGTPL 183
+H + ++H D+ N L A S KI D G+A + + PL
Sbjct: 115 WLHQADFIHSDLALRNCQLTADLS----VKIGDYGLA----LEQYPEDYYITKDCHAVPL 166
Query: 184 -YLAPETVVQHMQE-------APSDIWALGCVVLEM 211
+LAPE V Q+ S+IW+LG + E+
Sbjct: 167 RWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWEL 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 4e-09
Identities = 66/272 (24%), Positives = 113/272 (41%), Gaps = 39/272 (14%)
Query: 13 VIGQGSFGCVFIAKPKSN-SSFLPPLMAVKSAEVSASASLQ----KEKEVFDNLNGCPFV 67
+G+G FG VF+AK K L+ VK+ + + +LQ +E ++F L+ V
Sbjct: 12 TLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSH-KNV 70
Query: 68 LECFGEEITMGENGEMAYNLLLEYAAGGTLGDL----------IEKCNGNGLPEKDVRHF 117
+ G + E Y ++LEY LGDL EK L K
Sbjct: 71 VRLLG----LCREAEPHY-MILEYT---DLGDLKQFLRATKSKDEKLKPPPLSTKQKVAL 122
Query: 118 TRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAK---RSRHCK-RQK 173
I G+ H+ ++ +VH D+ N L+ S + K++ L ++K S + K R
Sbjct: 123 CTQIALGMDHLSNARFVHRDLAARNCLV----SSQREVKVSLLSLSKDVYNSEYYKLRNA 178
Query: 174 FDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSII 233
P +R +LAPE V + SD+W+ G ++ E+ + Q + S +++ + +
Sbjct: 179 LIP-LR----WLAPEAVQEDDFSTKSDVWSFGVLMWEVFT--QGELPFYGLSDEEVLNRL 231
Query: 234 GDEHSLPEIPSRVSKEARDFLRRCFVRKPAFR 265
+P + RC+ P R
Sbjct: 232 QAGKLELPVPEGCPSRLYKLMTRCWAVNPKDR 263
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 4e-09
Identities = 59/257 (22%), Positives = 115/257 (44%), Gaps = 22/257 (8%)
Query: 14 IGQGSFGCV---FIAKPKSNSSFLPPLMAVKSAEVSASASLQKEKEVFDNLNGCPFVLEC 70
+G G+FG V KS + ++ + + + L +E V L+ P+++
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDN-PYIVRM 61
Query: 71 FGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHD 130
G I E+ + L++E A G L ++K N + + EK++ + G+ ++ +
Sbjct: 62 IG--ICEAES----WMLVMELAELGPLNKFLQK-NKH-VTEKNITELVHQVSMGMKYLEE 113
Query: 131 SGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMRGTPL-YLAPET 189
+ +VH D+ N+LLV TQ AKI+D G++K + + P+ + APE
Sbjct: 114 TNFVHRDLAARNVLLV-TQH---YAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPEC 169
Query: 190 VVQHMQEAPSDIWALGCVVLEMLS-GRQAWVVKEDCSIDQLFSIIGDEHSLPEIPSRVSK 248
+ + + SD+W+ G ++ E S G++ + + + Q+ + E P R
Sbjct: 170 MNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMI----ESGERMECPQRCPP 225
Query: 249 EARDFLRRCFVRKPAFR 265
E D ++ C+ R
Sbjct: 226 EMYDLMKLCWTYGVDER 242
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 4e-09
Identities = 67/263 (25%), Positives = 113/263 (42%), Gaps = 33/263 (12%)
Query: 12 RVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVSAS----ASLQKEKEVFDNLNGCPFV 67
+++G+G+FG V + + K+ + M + EV + A E V N PF+
Sbjct: 1 KLLGKGTFGKVILVREKATGRYYA--MKILRKEVIIAKDEVAHTVTESRVLQNTRH-PFL 57
Query: 68 LECFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGH 127
+ + + + ++EYA GG L E+ R + I+ + +
Sbjct: 58 TAL---KYAFQTHDRLCF--VMEYANGGEL--FFHLSRERVFTEERARFYGAEIVSALEY 110
Query: 128 IHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFD-PSMR---GTPL 183
+H V+ D+K +N++L + G KI D G+ CK D +M+ GTP
Sbjct: 111 LHSRDVVYRDIKLENLML--DKDGHI--KITDFGL------CKEGISDGATMKTFCGTPE 160
Query: 184 YLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEHSLPEIP 243
YLAPE + + D W LG V+ EM+ GR + ++ ++LF +I E P
Sbjct: 161 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH---ERLFELILMEEI--RFP 215
Query: 244 SRVSKEARDFLRRCFVRKPAFRF 266
+S EA+ L + P R
Sbjct: 216 RTLSPEAKSLLAGLLKKDPKQRL 238
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 4e-09
Identities = 48/193 (24%), Positives = 86/193 (44%), Gaps = 31/193 (16%)
Query: 111 EKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCK 170
E ++ F + +LEG+ + H ++H D+K NILL G+ K+AD G+A R + +
Sbjct: 115 EDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILL--NNKGQI--KLADFGLA-RLYNSE 169
Query: 171 RQKFDPSMRGTPLYLAPETVVQHMQEAPS-DIWALGCVVLEMLSGRQAWVVKEDCSIDQL 229
+ + T Y PE ++ + P+ D+W+ GC++ E+ + + + ++ + +L
Sbjct: 170 ESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLEL 229
Query: 230 FS-IIG--------DEHSLP----------------EIPSRVSKEARDFLRRCFVRKPAF 264
S + G D LP E S + A D L P+
Sbjct: 230 ISRLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSK 289
Query: 265 RFTAEMLLDDPFV 277
R TAE L+ P++
Sbjct: 290 RCTAEEALNSPWL 302
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 56.5 bits (136), Expect = 4e-09
Identities = 41/146 (28%), Positives = 71/146 (48%), Gaps = 9/146 (6%)
Query: 87 LLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLV 146
L+ EY L +L+E+ PEK VR + +++ I H + VH D+KP+N+L+
Sbjct: 77 LVFEYVEKNML-ELLEEMPNGVPPEK-VRSYIYQLIKAIHWCHKNDIVHRDIKPENLLIS 134
Query: 147 ATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGC 206
V K+ D G A+ + + T Y +PE ++ D+W++GC
Sbjct: 135 HND----VLKLCDFGFARNLSEGSNANYTEYV-ATRWYRSPELLLGAPYGKAVDMWSVGC 189
Query: 207 VVLEMLSGRQAWVVKEDCSIDQLFSI 232
++ E+ G+ + + IDQLF+I
Sbjct: 190 ILGELSDGQP--LFPGESEIDQLFTI 213
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 4e-09
Identities = 64/275 (23%), Positives = 112/275 (40%), Gaps = 40/275 (14%)
Query: 12 RVIGQGSFGCVFIAK-----PKSNSSFLPPLMAVKSAEVSASASLQKEKEVFDNLNG--- 63
R +G+G+FG VF+A+ P+ + L + +K A +A +E E+ NL
Sbjct: 11 RELGEGAFGKVFLAECYNLCPEQDK-ILVAVKTLKDASDNARKDFHREAELLTNLQHEHI 69
Query: 64 CPFVLECF-GEEITMGENGEMAYNLLLEYAAGGTLG--------DLIEKCNGN---GLPE 111
F C G+ + M + EY G L D + GN L +
Sbjct: 70 VKFYGVCVEGDPLIM----------VFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQ 119
Query: 112 KDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKR 171
+ H + I G+ ++ +VH D+ N L+ + KI D G+++
Sbjct: 120 SQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLV----GENLLVKIGDFGMSRDVYSTDY 175
Query: 172 QKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLS-GRQAWVVKEDCSIDQLF 230
+ ++ PE+++ SD+W+LG V+ E+ + G+Q W S +++
Sbjct: 176 YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWY---QLSNNEVI 232
Query: 231 SIIGDEHSLPEIPSRVSKEARDFLRRCFVRKPAFR 265
I L + P KE D + C+ R+P R
Sbjct: 233 ECITQGRVL-QRPRTCPKEVYDLMLGCWQREPHMR 266
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 8e-09
Identities = 31/94 (32%), Positives = 51/94 (54%), Gaps = 7/94 (7%)
Query: 121 ILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMRG 180
+L GI H+H +G +H D+KP NI++ KI D G+A+ + C P +
Sbjct: 132 MLCGIKHLHSAGIIHRDLKPSNIVV----KSDCTLKILDFGLARTA--CTNFMMTPYVV- 184
Query: 181 TPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSG 214
T Y APE ++ + DIW++GC++ E++ G
Sbjct: 185 TRYYRAPEVILGMGYKENVDIWSVGCIMGELVKG 218
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 9e-09
Identities = 56/244 (22%), Positives = 98/244 (40%), Gaps = 58/244 (23%)
Query: 87 LLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLV 146
+++Y GG + L+ + PE R + + I +H G++H D+KPDNIL+
Sbjct: 78 FVMDYIPGGDMMSLLIRMEV--FPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILI- 134
Query: 147 ATQSGKFVAKIADLGVA------------KRSRHCKRQKFDPS----------------- 177
G K+ D G+ ++ H ++ +PS
Sbjct: 135 -DLDGHI--KLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKT 191
Query: 178 ----------------MRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVK 221
+ GTP Y+APE +++ D W++G ++ EML G+ ++
Sbjct: 192 LEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEMLVGQPPFLAP 251
Query: 222 EDCSIDQLFSIIGDEHSLPEIPSRV--SKEARDFLRR--CFVRKPAFRFTAEMLLDDPFV 277
+ +I E++L IP +V S EA D + + C + R A+ + PF
Sbjct: 252 T--PTETQLKVINWENTL-HIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAHPFF 308
Query: 278 KGVD 281
VD
Sbjct: 309 SEVD 312
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 1e-08
Identities = 70/272 (25%), Positives = 119/272 (43%), Gaps = 37/272 (13%)
Query: 13 VIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVSASASLQK----EKEVFDNLNGCPFVL 68
VIG+G+FG V A+ K + L A+K + AS + E EV L P ++
Sbjct: 14 VIGEGNFGQVLKARIKKDG--LRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 71
Query: 69 ECFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKC--------------NGNGLPEKDV 114
G E+ Y L +EYA G L D + K + L + +
Sbjct: 72 NLLGA----CEHRGYLY-LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 126
Query: 115 RHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKF 174
HF + G+ ++ ++H D+ NIL+ +VAKIAD G++ R + +K
Sbjct: 127 LHFAADVARGMDYLSQKQFIHRDLAARNILV----GENYVAKIADFGLS-RGQEVYVKK- 180
Query: 175 DPSMRGTPL-YLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSII 233
+M P+ ++A E++ + SD+W+ G ++ E++S C+ +L+ +
Sbjct: 181 --TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA--ELYEKL 236
Query: 234 GDEHSLPEIPSRVSKEARDFLRRCFVRKPAFR 265
+ L E P E D +R+C+ KP R
Sbjct: 237 PQGYRL-EKPLNCDDEVYDLMRQCWREKPYER 267
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.5 bits (134), Expect = 1e-08
Identities = 48/164 (29%), Positives = 75/164 (45%), Gaps = 24/164 (14%)
Query: 101 IEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADL 160
++ C G GL +VR F +L G+ + H +H D+KP N+L+ ++ G+ K+AD
Sbjct: 93 MDDC-GGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLI--SERGEL--KLADF 147
Query: 161 GVAKRSRHCKRQKFDP----SMRGTPLYLAPETVVQHMQE--APSDIWALGCVVLEMLSG 214
G+A R K P S L+ P V+ E D+W +GC+ EM +G
Sbjct: 148 GLA-------RAKSVPSKTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATG 200
Query: 215 RQAWVVKEDCSIDQL---FSIIG--DEHSLPEIPSRVSKEARDF 253
R + D DQL F ++G E + P + S + F
Sbjct: 201 RPLFPGSTD-VEDQLHKIFRVLGTPTEETWPGVSSNPEFKPYSF 243
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 1e-08
Identities = 67/296 (22%), Positives = 126/296 (42%), Gaps = 55/296 (18%)
Query: 11 GRVIGQGSFGCVFIA------KPKSNSSFLPPLMAVKS-----------AEVSASASLQK 53
G+ +G+G FG V +A K K N + +KS +E+ + K
Sbjct: 23 GKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 82
Query: 54 EKEVFDNLNGCPFVLECFGEEITMGENGEMAYNLLLEYAAGGTLGDLI--------EKC- 104
K + + L C ++G + +++EYA+ G L + + E C
Sbjct: 83 HKNIINLLGACT-------------QDGPLY--VIVEYASKGNLREYLRARRPPGMEYCY 127
Query: 105 NGNGLPE-----KDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIAD 159
N +PE KD+ + G+ ++ +H D+ N+L+ V KIAD
Sbjct: 128 NPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDN----VMKIAD 183
Query: 160 LGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLS-GRQAW 218
G+A+ H K + R ++APE + + SD+W+ G ++ E+ + G +
Sbjct: 184 FGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPY 243
Query: 219 VVKEDCSIDQLFSIIGDEHSLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDD 274
+++LF ++ + H + + PS + E +R C+ P+ R T + L++D
Sbjct: 244 ---PGVPVEELFKLLKEGHRMDK-PSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 295
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 1e-08
Identities = 61/209 (29%), Positives = 90/209 (43%), Gaps = 26/209 (12%)
Query: 12 RVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVSASASLQKEKEVFD-----NLNGCPF 66
R +G GSFG V +A K N F PP+ A+K E S ++ VF N PF
Sbjct: 36 RTLGTGSFGRVILATYK-NEDF-PPV-AIKRFEKSKIIKQKQVDHVFSERKILNYINHPF 92
Query: 67 VLECFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRC-ILEGI 125
+ +G E L+LE+ GG + + N DV F I+
Sbjct: 93 CVNLYGSF-----KDESYLYLVLEFVIGGEFFTFLRR---NKRFPNDVGCFYAAQIVLIF 144
Query: 126 GHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMRGTPLYL 185
++ V+ D+KP+N+LL F+ K+ D G AK ++ GTP Y+
Sbjct: 145 EYLQSLNIVYRDLKPENLLL---DKDGFI-KMTDFGFAKVV-----DTRTYTLCGTPEYI 195
Query: 186 APETVVQHMQEAPSDIWALGCVVLEMLSG 214
APE ++ +D W LG + E+L G
Sbjct: 196 APEILLNVGHGKAADWWTLGIFIYEILVG 224
|
Length = 340 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 55.5 bits (134), Expect = 1e-08
Identities = 50/197 (25%), Positives = 84/197 (42%), Gaps = 37/197 (18%)
Query: 109 LPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRH 168
L + ++F +L G+ +IH + +H D+KP N+LL A KI D G+A+ +
Sbjct: 105 LSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCD----LKICDFGLARTT-- 158
Query: 169 CKRQKFDPSMRGTPLYLAPETVVQHMQEAPS-DIWALGCVVLEMLSGRQAWVVKEDCSID 227
++ F T Y APE ++ + + D+W++GC+ E+L GR+ +D +
Sbjct: 159 SEKGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELL-GRKPLFPGKDY-VH 216
Query: 228 QL---FSIIG--DEHSLPEIPS-----------------------RVSKEARDFLRRCFV 259
QL ++G E L I + + A D L + V
Sbjct: 217 QLKLITELLGSPSEEDLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLV 276
Query: 260 RKPAFRFTAEMLLDDPF 276
P+ R T E L P+
Sbjct: 277 FDPSKRITVEEALAHPY 293
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 55.9 bits (135), Expect = 1e-08
Identities = 48/194 (24%), Positives = 80/194 (41%), Gaps = 44/194 (22%)
Query: 121 ILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFV-AKIADLGVAKRSRHCKRQKFDPSMR 179
I I ++H G +H D+KPDNILL G F I D G A + + D +
Sbjct: 122 ICATIEYVHSKGVLHRDLKPDNILL-----GLFGEVVILDWGAAIFKKLEEEDLLDIDVD 176
Query: 180 ----------------GTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKED 223
GTP Y+APE ++ +DI+ALG ++ +ML+ + K+
Sbjct: 177 ERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKK- 235
Query: 224 CSIDQLFSIIGDEHSLPEIPSRVS--KEARDFLRRCFVR----KPAFRFTAEMLLDDPFV 277
I + P V+ +E FL + ++ PA R+++ V
Sbjct: 236 ------GRKISYRDVILS-PIEVAPYREIPPFLSQIAMKALAVDPAERYSS--------V 280
Query: 278 KGVDEELSRELEGD 291
+ + ++L L+G
Sbjct: 281 QELKQDLEPHLQGS 294
|
Length = 932 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 2e-08
Identities = 38/113 (33%), Positives = 60/113 (53%), Gaps = 9/113 (7%)
Query: 108 GLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSR 167
GL +VR F +L G+ +IH +H D+KP N+L+ + G+ K+AD G+A R++
Sbjct: 99 GLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLI--SYLGEL--KLADFGLA-RAK 153
Query: 168 HCKRQKFDPSMRGTPLYLAPETVVQHMQEAPS--DIWALGCVVLEMLSGRQAW 218
Q + S L+ P V+ + S DIW GC+ +EML G+ A+
Sbjct: 154 SIPSQTY--SSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAF 204
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 2e-08
Identities = 60/258 (23%), Positives = 105/258 (40%), Gaps = 18/258 (6%)
Query: 12 RVIGQGSFGCVFIAKPKSNSSFLP--PLMAVKSAEVSASASLQKEKEVFDNLNGCPFVLE 69
RV+G+G FG V + ++ L + + A EK + + +N V
Sbjct: 6 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSL 65
Query: 70 CFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIH 129
+ E + A L+L GG L I G E+ + + G+ +
Sbjct: 66 AYAYET------KDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQ 119
Query: 130 DSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMRGTPLYLAPET 189
V+ D+KP+NILL G +I+DLG+A + + + GT Y+APE
Sbjct: 120 RERIVYRDLKPENILL--DDRGHI--RISDLGLAVQIPEGETVR---GRVGTVGYMAPEV 172
Query: 190 VVQHMQEAPSDIWALGCVVLEMLSGRQAW-VVKEDCSIDQLFSIIGDEHSLPEIPSRVSK 248
+ D W LGC++ EM+ G+ + KE +++ + ++ E + S+
Sbjct: 173 INNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQE--EYSEKFSE 230
Query: 249 EARDFLRRCFVRKPAFRF 266
+A+ R + P R
Sbjct: 231 DAKSICRMLLTKNPKERL 248
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 3e-08
Identities = 66/253 (26%), Positives = 94/253 (37%), Gaps = 69/253 (27%)
Query: 11 GRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVSASASLQKEKEVFDN-------LNG 63
G+ +G+G+FG V+ A S + + V A+ E++ N N
Sbjct: 137 GKKLGEGAFGVVYKA------SLVNKQSKKEGKYVLKKATEYGAVEIWMNERVRRACPNS 190
Query: 64 CPFVLECFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCN------------GNGLPE 111
C + F E + E Y L+ Y TL DL++ LP+
Sbjct: 191 CADFVYGFLEPV--SSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPK 248
Query: 112 ------KDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKR 165
K ++ R IL + +H +G VH DVKP NI+ + SG F KI DLG A
Sbjct: 249 GLERENKIIQTIMRQILFALDGLHSTGIVHRDVKPQNIIF-SEGSGSF--KIIDLGAAAD 305
Query: 166 SR-----HCKRQKFDPSMRGTPLYLAPETVVQHMQ--EAPS------------------- 199
R K DP Y APE + Q APS
Sbjct: 306 LRVGINYIPKEFLLDPR------YAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDR 359
Query: 200 -DIWALGCVVLEM 211
DI++ G + L+M
Sbjct: 360 FDIYSAGLIFLQM 372
|
Length = 566 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 53.9 bits (130), Expect = 3e-08
Identities = 65/291 (22%), Positives = 121/291 (41%), Gaps = 47/291 (16%)
Query: 14 IGQGSFGCVF-IAKPKSNSSFLPPLMAVKSAEVSASASLQK----EKEVFDNLNGCPFVL 68
IG+G+FG V + S + +MAVK + QK + +V + CP+++
Sbjct: 12 IGRGAFGTVNKMLHKPSGT-----IMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIV 66
Query: 69 ECFGEEITMG------ENGEMAYNLLLEYAAGGTLGDLIEKCNGNG-LPEKDVRHFTRCI 121
+ +G G E +++ + +Y +PE+ +
Sbjct: 67 KFYGALFREGDCWICMELMDISLDKFYKYV----------YEVLKSVIPEEILGKIAVAT 116
Query: 122 LEGIGHI-HDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMRG 180
++ + ++ + +H DVKP NILL K+ D G++ + + D R
Sbjct: 117 VKALNYLKEELKIIHRDVKPSNILL----DRNGNIKLCDFGISGQLVDSIAKTRDAGCR- 171
Query: 181 TPLYLAPETVVQHMQEA---PSDIWALGCVVLEMLSGR---QAWVVKEDCSIDQLFSII- 233
P Y+APE + ++ SD+W+LG + E+ +G+ W + DQL ++
Sbjct: 172 -P-YMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKW----NSVFDQLTQVVK 225
Query: 234 GDEHSL-PEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGVDEE 283
GD L S +F+ C ++ + R + LL+ PF+K +E
Sbjct: 226 GDPPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEHPFIKDYEER 276
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 3e-08
Identities = 61/287 (21%), Positives = 123/287 (42%), Gaps = 37/287 (12%)
Query: 11 GRVIGQGSFGCVFIA--------KPKSNSSFLPPLMAVKSAEVSASASLQKEKEVFDNLN 62
G+ +G+G FG V +A KPK + ++ + E S L E E+ +
Sbjct: 20 GKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLS-DLVSEMEMMKMIG 78
Query: 63 GCPFVLECFGEEITMGENGEMAYNLLLEYAAGGTLGDL--------------IEKCNGNG 108
++ G ++G + +++EYA+ G L + I +
Sbjct: 79 KHKNIINLLG---ACTQDGPLY--VIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQ 133
Query: 109 LPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRH 168
+ KD+ T + G+ ++ +H D+ N+L+ V KIAD G+A+ +
Sbjct: 134 MTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVTENN----VMKIADFGLARDVNN 189
Query: 169 CKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLS-GRQAWVVKEDCSID 227
K + R ++APE + + SD+W+ G ++ E+ + G + ++
Sbjct: 190 IDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPY---PGIPVE 246
Query: 228 QLFSIIGDEHSLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDD 274
+LF ++ + H + + P+ + E +R C+ P+ R T + L++D
Sbjct: 247 ELFKLLKEGHRMDK-PANCTNELYMMMRDCWHAIPSHRPTFKQLVED 292
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 3e-08
Identities = 58/275 (21%), Positives = 122/275 (44%), Gaps = 60/275 (21%)
Query: 53 KEKEVFDNLNGCPFVLECFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEK 112
+E +V N P+++ +G + GE ++ +E+ GG+L ++++ +PE+
Sbjct: 52 RELQVLHECNS-PYIVGFYGAFYSDGE-----ISICMEHMDGGSLDQVLKE--AKRIPEE 103
Query: 113 DVRHFTRCILEGIGHIHDSGYV-HCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKR 171
+ + +L G+ ++ + + H DVKP NIL+ + + K+ D GV+ +
Sbjct: 104 ILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILV----NSRGEIKLCDFGVSGQLIDSMA 159
Query: 172 QKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFS 231
F GT Y++PE + SDIW++G ++E+ GR + ++ +F
Sbjct: 160 NSF----VGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFG 215
Query: 232 --II----GDEHSL------------------------------------PEIPSRV-SK 248
++ G+ HS+ P++P+ V +
Sbjct: 216 RPVVDGEEGEPHSISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTP 275
Query: 249 EARDFLRRCFVRKPAFRFTAEMLLDDPFVKGVDEE 283
+ ++F+ +C ++ PA R +ML++ F+K + E
Sbjct: 276 DFQEFVNKCLIKNPAERADLKMLMNHTFIKRSEVE 310
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 4e-08
Identities = 64/290 (22%), Positives = 113/290 (38%), Gaps = 53/290 (18%)
Query: 12 RVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVSASASLQ----KEKEVFDNL------ 61
RV+G+G FG V + + ++AVK+ + KE + L
Sbjct: 10 RVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIV 69
Query: 62 --NGCPFVLECFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTR 119
GC C E G L++EY G+L D + K + L + F +
Sbjct: 70 KYKGC-----C-------SEQGGKGLQLIMEYVPLGSLRDYLPK---HKLNLAQLLLFAQ 114
Query: 120 CILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAK-----RSRHCKRQKF 174
I EG+ ++H Y+H D+ N+LL + KI D G+AK + R+
Sbjct: 115 QICEGMAYLHSQHYIHRDLAARNVLL----DNDRLVKIGDFGLAKAVPEGHEYYRVREDG 170
Query: 175 DPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEML-------SGRQAW-----VVKE 222
D + + A E + ++ SD+W+ G + E+L S + + +
Sbjct: 171 DSPV----FWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQG 226
Query: 223 DCSIDQLFSIIGDEHSLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLL 272
++ +L ++ LP P +E ++ C+ + FR T L+
Sbjct: 227 QMTVVRLIELLERGMRLP-CPKNCPQEVYILMKNCWETEAKFRPTFRSLI 275
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 4e-08
Identities = 45/183 (24%), Positives = 81/183 (44%), Gaps = 20/183 (10%)
Query: 108 GLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSR 167
G PE +T I+ G+ H+H ++ D+KP+N+LL G +I+DLG+A +
Sbjct: 93 GFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLL--DNDGN--VRISDLGLAVELK 148
Query: 168 HCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVK----ED 223
Q GTP ++APE + + D +ALG + EM++ R + + E+
Sbjct: 149 --DGQSKTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVEN 206
Query: 224 CSIDQLFSIIGDEHSLPEIPSRVSKEARDFLRRCFVRKPAFRF-----TAEMLLDDPFVK 278
+ Q I+ D + P+ + S ++ F + P R + L P +
Sbjct: 207 KELKQ--RILNDSVTYPD---KFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTHPLFR 261
Query: 279 GVD 281
++
Sbjct: 262 DLN 264
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 54.1 bits (130), Expect = 5e-08
Identities = 68/299 (22%), Positives = 126/299 (42%), Gaps = 37/299 (12%)
Query: 3 SDGTSWFRGRVIGQGSFGCVFIAKPKSNS-SFLPPLMAVKSAEVSASASLQKEK---EVF 58
++ RV+G G+ G V AK S+ F AVK ++ + K + EV
Sbjct: 29 EQAKKYWISRVLGSGATGTVLCAKRVSDGEPF-----AVKVVDMEGMSEADKNRAQAEV- 82
Query: 59 DNLNGCPF--VLECFGEEITMGENGE-----MAYNLLLEYAAGGTLGDLIEKCNGNGLP- 110
L C F +++C + +A L+L+YA G L I+
Sbjct: 83 CCLLNCDFFSIVKCHEDFAKKDPRNPENVLMIA--LVLDYANAGDLRQEIKSRAKTNRTF 140
Query: 111 -EKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHC 169
E + +L + H+H +H D+K NILL + + K+ D G +K
Sbjct: 141 REHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNG----LVKLGDFGFSKMYAAT 196
Query: 170 KRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQL 229
+ GTP Y+APE + +D+++LG ++ E+L+ ++ + + +++++
Sbjct: 197 VSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPF---DGENMEEV 253
Query: 230 F--SIIGDEHSLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDP----FVKGVDE 282
++ G L P +S E ++ + P R ++ LL+ P F+ G+ E
Sbjct: 254 MHKTLAGRYDPL---PPSISPEMQEIVTALLSSDPKRRPSSSKLLNMPICKLFISGLLE 309
|
Length = 496 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 6e-08
Identities = 67/289 (23%), Positives = 127/289 (43%), Gaps = 41/289 (14%)
Query: 11 GRVIGQGSFGCVFIA------KPKSNSSFLPPLMAVKSAEVSAS----ASLQKEKEVFDN 60
G+ +G+G FG V +A K K N P +AVK + A+ + L E E+
Sbjct: 17 GKPLGEGCFGQVVMAEAIGIDKDKPNK---PVTVAVKMLKDDATDKDLSDLVSEMEMMKM 73
Query: 61 LNGCPFVLECFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNG---------LPE 111
+ ++ G ++G + +L+EYA+ G L + + G LPE
Sbjct: 74 IGKHKNIINLLG---ACTQDGPLY--VLVEYASKGNLREYLRARRPPGMDYSFDTCKLPE 128
Query: 112 -----KDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRS 166
KD+ + G+ ++ +H D+ N+L+ V KIAD G+A+
Sbjct: 129 EQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTEDN----VMKIADFGLARDV 184
Query: 167 RHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLS-GRQAWVVKEDCS 225
+ K + R ++APE + + SD+W+ G ++ E+ + G +
Sbjct: 185 HNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPY---PGIP 241
Query: 226 IDQLFSIIGDEHSLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDD 274
+++LF ++ + H + + P+ + E +R C+ P+ R T + L++D
Sbjct: 242 VEELFKLLKEGHRMDK-PANCTHELYMIMRECWHAVPSQRPTFKQLVED 289
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 7e-08
Identities = 48/195 (24%), Positives = 89/195 (45%), Gaps = 19/195 (9%)
Query: 87 LLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLV 146
++ EY A G+L D ++ G + + F+ I EG+ +I Y+H D++ N+L+
Sbjct: 78 IITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLV- 136
Query: 147 ATQSGKFVAKIADLGVAK---RSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWA 203
S + KIAD G+A+ + + R+ ++ T APE + SD+W+
Sbjct: 137 ---SESLMCKIADFGLARVIEDNEYTAREGAKFPIKWT----APEAINFGSFTIKSDVWS 189
Query: 204 LGCVVLEMLS-GRQAWVVKEDCSIDQLFSIIGDEHSLPEIPSRVSKEARDFLRRCFVRKP 262
G ++ E+++ G+ + S + S + + +P E D ++ C+ K
Sbjct: 190 FGILLYEIVTYGKIPY---PGMSNSDVMSALQRGYRMPR-MENCPDELYDIMKTCWKEKA 245
Query: 263 AFRFTAEML---LDD 274
R T + L LDD
Sbjct: 246 EERPTFDYLQSVLDD 260
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 52.8 bits (127), Expect = 8e-08
Identities = 51/198 (25%), Positives = 85/198 (42%), Gaps = 36/198 (18%)
Query: 109 LPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRH 168
E V+ +L G+ ++H++ +H D+K N+LL T G KIAD G+A+
Sbjct: 105 FSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLL--TDKG--CLKIADFGLARTYGL 160
Query: 169 CKRQKFDPSMRGTPLYLAPETVVQHMQEAPS-DIWALGCVVLEMLSGRQAWVVKEDCSID 227
+ P + T Y APE ++ + D+WA+GC++ E+L+ + K + I+
Sbjct: 161 PAKP-MTPKVV-TLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSE--IE 216
Query: 228 QLFSIIG-----DEH--------------SLPEIP--------SRVSKEARDFLRRCFVR 260
QL II +E +LP+ P +S+ L +
Sbjct: 217 QLDLIIQLLGTPNESIWPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMY 276
Query: 261 KPAFRFTAEMLLDDPFVK 278
P R TAE L+ + K
Sbjct: 277 DPKKRATAEEALESSYFK 294
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 1e-07
Identities = 61/242 (25%), Positives = 102/242 (42%), Gaps = 31/242 (12%)
Query: 3 SDGTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVSASASLQ------KEKE 56
S S+ G +IG GSFG V+ A + S +V+ LQ +E
Sbjct: 63 SPNKSYKLGNIIGNGSFGVVYEA-----------ICIDTSEKVAIKKVLQDPQYKNRELL 111
Query: 57 VFDNLN--GCPFVLECFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKC--NGNGLPEK 112
+ NLN F+ + + E + N+++E+ T+ ++ N + LP
Sbjct: 112 IMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLF 170
Query: 113 DVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQ 172
V+ ++ + + +IH H D+KP N+L+ K+ D G AK +R
Sbjct: 171 LVKLYSYQLCRALAYIHSKFICHRDLKPQNLLI---DPNTHTLKLCDFGSAKNLLAGQRS 227
Query: 173 KFDPSMRGTPLYLAPETVVQHMQEAPS-DIWALGCVVLEMLSGRQAWVVKEDCSIDQLFS 231
S + Y APE ++ D+W+LGC++ EM+ G + S+DQL
Sbjct: 228 V---SYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYP--IFSGQSSVDQLVR 282
Query: 232 II 233
II
Sbjct: 283 II 284
|
Length = 440 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 52.4 bits (126), Expect = 1e-07
Identities = 50/209 (23%), Positives = 101/209 (48%), Gaps = 18/209 (8%)
Query: 12 RVIGQGSFGCVFIAK--PKSNSSFLPPLMAVKSAEVSA----SASLQKEKEVFDNLNGCP 65
+ +G+G FG V + + P +++ +AVKS S + ++E E+ L+
Sbjct: 10 KQLGEGHFGKVELCRYDPLGDNTGE--QVAVKSLNHSGEEQHRSDFEREIEILRTLDH-E 66
Query: 66 FVLECFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGI 125
+++ G + G + L++EY G+L D +++ + + + K + F+ I +G+
Sbjct: 67 NIVKYKG---VCEKPGGRSLRLIMEYLPSGSLRDYLQR-HRDQINLKRLLLFSSQICKGM 122
Query: 126 GHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMRGTPL-Y 184
++ Y+H D+ NIL+ +S V KI+D G+AK K + +P+ +
Sbjct: 123 DYLGSQRYIHRDLAARNILV---ESEDLV-KISDFGLAKVLPEDKDYYYVKEPGESPIFW 178
Query: 185 LAPETVVQHMQEAPSDIWALGCVVLEMLS 213
APE + + SD+W+ G + E+ +
Sbjct: 179 YAPECLRTSKFSSASDVWSFGVTLYELFT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 52.3 bits (126), Expect = 1e-07
Identities = 55/229 (24%), Positives = 91/229 (39%), Gaps = 42/229 (18%)
Query: 87 LLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLV 146
++ A G+ DL++ GLPE + + +L + +IH G++H VK +ILL
Sbjct: 76 VVSPLMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILL- 134
Query: 147 ATQSGKFVAKIADLGVAKRS--RHCKRQK--FDPSMRGTPL--YLAPETVVQHMQ--EAP 198
+ GK ++ L + S +H KRQ+ D +L+PE + Q++Q
Sbjct: 135 -SGDGK--VVLSGLRYS-VSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEK 190
Query: 199 SDIWALGCVVLEMLSGRQAWVVKE-----------------DCSI------DQLFSIIGD 235
SDI+++G E+ +G + D S S +
Sbjct: 191 SDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYEDSMSQSRSSN 250
Query: 236 EHSLP----EIPS--RVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVK 278
EH + P S+ F+ C R P R +A LL+ F K
Sbjct: 251 EHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFK 299
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 52.4 bits (126), Expect = 1e-07
Identities = 33/100 (33%), Positives = 49/100 (49%), Gaps = 17/100 (17%)
Query: 121 ILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMRG 180
+L GI H+H +G +H D+KP NI++ KI D G+A R M
Sbjct: 127 MLCGIKHLHSAGIIHRDLKPSNIVV----KSDCTLKILDFGLA-------RTAGTSFMM- 174
Query: 181 TP-----LYLAPETVVQHMQEAPSDIWALGCVVLEMLSGR 215
TP Y APE ++ + DIW++GC++ EM+ G
Sbjct: 175 TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGT 214
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 2e-07
Identities = 55/210 (26%), Positives = 96/210 (45%), Gaps = 29/210 (13%)
Query: 14 IGQGSFGCVFIAKPKSNSSFLPPLMAVKSA----EVSASASLQKEKEVFDNLNGCPFVLE 69
+G+G++ VF K S L+A+K E A + +E + +L V
Sbjct: 14 LGEGTYATVF----KGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIV-- 67
Query: 70 CFGEEITMGE--NGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGH 127
T+ + + + + L+ EY L ++ C GN + +V+ F IL G+ +
Sbjct: 68 ------TLHDIVHTDKSLTLVFEYL-DKDLKQYMDDC-GNIMSMHNVKIFLYQILRGLAY 119
Query: 128 IHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMRGTPLYLAP 187
H +H D+KP N+L+ + G+ K+AD G+A R++ + + S L+ P
Sbjct: 120 CHRRKVLHRDLKPQNLLI--NERGEL--KLADFGLA-RAKSVPTKTY--SNEVVTLWYRP 172
Query: 188 ETVVQHMQEAPS--DIWALGCVVLEMLSGR 215
V+ E + D+W +GC+ EM SGR
Sbjct: 173 PDVLLGSSEYSTQIDMWGVGCIFFEMASGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 2e-07
Identities = 45/166 (27%), Positives = 77/166 (46%), Gaps = 27/166 (16%)
Query: 86 NLLLEYAAGGTLGDLIEKCNGN-GLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNIL 144
NL+++ A DL + + L E V+ IL G+ +H ++H D+ P NI
Sbjct: 96 NLVMDIMAS----DLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIF 151
Query: 145 LVATQSGKFVAKIADLGVAKR------SRHCKRQKFD-PSMRGTP-----LYLAPETVVQ 192
+ + K + KIAD G+A+R S + + T Y APE ++
Sbjct: 152 I----NSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMG 207
Query: 193 HMQEAPS-DIWALGCVVLEMLSGRQAWVVKEDCSIDQL---FSIIG 234
+ + D+W++GC+ E+L+G+ E+ IDQL F ++G
Sbjct: 208 AEKYHFAVDMWSVGCIFAELLTGK-PLFPGEN-EIDQLGRIFELLG 251
|
Length = 335 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 2e-07
Identities = 63/219 (28%), Positives = 95/219 (43%), Gaps = 50/219 (22%)
Query: 121 ILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRS-RHCKRQKFDPSMR 179
+L + +IH + H D+KP NIL A K KI D G+A+ + F
Sbjct: 112 LLRALKYIHTANVFHRDLKPKNIL--ANADCKL--KICDFGLARVAFNDTPTAIFWTDYV 167
Query: 180 GTPLYLAPETVVQHMQE-APS-DIWALGCVVLEMLSGRQAW----VVKEDCSIDQLFSII 233
T Y APE + P+ DIW++GC+ E+L+G+ + VV + +D + ++
Sbjct: 168 ATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQ---LDLITDLL 224
Query: 234 GDEHSLPEIPSRVSKE-ARDFLRRCFVRKP----------------------AF----RF 266
G PE SRV E AR +L ++P AF R
Sbjct: 225 GTPS--PETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRP 282
Query: 267 TAEMLLDDPFVKG---VDEELSRE----LEGDYSQGEVT 298
TAE L DP+ KG V+ E S + LE ++ + +T
Sbjct: 283 TAEEALADPYFKGLAKVEREPSAQPITKLEFEFERRRLT 321
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 3e-07
Identities = 31/95 (32%), Positives = 50/95 (52%), Gaps = 7/95 (7%)
Query: 121 ILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMRG 180
+L GI H+H +G +H D+KP NI++ KI D G+A+ + P +
Sbjct: 135 MLCGIKHLHSAGIIHRDLKPSNIVV----KSDCTLKILDFGLARTAG--TSFMMTPYVV- 187
Query: 181 TPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGR 215
T Y APE ++ + DIW++GC++ EM+ G
Sbjct: 188 TRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 222
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 3e-07
Identities = 58/249 (23%), Positives = 102/249 (40%), Gaps = 68/249 (27%)
Query: 87 LLLEYAAGGTLGDLIEKCNGNGLPEKDVRHF----TRCILEGIGHIHDSGYVHCDVKPDN 142
+++Y GG + L+ + G+ +D+ F C +E + H G++H D+KPDN
Sbjct: 78 FVMDYIPGGDMMSLLIRM---GIFPEDLARFYIAELTCAVESV---HKMGFIHRDIKPDN 131
Query: 143 ILLVATQSGKFVAKIADLGVAKRSR------------HCKRQKFDPSMR----------- 179
IL+ + G K+ D G+ R H ++ D S
Sbjct: 132 ILI--DRDGHI--KLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGD 187
Query: 180 ----------------------GTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQA 217
GTP Y+APE +++ D W++G ++ EML G+
Sbjct: 188 RLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPP 247
Query: 218 WVVKEDCSIDQLFSIIGDEHSLPEIP--SRVSKEARDFLRRCFVRKPAFRF---TAEMLL 272
++ + ++ +I + SL IP +++S EA D + + R P R A+ +
Sbjct: 248 FLAQT--PLETQMKVINWQTSL-HIPPQAKLSPEASDLIIK-LCRGPEDRLGKNGADEIK 303
Query: 273 DDPFVKGVD 281
PF K +D
Sbjct: 304 AHPFFKTID 312
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 50.4 bits (121), Expect = 3e-07
Identities = 61/283 (21%), Positives = 109/283 (38%), Gaps = 50/283 (17%)
Query: 14 IGQGSFGCVF--IAKPKSNSSFLPPLMAVK----SAEVSASASLQKEKEVFDNLNGCPFV 67
+G G+FG V + KS +AVK + +E V L+ P +
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVE---VAVKTLKQEHIAAGKKEFLREASVMAQLDH-PCI 58
Query: 68 LECFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGH 127
+ G + GE L++E A G L ++K +P D++ + G+ +
Sbjct: 59 VRLIG--VCKGE----PLMLVMELAPLGPLLKYLKK-RRE-IPVSDLKELAHQVAMGMAY 110
Query: 128 IHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAK---------RSRHCKRQKFDPSM 178
+ +VH D+ N+LLV + AKI+D G+++ R+ R
Sbjct: 111 LESKHFVHRDLAARNVLLVN----RHQAKISDFGMSRALGAGSDYYRATTAGRW------ 160
Query: 179 RGTPL-YLAPETVVQHMQEAPSDIWALGCVVLEMLS-GRQAWVVKEDCSIDQLFSIIGDE 236
PL + APE + + SD+W+ G + E S G + + + ++ +++
Sbjct: 161 ---PLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPY---GEMKGAEVIAMLESG 214
Query: 237 HSLPEIPSRVSKEARDFLRRCF----VRKPAFRFTAEMLLDDP 275
LP P +E + C+ +P F DP
Sbjct: 215 ERLPR-PEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP 256
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 4e-07
Identities = 39/140 (27%), Positives = 65/140 (46%), Gaps = 20/140 (14%)
Query: 121 ILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMRG 180
+L GI H+H +G +H D+KP NI++ KI D G+A+ + S
Sbjct: 128 MLCGIKHLHSAGIIHRDLKPSNIVV----KSDCTLKILDFGLARTA--------GTSFMM 175
Query: 181 TP-----LYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGD 235
TP Y APE ++ + DIW++GC++ EM+ R + IDQ +I
Sbjct: 176 TPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV--RHKILFPGRDYIDQWNKVIEQ 233
Query: 236 EHS-LPEIPSRVSKEARDFL 254
+ PE ++ R+++
Sbjct: 234 LGTPCPEFMKKLQPTVRNYV 253
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 50.5 bits (121), Expect = 5e-07
Identities = 50/200 (25%), Positives = 86/200 (43%), Gaps = 35/200 (17%)
Query: 104 CNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVA 163
CNG+ PE V+ F +L+G+ H +H D+KP N+L+ ++G+ K+AD G+A
Sbjct: 92 CNGDIDPEI-VKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLI--NKNGEL--KLADFGLA 146
Query: 164 KRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPS-DIWALGCVVLEMLSGRQAWVVKE 222
R+ + + + T Y P+ + + S D+W+ GC+ E+ + +
Sbjct: 147 -RAFGIPVRCYSAEVV-TLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGN 204
Query: 223 DCSIDQL---FSIIGDE--------HSLPEIP---------------SRVSKEARDFLRR 256
D DQL F ++G LP+ +++ RD L+
Sbjct: 205 DVD-DQLKRIFRLLGTPTEESWPGVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQN 263
Query: 257 CFVRKPAFRFTAEMLLDDPF 276
V P R +AE L P+
Sbjct: 264 LLVCNPVQRISAEEALQHPY 283
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 5e-07
Identities = 47/185 (25%), Positives = 81/185 (43%), Gaps = 26/185 (14%)
Query: 87 LLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLV 146
L+L++A GG L I K +PE+ V+ + ++ + +H G V D+ P+NILL
Sbjct: 62 LVLQHAEGGKLWSHISKFLN--IPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILL- 118
Query: 147 ATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMRGTP---LYLAPETVVQHMQEAPSDIWA 203
D G + + + + + S G +Y APE + D W+
Sbjct: 119 -----------DDRGHIQLTYFSRWSEVEDSCDGEAVENMYCAPEVGGISEETEACDWWS 167
Query: 204 LGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEHSLPEIPSRVSKEARDFLRRCFVRKPA 263
LG ++ E+L+G+ ++ + + H+ IP VS+EAR L++ P
Sbjct: 168 LGAILFELLTGK---------TLVECHPSGINTHTTLNIPEWVSEEARSLLQQLLQFNPT 218
Query: 264 FRFTA 268
R A
Sbjct: 219 ERLGA 223
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 5e-07
Identities = 59/275 (21%), Positives = 119/275 (43%), Gaps = 30/275 (10%)
Query: 11 GRVIGQGSFGCVFIAKP----KSNSSFLPPLMAVK----SAEVSASASLQKEKEVFDNLN 62
G+ +G G+FG V A KS++ +AVK +A S +L E ++ +L
Sbjct: 40 GKTLGAGAFGKVVEATAYGLSKSDAVMK---VAVKMLKPTAHSSEREALMSELKIMSHLG 96
Query: 63 GCPFVLECFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCIL 122
++ G G ++ EY G L + + + + L +D+ F+ +
Sbjct: 97 NHENIVNLLGACTIGG-----PILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVA 151
Query: 123 EGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMRGTP 182
+G+ + +H D+ N+LL GK + KI D G+A+ + + R
Sbjct: 152 KGMAFLASKNCIHRDLAARNVLLT---HGK-IVKICDFGLARDIMNDSNYVVKGNARLPV 207
Query: 183 LYLAPETVVQHMQEAPSDIWALGCVVLEMLS-GRQAWVVKEDCSIDQLF-SIIGDEHSLP 240
++APE++ + SD+W+ G ++ E+ S G + +D F +I + + +
Sbjct: 208 KWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPY---PGMPVDSKFYKLIKEGYRMA 264
Query: 241 EIPSRVSKEARDFLRRC----FVRKPAFRFTAEML 271
+ P E D ++ C +++P F+ +++
Sbjct: 265 Q-PEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLI 298
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 5e-07
Identities = 68/272 (25%), Positives = 120/272 (44%), Gaps = 33/272 (12%)
Query: 14 IGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVSASASLQKEKEVFDNLNGCPFVLECFGE 73
+GQG FG V++ N + + +K +S A LQ E +V L V
Sbjct: 14 LGQGCFGEVWMGT--WNGTTRVAIKTLKPGTMSPEAFLQ-EAQVMKKLRHEKLV------ 64
Query: 74 EITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGY 133
++ + E Y ++ EY + G+L D ++ G L + I G+ ++ Y
Sbjct: 65 QLYAVVSEEPIY-IVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNY 123
Query: 134 VHCDVKPDNILLVATQSGKFVAKIADLGVAK---RSRHCKRQKFDPSMRGTPLYLAPETV 190
VH D++ NIL+ V K+AD G+A+ + + RQ ++ T APE
Sbjct: 124 VHRDLRAANILV----GENLVCKVADFGLARLIEDNEYTARQGAKFPIKWT----APEAA 175
Query: 191 VQHMQEAPSDIWALGCVVLEMLS-GRQAW--VVKEDCSIDQLFSIIGDEHSLPEIPSRVS 247
+ SD+W+ G ++ E+ + GR + +V + +DQ + + +P P
Sbjct: 176 LYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREV-LDQ----VERGYRMP-CPPECP 229
Query: 248 KEARDFLRRCFVRKPAFRFTAEML---LDDPF 276
+ D + +C+ ++P R T E L L+D F
Sbjct: 230 ESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 261
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 7e-07
Identities = 69/297 (23%), Positives = 126/297 (42%), Gaps = 46/297 (15%)
Query: 13 VIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVSASASLQK----EKEVFDNLNGCPFVL 68
VIG+G+FG V A K + + A+K + AS + + E EV L P ++
Sbjct: 9 VIGEGNFGQVIRAMIKKDGLKMNA--AIKMLKEFASENDHRDFAGELEVLCKLGHHPNII 66
Query: 69 ECFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKC--------------NGNGLPEKDV 114
G EN Y + +EYA G L D + K + L + +
Sbjct: 67 NLLGA----CENRGYLY-IAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQL 121
Query: 115 RHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKF 174
F + G+ ++ + ++H D+ N+L+ +KIAD G++ R +K
Sbjct: 122 LQFASDVATGMQYLSEKQFIHRDLAARNVLV----GENLASKIADFGLS-RGEEVYVKK- 175
Query: 175 DPSMRGTPL-YLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSII 233
+M P+ ++A E++ + SD+W+ G ++ E++S C+ +L+ +
Sbjct: 176 --TMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCA--ELYEKL 231
Query: 234 GDEHSLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGVDEELSRELEG 290
+ + E P E + +R+C+ +P R PF + + +LSR LE
Sbjct: 232 PQGYRM-EKPRNCDDEVYELMRQCWRDRPYER--------PPFAQ-ISVQLSRMLEA 278
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 7e-07
Identities = 50/215 (23%), Positives = 92/215 (42%), Gaps = 27/215 (12%)
Query: 87 LLLEYAAGGTLGDLIE---------KCNGNGLPE-----KDVRHFTRCILEGIGHIHDSG 132
+++EYAA G L + + + +PE KD+ + G+ ++
Sbjct: 95 VIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR 154
Query: 133 YVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQ 192
+H D+ N+L+ V KIAD G+A+ K + R ++APE +
Sbjct: 155 CIHRDLAARNVLVTEDN----VMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFD 210
Query: 193 HMQEAPSDIWALGCVVLEM--LSGRQAWVVKEDCSIDQLFSIIGDEHSLPEIPSRVSKEA 250
+ SD+W+ G ++ E+ L G + +++LF ++ + H + + PS + E
Sbjct: 211 RVYTHQSDVWSFGILMWEIFTLGGSPYPGI----PVEELFKLLREGHRM-DKPSNCTHEL 265
Query: 251 RDFLRRCFVRKPAFRFTAEML--LDDPFVKGVDEE 283
+R C+ P R T + L D + V EE
Sbjct: 266 YMLMRECWHAVPTQRPTFKQLVEALDKVLAAVSEE 300
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 49.3 bits (118), Expect = 8e-07
Identities = 43/186 (23%), Positives = 73/186 (39%), Gaps = 15/186 (8%)
Query: 87 LLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLV 146
++ E A G+L D + K + + I G+ ++ ++H D+ NILL
Sbjct: 72 MVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLA 131
Query: 147 ATQSGKFVAKIADLGVAKR---SRHCKRQKFDPSMRGTPL-YLAPETVVQHMQEAPSDIW 202
S V KI D G+ + + + P + APE++ SD+W
Sbjct: 132 ---SDDKV-KIGDFGLMRALPQNEDHYVMEEH---LKVPFAWCAPESLRTRTFSHASDVW 184
Query: 203 ALGCVVLEMLS-GRQAWVVKEDCSIDQLFSIIGDEHSLPEIPSRVSKEARDFLRRCFVRK 261
G + EM + G + W S Q+ I E E P ++ + + +C+
Sbjct: 185 MFGVTLWEMFTYGEEPWA---GLSGSQILKKIDKEGERLERPEACPQDIYNVMLQCWAHN 241
Query: 262 PAFRFT 267
PA R T
Sbjct: 242 PADRPT 247
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 8e-07
Identities = 46/169 (27%), Positives = 82/169 (48%), Gaps = 16/169 (9%)
Query: 82 EMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPD 141
E + L+ EY L ++ C GN + +V+ F +L G+ + H +H D+KP
Sbjct: 76 EKSLTLVFEYL-DKDLKQYLDDC-GNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQ 133
Query: 142 NILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPS-D 200
N+L+ + G+ K+AD G+A R++ + + + T Y P+ ++ + D
Sbjct: 134 NLLI--NERGEL--KLADFGLA-RAKSIPTKTYSNEVV-TLWYRPPDILLGSTDYSTQID 187
Query: 201 IWALGCVVLEMLSGRQAW---VVKEDCSIDQLFSIIG--DEHSLPEIPS 244
+W +GC+ EM +GR + V+E +F I+G E + P I S
Sbjct: 188 MWGVGCIFYEMSTGRPLFPGSTVEEQLHF--IFRILGTPTEETWPGILS 234
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 1e-06
Identities = 52/212 (24%), Positives = 91/212 (42%), Gaps = 28/212 (13%)
Query: 11 GRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKS--AEVSASASLQKEKEVFDNLNGCPFVL 68
G +IG+G FG V + +AVK+ +V+A A L+ E V L+ V
Sbjct: 11 GEIIGEGEFGAVL------QGEYTGQKVAVKNIKCDVTAQAFLE-ETAVMTKLHHKNLVR 63
Query: 69 ECFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHI 128
+G +++E + G L + + + + F+ + EG+ ++
Sbjct: 64 -------LLGVILHNGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYL 116
Query: 129 HDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMRGTPL-YLAP 187
VH D+ NIL+ S VAK++D G+A+ D S P+ + AP
Sbjct: 117 ESKKLVHRDLAARNILV----SEDGVAKVSDFGLAR----VGSMGVDNSK--LPVKWTAP 166
Query: 188 ETVVQHMQEAPSDIWALGCVVLEMLS-GRQAW 218
E + + SD+W+ G ++ E+ S GR +
Sbjct: 167 EALKHKKFSSKSDVWSYGVLLWEVFSYGRAPY 198
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 49.3 bits (118), Expect = 1e-06
Identities = 66/290 (22%), Positives = 127/290 (43%), Gaps = 45/290 (15%)
Query: 11 GRVIGQGSFGCVFIA------KPKSNSSFLPPLMAVKSAEVSAS----ASLQKEKEVFDN 60
G+ +G+G+FG V A P S+ +AVK + A+ + L E E+
Sbjct: 17 GKPLGEGAFGQVVKAEAVGLDNPNETST-----VAVKMLKDDATEKDLSDLVSEMEMMKM 71
Query: 61 LNGCPFVLECFGEEITMGENGEMAYNLLLEYAAGGTLGDLI-------EKCNGNG----- 108
+ ++ G + G + +++EYAA G L D + E + +
Sbjct: 72 IGKHKNIINLLG---VCTQEGPLY--VVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPE 126
Query: 109 --LPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRS 166
L +KD+ F + G+ + +H D+ N+L+ + V KIAD G+A+
Sbjct: 127 ETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLV----TEDHVMKIADFGLARDI 182
Query: 167 RHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEM--LSGRQAWVVKEDC 224
H + + R ++APE + + SD+W+ G ++ E+ L G +
Sbjct: 183 HHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIP--- 239
Query: 225 SIDQLFSIIGDEHSLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDD 274
+++LF ++ + + + E P ++E +R C+ P+ R T + L++D
Sbjct: 240 -VEELFKLLKEGYRM-EKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVED 287
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 49.5 bits (118), Expect = 1e-06
Identities = 37/126 (29%), Positives = 54/126 (42%), Gaps = 5/126 (3%)
Query: 109 LPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRH 168
LP + R +LE + ++H G +H DVK +NI L ++ A + D G A +
Sbjct: 182 LPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPEN----AVLGDFGAACKLDA 237
Query: 169 CKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKE-DCSID 227
GT +PE + A +DIW+ G V+ EM K+ S
Sbjct: 238 HPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSS 297
Query: 228 QLFSII 233
QL SII
Sbjct: 298 QLRSII 303
|
Length = 392 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 1e-06
Identities = 50/199 (25%), Positives = 89/199 (44%), Gaps = 36/199 (18%)
Query: 87 LLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLV 146
++ EY G+L D ++ G L + I EG+ I Y+H D++ NIL+
Sbjct: 77 IITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILV- 135
Query: 147 ATQSGKFVAKIADLGVA---KRSRHCKRQ--KFDPSMRGTPL-YLAPETVVQHMQEAPSD 200
S KIAD G+A + + + R+ KF P+ + APE + SD
Sbjct: 136 ---SETLCCKIADFGLARLIEDNEYTAREGAKF-------PIKWTAPEAINYGTFTIKSD 185
Query: 201 IWALGCVVLEMLS-GRQAW-------VVKEDCSIDQLFSIIGDEHSLPEIPSRVSKEARD 252
+W+ G ++ E+++ GR + V++ ++++ + +P P +E +
Sbjct: 186 VWSFGILLTEIVTYGRIPYPGMTNPEVIQ---NLERGY-------RMPR-PDNCPEELYE 234
Query: 253 FLRRCFVRKPAFRFTAEML 271
+R C+ KP R T E L
Sbjct: 235 LMRLCWKEKPEERPTFEYL 253
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 2e-06
Identities = 63/297 (21%), Positives = 126/297 (42%), Gaps = 54/297 (18%)
Query: 11 GRVIGQGSFGCV-----FIAKPKSNSSFLPPLMAVKSAEVSASASLQKEKEVFDNLNGCP 65
G+ +G+G FG V F K ++ + + M ++A S L E + +N P
Sbjct: 5 GKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNH-P 63
Query: 66 FVLECFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEK-----CNGNG------------ 108
V++ +G G L++EYA G+L + + + G
Sbjct: 64 HVIKLYGACSQDG-----PLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDN 118
Query: 109 -----LPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLG-- 161
L D+ F I G+ ++ + VH D+ N+L+ G+ KI+D G
Sbjct: 119 PDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVA---EGR-KMKISDFGLS 174
Query: 162 --VAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLS-GRQAW 218
V + + KR K ++ ++A E++ H+ SD+W+ G ++ E+++ G +
Sbjct: 175 RDVYEEDSYVKRSKGRIPVK----WMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPY 230
Query: 219 VVKEDCSIDQLFSIIGDEHSLPEIPSRVSKEARDFLRRCFV----RKPAFRFTAEML 271
+ ++LF+++ + + E P S+E + + C+ ++P F ++ L
Sbjct: 231 ---PGIAPERLFNLLKTGYRM-ERPENCSEEMYNLMLTCWKQEPDKRPTFADISKEL 283
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 48.6 bits (116), Expect = 2e-06
Identities = 50/207 (24%), Positives = 102/207 (49%), Gaps = 19/207 (9%)
Query: 14 IGQGSFGCVFIAK--PKSNSSFLPPLMAVKSAEVSASASL---QKEKEVFDNLNGCPFVL 68
+G+G+FG V + + P +++ ++AVK + S + L ++E E+ +L ++
Sbjct: 12 LGKGNFGSVELCRYDPLQDNT--GEVVAVKKLQHSTAEHLRDFEREIEILKSLQ-HDNIV 68
Query: 69 ECFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHI 128
+ G + G L++EY G+L D ++K + L + + + I +G+ ++
Sbjct: 69 KYKGVCYSAGRRN---LRLVMEYLPYGSLRDYLQK-HRERLDHRKLLLYASQICKGMEYL 124
Query: 129 HDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMRG-TPLY-LA 186
YVH D+ NIL V +++ KI D G+ K ++ + G +P++ A
Sbjct: 125 GSKRYVHRDLATRNIL-VESEN---RVKIGDFGLTK-VLPQDKEYYKVREPGESPIFWYA 179
Query: 187 PETVVQHMQEAPSDIWALGCVVLEMLS 213
PE++ + SD+W+ G V+ E+ +
Sbjct: 180 PESLTESKFSVASDVWSFGVVLYELFT 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 2e-06
Identities = 44/192 (22%), Positives = 87/192 (45%), Gaps = 22/192 (11%)
Query: 87 LLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLV 146
++ E+ G+L D +++ +G L + I +G+ +I Y+H D++ NIL+
Sbjct: 77 IVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILV- 135
Query: 147 ATQSGKFVAKIADLGVAK---RSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWA 203
V KIAD G+A+ + + RQ ++ T APE + SD+W+
Sbjct: 136 ---GDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWT----APEAALYGRFTIKSDVWS 188
Query: 204 LGCVVLEMLS-GRQAW---VVKEDCSIDQLFSIIGDEHSLPEIPSRVSKEARDFLRRCFV 259
G ++ E+++ GR + V +E + + + +P P + + ++ C+
Sbjct: 189 FGILLTELVTKGRVPYPGMVNRE------VLEQVERGYRMP-CPQGCPESLHELMKLCWK 241
Query: 260 RKPAFRFTAEML 271
+ P R T E +
Sbjct: 242 KDPDERPTFEYI 253
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 2e-06
Identities = 52/206 (25%), Positives = 93/206 (45%), Gaps = 22/206 (10%)
Query: 12 RVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVSASA-SLQKEKEVFDNLNGCPFVLEC 70
+ IG+G FG V + + N +AVK + A+A + E V L V +
Sbjct: 12 QTIGKGEFGDVMLGDYRGNK------VAVKCIKNDATAQAFLAEASVMTQLRHSNLV-QL 64
Query: 71 FGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHD 130
G + + E G + ++ EY A G+L D + + L + F+ + E + ++
Sbjct: 65 LG--VIVEEKGGLY--IVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEA 120
Query: 131 SGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMRGTPLYLAPETV 190
+ +VH D+ N+L+ S VAK++D G+ K + + P + APE +
Sbjct: 121 NNFVHRDLAARNVLV----SEDNVAKVSDFGLTKEASSTQDTGKLPVK-----WTAPEAL 171
Query: 191 VQHMQEAPSDIWALGCVVLEMLS-GR 215
+ SD+W+ G ++ E+ S GR
Sbjct: 172 REKKFSTKSDVWSFGILLWEIYSFGR 197
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 3e-06
Identities = 58/279 (20%), Positives = 111/279 (39%), Gaps = 43/279 (15%)
Query: 12 RVIGQGSFGCVF--IAKPKSNSSFLPPLMAVKSAEVSASASLQKE--KEV-----FDNLN 62
+G G+FG V+ A P +AVK+ A+ +KE KE F++ N
Sbjct: 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPN 60
Query: 63 GCPFVLECFGEEITMGENGEMAYNLLLEYAAGGTL-----GDLIEKCNGNGLPEKDVRHF 117
+ C E +++E GG L +E+ L K++
Sbjct: 61 IVKLLGVCLLNE---------PQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDI 111
Query: 118 TRCILEGIGHIHDSGYVHCDVKPDNILL-VATQSGKFVAKIADLGVAK---RSRHCKRQK 173
+ +G ++ ++H D+ N L+ V KI D G+A+ +S + ++
Sbjct: 112 CLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRK-- 169
Query: 174 FDPSMRGTPL----YLAPETVVQHMQEAPSDIWALGCVVLEMLS-GRQAWVVKEDCSIDQ 228
G L ++APE+++ SD+W+ G ++ E+L+ G+Q + + + Q
Sbjct: 170 -----EGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQ 224
Query: 229 LFSIIGDEHSLPEIPSRVSKEARDFLRRCFVRKPAFRFT 267
+ G P ++ + C+ + P+ R T
Sbjct: 225 HVTAGGRLQKPENCPDKI----YQLMTNCWAQDPSERPT 259
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 47.2 bits (112), Expect = 5e-06
Identities = 35/136 (25%), Positives = 61/136 (44%), Gaps = 22/136 (16%)
Query: 87 LLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFT--------RCILEGIGHIHDSGYVHCDV 138
++ EY G+L + K +G FT R I G+ ++ D GYVH D+
Sbjct: 82 IVTEYMENGSLDAFLRKHDG---------QFTVIQLVGMLRGIASGMKYLSDMGYVHRDL 132
Query: 139 KPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMRGTPL-YLAPETVVQHMQEA 197
NIL+ + V K++D G+++ + P+ + APE + +
Sbjct: 133 AARNILV----NSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTS 188
Query: 198 PSDIWALGCVVLEMLS 213
SD+W+ G V+ E++S
Sbjct: 189 ASDVWSYGIVMWEVMS 204
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 5e-06
Identities = 61/273 (22%), Positives = 104/273 (38%), Gaps = 38/273 (13%)
Query: 14 IGQGSFGCVFIAK-----PKSNSSFLPPLMAVKSAEVSASASLQKEKEVFDNLNGCPFVL 68
+G+G+FG VF+A+ P+ + L + A+K A SA Q+E E+ L ++
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKM-LVAVKALKEASESARQDFQREAELLTVLQH-QHIV 70
Query: 69 ECFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEK---------------CNGNGLPEKD 113
+G T G M + EY G L + L +
Sbjct: 71 RFYG-VCTEGRPLLMVF----EYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQ-- 123
Query: 114 VRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQK 173
+ I G+ ++ +VH D+ N L+ V KI D G+++ +
Sbjct: 124 MLAIASQIASGMVYLASLHFVHRDLATRNCLV----GQGLVVKIGDFGMSRDIYSTDYYR 179
Query: 174 FDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLS-GRQAWVVKEDCSIDQLFSI 232
++ PE+++ SDIW+ G V+ E+ + G+Q W S +
Sbjct: 180 VGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWY---QLSNTEAIEC 236
Query: 233 IGDEHSLPEIPSRVSKEARDFLRRCFVRKPAFR 265
I L E P E ++ C+ R+P R
Sbjct: 237 ITQGREL-ERPRTCPPEVYAIMQGCWQREPQQR 268
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 7e-06
Identities = 64/268 (23%), Positives = 110/268 (41%), Gaps = 32/268 (11%)
Query: 10 RGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVSASASLQKEKEVFDNLNGCPFVLE 69
+ +VIG G FG VF K + A+K+ + + EK+ D L+ + +
Sbjct: 9 KQKVIGAGEFGEVFRGILKMPGRKEVAV-AIKTLKPGYT-----EKQRQDFLSEASIMGQ 62
Query: 70 CFGEEITMGENGEMAYN---LLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIG 126
I E + ++ EY G L + +G + V R I G+
Sbjct: 63 FSHHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLV-GMLRGIAAGMK 121
Query: 127 HIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMRGTPL-YL 185
++ D YVH D+ NIL+ + K++D G+++ + S P+ +
Sbjct: 122 YLSDMNYVHRDLAARNILV----NSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWT 177
Query: 186 APETVVQHMQEAPSDIWALGCVVLEMLS--GRQAWVVKEDCSIDQLFSIIGDEHSLP--- 240
APE + + SD+W+ G V+ E++S R W D S ++ I D LP
Sbjct: 178 APEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYW----DMSNHEVMKAINDGFRLPAPM 233
Query: 241 EIPSRVSKEARDFLRRCFV----RKPAF 264
+ PS V + + +C+ R+P F
Sbjct: 234 DCPSAVYQ----LMLQCWQQDRARRPRF 257
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 7e-06
Identities = 50/203 (24%), Positives = 85/203 (41%), Gaps = 15/203 (7%)
Query: 14 IGQGSFGCVFIAKPKSNSSFLPPLMAV--KSAEVSASASLQKEKEVFDNLNGCPFVLECF 71
+G G+FGCV K + + V E S + +E E+ L+ P+++
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDN-PYIVRMI 61
Query: 72 GEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDS 131
G + E A L++E A+GG L + + + +V + G+ ++
Sbjct: 62 G--VCEAE----ALMLVMEMASGGPLNKFLSG-KKDEITVSNVVELMHQVSMGMKYLEGK 114
Query: 132 GYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMRGTPL-YLAPETV 190
+VH D+ N+LLV AKI+D G++K S PL + APE +
Sbjct: 115 NFVHRDLAARNVLLVNQH----YAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECI 170
Query: 191 VQHMQEAPSDIWALGCVVLEMLS 213
+ SD+W+ G + E S
Sbjct: 171 NFRKFSSRSDVWSYGITMWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 8e-06
Identities = 35/133 (26%), Positives = 64/133 (48%), Gaps = 12/133 (9%)
Query: 87 LLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLV 146
++ EY + G+L D ++ G L ++ + G+ +I Y+H D++ NIL+
Sbjct: 77 IVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILV- 135
Query: 147 ATQSGKFVAKIADLGVAK---RSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWA 203
V KIAD G+A+ + + RQ ++ T APE + SD+W+
Sbjct: 136 ---GDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWT----APEAALYGRFTIKSDVWS 188
Query: 204 LGCVVLEMLS-GR 215
G ++ E+++ GR
Sbjct: 189 FGILLTELVTKGR 201
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 8e-06
Identities = 75/296 (25%), Positives = 127/296 (42%), Gaps = 46/296 (15%)
Query: 13 VIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVSASASLQK----EKEVFDNLNGCPFVL 68
VIG+G+FG V A+ K + L A+K + AS + E EV L P ++
Sbjct: 2 VIGEGNFGQVLKARIKKDG--LRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 59
Query: 69 ECFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKC--------------NGNGLPEKDV 114
G E+ Y L +EYA G L D + K + L + +
Sbjct: 60 NLLGA----CEHRGYLY-LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 114
Query: 115 RHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKF 174
HF + G+ ++ ++H D+ NIL+ +VAKIAD G++ R + +K
Sbjct: 115 LHFAADVARGMDYLSQKQFIHRDLAARNILV----GENYVAKIADFGLS-RGQEVYVKK- 168
Query: 175 DPSMRGTPL-YLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSII 233
+M P+ ++A E++ + SD+W+ G ++ E++S C+ +L+ +
Sbjct: 169 --TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA--ELYEKL 224
Query: 234 GDEHSLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGVDEELSRELE 289
+ L E P E D +R+C+ KP R F + + L+R LE
Sbjct: 225 PQGYRL-EKPLNCDDEVYDLMRQCWREKPYER--------PSFAQ-ILVSLNRMLE 270
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 8e-06
Identities = 59/253 (23%), Positives = 102/253 (40%), Gaps = 66/253 (26%)
Query: 91 YAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQS 150
+ A G+ DLI +G+ E + + + +L+ + +IH GYVH VK +IL+
Sbjct: 80 FMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVD-- 137
Query: 151 GKFVAKIADLGVAKRS-----RHCKRQKF-----DPSMRGTPLYLAPETVVQHMQ--EAP 198
K+ G+ RS H +R + S++ P +L+PE + Q++Q +A
Sbjct: 138 ----GKVYLSGL--RSNLSMINHGQRLRVVHDFPKYSVKVLP-WLSPEVLQQNLQGYDAK 190
Query: 199 SDIWALGCVVLEMLSGR---------QAWVVKEDCSIDQLF---SIIGDEHSLPEIPSR- 245
SDI+++G E+ +G Q + K + ++ L +I +E ++ PSR
Sbjct: 191 SDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIPAEELTMK--PSRS 248
Query: 246 ------------------------------VSKEARDFLRRCFVRKPAFRFTAEMLLDDP 275
S F+ +C R P R +A LL+
Sbjct: 249 GANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHS 308
Query: 276 FVKGVDEELSREL 288
F K + S L
Sbjct: 309 FFKQIKRRASEAL 321
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 46.3 bits (110), Expect = 9e-06
Identities = 46/211 (21%), Positives = 87/211 (41%), Gaps = 28/211 (13%)
Query: 12 RVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVSASASLQ----KEKEV---FDNLNGC 64
IG+G+FG V+ K N+ +AVK+ + L+ +E E+ +D+ N
Sbjct: 1 EKIGKGNFGDVYKGVLKGNTE-----VAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIV 55
Query: 65 PFVLECFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEG 124
+ C ++ +++E GG+L + K N L K + + G
Sbjct: 56 KLIGVCVQKQPIY---------IVMELVPGGSLLTFLRK-KKNRLTVKKLLQMSLDAAAG 105
Query: 125 IGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMRGTPL- 183
+ ++ +H D+ N L+ V KI+D G++ R ++ P+
Sbjct: 106 MEYLESKNCIHRDLAARNCLV----GENNVLKISDFGMS-REEEGGIYTVSDGLKQIPIK 160
Query: 184 YLAPETVVQHMQEAPSDIWALGCVVLEMLSG 214
+ APE + + SD+W+ G ++ E S
Sbjct: 161 WTAPEALNYGRYTSESDVWSYGILLWETFSL 191
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 46.3 bits (110), Expect = 9e-06
Identities = 44/215 (20%), Positives = 94/215 (43%), Gaps = 30/215 (13%)
Query: 10 RGRVIGQGSFGCVF--IAKPKSNSSFLPPLMAVKSAEVSASASLQKE--KEVF-----DN 60
+ +V+G G+FG V+ + P+ +P +A+K S KE E + D+
Sbjct: 11 KIKVLGSGAFGTVYKGVWIPEGEKVKIP--VAIKVLREETSPKANKEILDEAYVMASVDH 68
Query: 61 LNGCPFVLECFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRC 120
+ + C ++ M LL+Y + + + + + + ++
Sbjct: 69 PHVVRLLGICLSSQV-QLITQLMPLGCLLDYV----------RNHKDNIGSQYLLNWCVQ 117
Query: 121 ILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKR-SRHCKRQKFDPSMR 179
I +G+ ++ + VH D+ N+L+ ++ + V KI D G+AK K +
Sbjct: 118 IAKGMSYLEEKRLVHRDLAARNVLV---KTPQHV-KITDFGLAKLLDVDEKEYHAEGGK- 172
Query: 180 GTPL-YLAPETVVQHMQEAPSDIWALGCVVLEMLS 213
P+ ++A E+++ + SD+W+ G V E+++
Sbjct: 173 -VPIKWMALESILHRIYTHKSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 45.9 bits (109), Expect = 1e-05
Identities = 58/256 (22%), Positives = 104/256 (40%), Gaps = 19/256 (7%)
Query: 11 GRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVSASASLQKEKEVFDNLNGCPFVLEC 70
R +G G FG V+ K+ + +KS ++ QKE + L ++
Sbjct: 11 ERKLGSGYFGEVWEGLWKNRVRV--AIKILKSDDLLKQQDFQKEVQALKRLRH-KHLISL 67
Query: 71 FGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHD 130
F + GE Y ++ E G+L + G LP + + EG+ ++ +
Sbjct: 68 FA----VCSVGEPVY-IITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEE 122
Query: 131 SGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMRGTPL-YLAPET 189
+H D+ NIL+ V K+AD G+A R K + S + P + APE
Sbjct: 123 QNSIHRDLAARNILV----GEDLVCKVADFGLA---RLIKEDVYLSSDKKIPYKWTAPEA 175
Query: 190 VVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEHSLPEIPSRVSKE 249
SD+W+ G ++ EM + Q V + +++ I + +P P++ +E
Sbjct: 176 ASHGTFSTKSDVWSFGILLYEMFTYGQ--VPYPGMNNHEVYDQITAGYRMPC-PAKCPQE 232
Query: 250 ARDFLRRCFVRKPAFR 265
+ C+ +P R
Sbjct: 233 IYKIMLECWAAEPEDR 248
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 46.4 bits (110), Expect = 1e-05
Identities = 42/172 (24%), Positives = 64/172 (37%), Gaps = 24/172 (13%)
Query: 109 LPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRH 168
LP + ILEG+ ++H +H DVK +NI + I DLG A +
Sbjct: 154 LPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQ----VCIGDLGAA---QF 206
Query: 169 CKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSID- 227
+ GT APE + + + +DIW+ G V+ EML+ + +
Sbjct: 207 PVVAPAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEE 266
Query: 228 -------QLFSIIG----DEHSLPEIPSRVSKEARDFLR--RCFVRKPAFRF 266
L II P P S+ R F+ R+P R+
Sbjct: 267 YVKSCHSHLLKIISTLKVHPEEFPRDPG--SRLVRGFIEYASL-ERQPYTRY 315
|
Length = 357 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 45.1 bits (107), Expect = 2e-05
Identities = 62/282 (21%), Positives = 113/282 (40%), Gaps = 48/282 (17%)
Query: 12 RVIGQGSFGCVFIAK-----PKSNSSFLPPLMAVK----SAEVSASASLQKEKEVFDNLN 62
R +G+G+FG VF+ + P+++ L+AVK +A A ++E E+ N
Sbjct: 11 RELGEGAFGKVFLGECYHLEPENDKE----LVAVKTLKETASNDARKDFEREAELLTNF- 65
Query: 63 GCPFVLECFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNG-------------- 108
+++ +G T G+ M + EY G DL + +G
Sbjct: 66 QHENIVKFYGV-CTEGDPPIMVF----EYMEHG---DLNKFLRSHGPDAAFLKSPDSPMG 117
Query: 109 -LPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSR 167
L + I G+ ++ +VH D+ N L+ V KI D G+++
Sbjct: 118 ELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGY----DLVVKIGDFGMSRDVY 173
Query: 168 HCKRQKFDPSMRGTPL-YLAPETVVQHMQEAPSDIWALGCVVLEMLS-GRQAWVVKEDCS 225
+ P+ ++ PE+++ SD+W+ G V+ E+ + G+Q W S
Sbjct: 174 TTDYYRVGGH-TMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWY---GLS 229
Query: 226 IDQLFSIIGDEHSLPEIPSRVSKEARDFLRRCFVRKPAFRFT 267
+++ I + L + P E D + C+ R P R
Sbjct: 230 NEEVIECI-TQGRLLQRPRTCPSEVYDIMLGCWKRDPQQRIN 270
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 44.9 bits (106), Expect = 2e-05
Identities = 41/165 (24%), Positives = 74/165 (44%), Gaps = 20/165 (12%)
Query: 87 LLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLV 146
++ E+ G L + + +G + V R I G+ ++ + YVH D+ NIL+
Sbjct: 82 IITEFMENGALDSFLRQNDGQFTVIQLV-GMLRGIAAGMKYLSEMNYVHRDLAARNILV- 139
Query: 147 ATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMRGT-----PL-YLAPETVVQHMQEAPSD 200
+ V K++D G+ SR + DP+ + P+ + APE + + SD
Sbjct: 140 ---NSNLVCKVSDFGL---SRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASD 193
Query: 201 IWALGCVVLEMLS--GRQAWVVKEDCSIDQLFSIIGDEHSLPEIP 243
+W+ G V+ E++S R W D S + + I ++ LP
Sbjct: 194 VWSYGIVMWEVMSYGERPYW----DMSNQDVINAIEQDYRLPPPM 234
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 44.3 bits (105), Expect = 3e-05
Identities = 37/132 (28%), Positives = 66/132 (50%), Gaps = 14/132 (10%)
Query: 87 LLLEYAAGGTLGDLIEKCNGNGLPEKDVRH-FTRCILEGIGHIHDSGYVHCDVKPDNILL 145
++ EY A G+L D + + G + + F + EG+ ++ + +VH D+ N+L+
Sbjct: 77 IVTEYMAKGSLVDYL-RSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLV 135
Query: 146 VATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMRGTPL-YLAPETVVQHMQEAPSDIWAL 204
S VAK++D G+AK + Q D P+ + APE + + SD+W+
Sbjct: 136 ----SEDLVAKVSDFGLAKEA----SQGQDSGK--LPVKWTAPEALREKKFSTKSDVWSF 185
Query: 205 GCVVLEMLS-GR 215
G ++ E+ S GR
Sbjct: 186 GILLWEIYSFGR 197
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 4e-05
Identities = 34/124 (27%), Positives = 56/124 (45%), Gaps = 14/124 (11%)
Query: 95 GTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFV 154
+ +L+ GL D+ FT + G+ + VH D+ N+LL GK V
Sbjct: 220 SEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLL---AQGKIV 276
Query: 155 AKIADLGVAKRSRH-----CKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVL 209
KI D G+A+ H K F P ++APE++ ++ SD+W+ G ++
Sbjct: 277 -KICDFGLARDIMHDSNYVSKGSTFLPVK-----WMAPESIFDNLYTTLSDVWSYGILLW 330
Query: 210 EMLS 213
E+ S
Sbjct: 331 EIFS 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 44.3 bits (105), Expect = 5e-05
Identities = 34/127 (26%), Positives = 61/127 (48%), Gaps = 11/127 (8%)
Query: 90 EYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQ 149
EY G+L + + +G + V R I G+ ++ + YVH D+ NIL+
Sbjct: 85 EYMENGSLDKFLRENDGKFTVGQLVG-MLRGIASGMKYLSEMNYVHRDLAARNILV---- 139
Query: 150 SGKFVAKIADLGVAKRSRHCKRQKFDPSMRG--TPL-YLAPETVVQHMQEAPSDIWALGC 206
+ V K++D G SR + + + +G P+ + APE + + SD+W+ G
Sbjct: 140 NSNLVCKVSDFG---LSRRLEDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGI 196
Query: 207 VVLEMLS 213
V+ E++S
Sbjct: 197 VMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 6e-05
Identities = 48/210 (22%), Positives = 92/210 (43%), Gaps = 24/210 (11%)
Query: 12 RVIGQGSFGCVF--IAKPKSNSSFLPPLMAVKSAEVSASASLQKEKEVFDNLN-----GC 64
+V+G G+FG V+ I P + +P + V S A+ KE+ D G
Sbjct: 13 KVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKAN----KEILDEAYVMAGVGS 68
Query: 65 PFVLECFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEG 124
P+V G +T L+ + G L D + + N + + +D+ ++ I +G
Sbjct: 69 PYVCRLLGICLTS------TVQLVTQLMPYGCLLDYVRE-NKDRIGSQDLLNWCVQIAKG 121
Query: 125 IGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMRGTPL- 183
+ ++ + VH D+ N+L+ + KI D G+A R ++ P+
Sbjct: 122 MSYLEEVRLVHRDLAARNVLVKSPNH----VKITDFGLA-RLLDIDETEYHADGGKVPIK 176
Query: 184 YLAPETVVQHMQEAPSDIWALGCVVLEMLS 213
++A E+++ SD+W+ G V E+++
Sbjct: 177 WMALESILHRRFTHQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 7e-05
Identities = 56/220 (25%), Positives = 93/220 (42%), Gaps = 41/220 (18%)
Query: 14 IGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVSASASLQKEKEVFDNLNGCPF------- 66
IG G FG V +++ +++ + V E+ A+AS KE+ F G P+
Sbjct: 3 IGNGWFGKVLLSEIYTDTG----VARVVVKELKANASS-KEQNEFLQ-QGDPYRILQHPN 56
Query: 67 VLECFGEEITMGENGEMAYNLLLEYAAGGTLGDLI---EKCNGNGLPEKDVRHFTR--C- 120
+L+C G+ + + Y L+ EY G L + + N + R C
Sbjct: 57 ILQCLGQCVE-----AIPYLLVFEYCELGDLKSYLSQEQWHRRNS----QLLLLQRMACE 107
Query: 121 ILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMRG 180
I G+ H+H ++H D+ N L + K+ D G+ SR+ + +
Sbjct: 108 IAAGVTHMHKHNFLHSDLALRNCFL----TSDLTVKVGDYGIGP-SRYKEDYIETEDDKC 162
Query: 181 TPL-YLAPETVVQHM-------QEAPSDIWALGCVVLEML 212
PL +LAPE V + Q PS++WALG + E+
Sbjct: 163 VPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELF 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 43.5 bits (103), Expect = 7e-05
Identities = 37/133 (27%), Positives = 61/133 (45%), Gaps = 18/133 (13%)
Query: 90 EYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQ 149
EY + G+L D ++ G L + I EG+ ++ Y+H D+ NIL+
Sbjct: 81 EYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILV---- 136
Query: 150 SGKFVAKIADLGVA---KRSRHCKRQ--KFDPSMRGTPL-YLAPETVVQHMQEAPSDIWA 203
V KIAD G+A + + R+ KF P+ + APE SD+W+
Sbjct: 137 GENLVCKIADFGLARLIEDDEYTAREGAKF-------PIKWTAPEAANYGRFTIKSDVWS 189
Query: 204 LGCVVLEMLS-GR 215
G ++ E+++ GR
Sbjct: 190 FGILLTEIVTYGR 202
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 9e-05
Identities = 33/102 (32%), Positives = 50/102 (49%), Gaps = 5/102 (4%)
Query: 112 KDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKR 171
K R + +L + +IHD +H D+K +NI L GK V + D G A +R
Sbjct: 267 KQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFL--NCDGKIV--LGDFGTAMPFEK-ER 321
Query: 172 QKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLS 213
+ FD GT +PE + +DIW+ G ++L+MLS
Sbjct: 322 EAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLS 363
|
Length = 501 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 1e-04
Identities = 38/158 (24%), Positives = 65/158 (41%), Gaps = 26/158 (16%)
Query: 107 NGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRS 166
+ L D H I G+ ++ +VH D+ NIL+ + KI+DLG+++
Sbjct: 119 SSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILI----GEQLHVKISDLGLSREI 174
Query: 167 RHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCV------------------- 207
+ P ++ PE ++ + SDIW+ G V
Sbjct: 175 YSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQE 234
Query: 208 VLEMLSGRQAWVVKEDCSIDQLFSIIGDEHSLPEIPSR 245
V+EM+ RQ EDC +++S++ + E PSR
Sbjct: 235 VIEMVRKRQLLPCSEDCP-PRMYSLMTE--CWQEGPSR 269
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 42.6 bits (100), Expect = 2e-04
Identities = 49/213 (23%), Positives = 97/213 (45%), Gaps = 26/213 (12%)
Query: 10 RGRVIGQGSFGCVF--IAKPKSNSSFLPPLMAVKSAEVSASASLQKEKEVFDNLNGC--- 64
+ +++G G FG V I P+ +S +P +A+K+ + + Q +E+ D++
Sbjct: 11 KLKLLGSGVFGTVHKGIWIPEGDSIKIP--VAIKT--IQDRSGRQTFQEITDHMLAMGSL 66
Query: 65 --PFVLECFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRC-- 120
+++ G I G + L+ + + G+L D + + + P+ R C
Sbjct: 67 DHAYIVRLLG--ICPGA----SLQLVTQLSPLGSLLDHVRQHRDSLDPQ---RLLNWCVQ 117
Query: 121 ILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMRG 180
I +G+ ++ + VH ++ NILL + +IAD GVA ++ F +
Sbjct: 118 IAKGMYYLEEHRMVHRNLAARNILL----KSDSIVQIADFGVADLLYPDDKKYFYSEHKT 173
Query: 181 TPLYLAPETVVQHMQEAPSDIWALGCVVLEMLS 213
++A E+++ SD+W+ G V EM+S
Sbjct: 174 PIKWMALESILFGRYTHQSDVWSYGVTVWEMMS 206
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 3e-04
Identities = 65/282 (23%), Positives = 118/282 (41%), Gaps = 34/282 (12%)
Query: 12 RVIGQGSFGCVFIAKPKSNSSFLPPL-MAVKSAEVSASASLQKEKEVFDNLN-----GCP 65
R +GQGSFG V+ + +AVK+ V+ SASL++ E + + C
Sbjct: 12 RELGQGSFGMVYEGNARDIIKGEAETRVAVKT--VNESASLRERIEFLNEASVMKGFTCH 69
Query: 66 FVLECFGEEITMGENGEMAYNLLLEYAAGGTLGDLI-----EKCNGNGLPEKDVRHFTRC 120
V+ G ++ G+ +++E A G L + E N G P ++ +
Sbjct: 70 HVVRLLGV-VSKGQ----PTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQM 124
Query: 121 ---ILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPS 177
I +G+ +++ +VH D+ N ++ + F KI D G+ + +
Sbjct: 125 AAEIADGMAYLNAKKFVHRDLAARNCMV----AHDFTVKIGDFGMTRDIYETDYYRKGGK 180
Query: 178 MRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLS-GRQAWVVKEDCSIDQLFSIIGDE 236
++APE++ + SD+W+ G V+ E+ S Q + + S +Q+ + D
Sbjct: 181 GLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPY---QGLSNEQVLKFVMDG 237
Query: 237 HSLPEIPSRVSKEARDFLRRCFVRKPAFRFT----AEMLLDD 274
L + P + D +R C+ P R T +L DD
Sbjct: 238 GYLDQ-PDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDD 278
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 3e-04
Identities = 45/214 (21%), Positives = 83/214 (38%), Gaps = 48/214 (22%)
Query: 1 MDSDGTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMA-VKSAEVSASASLQKEKEVFD 59
+D G W ++IG G FGCV+ + S+ +A +++ E + ++ E V++
Sbjct: 7 IDITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLE---NETIVMETLVYN 63
Query: 60 NLN-----------------GCPFVLECFGEEITMGENGEMAYN------LLLEYAAGGT 96
N+ G P C G +LLE T
Sbjct: 64 NIYDIDKIALWKNIHNIDHLGIPKYYGC----------GSFKRCRMYYRFILLEKLVENT 113
Query: 97 LGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAK 156
++ ++ +K +++ + +L + +IH+ G H D+KP+NI++ G
Sbjct: 114 -KEIFKRIKCK--NKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMV----DGNNRGY 166
Query: 157 IADLGVAK----RSRHCKRQKFDPSMRGTPLYLA 186
I D G+A +H + K + LY A
Sbjct: 167 IIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYA 200
|
Length = 294 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 41.0 bits (96), Expect = 6e-04
Identities = 28/118 (23%), Positives = 54/118 (45%), Gaps = 7/118 (5%)
Query: 99 DLIEKCNGNG---LPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVA 155
D ++ + L D+ F+ + +G+ + +H DV N+LL + VA
Sbjct: 196 DSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLL----TDGRVA 251
Query: 156 KIADLGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLS 213
KI D G+A+ + + R ++APE++ + SD+W+ G ++ E+ S
Sbjct: 252 KICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 309
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 40.7 bits (95), Expect = 8e-04
Identities = 41/178 (23%), Positives = 69/178 (38%), Gaps = 18/178 (10%)
Query: 109 LPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRH 168
+ D+ R +L I ++H++ +H D+K +NI + G + D G A
Sbjct: 179 IAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFI--NHPGDVC--LGDFGAACFPVD 234
Query: 169 CKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKE----DC 224
K+ GT APE + + DIW+ G V+ EM + + K+ DC
Sbjct: 235 INANKY-YGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDC 293
Query: 225 SIDQLFSIIGDEHSLPEIPSRVSKEARDFLRRCFV-------RKPAFRFTAEMLLDDP 275
D+ +I P+ +A+ L ++ RKP R L + P
Sbjct: 294 DSDRQIKLIIRRSGTH--PNEFPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELP 349
|
Length = 391 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.001
Identities = 39/171 (22%), Positives = 76/171 (44%), Gaps = 22/171 (12%)
Query: 113 DVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRH---- 168
D+ F+ + G+ + VH D+ N+L+ GK V KI D G+A+
Sbjct: 240 DLVGFSYQVANGMEFLASKNCVHRDLAARNVLIC---EGKLV-KICDFGLARDIMRDSNY 295
Query: 169 -CKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLS-GRQAWVVKEDCSI 226
K F P ++APE++ ++ SD+W+ G ++ E+ + G + E
Sbjct: 296 ISKGSTFLPLK-----WMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPY--PELPMN 348
Query: 227 DQLFSIIGDEHSLPEIPSRVSKEARDFLRRC----FVRKPAFRFTAEMLLD 273
+Q ++ I + + + P+ S E + +++C F +P F ++ D
Sbjct: 349 EQFYNAIKRGYRMAK-PAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGD 398
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.001
Identities = 46/220 (20%), Positives = 99/220 (45%), Gaps = 32/220 (14%)
Query: 6 TSWFRGRVIGQGSFGCVF--IAKPKSNSSFLPPLMAVKSAEVSASASLQKEKEVFD---- 59
T + + +V+G G+FG V+ + P+ +P +A+K E+ + S + KE+ D
Sbjct: 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIP--VAIK--ELREATSPKANKEILDEAYV 62
Query: 60 -----NLNGCPFVLECFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDV 114
N + C + C + + M + LL+Y + + + + + +
Sbjct: 63 MASVDNPHVCRLLGICLTSTVQLITQ-LMPFGCLLDYV----------REHKDNIGSQYL 111
Query: 115 RHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKF 174
++ I +G+ ++ + VH D+ N+L+ Q KI D G+AK +++
Sbjct: 112 LNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQH----VKITDFGLAKL-LGADEKEY 166
Query: 175 DPSMRGTPL-YLAPETVVQHMQEAPSDIWALGCVVLEMLS 213
P+ ++A E+++ + SD+W+ G V E+++
Sbjct: 167 HAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 40.1 bits (94), Expect = 0.001
Identities = 53/229 (23%), Positives = 103/229 (44%), Gaps = 39/229 (17%)
Query: 11 GRVIGQGSFGCVFIA---KPKSNSSFLPPLMAVKSAEVSASASLQKEKEV--------FD 59
GR IG+G FG V+ P++ + +AVK+ + S S+ +EK + FD
Sbjct: 11 GRCIGEGQFGDVYQGVYMSPENEK--IA--VAVKTCKNCTSPSV-REKFLQEAYIMRQFD 65
Query: 60 NLNGCPFVLECFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTR 119
+ P +++ G IT E +++E A G L ++ N L + ++
Sbjct: 66 H----PHIVKLIG-VIT-----ENPVWIVMELAPLGELRSYLQV-NKYSLDLASLILYSY 114
Query: 120 CILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMR 179
+ + ++ +VH D+ N+L+ + K+ D G+ SR+ + + + + +
Sbjct: 115 QLSTALAYLESKRFVHRDIAARNVLVSSPDC----VKLGDFGL---SRYLEDESYYKASK 167
Query: 180 GT-PL-YLAPETVVQHMQEAPSDIWALGCVVLEMLS-GRQ--AWVVKED 223
G P+ ++APE++ + SD+W G + E+L G + V D
Sbjct: 168 GKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNND 216
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 40.3 bits (94), Expect = 0.001
Identities = 28/93 (30%), Positives = 42/93 (45%), Gaps = 4/93 (4%)
Query: 118 TRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPS 177
R +L I +IH G +H D+K +N+L+ +G + D G A +R F
Sbjct: 266 ARQLLSAIDYIHGEGIIHRDIKTENVLV----NGPEDICLGDFGAACFARGSWSTPFHYG 321
Query: 178 MRGTPLYLAPETVVQHMQEAPSDIWALGCVVLE 210
+ GT APE + DIW+ G V+ E
Sbjct: 322 IAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 0.002
Identities = 24/94 (25%), Positives = 45/94 (47%), Gaps = 17/94 (18%)
Query: 134 VHCDVKPDNILLVATQSGKFVA------------KIADLGVAKRSRHCKRQKFDPSMRGT 181
+H D+KP+NIL+ + + +I DLG RH + ++ T
Sbjct: 254 MHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLGGCCDERHSR-----TAIVST 308
Query: 182 PLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGR 215
Y +PE V+ +D+W++GC++ E+ +G+
Sbjct: 309 RHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGK 342
|
Length = 467 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 39.0 bits (91), Expect = 0.002
Identities = 53/219 (24%), Positives = 91/219 (41%), Gaps = 39/219 (17%)
Query: 12 RVIGQGSFGCVFIAKPKSNSSFLPP-----LMAVKS----AEVSASASLQKEKEVFDNLN 62
RVIG+G FGCV+ + + + AVKS ++ KE + + +
Sbjct: 1 RVIGKGHFGCVY------HGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFS 54
Query: 63 GCPFVLECFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPE-KDVRHFTRCI 121
P VL G I + G + ++L Y G L + I N P KD+ F +
Sbjct: 55 H-PNVLSLLG--ICLPSEG--SPLVVLPYMKHGDLRNFIRSETHN--PTVKDLIGFGLQV 107
Query: 122 LEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKR-------SRHCKRQKF 174
+G+ ++ +VH D+ N +L F K+AD G+A+ S H
Sbjct: 108 AKGMEYLASKKFVHRDLAARNCML----DESFTVKVADFGLARDIYDKEYYSVHNHTGAK 163
Query: 175 DPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLS 213
P ++A E++ SD+W+ G ++ E+++
Sbjct: 164 LPVK-----WMALESLQTQKFTTKSDVWSFGVLLWELMT 197
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 38.8 bits (90), Expect = 0.002
Identities = 31/129 (24%), Positives = 56/129 (43%), Gaps = 10/129 (7%)
Query: 87 LLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLV 146
++ EY + G L + K G L + + G+ ++ + GYVH + +L+
Sbjct: 83 IVTEYMSNGALDSFLRKHEGQ-LVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLV- 140
Query: 147 ATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMRGTPLYL--APETVVQHMQEAPSDIWAL 204
+ V KI+ + K + +M G L APE + H + SD+W+
Sbjct: 141 ---NSDLVCKISGFRRLQED---KSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSF 194
Query: 205 GCVVLEMLS 213
G V+ E++S
Sbjct: 195 GIVMWEVMS 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 38.9 bits (90), Expect = 0.003
Identities = 55/264 (20%), Positives = 104/264 (39%), Gaps = 20/264 (7%)
Query: 12 RVIGQGSFGCVFIAKPKSNSSFLPPL-MAVKSAEVSASA----SLQKEKEVFDNLNGCPF 66
R +GQGSFG V+ K P +A+K+ +AS E V N C
Sbjct: 12 RELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFN-CHH 70
Query: 67 VLECFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGL----PEKDVRHFTRCIL 122
V+ G ++ G+ + L+ L L + N + K + I
Sbjct: 71 VVRLLGV-VSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIA 129
Query: 123 EGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMRGTP 182
+G+ +++ + +VH D+ N ++ + F KI D G+ + +
Sbjct: 130 DGMAYLNANKFVHRDLAARNCMV----AEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPV 185
Query: 183 LYLAPETVVQHMQEAPSDIWALGCVVLEMLS-GRQAWVVKEDCSIDQLFSIIGDEHSLPE 241
+++PE++ + SD+W+ G V+ E+ + Q + + S +Q+ + E L +
Sbjct: 186 RWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPY---QGMSNEQVLRFVM-EGGLLD 241
Query: 242 IPSRVSKEARDFLRRCFVRKPAFR 265
P + +R C+ P R
Sbjct: 242 KPDNCPDMLFELMRMCWQYNPKMR 265
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 39.1 bits (91), Expect = 0.003
Identities = 43/156 (27%), Positives = 80/156 (51%), Gaps = 20/156 (12%)
Query: 14 IGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEV---SASASLQKEKEVFDNLNGCPFVLEC 70
I +G+FG V++ + K N+S L + VK A++ + +Q E++ L+ PF++
Sbjct: 12 ISRGAFGKVYLGR-KKNNSKLYAVKVVKKADMINKNMVHQVQAERDAL-ALSKSPFIVHL 69
Query: 71 FGEEITMGENGEMAYN--LLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHI 128
+ + + A N L++EY GG + L+ G E V++ + L + ++
Sbjct: 70 Y-------YSLQSANNVYLVMEYLIGGDVKSLLH-IYGYFDEEMAVKYISEVAL-ALDYL 120
Query: 129 HDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAK 164
H G +H D+KPDN+L+ S + K+ D G++K
Sbjct: 121 HRHGIIHRDLKPDNMLI----SNEGHIKLTDFGLSK 152
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 38.7 bits (90), Expect = 0.003
Identities = 36/168 (21%), Positives = 74/168 (44%), Gaps = 12/168 (7%)
Query: 109 LPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRH 168
L +D+ F+ + +G+ + +H D+ NILL + + KI D G+A+ R+
Sbjct: 211 LDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGR----ITKICDFGLARDIRN 266
Query: 169 CKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLS-GRQAWVVKEDCSID 227
+ R ++APE++ + SD+W+ G ++ E+ S G + +D
Sbjct: 267 DSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPY---PGMPVD 323
Query: 228 QLFSIIGDEHSLPEIPSRVSKEARDFLRRCF----VRKPAFRFTAEML 271
F + E P E D ++ C+ +++P F+ +++
Sbjct: 324 SKFYKMIKEGYRMLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLI 371
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 362 | |||
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 100.0 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 100.0 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 100.0 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 100.0 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.98 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.97 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.97 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.97 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.97 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.97 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.97 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.97 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.96 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.95 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.94 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.94 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.92 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.92 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.91 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.9 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.9 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.89 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.88 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.88 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.88 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.87 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.87 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.86 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.86 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.82 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.8 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.77 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.77 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.76 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.75 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.73 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.69 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.67 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.62 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.62 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.53 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.48 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.4 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.39 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.37 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.37 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.33 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.31 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.27 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 99.2 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.11 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.11 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.05 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 99.0 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.99 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.97 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.91 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.89 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.81 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 98.57 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.47 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.39 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.33 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.27 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.2 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.19 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.14 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.12 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.12 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.99 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.99 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.95 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 97.95 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.86 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 97.77 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.68 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.59 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.41 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.32 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.3 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.23 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.2 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 97.17 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 96.72 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 96.71 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 96.71 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 96.57 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 96.55 | |
| PLN02236 | 344 | choline kinase | 96.2 | |
| PTZ00384 | 383 | choline kinase; Provisional | 95.79 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 95.73 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 95.73 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 95.59 | |
| KOG1236 | 565 | consensus Predicted unusual protein kinase [Genera | 95.57 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 95.47 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 95.36 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 94.46 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 93.76 | |
| PF05445 | 434 | Pox_ser-thr_kin: Poxvirus serine/threonine protein | 93.65 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 93.21 | |
| PHA03111 | 444 | Ser/Thr kinase; Provisional | 92.91 | |
| smart00587 | 196 | CHK ZnF_C4 abd HLH domain containing kinases domai | 92.19 | |
| COG0510 | 269 | ycfN Thiamine kinase and related kinases [Coenzyme | 92.04 | |
| COG3231 | 266 | Aph Aminoglycoside phosphotransferase [Translation | 91.96 |
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-58 Score=427.51 Aligned_cols=259 Identities=27% Similarity=0.490 Sum_probs=226.9
Q ss_pred CCCCCceeecceecccCceEEEEEEECCCCCCCCceeeeech--hhhhhHHHHHHHHHHHHcCCCCcccccccceeeecC
Q 039291 2 DSDGTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSA--EVSASASLQKEKEVFDNLNGCPFVLECFGEEITMGE 79 (362)
Q Consensus 2 ~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~--~~~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~ 79 (362)
|....+|..+++||+|||+.+|.+++..+|+.+|.||+-|.. +......+.+|++|.+.|+ |||||++++.+.
T Consensus 14 D~~~~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~-HpnIV~f~~~FE---- 88 (592)
T KOG0575|consen 14 DPRSKRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLK-HPNIVQFYHFFE---- 88 (592)
T ss_pred cCCcceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcC-CCcEEeeeeEee----
Confidence 445588999999999999999999999999876666555543 3346678999999999999 999999999763
Q ss_pred CCceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEee
Q 039291 80 NGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIAD 159 (362)
Q Consensus 80 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~D 159 (362)
+..+.|+|+|+|..++|..+++. +++++|.+++.+++||+.||.|||+++|+|||||..|+|+ +++.+|||+|
T Consensus 89 -Ds~nVYivLELC~~~sL~el~Kr--rk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL----~~~~~VKIgD 161 (592)
T KOG0575|consen 89 -DSNNVYIVLELCHRGSLMELLKR--RKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFL----NENMNVKIGD 161 (592)
T ss_pred -cCCceEEEEEecCCccHHHHHHh--cCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheee----cCcCcEEecc
Confidence 34568899999999999999985 5679999999999999999999999999999999999999 8999999999
Q ss_pred cCCcccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHHcCCCCC
Q 039291 160 LGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEHSL 239 (362)
Q Consensus 160 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 239 (362)
||||.......... .+.||||.|.|||++....++..+||||+|||||.|++|++||+. ....+.+..|.....
T Consensus 162 FGLAt~le~~~Erk--~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFet---k~vkety~~Ik~~~Y- 235 (592)
T KOG0575|consen 162 FGLATQLEYDGERK--KTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFET---KTVKETYNKIKLNEY- 235 (592)
T ss_pred cceeeeecCccccc--ceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCccc---chHHHHHHHHHhcCc-
Confidence 99999887654444 479999999999999999999999999999999999999999954 467777777754443
Q ss_pred CCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCccC
Q 039291 240 PEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKG 279 (362)
Q Consensus 240 ~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~~~ 279 (362)
.+|..++.++++||.+||+.||.+|||++++|.|+||+.
T Consensus 236 -~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h~Ff~~ 274 (592)
T KOG0575|consen 236 -SMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDHPFFKS 274 (592)
T ss_pred -ccccccCHHHHHHHHHHhcCCcccCCCHHHHhcCHhhhC
Confidence 356689999999999999999999999999999999943
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-59 Score=414.59 Aligned_cols=261 Identities=28% Similarity=0.407 Sum_probs=215.9
Q ss_pred CCCceeecceecccCceEEEEEEECCCCCCCCceeeeechhhh----------hhHHHHHHHHHHHHcCCCCcccccccc
Q 039291 4 DGTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVS----------ASASLQKEKEVFDNLNGCPFVLECFGE 73 (362)
Q Consensus 4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~~----------~~~~~~~E~~il~~l~~h~~i~~~~~~ 73 (362)
..+.|.+.+.||+|+||.|-+|..+.+++ +||+|++... .....++|++||++|+ |||||++++.
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk----~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~-HP~IV~~~d~ 244 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGK----QVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLS-HPNIVRIKDF 244 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCc----EEEeeeeehhhcccccccccchhhhHHHHHHHHhcC-CCCEEEEeee
Confidence 45779999999999999999999999986 5666665332 2233679999999999 9999999997
Q ss_pred eeeecCCCceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCce
Q 039291 74 EITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKF 153 (362)
Q Consensus 74 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~ 153 (362)
+.. ...+|+||||++||+|.+.+-. .+.+.+...+.+++||+.|+.|||++||+||||||+|||+..+ .+..
T Consensus 245 f~~-----~ds~YmVlE~v~GGeLfd~vv~--nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~-~e~~ 316 (475)
T KOG0615|consen 245 FEV-----PDSSYMVLEYVEGGELFDKVVA--NKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSND-AEDC 316 (475)
T ss_pred eec-----CCceEEEEEEecCccHHHHHHh--ccccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccC-Ccce
Confidence 643 3346899999999999999987 4559999999999999999999999999999999999999543 3668
Q ss_pred EEEEeecCCcccccccccCCCCCCccCCCCccCchhhccccC---CCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHH
Q 039291 154 VAKIADLGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQ---EAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLF 230 (362)
Q Consensus 154 ~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~---~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~ 230 (362)
.+||+|||+|+..+ ...+..++|||+.|.|||++.+... ..++|+||+||+||-+++|.+||....... .+.
T Consensus 317 llKItDFGlAK~~g---~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~--sl~ 391 (475)
T KOG0615|consen 317 LLKITDFGLAKVSG---EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDP--SLK 391 (475)
T ss_pred EEEecccchhhccc---cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCc--cHH
Confidence 99999999999776 3345578999999999999997543 457899999999999999999997554332 133
Q ss_pred HHHcCC--CCCCCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCccCcch
Q 039291 231 SIIGDE--HSLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGVDE 282 (362)
Q Consensus 231 ~~~~~~--~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~~~~~~ 282 (362)
..|..+ ..-|..+..++.++++||.+||..||++|||++++|.||||+....
T Consensus 392 eQI~~G~y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~~~~ 445 (475)
T KOG0615|consen 392 EQILKGRYAFGPLQWDRISEEALDLINWMLVVDPENRPSADEALNHPWFKDAPC 445 (475)
T ss_pred HHHhcCcccccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhhcccc
Confidence 333322 2334567789999999999999999999999999999999987653
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-57 Score=396.95 Aligned_cols=265 Identities=28% Similarity=0.473 Sum_probs=227.8
Q ss_pred CCCCceeecceecccCceEEEEEEECCCCCCCCceeeeechh--hhhhHHHHHHHHHHHHcCCCCcccccccceeeecCC
Q 039291 3 SDGTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAE--VSASASLQKEKEVFDNLNGCPFVLECFGEEITMGEN 80 (362)
Q Consensus 3 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~--~~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~ 80 (362)
..-+.|.+.++||+|+||+|+.++.+++++.++.+|.-|..- ....+....|..||.+++ ||+||+++-.+ +
T Consensus 22 ~~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~-hPFiv~l~ysF-----Q 95 (357)
T KOG0598|consen 22 VGPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIK-HPFIVKLIYSF-----Q 95 (357)
T ss_pred CChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCC-CCcEeeeEEec-----c
Confidence 345789999999999999999999999987666555555432 234677889999999988 99999997654 3
Q ss_pred CceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEeec
Q 039291 81 GEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADL 160 (362)
Q Consensus 81 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Df 160 (362)
+...+|||+||+.||.|...|++ .+.|+|..++.++.+|+.||.|||++|||||||||+|||+ +.+|+++|+||
T Consensus 96 t~~kLylVld~~~GGeLf~hL~~--eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILL----d~~GHi~LtDF 169 (357)
T KOG0598|consen 96 TEEKLYLVLDYLNGGELFYHLQR--EGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILL----DEQGHIKLTDF 169 (357)
T ss_pred cCCeEEEEEeccCCccHHHHHHh--cCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeee----cCCCcEEEecc
Confidence 45568899999999999999987 4569999999999999999999999999999999999999 99999999999
Q ss_pred CCcccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHHcCCCCCC
Q 039291 161 GVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEHSLP 240 (362)
Q Consensus 161 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 240 (362)
||++..... .....++|||+.|||||++.+..|+..+|+||||+++|||++|.+||.+. +..++..++.... .+
T Consensus 170 gL~k~~~~~--~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~---~~~~~~~~I~~~k-~~ 243 (357)
T KOG0598|consen 170 GLCKEDLKD--GDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAE---DVKKMYDKILKGK-LP 243 (357)
T ss_pred ccchhcccC--CCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCc---cHHHHHHHHhcCc-CC
Confidence 999865542 23335689999999999999999999999999999999999999999655 5667777776555 34
Q ss_pred CCCccCCHHHHHHHHHHhccCCCCCC----CHHHHhcCCCccCcchhhh
Q 039291 241 EIPSRVSKEARDFLRRCFVRKPAFRF----TAEMLLDDPFVKGVDEELS 285 (362)
Q Consensus 241 ~~~~~~~~~~~~li~~~l~~~p~~R~----s~~~~l~~p~~~~~~~~~~ 285 (362)
..|..++.+++++|+++|..||++|. ++.++..||||+.+.|+..
T Consensus 244 ~~p~~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik~HpfF~~inW~~l 292 (357)
T KOG0598|consen 244 LPPGYLSEEARDLLKKLLKRDPRQRLGGPGDAEEIKRHPFFKGINWEKL 292 (357)
T ss_pred CCCccCCHHHHHHHHHHhccCHHHhcCCCCChHHhhcCcccccCCHHHH
Confidence 45666999999999999999999996 6899999999999999854
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-57 Score=411.32 Aligned_cols=274 Identities=29% Similarity=0.474 Sum_probs=230.4
Q ss_pred CCceeecceecccCceEEEEEEECCCCCCCCceeeeech--hhhhhHHHHHHHHHHHHcCCCCcccccccceeeecCCCc
Q 039291 5 GTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSA--EVSASASLQKEKEVFDNLNGCPFVLECFGEEITMGENGE 82 (362)
Q Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~--~~~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~~~ 82 (362)
-..|..++.||+|+|++|++|+++.++..++.+|.-|.. +....+.+.+|..+|.+|.+||.|+++|-.+ +++
T Consensus 72 ~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TF-----QD~ 146 (604)
T KOG0592|consen 72 PNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTF-----QDE 146 (604)
T ss_pred hhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEe-----ecc
Confidence 357999999999999999999999998766555555543 3345567889999999998899999998654 345
Q ss_pred eEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEeecCC
Q 039291 83 MAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGV 162 (362)
Q Consensus 83 ~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Dfgl 162 (362)
..+|+|+||+++|+|.++|++. +.|++..+++++.||+.||+|||++|||||||||+|||+ +++++++|+|||.
T Consensus 147 ~sLYFvLe~A~nGdll~~i~K~--Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILL----d~dmhikITDFGs 220 (604)
T KOG0592|consen 147 ESLYFVLEYAPNGDLLDLIKKY--GSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILL----DKDGHIKITDFGS 220 (604)
T ss_pred cceEEEEEecCCCcHHHHHHHh--CcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeE----cCCCcEEEeeccc
Confidence 5688999999999999999985 459999999999999999999999999999999999999 9999999999999
Q ss_pred cccccccccC---------CC--CCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHH
Q 039291 163 AKRSRHCKRQ---------KF--DPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFS 231 (362)
Q Consensus 163 a~~~~~~~~~---------~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~ 231 (362)
|+........ .. ..+++||..|.+||++.....+..+|+|+||||||+|+.|.+||.+.+ ...+++
T Consensus 221 AK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~N---eyliFq 297 (604)
T KOG0592|consen 221 AKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAAN---EYLIFQ 297 (604)
T ss_pred cccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCcccc---HHHHHH
Confidence 9865543222 11 146999999999999999999999999999999999999999996554 344454
Q ss_pred HHcCCCCCCCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCccCcchhhhhhhhCCCCC
Q 039291 232 IIGDEHSLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGVDEELSRELEGDYSQ 294 (362)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~~~~~~~~~~~~~~~~~~ 294 (362)
+|..-.. .+|+..++.+++||+++|..||.+|+|+++|..||||.++.|+......++..+
T Consensus 298 kI~~l~y--~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~Vdw~nlw~~~PP~l~ 358 (604)
T KOG0592|consen 298 KIQALDY--EFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEGVDWENLWQQTPPKLQ 358 (604)
T ss_pred HHHHhcc--cCCCCCCHHHHHHHHHHHccCccccccHHHHhhCcccccCChhhhhhcCCCccc
Confidence 4433221 467789999999999999999999999999999999999999875555544433
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-58 Score=399.91 Aligned_cols=260 Identities=28% Similarity=0.519 Sum_probs=224.9
Q ss_pred ceeecceecccCceEEEEEEECCCCCCCCceeeeechhhhhhHHHHHHHHHHHHcCCCCcccccccceeeecCCCceEEE
Q 039291 7 SWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVSASASLQKEKEVFDNLNGCPFVLECFGEEITMGENGEMAYN 86 (362)
Q Consensus 7 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~~~~~~~ 86 (362)
....++.||+|..|+||+++++.++..+|.|+..-.......+.+.+|++++++.+ ||+||.+|+.+...+. .++
T Consensus 80 dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~-spyIV~~ygaF~~~~~----~is 154 (364)
T KOG0581|consen 80 DLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQ-SPYIVGFYGAFYSNGE----EIS 154 (364)
T ss_pred HhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCC-CCCeeeEeEEEEeCCc----eEE
Confidence 55667899999999999999999986443333322235667788999999999997 9999999998875432 477
Q ss_pred EEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCceeCCCCCCCEEEeecCCCceEEEEeecCCccc
Q 039291 87 LLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHD-SGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKR 165 (362)
Q Consensus 87 lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~-~~ivH~Dlkp~Nill~~~~~~~~~~kl~Dfgla~~ 165 (362)
++||||+||+|.+++... ++++|.....++.++++||.|||+ ++||||||||+|||+ +.++.|||||||.++.
T Consensus 155 I~mEYMDgGSLd~~~k~~--g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLv----NskGeVKicDFGVS~~ 228 (364)
T KOG0581|consen 155 ICMEYMDGGSLDDILKRV--GRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLV----NSKGEVKICDFGVSGI 228 (364)
T ss_pred eehhhcCCCCHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeee----ccCCCEEeccccccHH
Confidence 999999999999999874 569999999999999999999995 999999999999999 8899999999999986
Q ss_pred ccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHhCCCCCccC--CCCCHHHHHHHHcCCCCCCCCC
Q 039291 166 SRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVK--EDCSIDQLFSIIGDEHSLPEIP 243 (362)
Q Consensus 166 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~--~~~~~~~~~~~~~~~~~~~~~~ 243 (362)
.... ...+++||..|||||.+.+..|+.++||||||++++||.+|+.||... ...++.+++..|..+.. |..|
T Consensus 229 lvnS----~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~pp-P~lP 303 (364)
T KOG0581|consen 229 LVNS----IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPP-PRLP 303 (364)
T ss_pred hhhh----hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCC-CCCC
Confidence 6543 556899999999999999999999999999999999999999999763 34567788887766543 5677
Q ss_pred cc-CCHHHHHHHHHHhccCCCCCCCHHHHhcCCCccCcch
Q 039291 244 SR-VSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGVDE 282 (362)
Q Consensus 244 ~~-~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~~~~~~ 282 (362)
.. +|+++++|+..||++||.+|+++.+++.|||+++...
T Consensus 304 ~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~~~~ 343 (364)
T KOG0581|consen 304 EGEFSPEFRSFVSCCLRKDPSERPSAKQLLQHPFIKKFED 343 (364)
T ss_pred cccCCHHHHHHHHHHhcCCcccCCCHHHHhcCHHHhhccc
Confidence 76 9999999999999999999999999999999987543
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-55 Score=389.80 Aligned_cols=263 Identities=27% Similarity=0.488 Sum_probs=220.7
Q ss_pred CCceeecceecccCceEEEEEEECCCCCCCCceeeee-chhhhhhHHHHHHHHHHHHcCCCCcccccccceeeecCCCce
Q 039291 5 GTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVK-SAEVSASASLQKEKEVFDNLNGCPFVLECFGEEITMGENGEM 83 (362)
Q Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K-~~~~~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~~~~ 83 (362)
-++|.+.+.||+|+||+||+|+++.++..+++|...| .+..+..+.+..|+.+|+.|+ |||||.+++++.. ..
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~-H~nIV~l~d~~~~-----~~ 82 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELK-HPNIVRLLDCIED-----DD 82 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcC-CcceeeEEEEEec-----CC
Confidence 4689999999999999999999999886443322222 224446677889999999999 9999999997643 34
Q ss_pred EEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCc--eEEEEeecC
Q 039291 84 AYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGK--FVAKIADLG 161 (362)
Q Consensus 84 ~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~--~~~kl~Dfg 161 (362)
++|||||||.||+|.+||+.. +.++|.+++.++.||+.||++||+++||||||||+|||+..+.... ..+||+|||
T Consensus 83 ~i~lVMEyC~gGDLs~yi~~~--~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFG 160 (429)
T KOG0595|consen 83 FIYLVMEYCNGGDLSDYIRRR--GRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFG 160 (429)
T ss_pred eEEEEEEeCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccc
Confidence 688999999999999999984 4599999999999999999999999999999999999997653333 789999999
Q ss_pred CcccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHHcC-CCCCC
Q 039291 162 VAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGD-EHSLP 240 (362)
Q Consensus 162 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~-~~~~~ 240 (362)
+|+.... .....+.+|++.|||||++....|+.|+|+||+|+|||+|++|++||... ...+++..+.. ....|
T Consensus 161 fAR~L~~---~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~---t~~eL~~~~~k~~~~~~ 234 (429)
T KOG0595|consen 161 FARFLQP---GSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAE---TPKELLLYIKKGNEIVP 234 (429)
T ss_pred hhhhCCc---hhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCcccc---CHHHHHHHHhccccccC
Confidence 9987764 33445789999999999999999999999999999999999999999544 55666555544 44456
Q ss_pred CCCccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCccCcc
Q 039291 241 EIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGVD 281 (362)
Q Consensus 241 ~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~~~~~ 281 (362)
.++..+++...+|+...|..+|..|.+..+-+.|+++..-.
T Consensus 235 ~~~~~~s~~~~~Ll~~ll~~~~~~~~~~~~~~~~~~l~~~p 275 (429)
T KOG0595|consen 235 VLPAELSNPLRELLISLLQRNPKDRISFEDFFDHPFLAANP 275 (429)
T ss_pred chhhhccCchhhhhhHHHhcCccccCchHHhhhhhhcccCc
Confidence 66777888999999999999999999999999999886643
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-55 Score=398.19 Aligned_cols=275 Identities=28% Similarity=0.480 Sum_probs=225.9
Q ss_pred CCCceeecceecccCceEEEEEEECCCCCCCCceeeeech--hhhhhHHHHHHHHHHHHcCCCCcccccccceeeecCCC
Q 039291 4 DGTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSA--EVSASASLQKEKEVFDNLNGCPFVLECFGEEITMGENG 81 (362)
Q Consensus 4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~--~~~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~~ 81 (362)
.-+.|.+++.||+|+||.||+|+.+.+|+++|.++..|.. .....+.+..|..+|.... .|+||++|-.+ ++
T Consensus 139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~d-s~~vVKLyYsF-----QD 212 (550)
T KOG0605|consen 139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVD-SPWVVKLYYSF-----QD 212 (550)
T ss_pred CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcC-CCcEEEEEEEe-----cC
Confidence 4578999999999999999999999999855433333331 2335567889999999976 89999998655 44
Q ss_pred ceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEeecC
Q 039291 82 EMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLG 161 (362)
Q Consensus 82 ~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Dfg 161 (362)
..++||||||++||++..+|.. ...|++..+++++.+++.|++.||+.|+|||||||+|+|| |..|++||+|||
T Consensus 213 ~~~LYLiMEylPGGD~mTLL~~--~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLi----D~~GHiKLSDFG 286 (550)
T KOG0605|consen 213 KEYLYLIMEYLPGGDMMTLLMR--KDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLI----DAKGHIKLSDFG 286 (550)
T ss_pred CCeeEEEEEecCCccHHHHHHh--cCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheee----cCCCCEeecccc
Confidence 5678999999999999999987 4569999999999999999999999999999999999999 999999999999
Q ss_pred Cccccccc-------------------ccC--------------------------CCCCCccCCCCccCchhhccccCC
Q 039291 162 VAKRSRHC-------------------KRQ--------------------------KFDPSMRGTPLYLAPETVVQHMQE 196 (362)
Q Consensus 162 la~~~~~~-------------------~~~--------------------------~~~~~~~gt~~y~aPE~~~~~~~~ 196 (362)
|++..... ... ....+.+|||.|||||++.+..|+
T Consensus 287 Ls~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~ 366 (550)
T KOG0605|consen 287 LSTGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYG 366 (550)
T ss_pred ccchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCC
Confidence 99532110 000 011256799999999999999999
Q ss_pred CcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHHcCCCCCCCCC--ccCCHHHHHHHHHHhccCCCCCC---CHHHH
Q 039291 197 APSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEHSLPEIP--SRVSKEARDFLRRCFVRKPAFRF---TAEML 271 (362)
Q Consensus 197 ~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~l~~~p~~R~---s~~~~ 271 (362)
..+|+||||||+||||.|.+||... ++.+.+++|......-.+| ..++.++++||.+||. ||++|. .++||
T Consensus 367 ~~cDwWSLG~ImyEmLvGyPPF~s~---tp~~T~rkI~nwr~~l~fP~~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EI 442 (550)
T KOG0605|consen 367 KECDWWSLGCIMYEMLVGYPPFCSE---TPQETYRKIVNWRETLKFPEEVDLSDEAKDLITRLLC-DPENRLGSKGAEEI 442 (550)
T ss_pred ccccHHHHHHHHHHHHhCCCCCCCC---CHHHHHHHHHHHhhhccCCCcCcccHHHHHHHHHHhc-CHHHhcCcccHHHH
Confidence 9999999999999999999999544 5677777765443222222 4578999999999999 999998 59999
Q ss_pred hcCCCccCcchhhhhhhhCCCCC
Q 039291 272 LDDPFVKGVDEELSRELEGDYSQ 294 (362)
Q Consensus 272 l~~p~~~~~~~~~~~~~~~~~~~ 294 (362)
.+||||+.+.|+..++...++..
T Consensus 443 K~HPfF~~v~W~~l~~~~apfvP 465 (550)
T KOG0605|consen 443 KKHPFFKGVDWDHLREMPAPFVP 465 (550)
T ss_pred hcCCccccCCcchhhcCCCCCCC
Confidence 99999999999987777766654
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-55 Score=389.17 Aligned_cols=263 Identities=44% Similarity=0.793 Sum_probs=220.3
Q ss_pred CCceeecceecccCceEEEEEEECCCCCCCCceeeeechhhhh---hHHHHHHHHHHHHcCCCCcccccccceeeecCCC
Q 039291 5 GTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVSA---SASLQKEKEVFDNLNGCPFVLECFGEEITMGENG 81 (362)
Q Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~~~---~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~~ 81 (362)
..+|..++.||+|+||+||++.+.+++. ..|+|...... .+.+.+|+.+|++|+ |||||++++...... .
T Consensus 16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~----~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~-~p~IV~~~G~~~~~~--~ 88 (313)
T KOG0198|consen 16 ISNWSKGKLLGRGSFGSVYLATNKKTGE----LMAVKSVELEDSPTSESLEREIRILSRLN-HPNIVQYYGSSSSRE--N 88 (313)
T ss_pred cchhhhhccccCccceEEEEEEecCCCc----ceeeeeeecccchhHHHHHHHHHHHHhCC-CCCEEeeCCcccccc--C
Confidence 3568999999999999999999998765 45666655443 566899999999999 999999999533211 1
Q ss_pred ceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCC-ceEEEEeec
Q 039291 82 EMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSG-KFVAKIADL 160 (362)
Q Consensus 82 ~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~-~~~~kl~Df 160 (362)
..++++|||++||+|.+++....+ ++++..++.+++|+++||.|||++|||||||||+|||+ +. ++.+||+||
T Consensus 89 -~~~~i~mEy~~~GsL~~~~~~~g~-~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl----~~~~~~~KlaDF 162 (313)
T KOG0198|consen 89 -DEYNIFMEYAPGGSLSDLIKRYGG-KLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILL----DPSNGDVKLADF 162 (313)
T ss_pred -eeeEeeeeccCCCcHHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEE----eCCCCeEEeccC
Confidence 468899999999999999998665 79999999999999999999999999999999999999 66 688999999
Q ss_pred CCcccccc-cccCCCCCCccCCCCccCchhhcc-ccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHHcCCCC
Q 039291 161 GVAKRSRH-CKRQKFDPSMRGTPLYLAPETVVQ-HMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEHS 238 (362)
Q Consensus 161 gla~~~~~-~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 238 (362)
|+++.... ...........||+.|||||++.. .....++|||||||++.||+||++||... .......-.+.....
T Consensus 163 G~a~~~~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~--~~~~~~~~~ig~~~~ 240 (313)
T KOG0198|consen 163 GLAKKLESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF--FEEAEALLLIGREDS 240 (313)
T ss_pred ccccccccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh--cchHHHHHHHhccCC
Confidence 99986653 112222346889999999999995 33445999999999999999999999654 334454555555667
Q ss_pred CCCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCccCcch
Q 039291 239 LPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGVDE 282 (362)
Q Consensus 239 ~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~~~~~~ 282 (362)
.|.+|..++.++++||.+||..+|++||||.++|.|||.+....
T Consensus 241 ~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~~~ 284 (313)
T KOG0198|consen 241 LPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQNSI 284 (313)
T ss_pred CCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhcccc
Confidence 78999999999999999999999999999999999999976544
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-54 Score=368.94 Aligned_cols=258 Identities=28% Similarity=0.460 Sum_probs=223.5
Q ss_pred CCceeecceecccCceEEEEEEECCCCCCCCceeeeec--hhhhhhHHHHHHHHHHHHcCCCCcccccccceeeecCCCc
Q 039291 5 GTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKS--AEVSASASLQKEKEVFDNLNGCPFVLECFGEEITMGENGE 82 (362)
Q Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~--~~~~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~~~ 82 (362)
-++|.+.+.||.|+||+|.+++.+.++.+++.++.-|. ++....+....|..+|+.+. ||+++++++.+. +.
T Consensus 43 l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~-~PFlv~l~~t~~-----d~ 116 (355)
T KOG0616|consen 43 LQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVS-HPFLVKLYGTFK-----DN 116 (355)
T ss_pred hhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhcc-CceeEEEEEeec-----cC
Confidence 35789999999999999999999999876654444332 23345567789999999999 999999987653 34
Q ss_pred eEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEeecCC
Q 039291 83 MAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGV 162 (362)
Q Consensus 83 ~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Dfgl 162 (362)
..+|+||||++||.|+.++++. ++|++..++.++.||+.||+|||+++|++|||||+|||+ |.+|.+||+|||+
T Consensus 117 ~~lymvmeyv~GGElFS~Lrk~--~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLl----D~~G~iKitDFGF 190 (355)
T KOG0616|consen 117 SNLYMVMEYVPGGELFSYLRKS--GRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLL----DQNGHIKITDFGF 190 (355)
T ss_pred CeEEEEEeccCCccHHHHHHhc--CCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeee----ccCCcEEEEeccc
Confidence 4688999999999999999984 459999999999999999999999999999999999999 9999999999999
Q ss_pred cccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHHcCCCCCCCC
Q 039291 163 AKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEHSLPEI 242 (362)
Q Consensus 163 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 242 (362)
|+..... ..+.||||.|+|||++..++|+.++|+|||||++|||+.|.+||... +..+++.+|..... .+
T Consensus 191 AK~v~~r-----T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~---~~~~iY~KI~~~~v--~f 260 (355)
T KOG0616|consen 191 AKRVSGR-----TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDD---NPIQIYEKILEGKV--KF 260 (355)
T ss_pred eEEecCc-----EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCC---ChHHHHHHHHhCcc--cC
Confidence 9866531 35789999999999999999999999999999999999999999654 45777777766554 46
Q ss_pred CccCCHHHHHHHHHHhccCCCCCC-----CHHHHhcCCCccCcchhh
Q 039291 243 PSRVSKEARDFLRRCFVRKPAFRF-----TAEMLLDDPFVKGVDEEL 284 (362)
Q Consensus 243 ~~~~~~~~~~li~~~l~~~p~~R~-----s~~~~l~~p~~~~~~~~~ 284 (362)
|..++.++++||+++|++|-.+|. ...++..||||+.+.|+.
T Consensus 261 P~~fs~~~kdLl~~LL~vD~t~R~gnlknG~~dIk~H~wF~~v~W~~ 307 (355)
T KOG0616|consen 261 PSYFSSDAKDLLKKLLQVDLTKRFGNLKNGVEDIKNHPWFKGVDWEA 307 (355)
T ss_pred CcccCHHHHHHHHHHHhhhhHhhhcCcCCCccccccCcccccccHHH
Confidence 778999999999999999999995 568999999999999884
|
|
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-54 Score=380.77 Aligned_cols=279 Identities=25% Similarity=0.401 Sum_probs=237.2
Q ss_pred CCceeecceecccCceEEEEEEECCCCCCCCceeeeech--hhhhhHHHHHHHHHHHHcCCCCcccccccceeeecCCCc
Q 039291 5 GTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSA--EVSASASLQKEKEVFDNLNGCPFVLECFGEEITMGENGE 82 (362)
Q Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~--~~~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~~~ 82 (362)
-++|.+++.||.|.-|+||+|+.++++..++.||.-|.. ..+...+++.|.+||..++ ||.++.+|..+ +.+
T Consensus 76 l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lD-HPFlPTLYa~f-----et~ 149 (459)
T KOG0610|consen 76 LRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLD-HPFLPTLYASF-----ETD 149 (459)
T ss_pred HHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcC-CCccchhhhee-----ecc
Confidence 357888999999999999999999998655555554432 2335567888999999999 99999999876 456
Q ss_pred eEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEeecCC
Q 039291 83 MAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGV 162 (362)
Q Consensus 83 ~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Dfgl 162 (362)
.++|++||||+||+|..+++++.++.|++..+++++.+++.||+|||-.|||+|||||+|||| .++|++.|+||.|
T Consensus 150 ~~~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILv----redGHIMLsDFDL 225 (459)
T KOG0610|consen 150 KYSCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILV----REDGHIMLSDFDL 225 (459)
T ss_pred ceeEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEE----ecCCcEEeeeccc
Confidence 679999999999999999999999999999999999999999999999999999999999999 8899999999999
Q ss_pred cccccc---------------------------------cccC---------------------CCCCCccCCCCccCch
Q 039291 163 AKRSRH---------------------------------CKRQ---------------------KFDPSMRGTPLYLAPE 188 (362)
Q Consensus 163 a~~~~~---------------------------------~~~~---------------------~~~~~~~gt~~y~aPE 188 (362)
+....- .... ....+++||..|+|||
T Consensus 226 S~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPE 305 (459)
T KOG0610|consen 226 SLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPE 305 (459)
T ss_pred cccCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccce
Confidence 853110 0000 1123678999999999
Q ss_pred hhccccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHHcCCCCCCCCCccCCHHHHHHHHHHhccCCCCCCC-
Q 039291 189 TVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEHSLPEIPSRVSKEARDFLRRCFVRKPAFRFT- 267 (362)
Q Consensus 189 ~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s- 267 (362)
++.+..++.++|+|+|||+||||+.|..||.+.+ ..+.+.+.+.+...+|..+ .++..+++||+++|.+||.+|..
T Consensus 306 vI~G~GHgsAVDWWtfGIflYEmLyG~TPFKG~~--~~~Tl~NIv~~~l~Fp~~~-~vs~~akDLIr~LLvKdP~kRlg~ 382 (459)
T KOG0610|consen 306 VIRGEGHGSAVDWWTFGIFLYEMLYGTTPFKGSN--NKETLRNIVGQPLKFPEEP-EVSSAAKDLIRKLLVKDPSKRLGS 382 (459)
T ss_pred eeecCCCCchhhHHHHHHHHHHHHhCCCCcCCCC--chhhHHHHhcCCCcCCCCC-cchhHHHHHHHHHhccChhhhhcc
Confidence 9999999999999999999999999999997664 3456667777777777765 68899999999999999999997
Q ss_pred ---HHHHhcCCCccCcchhhhhhhhCCCCCCc
Q 039291 268 ---AEMLLDDPFVKGVDEELSRELEGDYSQGE 296 (362)
Q Consensus 268 ---~~~~l~~p~~~~~~~~~~~~~~~~~~~~~ 296 (362)
|+|+..||||+++.|.+.+...++.....
T Consensus 383 ~rGA~eIK~HpFF~gVnWaLir~~~PP~iP~~ 414 (459)
T KOG0610|consen 383 KRGAAEIKRHPFFEGVNWALIRCARPPEIPKP 414 (459)
T ss_pred ccchHHhhcCccccCCChhheeccCCCcCCCc
Confidence 99999999999999998877777665443
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-54 Score=387.69 Aligned_cols=261 Identities=27% Similarity=0.435 Sum_probs=215.3
Q ss_pred CCceeecceecccCceEEEEEEECCCCCCCCceeeeechhhh----hhHHHHHHHHHHHHcCCCCcccccccceeeecCC
Q 039291 5 GTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVS----ASASLQKEKEVFDNLNGCPFVLECFGEEITMGEN 80 (362)
Q Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~~----~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~ 80 (362)
-+||.+++.||.|.||+||+|+.+.+++. ||+|.++.. ..-.-.||++.|++|+.||||++++.++.+
T Consensus 9 m~RY~~i~klGDGTfGsV~la~~~~~~~~----VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d---- 80 (538)
T KOG0661|consen 9 MDRYTVIRKLGDGTFGSVYLAKSKETGEL----VAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRD---- 80 (538)
T ss_pred HHHHHHHHHhcCCcceeEEEeeecCCCce----eeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhc----
Confidence 36899999999999999999999998874 666665433 334456999999999999999999998763
Q ss_pred CceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEeec
Q 039291 81 GEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADL 160 (362)
Q Consensus 81 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Df 160 (362)
....+|+||||++. +|.++++.+ ++.|++..++.|+.||++||+|+|.+|+.|||+||+|||+ ..+..+||+||
T Consensus 81 ~~~~L~fVfE~Md~-NLYqLmK~R-~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi----~~~~~iKiaDF 154 (538)
T KOG0661|consen 81 NDRILYFVFEFMDC-NLYQLMKDR-NRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILI----SGNDVIKIADF 154 (538)
T ss_pred cCceEeeeHHhhhh-hHHHHHhhc-CCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEe----cccceeEeccc
Confidence 22258899999975 999999985 7789999999999999999999999999999999999999 66778999999
Q ss_pred CCcccccccccCCCCCCccCCCCccCchhhcc-ccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHHcCCC--
Q 039291 161 GVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQ-HMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEH-- 237 (362)
Q Consensus 161 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~-- 237 (362)
|+|+...+.... +.++.|++|+|||++.. ..|+.+.|||++|||++|+.+-++.|.+.++.+..-.+..+...+
T Consensus 155 GLARev~SkpPY---TeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~ 231 (538)
T KOG0661|consen 155 GLAREVRSKPPY---TEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDK 231 (538)
T ss_pred ccccccccCCCc---chhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCcc
Confidence 999977653333 57899999999999885 578999999999999999999999998776543322222222111
Q ss_pred ---------------CCCC--------CCccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCccCcch
Q 039291 238 ---------------SLPE--------IPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGVDE 282 (362)
Q Consensus 238 ---------------~~~~--------~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~~~~~~ 282 (362)
.+|. +...++.++.++|.+||.+||++||||.++|+||||+....
T Consensus 232 ~~~~eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~~~~ 299 (538)
T KOG0661|consen 232 DSWPEGYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHPFFQVGRA 299 (538)
T ss_pred ccchhHHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCcccccccc
Confidence 1121 12347899999999999999999999999999999987543
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-53 Score=393.21 Aligned_cols=254 Identities=28% Similarity=0.486 Sum_probs=218.6
Q ss_pred CCCceeecceecccCceEEEEEEECCCCCCCCceeeeechhh--------hhhHHHHHHHHHHHHcCCCCccccccccee
Q 039291 4 DGTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEV--------SASASLQKEKEVFDNLNGCPFVLECFGEEI 75 (362)
Q Consensus 4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~--------~~~~~~~~E~~il~~l~~h~~i~~~~~~~~ 75 (362)
..++|.+++.||+|+||+|++|.+..++. +||+|.... ...+.+.+|+.+++++.+||||++++.+..
T Consensus 15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~----~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~ 90 (370)
T KOG0583|consen 15 SIGKYELGRTLGSGSFGKVKLAKHRLTGE----KVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFA 90 (370)
T ss_pred ccCceeeeeeecCCCCeeEEEeeeccCCC----eEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEe
Confidence 45799999999999999999999998885 455554332 234567799999999999999999999775
Q ss_pred eecCCCceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCc-eE
Q 039291 76 TMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGK-FV 154 (362)
Q Consensus 76 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~-~~ 154 (362)
. ...+++|||||.||+|.+++.. .+++.|..++.+++||+.|++|||++||+||||||+|||+ +.+ ++
T Consensus 91 t-----~~~~~ivmEy~~gGdL~~~i~~--~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENill----d~~~~~ 159 (370)
T KOG0583|consen 91 T-----PTKIYIVMEYCSGGDLFDYIVN--KGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILL----DGNEGN 159 (370)
T ss_pred c-----CCeEEEEEEecCCccHHHHHHH--cCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEe----cCCCCC
Confidence 3 2237899999999999999988 5669999999999999999999999999999999999999 777 89
Q ss_pred EEEeecCCcccccccccCCCCCCccCCCCccCchhhcccc-CC-CcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHH
Q 039291 155 AKIADLGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHM-QE-APSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSI 232 (362)
Q Consensus 155 ~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~ 232 (362)
+||+|||++.... .........+||+.|+|||++.+.. |+ .++||||+||+||.|++|+.||.. .+...++..
T Consensus 160 ~Kl~DFG~s~~~~--~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d---~~~~~l~~k 234 (370)
T KOG0583|consen 160 LKLSDFGLSAISP--GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDD---SNVPNLYRK 234 (370)
T ss_pred EEEeccccccccC--CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCC---ccHHHHHHH
Confidence 9999999998774 2344556899999999999999876 74 789999999999999999999954 566667777
Q ss_pred HcCCCCCCCCCccC-CHHHHHHHHHHhccCCCCCCCHHHHhcCCCccC
Q 039291 233 IGDEHSLPEIPSRV-SKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKG 279 (362)
Q Consensus 233 ~~~~~~~~~~~~~~-~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~~~ 279 (362)
+..... .+|..+ +.++++|+++||..||.+|+++.+++.||||+.
T Consensus 235 i~~~~~--~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~ 280 (370)
T KOG0583|consen 235 IRKGEF--KIPSYLLSPEARSLIEKMLVPDPSTRITLLEILEHPWFQK 280 (370)
T ss_pred HhcCCc--cCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHhhChhhcc
Confidence 655433 466677 999999999999999999999999999999986
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-55 Score=369.53 Aligned_cols=245 Identities=26% Similarity=0.480 Sum_probs=212.6
Q ss_pred CceeecceecccCceEEEEEEECCCCCCCCceeeeech-----hhhhhHHHHHHHHHHHHcCCCCcccccccceeeecCC
Q 039291 6 TSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSA-----EVSASASLQKEKEVFDNLNGCPFVLECFGEEITMGEN 80 (362)
Q Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~-----~~~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~ 80 (362)
..|.+.+.||+|+||+||++....++. .+|.|.+ +.........|+.+|++|+ |||||++++.... +
T Consensus 19 ~~y~Il~~IG~GsFg~vykv~~~~~g~----l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~-HpNIVqYy~~~f~---~ 90 (375)
T KOG0591|consen 19 ADYQILKKIGRGSFGEVYKVQCLLDGK----LVALKKIQFGMMDAKARQDCVKEISLLKQLN-HPNIVQYYAHSFI---E 90 (375)
T ss_pred HHHHHHHHHcCCcchheEEeeeccCcc----hhhhhhcchhhccHHHHHHHHHHHHHHHhcC-CchHHHHHHHhhh---c
Confidence 359999999999999999999998876 4555553 3446677889999999999 9999999984432 3
Q ss_pred CceEEEEEEEecCCCCHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHh--CC--ceeCCCCCCCEEEeecCCCceE
Q 039291 81 GEMAYNLLLEYAAGGTLGDLIEKCN--GNGLPEKDVRHFTRCILEGIGHIHD--SG--YVHCDVKPDNILLVATQSGKFV 154 (362)
Q Consensus 81 ~~~~~~lv~e~~~~~~L~~~l~~~~--~~~l~~~~~~~i~~ql~~~l~yLH~--~~--ivH~Dlkp~Nill~~~~~~~~~ 154 (362)
+...+++|||+|.+|+|.+.++..+ ++.++|.++|+++.||+.||.++|+ .. |+||||||.||++ +.+++
T Consensus 91 ~~evlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl----~~~gv 166 (375)
T KOG0591|consen 91 DNEVLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFL----TANGV 166 (375)
T ss_pred cchhhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEE----cCCCc
Confidence 3344789999999999999998643 3559999999999999999999999 55 9999999999999 88899
Q ss_pred EEEeecCCcccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHHc
Q 039291 155 AKIADLGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIG 234 (362)
Q Consensus 155 ~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~ 234 (362)
|||+||||++.... ...+..+.+|||.||+||++.+.+|+.++||||+||++|||+.-++||.+. +..++..+|.
T Consensus 167 vKLGDfGL~r~l~s--~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~---n~~~L~~KI~ 241 (375)
T KOG0591|consen 167 VKLGDFGLGRFLSS--KTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGD---NLLSLCKKIE 241 (375)
T ss_pred eeeccchhHhHhcc--hhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccc---cHHHHHHHHH
Confidence 99999999998776 344556899999999999999999999999999999999999999999776 7888989998
Q ss_pred CCCCCCCCC-ccCCHHHHHHHHHHhccCCCCCCCH
Q 039291 235 DEHSLPEIP-SRVSKEARDFLRRCFVRKPAFRFTA 268 (362)
Q Consensus 235 ~~~~~~~~~-~~~~~~~~~li~~~l~~~p~~R~s~ 268 (362)
+... |.+| ...|.++..||..|+.+||+.||+.
T Consensus 242 qgd~-~~~p~~~YS~~l~~li~~ci~vd~~~RP~t 275 (375)
T KOG0591|consen 242 QGDY-PPLPDEHYSTDLRELINMCIAVDPEQRPDT 275 (375)
T ss_pred cCCC-CCCcHHHhhhHHHHHHHHHccCCcccCCCc
Confidence 8754 4466 7789999999999999999999974
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-54 Score=367.01 Aligned_cols=259 Identities=27% Similarity=0.444 Sum_probs=212.8
Q ss_pred CceeecceecccCceEEEEEEECCCCCCCCceeeeechhhh-----hhHHHHHHHHHHHHcCCCCcccccccceeeecCC
Q 039291 6 TSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVS-----ASASLQKEKEVFDNLNGCPFVLECFGEEITMGEN 80 (362)
Q Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~~-----~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~ 80 (362)
++|.....+|+|+||+||+++++.+|+ .||+|++... ..+...||+++|++|+ |+|+|.++.++..
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~Tgq----IVAIKkF~Esedd~~VkKIAlREIrmLKqLk-H~NLVnLiEVFrr---- 72 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQ----IVAIKKFVESEDDPVVKKIALREIRMLKQLK-HENLVNLIEVFRR---- 72 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCccc----EEEEEeeccCCccHHHHHHHHHHHHHHHhcc-cchHHHHHHHHHh----
Confidence 478889999999999999999999986 7788876433 4456789999999999 9999999998743
Q ss_pred CceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEeec
Q 039291 81 GEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADL 160 (362)
Q Consensus 81 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Df 160 (362)
...++||+|||+. ++.+-++.+. .++++..+..+++|++.|+.|||++++|||||||+|||+ ..++.+|||||
T Consensus 73 -krklhLVFE~~dh-TvL~eLe~~p-~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILi----t~~gvvKLCDF 145 (396)
T KOG0593|consen 73 -KRKLHLVFEYCDH-TVLHELERYP-NGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILI----TQNGVVKLCDF 145 (396)
T ss_pred -cceeEEEeeecch-HHHHHHHhcc-CCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEE----ecCCcEEeccc
Confidence 4458899999986 6666676654 349999999999999999999999999999999999999 88889999999
Q ss_pred CCcccccccccCCCCCCccCCCCccCchhhcc-ccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHHc-----
Q 039291 161 GVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQ-HMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIG----- 234 (362)
Q Consensus 161 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~----- 234 (362)
|+|+..... ....+.++.|++|+|||.+.+ -+|+.++||||+||++.||++|.+.|.+.++.+....+.+..
T Consensus 146 GFAR~L~~p--gd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~p 223 (396)
T KOG0593|consen 146 GFARTLSAP--GDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIP 223 (396)
T ss_pred hhhHhhcCC--cchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCH
Confidence 999977642 223357889999999999998 589999999999999999999999998876544333332221
Q ss_pred -------CCC-----CCCCC---------CccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCccCcch
Q 039291 235 -------DEH-----SLPEI---------PSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGVDE 282 (362)
Q Consensus 235 -------~~~-----~~~~~---------~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~~~~~~ 282 (362)
..+ .+|.. -+.++.-+.+|+++||..||++|++.++++.||||.++.+
T Consensus 224 rhq~iF~~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yFd~~~e 292 (396)
T KOG0593|consen 224 RHQSIFSSNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYFDGFIE 292 (396)
T ss_pred HHHHHhccCCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcChHHHHHHH
Confidence 111 11211 1246678899999999999999999999999999977543
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-53 Score=396.88 Aligned_cols=258 Identities=33% Similarity=0.538 Sum_probs=225.3
Q ss_pred CCCceeecceecccCceEEEEEEECCCCCCCCceeeeech--hhhhhHHHHHHHHHHHHcCCCCcccccccceeeecCCC
Q 039291 4 DGTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSA--EVSASASLQKEKEVFDNLNGCPFVLECFGEEITMGENG 81 (362)
Q Consensus 4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~--~~~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~~ 81 (362)
+=+.|.+++.||.|+-|.|-+|++..||+.+++++..|.. .......+.+|+-||+.|. ||||+++|+++..
T Consensus 10 tiGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~-HpnVl~LydVwe~----- 83 (786)
T KOG0588|consen 10 TIGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIE-HPNVLRLYDVWEN----- 83 (786)
T ss_pred cccceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhc-CCCeeeeeeeecc-----
Confidence 3468999999999999999999999999866555555542 2234567899999999999 9999999998742
Q ss_pred ceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEeecC
Q 039291 82 EMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLG 161 (362)
Q Consensus 82 ~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Dfg 161 (362)
...+|+|+||++||.|++++.. ++++++.++.++++||+.|+.|||..+|+||||||+|+|+ +.+.++||+|||
T Consensus 84 ~~~lylvlEyv~gGELFdylv~--kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLL----d~~~nIKIADFG 157 (786)
T KOG0588|consen 84 KQHLYLVLEYVPGGELFDYLVR--KGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLL----DVKNNIKIADFG 157 (786)
T ss_pred CceEEEEEEecCCchhHHHHHh--hCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhh----hcccCEeeeccc
Confidence 4458899999999999999987 5679999999999999999999999999999999999999 777789999999
Q ss_pred CcccccccccCCCCCCccCCCCccCchhhccccC-CCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHHcCCCCCC
Q 039291 162 VAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQ-EAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEHSLP 240 (362)
Q Consensus 162 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 240 (362)
+|..-.. .....+.||++.|.|||++.+..| +.++||||+|||||.|++|++|| ++.++..++.++..+..
T Consensus 158 MAsLe~~---gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPF---dDdNir~LLlKV~~G~f-- 229 (786)
T KOG0588|consen 158 MASLEVP---GKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPF---DDDNIRVLLLKVQRGVF-- 229 (786)
T ss_pred eeecccC---CccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCC---CCccHHHHHHHHHcCcc--
Confidence 9965443 334457899999999999999877 68999999999999999999999 56788999888876654
Q ss_pred CCCccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCccCcc
Q 039291 241 EIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGVD 281 (362)
Q Consensus 241 ~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~~~~~ 281 (362)
++|..++.++++||++||++||++|+|.+++++|||+.+..
T Consensus 230 ~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~l~g~~ 270 (786)
T KOG0588|consen 230 EMPSNISSEAQDLLRRMLDVDPSTRITTEEILKHPFLSGYT 270 (786)
T ss_pred cCCCcCCHHHHHHHHHHhccCccccccHHHHhhCchhhcCC
Confidence 67889999999999999999999999999999999998754
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-52 Score=366.81 Aligned_cols=267 Identities=25% Similarity=0.352 Sum_probs=221.6
Q ss_pred CCceeecceecccCceEEEEEEECCCCCCCCceeeeechh-----hhhhHHHHHHHHHHHHcCCCCcccccccceeeecC
Q 039291 5 GTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAE-----VSASASLQKEKEVFDNLNGCPFVLECFGEEITMGE 79 (362)
Q Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~-----~~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~ 79 (362)
..+|...+.||+|+||.|+.|.++.+++ +||+|++. ....++..||+++|+.++ |+||+.+++++.....
T Consensus 21 ~~~y~~~~~iG~GAyGvVcsA~~~~t~~----~VAIKKi~~~F~~~~~akRtlRElklLr~~~-HeNIi~l~di~~p~~~ 95 (359)
T KOG0660|consen 21 PRYYVLIEPIGRGAYGVVCSAKDKRTGE----KVAIKKILNPFENQIDAKRTLRELKLLRHLR-HENIIGLLDIFRPPSR 95 (359)
T ss_pred cceecccccccCcceeeEEEEEEcCCCC----EeehhhhhhhhhchHHHHHHHHHHHHHHHhc-CCCcceEEeecccccc
Confidence 4667778999999999999999999985 67888764 235677889999999999 9999999998876444
Q ss_pred CCceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEee
Q 039291 80 NGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIAD 159 (362)
Q Consensus 80 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~D 159 (362)
+....+|+|+|++ +.+|.+.++. +..+++..+..+++||++||+|+|+.+|+||||||.|+|+ +.++.+||+|
T Consensus 96 ~~f~DvYiV~elM-etDL~~iik~--~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~----n~~c~lKI~D 168 (359)
T KOG0660|consen 96 DKFNDVYLVFELM-ETDLHQIIKS--QQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLL----NADCDLKICD 168 (359)
T ss_pred cccceeEEehhHH-hhHHHHHHHc--CccccHHHHHHHHHHHHHhcchhhcccccccccchhheee----ccCCCEEecc
Confidence 5566788999999 4599999987 4459999999999999999999999999999999999999 7888899999
Q ss_pred cCCcccccccccCCCCCCccCCCCccCchhhcc-ccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHHc----
Q 039291 160 LGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQ-HMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIG---- 234 (362)
Q Consensus 160 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~---- 234 (362)
||+|+...........+.++.|.+|+|||++.. ..|+.+.||||+|||++||++|++.|.+.+..+..+++..+.
T Consensus 169 FGLAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~ 248 (359)
T KOG0660|consen 169 FGLARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPS 248 (359)
T ss_pred ccceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCC
Confidence 999997765444455578899999999999875 589999999999999999999999998876544333222211
Q ss_pred -----------------CCCCCCC-----CCccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCccCcchh
Q 039291 235 -----------------DEHSLPE-----IPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGVDEE 283 (362)
Q Consensus 235 -----------------~~~~~~~-----~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~~~~~~~ 283 (362)
+.+..|. +.+..++.+.+|+++||..||.+|+|++|+|.|||+......
T Consensus 249 ~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~hdp 319 (359)
T KOG0660|consen 249 EEDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYHDP 319 (359)
T ss_pred HHHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhcCC
Confidence 1111121 224688999999999999999999999999999999887544
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-52 Score=359.00 Aligned_cols=272 Identities=24% Similarity=0.396 Sum_probs=220.2
Q ss_pred CceeecceecccCceEEEEEEECCCCCCCCceeeeechhhhhh-----HHHHHHHHHHHHcCCCCcccccccceeeecCC
Q 039291 6 TSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVSAS-----ASLQKEKEVFDNLNGCPFVLECFGEEITMGEN 80 (362)
Q Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~~~~-----~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~ 80 (362)
+.|..+..|++|+||.||+|+|+.+++ +||+|.++-+.. -...||+.+|.+++ |||||.+-.+.+ +.+
T Consensus 76 ~efe~lnrI~EGtyGiVYRakdk~t~e----IVALKr~kmekek~GFPItsLREIniLl~~~-H~NIV~vkEVVv--G~~ 148 (419)
T KOG0663|consen 76 EEFEKLNRIEEGTYGVVYRAKDKKTDE----IVALKRLKMEKEKEGFPITSLREINILLKAR-HPNIVEVKEVVV--GSN 148 (419)
T ss_pred HHHHHHhhcccCcceeEEEeccCCcce----eEEeeecccccccCCCcchhHHHHHHHHhcC-CCCeeeeEEEEe--ccc
Confidence 468888999999999999999999986 678887654322 24679999999999 999999987654 434
Q ss_pred CceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEeec
Q 039291 81 GEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADL 160 (362)
Q Consensus 81 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Df 160 (362)
-+. +|+|||||+. +|..++.... .+|...+++.++.|+++|++|||.+.|+|||||++|+|+ +..|.+||+||
T Consensus 149 ~d~-iy~VMe~~Eh-DLksl~d~m~-q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm----~~~G~lKiaDF 221 (419)
T KOG0663|consen 149 MDK-IYIVMEYVEH-DLKSLMETMK-QPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLL----SHKGILKIADF 221 (419)
T ss_pred cce-eeeeHHHHHh-hHHHHHHhcc-CCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheee----ccCCcEEeccc
Confidence 343 6799999976 9999999865 579999999999999999999999999999999999999 88999999999
Q ss_pred CCcccccccccCCCCCCccCCCCccCchhhcc-ccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHH-HHHHcC--C
Q 039291 161 GVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQ-HMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQL-FSIIGD--E 236 (362)
Q Consensus 161 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~-~~~~~~--~ 236 (362)
|+|+.++... ...+..+-|.+|+|||.+.+ ..|+.+.|+||+|||+.||+++++.|.+..+.+.... ++.++. +
T Consensus 222 GLAR~ygsp~--k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte 299 (419)
T KOG0663|consen 222 GLAREYGSPL--KPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSE 299 (419)
T ss_pred chhhhhcCCc--ccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCcc
Confidence 9999888743 22357788999999999997 5899999999999999999999999988766544333 333321 1
Q ss_pred CCCC--------------C---------CCc-cCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCccCcchhhhhhhhCCC
Q 039291 237 HSLP--------------E---------IPS-RVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGVDEELSRELEGDY 292 (362)
Q Consensus 237 ~~~~--------------~---------~~~-~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~~~~~~~~~~~~~~~~ 292 (362)
..+| . ++. .++....+|+..+|..||.+|.||.+.|+|.||.+.....+...-+.+
T Consensus 300 ~iwpg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e~P~p~~P~~~Pt~ 379 (419)
T KOG0663|consen 300 AIWPGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRETPLPIDPSMFPTW 379 (419)
T ss_pred ccCCCccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcccccccCCCCCChhhcCCC
Confidence 1111 1 111 156888999999999999999999999999999987655444444443
Q ss_pred C
Q 039291 293 S 293 (362)
Q Consensus 293 ~ 293 (362)
.
T Consensus 380 P 380 (419)
T KOG0663|consen 380 P 380 (419)
T ss_pred c
Confidence 3
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-52 Score=389.23 Aligned_cols=262 Identities=28% Similarity=0.446 Sum_probs=225.0
Q ss_pred CCCceeecceecccCceEEEEEEECCCCCCCCceeeeech--hhhhhHHHHHHHHHHHHcCCCCcccccccceeeecCCC
Q 039291 4 DGTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSA--EVSASASLQKEKEVFDNLNGCPFVLECFGEEITMGENG 81 (362)
Q Consensus 4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~--~~~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~~ 81 (362)
+-++|.++++||+|+||+|++|..+.+++++++|+..|.. .....+..+.|.+|+...++||.++.++..+. .
T Consensus 366 ~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQ-----T 440 (694)
T KOG0694|consen 366 TLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQ-----T 440 (694)
T ss_pred cccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccc-----c
Confidence 3468999999999999999999999999866555544432 33456778899999999999999999998663 3
Q ss_pred ceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEeecC
Q 039291 82 EMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLG 161 (362)
Q Consensus 82 ~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Dfg 161 (362)
...+|+||||+.||++..+++ ...|++..++.|+..|+.||+|||++||||||||.+|||+ |..|++||+|||
T Consensus 441 ~~~l~fvmey~~Ggdm~~~~~---~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLL----D~eGh~kiADFG 513 (694)
T KOG0694|consen 441 KEHLFFVMEYVAGGDLMHHIH---TDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLL----DTEGHVKIADFG 513 (694)
T ss_pred CCeEEEEEEecCCCcEEEEEe---cccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEE----cccCcEEecccc
Confidence 456889999999999655544 3559999999999999999999999999999999999999 999999999999
Q ss_pred CcccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHHcCCCCCCC
Q 039291 162 VAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEHSLPE 241 (362)
Q Consensus 162 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 241 (362)
+++..-... ....++||||.|||||++.+..|+.++|+|||||+||||+.|..||.+. +.++++..|.... +.
T Consensus 514 lcKe~m~~g--~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gd---dEee~FdsI~~d~--~~ 586 (694)
T KOG0694|consen 514 LCKEGMGQG--DRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGD---DEEEVFDSIVNDE--VR 586 (694)
T ss_pred cccccCCCC--CccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCC---CHHHHHHHHhcCC--CC
Confidence 998655322 2446899999999999999999999999999999999999999999655 5567777775443 45
Q ss_pred CCccCCHHHHHHHHHHhccCCCCCCC-----HHHHhcCCCccCcchhh
Q 039291 242 IPSRVSKEARDFLRRCFVRKPAFRFT-----AEMLLDDPFVKGVDEEL 284 (362)
Q Consensus 242 ~~~~~~~~~~~li~~~l~~~p~~R~s-----~~~~l~~p~~~~~~~~~ 284 (362)
+|..++.++.++++++|.++|++|.. ++++..||||+.+.|+.
T Consensus 587 yP~~ls~ea~~il~~ll~k~p~kRLG~~e~d~~~i~~hpFFr~i~w~~ 634 (694)
T KOG0694|consen 587 YPRFLSKEAIAIMRRLLRKNPEKRLGSGERDAEDIKKHPFFRSIDWDD 634 (694)
T ss_pred CCCcccHHHHHHHHHHhccCcccccCCCCCCchhhhhCCccccCCHHH
Confidence 77889999999999999999999984 68999999999999884
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-52 Score=347.92 Aligned_cols=255 Identities=25% Similarity=0.408 Sum_probs=211.8
Q ss_pred CceeecceecccCceEEEEEEECCCCCCCCceeeeechhhh-----hhHHHHHHHHHHHHcCCCCcccccccceeeecCC
Q 039291 6 TSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVS-----ASASLQKEKEVFDNLNGCPFVLECFGEEITMGEN 80 (362)
Q Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~~-----~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~ 80 (362)
.||...+.||+|.||+||+|++..+|+ .||+|++... ......||++.|+.++ |+||+.+++++....
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~----~VAIKKIkl~~~kdGi~~talREIK~Lqel~-h~nIi~LiD~F~~~~-- 74 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGK----RVAIKKIKLGNAKDGINRTALREIKLLQELK-HPNIIELIDVFPHKS-- 74 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCc----EEEEEEeeccccccCccHHHHHHHHHHHHcc-CcchhhhhhhccCCC--
Confidence 589999999999999999999999986 5677765432 3456889999999999 999999999886432
Q ss_pred CceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEeec
Q 039291 81 GEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADL 160 (362)
Q Consensus 81 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Df 160 (362)
.+.||+||++. +|...|+. ....++..+++.|+.++++||+|||++.|+||||||.|+|+ +.++.+||+||
T Consensus 75 ---~l~lVfEfm~t-dLe~vIkd-~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLi----s~~g~lKiADF 145 (318)
T KOG0659|consen 75 ---NLSLVFEFMPT-DLEVVIKD-KNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLI----SSDGQLKIADF 145 (318)
T ss_pred ---ceEEEEEeccc-cHHHHhcc-cccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEE----cCCCcEEeecc
Confidence 36799999975 99999987 45679999999999999999999999999999999999999 88899999999
Q ss_pred CCcccccccccCCCCCCccCCCCccCchhhcc-ccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHHc--CCC
Q 039291 161 GVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQ-HMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIG--DEH 237 (362)
Q Consensus 161 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~--~~~ 237 (362)
|+|+.+....... ...+-|.+|+|||.+.| +.|+..+||||.|||+.||+-|.+-|.+.++ .+++..++. ..+
T Consensus 146 GLAr~f~~p~~~~--~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sD--idQL~~If~~LGTP 221 (318)
T KOG0659|consen 146 GLARFFGSPNRIQ--THQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSD--IDQLSKIFRALGTP 221 (318)
T ss_pred cchhccCCCCccc--ccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCch--HHHHHHHHHHcCCC
Confidence 9999887644333 34478999999999997 5899999999999999999999988876654 445443332 111
Q ss_pred ---CCCC--------------------CCccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCccCc
Q 039291 238 ---SLPE--------------------IPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGV 280 (362)
Q Consensus 238 ---~~~~--------------------~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~~~~ 280 (362)
.+|. +....+.++.+|+.+||..||.+|+++.++++|+||+..
T Consensus 222 ~~~~WP~~~~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~~ 287 (318)
T KOG0659|consen 222 TPDQWPEMTSLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKSL 287 (318)
T ss_pred CcccCccccccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhcC
Confidence 1111 122467889999999999999999999999999999753
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-52 Score=378.05 Aligned_cols=260 Identities=22% Similarity=0.353 Sum_probs=218.7
Q ss_pred CCceeecceecccCceEEEEEEECCCCCCCCceeeeechhhh-----hhHHHHHHHHHHHHcCCCCcccccccceeeecC
Q 039291 5 GTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVS-----ASASLQKEKEVFDNLNGCPFVLECFGEEITMGE 79 (362)
Q Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~~-----~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~ 79 (362)
-+.|..++.||+|.||.||+|++..+++ .||+|++... ......||+.||++|+ ||||+++.+.....
T Consensus 116 ~~~feki~kIGeGTyg~VYkAr~~~tgk----ivALKKvr~d~~~~~~~~t~~REI~ILr~l~-HpNIikL~eivt~~-- 188 (560)
T KOG0600|consen 116 ADSFEKIEKIGEGTYGQVYKARDLETGK----IVALKKVRFDNEKEGFPITAIREIKILRRLD-HPNIIKLEEIVTSK-- 188 (560)
T ss_pred hHHHHHHHHhcCcchhheeEeeecccCc----EEEEEEeecccCCCcchHHHHHHHHHHHhcC-CCcccceeeEEEec--
Confidence 3568889999999999999999999985 6777776433 3456789999999999 99999999976542
Q ss_pred CCceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEee
Q 039291 80 NGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIAD 159 (362)
Q Consensus 80 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~D 159 (362)
....+|||+||++. ||..++.. .+-.|++.+++.++.||+.||+|||++||+|||||.+|||| |.+|++||+|
T Consensus 189 -~~~siYlVFeYMdh-DL~GLl~~-p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLi----dn~G~LKiaD 261 (560)
T KOG0600|consen 189 -LSGSIYLVFEYMDH-DLSGLLSS-PGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILI----DNNGVLKIAD 261 (560)
T ss_pred -CCceEEEEEecccc-hhhhhhcC-CCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEE----cCCCCEEecc
Confidence 23458899999986 99998876 44569999999999999999999999999999999999999 9999999999
Q ss_pred cCCcccccccccCCCCCCccCCCCccCchhhccc-cCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHHcCCC-
Q 039291 160 LGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQH-MQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEH- 237 (362)
Q Consensus 160 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~- 237 (362)
||||+.+........ ++.+-|.+|+|||++.|. .|+.++|+||+||||.||++|++.|.+..+....+.+.++...+
T Consensus 262 FGLAr~y~~~~~~~~-T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~ 340 (560)
T KOG0600|consen 262 FGLARFYTPSGSAPY-TSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPT 340 (560)
T ss_pred ccceeeccCCCCccc-ccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCC
Confidence 999998877655543 677889999999999985 79999999999999999999999999887655555554444322
Q ss_pred --CCC--CC-------------------CccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCccC
Q 039291 238 --SLP--EI-------------------PSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKG 279 (362)
Q Consensus 238 --~~~--~~-------------------~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~~~ 279 (362)
.|+ .+ ...++..+.+|+..||..||.+|.||.++|.++||..
T Consensus 341 e~~W~~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF~t 405 (560)
T KOG0600|consen 341 EDYWPVSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQSEYFTT 405 (560)
T ss_pred hhccccccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcCccccc
Confidence 111 11 1247889999999999999999999999999999943
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-52 Score=381.45 Aligned_cols=255 Identities=30% Similarity=0.488 Sum_probs=223.8
Q ss_pred CceeecceecccCceEEEEEEECCCCCCCCceeeeechhh-hhhHHHHHHHHHHHHcCCCCcccccccceeeecCCCceE
Q 039291 6 TSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEV-SASASLQKEKEVFDNLNGCPFVLECFGEEITMGENGEMA 84 (362)
Q Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~-~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~~~~~ 84 (362)
++|.+.+.||+|+||+||+|+.+.+.++++.++..|.-+. ...+.+.+|++|++.|+ ||||+.+++.+. ....
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lk-Hpniv~m~esfE-----t~~~ 75 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLK-HPNIVEMLESFE-----TSAH 75 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcC-CcchhhHHHhhc-----ccce
Confidence 5899999999999999999999999887666666665433 35567999999999999 999999998763 3445
Q ss_pred EEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEeecCCcc
Q 039291 85 YNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAK 164 (362)
Q Consensus 85 ~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Dfgla~ 164 (362)
+++|.|||.| +|..+++. .+.++|+.++.++.|++.||.|||+++|+|||+||+|||+ ++.+++|+||||+|+
T Consensus 76 ~~vVte~a~g-~L~~il~~--d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl----~~~~~~KlcdFg~Ar 148 (808)
T KOG0597|consen 76 LWVVTEYAVG-DLFTILEQ--DGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILL----EKGGTLKLCDFGLAR 148 (808)
T ss_pred EEEEehhhhh-hHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeee----cCCCceeechhhhhh
Confidence 7899999987 99999987 4569999999999999999999999999999999999999 999999999999998
Q ss_pred cccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHHcCCCCCCCCCc
Q 039291 165 RSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEHSLPEIPS 244 (362)
Q Consensus 165 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (362)
.... .....++..|||.|||||++.+..|+..+|+||+|||+|||++|++||... .+.++.+.|..++.. .|.
T Consensus 149 ~m~~--~t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~---si~~Lv~~I~~d~v~--~p~ 221 (808)
T KOG0597|consen 149 AMST--NTSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYAR---SITQLVKSILKDPVK--PPS 221 (808)
T ss_pred hccc--CceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHH---HHHHHHHHHhcCCCC--Ccc
Confidence 7765 444556788999999999999999999999999999999999999999654 567777777665543 356
Q ss_pred cCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCccCc
Q 039291 245 RVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGV 280 (362)
Q Consensus 245 ~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~~~~ 280 (362)
.++.++++|+..+|.+||.+|.+..+++.|||.++.
T Consensus 222 ~~S~~f~nfl~gLL~kdP~~RltW~~Ll~HpF~k~~ 257 (808)
T KOG0597|consen 222 TASSSFVNFLQGLLIKDPAQRLTWTDLLGHPFWKGK 257 (808)
T ss_pred cccHHHHHHHHHHhhcChhhcccHHHHhcChHHhhh
Confidence 899999999999999999999999999999998764
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-52 Score=347.58 Aligned_cols=262 Identities=25% Similarity=0.389 Sum_probs=219.1
Q ss_pred CCceeecceecccCceEEEEEEECCCCCCC-CceeeeechhhhhhHHHHHHHHHHHHcCCCCcccccccceeeecCCCce
Q 039291 5 GTSWFRGRVIGQGSFGCVFIAKPKSNSSFL-PPLMAVKSAEVSASASLQKEKEVFDNLNGCPFVLECFGEEITMGENGEM 83 (362)
Q Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~-~~~~~~K~~~~~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~~~~ 83 (362)
.++|.+-+.||+|.|+.|+++.++.+|+.+ ++.+..|.+.....+.+.+|++|-+.|+ ||||+++.+.+ ++..
T Consensus 10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~Lq-HP~IvrL~~ti-----~~~~ 83 (355)
T KOG0033|consen 10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQ-HPNIVRLHDSI-----QEES 83 (355)
T ss_pred chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcC-CCcEeehhhhh-----cccc
Confidence 467899999999999999999998887533 3444555555557788999999999999 99999998855 3455
Q ss_pred EEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEeecCCc
Q 039291 84 AYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVA 163 (362)
Q Consensus 84 ~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Dfgla 163 (362)
+.|+|+|++.|++|..-|-.. .-++|..+..+++||+++|.|||.+||||||+||+|+++.+. +....+||+|||+|
T Consensus 84 ~~ylvFe~m~G~dl~~eIV~R--~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK-~~~A~vKL~~FGvA 160 (355)
T KOG0033|consen 84 FHYLVFDLVTGGELFEDIVAR--EFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASK-AKGAAVKLADFGLA 160 (355)
T ss_pred eeEEEEecccchHHHHHHHHH--HHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeec-cCCCceeecccceE
Confidence 678999999999998766552 448999999999999999999999999999999999999654 44567999999999
Q ss_pred ccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHHcCC-CCCCC-
Q 039291 164 KRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDE-HSLPE- 241 (362)
Q Consensus 164 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~-~~~~~- 241 (362)
.... .......++|||.|||||++...+|+..+|||+.|||||-|+.|++||.+. +...++..|..+ ..++.
T Consensus 161 i~l~---~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~---~~~rlye~I~~g~yd~~~~ 234 (355)
T KOG0033|consen 161 IEVN---DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDE---DQHRLYEQIKAGAYDYPSP 234 (355)
T ss_pred EEeC---CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCc---cHHHHHHHHhccccCCCCc
Confidence 8776 233335788999999999999999999999999999999999999999654 345555555433 33333
Q ss_pred CCccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCccCcc
Q 039291 242 IPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGVD 281 (362)
Q Consensus 242 ~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~~~~~ 281 (362)
.+..+++++++|+++||..||.+|+|+.|+|+|||+++..
T Consensus 235 ~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~HpWi~~r~ 274 (355)
T KOG0033|consen 235 EWDTVTPEAKSLIRRMLTVNPKKRITADEALKHPWICNRE 274 (355)
T ss_pred ccCcCCHHHHHHHHHHhccChhhhccHHHHhCCchhcchH
Confidence 5678999999999999999999999999999999998754
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-50 Score=371.61 Aligned_cols=254 Identities=29% Similarity=0.511 Sum_probs=215.7
Q ss_pred CceeecceecccCceEEEEEEECCCCCCCCceeeeechhh---hhhHHHHHHHHHHHHcCCCCcccccccceeeecCCCc
Q 039291 6 TSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEV---SASASLQKEKEVFDNLNGCPFVLECFGEEITMGENGE 82 (362)
Q Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~---~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~~~ 82 (362)
..|.....||+|+.|.||.|+...+++ .||+|.+.. ...+-+..|+.+|+.++ |+|||++++.+...
T Consensus 273 ~~y~~~~kigqgaSG~vy~A~~~~~~~----~VaiK~m~l~~Q~~keLilnEi~Vm~~~~-H~NiVnfl~Sylv~----- 342 (550)
T KOG0578|consen 273 SKYTDFKKIGQGATGGVYVARKISTKQ----EVAIKRMDLRKQPKKELLLNEILVMRDLH-HPNIVNFLDSYLVG----- 342 (550)
T ss_pred hhhcchhhhccccccceeeeeeccCCc----eEEEEEEEeccCCchhhhHHHHHHHHhcc-chHHHHHHHHhccc-----
Confidence 568888999999999999999988876 466666542 35566889999999999 99999999977653
Q ss_pred eEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEeecCC
Q 039291 83 MAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGV 162 (362)
Q Consensus 83 ~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Dfgl 162 (362)
..+++||||++||+|-+.+... .++|.++..++++++.||+|||.+||+|||||.+|||+ ..++.+||+|||+
T Consensus 343 deLWVVMEym~ggsLTDvVt~~---~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL----~~~g~vKltDFGF 415 (550)
T KOG0578|consen 343 DELWVVMEYMEGGSLTDVVTKT---RMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILL----TMDGSVKLTDFGF 415 (550)
T ss_pred ceeEEEEeecCCCchhhhhhcc---cccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEe----ccCCcEEEeeeee
Confidence 2367999999999999999863 39999999999999999999999999999999999999 7778899999999
Q ss_pred cccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHHcCCCCCCCC
Q 039291 163 AKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEHSLPEI 242 (362)
Q Consensus 163 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 242 (362)
+........ ...+.+||+.|||||++..+.|+.++||||||++++||+.|.+||...+ ....++.+...+...-..
T Consensus 416 caqi~~~~~--KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~--PlrAlyLIa~ng~P~lk~ 491 (550)
T KOG0578|consen 416 CAQISEEQS--KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNEN--PLRALYLIATNGTPKLKN 491 (550)
T ss_pred eeccccccC--ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCC--hHHHHHHHhhcCCCCcCC
Confidence 987776433 3357899999999999999999999999999999999999999997532 333333333333333356
Q ss_pred CccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCccCc
Q 039291 243 PSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGV 280 (362)
Q Consensus 243 ~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~~~~ 280 (362)
+..+|+++++|+.+||+.|+++|++|.+||+||||+..
T Consensus 492 ~~klS~~~kdFL~~cL~~dv~~RasA~eLL~HpFl~~a 529 (550)
T KOG0578|consen 492 PEKLSPELKDFLDRCLVVDVEQRASAKELLEHPFLKMA 529 (550)
T ss_pred ccccCHHHHHHHHHHhhcchhcCCCHHHHhcChhhhhc
Confidence 77899999999999999999999999999999999543
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-49 Score=363.85 Aligned_cols=249 Identities=26% Similarity=0.391 Sum_probs=211.4
Q ss_pred CceeecceecccCceEEEEEEECCCCCCCCceeeeechhhhh-----hHHHHHHHHHHHHcCCCCcccccccceeeecCC
Q 039291 6 TSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVSA-----SASLQKEKEVFDNLNGCPFVLECFGEEITMGEN 80 (362)
Q Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~~~-----~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~ 80 (362)
....+.+.||+|+||+||+|.++++. .|++|.+.... .+.+.+|+.+|.+|+ |||||++++++...
T Consensus 41 ~~l~~~~~iG~G~~g~V~~~~~~g~~-----~vavK~~~~~~~~~~~~~~f~~E~~il~~l~-HpNIV~f~G~~~~~--- 111 (362)
T KOG0192|consen 41 DELPIEEVLGSGSFGTVYKGKWRGTD-----VVAVKIISDPDFDDESRKAFRREASLLSRLR-HPNIVQFYGACTSP--- 111 (362)
T ss_pred HHhhhhhhcccCCceeEEEEEeCCce-----eEEEEEecchhcChHHHHHHHHHHHHHHhCC-CCCeeeEEEEEcCC---
Confidence 34455677999999999999998863 27777765432 558999999999999 99999999987532
Q ss_pred CceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC-ceeCCCCCCCEEEeecCCCce-EEEEe
Q 039291 81 GEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSG-YVHCDVKPDNILLVATQSGKF-VAKIA 158 (362)
Q Consensus 81 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~-ivH~Dlkp~Nill~~~~~~~~-~~kl~ 158 (362)
...+++||||+++|+|.+++.......++...+..++.||++||.|||+++ ||||||||+|||+ +.+. ++||+
T Consensus 112 -~~~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv----~~~~~~~KI~ 186 (362)
T KOG0192|consen 112 -PGSLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILV----DLKGKTLKIA 186 (362)
T ss_pred -CCceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEE----cCCCCEEEEC
Confidence 115789999999999999998855567999999999999999999999999 9999999999999 7776 99999
Q ss_pred ecCCcccccccccCCCCCCccCCCCccCchhhc--cccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHHcCC
Q 039291 159 DLGVAKRSRHCKRQKFDPSMRGTPLYLAPETVV--QHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDE 236 (362)
Q Consensus 159 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 236 (362)
|||+++...... .......||+.|||||++. ...|+.++||||||++||||+||..||.... ..+....+...
T Consensus 187 DFGlsr~~~~~~--~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~---~~~~~~~v~~~ 261 (362)
T KOG0192|consen 187 DFGLSREKVISK--TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLA---PVQVASAVVVG 261 (362)
T ss_pred CCccceeecccc--ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCC---HHHHHHHHHhc
Confidence 999998665432 2223478999999999999 5699999999999999999999999995543 35555566666
Q ss_pred CCCCCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhc
Q 039291 237 HSLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLD 273 (362)
Q Consensus 237 ~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~ 273 (362)
...|.+|..+++.+..|+.+||..||++||++.+++.
T Consensus 262 ~~Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~ 298 (362)
T KOG0192|consen 262 GLRPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVS 298 (362)
T ss_pred CCCCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHH
Confidence 6777888889999999999999999999999999875
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-50 Score=358.35 Aligned_cols=258 Identities=24% Similarity=0.353 Sum_probs=208.8
Q ss_pred CCceeecceecccCceEEEEEEECCCCCCCCceeeeechhhh-----------------hhHHHHHHHHHHHHcCCCCcc
Q 039291 5 GTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVS-----------------ASASLQKEKEVFDNLNGCPFV 67 (362)
Q Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~~-----------------~~~~~~~E~~il~~l~~h~~i 67 (362)
-|+|.+++.||+|.||.|.+|++..+++ .+|+|++... ..+..++|+.||++|. ||||
T Consensus 96 lNqy~l~~eiG~G~yGkVkLar~~~~~~----l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~-H~nV 170 (576)
T KOG0585|consen 96 LNQYELIKEIGSGQYGKVKLARDEVDGK----LYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLH-HPNV 170 (576)
T ss_pred hhheehhhhhcCCccceEEEEeecCCCc----EEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcC-CcCe
Confidence 4789999999999999999999988876 5566654322 2357889999999999 8999
Q ss_pred cccccceeeecCCCceEEEEEEEecCCCCHHHHHHHhcCCC-CCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEe
Q 039291 68 LECFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNG-LPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLV 146 (362)
Q Consensus 68 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~-l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~ 146 (362)
|+++.+.-. . ....+|||+|||..|.+.+.= ..++ +++.++++|+++++.||+|||.+|||||||||+|+|+
T Consensus 171 V~LiEvLDD--P-~s~~~YlVley~s~G~v~w~p---~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl- 243 (576)
T KOG0585|consen 171 VKLIEVLDD--P-ESDKLYLVLEYCSKGEVKWCP---PDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLL- 243 (576)
T ss_pred eEEEEeecC--c-ccCceEEEEEeccCCccccCC---CCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEE-
Confidence 999985432 2 234578999999988775422 2344 9999999999999999999999999999999999999
Q ss_pred ecCCCceEEEEeecCCcccccccccC---CCCCCccCCCCccCchhhccc----cCCCcchHHHHHHHHHHHHhCCCCCc
Q 039291 147 ATQSGKFVAKIADLGVAKRSRHCKRQ---KFDPSMRGTPLYLAPETVVQH----MQEAPSDIWALGCVVLEMLSGRQAWV 219 (362)
Q Consensus 147 ~~~~~~~~~kl~Dfgla~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~----~~~~~~DiwslG~il~~l~~g~~pf~ 219 (362)
++.++|||+|||.+......... ......+|||.|+|||.+.++ ..+.+.||||+||+||.|+.|+.||.
T Consensus 244 ---~~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~ 320 (576)
T KOG0585|consen 244 ---SSDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFF 320 (576)
T ss_pred ---cCCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcc
Confidence 88899999999998755322111 111346799999999999873 23678899999999999999999995
Q ss_pred cCCCCCHHHHHHHHcCCCCCCCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCccCc
Q 039291 220 VKEDCSIDQLFSIIGDEHSLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGV 280 (362)
Q Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~~~~ 280 (362)
+. ...+++.+|..........+.+..++++||.+||++||++|.++.++..|||...-
T Consensus 321 ~~---~~~~l~~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~ 378 (576)
T KOG0585|consen 321 DD---FELELFDKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRD 378 (576)
T ss_pred cc---hHHHHHHHHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecceeccC
Confidence 44 56677777766655333334688999999999999999999999999999998654
|
|
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-49 Score=365.06 Aligned_cols=264 Identities=27% Similarity=0.439 Sum_probs=222.2
Q ss_pred CCceeecceecccCceEEEEEEECCCCCCCCceeeeechhhh--hhHHHHHHHHHHHHcCCCCcccccccceeeecCCCc
Q 039291 5 GTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVS--ASASLQKEKEVFDNLNGCPFVLECFGEEITMGENGE 82 (362)
Q Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~~--~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~~~ 82 (362)
...|.+++.||+|.||.||+++.+.+++.++.++..|..... ....+.+|+.+|++|.+||||+.+++.+.. .
T Consensus 34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~-----~ 108 (382)
T KOG0032|consen 34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFED-----P 108 (382)
T ss_pred cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEc-----C
Confidence 457999999999999999999999998766666655554332 336789999999999999999999997743 3
Q ss_pred eEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEeecCC
Q 039291 83 MAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGV 162 (362)
Q Consensus 83 ~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Dfgl 162 (362)
..+++|||+|.||.|.+.+.+. .+++..+..++.|++.++.|||+.||+||||||+|+|+....+.++.+|++|||+
T Consensus 109 ~~~~lvmEL~~GGeLfd~i~~~---~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGl 185 (382)
T KOG0032|consen 109 DSVYLVMELCEGGELFDRIVKK---HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGL 185 (382)
T ss_pred CeEEEEEEecCCchHHHHHHHc---cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCC
Confidence 3578999999999999999885 3999999999999999999999999999999999999977665567899999999
Q ss_pred cccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHHcCCCC-CCC
Q 039291 163 AKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEHS-LPE 241 (362)
Q Consensus 163 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~-~~~ 241 (362)
|..... .......+||+.|+|||++....|+..+||||+|+++|.|++|.+||.+..... ........... ...
T Consensus 186 a~~~~~---~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~--~~~~i~~~~~~f~~~ 260 (382)
T KOG0032|consen 186 AKFIKP---GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFE--IFLAILRGDFDFTSE 260 (382)
T ss_pred ceEccC---CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhH--HHHHHHcCCCCCCCC
Confidence 987765 223357899999999999999999999999999999999999999997665322 22233332222 223
Q ss_pred CCccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCccCcc
Q 039291 242 IPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGVD 281 (362)
Q Consensus 242 ~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~~~~~ 281 (362)
.+..++..++++|++||..||.+|+|+.++|+|||++...
T Consensus 261 ~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~HpWi~~~~ 300 (382)
T KOG0032|consen 261 PWDDISESAKDFIRKLLEFDPRKRLTAAQALQHPWIKSIG 300 (382)
T ss_pred CccccCHHHHHHHHHhcccCcccCCCHHHHhcCccccCCc
Confidence 4567899999999999999999999999999999998753
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-49 Score=361.94 Aligned_cols=251 Identities=26% Similarity=0.413 Sum_probs=207.7
Q ss_pred ceecccCceEEEEEEECCCCCCCCceeeeechhh------hhhHHHHHHHHHHHHcCCCCcccccccceeeecCCCceEE
Q 039291 12 RVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEV------SASASLQKEKEVFDNLNGCPFVLECFGEEITMGENGEMAY 85 (362)
Q Consensus 12 ~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~------~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~~~~~~ 85 (362)
+.||+|+||.||+|+++.+++ .+++|.... .....+.+|+.++++++ ||||+++++.+.. ...+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~----~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-hp~i~~~~~~~~~-----~~~~ 70 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGK----YYAMKILKKEVIIAKDEVAHTLTESRVLQNTR-HPFLTALKYSFQT-----HDRL 70 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCC----EEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCC-CCCCCCEEEEEEc-----CCEE
Confidence 579999999999999988876 455554432 23345778999999998 8999999876532 3357
Q ss_pred EEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEeecCCccc
Q 039291 86 NLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKR 165 (362)
Q Consensus 86 ~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Dfgla~~ 165 (362)
|+||||++|++|.+++.. .+.+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++.
T Consensus 71 ~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll----~~~~~~kl~DfG~a~~ 144 (323)
T cd05571 71 CFVMEYANGGELFFHLSR--ERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLML----DKDGHIKITDFGLCKE 144 (323)
T ss_pred EEEEeCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEE----CCCCCEEEeeCCCCcc
Confidence 899999999999999976 4569999999999999999999999999999999999999 7788899999999875
Q ss_pred ccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHHcCCCCCCCCCcc
Q 039291 166 SRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEHSLPEIPSR 245 (362)
Q Consensus 166 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (362)
.... .......+||+.|+|||++.+..++.++|||||||++|||++|..||... +...+...+.... ..++..
T Consensus 145 ~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~---~~~~~~~~~~~~~--~~~p~~ 217 (323)
T cd05571 145 GISD--GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ---DHEKLFELILMEE--IRFPRT 217 (323)
T ss_pred cccC--CCcccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCC---CHHHHHHHHHcCC--CCCCCC
Confidence 3321 11223567999999999999989999999999999999999999999643 3445544443332 345678
Q ss_pred CCHHHHHHHHHHhccCCCCCC-----CHHHHhcCCCccCcchhhh
Q 039291 246 VSKEARDFLRRCFVRKPAFRF-----TAEMLLDDPFVKGVDEELS 285 (362)
Q Consensus 246 ~~~~~~~li~~~l~~~p~~R~-----s~~~~l~~p~~~~~~~~~~ 285 (362)
++.++++||++||+.||++|| ++.++++||||..+.+...
T Consensus 218 ~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h~~f~~~~~~~~ 262 (323)
T cd05571 218 LSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEHRFFASINWQDV 262 (323)
T ss_pred CCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcCCCcCCCCHHHH
Confidence 999999999999999999999 8999999999999877643
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-50 Score=353.97 Aligned_cols=264 Identities=26% Similarity=0.397 Sum_probs=216.5
Q ss_pred ceeecceecccCceEEEEEEECCCCCCCCceeeeechhhhhhHHHHHHHHHHHHcCCCCcccccccceeeecCCCceEEE
Q 039291 7 SWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVSASASLQKEKEVFDNLNGCPFVLECFGEEITMGENGEMAYN 86 (362)
Q Consensus 7 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~~~~~~~ 86 (362)
+|...+++|.|+||.||.|+...+++ .+|+|+.-.. .+.-.+|+.+|+.+. |||||++.-.+....+.+....+
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~----~vAIKKv~~d-~r~knrEl~im~~l~-HpNIV~L~~~f~~~~~~d~~~ln 98 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEE----EVAIKKVLQD-KRYKNRELQIMRKLD-HPNIVRLLYFFSSSTESDEVYLN 98 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCc----eeEEEEecCC-CCcCcHHHHHHHhcC-CcCeeeEEEEEEecCCCchhHHH
Confidence 58889999999999999999998854 6788876433 234468999999998 99999999877765555455677
Q ss_pred EEEEecCCCCHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEeecCCcc
Q 039291 87 LLLEYAAGGTLGDLIEKC--NGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAK 164 (362)
Q Consensus 87 lv~e~~~~~~L~~~l~~~--~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Dfgla~ 164 (362)
+||||++. +|.+.++.. .+..++.-.++-+.+||++||.|||+.||+||||||+|+|++ ...+.+||||||.|+
T Consensus 99 lVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD---~~tg~LKicDFGSAK 174 (364)
T KOG0658|consen 99 LVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVD---PDTGVLKICDFGSAK 174 (364)
T ss_pred HHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEc---CCCCeEEeccCCcce
Confidence 89999986 999999853 345699999999999999999999999999999999999993 455899999999999
Q ss_pred cccccccCCCCCCccCCCCccCchhhccc-cCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHHcCCC------
Q 039291 165 RSRHCKRQKFDPSMRGTPLYLAPETVVQH-MQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEH------ 237 (362)
Q Consensus 165 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~------ 237 (362)
........ .++..|+.|+|||.+.+. .|+.+.||||.||++.||+-|++.|.+.+..+....+-++...+
T Consensus 175 ~L~~~epn---iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~ 251 (364)
T KOG0658|consen 175 VLVKGEPN---ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIK 251 (364)
T ss_pred eeccCCCc---eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHh
Confidence 87764444 478899999999999974 78999999999999999999999998876544433332222111
Q ss_pred ---------CCCC---------CCccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCccCcchh
Q 039291 238 ---------SLPE---------IPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGVDEE 283 (362)
Q Consensus 238 ---------~~~~---------~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~~~~~~~ 283 (362)
..|. +...+++++.+|+.++|..+|.+|.++.+++.||||.+....
T Consensus 252 ~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~~ 315 (364)
T KOG0658|consen 252 SMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRDP 315 (364)
T ss_pred hcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhCc
Confidence 1111 334688999999999999999999999999999999876554
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-48 Score=354.76 Aligned_cols=253 Identities=26% Similarity=0.425 Sum_probs=211.6
Q ss_pred CceeecceecccCceEEEEEEECCCCCCCCceeeeechhh------hhhHHHHHHHHHHHHcCCCCcccccccceeeecC
Q 039291 6 TSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEV------SASASLQKEKEVFDNLNGCPFVLECFGEEITMGE 79 (362)
Q Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~------~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~ 79 (362)
++|.+.+.||+|+||+||+|+++.+++ .+++|.... .....+.+|+.++++++ ||||+++++.+.
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~----~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~---- 71 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEH----YYALKVMAIPEVIRLKQEQHVHNEKRVLKEVS-HPFIIRLFWTEH---- 71 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCC----EEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCC-CCcHhhhHhhhc----
Confidence 479999999999999999999988775 456665432 23456788999999998 899999987653
Q ss_pred CCceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEee
Q 039291 80 NGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIAD 159 (362)
Q Consensus 80 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~D 159 (362)
....+++||||+++++|.+++.. .+.+++..+..++.|++.||+|||++||+||||||+|||+ +.++.+||+|
T Consensus 72 -~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli----~~~~~~kl~D 144 (291)
T cd05612 72 -DQRFLYMLMEYVPGGELFSYLRN--SGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILL----DKEGHIKLTD 144 (291)
T ss_pred -cCCeEEEEEeCCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEE----CCCCCEEEEe
Confidence 23457899999999999999986 4469999999999999999999999999999999999999 7778899999
Q ss_pred cCCcccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHHcCCCCC
Q 039291 160 LGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEHSL 239 (362)
Q Consensus 160 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 239 (362)
||+++..... .....||+.|+|||++.+..++.++|||||||++|+|++|..||... ........+....
T Consensus 145 fg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~---~~~~~~~~i~~~~-- 214 (291)
T cd05612 145 FGFAKKLRDR-----TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDD---NPFGIYEKILAGK-- 214 (291)
T ss_pred cCcchhccCC-----cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC---CHHHHHHHHHhCC--
Confidence 9998755321 12457999999999999888999999999999999999999999654 3344444443332
Q ss_pred CCCCccCCHHHHHHHHHHhccCCCCCCC-----HHHHhcCCCccCcchhh
Q 039291 240 PEIPSRVSKEARDFLRRCFVRKPAFRFT-----AEMLLDDPFVKGVDEEL 284 (362)
Q Consensus 240 ~~~~~~~~~~~~~li~~~l~~~p~~R~s-----~~~~l~~p~~~~~~~~~ 284 (362)
..++..++..+++||++||+.||.+|++ +++++.||||+.+.+..
T Consensus 215 ~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~~~~ 264 (291)
T cd05612 215 LEFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHRWFKSVDWDD 264 (291)
T ss_pred cCCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcCccccCCCHHH
Confidence 2456678999999999999999999995 99999999999877653
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-50 Score=331.37 Aligned_cols=257 Identities=25% Similarity=0.406 Sum_probs=220.3
Q ss_pred CCCceeecceecccCceEEEEEEECCCCCCCCceeeeech--hhhhhHHHHHHHHHHHHcCCCCcccccccceeeecCCC
Q 039291 4 DGTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSA--EVSASASLQKEKEVFDNLNGCPFVLECFGEEITMGENG 81 (362)
Q Consensus 4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~--~~~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~~ 81 (362)
+-++|.+++.||+|.||.||+|+.+.++..++.+|+.|.. .......+.+|++|...|+ ||||.++|+++. +
T Consensus 20 ~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~-hpnilrlY~~fh-----d 93 (281)
T KOG0580|consen 20 TLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLR-HPNILRLYGYFH-----D 93 (281)
T ss_pred chhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccC-CccHHhhhhhee-----c
Confidence 4468999999999999999999999988755555555543 2235567889999999999 999999999874 3
Q ss_pred ceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEeecC
Q 039291 82 EMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLG 161 (362)
Q Consensus 82 ~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Dfg 161 (362)
....||++||..+|+|...|+.....++++..++.++.|++.||.|+|.+++|||||||+|+|+ +..+.+||+|||
T Consensus 94 ~~riyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLl----g~~~~lkiAdfG 169 (281)
T KOG0580|consen 94 SKRIYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLL----GSAGELKIADFG 169 (281)
T ss_pred cceeEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhcc----CCCCCeeccCCC
Confidence 4457899999999999999997667779999999999999999999999999999999999999 778889999999
Q ss_pred CcccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHHcCCCCCCC
Q 039291 162 VAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEHSLPE 241 (362)
Q Consensus 162 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 241 (362)
-+..... . .....|||..|.+||...+..++..+|+|++|++.||++.|.+||+... ..+.++.|..-.. .
T Consensus 170 wsV~~p~-~---kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~---~~etYkrI~k~~~--~ 240 (281)
T KOG0580|consen 170 WSVHAPS-N---KRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQS---HSETYKRIRKVDL--K 240 (281)
T ss_pred ceeecCC-C---CceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhh---hHHHHHHHHHccc--c
Confidence 9865542 2 2247899999999999999999999999999999999999999996554 4555555543322 4
Q ss_pred CCccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCccC
Q 039291 242 IPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKG 279 (362)
Q Consensus 242 ~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~~~ 279 (362)
+|..++.+++++|.+||..+|.+|....++++|||+..
T Consensus 241 ~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hpwI~a 278 (281)
T KOG0580|consen 241 FPSTISGGAADLISRLLVKNPIERLALTEVMDHPWIVA 278 (281)
T ss_pred CCcccChhHHHHHHHHhccCccccccHHHHhhhHHHHh
Confidence 56789999999999999999999999999999999864
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-49 Score=349.12 Aligned_cols=263 Identities=25% Similarity=0.435 Sum_probs=218.4
Q ss_pred CCCCceeecceecccCceEEEEEEECCCCCCCCceeeeechhhh----hhHHHHHHHHHHHHcCCCCcccccccceeeec
Q 039291 3 SDGTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVS----ASASLQKEKEVFDNLNGCPFVLECFGEEITMG 78 (362)
Q Consensus 3 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~~----~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~ 78 (362)
.....|.+...||.|..++||+|+.+.+++ +|+||+++.+ ..+.+++|+..|+.++ ||||++++..++.
T Consensus 23 ~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e----~VAIK~inLEkc~~~ld~l~kE~~~msl~~-HPNIv~~~~sFvv-- 95 (516)
T KOG0582|consen 23 LNAKDYELQEVIGVGASAVVYLARCIPTNE----VVAIKIINLEKCNNDLDALRKEVQTMSLID-HPNIVTYHCSFVV-- 95 (516)
T ss_pred CCccceeEEEEEeccceeEeeeeeecccCC----EEEEEEeehhhhhhhHHHHHHHHHHhhhcC-CCCcceEEEEEEe--
Confidence 456789999999999999999999998885 7899987644 4577999999999998 9999999987764
Q ss_pred CCCceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEe
Q 039291 79 ENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIA 158 (362)
Q Consensus 79 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~ 158 (362)
+..+++||.|+.+|++.++++..-...++|..+..|+++++.||.|||.+|.||||||+.|||| +.+|.|||+
T Consensus 96 ---~~~LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi----~~dG~VkLa 168 (516)
T KOG0582|consen 96 ---DSELWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILI----DSDGTVKLA 168 (516)
T ss_pred ---cceeEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEE----cCCCcEEEc
Confidence 2347899999999999999998766679999999999999999999999999999999999999 999999999
Q ss_pred ecCCcccccccc-cCCCC-CCccCCCCccCchhhcc--ccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHHc
Q 039291 159 DLGVAKRSRHCK-RQKFD-PSMRGTPLYLAPETVVQ--HMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIG 234 (362)
Q Consensus 159 Dfgla~~~~~~~-~~~~~-~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~ 234 (362)
|||.+....... ..... ..++||++|||||++.. ..|+.|+||||||++..||.+|..||.... ....++..+.
T Consensus 169 dFgvsa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~p--PmkvLl~tLq 246 (516)
T KOG0582|consen 169 DFGVSASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYP--PMKVLLLTLQ 246 (516)
T ss_pred CceeeeeecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCC--hHHHHHHHhc
Confidence 999886443322 22222 56789999999999664 589999999999999999999999995332 2333444444
Q ss_pred CCCCCCC-------CCccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCccCcc
Q 039291 235 DEHSLPE-------IPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGVD 281 (362)
Q Consensus 235 ~~~~~~~-------~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~~~~~ 281 (362)
..+..+. -....+..++.+|..||+.||.+|||+.++++|+||+...
T Consensus 247 n~pp~~~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~k 300 (516)
T KOG0582|consen 247 NDPPTLLTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKAK 300 (516)
T ss_pred CCCCCcccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhcc
Confidence 3332111 1134678899999999999999999999999999998864
|
|
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-48 Score=362.72 Aligned_cols=260 Identities=28% Similarity=0.486 Sum_probs=209.7
Q ss_pred CceeecceecccCceEEEEEEECCCCCCCCceeeeechhh------hhhHHHHHHHHHHHHcCCCCcccccccceeeecC
Q 039291 6 TSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEV------SASASLQKEKEVFDNLNGCPFVLECFGEEITMGE 79 (362)
Q Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~------~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~ 79 (362)
++|.+++.||+|+||+||+|+++.++. .+++|.... .....+.+|+.+++.++ ||||+++++.+..
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~----~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~-h~~iv~~~~~~~~--- 72 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGH----IYAMKKLRKSEMLEKEQVAHVRAERDILAEAD-NPWVVKLYYSFQD--- 72 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCC----EEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCC-CCCCcceEEEEEc---
Confidence 479999999999999999999998876 456665532 23355778999999998 9999999886542
Q ss_pred CCceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEee
Q 039291 80 NGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIAD 159 (362)
Q Consensus 80 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~D 159 (362)
...+++||||++||+|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||+ +.++.++|+|
T Consensus 73 --~~~~~lv~E~~~~g~L~~~l~~--~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~----~~~~~~kl~D 144 (364)
T cd05599 73 --ENYLYLIMEYLPGGDMMTLLMK--KDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLL----DAKGHIKLSD 144 (364)
T ss_pred --CCeEEEEECCCCCcHHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEE----CCCCCEEEee
Confidence 3457899999999999999976 4469999999999999999999999999999999999999 7888999999
Q ss_pred cCCcccccccccC------------------------------------CCCCCccCCCCccCchhhccccCCCcchHHH
Q 039291 160 LGVAKRSRHCKRQ------------------------------------KFDPSMRGTPLYLAPETVVQHMQEAPSDIWA 203 (362)
Q Consensus 160 fgla~~~~~~~~~------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Diws 203 (362)
||++......... ......+||+.|+|||++.+..++.++||||
T Consensus 145 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS 224 (364)
T cd05599 145 FGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWS 224 (364)
T ss_pred cccceeccccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeec
Confidence 9998754321100 0112356999999999999989999999999
Q ss_pred HHHHHHHHHhCCCCCccCCCCCHHHHHHHHcCCCCCCCCC--ccCCHHHHHHHHHHhccCCCCCCC---HHHHhcCCCcc
Q 039291 204 LGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEHSLPEIP--SRVSKEARDFLRRCFVRKPAFRFT---AEMLLDDPFVK 278 (362)
Q Consensus 204 lG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~l~~~p~~R~s---~~~~l~~p~~~ 278 (362)
|||++|+|++|.+||... +..+....+........++ ..+++++++||.+||. +|.+|++ +++++.||||+
T Consensus 225 lG~il~el~~G~~Pf~~~---~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h~~~~ 300 (364)
T cd05599 225 LGVIMYEMLVGYPPFCSD---NPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSHPFFK 300 (364)
T ss_pred chhHHHHhhcCCCCCCCC---CHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcCCCcC
Confidence 999999999999999644 3344444433222111222 2478999999999996 9999998 99999999999
Q ss_pred Ccchhhh
Q 039291 279 GVDEELS 285 (362)
Q Consensus 279 ~~~~~~~ 285 (362)
...++..
T Consensus 301 ~~~~~~~ 307 (364)
T cd05599 301 GVDWEHI 307 (364)
T ss_pred CCCHHHH
Confidence 9877643
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-48 Score=358.51 Aligned_cols=254 Identities=24% Similarity=0.417 Sum_probs=213.0
Q ss_pred CCceeecceecccCceEEEEEEECCCCCCCCceeeeechhh------hhhHHHHHHHHHHHHcCCCCcccccccceeeec
Q 039291 5 GTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEV------SASASLQKEKEVFDNLNGCPFVLECFGEEITMG 78 (362)
Q Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~------~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~ 78 (362)
-++|.+.+.||+|+||.||+|+++.+++ .+++|.... .....+.+|+.++++++ ||||+++++.+..
T Consensus 17 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~----~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~-- 89 (329)
T PTZ00263 17 LSDFEMGETLGTGSFGRVRIAKHKGTGE----YYAIKCLKKREILKMKQVQHVAQEKSILMELS-HPFIVNMMCSFQD-- 89 (329)
T ss_pred chheEEEEEEEecCCeEEEEEEECCCCC----EEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCC-CCCCCcEEEEEEc--
Confidence 4689999999999999999999998876 455555432 23456789999999998 9999999986642
Q ss_pred CCCceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEe
Q 039291 79 ENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIA 158 (362)
Q Consensus 79 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~ 158 (362)
...+++||||+.|++|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+
T Consensus 90 ---~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll----~~~~~~kl~ 160 (329)
T PTZ00263 90 ---ENRVYFLLEFVVGGELFTHLRK--AGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLL----DNKGHVKVT 160 (329)
T ss_pred ---CCEEEEEEcCCCCChHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEE----CCCCCEEEe
Confidence 2357899999999999999986 3459999999999999999999999999999999999999 778889999
Q ss_pred ecCCcccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHHcCCCC
Q 039291 159 DLGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEHS 238 (362)
Q Consensus 159 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 238 (362)
|||++...... .....||+.|+|||++.+..++.++|||||||++|+|++|..||... ...+....+....
T Consensus 161 Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~---~~~~~~~~i~~~~- 231 (329)
T PTZ00263 161 DFGFAKKVPDR-----TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDD---TPFRIYEKILAGR- 231 (329)
T ss_pred eccCceEcCCC-----cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCC---CHHHHHHHHhcCC-
Confidence 99998755331 12457999999999999989999999999999999999999999543 3445555554332
Q ss_pred CCCCCccCCHHHHHHHHHHhccCCCCCCC-----HHHHhcCCCccCcchhh
Q 039291 239 LPEIPSRVSKEARDFLRRCFVRKPAFRFT-----AEMLLDDPFVKGVDEEL 284 (362)
Q Consensus 239 ~~~~~~~~~~~~~~li~~~l~~~p~~R~s-----~~~~l~~p~~~~~~~~~ 284 (362)
..++..++..+++||.+||..||.+|++ +++++.||||+...+..
T Consensus 232 -~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~hp~f~~~~~~~ 281 (329)
T PTZ00263 232 -LKFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNHPYFHGANWDK 281 (329)
T ss_pred -cCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCccCCCCHHH
Confidence 3456678999999999999999999996 79999999999876663
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-47 Score=359.05 Aligned_cols=261 Identities=26% Similarity=0.444 Sum_probs=207.7
Q ss_pred CceeecceecccCceEEEEEEECCCCCCCCceeeeechhh------hhhHHHHHHHHHHHHcCCCCcccccccceeeecC
Q 039291 6 TSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEV------SASASLQKEKEVFDNLNGCPFVLECFGEEITMGE 79 (362)
Q Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~------~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~ 79 (362)
++|.+++.||+|+||+||+|+++.++. .+++|.... .....+.+|+.++.+++ |++|+++++.+..
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~----~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~-~~~iv~~~~~~~~--- 72 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGH----VYAMKILRKADMLEKEQVGHIRAERDILVEAD-SLWVVKMFYSFQD--- 72 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCC----EEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCC-CCCcceEEEEEec---
Confidence 479999999999999999999988876 455555432 23356788999999998 8999999886542
Q ss_pred CCceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEee
Q 039291 80 NGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIAD 159 (362)
Q Consensus 80 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~D 159 (362)
...+|+||||++||+|.+++.. .+.+++..++.++.|++.||+|||++||+||||||+|||+ +.++.+||+|
T Consensus 73 --~~~~~lv~E~~~gg~L~~~l~~--~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi----~~~~~vkL~D 144 (363)
T cd05628 73 --KLNLYLIMEFLPGGDMMTLLMK--KDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLL----DSKGHVKLSD 144 (363)
T ss_pred --CCeEEEEEcCCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEE----CCCCCEEEee
Confidence 3357899999999999999986 4569999999999999999999999999999999999999 7778899999
Q ss_pred cCCccccccccc---------------------------------CCCCCCccCCCCccCchhhccccCCCcchHHHHHH
Q 039291 160 LGVAKRSRHCKR---------------------------------QKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGC 206 (362)
Q Consensus 160 fgla~~~~~~~~---------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ 206 (362)
||+++....... .......+||+.|+|||++.+..++.++|||||||
T Consensus 145 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGv 224 (363)
T cd05628 145 FGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGV 224 (363)
T ss_pred ccCcccccccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHH
Confidence 999874332100 00112457999999999999989999999999999
Q ss_pred HHHHHHhCCCCCccCCCCCHHHHHHHHcCCCCCCCCC--ccCCHHHHHHHHHHhccCCC---CCCCHHHHhcCCCccCcc
Q 039291 207 VVLEMLSGRQAWVVKEDCSIDQLFSIIGDEHSLPEIP--SRVSKEARDFLRRCFVRKPA---FRFTAEMLLDDPFVKGVD 281 (362)
Q Consensus 207 il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~l~~~p~---~R~s~~~~l~~p~~~~~~ 281 (362)
++|||++|+.||... ...+....+........+| ..++.+++++|.+|+. +|. .||++++++.||||+.+.
T Consensus 225 il~ell~G~~Pf~~~---~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~~~~r~~r~~~~ei~~hp~f~~~~ 300 (363)
T cd05628 225 IMYEMLIGYPPFCSE---TPQETYKKVMNWKETLIFPPEVPISEKAKDLILRFCC-EWEHRIGAPGVEEIKTNPFFEGVD 300 (363)
T ss_pred HHHHHHhCCCCCCCC---CHHHHHHHHHcCcCcccCCCcCCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhCCCCCCCCC
Confidence 999999999999644 3444444443322111222 2478999999999775 444 458999999999999998
Q ss_pred hhhhh
Q 039291 282 EELSR 286 (362)
Q Consensus 282 ~~~~~ 286 (362)
++...
T Consensus 301 ~~~~~ 305 (363)
T cd05628 301 WEHIR 305 (363)
T ss_pred HHHHH
Confidence 87543
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-48 Score=350.63 Aligned_cols=260 Identities=24% Similarity=0.370 Sum_probs=211.3
Q ss_pred ceeecceecccCceEEEEEEECCCCCCCCceeeeechhh------hhhHHHHHHHHHHHHcCCCCcccccccceeeecCC
Q 039291 7 SWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEV------SASASLQKEKEVFDNLNGCPFVLECFGEEITMGEN 80 (362)
Q Consensus 7 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~------~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~ 80 (362)
.|...+.||+|+||+||+|.++.++. .+++|.... .....+.+|+.++++++ |++|+++++.+..
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~----~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~-~~~iv~~~~~~~~---- 71 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGK----MYACKKLEKKRIKKRKGEAMALNEKRILEKVN-SRFVVSLAYAYET---- 71 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCc----eEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcC-CCcEEEEEEEEcc----
Confidence 47889999999999999999988876 455554432 22345678999999998 8999998876532
Q ss_pred CceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEeec
Q 039291 81 GEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADL 160 (362)
Q Consensus 81 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Df 160 (362)
...+++||||+++|+|.+++.......+++..+..++.|++.||+|||++||+||||||+|||+ +.++.++|+||
T Consensus 72 -~~~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill----~~~~~~kl~Df 146 (285)
T cd05631 72 -KDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILL----DDRGHIRISDL 146 (285)
T ss_pred -CCeEEEEEEecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEE----CCCCCEEEeeC
Confidence 2357899999999999988876555569999999999999999999999999999999999999 77788999999
Q ss_pred CCcccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHH-HHHHHHcCCCCC
Q 039291 161 GVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSID-QLFSIIGDEHSL 239 (362)
Q Consensus 161 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~-~~~~~~~~~~~~ 239 (362)
|++....... ......||..|+|||++.+..++.++|||||||++|+|++|+.||......... .....+. ...
T Consensus 147 g~~~~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~--~~~ 221 (285)
T cd05631 147 GLAVQIPEGE---TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVK--EDQ 221 (285)
T ss_pred CCcEEcCCCC---eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhh--ccc
Confidence 9987643211 113457999999999999989999999999999999999999999765443322 2222222 122
Q ss_pred CCCCccCCHHHHHHHHHHhccCCCCCCC-----HHHHhcCCCccCcchhhh
Q 039291 240 PEIPSRVSKEARDFLRRCFVRKPAFRFT-----AEMLLDDPFVKGVDEELS 285 (362)
Q Consensus 240 ~~~~~~~~~~~~~li~~~l~~~p~~R~s-----~~~~l~~p~~~~~~~~~~ 285 (362)
..++..++.++.+||++||..||.+|++ ++++++||||+.+.++..
T Consensus 222 ~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h~~~~~~~~~~~ 272 (285)
T cd05631 222 EEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQHPIFKNINFKRL 272 (285)
T ss_pred ccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcCHhhcCCCHHHH
Confidence 3456678999999999999999999997 899999999999877643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-48 Score=353.88 Aligned_cols=258 Identities=26% Similarity=0.427 Sum_probs=225.3
Q ss_pred CCceeecceecccCceEEEEEEECCCCCCCCceeeeechhh-----hhhHHHHHHHHHHHHcCCCCcccccccceeeecC
Q 039291 5 GTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEV-----SASASLQKEKEVFDNLNGCPFVLECFGEEITMGE 79 (362)
Q Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~-----~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~ 79 (362)
.++|..++++|+|+||.+++++++..+. ++++|.+.. ...+....|+.+++++. |||||.+.+.++
T Consensus 3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~----~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~-hP~iv~y~ds~~---- 73 (426)
T KOG0589|consen 3 MDNYEVLRQVGRGAFGSALLVRHKSDDK----LYVLKKINLEKLTEPERRSAIQEMDLLSKLL-HPNIVEYKDSFE---- 73 (426)
T ss_pred cchhhhhhhcCccccchhhhhhhccCCc----eEEEEEEeccccCchhhHHHHHHHHHHHhcc-CCCeeeeccchh----
Confidence 5789999999999999999999887764 667776543 24457889999999988 999999999776
Q ss_pred CCceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEee
Q 039291 80 NGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIAD 159 (362)
Q Consensus 80 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~D 159 (362)
.+...+||+|+||+||+|.+.|...++.-|+++.+..|+.|++.|+.|||++.|+|||||+.||++ ..+..|+|+|
T Consensus 74 ~~~~~l~Ivm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifl----tk~~~VkLgD 149 (426)
T KOG0589|consen 74 EDGQLLCIVMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFL----TKDKKVKLGD 149 (426)
T ss_pred cCCceEEEEEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhc----cccCceeecc
Confidence 344568899999999999999998877789999999999999999999999999999999999999 6666789999
Q ss_pred cCCcccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHHcCCCCC
Q 039291 160 LGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEHSL 239 (362)
Q Consensus 160 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 239 (362)
||+|+...... ....+.+||+.||.||.+.+.+|+.++|||||||++|||++-+++|... +...+..++.... .
T Consensus 150 fGlaK~l~~~~--~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~---~m~~Li~ki~~~~-~ 223 (426)
T KOG0589|consen 150 FGLAKILNPED--SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKAS---NMSELILKINRGL-Y 223 (426)
T ss_pred hhhhhhcCCch--hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCcc---chHHHHHHHhhcc-C
Confidence 99999877632 3456889999999999999999999999999999999999999999544 6667777766555 4
Q ss_pred CCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCccCcc
Q 039291 240 PEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGVD 281 (362)
Q Consensus 240 ~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~~~~~ 281 (362)
..+|...+.+++.+|+.||..+|..||++.++|.+|......
T Consensus 224 ~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~P~l~~~~ 265 (426)
T KOG0589|consen 224 SPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRRPHLLRYL 265 (426)
T ss_pred CCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhChhhhhHH
Confidence 567888999999999999999999999999999998876543
|
|
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-47 Score=354.31 Aligned_cols=263 Identities=25% Similarity=0.439 Sum_probs=208.7
Q ss_pred ceeecceecccCceEEEEEEECCCCCCCCceeeeechhh-------hhhHHHHHHHHHHHHcCCCCcccccccceeeecC
Q 039291 7 SWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEV-------SASASLQKEKEVFDNLNGCPFVLECFGEEITMGE 79 (362)
Q Consensus 7 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~-------~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~ 79 (362)
+|.+++.||+|+||+||+|++.... .....+++|.... .....+.+|+.+++.+.+||+|+++++.+.
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~---- 75 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGH-DTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQ---- 75 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccC-CCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEe----
Confidence 4889999999999999999875311 1123566665432 123457789999999988999999987553
Q ss_pred CCceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEee
Q 039291 80 NGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIAD 159 (362)
Q Consensus 80 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~D 159 (362)
....+++||||++||+|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|
T Consensus 76 -~~~~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili----~~~~~~kl~D 148 (332)
T cd05614 76 -TEAKLHLILDYVSGGEMFTHLYQ--RDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILL----DSEGHVVLTD 148 (332)
T ss_pred -cCCEEEEEEeCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEE----CCCCCEEEee
Confidence 23357799999999999999976 3459999999999999999999999999999999999999 7778899999
Q ss_pred cCCcccccccccCCCCCCccCCCCccCchhhccc-cCCCcchHHHHHHHHHHHHhCCCCCccCCCC-CHHHHHHHHcCCC
Q 039291 160 LGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQH-MQEAPSDIWALGCVVLEMLSGRQAWVVKEDC-SIDQLFSIIGDEH 237 (362)
Q Consensus 160 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~-~~~~~~~~~~~~~ 237 (362)
||+++........ ......||+.|+|||++.+. .++.++|||||||++|+|++|..||...... ........+..
T Consensus 149 fG~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~-- 225 (332)
T cd05614 149 FGLSKEFLSEEKE-RTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILK-- 225 (332)
T ss_pred CcCCccccccCCC-ccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhc--
Confidence 9998754332221 22356799999999999865 4788999999999999999999999754332 23333333322
Q ss_pred CCCCCCccCCHHHHHHHHHHhccCCCCCC-----CHHHHhcCCCccCcchhh
Q 039291 238 SLPEIPSRVSKEARDFLRRCFVRKPAFRF-----TAEMLLDDPFVKGVDEEL 284 (362)
Q Consensus 238 ~~~~~~~~~~~~~~~li~~~l~~~p~~R~-----s~~~~l~~p~~~~~~~~~ 284 (362)
..+.++..++..++++|.+||..||++|| +++++++||||+...+..
T Consensus 226 ~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~~~~ 277 (332)
T cd05614 226 CDPPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGLDWEA 277 (332)
T ss_pred CCCCCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCCCCHHH
Confidence 22345667899999999999999999999 888999999999876553
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-48 Score=356.96 Aligned_cols=257 Identities=24% Similarity=0.413 Sum_probs=210.9
Q ss_pred CceeecceecccCceEEEEEEECCCCCCCCceeeeechhh------hhhHHHHHHHHHHHHcCCCCcccccccceeeecC
Q 039291 6 TSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEV------SASASLQKEKEVFDNLNGCPFVLECFGEEITMGE 79 (362)
Q Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~------~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~ 79 (362)
++|.+.+.||+|+||.||+|+++.+++ .+++|.... .....+.+|+.+++.++ ||||+++++.+..
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~----~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~-h~~iv~~~~~~~~--- 72 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGE----IVALKRMKKSLLFKLNEVRHVLTERDILTTTK-SEWLVKLLYAFQD--- 72 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCC----EEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCC-CCCCccEEEEEEc---
Confidence 479999999999999999999998876 456665432 23455778999999998 9999999876542
Q ss_pred CCceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEee
Q 039291 80 NGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIAD 159 (362)
Q Consensus 80 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~D 159 (362)
...+|+||||++|++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|
T Consensus 73 --~~~~~lv~e~~~g~~L~~~l~~--~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~----~~~~~~kL~D 144 (333)
T cd05600 73 --DEYLYLAMEYVPGGDFRTLLNN--LGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLI----DASGHIKLTD 144 (333)
T ss_pred --CCEEEEEEeCCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEE----CCCCCEEEEe
Confidence 3357899999999999999976 4469999999999999999999999999999999999999 7788899999
Q ss_pred cCCcccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHHcCC---
Q 039291 160 LGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDE--- 236 (362)
Q Consensus 160 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~--- 236 (362)
||++..... ......||+.|+|||++.+..++.++|||||||++|+|++|..||... +..+....+...
T Consensus 145 fg~a~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~---~~~~~~~~i~~~~~~ 216 (333)
T cd05600 145 FGLSKGIVT-----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGS---TPNETWENLKYWKET 216 (333)
T ss_pred CcCCccccc-----ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCC---CHHHHHHHHHhcccc
Confidence 999875543 224567999999999999989999999999999999999999999654 333333333221
Q ss_pred CCCCCCC---ccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCccCcchhhhh
Q 039291 237 HSLPEIP---SRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGVDEELSR 286 (362)
Q Consensus 237 ~~~~~~~---~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~~~~~~~~~~ 286 (362)
...+... ..++.++.+||.+||..+|.+|+++.+++.||||+.+.+....
T Consensus 217 ~~~~~~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h~~~~~~~~~~~~ 269 (333)
T cd05600 217 LQRPVYDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNHPFFKEVDWNELR 269 (333)
T ss_pred ccCCCCCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhCcccCCCCHHHHh
Confidence 1112211 2568999999999999999999999999999999988765443
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-47 Score=359.23 Aligned_cols=260 Identities=23% Similarity=0.403 Sum_probs=204.8
Q ss_pred CceeecceecccCceEEEEEEECCCCCCCCceeeeechhh------hhhHHHHHHHHHHHHcCCCCcccccccceeeecC
Q 039291 6 TSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEV------SASASLQKEKEVFDNLNGCPFVLECFGEEITMGE 79 (362)
Q Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~------~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~ 79 (362)
+.|.+++.||+|+||+||+|+++.++. .+++|.... .....+.+|+.+++.++ ||||+++++.+..
T Consensus 1 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~----~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~-h~~iv~l~~~~~~--- 72 (381)
T cd05626 1 SMFVKIKTLGIGAFGEVCLACKVDTHA----LYAMKTLRKKDVLNRNQVAHVKAERDILAEAD-NEWVVKLYYSFQD--- 72 (381)
T ss_pred CCceEEEEEeecCCEEEEEEEECCCCC----EEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcC-CCCeeeeEEEEec---
Confidence 468999999999999999999988875 456665432 23456789999999998 8999999987642
Q ss_pred CCceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEee
Q 039291 80 NGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIAD 159 (362)
Q Consensus 80 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~D 159 (362)
...+++||||++||+|.+++.. ...+++..++.++.||+.||+|||+.||+||||||+|||+ +..+.+||+|
T Consensus 73 --~~~~~lv~E~~~gg~L~~~l~~--~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili----~~~~~~kL~D 144 (381)
T cd05626 73 --KDNLYFVMDYIPGGDMMSLLIR--MEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILI----DLDGHIKLTD 144 (381)
T ss_pred --CCEEEEEEecCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEE----CCCCCEEEee
Confidence 3357899999999999999976 3459999999999999999999999999999999999999 7778899999
Q ss_pred cCCccccccccc---------------------------------------------CCCCCCccCCCCccCchhhcccc
Q 039291 160 LGVAKRSRHCKR---------------------------------------------QKFDPSMRGTPLYLAPETVVQHM 194 (362)
Q Consensus 160 fgla~~~~~~~~---------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~ 194 (362)
||++........ .......+||+.|+|||++.+..
T Consensus 145 FGl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~ 224 (381)
T cd05626 145 FGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKG 224 (381)
T ss_pred CcCCcccccccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCC
Confidence 999753211000 00112457999999999999888
Q ss_pred CCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHHcCCCCCCCCC--ccCCHHHHHHHHHHhc--cCCCCCCCHHH
Q 039291 195 QEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEHSLPEIP--SRVSKEARDFLRRCFV--RKPAFRFTAEM 270 (362)
Q Consensus 195 ~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~l~--~~p~~R~s~~~ 270 (362)
++.++|||||||++|||++|..||..... .+....+........++ ..+++++++||.+|+. .++..|+++++
T Consensus 225 ~~~~~DiwSlG~il~elltG~~Pf~~~~~---~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~ 301 (381)
T cd05626 225 YTQLCDWWSVGVILFEMLVGQPPFLAPTP---TETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADD 301 (381)
T ss_pred CCCccceeehhhHHHHHHhCCCCCcCCCH---HHHHHHHHccccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHH
Confidence 99999999999999999999999965432 22222222111111222 3578999999999664 45555999999
Q ss_pred HhcCCCccCcchhh
Q 039291 271 LLDDPFVKGVDEEL 284 (362)
Q Consensus 271 ~l~~p~~~~~~~~~ 284 (362)
++.||||+++.+..
T Consensus 302 ~l~hp~f~~~~~~~ 315 (381)
T cd05626 302 IKAHPFFSEVDFSS 315 (381)
T ss_pred HhcCcccCCCChhH
Confidence 99999999887654
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-47 Score=351.28 Aligned_cols=250 Identities=26% Similarity=0.403 Sum_probs=205.1
Q ss_pred ceecccCceEEEEEEECCCCCCCCceeeeechhh------hhhHHHHHHHHHHHHcCCCCcccccccceeeecCCCceEE
Q 039291 12 RVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEV------SASASLQKEKEVFDNLNGCPFVLECFGEEITMGENGEMAY 85 (362)
Q Consensus 12 ~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~------~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~~~~~~ 85 (362)
+.||+|+||.||+|+++.++. .+++|.... .....+.+|+.+++.++ ||||+++++.+.. ...+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~----~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~i~~~~~~~~~-----~~~~ 70 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGR----YYAMKILRKEVIIAKDEVAHTVTESRVLQNTR-HPFLTALKYAFQT-----HDRL 70 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCC----EEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCC-CCCCcceeeEEec-----CCEE
Confidence 579999999999999988876 455555432 23345678999999998 8999999886642 2357
Q ss_pred EEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEeecCCccc
Q 039291 86 NLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKR 165 (362)
Q Consensus 86 ~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Dfgla~~ 165 (362)
|+||||+++|+|..++.. ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++..
T Consensus 71 ~lv~E~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll----~~~~~~kL~Dfg~~~~ 144 (323)
T cd05595 71 CFVMEYANGGELFFHLSR--ERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLML----DKDGHIKITDFGLCKE 144 (323)
T ss_pred EEEEeCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEE----cCCCCEEecccHHhcc
Confidence 899999999999998876 3469999999999999999999999999999999999999 7778899999999864
Q ss_pred ccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHHcCCCCCCCCCcc
Q 039291 166 SRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEHSLPEIPSR 245 (362)
Q Consensus 166 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (362)
.... ........||+.|+|||++.+..++.++|||||||++|+|++|+.||... +.......+.... ..++..
T Consensus 145 ~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~---~~~~~~~~~~~~~--~~~p~~ 217 (323)
T cd05595 145 GISD--GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ---DHERLFELILMEE--IRFPRT 217 (323)
T ss_pred ccCC--CCccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCC---CHHHHHHHHhcCC--CCCCCC
Confidence 3221 11123467999999999999889999999999999999999999999654 3344444433222 235667
Q ss_pred CCHHHHHHHHHHhccCCCCCC-----CHHHHhcCCCccCcchhh
Q 039291 246 VSKEARDFLRRCFVRKPAFRF-----TAEMLLDDPFVKGVDEEL 284 (362)
Q Consensus 246 ~~~~~~~li~~~l~~~p~~R~-----s~~~~l~~p~~~~~~~~~ 284 (362)
++++++++|.+||..||.+|+ ++.++++||||.+..+..
T Consensus 218 ~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h~~~~~~~~~~ 261 (323)
T cd05595 218 LSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQD 261 (323)
T ss_pred CCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcCCCcCCCCHHH
Confidence 899999999999999999998 899999999999887654
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-47 Score=360.10 Aligned_cols=264 Identities=26% Similarity=0.427 Sum_probs=208.3
Q ss_pred CceeecceecccCceEEEEEEECCCCCCCCceeeeechh------hhhhHHHHHHHHHHHHcCCCCcccccccceeeecC
Q 039291 6 TSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAE------VSASASLQKEKEVFDNLNGCPFVLECFGEEITMGE 79 (362)
Q Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~------~~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~ 79 (362)
++|.+++.||+|+||+||+|+++.+++. +++|... ......+.+|+++++.++ ||||+++++.+..
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~----~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~-hp~iv~~~~~~~~--- 72 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKI----YAMKTLLKSEMFKKDQLAHVKAERDVLAESD-SPWVVSLYYSFQD--- 72 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCE----EEEEEEEHHHHHHhHHHHHHHHHHHHHHhCC-CCCcceEEEEEEc---
Confidence 4799999999999999999999988764 4555432 223456788999999998 8999999986642
Q ss_pred CCceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEee
Q 039291 80 NGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIAD 159 (362)
Q Consensus 80 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~D 159 (362)
...+|+||||++||+|.+++.. ...+++..++.++.|++.||+|||+.||+||||||+|||+ +.++.+||+|
T Consensus 73 --~~~~~lv~E~~~gg~L~~~l~~--~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll----~~~~~~kl~D 144 (377)
T cd05629 73 --AQYLYLIMEFLPGGDLMTMLIK--YDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILI----DRGGHIKLSD 144 (377)
T ss_pred --CCeeEEEEeCCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEE----CCCCCEEEee
Confidence 3357899999999999999976 3559999999999999999999999999999999999999 7788899999
Q ss_pred cCCcccccccccC---------------------------------------------CCCCCccCCCCccCchhhcccc
Q 039291 160 LGVAKRSRHCKRQ---------------------------------------------KFDPSMRGTPLYLAPETVVQHM 194 (362)
Q Consensus 160 fgla~~~~~~~~~---------------------------------------------~~~~~~~gt~~y~aPE~~~~~~ 194 (362)
||+++........ ......+||+.|+|||++.+..
T Consensus 145 fGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 224 (377)
T cd05629 145 FGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQG 224 (377)
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCC
Confidence 9998632210000 0001357999999999999889
Q ss_pred CCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHHcCCCCCCCCC--ccCCHHHHHHHHHHhccCCCCC---CCHH
Q 039291 195 QEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEHSLPEIP--SRVSKEARDFLRRCFVRKPAFR---FTAE 269 (362)
Q Consensus 195 ~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~l~~~p~~R---~s~~ 269 (362)
++.++|||||||++|||++|.+||.... ..+.+..+........++ ..++.++++||.+||. +|.+| +++.
T Consensus 225 ~~~~~DiwSlGvil~elltG~~Pf~~~~---~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~ 300 (377)
T cd05629 225 YGQECDWWSLGAIMFECLIGWPPFCSEN---SHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAH 300 (377)
T ss_pred CCCceeeEecchhhhhhhcCCCCCCCCC---HHHHHHHHHccCCccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHH
Confidence 9999999999999999999999996543 334444443221111222 2478999999999997 77765 5999
Q ss_pred HHhcCCCccCcchhhhhhhh
Q 039291 270 MLLDDPFVKGVDEELSRELE 289 (362)
Q Consensus 270 ~~l~~p~~~~~~~~~~~~~~ 289 (362)
+++.||||+.+.++......
T Consensus 301 ~~l~hp~~~~~~~~~~~~~~ 320 (377)
T cd05629 301 EIKSHPFFRGVDWDTIRQIR 320 (377)
T ss_pred HHhcCCCcCCCCHHHHccCC
Confidence 99999999988776544333
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-48 Score=344.49 Aligned_cols=248 Identities=26% Similarity=0.419 Sum_probs=213.0
Q ss_pred CceeecceecccCceEEEEEEECCCCCCCCceeeeechhh------hhhHHHHHHHHHHHHcCCCCcccccccceeeecC
Q 039291 6 TSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEV------SASASLQKEKEVFDNLNGCPFVLECFGEEITMGE 79 (362)
Q Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~------~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~ 79 (362)
-||.+.+.||+|.||.|-+|.+...+. .||+|.+.. +..-.+.+|++||..|+ ||||+.+|.++..
T Consensus 53 HRyE~~etLGkGTYGKVk~A~e~~sgR----~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLN-HPhII~IyEVFEN--- 124 (668)
T KOG0611|consen 53 HRYEITETLGKGTYGKVKLAYEHKSGR----EVAIKSIRKDKIKDEQDLVHIRREIEIMSSLN-HPHIIQIYEVFEN--- 124 (668)
T ss_pred hHHHHHHHhcCCcccceeehhhccCCc----EeehhhhhhhhcccHHHHHHHHHHHHHHhhcC-CCceeehhhhhcC---
Confidence 479999999999999999999877765 566666543 34557889999999999 9999999998743
Q ss_pred CCceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEee
Q 039291 80 NGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIAD 159 (362)
Q Consensus 80 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~D 159 (362)
...+.+||||..+|.|.+|+..+ +.|++.+++.+++||+.|+.|||.++++|||||.+|||+ |.++++||+|
T Consensus 125 --kdKIvivMEYaS~GeLYDYiSer--~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILL----D~N~NiKIAD 196 (668)
T KOG0611|consen 125 --KDKIVIVMEYASGGELYDYISER--GSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILL----DQNNNIKIAD 196 (668)
T ss_pred --CceEEEEEEecCCccHHHHHHHh--ccccHHHHHHHHHHHHHHHHHHhhccceecccchhheee----cCCCCeeeec
Confidence 33477999999999999999984 459999999999999999999999999999999999999 8889999999
Q ss_pred cCCcccccccccCCCCCCccCCCCccCchhhccccC-CCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHHcCCCC
Q 039291 160 LGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQ-EAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEHS 238 (362)
Q Consensus 160 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 238 (362)
|||+..+.. ..+..++||++.|.+||++.+.+| ++.+|.|||||+||.|+.|..||.+. +...+++.|..+..
T Consensus 197 FGLSNly~~---~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~---Dhk~lvrQIs~GaY 270 (668)
T KOG0611|consen 197 FGLSNLYAD---KKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGR---DHKRLVRQISRGAY 270 (668)
T ss_pred cchhhhhcc---ccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCc---hHHHHHHHhhcccc
Confidence 999976653 445578999999999999999877 67899999999999999999999655 55667777765554
Q ss_pred CCCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCcc
Q 039291 239 LPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVK 278 (362)
Q Consensus 239 ~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~~ 278 (362)
.. +..+.++..||+.||.+||++|.|++++-.|=|+.
T Consensus 271 rE---P~~PSdA~gLIRwmLmVNP~RRATieDiAsHWWvN 307 (668)
T KOG0611|consen 271 RE---PETPSDASGLIRWMLMVNPERRATIEDIASHWWVN 307 (668)
T ss_pred cC---CCCCchHHHHHHHHHhcCcccchhHHHHhhhheee
Confidence 32 23567899999999999999999999999997653
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-47 Score=349.62 Aligned_cols=247 Identities=26% Similarity=0.449 Sum_probs=204.3
Q ss_pred ecccCceEEEEEEECCCCCCCCceeeeechhh------hhhHHHHHHHHHHHHcCCCCcccccccceeeecCCCceEEEE
Q 039291 14 IGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEV------SASASLQKEKEVFDNLNGCPFVLECFGEEITMGENGEMAYNL 87 (362)
Q Consensus 14 lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~------~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~~~~~~~l 87 (362)
||+|+||+||+|+++.++. .+++|.... .....+.+|+.++++++ ||||+++++.+.. ...+++
T Consensus 1 lg~G~~g~Vy~~~~~~~~~----~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~-----~~~~~l 70 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQR----IYALKTIRKAHIVSRSEVTHTLAERTVLAQVN-CPFIVPLKFSFQS-----PEKLYL 70 (312)
T ss_pred CCcCCCeEEEEEEECCCCC----EEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCC-CCcEeceeeEEec-----CCeEEE
Confidence 7999999999999988775 455554432 23456778999999998 9999999876532 335789
Q ss_pred EEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEeecCCccccc
Q 039291 88 LLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSR 167 (362)
Q Consensus 88 v~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Dfgla~~~~ 167 (362)
||||+++|+|.+++.. .+.+++..+..++.||+.||.|||++||+||||||+|||+ +.++.++|+|||+++...
T Consensus 71 v~e~~~~g~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili----~~~~~~kl~Dfg~~~~~~ 144 (312)
T cd05585 71 VLAFINGGELFHHLQR--EGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILL----DYQGHIALCDFGLCKLNM 144 (312)
T ss_pred EEcCCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEE----CCCCcEEEEECcccccCc
Confidence 9999999999999976 4469999999999999999999999999999999999999 778889999999987543
Q ss_pred ccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHHcCCCCCCCCCccCC
Q 039291 168 HCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEHSLPEIPSRVS 247 (362)
Q Consensus 168 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (362)
... ......+||+.|+|||++.+..++.++|||||||++|+|++|+.||... +..+....+.... ..++..++
T Consensus 145 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~---~~~~~~~~~~~~~--~~~~~~~~ 217 (312)
T cd05585 145 KDD--DKTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDE---NVNEMYRKILQEP--LRFPDGFD 217 (312)
T ss_pred cCC--CccccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCC---CHHHHHHHHHcCC--CCCCCcCC
Confidence 221 2223567999999999999989999999999999999999999999643 4455555554332 34567799
Q ss_pred HHHHHHHHHHhccCCCCCC---CHHHHhcCCCccCcchh
Q 039291 248 KEARDFLRRCFVRKPAFRF---TAEMLLDDPFVKGVDEE 283 (362)
Q Consensus 248 ~~~~~li~~~l~~~p~~R~---s~~~~l~~p~~~~~~~~ 283 (362)
.+++++|.+||..||.+|| ++.+++.||||....+.
T Consensus 218 ~~~~~li~~~L~~dp~~R~~~~~~~e~l~hp~~~~~~~~ 256 (312)
T cd05585 218 RDAKDLLIGLLSRDPTRRLGYNGAQEIKNHPFFSQLSWK 256 (312)
T ss_pred HHHHHHHHHHcCCCHHHcCCCCCHHHHHcCCCcCCCCHH
Confidence 9999999999999999997 58999999999987544
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-47 Score=350.50 Aligned_cols=257 Identities=28% Similarity=0.384 Sum_probs=210.9
Q ss_pred ceeecceecccCceEEEEEEECCCCCCCCceeeeechhh------hhhHHHHHHHHHHHHcCCCCcccccccceeeecCC
Q 039291 7 SWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEV------SASASLQKEKEVFDNLNGCPFVLECFGEEITMGEN 80 (362)
Q Consensus 7 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~------~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~ 80 (362)
.|.+.+.||+|+||.||+|+++.+++ .+++|.... .....+..|..++..+.+|++|+.+++.+..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~----~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~---- 72 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDE----LYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQT---- 72 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCC----EEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEc----
Confidence 48899999999999999999988875 456665432 2345677899999999977888888776532
Q ss_pred CceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEeec
Q 039291 81 GEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADL 160 (362)
Q Consensus 81 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Df 160 (362)
...+|+||||++||+|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||+ +.++.+||+||
T Consensus 73 -~~~~~lv~E~~~~g~L~~~~~~--~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill----~~~~~~kL~Df 145 (324)
T cd05587 73 -MDRLYFVMEYVNGGDLMYHIQQ--VGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVML----DAEGHIKIADF 145 (324)
T ss_pred -CCEEEEEEcCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEE----cCCCCEEEeec
Confidence 2347899999999999999976 3459999999999999999999999999999999999999 77788999999
Q ss_pred CCcccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHHcCCCCCC
Q 039291 161 GVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEHSLP 240 (362)
Q Consensus 161 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 240 (362)
|++...... .......+||+.|+|||++.+..++.++||||+||++|+|++|+.||... +..+....+... .+
T Consensus 146 g~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~---~~~~~~~~i~~~--~~ 218 (324)
T cd05587 146 GMCKENIFG--GKTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGE---DEDELFQSIMEH--NV 218 (324)
T ss_pred CcceecCCC--CCceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCC---CHHHHHHHHHcC--CC
Confidence 998643221 11223567999999999999988999999999999999999999999654 344455544332 23
Q ss_pred CCCccCCHHHHHHHHHHhccCCCCCCCH-----HHHhcCCCccCcchhhh
Q 039291 241 EIPSRVSKEARDFLRRCFVRKPAFRFTA-----EMLLDDPFVKGVDEELS 285 (362)
Q Consensus 241 ~~~~~~~~~~~~li~~~l~~~p~~R~s~-----~~~l~~p~~~~~~~~~~ 285 (362)
.++..++.++.+++.+||..||.+|++. +++++||||+.+.+...
T Consensus 219 ~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~hp~~~~~~~~~~ 268 (324)
T cd05587 219 SYPKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREHAFFRRIDWEKL 268 (324)
T ss_pred CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCCcCCCCHHHH
Confidence 4567799999999999999999999976 89999999999877643
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-48 Score=356.08 Aligned_cols=255 Identities=23% Similarity=0.380 Sum_probs=212.1
Q ss_pred CCceeecceecccCceEEEEEEECCCCCCCCceeeeechhh------hhhHHHHHHHHHHHHcCCCCcccccccceeeec
Q 039291 5 GTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEV------SASASLQKEKEVFDNLNGCPFVLECFGEEITMG 78 (362)
Q Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~------~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~ 78 (362)
-++|.+.+.||+|+||.||+|+++.++. ..+++|.... .....+.+|+.+++.++ ||||+++++.+..
T Consensus 29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~---~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~Iv~~~~~~~~-- 102 (340)
T PTZ00426 29 YEDFNFIRTLGTGSFGRVILATYKNEDF---PPVAIKRFEKSKIIKQKQVDHVFSERKILNYIN-HPFCVNLYGSFKD-- 102 (340)
T ss_pred hhhcEEEEEEeecCCeEEEEEEEECCCC---eEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCC-CCCCcceEEEEEe--
Confidence 4679999999999999999999766542 2466665432 23456778999999998 9999999987643
Q ss_pred CCCceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEe
Q 039291 79 ENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIA 158 (362)
Q Consensus 79 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~ 158 (362)
...+++||||++||+|.+++.. .+.+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+
T Consensus 103 ---~~~~~lv~Ey~~~g~L~~~i~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl----~~~~~ikL~ 173 (340)
T PTZ00426 103 ---ESYLYLVLEFVIGGEFFTFLRR--NKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLL----DKDGFIKMT 173 (340)
T ss_pred ---CCEEEEEEeCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEE----CCCCCEEEe
Confidence 2357899999999999999986 4469999999999999999999999999999999999999 778889999
Q ss_pred ecCCcccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHHcCCCC
Q 039291 159 DLGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEHS 238 (362)
Q Consensus 159 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 238 (362)
|||+++..... .....||+.|+|||++.+..++.++|||||||++|+|++|.+||... +.......+....
T Consensus 174 DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~---~~~~~~~~i~~~~- 244 (340)
T PTZ00426 174 DFGFAKVVDTR-----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYAN---EPLLIYQKILEGI- 244 (340)
T ss_pred cCCCCeecCCC-----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCC---CHHHHHHHHhcCC-
Confidence 99998754321 13567999999999999888999999999999999999999999654 3344444444332
Q ss_pred CCCCCccCCHHHHHHHHHHhccCCCCCC-----CHHHHhcCCCccCcchhh
Q 039291 239 LPEIPSRVSKEARDFLRRCFVRKPAFRF-----TAEMLLDDPFVKGVDEEL 284 (362)
Q Consensus 239 ~~~~~~~~~~~~~~li~~~l~~~p~~R~-----s~~~~l~~p~~~~~~~~~ 284 (362)
..+|..++.+++++|++||..||++|+ +++++++||||+++.+..
T Consensus 245 -~~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~~~~~~ 294 (340)
T PTZ00426 245 -IYFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPWFGNIDWVS 294 (340)
T ss_pred -CCCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcCCCcCCCCHHH
Confidence 235667899999999999999999996 899999999999987653
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-48 Score=337.06 Aligned_cols=264 Identities=25% Similarity=0.449 Sum_probs=211.3
Q ss_pred ceeecceecccCceEEEEEEECCCCCCCCceeeeechhhhh-----hHHHHHHHHHHHHcCCCCc-ccccccceeeecC-
Q 039291 7 SWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVSA-----SASLQKEKEVFDNLNGCPF-VLECFGEEITMGE- 79 (362)
Q Consensus 7 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~~~-----~~~~~~E~~il~~l~~h~~-i~~~~~~~~~~~~- 79 (362)
.|..++.||+|+||+||+|+.+.+|+ .||+|....+. -....+|+.+|++|+ |+| |+.+++++.....
T Consensus 12 ~~~~~eklGeGtyg~Vykar~~~~g~----~VALKkirl~~~~EG~P~taiREisllk~L~-~~~~iv~L~dv~~~~~~~ 86 (323)
T KOG0594|consen 12 DYEKVEKLGEGTYGVVYKARSKRTGK----FVALKKIRLEFEEEGVPSTAIREISLLKRLS-HANHIVRLHDVIHTSNNH 86 (323)
T ss_pred HHHHHHHhCCCCceEEEEEEEecCCC----EEEEEEEeccccccCCCchhhHHHHHHHHhC-CCcceEEEEeeeeecccc
Confidence 36778889999999999999999984 67888765442 345689999999999 777 9999997754221
Q ss_pred CCceEEEEEEEecCCCCHHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEE
Q 039291 80 NGEMAYNLLLEYAAGGTLGDLIEKCNG--NGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKI 157 (362)
Q Consensus 80 ~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl 157 (362)
.....+++|+||++- +|..++..... ..++...++.+++||+.||+|||++||+||||||+|||+ +..+.+||
T Consensus 87 ~~~~~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi----~~~G~lKl 161 (323)
T KOG0594|consen 87 RGIGKLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLI----SSSGVLKL 161 (323)
T ss_pred cccceEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEE----CCCCcEee
Confidence 123367899999965 99999988653 358889999999999999999999999999999999999 78999999
Q ss_pred eecCCcccccccccCCCCCCccCCCCccCchhhccc-cCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHHc--
Q 039291 158 ADLGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQH-MQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIG-- 234 (362)
Q Consensus 158 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~-- 234 (362)
+|||+|+...-.. ......++|.+|+|||++.+. .|+...||||+|||++||+++++.|.+..+ ..++..+..
T Consensus 162 aDFGlAra~~ip~--~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se--~~ql~~If~~l 237 (323)
T KOG0594|consen 162 ADFGLARAFSIPM--RTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSE--IDQLFRIFRLL 237 (323)
T ss_pred eccchHHHhcCCc--ccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcH--HHHHHHHHHHc
Confidence 9999998655322 223567899999999999986 789999999999999999999999977654 444443332
Q ss_pred C---CCCCCC-------------C---------CccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCccCcchhh
Q 039291 235 D---EHSLPE-------------I---------PSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGVDEEL 284 (362)
Q Consensus 235 ~---~~~~~~-------------~---------~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~~~~~~~~ 284 (362)
. +..+|. . .+..+++..+++.+||+.+|.+|.|++.++.||||.......
T Consensus 238 GtP~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~~~~~ 312 (323)
T KOG0594|consen 238 GTPNEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSELPEKS 312 (323)
T ss_pred CCCCccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhcccccch
Confidence 1 111111 1 012335899999999999999999999999999998875543
|
|
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-47 Score=349.57 Aligned_cols=252 Identities=28% Similarity=0.419 Sum_probs=207.5
Q ss_pred ceecccCceEEEEEEECCCCCCCCceeeeechhh------hhhHHHHHHHHHHHHcCCCCcccccccceeeecCCCceEE
Q 039291 12 RVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEV------SASASLQKEKEVFDNLNGCPFVLECFGEEITMGENGEMAY 85 (362)
Q Consensus 12 ~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~------~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~~~~~~ 85 (362)
+.||+|+||.||+|+++.++. .+++|.... .....+..|.+++..+.+||||+++++.+.. ...+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~----~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~-----~~~~ 71 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDE----VYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQT-----KDRL 71 (321)
T ss_pred CccccCCCeEEEEEEECCCCC----EEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEc-----CCeE
Confidence 479999999999999988776 455555432 2334567899999988779999999987642 2347
Q ss_pred EEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEeecCCccc
Q 039291 86 NLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKR 165 (362)
Q Consensus 86 ~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Dfgla~~ 165 (362)
|+||||+++++|..++.. ...+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++..
T Consensus 72 ~lv~E~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill----~~~~~~kL~Dfg~~~~ 145 (321)
T cd05591 72 FFVMEYVNGGDLMFQIQR--SRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILL----DAEGHCKLADFGMCKE 145 (321)
T ss_pred EEEEeCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEE----CCCCCEEEeeccccee
Confidence 899999999999999876 3459999999999999999999999999999999999999 7788899999999875
Q ss_pred ccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHHcCCCCCCCCCcc
Q 039291 166 SRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEHSLPEIPSR 245 (362)
Q Consensus 166 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (362)
.... ........||+.|+|||++.+..++.++|||||||++|+|++|+.||... +.......+.... ...+..
T Consensus 146 ~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~---~~~~~~~~i~~~~--~~~p~~ 218 (321)
T cd05591 146 GILN--GVTTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEAD---NEDDLFESILHDD--VLYPVW 218 (321)
T ss_pred cccC--CccccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCC---CHHHHHHHHHcCC--CCCCCC
Confidence 4321 12224567999999999999889999999999999999999999999654 3445555544333 234566
Q ss_pred CCHHHHHHHHHHhccCCCCCC-------CHHHHhcCCCccCcchhhh
Q 039291 246 VSKEARDFLRRCFVRKPAFRF-------TAEMLLDDPFVKGVDEELS 285 (362)
Q Consensus 246 ~~~~~~~li~~~l~~~p~~R~-------s~~~~l~~p~~~~~~~~~~ 285 (362)
++.++.++|.+||..||++|+ +++++++||||..+.+...
T Consensus 219 ~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~hp~~~~~~~~~~ 265 (321)
T cd05591 219 LSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQHPFFKEIDWVLL 265 (321)
T ss_pred CCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcCCccCCCCHHHH
Confidence 899999999999999999999 8999999999999877643
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-47 Score=349.75 Aligned_cols=250 Identities=26% Similarity=0.426 Sum_probs=205.6
Q ss_pred ceecccCceEEEEEEECCCCCCCCceeeeechhh------hhhHHHHHHHHHHHHcCCCCcccccccceeeecCCCceEE
Q 039291 12 RVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEV------SASASLQKEKEVFDNLNGCPFVLECFGEEITMGENGEMAY 85 (362)
Q Consensus 12 ~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~------~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~~~~~~ 85 (362)
+.||+|+||.||+|+++.++.. +++|.... .....+.+|+.+++.++ ||||+++++.+.. ...+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~----~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~-----~~~~ 70 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKY----YAMKILKKEVIIAKDEVAHTLTESRVLKNTR-HPFLTSLKYSFQT-----KDRL 70 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCE----EEEEEEEHHHhhhhhHHHHHHHHHHHHHhCC-CCCCcceEEEEEc-----CCEE
Confidence 5799999999999999888764 45554432 23456778999999998 8999999876532 3357
Q ss_pred EEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEeecCCccc
Q 039291 86 NLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKR 165 (362)
Q Consensus 86 ~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Dfgla~~ 165 (362)
++||||+++|+|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++.
T Consensus 71 ~lv~Ey~~~g~L~~~l~~--~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll----~~~~~~kL~DfG~~~~ 144 (328)
T cd05593 71 CFVMEYVNGGELFFHLSR--ERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLML----DKDGHIKITDFGLCKE 144 (328)
T ss_pred EEEEeCCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEE----CCCCcEEEecCcCCcc
Confidence 899999999999998876 3469999999999999999999999999999999999999 7788899999999875
Q ss_pred ccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHHcCCCCCCCCCcc
Q 039291 166 SRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEHSLPEIPSR 245 (362)
Q Consensus 166 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (362)
.... .......+||+.|+|||++.+..++.++|||||||++|+|++|+.||... +..+....+.... ..++..
T Consensus 145 ~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~---~~~~~~~~~~~~~--~~~p~~ 217 (328)
T cd05593 145 GITD--AATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ---DHEKLFELILMED--IKFPRT 217 (328)
T ss_pred CCCc--ccccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCC---CHHHHHHHhccCC--ccCCCC
Confidence 3321 11223567999999999999888999999999999999999999999644 3344444443322 245677
Q ss_pred CCHHHHHHHHHHhccCCCCCC-----CHHHHhcCCCccCcchhh
Q 039291 246 VSKEARDFLRRCFVRKPAFRF-----TAEMLLDDPFVKGVDEEL 284 (362)
Q Consensus 246 ~~~~~~~li~~~l~~~p~~R~-----s~~~~l~~p~~~~~~~~~ 284 (362)
++.++.+||++||..||++|+ ++.++++||||....+..
T Consensus 218 ~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~~~~~~ 261 (328)
T cd05593 218 LSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRHSFFTGVNWQD 261 (328)
T ss_pred CCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcCCCcCCCCHHH
Confidence 999999999999999999997 899999999999877653
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-49 Score=332.85 Aligned_cols=263 Identities=23% Similarity=0.358 Sum_probs=214.2
Q ss_pred CceeecceecccCceEEEEEEECCCCCCCCceeeeechhh-------hhhHHHHHHHHHHHHcCCCCcccccccceeeec
Q 039291 6 TSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEV-------SASASLQKEKEVFDNLNGCPFVLECFGEEITMG 78 (362)
Q Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~-------~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~ 78 (362)
+.|...+.||+|..++|.++..+.++..++.++..-.... .-.+.-.+|+.||+++.+||+|+++.+.+
T Consensus 17 ~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~y---- 92 (411)
T KOG0599|consen 17 AKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVY---- 92 (411)
T ss_pred hhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeec----
Confidence 4577889999999999999999988765433332222111 12234557999999999999999999866
Q ss_pred CCCceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEe
Q 039291 79 ENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIA 158 (362)
Q Consensus 79 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~ 158 (362)
+...++++|+|.|+.|.|++++.. .-.+++...+.|++||++|+.|||.++||||||||+|||+ +++.+++|+
T Consensus 93 -es~sF~FlVFdl~prGELFDyLts--~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILl----ddn~~i~is 165 (411)
T KOG0599|consen 93 -ESDAFVFLVFDLMPRGELFDYLTS--KVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILL----DDNMNIKIS 165 (411)
T ss_pred -cCcchhhhhhhhcccchHHHHhhh--heeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheee----ccccceEEe
Confidence 445678899999999999999987 4459999999999999999999999999999999999999 889999999
Q ss_pred ecCCcccccccccCCCCCCccCCCCccCchhhcc------ccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHH
Q 039291 159 DLGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQ------HMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSI 232 (362)
Q Consensus 159 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~ 232 (362)
|||+|+.......- ...||||+|+|||.+.+ ..|+..+|+|++|||||.|+.|.+||... ....+++.
T Consensus 166 DFGFa~~l~~GekL---relCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHR---kQmlMLR~ 239 (411)
T KOG0599|consen 166 DFGFACQLEPGEKL---RELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHR---KQMLMLRM 239 (411)
T ss_pred ccceeeccCCchhH---HHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHH---HHHHHHHH
Confidence 99999877654332 57899999999999874 35778899999999999999999999543 23344555
Q ss_pred HcCCCCC--CCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCccCcchhhh
Q 039291 233 IGDEHSL--PEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGVDEELS 285 (362)
Q Consensus 233 ~~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~~~~~~~~~ 285 (362)
|..+..- ..-+.+++.+.++||++||+.||.+|+|++++|.||||.++.....
T Consensus 240 ImeGkyqF~speWadis~~~KdLIsrlLqVdp~~Ritake~LaHpff~q~~~~~~ 294 (411)
T KOG0599|consen 240 IMEGKYQFRSPEWADISATVKDLISRLLQVDPTKRITAKEALAHPFFIQIAQQQA 294 (411)
T ss_pred HHhcccccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhcChHHHHHHHhcc
Confidence 5544432 2234678999999999999999999999999999999987655433
|
|
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-47 Score=349.74 Aligned_cols=251 Identities=30% Similarity=0.489 Sum_probs=206.9
Q ss_pred ceecccCceEEEEEEECCCCCCCCceeeeechhh------hhhHHHHHHHHHHHHcCCCCcccccccceeeecCCCceEE
Q 039291 12 RVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEV------SASASLQKEKEVFDNLNGCPFVLECFGEEITMGENGEMAY 85 (362)
Q Consensus 12 ~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~------~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~~~~~~ 85 (362)
+.||+|+||+||+|+++.++. .+++|.... .....+..|..++..+.+||||+++++.+.. ...+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~----~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~-----~~~~ 71 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGR----LYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQT-----PDRL 71 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCC----EEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEc-----CCEE
Confidence 579999999999999988775 456665432 2345567888999888779999999986542 3357
Q ss_pred EEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEeecCCccc
Q 039291 86 NLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKR 165 (362)
Q Consensus 86 ~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Dfgla~~ 165 (362)
|+||||++||+|.+++.. ...+++..+..++.|++.||+|||++||+||||||+|||+ +.++.+||+|||+++.
T Consensus 72 ~iv~Ey~~~g~L~~~i~~--~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli----~~~~~~kL~DfG~~~~ 145 (320)
T cd05590 72 FFVMEFVNGGDLMFHIQK--SRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLL----DHEGHCKLADFGMCKE 145 (320)
T ss_pred EEEEcCCCCchHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEE----CCCCcEEEeeCCCCee
Confidence 899999999999999876 3459999999999999999999999999999999999999 7788899999999875
Q ss_pred ccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHHcCCCCCCCCCcc
Q 039291 166 SRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEHSLPEIPSR 245 (362)
Q Consensus 166 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (362)
.... ........||+.|+|||++.+..++.++|||||||++|+|++|+.||... +..++...+.... ...+..
T Consensus 146 ~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~---~~~~~~~~i~~~~--~~~~~~ 218 (320)
T cd05590 146 GIFN--GKTTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAE---NEDDLFEAILNDE--VVYPTW 218 (320)
T ss_pred cCcC--CCcccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCC---CHHHHHHHHhcCC--CCCCCC
Confidence 3321 12223567999999999999888999999999999999999999999654 3445555554332 235567
Q ss_pred CCHHHHHHHHHHhccCCCCCCCH------HHHhcCCCccCcchhh
Q 039291 246 VSKEARDFLRRCFVRKPAFRFTA------EMLLDDPFVKGVDEEL 284 (362)
Q Consensus 246 ~~~~~~~li~~~l~~~p~~R~s~------~~~l~~p~~~~~~~~~ 284 (362)
++.+++++|++||..||++|+++ ++++.||||+.+.++.
T Consensus 219 ~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h~~f~~~~~~~ 263 (320)
T cd05590 219 LSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRHPFFKELDWEK 263 (320)
T ss_pred CCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcCCCcCCCCHHH
Confidence 89999999999999999999998 8999999999887653
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-47 Score=355.33 Aligned_cols=264 Identities=25% Similarity=0.345 Sum_probs=205.7
Q ss_pred ceeecceecccCceEEEEEEECCCCCCCCceeeeechhh-----hhhHHHHHHHHHHHHcCCCCcccccccceeeecCCC
Q 039291 7 SWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEV-----SASASLQKEKEVFDNLNGCPFVLECFGEEITMGENG 81 (362)
Q Consensus 7 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~-----~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~~ 81 (362)
+|.+.+.||+|+||.||+|+++.++. .+++|.... .....+.+|+.+++.++ ||||+++++++.......
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~----~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~ 75 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGE----KVAIKKINDVFEHVSDATRILREIKLLRLLR-HPDIVEIKHIMLPPSRRE 75 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCC----EEEEEEechhhccchhHHHHHHHHHHHHhCC-CCCEeeecceEeccCCCC
Confidence 69999999999999999999988875 556665432 23346789999999998 999999998776544333
Q ss_pred ceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEeecC
Q 039291 82 EMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLG 161 (362)
Q Consensus 82 ~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Dfg 161 (362)
...+|+||||+. ++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||
T Consensus 76 ~~~~~lv~e~~~-~~L~~~l~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll----~~~~~~kL~Dfg 148 (338)
T cd07859 76 FKDIYVVFELME-SDLHQVIKA--NDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILA----NADCKLKICDFG 148 (338)
T ss_pred CceEEEEEecCC-CCHHHHHHh--cccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEE----CCCCcEEEccCc
Confidence 445789999995 699998876 3459999999999999999999999999999999999999 788899999999
Q ss_pred Cccccccccc-CCCCCCccCCCCccCchhhcc--ccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHH--------
Q 039291 162 VAKRSRHCKR-QKFDPSMRGTPLYLAPETVVQ--HMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLF-------- 230 (362)
Q Consensus 162 la~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~-------- 230 (362)
+++....... ........||+.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+.......+
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~ 228 (338)
T cd07859 149 LARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPS 228 (338)
T ss_pred cccccccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCC
Confidence 9975432211 112234679999999999876 57889999999999999999999999654321111110
Q ss_pred ----------------HHHcCCCCC--CCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCccCcch
Q 039291 231 ----------------SIIGDEHSL--PEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGVDE 282 (362)
Q Consensus 231 ----------------~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~~~~~~ 282 (362)
..+...... ......+++++.++|.+||..||++|||+++++.||||+....
T Consensus 229 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~~~ 298 (338)
T cd07859 229 PETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGLAK 298 (338)
T ss_pred HHHHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhhcCc
Confidence 000000000 0111246788999999999999999999999999999987544
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-47 Score=346.25 Aligned_cols=261 Identities=26% Similarity=0.438 Sum_probs=202.8
Q ss_pred CceeecceecccCceEEEEEEECCCCCCCCceeeeechhh-----hhhHHHHHHHHHHHHcC--CCCcccccccceeeec
Q 039291 6 TSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEV-----SASASLQKEKEVFDNLN--GCPFVLECFGEEITMG 78 (362)
Q Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~-----~~~~~~~~E~~il~~l~--~h~~i~~~~~~~~~~~ 78 (362)
++|.+.+.||+|+||+||+|++..++. ..+++|.... .......+|+.+++.+. .||||+++++++....
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~---~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~ 77 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGG---RFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR 77 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCC---eEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEeccc
Confidence 479999999999999999999865432 2456665432 12335667888888775 4999999998775433
Q ss_pred CCCceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEe
Q 039291 79 ENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIA 158 (362)
Q Consensus 79 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~ 158 (362)
.+....+++||||+. ++|.+++.......+++..+..++.|++.||.|||++||+||||||+|||+ +.++.+||+
T Consensus 78 ~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~----~~~~~~kl~ 152 (290)
T cd07862 78 TDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILV----TSSGQIKLA 152 (290)
T ss_pred CCCCCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEE----cCCCCEEEc
Confidence 334456789999996 599999987555669999999999999999999999999999999999999 777889999
Q ss_pred ecCCcccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHH-HHHHHHcC--
Q 039291 159 DLGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSID-QLFSIIGD-- 235 (362)
Q Consensus 159 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~-~~~~~~~~-- 235 (362)
|||+++..... .......||+.|+|||++.+..++.++|||||||++|+|++|.+||.+..+.+.. .+......
T Consensus 153 Dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~ 229 (290)
T cd07862 153 DFGLARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPG 229 (290)
T ss_pred cccceEeccCC---cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCC
Confidence 99998755432 2223567999999999999888999999999999999999999999765332111 11111100
Q ss_pred CCC-------------------CCCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCc
Q 039291 236 EHS-------------------LPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFV 277 (362)
Q Consensus 236 ~~~-------------------~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~ 277 (362)
... ...+...++..+++|+.+||..||++|||+.++++||||
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp~f 290 (290)
T cd07862 230 EEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 290 (290)
T ss_pred hhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcCCCC
Confidence 000 001223578889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-47 Score=347.05 Aligned_cols=255 Identities=24% Similarity=0.416 Sum_probs=199.4
Q ss_pred CCceeecceecccCceEEEEEEECCCCCCCCceeeeechh----hhhhHHHHHHHHHHHHcCCCCcccccccceeeecCC
Q 039291 5 GTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAE----VSASASLQKEKEVFDNLNGCPFVLECFGEEITMGEN 80 (362)
Q Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~----~~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~ 80 (362)
-++|.+.+.||+|+||+||+|+++.++. .+++|... ......+.+|+.+++.++ ||||+++++.+..
T Consensus 4 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~----~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~---- 74 (288)
T cd07871 4 LETYVKLDKLGEGTYATVFKGRSKLTEN----LVALKEIRLEHEEGAPCTAIREVSLLKNLK-HANIVTLHDIIHT---- 74 (288)
T ss_pred cccceEeeEEecCCCEEEEEEEECCCCC----EEEEEEecccccCCcchhHHHHHHHHHhCC-CCCEeeEEEEEcC----
Confidence 3679999999999999999999988775 45555443 223446779999999998 8999999986542
Q ss_pred CceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEeec
Q 039291 81 GEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADL 160 (362)
Q Consensus 81 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Df 160 (362)
...+++||||+.+ +|.+++... +..+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+||
T Consensus 75 -~~~~~lv~e~~~~-~l~~~l~~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~----~~~~~~kl~Df 147 (288)
T cd07871 75 -ERCLTLVFEYLDS-DLKQYLDNC-GNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLI----NEKGELKLADF 147 (288)
T ss_pred -CCeEEEEEeCCCc-CHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEE----CCCCCEEECcC
Confidence 2357799999975 999988763 3458999999999999999999999999999999999999 77788999999
Q ss_pred CCcccccccccCCCCCCccCCCCccCchhhcc-ccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHH-HHHcCC--
Q 039291 161 GVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQ-HMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLF-SIIGDE-- 236 (362)
Q Consensus 161 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~-~~~~~~-- 236 (362)
|+++..... ........|++.|+|||++.+ ..++.++||||+||++|+|++|++||...+........ ..+...
T Consensus 148 G~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 225 (288)
T cd07871 148 GLARAKSVP--TKTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTE 225 (288)
T ss_pred cceeeccCC--CccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCh
Confidence 998754322 112234568999999999876 46889999999999999999999999654322111111 111100
Q ss_pred --------------CCCCC--------CCccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCc
Q 039291 237 --------------HSLPE--------IPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFV 277 (362)
Q Consensus 237 --------------~~~~~--------~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~ 277 (362)
...+. ....++.++++||++||..||.+|||++++++||||
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~f 288 (288)
T cd07871 226 ETWPGITSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF 288 (288)
T ss_pred HHhhccccchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCCC
Confidence 00011 113468899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-47 Score=347.62 Aligned_cols=251 Identities=27% Similarity=0.432 Sum_probs=205.8
Q ss_pred ceecccCceEEEEEEECCCCCCCCceeeeechhh------hhhHHHHHHHHHHHHcCCCCcccccccceeeecCCCceEE
Q 039291 12 RVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEV------SASASLQKEKEVFDNLNGCPFVLECFGEEITMGENGEMAY 85 (362)
Q Consensus 12 ~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~------~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~~~~~~ 85 (362)
+.||+|+||.||+|+++.++. .+++|.... ........|..++..+.+||+|+++++.+.. ...+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~----~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~-----~~~~ 71 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGE----YFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQT-----KEHL 71 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCC----EEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEe-----CCEE
Confidence 579999999999999998876 456665432 2334567788888877669999999886642 2357
Q ss_pred EEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEeecCCccc
Q 039291 86 NLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKR 165 (362)
Q Consensus 86 ~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Dfgla~~ 165 (362)
|+||||+.||+|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||+ +.++.++|+|||+++.
T Consensus 72 ~lv~E~~~~g~L~~~i~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~----~~~~~~kl~Dfg~~~~ 145 (316)
T cd05620 72 FFVMEFLNGGDLMFHIQD--KGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVML----DRDGHIKIADFGMCKE 145 (316)
T ss_pred EEEECCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEE----CCCCCEEeCccCCCee
Confidence 899999999999999876 3559999999999999999999999999999999999999 7778899999999864
Q ss_pred ccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHHcCCCCCCCCCcc
Q 039291 166 SRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEHSLPEIPSR 245 (362)
Q Consensus 166 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (362)
.... .......+||+.|+|||++.+..++.++|||||||++|+|++|..||... +..++...+... .+.++..
T Consensus 146 ~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~---~~~~~~~~~~~~--~~~~~~~ 218 (316)
T cd05620 146 NVFG--DNRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGD---DEDELFESIRVD--TPHYPRW 218 (316)
T ss_pred cccC--CCceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCC---CHHHHHHHHHhC--CCCCCCC
Confidence 3221 12224567999999999999989999999999999999999999999654 334444444322 3456667
Q ss_pred CCHHHHHHHHHHhccCCCCCCCH-HHHhcCCCccCcchhh
Q 039291 246 VSKEARDFLRRCFVRKPAFRFTA-EMLLDDPFVKGVDEEL 284 (362)
Q Consensus 246 ~~~~~~~li~~~l~~~p~~R~s~-~~~l~~p~~~~~~~~~ 284 (362)
++.+++++|++||+.||++|+++ +++++||||+.+.+..
T Consensus 219 ~~~~~~~li~~~l~~dP~~R~~~~~~~~~h~~f~~~~~~~ 258 (316)
T cd05620 219 ITKESKDILEKLFERDPTRRLGVVGNIRGHPFFKTINWTA 258 (316)
T ss_pred CCHHHHHHHHHHccCCHHHcCCChHHHHcCCCcCCCCHHH
Confidence 89999999999999999999997 5899999999987653
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-47 Score=346.70 Aligned_cols=251 Identities=31% Similarity=0.494 Sum_probs=205.2
Q ss_pred ceecccCceEEEEEEECCCCCCCCceeeeechhh------hhhHHHHHHHHHHHHcCCCCcccccccceeeecCCCceEE
Q 039291 12 RVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEV------SASASLQKEKEVFDNLNGCPFVLECFGEEITMGENGEMAY 85 (362)
Q Consensus 12 ~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~------~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~~~~~~ 85 (362)
+.||+|+||+||+|+++.+++. +++|.... ........|..++..+.+||||+++++.+.. ...+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~----vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~-----~~~~ 71 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEF----FAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQT-----KEHL 71 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCE----EEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEc-----CCEE
Confidence 4799999999999999888764 55554432 2334456778888877679999999876532 2357
Q ss_pred EEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEeecCCccc
Q 039291 86 NLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKR 165 (362)
Q Consensus 86 ~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Dfgla~~ 165 (362)
++||||++||+|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++.
T Consensus 72 ~lv~e~~~gg~L~~~~~~--~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill----~~~~~~kL~Dfg~a~~ 145 (316)
T cd05592 72 FFVMEYLNGGDLMFHIQS--SGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLL----DKDGHIKIADFGMCKE 145 (316)
T ss_pred EEEEcCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEE----CCCCCEEEccCcCCeE
Confidence 899999999999999976 3459999999999999999999999999999999999999 7778899999999875
Q ss_pred ccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHHcCCCCCCCCCcc
Q 039291 166 SRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEHSLPEIPSR 245 (362)
Q Consensus 166 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (362)
..... ......+||+.|+|||++.+..++.++|||||||++|+|++|..||.+. +..++...+.. ..+.++..
T Consensus 146 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~---~~~~~~~~i~~--~~~~~~~~ 218 (316)
T cd05592 146 NMNGE--GKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGE---DEDELFDSILN--DRPHFPRW 218 (316)
T ss_pred CCCCC--CccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCC---CHHHHHHHHHc--CCCCCCCC
Confidence 43322 2224567999999999999888999999999999999999999999654 33445444433 23456677
Q ss_pred CCHHHHHHHHHHhccCCCCCCCH-HHHhcCCCccCcchhh
Q 039291 246 VSKEARDFLRRCFVRKPAFRFTA-EMLLDDPFVKGVDEEL 284 (362)
Q Consensus 246 ~~~~~~~li~~~l~~~p~~R~s~-~~~l~~p~~~~~~~~~ 284 (362)
++.++.++|.+||+.||++|+++ .++++||||+.+.+..
T Consensus 219 ~~~~~~~ll~~~l~~~P~~R~~~~~~l~~h~~~~~~~~~~ 258 (316)
T cd05592 219 ISKEAKDCLSKLFERDPTKRLGVDGDIRQHPFFRGIDWER 258 (316)
T ss_pred CCHHHHHHHHHHccCCHHHcCCChHHHHcCcccCCCCHHH
Confidence 99999999999999999999986 5899999999987654
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-47 Score=355.13 Aligned_cols=260 Identities=29% Similarity=0.502 Sum_probs=212.4
Q ss_pred CceeecceecccCceEEEEEEECCCCCCCCceeeeechhh------hhhHHHHHHHHHHHHcCCCCcccccccceeeecC
Q 039291 6 TSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEV------SASASLQKEKEVFDNLNGCPFVLECFGEEITMGE 79 (362)
Q Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~------~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~ 79 (362)
++|.+.+.||+|+||+||+|+++.+++ .+++|.... .....+.+|+.++..++ ||||+++++.+..
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~----~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~--- 72 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQ----VYAMKVLRKSDMIKRNQIAHVRAERDILADAD-SPWIVKLYYSFQD--- 72 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCC----EEEEEEEEHHHHhhccHHHHHHHHHHHHHhcC-CCCccchhhheec---
Confidence 579999999999999999999998775 456665432 23456788999999998 9999999886542
Q ss_pred CCceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEee
Q 039291 80 NGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIAD 159 (362)
Q Consensus 80 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~D 159 (362)
...+++||||++|++|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|
T Consensus 73 --~~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll----~~~~~~kL~D 144 (350)
T cd05573 73 --EEHLYLVMEYMPGGDLMNLLIRK--DVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILI----DADGHIKLAD 144 (350)
T ss_pred --CCeEEEEEcCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEE----CCCCCEEeec
Confidence 33578999999999999999873 569999999999999999999999999999999999999 7788899999
Q ss_pred cCCcccccccc---------------------------cCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHH
Q 039291 160 LGVAKRSRHCK---------------------------RQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEML 212 (362)
Q Consensus 160 fgla~~~~~~~---------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~ 212 (362)
||++....... .........||+.|+|||++.+..++.++|||||||++|+|+
T Consensus 145 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell 224 (350)
T cd05573 145 FGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEML 224 (350)
T ss_pred CCCCccCcccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhc
Confidence 99997554322 011223467999999999999999999999999999999999
Q ss_pred hCCCCCccCCCCCHHHHHHHHcC---CCCCCCCCccCCHHHHHHHHHHhccCCCCCCC-HHHHhcCCCccCcchhhhh
Q 039291 213 SGRQAWVVKEDCSIDQLFSIIGD---EHSLPEIPSRVSKEARDFLRRCFVRKPAFRFT-AEMLLDDPFVKGVDEELSR 286 (362)
Q Consensus 213 ~g~~pf~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s-~~~~l~~p~~~~~~~~~~~ 286 (362)
+|+.||.... .......+.. ....|.. ..+++++++||.+||. ||.+|++ +++++.||||+.+.++...
T Consensus 225 ~g~~Pf~~~~---~~~~~~~i~~~~~~~~~p~~-~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp~~~~~~~~~~~ 297 (350)
T cd05573 225 YGFPPFYSDT---LQETYNKIINWKESLRFPPD-PPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHPFFKGIDWENLR 297 (350)
T ss_pred cCCCCCCCCC---HHHHHHHHhccCCcccCCCC-CCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCCCcCCCCHHHHh
Confidence 9999996543 3333333333 2222222 2369999999999997 9999999 9999999999998776543
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-47 Score=348.77 Aligned_cols=250 Identities=27% Similarity=0.451 Sum_probs=201.5
Q ss_pred ceecccCceEEEEEEECCCCCCCCceeeeechhhh------hhHHHHHHHHH-HHHcCCCCcccccccceeeecCCCceE
Q 039291 12 RVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVS------ASASLQKEKEV-FDNLNGCPFVLECFGEEITMGENGEMA 84 (362)
Q Consensus 12 ~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~~------~~~~~~~E~~i-l~~l~~h~~i~~~~~~~~~~~~~~~~~ 84 (362)
+.||+|+||+||+|+++.+++ .+++|..... ....+..|..+ ++.++ ||||+++++.+.. ...
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~----~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~-hp~iv~~~~~~~~-----~~~ 70 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGK----FYAVKVLQKKAILKKKEQKHIMAERNVLLKNVK-HPFLVGLHYSFQT-----ADK 70 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCC----EEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCC-CCCCCCeeEEEEe-----CCE
Confidence 579999999999999988876 4566654322 22334455554 56676 9999999876542 235
Q ss_pred EEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEeecCCcc
Q 039291 85 YNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAK 164 (362)
Q Consensus 85 ~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Dfgla~ 164 (362)
+++||||++||+|..++.. ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++
T Consensus 71 ~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll----~~~~~~kl~Dfg~~~ 144 (323)
T cd05575 71 LYFVLDYVNGGELFFHLQR--ERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILL----DSQGHVVLTDFGLCK 144 (323)
T ss_pred EEEEEcCCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEE----CCCCcEEEeccCCCc
Confidence 7799999999999999976 4569999999999999999999999999999999999999 778889999999986
Q ss_pred cccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHHcCCCCCCCCCc
Q 039291 165 RSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEHSLPEIPS 244 (362)
Q Consensus 165 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (362)
.... ........+||+.|+|||++.+..++.++|||||||++|+|++|..||... +..++...+.... ..++.
T Consensus 145 ~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~---~~~~~~~~i~~~~--~~~~~ 217 (323)
T cd05575 145 EGIE--HSKTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSR---DTAEMYDNILNKP--LRLKP 217 (323)
T ss_pred cccc--CCCccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCC---CHHHHHHHHHcCC--CCCCC
Confidence 4332 122223567999999999999989999999999999999999999999644 4455555543332 23456
Q ss_pred cCCHHHHHHHHHHhccCCCCCCCH----HHHhcCCCccCcchhh
Q 039291 245 RVSKEARDFLRRCFVRKPAFRFTA----EMLLDDPFVKGVDEEL 284 (362)
Q Consensus 245 ~~~~~~~~li~~~l~~~p~~R~s~----~~~l~~p~~~~~~~~~ 284 (362)
.++.++.++|.+||+.||.+||++ .++++||||..+.+..
T Consensus 218 ~~~~~~~~li~~~l~~~p~~R~~~~~~~~~il~~~~~~~~~~~~ 261 (323)
T cd05575 218 NISVSARHLLEGLLQKDRTKRLGAKDDFLEIKNHVFFSSINWDD 261 (323)
T ss_pred CCCHHHHHHHHHHhhcCHHhCCCCCCCHHHHHcCCCcCCCCHHH
Confidence 789999999999999999999987 6999999999877653
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-47 Score=347.70 Aligned_cols=257 Identities=27% Similarity=0.375 Sum_probs=210.6
Q ss_pred ceeecceecccCceEEEEEEECCCCCCCCceeeeechhh------hhhHHHHHHHHHHHHcCCCCcccccccceeeecCC
Q 039291 7 SWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEV------SASASLQKEKEVFDNLNGCPFVLECFGEEITMGEN 80 (362)
Q Consensus 7 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~------~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~ 80 (362)
.|.+.+.||+|+||+||+|+++.++. .+++|.... ........|..++..+.+|++|+++++.+..
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~----~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~---- 72 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDE----LYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQT---- 72 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCC----EEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEec----
Confidence 48899999999999999999988875 445554432 2234466788888888889999988876532
Q ss_pred CceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEeec
Q 039291 81 GEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADL 160 (362)
Q Consensus 81 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Df 160 (362)
...+++||||+++|+|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||+ +.++.+||+||
T Consensus 73 -~~~~~lv~E~~~~g~L~~~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill----~~~~~~kL~Df 145 (323)
T cd05616 73 -MDRLYFVMEYVNGGDLMYQIQQ--VGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVML----DSEGHIKIADF 145 (323)
T ss_pred -CCEEEEEEcCCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEE----CCCCcEEEccC
Confidence 2357899999999999999876 3459999999999999999999999999999999999999 78889999999
Q ss_pred CCcccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHHcCCCCCC
Q 039291 161 GVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEHSLP 240 (362)
Q Consensus 161 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 240 (362)
|+++..... .......+||+.|+|||++.+..++.++|||||||++|+|++|+.||... +...+...+.... .
T Consensus 146 G~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~---~~~~~~~~i~~~~--~ 218 (323)
T cd05616 146 GMCKENMWD--GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGE---DEDELFQSIMEHN--V 218 (323)
T ss_pred CCceecCCC--CCccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCC---CHHHHHHHHHhCC--C
Confidence 998743321 11223567999999999999999999999999999999999999999654 3445555544332 2
Q ss_pred CCCccCCHHHHHHHHHHhccCCCCCCC-----HHHHhcCCCccCcchhhh
Q 039291 241 EIPSRVSKEARDFLRRCFVRKPAFRFT-----AEMLLDDPFVKGVDEELS 285 (362)
Q Consensus 241 ~~~~~~~~~~~~li~~~l~~~p~~R~s-----~~~~l~~p~~~~~~~~~~ 285 (362)
.+|..++.++++++.+||+.||.+|++ ..+++.||||+.+.+...
T Consensus 219 ~~p~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~~~~~~~~~~ 268 (323)
T cd05616 219 AYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEKL 268 (323)
T ss_pred CCCCcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcCCCcCCCCHHHH
Confidence 456779999999999999999999997 489999999999877643
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-47 Score=357.19 Aligned_cols=260 Identities=23% Similarity=0.410 Sum_probs=206.6
Q ss_pred CceeecceecccCceEEEEEEECCCCCCCCceeeeechhh------hhhHHHHHHHHHHHHcCCCCcccccccceeeecC
Q 039291 6 TSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEV------SASASLQKEKEVFDNLNGCPFVLECFGEEITMGE 79 (362)
Q Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~------~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~ 79 (362)
+.|.+++.||+|+||+||+|+++.+++ .+++|.+.. .....+.+|+.++++++ ||||+++++.+..
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~----~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~-h~~iv~~~~~~~~--- 72 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNA----LYAMKTLRKADVLMRNQAAHVKAERDILAEAD-NEWVVKLYYSFQD--- 72 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCC----EEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCC-CCCcceEEEEEEc---
Confidence 479999999999999999999988875 566665532 23455788999999998 8999999876542
Q ss_pred CCceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEee
Q 039291 80 NGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIAD 159 (362)
Q Consensus 80 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~D 159 (362)
...+|+||||++||+|.+++.. .+.+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|
T Consensus 73 --~~~~~lv~E~~~~g~L~~~i~~--~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill----~~~~~ikL~D 144 (376)
T cd05598 73 --KDNLYFVMDYIPGGDMMSLLIR--LGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILI----DRDGHIKLTD 144 (376)
T ss_pred --CCEEEEEEeCCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEE----CCCCCEEEEe
Confidence 3357899999999999999976 3458999999999999999999999999999999999999 7788899999
Q ss_pred cCCcccccccc-----------------------------------------cCCCCCCccCCCCccCchhhccccCCCc
Q 039291 160 LGVAKRSRHCK-----------------------------------------RQKFDPSMRGTPLYLAPETVVQHMQEAP 198 (362)
Q Consensus 160 fgla~~~~~~~-----------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~ 198 (362)
||++....... ........+||+.|+|||++.+..++.+
T Consensus 145 FG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~ 224 (376)
T cd05598 145 FGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQL 224 (376)
T ss_pred CCCCccccccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcc
Confidence 99975321000 0001123579999999999999999999
Q ss_pred chHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHHcCCCCCCC--CCccCCHHHHHHHHHHhccCCCCCC---CHHHHhc
Q 039291 199 SDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEHSLPE--IPSRVSKEARDFLRRCFVRKPAFRF---TAEMLLD 273 (362)
Q Consensus 199 ~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~~l~~~p~~R~---s~~~~l~ 273 (362)
+|||||||++|+|++|+.||.... ..+....+........ ....++.++.++|.+|+ .+|.+|+ ++.+++.
T Consensus 225 ~DiwSlGvilyell~G~~Pf~~~~---~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~ 300 (376)
T cd05598 225 CDWWSVGVILYEMLVGQPPFLADT---PAETQLKVINWETTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKA 300 (376)
T ss_pred eeeeeccceeeehhhCCCCCCCCC---HHHHHHHHhccCccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhC
Confidence 999999999999999999996543 2232222222111111 12358899999999976 5999999 9999999
Q ss_pred CCCccCcchhhh
Q 039291 274 DPFVKGVDEELS 285 (362)
Q Consensus 274 ~p~~~~~~~~~~ 285 (362)
||||+.+.....
T Consensus 301 h~~~~~~~~~~~ 312 (376)
T cd05598 301 HPFFKGIDFASL 312 (376)
T ss_pred CCCcCCCCHHHH
Confidence 999999876543
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-47 Score=348.69 Aligned_cols=250 Identities=26% Similarity=0.435 Sum_probs=198.9
Q ss_pred ceecccCceEEEEEEECCCCCCCCceeeeechhh------hhhHHHHHHHH-HHHHcCCCCcccccccceeeecCCCceE
Q 039291 12 RVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEV------SASASLQKEKE-VFDNLNGCPFVLECFGEEITMGENGEMA 84 (362)
Q Consensus 12 ~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~------~~~~~~~~E~~-il~~l~~h~~i~~~~~~~~~~~~~~~~~ 84 (362)
+.||+|+||+||+|+++.++.. +++|.... .....+..|.. +++.++ ||||+++++.+.. ...
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~----~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~-h~~Iv~~~~~~~~-----~~~ 70 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKF----YAVKVLQKKAILKKKEEKHIMSERNVLLKNVK-HPFLVGLHFSFQT-----ADK 70 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCE----EEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCC-CCCCCceeEEEEc-----CCe
Confidence 5799999999999999888764 45554332 12233444544 456666 9999999876542 234
Q ss_pred EEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEeecCCcc
Q 039291 85 YNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAK 164 (362)
Q Consensus 85 ~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Dfgla~ 164 (362)
+++||||++|++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++
T Consensus 71 ~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili----~~~~~~kl~DfG~a~ 144 (325)
T cd05602 71 LYFVLDYINGGELFYHLQR--ERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILL----DSQGHIVLTDFGLCK 144 (325)
T ss_pred EEEEEeCCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEE----CCCCCEEEccCCCCc
Confidence 7799999999999999976 4558999999999999999999999999999999999999 777889999999987
Q ss_pred cccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHHcCCCCCCCCCc
Q 039291 165 RSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEHSLPEIPS 244 (362)
Q Consensus 165 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (362)
..... .......+||+.|+|||++.+..++.++|||||||++|+|++|.+||... +..+.+..+.... ..++.
T Consensus 145 ~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~---~~~~~~~~i~~~~--~~~~~ 217 (325)
T cd05602 145 ENIEH--NGTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSR---NTAEMYDNILNKP--LQLKP 217 (325)
T ss_pred ccccC--CCCcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCC---CHHHHHHHHHhCC--cCCCC
Confidence 54321 22224567999999999999989999999999999999999999999644 3444444443322 23455
Q ss_pred cCCHHHHHHHHHHhccCCCCCCCHH----HHhcCCCccCcchhh
Q 039291 245 RVSKEARDFLRRCFVRKPAFRFTAE----MLLDDPFVKGVDEEL 284 (362)
Q Consensus 245 ~~~~~~~~li~~~l~~~p~~R~s~~----~~l~~p~~~~~~~~~ 284 (362)
.++.++.++|++||+.||.+|+++. ++++|+||....+..
T Consensus 218 ~~~~~~~~li~~~l~~~p~~R~~~~~~~~~i~~~~~~~~~~~~~ 261 (325)
T cd05602 218 NITNSARHLLEGLLQKDRTKRLGAKDDFMEIKNHIFFSPINWDD 261 (325)
T ss_pred CCCHHHHHHHHHHcccCHHHCCCCCCCHHHHhcCcccCCCCHHH
Confidence 7899999999999999999999865 899999999887653
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-49 Score=353.01 Aligned_cols=254 Identities=28% Similarity=0.509 Sum_probs=216.7
Q ss_pred CCceeecceecccCceEEEEEEECCCCCCCCceeeeechhhh----hhHHHHHHHHHHHHcCCCCcccccccceeeecCC
Q 039291 5 GTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVS----ASASLQKEKEVFDNLNGCPFVLECFGEEITMGEN 80 (362)
Q Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~~----~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~ 80 (362)
...|...++||+|+||.||+|.+..+++ .||+|.+..+ ....+++|+.+|..++ ++||.++|+.++..
T Consensus 12 ~~~~~~~~~IgrGsfG~Vyk~~d~~t~k----~vAiKii~Le~~~deIediqqei~~Ls~~~-~~~it~yygsyl~g--- 83 (467)
T KOG0201|consen 12 ELLYTKLELIGRGSFGEVYKAIDNKTKK----VVAIKIIDLEEAEDEIEDIQQEISVLSQCD-SPNITEYYGSYLKG--- 83 (467)
T ss_pred ccccccchhccccccceeeeeeeccccc----eEEEEEechhhcchhhHHHHHHHHHHHhcC-cchHHhhhhheeec---
Confidence 4578889999999999999999999875 6788887654 3456889999999999 79999999977642
Q ss_pred CceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEeec
Q 039291 81 GEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADL 160 (362)
Q Consensus 81 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Df 160 (362)
..+.++||||.||++.++++. +..+++..+..++++++.||.|||.++.+|||||+.|||+ ...+.|||+||
T Consensus 84 --~~LwiiMey~~gGsv~~lL~~--~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~----s~~g~vkl~Df 155 (467)
T KOG0201|consen 84 --TKLWIIMEYCGGGSVLDLLKS--GNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILL----SESGDVKLADF 155 (467)
T ss_pred --ccHHHHHHHhcCcchhhhhcc--CCCCccceeeeehHHHHHHhhhhhhcceecccccccceeE----eccCcEEEEec
Confidence 236799999999999999987 4556999999999999999999999999999999999999 66688999999
Q ss_pred CCcccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHHcCCCCCC
Q 039291 161 GVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEHSLP 240 (362)
Q Consensus 161 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 240 (362)
|.+.......... ..++||+.|||||++.+..|+.++||||||++.+||.+|.+||..... ...+..| -....|
T Consensus 156 gVa~ql~~~~~rr--~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hP---mrvlflI-pk~~PP 229 (467)
T KOG0201|consen 156 GVAGQLTNTVKRR--KTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHP---MRVLFLI-PKSAPP 229 (467)
T ss_pred ceeeeeechhhcc--ccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCc---ceEEEec-cCCCCC
Confidence 9998776543333 689999999999999998999999999999999999999999955433 2221122 233445
Q ss_pred CCCccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCccCc
Q 039291 241 EIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGV 280 (362)
Q Consensus 241 ~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~~~~ 280 (362)
.+...+++.+++|+..||+.||+.||+|.++|+|+|++..
T Consensus 230 ~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh~FIk~a 269 (467)
T KOG0201|consen 230 RLDGDFSPPFKEFVEACLDKNPEFRPSAKELLKHKFIKRA 269 (467)
T ss_pred ccccccCHHHHHHHHHHhhcCcccCcCHHHHhhhHHHHhc
Confidence 6666899999999999999999999999999999999874
|
|
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-48 Score=358.70 Aligned_cols=250 Identities=31% Similarity=0.529 Sum_probs=214.3
Q ss_pred eecccCceEEEEEEECCCCCCCCceeeeechhhhhh---HHHHHHHHHHHHcCCCCcccccccceeeecCCCceEEEEEE
Q 039291 13 VIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVSAS---ASLQKEKEVFDNLNGCPFVLECFGEEITMGENGEMAYNLLL 89 (362)
Q Consensus 13 ~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~~~~---~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~~~~~~~lv~ 89 (362)
+||+|.||+||.|+|..++ ..+++|.+..... .-+..|+.+.++|. |.|||++++.+.. ..++-+.|
T Consensus 582 VLGKGTYG~VYA~RD~~tq----vrIaIKEIpekdsr~~QPLhEEIaLH~~Lr-HkNIVrYLGs~se-----nGf~kIFM 651 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQ----VRIAIKEIPEKDSREVQPLHEEIALHSTLR-HKNIVRYLGSVSE-----NGFFKIFM 651 (1226)
T ss_pred EeecCceeEEEeeccccce----eEEEeeecccccchhhccHHHHHHHHHHHh-hHhHHHHhhccCC-----CCeEEEEe
Confidence 6999999999999999986 3678888765433 44779999999999 9999999997542 23567899
Q ss_pred EecCCCCHHHHHHHhcCCCC--CHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEeecCCccccc
Q 039291 90 EYAAGGTLGDLIEKCNGNGL--PEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSR 167 (362)
Q Consensus 90 e~~~~~~L~~~l~~~~~~~l--~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Dfgla~~~~ 167 (362)
|-++||+|.++++. .-+++ +|.++.++..||++||.|||++.|||||||-+|||+ +.-.|.+||.|||-+++..
T Consensus 652 EqVPGGSLSsLLrs-kWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLv---NTySGvlKISDFGTsKRLA 727 (1226)
T KOG4279|consen 652 EQVPGGSLSSLLRS-KWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLV---NTYSGVLKISDFGTSKRLA 727 (1226)
T ss_pred ecCCCCcHHHHHHh-ccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEE---eeccceEEecccccchhhc
Confidence 99999999999987 45667 899999999999999999999999999999999999 3677899999999988665
Q ss_pred ccccCCCCCCccCCCCccCchhhcc--ccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHHcCCCCCCCCCcc
Q 039291 168 HCKRQKFDPSMRGTPLYLAPETVVQ--HMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEHSLPEIPSR 245 (362)
Q Consensus 168 ~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (362)
.. .....++.||..|||||++.. +.|+.++|||||||++.||.||++||..- ..+...+-+++--...|.+|..
T Consensus 728 gi--nP~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~El--gspqAAMFkVGmyKvHP~iPee 803 (1226)
T KOG4279|consen 728 GI--NPCTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVEL--GSPQAAMFKVGMYKVHPPIPEE 803 (1226)
T ss_pred cC--CccccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeec--CChhHhhhhhcceecCCCCcHH
Confidence 42 233357889999999999996 47899999999999999999999999643 3455555666666667889999
Q ss_pred CCHHHHHHHHHHhccCCCCCCCHHHHhcCCCccCc
Q 039291 246 VSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGV 280 (362)
Q Consensus 246 ~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~~~~ 280 (362)
++.+++.||.+|+..+|..||+|.++|.+||++.-
T Consensus 804 lsaeak~FilrcFepd~~~R~sA~~LL~DpFlq~~ 838 (1226)
T KOG4279|consen 804 LSAEAKNFILRCFEPDPCDRPSAKDLLQDPFLQHN 838 (1226)
T ss_pred HHHHHHHHHHHHcCCCcccCccHHHhccCcccccC
Confidence 99999999999999999999999999999999765
|
|
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-46 Score=345.34 Aligned_cols=254 Identities=26% Similarity=0.446 Sum_probs=204.8
Q ss_pred cceecccCceEEEEEEECCCCCCCCceeeeechhh-------hhhHHHHHHHHHHHHcCCCCcccccccceeeecCCCce
Q 039291 11 GRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEV-------SASASLQKEKEVFDNLNGCPFVLECFGEEITMGENGEM 83 (362)
Q Consensus 11 ~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~-------~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~~~~ 83 (362)
++.||+|+||.||+|++.... .....+++|.... .....+.+|+.+++.++ ||||+++++.+.. ..
T Consensus 1 ~~~lg~G~~g~V~~~~~~~~~-~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~-hp~iv~~~~~~~~-----~~ 73 (323)
T cd05584 1 LKVLGKGGYGKVFQVRKVTGA-DTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVK-HPFIVDLIYAFQT-----GG 73 (323)
T ss_pred CceeeecCCeEEEEEEEcccC-CCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCC-CCchhceeeEEec-----CC
Confidence 478999999999999875321 1224567766532 12345678999999998 9999999887643 23
Q ss_pred EEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEeecCCc
Q 039291 84 AYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVA 163 (362)
Q Consensus 84 ~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Dfgla 163 (362)
.+|+||||+.|++|.+++.. .+.+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++
T Consensus 74 ~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~----~~~~~~kl~Dfg~~ 147 (323)
T cd05584 74 KLYLILEYLSGGELFMHLER--EGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILL----DAQGHVKLTDFGLC 147 (323)
T ss_pred eEEEEEeCCCCchHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEE----CCCCCEEEeeCcCC
Confidence 57899999999999999976 4558999999999999999999999999999999999999 77888999999998
Q ss_pred ccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHHcCCCCCCCCC
Q 039291 164 KRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEHSLPEIP 243 (362)
Q Consensus 164 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (362)
+..... ........||+.|+|||++.+..++.++|||||||++|+|++|+.||...+ .......+.... ..++
T Consensus 148 ~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~---~~~~~~~~~~~~--~~~~ 220 (323)
T cd05584 148 KESIHE--GTVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAEN---RKKTIDKILKGK--LNLP 220 (323)
T ss_pred eecccC--CCcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCC---HHHHHHHHHcCC--CCCC
Confidence 754322 122235679999999999998889999999999999999999999996543 333344443322 2456
Q ss_pred ccCCHHHHHHHHHHhccCCCCCC-----CHHHHhcCCCccCcchhh
Q 039291 244 SRVSKEARDFLRRCFVRKPAFRF-----TAEMLLDDPFVKGVDEEL 284 (362)
Q Consensus 244 ~~~~~~~~~li~~~l~~~p~~R~-----s~~~~l~~p~~~~~~~~~ 284 (362)
..+++++++||.+||..||++|| ++++++.||||....+..
T Consensus 221 ~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h~~~~~~~~~~ 266 (323)
T cd05584 221 PYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSHPFFRHVNWDD 266 (323)
T ss_pred CCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcCCCcCCCCHHH
Confidence 77899999999999999999999 899999999998876553
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-47 Score=346.17 Aligned_cols=259 Identities=24% Similarity=0.373 Sum_probs=200.9
Q ss_pred CCceeecceecccCceEEEEEEECCCCCCCCceeeeechhh----hhhHHHHHHHHHHHHcCCCCcccccccceeeecCC
Q 039291 5 GTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEV----SASASLQKEKEVFDNLNGCPFVLECFGEEITMGEN 80 (362)
Q Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~----~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~ 80 (362)
.++|.+.+.||+|+||+||+|+++.++. .+++|.... .....+.+|+.+++.++ ||||+++++.+..
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~----~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~---- 74 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGK----LVALKVIRLQEEEGTPFTAIREASLLKGLK-HANIVLLHDIIHT---- 74 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCC----EEEEEEeccccccccchhHHHHHHHHhhCC-CCCcCeEEEEEec----
Confidence 4789999999999999999999988775 456665432 22345678999999998 8999999886542
Q ss_pred CceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEeec
Q 039291 81 GEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADL 160 (362)
Q Consensus 81 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Df 160 (362)
...+++||||+. ++|.+++... ...+++..++.++.|++.||+|||++||+||||||+|||+ +.++.+||+||
T Consensus 75 -~~~~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill----~~~~~~kl~Df 147 (303)
T cd07869 75 -KETLTLVFEYVH-TDLCQYMDKH-PGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLI----SDTGELKLADF 147 (303)
T ss_pred -CCeEEEEEECCC-cCHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE----CCCCCEEECCC
Confidence 335789999996 5888888763 3559999999999999999999999999999999999999 77788999999
Q ss_pred CCcccccccccCCCCCCccCCCCccCchhhcc-ccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHH---cCC
Q 039291 161 GVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQ-HMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSII---GDE 236 (362)
Q Consensus 161 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~---~~~ 236 (362)
|++...... ........||+.|+|||++.+ ..++.++|||||||++|+|++|..||....+ .......+ ...
T Consensus 148 g~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~--~~~~~~~~~~~~~~ 223 (303)
T cd07869 148 GLARAKSVP--SHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKD--IQDQLERIFLVLGT 223 (303)
T ss_pred CcceeccCC--CccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCcc--HHHHHHHHHHHhCC
Confidence 998644321 112234668999999999875 4578899999999999999999999975432 22111111 000
Q ss_pred C---CC------CC---------CC---------ccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCccCcchh
Q 039291 237 H---SL------PE---------IP---------SRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGVDEE 283 (362)
Q Consensus 237 ~---~~------~~---------~~---------~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~~~~~~~ 283 (362)
. .+ +. .+ ...+.++++|+++||+.||++|||+.++++||||+.+...
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~~~~~~ 297 (303)
T cd07869 224 PNEDTWPGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSDLPPR 297 (303)
T ss_pred CChhhccchhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCcccccCChh
Confidence 0 00 00 00 1245789999999999999999999999999999887543
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-47 Score=350.75 Aligned_cols=260 Identities=24% Similarity=0.397 Sum_probs=208.6
Q ss_pred CceeecceecccCceEEEEEEECCCCCCCCceeeeechhh------hhhHHHHHHHHHHHHcCCCCcccccccceeeecC
Q 039291 6 TSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEV------SASASLQKEKEVFDNLNGCPFVLECFGEEITMGE 79 (362)
Q Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~------~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~ 79 (362)
++|.+.+.||+|+||+||+|+++.+++ .+++|.... .....+.+|+.+++.++ ||||+++++.+..
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~----~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~-~~~i~~~~~~~~~--- 72 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGD----IYAMKVMKKSVLLAQETVSFFEEERDILSISN-SPWIPQLQYAFQD--- 72 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCC----EEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCC-CCCCcceeeEEec---
Confidence 479999999999999999999998876 455555432 23456778999999887 9999999876532
Q ss_pred CCceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEee
Q 039291 80 NGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIAD 159 (362)
Q Consensus 80 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~D 159 (362)
...+++||||++|++|.+++... ...+++..++.++.|++.||.|||++||+||||||+|||+ +..+.+||+|
T Consensus 73 --~~~~~lv~e~~~~~~L~~~l~~~-~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll----~~~~~~kL~D 145 (330)
T cd05601 73 --KDNLYLVMEYQPGGDLLSLLNRY-EDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLI----DRTGHIKLAD 145 (330)
T ss_pred --CCeEEEEECCCCCCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEE----CCCCCEEecc
Confidence 33578999999999999999874 2469999999999999999999999999999999999999 7788899999
Q ss_pred cCCcccccccccCCCCCCccCCCCccCchhhc------cccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHH
Q 039291 160 LGVAKRSRHCKRQKFDPSMRGTPLYLAPETVV------QHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSII 233 (362)
Q Consensus 160 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~ 233 (362)
||++......... ......||+.|+|||++. ...++.++|||||||++|+|++|..||... .....+..+
T Consensus 146 fg~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~---~~~~~~~~i 221 (330)
T cd05601 146 FGSAARLTANKMV-NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEG---TSAKTYNNI 221 (330)
T ss_pred CCCCeECCCCCce-eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCC---CHHHHHHHH
Confidence 9999765432211 223457999999999987 456778999999999999999999999544 233334443
Q ss_pred cCCCCCCCCC--ccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCccCcchhhh
Q 039291 234 GDEHSLPEIP--SRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGVDEELS 285 (362)
Q Consensus 234 ~~~~~~~~~~--~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~~~~~~~~~ 285 (362)
........++ ..++.++++||.+||. +|.+||++++++.||||+.+.+...
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h~~~~~~~~~~~ 274 (330)
T cd05601 222 MNFQRFLKFPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCHPFFSKIDWNNI 274 (330)
T ss_pred HcCCCccCCCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCCCCcCCCCHHHH
Confidence 3322222222 3578999999999998 9999999999999999998877643
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-47 Score=356.79 Aligned_cols=259 Identities=24% Similarity=0.428 Sum_probs=206.0
Q ss_pred CceeecceecccCceEEEEEEECCCCCCCCceeeeechhh------hhhHHHHHHHHHHHHcCCCCcccccccceeeecC
Q 039291 6 TSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEV------SASASLQKEKEVFDNLNGCPFVLECFGEEITMGE 79 (362)
Q Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~------~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~ 79 (362)
++|..++.||+|+||+||+|+++.++. .+++|.... .....+.+|+.+++.++ ||||+++++.+..
T Consensus 1 ~~f~~~~~LG~G~~g~Vy~a~~~~~~~----~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~-h~~iv~~~~~~~~--- 72 (382)
T cd05625 1 SMFVKIKTLGIGAFGEVCLARKVDTKA----LYAMKTLRKKDVLLRNQVAHVKAERDILAEAD-NEWVVRLYYSFQD--- 72 (382)
T ss_pred CCcEEEEEEEeCCCEEEEEEEECCCCC----EEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCC-CCcCCeEEEEEEe---
Confidence 469999999999999999999988876 456665432 23456788999999998 8999999987642
Q ss_pred CCceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEee
Q 039291 80 NGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIAD 159 (362)
Q Consensus 80 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~D 159 (362)
...+|+||||++||+|.+++.. .+.+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|
T Consensus 73 --~~~~~lv~E~~~gg~L~~~l~~--~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl----~~~g~~kL~D 144 (382)
T cd05625 73 --KDNLYFVMDYIPGGDMMSLLIR--MGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILI----DRDGHIKLTD 144 (382)
T ss_pred --CCEEEEEEeCCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE----CCCCCEEEeE
Confidence 2357899999999999999976 3459999999999999999999999999999999999999 7788999999
Q ss_pred cCCcccccccc---------------------------------------------cCCCCCCccCCCCccCchhhcccc
Q 039291 160 LGVAKRSRHCK---------------------------------------------RQKFDPSMRGTPLYLAPETVVQHM 194 (362)
Q Consensus 160 fgla~~~~~~~---------------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~ 194 (362)
||++....... ........+||+.|+|||++.+..
T Consensus 145 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~ 224 (382)
T cd05625 145 FGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTG 224 (382)
T ss_pred CCCCccccccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCC
Confidence 99975321100 000112357999999999999989
Q ss_pred CCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHHcCCCCCCCC--CccCCHHHHHHHHHHhccCCCCCCC---HH
Q 039291 195 QEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEHSLPEI--PSRVSKEARDFLRRCFVRKPAFRFT---AE 269 (362)
Q Consensus 195 ~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~li~~~l~~~p~~R~s---~~ 269 (362)
++.++|||||||++|||++|++||...+ ..+....+......... ...+++++.++|.+|+ .+|.+|++ ++
T Consensus 225 ~~~~~DiwSlGvil~elltG~~Pf~~~~---~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ 300 (382)
T cd05625 225 YTQLCDWWSVGVILYEMLVGQPPFLAQT---PLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGAD 300 (382)
T ss_pred CCCeeeEEechHHHHHHHhCCCCCCCCC---HHHHHHHHHccCCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHH
Confidence 9999999999999999999999996543 23322222221111112 2457999999999976 59999997 99
Q ss_pred HHhcCCCccCcchhh
Q 039291 270 MLLDDPFVKGVDEEL 284 (362)
Q Consensus 270 ~~l~~p~~~~~~~~~ 284 (362)
+++.||||+.+.+..
T Consensus 301 ei~~hp~f~~~~~~~ 315 (382)
T cd05625 301 EIKAHPFFKTIDFSS 315 (382)
T ss_pred HHhcCCCcCCcChHH
Confidence 999999999886653
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-47 Score=343.39 Aligned_cols=255 Identities=22% Similarity=0.341 Sum_probs=199.2
Q ss_pred CceeecceecccCceEEEEEEECCCCCCCCceeeeechh-----hhhhHHHHHHHHHHHHcCCCCcccccccceeeecCC
Q 039291 6 TSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAE-----VSASASLQKEKEVFDNLNGCPFVLECFGEEITMGEN 80 (362)
Q Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~-----~~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~ 80 (362)
++|.+.+.||+|+||+||+|+++.++. .+++|... ......+.+|+.+++.++ ||||+++++.+..
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~----~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~---- 71 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKE----IVAIKKFKDSEENEEVKETTLRELKMLRTLK-QENIVELKEAFRR---- 71 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCc----EEEEEEEecccccccchhhHHHHHHHHHhCC-CccccchhhhEec----
Confidence 579999999999999999999988776 34555433 223456788999999998 8999999987642
Q ss_pred CceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEeec
Q 039291 81 GEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADL 160 (362)
Q Consensus 81 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Df 160 (362)
...+++||||++++.+..+... ...+++..++.++.|++.||.|||+.||+||||||+||++ +.++.+||+||
T Consensus 72 -~~~~~lv~e~~~~~~l~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill----~~~~~~kl~Df 144 (287)
T cd07848 72 -RGKLYLVFEYVEKNMLELLEEM--PNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLI----SHNDVLKLCDF 144 (287)
T ss_pred -CCEEEEEEecCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE----cCCCcEEEeec
Confidence 2357899999998766655433 3459999999999999999999999999999999999999 77788999999
Q ss_pred CCcccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHHc------
Q 039291 161 GVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIG------ 234 (362)
Q Consensus 161 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~------ 234 (362)
|++......... ......||+.|+|||++.+..++.++|+|||||++|+|++|++||......+.........
T Consensus 145 g~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 223 (287)
T cd07848 145 GFARNLSEGSNA-NYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAE 223 (287)
T ss_pred cCcccccccccc-cccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHH
Confidence 999765432211 1134578999999999998889999999999999999999999997543221111111110
Q ss_pred ------CCC-----CCC----------CCCccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCc
Q 039291 235 ------DEH-----SLP----------EIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFV 277 (362)
Q Consensus 235 ------~~~-----~~~----------~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~ 277 (362)
... ..+ .....++.++++||++||+.||++|||++++++||||
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~f 287 (287)
T cd07848 224 QMKLFYSNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF 287 (287)
T ss_pred HHHhhhccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 000 001 0112368889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-47 Score=349.33 Aligned_cols=255 Identities=28% Similarity=0.455 Sum_probs=206.2
Q ss_pred ceecccCceEEEEEEECCCCCCCCceeeeechhh------hhhHHHHHHHHHHHHcCCCCcccccccceeeecCCCceEE
Q 039291 12 RVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEV------SASASLQKEKEVFDNLNGCPFVLECFGEEITMGENGEMAY 85 (362)
Q Consensus 12 ~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~------~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~~~~~~ 85 (362)
+.||+|+||.||+|+++.++. .+++|.... ...+.+.+|..++..+.+||||+++++.+.. ...+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~----~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~-----~~~~ 71 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRR----IYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQT-----ESRL 71 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCC----EEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEc-----CCEE
Confidence 579999999999999988876 455555432 2335578899999999779999999886542 3357
Q ss_pred EEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEeecCCccc
Q 039291 86 NLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKR 165 (362)
Q Consensus 86 ~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Dfgla~~ 165 (362)
|+||||++||+|.+++.. .+++++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++.
T Consensus 72 ~lv~e~~~~g~L~~~~~~--~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili----~~~~~~kL~Dfg~~~~ 145 (329)
T cd05588 72 FFVIEFVSGGDLMFHMQR--QRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLL----DAEGHIKLTDYGMCKE 145 (329)
T ss_pred EEEEeCCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEE----CCCCCEEECcCccccc
Confidence 899999999999998876 3569999999999999999999999999999999999999 7778899999999864
Q ss_pred ccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHhCCCCCccCCC------CCHHHHHHHHcCCCCC
Q 039291 166 SRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKED------CSIDQLFSIIGDEHSL 239 (362)
Q Consensus 166 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~------~~~~~~~~~~~~~~~~ 239 (362)
.... .......+||+.|+|||++.+..++.++|+|||||++|+|++|+.||..... .....+...+....
T Consensus 146 ~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~-- 221 (329)
T cd05588 146 GIRP--GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQ-- 221 (329)
T ss_pred cccC--CCccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCC--
Confidence 3221 1222356799999999999998999999999999999999999999963211 11222333333222
Q ss_pred CCCCccCCHHHHHHHHHHhccCCCCCCC------HHHHhcCCCccCcchhhh
Q 039291 240 PEIPSRVSKEARDFLRRCFVRKPAFRFT------AEMLLDDPFVKGVDEELS 285 (362)
Q Consensus 240 ~~~~~~~~~~~~~li~~~l~~~p~~R~s------~~~~l~~p~~~~~~~~~~ 285 (362)
..+|..++.++.++|.+||..||.+|++ ++++++||||..+.+...
T Consensus 222 ~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~hp~~~~~~~~~~ 273 (329)
T cd05588 222 IRIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFRNIDWDLL 273 (329)
T ss_pred CCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcCCCCCCCCHHHH
Confidence 2456778999999999999999999987 789999999998877643
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-46 Score=345.99 Aligned_cols=259 Identities=28% Similarity=0.441 Sum_probs=205.6
Q ss_pred ceecccCceEEEEEEECCCCCCCCceeeeech--hhhhhHHHHHHHHHHHHcCCCCcccccccceeeecCCCceEEEEEE
Q 039291 12 RVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSA--EVSASASLQKEKEVFDNLNGCPFVLECFGEEITMGENGEMAYNLLL 89 (362)
Q Consensus 12 ~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~--~~~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~~~~~~~lv~ 89 (362)
+.||+|+||+||+|+++.++..++.++..|.. .......+.+|+.++.++.+||||+++++.+.. ...+++||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~-----~~~~~lv~ 75 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQT-----ESRLFFVI 75 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEe-----CCEEEEEE
Confidence 57999999999999999887644333333321 112334577899999888779999999986643 23578999
Q ss_pred EecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEeecCCccccccc
Q 039291 90 EYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHC 169 (362)
Q Consensus 90 e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Dfgla~~~~~~ 169 (362)
||+++++|..++.. .+.+++..++.++.||+.||.|||++||+||||||+||++ +.++.+||+|||+++.....
T Consensus 76 E~~~~~~L~~~~~~--~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili----~~~~~~kL~DfG~~~~~~~~ 149 (329)
T cd05618 76 EYVNGGDLMFHMQR--QRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLL----DSEGHIKLTDYGMCKEGLRP 149 (329)
T ss_pred eCCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEE----CCCCCEEEeeCCccccccCC
Confidence 99999999998876 3569999999999999999999999999999999999999 77888999999998743321
Q ss_pred ccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHhCCCCCccCC------CCCHHHHHHHHcCCCCCCCCC
Q 039291 170 KRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKE------DCSIDQLFSIIGDEHSLPEIP 243 (362)
Q Consensus 170 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~------~~~~~~~~~~~~~~~~~~~~~ 243 (362)
........||+.|+|||++.+..++.++|||||||++|+|++|+.||.... ......+...+... ...+|
T Consensus 150 --~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~--~~~~p 225 (329)
T cd05618 150 --GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK--QIRIP 225 (329)
T ss_pred --CCccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcC--CCCCC
Confidence 112235679999999999999999999999999999999999999995321 11122233333222 22466
Q ss_pred ccCCHHHHHHHHHHhccCCCCCCC------HHHHhcCCCccCcchhhh
Q 039291 244 SRVSKEARDFLRRCFVRKPAFRFT------AEMLLDDPFVKGVDEELS 285 (362)
Q Consensus 244 ~~~~~~~~~li~~~l~~~p~~R~s------~~~~l~~p~~~~~~~~~~ 285 (362)
..++.++.++|.+||..||++|++ ++++++||||+.+.+...
T Consensus 226 ~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~hp~f~~~~~~~~ 273 (329)
T cd05618 226 RSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDLM 273 (329)
T ss_pred CCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcCCCCCCCCHHHH
Confidence 788999999999999999999998 579999999999877643
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-47 Score=347.32 Aligned_cols=250 Identities=26% Similarity=0.425 Sum_probs=199.8
Q ss_pred ceecccCceEEEEEEECCCCCCCCceeeeechhh------hhhHHHHHHHHH-HHHcCCCCcccccccceeeecCCCceE
Q 039291 12 RVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEV------SASASLQKEKEV-FDNLNGCPFVLECFGEEITMGENGEMA 84 (362)
Q Consensus 12 ~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~------~~~~~~~~E~~i-l~~l~~h~~i~~~~~~~~~~~~~~~~~ 84 (362)
+.||+|+||+||+|+++.+++ .+++|.... .....+.+|..+ ++.++ ||||+++++.+.. ...
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~----~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~-hp~iv~~~~~~~~-----~~~ 70 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGK----CYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVK-HPFLVGLHYSFQT-----TEK 70 (325)
T ss_pred CceeeCCCeEEEEEEECCCCC----EEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCC-CCCCccEEEEEec-----CCE
Confidence 579999999999999988876 455555432 223345556554 55566 9999999876542 335
Q ss_pred EEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEeecCCcc
Q 039291 85 YNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAK 164 (362)
Q Consensus 85 ~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Dfgla~ 164 (362)
+++||||+.||+|..++.. ...+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++
T Consensus 71 ~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll----~~~~~~kL~DfG~~~ 144 (325)
T cd05604 71 LYFVLDFVNGGELFFHLQR--ERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILL----DSQGHVVLTDFGLCK 144 (325)
T ss_pred EEEEEcCCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEE----CCCCCEEEeecCCcc
Confidence 7799999999999998876 4569999999999999999999999999999999999999 778889999999986
Q ss_pred cccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHHcCCCCCCCCCc
Q 039291 165 RSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEHSLPEIPS 244 (362)
Q Consensus 165 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (362)
..... .......+||+.|+|||++.+..++.++|||||||++|+|++|..||... +..++...+.... ..++.
T Consensus 145 ~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~---~~~~~~~~~~~~~--~~~~~ 217 (325)
T cd05604 145 EGIAQ--SDTTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCR---DVAEMYDNILHKP--LVLRP 217 (325)
T ss_pred cCCCC--CCCcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCC---CHHHHHHHHHcCC--ccCCC
Confidence 43321 12224567999999999999989999999999999999999999999654 3445555443332 23345
Q ss_pred cCCHHHHHHHHHHhccCCCCCCCH----HHHhcCCCccCcchhh
Q 039291 245 RVSKEARDFLRRCFVRKPAFRFTA----EMLLDDPFVKGVDEEL 284 (362)
Q Consensus 245 ~~~~~~~~li~~~l~~~p~~R~s~----~~~l~~p~~~~~~~~~ 284 (362)
..+..+.++|.+||..+|.+||++ .++++||||....+..
T Consensus 218 ~~~~~~~~ll~~ll~~~p~~R~~~~~~~~~i~~h~~f~~~~~~~ 261 (325)
T cd05604 218 GASLTAWSILEELLEKDRQRRLGAKEDFLEIQEHPFFESLSWTD 261 (325)
T ss_pred CCCHHHHHHHHHHhccCHHhcCCCCCCHHHHhcCCCcCCCCHHH
Confidence 688999999999999999999976 5899999999876653
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-47 Score=348.37 Aligned_cols=258 Identities=23% Similarity=0.424 Sum_probs=205.7
Q ss_pred CCCCceeecceecccCceEEEEEEECCCCCCCCceeeeechh----hhhhHHHHHHHHHHHHcCCCCcccccccceeeec
Q 039291 3 SDGTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAE----VSASASLQKEKEVFDNLNGCPFVLECFGEEITMG 78 (362)
Q Consensus 3 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~----~~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~ 78 (362)
...++|.+.+.||+|+||.||+|++..++.. +++|... ......+.+|++++++++ ||||+++++.+..
T Consensus 2 l~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~----~a~k~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~-- 74 (331)
T cd06649 2 LKDDDFERISELGAGNGGVVTKVQHKPSGLI----MARKLIHLEIKPAIRNQIIRELQVLHECN-SPYIVGFYGAFYS-- 74 (331)
T ss_pred CCcccceEEEeecCCCCEEEEEEEECCCCcE----EEEEEeecccCHHHHHHHHHHHHHHHHCC-CCCCCeEEEEEEE--
Confidence 3568999999999999999999999988764 4555432 334567889999999998 9999999987643
Q ss_pred CCCceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC-CceeCCCCCCCEEEeecCCCceEEEE
Q 039291 79 ENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDS-GYVHCDVKPDNILLVATQSGKFVAKI 157 (362)
Q Consensus 79 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~-~ivH~Dlkp~Nill~~~~~~~~~~kl 157 (362)
...+++||||+++++|.+++.. ...+++..+..++.|++.||.|||+. +|+||||||+|||+ +.++.++|
T Consensus 75 ---~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~----~~~~~~kl 145 (331)
T cd06649 75 ---DGEISICMEHMDGGSLDQVLKE--AKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILV----NSRGEIKL 145 (331)
T ss_pred ---CCEEEEEeecCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEE----cCCCcEEE
Confidence 2247799999999999999986 34599999999999999999999986 69999999999999 77788999
Q ss_pred eecCCcccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHH--------
Q 039291 158 ADLGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQL-------- 229 (362)
Q Consensus 158 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~-------- 229 (362)
+|||++...... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||...+.......
T Consensus 146 ~Dfg~~~~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~ 221 (331)
T cd06649 146 CDFGVSGQLIDS----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDG 221 (331)
T ss_pred ccCccccccccc----ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhccccccc
Confidence 999998754321 22346799999999999988899999999999999999999999964332111111
Q ss_pred -----------------------------------HHHHcCCCCCCCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhcC
Q 039291 230 -----------------------------------FSIIGDEHSLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDD 274 (362)
Q Consensus 230 -----------------------------------~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~ 274 (362)
...+............++.++++||.+||..||++|||+.++++|
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h 301 (331)
T cd06649 222 EEGEPHSISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNH 301 (331)
T ss_pred ccCCccccCcccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 111111111111112467899999999999999999999999999
Q ss_pred CCccCc
Q 039291 275 PFVKGV 280 (362)
Q Consensus 275 p~~~~~ 280 (362)
|||+..
T Consensus 302 ~~~~~~ 307 (331)
T cd06649 302 TFIKRS 307 (331)
T ss_pred hHHhhc
Confidence 999764
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-47 Score=348.32 Aligned_cols=265 Identities=28% Similarity=0.434 Sum_probs=208.4
Q ss_pred CceeecceecccCceEEEEEEECCCCCCCCceeeeechhh------hhhHHHHHHHHHHHHcCCCCcccccccceeeecC
Q 039291 6 TSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEV------SASASLQKEKEVFDNLNGCPFVLECFGEEITMGE 79 (362)
Q Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~------~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~ 79 (362)
++|.+.+.||+|+||+||+++++.++.. +++|.... .....+.+|..++..++ |++|+.+++.+..
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~----~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~-~~~i~~l~~~~~~--- 72 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERI----YAMKILNKWEMLKRAETACFREERNVLVNGD-CQWITTLHYAFQD--- 72 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCE----EEEEEEeHHHHHhhHHHHHHHHHHHHHHhCC-CCCEeeEEEEEEc---
Confidence 5799999999999999999999888764 45554432 23344678888888887 8999999876542
Q ss_pred CCceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEee
Q 039291 80 NGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIAD 159 (362)
Q Consensus 80 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~D 159 (362)
...+|+||||++||+|.+++... ...+++..++.++.|++.||+|||++||+||||||+|||+ +.++.+||+|
T Consensus 73 --~~~~~lv~Ey~~gg~L~~~l~~~-~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill----~~~~~~kl~D 145 (331)
T cd05624 73 --ENYLYLVMDYYVGGDLLTLLSKF-EDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLL----DMNGHIRLAD 145 (331)
T ss_pred --CCEEEEEEeCCCCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEE----cCCCCEEEEe
Confidence 34578999999999999999863 3459999999999999999999999999999999999999 7778899999
Q ss_pred cCCcccccccccCCCCCCccCCCCccCchhhcc-----ccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHHc
Q 039291 160 LGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQ-----HMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIG 234 (362)
Q Consensus 160 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~ 234 (362)
||++......... ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||... +..+....+.
T Consensus 146 fG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~---~~~~~~~~i~ 221 (331)
T cd05624 146 FGSCLKMNQDGTV-QSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAE---SLVETYGKIM 221 (331)
T ss_pred ccceeeccCCCce-eeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCC---CHHHHHHHHH
Confidence 9998755432111 1123569999999999875 45788999999999999999999999644 3334444443
Q ss_pred CCC---CCCCCCccCCHHHHHHHHHHhccCCCC--CCCHHHHhcCCCccCcchhhhhhhh
Q 039291 235 DEH---SLPEIPSRVSKEARDFLRRCFVRKPAF--RFTAEMLLDDPFVKGVDEELSRELE 289 (362)
Q Consensus 235 ~~~---~~~~~~~~~~~~~~~li~~~l~~~p~~--R~s~~~~l~~p~~~~~~~~~~~~~~ 289 (362)
... .+|.....++.+++++|.+||..++.+ |++++++++||||+.+.++......
T Consensus 222 ~~~~~~~~p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h~~f~~~~~~~~~~~~ 281 (331)
T cd05624 222 NHEERFQFPSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKHAFFEGIDWENIRNLE 281 (331)
T ss_pred cCCCcccCCCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcCCCcCCCCHHHHhhCC
Confidence 322 233333457899999999999876554 4689999999999998877654433
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-46 Score=343.73 Aligned_cols=251 Identities=29% Similarity=0.462 Sum_probs=207.0
Q ss_pred ceecccCceEEEEEEECCCCCCCCceeeeechhh------hhhHHHHHHHHHHHHcCCCCcccccccceeeecCCCceEE
Q 039291 12 RVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEV------SASASLQKEKEVFDNLNGCPFVLECFGEEITMGENGEMAY 85 (362)
Q Consensus 12 ~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~------~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~~~~~~ 85 (362)
+.||+|+||+||+|+++.++. .+++|.... .....+.+|..+++.+.+||||+++++.+.. ...+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~----~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~-----~~~~ 71 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDE----LYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQT-----KDRL 71 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCC----EEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEc-----CCEE
Confidence 579999999999999988776 455554432 2345567899999988779999999986642 2357
Q ss_pred EEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEeecCCccc
Q 039291 86 NLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKR 165 (362)
Q Consensus 86 ~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Dfgla~~ 165 (362)
|+||||++|++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+||++ +.++.++|+|||+++.
T Consensus 72 ~lv~e~~~~~~L~~~~~~--~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill----~~~~~~kl~Dfg~~~~ 145 (318)
T cd05570 72 FFVMEYVNGGDLMFHIQR--SGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLL----DSEGHIKIADFGMCKE 145 (318)
T ss_pred EEEEcCCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEE----CCCCcEEecccCCCee
Confidence 899999999999999876 3459999999999999999999999999999999999999 7788899999999864
Q ss_pred ccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHHcCCCCCCCCCcc
Q 039291 166 SRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEHSLPEIPSR 245 (362)
Q Consensus 166 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (362)
.... .......+||+.|+|||++.+..++.++|+|||||++|+|++|+.||... +.......+.... +.++..
T Consensus 146 ~~~~--~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~---~~~~~~~~i~~~~--~~~~~~ 218 (318)
T cd05570 146 GILG--GVTTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGD---DEDELFQSILEDE--VRYPRW 218 (318)
T ss_pred cCcC--CCcccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCC---CHHHHHHHHHcCC--CCCCCc
Confidence 3221 11223467999999999999999999999999999999999999999644 3445544443332 245667
Q ss_pred CCHHHHHHHHHHhccCCCCCCCH-----HHHhcCCCccCcchhh
Q 039291 246 VSKEARDFLRRCFVRKPAFRFTA-----EMLLDDPFVKGVDEEL 284 (362)
Q Consensus 246 ~~~~~~~li~~~l~~~p~~R~s~-----~~~l~~p~~~~~~~~~ 284 (362)
++.++++||++||..||++||++ .+++.||||+.+.+..
T Consensus 219 ~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~~~~~~~~~~~ 262 (318)
T cd05570 219 LSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGHPFFREIDWDK 262 (318)
T ss_pred CCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcCCCcCCCCHHH
Confidence 89999999999999999999999 9999999999987653
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-46 Score=345.63 Aligned_cols=261 Identities=28% Similarity=0.435 Sum_probs=205.6
Q ss_pred CceeecceecccCceEEEEEEECCCCCCCCceeeeechhh------hhhHHHHHHHHHHHHcCCCCcccccccceeeecC
Q 039291 6 TSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEV------SASASLQKEKEVFDNLNGCPFVLECFGEEITMGE 79 (362)
Q Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~------~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~ 79 (362)
++|.+++.||+|+||+||+|+++.+++ .+++|.... .....+.+|+.+++.++ |+||+++++.+..
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~----~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~--- 72 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQ----VYAMKILNKWEMLKRAETACFREERDVLVNGD-RRWITNLHYAFQD--- 72 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCC----EEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCC-CCCCCceEEEEec---
Confidence 479999999999999999999998875 456665432 23345778999999887 8999999886542
Q ss_pred CCceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEee
Q 039291 80 NGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIAD 159 (362)
Q Consensus 80 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~D 159 (362)
...+|+||||++||+|.+++... ...+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|
T Consensus 73 --~~~~~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill----~~~~~~kl~D 145 (331)
T cd05597 73 --ENNLYLVMDYYVGGDLLTLLSKF-EDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLL----DKNGHIRLAD 145 (331)
T ss_pred --CCeEEEEEecCCCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEE----CCCCCEEEEE
Confidence 34578999999999999999763 3459999999999999999999999999999999999999 7778899999
Q ss_pred cCCcccccccccCCCCCCccCCCCccCchhhcc-----ccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHHc
Q 039291 160 LGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQ-----HMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIG 234 (362)
Q Consensus 160 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~ 234 (362)
||++........ .......||+.|+|||++.. ..++.++|||||||++|+|++|+.||... ...+....+.
T Consensus 146 fg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~---~~~~~~~~i~ 221 (331)
T cd05597 146 FGSCLRLLADGT-VQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAE---SLVETYGKIM 221 (331)
T ss_pred CCceeecCCCCC-ccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCC---CHHHHHHHHH
Confidence 999865433211 11123569999999999873 35678999999999999999999999643 3334433433
Q ss_pred CC---CCCCCCCccCCHHHHHHHHHHhccCCCC--CCCHHHHhcCCCccCcchhhh
Q 039291 235 DE---HSLPEIPSRVSKEARDFLRRCFVRKPAF--RFTAEMLLDDPFVKGVDEELS 285 (362)
Q Consensus 235 ~~---~~~~~~~~~~~~~~~~li~~~l~~~p~~--R~s~~~~l~~p~~~~~~~~~~ 285 (362)
.. ...+.....++.+++++|++||..++++ |+++++++.||||....+...
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp~~~~~~~~~~ 277 (331)
T cd05597 222 NHKEHFQFPPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDHPFFEGIDWDNI 277 (331)
T ss_pred cCCCcccCCCccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCCCCCCCCHHHH
Confidence 22 2233333458999999999998764444 789999999999998876643
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-47 Score=355.24 Aligned_cols=257 Identities=18% Similarity=0.225 Sum_probs=201.7
Q ss_pred CCCceeecceecccCceEEEEEEECCCCCCCCceeeeechhhhhhHHHHHHHHHHHHcCCCCcccccccceeeecCCCce
Q 039291 4 DGTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVSASASLQKEKEVFDNLNGCPFVLECFGEEITMGENGEM 83 (362)
Q Consensus 4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~~~~ 83 (362)
..++|.+.+.||+|+||.||+|.++.+++ .+++|... ...+.+|+.++++|+ ||||+++++.+.. ..
T Consensus 90 ~~~~y~~~~~lg~G~~g~V~~~~d~~~~~----~vaiK~~~---~~~~~~E~~il~~l~-HpnIv~~~~~~~~-----~~ 156 (391)
T PHA03212 90 EKAGFSILETFTPGAEGFAFACIDNKTCE----HVVIKAGQ---RGGTATEAHILRAIN-HPSIIQLKGTFTY-----NK 156 (391)
T ss_pred ccCCcEEEEEEcCCCCeEEEEEEECCCCC----EEEEechh---hhhhHHHHHHHHhCC-CCCCCCEeEEEEE-----CC
Confidence 45789999999999999999999998875 56777643 345679999999998 8999999987643 23
Q ss_pred EEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEeecCCc
Q 039291 84 AYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVA 163 (362)
Q Consensus 84 ~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Dfgla 163 (362)
..++|||++. ++|..++.. ...+++..++.++.||+.||.|||++||+||||||+|||+ +..+.+||+|||+|
T Consensus 157 ~~~lv~e~~~-~~L~~~l~~--~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll----~~~~~vkL~DFG~a 229 (391)
T PHA03212 157 FTCLILPRYK-TDLYCYLAA--KRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFI----NHPGDVCLGDFGAA 229 (391)
T ss_pred eeEEEEecCC-CCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEE----cCCCCEEEEeCCcc
Confidence 4679999995 689888876 3459999999999999999999999999999999999999 77788999999998
Q ss_pred ccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHhCCCCCccCCCC----C-HHH---HHHHHcC
Q 039291 164 KRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDC----S-IDQ---LFSIIGD 235 (362)
Q Consensus 164 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~----~-~~~---~~~~~~~ 235 (362)
+....... .......||+.|+|||++.+..++.++|||||||++|+|++|..||...... + ..+ +....+.
T Consensus 230 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~ 308 (391)
T PHA03212 230 CFPVDINA-NKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGT 308 (391)
T ss_pred cccccccc-cccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcC
Confidence 64332211 1223567999999999999889999999999999999999999887543211 0 011 1111100
Q ss_pred ----------------------C-CCCCC-C-----CccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCccCcc
Q 039291 236 ----------------------E-HSLPE-I-----PSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGVD 281 (362)
Q Consensus 236 ----------------------~-~~~~~-~-----~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~~~~~ 281 (362)
. ...+. . ...++.++.+||.+||..||++|||+++++.||||+.+.
T Consensus 309 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~ 383 (391)
T PHA03212 309 HPNEFPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQDIP 383 (391)
T ss_pred ChhhcCcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhccCC
Confidence 0 00000 0 013567899999999999999999999999999998754
|
|
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-46 Score=346.87 Aligned_cols=250 Identities=27% Similarity=0.416 Sum_probs=204.3
Q ss_pred ceecccCceEEEEEEECCCCCCCCceeeeechhh------hhhHHHHHHHHHHHHcCCCCcccccccceeeecCCCceEE
Q 039291 12 RVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEV------SASASLQKEKEVFDNLNGCPFVLECFGEEITMGENGEMAY 85 (362)
Q Consensus 12 ~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~------~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~~~~~~ 85 (362)
+.||+|+||.||+|+++.++.. +++|.... .....+.+|+++++.++ ||||+++++.+.. ...+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~----~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~-hp~i~~~~~~~~~-----~~~~ 70 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRY----YAMKILKKEVIVAKDEVAHTLTENRVLQNSR-HPFLTALKYSFQT-----HDRL 70 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCE----EEEEEEEHHHhhhhhHHHHHHHHHHHHHhCC-CCCCCceEEEEEc-----CCEE
Confidence 5799999999999999888764 45554432 23345678999999998 8999999876532 3357
Q ss_pred EEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCceeCCCCCCCEEEeecCCCceEEEEeecCCcc
Q 039291 86 NLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHD-SGYVHCDVKPDNILLVATQSGKFVAKIADLGVAK 164 (362)
Q Consensus 86 ~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~-~~ivH~Dlkp~Nill~~~~~~~~~~kl~Dfgla~ 164 (362)
|+||||+++|+|..++.. .+.+++..++.++.||+.||.|||+ .||+||||||+|||+ +.++.+||+|||+++
T Consensus 71 ~lv~E~~~~~~L~~~l~~--~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll----~~~~~~kL~Dfg~~~ 144 (325)
T cd05594 71 CFVMEYANGGELFFHLSR--ERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLML----DKDGHIKITDFGLCK 144 (325)
T ss_pred EEEEeCCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEE----CCCCCEEEecCCCCe
Confidence 899999999999998876 4469999999999999999999997 899999999999999 778889999999986
Q ss_pred cccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHHcCCCCCCCCCc
Q 039291 165 RSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEHSLPEIPS 244 (362)
Q Consensus 165 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (362)
..... ........||+.|+|||++.+..++.++|||||||++|+|++|..||... +.......+.... ..++.
T Consensus 145 ~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~---~~~~~~~~i~~~~--~~~p~ 217 (325)
T cd05594 145 EGIKD--GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ---DHEKLFELILMEE--IRFPR 217 (325)
T ss_pred ecCCC--CcccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCC---CHHHHHHHHhcCC--CCCCC
Confidence 43321 11223467999999999999889999999999999999999999999654 3344444443322 24566
Q ss_pred cCCHHHHHHHHHHhccCCCCCC-----CHHHHhcCCCccCcchhh
Q 039291 245 RVSKEARDFLRRCFVRKPAFRF-----TAEMLLDDPFVKGVDEEL 284 (362)
Q Consensus 245 ~~~~~~~~li~~~l~~~p~~R~-----s~~~~l~~p~~~~~~~~~ 284 (362)
.+++++.+||.+||+.||++|+ ++.++++||||.++.+..
T Consensus 218 ~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~~~~~~ 262 (325)
T cd05594 218 TLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQHKFFAGIVWQD 262 (325)
T ss_pred CCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcCCCcCCCCHHH
Confidence 7899999999999999999997 899999999999877653
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-46 Score=350.47 Aligned_cols=259 Identities=26% Similarity=0.423 Sum_probs=208.4
Q ss_pred CCCceeecceecccCceEEEEEEECCCCCCCCceeeeechhh------hhhHHHHHHHHHHHHcCCCCcccccccceeee
Q 039291 4 DGTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEV------SASASLQKEKEVFDNLNGCPFVLECFGEEITM 77 (362)
Q Consensus 4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~------~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~ 77 (362)
..++|.+.+.||+|+||+||+|+++.++. .+++|.... .....+.+|+.+++.++ ||||+++++.+.
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~----~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~-h~~iv~~~~~~~-- 113 (370)
T cd05596 41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQ----VYAMKLLSKFEMIKRSDSAFFWEERDIMAHAN-SEWIVQLHYAFQ-- 113 (370)
T ss_pred CHHHcEEEEEEeeCCCEEEEEEEECCCCC----EEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCC-CCCcceEEEEEe--
Confidence 45689999999999999999999998876 456665432 23345678999999998 999999987653
Q ss_pred cCCCceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEE
Q 039291 78 GENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKI 157 (362)
Q Consensus 78 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl 157 (362)
....+++||||++||+|.+++.. ..+++..+..++.||+.||+|||++||+||||||+|||+ +.++.+||
T Consensus 114 ---~~~~~~lv~Ey~~gg~L~~~l~~---~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl----~~~~~~kL 183 (370)
T cd05596 114 ---DDKYLYMVMEYMPGGDLVNLMSN---YDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLL----DKSGHLKL 183 (370)
T ss_pred ---cCCEEEEEEcCCCCCcHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEE----cCCCCEEE
Confidence 23457899999999999999875 348999999999999999999999999999999999999 77889999
Q ss_pred eecCCcccccccccCCCCCCccCCCCccCchhhccc----cCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHH
Q 039291 158 ADLGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQH----MQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSII 233 (362)
Q Consensus 158 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~ 233 (362)
+|||++........ ......+||+.|+|||++.+. .++.++|||||||++|+|++|++||...+ ....+..+
T Consensus 184 ~DfG~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~---~~~~~~~i 259 (370)
T cd05596 184 ADFGTCMKMDANGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADS---LVGTYSKI 259 (370)
T ss_pred EeccceeeccCCCc-ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCC---HHHHHHHH
Confidence 99999875543211 122356799999999998753 47889999999999999999999996543 34444444
Q ss_pred cCCCCCCCCCc--cCCHHHHHHHHHHhccCCCC--CCCHHHHhcCCCccCcchh
Q 039291 234 GDEHSLPEIPS--RVSKEARDFLRRCFVRKPAF--RFTAEMLLDDPFVKGVDEE 283 (362)
Q Consensus 234 ~~~~~~~~~~~--~~~~~~~~li~~~l~~~p~~--R~s~~~~l~~p~~~~~~~~ 283 (362)
........++. .++.++++||.+||..+|.+ |+++++++.||||+...+.
T Consensus 260 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~~~~~~~~~ 313 (370)
T cd05596 260 MDHKNSLTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSHPFFKNDQWT 313 (370)
T ss_pred HcCCCcCCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcCcccCCCChh
Confidence 33222222332 57999999999999999988 9999999999999986654
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-46 Score=344.24 Aligned_cols=254 Identities=30% Similarity=0.486 Sum_probs=205.5
Q ss_pred eeecceecccCceEEEEEEECCCCCCCCceeeeechhh------hhhHHHHHHHHHHHHcC--CCCcccccccceeeecC
Q 039291 8 WFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEV------SASASLQKEKEVFDNLN--GCPFVLECFGEEITMGE 79 (362)
Q Consensus 8 y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~------~~~~~~~~E~~il~~l~--~h~~i~~~~~~~~~~~~ 79 (362)
|.+.+.||+|+||.||+|.++.++. .+++|.... .....+.+|++++..+. .||||+++++.+..
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~----~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~--- 73 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGE----LYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQT--- 73 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCC----EEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEc---
Confidence 6789999999999999999988876 455555432 23355777777765443 39999999986642
Q ss_pred CCceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEee
Q 039291 80 NGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIAD 159 (362)
Q Consensus 80 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~D 159 (362)
...+|+||||++|++|..++.. ..+++..++.++.||+.||+|||++||+||||||+||++ +.++.+||+|
T Consensus 74 --~~~~~lv~E~~~~~~L~~~~~~---~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill----~~~~~~kL~D 144 (324)
T cd05589 74 --EDHVCFVMEYAAGGDLMMHIHT---DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLL----DTEGFVKIAD 144 (324)
T ss_pred --CCEEEEEEcCCCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEE----CCCCcEEeCc
Confidence 2357899999999999988864 459999999999999999999999999999999999999 7788899999
Q ss_pred cCCcccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHHcCCCCC
Q 039291 160 LGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEHSL 239 (362)
Q Consensus 160 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 239 (362)
||+++..... .......+||+.|+|||++.+..++.++|||||||++|+|++|+.||... +..+....+....
T Consensus 145 fg~~~~~~~~--~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~---~~~~~~~~i~~~~-- 217 (324)
T cd05589 145 FGLCKEGMGF--GDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGD---DEEEVFDSIVNDE-- 217 (324)
T ss_pred ccCCccCCCC--CCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCC---CHHHHHHHHHhCC--
Confidence 9998643321 12223567999999999999989999999999999999999999999654 3344444443322
Q ss_pred CCCCccCCHHHHHHHHHHhccCCCCCC-----CHHHHhcCCCccCcchhh
Q 039291 240 PEIPSRVSKEARDFLRRCFVRKPAFRF-----TAEMLLDDPFVKGVDEEL 284 (362)
Q Consensus 240 ~~~~~~~~~~~~~li~~~l~~~p~~R~-----s~~~~l~~p~~~~~~~~~ 284 (362)
+..+..++.++.++|.+||..||.+|| ++.++++||||+.+.+..
T Consensus 218 ~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~~~f~~~~~~~ 267 (324)
T cd05589 218 VRYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQPFFRDINWDD 267 (324)
T ss_pred CCCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhCCCcCCCCHHH
Confidence 235667899999999999999999999 799999999999876553
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-46 Score=342.48 Aligned_cols=252 Identities=29% Similarity=0.457 Sum_probs=205.9
Q ss_pred ceecccCceEEEEEEECCCCCCCCceeeeechhhh------hhHHHHHHHHHHHHcCCCCcccccccceeeecCCCceEE
Q 039291 12 RVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVS------ASASLQKEKEVFDNLNGCPFVLECFGEEITMGENGEMAY 85 (362)
Q Consensus 12 ~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~~------~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~~~~~~ 85 (362)
+.||+|+||+||+|+++.++. .+++|..... .......|..++..+.+||||+++++.+.. ...+
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~----~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~-----~~~~ 71 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQ----FFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQT-----KENL 71 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCC----EEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEe-----CCEE
Confidence 579999999999999988875 4566654322 334566788888877669999999987643 2347
Q ss_pred EEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEeecCCccc
Q 039291 86 NLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKR 165 (362)
Q Consensus 86 ~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Dfgla~~ 165 (362)
++||||++||+|.+++.. ...+++..+..++.|++.||.|||++||+||||||+|||+ +.++.+||+|||++..
T Consensus 72 ~lv~ey~~~g~L~~~l~~--~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~----~~~~~~kl~Dfg~~~~ 145 (316)
T cd05619 72 FFVMEYLNGGDLMFHIQS--CHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILL----DTDGHIKIADFGMCKE 145 (316)
T ss_pred EEEEeCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEE----CCCCCEEEccCCcceE
Confidence 799999999999999976 3459999999999999999999999999999999999999 7778899999999874
Q ss_pred ccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHHcCCCCCCCCCcc
Q 039291 166 SRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEHSLPEIPSR 245 (362)
Q Consensus 166 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (362)
.... ........||+.|+|||++.+..++.++|||||||++|+|++|..||... +..++...+.... +.++..
T Consensus 146 ~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~---~~~~~~~~i~~~~--~~~~~~ 218 (316)
T cd05619 146 NMLG--DAKTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGH---DEEELFQSIRMDN--PCYPRW 218 (316)
T ss_pred CCCC--CCceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCC---CHHHHHHHHHhCC--CCCCcc
Confidence 3221 11223567999999999999888999999999999999999999999654 3445554443322 345667
Q ss_pred CCHHHHHHHHHHhccCCCCCCCHH-HHhcCCCccCcchhhh
Q 039291 246 VSKEARDFLRRCFVRKPAFRFTAE-MLLDDPFVKGVDEELS 285 (362)
Q Consensus 246 ~~~~~~~li~~~l~~~p~~R~s~~-~~l~~p~~~~~~~~~~ 285 (362)
++.+++++|.+||..||++|+++. +++.||||+.+.+...
T Consensus 219 ~~~~~~~li~~~l~~~P~~R~~~~~~l~~h~~~~~~~~~~~ 259 (316)
T cd05619 219 LTREAKDILVKLFVREPERRLGVKGDIRQHPFFREIDWSAL 259 (316)
T ss_pred CCHHHHHHHHHHhccCHhhcCCChHHHHcCcccCCCCHHHH
Confidence 899999999999999999999996 8999999999877643
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-47 Score=361.48 Aligned_cols=263 Identities=25% Similarity=0.395 Sum_probs=203.9
Q ss_pred CCCceeecceecccCceEEEEEEECCCCCCCCceeeeechhhhhhHHHHHHHHHHHHcCCCCcccccccceeeec---CC
Q 039291 4 DGTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVSASASLQKEKEVFDNLNGCPFVLECFGEEITMG---EN 80 (362)
Q Consensus 4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~---~~ 80 (362)
...+|.+++.||+|+||+||+|.+..++. .+|+|..... .....+|+.+++.++ ||||+++++++.... ..
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~----~vAiK~i~~~-~~~~~~Ei~il~~l~-h~niv~l~~~~~~~~~~~~~ 137 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSE----KVAIKKVLQD-PQYKNRELLIMKNLN-HINIIFLKDYYYTECFKKNE 137 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCCC----EEEEEEEecC-cchHHHHHHHHHhcC-CCCCcceeeeEeecccccCC
Confidence 35689999999999999999999988775 5677765332 233567999999998 999999988654322 12
Q ss_pred CceEEEEEEEecCCCCHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCc-eEEEE
Q 039291 81 GEMAYNLLLEYAAGGTLGDLIEKC--NGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGK-FVAKI 157 (362)
Q Consensus 81 ~~~~~~lv~e~~~~~~L~~~l~~~--~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~-~~~kl 157 (362)
...++++||||+++ +|.+++... ....+++..++.++.||+.||+|||++||+||||||+|||+ +.+ +.+||
T Consensus 138 ~~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl----~~~~~~vkL 212 (440)
T PTZ00036 138 KNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLI----DPNTHTLKL 212 (440)
T ss_pred CceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEE----cCCCCceee
Confidence 23467799999975 787777542 34569999999999999999999999999999999999999 533 47999
Q ss_pred eecCCcccccccccCCCCCCccCCCCccCchhhccc-cCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHHc--
Q 039291 158 ADLGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQH-MQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIG-- 234 (362)
Q Consensus 158 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~-- 234 (362)
+|||+|+...... ......||+.|+|||++.+. .++.++|||||||++|+|++|.+||.+... ...+...+.
T Consensus 213 ~DFGla~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~--~~~~~~i~~~~ 287 (440)
T PTZ00036 213 CDFGSAKNLLAGQ---RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSS--VDQLVRIIQVL 287 (440)
T ss_pred eccccchhccCCC---CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh--HHHHHHHHHHh
Confidence 9999997654322 12356789999999998764 689999999999999999999999976532 222221111
Q ss_pred -C--------------CCCCC---------CCCccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCccCcch
Q 039291 235 -D--------------EHSLP---------EIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGVDE 282 (362)
Q Consensus 235 -~--------------~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~~~~~~ 282 (362)
. ...++ .+|...+.++++||.+||..||.+|+|+.+++.||||+.+..
T Consensus 288 ~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~~~ 359 (440)
T PTZ00036 288 GTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDLRD 359 (440)
T ss_pred CCCCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhhhc
Confidence 0 00111 133457889999999999999999999999999999987644
|
|
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-47 Score=352.27 Aligned_cols=260 Identities=26% Similarity=0.452 Sum_probs=208.1
Q ss_pred CceeecceecccCceEEEEEEECCCCCCCCceeeeechhh------hhhHHHHHHHHHHHHcCCCCcccccccceeeecC
Q 039291 6 TSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEV------SASASLQKEKEVFDNLNGCPFVLECFGEEITMGE 79 (362)
Q Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~------~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~ 79 (362)
+.|.+.+.||+|+||+||+|+++.++. .+++|.... .....+.+|+.++..++ ||+|+++++.+.
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~----~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~iv~~~~~~~---- 71 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGH----IYAMKILRKADMLEKEQVAHIRAERDILVEAD-GAWVVKMFYSFQ---- 71 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCC----EEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCC-CCCEeeEEEEEE----
Confidence 468999999999999999999998876 456665432 23456788999999998 899999987653
Q ss_pred CCceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEee
Q 039291 80 NGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIAD 159 (362)
Q Consensus 80 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~D 159 (362)
....+++||||++||+|.+++.. ...+++..++.++.|++.||+|||++||+||||||+|||+ +.++.++|+|
T Consensus 72 -~~~~~~lv~E~~~gg~L~~~l~~--~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli----~~~~~vkL~D 144 (360)
T cd05627 72 -DKRNLYLIMEFLPGGDMMTLLMK--KDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLL----DAKGHVKLSD 144 (360)
T ss_pred -cCCEEEEEEeCCCCccHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEE----CCCCCEEEee
Confidence 23357899999999999999976 3459999999999999999999999999999999999999 7788999999
Q ss_pred cCCccccccccc---------------------------------CCCCCCccCCCCccCchhhccccCCCcchHHHHHH
Q 039291 160 LGVAKRSRHCKR---------------------------------QKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGC 206 (362)
Q Consensus 160 fgla~~~~~~~~---------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ 206 (362)
||+++....... .......+||+.|+|||++.+..++.++|||||||
T Consensus 145 fG~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGv 224 (360)
T cd05627 145 FGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGV 224 (360)
T ss_pred ccCCcccccccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccc
Confidence 999864322100 01112457999999999999999999999999999
Q ss_pred HHHHHHhCCCCCccCCCCCHHHHHHHHcCCCCCCCCCc--cCCHHHHHHHHHHhccCCCCCC---CHHHHhcCCCccCcc
Q 039291 207 VVLEMLSGRQAWVVKEDCSIDQLFSIIGDEHSLPEIPS--RVSKEARDFLRRCFVRKPAFRF---TAEMLLDDPFVKGVD 281 (362)
Q Consensus 207 il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~li~~~l~~~p~~R~---s~~~~l~~p~~~~~~ 281 (362)
++|+|++|++||... ........+........++. .++.++++||.+|+ .||.+|+ ++.+++.||||+++.
T Consensus 225 ilyel~tG~~Pf~~~---~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp~f~~~~ 300 (360)
T cd05627 225 IMYEMLIGYPPFCSE---TPQETYRKVMNWKETLVFPPEVPISEKAKDLILRFC-TDSENRIGSNGVEEIKSHPFFEGVD 300 (360)
T ss_pred eeeecccCCCCCCCC---CHHHHHHHHHcCCCceecCCCCCCCHHHHHHHHHhc-cChhhcCCCCCHHHHhcCCCCCCCC
Confidence 999999999999644 33444444433221112222 37899999999977 4999998 489999999999998
Q ss_pred hhhh
Q 039291 282 EELS 285 (362)
Q Consensus 282 ~~~~ 285 (362)
+...
T Consensus 301 ~~~~ 304 (360)
T cd05627 301 WGHI 304 (360)
T ss_pred HHHH
Confidence 8754
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-46 Score=348.98 Aligned_cols=261 Identities=21% Similarity=0.310 Sum_probs=203.1
Q ss_pred CCCCCceeecceecccCceEEEEEEECCCC-CCCCceeeeechhh----hhhHHHHHHHHHHHHcCCCCcccccccceee
Q 039291 2 DSDGTSWFRGRVIGQGSFGCVFIAKPKSNS-SFLPPLMAVKSAEV----SASASLQKEKEVFDNLNGCPFVLECFGEEIT 76 (362)
Q Consensus 2 ~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~-~~~~~~~~~K~~~~----~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~ 76 (362)
....++|.+++.||+|+||.||+|.+...+ ......|++|.... .....+.+|+.+++.+.+||||+++++.+..
T Consensus 3 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~ 82 (338)
T cd05102 3 EFPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTK 82 (338)
T ss_pred ccchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecC
Confidence 356789999999999999999999864322 11223566666542 2345688999999999669999999986542
Q ss_pred ecCCCceEEEEEEEecCCCCHHHHHHHhc---------------------------------------------------
Q 039291 77 MGENGEMAYNLLLEYAAGGTLGDLIEKCN--------------------------------------------------- 105 (362)
Q Consensus 77 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--------------------------------------------------- 105 (362)
....+++||||+++|+|.+++....
T Consensus 83 ----~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (338)
T cd05102 83 ----PNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTN 158 (338)
T ss_pred ----CCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccc
Confidence 2234779999999999999997532
Q ss_pred ---------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEeecCCcccccccccCCCCC
Q 039291 106 ---------GNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDP 176 (362)
Q Consensus 106 ---------~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Dfgla~~~~~~~~~~~~~ 176 (362)
..++++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++............
T Consensus 159 ~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~----~~~~~~kl~DfG~a~~~~~~~~~~~~~ 234 (338)
T cd05102 159 PPQETDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILL----SENNVVKICDFGLARDIYKDPDYVRKG 234 (338)
T ss_pred cchhccccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEE----cCCCcEEEeecccccccccCcchhccc
Confidence 1247888999999999999999999999999999999999 777889999999997543322222222
Q ss_pred CccCCCCccCchhhccccCCCcchHHHHHHHHHHHHh-CCCCCccCCCCCHHHHHHHHcCCCCCCCCCccCCHHHHHHHH
Q 039291 177 SMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLS-GRQAWVVKEDCSIDQLFSIIGDEHSLPEIPSRVSKEARDFLR 255 (362)
Q Consensus 177 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 255 (362)
...++..|+|||++.+..++.++|||||||++|||++ |..||...... ......+... ..+..+..+++++.+++.
T Consensus 235 ~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~--~~~~~~~~~~-~~~~~~~~~~~~l~~li~ 311 (338)
T cd05102 235 SARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIN--EEFCQRLKDG-TRMRAPENATPEIYRIML 311 (338)
T ss_pred CCCCCccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCcc--HHHHHHHhcC-CCCCCCCCCCHHHHHHHH
Confidence 3456788999999998899999999999999999997 99999654321 2222333222 223456678999999999
Q ss_pred HHhccCCCCCCCHHHHhc
Q 039291 256 RCFVRKPAFRFTAEMLLD 273 (362)
Q Consensus 256 ~~l~~~p~~R~s~~~~l~ 273 (362)
+||..||++|||+.++++
T Consensus 312 ~cl~~dp~~RPs~~el~~ 329 (338)
T cd05102 312 ACWQGDPKERPTFSALVE 329 (338)
T ss_pred HHccCChhhCcCHHHHHH
Confidence 999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-46 Score=345.33 Aligned_cols=257 Identities=26% Similarity=0.375 Sum_probs=210.0
Q ss_pred ceeecceecccCceEEEEEEECCCCCCCCceeeeechhh------hhhHHHHHHHHHHHHcCCCCcccccccceeeecCC
Q 039291 7 SWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEV------SASASLQKEKEVFDNLNGCPFVLECFGEEITMGEN 80 (362)
Q Consensus 7 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~------~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~ 80 (362)
+|...+.||+|+||+||+|+++.++. .+++|.... .....+..|..++..+.+|++|+++++.+..
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~----~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~---- 72 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDE----LYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQT---- 72 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCC----EEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEec----
Confidence 47788999999999999999998876 455555432 2334577899999999888999888875532
Q ss_pred CceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEeec
Q 039291 81 GEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADL 160 (362)
Q Consensus 81 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Df 160 (362)
...+|+||||++||+|.+++.. ...+++..++.++.|++.||.|||++||+||||||+|||+ +.++.+||+||
T Consensus 73 -~~~~~lv~Ey~~~g~L~~~i~~--~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill----~~~~~ikL~Df 145 (323)
T cd05615 73 -VDRLYFVMEYVNGGDLMYHIQQ--VGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVML----DSEGHIKIADF 145 (323)
T ss_pred -CCEEEEEEcCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEE----CCCCCEEEecc
Confidence 2357899999999999999976 3459999999999999999999999999999999999999 77788999999
Q ss_pred CCcccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHHcCCCCCC
Q 039291 161 GVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEHSLP 240 (362)
Q Consensus 161 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 240 (362)
|+++..... ........||+.|+|||++.+..++.++||||+||++|+|++|..||... ....+...+.... .
T Consensus 146 g~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~---~~~~~~~~i~~~~--~ 218 (323)
T cd05615 146 GMCKEHMVD--GVTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGE---DEDELFQSIMEHN--V 218 (323)
T ss_pred ccccccCCC--CccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCC---CHHHHHHHHHhCC--C
Confidence 998753321 11223567999999999999888999999999999999999999999654 3444444443322 2
Q ss_pred CCCccCCHHHHHHHHHHhccCCCCCCC-----HHHHhcCCCccCcchhhh
Q 039291 241 EIPSRVSKEARDFLRRCFVRKPAFRFT-----AEMLLDDPFVKGVDEELS 285 (362)
Q Consensus 241 ~~~~~~~~~~~~li~~~l~~~p~~R~s-----~~~~l~~p~~~~~~~~~~ 285 (362)
.+|..++.++++++.+||..+|.+|++ .++++.||||+.+.+...
T Consensus 219 ~~p~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~f~~~~~~~~ 268 (323)
T cd05615 219 SYPKSLSKEAVSICKGLMTKHPSKRLGCGPEGERDIREHAFFRRIDWDKL 268 (323)
T ss_pred CCCccCCHHHHHHHHHHcccCHhhCCCCCCCCHHHHhcCcccCCCCHHHH
Confidence 456678999999999999999999997 578999999999877643
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-47 Score=347.43 Aligned_cols=263 Identities=24% Similarity=0.417 Sum_probs=217.8
Q ss_pred CCCCCceeecceecccCceEEEEEEECCCCCCCCceeeeechhhhhhHHHHHHHHHHHHcCCCCcccccccceeeecCCC
Q 039291 2 DSDGTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVSASASLQKEKEVFDNLNGCPFVLECFGEEITMGENG 81 (362)
Q Consensus 2 ~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~~ 81 (362)
.+.|..|+++++||+||.+.||+++..+.+.+++++|..+.........+..|+..|.+|++|.+|+.++++.+.
T Consensus 357 ~Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~----- 431 (677)
T KOG0596|consen 357 KVKGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVT----- 431 (677)
T ss_pred EECcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeecc-----
Confidence 357889999999999999999999998888888888888888888888999999999999999999999997764
Q ss_pred ceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEeecC
Q 039291 82 EMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLG 161 (362)
Q Consensus 82 ~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Dfg 161 (362)
+.++|+||||-+ .+|..+|++.... ++...++.+..|++.++.++|.+||||.||||.|+|+. .|.+||+|||
T Consensus 432 d~~lYmvmE~Gd-~DL~kiL~k~~~~-~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlV-----kG~LKLIDFG 504 (677)
T KOG0596|consen 432 DGYLYMVMECGD-IDLNKILKKKKSI-DPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLV-----KGRLKLIDFG 504 (677)
T ss_pred CceEEEEeeccc-ccHHHHHHhccCC-CchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEE-----eeeEEeeeec
Confidence 457899999985 5999999884332 44358999999999999999999999999999999994 4679999999
Q ss_pred CcccccccccCCCCCCccCCCCccCchhhcccc-----------CCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHH
Q 039291 162 VAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHM-----------QEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLF 230 (362)
Q Consensus 162 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-----------~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~ 230 (362)
+|.............+.+||+.||+||.+.... .+.++||||||||||+|+.|++||... .+....+
T Consensus 505 IA~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~--~n~~aKl 582 (677)
T KOG0596|consen 505 IANAIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQI--INQIAKL 582 (677)
T ss_pred hhcccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHH--HHHHHHH
Confidence 998877766666667889999999999987432 357899999999999999999999422 1122333
Q ss_pred HHHcCC-C--CCCCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCccCc
Q 039291 231 SIIGDE-H--SLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGV 280 (362)
Q Consensus 231 ~~~~~~-~--~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~~~~ 280 (362)
..|..- . .+|.++.. .++.++++.||.+||++||++.++|.|||++.+
T Consensus 583 ~aI~~P~~~Iefp~~~~~--~~li~~mK~CL~rdPkkR~si~eLLqhpFl~~~ 633 (677)
T KOG0596|consen 583 HAITDPNHEIEFPDIPEN--DELIDVMKCCLARDPKKRWSIPELLQHPFLQIQ 633 (677)
T ss_pred HhhcCCCccccccCCCCc--hHHHHHHHHHHhcCcccCCCcHHHhcCcccccc
Confidence 333322 2 33444332 349999999999999999999999999999874
|
|
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-46 Score=351.98 Aligned_cols=259 Identities=27% Similarity=0.432 Sum_probs=205.3
Q ss_pred CCCCceeecceecccCceEEEEEEECCCCCCCCceeeeechhh------hhhHHHHHHHHHHHHcCCCCcccccccceee
Q 039291 3 SDGTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEV------SASASLQKEKEVFDNLNGCPFVLECFGEEIT 76 (362)
Q Consensus 3 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~------~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~ 76 (362)
...++|.+.+.||+|+||.||+|+++.+++. +++|.... .....+.+|+.+++.++ ||||+++++.+..
T Consensus 40 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~----~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~-hp~iv~~~~~~~~ 114 (370)
T cd05621 40 MKAEDYDVVKVIGRGAFGEVQLVRHKSSQKV----YAMKLLSKFEMIKRSDSAFFWEERDIMAFAN-SPWVVQLFCAFQD 114 (370)
T ss_pred CCHHHCeEEEEEEecCCeEEEEEEECCCCCE----EEEEEEEHHHhhhhhhHHHHHHHHHHHHhCC-CCCEeeEEEEEEc
Confidence 3457899999999999999999999988764 45554321 23445778999999988 9999999986542
Q ss_pred ecCCCceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEE
Q 039291 77 MGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAK 156 (362)
Q Consensus 77 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~k 156 (362)
...+|+||||++||+|.+++.. ..+++..+..++.||+.||+|||++||+||||||+|||+ +.++.+|
T Consensus 115 -----~~~~~lv~Ey~~gg~L~~~l~~---~~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl----~~~~~~k 182 (370)
T cd05621 115 -----DKYLYMVMEYMPGGDLVNLMSN---YDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLL----DKHGHLK 182 (370)
T ss_pred -----CCEEEEEEcCCCCCcHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEE----CCCCCEE
Confidence 3457899999999999999975 348999999999999999999999999999999999999 7788899
Q ss_pred EeecCCcccccccccCCCCCCccCCCCccCchhhccc----cCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHH
Q 039291 157 IADLGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQH----MQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSI 232 (362)
Q Consensus 157 l~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~ 232 (362)
|+|||++....... .......+||+.|+|||++.+. .++.++|||||||++|+|++|..||...+ .......
T Consensus 183 L~DFG~a~~~~~~~-~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~---~~~~~~~ 258 (370)
T cd05621 183 LADFGTCMKMDETG-MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADS---LVGTYSK 258 (370)
T ss_pred EEecccceecccCC-ceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCC---HHHHHHH
Confidence 99999997654221 1122356799999999999764 37789999999999999999999996543 3334444
Q ss_pred HcCCCCCCCCCc--cCCHHHHHHHHHHhccCCCC--CCCHHHHhcCCCccCcch
Q 039291 233 IGDEHSLPEIPS--RVSKEARDFLRRCFVRKPAF--RFTAEMLLDDPFVKGVDE 282 (362)
Q Consensus 233 ~~~~~~~~~~~~--~~~~~~~~li~~~l~~~p~~--R~s~~~~l~~p~~~~~~~ 282 (362)
+........++. .++..+++++.+||..++.+ |+++.+++.||||+...+
T Consensus 259 i~~~~~~~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp~~~~~~~ 312 (370)
T cd05621 259 IMDHKNSLNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQHPFFKNDQW 312 (370)
T ss_pred HHhCCcccCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcCcccCCCCc
Confidence 433222222333 57899999999999865544 889999999999987543
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-46 Score=344.31 Aligned_cols=262 Identities=27% Similarity=0.427 Sum_probs=206.6
Q ss_pred CceeecceecccCceEEEEEEECCCCCCCCceeeeechhh------hhhHHHHHHHHHHHHcCCCCcccccccceeeecC
Q 039291 6 TSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEV------SASASLQKEKEVFDNLNGCPFVLECFGEEITMGE 79 (362)
Q Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~------~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~ 79 (362)
++|.+.+.||+|+||+||+++++.++. .+++|.... .....+.+|+.++..++ |++|+++++.+.
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~----~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~---- 71 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADK----VFAMKILNKWEMLKRAETACFREERDVLVNGD-NQWITTLHYAFQ---- 71 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCC----EEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCC-CCCEeeEEEEEe----
Confidence 479999999999999999999988775 455555432 22334778888888887 899999987653
Q ss_pred CCceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEee
Q 039291 80 NGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIAD 159 (362)
Q Consensus 80 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~D 159 (362)
....+++||||+++|+|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|
T Consensus 72 -~~~~~~lv~ey~~~g~L~~~l~~~-~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili----~~~~~~kL~D 145 (332)
T cd05623 72 -DENNLYLVMDYYVGGDLLTLLSKF-EDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILM----DMNGHIRLAD 145 (332)
T ss_pred -cCCEEEEEEeccCCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEE----CCCCCEEEee
Confidence 234578999999999999999763 3459999999999999999999999999999999999999 7778899999
Q ss_pred cCCcccccccccCCCCCCccCCCCccCchhhcc-----ccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHHc
Q 039291 160 LGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQ-----HMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIG 234 (362)
Q Consensus 160 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~ 234 (362)
||++....... .......+||+.|+|||++.+ ..++.++|||||||++|||++|+.||... +..+....+.
T Consensus 146 fG~a~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~---~~~~~~~~i~ 221 (332)
T cd05623 146 FGSCLKLMEDG-TVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAE---SLVETYGKIM 221 (332)
T ss_pred cchheecccCC-cceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCC---CHHHHHHHHh
Confidence 99986543211 111234579999999999862 45788999999999999999999999644 3444444443
Q ss_pred CCC---CCCCCCccCCHHHHHHHHHHhccCCCC--CCCHHHHhcCCCccCcchhhhh
Q 039291 235 DEH---SLPEIPSRVSKEARDFLRRCFVRKPAF--RFTAEMLLDDPFVKGVDEELSR 286 (362)
Q Consensus 235 ~~~---~~~~~~~~~~~~~~~li~~~l~~~p~~--R~s~~~~l~~p~~~~~~~~~~~ 286 (362)
... .+|.....++.++++||++||..++.+ |++++++++||||.++.+....
T Consensus 222 ~~~~~~~~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h~~f~~~~~~~~~ 278 (332)
T cd05623 222 NHKERFQFPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQHPFFTGIDWDNIR 278 (332)
T ss_pred CCCccccCCCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCCCCcCCCCHHHHh
Confidence 332 233444568999999999999765544 6899999999999998876443
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-47 Score=324.90 Aligned_cols=264 Identities=23% Similarity=0.334 Sum_probs=220.3
Q ss_pred Cceeec-ceecccCceEEEEEEECCCCCCCCceeeeechhhhhhHHHHHHHHHHHHcCCCCcccccccceeeecCCCceE
Q 039291 6 TSWFRG-RVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVSASASLQKEKEVFDNLNGCPFVLECFGEEITMGENGEMA 84 (362)
Q Consensus 6 ~~y~~~-~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~~~~~ 84 (362)
+.|.+- ++||-|--|.|..+.++.+++ ++|+|.+.. ....++|+++.-...+|||||.+++++.+.... ..-
T Consensus 61 edY~is~qvLG~GinGkV~~C~~k~T~e----kfALKvL~D--s~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~-rkc 133 (400)
T KOG0604|consen 61 EDYSISWQVLGAGINGKVVQCVHKRTQE----KFALKVLLD--SPKARREVELHWMASGHPHIVSIIDVYENSYQG-RKC 133 (400)
T ss_pred hhheehhhhhccccCCceEEEEeccchh----hhHHHHHhc--CHHHHhHhhhhhhhcCCCceEEeehhhhhhccC-cee
Confidence 456664 789999999999999999987 668887753 445678999988888999999999988765544 444
Q ss_pred EEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEeecCCcc
Q 039291 85 YNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAK 164 (362)
Q Consensus 85 ~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Dfgla~ 164 (362)
+.+|||.++||.|+..|+.++...|+|.++..|+.||..|+.|||+.+|.||||||+|+|...+ ..+..+||+|||+|+
T Consensus 134 LLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t-~~na~lKLtDfGFAK 212 (400)
T KOG0604|consen 134 LLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTT-SPNAPLKLTDFGFAK 212 (400)
T ss_pred eEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecC-CCCcceEeccccccc
Confidence 6699999999999999999888889999999999999999999999999999999999999765 456789999999998
Q ss_pred cccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCH-HHHHHHHcCC-CCCC-C
Q 039291 165 RSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSI-DQLFSIIGDE-HSLP-E 241 (362)
Q Consensus 165 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~-~~~~~~~~~~-~~~~-~ 241 (362)
.... .....+.+.|+.|.|||++....|+...|+||+||++|-|++|.+||.......+ .-+..+|..+ ..+| .
T Consensus 213 ~t~~---~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~FP~p 289 (400)
T KOG0604|consen 213 ETQE---PGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYEFPEP 289 (400)
T ss_pred ccCC---CccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCccCCCh
Confidence 6654 2223467899999999999989999999999999999999999999986544222 1233333322 2233 2
Q ss_pred CCccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCccCc
Q 039291 242 IPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGV 280 (362)
Q Consensus 242 ~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~~~~ 280 (362)
-+..+|.+++++|+++|..+|.+|.|+.++++|||+.+.
T Consensus 290 EWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~ 328 (400)
T KOG0604|consen 290 EWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQY 328 (400)
T ss_pred hHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhccc
Confidence 345689999999999999999999999999999999764
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-47 Score=346.71 Aligned_cols=247 Identities=23% Similarity=0.396 Sum_probs=208.7
Q ss_pred ceeecceecccCceEEEEEEECCCCCCCCceeeeechhh--hhhHHHHHHHHHHHHcCCCCcccccccceeeecCCCceE
Q 039291 7 SWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEV--SASASLQKEKEVFDNLNGCPFVLECFGEEITMGENGEMA 84 (362)
Q Consensus 7 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~--~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~~~~~ 84 (362)
.+..++.||+|.||+||+|.++.+.. |++|.+.. .....+.+|+++|++|+ |++||++++++... ..
T Consensus 207 ~l~l~~~LG~G~FG~V~~g~~~~~~~-----vavk~ik~~~m~~~~f~~Ea~iMk~L~-H~~lV~l~gV~~~~-----~p 275 (468)
T KOG0197|consen 207 ELKLIRELGSGQFGEVWLGKWNGSTK-----VAVKTIKEGSMSPEAFLREAQIMKKLR-HEKLVKLYGVCTKQ-----EP 275 (468)
T ss_pred HHHHHHHhcCCccceEEEEEEcCCCc-----ccceEEeccccChhHHHHHHHHHHhCc-ccCeEEEEEEEecC-----Cc
Confidence 44567899999999999999998753 55555443 23456789999999999 99999999988532 25
Q ss_pred EEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEeecCCcc
Q 039291 85 YNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAK 164 (362)
Q Consensus 85 ~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Dfgla~ 164 (362)
+||||||++.|+|.++|+...+..+...+...++.||++|++||+++++|||||...|||| +++..+||+|||||+
T Consensus 276 iyIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV----~~~~~vKIsDFGLAr 351 (468)
T KOG0197|consen 276 IYIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILV----DEDLVVKISDFGLAR 351 (468)
T ss_pred eEEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheee----ccCceEEEccccccc
Confidence 8899999999999999998667779999999999999999999999999999999999999 888899999999999
Q ss_pred cccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHh-CCCCCccCCCCCHHHHHHHHcCCCCCCCCC
Q 039291 165 RSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLS-GRQAWVVKEDCSIDQLFSIIGDEHSLPEIP 243 (362)
Q Consensus 165 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (362)
..... .........-...|.|||.+....++.+||||||||+|+||+| |+.||.+. ...+.+..+..+..+|. |
T Consensus 352 ~~~d~-~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~m---sn~ev~~~le~GyRlp~-P 426 (468)
T KOG0197|consen 352 LIGDD-EYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGM---SNEEVLELLERGYRLPR-P 426 (468)
T ss_pred ccCCC-ceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCC---CHHHHHHHHhccCcCCC-C
Confidence 43322 2222223334566999999999999999999999999999999 89998544 56777888888888874 7
Q ss_pred ccCCHHHHHHHHHHhccCCCCCCCHHHHhc
Q 039291 244 SRVSKEARDFLRRCFVRKPAFRFTAEMLLD 273 (362)
Q Consensus 244 ~~~~~~~~~li~~~l~~~p~~R~s~~~~l~ 273 (362)
..+|+++-+++..||..+|++|||++.+..
T Consensus 427 ~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~ 456 (468)
T KOG0197|consen 427 EGCPDEVYELMKSCWHEDPEDRPTFETLRE 456 (468)
T ss_pred CCCCHHHHHHHHHHhhCCcccCCCHHHHHH
Confidence 889999999999999999999999987653
|
|
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-47 Score=344.60 Aligned_cols=259 Identities=24% Similarity=0.401 Sum_probs=214.9
Q ss_pred ceeecceecccCceEEEEEEECCCCCCCCceeeeech-hhhhhHHHHHHHHHHHHcCCCCcccccccceeeecCCCceEE
Q 039291 7 SWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSA-EVSASASLQKEKEVFDNLNGCPFVLECFGEEITMGENGEMAY 85 (362)
Q Consensus 7 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~-~~~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~~~~~~ 85 (362)
=|-+.+.||+|.|.+|-+|++--+|+.++.+|.-|.. ..-....+.+|++-|+.++ |||||++|.+. +.+..+
T Consensus 19 LYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQ-HpNiVRLYEVi-----DTQTKl 92 (864)
T KOG4717|consen 19 LYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQ-HPNIVRLYEVI-----DTQTKL 92 (864)
T ss_pred eehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhc-CcCeeeeeehh-----cccceE
Confidence 4778899999999999999998888744444333322 2224566889999999999 99999999865 445668
Q ss_pred EEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEeecCCccc
Q 039291 86 NLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKR 165 (362)
Q Consensus 86 ~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Dfgla~~ 165 (362)
|||+|.-+||+|.+||.++.. .++|..+++|+.||+.|+.|||...+|||||||+||++. ...|.|||.|||++..
T Consensus 93 yLiLELGD~GDl~DyImKHe~-Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFF---EKlGlVKLTDFGFSNk 168 (864)
T KOG4717|consen 93 YLILELGDGGDLFDYIMKHEE-GLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFF---EKLGLVKLTDFGFSNK 168 (864)
T ss_pred EEEEEecCCchHHHHHHhhhc-cccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEe---eecCceEeeecccccc
Confidence 899999999999999988654 499999999999999999999999999999999999985 4557899999999987
Q ss_pred ccccccCCCCCCccCCCCccCchhhccccCC-CcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHHcCCCCCCCCCc
Q 039291 166 SRHCKRQKFDPSMRGTPLYLAPETVVQHMQE-APSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEHSLPEIPS 244 (362)
Q Consensus 166 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (362)
+.....- ...||+..|.|||++.+..|+ +++||||||||||.|++|++||+..++.. .+..++.-.. .+|.
T Consensus 169 f~PG~kL---~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSE--TLTmImDCKY---tvPs 240 (864)
T KOG4717|consen 169 FQPGKKL---TTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSE--TLTMIMDCKY---TVPS 240 (864)
T ss_pred CCCcchh---hcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchh--hhhhhhcccc---cCch
Confidence 7653322 578999999999999998886 46799999999999999999997655432 2222222222 3567
Q ss_pred cCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCccCcchh
Q 039291 245 RVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGVDEE 283 (362)
Q Consensus 245 ~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~~~~~~~ 283 (362)
.++.++++||..||..||.+|.+.+++..++|++.++..
T Consensus 241 hvS~eCrdLI~sMLvRdPkkRAslEeI~s~~Wlq~~D~~ 279 (864)
T KOG4717|consen 241 HVSKECRDLIQSMLVRDPKKRASLEEIVSTSWLQAGDRG 279 (864)
T ss_pred hhhHHHHHHHHHHHhcCchhhccHHHHhccccccCCCCC
Confidence 899999999999999999999999999999999988654
|
|
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-46 Score=339.35 Aligned_cols=259 Identities=24% Similarity=0.417 Sum_probs=202.5
Q ss_pred ceeecceecccCceEEEEEEECCCCCCCCceeeeechhhh-----hhHHHHHHHHHHHHcC--CCCcccccccceeeecC
Q 039291 7 SWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVS-----ASASLQKEKEVFDNLN--GCPFVLECFGEEITMGE 79 (362)
Q Consensus 7 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~~-----~~~~~~~E~~il~~l~--~h~~i~~~~~~~~~~~~ 79 (362)
+|.+.+.||+|+||+||+|+++.+++ .+++|..... ......+|+.+++.+. .||||+++++++.....
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~----~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~ 76 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGH----FVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRT 76 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCc----EEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccC
Confidence 68999999999999999999998876 4555544321 2234667888888774 49999999987655433
Q ss_pred CCceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEee
Q 039291 80 NGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIAD 159 (362)
Q Consensus 80 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~D 159 (362)
.....++++|||+.+ +|.+++.......+++..++.++.|++.||.|||++||+||||||+|||+ +.++.+||+|
T Consensus 77 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili----~~~~~~kl~d 151 (288)
T cd07863 77 DRETKVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILV----TSGGQVKLAD 151 (288)
T ss_pred CCCceEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE----CCCCCEEECc
Confidence 445567899999975 89999887555569999999999999999999999999999999999999 7778899999
Q ss_pred cCCcccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHH-HHHHHHcCC--
Q 039291 160 LGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSID-QLFSIIGDE-- 236 (362)
Q Consensus 160 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~-~~~~~~~~~-- 236 (362)
||++....... ......||..|+|||++.+..++.++|||||||++|+|++|.+||......... .+...+...
T Consensus 152 fg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~ 228 (288)
T cd07863 152 FGLARIYSCQM---ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPE 228 (288)
T ss_pred cCccccccCcc---cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCCh
Confidence 99987554321 123456899999999999888999999999999999999999999654322111 111111100
Q ss_pred CC-------------------CCCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCc
Q 039291 237 HS-------------------LPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFV 277 (362)
Q Consensus 237 ~~-------------------~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~ 277 (362)
.. ...+...++.+++++|.+||+.||++|||+.+++.||||
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp~f 288 (288)
T cd07863 229 DDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288 (288)
T ss_pred hhCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 00 001223577889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-46 Score=360.65 Aligned_cols=267 Identities=22% Similarity=0.356 Sum_probs=217.9
Q ss_pred CCCCceeecceecccCceEEEEEEECCCCCCCCceeeeechh-----hhhhHHHHHHHHHHHHcCCCCcccccccceeee
Q 039291 3 SDGTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAE-----VSASASLQKEKEVFDNLNGCPFVLECFGEEITM 77 (362)
Q Consensus 3 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~-----~~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~ 77 (362)
..+++|.+.+.||+|+||+||+|++..++. .+++|... ......+.+|+.++..++ |+|+++++..+...
T Consensus 29 ~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~----~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~-h~~iv~~~~~~~~~ 103 (496)
T PTZ00283 29 EQAKKYWISRVLGSGATGTVLCAKRVSDGE----PFAVKVVDMEGMSEADKNRAQAEVCCLLNCD-FFSIVKCHEDFAKK 103 (496)
T ss_pred ccCCCEEEEEEEecCCCEEEEEEEEcCCCC----EEEEEEEecccCCHHHHHHHHHHHHHHhcCC-CCcEEEeecceecc
Confidence 467899999999999999999999988775 55666543 234456788999999998 89999988765432
Q ss_pred cC---CCceEEEEEEEecCCCCHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCc
Q 039291 78 GE---NGEMAYNLLLEYAAGGTLGDLIEKCN--GNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGK 152 (362)
Q Consensus 78 ~~---~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~ 152 (362)
.. .....+++||||+++|+|.+++.... ...+++..++.++.|++.||.|||++||+||||||+|||+ +.+
T Consensus 104 ~~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl----~~~ 179 (496)
T PTZ00283 104 DPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILL----CSN 179 (496)
T ss_pred cccCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEE----eCC
Confidence 22 12224679999999999999987532 3469999999999999999999999999999999999999 777
Q ss_pred eEEEEeecCCcccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHH
Q 039291 153 FVAKIADLGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSI 232 (362)
Q Consensus 153 ~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~ 232 (362)
+.+||+|||+++..............+||+.|+|||++.+..++.++|||||||++|+|++|+.||... +..+.+..
T Consensus 180 ~~vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~---~~~~~~~~ 256 (496)
T PTZ00283 180 GLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGE---NMEEVMHK 256 (496)
T ss_pred CCEEEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCC---CHHHHHHH
Confidence 889999999998655433333334678999999999999989999999999999999999999999543 44455554
Q ss_pred HcCCCCCCCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCccCcch
Q 039291 233 IGDEHSLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGVDE 282 (362)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~~~~~~ 282 (362)
+.... .+.++..+++++.+++.+||..||.+||++.+++.|||++....
T Consensus 257 ~~~~~-~~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~p~~~~~~~ 305 (496)
T PTZ00283 257 TLAGR-YDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNMPICKLFIS 305 (496)
T ss_pred HhcCC-CCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhCHHHHHhhh
Confidence 44333 23456788999999999999999999999999999999876543
|
|
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-46 Score=344.52 Aligned_cols=255 Identities=29% Similarity=0.451 Sum_probs=206.6
Q ss_pred ceecccCceEEEEEEECCCCCCCCceeeeechhh------hhhHHHHHHHHHHHHcCCCCcccccccceeeecCCCceEE
Q 039291 12 RVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEV------SASASLQKEKEVFDNLNGCPFVLECFGEEITMGENGEMAY 85 (362)
Q Consensus 12 ~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~------~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~~~~~~ 85 (362)
+.||+|+||+||+|+++.++.. +++|.... ...+.+.+|+.++.++.+||+|+.+++.+.. ...+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~----~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~-----~~~~ 71 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQI----YAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQT-----TSRL 71 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCE----EEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEe-----CCEE
Confidence 5799999999999999888764 45554432 2345578899999999889999999886532 2357
Q ss_pred EEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEeecCCccc
Q 039291 86 NLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKR 165 (362)
Q Consensus 86 ~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Dfgla~~ 165 (362)
|+||||++|++|..++.. .+.+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++.
T Consensus 72 ~lv~e~~~~~~L~~~~~~--~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili----~~~~~~kl~Dfg~~~~ 145 (327)
T cd05617 72 FLVIEYVNGGDLMFHMQR--QRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLL----DADGHIKLTDYGMCKE 145 (327)
T ss_pred EEEEeCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEE----eCCCCEEEecccccee
Confidence 899999999999998876 3459999999999999999999999999999999999999 7778899999999874
Q ss_pred ccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHhCCCCCccCCC----CCHHHHHHHHcCCCCCCC
Q 039291 166 SRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKED----CSIDQLFSIIGDEHSLPE 241 (362)
Q Consensus 166 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~----~~~~~~~~~~~~~~~~~~ 241 (362)
.... .......+||+.|+|||++.+..++.++|||||||++|+|++|..||..... .....+...+.... ..
T Consensus 146 ~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~--~~ 221 (327)
T cd05617 146 GLGP--GDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKP--IR 221 (327)
T ss_pred ccCC--CCceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCC--CC
Confidence 3221 1122356799999999999999999999999999999999999999964321 12233334443322 24
Q ss_pred CCccCCHHHHHHHHHHhccCCCCCCC------HHHHhcCCCccCcchhhh
Q 039291 242 IPSRVSKEARDFLRRCFVRKPAFRFT------AEMLLDDPFVKGVDEELS 285 (362)
Q Consensus 242 ~~~~~~~~~~~li~~~l~~~p~~R~s------~~~~l~~p~~~~~~~~~~ 285 (362)
+|..++..+.++|.+||..||.+|++ +.++++||||+.+.++..
T Consensus 222 ~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h~~f~~~~~~~~ 271 (327)
T cd05617 222 IPRFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSHTFFRSIDWDLL 271 (327)
T ss_pred CCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcCCCCCCCCHHHH
Confidence 66778999999999999999999997 579999999999987754
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-46 Score=344.60 Aligned_cols=262 Identities=23% Similarity=0.448 Sum_probs=205.9
Q ss_pred CCCCceeecceecccCceEEEEEEECCCCCCCCceeeeechhhhhhHHHHHHHHHHHHcCCCCcccccccceeeecCCCc
Q 039291 3 SDGTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVSASASLQKEKEVFDNLNGCPFVLECFGEEITMGENGE 82 (362)
Q Consensus 3 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~~~ 82 (362)
...++|.+.+.||+|+||.||+|.++.++..+++++............+.+|+++++.++ ||||+++++.+.. .
T Consensus 2 l~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~-----~ 75 (333)
T cd06650 2 LKDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECN-SPYIVGFYGAFYS-----D 75 (333)
T ss_pred cchhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCC-CCcccceeEEEEE-----C
Confidence 467899999999999999999999988876433322221222234456889999999998 9999999987653 2
Q ss_pred eEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC-CceeCCCCCCCEEEeecCCCceEEEEeecC
Q 039291 83 MAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDS-GYVHCDVKPDNILLVATQSGKFVAKIADLG 161 (362)
Q Consensus 83 ~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~-~ivH~Dlkp~Nill~~~~~~~~~~kl~Dfg 161 (362)
..+++||||+++++|.+++.. .+.+++..+..++.|++.||.|||+. +|+||||||+|||+ +.++.+||+|||
T Consensus 76 ~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili----~~~~~~kL~Dfg 149 (333)
T cd06650 76 GEISICMEHMDGGSLDQVLKK--AGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILV----NSRGEIKLCDFG 149 (333)
T ss_pred CEEEEEEecCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEE----cCCCCEEEeeCC
Confidence 357899999999999999976 34589999999999999999999975 79999999999999 777789999999
Q ss_pred CcccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHH-----------
Q 039291 162 VAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLF----------- 230 (362)
Q Consensus 162 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~----------- 230 (362)
++...... ......||..|+|||++.+..++.++|+|||||++|+|++|+.||............
T Consensus 150 ~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 225 (333)
T cd06650 150 VSGQLIDS----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAES 225 (333)
T ss_pred cchhhhhh----ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCcccc
Confidence 98754321 123457999999999999888999999999999999999999999654322211111
Q ss_pred ------------------------------HHHcCCCCCCCCC-ccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCccC
Q 039291 231 ------------------------------SIIGDEHSLPEIP-SRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKG 279 (362)
Q Consensus 231 ------------------------------~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~~~ 279 (362)
..+.... .+..+ ...+.++++||.+||+.||++|||+.+++.||||+.
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~~ 304 (333)
T cd06650 226 ETSPRPRPPGRPLSSYGPDSRPPMAIFELLDYIVNEP-PPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIKR 304 (333)
T ss_pred ccCcccCCccchhhhhcccccccccHHHHHHHHhcCC-CccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHhc
Confidence 1111111 11111 236788999999999999999999999999999976
Q ss_pred cc
Q 039291 280 VD 281 (362)
Q Consensus 280 ~~ 281 (362)
..
T Consensus 305 ~~ 306 (333)
T cd06650 305 SE 306 (333)
T ss_pred Cc
Confidence 53
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-46 Score=335.69 Aligned_cols=259 Identities=27% Similarity=0.403 Sum_probs=210.1
Q ss_pred ceeecceecccCceEEEEEEECCCCCCCCceeeeechhhh------hhHHHHHHHHHHHHcCCCCcccccccceeeecCC
Q 039291 7 SWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVS------ASASLQKEKEVFDNLNGCPFVLECFGEEITMGEN 80 (362)
Q Consensus 7 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~~------~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~ 80 (362)
.|++.+.||+|+||+||++.+..++. .+++|..... ....+.+|+.+++.++ ||||+++++.+..
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~----~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~---- 71 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGK----MYACKKLEKKRIKKRKGEAMALNEKQILEKVN-SRFVVSLAYAYET---- 71 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCc----eEEEEEEehhhhhhhhhHHHHHHHHHHHHhcC-CCCEeeeeeeecC----
Confidence 48899999999999999999987765 4566654321 2344678999999998 8999999886532
Q ss_pred CceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEeec
Q 039291 81 GEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADL 160 (362)
Q Consensus 81 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Df 160 (362)
...+++||||+++|+|.+++.......+++..+..++.|++.||.|||++||+||||||+||++ ++++.++|+||
T Consensus 72 -~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~----~~~~~~~l~Df 146 (285)
T cd05605 72 -KDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILL----DDYGHIRISDL 146 (285)
T ss_pred -CCeEEEEEeccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEE----CCCCCEEEeeC
Confidence 2357899999999999998876444569999999999999999999999999999999999999 77788999999
Q ss_pred CCcccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHH-HHHHHHcCCCCC
Q 039291 161 GVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSID-QLFSIIGDEHSL 239 (362)
Q Consensus 161 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~-~~~~~~~~~~~~ 239 (362)
|++....... ......|+..|+|||++.+..++.++||||+||++|+|++|..||......... .....+. ...
T Consensus 147 g~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~--~~~ 221 (285)
T cd05605 147 GLAVEIPEGE---TIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVK--EDQ 221 (285)
T ss_pred CCceecCCCC---ccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhh--hcc
Confidence 9987643221 113457899999999999888999999999999999999999999765432222 2222222 222
Q ss_pred CCCCccCCHHHHHHHHHHhccCCCCCC-----CHHHHhcCCCccCcchhh
Q 039291 240 PEIPSRVSKEARDFLRRCFVRKPAFRF-----TAEMLLDDPFVKGVDEEL 284 (362)
Q Consensus 240 ~~~~~~~~~~~~~li~~~l~~~p~~R~-----s~~~~l~~p~~~~~~~~~ 284 (362)
+.++..++..+++||.+||..||++|| ++++++.||||....+..
T Consensus 222 ~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~~~~ 271 (285)
T cd05605 222 EEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRTANFKR 271 (285)
T ss_pred cccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcCcCccCCCHHH
Confidence 345567899999999999999999999 899999999999876653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-46 Score=347.38 Aligned_cols=258 Identities=27% Similarity=0.420 Sum_probs=208.8
Q ss_pred CCceeecceecccCceEEEEEEECCCCCCCCceeeeechhhh--hhHHHHHHHHHHHHcCCC-----Ccccccccceeee
Q 039291 5 GTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVS--ASASLQKEKEVFDNLNGC-----PFVLECFGEEITM 77 (362)
Q Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~~--~~~~~~~E~~il~~l~~h-----~~i~~~~~~~~~~ 77 (362)
..||.+.+.||+|+||.|.+|.|..+++ .||+|+++.. .....+.|+++|..|+.| -|+|++++++..
T Consensus 185 ~~rY~V~e~LGkGtFGQVvk~~d~~T~e----~VAIKIiKN~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~f- 259 (586)
T KOG0667|consen 185 AYRYEVLEVLGKGSFGQVVKAYDHKTGE----IVAIKIIKNKKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYF- 259 (586)
T ss_pred EEEEEEEEEecccccceeEEEEecCCCc----EEEEEeeccChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecccc-
Confidence 3489999999999999999999999986 7788887643 445577899999999843 378999997753
Q ss_pred cCCCceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEE
Q 039291 78 GENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKI 157 (362)
Q Consensus 78 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl 157 (362)
...+|||+|.+. .+|.++|+..+-.+|+...++.++.||+.||.+||+.||||+||||+||||... ....|||
T Consensus 260 ----r~HlciVfELL~-~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~--~r~~vKV 332 (586)
T KOG0667|consen 260 ----RNHLCIVFELLS-TNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDP--KRSRIKV 332 (586)
T ss_pred ----ccceeeeehhhh-hhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccC--CcCceeE
Confidence 445899999995 599999999777789999999999999999999999999999999999999653 3447999
Q ss_pred eecCCcccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHHc---
Q 039291 158 ADLGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIG--- 234 (362)
Q Consensus 158 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~--- 234 (362)
+|||.|..... ....++.++.|+|||++.+.+|+.+.||||||||++||++|.+.|.+.++.+ ++..++.
T Consensus 333 IDFGSSc~~~q-----~vytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~D--Ql~~I~e~lG 405 (586)
T KOG0667|consen 333 IDFGSSCFESQ-----RVYTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYD--QLARIIEVLG 405 (586)
T ss_pred EecccccccCC-----cceeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHH--HHHHHHHHhC
Confidence 99999865443 2236789999999999999999999999999999999999999997765433 2222221
Q ss_pred -----------------CC-CCCC----------------------------CCC-----------ccCCHHHHHHHHHH
Q 039291 235 -----------------DE-HSLP----------------------------EIP-----------SRVSKEARDFLRRC 257 (362)
Q Consensus 235 -----------------~~-~~~~----------------------------~~~-----------~~~~~~~~~li~~~ 257 (362)
.. ...+ ..| ..-...+.+||.+|
T Consensus 406 ~Pp~~mL~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~ 485 (586)
T KOG0667|consen 406 LPPPKMLDTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRC 485 (586)
T ss_pred CCCHHHHHhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHH
Confidence 00 0000 011 01224578999999
Q ss_pred hccCCCCCCCHHHHhcCCCccCcc
Q 039291 258 FVRKPAFRFTAEMLLDDPFVKGVD 281 (362)
Q Consensus 258 l~~~p~~R~s~~~~l~~p~~~~~~ 281 (362)
|++||.+|+|+.++++||||....
T Consensus 486 L~~dP~~R~tp~qal~Hpfl~~~~ 509 (586)
T KOG0667|consen 486 LEWDPAERITPAQALNHPFLTGTS 509 (586)
T ss_pred hccCchhcCCHHHHhcCccccccc
Confidence 999999999999999999998653
|
|
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-46 Score=334.80 Aligned_cols=252 Identities=23% Similarity=0.385 Sum_probs=202.1
Q ss_pred ecccCceEEEEEEECCCCCCCCceeeeechhhh------hhHHHHHHHHHHHHcCCCCcccccccceeeecCCCceEEEE
Q 039291 14 IGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVS------ASASLQKEKEVFDNLNGCPFVLECFGEEITMGENGEMAYNL 87 (362)
Q Consensus 14 lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~~------~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~~~~~~~l 87 (362)
||+|+||+||+|.++.+++ .+++|..... ....+..|+.+++.++ |+||+++.+.+.. ...+++
T Consensus 1 lg~G~~g~Vy~~~~~~~~~----~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~-~~~i~~~~~~~~~-----~~~~~l 70 (280)
T cd05608 1 LGKGGFGEVSACQMRATGK----LYACKKLNKKRLKKRKGYEGAMVEKRILAKVH-SRFIVSLAYAFQT-----KTDLCL 70 (280)
T ss_pred CCCCCceeEEEEEEccCCc----EEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCC-CCcEeeeeEEEcC-----CCeEEE
Confidence 7999999999999988875 4566654322 2245678999999997 8999998875532 334789
Q ss_pred EEEecCCCCHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEeecCCccc
Q 039291 88 LLEYAAGGTLGDLIEKC--NGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKR 165 (362)
Q Consensus 88 v~e~~~~~~L~~~l~~~--~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Dfgla~~ 165 (362)
||||++||+|.+++... ....+++..+..++.||+.||+|||++||+||||||+||++ +.++.++|+|||++..
T Consensus 71 v~e~~~~g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili----~~~~~~~l~dfg~~~~ 146 (280)
T cd05608 71 VMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLL----DNDGNVRISDLGLAVE 146 (280)
T ss_pred EEeCCCCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE----CCCCCEEEeeCcccee
Confidence 99999999999887542 23459999999999999999999999999999999999999 7778899999999875
Q ss_pred ccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHhCCCCCccCCCCC-HHHHHHHHcCCCCCCCCCc
Q 039291 166 SRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCS-IDQLFSIIGDEHSLPEIPS 244 (362)
Q Consensus 166 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~ 244 (362)
...... ......||+.|+|||++.+..++.++|+|||||++|+|++|+.||....... .......+... ...++.
T Consensus 147 ~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~--~~~~~~ 222 (280)
T cd05608 147 LKDGQS--KTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILND--SVTYPD 222 (280)
T ss_pred cCCCCc--cccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhccc--CCCCcc
Confidence 543221 2234679999999999999999999999999999999999999997543322 22222222222 224556
Q ss_pred cCCHHHHHHHHHHhccCCCCCC-----CHHHHhcCCCccCcchh
Q 039291 245 RVSKEARDFLRRCFVRKPAFRF-----TAEMLLDDPFVKGVDEE 283 (362)
Q Consensus 245 ~~~~~~~~li~~~l~~~p~~R~-----s~~~~l~~p~~~~~~~~ 283 (362)
.++.++.+++.+||+.||++|+ +++++++||||+...+.
T Consensus 223 ~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h~~~~~~~~~ 266 (280)
T cd05608 223 KFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTHPLFRDLNWR 266 (280)
T ss_pred cCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcChhhhcCCHh
Confidence 7899999999999999999999 88999999999987665
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-46 Score=342.60 Aligned_cols=254 Identities=30% Similarity=0.461 Sum_probs=204.3
Q ss_pred cceecccCceEEEEEEECCCCCCCCceeeeechhhh-----hhHHHHHHHHHHHHcCCCCcccccccceeeecCCCceEE
Q 039291 11 GRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVS-----ASASLQKEKEVFDNLNGCPFVLECFGEEITMGENGEMAY 85 (362)
Q Consensus 11 ~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~~-----~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~~~~~~ 85 (362)
++.||+|+||.||++++.... .....+++|..... ....+.+|++++++++ ||||+++++.+.. ...+
T Consensus 1 l~~lg~G~~g~Vy~~~~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~-----~~~~ 73 (318)
T cd05582 1 LKVLGQGSFGKVFLVRKITGP-DAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVN-HPFIVKLHYAFQT-----EGKL 73 (318)
T ss_pred CceeeeCCCEEEEEEEEeccC-CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCC-CCCcccEEEEEEc-----CCEE
Confidence 368999999999999874211 11235666655422 3345678999999998 9999999886642 3357
Q ss_pred EEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEeecCCccc
Q 039291 86 NLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKR 165 (362)
Q Consensus 86 ~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Dfgla~~ 165 (362)
|+||||+++++|.+++.+ ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++..
T Consensus 74 ~lv~e~~~~~~L~~~l~~--~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~----~~~~~~kL~Dfg~~~~ 147 (318)
T cd05582 74 YLILDFLRGGDLFTRLSK--EVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILL----DEEGHIKLTDFGLSKE 147 (318)
T ss_pred EEEEcCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEE----CCCCcEEEeeccCCcc
Confidence 899999999999999976 4459999999999999999999999999999999999999 7778899999999875
Q ss_pred ccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHHcCCCCCCCCCcc
Q 039291 166 SRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEHSLPEIPSR 245 (362)
Q Consensus 166 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (362)
..... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||... +..+....+.... ..++..
T Consensus 148 ~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~---~~~~~~~~i~~~~--~~~p~~ 220 (318)
T cd05582 148 SIDHE--KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGK---DRKETMTMILKAK--LGMPQF 220 (318)
T ss_pred cCCCC--CceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCC---CHHHHHHHHHcCC--CCCCCC
Confidence 44321 1223567999999999999888999999999999999999999999654 3344444443222 245667
Q ss_pred CCHHHHHHHHHHhccCCCCCCC-----HHHHhcCCCccCcchhh
Q 039291 246 VSKEARDFLRRCFVRKPAFRFT-----AEMLLDDPFVKGVDEEL 284 (362)
Q Consensus 246 ~~~~~~~li~~~l~~~p~~R~s-----~~~~l~~p~~~~~~~~~ 284 (362)
++.++.+||++||+.||++||+ +.+++.||||..+.+..
T Consensus 221 ~~~~~~~li~~~l~~~P~~R~~a~~~~~~~~~~~~~~~~~~~~~ 264 (318)
T cd05582 221 LSPEAQSLLRALFKRNPANRLGAGPDGVEEIKRHPFFSTIDWNK 264 (318)
T ss_pred CCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhCCCCcCCCCHHH
Confidence 8999999999999999999999 77799999999987654
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-46 Score=348.26 Aligned_cols=252 Identities=30% Similarity=0.455 Sum_probs=202.0
Q ss_pred CceeecceecccCceEEEEEEECCCCCCCCceeeeechh----hhhhHHHHHHHHHHHHcCCCCcccccccceeeecCCC
Q 039291 6 TSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAE----VSASASLQKEKEVFDNLNGCPFVLECFGEEITMGENG 81 (362)
Q Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~----~~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~~ 81 (362)
+.|..++.||+|+||+||+|+++.+++ .+++|... ......+.+|+++++.++ |+||+++++.+..
T Consensus 74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~----~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~----- 143 (353)
T PLN00034 74 SELERVNRIGSGAGGTVYKVIHRPTGR----LYALKVIYGNHEDTVRRQICREIEILRDVN-HPNVVKCHDMFDH----- 143 (353)
T ss_pred HHHhhhhhccCCCCeEEEEEEECCCCC----EEEEEEEecCCcHHHHHHHHHHHHHHHhCC-CCCcceeeeEecc-----
Confidence 568889999999999999999988775 45555542 234466889999999998 8999999986532
Q ss_pred ceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEeecC
Q 039291 82 EMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLG 161 (362)
Q Consensus 82 ~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Dfg 161 (362)
...+++||||+++++|.+. ...++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||
T Consensus 144 ~~~~~lv~e~~~~~~L~~~------~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll----~~~~~~kL~DfG 213 (353)
T PLN00034 144 NGEIQVLLEFMDGGSLEGT------HIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLI----NSAKNVKIADFG 213 (353)
T ss_pred CCeEEEEEecCCCCccccc------ccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEE----cCCCCEEEcccc
Confidence 3347799999999998642 236788889999999999999999999999999999999 777889999999
Q ss_pred CcccccccccCCCCCCccCCCCccCchhhcc-----ccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHHcCC
Q 039291 162 VAKRSRHCKRQKFDPSMRGTPLYLAPETVVQ-----HMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDE 236 (362)
Q Consensus 162 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 236 (362)
+++...... .......||..|+|||++.. ...+.++|||||||++|+|++|+.||......+...+...+...
T Consensus 214 ~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~ 291 (353)
T PLN00034 214 VSRILAQTM--DPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMS 291 (353)
T ss_pred cceeccccc--ccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhcc
Confidence 987654321 11234579999999998753 23456899999999999999999999754444444444443322
Q ss_pred CCCCCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCccCc
Q 039291 237 HSLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGV 280 (362)
Q Consensus 237 ~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~~~~ 280 (362)
..+..+..++.++++||.+||..||++||++.+++.||||...
T Consensus 292 -~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~hp~~~~~ 334 (353)
T PLN00034 292 -QPPEAPATASREFRHFISCCLQREPAKRWSAMQLLQHPFILRA 334 (353)
T ss_pred -CCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcCcccccC
Confidence 2234566789999999999999999999999999999999764
|
|
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-45 Score=338.72 Aligned_cols=250 Identities=28% Similarity=0.440 Sum_probs=200.4
Q ss_pred ceecccCceEEEEEEECCCCCCCCceeeeechhh------hhhHHHHHHHH-HHHHcCCCCcccccccceeeecCCCceE
Q 039291 12 RVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEV------SASASLQKEKE-VFDNLNGCPFVLECFGEEITMGENGEMA 84 (362)
Q Consensus 12 ~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~------~~~~~~~~E~~-il~~l~~h~~i~~~~~~~~~~~~~~~~~ 84 (362)
+.||+|+||+||+|+++.++.. +++|.... .....+.+|.. +++.++ ||||+++++.+.. ...
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~----~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~-h~~iv~~~~~~~~-----~~~ 70 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSF----YAVKVLQKKTILKKKEQNHIMAERNVLLKNLK-HPFLVGLHYSFQT-----AEK 70 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCE----EEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCC-CCCccceeeEEEc-----CCE
Confidence 4799999999999999888764 45554322 12334555554 466676 9999999876532 235
Q ss_pred EEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEeecCCcc
Q 039291 85 YNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAK 164 (362)
Q Consensus 85 ~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Dfgla~ 164 (362)
+++||||++|++|..++.. ...+++..++.++.||+.||.|||++||+||||||+||++ +.++.+||+|||+++
T Consensus 71 ~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll----~~~~~~kl~Dfg~~~ 144 (321)
T cd05603 71 LYFVLDYVNGGELFFHLQR--ERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILL----DSQGHVVLTDFGLCK 144 (321)
T ss_pred EEEEEcCCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEE----CCCCCEEEccCCCCc
Confidence 7899999999999988876 4559999999999999999999999999999999999999 778889999999987
Q ss_pred cccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHHcCCCCCCCCCc
Q 039291 165 RSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEHSLPEIPS 244 (362)
Q Consensus 165 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (362)
..... .......+||+.|+|||++.+..++.++|||||||++|+|++|..||... +..++...+.... ..++.
T Consensus 145 ~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~---~~~~~~~~i~~~~--~~~~~ 217 (321)
T cd05603 145 EGVEP--EETTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSR---DVSQMYDNILHKP--LQLPG 217 (321)
T ss_pred cCCCC--CCccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCC---CHHHHHHHHhcCC--CCCCC
Confidence 43221 22224567999999999999888999999999999999999999999654 3445555554332 34566
Q ss_pred cCCHHHHHHHHHHhccCCCCCCCH----HHHhcCCCccCcchhh
Q 039291 245 RVSKEARDFLRRCFVRKPAFRFTA----EMLLDDPFVKGVDEEL 284 (362)
Q Consensus 245 ~~~~~~~~li~~~l~~~p~~R~s~----~~~l~~p~~~~~~~~~ 284 (362)
..+.++.++|.+||+.||.+|+++ .++++|+||..+.+..
T Consensus 218 ~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~~~~~~~~~~~ 261 (321)
T cd05603 218 GKTVAACDLLVGLLHKDQRRRLGAKADFLEIKNHVFFSPINWDD 261 (321)
T ss_pred CCCHHHHHHHHHHccCCHhhcCCCCCCHHHHhCCCCcCCCCHHH
Confidence 788999999999999999999875 5999999999887653
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-46 Score=346.28 Aligned_cols=259 Identities=27% Similarity=0.406 Sum_probs=205.1
Q ss_pred CCCCceeecceecccCceEEEEEEECCCCCCCCceeeeechhh------hhhHHHHHHHHHHHHcCCCCcccccccceee
Q 039291 3 SDGTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEV------SASASLQKEKEVFDNLNGCPFVLECFGEEIT 76 (362)
Q Consensus 3 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~------~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~ 76 (362)
...++|.+.+.||+|+||.||+|+++.++.. +++|.... .....+.+|+.+++.++ ||||+++++.+..
T Consensus 40 ~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~----~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~-hp~iv~~~~~~~~ 114 (371)
T cd05622 40 MKAEDYEVVKVIGRGAFGEVQLVRHKSTRKV----YAMKLLSKFEMIKRSDSAFFWEERDIMAFAN-SPWVVQLFYAFQD 114 (371)
T ss_pred cchhhcEEEEEEeecCCeEEEEEEECCCCcE----EEEEEEEHHHhhhhHHHHHHHHHHHHHHhCC-CCCCCeEEEEEEc
Confidence 4468999999999999999999999988764 45554321 23345678999999888 9999999876542
Q ss_pred ecCCCceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEE
Q 039291 77 MGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAK 156 (362)
Q Consensus 77 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~k 156 (362)
...+++||||++||+|.+++.. ..+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+|
T Consensus 115 -----~~~~~lv~Ey~~gg~L~~~~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll----~~~~~ik 182 (371)
T cd05622 115 -----DRYLYMVMEYMPGGDLVNLMSN---YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLL----DKSGHLK 182 (371)
T ss_pred -----CCEEEEEEcCCCCCcHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEE----CCCCCEE
Confidence 3457899999999999999975 348999999999999999999999999999999999999 7778899
Q ss_pred EeecCCcccccccccCCCCCCccCCCCccCchhhcccc----CCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHH
Q 039291 157 IADLGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHM----QEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSI 232 (362)
Q Consensus 157 l~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~ 232 (362)
|+|||++....... .......+||+.|+|||++.+.. ++.++|||||||++|+|++|..||... +.......
T Consensus 183 L~DfG~a~~~~~~~-~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~---~~~~~~~~ 258 (371)
T cd05622 183 LADFGTCMKMNKEG-MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYAD---SLVGTYSK 258 (371)
T ss_pred EEeCCceeEcCcCC-cccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCC---CHHHHHHH
Confidence 99999997654321 11223567999999999997543 788999999999999999999999654 34444444
Q ss_pred HcCCCCCCCC--CccCCHHHHHHHHHHhccCCCC--CCCHHHHhcCCCccCcch
Q 039291 233 IGDEHSLPEI--PSRVSKEARDFLRRCFVRKPAF--RFTAEMLLDDPFVKGVDE 282 (362)
Q Consensus 233 ~~~~~~~~~~--~~~~~~~~~~li~~~l~~~p~~--R~s~~~~l~~p~~~~~~~ 282 (362)
+........+ +..++.+++++|.+||..++.+ |++++++++||||++..+
T Consensus 259 i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~~~~~~~ 312 (371)
T cd05622 259 IMNHKNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQW 312 (371)
T ss_pred HHcCCCcccCCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCcccCCCCh
Confidence 4432211122 3468999999999999844433 789999999999988544
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-46 Score=341.95 Aligned_cols=249 Identities=27% Similarity=0.438 Sum_probs=197.9
Q ss_pred ecccCceEEEEEEECCCCCCCCceeeeechhhh------hhHHHHHHHHHHHHcC--CCCcccccccceeeecCCCceEE
Q 039291 14 IGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVS------ASASLQKEKEVFDNLN--GCPFVLECFGEEITMGENGEMAY 85 (362)
Q Consensus 14 lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~~------~~~~~~~E~~il~~l~--~h~~i~~~~~~~~~~~~~~~~~~ 85 (362)
||+|+||+||+|+++.++. .+++|..... .......|..++..+. +||+|+++++.+.. ...+
T Consensus 1 lG~G~~g~Vy~~~~~~~~~----~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~-----~~~~ 71 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRR----IYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQT-----DSDL 71 (330)
T ss_pred CCCCCceEEEEEEECCCCC----EEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEec-----CCeE
Confidence 7999999999999988876 4555554321 2233455677776654 69999999876532 3357
Q ss_pred EEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEeecCCccc
Q 039291 86 NLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKR 165 (362)
Q Consensus 86 ~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Dfgla~~ 165 (362)
++||||+++|+|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||+ +.++.++|+|||++..
T Consensus 72 ~lv~e~~~~g~L~~~l~~--~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili----~~~~~~kl~Dfg~a~~ 145 (330)
T cd05586 72 YLVTDYMSGGELFWHLQK--EGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILL----DATGHIALCDFGLSKA 145 (330)
T ss_pred EEEEcCCCCChHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEE----CCCCCEEEecCCcCcC
Confidence 899999999999999876 4569999999999999999999999999999999999999 7778899999999865
Q ss_pred ccccccCCCCCCccCCCCccCchhhccc-cCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHHcCCCCCCCCC-
Q 039291 166 SRHCKRQKFDPSMRGTPLYLAPETVVQH-MQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEHSLPEIP- 243 (362)
Q Consensus 166 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~- 243 (362)
.... .......+||+.|+|||++.+. .++.++|||||||++|+|++|+.||... +..++...+..... .++
T Consensus 146 ~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~---~~~~~~~~i~~~~~--~~~~ 218 (330)
T cd05586 146 NLTD--NKTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAE---DTQQMYRNIAFGKV--RFPK 218 (330)
T ss_pred CCCC--CCCccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCC---CHHHHHHHHHcCCC--CCCC
Confidence 3321 1222456799999999998764 5789999999999999999999999654 34455555443322 122
Q ss_pred ccCCHHHHHHHHHHhccCCCCCC----CHHHHhcCCCccCcchhh
Q 039291 244 SRVSKEARDFLRRCFVRKPAFRF----TAEMLLDDPFVKGVDEEL 284 (362)
Q Consensus 244 ~~~~~~~~~li~~~l~~~p~~R~----s~~~~l~~p~~~~~~~~~ 284 (362)
..++.++++||++||..||.+|| +++++++||||+...+..
T Consensus 219 ~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h~~~~~~~~~~ 263 (330)
T cd05586 219 NVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEHPFFADIDWDL 263 (330)
T ss_pred ccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcCccccCCCHHH
Confidence 34789999999999999999998 799999999999877654
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-46 Score=367.27 Aligned_cols=270 Identities=27% Similarity=0.431 Sum_probs=226.0
Q ss_pred CCCceeecceecccCceEEEEEEECCCCCCCCceeeeechhh------hhhHHHHHHHHHHHHcCCCCcccccccceeee
Q 039291 4 DGTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEV------SASASLQKEKEVFDNLNGCPFVLECFGEEITM 77 (362)
Q Consensus 4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~------~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~ 77 (362)
.-..|.++++||+|+||.|.+++.+.+++. +|+|++++ ...+-|..|..||..-+ .+.|+.++-.+
T Consensus 73 ~~~DfeilKvIGrGaFGEV~lVr~k~t~~V----YAMK~lnK~eMlKr~~tA~F~EERDimv~~n-s~Wiv~LhyAF--- 144 (1317)
T KOG0612|consen 73 KAEDFEILKVIGRGAFGEVALVRHKSTEKV----YAMKILNKWEMLKRAETACFREERDIMVFGN-SEWIVQLHYAF--- 144 (1317)
T ss_pred CHHhhHHHHHhcccccceeEEEEeeccccc----hhHHHhhHHHHhhchhHHHHHHHhHHHHcCC-cHHHHHHHHHh---
Confidence 446799999999999999999999999874 46665543 24556778888888777 89999887654
Q ss_pred cCCCceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEE
Q 039291 78 GENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKI 157 (362)
Q Consensus 78 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl 157 (362)
.+..++|+||||++||+|-.++.+.. +++++.+++|+..|+.||+-||+.|+|||||||+|||+ +..|++||
T Consensus 145 --QD~~~LYlVMdY~pGGDlltLlSk~~--~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLl----d~~GHikL 216 (1317)
T KOG0612|consen 145 --QDERYLYLVMDYMPGGDLLTLLSKFD--RLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLL----DKSGHIKL 216 (1317)
T ss_pred --cCccceEEEEecccCchHHHHHhhcC--CChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEe----cccCcEee
Confidence 45667899999999999999999865 69999999999999999999999999999999999999 99999999
Q ss_pred eecCCcccccccccCCCCCCccCCCCccCchhhc----c-ccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHH
Q 039291 158 ADLGVAKRSRHCKRQKFDPSMRGTPLYLAPETVV----Q-HMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSI 232 (362)
Q Consensus 158 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~----~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~ 232 (362)
+|||........ +.......+|||.|.+||++. + +.|+..+|+||+||++|||+.|..||+.. ...+.+.+
T Consensus 217 ADFGsClkm~~d-G~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYad---slveTY~K 292 (1317)
T KOG0612|consen 217 ADFGSCLKMDAD-GTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYAD---SLVETYGK 292 (1317)
T ss_pred ccchhHHhcCCC-CcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHH---HHHHHHHH
Confidence 999987665532 223335678999999999997 2 56899999999999999999999999654 56677777
Q ss_pred HcCCCCCCCCC--ccCCHHHHHHHHHHhccCCCCCCC---HHHHhcCCCccCcchhhhhhhhCCCCC
Q 039291 233 IGDEHSLPEIP--SRVSKEARDFLRRCFVRKPAFRFT---AEMLLDDPFVKGVDEELSRELEGDYSQ 294 (362)
Q Consensus 233 ~~~~~~~~~~~--~~~~~~~~~li~~~l~~~p~~R~s---~~~~l~~p~~~~~~~~~~~~~~~~~~~ 294 (362)
|......-.+| .++|.++++||++++. +|+.|.. ++++..||||.++.|+..++..+++.+
T Consensus 293 Im~hk~~l~FP~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~HpFF~g~~W~~iR~~~pP~vP 358 (1317)
T KOG0612|consen 293 IMNHKESLSFPDETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNHPFFEGIDWDNIRESVPPVVP 358 (1317)
T ss_pred HhchhhhcCCCcccccCHHHHHHHHHHhc-ChhhhcccccHHHHHhCccccCCChhhhhhcCCCCCC
Confidence 76654433444 5699999999999765 7889987 999999999999999887877777654
|
|
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-46 Score=335.56 Aligned_cols=268 Identities=24% Similarity=0.370 Sum_probs=221.6
Q ss_pred CCCCCceeecceecccCceEEEEEEECCCCCCCCceeeeech-h-hhhhHHHHHHHHHHHHcCCCCcccccccceeeecC
Q 039291 2 DSDGTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSA-E-VSASASLQKEKEVFDNLNGCPFVLECFGEEITMGE 79 (362)
Q Consensus 2 ~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~-~-~~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~ 79 (362)
.++.+.|..-++||+|+||.||.++.+.+|+-++.+..-|+. + .........|..||.+++ .+.||.+--.+
T Consensus 181 pvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~-s~FiVslaYAf----- 254 (591)
T KOG0986|consen 181 PVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVS-SPFIVSLAYAF----- 254 (591)
T ss_pred hccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhc-cCcEEEEeeee-----
Confidence 356788999999999999999999999999755433333321 1 224445678999999999 78887664332
Q ss_pred CCceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEee
Q 039291 80 NGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIAD 159 (362)
Q Consensus 80 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~D 159 (362)
+....+|+||..++||+|.-+|.......|++..+++++.+|++||++||+.+||+|||||+|||+ |+.|+++|+|
T Consensus 255 eTkd~LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILL----Dd~GhvRISD 330 (591)
T KOG0986|consen 255 ETKDALCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILL----DDHGHVRISD 330 (591)
T ss_pred cCCCceEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheee----ccCCCeEeec
Confidence 455679999999999999998888777779999999999999999999999999999999999999 9999999999
Q ss_pred cCCcccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHH-HHHHHHcCCCC
Q 039291 160 LGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSID-QLFSIIGDEHS 238 (362)
Q Consensus 160 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~-~~~~~~~~~~~ 238 (362)
+|||......... ...+||.+|||||++.+..|+...|+|||||+||||+.|+.||......... ++-+.+....
T Consensus 331 LGLAvei~~g~~~---~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~~~- 406 (591)
T KOG0986|consen 331 LGLAVEIPEGKPI---RGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLEDP- 406 (591)
T ss_pred cceEEecCCCCcc---ccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhcch-
Confidence 9999877653332 3558999999999999999999999999999999999999999765443333 4444443322
Q ss_pred CCCCCccCCHHHHHHHHHHhccCCCCCC-----CHHHHhcCCCccCcchhh
Q 039291 239 LPEIPSRVSKEARDFLRRCFVRKPAFRF-----TAEMLLDDPFVKGVDEEL 284 (362)
Q Consensus 239 ~~~~~~~~~~~~~~li~~~l~~~p~~R~-----s~~~~l~~p~~~~~~~~~ 284 (362)
..++...|+++++|.+.+|..||.+|. .++++.+||||+.+.|..
T Consensus 407 -~ey~~kFS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~lnw~r 456 (591)
T KOG0986|consen 407 -EEYSDKFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEHPFFKDLNWRR 456 (591)
T ss_pred -hhcccccCHHHHHHHHHHHccCHHHhccCCCcCcchhhhCcccccCCHhH
Confidence 256678999999999999999999997 578999999999988763
|
|
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-45 Score=354.90 Aligned_cols=257 Identities=23% Similarity=0.358 Sum_probs=209.6
Q ss_pred CCCCceeecceecccCceEEEEEEECCCCCCCCceeeeech---hhhhhHHHHHHHHHHHHcCCCCccccccc-ceeee-
Q 039291 3 SDGTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSA---EVSASASLQKEKEVFDNLNGCPFVLECFG-EEITM- 77 (362)
Q Consensus 3 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~---~~~~~~~~~~E~~il~~l~~h~~i~~~~~-~~~~~- 77 (362)
+.+-++++.+.|.+|||+.||+|.+...+ ..+|+|.+ +....+.+.+|+.+|+.|.+|+|||.+++ .....
T Consensus 34 Vg~~~v~V~~vLAEGGFa~VYla~~~~~~----~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~ 109 (738)
T KOG1989|consen 34 VGSHRVTVEKVLAEGGFAQVYLAQDVKGG----KKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRS 109 (738)
T ss_pred ECCEEEEEEEEEccCCcEEEEEEEecCCC----ceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEecccccccc
Confidence 45678899999999999999999998875 35666654 45567788999999999999999999999 33332
Q ss_pred cCCCceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--ceeCCCCCCCEEEeecCCCceEE
Q 039291 78 GENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSG--YVHCDVKPDNILLVATQSGKFVA 155 (362)
Q Consensus 78 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~--ivH~Dlkp~Nill~~~~~~~~~~ 155 (362)
+..+...++|+||||.||.|-+++..+-...|+|.++.+|++|+++|+.+||... |||||||-+|||| +.++..
T Consensus 110 ~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLl----s~~g~~ 185 (738)
T KOG1989|consen 110 SNNGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLL----SADGNY 185 (738)
T ss_pred CCCceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEE----cCCCCE
Confidence 3332456779999999999999999766666999999999999999999999988 9999999999999 788899
Q ss_pred EEeecCCcccccccccCCCC-------CCccCCCCccCchhhc---cccCCCcchHHHHHHHHHHHHhCCCCCccCCCCC
Q 039291 156 KIADLGVAKRSRHCKRQKFD-------PSMRGTPLYLAPETVV---QHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCS 225 (362)
Q Consensus 156 kl~Dfgla~~~~~~~~~~~~-------~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~ 225 (362)
||||||.|............ -...-|+.|+|||.+. +...+.|+|||+|||+||-||....||+....
T Consensus 186 KLCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~-- 263 (738)
T KOG1989|consen 186 KLCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGK-- 263 (738)
T ss_pred EeCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcc--
Confidence 99999998743332211100 0223699999999876 66889999999999999999999999965422
Q ss_pred HHHHHHHHcCCCCCCCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhcC
Q 039291 226 IDQLFSIIGDEHSLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDD 274 (362)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~ 274 (362)
+.++.....+|.. ...+..+.+||+.||+.||++||++-+++.+
T Consensus 264 ----laIlng~Y~~P~~-p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~ 307 (738)
T KOG1989|consen 264 ----LAILNGNYSFPPF-PNYSDRLKDLIRTMLQPNPDERPNIYQVLEE 307 (738)
T ss_pred ----eeEEeccccCCCC-ccHHHHHHHHHHHHhccCcccCCCHHHHHHH
Confidence 2344455666655 4589999999999999999999999988763
|
|
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-45 Score=330.70 Aligned_cols=252 Identities=26% Similarity=0.397 Sum_probs=200.1
Q ss_pred ecccCceEEEEEEECCCCCCCCceeeeechhh------hhhHHHHHHHHHHHHcCCCCcccccccceeeecCCCceEEEE
Q 039291 14 IGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEV------SASASLQKEKEVFDNLNGCPFVLECFGEEITMGENGEMAYNL 87 (362)
Q Consensus 14 lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~------~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~~~~~~~l 87 (362)
||+|+||+||+++++.+++ .+++|.... .....+..|++++++++ ||||+++++.+. ....+++
T Consensus 1 lg~G~~g~Vy~~~~~~~~~----~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~-hp~i~~~~~~~~-----~~~~~~l 70 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGK----MYACKKLDKKRLKKKSGEKMALLEKEILEKVN-SPFIVNLAYAFE-----SKTHLCL 70 (277)
T ss_pred CCCCCceEEEEEEEccCCc----EEEEEEEcHHHhhcchhhHHHHHHHHHHHhcC-CCcEEEEEEEEe-----cCCeEEE
Confidence 7999999999999988876 445554432 12334567999999997 999999887653 2345789
Q ss_pred EEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEeecCCccccc
Q 039291 88 LLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSR 167 (362)
Q Consensus 88 v~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Dfgla~~~~ 167 (362)
||||++|++|.+++.......+++..+..++.|++.||+|||+.||+||||||+||++ +.++.++|+|||++....
T Consensus 71 v~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili----~~~~~~~l~Dfg~~~~~~ 146 (277)
T cd05607 71 VMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLL----DDQGNCRLSDLGLAVELK 146 (277)
T ss_pred EEecCCCCCHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEE----cCCCCEEEeeceeeeecC
Confidence 9999999999998876555569999999999999999999999999999999999999 777889999999987554
Q ss_pred ccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHhCCCCCccCCCC-CHHHHHHHHcCCCCCCCCCccC
Q 039291 168 HCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDC-SIDQLFSIIGDEHSLPEIPSRV 246 (362)
Q Consensus 168 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 246 (362)
.... .....|+..|+|||++.+..++.++|+||+||++|+|++|+.||...... ...+......... .+.....+
T Consensus 147 ~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 222 (277)
T cd05607 147 DGKT---ITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDE-VKFEHQNF 222 (277)
T ss_pred CCce---eeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhccc-cccccccC
Confidence 3211 12356899999999999888999999999999999999999999654321 2233333332221 12223468
Q ss_pred CHHHHHHHHHHhccCCCCCCCH----HHHhcCCCccCcchh
Q 039291 247 SKEARDFLRRCFVRKPAFRFTA----EMLLDDPFVKGVDEE 283 (362)
Q Consensus 247 ~~~~~~li~~~l~~~p~~R~s~----~~~l~~p~~~~~~~~ 283 (362)
+.++++|+.+||+.||++||++ ++++.||||+.+.+.
T Consensus 223 ~~~~~~li~~~L~~~P~~R~~~~~~~~~~~~h~~f~~~~~~ 263 (277)
T cd05607 223 TEESKDICRLFLAKKPEDRLGSREKNDDPRKHEFFKTINFP 263 (277)
T ss_pred CHHHHHHHHHHhccCHhhCCCCccchhhhhcChhhcCCCHH
Confidence 9999999999999999999999 678899999987654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-45 Score=347.62 Aligned_cols=263 Identities=20% Similarity=0.240 Sum_probs=206.3
Q ss_pred CCceeecceecccCceEEEEEEECCCCCCCCceeeeechhhhhhHHHHHHHHHHHHcCCCCcccccccceeeecCCCceE
Q 039291 5 GTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVSASASLQKEKEVFDNLNGCPFVLECFGEEITMGENGEMA 84 (362)
Q Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~~~~~ 84 (362)
..+|.+++.||+|+||.||+|...+.. ...++++|..... ....+|+.+++.|+ ||||+++++.+.. ...
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~--~~~~v~vK~~~~~--~~~~~E~~il~~l~-h~~iv~~~~~~~~-----~~~ 160 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDE--QRKKVIVKAVTGG--KTPGREIDILKTIS-HRAIINLIHAYRW-----KST 160 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCc--cceeEEEEecccc--ccHHHHHHHHHhcC-CCCccceeeeEee-----CCE
Confidence 457999999999999999999865432 2356788876533 34568999999998 8999999886542 235
Q ss_pred EEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEeecCCcc
Q 039291 85 YNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAK 164 (362)
Q Consensus 85 ~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Dfgla~ 164 (362)
+|++||++. ++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||+ +..+.++|+|||++.
T Consensus 161 ~~lv~e~~~-~~l~~~l~~--~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill----~~~~~~~l~DfG~a~ 233 (392)
T PHA03207 161 VCMVMPKYK-CDLFTYVDR--SGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFL----DEPENAVLGDFGAAC 233 (392)
T ss_pred EEEEehhcC-CCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEE----cCCCCEEEccCcccc
Confidence 789999996 589888854 4569999999999999999999999999999999999999 777889999999997
Q ss_pred cccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHH-HHHHHHc---CC----
Q 039291 165 RSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSID-QLFSIIG---DE---- 236 (362)
Q Consensus 165 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~-~~~~~~~---~~---- 236 (362)
...............||+.|+|||++.+..++.++|||||||++|+|++|+.||.+....... .+...+. ..
T Consensus 234 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~ 313 (392)
T PHA03207 234 KLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEF 313 (392)
T ss_pred ccCcccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCcccc
Confidence 655433333334567999999999999889999999999999999999999999765432211 1111110 00
Q ss_pred ------------------C----CCCCC--CccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCccCcchhh
Q 039291 237 ------------------H----SLPEI--PSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGVDEEL 284 (362)
Q Consensus 237 ------------------~----~~~~~--~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~~~~~~~~ 284 (362)
. ..+.. ...++.++.++|.+||..||++||++.+++.||||+...+..
T Consensus 314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~~~~~~ 385 (392)
T PHA03207 314 PQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTKEPINL 385 (392)
T ss_pred CCccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhhccchhh
Confidence 0 00000 123567899999999999999999999999999998766553
|
|
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-45 Score=328.50 Aligned_cols=262 Identities=24% Similarity=0.422 Sum_probs=209.3
Q ss_pred CCCCceeecceecccCceEEEEEEECCCCCCCCceeeeechhh--hhhHHHHHHHHHHHHcCCCCcccccccceeeecCC
Q 039291 3 SDGTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEV--SASASLQKEKEVFDNLNGCPFVLECFGEEITMGEN 80 (362)
Q Consensus 3 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~--~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~ 80 (362)
..+++|.+.+.||+|+||.||+|+++.++. .+++|.... .....+.+|+.+++++.+|+||+++++.+......
T Consensus 3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~----~~aik~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~ 78 (272)
T cd06637 3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQ----LAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPP 78 (272)
T ss_pred ChhhhhhHHHheeecCCeEEEEEEEcCCCc----EEEEEEEEcCCccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCC
Confidence 346889999999999999999999988775 456665432 23456789999999997799999999977643221
Q ss_pred -CceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEee
Q 039291 81 -GEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIAD 159 (362)
Q Consensus 81 -~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~D 159 (362)
....++++|||+.+++|.+++.......+++..+..++.|++.||.|||+++|+|+||||+||++ +.++.++|+|
T Consensus 79 ~~~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili----~~~~~~~l~D 154 (272)
T cd06637 79 GMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLL----TENAEVKLVD 154 (272)
T ss_pred CCCcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEE----CCCCCEEEcc
Confidence 13457899999999999999987555669999999999999999999999999999999999999 7778899999
Q ss_pred cCCcccccccccCCCCCCccCCCCccCchhhcc-----ccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHHc
Q 039291 160 LGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQ-----HMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIG 234 (362)
Q Consensus 160 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~ 234 (362)
||++....... .......|+..|+|||++.+ ..++.++|+|||||++|+|++|..||.... .......+.
T Consensus 155 fg~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~---~~~~~~~~~ 229 (272)
T cd06637 155 FGVSAQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMH---PMRALFLIP 229 (272)
T ss_pred CCCceeccccc--ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccC---HHHHHHHHh
Confidence 99987554322 12235679999999999863 357889999999999999999999995432 222222222
Q ss_pred CCCCCCCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCc
Q 039291 235 DEHSLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFV 277 (362)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~ 277 (362)
........+..++.++++|+.+||..+|.+|||+.+++.||||
T Consensus 230 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~~ 272 (272)
T cd06637 230 RNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKHPFI 272 (272)
T ss_pred cCCCCCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhCCCC
Confidence 2222223345678999999999999999999999999999997
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-45 Score=354.54 Aligned_cols=264 Identities=18% Similarity=0.228 Sum_probs=196.3
Q ss_pred CCCCceeecceecccCceEEEEEEECCCCCCCCceeeeechhh--hhhHHHHHHHHHHHHcCC-----CCccccccccee
Q 039291 3 SDGTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEV--SASASLQKEKEVFDNLNG-----CPFVLECFGEEI 75 (362)
Q Consensus 3 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~--~~~~~~~~E~~il~~l~~-----h~~i~~~~~~~~ 75 (362)
...++|.+.+.||+|+||+||+|.+..+++ .||+|.+.. ........|+.+++.+.+ |.+++++++++.
T Consensus 126 ~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~----~vAvK~i~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~ 201 (467)
T PTZ00284 126 VSTQRFKILSLLGEGTFGKVVEAWDRKRKE----YCAVKIVRNVPKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQ 201 (467)
T ss_pred cCCCcEEEEEEEEeccCEEEEEEEEcCCCe----EEEEEEEecchhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEE
Confidence 346889999999999999999999988765 466666532 233446678888887762 345666665443
Q ss_pred eecCCCceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCceeCCCCCCCEEEeecCC----
Q 039291 76 TMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHD-SGYVHCDVKPDNILLVATQS---- 150 (362)
Q Consensus 76 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~-~~ivH~Dlkp~Nill~~~~~---- 150 (362)
.....+|+|||++ |++|.+++.+ .+.+++..++.++.||+.||+|||+ .|||||||||+|||+...+.
T Consensus 202 ----~~~~~~~iv~~~~-g~~l~~~l~~--~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~ 274 (467)
T PTZ00284 202 ----NETGHMCIVMPKY-GPCLLDWIMK--HGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDP 274 (467)
T ss_pred ----cCCceEEEEEecc-CCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCccccc
Confidence 2234578999998 6799998876 3569999999999999999999998 59999999999999943221
Q ss_pred --------CceEEEEeecCCcccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHhCCCCCccCC
Q 039291 151 --------GKFVAKIADLGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKE 222 (362)
Q Consensus 151 --------~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~ 222 (362)
+...+||+|||++..... .....+||+.|+|||++.+..++.++|||||||++|||++|++||.+.+
T Consensus 275 ~~~~~~~~~~~~vkl~DfG~~~~~~~-----~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~ 349 (467)
T PTZ00284 275 VTNRALPPDPCRVRICDLGGCCDERH-----SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHD 349 (467)
T ss_pred ccccccCCCCceEEECCCCccccCcc-----ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 123599999998753221 2245789999999999999999999999999999999999999997654
Q ss_pred CCCHHHHHHHHcCCC----------------------CCCCCC---------------ccCCHHHHHHHHHHhccCCCCC
Q 039291 223 DCSIDQLFSIIGDEH----------------------SLPEIP---------------SRVSKEARDFLRRCFVRKPAFR 265 (362)
Q Consensus 223 ~~~~~~~~~~~~~~~----------------------~~~~~~---------------~~~~~~~~~li~~~l~~~p~~R 265 (362)
.......+....... ..+... ...+..+.+||.+||+.||++|
T Consensus 350 ~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R 429 (467)
T PTZ00284 350 NLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKR 429 (467)
T ss_pred hHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhC
Confidence 322222211111000 000000 0113567899999999999999
Q ss_pred CCHHHHhcCCCccCcch
Q 039291 266 FTAEMLLDDPFVKGVDE 282 (362)
Q Consensus 266 ~s~~~~l~~p~~~~~~~ 282 (362)
||++++|+||||.....
T Consensus 430 ~ta~e~L~Hp~~~~~~~ 446 (467)
T PTZ00284 430 LNARQMTTHPYVLKYYP 446 (467)
T ss_pred CCHHHHhcCccccccCC
Confidence 99999999999987543
|
|
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-46 Score=322.61 Aligned_cols=267 Identities=27% Similarity=0.424 Sum_probs=221.4
Q ss_pred CCCceeecceecccCceEEEEEEECCCCCCCCceeeeechhh------hhhHHHHHHHHHHHHcCCCCcccccccceeee
Q 039291 4 DGTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEV------SASASLQKEKEVFDNLNGCPFVLECFGEEITM 77 (362)
Q Consensus 4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~------~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~ 77 (362)
+-+.|...++||+|.||+|-+++.+.+++.+ |+|++++ ...+.-..|-++|+.-. ||.+..+.-.+
T Consensus 166 Tm~dFdfLKvLGkGTFGKVIL~rEKat~k~Y----AiKIlkKeviiakdEVAHTlTE~RVL~~~~-HPFLt~LKYsF--- 237 (516)
T KOG0690|consen 166 TMEDFDFLKVLGKGTFGKVILCREKATGKLY----AIKILKKEVIIAKDEVAHTLTENRVLQNCR-HPFLTSLKYSF--- 237 (516)
T ss_pred ccchhhHHHHhcCCccceEEEEeecccCcee----ehhhhhhhheeehHHhhhhhhHHHHHHhcc-CcHHHHhhhhh---
Confidence 3456778999999999999999999998654 5555443 24455667899999988 89997765433
Q ss_pred cCCCceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEE
Q 039291 78 GENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKI 157 (362)
Q Consensus 78 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl 157 (362)
+....+|+||||+.||.|.-.++. .+.|+++.++.+..+|+.||.|||+++||+||||.+|+|+ +.+|++||
T Consensus 238 --Qt~drlCFVMeyanGGeLf~HLsr--er~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlL----DkDGHIKi 309 (516)
T KOG0690|consen 238 --QTQDRLCFVMEYANGGELFFHLSR--ERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLL----DKDGHIKI 309 (516)
T ss_pred --ccCceEEEEEEEccCceEeeehhh--hhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhhee----ccCCceEe
Confidence 345569999999999999998887 4559999999999999999999999999999999999999 99999999
Q ss_pred eecCCcccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHHcCCC
Q 039291 158 ADLGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEH 237 (362)
Q Consensus 158 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 237 (362)
+|||+.+..... ......+||||.|+|||++....|+.++|+|.+||++|||++|++||...+. ..++..|.-..
T Consensus 310 tDFGLCKE~I~~--g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh---~kLFeLIl~ed 384 (516)
T KOG0690|consen 310 TDFGLCKEEIKY--GDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDH---EKLFELILMED 384 (516)
T ss_pred eecccchhcccc--cceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccch---hHHHHHHHhhh
Confidence 999998754432 2233689999999999999999999999999999999999999999976654 44444443333
Q ss_pred CCCCCCccCCHHHHHHHHHHhccCCCCCC-----CHHHHhcCCCccCcchhhh--hhhhCCCC
Q 039291 238 SLPEIPSRVSKEARDFLRRCFVRKPAFRF-----TAEMLLDDPFVKGVDEELS--RELEGDYS 293 (362)
Q Consensus 238 ~~~~~~~~~~~~~~~li~~~l~~~p~~R~-----s~~~~l~~p~~~~~~~~~~--~~~~~~~~ 293 (362)
. .+|..++++++.|+..+|.+||.+|. .+.++..|+||..+.|+.. ..+.+++.
T Consensus 385 ~--kFPr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h~FF~~v~W~~~~~Kki~PPfK 445 (516)
T KOG0690|consen 385 L--KFPRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRHRFFASVDWEATYRKKIEPPFK 445 (516)
T ss_pred c--cCCccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhhhhhccCCHHHHHHhccCCCCC
Confidence 2 46788999999999999999999997 5899999999999998854 44555544
|
|
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-45 Score=345.82 Aligned_cols=262 Identities=24% Similarity=0.342 Sum_probs=204.1
Q ss_pred ceeecceecccCceEEEEEEECCCCCCCCceeeeechhh-----hhhHHHHHHHHHHHHcCCCCcccccccceeeecCCC
Q 039291 7 SWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEV-----SASASLQKEKEVFDNLNGCPFVLECFGEEITMGENG 81 (362)
Q Consensus 7 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~-----~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~~ 81 (362)
.|.+++.||+|+||+||+|.+..+++ .+++|.... .....+.+|+.+++.++ |+||+++++.+.......
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~----~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~ 75 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGK----RVALKKMPNVFQNLVSCKRVFRELKMLCFFK-HDNVLSALDILQPPHIDP 75 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCC----EEEEEeccccccchHHHHHHHHHHHHHHhCC-CCCcCCHhheecCCCccc
Confidence 47889999999999999999987775 456665432 23456889999999998 999999999775433222
Q ss_pred ceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEeecC
Q 039291 82 EMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLG 161 (362)
Q Consensus 82 ~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Dfg 161 (362)
...+|+||||+. ++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||
T Consensus 76 ~~~~~lv~e~~~-~~l~~~~~~--~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili----~~~~~~kL~Dfg 148 (372)
T cd07853 76 FEEIYVVTELMQ-SDLHKIIVS--PQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLV----NSNCVLKICDFG 148 (372)
T ss_pred cceEEEEeeccc-cCHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEE----CCCCCEEecccc
Confidence 335789999996 588888865 4569999999999999999999999999999999999999 778899999999
Q ss_pred CcccccccccCCCCCCccCCCCccCchhhccc-cCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHH--------
Q 039291 162 VAKRSRHCKRQKFDPSMRGTPLYLAPETVVQH-MQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSI-------- 232 (362)
Q Consensus 162 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~-------- 232 (362)
+++........ ......+|+.|+|||++.+. .++.++|||||||++|+|++|++||...+.......+..
T Consensus 149 ~a~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~ 227 (372)
T cd07853 149 LARVEEPDESK-HMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLE 227 (372)
T ss_pred ceeecccCccc-cCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHH
Confidence 99755432222 22345689999999999874 578999999999999999999999975543221111111
Q ss_pred ------------HcC-CCCCC------CCCccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCccCcc
Q 039291 233 ------------IGD-EHSLP------EIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGVD 281 (362)
Q Consensus 233 ------------~~~-~~~~~------~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~~~~~ 281 (362)
+.. ....+ .+....+.++.+||.+||+.||++|||+.+++.||||++..
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~ 295 (372)
T cd07853 228 AMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDEGR 295 (372)
T ss_pred HHHHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCCCc
Confidence 000 11111 12345688999999999999999999999999999998754
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-45 Score=352.92 Aligned_cols=258 Identities=22% Similarity=0.339 Sum_probs=210.5
Q ss_pred CceeecceecccCceEEEEEEECCC-CCCCCceeeeechh---hhhhHHHHHHHHHHHHcCCCCcccccccceeeecCCC
Q 039291 6 TSWFRGRVIGQGSFGCVFIAKPKSN-SSFLPPLMAVKSAE---VSASASLQKEKEVFDNLNGCPFVLECFGEEITMGENG 81 (362)
Q Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~-~~~~~~~~~~K~~~---~~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~~ 81 (362)
..|.+.+.||+|++|.||+|.+..+ +. ++++|... ......+.+|+.+++.++ ||||+++++.+..
T Consensus 67 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~----~vv~K~~~~~~~~~~~~~~~E~~~l~~l~-Hpniv~~~~~~~~----- 136 (478)
T PTZ00267 67 HMYVLTTLVGRNPTTAAFVATRGSDPKE----KVVAKFVMLNDERQAAYARSELHCLAACD-HFGIVKHFDDFKS----- 136 (478)
T ss_pred eeEEEEEEEEeCCCcEEEEEEEcCCCCe----EEEEEEcccCCHHHHHHHHHHHHHHHhCC-CCCEeEEEEEEEE-----
Confidence 4599999999999999999998766 43 34445432 233456778999999998 9999999997643
Q ss_pred ceEEEEEEEecCCCCHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEee
Q 039291 82 EMAYNLLLEYAAGGTLGDLIEKC--NGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIAD 159 (362)
Q Consensus 82 ~~~~~lv~e~~~~~~L~~~l~~~--~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~D 159 (362)
...+|+||||++||+|.+++... ...++++..+..++.|++.||.|||++||+||||||+|||+ +.++.+||+|
T Consensus 137 ~~~~~lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll----~~~~~~kL~D 212 (478)
T PTZ00267 137 DDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFL----MPTGIIKLGD 212 (478)
T ss_pred CCEEEEEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEE----CCCCcEEEEe
Confidence 23578999999999999988642 23469999999999999999999999999999999999999 7778899999
Q ss_pred cCCcccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHHcCCCCC
Q 039291 160 LGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEHSL 239 (362)
Q Consensus 160 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 239 (362)
||+++..............+||+.|+|||++.+..++.++|||||||++|+|++|+.||... ...+++..+.....
T Consensus 213 Fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~---~~~~~~~~~~~~~~- 288 (478)
T PTZ00267 213 FGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGP---SQREIMQQVLYGKY- 288 (478)
T ss_pred CcCceecCCccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCC---CHHHHHHHHHhCCC-
Confidence 99998655433323334667999999999999889999999999999999999999999543 34444444433322
Q ss_pred CCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCccCcc
Q 039291 240 PEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGVD 281 (362)
Q Consensus 240 ~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~~~~~ 281 (362)
+..+..++.+++++|.+||..||++||++.+++.|+|++...
T Consensus 289 ~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~~~~~~~~ 330 (478)
T PTZ00267 289 DPFPCPVSSGMKALLDPLLSKNPALRPTTQQLLHTEFLKYVA 330 (478)
T ss_pred CCCCccCCHHHHHHHHHHhccChhhCcCHHHHHhCHHHHHHH
Confidence 234567899999999999999999999999999999987643
|
|
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-45 Score=342.16 Aligned_cols=259 Identities=22% Similarity=0.317 Sum_probs=200.3
Q ss_pred CCceeecceecccCceEEEEEEECCCCCCCCceeeeechh-----hhhhHHHHHHHHHHHHcCCCCcccccccceeeecC
Q 039291 5 GTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAE-----VSASASLQKEKEVFDNLNGCPFVLECFGEEITMGE 79 (362)
Q Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~-----~~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~ 79 (362)
-++|.+.+.||+|+||.||+|+++.++. .+++|... ......+.+|+.+++.++ ||||+++++++.....
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~----~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~ 94 (359)
T cd07876 20 LKRYQQLKPIGSGAQGIVCAAFDTVLGI----NVAVKKLSRPFQNQTHAKRAYRELVLLKCVN-HKNIISLLNVFTPQKS 94 (359)
T ss_pred hhceEEEEEeecCCCEEEEEEEEcCCCc----eeEEEEecccccchhHHHHHHHHHHHHHhCC-CCCEeeeeeeeccCCC
Confidence 4789999999999999999999988775 45555542 234556789999999998 9999999987653221
Q ss_pred -CCceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEe
Q 039291 80 -NGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIA 158 (362)
Q Consensus 80 -~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~ 158 (362)
.....+|+||||+.+ +|.+.+.. .+++..+..++.|++.||.|||++||+||||||+|||+ +.++.+||+
T Consensus 95 ~~~~~~~~lv~e~~~~-~l~~~~~~----~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~----~~~~~~kl~ 165 (359)
T cd07876 95 LEEFQDVYLVMELMDA-NLCQVIHM----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV----KSDCTLKIL 165 (359)
T ss_pred ccccceeEEEEeCCCc-CHHHHHhc----cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEE----CCCCCEEEe
Confidence 122346899999975 67666643 38999999999999999999999999999999999999 778889999
Q ss_pred ecCCcccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHH-HHH------
Q 039291 159 DLGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQ-LFS------ 231 (362)
Q Consensus 159 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~-~~~------ 231 (362)
|||+++..... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||...+...... ...
T Consensus 166 Dfg~a~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~ 242 (359)
T cd07876 166 DFGLARTACTN---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPS 242 (359)
T ss_pred cCCCccccccC---ccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCc
Confidence 99998754321 12235678999999999999899999999999999999999999997553211100 000
Q ss_pred -------------HHcCCCCCC-----------------CCCccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCccCc
Q 039291 232 -------------IIGDEHSLP-----------------EIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGV 280 (362)
Q Consensus 232 -------------~~~~~~~~~-----------------~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~~~~ 280 (362)
........+ ......+.++++||.+||..||++|||+++++.||||..+
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~ 321 (359)
T cd07876 243 AEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYITVW 321 (359)
T ss_pred HHHHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchhhhh
Confidence 000111110 0112246789999999999999999999999999999764
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-45 Score=335.76 Aligned_cols=259 Identities=22% Similarity=0.387 Sum_probs=201.8
Q ss_pred CCceeecceecccCceEEEEEEECCCCCCCCceeeeechhh----hhhHHHHHHHHHHHHcCCCCcccccccceeeecCC
Q 039291 5 GTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEV----SASASLQKEKEVFDNLNGCPFVLECFGEEITMGEN 80 (362)
Q Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~----~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~ 80 (362)
-.+|.+.+.||+|+||+||+|+++.++. .+++|.... .....+.+|+.++++++ ||||+++++.+..
T Consensus 5 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~----~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~---- 75 (309)
T cd07872 5 METYIKLEKLGEGTYATVFKGRSKLTEN----LVALKEIRLEHEEGAPCTAIREVSLLKDLK-HANIVTLHDIVHT---- 75 (309)
T ss_pred CCceEEEEEecccCCEEEEEEEecCCCC----eEEEEEeeccccCCcchhHHHHHHHHHhCC-CCCcceEEEEEee----
Confidence 3679999999999999999999987765 456665432 23345778999999998 8999999987643
Q ss_pred CceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEeec
Q 039291 81 GEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADL 160 (362)
Q Consensus 81 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Df 160 (362)
...+++||||+++ +|.+++... +..+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+||
T Consensus 76 -~~~~~lv~e~~~~-~l~~~~~~~-~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill----~~~~~~kl~Df 148 (309)
T cd07872 76 -DKSLTLVFEYLDK-DLKQYMDDC-GNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLI----NERGELKLADF 148 (309)
T ss_pred -CCeEEEEEeCCCC-CHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE----CCCCCEEECcc
Confidence 2347899999975 888888763 3458999999999999999999999999999999999999 77788999999
Q ss_pred CCcccccccccCCCCCCccCCCCccCchhhcc-ccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHHcCC---
Q 039291 161 GVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQ-HMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDE--- 236 (362)
Q Consensus 161 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~--- 236 (362)
|++....... .......+|+.|+|||++.+ ..++.++|||||||++|+|++|++||...+..+...........
T Consensus 149 g~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~ 226 (309)
T cd07872 149 GLARAKSVPT--KTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTE 226 (309)
T ss_pred ccceecCCCc--cccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH
Confidence 9987543221 11234568999999999875 46789999999999999999999999655432222211111000
Q ss_pred --------------CCCC--------CCCccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCccCcc
Q 039291 237 --------------HSLP--------EIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGVD 281 (362)
Q Consensus 237 --------------~~~~--------~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~~~~~ 281 (362)
...+ .....++.++++||.+||..||.+|||+.+++.||||+...
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~ 293 (309)
T cd07872 227 ETWPGISSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSLG 293 (309)
T ss_pred HHHhhhcchhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhhcc
Confidence 0000 01134788999999999999999999999999999998754
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-45 Score=334.19 Aligned_cols=260 Identities=27% Similarity=0.392 Sum_probs=194.4
Q ss_pred cceecccCceEEEEEEECCCCCCCCceeeeechhhh-hhHHHHHHHHHHHHcCCCCcccccccceeeecCCCceEEEEEE
Q 039291 11 GRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVS-ASASLQKEKEVFDNLNGCPFVLECFGEEITMGENGEMAYNLLL 89 (362)
Q Consensus 11 ~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~~-~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~~~~~~~lv~ 89 (362)
++.||+|+||+||+|+++.... ...+++|..... ....+.+|+.++++++ ||||+++++.+.. .....++++|
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~--~~~~aiK~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~---~~~~~~~lv~ 79 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKD--DRDYALKQIEGTGISMSACREIALLRELK-HPNVISLQKVFLS---HADRKVWLLF 79 (317)
T ss_pred ccccccCCCeEEEEEEEccCCC--CceEEEEEECCCCCcHHHHHHHHHHHhcC-CCCCcceeeeEec---CCCcEEEEEE
Confidence 5789999999999999764321 235677765432 2345789999999998 9999999887643 2234577999
Q ss_pred EecCCCCHHHHHHHhc-------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEeecCC
Q 039291 90 EYAAGGTLGDLIEKCN-------GNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGV 162 (362)
Q Consensus 90 e~~~~~~L~~~l~~~~-------~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Dfgl 162 (362)
||+. ++|.+++.... ...+++..++.++.||+.||+|||++||+||||||+|||+..+++..+.+||+|||+
T Consensus 80 e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~ 158 (317)
T cd07868 80 DYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGF 158 (317)
T ss_pred eccC-CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCc
Confidence 9996 58988886421 124899999999999999999999999999999999999976556677899999999
Q ss_pred cccccccccC-CCCCCccCCCCccCchhhcc-ccCCCcchHHHHHHHHHHHHhCCCCCccCCCCC-------HHHH---H
Q 039291 163 AKRSRHCKRQ-KFDPSMRGTPLYLAPETVVQ-HMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCS-------IDQL---F 230 (362)
Q Consensus 163 a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~-------~~~~---~ 230 (362)
++........ .......||+.|+|||++.+ ..++.++||||+||++|+|++|++||....... ..++ +
T Consensus 159 a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~ 238 (317)
T cd07868 159 ARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIF 238 (317)
T ss_pred eeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHH
Confidence 9765432211 12235678999999999987 458899999999999999999999996543210 1111 1
Q ss_pred HHHcCC-----------C------------CC---------CCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCc
Q 039291 231 SIIGDE-----------H------------SL---------PEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFV 277 (362)
Q Consensus 231 ~~~~~~-----------~------------~~---------~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~ 277 (362)
...... . .. .......+.++.+||.+||..||.+|||++++++||||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07868 239 NVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYF 317 (317)
T ss_pred HhcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 110000 0 00 00011235678999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-45 Score=329.75 Aligned_cols=259 Identities=26% Similarity=0.386 Sum_probs=207.5
Q ss_pred ceeecceecccCceEEEEEEECCCCCCCCceeeeechhhh------hhHHHHHHHHHHHHcCCCCcccccccceeeecCC
Q 039291 7 SWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVS------ASASLQKEKEVFDNLNGCPFVLECFGEEITMGEN 80 (362)
Q Consensus 7 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~~------~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~ 80 (362)
.|++.+.||+|+||+||+|.++.++. .+++|..... ....+.+|+.++++++ |++++.+++.+..
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~----~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~-~~~i~~~~~~~~~---- 71 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGK----MYACKKLEKKRIKKRKGESMALNEKQILEKVN-SRFVVSLAYAYET---- 71 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCc----eEEEEEEehhhccchHHHHHHHHHHHHHHhCC-CCCeeeeeEEEec----
Confidence 47888999999999999999998875 4566554321 2345678999999998 8999998876532
Q ss_pred CceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEeec
Q 039291 81 GEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADL 160 (362)
Q Consensus 81 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Df 160 (362)
...+++||||++|++|.+++.......+++..+..++.|++.||.|||+.||+||||||+||++ +..+.++|+||
T Consensus 72 -~~~~~lv~e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~----~~~~~~~l~Df 146 (285)
T cd05630 72 -KDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILL----DDHGHIRISDL 146 (285)
T ss_pred -CCEEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEE----CCCCCEEEeec
Confidence 2357899999999999999876555569999999999999999999999999999999999999 77778999999
Q ss_pred CCcccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHHcCCCCCC
Q 039291 161 GVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEHSLP 240 (362)
Q Consensus 161 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 240 (362)
|++........ .....|+..|+|||++.+..++.++|+||+||++|+|++|+.||..............+... ...
T Consensus 147 g~~~~~~~~~~---~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~-~~~ 222 (285)
T cd05630 147 GLAVHVPEGQT---IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKE-VQE 222 (285)
T ss_pred cceeecCCCcc---ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhh-hhh
Confidence 99865432211 12457999999999999888999999999999999999999999754332222222211111 112
Q ss_pred CCCccCCHHHHHHHHHHhccCCCCCCC-----HHHHhcCCCccCcchh
Q 039291 241 EIPSRVSKEARDFLRRCFVRKPAFRFT-----AEMLLDDPFVKGVDEE 283 (362)
Q Consensus 241 ~~~~~~~~~~~~li~~~l~~~p~~R~s-----~~~~l~~p~~~~~~~~ 283 (362)
..+..+++++++|+.+||+.||++||| ++++++||||+++.+.
T Consensus 223 ~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h~~~~~~~~~ 270 (285)
T cd05630 223 EYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHPLFKQINFK 270 (285)
T ss_pred hcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcChhhhccCHH
Confidence 345668899999999999999999999 9999999999887555
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-45 Score=345.70 Aligned_cols=256 Identities=24% Similarity=0.288 Sum_probs=200.5
Q ss_pred CCceeecceecccCceEEEEEEECCCCCCCCceeeeechhhhhhHHHHHHHHHHHHcCCCCcccccccceeeecCCCceE
Q 039291 5 GTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVSASASLQKEKEVFDNLNGCPFVLECFGEEITMGENGEMA 84 (362)
Q Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~~~~~ 84 (362)
+..|.+.+.||+|+||.||+|.+..++. .|++|... ...+.+|++++++|+ |+||+++++++.. ...
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~----~vavK~~~---~~~~~~E~~iL~~L~-HpnIv~l~~~~~~-----~~~ 234 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQ----RVVVKAGW---YASSVHEARLLRRLS-HPAVLALLDVRVV-----GGL 234 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCC----EEEEeccc---ccCHHHHHHHHHHCC-CCCCCcEEEEEEE-----CCE
Confidence 5689999999999999999999988764 67787542 234678999999999 9999999987643 224
Q ss_pred EEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEeecCCcc
Q 039291 85 YNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAK 164 (362)
Q Consensus 85 ~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Dfgla~ 164 (362)
.++|||++. ++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.++|+|||+++
T Consensus 235 ~~lv~e~~~-~~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl----~~~~~vkL~DFGla~ 308 (461)
T PHA03211 235 TCLVLPKYR-SDLYTYLGAR-LRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLV----NGPEDICLGDFGAAC 308 (461)
T ss_pred EEEEEEccC-CCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEE----CCCCCEEEcccCCce
Confidence 679999995 6898888653 3469999999999999999999999999999999999999 777789999999997
Q ss_pred cccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHhCCCCCccCCC-----CCHHHHHHHHcCCC--
Q 039291 165 RSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKED-----CSIDQLFSIIGDEH-- 237 (362)
Q Consensus 165 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~-----~~~~~~~~~~~~~~-- 237 (362)
...............||..|+|||++.+..++.++|||||||+||||++|..|+..... ....++.+.+....
T Consensus 309 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~ 388 (461)
T PHA03211 309 FARGSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVH 388 (461)
T ss_pred ecccccccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccc
Confidence 65433222223356799999999999999999999999999999999998866543211 11122222222110
Q ss_pred --CCCC---------------------C-------CccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCccC
Q 039291 238 --SLPE---------------------I-------PSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKG 279 (362)
Q Consensus 238 --~~~~---------------------~-------~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~~~ 279 (362)
.++. . ...++.++.+||.+||..||.+|||+.|+|+||||+.
T Consensus 389 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~f~~ 460 (461)
T PHA03211 389 VDEFPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRLPLFQS 460 (461)
T ss_pred cccCCCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhCcccCC
Confidence 0000 0 0135668999999999999999999999999999964
|
|
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-46 Score=346.02 Aligned_cols=259 Identities=25% Similarity=0.428 Sum_probs=213.7
Q ss_pred CceeecceecccCceEEEEEEECCCCCCCCceeeeechhhhhhHHHHHHHHHHHHcCCCCcccccccceeeecCCCceEE
Q 039291 6 TSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVSASASLQKEKEVFDNLNGCPFVLECFGEEITMGENGEMAY 85 (362)
Q Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~~~~~~ 85 (362)
+.|.|+..||-|+||.||+|.++.++-.++.++.- ....+....+.-|+.||.... ||+|+++++.+... +.+
T Consensus 32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIe-tkseEELEDylVEIeILa~Cd-HP~ivkLl~ayy~e-----nkL 104 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIE-TKSEEELEDYLVEIEILAECD-HPVIVKLLSAYYFE-----NKL 104 (1187)
T ss_pred HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhc-ccchhHHhhhhhhhhhhhcCC-ChHHHHHHHHHhcc-----Cce
Confidence 56889999999999999999999876544433322 223445666788999999999 99999999976532 236
Q ss_pred EEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEeecCCccc
Q 039291 86 NLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKR 165 (362)
Q Consensus 86 ~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Dfgla~~ 165 (362)
+++.|||.||-+..++-.. +.+|++.++..+++|++.||.|||+++|||||||..|||+ .-+|.++|+|||.+..
T Consensus 105 wiliEFC~GGAVDaimlEL-~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~----TldGdirLADFGVSAK 179 (1187)
T KOG0579|consen 105 WILIEFCGGGAVDAIMLEL-GRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILL----TLDGDIRLADFGVSAK 179 (1187)
T ss_pred EEEEeecCCchHhHHHHHh-ccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEE----EecCcEeeeccccccc
Confidence 7899999999999888764 4569999999999999999999999999999999999999 6667799999999865
Q ss_pred ccccccCCCCCCccCCCCccCchhhcc-----ccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCH-HHHHHHHcCCCCC
Q 039291 166 SRHCKRQKFDPSMRGTPLYLAPETVVQ-----HMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSI-DQLFSIIGDEHSL 239 (362)
Q Consensus 166 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~-~~~~~~~~~~~~~ 239 (362)
... ......+++|||+|||||++.+ .+|++++||||||++|.||.-+.+|- .+.++ ..++.+....+..
T Consensus 180 n~~--t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPH---helnpMRVllKiaKSePPT 254 (1187)
T KOG0579|consen 180 NKS--TRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPH---HELNPMRVLLKIAKSEPPT 254 (1187)
T ss_pred chh--HHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCc---cccchHHHHHHHhhcCCCc
Confidence 543 2223368999999999999874 57899999999999999999999987 33344 3445555555554
Q ss_pred CCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCccCcc
Q 039291 240 PEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGVD 281 (362)
Q Consensus 240 ~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~~~~~ 281 (362)
-.-|..++..+.+|+.+||..||..||++.++++||||..+.
T Consensus 255 LlqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~Hpfv~~~~ 296 (1187)
T KOG0579|consen 255 LLQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKHPFVQNAP 296 (1187)
T ss_pred ccCcchhhhHHHHHHHHHHhcCCccCCCHHHHhhCcccccCC
Confidence 456788999999999999999999999999999999999764
|
|
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-45 Score=315.20 Aligned_cols=264 Identities=23% Similarity=0.362 Sum_probs=212.6
Q ss_pred cceecccCceEEEEEEECCCCCCCCceeeeechhhhhhHHHHHHHHHHHHcCCCCcccccccceeeecCCCceEEEEEEE
Q 039291 11 GRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVSASASLQKEKEVFDNLNGCPFVLECFGEEITMGENGEMAYNLLLE 90 (362)
Q Consensus 11 ~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~~~~~~~lv~e 90 (362)
.+.||+|+|+.|-.++...++..++.++.-|. ..-...++.||++++.+.++|+||+.+++++. ++..+|||||
T Consensus 83 ~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq-~gHsR~RvfREVe~f~~Cqgh~nilqLiefFE-----dd~~FYLVfE 156 (463)
T KOG0607|consen 83 SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQ-PGHSRSRVFREVETFYQCQGHKNILQLIEFFE-----DDTRFYLVFE 156 (463)
T ss_pred HHHhcCccceeeeeeeeeccchhhhhhhhhcC-CchHHHHHHHHHHHHHHhcCCccHHHHHHHhc-----ccceEEEEEe
Confidence 47899999999999999998876655555544 23366788999999999999999999998763 3445779999
Q ss_pred ecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEeecCCcccccccc
Q 039291 91 YAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCK 170 (362)
Q Consensus 91 ~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Dfgla~~~~~~~ 170 (362)
.+.||+|...|+++ +.|+|.++..++.+|+.||.+||.+||.||||||+|||.... +.-..||||||.|........
T Consensus 157 Km~GGplLshI~~~--~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~p-n~vsPvKiCDfDLgSg~k~~~ 233 (463)
T KOG0607|consen 157 KMRGGPLLSHIQKR--KHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESP-NKVSPVKICDFDLGSGIKLNN 233 (463)
T ss_pred cccCchHHHHHHHh--hhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCC-CCcCceeeeccccccccccCC
Confidence 99999999999984 459999999999999999999999999999999999999554 344569999999875322111
Q ss_pred -----cCCCCCCccCCCCccCchhhc-----cccCCCcchHHHHHHHHHHHHhCCCCCccCCCCC------------HHH
Q 039291 171 -----RQKFDPSMRGTPLYLAPETVV-----QHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCS------------IDQ 228 (362)
Q Consensus 171 -----~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~------------~~~ 228 (362)
......+.+|+..|||||+.. ...|+.+.|.||||||||-|+.|++||.+.-+.+ ...
T Consensus 234 ~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~ 313 (463)
T KOG0607|consen 234 DCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNK 313 (463)
T ss_pred CCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHH
Confidence 112223678999999999876 2468899999999999999999999998653222 234
Q ss_pred HHHHHcCCC-CCC-CCCccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCccCcchh
Q 039291 229 LFSIIGDEH-SLP-EIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGVDEE 283 (362)
Q Consensus 229 ~~~~~~~~~-~~~-~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~~~~~~~ 283 (362)
++..|..+. .+| .-+.++|.+++++|+.+|..|+..|.++.+++.|||++....+
T Consensus 314 LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~~~~e 370 (463)
T KOG0607|consen 314 LFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQRCAPE 370 (463)
T ss_pred HHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCccccccchh
Confidence 555554433 233 2346799999999999999999999999999999999988766
|
|
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-44 Score=320.65 Aligned_cols=253 Identities=32% Similarity=0.546 Sum_probs=206.9
Q ss_pred CceeecceecccCceEEEEEEECCCCCCCCceeeeechhh--------hhhHHHHHHHHHHHHcCCCCcccccccceeee
Q 039291 6 TSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEV--------SASASLQKEKEVFDNLNGCPFVLECFGEEITM 77 (362)
Q Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~--------~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~ 77 (362)
+.|.+.+.||+|++|.||.|.+..++. .+++|.... .....+.+|+.++++++ ||||+++++.+..
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~----~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~- 75 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGR----ELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQ-HERIVQYYGCLRD- 75 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCc----EEEEEEEeecccchhhHHHHHHHHHHHHHHHhCC-CCCeeeeEEEEcc-
Confidence 469999999999999999999887775 455554321 12346788999999998 9999999987642
Q ss_pred cCCCceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEE
Q 039291 78 GENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKI 157 (362)
Q Consensus 78 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl 157 (362)
...+++|+||+++++|.+++.. ...+++..+..++.|++.||.|||+.||+|+||+|+||++ +.++.++|
T Consensus 76 ----~~~~~~v~e~~~~~~l~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv----~~~~~~~l 145 (263)
T cd06625 76 ----DETLSIFMEYMPGGSVKDQLKA--YGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILR----DSAGNVKL 145 (263)
T ss_pred ----CCeEEEEEEECCCCcHHHHHHH--hCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE----cCCCCEEE
Confidence 2357899999999999999976 3458999999999999999999999999999999999999 67778999
Q ss_pred eecCCcccccccccCCC-CCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHHcCC
Q 039291 158 ADLGVAKRSRHCKRQKF-DPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDE 236 (362)
Q Consensus 158 ~Dfgla~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 236 (362)
+|||+++.......... .....|+..|+|||++.+..++.++||||||+++|+|++|+.||... +.......+...
T Consensus 146 ~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~---~~~~~~~~~~~~ 222 (263)
T cd06625 146 GDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEF---EAMAAIFKIATQ 222 (263)
T ss_pred eecccceeccccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCcccc---chHHHHHHHhcc
Confidence 99999875433211111 12456888999999999988999999999999999999999999543 223333333344
Q ss_pred CCCCCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCc
Q 039291 237 HSLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFV 277 (362)
Q Consensus 237 ~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~ 277 (362)
...+.++..++.++.++|.+||..+|++|||+.+++.||||
T Consensus 223 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~ 263 (263)
T cd06625 223 PTNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRHFFV 263 (263)
T ss_pred CCCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhCCCC
Confidence 44456777899999999999999999999999999999997
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-45 Score=338.33 Aligned_cols=260 Identities=21% Similarity=0.309 Sum_probs=200.8
Q ss_pred CCceeecceecccCceEEEEEEECCCCCCCCceeeeechh-----hhhhHHHHHHHHHHHHcCCCCcccccccceeeecC
Q 039291 5 GTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAE-----VSASASLQKEKEVFDNLNGCPFVLECFGEEITMGE 79 (362)
Q Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~-----~~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~ 79 (362)
-++|.+.+.||+|+||.||+|.+..++. .+++|... ......+.+|+.+++.++ ||||+++++++.....
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~----~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~ 90 (355)
T cd07874 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDR----NVAIKKLSRPFQNQTHAKRAYRELVLMKCVN-HKNIISLLNVFTPQKS 90 (355)
T ss_pred hhceeEEEEeeecCCEEEEEEEecCCCc----eEEEEEeCCcccChHHHHHHHHHHHHHHHhC-CCchhceeeeeecccc
Confidence 4789999999999999999999887765 45666543 223456778999999998 9999999987654221
Q ss_pred -CCceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEe
Q 039291 80 -NGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIA 158 (362)
Q Consensus 80 -~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~ 158 (362)
.....+++||||+++ +|.+.+.. .+++..++.++.|++.||.|||++||+||||||+|||+ +.++.+||+
T Consensus 91 ~~~~~~~~lv~e~~~~-~l~~~~~~----~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill----~~~~~~kl~ 161 (355)
T cd07874 91 LEEFQDVYLVMELMDA-NLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV----KSDCTLKIL 161 (355)
T ss_pred ccccceeEEEhhhhcc-cHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEE----CCCCCEEEe
Confidence 123346799999975 77777653 38999999999999999999999999999999999999 777889999
Q ss_pred ecCCcccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHH-HHHHHH----
Q 039291 159 DLGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSID-QLFSII---- 233 (362)
Q Consensus 159 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~-~~~~~~---- 233 (362)
|||+++..... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..... .....+
T Consensus 162 Dfg~~~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~ 238 (355)
T cd07874 162 DFGLARTAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPC 238 (355)
T ss_pred eCcccccCCCc---cccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence 99999754332 1223567999999999999989999999999999999999999999654321110 000000
Q ss_pred ---------------cCCCC-----C------------CCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCccCcc
Q 039291 234 ---------------GDEHS-----L------------PEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGVD 281 (362)
Q Consensus 234 ---------------~~~~~-----~------------~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~~~~~ 281 (362)
..... . ...+...+.++++||.+||..||++|||+.+++.||||..+.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~~~~~ 318 (355)
T cd07874 239 PEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYINVWY 318 (355)
T ss_pred HHHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcchhccc
Confidence 00000 0 011123457889999999999999999999999999997653
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-44 Score=359.79 Aligned_cols=265 Identities=27% Similarity=0.422 Sum_probs=210.3
Q ss_pred CCCCceeecceecccCceEEEEEEECCCCCCCCceeeeech-----hhhhhHHHHHHHHHHHHcCCCCcccccccceeee
Q 039291 3 SDGTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSA-----EVSASASLQKEKEVFDNLNGCPFVLECFGEEITM 77 (362)
Q Consensus 3 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~-----~~~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~ 77 (362)
+.-++|.+++.||+|+||+||+|+++.++.. +++|.+ .......+.+|+.+++.|. ||||+++++.+...
T Consensus 10 ~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~----vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~-HPNIVrl~d~f~de 84 (1021)
T PTZ00266 10 SRLNEYEVIKKIGNGRFGEVFLVKHKRTQEF----FCWKAISYRGLKEREKSQLVIEVNVMRELK-HKNIVRYIDRFLNK 84 (1021)
T ss_pred cccCCEEEEEEEecCCCeEEEEEEECCCCeE----EEEEEEeccccCHHHHHHHHHHHHHHHHcC-CCCcCeEEEEEEec
Confidence 3457899999999999999999999987754 344433 2334566889999999999 89999999876532
Q ss_pred cCCCceEEEEEEEecCCCCHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhC-------CceeCCCCCCCEEEeec
Q 039291 78 GENGEMAYNLLLEYAAGGTLGDLIEKCN--GNGLPEKDVRHFTRCILEGIGHIHDS-------GYVHCDVKPDNILLVAT 148 (362)
Q Consensus 78 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~l~~~~~~~i~~ql~~~l~yLH~~-------~ivH~Dlkp~Nill~~~ 148 (362)
....+||||||+++++|.++|.... ...+++..++.|+.||+.||.|||+. +||||||||+||||...
T Consensus 85 ---~~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~ 161 (1021)
T PTZ00266 85 ---ANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTG 161 (1021)
T ss_pred ---CCCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecC
Confidence 2345789999999999999997632 24699999999999999999999985 49999999999999532
Q ss_pred C-------------CCceEEEEeecCCcccccccccCCCCCCccCCCCccCchhhcc--ccCCCcchHHHHHHHHHHHHh
Q 039291 149 Q-------------SGKFVAKIADLGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQ--HMQEAPSDIWALGCVVLEMLS 213 (362)
Q Consensus 149 ~-------------~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~~l~~ 213 (362)
. +....+||+|||++...... .......||+.|+|||++.+ ..++.++||||||||||+|++
T Consensus 162 ~~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~---s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLT 238 (1021)
T PTZ00266 162 IRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIE---SMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCS 238 (1021)
T ss_pred ccccccccccccccCCCCceEEccCCcccccccc---ccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHH
Confidence 1 23456999999999755432 12235679999999999864 457889999999999999999
Q ss_pred CCCCCccCCCCCHHHHHHHHcCCCCCCCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCccCcch
Q 039291 214 GRQAWVVKEDCSIDQLFSIIGDEHSLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGVDE 282 (362)
Q Consensus 214 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~~~~~~ 282 (362)
|..||.... ....++..+.....++ ....+.++.+||.+||..+|.+||++.++|.|||++.+..
T Consensus 239 Gk~PF~~~~--~~~qli~~lk~~p~lp--i~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~i~~ 303 (1021)
T PTZ00266 239 GKTPFHKAN--NFSQLISELKRGPDLP--IKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKNVGP 303 (1021)
T ss_pred CCCCCCcCC--cHHHHHHHHhcCCCCC--cCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhhcCC
Confidence 999996432 3455555554443322 2346899999999999999999999999999999986644
|
|
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-44 Score=337.83 Aligned_cols=259 Identities=20% Similarity=0.303 Sum_probs=200.2
Q ss_pred CCceeecceecccCceEEEEEEECCCCCCCCceeeeechh-----hhhhHHHHHHHHHHHHcCCCCcccccccceeeecC
Q 039291 5 GTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAE-----VSASASLQKEKEVFDNLNGCPFVLECFGEEITMGE 79 (362)
Q Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~-----~~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~ 79 (362)
-++|.+.+.||+|+||.||+|.+..++. .+++|... ......+.+|+.+++.++ ||||+++++++.....
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~----~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~ii~~~~~~~~~~~ 97 (364)
T cd07875 23 LKRYQNLKPIGSGAQGIVCAAYDAILER----NVAIKKLSRPFQNQTHAKRAYRELVLMKCVN-HKNIIGLLNVFTPQKS 97 (364)
T ss_pred hcceeEEEEeecCCCeEEEEEEECCCCc----EEEEEEeCccccCchhHHHHHHHHHHHHhcC-CCCccccceeeccccc
Confidence 4789999999999999999999988775 45666543 223456778999999998 9999999886643211
Q ss_pred -CCceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEe
Q 039291 80 -NGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIA 158 (362)
Q Consensus 80 -~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~ 158 (362)
.....+|+||||+++ +|.+++.. .+++..+..++.|++.||.|||++||+||||||+|||+ +.++.+||+
T Consensus 98 ~~~~~~~~lv~e~~~~-~l~~~~~~----~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll----~~~~~~kL~ 168 (364)
T cd07875 98 LEEFQDVYIVMELMDA-NLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV----KSDCTLKIL 168 (364)
T ss_pred ccccCeEEEEEeCCCC-CHHHHHHh----cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEE----CCCCcEEEE
Confidence 223357899999975 78777753 38899999999999999999999999999999999999 777889999
Q ss_pred ecCCcccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHH-HHHHH----
Q 039291 159 DLGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQ-LFSII---- 233 (362)
Q Consensus 159 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~-~~~~~---- 233 (362)
|||+++..... .......||..|+|||++.+..++.++|||||||++|+|++|+.||...+...... ....+
T Consensus 169 DfG~a~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~ 245 (364)
T cd07875 169 DFGLARTAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPC 245 (364)
T ss_pred eCCCccccCCC---CcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCC
Confidence 99999755432 12235679999999999999899999999999999999999999996543211110 00000
Q ss_pred ---------------cCCCCC-----------------CCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCccCc
Q 039291 234 ---------------GDEHSL-----------------PEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGV 280 (362)
Q Consensus 234 ---------------~~~~~~-----------------~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~~~~ 280 (362)
...... .......+.++++||.+||..||.+|||+.+++.||||..+
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~~~~ 324 (364)
T cd07875 246 PEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVW 324 (364)
T ss_pred HHHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCcccccc
Confidence 000000 00111235688999999999999999999999999999754
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-44 Score=323.87 Aligned_cols=262 Identities=25% Similarity=0.421 Sum_probs=207.7
Q ss_pred CCCCceeecceecccCceEEEEEEECCCCCCCCceeeeechhh--hhhHHHHHHHHHHHHcCCCCcccccccceeeecC-
Q 039291 3 SDGTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEV--SASASLQKEKEVFDNLNGCPFVLECFGEEITMGE- 79 (362)
Q Consensus 3 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~--~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~- 79 (362)
...++|.+.+.||+|+||.||+|+++.+++ .+++|.... .....+..|+.+++++.+|+||+++++.+.....
T Consensus 13 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~----~~a~K~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~ 88 (282)
T cd06636 13 DPAGIFELVEVVGNGTYGQVYKGRHVKTGQ----LAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPP 88 (282)
T ss_pred ChhhhhhhheeeccCCCeEEEEEEEcCCCc----EEEEEEEecChHHHHHHHHHHHHHHHhcCCCcEEEEeeehhccccc
Confidence 345789999999999999999999988775 456665432 2345678899999999779999999987654211
Q ss_pred CCceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEee
Q 039291 80 NGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIAD 159 (362)
Q Consensus 80 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~D 159 (362)
.....++++|||+.+++|.+++.......+++..+..++.||+.||.|||+.||+|+||||+||++ +.++.++|+|
T Consensus 89 ~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili----~~~~~~~l~d 164 (282)
T cd06636 89 GHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLL----TENAEVKLVD 164 (282)
T ss_pred CCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE----CCCCCEEEee
Confidence 234567899999999999999987656668999999999999999999999999999999999999 6777899999
Q ss_pred cCCcccccccccCCCCCCccCCCCccCchhhc-----cccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHHc
Q 039291 160 LGVAKRSRHCKRQKFDPSMRGTPLYLAPETVV-----QHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIG 234 (362)
Q Consensus 160 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~ 234 (362)
||++........ ......|+..|+|||++. ...++.++|+|||||++|+|++|..||.... .......+.
T Consensus 165 fg~~~~~~~~~~--~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~---~~~~~~~~~ 239 (282)
T cd06636 165 FGVSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMH---PMRALFLIP 239 (282)
T ss_pred Ccchhhhhcccc--CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccC---HHhhhhhHh
Confidence 999875433211 223467899999999986 3457889999999999999999999995432 222222222
Q ss_pred CCCCCCCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCc
Q 039291 235 DEHSLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFV 277 (362)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~ 277 (362)
...........++.++.+||.+||..||.+||++.+++.||||
T Consensus 240 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~~~~ 282 (282)
T cd06636 240 RNPPPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI 282 (282)
T ss_pred hCCCCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhcCCCC
Confidence 2222222334678999999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-44 Score=328.21 Aligned_cols=261 Identities=21% Similarity=0.377 Sum_probs=202.7
Q ss_pred CCceeecceecccCceEEEEEEECCCCCCCCceeeeechhh----hhhHHHHHHHHHHHHcCCCCcccccccceeeecCC
Q 039291 5 GTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEV----SASASLQKEKEVFDNLNGCPFVLECFGEEITMGEN 80 (362)
Q Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~----~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~ 80 (362)
-++|.+.+.||+|+||.||+|+++.+++ .+++|.... .....+.+|+.+++.++ ||||+++++.+..
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~----~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~-h~nI~~~~~~~~~---- 75 (301)
T cd07873 5 LETYIKLDKLGEGTYATVYKGRSKLTDN----LVALKEIRLEHEEGAPCTAIREVSLLKDLK-HANIVTLHDIIHT---- 75 (301)
T ss_pred ccceEEeeEeccCcCEEEEEEEEcCCCc----EEEEEEEecccccCchhHHHHHHHHHHhcC-CCCcceEEEEEec----
Confidence 4689999999999999999999988775 455665432 23345778999999998 8999999987642
Q ss_pred CceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEeec
Q 039291 81 GEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADL 160 (362)
Q Consensus 81 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Df 160 (362)
...+++||||+. ++|.+++... ...+++..++.++.|++.||.|||++||+|+||||+||++ +.++.++|+||
T Consensus 76 -~~~~~lv~e~~~-~~l~~~l~~~-~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~----~~~~~~kl~df 148 (301)
T cd07873 76 -EKSLTLVFEYLD-KDLKQYLDDC-GNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLI----NERGELKLADF 148 (301)
T ss_pred -CCeEEEEEeccc-cCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEE----CCCCcEEECcC
Confidence 235789999997 5899888763 3458999999999999999999999999999999999999 77788999999
Q ss_pred CCcccccccccCCCCCCccCCCCccCchhhccc-cCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHHcCC---
Q 039291 161 GVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQH-MQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDE--- 236 (362)
Q Consensus 161 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~--- 236 (362)
|++....... .......+++.|+|||++.+. .++.++|||||||++|+|++|++||...+..........+...
T Consensus 149 g~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~ 226 (301)
T cd07873 149 GLARAKSIPT--KTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTE 226 (301)
T ss_pred cchhccCCCC--CcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCh
Confidence 9987543211 112344678999999998764 5788999999999999999999999654321111111111000
Q ss_pred --------------CCCCC--------CCccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCccCcchh
Q 039291 237 --------------HSLPE--------IPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGVDEE 283 (362)
Q Consensus 237 --------------~~~~~--------~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~~~~~~~ 283 (362)
...+. ....+++++++||.+||..||.+|||+++++.||||+...+.
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~~~~~ 295 (301)
T cd07873 227 ETWPGILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCLGER 295 (301)
T ss_pred hhchhhhccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccccch
Confidence 00111 123578899999999999999999999999999999887654
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-44 Score=335.64 Aligned_cols=253 Identities=22% Similarity=0.295 Sum_probs=194.9
Q ss_pred CCceeecceecccCceEEEEEEECCCCCCCCceeeeechhhhhhHHHHHHHHHHHHcCCCCcccccccceeeecCCCceE
Q 039291 5 GTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVSASASLQKEKEVFDNLNGCPFVLECFGEEITMGENGEMA 84 (362)
Q Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~~~~~ 84 (362)
..+|.+++.||+|+||.||+|++..++. .+++|.... .....|+.++++++ ||||+++++.+.. ...
T Consensus 65 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~----~valK~~~~---~~~~~E~~~l~~l~-h~~iv~~~~~~~~-----~~~ 131 (357)
T PHA03209 65 SLGYTVIKTLTPGSEGRVFVATKPGQPD----PVVLKIGQK---GTTLIEAMLLQNVN-HPSVIRMKDTLVS-----GAI 131 (357)
T ss_pred hcCcEEEEEecCCCCeEEEEEEECCCCc----eEEEEeCCc---cccHHHHHHHHhCC-CCCCcChhheEEe-----CCe
Confidence 4579999999999999999999988765 566775432 23457999999999 8999999997653 234
Q ss_pred EEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEeecCCcc
Q 039291 85 YNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAK 164 (362)
Q Consensus 85 ~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Dfgla~ 164 (362)
.++|||++. ++|.+++... ..++++..++.++.||+.||.|||++||+||||||+|||+ +..+.+||+|||+++
T Consensus 132 ~~lv~e~~~-~~l~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill----~~~~~~kl~DfG~a~ 205 (357)
T PHA03209 132 TCMVLPHYS-SDLYTYLTKR-SRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFI----NDVDQVCIGDLGAAQ 205 (357)
T ss_pred eEEEEEccC-CcHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE----CCCCCEEEecCcccc
Confidence 679999996 5888888653 4569999999999999999999999999999999999999 777889999999986
Q ss_pred cccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCH--------HHHHHHHcCC
Q 039291 165 RSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSI--------DQLFSIIGDE 236 (362)
Q Consensus 165 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~--------~~~~~~~~~~ 236 (362)
..... .......||+.|+|||++.+..++.++|||||||++|||+++..|+........ ..+...+...
T Consensus 206 ~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~ 282 (357)
T PHA03209 206 FPVVA---PAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTL 282 (357)
T ss_pred ccccC---cccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHh
Confidence 43321 112346699999999999998999999999999999999986544432221110 1111111100
Q ss_pred ----CCCC-----------------------C----CCccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCccC
Q 039291 237 ----HSLP-----------------------E----IPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKG 279 (362)
Q Consensus 237 ----~~~~-----------------------~----~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~~~ 279 (362)
..++ . ....++.++.+||.+||..||.+|||+.+++.||||+.
T Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~f~~ 356 (357)
T PHA03209 283 KVHPEEFPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMFAQ 356 (357)
T ss_pred ccChhhcCCCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCchhcc
Confidence 0000 0 00135677888999999999999999999999999975
|
|
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-44 Score=335.51 Aligned_cols=259 Identities=21% Similarity=0.329 Sum_probs=200.9
Q ss_pred CCceeecceecccCceEEEEEEECCCCCCCCceeeeechhh-----hhhHHHHHHHHHHHHcCCCCcccccccceeeecC
Q 039291 5 GTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEV-----SASASLQKEKEVFDNLNGCPFVLECFGEEITMGE 79 (362)
Q Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~-----~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~ 79 (362)
.++|.+++.||+|+||+||+|.+..++. .+++|.... .....+.+|+.+++.++ ||||+++++++.....
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~----~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~ 88 (343)
T cd07878 14 PERYQNLTPVGSGAYGSVCSAYDTRLRQ----KVAVKKLSRPFQSLIHARRTYRELRLLKHMK-HENVIGLLDVFTPATS 88 (343)
T ss_pred hhhhhhheecccCCCeEEEEEEECCCCC----EEEEEEeCchhhhhHHHHHHHHHHHHHHhcC-CCchhhhhhhhccccc
Confidence 4689999999999999999999988765 456665432 23345778999999998 8999999987643211
Q ss_pred -CCceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEe
Q 039291 80 -NGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIA 158 (362)
Q Consensus 80 -~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~ 158 (362)
.....+|++++++ +++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+
T Consensus 89 ~~~~~~~~~~~~~~-~~~l~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~----~~~~~~kl~ 160 (343)
T cd07878 89 IENFNEVYLVTNLM-GADLNNIVKC---QKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAV----NEDCELRIL 160 (343)
T ss_pred ccccCcEEEEeecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEE----CCCCCEEEc
Confidence 1223467999988 7799888764 459999999999999999999999999999999999999 777889999
Q ss_pred ecCCcccccccccCCCCCCccCCCCccCchhhcc-ccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHHcCC-
Q 039291 159 DLGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQ-HMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDE- 236 (362)
Q Consensus 159 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~- 236 (362)
|||+++..... .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...+..+...........
T Consensus 161 Dfg~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~ 235 (343)
T cd07878 161 DFGLARQADDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTP 235 (343)
T ss_pred CCccceecCCC-----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCC
Confidence 99998754321 234679999999999987 46889999999999999999999999654321111111000000
Q ss_pred -----------------CCCCC--------CCccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCccCcc
Q 039291 237 -----------------HSLPE--------IPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGVD 281 (362)
Q Consensus 237 -----------------~~~~~--------~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~~~~~ 281 (362)
..++. .....++.+.+||.+||..||++|||+.+++.||||....
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~~~ 305 (343)
T cd07878 236 SPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQYH 305 (343)
T ss_pred CHHHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhccC
Confidence 00111 1123567789999999999999999999999999997653
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-44 Score=323.52 Aligned_cols=258 Identities=25% Similarity=0.390 Sum_probs=207.3
Q ss_pred ceeecceecccCceEEEEEEECCCCCCCCceeeeechhhh------hhHHHHHHHHHHHHcCCCCcccccccceeeecCC
Q 039291 7 SWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVS------ASASLQKEKEVFDNLNGCPFVLECFGEEITMGEN 80 (362)
Q Consensus 7 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~~------~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~ 80 (362)
.|+..+.||+|+||+||+|.+..+++ .+++|..... ....+.+|+.+++.++ |++|+.+++.+..
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~~~~----~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~-~~~i~~~~~~~~~---- 71 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRATGK----MYACKRLEKKRIKKRKGESMALNEKQILEKVN-SQFVVNLAYAYET---- 71 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECCCCc----EEEEEEeehhhhhhhhHHHHHHHHHHHHHHcC-CcCceeEEEEEec----
Confidence 47888999999999999999988875 4566654321 2344678999999998 8999988776532
Q ss_pred CceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEeec
Q 039291 81 GEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADL 160 (362)
Q Consensus 81 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Df 160 (362)
...++++|||+.+++|.+++......++++..+..++.|++.||.|||++||+||||||+||++ +.++.++|+||
T Consensus 72 -~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili----~~~~~~kl~Df 146 (285)
T cd05632 72 -KDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILL----DDYGHIRISDL 146 (285)
T ss_pred -CCEEEEEEEeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEE----CCCCCEEEecC
Confidence 3357899999999999988876545569999999999999999999999999999999999999 77778999999
Q ss_pred CCcccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCH-HHHHHHHcCCCCC
Q 039291 161 GVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSI-DQLFSIIGDEHSL 239 (362)
Q Consensus 161 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~-~~~~~~~~~~~~~ 239 (362)
|++....... ......|+..|+|||++.+..++.++|+|||||++|+|++|..||........ ......+.. ..
T Consensus 147 g~~~~~~~~~---~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~--~~ 221 (285)
T cd05632 147 GLAVKIPEGE---SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLE--TE 221 (285)
T ss_pred CcceecCCCC---cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhc--cc
Confidence 9986543211 11345789999999999988899999999999999999999999975433221 122222211 12
Q ss_pred CCCCccCCHHHHHHHHHHhccCCCCCCC-----HHHHhcCCCccCcchh
Q 039291 240 PEIPSRVSKEARDFLRRCFVRKPAFRFT-----AEMLLDDPFVKGVDEE 283 (362)
Q Consensus 240 ~~~~~~~~~~~~~li~~~l~~~p~~R~s-----~~~~l~~p~~~~~~~~ 283 (362)
..++..++.++.+|+.+||+.||++||+ +.+++.|+||+.....
T Consensus 222 ~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~~~~ 270 (285)
T cd05632 222 EVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRHPFFRNMNFK 270 (285)
T ss_pred cccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcChhhhcCCHH
Confidence 2345678899999999999999999999 8899999999987555
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-47 Score=323.26 Aligned_cols=253 Identities=27% Similarity=0.478 Sum_probs=212.6
Q ss_pred eeecceecccCceEEEEEEECCCCCCCCceeeeechhhh-hhHHHHHHHHHHHHcCCCCcccccccceeeecCCCceEEE
Q 039291 8 WFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVS-ASASLQKEKEVFDNLNGCPFVLECFGEEITMGENGEMAYN 86 (362)
Q Consensus 8 y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~~-~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~~~~~~~ 86 (362)
|-++..||+|+||.||+|+++.+|. .+|+|....+ ....+..|+.||.+.. .|+||++|+.+.... .++
T Consensus 35 FDi~~KLGEGSYGSV~KAIH~EsG~----v~AIK~VPV~sDLQEIIKEISIMQQC~-S~yVVKYYGSYFK~s-----DLW 104 (502)
T KOG0574|consen 35 FDIVGKLGEGSYGSVHKAIHRESGH----VLAIKKVPVDTDLQEIIKEISIMQQCK-SKYVVKYYGSYFKHS-----DLW 104 (502)
T ss_pred HHHHHHhcCCcchHHHHHHHhccCc----EEEEEecCccchHHHHHHHHHHHHHcC-CchhhhhhhhhccCC-----ceE
Confidence 4567899999999999999999986 6788887644 6678899999999999 899999999765322 267
Q ss_pred EEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEeecCCcccc
Q 039291 87 LLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRS 166 (362)
Q Consensus 87 lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Dfgla~~~ 166 (362)
+|||||..|++.++++. +++++++.++..+++.-+.||+|||...-||||||..|||+ +..++.||+|||.|...
T Consensus 105 IVMEYCGAGSiSDI~R~-R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILL----NT~G~AKLADFGVAGQL 179 (502)
T KOG0574|consen 105 IVMEYCGAGSISDIMRA-RRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILL----NTDGIAKLADFGVAGQL 179 (502)
T ss_pred eehhhcCCCcHHHHHHH-hcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEE----cccchhhhhhccccchh
Confidence 99999999999999987 45789999999999999999999999999999999999999 88899999999999766
Q ss_pred cccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHHcC-CCCCCCCCcc
Q 039291 167 RHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGD-EHSLPEIPSR 245 (362)
Q Consensus 167 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~ 245 (362)
....... ....||+.|||||++..-.|+.++||||||++..||..|++||..- .+...+-.|.. .+....-|..
T Consensus 180 TDTMAKR--NTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDI---HPMRAIFMIPT~PPPTF~KPE~ 254 (502)
T KOG0574|consen 180 TDTMAKR--NTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDI---HPMRAIFMIPTKPPPTFKKPEE 254 (502)
T ss_pred hhhHHhh--CccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccc---cccceeEeccCCCCCCCCChHh
Confidence 5432222 4678999999999999999999999999999999999999999533 22222112211 2222234566
Q ss_pred CCHHHHHHHHHHhccCCCCCCCHHHHhcCCCccCc
Q 039291 246 VSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGV 280 (362)
Q Consensus 246 ~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~~~~ 280 (362)
.+.++.+|+++||..+|++|-|+.++++|||+++.
T Consensus 255 WS~~F~DFi~~CLiK~PE~R~TA~~L~~H~FiknA 289 (502)
T KOG0574|consen 255 WSSEFNDFIRSCLIKKPEERKTALRLCEHTFIKNA 289 (502)
T ss_pred hhhHHHHHHHHHhcCCHHHHHHHHHHhhhhhhcCC
Confidence 88999999999999999999999999999999874
|
|
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=325.69 Aligned_cols=262 Identities=29% Similarity=0.467 Sum_probs=210.5
Q ss_pred CceeecceecccCceEEEEEEECCCCCCCCceeeeechhh------hhhHHHHHHHHHHHHcCCCCcccccccceeeecC
Q 039291 6 TSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEV------SASASLQKEKEVFDNLNGCPFVLECFGEEITMGE 79 (362)
Q Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~------~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~ 79 (362)
++|.+.+.||+|++|.||+|.+..++. .+++|.... .....+.+|+++++.++ ||||+++++.+..
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~----~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~--- 72 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGK----LFALKVLDKKEMIKRNKVKRVLTEQEILATLD-HPFLPTLYASFQT--- 72 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCc----EEEEEEEeccccchHHHHHHHHHHHHHHHhCC-CCCchhheeeeec---
Confidence 479999999999999999999988765 455555432 23456788999999999 9999999886532
Q ss_pred CCceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEee
Q 039291 80 NGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIAD 159 (362)
Q Consensus 80 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~D 159 (362)
....++||||+.|++|.+++....+..+++..++.++.|++.||+|||+.|++|+||||+||++ +.++.++|+|
T Consensus 73 --~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili----~~~~~~~l~d 146 (316)
T cd05574 73 --ETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILL----HESGHIMLSD 146 (316)
T ss_pred --CCEEEEEEEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEE----cCCCCEEEee
Confidence 3357899999999999999987555679999999999999999999999999999999999999 6677899999
Q ss_pred cCCcccccccccC---------------------------CCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHH
Q 039291 160 LGVAKRSRHCKRQ---------------------------KFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEML 212 (362)
Q Consensus 160 fgla~~~~~~~~~---------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~ 212 (362)
||++......... .......||..|+|||++.+..++.++||||||+++|+|+
T Consensus 147 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~ 226 (316)
T cd05574 147 FDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEML 226 (316)
T ss_pred cchhhcccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHh
Confidence 9998754321110 0112346899999999999888999999999999999999
Q ss_pred hCCCCCccCCCCCHHHHHHHHc-CCCCCCCCCccCCHHHHHHHHHHhccCCCCCCC----HHHHhcCCCccCcchhhh
Q 039291 213 SGRQAWVVKEDCSIDQLFSIIG-DEHSLPEIPSRVSKEARDFLRRCFVRKPAFRFT----AEMLLDDPFVKGVDEELS 285 (362)
Q Consensus 213 ~g~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s----~~~~l~~p~~~~~~~~~~ 285 (362)
+|..||...+ ....+..+. .....+. ...++.+++++|.+||..||++||+ +++++.||||+...+...
T Consensus 227 ~g~~pf~~~~---~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~~~~~~~~~~~ 300 (316)
T cd05574 227 YGTTPFKGSN---RDETFSNILKKEVTFPG-SPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFRGVNWALI 300 (316)
T ss_pred hCCCCCCCCc---hHHHHHHHhcCCccCCC-ccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcCchhhcCChhhc
Confidence 9999996543 223333332 2222222 2237899999999999999999999 999999999998776643
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=315.24 Aligned_cols=252 Identities=24% Similarity=0.462 Sum_probs=207.0
Q ss_pred ceeecceecccCceEEEEEEECCCCCCCCceeeeechhh-----hhhHHHHHHHHHHHHcCCCCcccccccceeeecCCC
Q 039291 7 SWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEV-----SASASLQKEKEVFDNLNGCPFVLECFGEEITMGENG 81 (362)
Q Consensus 7 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~-----~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~~ 81 (362)
.|.+.+.||+|++|.||+|+++.+++ .+++|.... ...+.+.+|+.++++++ |+|++++++.+. ..
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~----~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~----~~ 71 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGK----QYVIKKLNLRNASRRERKAAEQEAQLLSQLK-HPNIVAYRESWE----GE 71 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCc----EEEEEEEehhhcCHHHHHHHHHHHHHHHhCC-CCCeeeeeeeec----CC
Confidence 48999999999999999999988765 456665432 23456788999999998 899999887542 22
Q ss_pred ceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEeecC
Q 039291 82 EMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLG 161 (362)
Q Consensus 82 ~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Dfg 161 (362)
...++++|||+++++|.+++.......+++.++..++.|++.||.|||++|++|+||||+||++ +..+.++|+|||
T Consensus 72 ~~~~~lv~e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~----~~~~~~~l~df~ 147 (257)
T cd08223 72 DGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFL----TRTNIIKVGDLG 147 (257)
T ss_pred CCEEEEEecccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEE----ecCCcEEEeccc
Confidence 3457899999999999999987555669999999999999999999999999999999999999 777889999999
Q ss_pred CcccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHHcCCCCCCC
Q 039291 162 VAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEHSLPE 241 (362)
Q Consensus 162 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 241 (362)
++....... .......|++.|+|||++.+..++.++|+||||+++++|++|..||...+ .......+... ..+.
T Consensus 148 ~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~---~~~~~~~~~~~-~~~~ 221 (257)
T cd08223 148 IARVLENQC--DMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKD---MNSLVYRIIEG-KLPP 221 (257)
T ss_pred ceEEecccC--CccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCC---HHHHHHHHHhc-CCCC
Confidence 987654322 22234568999999999998889999999999999999999999996443 33333333222 2345
Q ss_pred CCccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCc
Q 039291 242 IPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFV 277 (362)
Q Consensus 242 ~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~ 277 (362)
.+..++.++.+++.+||..+|++||++.+++.||||
T Consensus 222 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~~ 257 (257)
T cd08223 222 MPKDYSPELGELIATMLSKRPEKRPSVKSILRQPYI 257 (257)
T ss_pred CccccCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 667789999999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-45 Score=302.63 Aligned_cols=265 Identities=25% Similarity=0.347 Sum_probs=207.7
Q ss_pred CCCCceeecceecccCceEEEEEEECCCCCCCCceeeeechhhhhhHHHHHHHHHHHHcCCCCcccccccceeeecCCCc
Q 039291 3 SDGTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVSASASLQKEKEVFDNLNGCPFVLECFGEEITMGENGE 82 (362)
Q Consensus 3 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~~~ 82 (362)
++++||.+.+.||+|||+-||+++...++..++.|... .-..+..+..++|++..++++ ||||+++++..+....+..
T Consensus 18 In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~-c~~~~~~e~~~rEid~~rkf~-s~~vl~l~dh~l~~~~D~~ 95 (302)
T KOG2345|consen 18 INNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKIL-CHSQEDIEEALREIDNHRKFN-SPNVLRLVDHQLREEKDGK 95 (302)
T ss_pred EcCceEEEeeeecCCCceeeeeecccCcccchhhheee-ccchHHHHHHHHHHHHHHhhC-CcchHHHHHHHHHhhccCc
Confidence 67899999999999999999999988877655332221 223556778899999999999 7999999998877666677
Q ss_pred eEEEEEEEecCCCCHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC--ceeCCCCCCCEEEeecCCCceEEEEe
Q 039291 83 MAYNLLLEYAAGGTLGDLIEKCN--GNGLPEKDVRHFTRCILEGIGHIHDSG--YVHCDVKPDNILLVATQSGKFVAKIA 158 (362)
Q Consensus 83 ~~~~lv~e~~~~~~L~~~l~~~~--~~~l~~~~~~~i~~ql~~~l~yLH~~~--ivH~Dlkp~Nill~~~~~~~~~~kl~ 158 (362)
...|++++|...|+|.+.++... +..+++.++..|+.+|++||++||+.. ++||||||.|||+ .+.+.++|.
T Consensus 96 ~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILl----s~~~~~vl~ 171 (302)
T KOG2345|consen 96 HEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILL----SDSGLPVLM 171 (302)
T ss_pred eeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEe----cCCCceEEE
Confidence 78889999999999999998753 335999999999999999999999999 9999999999999 667889999
Q ss_pred ecCCcccccccccCCCC-------CCccCCCCccCchhhccc---cCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHH
Q 039291 159 DLGVAKRSRHCKRQKFD-------PSMRGTPLYLAPETVVQH---MQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQ 228 (362)
Q Consensus 159 Dfgla~~~~~~~~~~~~-------~~~~gt~~y~aPE~~~~~---~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~ 228 (362)
|||.++...-....... .+...|..|+|||.+..+ ..+.++|||||||+||.|+.|..||+.....-...
T Consensus 172 D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSl 251 (302)
T KOG2345|consen 172 DLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSL 251 (302)
T ss_pred eccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeE
Confidence 99998755432211110 134579999999999854 56889999999999999999999995321100000
Q ss_pred HHHHHcCCCCCCCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhcC
Q 039291 229 LFSIIGDEHSLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDD 274 (362)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~ 274 (362)
.+........+|.- ...|..+.++|++||++||.+||++.+++.+
T Consensus 252 aLAv~n~q~s~P~~-~~yse~l~~lik~mlqvdP~qRP~i~~ll~~ 296 (302)
T KOG2345|consen 252 ALAVQNAQISIPNS-SRYSEALHQLIKSMLQVDPNQRPTIPELLSK 296 (302)
T ss_pred EEeeeccccccCCC-CCccHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence 00111112333433 3389999999999999999999999999864
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-45 Score=310.48 Aligned_cols=269 Identities=26% Similarity=0.365 Sum_probs=213.4
Q ss_pred CceeecceecccCceEEEEEEECCCCCCCCceeeeechhhh-----hhHHHHHHHHHHHHcCCCCcccccccceeeecCC
Q 039291 6 TSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVS-----ASASLQKEKEVFDNLNGCPFVLECFGEEITMGEN 80 (362)
Q Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~~-----~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~ 80 (362)
..|.+...||+|.||.||+|.-++++....+.+|+|.++.+ .....-||+.+++.|+ ||||+.+..+++..
T Consensus 24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~-h~nvi~Lv~Vfl~~--- 99 (438)
T KOG0666|consen 24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELK-HPNVISLVKVFLSH--- 99 (438)
T ss_pred HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhc-CCcchhHHHHHhcc---
Confidence 46889999999999999999777766544567888887654 4456789999999999 99999999887742
Q ss_pred CceEEEEEEEecCCCCHHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEE
Q 039291 81 GEMAYNLLLEYAAGGTLGDLIEKCNG---NGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKI 157 (362)
Q Consensus 81 ~~~~~~lv~e~~~~~~L~~~l~~~~~---~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl 157 (362)
+..+++++||.+. +|+++|+-++. +.++...++.|+.||+.|+.|||++-|+||||||.|||+..+..+.|.|||
T Consensus 100 -d~~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKI 177 (438)
T KOG0666|consen 100 -DKKVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKI 177 (438)
T ss_pred -CceEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEe
Confidence 3347799999976 99999976432 459999999999999999999999999999999999999888778899999
Q ss_pred eecCCcccccccccCC-CCCCccCCCCccCchhhccc-cCCCcchHHHHHHHHHHHHhCCCCCccCCC-------CCHHH
Q 039291 158 ADLGVAKRSRHCKRQK-FDPSMRGTPLYLAPETVVQH-MQEAPSDIWALGCVVLEMLSGRQAWVVKED-------CSIDQ 228 (362)
Q Consensus 158 ~Dfgla~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~-------~~~~~ 228 (362)
+|||+++.+...-..- .....+-|.+|+|||.+.+. -|+.+.|||++|||+.||++-.+.|.+.+. ....+
T Consensus 178 aDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQ 257 (438)
T KOG0666|consen 178 ADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQ 257 (438)
T ss_pred ecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHH
Confidence 9999999776543222 23456789999999999985 688999999999999999999998876532 12223
Q ss_pred HHHHHc--C---CCCCCC---CCc--------------------------cCCHHHHHHHHHHhccCCCCCCCHHHHhcC
Q 039291 229 LFSIIG--D---EHSLPE---IPS--------------------------RVSKEARDFLRRCFVRKPAFRFTAEMLLDD 274 (362)
Q Consensus 229 ~~~~~~--~---~~~~~~---~~~--------------------------~~~~~~~~li~~~l~~~p~~R~s~~~~l~~ 274 (362)
+.+++. . ...+|. +|. .-++.+.+|+.+||..||.+|+|++++++|
T Consensus 258 l~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh 337 (438)
T KOG0666|consen 258 LDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEH 337 (438)
T ss_pred HHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhcc
Confidence 322221 1 111111 110 124558899999999999999999999999
Q ss_pred CCccCc
Q 039291 275 PFVKGV 280 (362)
Q Consensus 275 p~~~~~ 280 (362)
+||..-
T Consensus 338 ~yF~~d 343 (438)
T KOG0666|consen 338 PYFTED 343 (438)
T ss_pred cccccC
Confidence 999875
|
|
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-45 Score=323.17 Aligned_cols=252 Identities=28% Similarity=0.457 Sum_probs=199.7
Q ss_pred eeecceecccCceEEEEEEECCCCCCCCceeeeechhhh-----hhHHHHHHHHHHHHcCCCCcccccccceeeecCCCc
Q 039291 8 WFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVS-----ASASLQKEKEVFDNLNGCPFVLECFGEEITMGENGE 82 (362)
Q Consensus 8 y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~~-----~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~~~ 82 (362)
|++++.||+|+||+||+|++..+++ .+++|..... ......+|+.++++++ ||||+++++.... .
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~----~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~-~~~i~~~~~~~~~-----~ 70 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQ----KVAVKIIDKSEIEEEEREENIREIKILRRLR-HPNIVQILDVFQD-----D 70 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTE----EEEEEEEESTTHHHHHHHHHHHHHHHHHHHT-BTTBCHEEEEEEE-----S
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCe----EEEEEEeccccccccccchhhhhhhcccccc-ccccccccccccc-----c
Confidence 8899999999999999999999876 4555554332 2223355999999996 9999999887654 3
Q ss_pred eEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEeecCC
Q 039291 83 MAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGV 162 (362)
Q Consensus 83 ~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Dfgl 162 (362)
..+++||||+.+++|.+++.. ...+++..+..++.|++.||.|||++|++|+||||+||++ +.++.++|+|||.
T Consensus 71 ~~~~~v~~~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~----~~~~~~~l~Dfg~ 144 (260)
T PF00069_consen 71 NYLYIVMEYCPGGSLQDYLQK--NKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILL----DENGEVKLIDFGS 144 (260)
T ss_dssp SEEEEEEEEETTEBHHHHHHH--HSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEE----STTSEEEESSGTT
T ss_pred ccccccccccccccccccccc--cccccccccccccccccccccccccccccccccccccccc----ccccccccccccc
Confidence 346799999999999999984 3459999999999999999999999999999999999999 8888899999999
Q ss_pred cccccccccCCCCCCccCCCCccCchhhc-cccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHHcCCCCCCC
Q 039291 163 AKRSRHCKRQKFDPSMRGTPLYLAPETVV-QHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEHSLPE 241 (362)
Q Consensus 163 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 241 (362)
+..... .........++..|+|||++. +..++.++|+||||+++++|++|..||......+................
T Consensus 145 ~~~~~~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~ 222 (260)
T PF00069_consen 145 SVKLSE--NNENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSS 222 (260)
T ss_dssp TEESTS--TTSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHH
T ss_pred cccccc--cccccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhccccccccc
Confidence 875311 122224567899999999998 78899999999999999999999999975522223333322221111001
Q ss_pred CC--ccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCc
Q 039291 242 IP--SRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFV 277 (362)
Q Consensus 242 ~~--~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~ 277 (362)
.. ...+.++.++|.+||+.||++||++.++++||||
T Consensus 223 ~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~~~~ 260 (260)
T PF00069_consen 223 SQQSREKSEELRDLIKKMLSKDPEQRPSAEELLKHPWF 260 (260)
T ss_dssp TTSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTSGGG
T ss_pred ccccchhHHHHHHHHHHHccCChhHCcCHHHHhcCCCC
Confidence 11 1123899999999999999999999999999997
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-43 Score=316.44 Aligned_cols=256 Identities=28% Similarity=0.551 Sum_probs=208.4
Q ss_pred ceeecceecccCceEEEEEEECCCCCCCCceeeeechhh---------hhhHHHHHHHHHHHHcCCCCcccccccceeee
Q 039291 7 SWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEV---------SASASLQKEKEVFDNLNGCPFVLECFGEEITM 77 (362)
Q Consensus 7 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~---------~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~ 77 (362)
+|..++.||+|+||.||+|++..+++ .+++|.... .....+.+|+.++++++ |+||+++++.+..
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~----~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~- 74 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGT----LMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLN-HPHIIRMLGATCE- 74 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCc----EEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcC-CCceehhhceecc-
Confidence 58899999999999999999988776 445554432 13467889999999998 8999999997642
Q ss_pred cCCCceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCc-eEEE
Q 039291 78 GENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGK-FVAK 156 (362)
Q Consensus 78 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~-~~~k 156 (362)
...+++||||++|++|.+++.. ..++++..+..++.||+.||.|||++|++|+||||+||++ +.+ ..++
T Consensus 75 ----~~~~~~v~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~----~~~~~~~~ 144 (268)
T cd06630 75 ----DSHFNLFVEWMAGGSVSHLLSK--YGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLI----DSTGQRLR 144 (268)
T ss_pred ----CCeEEEEEeccCCCcHHHHHHH--hCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE----cCCCCEEE
Confidence 2347799999999999999976 3469999999999999999999999999999999999999 444 3699
Q ss_pred EeecCCcccccccccC--CCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHHc
Q 039291 157 IADLGVAKRSRHCKRQ--KFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIG 234 (362)
Q Consensus 157 l~Dfgla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~ 234 (362)
|+|||++......... .......|+..|+|||++.+..++.++|+||+|+++++|++|..||..............+.
T Consensus 145 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~ 224 (268)
T cd06630 145 IADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIA 224 (268)
T ss_pred EcccccccccccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHh
Confidence 9999998765432111 11224568899999999988889999999999999999999999996554433344443333
Q ss_pred CCCCCCCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCcc
Q 039291 235 DEHSLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVK 278 (362)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~~ 278 (362)
.....+..+..+++++.+++.+||..+|++||++.++++||||+
T Consensus 225 ~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~~~~~ 268 (268)
T cd06630 225 SATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKHPVFR 268 (268)
T ss_pred ccCCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcCcccC
Confidence 33444566777899999999999999999999999999999985
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-44 Score=325.97 Aligned_cols=255 Identities=25% Similarity=0.443 Sum_probs=202.1
Q ss_pred CceeecceecccCceEEEEEEECCCCCCCCceeeeechh----hhhhHHHHHHHHHHHHcCCCCcccccccceeeecCCC
Q 039291 6 TSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAE----VSASASLQKEKEVFDNLNGCPFVLECFGEEITMGENG 81 (362)
Q Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~----~~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~~ 81 (362)
++|.+.+.||+|+||.||+|++..++.. +++|... ......+.+|++++++++ ||||+++++.+..
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~----~a~k~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~----- 70 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLI----MARKLIHLEIKPAIRNQIIRELKVLHECN-SPYIVGFYGAFYS----- 70 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeE----EEEEEeccccCHHHHHHHHHHHHHHHhCC-CCCCCeEEEEEee-----
Confidence 4799999999999999999999888753 4544432 233456789999999997 9999999987643
Q ss_pred ceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCceeCCCCCCCEEEeecCCCceEEEEeec
Q 039291 82 EMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHD-SGYVHCDVKPDNILLVATQSGKFVAKIADL 160 (362)
Q Consensus 82 ~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~-~~ivH~Dlkp~Nill~~~~~~~~~~kl~Df 160 (362)
...+++||||++|++|.+++... ..+++..+..++.|++.||.|||+ .+++|+||||+||++ +.++.++|+||
T Consensus 71 ~~~~~lv~ey~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~----~~~~~~~l~df 144 (308)
T cd06615 71 DGEISICMEHMDGGSLDQVLKKA--GRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILV----NSRGEIKLCDF 144 (308)
T ss_pred CCEEEEEeeccCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEE----ecCCcEEEccC
Confidence 23578999999999999999873 559999999999999999999997 699999999999999 66778999999
Q ss_pred CCcccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHHcC-----
Q 039291 161 GVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGD----- 235 (362)
Q Consensus 161 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~----- 235 (362)
|++...... ......|+..|+|||++.+..++.++|+|||||++|+|++|..||...+.............
T Consensus 145 g~~~~~~~~----~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 220 (308)
T cd06615 145 GVSGQLIDS----MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAK 220 (308)
T ss_pred CCccccccc----ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCcccccccc
Confidence 998654321 12356789999999999888889999999999999999999999864332111111110000
Q ss_pred ---------------------------CCCCCCCC-ccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCccCc
Q 039291 236 ---------------------------EHSLPEIP-SRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGV 280 (362)
Q Consensus 236 ---------------------------~~~~~~~~-~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~~~~ 280 (362)
....|..+ ..++.++++|+.+||..+|++||++.+++.||||...
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~ 293 (308)
T cd06615 221 ESHRPVSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKRA 293 (308)
T ss_pred CCcccccCCCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhhc
Confidence 00111222 1367889999999999999999999999999999765
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-43 Score=319.41 Aligned_cols=262 Identities=27% Similarity=0.425 Sum_probs=205.3
Q ss_pred CCCceeecceecccCceEEEEEEECCCCCCCCceeeeechhh--hhhHHHHHHHHHHHHcCCCCcccccccceeeecCCC
Q 039291 4 DGTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEV--SASASLQKEKEVFDNLNGCPFVLECFGEEITMGENG 81 (362)
Q Consensus 4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~--~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~~ 81 (362)
..++|.+.+.||+|+||.||+|+++.++. .+++|.... .....+.+|+.+++.+..||||+++++.+.......
T Consensus 16 ~~~~~~~~~~lg~g~~~~vy~~~~~~~~~----~~~ik~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~ 91 (286)
T cd06638 16 PSDTWEIIETIGKGTYGKVFKVLNKKNGS----KAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKN 91 (286)
T ss_pred cccceeeeeeeccCCCcEEEEEEECCCCc----eeEEEeeccccchHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCC
Confidence 45799999999999999999999988775 455655432 233567889999999966999999998765433334
Q ss_pred ceEEEEEEEecCCCCHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEee
Q 039291 82 EMAYNLLLEYAAGGTLGDLIEKC--NGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIAD 159 (362)
Q Consensus 82 ~~~~~lv~e~~~~~~L~~~l~~~--~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~D 159 (362)
...+++||||++|++|.+++... ....+++..++.++.|++.||.|||+++|+||||||+||++ +.++.++|+|
T Consensus 92 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili----~~~~~~kl~d 167 (286)
T cd06638 92 GDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILL----TTEGGVKLVD 167 (286)
T ss_pred CCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEE----CCCCCEEEcc
Confidence 45678999999999999988642 23458999999999999999999999999999999999999 6777899999
Q ss_pred cCCcccccccccCCCCCCccCCCCccCchhhcc-----ccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHHc
Q 039291 160 LGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQ-----HMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIG 234 (362)
Q Consensus 160 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~ 234 (362)
||++....... .......|+..|+|||++.. ..++.++||||+||++|+|++|+.||..... ...+.....
T Consensus 168 fg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~--~~~~~~~~~ 243 (286)
T cd06638 168 FGVSAQLTSTR--LRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHP--MRALFKIPR 243 (286)
T ss_pred CCceeecccCC--CccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCch--hHHHhhccc
Confidence 99987554321 11234569999999999853 3478899999999999999999999964322 222222211
Q ss_pred CCCCCCCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCc
Q 039291 235 DEHSLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFV 277 (362)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~ 277 (362)
........+..++.+++++|.+||..||++||++.++++|+||
T Consensus 244 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~~ 286 (286)
T cd06638 244 NPPPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI 286 (286)
T ss_pred cCCCcccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcccC
Confidence 1111112344568899999999999999999999999999997
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-43 Score=317.44 Aligned_cols=264 Identities=26% Similarity=0.466 Sum_probs=208.3
Q ss_pred CCCCCceeecceecccCceEEEEEEECCCCCCCCceeeeechhh--hhhHHHHHHHHHHHHcCCCCcccccccceeeecC
Q 039291 2 DSDGTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEV--SASASLQKEKEVFDNLNGCPFVLECFGEEITMGE 79 (362)
Q Consensus 2 ~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~--~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~ 79 (362)
....++|.+.+.||+|++|.||+|+++.++. .+++|.... .....+.+|+.+++++..|+||+++++.+.....
T Consensus 2 ~~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~----~~~~k~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~ 77 (275)
T cd06608 2 PDPTGIFELVEVIGEGTYGKVYKARHKKTGQ----LVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNP 77 (275)
T ss_pred CCchhheeheeeecCCCCeEEEEEEECCCCc----EEEEEEEecCchhHHHHHHHHHHHHHhcCCCChheEEEEEEecCC
Confidence 3457899999999999999999999987765 455555432 2345688999999999779999999998765432
Q ss_pred -CCceEEEEEEEecCCCCHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEE
Q 039291 80 -NGEMAYNLLLEYAAGGTLGDLIEKCN--GNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAK 156 (362)
Q Consensus 80 -~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~k 156 (362)
.....+++||||+++++|.+++.... ...+++..++.++.|++.||.|||+.|++|+||+|+||++ +.++.++
T Consensus 78 ~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~----~~~~~~~ 153 (275)
T cd06608 78 PGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILL----TKNAEVK 153 (275)
T ss_pred CCcceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEE----ccCCeEE
Confidence 23456789999999999999987643 4569999999999999999999999999999999999999 7778899
Q ss_pred EeecCCcccccccccCCCCCCccCCCCccCchhhcc-----ccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHH
Q 039291 157 IADLGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQ-----HMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFS 231 (362)
Q Consensus 157 l~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~ 231 (362)
|+|||++......... .....|+..|+|||++.. ..++.++|||||||++|+|++|..||.... .......
T Consensus 154 l~d~~~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~--~~~~~~~ 229 (275)
T cd06608 154 LVDFGVSAQLDSTLGR--RNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMH--PMRALFK 229 (275)
T ss_pred ECCCccceecccchhh--hcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccc--hHHHHHH
Confidence 9999998755432221 234568999999998864 246778999999999999999999995432 2223333
Q ss_pred HHcCCCCCCCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCc
Q 039291 232 IIGDEHSLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFV 277 (362)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~ 277 (362)
........-..+..++.++++||.+||..||++|||+.+++.|||+
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~~~ 275 (275)
T cd06608 230 IPRNPPPTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI 275 (275)
T ss_pred hhccCCCCCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcCCCC
Confidence 2222111111223477899999999999999999999999999996
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-44 Score=327.74 Aligned_cols=260 Identities=27% Similarity=0.395 Sum_probs=194.1
Q ss_pred cceecccCceEEEEEEECCCCCCCCceeeeechhhh-hhHHHHHHHHHHHHcCCCCcccccccceeeecCCCceEEEEEE
Q 039291 11 GRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVS-ASASLQKEKEVFDNLNGCPFVLECFGEEITMGENGEMAYNLLL 89 (362)
Q Consensus 11 ~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~~-~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~~~~~~~lv~ 89 (362)
++.||+|+||+||+|+++.... ...+++|..... ....+.+|+.++++++ ||||+++++.+.. .....+++||
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~--~~~~a~k~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~---~~~~~~~lv~ 79 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKD--EKEYALKQIEGTGISMSACREIALLRELK-HPNVIALQKVFLS---HSDRKVWLLF 79 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCc--cceEEEEEecCCCCcHHHHHHHHHHHhCC-CCCeeeEEEEEec---cCCCeEEEEE
Confidence 4789999999999999765322 246677765433 2345789999999999 8999999987653 2234577999
Q ss_pred EecCCCCHHHHHHHhc-------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEeecCC
Q 039291 90 EYAAGGTLGDLIEKCN-------GNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGV 162 (362)
Q Consensus 90 e~~~~~~L~~~l~~~~-------~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Dfgl 162 (362)
||+.+ +|.+++.... ...+++..++.++.||+.||.|||+.||+||||||+|||+..+++..+.+||+|||+
T Consensus 80 e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~ 158 (317)
T cd07867 80 DYAEH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGF 158 (317)
T ss_pred eeeCC-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeeccc
Confidence 99965 8888875421 224889999999999999999999999999999999999976556677899999999
Q ss_pred cccccccccC-CCCCCccCCCCccCchhhcc-ccCCCcchHHHHHHHHHHHHhCCCCCccCCCCC-------HHHH---H
Q 039291 163 AKRSRHCKRQ-KFDPSMRGTPLYLAPETVVQ-HMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCS-------IDQL---F 230 (362)
Q Consensus 163 a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~-------~~~~---~ 230 (362)
++........ .......||+.|+|||++.+ ..++.++|||||||++|+|++|.+||....... ..++ .
T Consensus 159 a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~ 238 (317)
T cd07867 159 ARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIF 238 (317)
T ss_pred eeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHH
Confidence 9765432211 11234678999999999976 457899999999999999999999996543210 0111 1
Q ss_pred HHHc-----------CCC---------------------CCCCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCc
Q 039291 231 SIIG-----------DEH---------------------SLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFV 277 (362)
Q Consensus 231 ~~~~-----------~~~---------------------~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~ 277 (362)
.... ... ..+......+..+.+||.+||+.||.+|||+++++.||||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07867 239 SVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQDPYF 317 (317)
T ss_pred HhcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 1000 000 0000112245678899999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-43 Score=320.06 Aligned_cols=253 Identities=27% Similarity=0.449 Sum_probs=211.6
Q ss_pred CceeecceecccCceEEEEEEECCCCCCCCceeeeechhh------hhhHHHHHHHHHHHHcCCCCcccccccceeeecC
Q 039291 6 TSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEV------SASASLQKEKEVFDNLNGCPFVLECFGEEITMGE 79 (362)
Q Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~------~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~ 79 (362)
++|.+.+.||+|+||.||+|.+..+++ .+++|.... .....+.+|++++++++ ||||+++++.+..
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~----~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~--- 72 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGK----YYALKILSKAKIVKLKQVEHVLNEKRILQSIR-HPFLVNLYGSFQD--- 72 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCC----EEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCC-CCCccceeeEEEc---
Confidence 579999999999999999999988765 455555432 23456889999999999 9999999986642
Q ss_pred CCceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEee
Q 039291 80 NGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIAD 159 (362)
Q Consensus 80 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~D 159 (362)
...+++||||+++++|.+++... ..+++..+..++.|++.||.|||+.|++|+||+|.||++ +.++.+||+|
T Consensus 73 --~~~~~~v~e~~~~~~L~~~~~~~--~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili----~~~~~~kl~d 144 (290)
T cd05580 73 --DSNLYLVMEYVPGGELFSHLRKS--GRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLL----DSDGYIKITD 144 (290)
T ss_pred --CCeEEEEEecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEE----CCCCCEEEee
Confidence 23577999999999999999873 569999999999999999999999999999999999999 7778899999
Q ss_pred cCCcccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHHcCCCCC
Q 039291 160 LGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEHSL 239 (362)
Q Consensus 160 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 239 (362)
||++...... .....|++.|+|||.+.+...+.++|+||||+++|+|++|..||...+ .......+... .
T Consensus 145 fg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~---~~~~~~~~~~~--~ 214 (290)
T cd05580 145 FGFAKRVKGR-----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDN---PIQIYEKILEG--K 214 (290)
T ss_pred CCCccccCCC-----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHhcC--C
Confidence 9998765432 234568999999999988888999999999999999999999996443 34444443322 2
Q ss_pred CCCCccCCHHHHHHHHHHhccCCCCCC-----CHHHHhcCCCccCcchhh
Q 039291 240 PEIPSRVSKEARDFLRRCFVRKPAFRF-----TAEMLLDDPFVKGVDEEL 284 (362)
Q Consensus 240 ~~~~~~~~~~~~~li~~~l~~~p~~R~-----s~~~~l~~p~~~~~~~~~ 284 (362)
..++..++..++++|.+||..||.+|+ ++++++.||||+.+.+..
T Consensus 215 ~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~~~ 264 (290)
T cd05580 215 VRFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNHPWFAGIDWIA 264 (290)
T ss_pred ccCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcCcccccCCHHH
Confidence 345667899999999999999999999 899999999999887664
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-44 Score=335.12 Aligned_cols=257 Identities=21% Similarity=0.307 Sum_probs=200.5
Q ss_pred CCceeecceecccCceEEEEEEECCCCC-CCCceeeeechhhh----hhHHHHHHHHHHHHcCCCCcccccccceeeecC
Q 039291 5 GTSWFRGRVIGQGSFGCVFIAKPKSNSS-FLPPLMAVKSAEVS----ASASLQKEKEVFDNLNGCPFVLECFGEEITMGE 79 (362)
Q Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~-~~~~~~~~K~~~~~----~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~ 79 (362)
.++|.+++.||+|+||.||+|++...+. .....|++|..... ....+.+|+.+++.+..|+||+++++.+..
T Consensus 37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~--- 113 (374)
T cd05106 37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTH--- 113 (374)
T ss_pred HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecC---
Confidence 4579999999999999999999765442 22346778776432 345678999999999669999999987643
Q ss_pred CCceEEEEEEEecCCCCHHHHHHHhc------------------------------------------------------
Q 039291 80 NGEMAYNLLLEYAAGGTLGDLIEKCN------------------------------------------------------ 105 (362)
Q Consensus 80 ~~~~~~~lv~e~~~~~~L~~~l~~~~------------------------------------------------------ 105 (362)
...+++||||+++|+|.+++....
T Consensus 114 --~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (374)
T cd05106 114 --GGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSS 191 (374)
T ss_pred --CCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccc
Confidence 234779999999999999986521
Q ss_pred --------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEeecCCccccccccc
Q 039291 106 --------------GNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKR 171 (362)
Q Consensus 106 --------------~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Dfgla~~~~~~~~ 171 (362)
..++++..++.++.|++.||.|||++||+||||||+|||+ +.++.+||+|||+++.......
T Consensus 192 ~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~----~~~~~~kL~DfGla~~~~~~~~ 267 (374)
T cd05106 192 SQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLL----TDGRVAKICDFGLARDIMNDSN 267 (374)
T ss_pred cccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEE----eCCCeEEEeeceeeeeccCCcc
Confidence 1247889999999999999999999999999999999999 6778899999999875543222
Q ss_pred CCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHh-CCCCCccCCCCCHHHHHHHHcCCCCCCCCCccCCHHH
Q 039291 172 QKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLS-GRQAWVVKEDCSIDQLFSIIGDEHSLPEIPSRVSKEA 250 (362)
Q Consensus 172 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (362)
........++..|+|||++.+..++.++|||||||++|+|++ |+.||...... ......+... ..+..+..+++++
T Consensus 268 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~--~~~~~~~~~~-~~~~~~~~~~~~l 344 (374)
T cd05106 268 YVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVN--SKFYKMVKRG-YQMSRPDFAPPEI 344 (374)
T ss_pred eeeccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCcccccc--HHHHHHHHcc-cCccCCCCCCHHH
Confidence 222223345678999999998899999999999999999997 99999654321 1222222222 2233455678999
Q ss_pred HHHHHHHhccCCCCCCCHHHHhc
Q 039291 251 RDFLRRCFVRKPAFRFTAEMLLD 273 (362)
Q Consensus 251 ~~li~~~l~~~p~~R~s~~~~l~ 273 (362)
.+++.+||..||++||++.++++
T Consensus 345 ~~li~~cl~~dp~~RPs~~~l~~ 367 (374)
T cd05106 345 YSIMKMCWNLEPTERPTFSQISQ 367 (374)
T ss_pred HHHHHHHcCCChhhCcCHHHHHH
Confidence 99999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-43 Score=317.85 Aligned_cols=263 Identities=25% Similarity=0.441 Sum_probs=205.7
Q ss_pred CCCceeecceecccCceEEEEEEECCCCCCCCceeeeechhh--hhhHHHHHHHHHHHHcCCCCcccccccceeeecCCC
Q 039291 4 DGTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEV--SASASLQKEKEVFDNLNGCPFVLECFGEEITMGENG 81 (362)
Q Consensus 4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~--~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~~ 81 (362)
..++|.+.+.||+|+||.||+|.++.+++ .+++|.... .....+.+|+.+++++.+|||++++++.+.......
T Consensus 20 ~~~~y~~~~~l~~g~~~~vy~~~~~~~~~----~~aik~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~ 95 (291)
T cd06639 20 PTDTWEIIETIGKGTYGKVYKVTNKKDGS----LAAVKILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLV 95 (291)
T ss_pred CCCCeEEEEEeecCCCeEEEEEEECCCCC----EEEEEEecccccHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccC
Confidence 35789999999999999999999988775 455555432 234567789999999966999999999776533323
Q ss_pred ceEEEEEEEecCCCCHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEee
Q 039291 82 EMAYNLLLEYAAGGTLGDLIEKC--NGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIAD 159 (362)
Q Consensus 82 ~~~~~lv~e~~~~~~L~~~l~~~--~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~D 159 (362)
...+++||||++|++|.++++.. .+..+++..++.++.|++.||.|||+.|++|+||||+||++ +.++.++|+|
T Consensus 96 ~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili----~~~~~~kl~d 171 (291)
T cd06639 96 GGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILL----TTEGGVKLVD 171 (291)
T ss_pred CCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEE----cCCCCEEEee
Confidence 34578999999999999988642 34568999999999999999999999999999999999999 6777899999
Q ss_pred cCCcccccccccCCCCCCccCCCCccCchhhccc-----cCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHHc
Q 039291 160 LGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQH-----MQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIG 234 (362)
Q Consensus 160 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~ 234 (362)
||++......... .....|+..|+|||++... .++.++|+|||||++|+|++|++||.... ....+.....
T Consensus 172 fg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~--~~~~~~~~~~ 247 (291)
T cd06639 172 FGVSAQLTSTRLR--RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMH--PVKTLFKIPR 247 (291)
T ss_pred cccchhccccccc--ccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCc--HHHHHHHHhc
Confidence 9998754432211 1245688999999998643 35789999999999999999999996432 1222322222
Q ss_pred CCCCCCCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCcc
Q 039291 235 DEHSLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVK 278 (362)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~~ 278 (362)
........+...+.++.++|.+||..+|++||++.+++.||||+
T Consensus 248 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~ 291 (291)
T cd06639 248 NPPPTLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK 291 (291)
T ss_pred CCCCCCCcccccCHHHHHHHHHHhhcChhhCcCHHHHhcCcccC
Confidence 21111122445778999999999999999999999999999984
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-43 Score=315.67 Aligned_cols=255 Identities=31% Similarity=0.544 Sum_probs=204.9
Q ss_pred CceeecceecccCceEEEEEEECCCCCCCCceeeeechhh--------hhhHHHHHHHHHHHHcCCCCcccccccceeee
Q 039291 6 TSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEV--------SASASLQKEKEVFDNLNGCPFVLECFGEEITM 77 (362)
Q Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~--------~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~ 77 (362)
..|...+.||+|+||.||+|.+..++. .+++|.... .....+.+|+.+++.++ ||||+++++.+..
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~----~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~- 75 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGR----ELAAKQVQFDPESPETSKEVSALECEIQLLKNLQ-HERIVQYYGCLRD- 75 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCc----EEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcC-CCCeeeEEEEEEc-
Confidence 579999999999999999999988775 455554321 23346788999999998 9999999886542
Q ss_pred cCCCceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEE
Q 039291 78 GENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKI 157 (362)
Q Consensus 78 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl 157 (362)
.....+++++||+++++|.+++.. ...+++..++.++.|++.||+|||+.+|+|+||||+||++ +.++.++|
T Consensus 76 --~~~~~~~l~~e~~~~~~L~~~l~~--~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~----~~~~~~~l 147 (266)
T cd06651 76 --RAEKTLTIFMEYMPGGSVKDQLKA--YGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILR----DSAGNVKL 147 (266)
T ss_pred --CCCCEEEEEEeCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEE----CCCCCEEE
Confidence 223457799999999999999976 3458999999999999999999999999999999999999 77778999
Q ss_pred eecCCccccccccc-CCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHHcCC
Q 039291 158 ADLGVAKRSRHCKR-QKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDE 236 (362)
Q Consensus 158 ~Dfgla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 236 (362)
+|||++........ ........++..|+|||++.+..++.++|+||+||++|+|++|+.||... +..+........
T Consensus 148 ~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~---~~~~~~~~~~~~ 224 (266)
T cd06651 148 GDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEY---EAMAAIFKIATQ 224 (266)
T ss_pred ccCCCccccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCcccc---chHHHHHHHhcC
Confidence 99999875432111 11112355889999999999888999999999999999999999999643 223333333334
Q ss_pred CCCCCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCcc
Q 039291 237 HSLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVK 278 (362)
Q Consensus 237 ~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~~ 278 (362)
...+.++..++..+++++ +||..+|++||++++++.||||+
T Consensus 225 ~~~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~hp~~~ 265 (266)
T cd06651 225 PTNPQLPSHISEHARDFL-GCIFVEARHRPSAEELLRHPFAQ 265 (266)
T ss_pred CCCCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhcCcccc
Confidence 445667777899999999 67778999999999999999986
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-43 Score=318.92 Aligned_cols=252 Identities=24% Similarity=0.404 Sum_probs=201.2
Q ss_pred CceeecceecccCceEEEEEEECCCCCCCCceeeeech----hhhhhHHHHHHHHHHHHcCCCCcccccccceeeecCCC
Q 039291 6 TSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSA----EVSASASLQKEKEVFDNLNGCPFVLECFGEEITMGENG 81 (362)
Q Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~----~~~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~~ 81 (362)
.+|.+.+.||+|+||.||+|++..++.. +++|.. .......+.+|+.++++++ ||||+++++.+..
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~----~aiK~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~----- 70 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRI----LAVKVIPLDITVELQKQIMSELEILYKCD-SPYIIGFYGAFFV----- 70 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcE----EEEEEEecCCChHHHHHHHHHHHHHHhCC-CCCeeeEEEEEEE-----
Confidence 3688899999999999999999887764 455543 2334456889999999998 8999999997653
Q ss_pred ceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEeecC
Q 039291 82 EMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLG 161 (362)
Q Consensus 82 ~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Dfg 161 (362)
...+++||||+++++|..+. .+++..+..++.|++.||.|||+.||+|+||||+||++ +.++.++|+|||
T Consensus 71 ~~~~~lv~e~~~~~~l~~~~------~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill----~~~~~~~l~dfg 140 (279)
T cd06619 71 ENRISICTEFMDGGSLDVYR------KIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLV----NTRGQVKLCDFG 140 (279)
T ss_pred CCEEEEEEecCCCCChHHhh------cCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEE----CCCCCEEEeeCC
Confidence 23467999999999986542 37899999999999999999999999999999999999 777889999999
Q ss_pred CcccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHhCCCCCccCCCC----CHHHHHHHHcCCC
Q 039291 162 VAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDC----SIDQLFSIIGDEH 237 (362)
Q Consensus 162 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~----~~~~~~~~~~~~~ 237 (362)
++...... ......||..|+|||++.+..++.++|+|||||++|+|++|..||...... ........+....
T Consensus 141 ~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 216 (279)
T cd06619 141 VSTQLVNS----IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDED 216 (279)
T ss_pred cceecccc----cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccC
Confidence 98754322 123467999999999999888999999999999999999999999643221 1222223322222
Q ss_pred CCCCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCccCcc
Q 039291 238 SLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGVD 281 (362)
Q Consensus 238 ~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~~~~~ 281 (362)
.........+.++++++.+||..+|++||++++++.||||....
T Consensus 217 ~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~~~~~~~~ 260 (279)
T cd06619 217 PPVLPVGQFSEKFVHFITQCMRKQPKERPAPENLMDHPFIVQYN 260 (279)
T ss_pred CCCCCCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcCccccccc
Confidence 11112235788999999999999999999999999999998764
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-44 Score=334.72 Aligned_cols=258 Identities=21% Similarity=0.321 Sum_probs=199.5
Q ss_pred CCCceeecceecccCceEEEEEEECCC-CCCCCceeeeechhh----hhhHHHHHHHHHHHHcCCCCcccccccceeeec
Q 039291 4 DGTSWFRGRVIGQGSFGCVFIAKPKSN-SSFLPPLMAVKSAEV----SASASLQKEKEVFDNLNGCPFVLECFGEEITMG 78 (362)
Q Consensus 4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~-~~~~~~~~~~K~~~~----~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~ 78 (362)
..++|.+++.||+|+||+||+|++... .......+++|.... .....+.+|+.+++.+..||||+++++.+..
T Consensus 33 ~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~-- 110 (375)
T cd05104 33 PRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTV-- 110 (375)
T ss_pred chHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeecc--
Confidence 356899999999999999999975321 111224677777643 2345678999999999669999999987643
Q ss_pred CCCceEEEEEEEecCCCCHHHHHHHhc-----------------------------------------------------
Q 039291 79 ENGEMAYNLLLEYAAGGTLGDLIEKCN----------------------------------------------------- 105 (362)
Q Consensus 79 ~~~~~~~~lv~e~~~~~~L~~~l~~~~----------------------------------------------------- 105 (362)
....++||||++||+|.++++...
T Consensus 111 ---~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 187 (375)
T cd05104 111 ---GGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRR 187 (375)
T ss_pred ---CCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccc
Confidence 223679999999999999997532
Q ss_pred --------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEeecCCccc
Q 039291 106 --------------------GNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKR 165 (362)
Q Consensus 106 --------------------~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Dfgla~~ 165 (362)
...+++..+..++.||+.||.|||++||+||||||+|||+ +.+..+||+|||+++.
T Consensus 188 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill----~~~~~~kl~DfG~a~~ 263 (375)
T cd05104 188 SVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILL----THGRITKICDFGLARD 263 (375)
T ss_pred ccccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEE----ECCCcEEEecCcccee
Confidence 1247888999999999999999999999999999999999 6677899999999976
Q ss_pred ccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHh-CCCCCccCCCCCHHHHHHHHcCCCCCCCCCc
Q 039291 166 SRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLS-GRQAWVVKEDCSIDQLFSIIGDEHSLPEIPS 244 (362)
Q Consensus 166 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (362)
..............++..|+|||++.+..++.++|||||||++|+|++ |..||..... .......+.... .+..+.
T Consensus 264 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~--~~~~~~~~~~~~-~~~~~~ 340 (375)
T cd05104 264 IRNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPV--DSKFYKMIKEGY-RMLSPE 340 (375)
T ss_pred ccCcccccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCc--hHHHHHHHHhCc-cCCCCC
Confidence 543222222223345677999999999899999999999999999998 8899854322 223333333322 233455
Q ss_pred cCCHHHHHHHHHHhccCCCCCCCHHHHhc
Q 039291 245 RVSKEARDFLRRCFVRKPAFRFTAEMLLD 273 (362)
Q Consensus 245 ~~~~~~~~li~~~l~~~p~~R~s~~~~l~ 273 (362)
..+.++++|+.+||+.||++||++.+++.
T Consensus 341 ~~~~~l~~li~~cl~~dP~~RPs~~eil~ 369 (375)
T cd05104 341 CAPSEMYDIMKSCWDADPLKRPTFKQIVQ 369 (375)
T ss_pred CCCHHHHHHHHHHccCChhHCcCHHHHHH
Confidence 67899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-44 Score=319.57 Aligned_cols=269 Identities=27% Similarity=0.405 Sum_probs=223.3
Q ss_pred CceeecceecccCceEEEEEEECCCCCCCCceeeeechhh--hhhHHHHHHHHHHHHcCCCCcccccccceeeecCCCce
Q 039291 6 TSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEV--SASASLQKEKEVFDNLNGCPFVLECFGEEITMGENGEM 83 (362)
Q Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~--~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~~~~ 83 (362)
..|..+.+||+|+||.|-+|..+++.+-++.++..|..-. ...+--..|.++|....+-|.++.++..+.+.+
T Consensus 349 tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmD----- 423 (683)
T KOG0696|consen 349 TDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMD----- 423 (683)
T ss_pred cccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhh-----
Confidence 4577789999999999999999998875544444333222 233445678889988888889999988664432
Q ss_pred EEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEeecCCc
Q 039291 84 AYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVA 163 (362)
Q Consensus 84 ~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Dfgla 163 (362)
.+|+||||+.||+|--.|+.. +++.|..+..++.+|+.||-+||++|||+||||.+|||+ +..+++||+|||+.
T Consensus 424 RLyFVMEyvnGGDLMyhiQQ~--GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmL----d~eGHiKi~DFGmc 497 (683)
T KOG0696|consen 424 RLYFVMEYVNGGDLMYHIQQV--GKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVML----DSEGHIKIADFGMC 497 (683)
T ss_pred heeeEEEEecCchhhhHHHHh--cccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEe----ccCCceEeeecccc
Confidence 478999999999999999874 459999999999999999999999999999999999999 99999999999998
Q ss_pred ccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHHcCCCCCCCCC
Q 039291 164 KRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEHSLPEIP 243 (362)
Q Consensus 164 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (362)
+.... ......+++|||.|+|||++...+|+.++|+||+||+||||+.|++||.+. +..++++.|..... .+|
T Consensus 498 KEni~--~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGe---DE~elF~aI~ehnv--syP 570 (683)
T KOG0696|consen 498 KENIF--DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGE---DEDELFQAIMEHNV--SYP 570 (683)
T ss_pred ccccc--CCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCC---CHHHHHHHHHHccC--cCc
Confidence 75443 334456899999999999999999999999999999999999999999665 56677777765443 578
Q ss_pred ccCCHHHHHHHHHHhccCCCCCCC-----HHHHhcCCCccCcchhhh--hhhhCCC
Q 039291 244 SRVSKEARDFLRRCFVRKPAFRFT-----AEMLLDDPFVKGVDEELS--RELEGDY 292 (362)
Q Consensus 244 ~~~~~~~~~li~~~l~~~p~~R~s-----~~~~l~~p~~~~~~~~~~--~~~~~~~ 292 (362)
..+|.++.++++.+|...|.+|.. -.++..||||+.++|+.. +++++++
T Consensus 571 KslSkEAv~ickg~ltK~P~kRLGcg~~ge~di~~H~FFR~iDWek~E~~eiqPPf 626 (683)
T KOG0696|consen 571 KSLSKEAVAICKGLLTKHPGKRLGCGPEGERDIREHPFFRRIDWEKLERREIQPPF 626 (683)
T ss_pred ccccHHHHHHHHHHhhcCCccccCCCCccccchhhCcchhhccHHHHhhccCCCCC
Confidence 899999999999999999999974 378999999999999854 3444443
|
|
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-43 Score=319.00 Aligned_cols=259 Identities=28% Similarity=0.446 Sum_probs=205.8
Q ss_pred CCceeecceecccCceEEEEEEECCCCCCCCceeeeechh---hhhhHHHHHHHHHHHHcCCCCcccccccceeeecCCC
Q 039291 5 GTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAE---VSASASLQKEKEVFDNLNGCPFVLECFGEEITMGENG 81 (362)
Q Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~---~~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~~ 81 (362)
++.|++++.||.|+||.||+|++..++. .+++|... ......+.+|+.+++.++ |+||+++++.+..
T Consensus 11 ~~~y~i~~~lg~g~~g~vy~~~~~~~~~----~~~~k~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~----- 80 (292)
T cd06644 11 NEVWEIIGELGDGAFGKVYKAKNKETGA----LAAAKVIETKSEEELEDYMVEIEILATCN-HPYIVKLLGAFYW----- 80 (292)
T ss_pred chhhhhhheecCCCCeEEEEEEECCCCc----eEEEEEeccCCHHHHHHHHHHHHHHHhCC-CCcEeeeEEEEEe-----
Confidence 4679999999999999999999988775 45555543 234456788999999999 9999999987643
Q ss_pred ceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEeecC
Q 039291 82 EMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLG 161 (362)
Q Consensus 82 ~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Dfg 161 (362)
...+++||||+++++|..++... ...+++..+..++.|++.+|.|||++|++||||||+||++ +.++.++|+|||
T Consensus 81 ~~~~~lv~e~~~~~~l~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili----~~~~~~kl~dfg 155 (292)
T cd06644 81 DGKLWIMIEFCPGGAVDAIMLEL-DRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLL----TLDGDIKLADFG 155 (292)
T ss_pred CCeEEEEEecCCCCcHHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEE----cCCCCEEEccCc
Confidence 23578999999999998887653 3459999999999999999999999999999999999999 667789999999
Q ss_pred CcccccccccCCCCCCccCCCCccCchhhc-----cccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHHc-C
Q 039291 162 VAKRSRHCKRQKFDPSMRGTPLYLAPETVV-----QHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIG-D 235 (362)
Q Consensus 162 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~-~ 235 (362)
++...... ........++..|+|||++. ...++.++|+|||||++|+|++|.+||.... .......+. .
T Consensus 156 ~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~---~~~~~~~~~~~ 230 (292)
T cd06644 156 VSAKNVKT--LQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELN---PMRVLLKIAKS 230 (292)
T ss_pred cceecccc--ccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCcccc---HHHHHHHHhcC
Confidence 98653321 11123456889999999985 3346788999999999999999999995443 222222222 2
Q ss_pred CCCCCCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCccCcchh
Q 039291 236 EHSLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGVDEE 283 (362)
Q Consensus 236 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~~~~~~~ 283 (362)
.......+..++.++.++|.+||..+|++||+++++++||||..+...
T Consensus 231 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~~ 278 (292)
T cd06644 231 EPPTLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEHPFVSSVTSN 278 (292)
T ss_pred CCccCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccccc
Confidence 221222345678999999999999999999999999999999876554
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-45 Score=328.76 Aligned_cols=258 Identities=24% Similarity=0.417 Sum_probs=224.8
Q ss_pred CceeecceecccCceEEEEEEECCCCCCCCceeeeechh------hhhhHHHHHHHHHHHHcCCCCcccccccceeeecC
Q 039291 6 TSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAE------VSASASLQKEKEVFDNLNGCPFVLECFGEEITMGE 79 (362)
Q Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~------~~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~ 79 (362)
....++..||-|+||.|-+++.+.... .+|+|+++ ......+..|.+||.... .|.||++|..+.
T Consensus 420 ~dl~~iaTLGvGgFGRVELV~~~~~~~----~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~-s~fIvrLYrTfr---- 490 (732)
T KOG0614|consen 420 SDLKRIATLGVGGFGRVELVKVNSQKA----TFALKILKKKHIVDTKQQEHVFSERNIMMECR-SDFIVRLYRTFR---- 490 (732)
T ss_pred hhhhhhhhcccCccceEEEEEecccch----HHHHHHHhHhhccchhHHHHHHhHHHHHHhcC-chHHHHHHHHhc----
Confidence 455677889999999999998877643 34555443 235567889999999999 899999998653
Q ss_pred CCceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEee
Q 039291 80 NGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIAD 159 (362)
Q Consensus 80 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~D 159 (362)
+..+.|++||-|-||.|+..++. ++.|++.++++++..+++|++|||++|||+|||||+|+++ +.+|-+||.|
T Consensus 491 -d~kyvYmLmEaClGGElWTiLrd--Rg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllL----d~~Gy~KLVD 563 (732)
T KOG0614|consen 491 -DSKYVYMLMEACLGGELWTILRD--RGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLL----DNRGYLKLVD 563 (732)
T ss_pred -cchhhhhhHHhhcCchhhhhhhh--cCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheee----ccCCceEEee
Confidence 34567899999999999999987 5569999999999999999999999999999999999999 9999999999
Q ss_pred cCCcccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHHcCCCCC
Q 039291 160 LGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEHSL 239 (362)
Q Consensus 160 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 239 (362)
||+|+........ -++|||+.|.|||++.++.++.++|.||||+++|||++|.+||.+. ++...+..|..+...
T Consensus 564 FGFAKki~~g~KT---wTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~---dpmktYn~ILkGid~ 637 (732)
T KOG0614|consen 564 FGFAKKIGSGRKT---WTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGV---DPMKTYNLILKGIDK 637 (732)
T ss_pred hhhHHHhccCCce---eeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCC---chHHHHHHHHhhhhh
Confidence 9999988764433 4799999999999999999999999999999999999999999554 677777888777777
Q ss_pred CCCCccCCHHHHHHHHHHhccCCCCCCC-----HHHHhcCCCccCcchhhh
Q 039291 240 PEIPSRVSKEARDFLRRCFVRKPAFRFT-----AEMLLDDPFVKGVDEELS 285 (362)
Q Consensus 240 ~~~~~~~~~~~~~li~~~l~~~p~~R~s-----~~~~l~~p~~~~~~~~~~ 285 (362)
-.+|..++..+.+||+++...+|.+|.. +.++.+|.||.+.+|+-.
T Consensus 638 i~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~gfdwegl 688 (732)
T KOG0614|consen 638 IEFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHRWFEGFDWEGL 688 (732)
T ss_pred hhcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhhhhhcCChhhh
Confidence 7889999999999999999999999984 899999999999998843
|
|
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-43 Score=318.47 Aligned_cols=260 Identities=27% Similarity=0.471 Sum_probs=202.1
Q ss_pred CceeecceecccCceEEEEEEECCCCCCCCceeeeechhhh-----hhHHHHHHHHHHHHcCCCCcccccccceeeecCC
Q 039291 6 TSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVS-----ASASLQKEKEVFDNLNGCPFVLECFGEEITMGEN 80 (362)
Q Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~~-----~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~ 80 (362)
++|.+.+.||+|+||.||+|.+..++. .+++|..... ....+.+|+.+++.+.+||||+++++.+.....+
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~----~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~ 76 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGK----LVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKN 76 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCc----EEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCC
Confidence 479999999999999999999988775 4566654322 2345788999999998889999999877654433
Q ss_pred CceEEEEEEEecCCCCHHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCC-ceEEE
Q 039291 81 GEMAYNLLLEYAAGGTLGDLIEKCN---GNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSG-KFVAK 156 (362)
Q Consensus 81 ~~~~~~lv~e~~~~~~L~~~l~~~~---~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~-~~~~k 156 (362)
....+++||||+++ +|.+++.... ...+++..++.++.||+.||.|||++||+||||||+||++ +. ++.++
T Consensus 77 ~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~----~~~~~~~k 151 (295)
T cd07837 77 GKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLV----DKQKGLLK 151 (295)
T ss_pred CCceEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEE----ecCCCeEE
Confidence 44457899999986 8988886543 2358999999999999999999999999999999999999 55 67899
Q ss_pred EeecCCcccccccccCCCCCCccCCCCccCchhhcc-ccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHHcC
Q 039291 157 IADLGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQ-HMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGD 235 (362)
Q Consensus 157 l~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~ 235 (362)
|+|||++......... .....+++.|+|||++.+ ..++.++|+||||+++|+|++|.+||...+. ..+.......
T Consensus 152 l~dfg~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~--~~~~~~~~~~ 227 (295)
T cd07837 152 IADLGLGRAFSIPVKS--YTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSE--LQQLLHIFKL 227 (295)
T ss_pred EeecccceecCCCccc--cCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCH--HHHHHHHHHH
Confidence 9999998755332111 123457889999998875 4578999999999999999999999965432 2222221110
Q ss_pred --CC---C------------CC--------CCCccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCcc
Q 039291 236 --EH---S------------LP--------EIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVK 278 (362)
Q Consensus 236 --~~---~------------~~--------~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~~ 278 (362)
.. . .+ .....++.++.+||.+||..||.+||++.+++.||||+
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~~~ 295 (295)
T cd07837 228 LGTPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYFD 295 (295)
T ss_pred hCCCChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcCCCcC
Confidence 00 0 00 01134788999999999999999999999999999985
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=328.12 Aligned_cols=261 Identities=21% Similarity=0.285 Sum_probs=204.4
Q ss_pred CCCCceeecceecccCceEEEEEEECCCC-CCCCceeeeechhh----hhhHHHHHHHHHHHHcCCCCcccccccceeee
Q 039291 3 SDGTSWFRGRVIGQGSFGCVFIAKPKSNS-SFLPPLMAVKSAEV----SASASLQKEKEVFDNLNGCPFVLECFGEEITM 77 (362)
Q Consensus 3 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~-~~~~~~~~~K~~~~----~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~ 77 (362)
..+++|.+.+.||+|+||.||+|.+..++ ....+.+++|.... .....+.+|+.++.++.+|+||+++++.+..
T Consensus 4 ~~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~- 82 (337)
T cd05054 4 FPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTK- 82 (337)
T ss_pred cCHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEec-
Confidence 45679999999999999999999865543 22235678887542 2335677899999999669999999986643
Q ss_pred cCCCceEEEEEEEecCCCCHHHHHHHhcC---------------------------------------------------
Q 039291 78 GENGEMAYNLLLEYAAGGTLGDLIEKCNG--------------------------------------------------- 106 (362)
Q Consensus 78 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--------------------------------------------------- 106 (362)
....++++|||+++++|.+++.....
T Consensus 83 ---~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (337)
T cd05054 83 ---PGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEED 159 (337)
T ss_pred ---CCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccc
Confidence 22357799999999999999865321
Q ss_pred --------CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEeecCCcccccccccCCCCCCc
Q 039291 107 --------NGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSM 178 (362)
Q Consensus 107 --------~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Dfgla~~~~~~~~~~~~~~~ 178 (362)
.++++..+..++.|++.||.|||++||+||||||+|||+ +.++.++|+|||++...............
T Consensus 160 ~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill----~~~~~vkL~DfG~a~~~~~~~~~~~~~~~ 235 (337)
T cd05054 160 EEGDELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILL----SENNVVKICDFGLARDIYKDPDYVRKGDA 235 (337)
T ss_pred hhhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEE----eCCCcEEEeccccchhcccCcchhhccCC
Confidence 258899999999999999999999999999999999999 66778999999999865432222222344
Q ss_pred cCCCCccCchhhccccCCCcchHHHHHHHHHHHHh-CCCCCccCCCCCHHHHHHHHcCCCCCCCCCccCCHHHHHHHHHH
Q 039291 179 RGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLS-GRQAWVVKEDCSIDQLFSIIGDEHSLPEIPSRVSKEARDFLRRC 257 (362)
Q Consensus 179 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 257 (362)
.++..|+|||++.+..++.++|||||||++|+|++ |..||...... ..+...+.. ...+..+...+.++.+++.+|
T Consensus 236 ~~~~~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~--~~~~~~~~~-~~~~~~~~~~~~~~~~l~~~c 312 (337)
T cd05054 236 RLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQID--EEFCRRLKE-GTRMRAPEYATPEIYSIMLDC 312 (337)
T ss_pred CCCccccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCcc--HHHHHHHhc-cCCCCCCccCCHHHHHHHHHH
Confidence 56778999999999999999999999999999998 99999653221 122222222 223344566889999999999
Q ss_pred hccCCCCCCCHHHHhcC
Q 039291 258 FVRKPAFRFTAEMLLDD 274 (362)
Q Consensus 258 l~~~p~~R~s~~~~l~~ 274 (362)
|+.+|++||++.++++|
T Consensus 313 l~~~p~~RPs~~ell~~ 329 (337)
T cd05054 313 WHNNPEDRPTFSELVEI 329 (337)
T ss_pred ccCChhhCcCHHHHHHH
Confidence 99999999999999874
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-44 Score=333.86 Aligned_cols=259 Identities=24% Similarity=0.397 Sum_probs=217.8
Q ss_pred CCceee-cceecccCceEEEEEEECCCCCCCCc-eeeeechh--hhhhHHHHHHHHHHHHcCCCCcccccccceeeecCC
Q 039291 5 GTSWFR-GRVIGQGSFGCVFIAKPKSNSSFLPP-LMAVKSAE--VSASASLQKEKEVFDNLNGCPFVLECFGEEITMGEN 80 (362)
Q Consensus 5 ~~~y~~-~~~lG~G~~g~V~~a~~~~~~~~~~~-~~~~K~~~--~~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~ 80 (362)
++||.. ...||+|+|-+||+|.|..+|..++. .+.+..+. .....++..|+.+|+.|+ ||||+++|..++....
T Consensus 38 ~gRy~k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~-H~NIirfy~SW~d~~n- 115 (632)
T KOG0584|consen 38 TGRYLKFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLK-HPNIIRFYDSWVDTDN- 115 (632)
T ss_pred CCceeehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCC-CCceeeeeeheecCCC-
Confidence 456654 68899999999999999888765542 22222222 234588999999999999 9999999998876433
Q ss_pred CceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--ceeCCCCCCCEEEeecCCCceEEEEe
Q 039291 81 GEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSG--YVHCDVKPDNILLVATQSGKFVAKIA 158 (362)
Q Consensus 81 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~--ivH~Dlkp~Nill~~~~~~~~~~kl~ 158 (362)
..+.+|+|.+..|+|+.|+++.+ ..+...++.|++||+.||.|||++. |||||||-+||+|+ ...|.|||+
T Consensus 116 --~~in~iTEL~TSGtLr~Y~kk~~--~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFin---G~~G~VKIG 188 (632)
T KOG0584|consen 116 --KTINFITELFTSGTLREYRKKHR--RVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVN---GNLGEVKIG 188 (632)
T ss_pred --ceeeeeeecccCCcHHHHHHHhc--cCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEc---CCcCceeec
Confidence 45679999999999999999854 4999999999999999999999875 99999999999994 445789999
Q ss_pred ecCCcccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHHcCCCC
Q 039291 159 DLGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEHS 238 (362)
Q Consensus 159 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 238 (362)
|+|||+.... ....+.+|||.|||||++. ..|+..+||||||++|+||+|+..||. +-.+..++++++.++..
T Consensus 189 DLGLAtl~r~----s~aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYs--EC~n~AQIYKKV~SGiK 261 (632)
T KOG0584|consen 189 DLGLATLLRK----SHAKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYS--ECTNPAQIYKKVTSGIK 261 (632)
T ss_pred chhHHHHhhc----cccceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChh--hhCCHHHHHHHHHcCCC
Confidence 9999986654 2334678999999999886 679999999999999999999999995 33468899999988887
Q ss_pred CCCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCccCc
Q 039291 239 LPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGV 280 (362)
Q Consensus 239 ~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~~~~ 280 (362)
...+..--.+++++||.+||.. ...|+|+.|||.||||+..
T Consensus 262 P~sl~kV~dPevr~fIekCl~~-~~~R~sa~eLL~d~Ff~~d 302 (632)
T KOG0584|consen 262 PAALSKVKDPEVREFIEKCLAT-KSERLSAKELLKDPFFDED 302 (632)
T ss_pred HHHhhccCCHHHHHHHHHHhcC-chhccCHHHHhhChhhccc
Confidence 6666555679999999999999 8999999999999999874
|
|
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-43 Score=310.37 Aligned_cols=251 Identities=28% Similarity=0.467 Sum_probs=208.1
Q ss_pred ceeecceecccCceEEEEEEECCCCCCCCceeeeechh-----hhhhHHHHHHHHHHHHcCCCCcccccccceeeecCCC
Q 039291 7 SWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAE-----VSASASLQKEKEVFDNLNGCPFVLECFGEEITMGENG 81 (362)
Q Consensus 7 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~-----~~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~~ 81 (362)
.|.+.+.||+|++|.||+|.++.++. .+++|... ......+.+|+++++.++ |||++++++.+..
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~----~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~----- 70 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKR----VYAMKQIDLSKMNRREREEAIDEARVLAKLD-SSYIIRYYESFLD----- 70 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCc----EEEEEEeehhhCCHHHHHHHHHHHHHHHhcC-CCCeehheeeecc-----
Confidence 47889999999999999999988775 45555432 334566889999999998 9999999987643
Q ss_pred ceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEeecC
Q 039291 82 EMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLG 161 (362)
Q Consensus 82 ~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Dfg 161 (362)
...+++||||++|++|.+++.......+++..++.++.|++.||.|||+.|++|+||||+||++ +.++.++|+|||
T Consensus 71 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili----~~~~~~~l~df~ 146 (256)
T cd08529 71 KGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFL----DAYDNVKIGDLG 146 (256)
T ss_pred CCEEEEEEEeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEE----eCCCCEEEcccc
Confidence 2357799999999999999987655679999999999999999999999999999999999999 667789999999
Q ss_pred CcccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHHcCCCCCCC
Q 039291 162 VAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEHSLPE 241 (362)
Q Consensus 162 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 241 (362)
+++....... ......|++.|+|||++.+..++.++|+|||||++++|++|+.||.... .......+... ..+.
T Consensus 147 ~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~---~~~~~~~~~~~-~~~~ 220 (256)
T cd08529 147 VAKLLSDNTN--FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANN---QGALILKIIRG-VFPP 220 (256)
T ss_pred cceeccCccc--hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHHcC-CCCC
Confidence 9876543221 1234568999999999998889999999999999999999999996443 33444444332 3344
Q ss_pred CCccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCc
Q 039291 242 IPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFV 277 (362)
Q Consensus 242 ~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~ 277 (362)
++..++.++.+++.+||..+|++||++.+++.|||+
T Consensus 221 ~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 256 (256)
T cd08529 221 VSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRNPSL 256 (256)
T ss_pred CccccCHHHHHHHHHHccCCcccCcCHHHHhhCCCC
Confidence 566789999999999999999999999999999985
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-43 Score=313.56 Aligned_cols=252 Identities=29% Similarity=0.566 Sum_probs=203.6
Q ss_pred ceeecceecccCceEEEEEEECCCCCCCCceeeeechh---------hhhhHHHHHHHHHHHHcCCCCcccccccceeee
Q 039291 7 SWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAE---------VSASASLQKEKEVFDNLNGCPFVLECFGEEITM 77 (362)
Q Consensus 7 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~---------~~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~ 77 (362)
+|.+++.||+|+||+||+|.+.. +. .+++|... ......+.+|+.++++++ |+||+++++.+..
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~-~~----~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~- 73 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQ-GQ----LIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLK-HVNIVQYLGTCLD- 73 (265)
T ss_pred CccccceEeccCCeEEEEEEEcC-CC----eEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcC-CCCEeeEeeEeec-
Confidence 58899999999999999998753 33 35555432 123356888999999998 8999999987642
Q ss_pred cCCCceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEE
Q 039291 78 GENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKI 157 (362)
Q Consensus 78 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl 157 (362)
...+++++||++|++|.+++.. ..++++..++.++.|++.||+|||+.+|+|+||+|+||++ +.++.++|
T Consensus 74 ----~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~----~~~~~~~l 143 (265)
T cd06631 74 ----DNTISIFMEFVPGGSISSILNR--FGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVML----MPNGIIKL 143 (265)
T ss_pred ----CCeEEEEEecCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEE----CCCCeEEe
Confidence 2457899999999999999976 3458999999999999999999999999999999999999 77788999
Q ss_pred eecCCcccccccc----cCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHH
Q 039291 158 ADLGVAKRSRHCK----RQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSII 233 (362)
Q Consensus 158 ~Dfgla~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~ 233 (362)
+|||++....... .........|+..|+|||++.+..++.++|+|||||++|+|++|..||...+. ........
T Consensus 144 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~--~~~~~~~~ 221 (265)
T cd06631 144 IDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDR--LAAMFYIG 221 (265)
T ss_pred ccchhhHhhhhccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCCh--HHHHHHhh
Confidence 9999987543211 11122345689999999999988899999999999999999999999964322 22222222
Q ss_pred cCCCCCCCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCc
Q 039291 234 GDEHSLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFV 277 (362)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~ 277 (362)
......+..+..++.++.++|++||..+|++||++.+++.||||
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~ 265 (265)
T cd06631 222 AHRGLMPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLRHDFL 265 (265)
T ss_pred hccCCCCCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 23334556777899999999999999999999999999999997
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-43 Score=316.60 Aligned_cols=252 Identities=26% Similarity=0.411 Sum_probs=199.7
Q ss_pred CCceeecceecccCceEEEEEEECCCCCCCCceeeeechhh---hhhHHHHHHHHHHHHcCCCCcccccccceeeecCCC
Q 039291 5 GTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEV---SASASLQKEKEVFDNLNGCPFVLECFGEEITMGENG 81 (362)
Q Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~---~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~~ 81 (362)
.++|.+.+.||+|+||.||+|++..++. .+++|.... .....+.+|+.+++.++ ||||+++++.+..
T Consensus 8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~----~~~ik~~~~~~~~~~~~~~~e~~~~~~l~-h~~ii~~~~~~~~----- 77 (267)
T cd06645 8 QEDFELIQRIGSGTYGDVYKARNVNTGE----LAAIKVIKLEPGEDFAVVQQEIIMMKDCK-HSNIVAYFGSYLR----- 77 (267)
T ss_pred HHHHHHHHHhCCCCCeEEEEEEEcCCCc----EEEEEEEecCchhHHHHHHHHHHHHHhCC-CCCeeeEEEEEEe-----
Confidence 4689999999999999999999988775 455555432 23345778999999998 9999999986643
Q ss_pred ceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEeecC
Q 039291 82 EMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLG 161 (362)
Q Consensus 82 ~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Dfg 161 (362)
...++++|||+++++|.+++.. .+.+++.+++.++.|++.||.|||++|++|+||||+||++ +.++.++|+|||
T Consensus 78 ~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili----~~~~~~~l~dfg 151 (267)
T cd06645 78 RDKLWICMEFCGGGSLQDIYHV--TGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILL----TDNGHVKLADFG 151 (267)
T ss_pred CCEEEEEEeccCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE----CCCCCEEECcce
Confidence 2347799999999999999976 3469999999999999999999999999999999999999 777789999999
Q ss_pred CcccccccccCCCCCCccCCCCccCchhhc---cccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHHcCCCC
Q 039291 162 VAKRSRHCKRQKFDPSMRGTPLYLAPETVV---QHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEHS 238 (362)
Q Consensus 162 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 238 (362)
++...... ........|+..|+|||++. ...++.++|+|||||++|+|++|..||..... .............
T Consensus 152 ~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~--~~~~~~~~~~~~~ 227 (267)
T cd06645 152 VSAQITAT--IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHP--MRALFLMTKSNFQ 227 (267)
T ss_pred eeeEccCc--ccccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccc--hhhHHhhhccCCC
Confidence 98654332 11123567999999999975 44578899999999999999999999854332 1222222111211
Q ss_pred CCCC--CccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCC
Q 039291 239 LPEI--PSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPF 276 (362)
Q Consensus 239 ~~~~--~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~ 276 (362)
.+.. ...++..+.++|.+||..+|++||+++++++|||
T Consensus 228 ~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~~~ 267 (267)
T cd06645 228 PPKLKDKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQHPF 267 (267)
T ss_pred CCcccccCCCCHHHHHHHHHHccCCchhCcCHHHHhcCCC
Confidence 1211 1246789999999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-43 Score=322.34 Aligned_cols=255 Identities=20% Similarity=0.318 Sum_probs=206.9
Q ss_pred CCCceeecceecccCceEEEEEEECCCCCCCCceeeeechhh----hhhHHHHHHHHHHHHcCCCCcccccccceeeecC
Q 039291 4 DGTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEV----SASASLQKEKEVFDNLNGCPFVLECFGEEITMGE 79 (362)
Q Consensus 4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~----~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~ 79 (362)
..++|.+.+.||+|+||.||+|++..++......+++|.... .....+.+|+.+++.++ ||||+++++.+...
T Consensus 5 ~~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~g~~~~~-- 81 (316)
T cd05108 5 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD-NPHVCRLLGICLTS-- 81 (316)
T ss_pred chhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCC-CCCCCeEEEEEcCC--
Confidence 457899999999999999999998877776666788888643 23456888999999998 99999999876531
Q ss_pred CCceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEee
Q 039291 80 NGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIAD 159 (362)
Q Consensus 80 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~D 159 (362)
..++++||+++|+|.+++... ...+++..+..++.|++.||+|||++||+||||||+|||+ +.++.+||+|
T Consensus 82 ----~~~~v~e~~~~g~l~~~l~~~-~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill----~~~~~~kl~D 152 (316)
T cd05108 82 ----TVQLITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLV----KTPQHVKITD 152 (316)
T ss_pred ----CceeeeecCCCCCHHHHHHhc-cccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEe----cCCCcEEEcc
Confidence 246899999999999999863 3458999999999999999999999999999999999999 7777899999
Q ss_pred cCCcccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHh-CCCCCccCCCCCHHHHHHHHcCCCC
Q 039291 160 LGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLS-GRQAWVVKEDCSIDQLFSIIGDEHS 238 (362)
Q Consensus 160 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~ 238 (362)
||+++...............++..|+|||++.+..++.++|||||||++|||++ |..||... ...++...+.....
T Consensus 153 fG~a~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~---~~~~~~~~~~~~~~ 229 (316)
T cd05108 153 FGLAKLLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI---PASEISSILEKGER 229 (316)
T ss_pred ccccccccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCC---CHHHHHHHHhCCCC
Confidence 999986553222222223335678999999999899999999999999999998 99999543 33344444433333
Q ss_pred CCCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhcC
Q 039291 239 LPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDD 274 (362)
Q Consensus 239 ~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~ 274 (362)
.+ .+..++.++.+++.+||..+|++||++.+++.+
T Consensus 230 ~~-~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~ 264 (316)
T cd05108 230 LP-QPPICTIDVYMIMVKCWMIDADSRPKFRELIIE 264 (316)
T ss_pred CC-CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 33 355688999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-43 Score=323.26 Aligned_cols=258 Identities=23% Similarity=0.305 Sum_probs=197.4
Q ss_pred ecceeccc--CceEEEEEEECCCCCCCCceeeeechhh-----hhhHHHHHHHHHHHHcCCCCcccccccceeeecCCCc
Q 039291 10 RGRVIGQG--SFGCVFIAKPKSNSSFLPPLMAVKSAEV-----SASASLQKEKEVFDNLNGCPFVLECFGEEITMGENGE 82 (362)
Q Consensus 10 ~~~~lG~G--~~g~V~~a~~~~~~~~~~~~~~~K~~~~-----~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~~~ 82 (362)
++++||+| +||+||+++++.+++ .+++|.... .....+.+|+.+++.++ ||||+++++.+.. .
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~----~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~-hpniv~~~~~~~~-----~ 71 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGE----YVTVRRINLEACTNEMVTFLQGELHVSKLFN-HPNIVPYRATFIA-----D 71 (327)
T ss_pred hhhhccccccceEEEEEEeecccCc----EEEEEEechhhccHHHHHHHHHHHHHHHhcC-CCCeeeEEEEEEE-----C
Confidence 57889999 789999999998876 466666543 23456778999999998 8999999987753 2
Q ss_pred eEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEeecCC
Q 039291 83 MAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGV 162 (362)
Q Consensus 83 ~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Dfgl 162 (362)
..+++||||+++++|.+++.......+++..++.++.|++.||+|||++||+||||||+|||+ +.++.++++||+.
T Consensus 72 ~~~~lv~e~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~----~~~~~~~l~~~~~ 147 (327)
T cd08227 72 NELWVVTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILI----SVDGKVYLSGLRS 147 (327)
T ss_pred CEEEEEEeccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEE----ecCCcEEEcccch
Confidence 347799999999999999976545569999999999999999999999999999999999999 6677899999986
Q ss_pred ccccccccc-----CCCCCCccCCCCccCchhhcc--ccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHHcC
Q 039291 163 AKRSRHCKR-----QKFDPSMRGTPLYLAPETVVQ--HMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGD 235 (362)
Q Consensus 163 a~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~ 235 (362)
......... ........++..|+|||++.+ ..++.++|||||||++|+|++|+.||...... ......+..
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~--~~~~~~~~~ 225 (327)
T cd08227 148 NLSMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPAT--QMLLEKLNG 225 (327)
T ss_pred hhccccccccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchh--HHHHHHhcC
Confidence 543221111 011123457788999999976 45889999999999999999999999643221 111111110
Q ss_pred CC-------------------------------------------CCCCCCccCCHHHHHHHHHHhccCCCCCCCHHHHh
Q 039291 236 EH-------------------------------------------SLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLL 272 (362)
Q Consensus 236 ~~-------------------------------------------~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l 272 (362)
.. ........+++++.+||++||+.||++|||+++++
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell 305 (327)
T cd08227 226 TVPCLLDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLL 305 (327)
T ss_pred CccccccccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHh
Confidence 00 00011223577899999999999999999999999
Q ss_pred cCCCccCcchh
Q 039291 273 DDPFVKGVDEE 283 (362)
Q Consensus 273 ~~p~~~~~~~~ 283 (362)
+||||++....
T Consensus 306 ~~p~f~~~~~~ 316 (327)
T cd08227 306 NHSFFKQIKRR 316 (327)
T ss_pred cChhhhhcchh
Confidence 99999876544
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-43 Score=312.96 Aligned_cols=251 Identities=36% Similarity=0.626 Sum_probs=203.7
Q ss_pred ceeecceecccCceEEEEEEECCCCCCCCceeeeechhh------------hhhHHHHHHHHHHHHcCCCCcccccccce
Q 039291 7 SWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEV------------SASASLQKEKEVFDNLNGCPFVLECFGEE 74 (362)
Q Consensus 7 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~------------~~~~~~~~E~~il~~l~~h~~i~~~~~~~ 74 (362)
+|.+++.||+|++|.||+|.+..++. .+++|.... ...+.+.+|+.++++++ ||||+++++.+
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~----~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~ 75 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGE----LMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQ-HENIVQYLGSS 75 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCc----EEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcC-CCCeeeEEEEE
Confidence 68999999999999999999877664 445553321 12246788999999998 89999999876
Q ss_pred eeecCCCceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceE
Q 039291 75 ITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFV 154 (362)
Q Consensus 75 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~ 154 (362)
.. ...++++|||+++++|.+++.. .+.+++..+..++.|++.||+|||++|++||||+|+||++ +.++.
T Consensus 76 ~~-----~~~~~lv~e~~~~~~L~~~l~~--~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~----~~~~~ 144 (267)
T cd06628 76 LD-----ADHLNIFLEYVPGGSVAALLNN--YGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILV----DNKGG 144 (267)
T ss_pred Ee-----CCccEEEEEecCCCCHHHHHHh--ccCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEE----cCCCC
Confidence 43 2346799999999999999976 3458999999999999999999999999999999999999 77788
Q ss_pred EEEeecCCccccccccc----CCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHH
Q 039291 155 AKIADLGVAKRSRHCKR----QKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLF 230 (362)
Q Consensus 155 ~kl~Dfgla~~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~ 230 (362)
++|+|||+++....... ........|+..|+|||.+.+..++.++|+|||||++|+|++|+.||.... .....
T Consensus 145 ~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~---~~~~~ 221 (267)
T cd06628 145 IKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCT---QLQAI 221 (267)
T ss_pred EEecccCCCcccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCcc---HHHHH
Confidence 99999999876542111 111124568899999999998888999999999999999999999996432 22222
Q ss_pred HHHcCCCCCCCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCc
Q 039291 231 SIIGDEHSLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFV 277 (362)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~ 277 (362)
..+.. ...+.++..++.++.++|++||+.||.+||++.++++||||
T Consensus 222 ~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~ 267 (267)
T cd06628 222 FKIGE-NASPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLKHPFL 267 (267)
T ss_pred HHHhc-cCCCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhhCCCC
Confidence 22222 33455677889999999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-43 Score=317.24 Aligned_cols=257 Identities=27% Similarity=0.464 Sum_probs=205.2
Q ss_pred CceeecceecccCceEEEEEEECCCCCCCCceeeeechh----hhhhHHHHHHHHHHHHcCCCCcccccccceeeecCCC
Q 039291 6 TSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAE----VSASASLQKEKEVFDNLNGCPFVLECFGEEITMGENG 81 (362)
Q Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~----~~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~~ 81 (362)
++|.+.+.||+|+||.||+|++..++. .+++|... ......+.+|+.++++++ ||||+++++.+..
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~----~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~----- 70 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGV----TMAMKEIRLELDESKFNQIIMELDILHKAV-SPYIVDFYGAFFI----- 70 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCc----EEEEEEeecccCHHHHHHHHHHHHHHHhcC-CCcHHhhhhheec-----
Confidence 478999999999999999999987775 34555432 233456889999999997 8999999997643
Q ss_pred ceEEEEEEEecCCCCHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHh-CCceeCCCCCCCEEEeecCCCceEEEEee
Q 039291 82 EMAYNLLLEYAAGGTLGDLIEKCN-GNGLPEKDVRHFTRCILEGIGHIHD-SGYVHCDVKPDNILLVATQSGKFVAKIAD 159 (362)
Q Consensus 82 ~~~~~lv~e~~~~~~L~~~l~~~~-~~~l~~~~~~~i~~ql~~~l~yLH~-~~ivH~Dlkp~Nill~~~~~~~~~~kl~D 159 (362)
...+++||||+++++|..++.... ...+++..+..++.|++.||.|||+ .||+|+||||+||++ +.++.++|+|
T Consensus 71 ~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~----~~~~~~~l~d 146 (286)
T cd06622 71 EGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLV----NGNGQVKLCD 146 (286)
T ss_pred CCeEEEEEeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEE----CCCCCEEEee
Confidence 335779999999999999887621 2359999999999999999999997 599999999999999 6678899999
Q ss_pred cCCcccccccccCCCCCCccCCCCccCchhhccc------cCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHH
Q 039291 160 LGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQH------MQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSII 233 (362)
Q Consensus 160 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~ 233 (362)
||++...... ......++..|+|||++.+. .++.++|+|||||++|+|++|..||..............+
T Consensus 147 fg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~ 222 (286)
T cd06622 147 FGVSGNLVAS----LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAI 222 (286)
T ss_pred cCCcccccCC----ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHH
Confidence 9998654321 11234688899999998643 3478999999999999999999999654332322222333
Q ss_pred cCCCCCCCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCccCcc
Q 039291 234 GDEHSLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGVD 281 (362)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~~~~~ 281 (362)
.. ...+.++..++.+++++|.+||..+|++||++++++.||||....
T Consensus 223 ~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~~~~~~ 269 (286)
T cd06622 223 VD-GDPPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKYK 269 (286)
T ss_pred hh-cCCCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcChhhhhcc
Confidence 22 233456677999999999999999999999999999999997654
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-43 Score=315.62 Aligned_cols=255 Identities=27% Similarity=0.470 Sum_probs=209.4
Q ss_pred CceeecceecccCceEEEEEEECCCCCCCCceeeeechhh----hhhHHHHHHHHHHHHcCCCCcccccccceeeecCCC
Q 039291 6 TSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEV----SASASLQKEKEVFDNLNGCPFVLECFGEEITMGENG 81 (362)
Q Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~----~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~~ 81 (362)
++|.+.+.||.|++|.||+|++..++. .+++|.... .....+.+|+.+++.++ |+||+++++.+..
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~----~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~----- 70 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQ----VVAIKVIDLEEAEDEIEDIQQEIQFLSQCR-SPYITKYYGSFLK----- 70 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCe----EEEEEEeeccccchHHHHHHHHHHHHHHcC-CCCeeeeeEEEEE-----
Confidence 579999999999999999999988775 456665432 23456789999999999 9999999886542
Q ss_pred ceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEeecC
Q 039291 82 EMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLG 161 (362)
Q Consensus 82 ~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Dfg 161 (362)
...+++|+||+++++|.+++... ++++..++.++.|++.||.|||+++++|+||+|+||++ +.++.++|+|||
T Consensus 71 ~~~~~~v~e~~~~~~L~~~~~~~---~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i----~~~~~~~l~d~g 143 (274)
T cd06609 71 GSKLWIIMEYCGGGSCLDLLKPG---KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILL----SEEGDVKLADFG 143 (274)
T ss_pred CCeEEEEEEeeCCCcHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEE----CCCCCEEEcccc
Confidence 24578999999999999999762 69999999999999999999999999999999999999 778889999999
Q ss_pred CcccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHHcCCCCCCC
Q 039291 162 VAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEHSLPE 241 (362)
Q Consensus 162 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 241 (362)
+++....... ......|+..|+|||++.+..++.++|||||||++|+|++|..||...+ .......+... ..+.
T Consensus 144 ~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~---~~~~~~~~~~~-~~~~ 217 (274)
T cd06609 144 VSGQLTSTMS--KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLH---PMRVLFLIPKN-NPPS 217 (274)
T ss_pred cceeeccccc--ccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCc---hHHHHHHhhhc-CCCC
Confidence 9976654321 2234568899999999998889999999999999999999999996443 23333333222 2333
Q ss_pred CCcc-CCHHHHHHHHHHhccCCCCCCCHHHHhcCCCccCcchh
Q 039291 242 IPSR-VSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGVDEE 283 (362)
Q Consensus 242 ~~~~-~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~~~~~~~ 283 (362)
.+.. ++.++.+++.+||..+|++||++++++.||||+.....
T Consensus 218 ~~~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~~~~~~~~~~ 260 (274)
T cd06609 218 LEGNKFSKPFKDFVSLCLNKDPKERPSAKELLKHKFIKKAKKT 260 (274)
T ss_pred CcccccCHHHHHHHHHHhhCChhhCcCHHHHhhChhhcCCCcc
Confidence 4444 88999999999999999999999999999999876544
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-45 Score=329.13 Aligned_cols=270 Identities=26% Similarity=0.373 Sum_probs=219.5
Q ss_pred cceecccCceEEEEEEECCCCCCCCceeeeech-hhhhhHHHHHHHHHHHHcCCCCcccccccceeeecCCCceEEEEEE
Q 039291 11 GRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSA-EVSASASLQKEKEVFDNLNGCPFVLECFGEEITMGENGEMAYNLLL 89 (362)
Q Consensus 11 ~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~-~~~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~~~~~~~lv~ 89 (362)
.+.||+|.||+||-|+++.+|+.++.++.-|.. ..+....++.|+.||.++. ||.||.+-.++. .....++||
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~-HPGiV~le~M~E-----T~ervFVVM 642 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLH-HPGIVNLECMFE-----TPERVFVVM 642 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcC-CCCeeEEEEeec-----CCceEEEEe
Confidence 488999999999999999999877666666653 3345677899999999999 999998876653 344577999
Q ss_pred EecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEeecCCccccccc
Q 039291 90 EYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHC 169 (362)
Q Consensus 90 e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Dfgla~~~~~~ 169 (362)
|.+.| ++.+.|-....+++++....+++.||+.||.|||.++|+|+||||+|||+... +....+||||||+|+..+.
T Consensus 643 EKl~G-DMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~-~~FPQvKlCDFGfARiIgE- 719 (888)
T KOG4236|consen 643 EKLHG-DMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASA-SPFPQVKLCDFGFARIIGE- 719 (888)
T ss_pred hhhcc-hHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccC-CCCCceeeccccceeecch-
Confidence 99976 66555544566789999999999999999999999999999999999999654 5667899999999998874
Q ss_pred ccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHHcCCCCCCCCCccCCHH
Q 039291 170 KRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEHSLPEIPSRVSKE 249 (362)
Q Consensus 170 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 249 (362)
..+..+.+||+.|+|||++.++.|+..-|+||+|||+|.-+.|..||. ++.++.+.++...-. ..|.-+..++.+
T Consensus 720 --ksFRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFN--EdEdIndQIQNAaFM-yPp~PW~eis~~ 794 (888)
T KOG4236|consen 720 --KSFRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFN--EDEDINDQIQNAAFM-YPPNPWSEISPE 794 (888)
T ss_pred --hhhhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCC--CccchhHHhhccccc-cCCCchhhcCHH
Confidence 445568999999999999999999999999999999999999999995 333444443332111 223345679999
Q ss_pred HHHHHHHHhccCCCCCCCHHHHhcCCCccCcchhh-hhhhhCCCCC
Q 039291 250 ARDFLRRCFVRKPAFRFTAEMLLDDPFVKGVDEEL-SRELEGDYSQ 294 (362)
Q Consensus 250 ~~~li~~~l~~~p~~R~s~~~~l~~p~~~~~~~~~-~~~~~~~~~~ 294 (362)
+.+||..+|++.-.+|.+.+..++|||+++..-.+ .++++....+
T Consensus 795 AidlIn~LLqVkm~kRysvdk~lsh~Wlq~yq~w~DLRelE~~ige 840 (888)
T KOG4236|consen 795 AIDLINNLLQVKMRKRYSVDKSLSHPWLQDYQTWLDLRELEVRIGE 840 (888)
T ss_pred HHHHHHHHHHHHHHHhcchHhhccchhhhcchHHHHHHHHHHhhCc
Confidence 99999999999999999999999999999865333 3556554443
|
|
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-43 Score=317.02 Aligned_cols=257 Identities=27% Similarity=0.433 Sum_probs=206.3
Q ss_pred CceeecceecccCceEEEEEEECCCCCCCCceeeeechh---hhhhHHHHHHHHHHHHcCCCCcccccccceeeecCCCc
Q 039291 6 TSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAE---VSASASLQKEKEVFDNLNGCPFVLECFGEEITMGENGE 82 (362)
Q Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~---~~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~~~ 82 (362)
++|.+.+.||.|+||.||+|+++.++. .+++|... ......+.+|+.++++++ ||||+++++.+.. .
T Consensus 5 ~~~~i~~~l~~g~~~~v~~~~~~~~~~----~~~iK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~-----~ 74 (280)
T cd06611 5 DIWEIIGELGDGAFGKVYKAQHKETGL----FAAAKIIQIESEEELEDFMVEIDILSECK-HPNIVGLYEAYFY-----E 74 (280)
T ss_pred hHHHHHHHhcCCCCceEEEEEEcCCCc----EEEEEEEeeCCHHHHHHHHHHHHHHHhCC-CCceeEEEEEEec-----C
Confidence 679999999999999999999987665 45555543 234456788999999999 9999999997643 3
Q ss_pred eEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEeecCC
Q 039291 83 MAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGV 162 (362)
Q Consensus 83 ~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Dfgl 162 (362)
..+++||||+++++|.+++... ...+++..++.++.|++.||.|||++||+|+||||+||++ +.++.++|+|||+
T Consensus 75 ~~~~lv~e~~~~~~L~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili----~~~~~~~l~d~g~ 149 (280)
T cd06611 75 NKLWILIEFCDGGALDSIMLEL-ERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILL----TLDGDVKLADFGV 149 (280)
T ss_pred CeEEEEeeccCCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEE----CCCCCEEEccCcc
Confidence 3578999999999999998763 3469999999999999999999999999999999999999 7778899999999
Q ss_pred cccccccccCCCCCCccCCCCccCchhhcc-----ccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHHcCC-
Q 039291 163 AKRSRHCKRQKFDPSMRGTPLYLAPETVVQ-----HMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDE- 236 (362)
Q Consensus 163 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~- 236 (362)
+........ ......|+..|+|||++.. ..++.++|+|||||++|+|++|.+||... +.......+...
T Consensus 150 ~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~---~~~~~~~~~~~~~ 224 (280)
T cd06611 150 SAKNKSTLQ--KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHEL---NPMRVLLKILKSE 224 (280)
T ss_pred chhhccccc--ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccC---CHHHHHHHHhcCC
Confidence 865443211 1234568999999999853 34677899999999999999999999543 233333333222
Q ss_pred CCCCCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCccCcch
Q 039291 237 HSLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGVDE 282 (362)
Q Consensus 237 ~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~~~~~~ 282 (362)
......+..++.++.++|.+||..+|.+||++++++.||||....+
T Consensus 225 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~ 270 (280)
T cd06611 225 PPTLDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKHPFVSDQSD 270 (280)
T ss_pred CCCcCCcccCCHHHHHHHHHHhccChhhCcCHHHHhcChhhcccch
Confidence 2222335568899999999999999999999999999999987643
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-43 Score=317.83 Aligned_cols=256 Identities=26% Similarity=0.426 Sum_probs=206.3
Q ss_pred CCCceeecceecccCceEEEEEEECCCCCCCCceeeeechhh---hhhHHHHHHHHHHHHcCCCCcccccccceeeecCC
Q 039291 4 DGTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEV---SASASLQKEKEVFDNLNGCPFVLECFGEEITMGEN 80 (362)
Q Consensus 4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~---~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~ 80 (362)
...+|.+.+.||+|+||.||+|++..++. .+++|.... .....+.+|+.+++.+. |+||+++++.+..
T Consensus 18 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~----~v~ik~~~~~~~~~~~~~~~e~~~l~~~~-h~~v~~~~~~~~~---- 88 (296)
T cd06654 18 PKKKYTRFEKIGQGASGTVYTAMDVATGQ----EVAIRQMNLQQQPKKELIINEILVMRENK-NPNIVNYLDSYLV---- 88 (296)
T ss_pred cccceeeEEEecCCCCeEEEEEEECCCCc----EEEEEEEecCCcchHHHHHHHHHHHHhCC-CCCEeeEEEEEEe----
Confidence 34689999999999999999999887775 445554432 23456788999999987 9999999986643
Q ss_pred CceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEeec
Q 039291 81 GEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADL 160 (362)
Q Consensus 81 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Df 160 (362)
...+++||||++|++|.+++.. ..+++.++..++.|++.||.|||+.||+||||||+||++ +.++.++|+||
T Consensus 89 -~~~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill----~~~~~~kl~df 160 (296)
T cd06654 89 -GDELWVVMEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILL----GMDGSVKLTDF 160 (296)
T ss_pred -CCEEEEeecccCCCCHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE----cCCCCEEECcc
Confidence 2357899999999999999864 348999999999999999999999999999999999999 67778999999
Q ss_pred CCcccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHHcCCCCCC
Q 039291 161 GVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEHSLP 240 (362)
Q Consensus 161 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 240 (362)
|++........ ......|++.|+|||.+.+..++.++|+|||||++|+|++|+.||..... ...............
T Consensus 161 g~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~--~~~~~~~~~~~~~~~ 236 (296)
T cd06654 161 GFCAQITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP--LRALYLIATNGTPEL 236 (296)
T ss_pred ccchhcccccc--ccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCH--HHhHHHHhcCCCCCC
Confidence 99875443221 11345689999999999888889999999999999999999999965432 222222222222222
Q ss_pred CCCccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCccCc
Q 039291 241 EIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGV 280 (362)
Q Consensus 241 ~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~~~~ 280 (362)
..+..++..+.+++.+||..+|++||++.+++.||||...
T Consensus 237 ~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~~~~~~~ 276 (296)
T cd06654 237 QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIA 276 (296)
T ss_pred CCccccCHHHHHHHHHHCcCCcccCcCHHHHhhChhhhcc
Confidence 3456688999999999999999999999999999999754
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-43 Score=313.64 Aligned_cols=255 Identities=18% Similarity=0.293 Sum_probs=202.4
Q ss_pred CCCCCceeecceecccCceEEEEEEECCCCCCCCceeeeechhhh----hhHHHHHHHHHHHHcCCCCcccccccceeee
Q 039291 2 DSDGTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVS----ASASLQKEKEVFDNLNGCPFVLECFGEEITM 77 (362)
Q Consensus 2 ~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~~----~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~ 77 (362)
+.+.++|.+.+.||+|+||.||+|.++..+. ....+++|..... ....+.+|+.++++++ ||||+++++.+..
T Consensus 1 ~i~~~~~~~~~~ig~G~fg~V~~~~~~~~~~-~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~- 77 (266)
T cd05064 1 ELDNKSIKIERILGTGRFGELCRGCLKLPSK-RELPVAIHTLRAGCSDKQRRGFLAEALTLGQFD-HSNIVRLEGVITR- 77 (266)
T ss_pred CCchHHeEEeeeecccCCCeEEEEEEecCCC-ceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCC-CCCcCeEEEEEec-
Confidence 3567899999999999999999998764321 2246777765432 3346788999999997 9999999986642
Q ss_pred cCCCceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEE
Q 039291 78 GENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKI 157 (362)
Q Consensus 78 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl 157 (362)
...+++||||+++|+|.+++... ...+++..++.++.|++.||+|||++|++||||||+||++ +.++.+++
T Consensus 78 ----~~~~~lv~e~~~~~~L~~~l~~~-~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili----~~~~~~~l 148 (266)
T cd05064 78 ----GNTMMIVTEYMSNGALDSFLRKH-EGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLV----NSDLVCKI 148 (266)
T ss_pred ----CCCcEEEEEeCCCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEE----cCCCcEEE
Confidence 23467999999999999999763 3468999999999999999999999999999999999999 77788999
Q ss_pred eecCCcccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHh-CCCCCccCCCCCHHHHHHHHcCC
Q 039291 158 ADLGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLS-GRQAWVVKEDCSIDQLFSIIGDE 236 (362)
Q Consensus 158 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~ 236 (362)
+|||.+....... ........++..|+|||++.+..++.++|||||||++|++++ |..||... ........+...
T Consensus 149 ~dfg~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~---~~~~~~~~~~~~ 224 (266)
T cd05064 149 SGFRRLQEDKSEA-IYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDM---SGQDVIKAVEDG 224 (266)
T ss_pred CCCcccccccccc-hhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcC---CHHHHHHHHHCC
Confidence 9999876432211 111123345678999999998899999999999999999775 99999544 334444444444
Q ss_pred CCCCCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhc
Q 039291 237 HSLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLD 273 (362)
Q Consensus 237 ~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~ 273 (362)
... ..+..++..+.+++.+||..+|++||+++++++
T Consensus 225 ~~~-~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~ 260 (266)
T cd05064 225 FRL-PAPRNCPNLLHQLMLDCWQKERGERPRFSQIHS 260 (266)
T ss_pred CCC-CCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHH
Confidence 333 356778999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-43 Score=316.15 Aligned_cols=255 Identities=27% Similarity=0.434 Sum_probs=202.5
Q ss_pred ceeecceecccCceEEEEEEECCCCCCCCceeeeechh---hhhhHHHHHHHHHHHHcCCCCcccccccceeeecCCCce
Q 039291 7 SWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAE---VSASASLQKEKEVFDNLNGCPFVLECFGEEITMGENGEM 83 (362)
Q Consensus 7 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~---~~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~~~~ 83 (362)
-|++.+.||+|+||.||+|.+..++. .+++|... ......+.+|+.+++.++ |||++++++.+.. ..
T Consensus 6 ~~~i~~~lg~g~~g~v~~~~~~~~~~----~~~~k~~~~~~~~~~~~~~~e~~~l~~l~-h~~ii~~~~~~~~-----~~ 75 (282)
T cd06643 6 FWEIIGELGDGAFGKVYKAQNKETGV----LAAAKVIDTKSEEELEDYMVEIDILASCD-HPNIVKLLDAFYY-----EN 75 (282)
T ss_pred HHHHHhhcccCCCeEEEEEEECCCCe----EEEEEEeCCCCHHHHHHHHHHHHHHHHCC-CCCeeeEEEEEee-----CC
Confidence 47888999999999999999988765 34555432 234456788999999998 9999999987643 23
Q ss_pred EEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEeecCCc
Q 039291 84 AYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVA 163 (362)
Q Consensus 84 ~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Dfgla 163 (362)
.+++||||+++++|..++.. ...++++..+..++.|++.||.|||+.|++||||||+||++ +.++.++|+|||++
T Consensus 76 ~~~~v~e~~~~~~l~~~~~~-~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili----~~~~~~kl~dfg~~ 150 (282)
T cd06643 76 NLWILIEFCAGGAVDAVMLE-LERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILF----TLDGDIKLADFGVS 150 (282)
T ss_pred EEEEEEEecCCCcHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEE----ccCCCEEEcccccc
Confidence 57799999999999988765 23569999999999999999999999999999999999999 67778999999998
Q ss_pred ccccccccCCCCCCccCCCCccCchhhc-----cccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHHcCCCC
Q 039291 164 KRSRHCKRQKFDPSMRGTPLYLAPETVV-----QHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEHS 238 (362)
Q Consensus 164 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 238 (362)
....... .......|+..|+|||++. +..++.++|+|||||++|+|++|.+||.... ..............
T Consensus 151 ~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~--~~~~~~~~~~~~~~ 226 (282)
T cd06643 151 AKNTRTI--QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELN--PMRVLLKIAKSEPP 226 (282)
T ss_pred ccccccc--cccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccC--HHHHHHHHhhcCCC
Confidence 6543321 1123456899999999984 3456789999999999999999999995432 22222222222222
Q ss_pred CCCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCccCc
Q 039291 239 LPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGV 280 (362)
Q Consensus 239 ~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~~~~ 280 (362)
....+..++.+++++|.+||..||++||++++++.||||...
T Consensus 227 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 268 (282)
T cd06643 227 TLAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHPFVTVN 268 (282)
T ss_pred CCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCCCEecc
Confidence 223456688999999999999999999999999999999764
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=310.41 Aligned_cols=255 Identities=31% Similarity=0.535 Sum_probs=204.5
Q ss_pred CceeecceecccCceEEEEEEECCCCCCCCceeeeechh--------hhhhHHHHHHHHHHHHcCCCCcccccccceeee
Q 039291 6 TSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAE--------VSASASLQKEKEVFDNLNGCPFVLECFGEEITM 77 (362)
Q Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~--------~~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~ 77 (362)
..|.+++.||+|+||.||+|.+..++. .+++|... ......+.+|+.+++++. ||||+++++.+..
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~----~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~- 75 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGR----ELAVKQVQFDPESPETSKEVNALECEIQLLKNLL-HERIVQYYGCLRD- 75 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCc----EEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcC-CCCeeeEEeEecc-
Confidence 579999999999999999999988775 45555432 123456788999999998 9999999886432
Q ss_pred cCCCceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEE
Q 039291 78 GENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKI 157 (362)
Q Consensus 78 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl 157 (362)
.....++++|||+++++|.+++... ..+++..+..++.|++.||.|||+++++|+||||+||++ +.++.++|
T Consensus 76 --~~~~~~~~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~----~~~~~~~l 147 (265)
T cd06652 76 --PMERTLSIFMEHMPGGSIKDQLKSY--GALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILR----DSVGNVKL 147 (265)
T ss_pred --CCCceEEEEEEecCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEe----cCCCCEEE
Confidence 2234577999999999999999763 458999999999999999999999999999999999999 77778999
Q ss_pred eecCCcccccccccC-CCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHHcCC
Q 039291 158 ADLGVAKRSRHCKRQ-KFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDE 236 (362)
Q Consensus 158 ~Dfgla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 236 (362)
+|||++......... .......|+..|+|||++.+..++.++|+|||||++|+|++|+.||.... ..... ......
T Consensus 148 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~--~~~~~-~~~~~~ 224 (265)
T cd06652 148 GDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFE--AMAAI-FKIATQ 224 (265)
T ss_pred CcCccccccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccc--hHHHH-HHHhcC
Confidence 999998754321111 11124568999999999988888999999999999999999999996432 22222 333333
Q ss_pred CCCCCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCcc
Q 039291 237 HSLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVK 278 (362)
Q Consensus 237 ~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~~ 278 (362)
...+..+...+..+.++|++||. +|++||++++++.|||+.
T Consensus 225 ~~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~~~~~ 265 (265)
T cd06652 225 PTNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRHTFVH 265 (265)
T ss_pred CCCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcCcccC
Confidence 44456677788999999999995 999999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-43 Score=319.96 Aligned_cols=261 Identities=19% Similarity=0.268 Sum_probs=197.4
Q ss_pred CCCCceeecceecccCceEEEEEEECCCCCC------------CCceeeeechhh----hhhHHHHHHHHHHHHcCCCCc
Q 039291 3 SDGTSWFRGRVIGQGSFGCVFIAKPKSNSSF------------LPPLMAVKSAEV----SASASLQKEKEVFDNLNGCPF 66 (362)
Q Consensus 3 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~------------~~~~~~~K~~~~----~~~~~~~~E~~il~~l~~h~~ 66 (362)
...++|.+.+.||+|+||.||+|.+...... ....+++|.... .....+.+|+.++.+++ |||
T Consensus 2 ~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~-h~n 80 (304)
T cd05096 2 FPRGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLK-DPN 80 (304)
T ss_pred CchhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcC-CCC
Confidence 3467999999999999999999987543211 113577776543 23456889999999998 899
Q ss_pred ccccccceeeecCCCceEEEEEEEecCCCCHHHHHHHhcC-----------------CCCCHHHHHHHHHHHHHHHHHHH
Q 039291 67 VLECFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNG-----------------NGLPEKDVRHFTRCILEGIGHIH 129 (362)
Q Consensus 67 i~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-----------------~~l~~~~~~~i~~ql~~~l~yLH 129 (362)
|+++++.+... ..+++||||+.+++|.+++..... ..+++..+..++.||+.||.|||
T Consensus 81 iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH 155 (304)
T cd05096 81 IIRLLGVCVDE-----DPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLS 155 (304)
T ss_pred eeEEEEEEecC-----CceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHH
Confidence 99999876532 236899999999999999865321 23678889999999999999999
Q ss_pred hCCceeCCCCCCCEEEeecCCCceEEEEeecCCcccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHH
Q 039291 130 DSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVL 209 (362)
Q Consensus 130 ~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ 209 (362)
+.||+||||||+|||+ +.++.+||+|||+++...............++..|+|||++.+..++.++|||||||++|
T Consensus 156 ~~~ivH~dlkp~Nill----~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~ 231 (304)
T cd05096 156 SLNFVHRDLATRNCLV----GENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLW 231 (304)
T ss_pred HCCccccCcchhheEE----cCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHH
Confidence 9999999999999999 777889999999987554322222223345678899999999888999999999999999
Q ss_pred HHHh--CCCCCccCCCCCHHHHHHH-HcC--CCCCCCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhc
Q 039291 210 EMLS--GRQAWVVKEDCSIDQLFSI-IGD--EHSLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLD 273 (362)
Q Consensus 210 ~l~~--g~~pf~~~~~~~~~~~~~~-~~~--~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~ 273 (362)
+|++ +..||.............. ... .......+..++..+.+|+.+||..||++|||+.++..
T Consensus 232 el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~ 300 (304)
T cd05096 232 EILMLCKEQPYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHA 300 (304)
T ss_pred HHHHccCCCCCCcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHH
Confidence 9987 5567754332221111111 111 11122334568899999999999999999999999853
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-43 Score=314.15 Aligned_cols=255 Identities=26% Similarity=0.491 Sum_probs=208.1
Q ss_pred CceeecceecccCceEEEEEEECCCCCCCCceeeeechh----hhhhHHHHHHHHHHHHcCCCCcccccccceeeecCCC
Q 039291 6 TSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAE----VSASASLQKEKEVFDNLNGCPFVLECFGEEITMGENG 81 (362)
Q Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~----~~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~~ 81 (362)
++|...+.||+|+||.||+|.++.+++. +++|... ......+.+|+++++++. ||||+++++.+..
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~----~~ik~~~~~~~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~----- 70 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKI----MAVKTIRLEINEAIQKQILRELDILHKCN-SPYIVGFYGAFYN----- 70 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcE----EEEEEEecccChHHHHHHHHHHHHHHHCC-CCchhhhheeeec-----
Confidence 4688899999999999999999887764 4555432 334566889999999999 9999999987643
Q ss_pred ceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCceeCCCCCCCEEEeecCCCceEEEEeec
Q 039291 82 EMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHD-SGYVHCDVKPDNILLVATQSGKFVAKIADL 160 (362)
Q Consensus 82 ~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~-~~ivH~Dlkp~Nill~~~~~~~~~~kl~Df 160 (362)
...+++++||+.+++|.+++.... ..+++..+..++.|++.||.|||+ .|++|+||||+||++ +.++.++|+||
T Consensus 71 ~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~----~~~~~~~l~d~ 145 (265)
T cd06605 71 NGDISICMEYMDGGSLDKILKEVQ-GRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILV----NSRGQIKLCDF 145 (265)
T ss_pred CCEEEEEEEecCCCcHHHHHHHcc-CCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEE----CCCCCEEEeec
Confidence 245789999999999999998743 569999999999999999999999 999999999999999 77788999999
Q ss_pred CCcccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHhCCCCCccCC--CCCHHHHHHHHcCCCC
Q 039291 161 GVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKE--DCSIDQLFSIIGDEHS 238 (362)
Q Consensus 161 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~--~~~~~~~~~~~~~~~~ 238 (362)
|.+......... ...++..|+|||.+.+..++.++|+||||+++++|++|..||.... ..........+....
T Consensus 146 g~~~~~~~~~~~----~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~- 220 (265)
T cd06605 146 GVSGQLVNSLAK----TFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEP- 220 (265)
T ss_pred ccchhhHHHHhh----cccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCC-
Confidence 998755432111 2668899999999998899999999999999999999999996442 122333444333332
Q ss_pred CCCCCcc-CCHHHHHHHHHHhccCCCCCCCHHHHhcCCCccCc
Q 039291 239 LPEIPSR-VSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGV 280 (362)
Q Consensus 239 ~~~~~~~-~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~~~~ 280 (362)
.+..+.. ++.+++++|.+||..+|++|||+.+++.||||+..
T Consensus 221 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~~~~ 263 (265)
T cd06605 221 PPRLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLEHPFIKKY 263 (265)
T ss_pred CCCCChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhCchhhcc
Confidence 2334444 88999999999999999999999999999999765
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-43 Score=314.73 Aligned_cols=253 Identities=26% Similarity=0.376 Sum_probs=198.5
Q ss_pred CCCceeecceecccCceEEEEEEECCCCCCCCceeeeechhh---hhhHHHHHHHHHHHHcCCCCcccccccceeeecCC
Q 039291 4 DGTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEV---SASASLQKEKEVFDNLNGCPFVLECFGEEITMGEN 80 (362)
Q Consensus 4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~---~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~ 80 (362)
..++|.+++.||+|+||.||+|+++.++. .+++|.... .....+.+|+.++++++ ||||+++++.+..
T Consensus 7 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~----~~aik~~~~~~~~~~~~~~~e~~~l~~~~-h~~ii~~~~~~~~---- 77 (267)
T cd06646 7 PQHDYELIQRVGSGTYGDVYKARNLHTGE----LAAVKIIKLEPGDDFSLIQQEIFMVKECK-HCNIVAYFGSYLS---- 77 (267)
T ss_pred chhhcchhheeecCCCeEEEEEEECCCCe----EEEEEEEecCccchHHHHHHHHHHHHhcC-CCCeeeeeEEEEe----
Confidence 45679999999999999999999988775 445554432 23445778999999998 8999999987643
Q ss_pred CceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEeec
Q 039291 81 GEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADL 160 (362)
Q Consensus 81 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Df 160 (362)
...+++||||+++++|.+++.. ..++++..+..++.|++.||.|||+.||+||||||+||++ +.++.++|+||
T Consensus 78 -~~~~~iv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill----~~~~~~~l~df 150 (267)
T cd06646 78 -REKLWICMEYCGGGSLQDIYHV--TGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILL----TDNGDVKLADF 150 (267)
T ss_pred -CCEEEEEEeCCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEE----CCCCCEEECcC
Confidence 2346799999999999999875 3469999999999999999999999999999999999999 77778999999
Q ss_pred CCcccccccccCCCCCCccCCCCccCchhhc---cccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHHcCCC
Q 039291 161 GVAKRSRHCKRQKFDPSMRGTPLYLAPETVV---QHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEH 237 (362)
Q Consensus 161 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 237 (362)
|++........ ......|+..|+|||.+. ...++.++|+||+||++|+|++|..||...... ...........
T Consensus 151 g~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~--~~~~~~~~~~~ 226 (267)
T cd06646 151 GVAAKITATIA--KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPM--RALFLMSKSNF 226 (267)
T ss_pred ccceeeccccc--ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchh--hhheeeecCCC
Confidence 99875543211 113456899999999885 334678999999999999999999998543211 11111111111
Q ss_pred CCCC--CCccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCC
Q 039291 238 SLPE--IPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPF 276 (362)
Q Consensus 238 ~~~~--~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~ 276 (362)
..+. ....++..+.++|++||..+|++||+++++++|+|
T Consensus 227 ~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l~ 267 (267)
T cd06646 227 QPPKLKDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHLF 267 (267)
T ss_pred CCCCCccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCCC
Confidence 1111 12346889999999999999999999999999987
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-43 Score=316.98 Aligned_cols=262 Identities=23% Similarity=0.401 Sum_probs=208.4
Q ss_pred CCCCCceeecceecccCceEEEEEEECCCCCCCCceeeeechhhhhhHHHHHHHHHHHHcCCCCcccccccceeeecCCC
Q 039291 2 DSDGTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVSASASLQKEKEVFDNLNGCPFVLECFGEEITMGENG 81 (362)
Q Consensus 2 ~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~~ 81 (362)
|...++|++.+.||+|+||+||+|.+..++..++.++..+.........+.+|+++++.++ ||||+++++.+..
T Consensus 1 ~l~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~----- 74 (284)
T cd06620 1 DLRNEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECR-SPYIVSFYGAFLN----- 74 (284)
T ss_pred CccHHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcC-CCCcceEeeeEec-----
Confidence 4567899999999999999999999988776444433333223334567889999999998 9999999987653
Q ss_pred ceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCceeCCCCCCCEEEeecCCCceEEEEeec
Q 039291 82 EMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHD-SGYVHCDVKPDNILLVATQSGKFVAKIADL 160 (362)
Q Consensus 82 ~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~-~~ivH~Dlkp~Nill~~~~~~~~~~kl~Df 160 (362)
...+++||||+++++|.+++.. .+.+++..+..++.|++.||.|||+ .+++||||||+||++ +.++.++|+||
T Consensus 75 ~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~----~~~~~~~l~d~ 148 (284)
T cd06620 75 ENNICMCMEFMDCGSLDRIYKK--GGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILV----NSRGQIKLCDF 148 (284)
T ss_pred CCEEEEEEecCCCCCHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEE----CCCCcEEEccC
Confidence 2357899999999999999876 3469999999999999999999997 699999999999999 77788999999
Q ss_pred CCcccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHhCCCCCccCCCC-----C---HHHHHHH
Q 039291 161 GVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDC-----S---IDQLFSI 232 (362)
Q Consensus 161 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~-----~---~~~~~~~ 232 (362)
|++...... ......|+..|+|||++.+..++.++|+|||||++|+|++|..||...... . .......
T Consensus 149 gl~~~~~~~----~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~ 224 (284)
T cd06620 149 GVSGELINS----IADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQ 224 (284)
T ss_pred Ccccchhhh----ccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHH
Confidence 998644221 112457899999999998888999999999999999999999999754321 1 1122222
Q ss_pred HcCCCCCCCCCc-cCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCccCc
Q 039291 233 IGDEHSLPEIPS-RVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGV 280 (362)
Q Consensus 233 ~~~~~~~~~~~~-~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~~~~ 280 (362)
+.... .+.++. .++.++.+|+.+||..||++||++.++++|+||.+-
T Consensus 225 ~~~~~-~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~~ 272 (284)
T cd06620 225 IVQEP-PPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQA 272 (284)
T ss_pred Hhhcc-CCCCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccc
Confidence 22222 222332 378899999999999999999999999999999653
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-43 Score=326.15 Aligned_cols=265 Identities=23% Similarity=0.331 Sum_probs=203.8
Q ss_pred CCceeecceecccCceEEEEEEECCCCCCCCceeeeechhh----hhhHHHHHHHHHHHHcCCCCcccccccceeeecCC
Q 039291 5 GTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEV----SASASLQKEKEVFDNLNGCPFVLECFGEEITMGEN 80 (362)
Q Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~----~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~ 80 (362)
+++|.+.+.||+|+||.||+|+++.++. .|++|.... .....+.+|+.++++++ |+||+++++........
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~----~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~ 78 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGV----KVAIKKISPFEHQTFCQRTLREIKILRRFK-HENIIGILDIIRPPSFE 78 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCC----eEEEEEecccccchhHHHHHHHHHHHHhCC-CCCcCchhheeeccccc
Confidence 4789999999999999999999988875 456665432 23455778999999999 99999999876544333
Q ss_pred CceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEeec
Q 039291 81 GEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADL 160 (362)
Q Consensus 81 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Df 160 (362)
.....++++||+.+ +|.+++.. ..+++..++.++.|++.||.|||++||+||||||+||++ +.++.++|+||
T Consensus 79 ~~~~~~lv~e~~~~-~l~~~~~~---~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill----~~~~~~kl~df 150 (336)
T cd07849 79 SFNDVYIVQELMET-DLYKLIKT---QHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLL----NTNCDLKICDF 150 (336)
T ss_pred ccceEEEEehhccc-CHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEE----CCCCCEEECcc
Confidence 34457899999965 88877754 459999999999999999999999999999999999999 77888999999
Q ss_pred CCcccccccccC-CCCCCccCCCCccCchhhcc-ccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHHcC---
Q 039291 161 GVAKRSRHCKRQ-KFDPSMRGTPLYLAPETVVQ-HMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGD--- 235 (362)
Q Consensus 161 gla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~--- 235 (362)
|++......... .......||..|+|||++.+ ..++.++||||+||++|+|++|+.||...+.......+..+..
T Consensus 151 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~ 230 (336)
T cd07849 151 GLARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPS 230 (336)
T ss_pred cceeeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCC
Confidence 998765432211 12234578999999998765 4688999999999999999999999965432111000000000
Q ss_pred ------------------CCCCC-----CCCccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCccCcch
Q 039291 236 ------------------EHSLP-----EIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGVDE 282 (362)
Q Consensus 236 ------------------~~~~~-----~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~~~~~~ 282 (362)
....+ ......+.++.+++.+||+.+|++|||+.+++.||||+....
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~~ 300 (336)
T cd07849 231 QEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYHD 300 (336)
T ss_pred HHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccCC
Confidence 00000 111346788999999999999999999999999999987643
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=315.73 Aligned_cols=256 Identities=27% Similarity=0.447 Sum_probs=207.1
Q ss_pred CCCceeecceecccCceEEEEEEECCCCCCCCceeeeechhh---hhhHHHHHHHHHHHHcCCCCcccccccceeeecCC
Q 039291 4 DGTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEV---SASASLQKEKEVFDNLNGCPFVLECFGEEITMGEN 80 (362)
Q Consensus 4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~---~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~ 80 (362)
...+|.+.+.||.|+||.||+|.+..+++ .+++|.... .....+.+|+.+++.++ |||++++++.+..
T Consensus 17 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~----~v~iK~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~---- 87 (296)
T cd06655 17 PKKKYTRYEKIGQGASGTVFTAIDVATGQ----EVAIKQINLQKQPKKELIINEILVMKELK-NPNIVNFLDSFLV---- 87 (296)
T ss_pred CcceEEEEEEEecCCCeEEEEEEEcCCCc----EEEEEEEecccCchHHHHHHHHHHHHhcC-CCceeeeeeeEec----
Confidence 34679999999999999999999988775 445554322 23456788999999998 9999999987642
Q ss_pred CceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEeec
Q 039291 81 GEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADL 160 (362)
Q Consensus 81 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Df 160 (362)
...+++|+||+++++|.+++.. ..+++.++..++.|++.||.|||++|++|+||||+||++ +.++.++|+||
T Consensus 88 -~~~~~lv~e~~~~~~L~~~~~~---~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili----~~~~~~kl~df 159 (296)
T cd06655 88 -GDELFVVMEYLAGGSLTDVVTE---TCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLL----GMDGSVKLTDF 159 (296)
T ss_pred -CceEEEEEEecCCCcHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE----CCCCCEEEccC
Confidence 2357799999999999998865 358999999999999999999999999999999999999 77788999999
Q ss_pred CCcccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHHcCCCCCC
Q 039291 161 GVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEHSLP 240 (362)
Q Consensus 161 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 240 (362)
|++........ ......|+..|+|||.+.+..++.++|+|||||++|+|++|+.||...+. ...............
T Consensus 160 g~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~--~~~~~~~~~~~~~~~ 235 (296)
T cd06655 160 GFCAQITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENP--LRALYLIATNGTPEL 235 (296)
T ss_pred ccchhcccccc--cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHhcCCccc
Confidence 99875443221 12345689999999999888899999999999999999999999965432 222222222222222
Q ss_pred CCCccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCccCc
Q 039291 241 EIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGV 280 (362)
Q Consensus 241 ~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~~~~ 280 (362)
..+..++..++++|++||..||++||++.+++.||||+..
T Consensus 236 ~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~~~~~~~ 275 (296)
T cd06655 236 QNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQHPFLKLA 275 (296)
T ss_pred CCcccCCHHHHHHHHHHhhcChhhCCCHHHHhhChHhhhc
Confidence 3456788999999999999999999999999999999754
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-44 Score=329.31 Aligned_cols=236 Identities=24% Similarity=0.392 Sum_probs=198.0
Q ss_pred cceecccCceEEEEEEECCCCCCCCceeeeechhhhhhHHHHHHHHHHHHcCCCCcccccccceeeecCCCceEEEEEEE
Q 039291 11 GRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVSASASLQKEKEVFDNLNGCPFVLECFGEEITMGENGEMAYNLLLE 90 (362)
Q Consensus 11 ~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~~~~~~~lv~e 90 (362)
++-||.|+.|-||+|+.++. .||+|+++.. -..+++.|++|+ ||||+.+.+++.. ..-||||||
T Consensus 129 LeWlGSGaQGAVF~Grl~ne------tVAVKKV~el----kETdIKHLRkLk-H~NII~FkGVCtq-----sPcyCIiME 192 (904)
T KOG4721|consen 129 LEWLGSGAQGAVFLGRLHNE------TVAVKKVREL----KETDIKHLRKLK-HPNIITFKGVCTQ-----SPCYCIIME 192 (904)
T ss_pred hhhhccCcccceeeeeccCc------eehhHHHhhh----hhhhHHHHHhcc-CcceeeEeeeecC-----CceeEEeee
Confidence 45699999999999998764 5788887543 246788999999 9999999999853 345899999
Q ss_pred ecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEeecCCcccccccc
Q 039291 91 YAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCK 170 (362)
Q Consensus 91 ~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Dfgla~~~~~~~ 170 (362)
||..|.|.+.|+. +++++......|..+|+.|+.|||.+.|||||||.-|||| ..+..|||+|||-++.....
T Consensus 193 fCa~GqL~~VLka--~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLI----s~~d~VKIsDFGTS~e~~~~- 265 (904)
T KOG4721|consen 193 FCAQGQLYEVLKA--GRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILI----SYDDVVKISDFGTSKELSDK- 265 (904)
T ss_pred ccccccHHHHHhc--cCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEe----eccceEEeccccchHhhhhh-
Confidence 9999999999987 6679999999999999999999999999999999999999 66668999999998755432
Q ss_pred cCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHHcCCCCCCCCCccCCHHH
Q 039291 171 RQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEHSLPEIPSRVSKEA 250 (362)
Q Consensus 171 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (362)
...-+++||..|||||++.+.+.+.|+|||||||+||||+||..||..- +...++--++.+-..-..|..++..+
T Consensus 266 --STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdV---dssAIIwGVGsNsL~LpvPstcP~Gf 340 (904)
T KOG4721|consen 266 --STKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDV---DSSAIIWGVGSNSLHLPVPSTCPDGF 340 (904)
T ss_pred --hhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCcccc---chheeEEeccCCcccccCcccCchHH
Confidence 2334789999999999999999999999999999999999999999432 22222222233333334678899999
Q ss_pred HHHHHHHhccCCCCCCCHHHHhcC
Q 039291 251 RDFLRRCFVRKPAFRFTAEMLLDD 274 (362)
Q Consensus 251 ~~li~~~l~~~p~~R~s~~~~l~~ 274 (362)
+-||+.||...|..||++.+++.|
T Consensus 341 klL~Kqcw~sKpRNRPSFrqil~H 364 (904)
T KOG4721|consen 341 KLLLKQCWNSKPRNRPSFRQILLH 364 (904)
T ss_pred HHHHHHHHhcCCCCCccHHHHHHH
Confidence 999999999999999999999887
|
|
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-43 Score=311.93 Aligned_cols=250 Identities=26% Similarity=0.481 Sum_probs=205.5
Q ss_pred ecccCceEEEEEEECCCCCCCCceeeeechhh------hhhHHHHHHHHHHHHcCCCCcccccccceeeecCCCceEEEE
Q 039291 14 IGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEV------SASASLQKEKEVFDNLNGCPFVLECFGEEITMGENGEMAYNL 87 (362)
Q Consensus 14 lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~------~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~~~~~~~l 87 (362)
||.|++|.||+|+++.++.. +++|.... ...+.+.+|+.+++.++ ||||+++++.+.. ...+++
T Consensus 1 lg~g~~~~v~~~~~~~~~~~----~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~-----~~~~~l 70 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRT----FALKCVKKRHIVETGQQEHIFSEKEILEECN-HPFIVKLYRTFKD-----KKYIYM 70 (262)
T ss_pred CCCCCceEEEEEEECCCCcE----EEEEEEehhcchhhhHHHHHHHHHHHHHhCC-CCCEeeeeeeEEc-----CCccEE
Confidence 79999999999999887654 45554321 24466889999999997 9999999886532 234779
Q ss_pred EEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEeecCCccccc
Q 039291 88 LLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSR 167 (362)
Q Consensus 88 v~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Dfgla~~~~ 167 (362)
++||+++++|.+++.+ ...+++..+..++.||+.||.|||++|++|+||+|+||++ +.++.++|+|||++....
T Consensus 71 v~e~~~~~~L~~~l~~--~~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv----~~~~~~~l~df~~~~~~~ 144 (262)
T cd05572 71 LMEYCLGGELWTILRD--RGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLL----DSNGYVKLVDFGFAKKLK 144 (262)
T ss_pred EEecCCCCcHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEE----cCCCCEEEeeCCcccccC
Confidence 9999999999999986 3458999999999999999999999999999999999999 677789999999987654
Q ss_pred ccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHHcCCCCCCCCCccCC
Q 039291 168 HCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEHSLPEIPSRVS 247 (362)
Q Consensus 168 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (362)
... ......|+..|+|||.+.+..++.++|+||+|+++|+|++|..||..... +.......+......+..+...+
T Consensus 145 ~~~---~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 220 (262)
T cd05572 145 SGQ---KTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDE-DPMEIYNDILKGNGKLEFPNYID 220 (262)
T ss_pred ccc---ccccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCC-CHHHHHHHHhccCCCCCCCcccC
Confidence 422 12345689999999999888899999999999999999999999976543 24444444443344455666779
Q ss_pred HHHHHHHHHHhccCCCCCCC-----HHHHhcCCCccCcchh
Q 039291 248 KEARDFLRRCFVRKPAFRFT-----AEMLLDDPFVKGVDEE 283 (362)
Q Consensus 248 ~~~~~li~~~l~~~p~~R~s-----~~~~l~~p~~~~~~~~ 283 (362)
.+++++|.+||..+|++|++ ++++++||||+...|+
T Consensus 221 ~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~~ 261 (262)
T cd05572 221 KAAKDLIKQLLRRNPEERLGNLKGGIKDIKKHKWFNGFDWE 261 (262)
T ss_pred HHHHHHHHHHccCChhhCcCCcccCHHHHhcChhhhCCCCC
Confidence 99999999999999999999 9999999999876553
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-43 Score=311.71 Aligned_cols=250 Identities=26% Similarity=0.416 Sum_probs=208.6
Q ss_pred ceeecceecccCceEEEEEEECCCCCCCCceeeeechhh------hhhHHHHHHHHHHHHcCCCCcccccccceeeecCC
Q 039291 7 SWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEV------SASASLQKEKEVFDNLNGCPFVLECFGEEITMGEN 80 (362)
Q Consensus 7 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~------~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~ 80 (362)
+|.+.+.||.|+||.||+|+++.++.. +++|.... ...+.+.+|++++++++ ||||+++++.+.
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~----~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~----- 70 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKM----FAMKYMNKQKCVEKGSVRNVLNERRILQELN-HPFLVNLWYSFQ----- 70 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcE----EEEEEEehhhhcchhHHHHHHHHHHHHHhCC-CCChHHHHHhhc-----
Confidence 589999999999999999999887764 45554432 24567889999999998 899999987653
Q ss_pred CceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEeec
Q 039291 81 GEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADL 160 (362)
Q Consensus 81 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Df 160 (362)
....+++|+||+.|++|.+++... .++++..+..++.||+.||.|||++|++|+||+|+||++ +.++.++|+||
T Consensus 71 ~~~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~----~~~~~~~l~d~ 144 (258)
T cd05578 71 DEENMYLVVDLLLGGDLRYHLSQK--VKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILL----DEQGHVHITDF 144 (258)
T ss_pred CCCeEEEEEeCCCCCCHHHHHHhc--CCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEE----cCCCCEEEeec
Confidence 233578999999999999999873 469999999999999999999999999999999999999 77788999999
Q ss_pred CCcccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHHcCCCCCC
Q 039291 161 GVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEHSLP 240 (362)
Q Consensus 161 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 240 (362)
|++....... ......|+..|+|||++.+..++.++|+||||+++|+|++|..||................. ..+
T Consensus 145 ~~~~~~~~~~---~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~--~~~ 219 (258)
T cd05578 145 NIATKVTPDT---LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQET--ADV 219 (258)
T ss_pred ccccccCCCc---cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhcc--ccc
Confidence 9987654322 12345688999999999988899999999999999999999999976554334444444432 334
Q ss_pred CCCccCCHHHHHHHHHHhccCCCCCCCH--HHHhcCCCc
Q 039291 241 EIPSRVSKEARDFLRRCFVRKPAFRFTA--EMLLDDPFV 277 (362)
Q Consensus 241 ~~~~~~~~~~~~li~~~l~~~p~~R~s~--~~~l~~p~~ 277 (362)
..+..++.++.++|.+||..||.+||++ ++++.||||
T Consensus 220 ~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~~~~~ 258 (258)
T cd05578 220 LYPATWSTEAIDAINKLLERDPQKRLGDNLKDLKNHPYF 258 (258)
T ss_pred cCcccCcHHHHHHHHHHccCChhHcCCccHHHHhcCCCC
Confidence 5667789999999999999999999999 999999997
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-43 Score=328.60 Aligned_cols=259 Identities=22% Similarity=0.323 Sum_probs=203.8
Q ss_pred CCCCceeecceecccCceEEEEEEECCCCC-CCCceeeeechhhh----hhHHHHHHHHHHHHcCCCCcccccccceeee
Q 039291 3 SDGTSWFRGRVIGQGSFGCVFIAKPKSNSS-FLPPLMAVKSAEVS----ASASLQKEKEVFDNLNGCPFVLECFGEEITM 77 (362)
Q Consensus 3 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~-~~~~~~~~K~~~~~----~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~ 77 (362)
...++|.+++.||+|+||.||+|++...+. ....+|++|..... ....+.+|+.+++++..||||+++++.+..
T Consensus 34 ~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~- 112 (400)
T cd05105 34 FPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTK- 112 (400)
T ss_pred ccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEcc-
Confidence 346788899999999999999999865432 22346788876532 345688999999999879999999987642
Q ss_pred cCCCceEEEEEEEecCCCCHHHHHHHhc----------------------------------------------------
Q 039291 78 GENGEMAYNLLLEYAAGGTLGDLIEKCN---------------------------------------------------- 105 (362)
Q Consensus 78 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~---------------------------------------------------- 105 (362)
...+|+|||||++|+|.+++....
T Consensus 113 ----~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 188 (400)
T cd05105 113 ----SGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQY 188 (400)
T ss_pred ----CCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhccccccccccccccccc
Confidence 234789999999999999886531
Q ss_pred ------------------------------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCE
Q 039291 106 ------------------------------------------GNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNI 143 (362)
Q Consensus 106 ------------------------------------------~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Ni 143 (362)
...+++..+..++.|++.||.|||+++|+||||||+||
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Ni 268 (400)
T cd05105 189 VPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNV 268 (400)
T ss_pred chhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhE
Confidence 12478888999999999999999999999999999999
Q ss_pred EEeecCCCceEEEEeecCCcccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHh-CCCCCccCC
Q 039291 144 LLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLS-GRQAWVVKE 222 (362)
Q Consensus 144 ll~~~~~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~ 222 (362)
|+ +.++.+||+|||+++...............++..|+|||++.+..++.++|||||||++|+|++ |..||....
T Consensus 269 ll----~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~ 344 (400)
T cd05105 269 LL----AQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMI 344 (400)
T ss_pred EE----eCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccc
Confidence 99 6777899999999976543222222234457788999999998889999999999999999997 999986432
Q ss_pred CCCHHHHHHHHcCCCCCCCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhc
Q 039291 223 DCSIDQLFSIIGDEHSLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLD 273 (362)
Q Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~ 273 (362)
. .......+..... +..+..++.++.+++.+||..+|++||++.++.+
T Consensus 345 ~--~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~ 392 (400)
T cd05105 345 V--DSTFYNKIKSGYR-MAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSD 392 (400)
T ss_pred h--hHHHHHHHhcCCC-CCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHH
Confidence 2 1223333333322 3345678999999999999999999999988765
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-44 Score=328.04 Aligned_cols=250 Identities=28% Similarity=0.418 Sum_probs=209.0
Q ss_pred CceeecceecccCceEEEEEEECCCCCCCCceeeeechh------hhhhHHHHHHHHHHHHcCCCCcccccccceeeecC
Q 039291 6 TSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAE------VSASASLQKEKEVFDNLNGCPFVLECFGEEITMGE 79 (362)
Q Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~------~~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~ 79 (362)
..|...+.||.|+||-||-|++..+.+ .||||++. .+....+..|+++|++|. |||++.+.+.+.-.
T Consensus 26 klf~dLrEIGHGSFGAVYfArd~~n~e----vVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~-HPntieYkgCyLre-- 98 (948)
T KOG0577|consen 26 KLFSDLREIGHGSFGAVYFARDVRNSE----VVAIKKMSYSGKQSNEKWQDILKEVRFLRQLR-HPNTIEYKGCYLRE-- 98 (948)
T ss_pred HHHHHHHHhcCCccceeEEeeccCccc----eeeeeeccccccccHHHHHHHHHHHHHHHhcc-CCCcccccceeecc--
Confidence 357788999999999999999998876 67888764 235567889999999999 99999999877532
Q ss_pred CCceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEee
Q 039291 80 NGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIAD 159 (362)
Q Consensus 80 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~D 159 (362)
...+||||||-| +-.|++.-. ++++-+.++..|..+.+.||+|||+.+.||||||..|||+ .+.+.|||+|
T Consensus 99 ---~TaWLVMEYClG-SAsDlleVh-kKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILL----se~g~VKLaD 169 (948)
T KOG0577|consen 99 ---HTAWLVMEYCLG-SASDLLEVH-KKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILL----SEPGLVKLAD 169 (948)
T ss_pred ---chHHHHHHHHhc-cHHHHHHHH-hccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEe----cCCCeeeecc
Confidence 224599999975 999999874 4679999999999999999999999999999999999999 8899999999
Q ss_pred cCCcccccccccCCCCCCccCCCCccCchhhc---cccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHHcCC
Q 039291 160 LGVAKRSRHCKRQKFDPSMRGTPLYLAPETVV---QHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDE 236 (362)
Q Consensus 160 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 236 (362)
||.|....+ ..+++|||.|||||++. .+.|+-++||||||++-.||...++|+... +....+.-|.++
T Consensus 170 FGSAsi~~P------AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnM---NAMSALYHIAQN 240 (948)
T KOG0577|consen 170 FGSASIMAP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM---NAMSALYHIAQN 240 (948)
T ss_pred ccchhhcCc------hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCc---hHHHHHHHHHhc
Confidence 999865543 24789999999999987 478999999999999999999999998544 233333334333
Q ss_pred CCCCCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCccCc
Q 039291 237 HSLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGV 280 (362)
Q Consensus 237 ~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~~~~ 280 (362)
....--...++..++.|+..||.+-|..|||.++++.|+|+..-
T Consensus 241 esPtLqs~eWS~~F~~Fvd~CLqKipqeRptse~ll~H~fv~R~ 284 (948)
T KOG0577|consen 241 ESPTLQSNEWSDYFRNFVDSCLQKIPQERPTSEELLKHRFVLRE 284 (948)
T ss_pred CCCCCCCchhHHHHHHHHHHHHhhCcccCCcHHHHhhcchhccC
Confidence 33222245788999999999999999999999999999998654
|
|
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-43 Score=315.95 Aligned_cols=251 Identities=23% Similarity=0.427 Sum_probs=195.6
Q ss_pred ceeecceecccCceEEEEEEECCCCCCCCceeeeechhh-----hhhHHHHHHHHHHHHcCCCCcccccccceeeecCCC
Q 039291 7 SWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEV-----SASASLQKEKEVFDNLNGCPFVLECFGEEITMGENG 81 (362)
Q Consensus 7 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~-----~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~~ 81 (362)
+|.+.+.||+|+||.||+|+++.++.. +++|.... .....+.+|+.+++.++ ||||+++++.+..
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~----~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~-h~~i~~~~~~~~~----- 70 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEI----VALKRVRLDDDDEGVPSSALREICLLKELK-HKNIVRLYDVLHS----- 70 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcE----EEEEEeecccccccCccchhHHHHHHHhcC-CCCeeeHHHHhcc-----
Confidence 689999999999999999999888763 45554432 22345778999999998 8999999987642
Q ss_pred ceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEeecC
Q 039291 82 EMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLG 161 (362)
Q Consensus 82 ~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Dfg 161 (362)
...+++++||+.+ +|.+++... ...+++..++.++.||+.||.|||++||+||||||+||++ +.++.++|+|||
T Consensus 71 ~~~~~lv~e~~~~-~l~~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~----~~~~~~~l~dfg 144 (284)
T cd07839 71 DKKLTLVFEYCDQ-DLKKYFDSC-NGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLI----NKNGELKLADFG 144 (284)
T ss_pred CCceEEEEecCCC-CHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEE----cCCCcEEECccc
Confidence 2347899999974 888887653 3459999999999999999999999999999999999999 777889999999
Q ss_pred CcccccccccCCCCCCccCCCCccCchhhccc-cCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHHc------
Q 039291 162 VAKRSRHCKRQKFDPSMRGTPLYLAPETVVQH-MQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIG------ 234 (362)
Q Consensus 162 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~------ 234 (362)
++....... .......++..|+|||++.+. .++.++|||||||++|+|++|..||..... ..+....+.
T Consensus 145 ~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~--~~~~~~~~~~~~~~~ 220 (284)
T cd07839 145 LARAFGIPV--RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGND--VDDQLKRIFRLLGTP 220 (284)
T ss_pred hhhccCCCC--CCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCC--HHHHHHHHHHHhCCC
Confidence 987543321 111345678999999998764 478999999999999999999988643322 222211110
Q ss_pred ------------CCCCCC---------CCCccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCc
Q 039291 235 ------------DEHSLP---------EIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFV 277 (362)
Q Consensus 235 ------------~~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~ 277 (362)
.....+ .....++.+++++|.+||..||.+|||+++++.||||
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~f 284 (284)
T cd07839 221 TEESWPGVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF 284 (284)
T ss_pred ChHHhHHhhhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCCC
Confidence 000011 1123478899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-43 Score=315.69 Aligned_cols=257 Identities=20% Similarity=0.331 Sum_probs=207.3
Q ss_pred CCCceeecceecccCceEEEEEEECCCC-CCCCceeeeechhhh----hhHHHHHHHHHHHHcCCCCcccccccceeeec
Q 039291 4 DGTSWFRGRVIGQGSFGCVFIAKPKSNS-SFLPPLMAVKSAEVS----ASASLQKEKEVFDNLNGCPFVLECFGEEITMG 78 (362)
Q Consensus 4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~-~~~~~~~~~K~~~~~----~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~ 78 (362)
+-++|.+.+.||+|+||.||+|.+...+ ......+++|..... ....+.+|+.++++++ ||||+++++.+..
T Consensus 3 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~-h~~i~~~~~~~~~-- 79 (283)
T cd05048 3 PLSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQ-HPNIVCLLGVCTK-- 79 (283)
T ss_pred ChHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcC-CcccceEEEEEcC--
Confidence 3467899999999999999999987654 233356788876432 3456789999999998 8999999986542
Q ss_pred CCCceEEEEEEEecCCCCHHHHHHHhcC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEE
Q 039291 79 ENGEMAYNLLLEYAAGGTLGDLIEKCNG--------------NGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNIL 144 (362)
Q Consensus 79 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~--------------~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nil 144 (362)
....+++|||+++++|.+++..... ..+++..+..++.|++.||.|||++|++|+||||+||+
T Consensus 80 ---~~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil 156 (283)
T cd05048 80 ---EQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCL 156 (283)
T ss_pred ---CCceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEE
Confidence 2346799999999999999976321 45889999999999999999999999999999999999
Q ss_pred EeecCCCceEEEEeecCCcccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHh-CCCCCccCCC
Q 039291 145 LVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLS-GRQAWVVKED 223 (362)
Q Consensus 145 l~~~~~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~ 223 (362)
+ +.++.++|+|||+++...............+++.|+|||.+.+..++.++|||||||++|||++ |..||.+..
T Consensus 157 ~----~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~- 231 (283)
T cd05048 157 V----GEGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFS- 231 (283)
T ss_pred E----cCCCcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCC-
Confidence 9 7778899999999875543322222234557889999999988889999999999999999998 999996543
Q ss_pred CCHHHHHHHHcCCCCCCCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhcC
Q 039291 224 CSIDQLFSIIGDEHSLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDD 274 (362)
Q Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~ 274 (362)
..+....+.... .+..+..++.++.+|+.+||..||++||++.+++++
T Consensus 232 --~~~~~~~i~~~~-~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~ 279 (283)
T cd05048 232 --NQEVIEMIRSRQ-LLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTR 279 (283)
T ss_pred --HHHHHHHHHcCC-cCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 344555554433 344677899999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=313.40 Aligned_cols=267 Identities=21% Similarity=0.323 Sum_probs=207.1
Q ss_pred CCCCCceeecceecccCceEEEEEEECCCC-CCCCceeeeechhhh----hhHHHHHHHHHHHHcCCCCcccccccceee
Q 039291 2 DSDGTSWFRGRVIGQGSFGCVFIAKPKSNS-SFLPPLMAVKSAEVS----ASASLQKEKEVFDNLNGCPFVLECFGEEIT 76 (362)
Q Consensus 2 ~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~-~~~~~~~~~K~~~~~----~~~~~~~E~~il~~l~~h~~i~~~~~~~~~ 76 (362)
++..++|.+.+.||+|+||.||+|..+... ......+++|..... ....+.+|+.+++.++ ||||+++++.+..
T Consensus 2 ~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~ 80 (288)
T cd05061 2 EVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFT-CHHVVRLLGVVSK 80 (288)
T ss_pred cccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCC-CCCeeeEEEEEcC
Confidence 456789999999999999999999765321 112246777765422 2345678999999998 8999999986532
Q ss_pred ecCCCceEEEEEEEecCCCCHHHHHHHhcC--------CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeec
Q 039291 77 MGENGEMAYNLLLEYAAGGTLGDLIEKCNG--------NGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVAT 148 (362)
Q Consensus 77 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--------~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~ 148 (362)
....++||||+++|+|.+++..... ..++...+..++.|++.||.|||+++|+||||||+||++
T Consensus 81 -----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili--- 152 (288)
T cd05061 81 -----GQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMV--- 152 (288)
T ss_pred -----CCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEE---
Confidence 2246799999999999999976321 235677889999999999999999999999999999999
Q ss_pred CCCceEEEEeecCCcccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHh-CCCCCccCCCCCHH
Q 039291 149 QSGKFVAKIADLGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLS-GRQAWVVKEDCSID 227 (362)
Q Consensus 149 ~~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~ 227 (362)
+.++.++|+|||+++...............++..|+|||.+.+..++.++|+|||||++|||++ |..||... ...
T Consensus 153 -~~~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~---~~~ 228 (288)
T cd05061 153 -AHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGL---SNE 228 (288)
T ss_pred -cCCCcEEECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCC---CHH
Confidence 7778899999999875433222211123345778999999998889999999999999999998 78898543 334
Q ss_pred HHHHHHcCCCCCCCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhc------CCCccCcch
Q 039291 228 QLFSIIGDEHSLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLD------DPFVKGVDE 282 (362)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~------~p~~~~~~~ 282 (362)
+....+.... .+..+..++..+++++.+||+.||++|||+.++++ ||||+.+++
T Consensus 229 ~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~~~~ 288 (288)
T cd05061 229 QVLKFVMDGG-YLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFPEVSF 288 (288)
T ss_pred HHHHHHHcCC-CCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCCCCCCCC
Confidence 4444443322 23445677899999999999999999999999987 899987753
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-43 Score=313.86 Aligned_cols=251 Identities=25% Similarity=0.402 Sum_probs=194.9
Q ss_pred eecccCceEEEEEEECCCCCCCCceeeeechhh------hhhHHHHHHHHHHHHc--CCCCcccccccceeeecCCCceE
Q 039291 13 VIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEV------SASASLQKEKEVFDNL--NGCPFVLECFGEEITMGENGEMA 84 (362)
Q Consensus 13 ~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~------~~~~~~~~E~~il~~l--~~h~~i~~~~~~~~~~~~~~~~~ 84 (362)
.||+|+||.||+|++..++.. +++|.... .......+|..+++.+ .+||+|+.+++.+.. ...
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~----~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~-----~~~ 71 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKM----YAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHT-----PDK 71 (279)
T ss_pred CcccCCCeEEEEEEECCCCcE----EEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEec-----CCe
Confidence 489999999999999887764 45554321 1122334454444433 348999988776542 234
Q ss_pred EEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEeecCCcc
Q 039291 85 YNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAK 164 (362)
Q Consensus 85 ~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Dfgla~ 164 (362)
+++||||+++++|.+++.. .+.+++..+..++.|++.||.|||++||+||||||+|||+ +.++.++|+|||++.
T Consensus 72 ~~lv~e~~~~~~L~~~i~~--~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~----~~~~~~~l~dfg~~~ 145 (279)
T cd05633 72 LCFILDLMNGGDLHYHLSQ--HGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILL----DEHGHVRISDLGLAC 145 (279)
T ss_pred EEEEEecCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEE----CCCCCEEEccCCcce
Confidence 7799999999999999876 3459999999999999999999999999999999999999 777889999999986
Q ss_pred cccccccCCCCCCccCCCCccCchhhcc-ccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHHcCCCCCCCCC
Q 039291 165 RSRHCKRQKFDPSMRGTPLYLAPETVVQ-HMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEHSLPEIP 243 (362)
Q Consensus 165 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (362)
...... .....||..|+|||.+.+ ..++.++|+||+||++|+|++|..||................. ....++
T Consensus 146 ~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~--~~~~~~ 219 (279)
T cd05633 146 DFSKKK----PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLT--VNVELP 219 (279)
T ss_pred eccccC----ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHhhc--CCcCCc
Confidence 543321 123569999999999864 5688999999999999999999999976544444333222211 123456
Q ss_pred ccCCHHHHHHHHHHhccCCCCCC-----CHHHHhcCCCccCcchhh
Q 039291 244 SRVSKEARDFLRRCFVRKPAFRF-----TAEMLLDDPFVKGVDEEL 284 (362)
Q Consensus 244 ~~~~~~~~~li~~~l~~~p~~R~-----s~~~~l~~p~~~~~~~~~ 284 (362)
..++.+++++|.+||..||.+|+ +++++++||||+.+.+..
T Consensus 220 ~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h~~~~~~~~~~ 265 (279)
T cd05633 220 DSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHVFFKGIDWQQ 265 (279)
T ss_pred cccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhCccccCCCHhH
Confidence 67899999999999999999999 699999999999976543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-43 Score=311.42 Aligned_cols=256 Identities=27% Similarity=0.431 Sum_probs=203.7
Q ss_pred CceeecceecccCceEEEEEEECCCCCCCCceeeeechh----hhhhHHHHHHHHHHHHcCCCCcccccccceeeecCCC
Q 039291 6 TSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAE----VSASASLQKEKEVFDNLNGCPFVLECFGEEITMGENG 81 (362)
Q Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~----~~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~~ 81 (362)
++|.+++.||.|+||+||+|....++. .+++|... ....+.+.+|+.+++.+. |+|++++++.+..
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~----~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~----- 70 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNE----KVAIKRIDLEKCQTSVDELRKEVQAMSQCN-HPNVVKYYTSFVV----- 70 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCc----EEEEEEeccCCcchHHHHHHHHHHHHHhcC-CCCEEEEEEEEee-----
Confidence 479999999999999999999887665 45555443 224567889999999998 8999999876542
Q ss_pred ceEEEEEEEecCCCCHHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEeec
Q 039291 82 EMAYNLLLEYAAGGTLGDLIEKCNG-NGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADL 160 (362)
Q Consensus 82 ~~~~~lv~e~~~~~~L~~~l~~~~~-~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Df 160 (362)
...++++||++++++|.+++..... ..+++..++.++.|++.||.|||+.|++|+||||+||++ +.++.++|+||
T Consensus 71 ~~~~~iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~----~~~~~~~l~df 146 (267)
T cd06610 71 GDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILL----GEDGSVKIADF 146 (267)
T ss_pred CCEEEEEEeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEE----cCCCCEEEccc
Confidence 3357799999999999999976433 468999999999999999999999999999999999999 66778999999
Q ss_pred CCcccccccccC--CCCCCccCCCCccCchhhccc-cCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHHcCCC
Q 039291 161 GVAKRSRHCKRQ--KFDPSMRGTPLYLAPETVVQH-MQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEH 237 (362)
Q Consensus 161 gla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 237 (362)
|++......... .......|+..|+|||++... .++.++|+|||||++++|++|+.||..... ............
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~--~~~~~~~~~~~~ 224 (267)
T cd06610 147 GVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPP--MKVLMLTLQNDP 224 (267)
T ss_pred chHHHhccCccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccCh--hhhHHHHhcCCC
Confidence 998765543222 122345689999999998876 789999999999999999999999954432 122222222211
Q ss_pred -CCCCCC--ccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCc
Q 039291 238 -SLPEIP--SRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFV 277 (362)
Q Consensus 238 -~~~~~~--~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~ 277 (362)
..+... ..++.++.+++.+||..||++||++++++.||||
T Consensus 225 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~p~~ 267 (267)
T cd06610 225 PSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKHKFF 267 (267)
T ss_pred CCcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhhCCCC
Confidence 111111 3578999999999999999999999999999997
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-42 Score=310.30 Aligned_cols=253 Identities=35% Similarity=0.660 Sum_probs=200.3
Q ss_pred ceeecceecccCceEEEEEEECCCCCCCCceeeeechhh-------------hhhHHHHHHHHHHHHcCCCCcccccccc
Q 039291 7 SWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEV-------------SASASLQKEKEVFDNLNGCPFVLECFGE 73 (362)
Q Consensus 7 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~-------------~~~~~~~~E~~il~~l~~h~~i~~~~~~ 73 (362)
+|.+.+.||+|+||.||+|.+..++. .+++|.... ...+.+.+|+.+++.++ |||++++++.
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~----~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~ 76 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGE----MMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLD-HLNIVQYLGF 76 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCc----eeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcC-CCCcceEEEE
Confidence 68999999999999999999887765 445554321 11245778999999998 8999999986
Q ss_pred eeeecCCCceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCce
Q 039291 74 EITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKF 153 (362)
Q Consensus 74 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~ 153 (362)
+.. ...+++||||+++++|.+++... .++++..+..++.|++.||.|||+++++|+||+|+||++ +.++
T Consensus 77 ~~~-----~~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~----~~~~ 145 (272)
T cd06629 77 ETT-----EEYLSIFLEYVPGGSIGSCLRTY--GRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLV----DADG 145 (272)
T ss_pred ecc-----CCceEEEEecCCCCcHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEE----cCCC
Confidence 532 33577999999999999999874 569999999999999999999999999999999999999 7788
Q ss_pred EEEEeecCCcccccccccCCCCCCccCCCCccCchhhcccc--CCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHH
Q 039291 154 VAKIADLGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHM--QEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFS 231 (362)
Q Consensus 154 ~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~ 231 (362)
.++|+|||++................|+..|+|||++.... ++.++|+||||+++++|++|..||...+ .......
T Consensus 146 ~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~--~~~~~~~ 223 (272)
T cd06629 146 ICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEE--AIAAMFK 223 (272)
T ss_pred eEEEeeccccccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcc--hHHHHHH
Confidence 89999999987654322222233456899999999988654 7889999999999999999999995322 2222222
Q ss_pred HHcCCC---CCCCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCc
Q 039291 232 IIGDEH---SLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFV 277 (362)
Q Consensus 232 ~~~~~~---~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~ 277 (362)
...... ..+.....++.+++++|.+||..+|++||++++++.|||+
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~ 272 (272)
T cd06629 224 LGNKRSAPPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQHPFI 272 (272)
T ss_pred hhccccCCcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhCCCC
Confidence 221111 1112234568999999999999999999999999999996
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=313.97 Aligned_cols=240 Identities=14% Similarity=0.209 Sum_probs=195.8
Q ss_pred ceecccCceEEEEEEECCCCCCCCceeeeechhhh------hhHHHHHHHHHHHHcCCCCcccccccceeeecCCCceEE
Q 039291 12 RVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVS------ASASLQKEKEVFDNLNGCPFVLECFGEEITMGENGEMAY 85 (362)
Q Consensus 12 ~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~~------~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~~~~~~ 85 (362)
..||+|++|.||+|++.+ + .|++|..... ..+.+.+|+.+|++++ ||||+++++.+.... +....+
T Consensus 26 ~~i~~g~~~~v~~~~~~~--~----~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~~~g~~~~~~-~~~~~~ 97 (283)
T PHA02988 26 VLIKENDQNSIYKGIFNN--K----EVIIRTFKKFHKGHKVLIDITENEIKNLRRID-SNNILKIYGFIIDIV-DDLPRL 97 (283)
T ss_pred eEEeeCCceEEEEEEECC--E----EEEEEeccccccccHHHHHHHHHHHHHHHhcC-CCCEEEEeeeEEecc-cCCCce
Confidence 679999999999999843 2 5677765432 1355779999999998 899999999765421 223457
Q ss_pred EEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCceeCCCCCCCEEEeecCCCceEEEEeecCCcc
Q 039291 86 NLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHD-SGYVHCDVKPDNILLVATQSGKFVAKIADLGVAK 164 (362)
Q Consensus 86 ~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~-~~ivH~Dlkp~Nill~~~~~~~~~~kl~Dfgla~ 164 (362)
++||||+++|+|.+++.. .+.+++.....++.|++.||.|||+ .+++||||||+||++ +.++.+||+|||+++
T Consensus 98 ~lv~Ey~~~g~L~~~l~~--~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill----~~~~~~kl~dfg~~~ 171 (283)
T PHA02988 98 SLILEYCTRGYLREVLDK--EKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLV----TENYKLKIICHGLEK 171 (283)
T ss_pred EEEEEeCCCCcHHHHHhh--CCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEE----CCCCcEEEcccchHh
Confidence 799999999999999986 3469999999999999999999998 599999999999999 778899999999987
Q ss_pred cccccccCCCCCCccCCCCccCchhhcc--ccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHHcCCCCCCCC
Q 039291 165 RSRHCKRQKFDPSMRGTPLYLAPETVVQ--HMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEHSLPEI 242 (362)
Q Consensus 165 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 242 (362)
...... ....|+..|+|||++.+ ..++.++|||||||++|||++|..||... +..++...+......+..
T Consensus 172 ~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~---~~~~~~~~i~~~~~~~~~ 243 (283)
T PHA02988 172 ILSSPP-----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENL---TTKEIYDLIINKNNSLKL 243 (283)
T ss_pred hhcccc-----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCC---CHHHHHHHHHhcCCCCCC
Confidence 543211 23568999999999976 67899999999999999999999999644 344555555433334456
Q ss_pred CccCCHHHHHHHHHHhccCCCCCCCHHHHhc
Q 039291 243 PSRVSKEARDFLRRCFVRKPAFRFTAEMLLD 273 (362)
Q Consensus 243 ~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~ 273 (362)
+..++.++++|+.+||+.||++|||+++++.
T Consensus 244 ~~~~~~~l~~li~~cl~~dp~~Rps~~ell~ 274 (283)
T PHA02988 244 PLDCPLEIKCIVEACTSHDSIKRPNIKEILY 274 (283)
T ss_pred CCcCcHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence 6678999999999999999999999999985
|
|
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-43 Score=317.58 Aligned_cols=256 Identities=27% Similarity=0.436 Sum_probs=206.3
Q ss_pred CCceeecceecccCceEEEEEEECCCCCCCCceeeeechhh---hhhHHHHHHHHHHHHcCCCCcccccccceeeecCCC
Q 039291 5 GTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEV---SASASLQKEKEVFDNLNGCPFVLECFGEEITMGENG 81 (362)
Q Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~---~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~~ 81 (362)
..+|.+.+.||+|+||.||+|.+..++. .+++|.... .....+.+|+.+++.++ |+||+++++.+..
T Consensus 18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~----~vaiK~~~~~~~~~~~~~~~e~~~l~~~~-h~~i~~~~~~~~~----- 87 (297)
T cd06656 18 KKKYTRFEKIGQGASGTVYTAIDIATGQ----EVAIKQMNLQQQPKKELIINEILVMRENK-NPNIVNYLDSYLV----- 87 (297)
T ss_pred hhhceeeeeeccCCCeEEEEEEECCCCC----EEEEEEEecCccchHHHHHHHHHHHHhCC-CCCEeeEEEEEec-----
Confidence 4789999999999999999999987775 455555432 23456788999999997 9999999987642
Q ss_pred ceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEeecC
Q 039291 82 EMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLG 161 (362)
Q Consensus 82 ~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Dfg 161 (362)
...+++||||+++++|.+++.. ..+++..+..++.|++.||.|||+.|++||||||+|||+ +.++.++|+|||
T Consensus 88 ~~~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili----~~~~~~~l~Dfg 160 (297)
T cd06656 88 GDELWVVMEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILL----GMDGSVKLTDFG 160 (297)
T ss_pred CCEEEEeecccCCCCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE----CCCCCEEECcCc
Confidence 2347799999999999999865 348999999999999999999999999999999999999 777889999999
Q ss_pred CcccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHHcCCCCCCC
Q 039291 162 VAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEHSLPE 241 (362)
Q Consensus 162 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 241 (362)
++........ ......+++.|+|||.+.+..++.++|+|||||++|+|++|..||...+.. ..+............
T Consensus 161 ~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~--~~~~~~~~~~~~~~~ 236 (297)
T cd06656 161 FCAQITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPL--RALYLIATNGTPELQ 236 (297)
T ss_pred cceEccCCcc--CcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcc--hheeeeccCCCCCCC
Confidence 9875443221 123456899999999999888899999999999999999999999654321 111111111222223
Q ss_pred CCccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCccCcc
Q 039291 242 IPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGVD 281 (362)
Q Consensus 242 ~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~~~~~ 281 (362)
.+..++..+++|+.+||..+|++||+++++++||||+...
T Consensus 237 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~ 276 (297)
T cd06656 237 NPERLSAVFRDFLNRCLEMDVDRRGSAKELLQHPFLKLAK 276 (297)
T ss_pred CccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhcccc
Confidence 4566889999999999999999999999999999997653
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-43 Score=315.97 Aligned_cols=252 Identities=25% Similarity=0.417 Sum_probs=197.6
Q ss_pred ceeecceecccCceEEEEEEECCCCCCCCceeeeechhhh-----hhHHHHHHHHHHHHcCCCCcccccccceeeecCCC
Q 039291 7 SWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVS-----ASASLQKEKEVFDNLNGCPFVLECFGEEITMGENG 81 (362)
Q Consensus 7 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~~-----~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~~ 81 (362)
.|.+.+.||+|++|.||+|+++.++. .+++|..... ....+.+|+.++++++ ||||+++++.+..
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~----~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~----- 70 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQ----IVAMKKIRLESEEEGVPSTAIREISLLKELQ-HPNIVCLQDVLMQ----- 70 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCc----EEEEEEeccccccCCchHHHHHHHHHHHhcC-CCCEeeeEEEEee-----
Confidence 48899999999999999999987765 4566654321 2356788999999999 9999999997643
Q ss_pred ceEEEEEEEecCCCCHHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEeec
Q 039291 82 EMAYNLLLEYAAGGTLGDLIEKCNG-NGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADL 160 (362)
Q Consensus 82 ~~~~~lv~e~~~~~~L~~~l~~~~~-~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Df 160 (362)
...+++||||+. ++|.+++..... ..+++..++.++.||+.||.|||++|++|+||||+||++ +.++.++|+||
T Consensus 71 ~~~~~~v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~----~~~~~~~l~df 145 (285)
T cd07861 71 ESRLYLIFEFLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLI----DNKGVIKLADF 145 (285)
T ss_pred CCeEEEEEecCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEE----cCCCcEEECcc
Confidence 235789999997 589888876432 569999999999999999999999999999999999999 77888999999
Q ss_pred CCcccccccccCCCCCCccCCCCccCchhhccc-cCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHHc---C-
Q 039291 161 GVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQH-MQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIG---D- 235 (362)
Q Consensus 161 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~---~- 235 (362)
|++....... .......+++.|+|||++.+. .++.++|+|||||++|+|++|++||..... ......... .
T Consensus 146 g~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~--~~~~~~~~~~~~~~ 221 (285)
T cd07861 146 GLARAFGIPV--RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSE--IDQLFRIFRILGTP 221 (285)
T ss_pred cceeecCCCc--ccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCH--HHHHHHHHHHhCCC
Confidence 9987543221 111244678999999998754 578899999999999999999999965432 111111100 0
Q ss_pred ----------------------CCCCCCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCc
Q 039291 236 ----------------------EHSLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFV 277 (362)
Q Consensus 236 ----------------------~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~ 277 (362)
..........++++++++|++||..||++|||+.+++.||||
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~~ 285 (285)
T cd07861 222 TEDVWPGVTSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285 (285)
T ss_pred ChhhhhcchhhHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCCCC
Confidence 000011123478999999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-42 Score=307.27 Aligned_cols=251 Identities=27% Similarity=0.410 Sum_probs=207.7
Q ss_pred ceeecceecccCceEEEEEEECCCCCCCCceeeeech-----hhhhhHHHHHHHHHHHHcCCCCcccccccceeeecCCC
Q 039291 7 SWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSA-----EVSASASLQKEKEVFDNLNGCPFVLECFGEEITMGENG 81 (362)
Q Consensus 7 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~-----~~~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~~ 81 (362)
+|+..+.||+|+||.||.+++..++. .+++|.. .......+.+|+.++++++ |+||+++++.+..
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~----~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~-h~~i~~~~~~~~~----- 70 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDS----LVVWKEVNLTRLSEKERRDALNEIVILSLLQ-HPNIIAYYNHFMD----- 70 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCc----EEEEEEEeecccchhHHHHHHHHHHHHHhCC-CCCeeEEEeEEec-----
Confidence 69999999999999999999988775 3455542 2344566889999999998 8999999987653
Q ss_pred ceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEeecC
Q 039291 82 EMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLG 161 (362)
Q Consensus 82 ~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Dfg 161 (362)
...++++|||+++++|.+++.......+++..+..++.|++.||.|||+.|++|+||+|+||++ +.++.+||+|||
T Consensus 71 ~~~~~~~~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~----~~~~~~kl~d~~ 146 (256)
T cd08221 71 DNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFL----TKAGLIKLGDFG 146 (256)
T ss_pred CCeEEEEEEecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEE----eCCCCEEECcCc
Confidence 2357799999999999999987545569999999999999999999999999999999999999 667789999999
Q ss_pred CcccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHHcCCCCCCC
Q 039291 162 VAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEHSLPE 241 (362)
Q Consensus 162 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 241 (362)
++........ ......|++.|+|||++.+..++.++|+||||+++++|++|..||... +..+....+.... ++.
T Consensus 147 ~~~~~~~~~~--~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~---~~~~~~~~~~~~~-~~~ 220 (256)
T cd08221 147 ISKILGSEYS--MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDAT---NPLNLVVKIVQGN-YTP 220 (256)
T ss_pred ceEEcccccc--cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCC---CHHHHHHHHHcCC-CCC
Confidence 9876544221 223567899999999998888899999999999999999999999543 3444444443333 233
Q ss_pred CCccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCc
Q 039291 242 IPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFV 277 (362)
Q Consensus 242 ~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~ 277 (362)
.+..++.++.++|.+||..+|++||++.++++|||+
T Consensus 221 ~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~~l 256 (256)
T cd08221 221 VVSVYSSELISLVHSLLQQDPEKRPTADEVLDQPLL 256 (256)
T ss_pred CccccCHHHHHHHHHHcccCcccCCCHHHHhhCcCC
Confidence 456789999999999999999999999999999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=307.58 Aligned_cols=253 Identities=26% Similarity=0.477 Sum_probs=205.5
Q ss_pred CCceeecceecccCceEEEEEEECCCCCCCCceeeeechhhh-hhHHHHHHHHHHHHcCCCCcccccccceeeecCCCce
Q 039291 5 GTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVS-ASASLQKEKEVFDNLNGCPFVLECFGEEITMGENGEM 83 (362)
Q Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~~-~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~~~~ 83 (362)
.++|.+.+.||+|+||.||+|+++.++. .+++|..... ....+.+|++++++++ |+||+++++.+.. ..
T Consensus 2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~----~~~~k~~~~~~~~~~~~~e~~~~~~l~-~~~i~~~~~~~~~-----~~ 71 (256)
T cd06612 2 EEVFDILEKLGEGSYGSVYKAIHKETGQ----VVAIKVVPVEEDLQEIIKEISILKQCD-SPYIVKYYGSYFK-----NT 71 (256)
T ss_pred cccchhhhhhcCCCCeEEEEEEEcCCCc----EEEEEEeecHHHHHHHHHHHHHHHhCC-CCcEeeeeeeeec-----CC
Confidence 4789999999999999999999987654 5566665433 2567889999999996 9999999987653 23
Q ss_pred EEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEeecCCc
Q 039291 84 AYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVA 163 (362)
Q Consensus 84 ~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Dfgla 163 (362)
.+|+++||+.+++|.+++... +..+++..++.++.|++.||.|||+.+++|+||+|+||++ +.++.++|+|||++
T Consensus 72 ~~~l~~e~~~~~~L~~~l~~~-~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~----~~~~~~~l~dfg~~ 146 (256)
T cd06612 72 DLWIVMEYCGAGSVSDIMKIT-NKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILL----NEEGQAKLADFGVS 146 (256)
T ss_pred cEEEEEecCCCCcHHHHHHhC-ccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEE----CCCCcEEEcccccc
Confidence 577999999999999999763 3568999999999999999999999999999999999999 77778999999998
Q ss_pred ccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHHcC-CCCCCCC
Q 039291 164 KRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGD-EHSLPEI 242 (362)
Q Consensus 164 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~-~~~~~~~ 242 (362)
........ ......|+..|+|||++.+..++.++||||||+++|+|++|+.||...... .....+.. .......
T Consensus 147 ~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~---~~~~~~~~~~~~~~~~ 221 (256)
T cd06612 147 GQLTDTMA--KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPM---RAIFMIPNKPPPTLSD 221 (256)
T ss_pred hhcccCcc--ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchh---hhhhhhccCCCCCCCc
Confidence 76544221 123455889999999999888999999999999999999999999654322 21111111 1111123
Q ss_pred CccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCc
Q 039291 243 PSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFV 277 (362)
Q Consensus 243 ~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~ 277 (362)
+..++.++.++|.+||..||++|||+.+++.||||
T Consensus 222 ~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~~~~ 256 (256)
T cd06612 222 PEKWSPEFNDFVKKCLVKDPEERPSAIQLLQHPFI 256 (256)
T ss_pred hhhcCHHHHHHHHHHHhcChhhCcCHHHHhcCCCC
Confidence 44578899999999999999999999999999997
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-45 Score=361.10 Aligned_cols=256 Identities=36% Similarity=0.643 Sum_probs=213.8
Q ss_pred CceeecceecccCceEEEEEEECCCCCCCCceeeeechh-----hhhhHHHHHHHHHHHHcCCCCcccccccceeeecCC
Q 039291 6 TSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAE-----VSASASLQKEKEVFDNLNGCPFVLECFGEEITMGEN 80 (362)
Q Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~-----~~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~ 80 (362)
-||..+-+||.|.||.||.|.+..+|+ ..|+|... ......+.+|+.++..++ |||+|++|++.++..
T Consensus 1235 ~rWqrg~~Ig~G~fG~VYtavN~~tGe----llAvKEI~iq~~~~k~~~~i~eEm~vlE~ln-HpNlV~YyGVEvHRe-- 1307 (1509)
T KOG4645|consen 1235 FRWQRGNFIGGGTFGKVYTAVNLDTGE----LLAVKEIKIQDSDHKTFKLIAEEMKVLEGLN-HPNLVRYYGVEVHRE-- 1307 (1509)
T ss_pred eeeccccccCCcceeeeEEeecCCccc----hhhhhhhhcCccccccCcchHHHHHHHHhcc-CccccccCceeecHH--
Confidence 478889999999999999999999987 44555443 234456889999999999 999999999877532
Q ss_pred CceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEeec
Q 039291 81 GEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADL 160 (362)
Q Consensus 81 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Df 160 (362)
..+|.||||+||+|.++++. ++..+|...+.+..|++.|+.|||++|||||||||.||++ +.+|.+|++||
T Consensus 1308 ---kv~IFMEyC~~GsLa~ll~~--gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~L----d~~g~iK~~DF 1378 (1509)
T KOG4645|consen 1308 ---KVYIFMEYCEGGSLASLLEH--GRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILL----DFNGLIKYGDF 1378 (1509)
T ss_pred ---HHHHHHHHhccCcHHHHHHh--cchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceee----ecCCcEEeecc
Confidence 25699999999999999987 5568999999999999999999999999999999999999 88889999999
Q ss_pred CCccccccccc--CCCCCCccCCCCccCchhhcc---ccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHHcC
Q 039291 161 GVAKRSRHCKR--QKFDPSMRGTPLYLAPETVVQ---HMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGD 235 (362)
Q Consensus 161 gla~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~ 235 (362)
|.|........ .......+||+.|||||++.+ .+...++|||||||++.||+||+.||...+ +.-+++..+..
T Consensus 1379 Gsa~ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~d--ne~aIMy~V~~ 1456 (1509)
T KOG4645|consen 1379 GSAVKIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELD--NEWAIMYHVAA 1456 (1509)
T ss_pred cceeEecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhcc--chhHHHhHHhc
Confidence 99986654321 111236789999999999986 456788999999999999999999996443 23444445544
Q ss_pred CCCCCCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCccCc
Q 039291 236 EHSLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGV 280 (362)
Q Consensus 236 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~~~~ 280 (362)
++ .|.+|..++.+.++||.+||+.||++|.++.++++|.|-+.-
T Consensus 1457 gh-~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~~f~~~~ 1500 (1509)
T KOG4645|consen 1457 GH-KPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEHAFGKSC 1500 (1509)
T ss_pred cC-CCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHhhccccc
Confidence 43 477899999999999999999999999999999999886543
|
|
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=308.80 Aligned_cols=248 Identities=26% Similarity=0.424 Sum_probs=203.3
Q ss_pred ceeecceecccCceEEEEEEECCCCCCCCceeeeechh----hhhhHHHHHHHHHHHHcCCCCcccccccceeeecCCCc
Q 039291 7 SWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAE----VSASASLQKEKEVFDNLNGCPFVLECFGEEITMGENGE 82 (362)
Q Consensus 7 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~----~~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~~~ 82 (362)
+|.+.+.||+|+||.||+++++.++. .+++|... ....+.+.+|+.+++.++ |+||+++++.+.. .
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~----~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~-----~ 70 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQ----KYAMKEIRLPKSSSAVEDSRKEAVLLAKMK-HPNIVAFKESFEA-----D 70 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCc----eEEEEEEEcCcchHHHHHHHHHHHHHHhCC-CCCcceEEEEEEE-----C
Confidence 58899999999999999999988775 44555432 234466788999999998 8999999886542 3
Q ss_pred eEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEeecCC
Q 039291 83 MAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGV 162 (362)
Q Consensus 83 ~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Dfgl 162 (362)
..++++|||+++++|.+++.......+++..+..++.|++.||.|||++||+|+||||+||++ +.++.++|+|||+
T Consensus 71 ~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili----~~~~~~~l~dfg~ 146 (255)
T cd08219 71 GHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFL----TQNGKVKLGDFGS 146 (255)
T ss_pred CEEEEEEeeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEE----CCCCcEEEcccCc
Confidence 357899999999999999876555668999999999999999999999999999999999999 7777899999999
Q ss_pred cccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHHcCCCCCCCC
Q 039291 163 AKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEHSLPEI 242 (362)
Q Consensus 163 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 242 (362)
+....... .......|+..|+|||++.+..++.++|+||||+++|+|++|..||... +.......+.... .+..
T Consensus 147 ~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~---~~~~~~~~~~~~~-~~~~ 220 (255)
T cd08219 147 ARLLTSPG--AYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQAN---SWKNLILKVCQGS-YKPL 220 (255)
T ss_pred ceeecccc--cccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCC---CHHHHHHHHhcCC-CCCC
Confidence 87554322 1223466899999999999888999999999999999999999999543 3344444443332 3345
Q ss_pred CccCCHHHHHHHHHHhccCCCCCCCHHHHhcC
Q 039291 243 PSRVSKEARDFLRRCFVRKPAFRFTAEMLLDD 274 (362)
Q Consensus 243 ~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~ 274 (362)
+..++..++++|.+||+.||++||++.+++..
T Consensus 221 ~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 221 PSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred CcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 66789999999999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-42 Score=315.48 Aligned_cols=260 Identities=25% Similarity=0.435 Sum_probs=207.8
Q ss_pred CceeecceecccCceEEEEEEECCCCCCCCceeeeechhh------hhhHHHHHHHHHHHHcCCCCcccccccceeeecC
Q 039291 6 TSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEV------SASASLQKEKEVFDNLNGCPFVLECFGEEITMGE 79 (362)
Q Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~------~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~ 79 (362)
+.|.+.+.||+|+||.||+|.++.++. .+++|.... .....+.+|+.+++.++ ||||+++++.+..
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~----~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~--- 72 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQ----RFAMKKINKQNLILRNQIQQVFVERDILTFAE-NPFVVSMFCSFET--- 72 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCc----EEEEEEeehhhhhhHHHHHHHHHHHHHHHhCC-CCCeeeeEEEEec---
Confidence 478999999999999999999988765 456655432 23346778999999998 8999999876532
Q ss_pred CCceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEee
Q 039291 80 NGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIAD 159 (362)
Q Consensus 80 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~D 159 (362)
...+++||||++|++|.+++.. .+.+++..+..++.|++.||.|||++|++||||||+||++ +..+.++|+|
T Consensus 73 --~~~~~lv~e~~~g~~L~~~l~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll----~~~~~~~l~d 144 (305)
T cd05609 73 --KRHLCMVMEYVEGGDCATLLKN--IGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLI----TSMGHIKLTD 144 (305)
T ss_pred --CCEEEEEEecCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEE----CCCCCEEEee
Confidence 3357899999999999999976 3459999999999999999999999999999999999999 7778899999
Q ss_pred cCCcccccccc-------------cCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCH
Q 039291 160 LGVAKRSRHCK-------------RQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSI 226 (362)
Q Consensus 160 fgla~~~~~~~-------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~ 226 (362)
||+++...... .........|+..|+|||.+.+..++.++|+|||||++|+|++|..||.+. ..
T Consensus 145 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~---~~ 221 (305)
T cd05609 145 FGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGD---TP 221 (305)
T ss_pred CCCccccCcCccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCC---CH
Confidence 99986321100 000112345788999999998888999999999999999999999999644 33
Q ss_pred HHHHHHHcCC-CCCCCCCccCCHHHHHHHHHHhccCCCCCCC---HHHHhcCCCccCcchhh
Q 039291 227 DQLFSIIGDE-HSLPEIPSRVSKEARDFLRRCFVRKPAFRFT---AEMLLDDPFVKGVDEEL 284 (362)
Q Consensus 227 ~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s---~~~~l~~p~~~~~~~~~ 284 (362)
.++...+... ...+.....++.+++++|.+||..+|++||+ +.++++||||....+..
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~~~~~~ 283 (305)
T cd05609 222 EELFGQVISDDIEWPEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLGLDWNG 283 (305)
T ss_pred HHHHHHHHhcccCCCCccccCCHHHHHHHHHHhccChhhccCccCHHHHHhCccccCCCHHH
Confidence 4444443322 2333333468899999999999999999997 79999999998877664
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=307.93 Aligned_cols=251 Identities=27% Similarity=0.457 Sum_probs=206.3
Q ss_pred ceeecceecccCceEEEEEEECCCCCCCCceeeeechh-----hhhhHHHHHHHHHHHHcCCCCcccccccceeeecCCC
Q 039291 7 SWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAE-----VSASASLQKEKEVFDNLNGCPFVLECFGEEITMGENG 81 (362)
Q Consensus 7 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~-----~~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~~ 81 (362)
+|.+.+.||+|+||.||++++..++. .+++|... ......+.+|+.++++++ ||||+++++.+. .
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~----~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~-----~ 70 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGK----QYVIKEINISKMSPKEREESRKEVAVLSNMK-HPNIVQYQESFE-----E 70 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCC----EEEEEEEEhHhCChHHHHHHHHHHHHHHhCC-CCCeeeeEeeec-----C
Confidence 68999999999999999999988765 45666432 223456889999999999 899999988653 2
Q ss_pred ceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEeecC
Q 039291 82 EMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLG 161 (362)
Q Consensus 82 ~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Dfg 161 (362)
...+++|+||+.+++|.+++.......+++..+..++.|++.||.|||++|++|+||+|+||++ +.++.++|+|||
T Consensus 71 ~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~----~~~~~~~l~d~~ 146 (256)
T cd08218 71 NGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFL----TKDGTIKLGDFG 146 (256)
T ss_pred CCeEEEEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEE----cCCCCEEEeecc
Confidence 3457799999999999999987544568999999999999999999999999999999999999 667789999999
Q ss_pred CcccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHHcCCCCCCC
Q 039291 162 VAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEHSLPE 241 (362)
Q Consensus 162 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 241 (362)
++........ ......|+..|+|||++.+...+.++|+|||||++++|++|..||... +.......+... ..+.
T Consensus 147 ~~~~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~---~~~~~~~~~~~~-~~~~ 220 (256)
T cd08218 147 IARVLNSTVE--LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAG---NMKNLVLKIIRG-SYPP 220 (256)
T ss_pred ceeecCcchh--hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCC---CHHHHHHHHhcC-CCCC
Confidence 9875543211 112345888999999998888899999999999999999999999543 334444333322 2344
Q ss_pred CCccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCc
Q 039291 242 IPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFV 277 (362)
Q Consensus 242 ~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~ 277 (362)
.+..++.++.++|.+||+.+|++||++.+++.||||
T Consensus 221 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~~~~ 256 (256)
T cd08218 221 VSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEKNFI 256 (256)
T ss_pred CcccCCHHHHHHHHHHhhCChhhCcCHHHHhhCcCC
Confidence 567789999999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-42 Score=311.95 Aligned_cols=257 Identities=19% Similarity=0.296 Sum_probs=205.2
Q ss_pred CCCceeecceecccCceEEEEEEECCCCCCCCceeeeechhh----hhhHHHHHHHHHHHHcCCCCcccccccceeeecC
Q 039291 4 DGTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEV----SASASLQKEKEVFDNLNGCPFVLECFGEEITMGE 79 (362)
Q Consensus 4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~----~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~ 79 (362)
.-+.|++.+.||+|+||+||+|.+..++......+++|.... .....+.+|+.++++++ ||||+++++.+..
T Consensus 3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~--- 78 (283)
T cd05090 3 PLSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELH-HPNIVCLLGVVTQ--- 78 (283)
T ss_pred ChhhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCC-CCCeeeEEEEEec---
Confidence 346789999999999999999997655554556778887653 23356788999999998 9999999986542
Q ss_pred CCceEEEEEEEecCCCCHHHHHHHhc---------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEE
Q 039291 80 NGEMAYNLLLEYAAGGTLGDLIEKCN---------------GNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNIL 144 (362)
Q Consensus 80 ~~~~~~~lv~e~~~~~~L~~~l~~~~---------------~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nil 144 (362)
....+++|||+++++|.+++.... ...+++..+..++.|++.||.|||++|++||||||+|||
T Consensus 79 --~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nil 156 (283)
T cd05090 79 --EQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNIL 156 (283)
T ss_pred --CCceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEE
Confidence 224679999999999999986421 124789999999999999999999999999999999999
Q ss_pred EeecCCCceEEEEeecCCcccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHh-CCCCCccCCC
Q 039291 145 LVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLS-GRQAWVVKED 223 (362)
Q Consensus 145 l~~~~~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~ 223 (362)
+ +.++.+||+|||+++...............++..|+|||++.+..++.++|+|||||++|+|++ |..||....
T Consensus 157 i----~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~- 231 (283)
T cd05090 157 I----GEQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFS- 231 (283)
T ss_pred E----cCCCcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCC-
Confidence 9 6777899999999976543222222234556778999999988889999999999999999998 999996542
Q ss_pred CCHHHHHHHHcCCCCCCCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhcC
Q 039291 224 CSIDQLFSIIGDEHSLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDD 274 (362)
Q Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~ 274 (362)
.......+..... +..+..++.++++++.+||..||++||++.+++++
T Consensus 232 --~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 279 (283)
T cd05090 232 --NQEVIEMVRKRQL-LPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTR 279 (283)
T ss_pred --HHHHHHHHHcCCc-CCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 3344444443333 34567789999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=328.66 Aligned_cols=255 Identities=27% Similarity=0.394 Sum_probs=214.1
Q ss_pred CCceeecceecccCceEEEEEEECCCCCCCCceeeeechhhh-----hhHHHHHHHHHHHHcCCCCcccccccceeeecC
Q 039291 5 GTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVS-----ASASLQKEKEVFDNLNGCPFVLECFGEEITMGE 79 (362)
Q Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~~-----~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~ 79 (362)
-+-|.+.+.||+|.|++|.+|++..++. .|++|.+.+. ....+.+|+++|+.|+ ||||++++.+...
T Consensus 55 vg~y~i~~tig~g~f~~V~La~~~~t~~----~VaiK~idkt~ln~~~~~k~~rev~imk~l~-HPnIvkl~~v~~t--- 126 (596)
T KOG0586|consen 55 VGLYVIIKTIGKGNFAKVKLARHILTGT----EVAIKIIDKTQLNPSKRQKLGREVDIMKSLN-HPNIVKLFSVIET--- 126 (596)
T ss_pred ccceeeeeeeccceeEEEEeeEecCCCc----eEEEEEehhcccChHHHHHHHHHHHHHHhcC-Ccceeeeeeeeee---
Confidence 3579999999999999999999998875 5666665433 4456889999999999 9999999997643
Q ss_pred CCceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEee
Q 039291 80 NGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIAD 159 (362)
Q Consensus 80 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~D 159 (362)
+..+|+||||+.+|.+++++.+. +...+..++.++.|++.|++|||+++|||||||++|||+ +.+.++||+|
T Consensus 127 --~~~lylV~eya~~ge~~~yl~~~--gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL----~~~mnikIaD 198 (596)
T KOG0586|consen 127 --EATLYLVMEYASGGELFDYLVKH--GRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILL----DENMNIKIAD 198 (596)
T ss_pred --cceeEEEEEeccCchhHHHHHhc--ccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhccc----ccccceeeec
Confidence 34588999999999999999984 448889999999999999999999999999999999999 8888899999
Q ss_pred cCCcccccccccCCCCCCccCCCCccCchhhccccC-CCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHHcCCCC
Q 039291 160 LGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQ-EAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEHS 238 (362)
Q Consensus 160 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 238 (362)
||++..+.. .....+++|++.|.|||++.+..| ++.+|+||+|++||.|+.|.+||++..- .++.........
T Consensus 199 fgfS~~~~~---~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~l---k~Lr~rvl~gk~ 272 (596)
T KOG0586|consen 199 FGFSTFFDY---GLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNL---KELRPRVLRGKY 272 (596)
T ss_pred cccceeecc---cccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCccc---ccccchheeeee
Confidence 999987764 334468999999999999998766 6789999999999999999999976533 222222221211
Q ss_pred CCCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCccCcchh
Q 039291 239 LPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGVDEE 283 (362)
Q Consensus 239 ~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~~~~~~~ 283 (362)
.+|..++-+++++|+++|..+|.+|++.+++.+|.|.....++
T Consensus 273 --rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~~~W~n~~~~~ 315 (596)
T KOG0586|consen 273 --RIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKDRWRNDLLEA 315 (596)
T ss_pred --cccceeechhHHHHHHhhccCccccCCHHHhhhhcccchhhhh
Confidence 3566789999999999999999999999999999998665443
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-44 Score=292.44 Aligned_cols=261 Identities=22% Similarity=0.352 Sum_probs=214.5
Q ss_pred CCceeecceecccCceEEEEEEECCCCCCCCceeeeechhhhhhHHHHHHHHHHHHcCCCCcccccccceeeecCCCceE
Q 039291 5 GTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVSASASLQKEKEVFDNLNGCPFVLECFGEEITMGENGEMA 84 (362)
Q Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~~~~~ 84 (362)
-+.|++.+.+|+|.|++|+.|+...+++ ++.+|++++-..+.+.+|+.||..|.++|||++++++..... + ..
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~e----K~ViKiLKPVkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~--S-kt 109 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNE----KCVIKILKPVKKKKIKREIKILQNLRGGPNIIKLLDIVKDPE--S-KT 109 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCc----eEEEeeechHHHHHHHHHHHHHHhccCCCCeeehhhhhcCcc--c-cC
Confidence 3679999999999999999999887765 778999888888999999999999999999999999776432 2 23
Q ss_pred EEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEeecCCcc
Q 039291 85 YNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAK 164 (362)
Q Consensus 85 ~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Dfgla~ 164 (362)
..||+||+.+.+...+... ++.-.++.++.||+.||.|||++||+|||+||.|+++. .....++|+|+|+|.
T Consensus 110 paLiFE~v~n~Dfk~ly~t-----l~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmId---h~~rkLrlIDWGLAE 181 (338)
T KOG0668|consen 110 PSLIFEYVNNTDFKQLYPT-----LTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMID---HELRKLRLIDWGLAE 181 (338)
T ss_pred chhHhhhhccccHHHHhhh-----hchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeec---hhhceeeeeecchHh
Confidence 4589999999998888876 89999999999999999999999999999999999993 455679999999999
Q ss_pred cccccccCCCCCCccCCCCccCchhhcc-ccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHHc---------
Q 039291 165 RSRHCKRQKFDPSMRGTPLYLAPETVVQ-HMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIG--------- 234 (362)
Q Consensus 165 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~--------- 234 (362)
++....... ..+.+..|..||.+.. ..|+..-|+|||||+|..|+..+.||.... .+.+++.++..
T Consensus 182 FYHp~~eYn---VRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~-dN~DQLVkIakVLGt~el~~ 257 (338)
T KOG0668|consen 182 FYHPGKEYN---VRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGH-DNYDQLVKIAKVLGTDELYA 257 (338)
T ss_pred hcCCCceee---eeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCC-CCHHHHHHHHHHhChHHHHH
Confidence 887654443 4567889999999886 468999999999999999999999986432 24455443321
Q ss_pred --------------------CCCCCCC-----CCccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCccCcchhh
Q 039291 235 --------------------DEHSLPE-----IPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGVDEEL 284 (362)
Q Consensus 235 --------------------~~~~~~~-----~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~~~~~~~~ 284 (362)
....+.. ...-+++++.+|+.++|..|..+|+||.|++.||||..+.+..
T Consensus 258 Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF~~~~~~~ 332 (338)
T KOG0668|consen 258 YLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFAPVREAE 332 (338)
T ss_pred HHHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchHHHHHHHh
Confidence 0001110 1112569999999999999999999999999999998776553
|
|
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=312.47 Aligned_cols=252 Identities=26% Similarity=0.423 Sum_probs=202.5
Q ss_pred ecccCceEEEEEEECCCCCCCCceeeeechhh------hhhHHHHHHHHHHHHcCCCCcccccccceeeecCCCceEEEE
Q 039291 14 IGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEV------SASASLQKEKEVFDNLNGCPFVLECFGEEITMGENGEMAYNL 87 (362)
Q Consensus 14 lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~------~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~~~~~~~l 87 (362)
||+|+||+||+|.++.++.. +++|.... .....+.+|+++++.++ ||||+++++.+.. ...+|+
T Consensus 1 lg~g~~g~vy~~~~~~~~~~----~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~-----~~~~~l 70 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKM----YACKKLDKKRLKKRKGEQMALNEKKILEKVS-SRFIVSLAYAFET-----KDDLCL 70 (277)
T ss_pred CCCCCceeEEEEEEcCCCcE----EEEEEEehhhhhhhhhhHHHHHHHHHHHhCC-CCCEeeeeeEEec-----CCeEEE
Confidence 69999999999999887764 45554322 22345678999999998 9999999876532 235789
Q ss_pred EEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEeecCCccccc
Q 039291 88 LLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSR 167 (362)
Q Consensus 88 v~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Dfgla~~~~ 167 (362)
||||+++++|.+++.......+++..+..++.|++.||.|||+.|++|+||+|+||++ +.++.++|+|||++....
T Consensus 71 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~----~~~~~~~l~dfg~~~~~~ 146 (277)
T cd05577 71 VMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLL----DDHGNVRISDLGLAVELK 146 (277)
T ss_pred EEecCCCCcHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEE----CCCCCEEEccCcchhhhc
Confidence 9999999999999987554569999999999999999999999999999999999999 777789999999987543
Q ss_pred ccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHhCCCCCccCCC-CCHHHHHHHHcCCCCCCCCCccC
Q 039291 168 HCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKED-CSIDQLFSIIGDEHSLPEIPSRV 246 (362)
Q Consensus 168 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 246 (362)
. ........++..|+|||++.+..++.++|+|||||++|+|++|+.||..... .....+...+.. .....+..+
T Consensus 147 ~---~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~ 221 (277)
T cd05577 147 G---GKKIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLE--MAVEYPDKF 221 (277)
T ss_pred c---CCccccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhcccc--ccccCCccC
Confidence 3 1111345678899999999888899999999999999999999999965543 222333222221 223455678
Q ss_pred CHHHHHHHHHHhccCCCCCC-----CHHHHhcCCCccCcchhh
Q 039291 247 SKEARDFLRRCFVRKPAFRF-----TAEMLLDDPFVKGVDEEL 284 (362)
Q Consensus 247 ~~~~~~li~~~l~~~p~~R~-----s~~~~l~~p~~~~~~~~~ 284 (362)
+++++++|.+||+.+|.+|| ++.+++.||||....+..
T Consensus 222 ~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~h~~~~~~~~~~ 264 (277)
T cd05577 222 SPEAKDLCEALLQKDPEKRLGCRGGSADEVREHPLFKDLNWRR 264 (277)
T ss_pred CHHHHHHHHHHccCChhHccCCCcccHHHHHhChhhhcCChhh
Confidence 99999999999999999999 889999999998876653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-42 Score=313.14 Aligned_cols=254 Identities=28% Similarity=0.471 Sum_probs=198.1
Q ss_pred CceeecceecccCceEEEEEEECCCCCCCCceeeeechhh-----hhhHHHHHHHHHHHHcCCCCcccccccceeeecCC
Q 039291 6 TSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEV-----SASASLQKEKEVFDNLNGCPFVLECFGEEITMGEN 80 (362)
Q Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~-----~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~ 80 (362)
++|.+.+.||+|++|.||+|+++.+++. +++|.... ...+.+.+|+.+++.++ |+|++++++.+..
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~----~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~-h~~i~~~~~~~~~---- 71 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQI----VAIKKFVESEDDPVIKKIALREIRMLKQLK-HPNLVNLIEVFRR---- 71 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcE----EEEEEEeecccCccccHHHHHHHHHHHhCC-CCCEeeeeeEEee----
Confidence 5799999999999999999999887764 45554321 22345778999999998 8999999987642
Q ss_pred CceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEeec
Q 039291 81 GEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADL 160 (362)
Q Consensus 81 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Df 160 (362)
...+++||||++++.|..++.. ...+++..++.++.||+.||.|||++|++|+||||+||++ +.++.++|+||
T Consensus 72 -~~~~~~v~e~~~~~~l~~~~~~--~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~----~~~~~~~l~df 144 (286)
T cd07847 72 -KRKLHLVFEYCDHTVLNELEKN--PRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILI----TKQGQIKLCDF 144 (286)
T ss_pred -CCEEEEEEeccCccHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEE----cCCCcEEECcc
Confidence 2357799999999888877654 3459999999999999999999999999999999999999 77778999999
Q ss_pred CCcccccccccCCCCCCccCCCCccCchhhcc-ccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHH-HcC---
Q 039291 161 GVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQ-HMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSI-IGD--- 235 (362)
Q Consensus 161 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~-~~~--- 235 (362)
|++......... .....++..|+|||++.+ ..++.++|+||||+++|+|++|.+||.+....+....... ...
T Consensus 145 g~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 222 (286)
T cd07847 145 GFARILTGPGDD--YTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIP 222 (286)
T ss_pred ccceecCCCccc--ccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCh
Confidence 999765442211 124568889999999876 4578899999999999999999999975543222111111 000
Q ss_pred -------------CCCCCC---------CCccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCc
Q 039291 236 -------------EHSLPE---------IPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFV 277 (362)
Q Consensus 236 -------------~~~~~~---------~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~ 277 (362)
....+. ....++..+.+||.+||..+|++||++.+++.||||
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~f 286 (286)
T cd07847 223 RHQQIFSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF 286 (286)
T ss_pred HHhhhcccccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcCCCC
Confidence 000000 113467889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-42 Score=306.23 Aligned_cols=253 Identities=36% Similarity=0.645 Sum_probs=204.7
Q ss_pred ceeecceecccCceEEEEEEECCCCCCCCceeeeechh----hhhhHHHHHHHHHHHHcCCCCcccccccceeeecCCCc
Q 039291 7 SWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAE----VSASASLQKEKEVFDNLNGCPFVLECFGEEITMGENGE 82 (362)
Q Consensus 7 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~----~~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~~~ 82 (362)
+|...+.||+|++|+||+|.+..++..++.++..+... ....+.+.+|+.+++.++ |+||+++++.+.. .
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~-h~~i~~~~~~~~~-----~ 74 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQ-HPNIVQYLGTERE-----E 74 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcC-CCCchheeeeEec-----C
Confidence 68889999999999999999987665433332222111 124466889999999998 8999999986532 2
Q ss_pred eEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEeecCC
Q 039291 83 MAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGV 162 (362)
Q Consensus 83 ~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Dfgl 162 (362)
..+++++||+++++|.+++.. ...+++..+..++.||+.||.|||+.|++|+||+|+||++ +.++.+||+|||+
T Consensus 75 ~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~----~~~~~~kl~d~~~ 148 (258)
T cd06632 75 DNLYIFLELVPGGSLAKLLKK--YGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILV----DTNGVVKLADFGM 148 (258)
T ss_pred CeEEEEEEecCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE----CCCCCEEEccCcc
Confidence 357799999999999999976 3458999999999999999999999999999999999999 7778899999999
Q ss_pred cccccccccCCCCCCccCCCCccCchhhcccc-CCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHHcCCCCCCC
Q 039291 163 AKRSRHCKRQKFDPSMRGTPLYLAPETVVQHM-QEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEHSLPE 241 (362)
Q Consensus 163 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 241 (362)
+....... ......|+..|+|||.+.... ++.++|+|||||++|+|++|..||.... .......+......+.
T Consensus 149 ~~~~~~~~---~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~---~~~~~~~~~~~~~~~~ 222 (258)
T cd06632 149 AKQVVEFS---FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLE---GVAAVFKIGRSKELPP 222 (258)
T ss_pred ceeccccc---cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCc---HHHHHHHHHhcccCCC
Confidence 87554322 123456899999999988766 8899999999999999999999995433 2333333333344566
Q ss_pred CCccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCc
Q 039291 242 IPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFV 277 (362)
Q Consensus 242 ~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~ 277 (362)
++..++.++++++.+||..+|++||++.+++.|||+
T Consensus 223 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~~ 258 (258)
T cd06632 223 IPDHLSDEAKDFILKCLQRDPSLRPTAAELLEHPFV 258 (258)
T ss_pred cCCCcCHHHHHHHHHHhhcCcccCcCHHHHhcCCCC
Confidence 777889999999999999999999999999999996
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-42 Score=310.71 Aligned_cols=254 Identities=19% Similarity=0.309 Sum_probs=204.1
Q ss_pred CCCceeecceecccCceEEEEEEECCCCCCCCceeeeechhh----hhhHHHHHHHHHHHHcCCCCcccccccceeeecC
Q 039291 4 DGTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEV----SASASLQKEKEVFDNLNGCPFVLECFGEEITMGE 79 (362)
Q Consensus 4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~----~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~ 79 (362)
..++|.+.+.||+|+||+||+|++..++.....+|++|.... .....+.+|+.+++.++ ||||+++++.+..
T Consensus 5 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~--- 80 (279)
T cd05109 5 KETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVG-SPYVCRLLGICLT--- 80 (279)
T ss_pred chhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcC-CCCCceEEEEEcC---
Confidence 567899999999999999999998877776666778887542 23456778999999998 8999999886642
Q ss_pred CCceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEee
Q 039291 80 NGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIAD 159 (362)
Q Consensus 80 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~D 159 (362)
...++++||+++|+|.+++... ...+++..+..++.|++.||.|||++||+||||||+|||+ +.++.+||+|
T Consensus 81 ---~~~~l~~~~~~~g~l~~~l~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~----~~~~~~kL~d 152 (279)
T cd05109 81 ---STVQLVTQLMPYGCLLDYVREN-KDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLV----KSPNHVKITD 152 (279)
T ss_pred ---CCcEEEEEcCCCCCHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEE----cCCCcEEECC
Confidence 1245899999999999999763 3459999999999999999999999999999999999999 6667799999
Q ss_pred cCCcccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHh-CCCCCccCCCCCHHHHHHHHcCCCC
Q 039291 160 LGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLS-GRQAWVVKEDCSIDQLFSIIGDEHS 238 (362)
Q Consensus 160 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~ 238 (362)
||+++...............++..|+|||.+.+..++.++|||||||++|||++ |..||... ....+...+.....
T Consensus 153 fG~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~---~~~~~~~~~~~~~~ 229 (279)
T cd05109 153 FGLARLLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGI---PAREIPDLLEKGER 229 (279)
T ss_pred CCceeecccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCC---CHHHHHHHHHCCCc
Confidence 999976543222111122345678999999988889999999999999999998 99998543 33334444433333
Q ss_pred CCCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhc
Q 039291 239 LPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLD 273 (362)
Q Consensus 239 ~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~ 273 (362)
. ..+..++.++.+++.+||..||++||++.++++
T Consensus 230 ~-~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~ 263 (279)
T cd05109 230 L-PQPPICTIDVYMIMVKCWMIDSECRPRFRELVD 263 (279)
T ss_pred C-CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 2 345668899999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-44 Score=313.13 Aligned_cols=264 Identities=24% Similarity=0.354 Sum_probs=206.8
Q ss_pred CCCCCceeecceecccCceEEEEEEECCCCCCCCceeeeechhh--hhhHHHHHHHHHHHHcCCCC-----cccccccce
Q 039291 2 DSDGTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEV--SASASLQKEKEVFDNLNGCP-----FVLECFGEE 74 (362)
Q Consensus 2 ~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~--~~~~~~~~E~~il~~l~~h~-----~i~~~~~~~ 74 (362)
|.-.+||.+.+.+|+|.||.|..+.|..++. .||+|+++. ...+...-|+++|.+++++. .++.+.+++
T Consensus 85 D~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~----~vAlKIik~V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wF 160 (415)
T KOG0671|consen 85 DILTNRYEIVDLLGEGTFGKVVECWDRETKE----HVALKIIKNVDKYREAALIEIEVLQKINESDPNGKFRCVQMRDWF 160 (415)
T ss_pred cccccceehhhhhcCCcccceEEEeecCCCc----eehHHHHHHHHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhh
Confidence 4457899999999999999999999998854 567776542 23445678999999996432 233343322
Q ss_pred eeecCCCceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecC-----
Q 039291 75 ITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQ----- 149 (362)
Q Consensus 75 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~----- 149 (362)
+-....|+|+|.+ |.++.+++...+..+++..+++.+.+||+.+++|||+.+++|-||||+|||+.++.
T Consensus 161 -----dyrghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~ 234 (415)
T KOG0671|consen 161 -----DYRGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTY 234 (415)
T ss_pred -----hccCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEe
Confidence 3344589999999 66999999987778899999999999999999999999999999999999996442
Q ss_pred -----------CCceEEEEeecCCcccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHhCCCCC
Q 039291 150 -----------SGKFVAKIADLGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAW 218 (362)
Q Consensus 150 -----------~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf 218 (362)
..+..|+|+|||.|+...... ...+.|..|+|||++.+-+++.++||||+||||+|+++|...|
T Consensus 235 ~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~h-----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LF 309 (415)
T KOG0671|consen 235 NPKKKVCFIRPLKSTAIKVIDFGSATFDHEHH-----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLF 309 (415)
T ss_pred ccCCccceeccCCCcceEEEecCCcceeccCc-----ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceec
Confidence 124568999999997554321 4678999999999999999999999999999999999999999
Q ss_pred ccCCCCCHHHHHHHHcCCC-------------------CCCC--------------CC-----cc---CCHHHHHHHHHH
Q 039291 219 VVKEDCSIDQLFSIIGDEH-------------------SLPE--------------IP-----SR---VSKEARDFLRRC 257 (362)
Q Consensus 219 ~~~~~~~~~~~~~~~~~~~-------------------~~~~--------------~~-----~~---~~~~~~~li~~~ 257 (362)
+..++.....++..+.+.. .++. .| .. .-.++.+||++|
T Consensus 310 qtHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~m 389 (415)
T KOG0671|consen 310 QTHENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRM 389 (415)
T ss_pred ccCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHH
Confidence 8887555445555553211 0000 00 00 113477999999
Q ss_pred hccCCCCCCCHHHHhcCCCccCc
Q 039291 258 FVRKPAFRFTAEMLLDDPFVKGV 280 (362)
Q Consensus 258 l~~~p~~R~s~~~~l~~p~~~~~ 280 (362)
|..||.+|+|+.|+|.||||+..
T Consensus 390 L~fDP~~RiTl~EAL~HpFF~~~ 412 (415)
T KOG0671|consen 390 LEFDPARRITLREALSHPFFARL 412 (415)
T ss_pred HccCccccccHHHHhcCHHhhcC
Confidence 99999999999999999999764
|
|
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-43 Score=338.12 Aligned_cols=266 Identities=21% Similarity=0.213 Sum_probs=193.4
Q ss_pred CceeecceecccCceEEEEEEECCCCCCCC---------------ceeeeechh--hhhhHHHHHHHHHHHHcCCCCccc
Q 039291 6 TSWFRGRVIGQGSFGCVFIAKPKSNSSFLP---------------PLMAVKSAE--VSASASLQKEKEVFDNLNGCPFVL 68 (362)
Q Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~---------------~~~~~K~~~--~~~~~~~~~E~~il~~l~~h~~i~ 68 (362)
++|.+++.||+|+||+||+|..+....... .++..|... ......+.+|+.+|++++ ||||+
T Consensus 148 ~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~-HpnIv 226 (501)
T PHA03210 148 AHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLN-HENIL 226 (501)
T ss_pred hccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCC-CCCcC
Confidence 579999999999999999997654322111 111112211 123445789999999998 99999
Q ss_pred ccccceeeecCCCceEEEEEEEecCCCCHHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEE
Q 039291 69 ECFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCN---GNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILL 145 (362)
Q Consensus 69 ~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill 145 (362)
++++++.. ....|++++++. ++|.+++.... ........++.++.||+.||.|||++|||||||||+|||+
T Consensus 227 ~l~~~~~~-----~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl 300 (501)
T PHA03210 227 KIEEILRS-----EANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFL 300 (501)
T ss_pred cEeEEEEE-----CCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE
Confidence 99987643 224678999995 57777765421 1224467788999999999999999999999999999999
Q ss_pred eecCCCceEEEEeecCCcccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHhCCCCCcc-CCCC
Q 039291 146 VATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVV-KEDC 224 (362)
Q Consensus 146 ~~~~~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~-~~~~ 224 (362)
+.++.+||+|||+++...... ........||..|+|||++.+..++.++|||||||++|||++|..++.. ....
T Consensus 301 ----~~~~~vkL~DFGla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~ 375 (501)
T PHA03210 301 ----NCDGKIVLGDFGTAMPFEKER-EAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGK 375 (501)
T ss_pred ----CCCCCEEEEeCCCceecCccc-ccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCC
Confidence 777889999999997654321 1222356799999999999998999999999999999999998764433 2222
Q ss_pred CHHHHHHHHcCCC----CCC----------------CC---------CccCCHHHHHHHHHHhccCCCCCCCHHHHhcCC
Q 039291 225 SIDQLFSIIGDEH----SLP----------------EI---------PSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDP 275 (362)
Q Consensus 225 ~~~~~~~~~~~~~----~~~----------------~~---------~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p 275 (362)
...++...+.... .++ .. ...++.++.++|.+||..||.+|||+.+++.||
T Consensus 376 ~~~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp 455 (501)
T PHA03210 376 PGKQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALP 455 (501)
T ss_pred HHHHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhCh
Confidence 2223322221100 000 00 013567788899999999999999999999999
Q ss_pred CccCcchh
Q 039291 276 FVKGVDEE 283 (362)
Q Consensus 276 ~~~~~~~~ 283 (362)
||.....+
T Consensus 456 ~f~~~~~~ 463 (501)
T PHA03210 456 LFSAEEEE 463 (501)
T ss_pred hhhcCCch
Confidence 99876443
|
|
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-42 Score=310.68 Aligned_cols=254 Identities=18% Similarity=0.280 Sum_probs=204.8
Q ss_pred CCCceeecceecccCceEEEEEEECCCCCCCCceeeeechhhh----hhHHHHHHHHHHHHcCCCCcccccccceeeecC
Q 039291 4 DGTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVS----ASASLQKEKEVFDNLNGCPFVLECFGEEITMGE 79 (362)
Q Consensus 4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~~----~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~ 79 (362)
..++|.+.+.||+|+||+||+|++..++..++.++++|..... ....+..|+.+++++. ||||+++++++.
T Consensus 5 ~~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~-h~~iv~~~~~~~---- 79 (279)
T cd05111 5 KETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLD-HAYIVRLLGICP---- 79 (279)
T ss_pred CHhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCC-CCCcceEEEEEC----
Confidence 3468999999999999999999998888776677888887533 2345667777888888 899999998642
Q ss_pred CCceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEee
Q 039291 80 NGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIAD 159 (362)
Q Consensus 80 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~D 159 (362)
. ...++++||+++|+|.+++... ...+++..+..++.|++.||.|||++|++||||||+||++ +.++.+||+|
T Consensus 80 ~--~~~~~i~e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili----~~~~~~kl~D 152 (279)
T cd05111 80 G--ASLQLVTQLSPLGSLLDHVRQH-RDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILL----KSDSIVQIAD 152 (279)
T ss_pred C--CccEEEEEeCCCCcHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEE----cCCCcEEEcC
Confidence 1 1256899999999999999763 3459999999999999999999999999999999999999 7788899999
Q ss_pred cCCcccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHh-CCCCCccCCCCCHHHHHHHHcCCCC
Q 039291 160 LGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLS-GRQAWVVKEDCSIDQLFSIIGDEHS 238 (362)
Q Consensus 160 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~ 238 (362)
||+++...............++..|+|||++.+..++.++|||||||++|||++ |..||.+. ........+....
T Consensus 153 fg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~---~~~~~~~~~~~~~- 228 (279)
T cd05111 153 FGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGM---RPHEVPDLLEKGE- 228 (279)
T ss_pred CccceeccCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCC---CHHHHHHHHHCCC-
Confidence 999976543322222234557788999999988889999999999999999998 99999654 3333334343332
Q ss_pred CCCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhc
Q 039291 239 LPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLD 273 (362)
Q Consensus 239 ~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~ 273 (362)
.+..+..++.++.+++.+||..+|++|||+.++++
T Consensus 229 ~~~~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~ 263 (279)
T cd05111 229 RLAQPQICTIDVYMVMVKCWMIDENVRPTFKELAN 263 (279)
T ss_pred cCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 33345567889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=311.77 Aligned_cols=257 Identities=21% Similarity=0.361 Sum_probs=205.1
Q ss_pred CCCCceeecceecccCceEEEEEEECCCC-CCCCceeeeechhhh----hhHHHHHHHHHHHHcCCCCcccccccceeee
Q 039291 3 SDGTSWFRGRVIGQGSFGCVFIAKPKSNS-SFLPPLMAVKSAEVS----ASASLQKEKEVFDNLNGCPFVLECFGEEITM 77 (362)
Q Consensus 3 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~-~~~~~~~~~K~~~~~----~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~ 77 (362)
...++|.+.+.||+|+||.||+|++.... ......+++|..... ....+.+|+++++.+. |+||+++++.+...
T Consensus 2 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~ 80 (280)
T cd05049 2 VQRDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQ-HENIVKFYGVCTEG 80 (280)
T ss_pred CChHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcC-CCCchheeeEEecC
Confidence 34578999999999999999999875432 122346777765432 3467889999999998 89999999876532
Q ss_pred cCCCceEEEEEEEecCCCCHHHHHHHhc------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEE
Q 039291 78 GENGEMAYNLLLEYAAGGTLGDLIEKCN------------GNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILL 145 (362)
Q Consensus 78 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~------------~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill 145 (362)
...+++|||+++++|.+++.... ...+++..+..++.|++.||.|||++|++||||||+||++
T Consensus 81 -----~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili 155 (280)
T cd05049 81 -----DPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLV 155 (280)
T ss_pred -----CCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEE
Confidence 34779999999999999997632 1348899999999999999999999999999999999999
Q ss_pred eecCCCceEEEEeecCCcccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHh-CCCCCccCCCC
Q 039291 146 VATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLS-GRQAWVVKEDC 224 (362)
Q Consensus 146 ~~~~~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~ 224 (362)
+.++.++|+|||++................++..|+|||++.+..++.++|||||||++|+|++ |..||...+
T Consensus 156 ----~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~-- 229 (280)
T cd05049 156 ----GYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLS-- 229 (280)
T ss_pred ----cCCCeEEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCC--
Confidence 7778999999999875443222222234456788999999999899999999999999999998 999996443
Q ss_pred CHHHHHHHHcCCCCCCCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhc
Q 039291 225 SIDQLFSIIGDEHSLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLD 273 (362)
Q Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~ 273 (362)
.......+... ..+..+..++..+++++.+||..||++||+++++++
T Consensus 230 -~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 276 (280)
T cd05049 230 -NEEVIECITQG-RLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHE 276 (280)
T ss_pred -HHHHHHHHHcC-CcCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 33444444332 233445678999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-42 Score=309.09 Aligned_cols=248 Identities=24% Similarity=0.374 Sum_probs=194.1
Q ss_pred Cceeeccee--cccCceEEEEEEECCCCCCCCceeeeechhhhhhHHHHHHHHHHHHcCCCCcccccccceeeecCCCce
Q 039291 6 TSWFRGRVI--GQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVSASASLQKEKEVFDNLNGCPFVLECFGEEITMGENGEM 83 (362)
Q Consensus 6 ~~y~~~~~l--G~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~~~~ 83 (362)
+.|.+.+.+ |+|+||.||++.++.++. .+++|......... .|......+.+||||+++++.+.. ..
T Consensus 14 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~----~~~~k~~~~~~~~~--~e~~~~~~~~~h~~iv~~~~~~~~-----~~ 82 (267)
T PHA03390 14 KNCEIVKKLKLIDGKFGKVSVLKHKPTQK----LFVQKIIKAKNFNA--IEPMVHQLMKDNPNFIKLYYSVTT-----LK 82 (267)
T ss_pred HhhccccceeecCCCceEEEEEEEcCCCc----EEEEEEEehhhcch--hhHHHHHHhhcCCCEEEEEEEEec-----CC
Confidence 456666666 999999999999988875 45665554332221 233333334469999999987643 22
Q ss_pred EEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCce-EEEEeecCC
Q 039291 84 AYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKF-VAKIADLGV 162 (362)
Q Consensus 84 ~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~-~~kl~Dfgl 162 (362)
.+++||||+++++|.+++... .++++..++.++.|++.||.|||+.|++||||||+||++ +.++ .++|+|||+
T Consensus 83 ~~~iv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~----~~~~~~~~l~dfg~ 156 (267)
T PHA03390 83 GHVLIMDYIKDGDLFDLLKKE--GKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLY----DRAKDRIYLCDYGL 156 (267)
T ss_pred eeEEEEEcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEE----eCCCCeEEEecCcc
Confidence 578999999999999999763 369999999999999999999999999999999999999 5555 799999999
Q ss_pred cccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHhCCCCCccCCCCC--HHHHHHHHcCCCCCC
Q 039291 163 AKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCS--IDQLFSIIGDEHSLP 240 (362)
Q Consensus 163 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~ 240 (362)
+...... ....|+..|+|||++.+..++.++|+||+|+++|+|++|..||....... ...+.... ....
T Consensus 157 ~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~---~~~~ 227 (267)
T PHA03390 157 CKIIGTP------SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQ---QKKL 227 (267)
T ss_pred ceecCCC------ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhh---cccC
Confidence 8654321 23458999999999998889999999999999999999999997443322 22332222 1222
Q ss_pred CCCccCCHHHHHHHHHHhccCCCCCCC-HHHHhcCCCccC
Q 039291 241 EIPSRVSKEARDFLRRCFVRKPAFRFT-AEMLLDDPFVKG 279 (362)
Q Consensus 241 ~~~~~~~~~~~~li~~~l~~~p~~R~s-~~~~l~~p~~~~ 279 (362)
..+..++..+.++|.+||+.+|.+|++ ++++++||||+.
T Consensus 228 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h~~~~~ 267 (267)
T PHA03390 228 PFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKHPFLKI 267 (267)
T ss_pred CcccccCHHHHHHHHHHhccChhhCCchHHHHhcCCcccC
Confidence 345578999999999999999999996 699999999963
|
|
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-42 Score=308.42 Aligned_cols=253 Identities=27% Similarity=0.440 Sum_probs=202.2
Q ss_pred CCceeecceecccCceEEEEEEECCCCCCCCceeeeechhh---hhhHHHHHHHHHHHHcCCCCcccccccceeeecCCC
Q 039291 5 GTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEV---SASASLQKEKEVFDNLNGCPFVLECFGEEITMGENG 81 (362)
Q Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~---~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~~ 81 (362)
.++|.+.+.||.|+||.||+|++..++. .+++|.... .....+.+|+.+++.++ ||||+++++.+..
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~----~~~ik~~~~~~~~~~~~~~~e~~~l~~~~-h~~i~~~~~~~~~----- 71 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGE----LVAIKVIKLEPGDDFEIIQQEISMLKECR-HPNIVAYFGSYLR----- 71 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCC----EEEEEEEEcCchhhHHHHHHHHHHHHhCC-CCChhceEEEEEe-----
Confidence 3689999999999999999999987765 345554432 24567889999999998 9999999986643
Q ss_pred ceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEeecC
Q 039291 82 EMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLG 161 (362)
Q Consensus 82 ~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Dfg 161 (362)
...++++|||+.+++|.+++... ..++++..+..++.|++.||.|||++|++|+||||+||++ +.++.++|+|||
T Consensus 72 ~~~~~l~~e~~~~~~l~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i----~~~~~~~l~d~g 146 (262)
T cd06613 72 RDKLWIVMEYCGGGSLQDIYQVT-RGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILL----TEDGDVKLADFG 146 (262)
T ss_pred CCEEEEEEeCCCCCcHHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEE----CCCCCEEECccc
Confidence 23478999999999999998763 2469999999999999999999999999999999999999 777889999999
Q ss_pred CcccccccccCCCCCCccCCCCccCchhhccc---cCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHHcCCCC
Q 039291 162 VAKRSRHCKRQKFDPSMRGTPLYLAPETVVQH---MQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEHS 238 (362)
Q Consensus 162 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 238 (362)
++........ ......++..|+|||.+.+. .++.++|+|||||++|+|++|.+||..... .............
T Consensus 147 ~~~~~~~~~~--~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~--~~~~~~~~~~~~~ 222 (262)
T cd06613 147 VSAQLTATIA--KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHP--MRALFLISKSNFP 222 (262)
T ss_pred cchhhhhhhh--ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHhccCC
Confidence 9876543221 12345688999999999876 788999999999999999999999964432 1222222111111
Q ss_pred --CCCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCC
Q 039291 239 --LPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPF 276 (362)
Q Consensus 239 --~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~ 276 (362)
....+...+.++.+++++||..+|..|||+.+++.|+|
T Consensus 223 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~ 262 (262)
T cd06613 223 PPKLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQHPF 262 (262)
T ss_pred CccccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhcCCC
Confidence 11223456788999999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-44 Score=328.70 Aligned_cols=249 Identities=22% Similarity=0.350 Sum_probs=207.1
Q ss_pred CCCCceeecceecccCceEEEEEEECCCCCCCCceeeeech-----hhhhhHHHHHHHHHHHHcCCCCcccccccceeee
Q 039291 3 SDGTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSA-----EVSASASLQKEKEVFDNLNGCPFVLECFGEEITM 77 (362)
Q Consensus 3 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~-----~~~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~ 77 (362)
+.-+...+++.||+|.||+||+|++-+. ||+|.+ ..+..+.|+.|+.++++-. |.||+-+.|++...
T Consensus 389 Ip~~ev~l~~rIGsGsFGtV~Rg~whGd-------VAVK~Lnv~~pt~~qlqaFKnEVa~lkkTR-H~NIlLFMG~~~~p 460 (678)
T KOG0193|consen 389 IPPEEVLLGERIGSGSFGTVYRGRWHGD-------VAVKLLNVDDPTPEQLQAFKNEVAVLKKTR-HENILLFMGACMNP 460 (678)
T ss_pred cCHHHhhccceeccccccceeecccccc-------eEEEEEecCCCCHHHHHHHHHHHHHHhhcc-hhhheeeehhhcCC
Confidence 3445667889999999999999998764 566664 3457788999999999999 89999998877532
Q ss_pred cCCCceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEE
Q 039291 78 GENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKI 157 (362)
Q Consensus 78 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl 157 (362)
.+.+|..+|+|-+|..+++-.+ .+|+..+.+.|++|+++|+.|||.++|||||||..||++ .+++.|||
T Consensus 461 ------~~AIiTqwCeGsSLY~hlHv~e-tkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl----~~~~kVkI 529 (678)
T KOG0193|consen 461 ------PLAIITQWCEGSSLYTHLHVQE-TKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFL----HEDLKVKI 529 (678)
T ss_pred ------ceeeeehhccCchhhhhccchh-hhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEE----ccCCcEEE
Confidence 2469999999999999998744 459999999999999999999999999999999999999 88899999
Q ss_pred eecCCcccccccccCCCCCCccCCCCccCchhhcc---ccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHHc
Q 039291 158 ADLGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQ---HMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIG 234 (362)
Q Consensus 158 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~ 234 (362)
+||||+................|...|||||+++. .+|+..+|||||||++|||++|..||. ....++++-.++
T Consensus 530 gDFGLatvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPys---i~~~dqIifmVG 606 (678)
T KOG0193|consen 530 GDFGLATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYS---IQNRDQIIFMVG 606 (678)
T ss_pred ecccceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcC---CCChhheEEEec
Confidence 99999986554433333345568899999999983 578999999999999999999999996 335566666666
Q ss_pred CCCCCCC---CCccCCHHHHHHHHHHhccCCCCCCCHHHHhc
Q 039291 235 DEHSLPE---IPSRVSKEARDFLRRCFVRKPAFRFTAEMLLD 273 (362)
Q Consensus 235 ~~~~~~~---~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~ 273 (362)
.+...|. ...++++++++|+..||..++++||.+.++|.
T Consensus 607 rG~l~pd~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~ 648 (678)
T KOG0193|consen 607 RGYLMPDLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLS 648 (678)
T ss_pred ccccCccchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHH
Confidence 6644443 34567889999999999999999999999886
|
|
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-42 Score=310.15 Aligned_cols=261 Identities=25% Similarity=0.466 Sum_probs=206.2
Q ss_pred CceeecceecccCceEEEEEEECCCCCCCCceeeeechh----hhhhHHHHHHHHHHHHcCCCCcccccccceeeecCCC
Q 039291 6 TSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAE----VSASASLQKEKEVFDNLNGCPFVLECFGEEITMGENG 81 (362)
Q Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~----~~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~~ 81 (362)
++|...+.||.|++|.||+|.+..++. .+++|... ......+.+|++++++++ ||||+++++.+.. ..
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~----~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~---~~ 72 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGM----IFALKTITTDPNPDLQKQILRELEINKSCK-SPYIVKYYGAFLD---ES 72 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCe----EEEEEEEecCCchHHHHHHHHHHHHHHhCC-CCCeeeeeeEEEc---cC
Confidence 478999999999999999999988765 45555543 234566889999999998 9999999987643 22
Q ss_pred ceEEEEEEEecCCCCHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEee
Q 039291 82 EMAYNLLLEYAAGGTLGDLIEKC--NGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIAD 159 (362)
Q Consensus 82 ~~~~~lv~e~~~~~~L~~~l~~~--~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~D 159 (362)
...+++||||++|++|.+++... ....+++..+..++.||+.||.|||+.|++|+||+|+||++ +.++.++|+|
T Consensus 73 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~----~~~~~~~l~d 148 (287)
T cd06621 73 SSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILL----TRKGQVKLCD 148 (287)
T ss_pred CCeEEEEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE----ecCCeEEEee
Confidence 33577999999999999987642 23558999999999999999999999999999999999999 6677899999
Q ss_pred cCCcccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHhCCCCCccCCC--CCHHHHHHHHcCCC
Q 039291 160 LGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKED--CSIDQLFSIIGDEH 237 (362)
Q Consensus 160 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~--~~~~~~~~~~~~~~ 237 (362)
||++........ ....++..|+|||.+.+..++.++|+|||||++|+|++|..||..... ....+....+....
T Consensus 149 fg~~~~~~~~~~----~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 224 (287)
T cd06621 149 FGVSGELVNSLA----GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMP 224 (287)
T ss_pred cccccccccccc----ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCC
Confidence 999865432211 234578899999999988899999999999999999999999975522 22333333333211
Q ss_pred --CCCCCC---ccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCccCcch
Q 039291 238 --SLPEIP---SRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGVDE 282 (362)
Q Consensus 238 --~~~~~~---~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~~~~~~ 282 (362)
..+..+ ...+++++++|.+||..+|++|||+.+++.||||+....
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~~~~~ 274 (287)
T cd06621 225 NPELKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQMK 274 (287)
T ss_pred chhhccCCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCcccccccc
Confidence 111111 234678999999999999999999999999999976543
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-42 Score=306.52 Aligned_cols=253 Identities=28% Similarity=0.469 Sum_probs=208.2
Q ss_pred ceeecceecccCceEEEEEEECCCCCCCCceeeeech-----hhhhhHHHHHHHHHHHHcCCCCcccccccceeeecCCC
Q 039291 7 SWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSA-----EVSASASLQKEKEVFDNLNGCPFVLECFGEEITMGENG 81 (362)
Q Consensus 7 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~-----~~~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~~ 81 (362)
+|.+.+.||.|+||.||+|.+..++.. +++|.. .....+.+..|+.+++.++ |+||+++++.+.. ..
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~----~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~---~~ 72 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKI----LVWKEIDYGNMTEKEKQQLVSEVNILRELK-HPNIVRYYDRIID---RS 72 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCE----EEEEEEecccCCHHHHHHHHHHHHHHHhcC-CCccceeeeeeec---CC
Confidence 588999999999999999999887753 444443 2334556788999999999 8999999886543 22
Q ss_pred ceEEEEEEEecCCCCHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHH-----hCCceeCCCCCCCEEEeecCCCceE
Q 039291 82 EMAYNLLLEYAAGGTLGDLIEKCN--GNGLPEKDVRHFTRCILEGIGHIH-----DSGYVHCDVKPDNILLVATQSGKFV 154 (362)
Q Consensus 82 ~~~~~lv~e~~~~~~L~~~l~~~~--~~~l~~~~~~~i~~ql~~~l~yLH-----~~~ivH~Dlkp~Nill~~~~~~~~~ 154 (362)
...++++|||+++++|.+++.... ..++++..++.++.||+.||.||| +.+++|+||||+||++ +.++.
T Consensus 73 ~~~~~~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili----~~~~~ 148 (265)
T cd08217 73 NQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFL----DANNN 148 (265)
T ss_pred CCEEEEEehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEE----ecCCC
Confidence 345679999999999999997642 356999999999999999999999 9999999999999999 67788
Q ss_pred EEEeecCCcccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHHc
Q 039291 155 AKIADLGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIG 234 (362)
Q Consensus 155 ~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~ 234 (362)
++|+|||++........ ......|+..|+|||++.+..++.++|+||||+++++|++|+.||...+ ...+...+.
T Consensus 149 ~kl~d~g~~~~~~~~~~--~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~---~~~~~~~~~ 223 (265)
T cd08217 149 VKLGDFGLAKILGHDSS--FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARN---QLQLASKIK 223 (265)
T ss_pred EEEecccccccccCCcc--cccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcC---HHHHHHHHh
Confidence 99999999886654321 1234578999999999998888999999999999999999999996543 344444443
Q ss_pred CCCCCCCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCc
Q 039291 235 DEHSLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFV 277 (362)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~ 277 (362)
. ...+.++...+.++.+++.+||..+|++||+++++++|||+
T Consensus 224 ~-~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~~~~ 265 (265)
T cd08217 224 E-GKFRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQLPLI 265 (265)
T ss_pred c-CCCCCCccccCHHHHHHHHHHccCCcccCCCHHHHhhCCCC
Confidence 3 33455677889999999999999999999999999999995
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=312.63 Aligned_cols=257 Identities=23% Similarity=0.401 Sum_probs=199.2
Q ss_pred CceeecceecccCceEEEEEEECCCCCCCCceeeeechhh----hhhHHHHHHHHHHHHcCCCCcccccccceeeecCCC
Q 039291 6 TSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEV----SASASLQKEKEVFDNLNGCPFVLECFGEEITMGENG 81 (362)
Q Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~----~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~~ 81 (362)
++|.+.+.||+|+||.||+|+++.++. .+++|.... .....+..|..++.+..+||||+++++.+..
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~----~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~----- 71 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGT----IMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFR----- 71 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCc----EEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEec-----
Confidence 478999999999999999999998876 455554332 2334566677765555569999999987642
Q ss_pred ceEEEEEEEecCCCCHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhC-CceeCCCCCCCEEEeecCCCceEEEEe
Q 039291 82 EMAYNLLLEYAAGGTLGDLIEKC--NGNGLPEKDVRHFTRCILEGIGHIHDS-GYVHCDVKPDNILLVATQSGKFVAKIA 158 (362)
Q Consensus 82 ~~~~~lv~e~~~~~~L~~~l~~~--~~~~l~~~~~~~i~~ql~~~l~yLH~~-~ivH~Dlkp~Nill~~~~~~~~~~kl~ 158 (362)
...++++|||++ ++|.+++... ....+++..++.++.|++.||+|||++ +++||||||+||++ +.++.+||+
T Consensus 72 ~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~----~~~~~~kl~ 146 (283)
T cd06617 72 EGDVWICMEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLI----NRNGQVKLC 146 (283)
T ss_pred CCcEEEEhhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEE----CCCCCEEEe
Confidence 223679999997 5898888653 234599999999999999999999997 99999999999999 778889999
Q ss_pred ecCCcccccccccCCCCCCccCCCCccCchhhcc----ccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHHc
Q 039291 159 DLGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQ----HMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIG 234 (362)
Q Consensus 159 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~ 234 (362)
|||++....... ......|+..|+|||++.+ ..++.++|+|||||++|+|++|+.||..... ....+....
T Consensus 147 dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~-~~~~~~~~~- 221 (283)
T cd06617 147 DFGISGYLVDSV---AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKT-PFQQLKQVV- 221 (283)
T ss_pred eccccccccccc---ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCcccc-CHHHHHHHH-
Confidence 999987553221 1123568899999998865 4568899999999999999999999954322 223333332
Q ss_pred CCCCCCCCC-ccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCccCcch
Q 039291 235 DEHSLPEIP-SRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGVDE 282 (362)
Q Consensus 235 ~~~~~~~~~-~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~~~~~~ 282 (362)
.. ..+.++ ..++.++.++|.+||..+|++||++++++.||||.....
T Consensus 222 ~~-~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~ 269 (283)
T cd06617 222 EE-PSPQLPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQHPFFELHLS 269 (283)
T ss_pred hc-CCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhhhccc
Confidence 22 222232 357899999999999999999999999999999987543
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=321.31 Aligned_cols=261 Identities=20% Similarity=0.280 Sum_probs=202.3
Q ss_pred CCCCceeecceecccCceEEEEEEECCCCC-CCCceeeeechhh----hhhHHHHHHHHHHHHcCCCCcccccccceeee
Q 039291 3 SDGTSWFRGRVIGQGSFGCVFIAKPKSNSS-FLPPLMAVKSAEV----SASASLQKEKEVFDNLNGCPFVLECFGEEITM 77 (362)
Q Consensus 3 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~-~~~~~~~~K~~~~----~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~ 77 (362)
...++|.+++.||+|+||+||+|++...+. ...+.+++|.... .....+.+|+.++.++.+||||+++++.+...
T Consensus 4 ~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~ 83 (343)
T cd05103 4 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP 83 (343)
T ss_pred cchhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecC
Confidence 456799999999999999999998754322 2235678877643 23456789999999998899999999866432
Q ss_pred cCCCceEEEEEEEecCCCCHHHHHHHhc----------------------------------------------------
Q 039291 78 GENGEMAYNLLLEYAAGGTLGDLIEKCN---------------------------------------------------- 105 (362)
Q Consensus 78 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~---------------------------------------------------- 105 (362)
...++++|||+++|+|.+++....
T Consensus 84 ----~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (343)
T cd05103 84 ----GGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLS 159 (343)
T ss_pred ----CCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccc
Confidence 234679999999999999987532
Q ss_pred -------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEeecCCcccccccccC
Q 039291 106 -------------GNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQ 172 (362)
Q Consensus 106 -------------~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Dfgla~~~~~~~~~ 172 (362)
...+++..+..++.|++.||+|||++||+||||||+|||+ +.++.+||+|||++.........
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~----~~~~~~kl~dfg~~~~~~~~~~~ 235 (343)
T cd05103 160 DVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILL----SENNVVKICDFGLARDIYKDPDY 235 (343)
T ss_pred cchhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEE----cCCCcEEEEecccccccccCcch
Confidence 1236788889999999999999999999999999999999 77788999999998765332221
Q ss_pred CCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHh-CCCCCccCCCCCHHHHHHHHcCCCCCCCCCccCCHHHH
Q 039291 173 KFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLS-GRQAWVVKEDCSIDQLFSIIGDEHSLPEIPSRVSKEAR 251 (362)
Q Consensus 173 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (362)
.......++..|+|||++.+..++.++||||||+++|+|++ |..||..... .......+.... .+..+..+++++.
T Consensus 236 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~--~~~~~~~~~~~~-~~~~~~~~~~~~~ 312 (343)
T cd05103 236 VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI--DEEFCRRLKEGT-RMRAPDYTTPEMY 312 (343)
T ss_pred hhcCCCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccc--cHHHHHHHhccC-CCCCCCCCCHHHH
Confidence 11123345678999999988889999999999999999997 9999965422 122223332222 2334556788999
Q ss_pred HHHHHHhccCCCCCCCHHHHhcC
Q 039291 252 DFLRRCFVRKPAFRFTAEMLLDD 274 (362)
Q Consensus 252 ~li~~~l~~~p~~R~s~~~~l~~ 274 (362)
+++.+||..+|++||++.++++|
T Consensus 313 ~~~~~cl~~~p~~Rps~~eil~~ 335 (343)
T cd05103 313 QTMLDCWHGEPSQRPTFSELVEH 335 (343)
T ss_pred HHHHHHccCChhhCcCHHHHHHH
Confidence 99999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-42 Score=306.96 Aligned_cols=256 Identities=32% Similarity=0.556 Sum_probs=214.0
Q ss_pred CceeecceecccCceEEEEEEECCCCCCCCceeeeechhhh----hhHHHHHHHHHHHHcCCCCcccccccceeeecCCC
Q 039291 6 TSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVS----ASASLQKEKEVFDNLNGCPFVLECFGEEITMGENG 81 (362)
Q Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~~----~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~~ 81 (362)
++|.+.+.||+|++|.||+|+++.+++ .+++|..... ....+.+|+.++.+++ |+|++++++.+..
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~----~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~----- 70 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGK----IYALKKIHVDGDEEFRKQLLRELKTLRSCE-SPYVVKCYGAFYK----- 70 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCc----EEEEEEeccCcchHHHHHHHHHHHHHHhcC-CCCeeeEEEEEcc-----
Confidence 478999999999999999999998765 4566654433 3567889999999999 9999999987643
Q ss_pred ceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCceeCCCCCCCEEEeecCCCceEEEEeec
Q 039291 82 EMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHD-SGYVHCDVKPDNILLVATQSGKFVAKIADL 160 (362)
Q Consensus 82 ~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~-~~ivH~Dlkp~Nill~~~~~~~~~~kl~Df 160 (362)
...+++||||+++++|.+++... .++++..+..++.|++.||.|||+ .|++|+||+|+||++ +.++.++|+||
T Consensus 71 ~~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~----~~~~~~~l~df 144 (264)
T cd06623 71 EGEISIVLEYMDGGSLADLLKKV--GKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLI----NSKGEVKIADF 144 (264)
T ss_pred CCeEEEEEEecCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEE----CCCCCEEEccC
Confidence 24577999999999999999863 569999999999999999999999 999999999999999 77888999999
Q ss_pred CCcccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHHcCCCCCC
Q 039291 161 GVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEHSLP 240 (362)
Q Consensus 161 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 240 (362)
|++......... .....++..|+|||.+.+..++.++|+||||+++|+|++|..||.........+....+..... +
T Consensus 145 ~~~~~~~~~~~~--~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~-~ 221 (264)
T cd06623 145 GISKVLENTLDQ--CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPP-P 221 (264)
T ss_pred ccceecccCCCc--ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcCCC-C
Confidence 998765432222 1245688999999999988899999999999999999999999976543355555555554333 3
Q ss_pred CCCcc-CCHHHHHHHHHHhccCCCCCCCHHHHhcCCCccCc
Q 039291 241 EIPSR-VSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGV 280 (362)
Q Consensus 241 ~~~~~-~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~~~~ 280 (362)
..+.. ++..+.++|.+||..+|++||++.++++|||++..
T Consensus 222 ~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~~~~~~~ 262 (264)
T cd06623 222 SLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQHPFIKKA 262 (264)
T ss_pred CCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhCHHHHhc
Confidence 44555 89999999999999999999999999999999765
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-42 Score=304.22 Aligned_cols=251 Identities=30% Similarity=0.484 Sum_probs=204.7
Q ss_pred ceeecceecccCceEEEEEEECCCCCCCCceeeeechh-----hhhhHHHHHHHHHHHHcCCCCcccccccceeeecCCC
Q 039291 7 SWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAE-----VSASASLQKEKEVFDNLNGCPFVLECFGEEITMGENG 81 (362)
Q Consensus 7 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~-----~~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~~ 81 (362)
+|.+.+.||+|+||.||+|.+..++. .+++|... ......+.+|+.++++++ |||++++++.+..
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~----~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~----- 70 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQK----LVIIKQIPVEQMTKDERLAAQNECQVLKLLS-HPNIIEYYENFLE----- 70 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCc----EEEEEEEeccccccHHHHHHHHHHHHHhhCC-CCchhheeeeEec-----
Confidence 68999999999999999999987765 44555432 234566889999999998 8999999886532
Q ss_pred ceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEeecC
Q 039291 82 EMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLG 161 (362)
Q Consensus 82 ~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Dfg 161 (362)
...+++||||+++++|.+++.......+++..+..++.|++.+|.|||++|++|+||||+||++. +.+..++|+|||
T Consensus 71 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~---~~~~~~~l~d~~ 147 (256)
T cd08220 71 DKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLD---KHKMVVKIGDFG 147 (256)
T ss_pred CCEEEEEEecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEc---CCCCEEEEccCC
Confidence 33578999999999999999875555699999999999999999999999999999999999993 234568999999
Q ss_pred CcccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHHcCCCCCCC
Q 039291 162 VAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEHSLPE 241 (362)
Q Consensus 162 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 241 (362)
++........ .....|+..|+|||.+.+..++.++|+||||+++|+|++|..||...+ .......+.... .+.
T Consensus 148 ~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~---~~~~~~~~~~~~-~~~ 220 (256)
T cd08220 148 ISKILSSKSK---AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAAN---LPALVLKIMSGT-FAP 220 (256)
T ss_pred CceecCCCcc---ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCc---hHHHHHHHHhcC-CCC
Confidence 9876543221 123568999999999988888999999999999999999999995543 233333333222 234
Q ss_pred CCccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCc
Q 039291 242 IPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFV 277 (362)
Q Consensus 242 ~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~ 277 (362)
++..++.++++++.+||..+|++|||+.+++.||||
T Consensus 221 ~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~p~~ 256 (256)
T cd08220 221 ISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQPIC 256 (256)
T ss_pred CCCCcCHHHHHHHHHHccCChhhCCCHHHHhhCCCC
Confidence 566789999999999999999999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-42 Score=313.85 Aligned_cols=260 Identities=23% Similarity=0.402 Sum_probs=206.3
Q ss_pred CCCCCceeecceecccCceEEEEEEECCCCC-CCCceeeeechhh----hhhHHHHHHHHHHHHcCCCCcccccccceee
Q 039291 2 DSDGTSWFRGRVIGQGSFGCVFIAKPKSNSS-FLPPLMAVKSAEV----SASASLQKEKEVFDNLNGCPFVLECFGEEIT 76 (362)
Q Consensus 2 ~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~-~~~~~~~~K~~~~----~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~ 76 (362)
....++|.+.+.||+|+||.||+|.++.... .....+++|.... .....+.+|+.+++++.+|+||+++++.+..
T Consensus 8 ~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~ 87 (293)
T cd05053 8 ELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQ 87 (293)
T ss_pred ccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcC
Confidence 4567899999999999999999999865431 1224567776543 2334578899999999669999999986542
Q ss_pred ecCCCceEEEEEEEecCCCCHHHHHHHh--------------cCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCC
Q 039291 77 MGENGEMAYNLLLEYAAGGTLGDLIEKC--------------NGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDN 142 (362)
Q Consensus 77 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~--------------~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~N 142 (362)
...++++|||+++++|.++++.. ....+++..+..++.|++.||.|||++||+||||||+|
T Consensus 88 -----~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~N 162 (293)
T cd05053 88 -----EGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARN 162 (293)
T ss_pred -----CCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceee
Confidence 22467999999999999999752 23458999999999999999999999999999999999
Q ss_pred EEEeecCCCceEEEEeecCCcccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHh-CCCCCccC
Q 039291 143 ILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLS-GRQAWVVK 221 (362)
Q Consensus 143 ill~~~~~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~ 221 (362)
|++ +.++.+||+|||+++...............++..|+|||++.+..++.++|||||||++|+|++ |..||...
T Consensus 163 il~----~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~ 238 (293)
T cd05053 163 VLV----TEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGI 238 (293)
T ss_pred EEE----cCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCC
Confidence 999 7778899999999986544322222223345678999999988889999999999999999997 99998543
Q ss_pred CCCCHHHHHHHHcCCCCCCCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhcC
Q 039291 222 EDCSIDQLFSIIGDEHSLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDD 274 (362)
Q Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~ 274 (362)
...+....+..... +..+..++.++.+|+.+||..||++|||+.+++++
T Consensus 239 ---~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~ 287 (293)
T cd05053 239 ---PVEELFKLLKEGYR-MEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVED 287 (293)
T ss_pred ---CHHHHHHHHHcCCc-CCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 44455555544432 34566788999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=321.10 Aligned_cols=263 Identities=22% Similarity=0.349 Sum_probs=204.6
Q ss_pred CCceeecceecccCceEEEEEEECCCCCCCCceeeeechhh-----hhhHHHHHHHHHHHHcCCCCcccccccceeeecC
Q 039291 5 GTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEV-----SASASLQKEKEVFDNLNGCPFVLECFGEEITMGE 79 (362)
Q Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~-----~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~ 79 (362)
+++|.+.+.||+|+||+||+|++..++. .+++|.... .....+.+|+.+++.++ |+||+++++++.....
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~----~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~ni~~~~~~~~~~~~ 78 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNE----KVAIKKIANAFDNRIDAKRTLREIKLLRHLD-HENVIAIKDIMPPPHR 78 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCC----eEEEEEecccccccchhHHHHHHHHHHHhcC-CCCccchHHheecccc
Confidence 5789999999999999999999988775 455554432 23445778999999998 8999999997654332
Q ss_pred CCceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEee
Q 039291 80 NGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIAD 159 (362)
Q Consensus 80 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~D 159 (362)
......++++||+. ++|.+++.. ...+++..+..++.|++.||.|||+++++||||||+||++ +.++.+||+|
T Consensus 79 ~~~~~~~lv~e~~~-~~L~~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~----~~~~~~kL~D 151 (337)
T cd07858 79 EAFNDVYIVYELMD-TDLHQIIRS--SQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLL----NANCDLKICD 151 (337)
T ss_pred cccCcEEEEEeCCC-CCHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEE----cCCCCEEECc
Confidence 33345789999996 689988876 3569999999999999999999999999999999999999 6777899999
Q ss_pred cCCcccccccccCCCCCCccCCCCccCchhhcc-ccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHH-----
Q 039291 160 LGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQ-HMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSII----- 233 (362)
Q Consensus 160 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~----- 233 (362)
||++....... .......++..|+|||++.+ ..++.++|+|||||++|+|++|++||...+...........
T Consensus 152 fg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 229 (337)
T cd07858 152 FGLARTTSEKG--DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPS 229 (337)
T ss_pred CccccccCCCc--ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCC
Confidence 99997654321 22235568999999998875 46889999999999999999999999654321111111000
Q ss_pred ----------------c---CC--CCCCCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCccCcc
Q 039291 234 ----------------G---DE--HSLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGVD 281 (362)
Q Consensus 234 ----------------~---~~--~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~~~~~ 281 (362)
. .. .........++.+++++|++||+.+|++|||+++++.||||..+.
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~ 298 (337)
T cd07858 230 EEDLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLH 298 (337)
T ss_pred hHHhhhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhc
Confidence 0 00 001112345789999999999999999999999999999997653
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-42 Score=305.40 Aligned_cols=253 Identities=19% Similarity=0.331 Sum_probs=205.0
Q ss_pred CCCCCceeecceecccCceEEEEEEECCCCCCCCceeeeechhhh--hhHHHHHHHHHHHHcCCCCcccccccceeeecC
Q 039291 2 DSDGTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVS--ASASLQKEKEVFDNLNGCPFVLECFGEEITMGE 79 (362)
Q Consensus 2 ~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~~--~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~ 79 (362)
++....|.+.+.||+|+||.||+|.++.++. .+++|..... ....+.+|+.+++.++ |+||+++++.+..
T Consensus 2 ~~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~----~~~~K~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~--- 73 (263)
T cd05052 2 EMERTDITMKHKLGGGQYGEVYEGVWKKYSL----TVAVKTLKEDTMEVEEFLKEAAVMKEIK-HPNLVQLLGVCTR--- 73 (263)
T ss_pred CCchHHeEEeeecCCcccceEEEEEEecCCc----eEEEEEecCCchHHHHHHHHHHHHHhCC-CCChhheEEEEcC---
Confidence 4566789999999999999999999987765 4566654432 3456889999999998 8999999986542
Q ss_pred CCceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEee
Q 039291 80 NGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIAD 159 (362)
Q Consensus 80 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~D 159 (362)
...++++|||+++++|.+++.......+++..++.++.|++.||.|||++|++||||||+||++ +.++.+||+|
T Consensus 74 --~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~----~~~~~~kl~d 147 (263)
T cd05052 74 --EPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLV----GENHLVKVAD 147 (263)
T ss_pred --CCCcEEEEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEE----cCCCcEEeCC
Confidence 2346799999999999999987555569999999999999999999999999999999999999 7778899999
Q ss_pred cCCcccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHh-CCCCCccCCCCCHHHHHHHHcCCCC
Q 039291 160 LGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLS-GRQAWVVKEDCSIDQLFSIIGDEHS 238 (362)
Q Consensus 160 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~ 238 (362)
||++.......... .....++..|+|||.+.+..++.++|||||||++|+|++ |..||... +..+....+....
T Consensus 148 f~~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~---~~~~~~~~~~~~~- 222 (263)
T cd05052 148 FGLSRLMTGDTYTA-HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI---DLSQVYELLEKGY- 222 (263)
T ss_pred Cccccccccceeec-cCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCC---CHHHHHHHHHCCC-
Confidence 99987654321111 112234667999999998889999999999999999998 99998543 4455555554433
Q ss_pred CCCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhc
Q 039291 239 LPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLD 273 (362)
Q Consensus 239 ~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~ 273 (362)
.+..+..++.++.+++.+||..+|++||++.++++
T Consensus 223 ~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 257 (263)
T cd05052 223 RMERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQ 257 (263)
T ss_pred CCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 23456778999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-43 Score=314.08 Aligned_cols=255 Identities=27% Similarity=0.476 Sum_probs=206.7
Q ss_pred CceeecceecccCceEEEEEEECCCCCCCCceeeeechh----hhhhHHHHHHHHHHHHcCCCCcccccccceeeecCCC
Q 039291 6 TSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAE----VSASASLQKEKEVFDNLNGCPFVLECFGEEITMGENG 81 (362)
Q Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~----~~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~~ 81 (362)
..|...+.||+|+||.||+|.+..++. .+++|... ......+.+|+.++++++ ||||+++++.+..
T Consensus 4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~----~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~----- 73 (277)
T cd06642 4 ELFTKLERIGKGSFGEVYKGIDNRTKE----VVAIKIIDLEEAEDEIEDIQQEITVLSQCD-SPYITRYYGSYLK----- 73 (277)
T ss_pred HHHHHHHHhcCCCCeeEEEEEEcCCCe----EEEEEEeccccchHHHHHHHHHHHHHHcCC-CCccHhhhccccc-----
Confidence 468889999999999999999987765 45666543 233456889999999998 9999999987642
Q ss_pred ceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEeecC
Q 039291 82 EMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLG 161 (362)
Q Consensus 82 ~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Dfg 161 (362)
...+++||||+++++|.+++.. ..+++..++.++.|++.||.|||++|++|+||+|+||++ +.++.++|+|||
T Consensus 74 ~~~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i----~~~~~~~l~dfg 146 (277)
T cd06642 74 GTKLWIIMEYLGGGSALDLLKP---GPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLL----SEQGDVKLADFG 146 (277)
T ss_pred CCceEEEEEccCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEE----eCCCCEEEcccc
Confidence 2347899999999999998864 458999999999999999999999999999999999999 667789999999
Q ss_pred CcccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHHcCCCCCCC
Q 039291 162 VAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEHSLPE 241 (362)
Q Consensus 162 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 241 (362)
++....... .......|+..|+|||++.+..++.++|+|||||++|+|++|..||.... .......+. ....+.
T Consensus 147 ~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~---~~~~~~~~~-~~~~~~ 220 (277)
T cd06642 147 VAGQLTDTQ--IKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLH---PMRVLFLIP-KNSPPT 220 (277)
T ss_pred ccccccCcc--hhhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccc---hhhHHhhhh-cCCCCC
Confidence 987544321 11123568899999999998889999999999999999999999985432 222222222 222344
Q ss_pred CCccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCccCcchh
Q 039291 242 IPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGVDEE 283 (362)
Q Consensus 242 ~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~~~~~~~ 283 (362)
.+..++.++.++|.+||..+|++||++.+++.||||......
T Consensus 221 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~~ 262 (277)
T cd06642 221 LEGQYSKPFKEFVEACLNKDPRFRPTAKELLKHKFITRYTKK 262 (277)
T ss_pred CCcccCHHHHHHHHHHccCCcccCcCHHHHHHhHHHHHHhhh
Confidence 556788999999999999999999999999999999876544
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-42 Score=310.43 Aligned_cols=259 Identities=19% Similarity=0.321 Sum_probs=202.3
Q ss_pred CCCCCceeecceecccCceEEEEEEECCCC-CCCCceeeeechhh----hhhHHHHHHHHHHHHcCCCCcccccccceee
Q 039291 2 DSDGTSWFRGRVIGQGSFGCVFIAKPKSNS-SFLPPLMAVKSAEV----SASASLQKEKEVFDNLNGCPFVLECFGEEIT 76 (362)
Q Consensus 2 ~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~-~~~~~~~~~K~~~~----~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~ 76 (362)
++..++|.+.+.||+|+||.||+|.++... ......+++|.... .....+.+|+.+++.++ ||||+++++.+..
T Consensus 2 ~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~-~~~iv~~~~~~~~ 80 (277)
T cd05062 2 EVAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFN-CHHVVRLLGVVSQ 80 (277)
T ss_pred cccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCC-CCCeeeEEEEEcC
Confidence 467789999999999999999999876421 11234677776542 23345778999999998 8999999886532
Q ss_pred ecCCCceEEEEEEEecCCCCHHHHHHHhcC--------CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeec
Q 039291 77 MGENGEMAYNLLLEYAAGGTLGDLIEKCNG--------NGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVAT 148 (362)
Q Consensus 77 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--------~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~ 148 (362)
....++||||+++++|.+++..... ..+++..+..++.|++.||.|||+.|++|+||||+||++
T Consensus 81 -----~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~--- 152 (277)
T cd05062 81 -----GQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMV--- 152 (277)
T ss_pred -----CCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEE---
Confidence 2346799999999999999976321 236788899999999999999999999999999999999
Q ss_pred CCCceEEEEeecCCcccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHh-CCCCCccCCCCCHH
Q 039291 149 QSGKFVAKIADLGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLS-GRQAWVVKEDCSID 227 (362)
Q Consensus 149 ~~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~ 227 (362)
+.++.++|+|||+++...............++..|+|||++.+..++.++|||||||++|+|++ |..||... ...
T Consensus 153 -~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~---~~~ 228 (277)
T cd05062 153 -AEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGM---SNE 228 (277)
T ss_pred -cCCCCEEECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCC---CHH
Confidence 7778899999999875433222111123345778999999998889999999999999999999 78898543 333
Q ss_pred HHHHHHcCCCCCCCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhcC
Q 039291 228 QLFSIIGDEHSLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDD 274 (362)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~ 274 (362)
+....+... ..+..+..++..+++++.+||+.+|++|||+.+++++
T Consensus 229 ~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 274 (277)
T cd05062 229 QVLRFVMEG-GLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 274 (277)
T ss_pred HHHHHHHcC-CcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 444433322 2344566788999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=304.48 Aligned_cols=254 Identities=30% Similarity=0.518 Sum_probs=205.8
Q ss_pred CceeecceecccCceEEEEEEECCCCCCCCceeeeechh--------hhhhHHHHHHHHHHHHcCCCCcccccccceeee
Q 039291 6 TSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAE--------VSASASLQKEKEVFDNLNGCPFVLECFGEEITM 77 (362)
Q Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~--------~~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~ 77 (362)
.+|.+.+.||+|+||.||+|+++.++. .+++|... ......+.+|+.++++++ |+||+++++.+..
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~----~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~-h~~i~~~~~~~~~- 75 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGR----ELAVKQVPFDPDSQETSKEVNALECEIQLLKNLR-HDRIVQYYGCLRD- 75 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCC----EEEEEEEecCcccchhhHHHHHHHHHHHHHHHcC-CCCcceEEEEEEc-
Confidence 579999999999999999999988775 45555432 223457889999999998 8999999986532
Q ss_pred cCCCceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEE
Q 039291 78 GENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKI 157 (362)
Q Consensus 78 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl 157 (362)
.....+++++||+++++|.+++.. ...+++..+..++.|++.||.|||+.|++|+||||+||++ +.++.++|
T Consensus 76 --~~~~~~~~v~e~~~~~~L~~~~~~--~~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i----~~~~~~~l 147 (264)
T cd06653 76 --PEEKKLSIFVEYMPGGSIKDQLKA--YGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILR----DSAGNVKL 147 (264)
T ss_pred --CCCCEEEEEEEeCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEE----cCCCCEEE
Confidence 223456799999999999999976 3458999999999999999999999999999999999999 66778999
Q ss_pred eecCCcccccccccC-CCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHHcCC
Q 039291 158 ADLGVAKRSRHCKRQ-KFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDE 236 (362)
Q Consensus 158 ~Dfgla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 236 (362)
+|||+++........ .......|+..|+|||++.+..++.++|+|||||++|+|++|+.||... ........+...
T Consensus 148 ~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~---~~~~~~~~~~~~ 224 (264)
T cd06653 148 GDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEY---EAMAAIFKIATQ 224 (264)
T ss_pred CccccccccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCcc---CHHHHHHHHHcC
Confidence 999999755332111 1112456899999999999888899999999999999999999999543 223333334344
Q ss_pred CCCCCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCc
Q 039291 237 HSLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFV 277 (362)
Q Consensus 237 ~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~ 277 (362)
...+.+|..++.++.++|.+||. +|.+||++.+++.|||+
T Consensus 225 ~~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~~~~ 264 (264)
T cd06653 225 PTKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRHPFV 264 (264)
T ss_pred CCCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhcCCCC
Confidence 44566788899999999999999 57999999999999985
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-42 Score=313.66 Aligned_cols=258 Identities=23% Similarity=0.387 Sum_probs=204.1
Q ss_pred CCCceeecceecccCceEEEEEEECCCCC---CCCceeeeechhhh----hhHHHHHHHHHHHHcCCCCcccccccceee
Q 039291 4 DGTSWFRGRVIGQGSFGCVFIAKPKSNSS---FLPPLMAVKSAEVS----ASASLQKEKEVFDNLNGCPFVLECFGEEIT 76 (362)
Q Consensus 4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~---~~~~~~~~K~~~~~----~~~~~~~E~~il~~l~~h~~i~~~~~~~~~ 76 (362)
..++|.+++.||+|+||.||+|++...+. .....+++|..... ....+.+|+.+++.+..||||+++++.+..
T Consensus 16 ~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 95 (307)
T cd05098 16 PRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 95 (307)
T ss_pred ehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEec
Confidence 34789999999999999999998754322 12346788776532 334677899999999779999999987642
Q ss_pred ecCCCceEEEEEEEecCCCCHHHHHHHhcC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCC
Q 039291 77 MGENGEMAYNLLLEYAAGGTLGDLIEKCNG--------------NGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDN 142 (362)
Q Consensus 77 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--------------~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~N 142 (362)
...+++||||+.+++|.+++..... ..+++.++..++.|++.||+|||++|++||||||+|
T Consensus 96 -----~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~N 170 (307)
T cd05098 96 -----DGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARN 170 (307)
T ss_pred -----CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHh
Confidence 2246799999999999999976421 248899999999999999999999999999999999
Q ss_pred EEEeecCCCceEEEEeecCCcccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHh-CCCCCccC
Q 039291 143 ILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLS-GRQAWVVK 221 (362)
Q Consensus 143 ill~~~~~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~ 221 (362)
|++ +.++.++|+|||++................++..|+|||++.+..++.++|+|||||++|+|++ |..||...
T Consensus 171 ill----~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~ 246 (307)
T cd05098 171 VLV----TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV 246 (307)
T ss_pred eEE----cCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcC
Confidence 999 7777899999999875543211111122334568999999998889999999999999999998 88898543
Q ss_pred CCCCHHHHHHHHcCCCCCCCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhcC
Q 039291 222 EDCSIDQLFSIIGDEHSLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDD 274 (362)
Q Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~ 274 (362)
...++...+.... ....+..++.++.+|+.+||..+|++||++.+++++
T Consensus 247 ---~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~ 295 (307)
T cd05098 247 ---PVEELFKLLKEGH-RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 295 (307)
T ss_pred ---CHHHHHHHHHcCC-CCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 4555555554443 234566789999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-42 Score=310.62 Aligned_cols=256 Identities=27% Similarity=0.475 Sum_probs=208.5
Q ss_pred CCceeecceecccCceEEEEEEECCCCCCCCceeeeechh----hhhhHHHHHHHHHHHHcCCCCcccccccceeeecCC
Q 039291 5 GTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAE----VSASASLQKEKEVFDNLNGCPFVLECFGEEITMGEN 80 (362)
Q Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~----~~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~ 80 (362)
...|...+.||.|+||.||+|+++.++. .+++|... ......+.+|+.+++++. |+||+++++.+..
T Consensus 3 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~----~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~---- 73 (277)
T cd06640 3 EELFTKLERIGKGSFGEVFKGIDNRTQQ----VVAIKIIDLEEAEDEIEDIQQEITVLSQCD-SPYVTKYYGSYLK---- 73 (277)
T ss_pred HHhhhhhhhcccCCCeEEEEEEEccCCE----EEEEEEEeccccHHHHHHHHHHHHHHHhCC-CCCEeeEEEEEEE----
Confidence 3568889999999999999999988765 45555443 234566889999999998 8999999997643
Q ss_pred CceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEeec
Q 039291 81 GEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADL 160 (362)
Q Consensus 81 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Df 160 (362)
...+++||||++|++|.+++.. .++++..+..++.|++.||+|||+.+++|+||+|+||++ +.++.++|+||
T Consensus 74 -~~~~~lv~e~~~~~~L~~~i~~---~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~----~~~~~~~l~df 145 (277)
T cd06640 74 -GTKLWIIMEYLGGGSALDLLRA---GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLL----SEQGDVKLADF 145 (277)
T ss_pred -CCEEEEEEecCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEE----cCCCCEEEccc
Confidence 2357899999999999999864 458999999999999999999999999999999999999 66778999999
Q ss_pred CCcccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHHcCCCCCC
Q 039291 161 GVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEHSLP 240 (362)
Q Consensus 161 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 240 (362)
|++....... .......++..|+|||++.+...+.++|+|||||++|+|++|..||.... .......+. ....+
T Consensus 146 g~~~~~~~~~--~~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~---~~~~~~~~~-~~~~~ 219 (277)
T cd06640 146 GVAGQLTDTQ--IKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMH---PMRVLFLIP-KNNPP 219 (277)
T ss_pred ccceeccCCc--cccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcC---hHhHhhhhh-cCCCC
Confidence 9987554322 11234568889999999988889999999999999999999999996443 222222221 22334
Q ss_pred CCCccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCccCcchh
Q 039291 241 EIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGVDEE 283 (362)
Q Consensus 241 ~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~~~~~~~ 283 (362)
.++..++.++.+++.+||..+|++||++.+++.||||......
T Consensus 220 ~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~~ 262 (277)
T cd06640 220 TLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKHKFIVKNAKK 262 (277)
T ss_pred CCchhhhHHHHHHHHHHcccCcccCcCHHHHHhChHhhhcchh
Confidence 5666788999999999999999999999999999999776543
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-42 Score=309.71 Aligned_cols=262 Identities=19% Similarity=0.325 Sum_probs=203.0
Q ss_pred CCCCCceeecceecccCceEEEEEEECCCC-CCCCceeeeechhh----hhhHHHHHHHHHHHHcCCCCcccccccceee
Q 039291 2 DSDGTSWFRGRVIGQGSFGCVFIAKPKSNS-SFLPPLMAVKSAEV----SASASLQKEKEVFDNLNGCPFVLECFGEEIT 76 (362)
Q Consensus 2 ~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~-~~~~~~~~~K~~~~----~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~ 76 (362)
+..+++|.+.+.||+|++|.||+|.++... ......+++|.... .....+.+|+.+++.++ |+||+++++.+..
T Consensus 2 ~~~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~ 80 (277)
T cd05036 2 EVPRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFN-HQNIVRLIGVSFE 80 (277)
T ss_pred CCCHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCC-CCCEeeEEEEEcc
Confidence 467789999999999999999999987621 11234677776542 23456888999999998 8999999986542
Q ss_pred ecCCCceEEEEEEEecCCCCHHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCC
Q 039291 77 MGENGEMAYNLLLEYAAGGTLGDLIEKCNG-----NGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSG 151 (362)
Q Consensus 77 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-----~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~ 151 (362)
...+++||||++|++|.+++..... ..+++..+..++.||+.||+|||+++++||||||+||++..++ .
T Consensus 81 -----~~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~-~ 154 (277)
T cd05036 81 -----RLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKG-P 154 (277)
T ss_pred -----CCCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccC-C
Confidence 2235799999999999999976432 2489999999999999999999999999999999999995322 2
Q ss_pred ceEEEEeecCCcccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHh-CCCCCccCCCCCHHHHH
Q 039291 152 KFVAKIADLGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLS-GRQAWVVKEDCSIDQLF 230 (362)
Q Consensus 152 ~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~ 230 (362)
...+||+|||+++................+..|+|||++.+..++.++|||||||++|+|++ |..||.... .....
T Consensus 155 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~---~~~~~ 231 (277)
T cd05036 155 GRVAKIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRT---NQEVM 231 (277)
T ss_pred CcceEeccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCC---HHHHH
Confidence 34689999999876532111111112234567999999998889999999999999999997 999996443 33444
Q ss_pred HHHcCCCCCCCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhcC
Q 039291 231 SIIGDEHSLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDD 274 (362)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~ 274 (362)
..+.... .+..+..++..+.+++.+||..+|++||++.++++|
T Consensus 232 ~~~~~~~-~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~ 274 (277)
T cd05036 232 EFVTGGG-RLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILER 274 (277)
T ss_pred HHHHcCC-cCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 4443332 234567789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-42 Score=311.41 Aligned_cols=253 Identities=28% Similarity=0.465 Sum_probs=198.9
Q ss_pred ceeecceecccCceEEEEEEECCCCCCCCceeeeechh-----hhhhHHHHHHHHHHHHcCCCCcccccccceeeecCCC
Q 039291 7 SWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAE-----VSASASLQKEKEVFDNLNGCPFVLECFGEEITMGENG 81 (362)
Q Consensus 7 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~-----~~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~~ 81 (362)
+|.+.+.||+|+||.||+|++..++. .+++|... ......+.+|+.++++++ ||||+++++.+..
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~----~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~----- 70 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGE----TVALKKVALRRLEGGIPNQALREIKALQACQ-HPYVVKLLDVFPH----- 70 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCc----eEEEEEEEcccccchhhHHHHHHHHHHHhCC-CCCCcceeeEEec-----
Confidence 68999999999999999999987765 34555443 223456889999999998 9999999987643
Q ss_pred ceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEeecC
Q 039291 82 EMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLG 161 (362)
Q Consensus 82 ~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Dfg 161 (362)
...+++||||+ +++|.+++.... .++++..++.++.|++.||.|||+.|++|+||||+||++ +.++.++|+|||
T Consensus 71 ~~~~~~v~e~~-~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~----~~~~~~~l~dfg 144 (286)
T cd07832 71 GSGFVLVMEYM-PSDLSEVLRDEE-RPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLI----SADGVLKIADFG 144 (286)
T ss_pred CCeeEEEeccc-CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEE----cCCCcEEEeeee
Confidence 34578999999 999999987643 569999999999999999999999999999999999999 667889999999
Q ss_pred CcccccccccCCCCCCccCCCCccCchhhccc-cCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHHc--CCC-
Q 039291 162 VAKRSRHCKRQKFDPSMRGTPLYLAPETVVQH-MQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIG--DEH- 237 (362)
Q Consensus 162 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~--~~~- 237 (362)
++........ .......|+..|+|||.+.+. .++.++||||+||++++|++|.+||....+ .......+. ...
T Consensus 145 ~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~--~~~~~~~~~~~~~~~ 221 (286)
T cd07832 145 LARLFSEEEP-RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGEND--IEQLAIVFRTLGTPN 221 (286)
T ss_pred ecccccCCCC-CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCH--HHHHHHHHHHcCCCC
Confidence 9876544322 112345689999999998754 468899999999999999999888854432 111111110 000
Q ss_pred ----------------C--------CCCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCcc
Q 039291 238 ----------------S--------LPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVK 278 (362)
Q Consensus 238 ----------------~--------~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~~ 278 (362)
. +.......+.++.++|.+||..+|++||++++++.||||.
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~~~ 286 (286)
T cd07832 222 EETWPGLTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYFT 286 (286)
T ss_pred hHHHhhccCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCcCcC
Confidence 0 0011234678999999999999999999999999999983
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=304.40 Aligned_cols=249 Identities=31% Similarity=0.547 Sum_probs=196.7
Q ss_pred ecceecccCceEEEEEEECCCCCCCCceeeeechhh---hhhHHHHHHHHHHHHcCCCCcccccccceeeecCCCceEEE
Q 039291 10 RGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEV---SASASLQKEKEVFDNLNGCPFVLECFGEEITMGENGEMAYN 86 (362)
Q Consensus 10 ~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~---~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~~~~~~~ 86 (362)
....||+|+||.||+|++..++. .+++|.... .....+.+|+.+++.++ |+||+++++.+.. ...++
T Consensus 12 ~~~~lg~g~~g~v~~~~~~~~~~----~v~~k~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~-----~~~~~ 81 (268)
T cd06624 12 ERVVLGKGTYGIVYAARDLSTQV----RIAIKEIPERDSRYVQPLHEEIALHSYLK-HRNIVQYLGSDSE-----NGFFK 81 (268)
T ss_pred ceEEEecCCceEEEEeEecCCCc----EEEEEEecCCCHHHHHHHHHHHHHHHhcC-CCCeeeeeeeecc-----CCEEE
Confidence 34689999999999999887764 456665432 24456889999999998 9999999986542 23577
Q ss_pred EEEEecCCCCHHHHHHHhcCCCC--CHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCC-ceEEEEeecCCc
Q 039291 87 LLLEYAAGGTLGDLIEKCNGNGL--PEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSG-KFVAKIADLGVA 163 (362)
Q Consensus 87 lv~e~~~~~~L~~~l~~~~~~~l--~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~-~~~~kl~Dfgla 163 (362)
+|+||+++++|.+++.... ..+ ++..+..++.|++.||.|||++||+||||||+||++ +. .+.++|+|||++
T Consensus 82 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~----~~~~~~~~l~dfg~~ 156 (268)
T cd06624 82 IFMEQVPGGSLSALLRSKW-GPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLV----NTYSGVVKISDFGTS 156 (268)
T ss_pred EEEecCCCCCHHHHHHHhc-ccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEE----cCCCCeEEEecchhh
Confidence 9999999999999997632 335 889999999999999999999999999999999999 43 567999999998
Q ss_pred ccccccccCCCCCCccCCCCccCchhhccc--cCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHHcCCCCCCC
Q 039291 164 KRSRHCKRQKFDPSMRGTPLYLAPETVVQH--MQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEHSLPE 241 (362)
Q Consensus 164 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 241 (362)
....... .......|+..|+|||++.+. .++.++|+||||+++|+|++|..||....... ............+.
T Consensus 157 ~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~--~~~~~~~~~~~~~~ 232 (268)
T cd06624 157 KRLAGIN--PCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQ--AAMFKVGMFKIHPE 232 (268)
T ss_pred eecccCC--CccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChh--hhHhhhhhhccCCC
Confidence 7553321 122345689999999998754 37889999999999999999999996433211 11111212223345
Q ss_pred CCccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCc
Q 039291 242 IPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFV 277 (362)
Q Consensus 242 ~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~ 277 (362)
++..++.++++++.+||..+|++|||+.+++.||||
T Consensus 233 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~ 268 (268)
T cd06624 233 IPESLSAEAKNFILRCFEPDPDKRASAHDLLQDPFL 268 (268)
T ss_pred CCcccCHHHHHHHHHHcCCCchhCCCHHHHHhCCCC
Confidence 677789999999999999999999999999999997
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-42 Score=312.88 Aligned_cols=259 Identities=20% Similarity=0.313 Sum_probs=203.8
Q ss_pred CCCCceeecceecccCceEEEEEEECCC-CCCCCceeeeechhh----hhhHHHHHHHHHHHHcCCCCcccccccceeee
Q 039291 3 SDGTSWFRGRVIGQGSFGCVFIAKPKSN-SSFLPPLMAVKSAEV----SASASLQKEKEVFDNLNGCPFVLECFGEEITM 77 (362)
Q Consensus 3 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~-~~~~~~~~~~K~~~~----~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~ 77 (362)
...++|.+.+.||+|+||.||+|.+... .......+++|.... .....+.+|+.+++++..||||+++++.+..
T Consensus 32 ~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~- 110 (302)
T cd05055 32 FPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTI- 110 (302)
T ss_pred ccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEec-
Confidence 4567899999999999999999986432 223345788886543 2345688999999999669999999986642
Q ss_pred cCCCceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEE
Q 039291 78 GENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKI 157 (362)
Q Consensus 78 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl 157 (362)
....+++|||+.+++|.++++......+++.++..++.|++.||.|||+++|+|+||||+|||+ +.++.++|
T Consensus 111 ----~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~----~~~~~~~l 182 (302)
T cd05055 111 ----GGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLL----THGKIVKI 182 (302)
T ss_pred ----CCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEE----cCCCeEEE
Confidence 2246799999999999999976444458999999999999999999999999999999999999 67778999
Q ss_pred eecCCcccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHh-CCCCCccCCCCCHHHHHHHHcCC
Q 039291 158 ADLGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLS-GRQAWVVKEDCSIDQLFSIIGDE 236 (362)
Q Consensus 158 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~ 236 (362)
+|||+++...............++..|+|||++.+..++.++||||+||++|+|++ |..||..... .......+...
T Consensus 183 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~--~~~~~~~~~~~ 260 (302)
T cd05055 183 CDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPV--DSKFYKLIKEG 260 (302)
T ss_pred CCCcccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCc--hHHHHHHHHcC
Confidence 99999875543221111223456788999999998889999999999999999998 9999864432 22223333222
Q ss_pred CCCCCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhc
Q 039291 237 HSLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLD 273 (362)
Q Consensus 237 ~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~ 273 (362)
. .+..+...+.++.+++.+||..+|++||++.+++.
T Consensus 261 ~-~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~ 296 (302)
T cd05055 261 Y-RMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQ 296 (302)
T ss_pred C-cCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 2 22345567899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=302.50 Aligned_cols=251 Identities=28% Similarity=0.481 Sum_probs=205.0
Q ss_pred ceeecceecccCceEEEEEEECCCCCCCCceeeeechhh-----hhhHHHHHHHHHHHHcCCCCcccccccceeeecCCC
Q 039291 7 SWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEV-----SASASLQKEKEVFDNLNGCPFVLECFGEEITMGENG 81 (362)
Q Consensus 7 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~-----~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~~ 81 (362)
+|.+.+.||+|+||.||+|.++.++. .+++|.... ...+.+.+|+.+++.++ |+||+++++.+..
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~----~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~-h~~i~~~~~~~~~----- 70 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSE----HCVIKEIDLTKMPVKEKEASKKEVILLAKMK-HPNIVTFFASFQE----- 70 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCc----eEEEEEeeHhhccchhhHHHHHHHHHHHhCC-CCChhhhhheecc-----
Confidence 58999999999999999999988775 356665432 24456789999999998 8999999986532
Q ss_pred ceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCc-eEEEEeec
Q 039291 82 EMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGK-FVAKIADL 160 (362)
Q Consensus 82 ~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~-~~~kl~Df 160 (362)
...+++|+||+++++|.+++....+..+++..+..++.|++.||.|||+.+++|+||||+||++ +.+ ..++|+||
T Consensus 71 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~----~~~~~~~~l~d~ 146 (257)
T cd08225 71 NGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFL----SKNGMVAKLGDF 146 (257)
T ss_pred CCeEEEEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEE----cCCCCeEEeccc
Confidence 3357899999999999999987555568999999999999999999999999999999999999 444 45799999
Q ss_pred CCcccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHHcCCCCCC
Q 039291 161 GVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEHSLP 240 (362)
Q Consensus 161 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 240 (362)
|.+....... .......|++.|+|||++.+..++.++|+||||+++++|++|..||... +..+....+... ..+
T Consensus 147 ~~~~~~~~~~--~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~---~~~~~~~~~~~~-~~~ 220 (257)
T cd08225 147 GIARQLNDSM--ELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGN---NLHQLVLKICQG-YFA 220 (257)
T ss_pred ccchhccCCc--ccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCc---cHHHHHHHHhcc-cCC
Confidence 9987654322 1223356899999999998888999999999999999999999999543 333333333333 233
Q ss_pred CCCccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCc
Q 039291 241 EIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFV 277 (362)
Q Consensus 241 ~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~ 277 (362)
......+.+++++|.+||..+|++|||+.+++.||||
T Consensus 221 ~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~~~~ 257 (257)
T cd08225 221 PISPNFSRDLRSLISQLFKVSPRDRPSITSILKRPFL 257 (257)
T ss_pred CCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhCCCC
Confidence 4556688999999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-42 Score=319.03 Aligned_cols=266 Identities=23% Similarity=0.353 Sum_probs=205.9
Q ss_pred CCceeecceecccCceEEEEEEECCCCCCCCceeeeechhh-----hhhHHHHHHHHHHHHcCCCCcccccccceeeecC
Q 039291 5 GTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEV-----SASASLQKEKEVFDNLNGCPFVLECFGEEITMGE 79 (362)
Q Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~-----~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~ 79 (362)
+++|.+.+.||+|+||.||+|.++.++. .+++|.... .....+.+|+.+++.++ ||||+++++.+....
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~----~valK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~- 77 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGK----KVAIKKIPHAFDVPTLAKRTLRELKILRHFK-HDNIIAIRDILRPPG- 77 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCC----EEEEEEeccccccccchHHHHHHHHHHHhcC-CCCccCHHHhccccC-
Confidence 4899999999999999999999998876 455555432 23456778999999999 999999998665433
Q ss_pred CCceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEee
Q 039291 80 NGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIAD 159 (362)
Q Consensus 80 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~D 159 (362)
.....+++||||+. ++|.+++.. ...+++..++.++.|++.||.|||++||+||||||+||++ +.++.+||+|
T Consensus 78 ~~~~~~~lv~e~~~-~~l~~~~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~----~~~~~~kl~d 150 (334)
T cd07855 78 ADFKDVYVVMDLME-SDLHHIIHS--DQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLV----NEDCELRIGD 150 (334)
T ss_pred CCCceEEEEEehhh-hhHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE----cCCCcEEecc
Confidence 23445789999996 589988865 3459999999999999999999999999999999999999 7788899999
Q ss_pred cCCcccccccccC--CCCCCccCCCCccCchhhcc-ccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHH---
Q 039291 160 LGVAKRSRHCKRQ--KFDPSMRGTPLYLAPETVVQ-HMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSII--- 233 (362)
Q Consensus 160 fgla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~--- 233 (362)
||++......... .......|+..|+|||.+.+ ..++.++|||||||++|+|++|+.||...+...........
T Consensus 151 fg~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~ 230 (334)
T cd07855 151 FGMARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGS 230 (334)
T ss_pred cccceeecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCC
Confidence 9998755432211 12234578999999999865 46889999999999999999999999654321111111000
Q ss_pred ------------------cCCCCC-----CCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCccCcchh
Q 039291 234 ------------------GDEHSL-----PEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGVDEE 283 (362)
Q Consensus 234 ------------------~~~~~~-----~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~~~~~~~ 283 (362)
...... ..+....+.+++++|.+||+.+|++||++.+++.||||.+....
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~~~~~ 303 (334)
T cd07855 231 PSEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQYHDP 303 (334)
T ss_pred ChhHhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhhccCC
Confidence 000000 11124468999999999999999999999999999999876544
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=303.96 Aligned_cols=252 Identities=22% Similarity=0.352 Sum_probs=202.5
Q ss_pred CCCCCceeecceecccCceEEEEEEECCCCCCCCceeeeechhhh--hhHHHHHHHHHHHHcCCCCcccccccceeeecC
Q 039291 2 DSDGTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVS--ASASLQKEKEVFDNLNGCPFVLECFGEEITMGE 79 (362)
Q Consensus 2 ~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~~--~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~ 79 (362)
++..++|.+.+.||+|+||.||+|.+..+. .+++|..... ..+.+.+|+.+++.++ |+||+++++.+.
T Consensus 2 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~-----~v~iK~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~---- 71 (261)
T cd05072 2 EIPRESIKLVKKLGAGQFGEVWMGYYNNST-----KVAVKTLKPGTMSVQAFLEEANLMKTLQ-HDKLVRLYAVVT---- 71 (261)
T ss_pred cCchHHeEEeeecCCcCCceEEEEEecCCc-----eEEEEEccCCchhHHHHHHHHHHHHhCC-CCCeeeEEEEEc----
Confidence 467789999999999999999999976543 4666654422 3457889999999998 999999987653
Q ss_pred CCceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEee
Q 039291 80 NGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIAD 159 (362)
Q Consensus 80 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~D 159 (362)
.....+++|||+++++|.+++.......+++..+..++.|++.||+|||+.+++||||||+||++ +..+.++|+|
T Consensus 72 -~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili----~~~~~~~l~d 146 (261)
T cd05072 72 -KEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLV----SESLMCKIAD 146 (261)
T ss_pred -CCCCcEEEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEe----cCCCcEEECC
Confidence 22346799999999999999987555668999999999999999999999999999999999999 7778899999
Q ss_pred cCCcccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHh-CCCCCccCCCCCHHHHHHHHcCCCC
Q 039291 160 LGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLS-GRQAWVVKEDCSIDQLFSIIGDEHS 238 (362)
Q Consensus 160 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~ 238 (362)
||++......... ......++..|+|||++.+..++.++|||||||++|+|++ |..||... ........+.....
T Consensus 147 fg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~---~~~~~~~~~~~~~~ 222 (261)
T cd05072 147 FGLARVIEDNEYT-AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGM---SNSDVMSALQRGYR 222 (261)
T ss_pred CccceecCCCcee-ccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCC---CHHHHHHHHHcCCC
Confidence 9999765432211 1123346678999999988888999999999999999998 99999543 23334444433333
Q ss_pred CCCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhc
Q 039291 239 LPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLD 273 (362)
Q Consensus 239 ~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~ 273 (362)
.+ .+..++.++.+++.+||..+|++||+++++.+
T Consensus 223 ~~-~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 256 (261)
T cd05072 223 MP-RMENCPDELYDIMKTCWKEKAEERPTFDYLQS 256 (261)
T ss_pred CC-CCCCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 33 34568899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-42 Score=313.94 Aligned_cols=262 Identities=24% Similarity=0.340 Sum_probs=200.9
Q ss_pred CCCceeecceecccCceEEEEEEECCCCCCCCceeeeechhhh-----hhHHHHHHHHHHHHcCCCCcccccccceeeec
Q 039291 4 DGTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVS-----ASASLQKEKEVFDNLNGCPFVLECFGEEITMG 78 (362)
Q Consensus 4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~~-----~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~ 78 (362)
..++|.+.+.||+|+||.||+|+++.+++ .+++|..... ......+|+.++++++ |+||+++++.+..
T Consensus 5 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~----~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~-- 77 (309)
T cd07845 5 SVTEFEKLNRIGEGTYGIVYRARDTTSGE----IVALKKVRMDNERDGIPISSLREITLLLNLR-HPNIVELKEVVVG-- 77 (309)
T ss_pred cccceeEeeeeeecCCEEEEEEEECCCCc----EEEEEEEEeccCCCCCcchhhHHHHHHHhCC-CCCCcceEEEEec--
Confidence 34689999999999999999999988776 4556554322 1234568999999998 8999999987642
Q ss_pred CCCceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEe
Q 039291 79 ENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIA 158 (362)
Q Consensus 79 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~ 158 (362)
.....+++||||+.+ +|.+++... ...+++..++.++.|++.||.|||+.|++||||||+||++ +.++.++|+
T Consensus 78 -~~~~~~~lv~e~~~~-~l~~~l~~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~----~~~~~~kL~ 150 (309)
T cd07845 78 -KHLDSIFLVMEYCEQ-DLASLLDNM-PTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLL----TDKGCLKIA 150 (309)
T ss_pred -CCCCeEEEEEecCCC-CHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE----CCCCCEEEC
Confidence 222356799999975 899888763 3569999999999999999999999999999999999999 777889999
Q ss_pred ecCCcccccccccCCCCCCccCCCCccCchhhcc-ccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHHcCCC
Q 039291 159 DLGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQ-HMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEH 237 (362)
Q Consensus 159 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 237 (362)
|||++....... .......++..|+|||++.+ ..++.++|+|||||++|+|++|++||...+...............
T Consensus 151 dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~ 228 (309)
T cd07845 151 DFGLARTYGLPA--KPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTP 228 (309)
T ss_pred ccceeeecCCcc--CCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence 999997655322 11123456888999999875 467899999999999999999999996543322211111110000
Q ss_pred -----------------CCCCC--------CccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCccCcc
Q 039291 238 -----------------SLPEI--------PSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGVD 281 (362)
Q Consensus 238 -----------------~~~~~--------~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~~~~~ 281 (362)
..+.. ....++++.++|.+||+.||++|||+.+++.||||+...
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~~~ 297 (309)
T cd07845 229 NESIWPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEKP 297 (309)
T ss_pred ChhhchhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccCC
Confidence 00000 112578899999999999999999999999999997543
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-42 Score=320.12 Aligned_cols=261 Identities=21% Similarity=0.331 Sum_probs=201.2
Q ss_pred CCceeecceecccCceEEEEEEECCCCCCCCceeeeechh-----hhhhHHHHHHHHHHHHcCCCCcccccccceeeecC
Q 039291 5 GTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAE-----VSASASLQKEKEVFDNLNGCPFVLECFGEEITMGE 79 (362)
Q Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~-----~~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~ 79 (362)
.++|.+.+.||+|+||.||+|++..++. .+++|... ......+.+|+.++++++ |+||+++++.+.....
T Consensus 15 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~----~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~ 89 (353)
T cd07850 15 LKRYQNLKPIGSGAQGIVCAAYDTVTGQ----NVAIKKLSRPFQNVTHAKRAYRELVLMKLVN-HKNIIGLLNVFTPQKS 89 (353)
T ss_pred hcceEEEEEeccCCCEEEEEEEECCCCC----EEEEEecCccccChhHHHHHHHHHHHHHhcC-CCCCcceeeeeccCCC
Confidence 5789999999999999999999988775 45666543 223456778999999998 8999999986643221
Q ss_pred -CCceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEe
Q 039291 80 -NGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIA 158 (362)
Q Consensus 80 -~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~ 158 (362)
......|+||||+.+ +|.+.+.. . +++..+..++.|++.||+|||++||+||||||+||++ +.++.+||+
T Consensus 90 ~~~~~~~~lv~e~~~~-~l~~~~~~--~--l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~----~~~~~~kL~ 160 (353)
T cd07850 90 LEEFQDVYLVMELMDA-NLCQVIQM--D--LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV----KSDCTLKIL 160 (353)
T ss_pred ccccCcEEEEEeccCC-CHHHHHhh--c--CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEE----CCCCCEEEc
Confidence 122346799999965 88888764 2 8999999999999999999999999999999999999 778889999
Q ss_pred ecCCcccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHH-HHHHHH----
Q 039291 159 DLGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSID-QLFSII---- 233 (362)
Q Consensus 159 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~-~~~~~~---- 233 (362)
|||+++...... ......++..|+|||++.+..++.++|||||||++|+|++|+.||...+..... .+...+
T Consensus 161 Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 237 (353)
T cd07850 161 DFGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPS 237 (353)
T ss_pred cCccceeCCCCC---CCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCC
Confidence 999997654321 123456899999999999989999999999999999999999999654321100 000000
Q ss_pred ---------------cCCCC--------------CCC----CCccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCccCc
Q 039291 234 ---------------GDEHS--------------LPE----IPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGV 280 (362)
Q Consensus 234 ---------------~~~~~--------------~~~----~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~~~~ 280 (362)
..... .+. .+...+..++++|.+||+.||++|||+.+++.||||+.+
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~~~~ 317 (353)
T cd07850 238 DEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYINVW 317 (353)
T ss_pred HHHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhHhhc
Confidence 00000 000 011346678999999999999999999999999999865
Q ss_pred ch
Q 039291 281 DE 282 (362)
Q Consensus 281 ~~ 282 (362)
..
T Consensus 318 ~~ 319 (353)
T cd07850 318 YD 319 (353)
T ss_pred cC
Confidence 43
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-42 Score=309.47 Aligned_cols=252 Identities=26% Similarity=0.450 Sum_probs=198.3
Q ss_pred ceeecceecccCceEEEEEEECCCCCCCCceeeeechhhh-----hhHHHHHHHHHHHHcCCCCcccccccceeeecCCC
Q 039291 7 SWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVS-----ASASLQKEKEVFDNLNGCPFVLECFGEEITMGENG 81 (362)
Q Consensus 7 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~~-----~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~~ 81 (362)
.|.+.+.||.|++|.||+|+++.++. .+++|..... ....+.+|++++++++ ||||+++++.+..
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~----~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~----- 70 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGE----VVALKKIRLDTETEGVPSTAIREISLLKELN-HPNIVKLLDVIHT----- 70 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCC----EEEEEEccccccccccchHHHHHHHHHHhcC-CCCCcchhhhccc-----
Confidence 48899999999999999999988775 4566654322 2346789999999998 8999999997642
Q ss_pred ceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEeecC
Q 039291 82 EMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLG 161 (362)
Q Consensus 82 ~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Dfg 161 (362)
...+++||||+. ++|..++.......+++..++.++.|++.||+|||+.|++|+||+|+||++ +.++.++|+|||
T Consensus 71 ~~~~~~v~e~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill----~~~~~~~l~dfg 145 (284)
T cd07860 71 ENKLYLVFEFLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLI----NTEGAIKLADFG 145 (284)
T ss_pred CCcEEEEeeccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE----CCCCCEEEeecc
Confidence 234779999996 589999877556679999999999999999999999999999999999999 777889999999
Q ss_pred CcccccccccCCCCCCccCCCCccCchhhccc-cCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHHcCCC---
Q 039291 162 VAKRSRHCKRQKFDPSMRGTPLYLAPETVVQH-MQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEH--- 237 (362)
Q Consensus 162 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~--- 237 (362)
++........ ......++..|+|||++.+. .++.++|+|||||++|+|++|+.||...+. .....+.+....
T Consensus 146 ~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~--~~~~~~~~~~~~~~~ 221 (284)
T cd07860 146 LARAFGVPVR--TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSE--IDQLFRIFRTLGTPD 221 (284)
T ss_pred chhhcccCcc--ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCH--HHHHHHHHHHhCCCC
Confidence 9875543211 11234578899999988764 468889999999999999999999965432 222222111000
Q ss_pred ---------------CC--------CCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCc
Q 039291 238 ---------------SL--------PEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFV 277 (362)
Q Consensus 238 ---------------~~--------~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~ 277 (362)
.+ ..+...++.+++++|.+||+.||.+||++++++.||||
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~f 284 (284)
T cd07860 222 EVVWPGVTSLPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF 284 (284)
T ss_pred hhhhhhhhHHHHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcCCCC
Confidence 00 01123478899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-42 Score=305.17 Aligned_cols=247 Identities=29% Similarity=0.512 Sum_probs=196.4
Q ss_pred ceecccCceEEEEEEECCCCCCCCceeeeechhhh------hhHHHHHHHHHHHHcCCCCcccccccceeeecCCCceEE
Q 039291 12 RVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVS------ASASLQKEKEVFDNLNGCPFVLECFGEEITMGENGEMAY 85 (362)
Q Consensus 12 ~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~~------~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~~~~~~ 85 (362)
+.||+|+||.||+|.++.+++ .+++|..... ....+..|..++....+|+|++++++.+.. ...+
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~----~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~-----~~~~ 72 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGD----YFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQS-----KDYL 72 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCC----eEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEc-----CCeE
Confidence 679999999999999988775 4556654321 223345566666555569999999987642 2357
Q ss_pred EEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEeecCCccc
Q 039291 86 NLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKR 165 (362)
Q Consensus 86 ~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Dfgla~~ 165 (362)
++|+||++|++|.++++. ...+++..+..++.|++.||.|||+.+++|+||+|+||++ +.++.++|+|||++..
T Consensus 73 ~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~----~~~~~~~l~dfg~~~~ 146 (260)
T cd05611 73 YLVMEYLNGGDCASLIKT--LGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLI----DQTGHLKLTDFGLSRN 146 (260)
T ss_pred EEEEeccCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEE----CCCCcEEEeeccccee
Confidence 899999999999999986 3459999999999999999999999999999999999999 6777899999999865
Q ss_pred ccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHHcCCC--CCCCCC
Q 039291 166 SRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEH--SLPEIP 243 (362)
Q Consensus 166 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~--~~~~~~ 243 (362)
... .....|+..|+|||.+.+..++.++|+||||+++|+|++|..||...+ ..+....+.... ..+...
T Consensus 147 ~~~------~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~---~~~~~~~~~~~~~~~~~~~~ 217 (260)
T cd05611 147 GLE------NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAET---PDAVFDNILSRRINWPEEVK 217 (260)
T ss_pred ccc------cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCC---HHHHHHHHHhcccCCCCccc
Confidence 432 134568899999999988888999999999999999999999996443 344443332222 122334
Q ss_pred ccCCHHHHHHHHHHhccCCCCCCC---HHHHhcCCCccCcch
Q 039291 244 SRVSKEARDFLRRCFVRKPAFRFT---AEMLLDDPFVKGVDE 282 (362)
Q Consensus 244 ~~~~~~~~~li~~~l~~~p~~R~s---~~~~l~~p~~~~~~~ 282 (362)
..++.++.+++.+||..+|++||+ +++++.||||+.+.|
T Consensus 218 ~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~~~~~~~~~ 259 (260)
T cd05611 218 EFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSHPFFKSINW 259 (260)
T ss_pred ccCCHHHHHHHHHHccCCHHHccCCCcHHHHHcChHhhcCCC
Confidence 468899999999999999999994 579999999987755
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-42 Score=307.49 Aligned_cols=251 Identities=24% Similarity=0.410 Sum_probs=194.9
Q ss_pred eecccCceEEEEEEECCCCCCCCceeeeechhhh------hhHHHHHHHHHHHHc--CCCCcccccccceeeecCCCceE
Q 039291 13 VIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVS------ASASLQKEKEVFDNL--NGCPFVLECFGEEITMGENGEMA 84 (362)
Q Consensus 13 ~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~~------~~~~~~~E~~il~~l--~~h~~i~~~~~~~~~~~~~~~~~ 84 (362)
.||+|+||.||+|++..+++ .+++|..... .......|..+++.+ .+||+|+.+++.+.. ...
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~----~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~-----~~~ 71 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGK----MYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHT-----PDK 71 (278)
T ss_pred CcccCCCeEEEEEEEecCCC----EEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeec-----CCE
Confidence 48999999999999988776 4455543321 112233444443333 248999988876542 235
Q ss_pred EEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEeecCCcc
Q 039291 85 YNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAK 164 (362)
Q Consensus 85 ~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Dfgla~ 164 (362)
+++||||+.|++|.+++.. ...+++..++.++.|++.||.|||+.+|+||||||+||++ +.++.++|+|||++.
T Consensus 72 ~~~v~e~~~g~~L~~~l~~--~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili----~~~~~~kl~dfg~~~ 145 (278)
T cd05606 72 LSFILDLMNGGDLHYHLSQ--HGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILL----DEHGHVRISDLGLAC 145 (278)
T ss_pred EEEEEecCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEE----CCCCCEEEccCcCcc
Confidence 7799999999999998875 4569999999999999999999999999999999999999 777789999999987
Q ss_pred cccccccCCCCCCccCCCCccCchhhccc-cCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHHcCCCCCCCCC
Q 039291 165 RSRHCKRQKFDPSMRGTPLYLAPETVVQH-MQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEHSLPEIP 243 (362)
Q Consensus 165 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (362)
...... .....|+..|+|||++.+. .++.++|+||+||++|+|++|+.||................. ..+.++
T Consensus 146 ~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~ 219 (278)
T cd05606 146 DFSKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLT--MAVELP 219 (278)
T ss_pred ccCccC----CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhhc--cCCCCC
Confidence 543221 1245799999999999754 688999999999999999999999976543333333333221 123456
Q ss_pred ccCCHHHHHHHHHHhccCCCCCC-----CHHHHhcCCCccCcchhh
Q 039291 244 SRVSKEARDFLRRCFVRKPAFRF-----TAEMLLDDPFVKGVDEEL 284 (362)
Q Consensus 244 ~~~~~~~~~li~~~l~~~p~~R~-----s~~~~l~~p~~~~~~~~~ 284 (362)
..++.++.+++.+||..+|.+|+ ++.++++||||+...+..
T Consensus 220 ~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~~~~~~~~~~~ 265 (278)
T cd05606 220 DSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEHPFFRSLDWQM 265 (278)
T ss_pred CcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhCccccCCCchH
Confidence 66899999999999999999999 999999999999877653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-42 Score=303.29 Aligned_cols=243 Identities=20% Similarity=0.325 Sum_probs=191.0
Q ss_pred ceecccCceEEEEEEECCCCCCCCceeeeech----hhhhhHHHHHHHHHHHHcCCCCcccccccceeeecCCCceEEEE
Q 039291 12 RVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSA----EVSASASLQKEKEVFDNLNGCPFVLECFGEEITMGENGEMAYNL 87 (362)
Q Consensus 12 ~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~----~~~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~~~~~~~l 87 (362)
+.||+|+||.||+|+++.++. .+++|.. ..+....+.+|++++++++ ||||+++++.+.. ...+++
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~----~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~-----~~~~~l 70 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNT----PVAVKSCRETLPPDLKAKFLQEARILKQYS-HPNIVRLIGVCTQ-----KQPIYI 70 (252)
T ss_pred CccCcccCccEEEEEEecCCc----eEEEEecCccCCHHHHHHHHHHHHHHHhCC-CCCcceEEEEEcC-----CCCeEE
Confidence 479999999999999987765 4555543 2334567889999999998 9999999987642 234679
Q ss_pred EEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEeecCCccccc
Q 039291 88 LLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSR 167 (362)
Q Consensus 88 v~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Dfgla~~~~ 167 (362)
||||+++++|.+++... +..+++..++.++.|++.||.|||++|++||||||+||++ +.++.+||+|||++....
T Consensus 71 v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~----~~~~~~kl~dfg~~~~~~ 145 (252)
T cd05084 71 VMELVQGGDFLTFLRTE-GPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLV----TEKNVLKISDFGMSREEE 145 (252)
T ss_pred EEeeccCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEE----cCCCcEEECccccCcccc
Confidence 99999999999999753 3458999999999999999999999999999999999999 677789999999986543
Q ss_pred ccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHh-CCCCCccCCCCCHHHHHHHHcCCCCCCCCCccC
Q 039291 168 HCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLS-GRQAWVVKEDCSIDQLFSIIGDEHSLPEIPSRV 246 (362)
Q Consensus 168 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (362)
............++..|+|||.+.+..++.++|+|||||++|+|++ |..||.... .......+.... ....+..+
T Consensus 146 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~---~~~~~~~~~~~~-~~~~~~~~ 221 (252)
T cd05084 146 DGVYASTGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLS---NQQTREAIEQGV-RLPCPELC 221 (252)
T ss_pred cccccccCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccC---HHHHHHHHHcCC-CCCCcccC
Confidence 2111111111123456999999988889999999999999999998 888885432 233333333222 22456678
Q ss_pred CHHHHHHHHHHhccCCCCCCCHHHHhc
Q 039291 247 SKEARDFLRRCFVRKPAFRFTAEMLLD 273 (362)
Q Consensus 247 ~~~~~~li~~~l~~~p~~R~s~~~~l~ 273 (362)
+..+.+++.+||..+|++|||+.++++
T Consensus 222 ~~~~~~li~~~l~~~p~~Rps~~~~~~ 248 (252)
T cd05084 222 PDAVYRLMERCWEYDPGQRPSFSTVHQ 248 (252)
T ss_pred CHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-42 Score=307.95 Aligned_cols=258 Identities=20% Similarity=0.311 Sum_probs=206.4
Q ss_pred CCCCCceeecceecccCceEEEEEEECCCC-CCCCceeeeechhhh----hhHHHHHHHHHHHHcCCCCcccccccceee
Q 039291 2 DSDGTSWFRGRVIGQGSFGCVFIAKPKSNS-SFLPPLMAVKSAEVS----ASASLQKEKEVFDNLNGCPFVLECFGEEIT 76 (362)
Q Consensus 2 ~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~-~~~~~~~~~K~~~~~----~~~~~~~E~~il~~l~~h~~i~~~~~~~~~ 76 (362)
++..++|.+.+.||+|+||.||+|.++... ......+++|..... ....+.+|+.+++.++ ||||+++++.+..
T Consensus 2 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~ 80 (277)
T cd05032 2 ELPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFN-CHHVVRLLGVVST 80 (277)
T ss_pred ccchHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCC-CCceeEEEEEEcC
Confidence 456689999999999999999999987543 222356788876432 2345778999999998 8999999987642
Q ss_pred ecCCCceEEEEEEEecCCCCHHHHHHHhc--------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeec
Q 039291 77 MGENGEMAYNLLLEYAAGGTLGDLIEKCN--------GNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVAT 148 (362)
Q Consensus 77 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--------~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~ 148 (362)
...+++||||+++++|.+++.... ...+++..+..++.|++.||.|||+++++||||||+||++
T Consensus 81 -----~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill--- 152 (277)
T cd05032 81 -----GQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMV--- 152 (277)
T ss_pred -----CCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEE---
Confidence 234679999999999999997532 1237888999999999999999999999999999999999
Q ss_pred CCCceEEEEeecCCcccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHh-CCCCCccCCCCCHH
Q 039291 149 QSGKFVAKIADLGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLS-GRQAWVVKEDCSID 227 (362)
Q Consensus 149 ~~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~ 227 (362)
+.++.+||+|||+++...............++..|+|||.+.+..++.++|||||||++|+|++ |..||... ...
T Consensus 153 -~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~---~~~ 228 (277)
T cd05032 153 -AEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGL---SNE 228 (277)
T ss_pred -cCCCCEEECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccC---CHH
Confidence 7778899999999875543222222234457888999999988889999999999999999998 99999543 344
Q ss_pred HHHHHHcCCCCCCCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhc
Q 039291 228 QLFSIIGDEHSLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLD 273 (362)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~ 273 (362)
+....+... ..+..+..++.++.+++.+||..+|++|||+.++++
T Consensus 229 ~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 273 (277)
T cd05032 229 EVLKFVIDG-GHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVS 273 (277)
T ss_pred HHHHHHhcC-CCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 555555433 334556778999999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-42 Score=308.58 Aligned_cols=260 Identities=18% Similarity=0.266 Sum_probs=207.2
Q ss_pred CCCCCCceeecceecccCceEEEEEEECCCCCCCCceeeeechh----hhhhHHHHHHHHHHHHcCCCCcccccccceee
Q 039291 1 MDSDGTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAE----VSASASLQKEKEVFDNLNGCPFVLECFGEEIT 76 (362)
Q Consensus 1 ~~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~----~~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~ 76 (362)
+++.+++|.+.+.||+|+||.||+|.+..++......+++|... ......+.+|+.+++.++ |+||+++++....
T Consensus 1 ~~~~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~-h~ni~~~~~~~~~ 79 (280)
T cd05043 1 IAISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLS-HQNILPILHVCIE 79 (280)
T ss_pred CccchhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCC-CCCCCeEEEEEec
Confidence 56789999999999999999999999877432222456666543 234566789999999997 9999999986643
Q ss_pred ecCCCceEEEEEEEecCCCCHHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCC
Q 039291 77 MGENGEMAYNLLLEYAAGGTLGDLIEKCNG------NGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQS 150 (362)
Q Consensus 77 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~------~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~ 150 (362)
. ....++++||+.+++|.+++..... ..+++..+..++.|++.||+|||+++++||||||+||++ +
T Consensus 80 ~----~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~----~ 151 (280)
T cd05043 80 D----GEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVI----D 151 (280)
T ss_pred C----CCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEE----c
Confidence 2 2346699999999999999976432 358999999999999999999999999999999999999 7
Q ss_pred CceEEEEeecCCcccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHh-CCCCCccCCCCCHHHH
Q 039291 151 GKFVAKIADLGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLS-GRQAWVVKEDCSIDQL 229 (362)
Q Consensus 151 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~ 229 (362)
.++.+||+|||+++...............++..|+|||++.+..++.++|||||||++|++++ |++||... +...+
T Consensus 152 ~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~---~~~~~ 228 (280)
T cd05043 152 EELQVKITDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEI---DPFEM 228 (280)
T ss_pred CCCcEEECCCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcC---CHHHH
Confidence 778899999999975543222212223446778999999998889999999999999999999 99999543 44455
Q ss_pred HHHHcCCCCCCCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhc
Q 039291 230 FSIIGDEHSLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLD 273 (362)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~ 273 (362)
...+...... ..+..++.++.+++.+||..+|++|||+.+++.
T Consensus 229 ~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 271 (280)
T cd05043 229 AAYLKDGYRL-AQPINCPDELFAVMACCWALDPEERPSFSQLVQ 271 (280)
T ss_pred HHHHHcCCCC-CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 5554444333 234567899999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-42 Score=312.28 Aligned_cols=262 Identities=23% Similarity=0.350 Sum_probs=198.3
Q ss_pred CCceeecceecccCceEEEEEEECCCCCCCCceeeeechhh-----hhhHHHHHHHHHHHHcCCCCcccccccceeeecC
Q 039291 5 GTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEV-----SASASLQKEKEVFDNLNGCPFVLECFGEEITMGE 79 (362)
Q Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~-----~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~ 79 (362)
-++|.+.+.||+|+||.||+|+++.++. .+++|.... .....+.+|+.+++++. ||||+++++++.....
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~----~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~ 85 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQ----IVALKKVLMENEKEGFPITALREIKILQLLK-HENVVNLIEICRTKAT 85 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECCCCc----EEEEEEEeccCCcCCchhHHHHHHHHHHhCC-CCCccceEEEEecccc
Confidence 3579999999999999999999988775 456665422 12334568999999998 9999999987654321
Q ss_pred ---CCceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEE
Q 039291 80 ---NGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAK 156 (362)
Q Consensus 80 ---~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~k 156 (362)
.....+++||||+.+ +|.+++... ...+++.+++.++.|++.||.|||++|++|+||||+||++ +.++.+|
T Consensus 86 ~~~~~~~~~~lv~e~~~~-~l~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~----~~~~~~k 159 (310)
T cd07865 86 PYNRYKGSFYLVFEFCEH-DLAGLLSNK-NVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILI----TKDGILK 159 (310)
T ss_pred cccCCCceEEEEEcCCCc-CHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEE----CCCCcEE
Confidence 123456799999964 888888763 3459999999999999999999999999999999999999 7778899
Q ss_pred EeecCCcccccccccC--CCCCCccCCCCccCchhhccc-cCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHH
Q 039291 157 IADLGVAKRSRHCKRQ--KFDPSMRGTPLYLAPETVVQH-MQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSII 233 (362)
Q Consensus 157 l~Dfgla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~ 233 (362)
|+|||++......... .......++..|+|||.+.+. .++.++|+||||+++|+|++|++||...+.......+..+
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~ 239 (310)
T cd07865 160 LADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQL 239 (310)
T ss_pred ECcCCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Confidence 9999999755432221 111245678899999988764 4688999999999999999999999655432222222222
Q ss_pred cCCCC-----------------CCC-----C-----CccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCc
Q 039291 234 GDEHS-----------------LPE-----I-----PSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFV 277 (362)
Q Consensus 234 ~~~~~-----------------~~~-----~-----~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~ 277 (362)
..... .+. . +...+..+++||.+||..||++|||++++++||||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~~f 310 (310)
T cd07865 240 CGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF 310 (310)
T ss_pred hCCCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcCCCC
Confidence 11000 000 0 01135678899999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=301.05 Aligned_cols=255 Identities=40% Similarity=0.712 Sum_probs=211.6
Q ss_pred ceeecceecccCceEEEEEEECCCCCCCCceeeeechhh-----hhhHHHHHHHHHHHHcCCCCcccccccceeeecCCC
Q 039291 7 SWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEV-----SASASLQKEKEVFDNLNGCPFVLECFGEEITMGENG 81 (362)
Q Consensus 7 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~-----~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~~ 81 (362)
+|...+.||+|++|.||+|.++.++. .+++|.... ...+.+.+|+.++++++ ||||+++++..... .
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~----~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~---~ 72 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGE----LMAVKSVELSGDSEEELEALEREIRILSSLQ-HPNIVRYYGSERDE---E 72 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCc----EEEEEEeeccccchHHHHHHHHHHHHHHHcC-CCCEeeEEEEEecC---C
Confidence 58889999999999999999987765 455555433 23667889999999999 99999998866432 1
Q ss_pred ceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEeecC
Q 039291 82 EMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLG 161 (362)
Q Consensus 82 ~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Dfg 161 (362)
...+++++||+++++|.+++.... .+++..+..++.|++.||.|||+.|++|+||+|+||++ +.++.++|+|||
T Consensus 73 ~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i----~~~~~~~l~d~~ 146 (260)
T cd06606 73 KNTLNIFLEYVSGGSLSSLLKKFG--KLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILV----DSDGVVKLADFG 146 (260)
T ss_pred CCeEEEEEEecCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEE----cCCCCEEEcccc
Confidence 245779999999999999998743 69999999999999999999999999999999999999 667889999999
Q ss_pred CcccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHHcCCCCCCC
Q 039291 162 VAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEHSLPE 241 (362)
Q Consensus 162 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 241 (362)
.+................++..|+|||.+.+...+.++|+||||+++++|++|..||...+ +.......+......+.
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~--~~~~~~~~~~~~~~~~~ 224 (260)
T cd06606 147 CAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELG--NPMAALYKIGSSGEPPE 224 (260)
T ss_pred cEEecccccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--chHHHHHhccccCCCcC
Confidence 9886665432111234668999999999988889999999999999999999999996554 23333344443445566
Q ss_pred CCccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCc
Q 039291 242 IPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFV 277 (362)
Q Consensus 242 ~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~ 277 (362)
++..++.+++++|.+||..+|++||++.+++.||||
T Consensus 225 ~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 260 (260)
T cd06606 225 IPEHLSEEAKDFLRKCLRRDPKKRPTADELLQHPFL 260 (260)
T ss_pred CCcccCHHHHHHHHHhCcCChhhCCCHHHHhhCCCC
Confidence 777889999999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=303.70 Aligned_cols=250 Identities=21% Similarity=0.340 Sum_probs=200.9
Q ss_pred CCCCceeecceecccCceEEEEEEECCCCCCCCceeeeechhhh--hhHHHHHHHHHHHHcCCCCcccccccceeeecCC
Q 039291 3 SDGTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVS--ASASLQKEKEVFDNLNGCPFVLECFGEEITMGEN 80 (362)
Q Consensus 3 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~~--~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~ 80 (362)
+..++|.+.+.||+|+||.||+|++..++ .+++|..... ....+.+|+.+++.++ ||||+++++... .
T Consensus 3 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~-----~valK~~~~~~~~~~~~~~E~~~l~~l~-~~~i~~~~~~~~----~ 72 (262)
T cd05071 3 IPRESLRLEVKLGQGCFGEVWMGTWNGTT-----RVAIKTLKPGTMSPEAFLQEAQVMKKLR-HEKLVQLYAVVS----E 72 (262)
T ss_pred CChHHeeEeeecCCCCCCcEEEEEecCCc-----eEEEEecccCccCHHHHHHHHHHHHhCC-CCCcceEEEEEC----C
Confidence 45689999999999999999999887653 3677766532 3456889999999998 899999987542 1
Q ss_pred CceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEeec
Q 039291 81 GEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADL 160 (362)
Q Consensus 81 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Df 160 (362)
..+++||||+++++|.+++.......+++..+..++.|++.||.|||+.+++|+||||+||++ +.++.++|+||
T Consensus 73 --~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill----~~~~~~~L~df 146 (262)
T cd05071 73 --EPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILV----GENLVCKVADF 146 (262)
T ss_pred --CCcEEEEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEE----cCCCcEEeccC
Confidence 235799999999999999987545568999999999999999999999999999999999999 67788999999
Q ss_pred CCcccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHh-CCCCCccCCCCCHHHHHHHHcCCCCC
Q 039291 161 GVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLS-GRQAWVVKEDCSIDQLFSIIGDEHSL 239 (362)
Q Consensus 161 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~ 239 (362)
|++........ .......++..|+|||++.+..++.++|+|||||++|+|++ |..||... ...+....+......
T Consensus 147 g~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~---~~~~~~~~~~~~~~~ 222 (262)
T cd05071 147 GLARLIEDNEY-TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM---VNREVLDQVERGYRM 222 (262)
T ss_pred Cceeecccccc-ccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCC---ChHHHHHHHhcCCCC
Confidence 99875543221 11123446778999999988889999999999999999999 88888543 233444444333322
Q ss_pred CCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhc
Q 039291 240 PEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLD 273 (362)
Q Consensus 240 ~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~ 273 (362)
..+..++..+.+++.+||..+|++||+++++++
T Consensus 223 -~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~ 255 (262)
T cd05071 223 -PCPPECPESLHDLMCQCWRKEPEERPTFEYLQA 255 (262)
T ss_pred -CCccccCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 335678999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-42 Score=311.09 Aligned_cols=253 Identities=23% Similarity=0.424 Sum_probs=195.4
Q ss_pred CCceeecceecccCceEEEEEEECCCCCCCCceeeeechhhh----hhHHHHHHHHHHHHcCCCCcccccccceeeecCC
Q 039291 5 GTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVS----ASASLQKEKEVFDNLNGCPFVLECFGEEITMGEN 80 (362)
Q Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~~----~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~ 80 (362)
-++|.+.+.||+|++|.||+|.++.++. .+++|..... ....+.+|+.+++.++ |+||+++++++..
T Consensus 4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~----~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~---- 74 (291)
T cd07844 4 LETYKKLDKLGEGSYATVYKGRSKLTGQ----LVALKEIRLEHEEGAPFTAIREASLLKDLK-HANIVTLHDIIHT---- 74 (291)
T ss_pred ccceeEEEEEeecCCeEEEEEEEcCCCc----EEEEEEEecccccCCchhHHHHHHHHhhCC-CcceeeEEEEEec----
Confidence 3689999999999999999999987765 5666665322 2244678999999998 9999999987542
Q ss_pred CceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEeec
Q 039291 81 GEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADL 160 (362)
Q Consensus 81 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Df 160 (362)
....++||||+.+ +|.+++.... ..+++..++.++.|++.||.|||++||+||||||+||++ +.++.++|+||
T Consensus 75 -~~~~~lv~e~~~~-~L~~~~~~~~-~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~----~~~~~~kl~df 147 (291)
T cd07844 75 -KKTLTLVFEYLDT-DLKQYMDDCG-GGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLI----SERGELKLADF 147 (291)
T ss_pred -CCeEEEEEecCCC-CHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEE----cCCCCEEECcc
Confidence 2357799999985 9999887643 468999999999999999999999999999999999999 77788999999
Q ss_pred CCcccccccccCCCCCCccCCCCccCchhhcc-ccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHH----cC
Q 039291 161 GVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQ-HMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSII----GD 235 (362)
Q Consensus 161 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~----~~ 235 (362)
|+++....... ......++..|+|||++.+ ..++.++||||+|+++|+|++|+.||..... ..+....+ ..
T Consensus 148 g~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~--~~~~~~~~~~~~~~ 223 (291)
T cd07844 148 GLARAKSVPSK--TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTD--VEDQLHKIFRVLGT 223 (291)
T ss_pred ccccccCCCCc--cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCcc--HHHHHHHHHHhcCC
Confidence 99864432111 1123357889999999875 4578999999999999999999999964431 11111111 00
Q ss_pred C----------------CCCC--------CCCccCC--HHHHHHHHHHhccCCCCCCCHHHHhcCCCc
Q 039291 236 E----------------HSLP--------EIPSRVS--KEARDFLRRCFVRKPAFRFTAEMLLDDPFV 277 (362)
Q Consensus 236 ~----------------~~~~--------~~~~~~~--~~~~~li~~~l~~~p~~R~s~~~~l~~p~~ 277 (362)
. ...+ .....++ .++.+++.+||..+|++||++.+++.||||
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~f 291 (291)
T cd07844 224 PTEETWPGVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF 291 (291)
T ss_pred CChhhhhhhhhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 0 0000 0011234 788999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-42 Score=311.79 Aligned_cols=259 Identities=24% Similarity=0.395 Sum_probs=200.9
Q ss_pred ceeecceecccCceEEEEEEECCCCCCCCceeeeechhhh--------hhHHHHHHHHHHHHcCCCCcccccccceeeec
Q 039291 7 SWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVS--------ASASLQKEKEVFDNLNGCPFVLECFGEEITMG 78 (362)
Q Consensus 7 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~~--------~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~ 78 (362)
+|.+.+.||+|+||.||+|.++.++. .+++|..... ....+..|++++++++ |+||+++++.+..
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~----~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~-h~~i~~~~~~~~~-- 73 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGR----IVAIKKIKLGERKEAKDGINFTALREIKLLQELK-HPNIIGLLDVFGH-- 73 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCc----EEEEEEEeccccccccchhhHHHHHHHHHHhhcC-CCCChhhhheeec--
Confidence 58899999999999999999987765 5566655332 2345678999999999 9999999987653
Q ss_pred CCCceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEe
Q 039291 79 ENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIA 158 (362)
Q Consensus 79 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~ 158 (362)
...+++||||+ +++|.+++.... ..+++..+..++.||+.||.|||++||+|+||||+||++ +.++.++|+
T Consensus 74 ---~~~~~lv~e~~-~~~L~~~i~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill----~~~~~~~l~ 144 (298)
T cd07841 74 ---KSNINLVFEFM-ETDLEKVIKDKS-IVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLI----ASDGVLKLA 144 (298)
T ss_pred ---CCEEEEEEccc-CCCHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEE----cCCCCEEEc
Confidence 34578999999 889999997632 369999999999999999999999999999999999999 777889999
Q ss_pred ecCCcccccccccCCCCCCccCCCCccCchhhcc-ccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHH-HHHHHcCC
Q 039291 159 DLGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQ-HMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQ-LFSIIGDE 236 (362)
Q Consensus 159 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~-~~~~~~~~ 236 (362)
|||++........ ......+++.|+|||.+.+ ..++.++|+|||||++|+|++|.+||....+..... ........
T Consensus 145 dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~ 222 (298)
T cd07841 145 DFGLARSFGSPNR--KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTP 222 (298)
T ss_pred cceeeeeccCCCc--cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCC
Confidence 9999976554221 1123457888999998865 467889999999999999999988886543321111 11110000
Q ss_pred ----------------------CCCCCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCccCcchh
Q 039291 237 ----------------------HSLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGVDEE 283 (362)
Q Consensus 237 ----------------------~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~~~~~~~ 283 (362)
..........+.++.++|.+||..+|++|||+.+++.||||++....
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~~~~ 291 (298)
T cd07841 223 TEENWPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSNDPAP 291 (298)
T ss_pred chhhhhhcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccCCCCC
Confidence 00001123457889999999999999999999999999999876443
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-43 Score=334.13 Aligned_cols=254 Identities=22% Similarity=0.377 Sum_probs=211.5
Q ss_pred CCceeecceecccCceEEEEEEECCCC-CCCCceeeeechhhh----hhHHHHHHHHHHHHcCCCCcccccccceeeecC
Q 039291 5 GTSWFRGRVIGQGSFGCVFIAKPKSNS-SFLPPLMAVKSAEVS----ASASLQKEKEVFDNLNGCPFVLECFGEEITMGE 79 (362)
Q Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~-~~~~~~~~~K~~~~~----~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~ 79 (362)
.+.-...+.||+|+||+||+|+--+-. ......||+|.++.. ....|+||++++..|+ |||||+++|++..
T Consensus 485 r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~-H~nIVrLlGVC~~--- 560 (774)
T KOG1026|consen 485 RSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQ-HPNIVRLLGVCRE--- 560 (774)
T ss_pred hhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhcc-CCCeEEEEEEEcc---
Confidence 344566899999999999999865432 223357888877543 4567999999999999 9999999999864
Q ss_pred CCceEEEEEEEecCCCCHHHHHHHhc--------CCC----CCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEee
Q 039291 80 NGEMAYNLLLEYAAGGTLGDLIEKCN--------GNG----LPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVA 147 (362)
Q Consensus 80 ~~~~~~~lv~e~~~~~~L~~~l~~~~--------~~~----l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~ 147 (362)
...+|+|+||+..|||.++|..+. +.. |+..+...|+.||+.|+.||-++.+|||||...|+||
T Consensus 561 --~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLV-- 636 (774)
T KOG1026|consen 561 --GDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLV-- 636 (774)
T ss_pred --CCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhcee--
Confidence 334789999999999999998732 122 8899999999999999999999999999999999999
Q ss_pred cCCCceEEEEeecCCcccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHh-CCCCCccCCCCCH
Q 039291 148 TQSGKFVAKIADLGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLS-GRQAWVVKEDCSI 226 (362)
Q Consensus 148 ~~~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~ 226 (362)
.++..|||+||||++.....+-.+......-..+|||||.+..+.++.+|||||+||+|||+++ |..||.+..+
T Consensus 637 --ge~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn--- 711 (774)
T KOG1026|consen 637 --GENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSN--- 711 (774)
T ss_pred --ccceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccch---
Confidence 8999999999999997665544444323334677999999999999999999999999999998 9999976644
Q ss_pred HHHHHHHcCCCCCCCCCccCCHHHHHHHHHHhccCCCCCCCHHHHh
Q 039291 227 DQLFSIIGDEHSLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLL 272 (362)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l 272 (362)
++.+..+.++..+ +.|..+|.++.+|+..||+.+|.+||++.+|-
T Consensus 712 ~EVIe~i~~g~lL-~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~ 756 (774)
T KOG1026|consen 712 QEVIECIRAGQLL-SCPENCPTEVYSLMLECWNENPKRRPSFKEIH 756 (774)
T ss_pred HHHHHHHHcCCcc-cCCCCCCHHHHHHHHHHhhcCcccCCCHHHHH
Confidence 4556666666664 57899999999999999999999999998874
|
|
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-42 Score=308.83 Aligned_cols=253 Identities=25% Similarity=0.379 Sum_probs=193.0
Q ss_pred eeecceecccCceEEEEEEECCCCCCCCceeeeechhh----hhhHHHHHHHHHHHHcCCCCcccccccceeeecCCCce
Q 039291 8 WFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEV----SASASLQKEKEVFDNLNGCPFVLECFGEEITMGENGEM 83 (362)
Q Consensus 8 y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~----~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~~~~ 83 (362)
|.+.+.||+|+||.||+|.++.++.. +++|.... .......+|+.++.++.+|+|++++++.+... ...
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~----~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~---~~~ 73 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKY----YAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDR---KTG 73 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcE----EEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecC---CCC
Confidence 67889999999999999999887764 45554332 22233457899999998899999999876532 123
Q ss_pred EEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEeecCCc
Q 039291 84 AYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVA 163 (362)
Q Consensus 84 ~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Dfgla 163 (362)
.+++||||+.+ +|.+.+... ...+++..++.++.|++.||.|||+.|++||||||+||++ +. +.+||+|||++
T Consensus 74 ~~~lv~e~~~~-~l~~~l~~~-~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l----~~-~~~kl~dfg~~ 146 (282)
T cd07831 74 RLALVFELMDM-NLYELIKGR-KRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILI----KD-DILKLADFGSC 146 (282)
T ss_pred cEEEEEecCCc-cHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEE----cC-CCeEEEecccc
Confidence 46899999975 888887653 3468999999999999999999999999999999999999 66 88999999998
Q ss_pred ccccccccCCCCCCccCCCCccCchhhcc-ccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHH-----------
Q 039291 164 KRSRHCKRQKFDPSMRGTPLYLAPETVVQ-HMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFS----------- 231 (362)
Q Consensus 164 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~----------- 231 (362)
......... ....++..|+|||++.. ..++.++|+|||||++|+|++|.+||...+..+......
T Consensus 147 ~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 223 (282)
T cd07831 147 RGIYSKPPY---TEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVL 223 (282)
T ss_pred cccccCCCc---CCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHH
Confidence 755432111 23568899999998754 456889999999999999999999996543211111110
Q ss_pred -HHcCC----CCCC--------CCCccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCc
Q 039291 232 -IIGDE----HSLP--------EIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFV 277 (362)
Q Consensus 232 -~~~~~----~~~~--------~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~ 277 (362)
..... ...+ .....++.+++++|.+||..+|++||++++++.||||
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~~ 282 (282)
T cd07831 224 KKFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF 282 (282)
T ss_pred HhhcccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhCCCC
Confidence 00000 0000 1123468999999999999999999999999999997
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=308.00 Aligned_cols=257 Identities=22% Similarity=0.405 Sum_probs=202.8
Q ss_pred CCCCceeecceecccCceEEEEEEECCCC-CCCCceeeeechhh---hhhHHHHHHHHHHHHcCCCCcccccccceeeec
Q 039291 3 SDGTSWFRGRVIGQGSFGCVFIAKPKSNS-SFLPPLMAVKSAEV---SASASLQKEKEVFDNLNGCPFVLECFGEEITMG 78 (362)
Q Consensus 3 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~-~~~~~~~~~K~~~~---~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~ 78 (362)
+.+..|.+.+.||+|+||+||++.+.... ..-...+++|.... .....+.+|+.++++++ ||||+++++.+..
T Consensus 2 ~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~-- 78 (288)
T cd05093 2 IKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQ-HEHIVKFYGVCVE-- 78 (288)
T ss_pred CchHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCC-CCCcceEEEEEec--
Confidence 45678999999999999999999864321 11223466666543 23456889999999998 8999999987642
Q ss_pred CCCceEEEEEEEecCCCCHHHHHHHhc-----------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEee
Q 039291 79 ENGEMAYNLLLEYAAGGTLGDLIEKCN-----------GNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVA 147 (362)
Q Consensus 79 ~~~~~~~~lv~e~~~~~~L~~~l~~~~-----------~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~ 147 (362)
...+++||||+++++|.+++.... ...+++..+..++.|++.||+|||++|++||||||+||++
T Consensus 79 ---~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili-- 153 (288)
T cd05093 79 ---GDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLV-- 153 (288)
T ss_pred ---CCccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEE--
Confidence 234779999999999999997532 1248999999999999999999999999999999999999
Q ss_pred cCCCceEEEEeecCCcccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHh-CCCCCccCCCCCH
Q 039291 148 TQSGKFVAKIADLGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLS-GRQAWVVKEDCSI 226 (362)
Q Consensus 148 ~~~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~ 226 (362)
+.++.++|+|||+++...............++..|+|||++.+..++.++|+|||||++|+|++ |.+||.... .
T Consensus 154 --~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~---~ 228 (288)
T cd05093 154 --GENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLS---N 228 (288)
T ss_pred --ccCCcEEeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC---H
Confidence 7778899999999875543222222223446788999999998889999999999999999998 999985442 3
Q ss_pred HHHHHHHcCCCCCCCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhc
Q 039291 227 DQLFSIIGDEHSLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLD 273 (362)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~ 273 (362)
......+..... +..+..++.++.+|+.+||..||.+|||+.++++
T Consensus 229 ~~~~~~i~~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~ 274 (288)
T cd05093 229 NEVIECITQGRV-LQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHS 274 (288)
T ss_pred HHHHHHHHcCCc-CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 344444443332 3345568899999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=310.26 Aligned_cols=260 Identities=22% Similarity=0.381 Sum_probs=206.2
Q ss_pred CCCCCceeecceecccCceEEEEEEECCC---CCCCCceeeeechhh----hhhHHHHHHHHHHHHcCCCCcccccccce
Q 039291 2 DSDGTSWFRGRVIGQGSFGCVFIAKPKSN---SSFLPPLMAVKSAEV----SASASLQKEKEVFDNLNGCPFVLECFGEE 74 (362)
Q Consensus 2 ~~~~~~y~~~~~lG~G~~g~V~~a~~~~~---~~~~~~~~~~K~~~~----~~~~~~~~E~~il~~l~~h~~i~~~~~~~ 74 (362)
+....+|.+++.||+|+||.||+|++... ...-...+++|.... .....+.+|+.+++.+.+||||+++++.+
T Consensus 11 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~ 90 (304)
T cd05101 11 EFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGAC 90 (304)
T ss_pred cccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEE
Confidence 45678999999999999999999986421 111223567776542 33456889999999996699999999866
Q ss_pred eeecCCCceEEEEEEEecCCCCHHHHHHHhc--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCC
Q 039291 75 ITMGENGEMAYNLLLEYAAGGTLGDLIEKCN--------------GNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKP 140 (362)
Q Consensus 75 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--------------~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp 140 (362)
.. ...++++|||+.+++|.+++.... ...++..++..++.|++.||.|||++|++||||||
T Consensus 91 ~~-----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp 165 (304)
T cd05101 91 TQ-----DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAA 165 (304)
T ss_pred ec-----CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeeccccc
Confidence 42 234679999999999999997632 12478889999999999999999999999999999
Q ss_pred CCEEEeecCCCceEEEEeecCCcccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHh-CCCCCc
Q 039291 141 DNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLS-GRQAWV 219 (362)
Q Consensus 141 ~Nill~~~~~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~ 219 (362)
+||++ +.++.+||+|||+++...............++..|+|||++.+..++.++||||||+++|+|++ |..||.
T Consensus 166 ~Nili----~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~ 241 (304)
T cd05101 166 RNVLV----TENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYP 241 (304)
T ss_pred ceEEE----cCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcc
Confidence 99999 6777899999999976543322222233446778999999988889999999999999999998 788884
Q ss_pred cCCCCCHHHHHHHHcCCCCCCCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhcC
Q 039291 220 VKEDCSIDQLFSIIGDEHSLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDD 274 (362)
Q Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~ 274 (362)
.. ...++...+..... ...+..++.++++|+.+||..+|++||++.++++.
T Consensus 242 ~~---~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~ 292 (304)
T cd05101 242 GI---PVEELFKLLKEGHR-MDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVED 292 (304)
T ss_pred cC---CHHHHHHHHHcCCc-CCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHH
Confidence 43 45566666554443 23456789999999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=323.00 Aligned_cols=250 Identities=27% Similarity=0.423 Sum_probs=203.7
Q ss_pred eeecceecccCceEEEEEEECCCCCCCCceeeeechh------hhhhHHHHHHHHHHHHcCCCCcccccccceeeecCCC
Q 039291 8 WFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAE------VSASASLQKEKEVFDNLNGCPFVLECFGEEITMGENG 81 (362)
Q Consensus 8 y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~------~~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~~ 81 (362)
-.+.+.||+|+||.||+|+.+..+......||+|... ......+.+|+++|++++ ||||+++||+...
T Consensus 159 v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~-H~NVVr~yGVa~~----- 232 (474)
T KOG0194|consen 159 IELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLN-HPNVVRFYGVAVL----- 232 (474)
T ss_pred ccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCC-CCCEEEEEEEEcC-----
Confidence 3456999999999999999877654222237777655 345677999999999999 9999999998753
Q ss_pred ceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEeecC
Q 039291 82 EMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLG 161 (362)
Q Consensus 82 ~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Dfg 161 (362)
...+++|||+|.||+|.++|++..+ .++..+...++.+.++||+|||++++|||||-..|+|+ ..+..+||+|||
T Consensus 233 ~~Pl~ivmEl~~gGsL~~~L~k~~~-~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~----~~~~~vKISDFG 307 (474)
T KOG0194|consen 233 EEPLMLVMELCNGGSLDDYLKKNKK-SLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLY----SKKGVVKISDFG 307 (474)
T ss_pred CCccEEEEEecCCCcHHHHHHhCCC-CCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHhee----cCCCeEEeCccc
Confidence 3347899999999999999998433 59999999999999999999999999999999999999 777779999999
Q ss_pred CcccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHh-CCCCCccCCCCCHHHHHHHHcCCCCCC
Q 039291 162 VAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLS-GRQAWVVKEDCSIDQLFSIIGDEHSLP 240 (362)
Q Consensus 162 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 240 (362)
+++.......... ...-...|+|||.+....++.++|||||||++||+++ |..||.+. ...++...+.......
T Consensus 308 Ls~~~~~~~~~~~--~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~---~~~~v~~kI~~~~~r~ 382 (474)
T KOG0194|consen 308 LSRAGSQYVMKKF--LKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGM---KNYEVKAKIVKNGYRM 382 (474)
T ss_pred cccCCcceeeccc--cccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCC---CHHHHHHHHHhcCccC
Confidence 9875542111110 1234567999999999999999999999999999999 88899554 4556666663333333
Q ss_pred CCCccCCHHHHHHHHHHhccCCCCCCCHHHHhc
Q 039291 241 EIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLD 273 (362)
Q Consensus 241 ~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~ 273 (362)
..+...+.++..++.+||..+|+.||++.++..
T Consensus 383 ~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~ 415 (474)
T KOG0194|consen 383 PIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKK 415 (474)
T ss_pred CCCCCCHHHHHHHHHHhccCChhhccCHHHHHH
Confidence 456788999999999999999999999988765
|
|
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=301.70 Aligned_cols=248 Identities=19% Similarity=0.318 Sum_probs=198.2
Q ss_pred CCceeecceecccCceEEEEEEECCCCCCCCceeeeechhhh--hhHHHHHHHHHHHHcCCCCcccccccceeeecCCCc
Q 039291 5 GTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVS--ASASLQKEKEVFDNLNGCPFVLECFGEEITMGENGE 82 (362)
Q Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~~--~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~~~ 82 (362)
-++|.+.+.||+|+||.||+|..+... .+++|..... ....+.+|+.++++++ ||||+++++.+.. .
T Consensus 3 ~~~~~~~~~lg~G~~~~vy~~~~~~~~-----~~a~K~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~-----~ 71 (256)
T cd05114 3 PSELTFMKELGSGQFGVVHLGKWRAQI-----KVAIKAINEGAMSEEDFIEEAKVMMKLS-HPKLVQLYGVCTQ-----Q 71 (256)
T ss_pred HHHcEEeeEecCCcCceEEEEEeccCc-----eEEEEecccCCccHHHHHHHHHHHHHCC-CCCceeEEEEEcc-----C
Confidence 467899999999999999999886542 4667664432 3456788999999998 8999999986532 2
Q ss_pred eEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEeecCC
Q 039291 83 MAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGV 162 (362)
Q Consensus 83 ~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Dfgl 162 (362)
..+++||||+++|+|.+++.... ..+++..+..++.|++.||.|||++||+||||||+||++ +.++.++|+|||+
T Consensus 72 ~~~~iv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i----~~~~~~kl~d~g~ 146 (256)
T cd05114 72 KPLYIVTEFMENGCLLNYLRQRQ-GKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLV----SSTGVVKVSDFGM 146 (256)
T ss_pred CCEEEEEEcCCCCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEE----cCCCeEEECCCCC
Confidence 34779999999999999997632 358999999999999999999999999999999999999 7778899999999
Q ss_pred cccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHh-CCCCCccCCCCCHHHHHHHHcCCCCCCC
Q 039291 163 AKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLS-GRQAWVVKEDCSIDQLFSIIGDEHSLPE 241 (362)
Q Consensus 163 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 241 (362)
++........ ......++..|+|||++.+..++.++|+||||+++|+|++ |+.||... +..+....+..... +.
T Consensus 147 ~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~---~~~~~~~~i~~~~~-~~ 221 (256)
T cd05114 147 TRYVLDDEYT-SSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKK---SNYEVVEMISRGFR-LY 221 (256)
T ss_pred ccccCCCcee-ccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCC---CHHHHHHHHHCCCC-CC
Confidence 8754322111 1122335668999999988889999999999999999999 89999544 33444444443332 23
Q ss_pred CCccCCHHHHHHHHHHhccCCCCCCCHHHHhc
Q 039291 242 IPSRVSKEARDFLRRCFVRKPAFRFTAEMLLD 273 (362)
Q Consensus 242 ~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~ 273 (362)
.+...+.++.+++.+||..+|++||++++++.
T Consensus 222 ~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~ 253 (256)
T cd05114 222 RPKLASMTVYEVMYSCWHEKPEGRPTFAELLR 253 (256)
T ss_pred CCCCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 45567889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=304.56 Aligned_cols=251 Identities=25% Similarity=0.408 Sum_probs=202.8
Q ss_pred CceeecceecccCceEEEEEEECCCCCCCCceeeeechh------hhhhHHHHHHHHHHHHcCCCCcccccccceeeecC
Q 039291 6 TSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAE------VSASASLQKEKEVFDNLNGCPFVLECFGEEITMGE 79 (362)
Q Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~------~~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~ 79 (362)
++|.+.+.||+|+||.||+|+++.++. .+++|... ......+.+|+.+++.++ ||||+++++.+..
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~----~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~--- 73 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRK----PVALKKVQIFEMMDAKARQDCVKEIDLLKQLN-HPNVIKYLDSFIE--- 73 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCC----EEEEEEeeccccCCHHHHHHHHHHHHHHHhCC-CcceeeeeeeEEE---
Confidence 689999999999999999999988775 45555432 233456788999999998 9999999987653
Q ss_pred CCceEEEEEEEecCCCCHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEE
Q 039291 80 NGEMAYNLLLEYAAGGTLGDLIEKCN--GNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKI 157 (362)
Q Consensus 80 ~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl 157 (362)
...+++++||+++++|.+++.... ...+++..+..++.|++.||.|||++|++|+||||+||++ +.++.++|
T Consensus 74 --~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~----~~~~~~~l 147 (267)
T cd08228 74 --DNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFI----TATGVVKL 147 (267)
T ss_pred --CCeEEEEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEE----cCCCCEEE
Confidence 234679999999999999886432 3458999999999999999999999999999999999999 66778999
Q ss_pred eecCCcccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHHcCCC
Q 039291 158 ADLGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEH 237 (362)
Q Consensus 158 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 237 (362)
+|||++........ ......|+..|+|||.+.+..++.++|+||+|+++|+|++|..||..... +.......+....
T Consensus 148 ~d~g~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~-~~~~~~~~~~~~~ 224 (267)
T cd08228 148 GDLGLGRFFSSKTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM-NLFSLCQKIEQCD 224 (267)
T ss_pred CccccceeccchhH--HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccc-cHHHHHHHHhcCC
Confidence 99999876543221 11245688999999999988889999999999999999999999964432 3344545554444
Q ss_pred CCCCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhc
Q 039291 238 SLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLD 273 (362)
Q Consensus 238 ~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~ 273 (362)
..+..+...+..+.+++.+||..+|++||++.+++.
T Consensus 225 ~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~ 260 (267)
T cd08228 225 YPPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQ 260 (267)
T ss_pred CCCCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHH
Confidence 333334567899999999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=311.85 Aligned_cols=258 Identities=23% Similarity=0.368 Sum_probs=202.8
Q ss_pred CCCCceeecceecccCceEEEEEEECCCCC---CCCceeeeechhh----hhhHHHHHHHHHHHHcCCCCccccccccee
Q 039291 3 SDGTSWFRGRVIGQGSFGCVFIAKPKSNSS---FLPPLMAVKSAEV----SASASLQKEKEVFDNLNGCPFVLECFGEEI 75 (362)
Q Consensus 3 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~---~~~~~~~~K~~~~----~~~~~~~~E~~il~~l~~h~~i~~~~~~~~ 75 (362)
....+|.+++.||+|+||.||+|++..... .....+++|.... .....+..|+.+++.+..||||+++++.+.
T Consensus 9 ~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 88 (314)
T cd05099 9 FPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCT 88 (314)
T ss_pred ccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEc
Confidence 456799999999999999999998753221 1123566666542 234567889999999977999999998664
Q ss_pred eecCCCceEEEEEEEecCCCCHHHHHHHhc--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCC
Q 039291 76 TMGENGEMAYNLLLEYAAGGTLGDLIEKCN--------------GNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPD 141 (362)
Q Consensus 76 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--------------~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~ 141 (362)
. ...++++|||+++|+|.+++.... ...+++.++..++.|++.||.|||++|++||||||+
T Consensus 89 ~-----~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~ 163 (314)
T cd05099 89 Q-----EGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAAR 163 (314)
T ss_pred c-----CCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccce
Confidence 2 234779999999999999997632 134889999999999999999999999999999999
Q ss_pred CEEEeecCCCceEEEEeecCCcccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHh-CCCCCcc
Q 039291 142 NILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLS-GRQAWVV 220 (362)
Q Consensus 142 Nill~~~~~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~ 220 (362)
|||+ +.++.+||+|||+++...............++..|+|||++.+..++.++|||||||++|+|++ |..||..
T Consensus 164 Nill----~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~ 239 (314)
T cd05099 164 NVLV----TEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPG 239 (314)
T ss_pred eEEE----cCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCC
Confidence 9999 6677899999999975543222221122334567999999998889999999999999999999 8899854
Q ss_pred CCCCCHHHHHHHHcCCCCCCCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhc
Q 039291 221 KEDCSIDQLFSIIGDEHSLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLD 273 (362)
Q Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~ 273 (362)
. ....+...+..... ...+..++.++++++.+||..+|++||++.++++
T Consensus 240 ~---~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~ 288 (314)
T cd05099 240 I---PVEELFKLLREGHR-MDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVE 288 (314)
T ss_pred C---CHHHHHHHHHcCCC-CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 3 44555555544332 3456678899999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-42 Score=310.47 Aligned_cols=252 Identities=31% Similarity=0.450 Sum_probs=198.1
Q ss_pred CceeecceecccCceEEEEEEECCCCCCCCceeeeechhhh-----hhHHHHHHHHHHHHcCCCCcccccccceeeecCC
Q 039291 6 TSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVS-----ASASLQKEKEVFDNLNGCPFVLECFGEEITMGEN 80 (362)
Q Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~~-----~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~ 80 (362)
++|.+.+.||+|+||.||+|.++.+++ .+++|..... ..+.+.+|+++++.++ ||||+++++.+.
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~----~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~----- 70 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQ----IVAIKKFLESEDDKMVKKIAMREIRMLKQLR-HENLVNLIEVFR----- 70 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCC----EEEEEeHhhccCcchhhHHHHHHHHHHHhcC-CcchhhHHHhcc-----
Confidence 479999999999999999999987765 4566654321 2345778999999998 899999998763
Q ss_pred CceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEeec
Q 039291 81 GEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADL 160 (362)
Q Consensus 81 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Df 160 (362)
....+++||||+++++|.++... ...+++..+..++.|++.||.|||+.|++|+||+|+||++ +.++.++|+||
T Consensus 71 ~~~~~~lv~e~~~~~~l~~~~~~--~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~----~~~~~~~l~df 144 (286)
T cd07846 71 RKKRLYLVFEFVDHTVLDDLEKY--PNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILV----SQSGVVKLCDF 144 (286)
T ss_pred cCCeEEEEEecCCccHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEE----CCCCcEEEEee
Confidence 23457899999999888887654 3459999999999999999999999999999999999999 77788999999
Q ss_pred CCcccccccccCCCCCCccCCCCccCchhhcc-ccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHH---c--
Q 039291 161 GVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQ-HMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSII---G-- 234 (362)
Q Consensus 161 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~---~-- 234 (362)
|++....... .......++..|+|||++.+ ..++.++||||||+++|+|++|++||..... ........ .
T Consensus 145 g~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~--~~~~~~~~~~~~~~ 220 (286)
T cd07846 145 GFARTLAAPG--EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSD--IDQLYHIIKCLGNL 220 (286)
T ss_pred eeeeeccCCc--cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCch--HHHHHHHHHHhCCC
Confidence 9987654322 12234568899999999875 3567889999999999999999999964432 11111111 0
Q ss_pred --------------CCCCCCC---------CCccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCc
Q 039291 235 --------------DEHSLPE---------IPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFV 277 (362)
Q Consensus 235 --------------~~~~~~~---------~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~ 277 (362)
.....+. ....++..+.+|+.+||..+|++||++.+++.||||
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 286 (286)
T cd07846 221 IPRHQEIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF 286 (286)
T ss_pred chhhHHHhccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCCCC
Confidence 0001111 123568899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=308.65 Aligned_cols=254 Identities=24% Similarity=0.348 Sum_probs=194.4
Q ss_pred CCceeecceecccCceEEEEEEECCCCCCCCceeeeechhh----hhhHHHHHHHHHHHHcCCCCcccccccceeeecCC
Q 039291 5 GTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEV----SASASLQKEKEVFDNLNGCPFVLECFGEEITMGEN 80 (362)
Q Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~----~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~ 80 (362)
.++|.+.+.||+|+||.||+|.++.++. .+++|.... .....+.+|+.+++.++ |+||+++++.+..
T Consensus 4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~----~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~-h~ni~~~~~~~~~---- 74 (291)
T cd07870 4 ATSYLNLEKLGEGSYATVYKGISRINGQ----LVALKVISMKTEEGVPFTAIREASLLKGLK-HANIVLLHDIIHT---- 74 (291)
T ss_pred cceeEEEEEEEecCCEEEEEEEEcCCCc----EEEEEEecccCcCCCcHHHHHHHHHHHhcC-CCCEeEEEEEEec----
Confidence 4789999999999999999999988775 456665432 22335678999999998 8999999987542
Q ss_pred CceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEeec
Q 039291 81 GEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADL 160 (362)
Q Consensus 81 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Df 160 (362)
....++||||+. ++|.+++... ...+++..+..++.|++.||.|||+.||+|+||||+||++ +.++.++|+||
T Consensus 75 -~~~~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~----~~~~~~~l~Df 147 (291)
T cd07870 75 -KETLTFVFEYMH-TDLAQYMIQH-PGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLI----SYLGELKLADF 147 (291)
T ss_pred -CCeEEEEEeccc-CCHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEE----cCCCcEEEecc
Confidence 235779999996 6787776543 3458899999999999999999999999999999999999 77788999999
Q ss_pred CCcccccccccCCCCCCccCCCCccCchhhccc-cCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHHc-----
Q 039291 161 GVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQH-MQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIG----- 234 (362)
Q Consensus 161 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~----- 234 (362)
|+++...... .......++..|+|||++.+. .++.++|+|||||++|+|++|..||..... ....+.....
T Consensus 148 g~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~-~~~~~~~~~~~~~~~ 224 (291)
T cd07870 148 GLARAKSIPS--QTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSD-VFEQLEKIWTVLGVP 224 (291)
T ss_pred ccccccCCCC--CCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchh-HHHHHHHHHHHcCCC
Confidence 9987543321 112345678999999998764 578899999999999999999999965432 1111111110
Q ss_pred ---------CCC-----CCC--------CCCc--cCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCc
Q 039291 235 ---------DEH-----SLP--------EIPS--RVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFV 277 (362)
Q Consensus 235 ---------~~~-----~~~--------~~~~--~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~ 277 (362)
... ..+ .+.. ..+.++.+++.+||..||.+|||+.+++.||||
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~~ 291 (291)
T cd07870 225 TEDTWPGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF 291 (291)
T ss_pred ChhhhhhhhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcCCCC
Confidence 000 000 0000 135789999999999999999999999999997
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=307.08 Aligned_cols=255 Identities=27% Similarity=0.438 Sum_probs=201.2
Q ss_pred CceeecceecccCceEEEEEEECCCCCCCCceeeeechhh-----hhhHHHHHHHHHHHHcCCCCcccccccceeeecCC
Q 039291 6 TSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEV-----SASASLQKEKEVFDNLNGCPFVLECFGEEITMGEN 80 (362)
Q Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~-----~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~ 80 (362)
++|.+.+.||+|++|.||+|.++.+++ .+++|.... .....+.+|+++++.+. |+||+++++.+..
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~----~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~---- 71 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGE----IVAIKKFKESEDDEDVKKTALREVKVLRQLR-HENIVNLKEAFRR---- 71 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCc----EEEEehhhhhcccccchhHHHHHHHHHHhcC-CCCeeehhheEEE----
Confidence 479999999999999999999988765 567776542 23456889999999999 9999999997753
Q ss_pred CceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEeec
Q 039291 81 GEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADL 160 (362)
Q Consensus 81 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Df 160 (362)
...++++|||++++.+..+... ...+++..+..++.|++.||.|||++|++|+||+|+||++ +.++.++|+||
T Consensus 72 -~~~~~iv~e~~~~~~l~~~~~~--~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~----~~~~~~kl~d~ 144 (288)
T cd07833 72 -KGRLYLVFEYVERTLLELLEAS--PGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILV----SESGVLKLCDF 144 (288)
T ss_pred -CCEEEEEEecCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEE----CCCCCEEEEee
Confidence 2347799999998666655544 3459999999999999999999999999999999999999 77888999999
Q ss_pred CCcccccccccCCCCCCccCCCCccCchhhccc-cCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHHcC----
Q 039291 161 GVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQH-MQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGD---- 235 (362)
Q Consensus 161 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~---- 235 (362)
|++........ .......++..|+|||++.+. .++.++|+||||+++|+|++|++||......+..........
T Consensus 145 g~~~~~~~~~~-~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~ 223 (288)
T cd07833 145 GFARALRARPA-SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPP 223 (288)
T ss_pred ecccccCCCcc-ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCH
Confidence 99876554322 122346788999999999887 889999999999999999999999965432211111111000
Q ss_pred --------CC-----CCC----------CCCccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCc
Q 039291 236 --------EH-----SLP----------EIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFV 277 (362)
Q Consensus 236 --------~~-----~~~----------~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~ 277 (362)
.. ..+ ..+..++.++++||++||..+|++||++++++.||||
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~f 288 (288)
T cd07833 224 SHQELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF 288 (288)
T ss_pred HHhhhcccCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcCCCC
Confidence 00 000 1223358899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-41 Score=306.59 Aligned_cols=253 Identities=26% Similarity=0.485 Sum_probs=203.9
Q ss_pred ceeecceecccCceEEEEEEECCCCCCCCceeeeechh----hhhhHHHHHHHHHHHHcC--CCCcccccccceeeecCC
Q 039291 7 SWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAE----VSASASLQKEKEVFDNLN--GCPFVLECFGEEITMGEN 80 (362)
Q Consensus 7 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~----~~~~~~~~~E~~il~~l~--~h~~i~~~~~~~~~~~~~ 80 (362)
.|.+.+.||+|+||.||+|.+..++. .+++|... ......+.+|+.+++.+. .|||++++++.+..
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~----~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~---- 73 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGR----VVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLK---- 73 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCc----EEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeee----
Confidence 58889999999999999999987775 45666543 234456888999999997 58999999986642
Q ss_pred CceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEeec
Q 039291 81 GEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADL 160 (362)
Q Consensus 81 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Df 160 (362)
...++++|||++|++|.++++. ..+++..+..++.|++.||.|||+.||+|+||+|+||++ +..+.++|+||
T Consensus 74 -~~~~~lv~e~~~~~~L~~~~~~---~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i----~~~~~~~l~df 145 (277)
T cd06917 74 -GPRLWIIMEYAEGGSVRTLMKA---GPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILV----TNTGNVKLCDF 145 (277)
T ss_pred -CCEEEEEEecCCCCcHHHHHHc---cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEE----cCCCCEEEccC
Confidence 2357799999999999999865 369999999999999999999999999999999999999 66788999999
Q ss_pred CCcccccccccCCCCCCccCCCCccCchhhcc-ccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHHcCCCCC
Q 039291 161 GVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQ-HMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEHSL 239 (362)
Q Consensus 161 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 239 (362)
|++......... .....|+..|+|||.+.+ ..++.++|+|||||++|+|++|..||.... .......+... ..
T Consensus 146 g~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~---~~~~~~~~~~~-~~ 219 (277)
T cd06917 146 GVAALLNQNSSK--RSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVD---AFRAMMLIPKS-KP 219 (277)
T ss_pred CceeecCCCccc--cccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCC---hhhhhhccccC-CC
Confidence 998765543221 234568999999999875 456889999999999999999999996432 22222222222 23
Q ss_pred CCCCcc-CCHHHHHHHHHHhccCCCCCCCHHHHhcCCCccCcc
Q 039291 240 PEIPSR-VSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGVD 281 (362)
Q Consensus 240 ~~~~~~-~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~~~~~ 281 (362)
+.++.. .+.++.+++.+||..||++||++.+++.|+||++..
T Consensus 220 ~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~~~~~~~~ 262 (277)
T cd06917 220 PRLEDNGYSKLLREFVAACLDEEPKERLSAEELLKSKWIKAHS 262 (277)
T ss_pred CCCCcccCCHHHHHHHHHHcCCCcccCcCHHHHhhChHhhccc
Confidence 344433 788999999999999999999999999999997754
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=305.42 Aligned_cols=255 Identities=18% Similarity=0.326 Sum_probs=199.3
Q ss_pred eeecceecccCceEEEEEEECCCCCCCCceeeeechh-----hhhhHHHHHHHHHHHHcCCCCcccccccceeeecC-CC
Q 039291 8 WFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAE-----VSASASLQKEKEVFDNLNGCPFVLECFGEEITMGE-NG 81 (362)
Q Consensus 8 y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~-----~~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~-~~ 81 (362)
+.+++.||+|+||.||+|.+..++.. ..+++|... ......+.+|+.+++.++ |+||+++++.+..... ..
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~--~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~ 77 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSI--LKVAVKTMKIAICTRSEMEDFLSEAVCMKEFD-HPNVMRLIGVCLQTVESEG 77 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCe--eeEEEEecccCcCCHHHHHHHHHHHHHHHhCC-CCCcceEEEEEccCCcccC
Confidence 45789999999999999998776542 356666543 234566888999999998 9999999986643221 12
Q ss_pred ceEEEEEEEecCCCCHHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEE
Q 039291 82 EMAYNLLLEYAAGGTLGDLIEKCN----GNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKI 157 (362)
Q Consensus 82 ~~~~~lv~e~~~~~~L~~~l~~~~----~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl 157 (362)
....+++|||+.+|+|.+++.... ...+++..+..++.|++.||+|||++||+||||||+|||+ +.++.++|
T Consensus 78 ~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~----~~~~~~kl 153 (272)
T cd05075 78 YPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCML----NENMNVCV 153 (272)
T ss_pred CCCcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEE----cCCCCEEE
Confidence 234679999999999998875321 2348999999999999999999999999999999999999 77788999
Q ss_pred eecCCcccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHh-CCCCCccCCCCCHHHHHHHHcCC
Q 039291 158 ADLGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLS-GRQAWVVKEDCSIDQLFSIIGDE 236 (362)
Q Consensus 158 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~ 236 (362)
+|||+++...............+++.|+|||++.+..++.++|||||||++|+|++ |..||... ...++...+...
T Consensus 154 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~---~~~~~~~~~~~~ 230 (272)
T cd05075 154 ADFGLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGV---ENSEIYDYLRQG 230 (272)
T ss_pred CCCCcccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCC---CHHHHHHHHHcC
Confidence 99999986543221111123346778999999998889999999999999999999 88999653 234444444443
Q ss_pred CCCCCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhc
Q 039291 237 HSLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLD 273 (362)
Q Consensus 237 ~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~ 273 (362)
.. +..+..++..+.++|.+||..||++|||+.++++
T Consensus 231 ~~-~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~ 266 (272)
T cd05075 231 NR-LKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRC 266 (272)
T ss_pred CC-CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 33 2345578899999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-42 Score=310.23 Aligned_cols=258 Identities=22% Similarity=0.356 Sum_probs=199.4
Q ss_pred CceeecceecccCceEEEEEEECCCCCCCCceeeeechhh----hhhHHHHHHHHHHHHcCCCCcccccccceeeecCCC
Q 039291 6 TSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEV----SASASLQKEKEVFDNLNGCPFVLECFGEEITMGENG 81 (362)
Q Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~----~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~~ 81 (362)
..|...+.||+|+||.||+++++.++. .+++|.... .....+.+|+.++.++..|+||+++++.+..
T Consensus 4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~----~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~----- 74 (288)
T cd06616 4 EDLKDLGEIGRGAFGTVNKMLHKPSGT----IMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFR----- 74 (288)
T ss_pred HHhHHHHHhCCCCceEEEEEEECCCCC----EEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEec-----
Confidence 467778999999999999999988875 456665432 3445678899999999879999999987643
Q ss_pred ceEEEEEEEecCCCCHHHHHH---HhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCceeCCCCCCCEEEeecCCCceEEEE
Q 039291 82 EMAYNLLLEYAAGGTLGDLIE---KCNGNGLPEKDVRHFTRCILEGIGHIHD-SGYVHCDVKPDNILLVATQSGKFVAKI 157 (362)
Q Consensus 82 ~~~~~lv~e~~~~~~L~~~l~---~~~~~~l~~~~~~~i~~ql~~~l~yLH~-~~ivH~Dlkp~Nill~~~~~~~~~~kl 157 (362)
....+++|||+.+ +|.++.. ......+++..+..++.|++.||+|||+ .+++||||||+||++ +..+.++|
T Consensus 75 ~~~~~~~~e~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~----~~~~~~kl 149 (288)
T cd06616 75 EGDCWICMELMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILL----DRNGNIKL 149 (288)
T ss_pred CCcEEEEEecccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEE----ccCCcEEE
Confidence 2235689999864 6665443 2234569999999999999999999997 499999999999999 66778999
Q ss_pred eecCCcccccccccCCCCCCccCCCCccCchhhccc---cCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHHc
Q 039291 158 ADLGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQH---MQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIG 234 (362)
Q Consensus 158 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~ 234 (362)
+|||++......... ....|+..|+|||++.+. .++.++|||||||++|+|++|+.||.... ...+....+.
T Consensus 150 ~dfg~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~--~~~~~~~~~~ 224 (288)
T cd06616 150 CDFGISGQLVDSIAK---TRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN--SVFDQLTQVV 224 (288)
T ss_pred eecchhHHhccCCcc---ccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc--hHHHHHhhhc
Confidence 999998754432111 234689999999999866 68899999999999999999999996543 2222222222
Q ss_pred CCC--C-CCCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCccCcch
Q 039291 235 DEH--S-LPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGVDE 282 (362)
Q Consensus 235 ~~~--~-~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~~~~~~ 282 (362)
... . ....+..++.++.+||.+||..+|++|||+++++.||||+...+
T Consensus 225 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~~~~~ 275 (288)
T cd06616 225 KGDPPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEHPFIKDYEE 275 (288)
T ss_pred CCCCCcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhchhh
Confidence 111 1 11222357899999999999999999999999999999987543
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=303.58 Aligned_cols=255 Identities=20% Similarity=0.334 Sum_probs=202.4
Q ss_pred CCCceeecceecccCceEEEEEEECCCCCCCCceeeeechhh----hhhHHHHHHHHHHHHcCCCCcccccccceeeecC
Q 039291 4 DGTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEV----SASASLQKEKEVFDNLNGCPFVLECFGEEITMGE 79 (362)
Q Consensus 4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~----~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~ 79 (362)
+.++|.+.+.||+|+||+||+|+++.++.. ...+++|.... .....+.+|+.+++.++ ||||+++++.+..
T Consensus 2 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~-~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~--- 76 (266)
T cd05033 2 DPSYVTIEKVIGGGEFGEVCRGRLKLPGKK-EIDVAIKTLKAGSSDKQRLDFLTEASIMGQFD-HPNIIRLEGVVTK--- 76 (266)
T ss_pred ChHHceeeeEecCCccceEEEEEEccCCCC-cceEEEEEcCCCCChHHHHHHHHHHHHHHhCC-CCCcceEeEEEec---
Confidence 457899999999999999999998754321 23566666532 23456788999999998 8999999986532
Q ss_pred CCceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEee
Q 039291 80 NGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIAD 159 (362)
Q Consensus 80 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~D 159 (362)
...++++|||+++++|.+++.... ..+++..+..++.|++.||.|||+++|+|+||||+||++ +.++.++|+|
T Consensus 77 --~~~~~iv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili----~~~~~~~l~d 149 (266)
T cd05033 77 --SRPVMIITEYMENGSLDKFLREND-GKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILV----NSNLVCKVSD 149 (266)
T ss_pred --CCceEEEEEcCCCCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEE----cCCCCEEECc
Confidence 234679999999999999997643 469999999999999999999999999999999999999 7778899999
Q ss_pred cCCcccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHh-CCCCCccCCCCCHHHHHHHHcCCCC
Q 039291 160 LGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLS-GRQAWVVKEDCSIDQLFSIIGDEHS 238 (362)
Q Consensus 160 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~ 238 (362)
||++................++..|+|||.+.+..++.++||||||+++|+|++ |..||... ...+....+.....
T Consensus 150 fg~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~---~~~~~~~~~~~~~~ 226 (266)
T cd05033 150 FGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDM---SNQDVIKAVEDGYR 226 (266)
T ss_pred cchhhcccccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCC---CHHHHHHHHHcCCC
Confidence 999986652222212123345678999999998889999999999999999998 99998543 33444444443332
Q ss_pred CCCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhcC
Q 039291 239 LPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDD 274 (362)
Q Consensus 239 ~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~ 274 (362)
. ..+..++..+.+++.+||..+|++||++.+++++
T Consensus 227 ~-~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~ 261 (266)
T cd05033 227 L-PPPMDCPSALYQLMLDCWQKDRNERPTFSQIVST 261 (266)
T ss_pred C-CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 2 3456789999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=302.39 Aligned_cols=250 Identities=30% Similarity=0.527 Sum_probs=200.8
Q ss_pred ecccCceEEEEEEECCCCCCCCceeeeechhh------hhhHHHHHHHHHHHHcCCCCcccccccceeeecCCCceEEEE
Q 039291 14 IGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEV------SASASLQKEKEVFDNLNGCPFVLECFGEEITMGENGEMAYNL 87 (362)
Q Consensus 14 lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~------~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~~~~~~~l 87 (362)
||+|+||.||+|++..+++ .+++|.... .....+.+|+.+++++. ||||+++++.+. ....+++
T Consensus 1 lg~g~~~~vy~~~~~~~~~----~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~-h~~i~~~~~~~~-----~~~~~~l 70 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGD----IYAIKVIKKADMIRKNQVDQVLTERDILSQAQ-SPYVVKLYYSFQ-----GKKNLYL 70 (265)
T ss_pred CCCCCceEEEEEEECCCCC----EEEEEEecchhhhhhhHHHHHHHHHHHHHhCC-CcchhHHHHhee-----cCcEEEE
Confidence 6999999999999988775 456665432 24456888999999998 999999987653 2345789
Q ss_pred EEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEeecCCccccc
Q 039291 88 LLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSR 167 (362)
Q Consensus 88 v~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Dfgla~~~~ 167 (362)
+|||+++++|.+++... ..+++..+..++.||+.||.|||+.|++|+||+|+||++ +.++.++|+|||++....
T Consensus 71 v~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~----~~~~~~~l~dfg~~~~~~ 144 (265)
T cd05579 71 VMEYLPGGDLASLLENV--GSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILI----DSNGHLKLTDFGLSKVGL 144 (265)
T ss_pred EEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEE----cCCCCEEEEecccchhcc
Confidence 99999999999999873 369999999999999999999999999999999999999 777889999999987544
Q ss_pred cccc------CCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHHcCCCCCCC
Q 039291 168 HCKR------QKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEHSLPE 241 (362)
Q Consensus 168 ~~~~------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 241 (362)
.... ........++..|+|||.+.+...+.++|+||||+++|+|++|..||... ........+......+.
T Consensus 145 ~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~---~~~~~~~~~~~~~~~~~ 221 (265)
T cd05579 145 VRRQINLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGE---TPEEIFQNILNGKIEWP 221 (265)
T ss_pred cCcccccccccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCC---CHHHHHHHHhcCCcCCC
Confidence 3211 11223456888999999998888899999999999999999999999544 34444444433222111
Q ss_pred CCccCCHHHHHHHHHHhccCCCCCCCH---HHHhcCCCccCcch
Q 039291 242 IPSRVSKEARDFLRRCFVRKPAFRFTA---EMLLDDPFVKGVDE 282 (362)
Q Consensus 242 ~~~~~~~~~~~li~~~l~~~p~~R~s~---~~~l~~p~~~~~~~ 282 (362)
....++..+.+++.+||+.+|.+|||+ .++++||||+.+.|
T Consensus 222 ~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~~~~~~~~~ 265 (265)
T cd05579 222 EDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPFFKGIDW 265 (265)
T ss_pred ccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcCccccCCCC
Confidence 112248999999999999999999999 99999999987754
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-42 Score=317.09 Aligned_cols=272 Identities=24% Similarity=0.416 Sum_probs=213.1
Q ss_pred CCCceeecceecccCceEEEEEEECCCCCCCCceeeeechhh------hhhHHHHHHHHHHHHcCCCCcccccccceeee
Q 039291 4 DGTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEV------SASASLQKEKEVFDNLNGCPFVLECFGEEITM 77 (362)
Q Consensus 4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~------~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~ 77 (362)
+..-|..++.||-|+||+|.+++..+++. ++|.|.+.+ +.....+.|..||.... .+.||++|-.+
T Consensus 627 dKSmFvkik~iGvGAFGeV~Lv~KvDT~~----lYAmKTLrKaDVl~rnQvaHVKAERDILAEAD-n~WVVrLyySF--- 698 (1034)
T KOG0608|consen 627 DKSMFVKIKTIGVGAFGEVCLVRKVDTRA----LYAMKTLRKADVLMRNQVAHVKAERDILAEAD-NEWVVRLYYSF--- 698 (1034)
T ss_pred cccceEEEeeecccccceeEEEeecchhh----HHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcC-CcceEEEEEEe---
Confidence 45668889999999999999999888864 566666543 34566788999999998 79999998644
Q ss_pred cCCCceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEE
Q 039291 78 GENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKI 157 (362)
Q Consensus 78 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl 157 (362)
.+...+|+||||++||++-.+|-+ -+.|.|..+++++.+|.+|+++.|+.|+|||||||+|||| |.+|++||
T Consensus 699 --QDkdnLYFVMdYIPGGDmMSLLIr--mgIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILI----DrdGHIKL 770 (1034)
T KOG0608|consen 699 --QDKDNLYFVMDYIPGGDMMSLLIR--MGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILI----DRDGHIKL 770 (1034)
T ss_pred --ccCCceEEEEeccCCccHHHHHHH--hccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEE----ccCCceee
Confidence 334457899999999999998876 3459999999999999999999999999999999999999 99999999
Q ss_pred eecCCcccccccccC----------------------------------------CCCCCccCCCCccCchhhccccCCC
Q 039291 158 ADLGVAKRSRHCKRQ----------------------------------------KFDPSMRGTPLYLAPETVVQHMQEA 197 (362)
Q Consensus 158 ~Dfgla~~~~~~~~~----------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~ 197 (362)
.||||.+-+...... ....+.+||+.|+|||++....|+.
T Consensus 771 TDFGLCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q 850 (1034)
T KOG0608|consen 771 TDFGLCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQ 850 (1034)
T ss_pred eeccccccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccc
Confidence 999998632211000 0112467999999999999999999
Q ss_pred cchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHHcCCCCCCCCCccCCHHHHHHHHHHhccCCCCCC---CHHHHhcC
Q 039291 198 PSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEHSLPEIPSRVSKEARDFLRRCFVRKPAFRF---TAEMLLDD 274 (362)
Q Consensus 198 ~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~---s~~~~l~~ 274 (362)
.+|+||.|||||||+.|++||...........+..-.....++ ....+++++.++|.++ ..+++.|. .++++..|
T Consensus 851 ~cdwws~gvil~em~~g~~pf~~~tp~~tq~kv~nw~~~l~~~-~~~~ls~e~~~li~kL-c~sad~RLGkng~d~vKaH 928 (1034)
T KOG0608|consen 851 LCDWWSVGVILYEMLVGQPPFLADTPGETQYKVINWRNFLHIP-YQGNLSKEALDLIQKL-CCSADSRLGKNGADQVKAH 928 (1034)
T ss_pred cchhhHhhHHHHHHhhCCCCccCCCCCcceeeeeehhhccccc-cccccCHHHHHHHHHH-hcChhhhhcccchhhhhcC
Confidence 9999999999999999999997654433222211111111111 2356899999999985 45788998 47789999
Q ss_pred CCccCcchhhhhhhhCCCC
Q 039291 275 PFVKGVDEELSRELEGDYS 293 (362)
Q Consensus 275 p~~~~~~~~~~~~~~~~~~ 293 (362)
|||++|+....+....++.
T Consensus 929 pfFkgIDfsslRkq~ApYI 947 (1034)
T KOG0608|consen 929 PFFKGIDFSSLRKQRAPYI 947 (1034)
T ss_pred ccccccchHhhhhccCCcC
Confidence 9999999886655555544
|
|
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=307.59 Aligned_cols=251 Identities=22% Similarity=0.353 Sum_probs=198.1
Q ss_pred CceeecceecccCceEEEEEEECCCCCCCCceeeeechh----hhhhHHHHHHHHHHHHcCCCCcccccccceeeecCCC
Q 039291 6 TSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAE----VSASASLQKEKEVFDNLNGCPFVLECFGEEITMGENG 81 (362)
Q Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~----~~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~~ 81 (362)
++|.+.+.||+|+||.||+|.++.++..+ .+++|... ......+.+|+.++.++.+||||+++++.+..
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~--~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~----- 74 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKM--NAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACEN----- 74 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcc--eeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEcc-----
Confidence 67999999999999999999987766432 23444332 22345688899999999779999999986542
Q ss_pred ceEEEEEEEecCCCCHHHHHHHhc--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEee
Q 039291 82 EMAYNLLLEYAAGGTLGDLIEKCN--------------GNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVA 147 (362)
Q Consensus 82 ~~~~~lv~e~~~~~~L~~~l~~~~--------------~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~ 147 (362)
...++++|||+++++|.+++.... ...+++..++.++.|++.||+|||++||+||||||+|||+
T Consensus 75 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill-- 152 (297)
T cd05089 75 RGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLV-- 152 (297)
T ss_pred CCcceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEE--
Confidence 234779999999999999997632 1248899999999999999999999999999999999999
Q ss_pred cCCCceEEEEeecCCcccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHh-CCCCCccCCCCCH
Q 039291 148 TQSGKFVAKIADLGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLS-GRQAWVVKEDCSI 226 (362)
Q Consensus 148 ~~~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~ 226 (362)
+.++.+||+|||++......... .....+..|+|||++.+..++.++|||||||++|+|++ |..||... ..
T Consensus 153 --~~~~~~kl~dfg~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~---~~ 224 (297)
T cd05089 153 --GENLASKIADFGLSRGEEVYVKK---TMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGM---TC 224 (297)
T ss_pred --CCCCeEEECCcCCCccccceecc---CCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCC---CH
Confidence 77788999999998633211111 11223557999999988889999999999999999997 99999544 34
Q ss_pred HHHHHHHcCCCCCCCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhcC
Q 039291 227 DQLFSIIGDEHSLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDD 274 (362)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~ 274 (362)
.+....+.... .+..+..++.++++|+.+||..+|.+||++++++..
T Consensus 225 ~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~ 271 (297)
T cd05089 225 AELYEKLPQGY-RMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQ 271 (297)
T ss_pred HHHHHHHhcCC-CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 44455544332 234556789999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=275.55 Aligned_cols=256 Identities=24% Similarity=0.442 Sum_probs=203.1
Q ss_pred ceeecceecccCceEEEEEEECCCCCCCCceeeeechhhh-----hhHHHHHHHHHHHHcCCCCcccccccceeeecCCC
Q 039291 7 SWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVS-----ASASLQKEKEVFDNLNGCPFVLECFGEEITMGENG 81 (362)
Q Consensus 7 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~~-----~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~~ 81 (362)
+|.-.+.||+|.||+|++|+++.+++ .|++|..... .-....+|+-+++.|+ |.||++++++. ++
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~e----ivalkrvrlddddegvpssalreicllkelk-hknivrl~dvl-----hs 72 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHE----IVALKRVRLDDDDEGVPSSALREICLLKELK-HKNIVRLHDVL-----HS 72 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccc----eEEEEEEeccCCCCCCcHHHHHHHHHHHHhh-hcceeehhhhh-----cc
Confidence 46667899999999999999999886 6777776543 3346889999999999 99999999975 44
Q ss_pred ceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEeecC
Q 039291 82 EMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLG 161 (362)
Q Consensus 82 ~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Dfg 161 (362)
+..+-+|+|||.. +|..++...+ +.++...++.++.|+++||.++|++++.|||+||+|+|+ +.++.+|++|||
T Consensus 73 dkkltlvfe~cdq-dlkkyfdsln-g~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnlli----n~ngelkladfg 146 (292)
T KOG0662|consen 73 DKKLTLVFEFCDQ-DLKKYFDSLN-GDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLI----NRNGELKLADFG 146 (292)
T ss_pred CceeEEeHHHhhH-HHHHHHHhcC-CcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEe----ccCCcEEecccc
Confidence 5567799999964 8999888754 459999999999999999999999999999999999999 899999999999
Q ss_pred CcccccccccCCCCCCccCCCCccCchhhccc-cCCCcchHHHHHHHHHHHHh-CCCCCccCCCCCHHH-HHHHHc--CC
Q 039291 162 VAKRSRHCKRQKFDPSMRGTPLYLAPETVVQH-MQEAPSDIWALGCVVLEMLS-GRQAWVVKEDCSIDQ-LFSIIG--DE 236 (362)
Q Consensus 162 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~-~~~~~~--~~ 236 (362)
+++-.+-...- ....+-|.+|++|.++.+. -|+...|+||.|||+.|+.. |++.|.+.+-.+... ++..++ .+
T Consensus 147 larafgipvrc--ysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~e 224 (292)
T KOG0662|consen 147 LARAFGIPVRC--YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTE 224 (292)
T ss_pred hhhhcCCceEe--eeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCcc
Confidence 99866542211 1244579999999999974 68899999999999999987 777776654332222 222222 11
Q ss_pred CCCCC------------CC---------ccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCccCc
Q 039291 237 HSLPE------------IP---------SRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGV 280 (362)
Q Consensus 237 ~~~~~------------~~---------~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~~~~ 280 (362)
..+|. +| +.++..-+++++++|.-+|.+|+++++++.||||...
T Consensus 225 d~wps~t~lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqhpyf~d~ 289 (292)
T KOG0662|consen 225 DQWPSMTKLPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHPYFSDF 289 (292)
T ss_pred ccCCccccCCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcCcccccc
Confidence 12221 11 2345567899999999999999999999999999753
|
|
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-42 Score=306.80 Aligned_cols=251 Identities=24% Similarity=0.391 Sum_probs=197.1
Q ss_pred eecceecccCceEEEEEEECCCCCCCCceeeeechhh----hhhHHHHHHHHHHHHcCCCCcccccccceeeecCCCceE
Q 039291 9 FRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEV----SASASLQKEKEVFDNLNGCPFVLECFGEEITMGENGEMA 84 (362)
Q Consensus 9 ~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~----~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~~~~~ 84 (362)
.+.+.||.|+||.||+|..+.........|++|.... .....+.+|++.+++++ ||||+++++.+.... .
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~-h~ni~~~~g~~~~~~-----~ 75 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLR-HPNIVKLYGFCIENE-----P 75 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHS-BTTBE-EEEEEESSS-----S
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccc-ccccccccccccccc-----c
Confidence 4578999999999999999843333345778887743 23577899999999996 999999999876211 2
Q ss_pred EEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEeecCCcc
Q 039291 85 YNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAK 164 (362)
Q Consensus 85 ~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Dfgla~ 164 (362)
+++|+||+++|+|.+++.......+++..+..++.|++.||.|||+++++|+||+++||++ +.++.+||+|||++.
T Consensus 76 ~~lv~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill----~~~~~~Kl~~f~~~~ 151 (259)
T PF07714_consen 76 LFLVMEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILL----DSNGQVKLSDFGLSR 151 (259)
T ss_dssp EEEEEE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEE----ETTTEEEEESTTTGE
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc----ccccccccccccccc
Confidence 6799999999999999998645679999999999999999999999999999999999999 778899999999997
Q ss_pred cccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHh-CCCCCccCCCCCHHHHHHHHcCCCCCCCCC
Q 039291 165 RSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLS-GRQAWVVKEDCSIDQLFSIIGDEHSLPEIP 243 (362)
Q Consensus 165 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (362)
...............+...|+|||.+.+..++.++||||||+++|||++ |+.||... ...+....+..... +..+
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~---~~~~~~~~~~~~~~-~~~~ 227 (259)
T PF07714_consen 152 PISEKSKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDY---DNEEIIEKLKQGQR-LPIP 227 (259)
T ss_dssp ETTTSSSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTS---CHHHHHHHHHTTEE-TTSB
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccc---cccccccccccccc-ceec
Confidence 6632222222234457778999999998889999999999999999999 78888443 45555555544433 3456
Q ss_pred ccCCHHHHHHHHHHhccCCCCCCCHHHHhc
Q 039291 244 SRVSKEARDFLRRCFVRKPAFRFTAEMLLD 273 (362)
Q Consensus 244 ~~~~~~~~~li~~~l~~~p~~R~s~~~~l~ 273 (362)
..++..+.++|.+||..+|++||++.++++
T Consensus 228 ~~~~~~~~~li~~C~~~~p~~RPs~~~i~~ 257 (259)
T PF07714_consen 228 DNCPKDIYSLIQQCWSHDPEKRPSFQEILQ 257 (259)
T ss_dssp TTSBHHHHHHHHHHT-SSGGGS--HHHHHH
T ss_pred cchhHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 778999999999999999999999999874
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-41 Score=304.95 Aligned_cols=256 Identities=22% Similarity=0.348 Sum_probs=196.7
Q ss_pred Cce-eecceecccCceEEEEEEECCCCCCCCceeeeechhhh----hhHHHHHHHHHHHHcCCCCcccccccceeeecCC
Q 039291 6 TSW-FRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVS----ASASLQKEKEVFDNLNGCPFVLECFGEEITMGEN 80 (362)
Q Consensus 6 ~~y-~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~~----~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~ 80 (362)
+|| .+.+.||+|+||+||++............+++|..... ....+.+|++++++++ ||||+++++.+.. .
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~---~ 78 (283)
T cd05080 3 KRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLY-HENIVKYKGCCSE---Q 78 (283)
T ss_pred hhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCC-CCCEeeEEEEEec---C
Confidence 456 89999999999999998754332223346777765432 3456789999999998 9999999886543 2
Q ss_pred CceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEeec
Q 039291 81 GEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADL 160 (362)
Q Consensus 81 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Df 160 (362)
....++++|||+++++|.+++.. ..+++..++.++.|++.||.|||++||+||||||+||++ +.++.++|+||
T Consensus 79 ~~~~~~lv~e~~~~~~l~~~~~~---~~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili----~~~~~~~l~df 151 (283)
T cd05080 79 GGKGLQLIMEYVPLGSLRDYLPK---HKLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLL----DNDRLVKIGDF 151 (283)
T ss_pred CCceEEEEecCCCCCCHHHHHHH---cCCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEE----cCCCcEEEeec
Confidence 23457799999999999999976 349999999999999999999999999999999999999 67778999999
Q ss_pred CCcccccccccC-CCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHhCCCCCccCCCCC------------HH
Q 039291 161 GVAKRSRHCKRQ-KFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCS------------ID 227 (362)
Q Consensus 161 gla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~------------~~ 227 (362)
|+++........ .......++..|+|||.+.+..++.++||||||+++|+|++|..||......- ..
T Consensus 152 g~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~ 231 (283)
T cd05080 152 GLAKAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVV 231 (283)
T ss_pred ccccccCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchh
Confidence 998765432211 11122345667999999988889999999999999999999999985432110 01
Q ss_pred HHHHHHcCCCCCCCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhc
Q 039291 228 QLFSIIGDEHSLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLD 273 (362)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~ 273 (362)
.....+... ..+..+..++.++.+++.+||..+|++|||+++++.
T Consensus 232 ~~~~~~~~~-~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~ 276 (283)
T cd05080 232 RLIELLERG-MRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIP 276 (283)
T ss_pred hhhhhhhcC-CCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 111111111 122345678899999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=305.31 Aligned_cols=256 Identities=30% Similarity=0.460 Sum_probs=206.1
Q ss_pred CceeecceecccCceEEEEEEECCCCCCCCceeeeech--hhhhhHHHHHHHHHHHHcCCCCcccccccceeeecCCCce
Q 039291 6 TSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSA--EVSASASLQKEKEVFDNLNGCPFVLECFGEEITMGENGEM 83 (362)
Q Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~--~~~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~~~~ 83 (362)
++|.+.+.||+|+||.||+|+++.++..++.++..+.. .......+.+|..+++++..|+||+++++.+.. ..
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~-----~~ 75 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQD-----EE 75 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcC-----Cc
Confidence 47999999999999999999998877644333332211 123346688899999999879999999986532 33
Q ss_pred EEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEeecCCc
Q 039291 84 AYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVA 163 (362)
Q Consensus 84 ~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Dfgla 163 (362)
.++++||++++++|.+++... ..+++..++.++.|++.||.|||+.|++|+||+|+||++ +.++.++|+|||++
T Consensus 76 ~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i----~~~~~~~l~df~~~ 149 (280)
T cd05581 76 NLYFVLEYAPNGELLQYIRKY--GSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILL----DKDMHIKITDFGTA 149 (280)
T ss_pred eEEEEEcCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEE----CCCCCEEecCCccc
Confidence 577999999999999999873 469999999999999999999999999999999999999 67778999999998
Q ss_pred ccccccccC------------------CCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHhCCCCCccCCCCC
Q 039291 164 KRSRHCKRQ------------------KFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCS 225 (362)
Q Consensus 164 ~~~~~~~~~------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~ 225 (362)
......... .......|+..|+|||++.+...+.++|+||||++++++++|..||....
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~--- 226 (280)
T cd05581 150 KVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSN--- 226 (280)
T ss_pred cccCCccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCcc---
Confidence 755432211 11234568899999999988888999999999999999999999996553
Q ss_pred HHHHHHHHcCCCCCCCCCccCCHHHHHHHHHHhccCCCCCCCH----HHHhcCCCc
Q 039291 226 IDQLFSIIGDEHSLPEIPSRVSKEARDFLRRCFVRKPAFRFTA----EMLLDDPFV 277 (362)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~----~~~l~~p~~ 277 (362)
....+..+.. ....++..+++.+.++|.+||..+|++||++ ++++.||||
T Consensus 227 ~~~~~~~~~~--~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~~ 280 (280)
T cd05581 227 EYLTFQKILK--LEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF 280 (280)
T ss_pred HHHHHHHHHh--cCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCCCC
Confidence 2233333321 1223556789999999999999999999999 999999997
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-41 Score=300.19 Aligned_cols=252 Identities=37% Similarity=0.656 Sum_probs=201.8
Q ss_pred ceeecceecccCceEEEEEEECCCCCCCCceeeeechhh-----hhhHHHHHHHHHHHHcCCCCcccccccceeeecCCC
Q 039291 7 SWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEV-----SASASLQKEKEVFDNLNGCPFVLECFGEEITMGENG 81 (362)
Q Consensus 7 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~-----~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~~ 81 (362)
||.+.+.||+|+||.||+|.+..++. .+++|.... ...+.+.+|+.+++.++ |+||+++++....
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~----~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~-~~~i~~~~~~~~~----- 70 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGE----LMAVKEIRIQDNDPKTIKEIADEMKVLELLK-HPNLVKYYGVEVH----- 70 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCc----EEEEEEEECcccchHHHHHHHHHHHHHHhCC-CCChhheeeeEec-----
Confidence 69999999999999999999887765 445554332 25567889999999998 8999999986532
Q ss_pred ceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEeecC
Q 039291 82 EMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLG 161 (362)
Q Consensus 82 ~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Dfg 161 (362)
...+++|+||+++++|.+++.. +..+++..++.++.|++.||.|||+.|++|+||+|+||++ +..+.+||+|||
T Consensus 71 ~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~----~~~~~~kl~d~g 144 (264)
T cd06626 71 REKVYIFMEYCSGGTLEELLEH--GRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFL----DHNGVIKLGDFG 144 (264)
T ss_pred CCEEEEEEecCCCCcHHHHHhh--cCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE----CCCCCEEEcccc
Confidence 3357799999999999999976 3458999999999999999999999999999999999999 677889999999
Q ss_pred CcccccccccCCC--CCCccCCCCccCchhhcccc---CCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHHcCC
Q 039291 162 VAKRSRHCKRQKF--DPSMRGTPLYLAPETVVQHM---QEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDE 236 (362)
Q Consensus 162 la~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~---~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 236 (362)
++........... .....++..|+|||++.+.. .+.++||||||+++++|++|+.||...+. .......+..
T Consensus 145 ~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~--~~~~~~~~~~- 221 (264)
T cd06626 145 CAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDN--EFQIMFHVGA- 221 (264)
T ss_pred cccccCCCCCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcc--hHHHHHHHhc-
Confidence 9876543222111 12356888999999998766 78899999999999999999999964432 2222222222
Q ss_pred CCCCCCCcc--CCHHHHHHHHHHhccCCCCCCCHHHHhcCCCc
Q 039291 237 HSLPEIPSR--VSKEARDFLRRCFVRKPAFRFTAEMLLDDPFV 277 (362)
Q Consensus 237 ~~~~~~~~~--~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~ 277 (362)
...+.++.. ++..+.++|.+||+.+|.+||++.+++.|||+
T Consensus 222 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~~~~~ 264 (264)
T cd06626 222 GHKPPIPDSLQLSPEGKDFLDRCLESDPKKRPTASELLQHPFV 264 (264)
T ss_pred CCCCCCCcccccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 223334443 48999999999999999999999999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=308.88 Aligned_cols=258 Identities=26% Similarity=0.429 Sum_probs=205.7
Q ss_pred CCCCceeecceecccCceEEEEEEECCCCCCCCceeeeechhh---hhhHHHHHHHHHHHHcCCCCcccccccceeeecC
Q 039291 3 SDGTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEV---SASASLQKEKEVFDNLNGCPFVLECFGEEITMGE 79 (362)
Q Consensus 3 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~---~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~ 79 (362)
...++|.+.+.||+|+||.||++.+..++. .+++|.... ...+.+.+|+.+++.++ ||||+++++.+..
T Consensus 16 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~----~v~iK~~~~~~~~~~~~~~~e~~~l~~l~-hp~i~~~~~~~~~--- 87 (293)
T cd06647 16 DPKKKYTRFEKIGQGASGTVYTAIDVATGQ----EVAIKQMNLQQQPKKELIINEILVMRENK-HPNIVNYLDSYLV--- 87 (293)
T ss_pred CchhhceeeeEecCCCCeEEEEEEEcCCCC----EEEEEEeccccchHHHHHHHHHHHHhhcC-CCCeeehhheeee---
Confidence 345799999999999999999999877664 455665432 23456788999999998 8999999987643
Q ss_pred CCceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEee
Q 039291 80 NGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIAD 159 (362)
Q Consensus 80 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~D 159 (362)
...+++|+||+++++|.+++.. ..+++..+..++.|++.||.|||++|++|+||||+||++ +..+.++|+|
T Consensus 88 --~~~~~lv~e~~~~~~L~~~~~~---~~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili----~~~~~~kL~d 158 (293)
T cd06647 88 --GDELWVVMEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILL----GMDGSVKLTD 158 (293)
T ss_pred --CCcEEEEEecCCCCcHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEE----cCCCCEEEcc
Confidence 2346799999999999999875 348899999999999999999999999999999999999 6677899999
Q ss_pred cCCcccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHHcCCCCC
Q 039291 160 LGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEHSL 239 (362)
Q Consensus 160 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 239 (362)
||++........ ......|++.|+|||.+.+..++.++|+|||||++|++++|+.||...... .............
T Consensus 159 fg~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~--~~~~~~~~~~~~~ 234 (293)
T cd06647 159 FGFCAQITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPL--RALYLIATNGTPE 234 (293)
T ss_pred Ccceeccccccc--ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChh--hheeehhcCCCCC
Confidence 998865443221 223456889999999998888899999999999999999999999654321 1211111111111
Q ss_pred CCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCccCcc
Q 039291 240 PEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGVD 281 (362)
Q Consensus 240 ~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~~~~~ 281 (362)
...+..++..++++|++||..+|++||++.+++.|+||+...
T Consensus 235 ~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h~~~~~~~ 276 (293)
T cd06647 235 LQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHPFLKIAK 276 (293)
T ss_pred CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhcCc
Confidence 123445788999999999999999999999999999997654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-42 Score=309.49 Aligned_cols=254 Identities=27% Similarity=0.416 Sum_probs=201.8
Q ss_pred CceeecceecccCceEEEEEEECCCCCCCCceeeeechh---hhhhHHHHHHHHHHHHcCCCCcccccccceeeecCCCc
Q 039291 6 TSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAE---VSASASLQKEKEVFDNLNGCPFVLECFGEEITMGENGE 82 (362)
Q Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~---~~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~~~ 82 (362)
..|.....||+|+||.||++.+..++. .+++|... ......+.+|+.+++.++ |+||+++++.+.. .
T Consensus 22 ~~~~~~~~lg~g~~g~v~~~~~~~~~~----~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-h~~ii~~~~~~~~-----~ 91 (292)
T cd06658 22 EYLDSFIKIGEGSTGIVCIATEKHTGK----QVAVKKMDLRKQQRRELLFNEVVIMRDYH-HENVVDMYNSYLV-----G 91 (292)
T ss_pred HHHhhhhcccCCCCeEEEEEEECCCCC----EEEEEEEecchHHHHHHHHHHHHHHHhCC-CCcHHHHHHheec-----C
Confidence 345556789999999999999887765 45555442 234456889999999998 9999999987642 2
Q ss_pred eEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEeecCC
Q 039291 83 MAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGV 162 (362)
Q Consensus 83 ~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Dfgl 162 (362)
..+++||||+++++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+||++ +.++.++|+|||+
T Consensus 92 ~~~~lv~e~~~~~~L~~~~~~---~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill----~~~~~~kL~dfg~ 164 (292)
T cd06658 92 DELWVVMEFLEGGALTDIVTH---TRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILL----TSDGRIKLSDFGF 164 (292)
T ss_pred CeEEEEEeCCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEE----cCCCCEEEccCcc
Confidence 346799999999999998854 358999999999999999999999999999999999999 6777899999999
Q ss_pred cccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHHcCC-CCCCC
Q 039291 163 AKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDE-HSLPE 241 (362)
Q Consensus 163 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~-~~~~~ 241 (362)
+........ ......|+..|+|||.+.+..++.++|+||||+++|+|++|+.||...+. ......+... .....
T Consensus 165 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~---~~~~~~~~~~~~~~~~ 239 (292)
T cd06658 165 CAQVSKEVP--KRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPP---LQAMRRIRDNLPPRVK 239 (292)
T ss_pred hhhcccccc--cCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHhcCCCccc
Confidence 865433211 12345689999999999888899999999999999999999999965432 2222222211 11111
Q ss_pred CCccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCccCcc
Q 039291 242 IPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGVD 281 (362)
Q Consensus 242 ~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~~~~~ 281 (362)
....++..+.+++.+||..||++|||+++++.||||+...
T Consensus 240 ~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~~~~~ 279 (292)
T cd06658 240 DSHKVSSVLRGFLDLMLVREPSQRATAQELLQHPFLKLAG 279 (292)
T ss_pred cccccCHHHHHHHHHHccCChhHCcCHHHHhhChhhhccC
Confidence 2235788999999999999999999999999999997653
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-41 Score=306.49 Aligned_cols=257 Identities=23% Similarity=0.388 Sum_probs=203.9
Q ss_pred CCCCceeecceecccCceEEEEEEECCCCC-CCCceeeeechhhh---hhHHHHHHHHHHHHcCCCCcccccccceeeec
Q 039291 3 SDGTSWFRGRVIGQGSFGCVFIAKPKSNSS-FLPPLMAVKSAEVS---ASASLQKEKEVFDNLNGCPFVLECFGEEITMG 78 (362)
Q Consensus 3 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~-~~~~~~~~K~~~~~---~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~ 78 (362)
....+|.+.+.||+|+||.||+|++..... .....+++|..... ....+.+|+.++++++ |+||+++++.+..
T Consensus 2 ~~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~-- 78 (291)
T cd05094 2 IKRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQ-HEHIVKFYGVCGD-- 78 (291)
T ss_pred CchHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCC-CCCcceEEEEEcc--
Confidence 456789999999999999999998754322 12234666765433 3356889999999998 8999999986642
Q ss_pred CCCceEEEEEEEecCCCCHHHHHHHhc--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEE
Q 039291 79 ENGEMAYNLLLEYAAGGTLGDLIEKCN--------------GNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNIL 144 (362)
Q Consensus 79 ~~~~~~~~lv~e~~~~~~L~~~l~~~~--------------~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nil 144 (362)
....++||||+++++|.+++.... ...+++..++.++.||+.||+|||++||+||||||+||+
T Consensus 79 ---~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil 155 (291)
T cd05094 79 ---GDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCL 155 (291)
T ss_pred ---CCceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEE
Confidence 234679999999999999997632 134899999999999999999999999999999999999
Q ss_pred EeecCCCceEEEEeecCCcccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHh-CCCCCccCCC
Q 039291 145 LVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLS-GRQAWVVKED 223 (362)
Q Consensus 145 l~~~~~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~ 223 (362)
+ +.++.++|+|||++................++..|+|||++.+..++.++|||||||++|+|++ |..||...
T Consensus 156 ~----~~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~-- 229 (291)
T cd05094 156 V----GANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQL-- 229 (291)
T ss_pred E----ccCCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--
Confidence 9 7778899999999975543322222234557888999999998889999999999999999999 99998544
Q ss_pred CCHHHHHHHHcCCCCCCCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhc
Q 039291 224 CSIDQLFSIIGDEHSLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLD 273 (362)
Q Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~ 273 (362)
...+....+... ..+..+..++..+.+++.+||..+|++||++.++++
T Consensus 230 -~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~ 277 (291)
T cd05094 230 -SNTEVIECITQG-RVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYK 277 (291)
T ss_pred -CHHHHHHHHhCC-CCCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence 333444444333 233445667899999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-41 Score=300.41 Aligned_cols=251 Identities=20% Similarity=0.343 Sum_probs=201.5
Q ss_pred CCCCCceeecceecccCceEEEEEEECCCCCCCCceeeeechhhh--hhHHHHHHHHHHHHcCCCCcccccccceeeecC
Q 039291 2 DSDGTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVS--ASASLQKEKEVFDNLNGCPFVLECFGEEITMGE 79 (362)
Q Consensus 2 ~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~~--~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~ 79 (362)
++.+++|.+.+.||+|++|.||+|.+..+. .+++|..... ....+.+|+.+++.+. |+|++++++.+.
T Consensus 2 ~~~~~~~~~~~~ig~g~~~~v~~~~~~~~~-----~~~lK~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~---- 71 (260)
T cd05069 2 EIPRESLRLDVKLGQGCFGEVWMGTWNGTT-----KVAIKTLKPGTMMPEAFLQEAQIMKKLR-HDKLVPLYAVVS---- 71 (260)
T ss_pred cCChHHeeeeeeecCcCCCeEEEEEEcCCc-----eEEEEEcccCCccHHHHHHHHHHHHhCC-CCCeeeEEEEEc----
Confidence 356788999999999999999999987654 3566665432 3356788999999998 899999887542
Q ss_pred CCceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEee
Q 039291 80 NGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIAD 159 (362)
Q Consensus 80 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~D 159 (362)
. ...+++|||+.+++|.+++.......+++..+..++.|++.||.|||+.|++|+||||+||++ +.++.++|+|
T Consensus 72 ~--~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill----~~~~~~~l~d 145 (260)
T cd05069 72 E--EPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILV----GDNLVCKIAD 145 (260)
T ss_pred C--CCcEEEEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEE----cCCCeEEECC
Confidence 1 235699999999999999987555568999999999999999999999999999999999999 7788899999
Q ss_pred cCCcccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHh-CCCCCccCCCCCHHHHHHHHcCCCC
Q 039291 160 LGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLS-GRQAWVVKEDCSIDQLFSIIGDEHS 238 (362)
Q Consensus 160 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~ 238 (362)
||++......... ......++..|+|||++.+..++.++|+||||+++|+|++ |..||... ........+.....
T Consensus 146 fg~~~~~~~~~~~-~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~---~~~~~~~~~~~~~~ 221 (260)
T cd05069 146 FGLARLIEDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGM---VNREVLEQVERGYR 221 (260)
T ss_pred CccceEccCCccc-ccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCC---CHHHHHHHHHcCCC
Confidence 9999755332111 1123346778999999988889999999999999999999 89999643 23344444443322
Q ss_pred CCCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhc
Q 039291 239 LPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLD 273 (362)
Q Consensus 239 ~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~ 273 (362)
+..+...+..+++++++||..||++||+++++++
T Consensus 222 -~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 255 (260)
T cd05069 222 -MPCPQGCPESLHELMKLCWKKDPDERPTFEYIQS 255 (260)
T ss_pred -CCCCcccCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 3345678999999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=309.35 Aligned_cols=253 Identities=25% Similarity=0.383 Sum_probs=199.0
Q ss_pred CCCceeecceecccCceEEEEEEECCCCCCCCceeeeechh----hhhhHHHHHHHHHHHHcCCCCcccccccceeeecC
Q 039291 4 DGTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAE----VSASASLQKEKEVFDNLNGCPFVLECFGEEITMGE 79 (362)
Q Consensus 4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~----~~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~ 79 (362)
.-+.|.+.+.||+|+||.||+|.++.++..+ .+++|... ......+.+|+.++.++.+|+||+++++.+..
T Consensus 5 ~~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~--~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~--- 79 (303)
T cd05088 5 EWNDIKFQDVIGEGNFGQVLKARIKKDGLRM--DAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEH--- 79 (303)
T ss_pred chhhceeeeeecCCCCceEEEEEEccCCcee--eEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECC---
Confidence 4578999999999999999999987765432 33444432 23445678899999999669999999987642
Q ss_pred CCceEEEEEEEecCCCCHHHHHHHhc--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEE
Q 039291 80 NGEMAYNLLLEYAAGGTLGDLIEKCN--------------GNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILL 145 (362)
Q Consensus 80 ~~~~~~~lv~e~~~~~~L~~~l~~~~--------------~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill 145 (362)
...+++||||+++++|.+++.... ...+++..++.++.|++.||+|||++|++||||||+|||+
T Consensus 80 --~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili 157 (303)
T cd05088 80 --RGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILV 157 (303)
T ss_pred --CCCceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEe
Confidence 234779999999999999997532 1358899999999999999999999999999999999999
Q ss_pred eecCCCceEEEEeecCCcccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHh-CCCCCccCCCC
Q 039291 146 VATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLS-GRQAWVVKEDC 224 (362)
Q Consensus 146 ~~~~~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~ 224 (362)
+.++.+||+|||++........ .....++..|+|||++.+..++.++|||||||++|+|++ |..||...+
T Consensus 158 ----~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~-- 228 (303)
T cd05088 158 ----GENYVAKIADFGLSRGQEVYVK---KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT-- 228 (303)
T ss_pred ----cCCCcEEeCccccCcccchhhh---cccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCC--
Confidence 7777899999999863321111 112234667999999988888999999999999999998 999996443
Q ss_pred CHHHHHHHHcCCCCCCCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhcC
Q 039291 225 SIDQLFSIIGDEHSLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDD 274 (362)
Q Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~ 274 (362)
..+....+.... .+..+..++.++.+|+.+||..+|++||++++++.+
T Consensus 229 -~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 276 (303)
T cd05088 229 -CAELYEKLPQGY-RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 276 (303)
T ss_pred -hHHHHHHHhcCC-cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 334444443332 223455678999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-41 Score=303.00 Aligned_cols=257 Identities=19% Similarity=0.321 Sum_probs=200.9
Q ss_pred eeecceecccCceEEEEEEECCCCCCCCceeeeechhh-----hhhHHHHHHHHHHHHcCCCCcccccccceeeecC-CC
Q 039291 8 WFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEV-----SASASLQKEKEVFDNLNGCPFVLECFGEEITMGE-NG 81 (362)
Q Consensus 8 y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~-----~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~-~~ 81 (362)
|.+++.||+|+||.||+|....++. ....+++|.... .....+.+|+.+++.++ ||||+++++....... +.
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~ 78 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDG-SQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFD-HPNVMKLIGVCFEASSLQK 78 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCC-CcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCC-CCCeeeEEeeeccCCcccc
Confidence 5788999999999999998765431 123567775432 23356889999999998 8999999987654222 22
Q ss_pred ceEEEEEEEecCCCCHHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEE
Q 039291 82 EMAYNLLLEYAAGGTLGDLIEKCN----GNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKI 157 (362)
Q Consensus 82 ~~~~~lv~e~~~~~~L~~~l~~~~----~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl 157 (362)
....+++|||+++++|..++.... ...+++..+..++.|++.||.|||+++++||||||+||++ ++++.+||
T Consensus 79 ~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~----~~~~~~kl 154 (273)
T cd05035 79 IPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCML----REDMTVCV 154 (273)
T ss_pred CcccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEE----CCCCeEEE
Confidence 344679999999999999886532 2358999999999999999999999999999999999999 77788999
Q ss_pred eecCCcccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHh-CCCCCccCCCCCHHHHHHHHcCC
Q 039291 158 ADLGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLS-GRQAWVVKEDCSIDQLFSIIGDE 236 (362)
Q Consensus 158 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~ 236 (362)
+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |.+||.... ..+....+...
T Consensus 155 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~---~~~~~~~~~~~ 231 (273)
T cd05035 155 ADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVE---NHEIYDYLRHG 231 (273)
T ss_pred CCccceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCC---HHHHHHHHHcC
Confidence 99999976543222211122335678999999988889999999999999999999 889985433 33444444433
Q ss_pred CCCCCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhcC
Q 039291 237 HSLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDD 274 (362)
Q Consensus 237 ~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~ 274 (362)
. .+..+..++.++.+++.+||..||++||++.+++++
T Consensus 232 ~-~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~ 268 (273)
T cd05035 232 N-RLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREV 268 (273)
T ss_pred C-CCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 3 334567789999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-41 Score=299.87 Aligned_cols=252 Identities=21% Similarity=0.326 Sum_probs=202.1
Q ss_pred CCCCCceeecceecccCceEEEEEEECCCCCCCCceeeeechhhh--hhHHHHHHHHHHHHcCCCCcccccccceeeecC
Q 039291 2 DSDGTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVS--ASASLQKEKEVFDNLNGCPFVLECFGEEITMGE 79 (362)
Q Consensus 2 ~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~~--~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~ 79 (362)
+...++|.+.+.||+|++|.||+|.+..+. .+++|..... ..+.+.+|+.++++++ ||||+++++.+..
T Consensus 2 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~-----~v~iK~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~--- 72 (261)
T cd05068 2 EIDRTSIQLLRKLGAGQFGEVWEGLWNNTT-----PVAVKTLKPGTMDPKDFLAEAQIMKKLR-HPKLIQLYAVCTL--- 72 (261)
T ss_pred ccchhheeeEEEecccCCccEEEEEecCCe-----EEEEEeeCCCcccHHHHHHHHHHHHHCC-CCCccceeEEEec---
Confidence 456788999999999999999999976542 4667765432 3456889999999998 8999999886532
Q ss_pred CCceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEee
Q 039291 80 NGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIAD 159 (362)
Q Consensus 80 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~D 159 (362)
...++++|||+.+++|.+++....+..+++..+..++.|++.||.|||++|++|+||||+||++ +.++.++|+|
T Consensus 73 --~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~----~~~~~~~l~d 146 (261)
T cd05068 73 --EEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLV----GENNICKVAD 146 (261)
T ss_pred --CCCeeeeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEE----cCCCCEEECC
Confidence 2346799999999999999987554569999999999999999999999999999999999999 7778899999
Q ss_pred cCCcccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHh-CCCCCccCCCCCHHHHHHHHcCCCC
Q 039291 160 LGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLS-GRQAWVVKEDCSIDQLFSIIGDEHS 238 (362)
Q Consensus 160 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~ 238 (362)
||++......... ......++..|+|||++.+..++.++|+||||+++|+|++ |+.||... ....+...+.....
T Consensus 147 fg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~---~~~~~~~~~~~~~~ 222 (261)
T cd05068 147 FGLARVIKEDIYE-AREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGM---TNAEVLQQVDQGYR 222 (261)
T ss_pred cceEEEccCCccc-ccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCC---CHHHHHHHHHcCCC
Confidence 9999765522111 1112223457999999988889999999999999999999 99999543 34444444444333
Q ss_pred CCCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhc
Q 039291 239 LPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLD 273 (362)
Q Consensus 239 ~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~ 273 (362)
. ..+..++..+.+++.+||..+|++||++.+++.
T Consensus 223 ~-~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~ 256 (261)
T cd05068 223 M-PCPPGCPKELYDIMLDCWKEDPDDRPTFETLQW 256 (261)
T ss_pred C-CCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence 2 345668899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-41 Score=306.52 Aligned_cols=258 Identities=22% Similarity=0.394 Sum_probs=199.7
Q ss_pred CceeecceecccCceEEEEEEECCCCCCCCceeeeechhhh-----hhHHHHHHHHHHHHcCCCCcccccccceeeecCC
Q 039291 6 TSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVS-----ASASLQKEKEVFDNLNGCPFVLECFGEEITMGEN 80 (362)
Q Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~~-----~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~ 80 (362)
++|.+.+.||+|++|+||+|+++.+++ .+++|..... ....+.+|+.++++++ ||||+++++.+..
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~----~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~---- 72 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNE----TIALKKIRLEQEDEGVPSTAIREISLLKEMQ-HGNIVRLQDVVHS---- 72 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCc----EEEEEehhhccccccchHHHHHHHHHHHhcc-CCCEeeEEEEEec----
Confidence 579999999999999999999988775 5666665432 2356788999999998 8999999987642
Q ss_pred CceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEeec
Q 039291 81 GEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADL 160 (362)
Q Consensus 81 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Df 160 (362)
...+++||||++ ++|.+++.......+++..++.++.||+.||+|||++|++|+||+|+||++. ..+..+||+||
T Consensus 73 -~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~---~~~~~~kl~df 147 (294)
T PLN00009 73 -EKRLYLVFEYLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLID---RRTNALKLADF 147 (294)
T ss_pred -CCeEEEEEeccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEE---CCCCEEEEccc
Confidence 235789999996 5888888764444578999999999999999999999999999999999993 23456999999
Q ss_pred CCcccccccccCCCCCCccCCCCccCchhhcc-ccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHH---cCC
Q 039291 161 GVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQ-HMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSII---GDE 236 (362)
Q Consensus 161 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~---~~~ 236 (362)
|++...... ........+++.|+|||++.+ ..++.++||||+||++|+|++|++||...+. ........ ...
T Consensus 148 g~~~~~~~~--~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~--~~~~~~~~~~~~~~ 223 (294)
T PLN00009 148 GLARAFGIP--VRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSE--IDELFKIFRILGTP 223 (294)
T ss_pred ccccccCCC--ccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHHHhCCC
Confidence 998654332 111134467899999999876 4578899999999999999999999965432 22222211 100
Q ss_pred C---------------CCC--------CCCccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCccCcc
Q 039291 237 H---------------SLP--------EIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGVD 281 (362)
Q Consensus 237 ~---------------~~~--------~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~~~~~ 281 (362)
. ..+ .....++.++.+++.+||..+|++||++.+++.||||..+.
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~~~~ 291 (294)
T PLN00009 224 NEETWPGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKDLG 291 (294)
T ss_pred ChhhccccccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchHhHHh
Confidence 0 000 01234688999999999999999999999999999998764
|
|
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=308.11 Aligned_cols=252 Identities=28% Similarity=0.432 Sum_probs=202.1
Q ss_pred ceeecceecccCceEEEEEEECCCCCCCCceeeeechh---hhhhHHHHHHHHHHHHcCCCCcccccccceeeecCCCce
Q 039291 7 SWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAE---VSASASLQKEKEVFDNLNGCPFVLECFGEEITMGENGEM 83 (362)
Q Consensus 7 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~---~~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~~~~ 83 (362)
-|.....||+|+||.||+|.+..++. .+++|... ......+.+|+.+++.+. ||||+++++.+.. ..
T Consensus 22 ~~~~~~~ig~g~~g~v~~~~~~~~~~----~v~iK~~~~~~~~~~~~~~~e~~~l~~l~-hp~i~~~~~~~~~-----~~ 91 (297)
T cd06659 22 LLENYIKIGEGSTGIVCIAREKHSGR----QVAVKMMDLRKQQRRELLFNEVVIMRDYQ-HQNVVEMYKSYLV-----GE 91 (297)
T ss_pred hHHhhhhcCCCCceeEEEEEEcCCCC----EEEEEEEEecccchHHHHHHHHHHHHhCC-CCchhhhhhheee-----CC
Confidence 35556789999999999999987665 44555432 223456788999999998 8999999987643 23
Q ss_pred EEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEeecCCc
Q 039291 84 AYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVA 163 (362)
Q Consensus 84 ~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Dfgla 163 (362)
.++++|||+++++|.+++.. ..+++..++.++.|++.||.|||++|++||||||+||++ +.++.++|+|||++
T Consensus 92 ~~~iv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill----~~~~~~kL~dfg~~ 164 (297)
T cd06659 92 ELWVLMEFLQGGALTDIVSQ---TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILL----TLDGRVKLSDFGFC 164 (297)
T ss_pred eEEEEEecCCCCCHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEE----ccCCcEEEeechhH
Confidence 47799999999999998764 458999999999999999999999999999999999999 77788999999998
Q ss_pred ccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHHcCC-CCCCCC
Q 039291 164 KRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDE-HSLPEI 242 (362)
Q Consensus 164 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~-~~~~~~ 242 (362)
........ ......|+..|+|||++.+..++.++|+|||||++|+|++|+.||...+ ..+....+... ......
T Consensus 165 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~---~~~~~~~~~~~~~~~~~~ 239 (297)
T cd06659 165 AQISKDVP--KRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDS---PVQAMKRLRDSPPPKLKN 239 (297)
T ss_pred hhcccccc--cccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHhccCCCCccc
Confidence 65433211 1234678999999999988889999999999999999999999996443 23333333222 222233
Q ss_pred CccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCccCc
Q 039291 243 PSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGV 280 (362)
Q Consensus 243 ~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~~~~ 280 (362)
+..++.++.++|.+||..+|++||++++++.||||.+.
T Consensus 240 ~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~~~~~~~ 277 (297)
T cd06659 240 AHKISPVLRDFLERMLTREPQERATAQELLDHPFLLQT 277 (297)
T ss_pred cCCCCHHHHHHHHHHhcCCcccCcCHHHHhhChhhccC
Confidence 45678999999999999999999999999999999754
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=307.21 Aligned_cols=257 Identities=19% Similarity=0.263 Sum_probs=203.3
Q ss_pred CCCCceeecceecccCceEEEEEEECCCC-CCCCceeeeechhhh----hhHHHHHHHHHHHHcCCCCcccccccceeee
Q 039291 3 SDGTSWFRGRVIGQGSFGCVFIAKPKSNS-SFLPPLMAVKSAEVS----ASASLQKEKEVFDNLNGCPFVLECFGEEITM 77 (362)
Q Consensus 3 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~-~~~~~~~~~K~~~~~----~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~ 77 (362)
++..+|.+.+.||+|+||.||+|.+..+. ......+++|..... ....+.+|+.++..++ ||||+++++.+..
T Consensus 2 i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~-h~~iv~~~~~~~~- 79 (283)
T cd05091 2 INLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQ-HPNIVCLLGVVTK- 79 (283)
T ss_pred CCHHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCC-CCCcCeEEEEEcC-
Confidence 45567899999999999999999886542 122346788876533 2355778999999998 8999999986642
Q ss_pred cCCCceEEEEEEEecCCCCHHHHHHHh--------------cCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCE
Q 039291 78 GENGEMAYNLLLEYAAGGTLGDLIEKC--------------NGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNI 143 (362)
Q Consensus 78 ~~~~~~~~~lv~e~~~~~~L~~~l~~~--------------~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Ni 143 (362)
....++++||+.+++|.+++... ....+++..+..++.|++.||.|||++||+||||||+||
T Consensus 80 ----~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Ni 155 (283)
T cd05091 80 ----EQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNV 155 (283)
T ss_pred ----CCceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhhe
Confidence 22367999999999999998531 123488899999999999999999999999999999999
Q ss_pred EEeecCCCceEEEEeecCCcccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHh-CCCCCccCC
Q 039291 144 LLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLS-GRQAWVVKE 222 (362)
Q Consensus 144 ll~~~~~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~ 222 (362)
++ +.++.+||+|||+++...............+++.|+|||++.+..++.++|||||||++|||++ |..||.+.
T Consensus 156 l~----~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~- 230 (283)
T cd05091 156 LV----FDKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGY- 230 (283)
T ss_pred Ee----cCCCceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCC-
Confidence 99 6677899999999875543222222234456788999999988889999999999999999998 88888543
Q ss_pred CCCHHHHHHHHcCCCCCCCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhc
Q 039291 223 DCSIDQLFSIIGDEHSLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLD 273 (362)
Q Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~ 273 (362)
...+....+..... +.++..++..+.+|+.+||+.+|.+||++++++.
T Consensus 231 --~~~~~~~~i~~~~~-~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~ 278 (283)
T cd05091 231 --SNQDVIEMIRNRQV-LPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHS 278 (283)
T ss_pred --CHHHHHHHHHcCCc-CCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHH
Confidence 34455555544433 3456789999999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-41 Score=300.22 Aligned_cols=250 Identities=21% Similarity=0.351 Sum_probs=199.7
Q ss_pred CCCCceeecceecccCceEEEEEEECCCCCCCCceeeeechhhh--hhHHHHHHHHHHHHcCCCCcccccccceeeecCC
Q 039291 3 SDGTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVS--ASASLQKEKEVFDNLNGCPFVLECFGEEITMGEN 80 (362)
Q Consensus 3 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~~--~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~ 80 (362)
...++|.+.+.||+|+||.||+|.+..+. .+++|..... ....+.+|+.++++++ |++++++++... .
T Consensus 3 ~~~~~~~~~~~ig~g~~~~v~~~~~~~~~-----~~~~k~~~~~~~~~~~~~~E~~~l~~l~-~~~i~~~~~~~~----~ 72 (260)
T cd05070 3 IPRESLQLIKKLGNGQFGEVWMGTWNGNT-----KVAVKTLKPGTMSPESFLEEAQIMKKLR-HDKLVQLYAVVS----E 72 (260)
T ss_pred CchHHhhhhheeccccCceEEEEEecCCc-----eeEEEEecCCCCCHHHHHHHHHHHHhcC-CCceEEEEeEEC----C
Confidence 45678999999999999999999876543 3566655422 3456889999999998 899999987542 1
Q ss_pred CceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEeec
Q 039291 81 GEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADL 160 (362)
Q Consensus 81 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Df 160 (362)
...+++|||+++++|.+++.......+++..++.++.|++.||.|||++|++||||||+||++ +.++.++|+||
T Consensus 73 --~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili----~~~~~~~l~df 146 (260)
T cd05070 73 --EPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILV----GDGLVCKIADF 146 (260)
T ss_pred --CCcEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEE----eCCceEEeCCc
Confidence 225699999999999999987555568999999999999999999999999999999999999 67788999999
Q ss_pred CCcccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHh-CCCCCccCCCCCHHHHHHHHcCCCCC
Q 039291 161 GVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLS-GRQAWVVKEDCSIDQLFSIIGDEHSL 239 (362)
Q Consensus 161 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~ 239 (362)
|++......... ......++..|+|||++.+..++.++|+||||+++|+|++ |.+||... +..+....+.....
T Consensus 147 g~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~---~~~~~~~~~~~~~~- 221 (260)
T cd05070 147 GLARLIEDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGM---NNREVLEQVERGYR- 221 (260)
T ss_pred eeeeeccCcccc-cccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCC---CHHHHHHHHHcCCC-
Confidence 998754432111 1122345667999999988889999999999999999999 89999543 33344444433322
Q ss_pred CCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhc
Q 039291 240 PEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLD 273 (362)
Q Consensus 240 ~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~ 273 (362)
+..+...+.++++|+.+||..+|++|||++++.+
T Consensus 222 ~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 255 (260)
T cd05070 222 MPCPQDCPISLHELMLQCWKKDPEERPTFEYLQS 255 (260)
T ss_pred CCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHH
Confidence 3345678899999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=305.08 Aligned_cols=253 Identities=28% Similarity=0.509 Sum_probs=205.7
Q ss_pred ceeecceecccCceEEEEEEECCCCCCCCceeeeechhh----hhhHHHHHHHHHHHHcCCCCcccccccceeeecCCCc
Q 039291 7 SWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEV----SASASLQKEKEVFDNLNGCPFVLECFGEEITMGENGE 82 (362)
Q Consensus 7 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~----~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~~~ 82 (362)
-|...+.||+|+||.||+|.+..++. .+++|.... .....+.+|+.++++++ ||||+++++.+.. .
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~----~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~-----~ 74 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQK----VVAIKIIDLEEAEDEIEDIQQEITVLSQCD-SPYVTKYYGSYLK-----D 74 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCc----EEEEEEeccccchHHHHHHHHHHHHHHhcC-CCCEeEEEEEEEe-----C
Confidence 47788999999999999999887765 556665432 23456888999999998 8999999987642 2
Q ss_pred eEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEeecCC
Q 039291 83 MAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGV 162 (362)
Q Consensus 83 ~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Dfgl 162 (362)
..+++||||+++++|.+++.. ..+++..+..++.|++.++.|||+.|++|+||||+||++ +.++.++|+|||+
T Consensus 75 ~~~~lv~e~~~~~~l~~~i~~---~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i----~~~~~~~l~dfg~ 147 (277)
T cd06641 75 TKLWIIMEYLGGGSALDLLEP---GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLL----SEHGEVKLADFGV 147 (277)
T ss_pred CeEEEEEEeCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEE----CCCCCEEEeeccc
Confidence 347799999999999999864 358999999999999999999999999999999999999 7778899999999
Q ss_pred cccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHHcCCCCCCCC
Q 039291 163 AKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEHSLPEI 242 (362)
Q Consensus 163 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 242 (362)
+....... .......++..|+|||.+.+...+.++|+|||||++|+|++|..||.... .......+.. ...+.+
T Consensus 148 ~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~---~~~~~~~~~~-~~~~~~ 221 (277)
T cd06641 148 AGQLTDTQ--IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELH---PMKVLFLIPK-NNPPTL 221 (277)
T ss_pred ceecccch--hhhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccc---hHHHHHHHhc-CCCCCC
Confidence 86544321 11234568899999999988888999999999999999999999995432 2333333322 234456
Q ss_pred CccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCccCcch
Q 039291 243 PSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGVDE 282 (362)
Q Consensus 243 ~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~~~~~~ 282 (362)
+..++.++.+++.+||..+|.+||++.+++.||||.+...
T Consensus 222 ~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~~~~~~ 261 (277)
T cd06641 222 EGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFIVRFAK 261 (277)
T ss_pred CcccCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhhhhh
Confidence 6678999999999999999999999999999999977543
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-41 Score=308.92 Aligned_cols=262 Identities=26% Similarity=0.399 Sum_probs=199.3
Q ss_pred ceeecceecccCceEEEEEEECC--CCCCCCceeeeechhh------hhhHHHHHHHHHHHHcCCCCcccccccceeeec
Q 039291 7 SWFRGRVIGQGSFGCVFIAKPKS--NSSFLPPLMAVKSAEV------SASASLQKEKEVFDNLNGCPFVLECFGEEITMG 78 (362)
Q Consensus 7 ~y~~~~~lG~G~~g~V~~a~~~~--~~~~~~~~~~~K~~~~------~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~ 78 (362)
+|.+.+.||+|+||.||+|.++. ++. .+++|.... .....+.+|+.+++.++ ||||+++++.+..
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~----~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~-- 73 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGK----EYAIKKFKGDKEQYTGISQSACREIALLRELK-HENVVSLVEVFLE-- 73 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCC----eEEEEEeccccccccCccHHHHHHHHHHHhcC-CCCccceEEEEeC--
Confidence 58899999999999999999987 443 567776544 22356778999999998 8999999987653
Q ss_pred CCCceEEEEEEEecCCCCHHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEE
Q 039291 79 ENGEMAYNLLLEYAAGGTLGDLIEKCN---GNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVA 155 (362)
Q Consensus 79 ~~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~ 155 (362)
.....+++||||+++ +|.+++.... ...+++..++.++.|++.||.|||+++|+||||||+||++..+++..+.+
T Consensus 74 -~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~ 151 (316)
T cd07842 74 -HADKSVYLLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVV 151 (316)
T ss_pred -CCCceEEEEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceE
Confidence 223457899999975 7877775432 23689999999999999999999999999999999999994433348999
Q ss_pred EEeecCCccccccccc-CCCCCCccCCCCccCchhhcc-ccCCCcchHHHHHHHHHHHHhCCCCCccCCCCC--------
Q 039291 156 KIADLGVAKRSRHCKR-QKFDPSMRGTPLYLAPETVVQ-HMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCS-------- 225 (362)
Q Consensus 156 kl~Dfgla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~-------- 225 (362)
||+|||++........ ........++..|+|||++.+ ..++.++|||||||++++|++|++||.......
T Consensus 152 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~ 231 (316)
T cd07842 152 KIGDLGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQR 231 (316)
T ss_pred EECCCccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHH
Confidence 9999999876543322 112234568899999998876 457899999999999999999999997654322
Q ss_pred --HHHHHHHHcC--------------------CCCCCCCC-----------ccCCHHHHHHHHHHhccCCCCCCCHHHHh
Q 039291 226 --IDQLFSIIGD--------------------EHSLPEIP-----------SRVSKEARDFLRRCFVRKPAFRFTAEMLL 272 (362)
Q Consensus 226 --~~~~~~~~~~--------------------~~~~~~~~-----------~~~~~~~~~li~~~l~~~p~~R~s~~~~l 272 (362)
...++..+.. .......+ ...+.++.+++.+||..||++|||+.+++
T Consensus 232 ~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil 311 (316)
T cd07842 232 DQLERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEAL 311 (316)
T ss_pred HHHHHHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHh
Confidence 0001110000 00000111 14667899999999999999999999999
Q ss_pred cCCCc
Q 039291 273 DDPFV 277 (362)
Q Consensus 273 ~~p~~ 277 (362)
.||||
T Consensus 312 ~~~~f 316 (316)
T cd07842 312 EHPYF 316 (316)
T ss_pred cCCCC
Confidence 99998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=292.14 Aligned_cols=252 Identities=24% Similarity=0.463 Sum_probs=201.6
Q ss_pred eecceecccCceEEEEEEECCCCCCCCceeeeechh----hhhhHHHHHHHHHHHHcCCCCcccccccceeeecCCCceE
Q 039291 9 FRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAE----VSASASLQKEKEVFDNLNGCPFVLECFGEEITMGENGEMA 84 (362)
Q Consensus 9 ~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~----~~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~~~~~ 84 (362)
.++..||.|+.|+||+++.+.+|. .+|+|.+. .+..+++.+.+.++..-+.+|+||+++++++...+
T Consensus 95 ~~l~dlGsGtcG~V~k~~~rs~~~----iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~d----- 165 (391)
T KOG0983|consen 95 ENLGDLGSGTCGQVWKMRFRSTGH----IIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTD----- 165 (391)
T ss_pred hhHHhhcCCCccceEEEEEcccce----EEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCch-----
Confidence 456789999999999999999875 66777654 44666778888888877779999999999876332
Q ss_pred EEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH-hCCceeCCCCCCCEEEeecCCCceEEEEeecCCc
Q 039291 85 YNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIH-DSGYVHCDVKPDNILLVATQSGKFVAKIADLGVA 163 (362)
Q Consensus 85 ~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH-~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Dfgla 163 (362)
..+.||.+. ..+..++.. -.++++|..+-++...++.||.||. ++||+|||+||+|||+ |+.|++||||||++
T Consensus 166 V~IcMelMs-~C~ekLlkr-ik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILl----De~GniKlCDFGIs 239 (391)
T KOG0983|consen 166 VFICMELMS-TCAEKLLKR-IKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILL----DERGNIKLCDFGIS 239 (391)
T ss_pred HHHHHHHHH-HHHHHHHHH-hcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEE----ccCCCEEeeccccc
Confidence 346788873 244445544 4567999999999999999999997 5799999999999999 99999999999998
Q ss_pred ccccccccCCCCCCccCCCCccCchhhcc---ccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHHcCCCCCC
Q 039291 164 KRSRHCKRQKFDPSMRGTPLYLAPETVVQ---HMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEHSLP 240 (362)
Q Consensus 164 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 240 (362)
.+...... .+...|-+.|||||.+.- ..|+.++||||||++|+||.||+.||.+.+. +.+.+...+..++ |
T Consensus 240 GrlvdSkA---htrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~t-dFe~ltkvln~eP--P 313 (391)
T KOG0983|consen 240 GRLVDSKA---HTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKT-DFEVLTKVLNEEP--P 313 (391)
T ss_pred ceeecccc---cccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCc-cHHHHHHHHhcCC--C
Confidence 76554322 234568889999999984 4688999999999999999999999976532 3444444443332 5
Q ss_pred CCCc--cCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCccCcc
Q 039291 241 EIPS--RVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGVD 281 (362)
Q Consensus 241 ~~~~--~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~~~~~ 281 (362)
.++. ..|+++++|+..||.+|+.+||...++|+|||+...+
T Consensus 314 ~L~~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h~Fi~~ye 356 (391)
T KOG0983|consen 314 LLPGHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEHPFIKRYE 356 (391)
T ss_pred CCCcccCcCHHHHHHHHHHhhcCcccCcchHHHhcCcceeecc
Confidence 5553 3799999999999999999999999999999997653
|
|
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-42 Score=315.60 Aligned_cols=262 Identities=23% Similarity=0.350 Sum_probs=206.7
Q ss_pred ceeecceecccCceEEEEEEECCCCCCCCceeeeechhh-----hhhHHHHHHHHHHHHcCCCCcccccccceeeecCCC
Q 039291 7 SWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEV-----SASASLQKEKEVFDNLNGCPFVLECFGEEITMGENG 81 (362)
Q Consensus 7 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~-----~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~~ 81 (362)
+|.+.+.||+|++|.||+|++..++. .+++|.... ...+.+.+|+.+++.++ |+||+++++++.......
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~----~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~ 75 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGR----KVAIKKISNVFDDLIDAKRILREIKLLRHLR-HENIIGLLDILRPPSPED 75 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCc----EEEEEeeccccccchhhhhHHHHHHHHHhcC-CcchhhhhhhhcccCccc
Confidence 68999999999999999999987765 456655432 24456889999999998 999999999776543223
Q ss_pred ceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEeecC
Q 039291 82 EMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLG 161 (362)
Q Consensus 82 ~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Dfg 161 (362)
...+|++|||+.+ +|.+++.. ..++++..++.++.||+.||+|||++||+|+||||+|||+ +.++.++|+|||
T Consensus 76 ~~~~~lv~e~~~~-~l~~~l~~--~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili----~~~~~~~L~dfg 148 (330)
T cd07834 76 FNDVYIVTELMET-DLHKVIKS--PQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILV----NSNCDLKICDFG 148 (330)
T ss_pred ccceEEEecchhh-hHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE----cCCCCEEEcccC
Confidence 3457899999974 89888875 3479999999999999999999999999999999999999 777889999999
Q ss_pred CcccccccccC-CCCCCccCCCCccCchhhccc-cCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHHcCCC--
Q 039291 162 VAKRSRHCKRQ-KFDPSMRGTPLYLAPETVVQH-MQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEH-- 237 (362)
Q Consensus 162 la~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~-- 237 (362)
++......... .......++..|+|||++.+. .++.++|+||||+++|+|++|.+||...+. .+....+....
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~---~~~~~~i~~~~~~ 225 (330)
T cd07834 149 LARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDY---IDQLNLIVEVLGT 225 (330)
T ss_pred ceEeecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCH---HHHHHHHHHhcCC
Confidence 99866543210 112345689999999999887 889999999999999999999999965532 11111111100
Q ss_pred ---------------------------CCCCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCccCcchh
Q 039291 238 ---------------------------SLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGVDEE 283 (362)
Q Consensus 238 ---------------------------~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~~~~~~~ 283 (362)
.+......++.++.++|.+||+.+|++||++++++.||||+.+..+
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~~ 298 (330)
T cd07834 226 PSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHDP 298 (330)
T ss_pred CChhHhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhccc
Confidence 0011123468899999999999999999999999999999876443
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=319.26 Aligned_cols=258 Identities=21% Similarity=0.321 Sum_probs=201.9
Q ss_pred CCCceeecceecccCceEEEEEEECCCC-CCCCceeeeechhhh----hhHHHHHHHHHHHHcCCCCcccccccceeeec
Q 039291 4 DGTSWFRGRVIGQGSFGCVFIAKPKSNS-SFLPPLMAVKSAEVS----ASASLQKEKEVFDNLNGCPFVLECFGEEITMG 78 (362)
Q Consensus 4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~-~~~~~~~~~K~~~~~----~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~ 78 (362)
..++|.+++.||+|+||.||+|++.... ......|++|..... ....+.+|+.+|.++..||||+++++.+...
T Consensus 35 ~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~- 113 (401)
T cd05107 35 PRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKG- 113 (401)
T ss_pred cHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccC-
Confidence 3467888999999999999999976432 222346788876532 2346788999999998899999999876432
Q ss_pred CCCceEEEEEEEecCCCCHHHHHHHhcC----------------------------------------------------
Q 039291 79 ENGEMAYNLLLEYAAGGTLGDLIEKCNG---------------------------------------------------- 106 (362)
Q Consensus 79 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~---------------------------------------------------- 106 (362)
..+++||||+.+|+|.+++.....
T Consensus 114 ----~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 189 (401)
T cd05107 114 ----GPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADY 189 (401)
T ss_pred ----CCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCc
Confidence 246799999999999999975321
Q ss_pred --------------------------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCC
Q 039291 107 --------------------------------------------NGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDN 142 (362)
Q Consensus 107 --------------------------------------------~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~N 142 (362)
..+++..+..++.||+.||.|||+.+|+||||||+|
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~N 269 (401)
T cd05107 190 VPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARN 269 (401)
T ss_pred cchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcce
Confidence 136777889999999999999999999999999999
Q ss_pred EEEeecCCCceEEEEeecCCcccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHh-CCCCCccC
Q 039291 143 ILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLS-GRQAWVVK 221 (362)
Q Consensus 143 ill~~~~~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~ 221 (362)
||+ +..+.++|+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |..||...
T Consensus 270 iLl----~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~ 345 (401)
T cd05107 270 VLI----CEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPEL 345 (401)
T ss_pred EEE----eCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCC
Confidence 999 6677899999999975433222112223457888999999998889999999999999999998 88998543
Q ss_pred CCCCHHHHHHHHcCCCCCCCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhc
Q 039291 222 EDCSIDQLFSIIGDEHSLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLD 273 (362)
Q Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~ 273 (362)
. ........+.... .+..+..++.++.+|+.+||..+|.+||++.+++.
T Consensus 346 ~--~~~~~~~~~~~~~-~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~ 394 (401)
T cd05107 346 P--MNEQFYNAIKRGY-RMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVH 394 (401)
T ss_pred C--chHHHHHHHHcCC-CCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 2 2223333333332 23456678999999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-41 Score=312.90 Aligned_cols=262 Identities=25% Similarity=0.389 Sum_probs=198.7
Q ss_pred CCceeecceecccCceEEEEEEECCCCCCCCceeeeechh---hhhhHHHHHHHHHHHHcCCCCcccccccceeeecCCC
Q 039291 5 GTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAE---VSASASLQKEKEVFDNLNGCPFVLECFGEEITMGENG 81 (362)
Q Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~---~~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~~ 81 (362)
+++|.+.+.||+|+||.||+|.++.++. .+++|... ....+.+.+|+.+++.++ ||||+++++.+.......
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~----~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~-h~~i~~~~~~~~~~~~~~ 78 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDK----RVAVKKIVLTDPQSVKHALREIKIIRRLD-HDNIVKVYEVLGPSGSDL 78 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCc----EEEEEEEecCCCchHHHHHHHHHHHHhcC-CCcchhhHhhhccccccc
Confidence 5899999999999999999999988875 34555432 234556888999999997 999999998654322111
Q ss_pred ---------ceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCc
Q 039291 82 ---------EMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGK 152 (362)
Q Consensus 82 ---------~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~ 152 (362)
...+++||||+. ++|.+++.. ..+++..++.++.||+.||.|||+.||+||||||+||++. ..+
T Consensus 79 ~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~---~~~ 151 (342)
T cd07854 79 TEDVGSLTELNSVYIVQEYME-TDLANVLEQ---GPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFIN---TED 151 (342)
T ss_pred ccccccccccceEEEEeeccc-ccHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEc---CCC
Confidence 134679999997 489888754 3599999999999999999999999999999999999993 244
Q ss_pred eEEEEeecCCccccccccc-CCCCCCccCCCCccCchhhcc-ccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHH
Q 039291 153 FVAKIADLGVAKRSRHCKR-QKFDPSMRGTPLYLAPETVVQ-HMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLF 230 (362)
Q Consensus 153 ~~~kl~Dfgla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~ 230 (362)
..++|+|||++........ ........|+..|+|||.+.+ ..++.++|||||||++|+|++|+.||...... ....
T Consensus 152 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~--~~~~ 229 (342)
T cd07854 152 LVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHEL--EQMQ 229 (342)
T ss_pred ceEEECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HHHH
Confidence 5789999999875432111 111123457889999998764 56788999999999999999999999654321 1111
Q ss_pred HHHcC----------------------CCCC-----CCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCccCc
Q 039291 231 SIIGD----------------------EHSL-----PEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGV 280 (362)
Q Consensus 231 ~~~~~----------------------~~~~-----~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~~~~ 280 (362)
..+.. .... ..+...++.++++||.+||..||++|||+.+++.||||+..
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~~ 306 (342)
T cd07854 230 LILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSCY 306 (342)
T ss_pred HHHHhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCccccc
Confidence 11100 0000 01123578899999999999999999999999999999865
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-41 Score=301.86 Aligned_cols=255 Identities=19% Similarity=0.300 Sum_probs=207.0
Q ss_pred CCCCceeecceecccCceEEEEEEECCCCCCCCceeeeechhhh----hhHHHHHHHHHHHHcCCCCcccccccceeeec
Q 039291 3 SDGTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVS----ASASLQKEKEVFDNLNGCPFVLECFGEEITMG 78 (362)
Q Consensus 3 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~~----~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~ 78 (362)
...++|.+.+.||+|+||+||+|.++.++......+++|..... ....+.+|+.++++++ ||||+++++.+..
T Consensus 4 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~-- 80 (279)
T cd05057 4 LKETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVD-HPHVVRLLGICLS-- 80 (279)
T ss_pred cCHHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCC-CCCcceEEEEEec--
Confidence 35678999999999999999999998877665567888875433 3456788999999998 9999999987653
Q ss_pred CCCceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEe
Q 039291 79 ENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIA 158 (362)
Q Consensus 79 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~ 158 (362)
...++||||+++|+|.+++... ...+++..+..++.|++.||+|||+.|++||||||+||++ +.++.+||+
T Consensus 81 ----~~~~~v~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~----~~~~~~kL~ 151 (279)
T cd05057 81 ----SQVQLITQLMPLGCLLDYVRNH-KDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLV----KTPQHVKIT 151 (279)
T ss_pred ----CceEEEEecCCCCcHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEE----cCCCeEEEC
Confidence 2467999999999999999763 3459999999999999999999999999999999999999 777789999
Q ss_pred ecCCcccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHh-CCCCCccCCCCCHHHHHHHHcCCC
Q 039291 159 DLGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLS-GRQAWVVKEDCSIDQLFSIIGDEH 237 (362)
Q Consensus 159 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~ 237 (362)
|||+++...............++..|+|||.+....++.++|+|||||++||+++ |..||... ...++...+....
T Consensus 152 dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~---~~~~~~~~~~~~~ 228 (279)
T cd05057 152 DFGLAKLLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGI---PAVEIPDLLEKGE 228 (279)
T ss_pred CCcccccccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCC---CHHHHHHHHhCCC
Confidence 9999976543222111112234567999999988889999999999999999998 99999554 4445555554433
Q ss_pred CCCCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhc
Q 039291 238 SLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLD 273 (362)
Q Consensus 238 ~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~ 273 (362)
.. ..+...+.++.+++.+||..+|++||++.++++
T Consensus 229 ~~-~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~ 263 (279)
T cd05057 229 RL-PQPPICTIDVYMVLVKCWMIDAESRPTFKELIN 263 (279)
T ss_pred CC-CCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 33 345568899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-41 Score=298.77 Aligned_cols=246 Identities=21% Similarity=0.339 Sum_probs=200.1
Q ss_pred CCCceeecceecccCceEEEEEEECCCCCCCCceeeeechhhh-hhHHHHHHHHHHHHcCCCCcccccccceeeecCCCc
Q 039291 4 DGTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVS-ASASLQKEKEVFDNLNGCPFVLECFGEEITMGENGE 82 (362)
Q Consensus 4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~~-~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~~~ 82 (362)
+..+|.+.+.||+|+||.||+|...+. .+++|..... ..+.+.+|+.++++++ |++++++++.... ..
T Consensus 4 ~~~~~~~~~~lg~g~~~~v~~~~~~~~------~~~~k~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~----~~ 72 (256)
T cd05082 4 NMKELKLLQTIGKGEFGDVMLGDYRGN------KVAVKCIKNDATAQAFLAEASVMTQLR-HSNLVQLLGVIVE----EK 72 (256)
T ss_pred cHHhCeeeeeecccCCCeEEEEEEcCC------cEEEEEeCCCchHHHHHHHHHHHHhCC-CCCeeeEEEEEEc----CC
Confidence 456899999999999999999987632 4566665433 3456889999999998 8999999886542 22
Q ss_pred eEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEeecCC
Q 039291 83 MAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGV 162 (362)
Q Consensus 83 ~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Dfgl 162 (362)
...+++|||+++++|.+++.......+++..+..++.|++.||+|||++|++||||||+||++ +.++.+||+|||+
T Consensus 73 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~----~~~~~~kl~dfg~ 148 (256)
T cd05082 73 GGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLV----SEDNVAKVSDFGL 148 (256)
T ss_pred CceEEEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEE----cCCCcEEecCCcc
Confidence 346799999999999999987555558999999999999999999999999999999999999 7778899999999
Q ss_pred cccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHh-CCCCCccCCCCCHHHHHHHHcCCCCCCC
Q 039291 163 AKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLS-GRQAWVVKEDCSIDQLFSIIGDEHSLPE 241 (362)
Q Consensus 163 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 241 (362)
+....... ....++..|+|||++.+..++.++|||||||++|+|++ |+.||... ...+....+.... .+.
T Consensus 149 ~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~---~~~~~~~~~~~~~-~~~ 219 (256)
T cd05082 149 TKEASSTQ-----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI---PLKDVVPRVEKGY-KMD 219 (256)
T ss_pred ceeccccC-----CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCC---CHHHHHHHHhcCC-CCC
Confidence 87443211 23345678999999988889999999999999999998 99998543 4445555444332 234
Q ss_pred CCccCCHHHHHHHHHHhccCCCCCCCHHHHhc
Q 039291 242 IPSRVSKEARDFLRRCFVRKPAFRFTAEMLLD 273 (362)
Q Consensus 242 ~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~ 273 (362)
.+..++..+.+++.+||..+|++|||+.++++
T Consensus 220 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 251 (256)
T cd05082 220 APDGCPPVVYDVMKQCWHLDAATRPSFLQLRE 251 (256)
T ss_pred CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 56678999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-41 Score=297.78 Aligned_cols=251 Identities=27% Similarity=0.488 Sum_probs=209.3
Q ss_pred ceeecceecccCceEEEEEEECCCCCCCCceeeeechhh-----hhhHHHHHHHHHHHHcCCCCcccccccceeeecCCC
Q 039291 7 SWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEV-----SASASLQKEKEVFDNLNGCPFVLECFGEEITMGENG 81 (362)
Q Consensus 7 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~-----~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~~ 81 (362)
+|.+.+.||.|+||.||+|.+..++. .+++|.... .....+.+|+++++.++ |+|++++++.+...
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~----~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~~~~~~~~~~~~---- 71 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGK----LYVLKEIDLSNMSEKEREDALNEVKILKKLN-HPNIIKYYESFEEK---- 71 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCc----EEEEEEeecccCChHHHHHHHHHHHHHHhcC-CCChhheEEEEecC----
Confidence 58999999999999999999987665 455665432 35566889999999999 99999998865432
Q ss_pred ceEEEEEEEecCCCCHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEee
Q 039291 82 EMAYNLLLEYAAGGTLGDLIEKCN--GNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIAD 159 (362)
Q Consensus 82 ~~~~~lv~e~~~~~~L~~~l~~~~--~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~D 159 (362)
..+++|+||+++++|.+++.... ...+++..+..++.|++.||.|||+.|++|+||+|+||++ +.++.++|+|
T Consensus 72 -~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~----~~~~~~~l~d 146 (258)
T cd08215 72 -GKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFL----TSNGLVKLGD 146 (258)
T ss_pred -CEEEEEEEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEE----cCCCcEEECC
Confidence 45779999999999999998743 3669999999999999999999999999999999999999 6778899999
Q ss_pred cCCcccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHHcCCCCC
Q 039291 160 LGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEHSL 239 (362)
Q Consensus 160 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 239 (362)
||++....... .......|++.|+|||.+.+..++.++|+||+|+++++|++|..||...+ ...+....... ..
T Consensus 147 ~~~~~~~~~~~--~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~---~~~~~~~~~~~-~~ 220 (258)
T cd08215 147 FGISKVLSSTV--DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGEN---LLELALKILKG-QY 220 (258)
T ss_pred ccceeecccCc--ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCc---HHHHHHHHhcC-CC
Confidence 99987655432 12234578999999999988889999999999999999999999995443 34444444333 34
Q ss_pred CCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCc
Q 039291 240 PEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFV 277 (362)
Q Consensus 240 ~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~ 277 (362)
+.++..++.++.+++.+||..+|++||++.+++.||||
T Consensus 221 ~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 258 (258)
T cd08215 221 PPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQSPFI 258 (258)
T ss_pred CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCCCC
Confidence 55667889999999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-41 Score=311.92 Aligned_cols=259 Identities=23% Similarity=0.388 Sum_probs=204.0
Q ss_pred CCCCceeecceecccCceEEEEEEECCCCCC---CCceeeeechhh----hhhHHHHHHHHHHHHcCCCCccccccccee
Q 039291 3 SDGTSWFRGRVIGQGSFGCVFIAKPKSNSSF---LPPLMAVKSAEV----SASASLQKEKEVFDNLNGCPFVLECFGEEI 75 (362)
Q Consensus 3 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~---~~~~~~~K~~~~----~~~~~~~~E~~il~~l~~h~~i~~~~~~~~ 75 (362)
....+|.+++.||+|+||.||+|++...++. ....+++|.... .....+.+|+.+++++.+||||+++++.+.
T Consensus 9 ~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 88 (334)
T cd05100 9 LSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACT 88 (334)
T ss_pred cCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEc
Confidence 4567899999999999999999987543221 113567776542 234568899999999966999999998764
Q ss_pred eecCCCceEEEEEEEecCCCCHHHHHHHhc--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCC
Q 039291 76 TMGENGEMAYNLLLEYAAGGTLGDLIEKCN--------------GNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPD 141 (362)
Q Consensus 76 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--------------~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~ 141 (362)
. ...++++|||+++|+|.+++.... ...++..++..++.|++.||.|||++|++||||||+
T Consensus 89 ~-----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~ 163 (334)
T cd05100 89 Q-----DGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAAR 163 (334)
T ss_pred c-----CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccc
Confidence 2 234679999999999999997632 124788899999999999999999999999999999
Q ss_pred CEEEeecCCCceEEEEeecCCcccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHh-CCCCCcc
Q 039291 142 NILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLS-GRQAWVV 220 (362)
Q Consensus 142 Nill~~~~~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~ 220 (362)
||++ +.++.+||+|||+++...............++..|+|||++.+..++.++|||||||++|+|++ |..||..
T Consensus 164 Nill----~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~ 239 (334)
T cd05100 164 NVLV----TEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPG 239 (334)
T ss_pred eEEE----cCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCC
Confidence 9999 6677899999999875543222211223334567999999999899999999999999999998 8889854
Q ss_pred CCCCCHHHHHHHHcCCCCCCCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhcC
Q 039291 221 KEDCSIDQLFSIIGDEHSLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDD 274 (362)
Q Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~ 274 (362)
. +.......+..... +..+..++.++.+++.+||+.+|++||++.+++.+
T Consensus 240 ~---~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~ 289 (334)
T cd05100 240 I---PVEELFKLLKEGHR-MDKPANCTHELYMIMRECWHAVPSQRPTFKQLVED 289 (334)
T ss_pred C---CHHHHHHHHHcCCC-CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 3 45555555544433 33456788999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-41 Score=298.39 Aligned_cols=248 Identities=24% Similarity=0.386 Sum_probs=201.7
Q ss_pred ceecccCceEEEEEEECCCCCCCCceeeeechhhh----hhHHHHHHHHHHHHcCCCCcccccccceeeecCCCceEEEE
Q 039291 12 RVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVS----ASASLQKEKEVFDNLNGCPFVLECFGEEITMGENGEMAYNL 87 (362)
Q Consensus 12 ~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~~----~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~~~~~~~l 87 (362)
+.||+|+||.||+|.+.... .....+++|..... ..+.+.+|+++++.++ |+|++++++.+.. ...+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~-~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~-----~~~~~l 73 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKD-GKTTEVAVKTLKEDASEEERKDFLKEARVMKKLG-HPNVVRLLGVCTE-----EEPLYL 73 (262)
T ss_pred CccccCCceEEEEEEEecCC-CCCceEEeEeeccccchhHHHHHHHHHHHHhhcC-CCChheeeeeecC-----CCceEE
Confidence 57999999999999987641 11235666665432 2567889999999999 9999999987653 345779
Q ss_pred EEEecCCCCHHHHHHHhc-------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEeec
Q 039291 88 LLEYAAGGTLGDLIEKCN-------GNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADL 160 (362)
Q Consensus 88 v~e~~~~~~L~~~l~~~~-------~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Df 160 (362)
+|||+++++|.+++.... ...+++..++.++.|++.||.|||++|++|+||||+||++ +.++.++|+||
T Consensus 74 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili----~~~~~~~l~df 149 (262)
T cd00192 74 VLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLV----GEDLVVKISDF 149 (262)
T ss_pred EEEeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEE----CCCCcEEEccc
Confidence 999999999999998741 3569999999999999999999999999999999999999 77788999999
Q ss_pred CCcccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHh-CCCCCccCCCCCHHHHHHHHcCCCCC
Q 039291 161 GVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLS-GRQAWVVKEDCSIDQLFSIIGDEHSL 239 (362)
Q Consensus 161 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~ 239 (362)
|.+................++..|+|||.+....++.++||||||+++|+|++ |..||... ...+....+.... .
T Consensus 150 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~---~~~~~~~~~~~~~-~ 225 (262)
T cd00192 150 GLSRDVYDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGL---SNEEVLEYLRKGY-R 225 (262)
T ss_pred ccccccccccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCC---CHHHHHHHHHcCC-C
Confidence 99986654332222345568889999999988889999999999999999999 69999654 4445555554432 3
Q ss_pred CCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhcC
Q 039291 240 PEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDD 274 (362)
Q Consensus 240 ~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~ 274 (362)
...+..++.++.+++.+||..+|.+||++.+++++
T Consensus 226 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~ 260 (262)
T cd00192 226 LPKPEYCPDELYELMLSCWQLDPEDRPTFSELVER 260 (262)
T ss_pred CCCCccCChHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 34567789999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-41 Score=304.45 Aligned_cols=254 Identities=22% Similarity=0.396 Sum_probs=196.6
Q ss_pred ceeecceecccCceEEEEEEECCCCCCCCceeeeechhh----hhhHHHHHHHHHHHHcCCCCcccccccceeeecCCCc
Q 039291 7 SWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEV----SASASLQKEKEVFDNLNGCPFVLECFGEEITMGENGE 82 (362)
Q Consensus 7 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~----~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~~~ 82 (362)
+|.+.+.||+|++|.||+|+++.++. .+++|.... .....+.+|+.+++.++ |+||+++++.+.. .
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~----~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~-----~ 70 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGE----IVALKEIHLDAEEGTPSTAIREISLMKELK-HENIVRLHDVIHT-----E 70 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCe----EEEEEEecccccccchHHHHHHHHHHHhhc-CCCEeeeeeeEee-----C
Confidence 58899999999999999999988775 456665432 23456778999999998 8999999987653 2
Q ss_pred eEEEEEEEecCCCCHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEeecC
Q 039291 83 MAYNLLLEYAAGGTLGDLIEKCN-GNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLG 161 (362)
Q Consensus 83 ~~~~lv~e~~~~~~L~~~l~~~~-~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Dfg 161 (362)
..+++||||+++ +|.+++.... ...+++..+..++.|++.||.|||+.|++||||||+||++ ++++.++|+|||
T Consensus 71 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~----~~~~~~~l~d~g 145 (284)
T cd07836 71 NKLMLVFEYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLI----NKRGELKLADFG 145 (284)
T ss_pred CcEEEEEecCCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEE----CCCCcEEEeecc
Confidence 346799999985 8988886533 2458999999999999999999999999999999999999 777889999999
Q ss_pred CcccccccccCCCCCCccCCCCccCchhhccc-cCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHH-HHH-------
Q 039291 162 VAKRSRHCKRQKFDPSMRGTPLYLAPETVVQH-MQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQL-FSI------- 232 (362)
Q Consensus 162 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~-~~~------- 232 (362)
++........ ......++..|++||++.+. .++.++|+|||||++|+|++|+.||...+....... ...
T Consensus 146 ~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~ 223 (284)
T cd07836 146 LARAFGIPVN--TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTES 223 (284)
T ss_pred hhhhhcCCcc--ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChh
Confidence 9875433211 11345678899999998764 568899999999999999999999975543211111 100
Q ss_pred ----HcCC----CCCC--------CCCccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCc
Q 039291 233 ----IGDE----HSLP--------EIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFV 277 (362)
Q Consensus 233 ----~~~~----~~~~--------~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~ 277 (362)
+... ...+ .+...++.++++++.+||+.||.+||++.+++.||||
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~f 284 (284)
T cd07836 224 TWPGISQLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF 284 (284)
T ss_pred hHHHHhcCchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 0000 0000 0112467889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-41 Score=307.96 Aligned_cols=262 Identities=23% Similarity=0.351 Sum_probs=197.9
Q ss_pred CCceeecceecccCceEEEEEEECCCCCCCCceeeeechhh-----hhhHHHHHHHHHHHHcCCCCcccccccceeeecC
Q 039291 5 GTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEV-----SASASLQKEKEVFDNLNGCPFVLECFGEEITMGE 79 (362)
Q Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~-----~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~ 79 (362)
-++|.+.+.||+|+||.||+|+++.+++. +++|.... .....+.+|+++++.++ ||||+++++.+.....
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~----~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~ 81 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRV----VALKKILMHNEKDGFPITALREIKILKKLK-HPNVVPLIDMAVERPD 81 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcE----EEEEEEEeccCCCCcchhHHHHHHHHHhcC-CCCccchhhheecccc
Confidence 47899999999999999999999887764 45554321 12235678999999998 8999999987654221
Q ss_pred ---CCceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEE
Q 039291 80 ---NGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAK 156 (362)
Q Consensus 80 ---~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~k 156 (362)
.....+++||||+.+ +|...+... ...+++..++.++.|++.||.|||++||+|+||||+||++ +.++.++
T Consensus 82 ~~~~~~~~~~lv~~~~~~-~l~~~~~~~-~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~----~~~~~~~ 155 (311)
T cd07866 82 KSKRKRGSVYMVTPYMDH-DLSGLLENP-SVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILI----DNQGILK 155 (311)
T ss_pred cccccCceEEEEEecCCc-CHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE----CCCCCEE
Confidence 223457799999975 777777652 3469999999999999999999999999999999999999 7788999
Q ss_pred EeecCCcccccccccCC---------CCCCccCCCCccCchhhccc-cCCCcchHHHHHHHHHHHHhCCCCCccCCCCCH
Q 039291 157 IADLGVAKRSRHCKRQK---------FDPSMRGTPLYLAPETVVQH-MQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSI 226 (362)
Q Consensus 157 l~Dfgla~~~~~~~~~~---------~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~ 226 (362)
|+|||++.......... ......|++.|+|||++.+. .++.++|||||||++|+|++|++||.+......
T Consensus 156 l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~ 235 (311)
T cd07866 156 IADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQ 235 (311)
T ss_pred ECcCccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 99999997544322111 11234678899999988754 578899999999999999999999965543222
Q ss_pred HHHHHHHcCCC------------------CCCCC-------CccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCc
Q 039291 227 DQLFSIIGDEH------------------SLPEI-------PSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFV 277 (362)
Q Consensus 227 ~~~~~~~~~~~------------------~~~~~-------~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~ 277 (362)
.+......... ..... ....+.++.++|.+||..||.+|||+.+++.||||
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~~~f 311 (311)
T cd07866 236 LHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHPYF 311 (311)
T ss_pred HHHHHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcCCCC
Confidence 22211111100 00000 12345788999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-41 Score=305.18 Aligned_cols=257 Identities=21% Similarity=0.305 Sum_probs=201.5
Q ss_pred CCCceeecceecccCceEEEEEEECCCCCCC------------Cceeeeechhhh----hhHHHHHHHHHHHHcCCCCcc
Q 039291 4 DGTSWFRGRVIGQGSFGCVFIAKPKSNSSFL------------PPLMAVKSAEVS----ASASLQKEKEVFDNLNGCPFV 67 (362)
Q Consensus 4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~------------~~~~~~K~~~~~----~~~~~~~E~~il~~l~~h~~i 67 (362)
..++|.+++.||+|+||.||+|.+...+..+ ...+++|..... ....+.+|+++++++. ||||
T Consensus 3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i 81 (296)
T cd05051 3 PRQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLS-DPNI 81 (296)
T ss_pred chhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcC-CCCE
Confidence 4578999999999999999999987655432 245677775432 4456788999999998 8999
Q ss_pred cccccceeeecCCCceEEEEEEEecCCCCHHHHHHHhc---------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCC
Q 039291 68 LECFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCN---------GNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDV 138 (362)
Q Consensus 68 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---------~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dl 138 (362)
+++++.+... ..++++|||+.+++|.+++.... ...+++..++.++.|++.||.|||++||+||||
T Consensus 82 ~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dl 156 (296)
T cd05051 82 ARLLGVCTVD-----PPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDL 156 (296)
T ss_pred eEEEEEEecC-----CCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCcccccc
Confidence 9998866431 34679999999999999997643 125899999999999999999999999999999
Q ss_pred CCCCEEEeecCCCceEEEEeecCCcccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHh--CCC
Q 039291 139 KPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLS--GRQ 216 (362)
Q Consensus 139 kp~Nill~~~~~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~--g~~ 216 (362)
||+||++ +..+.++|+|||+++...............++..|+|||++.+..++.++|||||||++|+|++ +..
T Consensus 157 kp~Nili----~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~ 232 (296)
T cd05051 157 ATRNCLV----GKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQ 232 (296)
T ss_pred chhceee----cCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCC
Confidence 9999999 7778899999999875543322222334557788999999988889999999999999999998 677
Q ss_pred CCccCCCCCHHHHHHHHcCC------CCCCCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhc
Q 039291 217 AWVVKEDCSIDQLFSIIGDE------HSLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLD 273 (362)
Q Consensus 217 pf~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~ 273 (362)
||.... ..+.+..+... ......+..++.++.+++.+||..||++|||+.+++.
T Consensus 233 p~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~ 292 (296)
T cd05051 233 PYEHLT---DQQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHL 292 (296)
T ss_pred CCCCcC---hHHHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHH
Confidence 875432 23333322211 1112234457899999999999999999999999965
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-41 Score=305.68 Aligned_cols=257 Identities=23% Similarity=0.403 Sum_probs=198.4
Q ss_pred CCceeecceecccCceEEEEEEECCCCCCCCceeeeechhhh-----hhHHHHHHHHHHHHcCCCCcccccccceeeecC
Q 039291 5 GTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVS-----ASASLQKEKEVFDNLNGCPFVLECFGEEITMGE 79 (362)
Q Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~~-----~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~ 79 (362)
-+.|.+.+.||+|+||.||+|+++.++. .+++|..... ....+.+|+.+++++. ||||+++++.+...
T Consensus 4 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~----~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~-h~ni~~~~~~~~~~-- 76 (293)
T cd07843 4 VDEYEKLNRIEEGTYGVVYRARDKKTGE----IVALKKLKMEKEKEGFPITSLREINILLKLQ-HPNIVTVKEVVVGS-- 76 (293)
T ss_pred hhhhhhhhhhcCCCCeEEEEEEECCCCc----EEEEEEEeeccccccchhhHHHHHHHHHhcC-CCCEEEEEEEEEec--
Confidence 3579999999999999999999987765 4555554321 2234678999999999 99999998876432
Q ss_pred CCceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEee
Q 039291 80 NGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIAD 159 (362)
Q Consensus 80 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~D 159 (362)
....+++||||+.+ +|.+++.... ..+++..++.++.|++.||+|||++|++|+||||+||++ +.++.++|+|
T Consensus 77 -~~~~~~lv~e~~~~-~L~~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili----~~~~~~~l~d 149 (293)
T cd07843 77 -NLDKIYMVMEYVEH-DLKSLMETMK-QPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLL----NNRGILKICD 149 (293)
T ss_pred -CCCcEEEEehhcCc-CHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEE----CCCCcEEEee
Confidence 12457899999975 9999887633 359999999999999999999999999999999999999 7788899999
Q ss_pred cCCcccccccccCCCCCCccCCCCccCchhhccc-cCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHH-HHHHHcC--
Q 039291 160 LGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQH-MQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQ-LFSIIGD-- 235 (362)
Q Consensus 160 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~-~~~~~~~-- 235 (362)
||++....... .......+++.|+|||.+.+. .++.++|+||||+++|+|++|.+||.......... +......
T Consensus 150 ~g~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~ 227 (293)
T cd07843 150 FGLAREYGSPL--KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPT 227 (293)
T ss_pred cCceeeccCCc--cccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCc
Confidence 99987655421 111345578899999998764 46889999999999999999999996543221111 1110000
Q ss_pred -----------------------CCCCCCCCcc-CCHHHHHHHHHHhccCCCCCCCHHHHhcCCCc
Q 039291 236 -----------------------EHSLPEIPSR-VSKEARDFLRRCFVRKPAFRFTAEMLLDDPFV 277 (362)
Q Consensus 236 -----------------------~~~~~~~~~~-~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~ 277 (362)
......++.. +++.+.++|++||+.+|++|||+.+++.||||
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~~~f 293 (293)
T cd07843 228 EKIWPGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF 293 (293)
T ss_pred hHHHHHhhccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcCCCC
Confidence 0000112222 58889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-41 Score=304.14 Aligned_cols=260 Identities=24% Similarity=0.435 Sum_probs=206.6
Q ss_pred ceeecceecccCceEEEEEEECC---CCCCCCceeeeechhh-------hhhHHHHHHHHHHHHcCCCCcccccccceee
Q 039291 7 SWFRGRVIGQGSFGCVFIAKPKS---NSSFLPPLMAVKSAEV-------SASASLQKEKEVFDNLNGCPFVLECFGEEIT 76 (362)
Q Consensus 7 ~y~~~~~lG~G~~g~V~~a~~~~---~~~~~~~~~~~K~~~~-------~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~ 76 (362)
.|.+.+.||+|+||.||+|++.. ++ ..+++|.... ...+.+.+|+.+++.+.+|+||+++++.+..
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g----~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~ 76 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSG----KLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT 76 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCC----ceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeec
Confidence 48899999999999999998753 33 3466665432 2335677899999999889999999876532
Q ss_pred ecCCCceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEE
Q 039291 77 MGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAK 156 (362)
Q Consensus 77 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~k 156 (362)
...+++||||+++++|.+++.. ..++++..+..++.|++.||.|||+.|++||||||+|||+ +.++.++
T Consensus 77 -----~~~~~lv~e~~~~~~L~~~l~~--~~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~----~~~~~~k 145 (290)
T cd05613 77 -----DTKLHLILDYINGGELFTHLSQ--RERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILL----DSNGHVV 145 (290)
T ss_pred -----CCeEEEEEecCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEE----CCCCCEE
Confidence 2357799999999999999986 3458999999999999999999999999999999999999 7778899
Q ss_pred EeecCCcccccccccCCCCCCccCCCCccCchhhccc--cCCCcchHHHHHHHHHHHHhCCCCCccCCC-CCHHHHHHHH
Q 039291 157 IADLGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQH--MQEAPSDIWALGCVVLEMLSGRQAWVVKED-CSIDQLFSII 233 (362)
Q Consensus 157 l~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~~l~~g~~pf~~~~~-~~~~~~~~~~ 233 (362)
|+|||++........ .......|+..|+|||.+.+. .++.++||||||+++|+|++|..||..... .....+...+
T Consensus 146 l~dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~ 224 (290)
T cd05613 146 LTDFGLSKEFHEDEV-ERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRI 224 (290)
T ss_pred EeeCccceecccccc-cccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHh
Confidence 999999875433211 111245689999999998753 467889999999999999999999964332 2233333333
Q ss_pred cCCCCCCCCCccCCHHHHHHHHHHhccCCCCCC-----CHHHHhcCCCccCcchhh
Q 039291 234 GDEHSLPEIPSRVSKEARDFLRRCFVRKPAFRF-----TAEMLLDDPFVKGVDEEL 284 (362)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~-----s~~~~l~~p~~~~~~~~~ 284 (362)
... .+.++..++..+.+++++||..||++|+ ++++++.||||....++.
T Consensus 225 ~~~--~~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~~~ 278 (290)
T cd05613 225 LKS--EPPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKINWDD 278 (290)
T ss_pred hcc--CCCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcCcccccCCHHH
Confidence 222 2345667899999999999999999997 899999999999988754
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-41 Score=305.36 Aligned_cols=253 Identities=23% Similarity=0.352 Sum_probs=199.0
Q ss_pred ceeecceecccCceEEEEEEECCCCC-CCCceeeeechhh----hhhHHHHHHHHHHHHcCCCCcccccccceeeecCCC
Q 039291 7 SWFRGRVIGQGSFGCVFIAKPKSNSS-FLPPLMAVKSAEV----SASASLQKEKEVFDNLNGCPFVLECFGEEITMGENG 81 (362)
Q Consensus 7 ~y~~~~~lG~G~~g~V~~a~~~~~~~-~~~~~~~~K~~~~----~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~~ 81 (362)
+|++.+.||+|+||.||+|.+..... .....+++|.... .....+.+|+.+++.++ ||||+++++.+..
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~----- 74 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVN-HPHVIKLYGACSQ----- 74 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCC-CCCEeeEEEEEec-----
Confidence 47889999999999999998754321 1223566665432 23456888999999998 9999999986542
Q ss_pred ceEEEEEEEecCCCCHHHHHHHhc----------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCC
Q 039291 82 EMAYNLLLEYAAGGTLGDLIEKCN----------------------GNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVK 139 (362)
Q Consensus 82 ~~~~~lv~e~~~~~~L~~~l~~~~----------------------~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlk 139 (362)
....++++||+.+++|.+++.... ..++++..+..++.|++.||.|||++|++|||||
T Consensus 75 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dik 154 (290)
T cd05045 75 DGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLA 154 (290)
T ss_pred CCCcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhh
Confidence 223679999999999999987532 1347899999999999999999999999999999
Q ss_pred CCCEEEeecCCCceEEEEeecCCcccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHh-CCCCC
Q 039291 140 PDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLS-GRQAW 218 (362)
Q Consensus 140 p~Nill~~~~~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~pf 218 (362)
|+|||+ +.++.++|+|||+++...............++..|+|||++.+..++.++||||||+++++|++ |..||
T Consensus 155 p~nill----~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~ 230 (290)
T cd05045 155 ARNVLV----AEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPY 230 (290)
T ss_pred hheEEE----cCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCC
Confidence 999999 6777899999999875433222111123446778999999988889999999999999999998 99999
Q ss_pred ccCCCCCHHHHHHHHcCCCCCCCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhc
Q 039291 219 VVKEDCSIDQLFSIIGDEHSLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLD 273 (362)
Q Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~ 273 (362)
.+. ....+...+..... +..+..++.++++++.+||+.+|++||++.++++
T Consensus 231 ~~~---~~~~~~~~~~~~~~-~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~ 281 (290)
T cd05045 231 PGI---APERLFNLLKTGYR-MERPENCSEEMYNLMLTCWKQEPDKRPTFADISK 281 (290)
T ss_pred CCC---CHHHHHHHHhCCCC-CCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 543 44555555543332 2346678999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-41 Score=298.53 Aligned_cols=253 Identities=25% Similarity=0.464 Sum_probs=200.5
Q ss_pred ceeecceecccCceEEEEEEECCCCCCCCceeeeech-----hhhhhHHHHHHHHHHHHcCCCCcccccccceeeecCCC
Q 039291 7 SWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSA-----EVSASASLQKEKEVFDNLNGCPFVLECFGEEITMGENG 81 (362)
Q Consensus 7 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~-----~~~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~~ 81 (362)
||.+.+.||+|+||.||+|++..++...+. ++.|.. .......+.+|+.+++.++ ||||+++++.+..
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~----- 73 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERL-KVLKEIPVGELNPNETVQANQEAQLLSKLD-HPAIVKFHASFLE----- 73 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceE-EEeccccccccCcchHHHHHHHHHHHHhCC-CCcHHHHHHHHhc-----
Confidence 699999999999999999998876543322 223321 2223345678999999998 9999999987642
Q ss_pred ceEEEEEEEecCCCCHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEee
Q 039291 82 EMAYNLLLEYAAGGTLGDLIEKC--NGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIAD 159 (362)
Q Consensus 82 ~~~~~lv~e~~~~~~L~~~l~~~--~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~D 159 (362)
...+++|+||+++++|.+++... ....+++..++.++.|++.||.|||++|++|+||||+||++ +. +.++|+|
T Consensus 74 ~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili----~~-~~~~l~d 148 (260)
T cd08222 74 RDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFL----KN-NLLKIGD 148 (260)
T ss_pred CCceEEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEe----ec-CCEeecc
Confidence 22467999999999999988752 23569999999999999999999999999999999999999 33 3499999
Q ss_pred cCCcccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHHcCCCCC
Q 039291 160 LGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEHSL 239 (362)
Q Consensus 160 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 239 (362)
||++....... .......|++.|+|||.+.+..++.++|+||||+++|+|++|..||... ........+.. ...
T Consensus 149 ~g~~~~~~~~~--~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~---~~~~~~~~~~~-~~~ 222 (260)
T cd08222 149 FGVSRLLMGSC--DLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQ---NFLSVVLRIVE-GPT 222 (260)
T ss_pred cCceeecCCCc--ccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCc---cHHHHHHHHHc-CCC
Confidence 99987654321 1223456889999999998888899999999999999999999999533 23333333322 334
Q ss_pred CCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCc
Q 039291 240 PEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFV 277 (362)
Q Consensus 240 ~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~ 277 (362)
+..+..++.++.++|.+||..+|++||++.+++.||||
T Consensus 223 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~ 260 (260)
T cd08222 223 PSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRNPFI 260 (260)
T ss_pred CCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhCCCC
Confidence 45567789999999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-41 Score=300.58 Aligned_cols=251 Identities=26% Similarity=0.427 Sum_probs=200.2
Q ss_pred CceeecceecccCceEEEEEEECCCCCCCCceeeeechh------hhhhHHHHHHHHHHHHcCCCCcccccccceeeecC
Q 039291 6 TSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAE------VSASASLQKEKEVFDNLNGCPFVLECFGEEITMGE 79 (362)
Q Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~------~~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~ 79 (362)
++|.+.+.||+|++|.||+|+++.++. .+++|... ......+.+|+.+++.++ |+||+++++.+..
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~----~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~-h~~i~~~~~~~~~--- 73 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGV----PVALKKVQIFDLMDAKARADCIKEIDLLKQLN-HPNVIKYYASFIE--- 73 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCc----eEEEEeeeehhhhhHHHHHHHHHHHHHHHHcc-CCchhhhhheeEe---
Confidence 578999999999999999999887765 45555432 223456788999999998 9999999987653
Q ss_pred CCceEEEEEEEecCCCCHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEE
Q 039291 80 NGEMAYNLLLEYAAGGTLGDLIEKC--NGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKI 157 (362)
Q Consensus 80 ~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl 157 (362)
...++++|||+++++|.+++... ....+++..++.++.|++.||.|||++|++|+||||+||++ +.++.++|
T Consensus 74 --~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili----~~~~~~~l 147 (267)
T cd08229 74 --DNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFI----TATGVVKL 147 (267)
T ss_pred --CCeEEEEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE----cCCCCEEE
Confidence 23467999999999999998742 23458999999999999999999999999999999999999 67778999
Q ss_pred eecCCcccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHHcCCC
Q 039291 158 ADLGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEH 237 (362)
Q Consensus 158 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 237 (362)
+|||++........ ......|+..|+|||++.+..++.++|+||||+++|+|++|..||..... +.......+....
T Consensus 148 ~dfg~~~~~~~~~~--~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-~~~~~~~~~~~~~ 224 (267)
T cd08229 148 GDLGLGRFFSSKTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM-NLYSLCKKIEQCD 224 (267)
T ss_pred CcchhhhccccCCc--ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccc-hHHHHhhhhhcCC
Confidence 99999875543211 11345689999999999888899999999999999999999999965432 2334434443332
Q ss_pred CCCCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhc
Q 039291 238 SLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLD 273 (362)
Q Consensus 238 ~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~ 273 (362)
..+..+..++.++++++.+||..+|++|||+.++++
T Consensus 225 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~ 260 (267)
T cd08229 225 YPPLPSDHYSEELRQLVNMCINPDPEKRPDITYVYD 260 (267)
T ss_pred CCCCCcccccHHHHHHHHHhcCCCcccCCCHHHHHH
Confidence 222333468899999999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-41 Score=300.59 Aligned_cols=248 Identities=20% Similarity=0.329 Sum_probs=201.7
Q ss_pred CCceeecceecccCceEEEEEEECCCCCCCCceeeeechhhh---hhHHHHHHHHHHHHcCCCCcccccccceeeecCCC
Q 039291 5 GTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVS---ASASLQKEKEVFDNLNGCPFVLECFGEEITMGENG 81 (362)
Q Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~~---~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~~ 81 (362)
...|.+++.||.|+||.||+|+++. +. .+++|..... ....+.+|+.+++.++ |+||+++++.+..
T Consensus 5 ~~~y~~~~~ig~g~~~~vy~~~~~~-~~----~~~~k~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~----- 73 (261)
T cd05148 5 REEFTLERKLGSGYFGEVWEGLWKN-RV----RVAIKILKSDDLLKQQDFQKEVQALKRLR-HKHLISLFAVCSV----- 73 (261)
T ss_pred HHHHHHhhhhccCCCccEEEeEecC-CC----cEEEEeccccchhhHHHHHHHHHHHhcCC-CcchhheeeeEec-----
Confidence 4579999999999999999999987 43 3555554322 3456889999999998 8999999886542
Q ss_pred ceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEeecC
Q 039291 82 EMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLG 161 (362)
Q Consensus 82 ~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Dfg 161 (362)
...+++||||+++++|.+++....+..+++..++.++.|++.||.|||++|++|+||||+||++ +.++.+||+|||
T Consensus 74 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv----~~~~~~kl~d~g 149 (261)
T cd05148 74 GEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILV----GEDLVCKVADFG 149 (261)
T ss_pred CCCeEEEEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEE----cCCceEEEcccc
Confidence 2346799999999999999987656679999999999999999999999999999999999999 777889999999
Q ss_pred CcccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHh-CCCCCccCCCCCHHHHHHHHcCCCCCC
Q 039291 162 VAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLS-GRQAWVVKEDCSIDQLFSIIGDEHSLP 240 (362)
Q Consensus 162 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 240 (362)
++......... .....++..|+|||++.+..++.++|+||||+++|+|++ |+.||.... ..+....+.... .+
T Consensus 150 ~~~~~~~~~~~--~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~---~~~~~~~~~~~~-~~ 223 (261)
T cd05148 150 LARLIKEDVYL--SSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMN---NHEVYDQITAGY-RM 223 (261)
T ss_pred chhhcCCcccc--ccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCC---HHHHHHHHHhCC-cC
Confidence 98755432111 123446778999999988889999999999999999998 899995443 444444444332 23
Q ss_pred CCCccCCHHHHHHHHHHhccCCCCCCCHHHHhc
Q 039291 241 EIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLD 273 (362)
Q Consensus 241 ~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~ 273 (362)
..+..++.++.+++.+||..||.+|||+.++++
T Consensus 224 ~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~ 256 (261)
T cd05148 224 PCPAKCPQEIYKIMLECWAAEPEDRPSFKALRE 256 (261)
T ss_pred CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 445678999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-41 Score=302.40 Aligned_cols=253 Identities=28% Similarity=0.440 Sum_probs=203.3
Q ss_pred ceeecceecccCceEEEEEEECCCCCCCCceeeeechh---hhhhHHHHHHHHHHHHcCCCCcccccccceeeecCCCce
Q 039291 7 SWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAE---VSASASLQKEKEVFDNLNGCPFVLECFGEEITMGENGEM 83 (362)
Q Consensus 7 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~---~~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~~~~ 83 (362)
.|...+.||+|++|.||+|.++.++. .+++|... ....+.+.+|+.+++.++ ||||+++++.+.. ..
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~----~~~iK~~~~~~~~~~~~~~~e~~~l~~~~-h~~vv~~~~~~~~-----~~ 89 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGR----QVAVKKMDLRKQQRRELLFNEVVIMRDYQ-HPNIVEMYSSYLV-----GD 89 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCC----EEEEEEEeccchhHHHHHHHHHHHHHHcC-CCChheEEEEEEc-----CC
Confidence 56667899999999999999887765 45555432 233455788999999998 8999999986642 23
Q ss_pred EEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEeecCCc
Q 039291 84 AYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVA 163 (362)
Q Consensus 84 ~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Dfgla 163 (362)
..++++||+.|++|.+++.. .++++..+..++.|++.||+|||++||+||||+|+||++ +.++.++|+|||++
T Consensus 90 ~~~~v~e~~~~~~L~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~----~~~~~~~l~d~g~~ 162 (285)
T cd06648 90 ELWVVMEFLEGGALTDIVTH---TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILL----TSDGRVKLSDFGFC 162 (285)
T ss_pred eEEEEEeccCCCCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEE----cCCCcEEEcccccc
Confidence 46799999999999999876 359999999999999999999999999999999999999 77788999999987
Q ss_pred ccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHHcCCC-CCCCC
Q 039291 164 KRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEH-SLPEI 242 (362)
Q Consensus 164 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~-~~~~~ 242 (362)
........ ......|+..|+|||.+.+..++.++|+|||||++|+|++|+.||... +.......+.... .....
T Consensus 163 ~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~---~~~~~~~~~~~~~~~~~~~ 237 (285)
T cd06648 163 AQVSKEVP--RRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNE---PPLQAMKRIRDNLPPKLKN 237 (285)
T ss_pred hhhccCCc--ccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCC---CHHHHHHHHHhcCCCCCcc
Confidence 65433211 113456899999999998888999999999999999999999999643 3333333333221 11112
Q ss_pred CccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCccCcc
Q 039291 243 PSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGVD 281 (362)
Q Consensus 243 ~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~~~~~ 281 (362)
+..++..+.+++.+||..+|++||++.+++.||||+...
T Consensus 238 ~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~ 276 (285)
T cd06648 238 LHKVSPRLRSFLDRMLVRDPAQRATAAELLNHPFLAKAG 276 (285)
T ss_pred cccCCHHHHHHHHHHcccChhhCcCHHHHccCcccccCC
Confidence 334789999999999999999999999999999998754
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-41 Score=298.48 Aligned_cols=250 Identities=18% Similarity=0.279 Sum_probs=198.4
Q ss_pred CCCceeecceecccCceEEEEEEECCCCCCCCceeeeechhhh--hhHHHHHHHHHHHHcCCCCcccccccceeeecCCC
Q 039291 4 DGTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVS--ASASLQKEKEVFDNLNGCPFVLECFGEEITMGENG 81 (362)
Q Consensus 4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~~--~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~~ 81 (362)
+..+|.+.+.||+|+||+||+|++.... .+++|..... ....+.+|+.++++++ ||||+++++.+..
T Consensus 2 ~~~~~~~~~~lg~G~~~~vy~~~~~~~~-----~~aik~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~----- 70 (256)
T cd05113 2 DPKDLTFLKELGTGQFGVVKYGKWRGQY-----DVAIKMIKEGSMSEDEFIEEAKVMMKLS-HEKLVQLYGVCTK----- 70 (256)
T ss_pred ChHHeEEeeEecCcccceEEEEEecCCC-----cEEEEEcCCCcccHHHHHHHHHHHhcCC-CCCeeeEEEEEcc-----
Confidence 3467999999999999999999876542 3566654432 2456889999999998 9999999987632
Q ss_pred ceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEeecC
Q 039291 82 EMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLG 161 (362)
Q Consensus 82 ~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Dfg 161 (362)
...++++|||+.+++|.+++.... ..+++..++.++.|++.||.|||+.|++|+||||+||++ +.++.+||+|||
T Consensus 71 ~~~~~lv~e~~~~~~l~~~i~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili----~~~~~~kl~d~g 145 (256)
T cd05113 71 QRPIYIVTEYMSNGCLLNYLREHG-KRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLV----DDQGCVKVSDFG 145 (256)
T ss_pred CCCcEEEEEcCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEE----cCCCCEEECCCc
Confidence 224679999999999999997633 368999999999999999999999999999999999999 777789999999
Q ss_pred CcccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHh-CCCCCccCCCCCHHHHHHHHcCCCCCC
Q 039291 162 VAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLS-GRQAWVVKEDCSIDQLFSIIGDEHSLP 240 (362)
Q Consensus 162 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 240 (362)
+++....... .......++..|+|||++.+..++.++|||||||++|+|++ |..||.... .......+..... +
T Consensus 146 ~~~~~~~~~~-~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~---~~~~~~~~~~~~~-~ 220 (256)
T cd05113 146 LSRYVLDDEY-TSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFN---NSETVEKVSQGLR-L 220 (256)
T ss_pred cceecCCCce-eecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCC---HHHHHHHHhcCCC-C
Confidence 9875432211 11122345678999999988889999999999999999998 999995433 3334444433332 2
Q ss_pred CCCccCCHHHHHHHHHHhccCCCCCCCHHHHhcC
Q 039291 241 EIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDD 274 (362)
Q Consensus 241 ~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~ 274 (362)
..+...+..+++++.+||..+|++||++.+++.+
T Consensus 221 ~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~ 254 (256)
T cd05113 221 YRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSS 254 (256)
T ss_pred CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHh
Confidence 3455678999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-41 Score=302.76 Aligned_cols=262 Identities=26% Similarity=0.476 Sum_probs=204.9
Q ss_pred ceeecceecccCceEEEEEEECCCCCCCCceeeeechhh-------hhhHHHHHHHHHHHHcCCCCcccccccceeeecC
Q 039291 7 SWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEV-------SASASLQKEKEVFDNLNGCPFVLECFGEEITMGE 79 (362)
Q Consensus 7 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~-------~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~ 79 (362)
+|.+.+.||+|+||.||+|++..... ....+++|.... .....+.+|+.++.++.+||||+++++.+..
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~-~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~--- 76 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHD-AGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQT--- 76 (288)
T ss_pred CceEEEEeccCCCceEEEEEEecccc-CCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeec---
Confidence 48899999999999999998653211 123455665432 2335577899999999889999999876532
Q ss_pred CCceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEee
Q 039291 80 NGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIAD 159 (362)
Q Consensus 80 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~D 159 (362)
...+++||||+.+++|.+++.. ...+++..++.++.|++.||.|||+.|++|+||||.||++ +.++.++|+|
T Consensus 77 --~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~----~~~~~~~l~d 148 (288)
T cd05583 77 --DTKLHLILDYVNGGELFTHLYQ--REHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILL----DSEGHVVLTD 148 (288)
T ss_pred --CCEEEEEEecCCCCcHHHHHhh--cCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEE----CCCCCEEEEE
Confidence 2357799999999999999876 3459999999999999999999999999999999999999 7777899999
Q ss_pred cCCcccccccccCCCCCCccCCCCccCchhhcccc--CCCcchHHHHHHHHHHHHhCCCCCccCCCCC-HHHHHHHHcCC
Q 039291 160 LGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHM--QEAPSDIWALGCVVLEMLSGRQAWVVKEDCS-IDQLFSIIGDE 236 (362)
Q Consensus 160 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwslG~il~~l~~g~~pf~~~~~~~-~~~~~~~~~~~ 236 (362)
||++....... ........|+..|+|||.+.+.. .+.++|+||||+++|+|++|..||....... ..+....+...
T Consensus 149 fg~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~ 227 (288)
T cd05583 149 FGLSKEFLAEE-EERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKS 227 (288)
T ss_pred Ccccccccccc-ccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHcc
Confidence 99987544321 11123456899999999987654 7889999999999999999999996433222 22333333222
Q ss_pred CCCCCCCccCCHHHHHHHHHHhccCCCCCCC---HHHHhcCCCccCcchh
Q 039291 237 HSLPEIPSRVSKEARDFLRRCFVRKPAFRFT---AEMLLDDPFVKGVDEE 283 (362)
Q Consensus 237 ~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s---~~~~l~~p~~~~~~~~ 283 (362)
.+..+..++.++.++|.+||..||++||| +.++++||||+.+.+.
T Consensus 228 --~~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~~~~~ 275 (288)
T cd05583 228 --KPPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQGIDWD 275 (288)
T ss_pred --CCCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCcccccCCHH
Confidence 23456678899999999999999999998 5778999999998775
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-41 Score=299.26 Aligned_cols=251 Identities=22% Similarity=0.363 Sum_probs=202.2
Q ss_pred CCCCCceeecceecccCceEEEEEEECCCCCCCCceeeeechhhh--hhHHHHHHHHHHHHcCCCCcccccccceeeecC
Q 039291 2 DSDGTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVS--ASASLQKEKEVFDNLNGCPFVLECFGEEITMGE 79 (362)
Q Consensus 2 ~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~~--~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~ 79 (362)
.+..++|.+++.||+|+||.||+|.++.+. .+++|..... ....+.+|+.++++++ |+||+++++...
T Consensus 2 ~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~-----~~a~K~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~---- 71 (260)
T cd05067 2 EVPRETLKLVKKLGAGQFGEVWMGYYNGHT-----KVAIKSLKQGSMSPEAFLAEANLMKQLQ-HPRLVRLYAVVT---- 71 (260)
T ss_pred ccchHHceeeeeeccCccceEEeeecCCCc-----eEEEEEecCCCCcHHHHHHHHHHHHhcC-CcCeeeEEEEEc----
Confidence 456789999999999999999999876542 4677765432 3356889999999998 899999987542
Q ss_pred CCceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEee
Q 039291 80 NGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIAD 159 (362)
Q Consensus 80 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~D 159 (362)
...++++|||+.+++|.+++....+..+++..+..++.|++.||+|||+.|++||||||+||++ +.++.++|+|
T Consensus 72 --~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i----~~~~~~~l~d 145 (260)
T cd05067 72 --QEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILV----SETLCCKIAD 145 (260)
T ss_pred --cCCcEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEE----cCCCCEEEcc
Confidence 1236799999999999999977555679999999999999999999999999999999999999 7778899999
Q ss_pred cCCcccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHh-CCCCCccCCCCCHHHHHHHHcCCCC
Q 039291 160 LGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLS-GRQAWVVKEDCSIDQLFSIIGDEHS 238 (362)
Q Consensus 160 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~ 238 (362)
||++........ .......++..|+|||++....++.++||||||+++|+|++ |++||...+ ..+....+.....
T Consensus 146 fg~~~~~~~~~~-~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~---~~~~~~~~~~~~~ 221 (260)
T cd05067 146 FGLARLIEDNEY-TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMT---NPEVIQNLERGYR 221 (260)
T ss_pred CcceeecCCCCc-ccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCC---hHHHHHHHHcCCC
Confidence 999875542111 11123446778999999988889999999999999999999 999996543 3333444433322
Q ss_pred CCCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhc
Q 039291 239 LPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLD 273 (362)
Q Consensus 239 ~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~ 273 (362)
+..+...+.++.+++.+||..+|++||++++++.
T Consensus 222 -~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05067 222 -MPRPDNCPEELYELMRLCWKEKPEERPTFEYLRS 255 (260)
T ss_pred -CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 2455678899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=296.78 Aligned_cols=243 Identities=23% Similarity=0.350 Sum_probs=192.4
Q ss_pred ceecccCceEEEEEEECCCCCCCCceeeeechhhh-----hhHHHHHHHHHHHHcCCCCcccccccceeeecCCCceEEE
Q 039291 12 RVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVS-----ASASLQKEKEVFDNLNGCPFVLECFGEEITMGENGEMAYN 86 (362)
Q Consensus 12 ~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~~-----~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~~~~~~~ 86 (362)
+.||+|+||.||+|.++.... ...+++|..... ..+.+.+|+.+++.+. ||||+++++.+. ...++
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~--~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~------~~~~~ 71 (257)
T cd05116 1 GELGSGNFGTVKKGMYKMKKS--EKTVAVKILKNDNNDPALKDELLREANVMQQLD-NPYIVRMIGICE------AESWM 71 (257)
T ss_pred CcCCCcCCcceEEeEEecCCC--ceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCC-CCCcceEEEEEc------CCCcE
Confidence 369999999999997643221 235677765322 3456888999999998 899999988542 12357
Q ss_pred EEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEeecCCcccc
Q 039291 87 LLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRS 166 (362)
Q Consensus 87 lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Dfgla~~~ 166 (362)
+||||+++++|.+++.. ...+++..+..++.|++.||+|||++||+||||||.||++ +.++.++|+|||++...
T Consensus 72 lv~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill----~~~~~~kl~Dfg~~~~~ 145 (257)
T cd05116 72 LVMELAELGPLNKFLQK--NKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLL----VTQHYAKISDFGLSKAL 145 (257)
T ss_pred EEEecCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEE----cCCCeEEECCCcccccc
Confidence 99999999999999976 3459999999999999999999999999999999999999 77788999999998765
Q ss_pred cccccCC-CCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHh-CCCCCccCCCCCHHHHHHHHcCCCCCCCCCc
Q 039291 167 RHCKRQK-FDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLS-GRQAWVVKEDCSIDQLFSIIGDEHSLPEIPS 244 (362)
Q Consensus 167 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (362)
....... ......++..|+|||.+....++.++|+|||||++|||++ |..||... ........+.... .+..+.
T Consensus 146 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~---~~~~~~~~i~~~~-~~~~~~ 221 (257)
T cd05116 146 GADENYYKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGM---KGNEVTQMIESGE-RMECPQ 221 (257)
T ss_pred CCCCCeeeecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCC---CHHHHHHHHHCCC-CCCCCC
Confidence 4322111 1122334678999999988888999999999999999998 99999644 3344455554443 345677
Q ss_pred cCCHHHHHHHHHHhccCCCCCCCHHHHhc
Q 039291 245 RVSKEARDFLRRCFVRKPAFRFTAEMLLD 273 (362)
Q Consensus 245 ~~~~~~~~li~~~l~~~p~~R~s~~~~l~ 273 (362)
.++.++.++|.+||+.||++||+++++..
T Consensus 222 ~~~~~l~~li~~~~~~~p~~Rp~~~~i~~ 250 (257)
T cd05116 222 RCPPEMYDLMKLCWTYGVDERPGFAVVEL 250 (257)
T ss_pred CCCHHHHHHHHHHhccCchhCcCHHHHHH
Confidence 89999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-41 Score=297.58 Aligned_cols=250 Identities=19% Similarity=0.299 Sum_probs=197.3
Q ss_pred CCCceeecceecccCceEEEEEEECCCCCCCCceeeeechhhh--hhHHHHHHHHHHHHcCCCCcccccccceeeecCCC
Q 039291 4 DGTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVS--ASASLQKEKEVFDNLNGCPFVLECFGEEITMGENG 81 (362)
Q Consensus 4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~~--~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~~ 81 (362)
+..+|.+.+.||+|+||.||+|+++.++ .+++|..... ....+.+|+.+++.++ ||||+++++.+..
T Consensus 2 ~~~~~~~~~~lg~G~~~~v~~~~~~~~~-----~~~iK~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~----- 70 (256)
T cd05059 2 DPSELTFLKELGSGQFGVVHLGKWRGKI-----DVAIKMIREGAMSEDDFIEEAKVMMKLS-HPNLVQLYGVCTK----- 70 (256)
T ss_pred ChHHcchhhhhccCCCceEEEeEecCCc-----cEEEEEeccCCCCHHHHHHHHHHHHhCC-CCCEEEEEEEEcC-----
Confidence 3467899999999999999999886532 3566654322 3346788999999998 8999999886532
Q ss_pred ceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEeecC
Q 039291 82 EMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLG 161 (362)
Q Consensus 82 ~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Dfg 161 (362)
....++||||++|++|.+++.... ..+++..+..++.|++.||.|||++|++||||||+||++ +.++.+||+|||
T Consensus 71 ~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i----~~~~~~kl~dfg 145 (256)
T cd05059 71 QRPIFIVTEYMANGCLLNYLRERK-GKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLV----GEDNVVKVSDFG 145 (256)
T ss_pred CCceEEEEecCCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEE----CCCCcEEECCcc
Confidence 234679999999999999997633 368999999999999999999999999999999999999 777889999999
Q ss_pred CcccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHh-CCCCCccCCCCCHHHHHHHHcCCCCCC
Q 039291 162 VAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLS-GRQAWVVKEDCSIDQLFSIIGDEHSLP 240 (362)
Q Consensus 162 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 240 (362)
+++........ ......++..|+|||.+.+..++.++|+||||+++|+|++ |..||.... ..+....+.... ..
T Consensus 146 ~~~~~~~~~~~-~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~---~~~~~~~~~~~~-~~ 220 (256)
T cd05059 146 LARYVLDDQYT-SSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFS---NSEVVESVSAGY-RL 220 (256)
T ss_pred cceeccccccc-ccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCC---HHHHHHHHHcCC-cC
Confidence 98754321111 1112224457999999998889999999999999999999 899996543 233344443332 22
Q ss_pred CCCccCCHHHHHHHHHHhccCCCCCCCHHHHhcC
Q 039291 241 EIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDD 274 (362)
Q Consensus 241 ~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~ 274 (362)
..+..++.++.+++.+||..+|++|||+.++++.
T Consensus 221 ~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~ 254 (256)
T cd05059 221 YRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQ 254 (256)
T ss_pred CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence 3455689999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-41 Score=310.62 Aligned_cols=264 Identities=22% Similarity=0.377 Sum_probs=201.7
Q ss_pred ceeecceecccCceEEEEEEECCC--CCCCCceeeeechhhh-----hhHHHHHHHHHHHHcCCCCcccccccceeeecC
Q 039291 7 SWFRGRVIGQGSFGCVFIAKPKSN--SSFLPPLMAVKSAEVS-----ASASLQKEKEVFDNLNGCPFVLECFGEEITMGE 79 (362)
Q Consensus 7 ~y~~~~~lG~G~~g~V~~a~~~~~--~~~~~~~~~~K~~~~~-----~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~ 79 (362)
+|.+.+.||+|+||.||+|++..+ +. .+++|..... ....+.+|+.+++++.+||||+++++......
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~----~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~- 75 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEE----TVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFP- 75 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCc----eEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeecc-
Confidence 588999999999999999999876 43 5666654321 23457789999999987999999988654322
Q ss_pred CCceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEee
Q 039291 80 NGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIAD 159 (362)
Q Consensus 80 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~D 159 (362)
.....+++++||+. ++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.++|+|
T Consensus 76 ~~~~~~~~~~e~~~-~~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili----~~~~~~kl~D 148 (332)
T cd07857 76 GNFNELYLYEELME-ADLHQIIRS--GQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLV----NADCELKICD 148 (332)
T ss_pred ccCCcEEEEEeccc-CCHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEE----cCCCCEEeCc
Confidence 22345678899986 589998865 4569999999999999999999999999999999999999 7778899999
Q ss_pred cCCcccccccccC--CCCCCccCCCCccCchhhcc-ccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCH----------
Q 039291 160 LGVAKRSRHCKRQ--KFDPSMRGTPLYLAPETVVQ-HMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSI---------- 226 (362)
Q Consensus 160 fgla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~---------- 226 (362)
||++......... .......||..|+|||++.+ ..++.++|+||+||++|+|++|.+||...+....
T Consensus 149 fg~a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 228 (332)
T cd07857 149 FGLARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGT 228 (332)
T ss_pred CCCceecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCC
Confidence 9999755432211 11234578999999998875 4688999999999999999999999965431110
Q ss_pred --HHHHHHHc------------C--CCCCCCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCccCcch
Q 039291 227 --DQLFSIIG------------D--EHSLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGVDE 282 (362)
Q Consensus 227 --~~~~~~~~------------~--~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~~~~~~ 282 (362)
......+. . ...++......+..+++++.+||+.||++|||+.+++.|||++.+..
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~~~~~ 300 (332)
T cd07857 229 PDEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAIWHD 300 (332)
T ss_pred CCHHHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhhhhcC
Confidence 00000000 0 01111222346789999999999999999999999999999977643
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-41 Score=302.13 Aligned_cols=256 Identities=22% Similarity=0.358 Sum_probs=199.3
Q ss_pred CCCceeecceecccCceEEEEEEECCC-CCCCCceeeeechhh---hhhHHHHHHHHHHHHcCCCCcccccccceeeecC
Q 039291 4 DGTSWFRGRVIGQGSFGCVFIAKPKSN-SSFLPPLMAVKSAEV---SASASLQKEKEVFDNLNGCPFVLECFGEEITMGE 79 (362)
Q Consensus 4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~-~~~~~~~~~~K~~~~---~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~ 79 (362)
...+|...++||+|+||.||+|+.... .......+++|.... .....+.+|+++++.++ |+||+++++.+..
T Consensus 3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~--- 78 (280)
T cd05092 3 KRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQ-HQHIVRFYGVCTE--- 78 (280)
T ss_pred ChHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCC-CCCCceEEEEEec---
Confidence 457889999999999999999975432 111123556665432 34456889999999998 8999999886542
Q ss_pred CCceEEEEEEEecCCCCHHHHHHHhcC-------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEe
Q 039291 80 NGEMAYNLLLEYAAGGTLGDLIEKCNG-------------NGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLV 146 (362)
Q Consensus 80 ~~~~~~~lv~e~~~~~~L~~~l~~~~~-------------~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~ 146 (362)
...++++|||+++++|.+++..... ..+++..+..++.|++.||+|||+.|++||||||+|||+
T Consensus 79 --~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~- 155 (280)
T cd05092 79 --GRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLV- 155 (280)
T ss_pred --CCceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEE-
Confidence 2346799999999999999976321 248899999999999999999999999999999999999
Q ss_pred ecCCCceEEEEeecCCcccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHh-CCCCCccCCCCC
Q 039291 147 ATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLS-GRQAWVVKEDCS 225 (362)
Q Consensus 147 ~~~~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~ 225 (362)
+.++.++|+|||++................+++.|+|||++.+..++.++|||||||++|+|++ |.+||... .
T Consensus 156 ---~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~---~ 229 (280)
T cd05092 156 ---GQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQL---S 229 (280)
T ss_pred ---cCCCCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccC---C
Confidence 6778899999999875443222222223445788999999998889999999999999999998 99999543 2
Q ss_pred HHHHHHHHcCCCCCCCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhc
Q 039291 226 IDQLFSIIGDEHSLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLD 273 (362)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~ 273 (362)
.......+..... +..+..+++.+.+++.+||..||++||++++++.
T Consensus 230 ~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~ 276 (280)
T cd05092 230 NTEAIECITQGRE-LERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHS 276 (280)
T ss_pred HHHHHHHHHcCcc-CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 3333333333322 2345678999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=296.99 Aligned_cols=250 Identities=26% Similarity=0.462 Sum_probs=201.8
Q ss_pred CceeecceecccCceEEEEEEECCCCCCCCceeeeechh------hhhhHHHHHHHHHHHHcCCCCcccccccceeeecC
Q 039291 6 TSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAE------VSASASLQKEKEVFDNLNGCPFVLECFGEEITMGE 79 (362)
Q Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~------~~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~ 79 (362)
++|.+.+.||+|+||.||+|.+..++. .+++|... ....+.+.+|++++++++ |++++++++.+..
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~----~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~-~~~i~~~~~~~~~--- 73 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGR----VVALKKVQIFEMMDAKARQDCLKEIDLLKQLD-HPNVIKYLASFIE--- 73 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCC----EEEEEEeecccccchhhHHHHHHHHHHHHhCC-CCCeeeeeeeeec---
Confidence 689999999999999999999987765 34555432 223567889999999998 8999999987653
Q ss_pred CCceEEEEEEEecCCCCHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEE
Q 039291 80 NGEMAYNLLLEYAAGGTLGDLIEKC--NGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKI 157 (362)
Q Consensus 80 ~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl 157 (362)
...+++||||+++++|.+++... ....+++..+..++.|++.||.|||+.||+|+||+|+||++ +.++.++|
T Consensus 74 --~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~----~~~~~~~l 147 (267)
T cd08224 74 --NNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFI----TATGVVKL 147 (267)
T ss_pred --CCeEEEEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEE----CCCCcEEE
Confidence 23467999999999999998753 23458999999999999999999999999999999999999 77788999
Q ss_pred eecCCcccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHHcCCC
Q 039291 158 ADLGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEH 237 (362)
Q Consensus 158 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 237 (362)
+|||++........ ......++..|+|||.+.+..++.++|+|||||++|+|++|+.||.... .+.......+....
T Consensus 148 ~d~~~~~~~~~~~~--~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~-~~~~~~~~~~~~~~ 224 (267)
T cd08224 148 GDLGLGRFFSSKTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK-MNLYSLCKKIEKCD 224 (267)
T ss_pred eccceeeeccCCCc--ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCC-ccHHHHHhhhhcCC
Confidence 99999875443211 1234568999999999998889999999999999999999999996543 23334444443332
Q ss_pred CCCCCCc-cCCHHHHHHHHHHhccCCCCCCCHHHHhc
Q 039291 238 SLPEIPS-RVSKEARDFLRRCFVRKPAFRFTAEMLLD 273 (362)
Q Consensus 238 ~~~~~~~-~~~~~~~~li~~~l~~~p~~R~s~~~~l~ 273 (362)
. +..+. .++.+++++|.+||..+|++||++.++++
T Consensus 225 ~-~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~ 260 (267)
T cd08224 225 Y-PPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQ 260 (267)
T ss_pred C-CCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 2 33333 68889999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-41 Score=302.14 Aligned_cols=251 Identities=26% Similarity=0.460 Sum_probs=197.0
Q ss_pred eeecceecccCceEEEEEEECCCCCCCCceeeeechhh-----hhhHHHHHHHHHHHHcCCCCcccccccceeeecCCCc
Q 039291 8 WFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEV-----SASASLQKEKEVFDNLNGCPFVLECFGEEITMGENGE 82 (362)
Q Consensus 8 y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~-----~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~~~ 82 (362)
|.+.+.||.|++|.||+|.++.++. .+++|.... .....+.+|+.+++.++ |||++++++.+.. .
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~----~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~-~~~iv~~~~~~~~-----~ 70 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGE----IVALKKIRLETEDEGVPSTAIREISLLKELN-HPNIVRLLDVVHS-----E 70 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCC----EEEEEEeecccccccchhHHHHHHHHHHhcC-CCCccCHhheecc-----C
Confidence 6788999999999999999987765 456665432 22355778999999999 9999999987642 2
Q ss_pred eEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEeecCC
Q 039291 83 MAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGV 162 (362)
Q Consensus 83 ~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Dfgl 162 (362)
...+++|||++ ++|.+++.......+++..+..++.|++.||+|||+++++|+||+|+||++ +.++.++|+|||+
T Consensus 71 ~~~~iv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~----~~~~~~~l~df~~ 145 (283)
T cd07835 71 NKLYLVFEFLD-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLI----DREGALKLADFGL 145 (283)
T ss_pred CeEEEEEeccC-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEE----cCCCcEEEeeccc
Confidence 45779999995 699999987544469999999999999999999999999999999999999 6678899999999
Q ss_pred cccccccccCCCCCCccCCCCccCchhhccc-cCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHHcC------
Q 039291 163 AKRSRHCKRQKFDPSMRGTPLYLAPETVVQH-MQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGD------ 235 (362)
Q Consensus 163 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~------ 235 (362)
+......... .....++..|+|||++.+. .++.++|+||||+++|+|++|++||...+. ..+.......
T Consensus 146 ~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~--~~~~~~~~~~~~~~~~ 221 (283)
T cd07835 146 ARAFGVPVRT--YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSE--IDQLFRIFRTLGTPDE 221 (283)
T ss_pred ccccCCCccc--cCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHHHhCCCCh
Confidence 8754332111 1234578899999988764 568899999999999999999999965432 1111111100
Q ss_pred --------------------CCCCCCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCc
Q 039291 236 --------------------EHSLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFV 277 (362)
Q Consensus 236 --------------------~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~ 277 (362)
..........++.++.++|.+||+.+|.+||++++++.||||
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~ 283 (283)
T cd07835 222 DVWPGVTSLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF 283 (283)
T ss_pred HHhhhhhhchhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCCCC
Confidence 001112234577899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-41 Score=301.51 Aligned_cols=259 Identities=23% Similarity=0.372 Sum_probs=199.6
Q ss_pred CCceeecceecccCceEEEEEEECCCCCCCCceeeeechhh----hhhHHHHHHHHHHHHcCCCCcccccccceeeecCC
Q 039291 5 GTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEV----SASASLQKEKEVFDNLNGCPFVLECFGEEITMGEN 80 (362)
Q Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~----~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~ 80 (362)
+.-|++.+.||+|+||.||+|+....+......+++|.... .....+.+|+.+++.++ |||++++++.+.. .
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~---~ 78 (284)
T cd05079 3 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLY-HENIVKYKGICTE---D 78 (284)
T ss_pred hhhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCC-CCCeeeeeeEEec---C
Confidence 45678999999999999999986544333345778887642 23456889999999998 8999999886643 2
Q ss_pred CceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEeec
Q 039291 81 GEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADL 160 (362)
Q Consensus 81 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Df 160 (362)
....+++||||++|++|.+++... ...+++..+..++.|++.||+|||++|++||||||+||++ +.++.++|+||
T Consensus 79 ~~~~~~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~----~~~~~~~l~df 153 (284)
T cd05079 79 GGNGIKLIMEFLPSGSLKEYLPRN-KNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLV----ESEHQVKIGDF 153 (284)
T ss_pred CCCceEEEEEccCCCCHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEE----cCCCCEEECCC
Confidence 234467999999999999999763 2358999999999999999999999999999999999999 66778999999
Q ss_pred CCcccccccccC-CCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHhCCCCCccCC------------CCCHH
Q 039291 161 GVAKRSRHCKRQ-KFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKE------------DCSID 227 (362)
Q Consensus 161 gla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~------------~~~~~ 227 (362)
|++......... .......++..|+|||++.+..++.++|||||||++|+|++++.|+.... .....
T Consensus 154 g~~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (284)
T cd05079 154 GLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVT 233 (284)
T ss_pred ccccccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHH
Confidence 998765432211 11124557778999999988889999999999999999999876542210 11112
Q ss_pred HHHHHHcCCCCCCCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhc
Q 039291 228 QLFSIIGDEHSLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLD 273 (362)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~ 273 (362)
.....+..... ...+..++.++.+|+.+||..+|++||++++++.
T Consensus 234 ~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 278 (284)
T cd05079 234 RLVRVLEEGKR-LPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIE 278 (284)
T ss_pred HHHHHHHcCcc-CCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 22222222222 2345678999999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=318.74 Aligned_cols=258 Identities=25% Similarity=0.438 Sum_probs=201.9
Q ss_pred CCCCceeecceecccCceEEEEEEECCCCCCCCceeeeechhhhhhHHHHHHHHHHHHcCCCCcccccccceeeec--CC
Q 039291 3 SDGTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVSASASLQKEKEVFDNLNGCPFVLECFGEEITMG--EN 80 (362)
Q Consensus 3 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~--~~ 80 (362)
..+.-|...+.||+||||.||+++++.+|+.+|.|.+-+.......+.+-+|+++|++|+ |+|||+++++-.... .-
T Consensus 10 ~~~y~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLn-h~NIVk~f~iee~~~~~~~ 88 (732)
T KOG4250|consen 10 GENYLWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLN-HPNIVKLFDIEETKFLGLV 88 (732)
T ss_pred CCCcceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcC-chhhhhhcccCCccccCcc
Confidence 345678888999999999999999999997554444444444457788999999999999 999999998653321 00
Q ss_pred CceEEEEEEEecCCCCHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEee
Q 039291 81 GEMAYNLLLEYAAGGTLGDLIEKC-NGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIAD 159 (362)
Q Consensus 81 ~~~~~~lv~e~~~~~~L~~~l~~~-~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~D 159 (362)
... -.+|||||.||||+..++.- +..+|++.+++.++..++.||.|||++||+||||||.||++....++....||+|
T Consensus 89 ~~~-~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtD 167 (732)
T KOG4250|consen 89 TRL-PVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTD 167 (732)
T ss_pred ccc-ceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeec
Confidence 122 34899999999999999763 2345999999999999999999999999999999999999988777888999999
Q ss_pred cCCcccccccccCCCCCCccCCCCccCchhhcc-ccCCCcchHHHHHHHHHHHHhCCCCCccCCCC--CHHHHHHHHcCC
Q 039291 160 LGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQ-HMQEAPSDIWALGCVVLEMLSGRQAWVVKEDC--SIDQLFSIIGDE 236 (362)
Q Consensus 160 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~--~~~~~~~~~~~~ 236 (362)
||.|+...... ...+.+||+.|++||++.. +.|+.-+|.|||||++|+++||..||...... +.+.+...+...
T Consensus 168 fG~Arel~d~s---~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkk 244 (732)
T KOG4250|consen 168 FGAARELDDNS---LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKK 244 (732)
T ss_pred ccccccCCCCC---eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccC
Confidence 99998776533 4468999999999999984 78899999999999999999999999765432 223333333221
Q ss_pred C-------------------CCCCCCccCCHH----HHHHHHHHhccCCCCCC
Q 039291 237 H-------------------SLPEIPSRVSKE----ARDFLRRCFVRKPAFRF 266 (362)
Q Consensus 237 ~-------------------~~~~~~~~~~~~----~~~li~~~l~~~p~~R~ 266 (362)
+ .+| .|..++.. +-..+..+|..+|.+|.
T Consensus 245 p~~v~i~~~~~eNgpv~~s~~lP-~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~ 296 (732)
T KOG4250|consen 245 PSGVAIGAQEEENGPVEWSSTLP-QPNHLSRGLATRLTKWLASMLEWNPRKRG 296 (732)
T ss_pred CCceeEeeecccCCceeeeccCC-CcccccHHHHhhhhHHHHHHHhhhHHHhC
Confidence 1 112 13344433 44667778899999998
|
|
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=298.92 Aligned_cols=255 Identities=18% Similarity=0.298 Sum_probs=201.2
Q ss_pred CCCCCCceeecceecccCceEEEEEEECCCCCCCCceeeeechh----hhhhHHHHHHHHHHHHcCCCCcccccccceee
Q 039291 1 MDSDGTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAE----VSASASLQKEKEVFDNLNGCPFVLECFGEEIT 76 (362)
Q Consensus 1 ~~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~----~~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~ 76 (362)
+++...+|.+.+.||+|+||.||+|.+...+. ....+++|... ....+.+.+|+.+++.+. ||||+++++.+..
T Consensus 1 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~-~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~-h~~i~~~~~~~~~ 78 (270)
T cd05056 1 YEIQREDITLGRCIGEGQFGDVYQGVYMSPEN-EKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFD-HPHIVKLIGVITE 78 (270)
T ss_pred CeechhhceeeeeeCCccceeEEEEEEecCCC-CCcceEEEecCCcCCHHHHHHHHHHHHHHHhCC-CCchhceeEEEcC
Confidence 46778899999999999999999999765421 11345666543 234457889999999998 8999999986532
Q ss_pred ecCCCceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEE
Q 039291 77 MGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAK 156 (362)
Q Consensus 77 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~k 156 (362)
...++||||+++++|.+++... ...+++..+..++.|++.||+|||+.|++|+||||+||++ +..+.++
T Consensus 79 ------~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili----~~~~~~~ 147 (270)
T cd05056 79 ------NPVWIVMELAPLGELRSYLQVN-KYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLV----SSPDCVK 147 (270)
T ss_pred ------CCcEEEEEcCCCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEE----ecCCCeE
Confidence 1256999999999999999763 3358999999999999999999999999999999999999 6677899
Q ss_pred EeecCCcccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHh-CCCCCccCCCCCHHHHHHHHcC
Q 039291 157 IADLGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLS-GRQAWVVKEDCSIDQLFSIIGD 235 (362)
Q Consensus 157 l~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~ 235 (362)
|+|||+++....... .......++..|+|||.+....++.++||||||+++|+|++ |..||.... ..+....+..
T Consensus 148 l~d~g~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~---~~~~~~~~~~ 223 (270)
T cd05056 148 LGDFGLSRYLEDESY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVK---NNDVIGRIEN 223 (270)
T ss_pred EccCceeeecccccc-eecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCC---HHHHHHHHHc
Confidence 999999875543211 11122334567999999988889999999999999999996 999995443 2333333333
Q ss_pred CCCCCCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhc
Q 039291 236 EHSLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLD 273 (362)
Q Consensus 236 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~ 273 (362)
.... ..+..++.++.+++.+||..+|++|||+.++++
T Consensus 224 ~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~ 260 (270)
T cd05056 224 GERL-PMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKA 260 (270)
T ss_pred CCcC-CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 3322 356678999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-41 Score=334.34 Aligned_cols=251 Identities=22% Similarity=0.264 Sum_probs=194.0
Q ss_pred CceeecceecccCceEEEEEEECCCCCCCCceeeeechhh------hhhHHHHHHHHHHHHcCCCCcccccccceeeecC
Q 039291 6 TSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEV------SASASLQKEKEVFDNLNGCPFVLECFGEEITMGE 79 (362)
Q Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~------~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~ 79 (362)
++|.+++.||+|+||.||+|.+..++. .|++|.... ...+++.+|++++++++ ||||+++++.+..
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~----~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~-HPNIVkl~~v~~d--- 73 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSR----RVALKKIREDLSENPLLKKRFLREAKIAADLI-HPGIVPVYSICSD--- 73 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCc----EEEEEEECcccccCHHHHHHHHHHHHHHHhCC-CcCcCeEEEEEee---
Confidence 689999999999999999999988775 566665432 23456889999999999 8999999986542
Q ss_pred CCceEEEEEEEecCCCCHHHHHHHhc---------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCC
Q 039291 80 NGEMAYNLLLEYAAGGTLGDLIEKCN---------GNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQS 150 (362)
Q Consensus 80 ~~~~~~~lv~e~~~~~~L~~~l~~~~---------~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~ 150 (362)
....+++|||++|++|.+++.... ...++...+..++.||+.||+|||++||+||||||+|||+ +
T Consensus 74 --~~~lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILL----d 147 (932)
T PRK13184 74 --GDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILL----G 147 (932)
T ss_pred --CCEEEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEE----c
Confidence 234679999999999999987521 1235677889999999999999999999999999999999 7
Q ss_pred CceEEEEeecCCccccccccc----------------CCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHhC
Q 039291 151 GKFVAKIADLGVAKRSRHCKR----------------QKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSG 214 (362)
Q Consensus 151 ~~~~~kl~Dfgla~~~~~~~~----------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g 214 (362)
..+.++|+|||+++....... .......+||+.|+|||++.+..++.++|||||||++|+|++|
T Consensus 148 ~dg~vKLiDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG 227 (932)
T PRK13184 148 LFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTL 227 (932)
T ss_pred CCCCEEEEecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHC
Confidence 778899999999976521110 0111235799999999999999999999999999999999999
Q ss_pred CCCCccCCCCCHHHHHHHHcCCCCCCCCCccCCHHHHHHHHHHhccCCCCCCCHHHHh
Q 039291 215 RQAWVVKEDCSIDQLFSIIGDEHSLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLL 272 (362)
Q Consensus 215 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l 272 (362)
..||........... ..+...... .....+++.+.+++.+||..||++|++..+.+
T Consensus 228 ~~PF~~~~~~ki~~~-~~i~~P~~~-~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeL 283 (932)
T PRK13184 228 SFPYRRKKGRKISYR-DVILSPIEV-APYREIPPFLSQIAMKALAVDPAERYSSVQEL 283 (932)
T ss_pred CCCCCCcchhhhhhh-hhccChhhc-cccccCCHHHHHHHHHHccCChhhCcCHHHHH
Confidence 999965432211111 111111111 11236789999999999999999998765544
|
|
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=304.26 Aligned_cols=255 Identities=17% Similarity=0.280 Sum_probs=204.1
Q ss_pred CCCceeecceecccCceEEEEEEECCCCCCCCceeeeechhhh----hhHHHHHHHHHHHHcCCCCcccccccceeeecC
Q 039291 4 DGTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVS----ASASLQKEKEVFDNLNGCPFVLECFGEEITMGE 79 (362)
Q Consensus 4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~~----~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~ 79 (362)
..++|...+.||+|+||.||+|.+..++..+...+++|..... ....+.+|+.+++.++ ||||+++++.+..
T Consensus 5 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~-h~niv~~~~~~~~--- 80 (303)
T cd05110 5 KETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMD-HPHLVRLLGVCLS--- 80 (303)
T ss_pred chhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCC-CCCcccEEEEEcC---
Confidence 3467899999999999999999998888766677888876533 2235778999999997 9999999986642
Q ss_pred CCceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEee
Q 039291 80 NGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIAD 159 (362)
Q Consensus 80 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~D 159 (362)
. ..++++||+++|+|.+++... ...+++..+..++.|++.||.|||++||+||||||+||++ +.++.+||+|
T Consensus 81 --~-~~~~v~e~~~~g~l~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill----~~~~~~kL~D 152 (303)
T cd05110 81 --P-TIQLVTQLMPHGCLLDYVHEH-KDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLV----KSPNHVKITD 152 (303)
T ss_pred --C-CceeeehhcCCCCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeee----cCCCceEEcc
Confidence 1 245899999999999998763 3358999999999999999999999999999999999999 6677899999
Q ss_pred cCCcccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHh-CCCCCccCCCCCHHHHHHHHcCCCC
Q 039291 160 LGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLS-GRQAWVVKEDCSIDQLFSIIGDEHS 238 (362)
Q Consensus 160 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~ 238 (362)
||+++...............++..|+|||++.+..++.++|||||||++|||++ |..||.... .......+.....
T Consensus 153 fg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~---~~~~~~~~~~~~~ 229 (303)
T cd05110 153 FGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIP---TREIPDLLEKGER 229 (303)
T ss_pred ccccccccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCC---HHHHHHHHHCCCC
Confidence 999976543222222223446778999999998889999999999999999997 899995442 3333333333333
Q ss_pred CCCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhcC
Q 039291 239 LPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDD 274 (362)
Q Consensus 239 ~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~ 274 (362)
. ..+..++.++.+++.+||..+|++||++++++..
T Consensus 230 ~-~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~ 264 (303)
T cd05110 230 L-PQPPICTIDVYMVMVKCWMIDADSRPKFKELAAE 264 (303)
T ss_pred C-CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 2 2345678899999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-41 Score=310.40 Aligned_cols=259 Identities=22% Similarity=0.382 Sum_probs=201.8
Q ss_pred CCCceeecceecccCceEEEEEEECCCCCCCCceeeeechhh-----hhhHHHHHHHHHHHHcCCCCcccccccceeeec
Q 039291 4 DGTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEV-----SASASLQKEKEVFDNLNGCPFVLECFGEEITMG 78 (362)
Q Consensus 4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~-----~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~ 78 (362)
-.++|.+.+.||+|+||.||+|.+..++. .+++|.... .....+.+|+.+++.++ ||||+++++.+....
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~----~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~ 87 (343)
T cd07880 13 VPDRYRDLKQVGSGAYGTVCSALDRRTGA----KVAIKKLYRPFQSELFAKRAYRELRLLKHMK-HENVIGLLDVFTPDL 87 (343)
T ss_pred cccceEEEEEeeecCCeEEEEEEECCCCc----EEEEEEecccccchHHHHHHHHHHHHHHhcC-CCCccceeeeecCCc
Confidence 35789999999999999999999988775 456665422 12345778999999998 999999998764321
Q ss_pred C-CCceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEE
Q 039291 79 E-NGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKI 157 (362)
Q Consensus 79 ~-~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl 157 (362)
. .....+++||||+ |++|.+++.. ..+++..++.++.|++.||.|||+.||+||||||+||++ +.++.++|
T Consensus 88 ~~~~~~~~~lv~e~~-~~~l~~~~~~---~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill----~~~~~~kl 159 (343)
T cd07880 88 SLDRFHDFYLVMPFM-GTDLGKLMKH---EKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAV----NEDCELKI 159 (343)
T ss_pred cccccceEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE----cCCCCEEE
Confidence 1 1123468999999 7799988864 459999999999999999999999999999999999999 67778999
Q ss_pred eecCCcccccccccCCCCCCccCCCCccCchhhcc-ccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHHcCC
Q 039291 158 ADLGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQ-HMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDE 236 (362)
Q Consensus 158 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 236 (362)
+|||++...... .....+++.|+|||++.+ ..++.++|+|||||++|+|++|..||...+. ...........
T Consensus 160 ~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~--~~~~~~~~~~~ 232 (343)
T cd07880 160 LDFGLARQTDSE-----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDH--LDQLMEIMKVT 232 (343)
T ss_pred eecccccccccC-----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHHhc
Confidence 999998754321 124567899999999876 4578899999999999999999999964432 11111111000
Q ss_pred ----------------------------CCCCCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCccCcch
Q 039291 237 ----------------------------HSLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGVDE 282 (362)
Q Consensus 237 ----------------------------~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~~~~~~ 282 (362)
..+......++.++.++|.+||..||++|||+.+++.||||+....
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~~ 306 (343)
T cd07880 233 GTPSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFHD 306 (343)
T ss_pred CCCCHHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhcC
Confidence 0011122457888999999999999999999999999999987644
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-41 Score=304.08 Aligned_cols=257 Identities=20% Similarity=0.327 Sum_probs=197.0
Q ss_pred CCCceeecceecccCceEEEEEEECCCCCC----------CCceeeeechhhh----hhHHHHHHHHHHHHcCCCCcccc
Q 039291 4 DGTSWFRGRVIGQGSFGCVFIAKPKSNSSF----------LPPLMAVKSAEVS----ASASLQKEKEVFDNLNGCPFVLE 69 (362)
Q Consensus 4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~----------~~~~~~~K~~~~~----~~~~~~~E~~il~~l~~h~~i~~ 69 (362)
..++|.+.+.||+|+||.||+|++..++.+ ....+++|..... ....+.+|++++++++ |+|+++
T Consensus 3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~-h~~i~~ 81 (295)
T cd05097 3 PRQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLK-NPNIIR 81 (295)
T ss_pred chHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCC-CCCcCe
Confidence 457999999999999999999987654321 1134677765432 3456888999999998 899999
Q ss_pred cccceeeecCCCceEEEEEEEecCCCCHHHHHHHhcC----------CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCC
Q 039291 70 CFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNG----------NGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVK 139 (362)
Q Consensus 70 ~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~----------~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlk 139 (362)
+++.+.. ....++||||+.+++|.+++..... ..+++..+..++.|++.||.|||++|++|+|||
T Consensus 82 ~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlk 156 (295)
T cd05097 82 LLGVCVS-----DDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLA 156 (295)
T ss_pred EEEEEcC-----CCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccC
Confidence 9987642 2346799999999999999965321 136888999999999999999999999999999
Q ss_pred CCCEEEeecCCCceEEEEeecCCcccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHh--CCCC
Q 039291 140 PDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLS--GRQA 217 (362)
Q Consensus 140 p~Nill~~~~~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~--g~~p 217 (362)
|+||++ +.++.+||+|||++................++..|+|||++.+..++.++|+|||||++|+|++ |..|
T Consensus 157 p~Nill----~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p 232 (295)
T cd05097 157 TRNCLV----GNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQP 232 (295)
T ss_pred hhhEEE----cCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCC
Confidence 999999 6677899999999875433222222223445778999999998889999999999999999998 5677
Q ss_pred CccCCCCCHHHHHHHHc------CCCCCCCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhc
Q 039291 218 WVVKEDCSIDQLFSIIG------DEHSLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLD 273 (362)
Q Consensus 218 f~~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~ 273 (362)
|..... .+....+. ........+..++..+.+|+.+||..||++||+++++++
T Consensus 233 ~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~ 291 (295)
T cd05097 233 YSLLSD---EQVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHH 291 (295)
T ss_pred CcccCh---HHHHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 754332 22222111 111222334567899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-41 Score=312.19 Aligned_cols=261 Identities=24% Similarity=0.376 Sum_probs=201.3
Q ss_pred CCceeecceecccCceEEEEEEECCCCCCCCceeeeechh-----hhhhHHHHHHHHHHHHcCCCCcccccccceeeecC
Q 039291 5 GTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAE-----VSASASLQKEKEVFDNLNGCPFVLECFGEEITMGE 79 (362)
Q Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~-----~~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~ 79 (362)
.++|.+.+.||+|+||.||+|.++.++. .+++|... ......+.+|+.+++++.+||||+++++++..
T Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~----~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~--- 78 (337)
T cd07852 6 LRKYEILQKLGKGAYGIVWKAIDRRTKE----VVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKA--- 78 (337)
T ss_pred hhHHHHhHhhcCCCCeeEEEEEEcCCCe----EEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeecc---
Confidence 4789999999999999999999987765 44555432 22345577899999999449999999986542
Q ss_pred CCceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEee
Q 039291 80 NGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIAD 159 (362)
Q Consensus 80 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~D 159 (362)
.....+++||||+.+ +|.+++.. +.+++..++.++.|++.||.|||++||+||||||+||++ +.++.+||+|
T Consensus 79 ~~~~~~~lv~e~~~~-~L~~~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill----~~~~~~kl~d 150 (337)
T cd07852 79 ENDKDIYLVFEYMET-DLHAVIRA---NILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILL----NSDCRVKLAD 150 (337)
T ss_pred CCCceEEEEeccccc-CHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE----cCCCcEEEee
Confidence 223456799999974 99988875 268999999999999999999999999999999999999 7888999999
Q ss_pred cCCcccccccccC---CCCCCccCCCCccCchhhcc-ccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHH-----
Q 039291 160 LGVAKRSRHCKRQ---KFDPSMRGTPLYLAPETVVQ-HMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLF----- 230 (362)
Q Consensus 160 fgla~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~----- 230 (362)
||++......... .......||..|+|||++.+ ..++.++|+||||+++|+|++|++||............
T Consensus 151 ~g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~ 230 (337)
T cd07852 151 FGLARSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIG 230 (337)
T ss_pred ccchhccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC
Confidence 9999755432221 12234568999999998865 45788999999999999999999999654321111100
Q ss_pred -------------------HHHcCC--CCCCCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCccCc
Q 039291 231 -------------------SIIGDE--HSLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGV 280 (362)
Q Consensus 231 -------------------~~~~~~--~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~~~~ 280 (362)
..+... .........++.++.++|.+||+.||++|||+.+++.|||++..
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~ 301 (337)
T cd07852 231 PPSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQF 301 (337)
T ss_pred CCCHHHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhh
Confidence 000000 01111223478999999999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=295.59 Aligned_cols=252 Identities=22% Similarity=0.350 Sum_probs=202.4
Q ss_pred CCCCCceeecceecccCceEEEEEEECCCCCCCCceeeeechhh--hhhHHHHHHHHHHHHcCCCCcccccccceeeecC
Q 039291 2 DSDGTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEV--SASASLQKEKEVFDNLNGCPFVLECFGEEITMGE 79 (362)
Q Consensus 2 ~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~--~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~ 79 (362)
++..++|.+.+.||+|+||.||+|.++.+. .+++|.... ...+.+.+|+.++++++ |+||+++++.+..
T Consensus 2 ~~~~~~~~i~~~ig~g~~~~v~~~~~~~~~-----~~~vK~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~--- 72 (261)
T cd05034 2 EIPRESLKLERKLGAGQFGEVWMGTWNGTT-----KVAVKTLKPGTMSPEAFLQEAQIMKKLR-HDKLVQLYAVCSE--- 72 (261)
T ss_pred ccchhheeeeeeeccCcceEEEEEEEcCCc-----eEEEEEecCCccCHHHHHHHHHHHhhCC-CCCEeeeeeeeec---
Confidence 467889999999999999999999976542 456666543 23456889999999999 8999999886532
Q ss_pred CCceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEee
Q 039291 80 NGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIAD 159 (362)
Q Consensus 80 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~D 159 (362)
...++++|||+++++|.+++.......+++..+..++.|++.||.|||++|++|+||||+||++ +.++.++|+|
T Consensus 73 --~~~~~~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili----~~~~~~~l~d 146 (261)
T cd05034 73 --EEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILV----GENLVCKIAD 146 (261)
T ss_pred --CCceEEEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEE----cCCCCEEECc
Confidence 2346799999999999999987555569999999999999999999999999999999999999 7778899999
Q ss_pred cCCcccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHh-CCCCCccCCCCCHHHHHHHHcCCCC
Q 039291 160 LGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLS-GRQAWVVKEDCSIDQLFSIIGDEHS 238 (362)
Q Consensus 160 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~ 238 (362)
||++......... ......++..|+|||.+.+..++.++|+||||+++|+|++ |+.||... ........+.....
T Consensus 147 ~g~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~---~~~~~~~~~~~~~~ 222 (261)
T cd05034 147 FGLARLIEDDEYT-AREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGM---TNREVLEQVERGYR 222 (261)
T ss_pred cccceeccchhhh-hhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCC---CHHHHHHHHHcCCC
Confidence 9998755431111 1112234668999999998889999999999999999998 99999544 33344444433322
Q ss_pred CCCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhc
Q 039291 239 LPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLD 273 (362)
Q Consensus 239 ~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~ 273 (362)
...+...+.++.+++.+||..+|++||+++++.+
T Consensus 223 -~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~ 256 (261)
T cd05034 223 -MPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQS 256 (261)
T ss_pred -CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 2345567899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-41 Score=312.05 Aligned_cols=259 Identities=23% Similarity=0.373 Sum_probs=201.8
Q ss_pred CCCceeecceecccCceEEEEEEECCCCCCCCceeeeechh-----hhhhHHHHHHHHHHHHcCCCCcccccccceeeec
Q 039291 4 DGTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAE-----VSASASLQKEKEVFDNLNGCPFVLECFGEEITMG 78 (362)
Q Consensus 4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~-----~~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~ 78 (362)
..++|.+.+.||+|++|.||+|++..++. .+++|... ......+.+|+.+++.+. |||++++.+.+....
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~----~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~ 87 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGR----KVAIKKLSRPFQSAIHAKRTYRELRLLKHMD-HENVIGLLDVFTPAS 87 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCCc----EEEEEecccccchhhHHHHHHHHHHHHHhcc-CCCHHHHHHHhhccc
Confidence 46789999999999999999999988765 45666543 223355778999999997 999999988654322
Q ss_pred C-CCceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEE
Q 039291 79 E-NGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKI 157 (362)
Q Consensus 79 ~-~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl 157 (362)
. .....+++|+||+ +++|.+++.. .++++..++.++.|++.||.|||+.||+||||||+||++ +.++.++|
T Consensus 88 ~~~~~~~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill----~~~~~~kL 159 (343)
T cd07851 88 SLEDFQDVYLVTHLM-GADLNNIVKC---QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAV----NEDCELKI 159 (343)
T ss_pred cccccccEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEE----CCCCCEEE
Confidence 1 2223477999999 6699998875 459999999999999999999999999999999999999 77788999
Q ss_pred eecCCcccccccccCCCCCCccCCCCccCchhhcc-ccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHHcCC
Q 039291 158 ADLGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQ-HMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDE 236 (362)
Q Consensus 158 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 236 (362)
+|||++...... .....++..|+|||.+.+ ..++.++|||||||++|+|++|+.||..... ...+...+...
T Consensus 160 ~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~--~~~~~~i~~~~ 232 (343)
T cd07851 160 LDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDH--IDQLKRIMNLV 232 (343)
T ss_pred cccccccccccc-----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCh--HHHHHHHHHhc
Confidence 999998755432 234568899999999875 3678899999999999999999999965432 11111111000
Q ss_pred C----------------------------CCCCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCccCcch
Q 039291 237 H----------------------------SLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGVDE 282 (362)
Q Consensus 237 ~----------------------------~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~~~~~~ 282 (362)
. .+.......+.++.++|.+||..+|++|||+.+++.||||+.+..
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~~~~ 306 (343)
T cd07851 233 GTPDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEYHD 306 (343)
T ss_pred CCCCHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCccccCC
Confidence 0 000111246889999999999999999999999999999987643
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=301.55 Aligned_cols=262 Identities=24% Similarity=0.418 Sum_probs=202.1
Q ss_pred CCCCceeecceecccCceEEEEEEECCCCCCCCceeeeechh----hhhhHHHHHHHHHHHHcCCCCcccccccceeeec
Q 039291 3 SDGTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAE----VSASASLQKEKEVFDNLNGCPFVLECFGEEITMG 78 (362)
Q Consensus 3 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~----~~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~ 78 (362)
...+.|.+.+.||+|+||.||+|+++.++. .+++|... ......+.+|+.++.++.+|+||+++++.+..
T Consensus 12 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~----~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~-- 85 (296)
T cd06618 12 ADLNDLENLGEIGSGTCGQVYKMRFKKTGH----VMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFIT-- 85 (296)
T ss_pred CCcchheeeeEeeccCCeEEEEEEECCCCe----EEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeec--
Confidence 456789999999999999999999987765 45555543 22344566788888888779999999997643
Q ss_pred CCCceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCceeCCCCCCCEEEeecCCCceEEEE
Q 039291 79 ENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHD-SGYVHCDVKPDNILLVATQSGKFVAKI 157 (362)
Q Consensus 79 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~-~~ivH~Dlkp~Nill~~~~~~~~~~kl 157 (362)
...++++|||+. ++|.+++.... ..+++..+..++.|++.||.|||+ .||+||||+|+||++ +.++.++|
T Consensus 86 ---~~~~~~v~e~~~-~~l~~l~~~~~-~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill----~~~~~~kL 156 (296)
T cd06618 86 ---DSDVFICMELMS-TCLDKLLKRIQ-GPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILL----DASGNVKL 156 (296)
T ss_pred ---CCeEEEEeeccC-cCHHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEE----cCCCCEEE
Confidence 234789999985 47888776633 469999999999999999999997 699999999999999 77788999
Q ss_pred eecCCcccccccccCCCCCCccCCCCccCchhhcccc----CCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHH
Q 039291 158 ADLGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHM----QEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSII 233 (362)
Q Consensus 158 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~ 233 (362)
+|||++......... ....++..|+|||.+.+.. ++.++|+||||+++|+|++|+.||..... ....+....
T Consensus 157 ~dfg~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-~~~~~~~~~ 232 (296)
T cd06618 157 CDFGISGRLVDSKAK---TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKT-EFEVLTKIL 232 (296)
T ss_pred CccccchhccCCCcc---cCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchh-HHHHHHHHh
Confidence 999998755432111 2345788999999987543 78899999999999999999999954321 122222222
Q ss_pred cCCCCCCCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCccCcchh
Q 039291 234 GDEHSLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGVDEE 283 (362)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~~~~~~~ 283 (362)
............++.++.+|+.+||..||++||++++++.||||......
T Consensus 233 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~~ 282 (296)
T cd06618 233 QEEPPSLPPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIRRYETA 282 (296)
T ss_pred cCCCCCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhccchh
Confidence 22211111123478999999999999999999999999999999876443
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=301.31 Aligned_cols=257 Identities=23% Similarity=0.338 Sum_probs=200.6
Q ss_pred CCCCceeecceecccCceEEEEEEECCCC-CCCCceeeeechhhh----hhHHHHHHHHHHHHcCCCCcccccccceeee
Q 039291 3 SDGTSWFRGRVIGQGSFGCVFIAKPKSNS-SFLPPLMAVKSAEVS----ASASLQKEKEVFDNLNGCPFVLECFGEEITM 77 (362)
Q Consensus 3 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~-~~~~~~~~~K~~~~~----~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~ 77 (362)
+..++|.+.+.||+|+||.||+|.+.... ......+++|..... ....+.+|+.+++++. ||||+++++.+..
T Consensus 2 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~-h~~iv~~~~~~~~- 79 (288)
T cd05050 2 YPRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFD-HPNIVKLLGVCAV- 79 (288)
T ss_pred CChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcC-CCchheEEEEEcC-
Confidence 45678999999999999999999975410 111245677765432 3456888999999998 8999999986542
Q ss_pred cCCCceEEEEEEEecCCCCHHHHHHHhc--------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeCC
Q 039291 78 GENGEMAYNLLLEYAAGGTLGDLIEKCN--------------------GNGLPEKDVRHFTRCILEGIGHIHDSGYVHCD 137 (362)
Q Consensus 78 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~--------------------~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~D 137 (362)
...++++|||+++++|.+++.... ...+++..+..++.|++.||.|||++|++|||
T Consensus 80 ----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~d 155 (288)
T cd05050 80 ----GKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRD 155 (288)
T ss_pred ----CCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeeccc
Confidence 224679999999999999997521 12478889999999999999999999999999
Q ss_pred CCCCCEEEeecCCCceEEEEeecCCcccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHh-CCC
Q 039291 138 VKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLS-GRQ 216 (362)
Q Consensus 138 lkp~Nill~~~~~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~ 216 (362)
|||+||++ +.++.++|+|||++................++..|+|||++.+..++.++|||||||++|+|++ |..
T Consensus 156 l~p~nil~----~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~ 231 (288)
T cd05050 156 LATRNCLV----GENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQ 231 (288)
T ss_pred ccHhheEe----cCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCC
Confidence 99999999 7778899999999875443222111122345677999999998889999999999999999997 888
Q ss_pred CCccCCCCCHHHHHHHHcCCCCCCCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhc
Q 039291 217 AWVVKEDCSIDQLFSIIGDEHSLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLD 273 (362)
Q Consensus 217 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~ 273 (362)
||... ...+....+..... ...+..++.++.+|+.+||..+|++|||+.++++
T Consensus 232 p~~~~---~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~ 284 (288)
T cd05050 232 PYYGM---AHEEVIYYVRDGNV-LSCPDNCPLELYNLMRLCWSKLPSDRPSFASINR 284 (288)
T ss_pred CCCCC---CHHHHHHHHhcCCC-CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 88543 33455455544333 2345678899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=298.11 Aligned_cols=257 Identities=21% Similarity=0.309 Sum_probs=202.1
Q ss_pred CCCceeecceecccCceEEEEEEECCCCC-CCCceeeeechhhh----hhHHHHHHHHHHHHcCCCCcccccccceeeec
Q 039291 4 DGTSWFRGRVIGQGSFGCVFIAKPKSNSS-FLPPLMAVKSAEVS----ASASLQKEKEVFDNLNGCPFVLECFGEEITMG 78 (362)
Q Consensus 4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~-~~~~~~~~K~~~~~----~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~ 78 (362)
...+|.+.+.||+|+||.||+|+.+.++. .....+++|..... ....+.+|++++++++ |+||+++++.+..
T Consensus 3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~-- 79 (275)
T cd05046 3 PRSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLS-HKNVVRLLGLCRE-- 79 (275)
T ss_pred ChHhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcC-CcceeeeEEEECC--
Confidence 45789999999999999999999876532 22346777776432 2356889999999997 8999999886532
Q ss_pred CCCceEEEEEEEecCCCCHHHHHHHhcC-------CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCC
Q 039291 79 ENGEMAYNLLLEYAAGGTLGDLIEKCNG-------NGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSG 151 (362)
Q Consensus 79 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~-------~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~ 151 (362)
....++||||+++++|.+++..... ..+++..+..++.||+.||+|||+.||+||||||+||++ +.
T Consensus 80 ---~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili----~~ 152 (275)
T cd05046 80 ---AEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLV----SS 152 (275)
T ss_pred ---CCcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEE----eC
Confidence 2346799999999999999986441 158999999999999999999999999999999999999 66
Q ss_pred ceEEEEeecCCcccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHh-CCCCCccCCCCCHHHHH
Q 039291 152 KFVAKIADLGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLS-GRQAWVVKEDCSIDQLF 230 (362)
Q Consensus 152 ~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~ 230 (362)
++.++++|||++......... ......++..|+|||.+.+...+.++||||||+++|+|++ |..||.... .....
T Consensus 153 ~~~~~l~~~~~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~---~~~~~ 228 (275)
T cd05046 153 QREVKVSLLSLSKDVYNSEYY-KLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLS---DEEVL 228 (275)
T ss_pred CCcEEEcccccccccCccccc-ccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccc---hHHHH
Confidence 778999999998644321111 1123456778999999988888999999999999999998 888985432 23334
Q ss_pred HHHcCCCCCCCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhcC
Q 039291 231 SIIGDEHSLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDD 274 (362)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~ 274 (362)
..+.........+..++..+.+++.+||..+|++||++.+++..
T Consensus 229 ~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~ 272 (275)
T cd05046 229 NRLQAGKLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSA 272 (275)
T ss_pred HHHHcCCcCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence 44433332223345688999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=330.18 Aligned_cols=256 Identities=22% Similarity=0.373 Sum_probs=206.4
Q ss_pred CCCceeecceecccCceEEEEEEECCCCC-CCCceeeeechhh----hhhHHHHHHHHHHHHcCCCCcccccccceeeec
Q 039291 4 DGTSWFRGRVIGQGSFGCVFIAKPKSNSS-FLPPLMAVKSAEV----SASASLQKEKEVFDNLNGCPFVLECFGEEITMG 78 (362)
Q Consensus 4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~-~~~~~~~~K~~~~----~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~ 78 (362)
...+-..++.||+|+||.||.|....... .....|++|.... +....|.+|+.+|++++ ||||++++++++..+
T Consensus 690 ~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~-HpNiv~liGv~l~~~ 768 (1025)
T KOG1095|consen 690 PRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFD-HPNIVSLIGVCLDSG 768 (1025)
T ss_pred ChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCC-CcceeeEEEeecCCC
Confidence 34566778999999999999998866533 2246788887653 45667999999999999 999999999987522
Q ss_pred CCCceEEEEEEEecCCCCHHHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCce
Q 039291 79 ENGEMAYNLLLEYAAGGTLGDLIEKCN-----GNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKF 153 (362)
Q Consensus 79 ~~~~~~~~lv~e~~~~~~L~~~l~~~~-----~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~ 153 (362)
..++++||++||+|..+|++.+ ...++..+...++.|+++|+.||+++++|||||...|+|+ +...
T Consensus 769 -----~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL----~~~r 839 (1025)
T KOG1095|consen 769 -----PPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLL----DERR 839 (1025)
T ss_pred -----CcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheee----cccC
Confidence 2569999999999999999852 2348999999999999999999999999999999999999 8889
Q ss_pred EEEEeecCCcccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHh-CCCCCccCCCCCHHHHHHH
Q 039291 154 VAKIADLGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLS-GRQAWVVKEDCSIDQLFSI 232 (362)
Q Consensus 154 ~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~ 232 (362)
+|||+|||+|+...............-...|||||.+....++.++|||||||+|||+++ |..||...+. .+++..
T Consensus 840 ~VKIaDFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n---~~v~~~ 916 (1025)
T KOG1095|consen 840 VVKIADFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSN---FEVLLD 916 (1025)
T ss_pred cEEEcccchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcch---HHHHHH
Confidence 999999999994443222221111123456999999999999999999999999999999 8999965543 333332
Q ss_pred HcCCCCCCCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhc
Q 039291 233 IGDEHSLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLD 273 (362)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~ 273 (362)
...+..+ ..|..++..+.+++..||..+|++||++..+++
T Consensus 917 ~~~ggRL-~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~ 956 (1025)
T KOG1095|consen 917 VLEGGRL-DPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVE 956 (1025)
T ss_pred HHhCCcc-CCCCCCChHHHHHHHHHccCChhhCccHHHHHh
Confidence 2222333 357889999999999999999999999999987
|
|
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=297.75 Aligned_cols=254 Identities=20% Similarity=0.351 Sum_probs=199.7
Q ss_pred CCCceeecceecccCceEEEEEEECCCCCCCCceeeeechhh----hhhHHHHHHHHHHHHcCCCCcccccccceeeecC
Q 039291 4 DGTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEV----SASASLQKEKEVFDNLNGCPFVLECFGEEITMGE 79 (362)
Q Consensus 4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~----~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~ 79 (362)
+..+|.+++.||+|+||.||+|+++.++.. ...+++|.... .....+.+|+.++++++ ||||+++++.+..
T Consensus 2 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~-~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~--- 76 (267)
T cd05066 2 DASCIKIEKVIGAGEFGEVCSGRLKLPGKR-EIPVAIKTLKAGYTEKQRRDFLSEASIMGQFD-HPNIIHLEGVVTK--- 76 (267)
T ss_pred CHHHeEeeeeecccCCCceEEEEEecCCCC-ceEEEEEECCCCCCHHHHHHHHHHHHHHHhCC-CCCcceEEEEEec---
Confidence 457899999999999999999998655431 12456665432 23456889999999998 9999999886532
Q ss_pred CCceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEee
Q 039291 80 NGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIAD 159 (362)
Q Consensus 80 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~D 159 (362)
....++||||+++++|.+++... ...+++.++..++.|++.||.|||++|++||||||+||++ +.++.++|+|
T Consensus 77 --~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili----~~~~~~~l~d 149 (267)
T cd05066 77 --SKPVMIVTEYMENGSLDAFLRKH-DGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILV----NSNLVCKVSD 149 (267)
T ss_pred --CCccEEEEEcCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEE----CCCCeEEeCC
Confidence 23467999999999999999763 3458999999999999999999999999999999999999 7778899999
Q ss_pred cCCcccccccccCCC-CCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHh-CCCCCccCCCCCHHHHHHHHcCCC
Q 039291 160 LGVAKRSRHCKRQKF-DPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLS-GRQAWVVKEDCSIDQLFSIIGDEH 237 (362)
Q Consensus 160 fgla~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~ 237 (362)
||++........... .....++..|+|||.+.+..++.++|+|||||++|++++ |..||.... ..+....+....
T Consensus 150 fg~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~---~~~~~~~~~~~~ 226 (267)
T cd05066 150 FGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMS---NQDVIKAIEEGY 226 (267)
T ss_pred CCcccccccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCC---HHHHHHHHhCCC
Confidence 999876543221111 112233567999999998889999999999999999886 999996443 333444444333
Q ss_pred CCCCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhc
Q 039291 238 SLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLD 273 (362)
Q Consensus 238 ~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~ 273 (362)
.. ..+..++.++.+++.+||+.+|.+||++.++++
T Consensus 227 ~~-~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 261 (267)
T cd05066 227 RL-PAPMDCPAALHQLMLDCWQKDRNERPKFEQIVS 261 (267)
T ss_pred cC-CCCCCCCHHHHHHHHHHcccCchhCCCHHHHHH
Confidence 22 334567899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=300.08 Aligned_cols=257 Identities=27% Similarity=0.445 Sum_probs=206.6
Q ss_pred CCCceeecceecccCceEEEEEEECCCCCCCCceeeeechhhh--hhHHHHHHHHHHHHcCCCCcccccccceeeecCCC
Q 039291 4 DGTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVS--ASASLQKEKEVFDNLNGCPFVLECFGEEITMGENG 81 (362)
Q Consensus 4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~~--~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~~ 81 (362)
..+.|...+.||+|++|.||+|++..++. .+++|..... ....+.+|+++++.++ |+|++++++.+...
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~----~~~iK~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~---- 87 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGK----EVAIKKMRLRKQNKELIINEILIMKDCK-HPNIVDYYDSYLVG---- 87 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCc----EEEEEEEecCchhHHHHHHHHHHHHHCC-CCCeeEEEEEEEEC----
Confidence 45679999999999999999999987664 4566655433 3566889999999998 89999999876542
Q ss_pred ceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEeecC
Q 039291 82 EMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLG 161 (362)
Q Consensus 82 ~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Dfg 161 (362)
...++++||++|++|.+++.... ..+++..+..++.|++.||.|||+.|++|+||+|+||++ +.++.++|+|||
T Consensus 88 -~~~~lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i----~~~~~~~l~d~~ 161 (286)
T cd06614 88 -DELWVVMEYMDGGSLTDIITQNF-VRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILL----SKDGSVKLADFG 161 (286)
T ss_pred -CEEEEEEeccCCCcHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEE----cCCCCEEECccc
Confidence 34779999999999999998743 369999999999999999999999999999999999999 777789999999
Q ss_pred CcccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHHcC-CCCCC
Q 039291 162 VAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGD-EHSLP 240 (362)
Q Consensus 162 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~-~~~~~ 240 (362)
++........ ......++..|+|||++.+..++.++|+|||||++|+|++|..||... +.......+.. .....
T Consensus 162 ~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~---~~~~~~~~~~~~~~~~~ 236 (286)
T cd06614 162 FAAQLTKEKS--KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLRE---PPLRALFLITTKGIPPL 236 (286)
T ss_pred hhhhhccchh--hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCC---CHHHHHHHHHhcCCCCC
Confidence 8865443211 112445888999999998888999999999999999999999999543 22222222222 21111
Q ss_pred CCCccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCccCc
Q 039291 241 EIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGV 280 (362)
Q Consensus 241 ~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~~~~ 280 (362)
..+..++.+++++|++||..+|.+||++.+++.|+||+..
T Consensus 237 ~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~ 276 (286)
T cd06614 237 KNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQHPFLKKA 276 (286)
T ss_pred cchhhCCHHHHHHHHHHhccChhhCcCHHHHhhChHhhcc
Confidence 1223478999999999999999999999999999999874
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=302.36 Aligned_cols=251 Identities=26% Similarity=0.408 Sum_probs=199.1
Q ss_pred CCceeecceecccCceEEEEEEECCCCCCCCceeeeechh------hhhhHHHHHHHHHHHHcCCCCcccccccceeeec
Q 039291 5 GTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAE------VSASASLQKEKEVFDNLNGCPFVLECFGEEITMG 78 (362)
Q Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~------~~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~ 78 (362)
..+|.+.+.||+|+||+||+|++..+++ .+++|... ......+.+|+.+++.++ ||||+++++.+..
T Consensus 14 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~----~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~-h~niv~~~~~~~~-- 86 (307)
T cd06607 14 EKLFTDLREIGHGSFGAVYFARDVRTNE----VVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLR-HPNTIEYKGCYLR-- 86 (307)
T ss_pred chhhhhheeecCCCCeEEEEEEEcCCCc----EEEEEEEeccccCcHHHHHHHHHHHHHHHhCC-CCCEEEEEEEEEe--
Confidence 4679999999999999999999987775 45555432 123356789999999998 9999999987653
Q ss_pred CCCceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEe
Q 039291 79 ENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIA 158 (362)
Q Consensus 79 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~ 158 (362)
....++||||+. |+|.+++... ...+++..+..++.|++.||.|||+.||+|+||+|+||++ +.++.++|+
T Consensus 87 ---~~~~~lv~e~~~-g~l~~~~~~~-~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~----~~~~~~kL~ 157 (307)
T cd06607 87 ---EHTAWLVMEYCL-GSASDILEVH-KKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILL----TEPGTVKLA 157 (307)
T ss_pred ---CCeEEEEHHhhC-CCHHHHHHHc-ccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEE----CCCCCEEEe
Confidence 224679999997 5787777653 3459999999999999999999999999999999999999 777889999
Q ss_pred ecCCcccccccccCCCCCCccCCCCccCchhhc---cccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHHcC
Q 039291 159 DLGVAKRSRHCKRQKFDPSMRGTPLYLAPETVV---QHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGD 235 (362)
Q Consensus 159 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~ 235 (362)
|||++...... ....++..|+|||++. ...++.++||||||+++|+|++|+.||...+ .......+..
T Consensus 158 dfg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~---~~~~~~~~~~ 228 (307)
T cd06607 158 DFGSASLVSPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN---AMSALYHIAQ 228 (307)
T ss_pred ecCcceecCCC------CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCcc---HHHHHHHHhc
Confidence 99998644321 2356888999999875 3567889999999999999999999995432 2222222222
Q ss_pred CCCCCCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCccCc
Q 039291 236 EHSLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGV 280 (362)
Q Consensus 236 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~~~~ 280 (362)
.......+..++.+++++|.+||..+|++||++.+++.||||...
T Consensus 229 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 273 (307)
T cd06607 229 NDSPTLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHRFVLRE 273 (307)
T ss_pred CCCCCCCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccc
Confidence 222112234578899999999999999999999999999999764
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-40 Score=293.33 Aligned_cols=251 Identities=23% Similarity=0.382 Sum_probs=201.2
Q ss_pred CCCCCceeecceecccCceEEEEEEECCCCCCCCceeeeechhhh--hhHHHHHHHHHHHHcCCCCcccccccceeeecC
Q 039291 2 DSDGTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVS--ASASLQKEKEVFDNLNGCPFVLECFGEEITMGE 79 (362)
Q Consensus 2 ~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~~--~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~ 79 (362)
.+...+|.+.+.||+|+||.||+|.+.... .+++|..... ....+.+|+.+++.++ |+||+++++.+..
T Consensus 2 ~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~-----~~~iK~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~--- 72 (260)
T cd05073 2 EIPRESLKLEKKLGAGQFGEVWMATYNKHT-----KVAVKTMKPGSMSVEAFLAEANVMKTLQ-HDKLVKLHAVVTK--- 72 (260)
T ss_pred cccccceeEEeEecCccceEEEEEEecCCc-----cEEEEecCCChhHHHHHHHHHHHHHhcC-CCCcceEEEEEcC---
Confidence 356789999999999999999999876543 3566654332 3456889999999998 8999999876532
Q ss_pred CCceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEee
Q 039291 80 NGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIAD 159 (362)
Q Consensus 80 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~D 159 (362)
..++++|||+++++|.+++.+.....+++..+..++.|++.||.|||+.|++|+||||+||++ +..+.++|+|
T Consensus 73 ---~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i----~~~~~~~l~d 145 (260)
T cd05073 73 ---EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILV----SASLVCKIAD 145 (260)
T ss_pred ---CCeEEEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEE----cCCCcEEECC
Confidence 236799999999999999987555568999999999999999999999999999999999999 7788999999
Q ss_pred cCCcccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHh-CCCCCccCCCCCHHHHHHHHcCCCC
Q 039291 160 LGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLS-GRQAWVVKEDCSIDQLFSIIGDEHS 238 (362)
Q Consensus 160 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~ 238 (362)
||++....... ........++..|+|||++....++.++|+|||||++|++++ |..||... +...+...+.....
T Consensus 146 ~~~~~~~~~~~-~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~---~~~~~~~~~~~~~~ 221 (260)
T cd05073 146 FGLARVIEDNE-YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGM---SNPEVIRALERGYR 221 (260)
T ss_pred CcceeeccCCC-cccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCC---CHHHHHHHHhCCCC
Confidence 99987543321 111123345677999999988889999999999999999998 99999643 33344444444433
Q ss_pred CCCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhc
Q 039291 239 LPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLD 273 (362)
Q Consensus 239 ~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~ 273 (362)
. ..+...+.++.+++.+||+.+|++||++.++++
T Consensus 222 ~-~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05073 222 M-PRPENCPEELYNIMMRCWKNRPEERPTFEYIQS 255 (260)
T ss_pred C-CCcccCCHHHHHHHHHHcccCcccCcCHHHHHH
Confidence 2 344678899999999999999999999988764
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-40 Score=297.74 Aligned_cols=260 Identities=20% Similarity=0.322 Sum_probs=197.1
Q ss_pred CCCceeecceecccCceEEEEEEECCCCCCCCceeeeechhhh---hhHHHHHHHHHHHHcCCCCcccccccceeeecCC
Q 039291 4 DGTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVS---ASASLQKEKEVFDNLNGCPFVLECFGEEITMGEN 80 (362)
Q Consensus 4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~~---~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~ 80 (362)
...+|.+.+.||+|+||.||+|.....+......+++|..... ..+.+.+|+++++.++ ||||+++++++...
T Consensus 2 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~--- 77 (284)
T cd05081 2 EERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQ-HDNIVKYKGVCYSA--- 77 (284)
T ss_pred ccccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCC-CCCeeEEEEEEccC---
Confidence 3568999999999999999999854322222346777775432 3456789999999998 99999998865432
Q ss_pred CceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEeec
Q 039291 81 GEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADL 160 (362)
Q Consensus 81 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Df 160 (362)
+...+++||||+++++|.+++... ...+++..+..++.|++.||.|||++||+||||||+||++ +.++.++|+||
T Consensus 78 ~~~~~~lv~e~~~~~~L~~~l~~~-~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili----~~~~~~~l~df 152 (284)
T cd05081 78 GRRNLRLVMEYLPYGSLRDYLQKH-RERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILV----ESENRVKIGDF 152 (284)
T ss_pred CCCceEEEEEecCCCCHHHHHHhc-CcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEE----CCCCeEEECCC
Confidence 233477999999999999999763 3458999999999999999999999999999999999999 77788999999
Q ss_pred CCcccccccccCC-CCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHhCCCCCccCCCC-------------CH
Q 039291 161 GVAKRSRHCKRQK-FDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDC-------------SI 226 (362)
Q Consensus 161 gla~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~-------------~~ 226 (362)
|++.......... ......++..|+|||++.+..++.++|||||||++|||++|..++...... ..
T Consensus 153 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (284)
T cd05081 153 GLTKVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIV 232 (284)
T ss_pred cccccccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccch
Confidence 9997654322111 111222445699999999888999999999999999999987765322110 01
Q ss_pred HHHHHHHcCCCCCCCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhc
Q 039291 227 DQLFSIIGDEHSLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLD 273 (362)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~ 273 (362)
..+...+..... ...+..++.++.+|+.+||..+|++|||+.+++.
T Consensus 233 ~~~~~~~~~~~~-~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05081 233 YHLIELLKNNGR-LPAPPGCPAEIYAIMKECWNNDPSQRPSFSELAL 278 (284)
T ss_pred HHHHHHHhcCCc-CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 112222222222 2345668899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=294.09 Aligned_cols=247 Identities=22% Similarity=0.349 Sum_probs=197.2
Q ss_pred ceecccCceEEEEEEECCCCCCCCceeeeechhhh----hhHHHHHHHHHHHHcCCCCcccccccceeeecCCCceEEEE
Q 039291 12 RVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVS----ASASLQKEKEVFDNLNGCPFVLECFGEEITMGENGEMAYNL 87 (362)
Q Consensus 12 ~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~~----~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~~~~~~~l 87 (362)
+.||+|++|.||+|.+...+.. ...+++|..... ..+.+.+|+.++++++ ||||+++++.+.. ..+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~------~~~~~ 72 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGK-VIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLD-HENLIRLYGVVLT------HPLMM 72 (257)
T ss_pred CcCCccCcccEEeeeEecCCCC-ceEEEEeecCCcccHHHHHHHHHHHHHHhhcC-CCCccceeEEEcC------CeEEE
Confidence 4789999999999998663221 235677766543 4457889999999998 8999999886542 45779
Q ss_pred EEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEeecCCccccc
Q 039291 88 LLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSR 167 (362)
Q Consensus 88 v~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Dfgla~~~~ 167 (362)
+|||+++++|.+++.......+++..++.++.|++.||.|||++|++|+||||+||++ +.++.+||+|||++....
T Consensus 73 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~----~~~~~~kl~dfg~~~~~~ 148 (257)
T cd05040 73 VTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILL----ASDDKVKIGDFGLMRALP 148 (257)
T ss_pred EEEecCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEE----ecCCEEEecccccccccc
Confidence 9999999999999987443568999999999999999999999999999999999999 667889999999997654
Q ss_pred ccccC-CCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHh-CCCCCccCCCCCHHHHHHHHcCCCCCCCCCcc
Q 039291 168 HCKRQ-KFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLS-GRQAWVVKEDCSIDQLFSIIGDEHSLPEIPSR 245 (362)
Q Consensus 168 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (362)
..... .......++..|+|||.+.+..++.++|||||||++|+|++ |..||... ...+....+.........+..
T Consensus 149 ~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~---~~~~~~~~~~~~~~~~~~~~~ 225 (257)
T cd05040 149 QNEDHYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGL---SGSQILKKIDKEGERLERPEA 225 (257)
T ss_pred ccccceecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCC---CHHHHHHHHHhcCCcCCCCcc
Confidence 32211 11123457788999999998889999999999999999998 99999543 334444444333333334566
Q ss_pred CCHHHHHHHHHHhccCCCCCCCHHHHhc
Q 039291 246 VSKEARDFLRRCFVRKPAFRFTAEMLLD 273 (362)
Q Consensus 246 ~~~~~~~li~~~l~~~p~~R~s~~~~l~ 273 (362)
.+..+.+++.+||..+|++||++.++++
T Consensus 226 ~~~~~~~li~~~l~~~p~~Rps~~~~~~ 253 (257)
T cd05040 226 CPQDIYNVMLQCWAHNPADRPTFAALRE 253 (257)
T ss_pred CCHHHHHHHHHHCCCCcccCCCHHHHHH
Confidence 8899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-40 Score=294.22 Aligned_cols=244 Identities=21% Similarity=0.330 Sum_probs=193.5
Q ss_pred ceecccCceEEEEEEECCCCCCCCceeeeechhhh----hhHHHHHHHHHHHHcCCCCcccccccceeeecCCCceEEEE
Q 039291 12 RVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVS----ASASLQKEKEVFDNLNGCPFVLECFGEEITMGENGEMAYNL 87 (362)
Q Consensus 12 ~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~~----~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~~~~~~~l 87 (362)
+.||+|+||.||+|++..++. ....+++|..... ..+.+.+|+.+++.+. |+||+++++.+. ...+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~-~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~------~~~~~~ 72 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSG-KEVEVAVKTLKQEHIAAGKKEFLREASVMAQLD-HPCIVRLIGVCK------GEPLML 72 (257)
T ss_pred CccCccCceeEEEeEeeccCC-CcceEEEEecccccchHHHHHHHHHHHHHHhcC-CCCeeeEEEEEc------CCceEE
Confidence 579999999999998766542 1135677765432 3456888999999998 899999988542 123579
Q ss_pred EEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEeecCCccccc
Q 039291 88 LLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSR 167 (362)
Q Consensus 88 v~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Dfgla~~~~ 167 (362)
||||+++++|.+++... ..+++..+..++.|++.||+|||+.+++|+||||+||++ +.++.+||+|||+++...
T Consensus 73 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili----~~~~~~kl~df~~~~~~~ 146 (257)
T cd05060 73 VMELAPLGPLLKYLKKR--REIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLL----VNRHQAKISDFGMSRALG 146 (257)
T ss_pred EEEeCCCCcHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEE----cCCCcEEeccccccceee
Confidence 99999999999999863 369999999999999999999999999999999999999 777889999999997654
Q ss_pred ccccCC-CCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHh-CCCCCccCCCCCHHHHHHHHcCCCCCCCCCcc
Q 039291 168 HCKRQK-FDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLS-GRQAWVVKEDCSIDQLFSIIGDEHSLPEIPSR 245 (362)
Q Consensus 168 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (362)
...... ......++..|+|||.+.+..++.++|||||||++|+|++ |.+||... +..+....+..... ...+..
T Consensus 147 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~---~~~~~~~~~~~~~~-~~~~~~ 222 (257)
T cd05060 147 AGSDYYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEM---KGAEVIAMLESGER-LPRPEE 222 (257)
T ss_pred cCCcccccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccC---CHHHHHHHHHcCCc-CCCCCC
Confidence 322111 1112224567999999998889999999999999999998 99999544 33444444444333 245667
Q ss_pred CCHHHHHHHHHHhccCCCCCCCHHHHhc
Q 039291 246 VSKEARDFLRRCFVRKPAFRFTAEMLLD 273 (362)
Q Consensus 246 ~~~~~~~li~~~l~~~p~~R~s~~~~l~ 273 (362)
++..++++|.+||..+|++||++.++++
T Consensus 223 ~~~~l~~li~~cl~~~p~~Rp~~~~l~~ 250 (257)
T cd05060 223 CPQEIYSIMLSCWKYRPEDRPTFSELES 250 (257)
T ss_pred CCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 8999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=296.87 Aligned_cols=253 Identities=19% Similarity=0.332 Sum_probs=198.9
Q ss_pred CCceeecceecccCceEEEEEEECCCCCCCCceeeeechhh----hhhHHHHHHHHHHHHcCCCCcccccccceeeecCC
Q 039291 5 GTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEV----SASASLQKEKEVFDNLNGCPFVLECFGEEITMGEN 80 (362)
Q Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~----~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~ 80 (362)
-+.|.+.+.||+|+||.||+|+++.++.. ...+++|.... .....+..|+.+++.++ ||||+++++.+..
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~-h~ni~~~~~~~~~---- 76 (269)
T cd05065 3 VSCVKIEEVIGAGEFGEVCRGRLKLPGKR-EIFVAIKTLKSGYTEKQRRDFLSEASIMGQFD-HPNIIHLEGVVTK---- 76 (269)
T ss_pred hHHeEEEeEecCCCCCeEEEEEEecCCCC-ceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCC-CcCcceEEEEECC----
Confidence 45799999999999999999998776542 13466666532 24457889999999998 9999999886532
Q ss_pred CceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEeec
Q 039291 81 GEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADL 160 (362)
Q Consensus 81 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Df 160 (362)
...+++||||+++++|.+++... .+.+++.+++.++.|++.||.|||++|++|+||||+||++ +.++.++|+||
T Consensus 77 -~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili----~~~~~~kl~df 150 (269)
T cd05065 77 -SRPVMIITEFMENGALDSFLRQN-DGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILV----NSNLVCKVSDF 150 (269)
T ss_pred -CCceEEEEecCCCCcHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEE----cCCCcEEECCC
Confidence 23467999999999999999763 3458999999999999999999999999999999999999 77788999999
Q ss_pred CCcccccccccCCCCCC-c--cCCCCccCchhhccccCCCcchHHHHHHHHHHHHh-CCCCCccCCCCCHHHHHHHHcCC
Q 039291 161 GVAKRSRHCKRQKFDPS-M--RGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLS-GRQAWVVKEDCSIDQLFSIIGDE 236 (362)
Q Consensus 161 gla~~~~~~~~~~~~~~-~--~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~ 236 (362)
|++.............. . ..+..|+|||.+.+..++.++|||||||++|||++ |..||... +.......+...
T Consensus 151 g~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~---~~~~~~~~i~~~ 227 (269)
T cd05065 151 GLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDM---SNQDVINAIEQD 227 (269)
T ss_pred ccccccccCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCC---CHHHHHHHHHcC
Confidence 99875443221111111 1 12457999999998889999999999999999886 99999544 333444444333
Q ss_pred CCCCCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhc
Q 039291 237 HSLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLD 273 (362)
Q Consensus 237 ~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~ 273 (362)
...+ .+..++..+.+++.+||..+|++||++++++.
T Consensus 228 ~~~~-~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 263 (269)
T cd05065 228 YRLP-PPMDCPTALHQLMLDCWQKDRNARPKFGQIVS 263 (269)
T ss_pred CcCC-CcccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 3322 34568899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-40 Score=298.08 Aligned_cols=258 Identities=26% Similarity=0.449 Sum_probs=198.5
Q ss_pred eeecceecccCceEEEEEEECCCCCCCCceeeeechhhh-----hhHHHHHHHHHHHHcC--CCCcccccccceeeecCC
Q 039291 8 WFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVS-----ASASLQKEKEVFDNLN--GCPFVLECFGEEITMGEN 80 (362)
Q Consensus 8 y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~~-----~~~~~~~E~~il~~l~--~h~~i~~~~~~~~~~~~~ 80 (362)
|.+.+.||+|+||.||+|+++.++. .+++|..... ....+.+|+.+++++. .|+|++++++.+......
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~----~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~ 76 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGR----FVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTD 76 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCC----EEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCC
Confidence 6789999999999999999987664 4566655321 2234667888887775 499999999987654333
Q ss_pred CceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEeec
Q 039291 81 GEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADL 160 (362)
Q Consensus 81 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Df 160 (362)
....++++|||+.+ +|.+++.......+++..++.++.|++.||.|||+.+++|+||+|+||++ +.++.++|+||
T Consensus 77 ~~~~~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili----~~~~~~~l~df 151 (287)
T cd07838 77 RELKLTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILV----TSDGQVKIADF 151 (287)
T ss_pred CCceeEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEE----ccCCCEEEecc
Confidence 34457899999975 89998877544469999999999999999999999999999999999999 77788999999
Q ss_pred CCcccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHH-HHHHHcCC--C
Q 039291 161 GVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQ-LFSIIGDE--H 237 (362)
Q Consensus 161 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~-~~~~~~~~--~ 237 (362)
|++........ .....++..|+|||++.+..++.++|+|||||++|+|++|.+||.......... ........ .
T Consensus 152 g~~~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 228 (287)
T cd07838 152 GLARIYSFEMA---LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEE 228 (287)
T ss_pred CcceeccCCcc---cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChH
Confidence 99876543221 123457889999999998889999999999999999999999996543221111 11111000 0
Q ss_pred -------------------CCCCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCc
Q 039291 238 -------------------SLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFV 277 (362)
Q Consensus 238 -------------------~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~ 277 (362)
........++..+.++|.+||..||.+||++++++.||||
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~~~ 287 (287)
T cd07838 229 EWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF 287 (287)
T ss_pred hcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcCcCC
Confidence 0001112456788999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=330.50 Aligned_cols=144 Identities=26% Similarity=0.433 Sum_probs=122.6
Q ss_pred CCceeecceecccCceEEEEEEECCCCCCCCceeeeechhh------hhhHHHHHHHHHHHHcCCCCcccccccceeeec
Q 039291 5 GTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEV------SASASLQKEKEVFDNLNGCPFVLECFGEEITMG 78 (362)
Q Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~------~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~ 78 (362)
-++|.+++.||+|+||+||+|++..++. .|++|.+.. .....+.+|+.+++.++ ||||++++..+..
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~----~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~-hp~Iv~~~~~~~~-- 75 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSK----LYAVKVVKKADMINKNMVHQVQAERDALALSK-SPFIVHLYYSLQS-- 75 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCc----EEEEEEEehhhccCHHHHHHHHHHHHHHHhcC-CCCcCeEEEEEEE--
Confidence 4689999999999999999999998775 456655432 22356788999999998 9999999875532
Q ss_pred CCCceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEe
Q 039291 79 ENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIA 158 (362)
Q Consensus 79 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~ 158 (362)
...+|+||||+.|++|.+++.. .+.+++..++.++.||+.||.|||.+||+||||||+|||+ +.++.+||+
T Consensus 76 ---~~~~~lVmEy~~g~~L~~li~~--~~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl----~~~g~vkL~ 146 (669)
T cd05610 76 ---ANNVYLVMEYLIGGDVKSLLHI--YGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLI----SNEGHIKLT 146 (669)
T ss_pred ---CCEEEEEEeCCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEE----cCCCCEEEE
Confidence 2357899999999999999976 3458999999999999999999999999999999999999 677889999
Q ss_pred ecCCcc
Q 039291 159 DLGVAK 164 (362)
Q Consensus 159 Dfgla~ 164 (362)
|||+++
T Consensus 147 DFGls~ 152 (669)
T cd05610 147 DFGLSK 152 (669)
T ss_pred eCCCCc
Confidence 999985
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-40 Score=292.80 Aligned_cols=246 Identities=24% Similarity=0.390 Sum_probs=202.4
Q ss_pred CCCCceeecceecccCceEEEEEEECCCCCCCCceeeeechhhh--hhHHHHHHHHHHHHcCCCCcccccccceeeecCC
Q 039291 3 SDGTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVS--ASASLQKEKEVFDNLNGCPFVLECFGEEITMGEN 80 (362)
Q Consensus 3 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~~--~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~ 80 (362)
+.++.|.+.+.||.|+||.||+|...+ ..+++|..... ....+.+|+.+++.++ |+||+++++.+..
T Consensus 3 ~~~~~~~~~~~ig~g~~g~v~~~~~~~------~~v~iK~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~---- 71 (256)
T cd05039 3 INSKELKLGATIGKGEFGDVMLGDYRG------QKVAVKCLKDDSTAAQAFLAEASVMTTLR-HPNLVQLLGVVLQ---- 71 (256)
T ss_pred cChhhccceeeeecCCCceEEEEEecC------cEEEEEEeccchhHHHHHHHHHHHHHhcC-CcceeeeEEEEcC----
Confidence 567899999999999999999998763 25677776544 3467889999999998 8999999987542
Q ss_pred CceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEeec
Q 039291 81 GEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADL 160 (362)
Q Consensus 81 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Df 160 (362)
....++||||+++++|.+++.......+++..+..++.|++.||.|||++|++|+||||+||++ +.++.++|+||
T Consensus 72 -~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili----~~~~~~~l~d~ 146 (256)
T cd05039 72 -GNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLV----SEDLVAKVSDF 146 (256)
T ss_pred -CCCeEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEE----eCCCCEEEccc
Confidence 2346799999999999999987554569999999999999999999999999999999999999 77788999999
Q ss_pred CCcccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHh-CCCCCccCCCCCHHHHHHHHcCCCCC
Q 039291 161 GVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLS-GRQAWVVKEDCSIDQLFSIIGDEHSL 239 (362)
Q Consensus 161 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~ 239 (362)
|+++....... ...++..|+|||++....++.++|+||||+++++|++ |..||... ....+...+.... .
T Consensus 147 g~~~~~~~~~~-----~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~---~~~~~~~~~~~~~-~ 217 (256)
T cd05039 147 GLAKEASQGQD-----SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI---PLKDVVPHVEKGY-R 217 (256)
T ss_pred ccccccccccc-----cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCC---CHHHHHHHHhcCC-C
Confidence 99876532211 2335667999999988889999999999999999997 99999543 3444444443332 2
Q ss_pred CCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhc
Q 039291 240 PEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLD 273 (362)
Q Consensus 240 ~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~ 273 (362)
+..+..+++++.++|.+||..+|++||++.+++.
T Consensus 218 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 251 (256)
T cd05039 218 MEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLRE 251 (256)
T ss_pred CCCccCCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence 3455678899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=294.55 Aligned_cols=243 Identities=21% Similarity=0.352 Sum_probs=190.5
Q ss_pred eecccCceEEEEEEECCCCCCCCceeeeechhhh----hhHHHHHHHHHHHHcCCCCcccccccceeeecCCCceEEEEE
Q 039291 13 VIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVS----ASASLQKEKEVFDNLNGCPFVLECFGEEITMGENGEMAYNLL 88 (362)
Q Consensus 13 ~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~~----~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~~~~~~~lv 88 (362)
.||+|+||.||+|.++..+. ...+++|..... ..+.+.+|+.++++++ ||||+++++.+. ...+++|
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~--~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~-h~~ii~~~~~~~------~~~~~lv 72 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKK--QIDVAIKVLKNENEKSVRDEMMREAEIMHQLD-NPYIVRMIGVCE------AEALMLV 72 (257)
T ss_pred ccCCCCcccEEEEEEecCCC--ceeEEEEEcccccChHHHHHHHHHHHHHHhcC-CCCeEEEEEEEc------CCCeEEE
Confidence 48999999999998763322 124666655432 3456889999999998 899999998642 1236799
Q ss_pred EEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEeecCCcccccc
Q 039291 89 LEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRH 168 (362)
Q Consensus 89 ~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Dfgla~~~~~ 168 (362)
|||+++++|.+++... ...+++..+..++.|++.||.|||++|++||||||+||++ +.++.+||+|||++.....
T Consensus 73 ~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~----~~~~~~kl~dfg~~~~~~~ 147 (257)
T cd05115 73 MEMASGGPLNKFLSGK-KDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLL----VNQHYAKISDFGLSKALGA 147 (257)
T ss_pred EEeCCCCCHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEE----cCCCcEEeccCCccccccC
Confidence 9999999999998753 3469999999999999999999999999999999999999 6777899999999875433
Q ss_pred cccCCC-CCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHh-CCCCCccCCCCCHHHHHHHHcCCCCCCCCCccC
Q 039291 169 CKRQKF-DPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLS-GRQAWVVKEDCSIDQLFSIIGDEHSLPEIPSRV 246 (362)
Q Consensus 169 ~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (362)
...... .....++..|+|||++.+..++.++|||||||++|+|++ |..||... ........+..... +..+...
T Consensus 148 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~---~~~~~~~~~~~~~~-~~~~~~~ 223 (257)
T cd05115 148 DDSYYKARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKM---KGPEVMSFIEQGKR-LDCPAEC 223 (257)
T ss_pred CccceeccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcC---CHHHHHHHHHCCCC-CCCCCCC
Confidence 221111 112234578999999988889999999999999999996 99999544 33344444443332 3456778
Q ss_pred CHHHHHHHHHHhccCCCCCCCHHHHhc
Q 039291 247 SKEARDFLRRCFVRKPAFRFTAEMLLD 273 (362)
Q Consensus 247 ~~~~~~li~~~l~~~p~~R~s~~~~l~ 273 (362)
+.++.++|.+||..+|++||++.++.+
T Consensus 224 ~~~l~~li~~c~~~~~~~Rp~~~~i~~ 250 (257)
T cd05115 224 PPEMYALMKDCWIYKWEDRPNFAKVEE 250 (257)
T ss_pred CHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-41 Score=320.45 Aligned_cols=264 Identities=26% Similarity=0.445 Sum_probs=223.6
Q ss_pred CCCceeecceecccCceEEEEEEECCCCCCCCceeeeec--hhhhhhHHHHHHHHHHHHcCCCCcccccccceeeecCCC
Q 039291 4 DGTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKS--AEVSASASLQKEKEVFDNLNGCPFVLECFGEEITMGENG 81 (362)
Q Consensus 4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~--~~~~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~~ 81 (362)
..+.|++.+.||.|.||.||+++.+.++. ..++|+ ...+....+..|.++++.+.+|||++.+++++.......
T Consensus 17 p~d~~ei~evig~Gtygkv~k~k~~~~~~----~aa~kI~~~~~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~ 92 (953)
T KOG0587|consen 17 PADIFEIIEVIGNGTYGKVYKGRHVKTGQ----LAAIKIMDPTEDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGN 92 (953)
T ss_pred CCCccEEEEEEeeccceeEEEEeeeecCc----eeeeEeecCCccccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCC
Confidence 45789999999999999999999988875 445555 445667788999999999999999999999988876666
Q ss_pred ceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEeecC
Q 039291 82 EMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLG 161 (362)
Q Consensus 82 ~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Dfg 161 (362)
...++||||||.||+.-|+++...+..+.|..+..|++.++.||.+||.+.++|||||-.|||+ ..++.|||+|||
T Consensus 93 ~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLL----T~e~~VKLvDFG 168 (953)
T KOG0587|consen 93 GDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLL----TENAEVKLVDFG 168 (953)
T ss_pred CCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEE----eccCcEEEeeee
Confidence 6678899999999999999998878889999999999999999999999999999999999999 788889999999
Q ss_pred CcccccccccCCCCCCccCCCCccCchhhccc-----cCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHHcCC
Q 039291 162 VAKRSRHCKRQKFDPSMRGTPLYLAPETVVQH-----MQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDE 236 (362)
Q Consensus 162 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 236 (362)
++.......... .+.+||+.|||||++.+. .|+..+|+||||++..||..|.+|+-.. .+...+-.|..+
T Consensus 169 vSaQldsT~grR--nT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~Dm---HPmraLF~IpRN 243 (953)
T KOG0587|consen 169 VSAQLDSTVGRR--NTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDM---HPMRALFLIPRN 243 (953)
T ss_pred eeeeeecccccc--cCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCc---chhhhhccCCCC
Confidence 998777644333 578899999999999853 4678899999999999999999998432 333333333333
Q ss_pred CCCC-CCCccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCccCc
Q 039291 237 HSLP-EIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGV 280 (362)
Q Consensus 237 ~~~~-~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~~~~ 280 (362)
+... .-|...++++.++|..||..|..+||+..++++|||+++.
T Consensus 244 PPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hpFi~e~ 288 (953)
T KOG0587|consen 244 PPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKHPFITEQ 288 (953)
T ss_pred CCccccchhhHHHHHHHHHHHHHhhccccCcchhhhccCCccccc
Confidence 3222 2356789999999999999999999999999999999853
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-42 Score=287.87 Aligned_cols=266 Identities=22% Similarity=0.336 Sum_probs=209.0
Q ss_pred CCCceeecceecccCceEEEEEEECCCCCCCCceeeeechhhh-----hhHHHHHHHHHHHHcCCCCcccccccceeeec
Q 039291 4 DGTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVS-----ASASLQKEKEVFDNLNGCPFVLECFGEEITMG 78 (362)
Q Consensus 4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~~-----~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~ 78 (362)
.++.|.-..+||+|.||+|++|+.+++++ +|++|+..-+ .-....+|+++|..|. |+|++.++.++....
T Consensus 15 ~~~~yek~~kigqGtfgeVFkAr~~n~~k----kvalkkvlmeneKeGfpitalreikiL~~lk-Henv~nliEic~tk~ 89 (376)
T KOG0669|consen 15 EVSKYEKLAKIGQGTFGEVFKARSKNTGK----KVALKKVLMENEKEGFPITALREIKILQLLK-HENVVNLIEICRTKA 89 (376)
T ss_pred cchHHHHHHhcCCchHHHHHHHhhcCccc----hhHHHHHHHhccccCCcHHHHHHHHHHHHhc-chhHHHHHHHHhhcc
Confidence 45678888999999999999999988875 5666654322 2234679999999999 999999988775421
Q ss_pred ---CCCceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEE
Q 039291 79 ---ENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVA 155 (362)
Q Consensus 79 ---~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~ 155 (362)
......+|+|+++|+. +|..++... ..+++..++..++.+|+.||.|+|++.|+|||+|+.|+|+ +.++++
T Consensus 90 Tp~~r~r~t~ylVf~~ceh-DLaGlLsn~-~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLI----t~dgil 163 (376)
T KOG0669|consen 90 TPTNRDRATFYLVFDFCEH-DLAGLLSNR-KVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLI----TKDGIL 163 (376)
T ss_pred CCcccccceeeeeHHHhhh-hHHHHhcCc-cccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEE----cCCceE
Confidence 1223457899999975 999999763 3569999999999999999999999999999999999999 899999
Q ss_pred EEeecCCcccccccccC--CCCCCccCCCCccCchhhcc-ccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHH
Q 039291 156 KIADLGVAKRSRHCKRQ--KFDPSMRGTPLYLAPETVVQ-HMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSI 232 (362)
Q Consensus 156 kl~Dfgla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~ 232 (362)
||+|||+++........ ...+..+-|.+|++||.+.+ +.|+++.|||..|||+.||.++.+-+.+..+....+++..
T Consensus 164 klADFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~ 243 (376)
T KOG0669|consen 164 KLADFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQ 243 (376)
T ss_pred EeeccccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHH
Confidence 99999999754432211 12235567999999999997 5889999999999999999999998877765544455544
Q ss_pred HcCCCC---CCC--------------CCc-------------cCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCccCc
Q 039291 233 IGDEHS---LPE--------------IPS-------------RVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGV 280 (362)
Q Consensus 233 ~~~~~~---~~~--------------~~~-------------~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~~~~ 280 (362)
+..... +|. ++. .-++++.+|+.++|..||.+|+++.++++|.||..-
T Consensus 244 LcGs~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~kd 321 (376)
T KOG0669|consen 244 LCGSITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWKD 321 (376)
T ss_pred HhccCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhcC
Confidence 432221 111 110 124578899999999999999999999999999654
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=300.40 Aligned_cols=269 Identities=26% Similarity=0.407 Sum_probs=210.7
Q ss_pred CCCceeecceecccCceEEEEEEECCCCCCCCceeeeechhh--hhhHHHHHHHHHHHHcCC-------CCcccccccce
Q 039291 4 DGTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEV--SASASLQKEKEVFDNLNG-------CPFVLECFGEE 74 (362)
Q Consensus 4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~--~~~~~~~~E~~il~~l~~-------h~~i~~~~~~~ 74 (362)
.++||.+.++||.|.|++||+|.|..+..+ ||+|+.+. .-.+....|+++|+++.. ...||++++.+
T Consensus 76 ~~gRY~v~rKLGWGHFSTVWLawDtq~~r~----VAlKVvKSAqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~F 151 (590)
T KOG1290|consen 76 NGGRYHVQRKLGWGHFSTVWLAWDTQNKRY----VALKVVKSAQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHF 151 (590)
T ss_pred cCceEEEEEeccccccceeEEEeeccCCeE----EEEEEEehhhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccc
Confidence 358999999999999999999999987754 45555432 234557789999999863 34799999999
Q ss_pred eeecCCCceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCceeCCCCCCCEEE--------
Q 039291 75 ITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHD-SGYVHCDVKPDNILL-------- 145 (362)
Q Consensus 75 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~-~~ivH~Dlkp~Nill-------- 145 (362)
...+.++.. +|+|+|++ |.+|..+|.+...+.++...++.|++||+.||.|||. .||||.||||+|||+
T Consensus 152 khsGpNG~H-VCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl~~~e~~~~ 229 (590)
T KOG1290|consen 152 KHSGPNGQH-VCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLLCSTEIDPA 229 (590)
T ss_pred eecCCCCcE-EEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeeeeccccchh
Confidence 988887665 78999999 7799999999888899999999999999999999996 699999999999999
Q ss_pred --------------------------------------------------------------------------------
Q 039291 146 -------------------------------------------------------------------------------- 145 (362)
Q Consensus 146 -------------------------------------------------------------------------------- 145 (362)
T Consensus 230 ~~~~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~~~s~n~~~~~ 309 (590)
T KOG1290|consen 230 KDAREAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPNQESYNNEPRI 309 (590)
T ss_pred hhhhhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhcccccccccccccccccccCC
Confidence
Q ss_pred ---------------------------ee-----------------------------------------------cCCC
Q 039291 146 ---------------------------VA-----------------------------------------------TQSG 151 (362)
Q Consensus 146 ---------------------------~~-----------------------------------------------~~~~ 151 (362)
.. .+..
T Consensus 310 n~~~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~v~p~~~~~~~ 389 (590)
T KOG1290|consen 310 NGNESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPLVNPDIPLPEC 389 (590)
T ss_pred CccccchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCccccccccccCCCCCCCcc
Confidence 00 0011
Q ss_pred ceEEEEeecCCcccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHhCCCCCccCCCC-------
Q 039291 152 KFVAKIADLGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDC------- 224 (362)
Q Consensus 152 ~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~------- 224 (362)
+..|||+|||-|.... ..-+.-+.|+.|+|||++.+..|+..+||||++|+++||+||...|......
T Consensus 390 di~vKIaDlGNACW~~-----khFT~DIQTRQYRapEVllGsgY~~~ADiWS~AC~~FELaTGDyLFePhsG~~Y~rDED 464 (590)
T KOG1290|consen 390 DIRVKIADLGNACWVH-----KHFTEDIQTRQYRAPEVLLGSGYSTSADIWSTACMAFELATGDYLFEPHSGENYSRDED 464 (590)
T ss_pred ceeEEEeeccchhhhh-----hhhchhhhhhhccCcceeecCCCCCchhHHHHHHHHHHhhcCceeecCCCCCCCCccHH
Confidence 2358999999885433 2234566899999999999999999999999999999999999999754322
Q ss_pred CHHHHHHHHcCC---------------------------CCCC---------CCCccCCHHHHHHHHHHhccCCCCCCCH
Q 039291 225 SIDQLFSIIGDE---------------------------HSLP---------EIPSRVSKEARDFLRRCFVRKPAFRFTA 268 (362)
Q Consensus 225 ~~~~~~~~~~~~---------------------------~~~~---------~~~~~~~~~~~~li~~~l~~~p~~R~s~ 268 (362)
.+..++..++.- ..+| .++..-..++.+||.-||+.+|++|+||
T Consensus 465 HiA~i~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmLef~PeKR~tA 544 (590)
T KOG1290|consen 465 HIALIMELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPMLEFDPEKRPTA 544 (590)
T ss_pred HHHHHHHHHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHHhcCccccccH
Confidence 222333322210 0111 1122334668899999999999999999
Q ss_pred HHHhcCCCccCcchh
Q 039291 269 EMLLDDPFVKGVDEE 283 (362)
Q Consensus 269 ~~~l~~p~~~~~~~~ 283 (362)
.++|+|||+..+...
T Consensus 545 ~~cl~hPwLn~~~~~ 559 (590)
T KOG1290|consen 545 AQCLKHPWLNPVAGP 559 (590)
T ss_pred HHHhcCccccCCCCC
Confidence 999999999876543
|
|
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-40 Score=295.77 Aligned_cols=256 Identities=20% Similarity=0.334 Sum_probs=201.7
Q ss_pred CCCCCceeecceecccCceEEEEEEECCCCCCCCceeeeechhh----hhhHHHHHHHHHHHHcCCCCcccccccceeee
Q 039291 2 DSDGTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEV----SASASLQKEKEVFDNLNGCPFVLECFGEEITM 77 (362)
Q Consensus 2 ~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~----~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~ 77 (362)
++..++|...+.||+|+||.||+|+++.++.. ...+++|.... .....+..|+++++.+. |+|++++++.+..
T Consensus 1 ~i~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~-~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~- 77 (268)
T cd05063 1 EIHPSHITKQKVIGAGEFGEVFRGILKMPGRK-EVAVAIKTLKPGYTEKQRQDFLSEASIMGQFS-HHNIIRLEGVVTK- 77 (268)
T ss_pred CCChHHceEeeEecCCCCccEEEEEEecCCCC-ceEEEEEeccccCCHHHHHHHHHHHHHHhcCC-CCCeeEEEEEEcc-
Confidence 35677899999999999999999998765432 13566666532 23456788999999998 8999999886642
Q ss_pred cCCCceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEE
Q 039291 78 GENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKI 157 (362)
Q Consensus 78 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl 157 (362)
....++||||+++++|.+++... ...+++..+..++.|++.||+|||+.|++|+||||+||++ +.++.++|
T Consensus 78 ----~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili----~~~~~~kl 148 (268)
T cd05063 78 ----FKPAMIITEYMENGALDKYLRDH-DGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILV----NSNLECKV 148 (268)
T ss_pred ----CCCcEEEEEcCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEE----cCCCcEEE
Confidence 22367999999999999999763 3568999999999999999999999999999999999999 67778999
Q ss_pred eecCCcccccccccCCCC-CCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHh-CCCCCccCCCCCHHHHHHHHcC
Q 039291 158 ADLGVAKRSRHCKRQKFD-PSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLS-GRQAWVVKEDCSIDQLFSIIGD 235 (362)
Q Consensus 158 ~Dfgla~~~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~ 235 (362)
+|||++............ .....+..|+|||++.+..++.++|||||||++|+|++ |..||.... ..+....+..
T Consensus 149 ~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~---~~~~~~~i~~ 225 (268)
T cd05063 149 SDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMS---NHEVMKAIND 225 (268)
T ss_pred CCCccceecccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCC---HHHHHHHHhc
Confidence 999998755432221111 11223457999999988888999999999999999997 999996443 3444444444
Q ss_pred CCCCCCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhc
Q 039291 236 EHSLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLD 273 (362)
Q Consensus 236 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~ 273 (362)
....+ .+..++.++.+++.+||..+|++||++.++++
T Consensus 226 ~~~~~-~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~ 262 (268)
T cd05063 226 GFRLP-APMDCPSAVYQLMLQCWQQDRARRPRFVDIVN 262 (268)
T ss_pred CCCCC-CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 33332 34568899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=296.50 Aligned_cols=244 Identities=25% Similarity=0.416 Sum_probs=191.7
Q ss_pred ceecccCceEEEEEEECCCCCCCCceeeeechh----hhhhHHHHHHHHHHHHcCCCCcccccccceeeecCCCceEEEE
Q 039291 12 RVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAE----VSASASLQKEKEVFDNLNGCPFVLECFGEEITMGENGEMAYNL 87 (362)
Q Consensus 12 ~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~----~~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~~~~~~~l 87 (362)
+.||+|+||.||+|+++.++..+ .+++|... ......+.+|+.++.++.+||||+++++.+.. ...+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~--~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~-----~~~~~l 73 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRM--DAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEH-----RGYLYL 73 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCee--EEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEec-----CCCceE
Confidence 46999999999999998765422 34555443 23445678899999999779999999987643 224679
Q ss_pred EEEecCCCCHHHHHHHhc--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCce
Q 039291 88 LLEYAAGGTLGDLIEKCN--------------GNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKF 153 (362)
Q Consensus 88 v~e~~~~~~L~~~l~~~~--------------~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~ 153 (362)
+|||+++++|.+++.... ...+++..+..++.|++.||+|||++|++||||||+||++ +.++
T Consensus 74 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili----~~~~ 149 (270)
T cd05047 74 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILV----GENY 149 (270)
T ss_pred EEEeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEE----cCCC
Confidence 999999999999997632 1247899999999999999999999999999999999999 7788
Q ss_pred EEEEeecCCcccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHh-CCCCCccCCCCCHHHHHHH
Q 039291 154 VAKIADLGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLS-GRQAWVVKEDCSIDQLFSI 232 (362)
Q Consensus 154 ~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~ 232 (362)
.+||+|||++......... .....+..|+|||++....++.++|+|||||++|+|++ |..||... +.......
T Consensus 150 ~~kl~dfgl~~~~~~~~~~---~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~---~~~~~~~~ 223 (270)
T cd05047 150 VAKIADFGLSRGQEVYVKK---TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGM---TCAELYEK 223 (270)
T ss_pred eEEECCCCCccccchhhhc---cCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCcccc---CHHHHHHH
Confidence 9999999998532211111 12234567999999988889999999999999999997 99999543 33444444
Q ss_pred HcCCCCCCCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhc
Q 039291 233 IGDEHSLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLD 273 (362)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~ 273 (362)
+..... ...+..++.++.+++.+||..+|.+|||+.+++.
T Consensus 224 ~~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 263 (270)
T cd05047 224 LPQGYR-LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILV 263 (270)
T ss_pred HhCCCC-CCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHH
Confidence 433322 2345568899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-40 Score=291.73 Aligned_cols=249 Identities=33% Similarity=0.639 Sum_probs=205.2
Q ss_pred ceeecceecccCceEEEEEEECCCCCCCCceeeeechhh-----hhhHHHHHHHHHHHHcCCCCcccccccceeeecCCC
Q 039291 7 SWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEV-----SASASLQKEKEVFDNLNGCPFVLECFGEEITMGENG 81 (362)
Q Consensus 7 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~-----~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~~ 81 (362)
+|.+.+.||+|++|.||+|++..++. .+++|.... .....+.+|+++++++. |+|++++++.+..
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~----~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~----- 70 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGD----FVAIKQISLEKIKEEALKSIMQEIDLLKNLK-HPNIVKYIGSIET----- 70 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCc----EEEEEEecccccCHHHHHHHHHHHHHHHhCC-CCCccEEEEEEEe-----
Confidence 58899999999999999999987765 345555432 24456889999999998 8999998876542
Q ss_pred ceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEeecC
Q 039291 82 EMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLG 161 (362)
Q Consensus 82 ~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Dfg 161 (362)
...++++|||+++++|.+++... ..+++..+..++.|++.||.|||+.||+|+||||+||++ +.++.++|+|||
T Consensus 71 ~~~~~~v~e~~~~~~L~~~~~~~--~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i----~~~~~~~l~d~~ 144 (254)
T cd06627 71 SDSLYIILEYAENGSLRQIIKKF--GPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILT----TKDGVVKLADFG 144 (254)
T ss_pred CCEEEEEEecCCCCcHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEE----CCCCCEEEeccc
Confidence 24577999999999999999873 569999999999999999999999999999999999999 667789999999
Q ss_pred CcccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHHcCCCCCCC
Q 039291 162 VAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEHSLPE 241 (362)
Q Consensus 162 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 241 (362)
++......... .....++..|+|||.+.+...+.++|+||+|+++++|++|..||.... ......... ....+.
T Consensus 145 ~~~~~~~~~~~--~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~--~~~~~~~~~--~~~~~~ 218 (254)
T cd06627 145 VATKLNDVSKD--DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLN--PMAALFRIV--QDDHPP 218 (254)
T ss_pred cceecCCCccc--ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCcc--HHHHHHHHh--ccCCCC
Confidence 99766543221 234568999999999988778899999999999999999999996443 222232322 223345
Q ss_pred CCccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCc
Q 039291 242 IPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFV 277 (362)
Q Consensus 242 ~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~ 277 (362)
++..++..+++++.+||..+|++||++.+++.||||
T Consensus 219 ~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~~ 254 (254)
T cd06627 219 LPEGISPELKDFLMQCFQKDPNLRPTAKQLLKHPWI 254 (254)
T ss_pred CCCCCCHHHHHHHHHHHhCChhhCcCHHHHhcCCCC
Confidence 667789999999999999999999999999999997
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-41 Score=307.92 Aligned_cols=252 Identities=25% Similarity=0.405 Sum_probs=194.8
Q ss_pred CceeecceecccCceEEEEEEECCCCCCCCceeeeechhhhh---hHHHHHHHHHHHHcCCCCcccccccceeeecCCCc
Q 039291 6 TSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVSA---SASLQKEKEVFDNLNGCPFVLECFGEEITMGENGE 82 (362)
Q Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~~~---~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~~~ 82 (362)
+.|.....||+|+||.||+|...+. ..||+|...... ...|.+|+.++.+++ |||+++++|++.....
T Consensus 75 ~~Fs~~~~ig~Ggfg~VYkG~l~~~-----~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~-H~Nlv~LlGyC~e~~~--- 145 (361)
T KOG1187|consen 75 NNFSESNLIGEGGFGTVYKGVLSDG-----TVVAVKRLSSNSGQGEREFLNEVEILSRLR-HPNLVKLLGYCLEGGE--- 145 (361)
T ss_pred hCCchhcceecCCCeEEEEEEECCC-----CEEEEEEecCCCCcchhHHHHHHHHHhcCC-CcCcccEEEEEecCCc---
Confidence 5777889999999999999998775 367888765433 466999999999999 9999999999874321
Q ss_pred eEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCCCCEEEeecCCCceEEEEee
Q 039291 83 MAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSG---YVHCDVKPDNILLVATQSGKFVAKIAD 159 (362)
Q Consensus 83 ~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~---ivH~Dlkp~Nill~~~~~~~~~~kl~D 159 (362)
..+||+||+++|+|.++|......+++|....+|+.++++||+|||... |||||||++|||+ |++.++||+|
T Consensus 146 -~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILL----D~~~~aKlsD 220 (361)
T KOG1187|consen 146 -HRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILL----DEDFNAKLSD 220 (361)
T ss_pred -eEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeE----CCCCCEEccC
Confidence 3569999999999999998743327999999999999999999999854 9999999999999 9999999999
Q ss_pred cCCcccccccccCCCCCCc-cCCCCccCchhhccccCCCcchHHHHHHHHHHHHhCCCCCccCC---CCCHHHHH-HHHc
Q 039291 160 LGVAKRSRHCKRQKFDPSM-RGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKE---DCSIDQLF-SIIG 234 (362)
Q Consensus 160 fgla~~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~---~~~~~~~~-~~~~ 234 (362)
||+|+..... ....... .||.+|+|||++..+..+.++|||||||+|.||++|+.+..... .....+.. ..+.
T Consensus 221 FGLa~~~~~~--~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~ 298 (361)
T KOG1187|consen 221 FGLAKLGPEG--DTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLE 298 (361)
T ss_pred ccCcccCCcc--ccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHH
Confidence 9999644431 1111122 79999999999998889999999999999999999998876432 11122211 1111
Q ss_pred CCC----CCCCCC-ccCC-----HHHHHHHHHHhccCCCCCCCHHHHhc
Q 039291 235 DEH----SLPEIP-SRVS-----KEARDFLRRCFVRKPAFRFTAEMLLD 273 (362)
Q Consensus 235 ~~~----~~~~~~-~~~~-----~~~~~li~~~l~~~p~~R~s~~~~l~ 273 (362)
... ..|.+. ...+ ..+..+..+|++.+|.+||+..++++
T Consensus 299 ~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~ 347 (361)
T KOG1187|consen 299 EGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVK 347 (361)
T ss_pred CcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHH
Confidence 111 112221 1222 23557778999999999999988643
|
|
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=308.22 Aligned_cols=261 Identities=21% Similarity=0.337 Sum_probs=200.0
Q ss_pred CCCceeecceecccCceEEEEEEECCCCCCCCceeeeechhh-----hhhHHHHHHHHHHHHcCCCCcccccccceeeec
Q 039291 4 DGTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEV-----SASASLQKEKEVFDNLNGCPFVLECFGEEITMG 78 (362)
Q Consensus 4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~-----~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~ 78 (362)
..++|.+.+.||+|+||.||+|.+..++. .+++|.... .....+.+|+.++++++ ||||+++++++....
T Consensus 15 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~----~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~-h~~iv~~~~~~~~~~ 89 (345)
T cd07877 15 VPERYQNLSPVGSGAYGSVCAAFDTKTGL----RVAVKKLSRPFQSIIHAKRTYRELRLLKHMK-HENVIGLLDVFTPAR 89 (345)
T ss_pred ccCceEEEEEeeecCCeEEEEEEEcCCCe----EEEEEEecCcchhhHHHHHHHHHHHHHHHcC-CCcccceeeeeeecc
Confidence 45889999999999999999999887765 556665432 23456778999999998 899999998764322
Q ss_pred C-CCceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEE
Q 039291 79 E-NGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKI 157 (362)
Q Consensus 79 ~-~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl 157 (362)
. .....++++++++ |++|.++++. ..+++..++.++.|++.||+|||++||+||||||+||++ +.++.++|
T Consensus 90 ~~~~~~~~~lv~~~~-~~~L~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll----~~~~~~kl 161 (345)
T cd07877 90 SLEEFNDVYLVTHLM-GADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV----NEDCELKI 161 (345)
T ss_pred cccccccEEEEehhc-ccCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEE----cCCCCEEE
Confidence 1 1223466888887 7799988864 359999999999999999999999999999999999999 77788999
Q ss_pred eecCCcccccccccCCCCCCccCCCCccCchhhcc-ccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHH-HHHc-
Q 039291 158 ADLGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQ-HMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLF-SIIG- 234 (362)
Q Consensus 158 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~-~~~~- 234 (362)
+|||++...... .....|+..|+|||++.+ ..++.++|||||||++|+|++|++||...+........ ....
T Consensus 162 ~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~ 236 (345)
T cd07877 162 LDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGT 236 (345)
T ss_pred eccccccccccc-----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Confidence 999998754321 124568999999999876 46788999999999999999999999654321111100 0000
Q ss_pred -------------------CCCCCC-----CCCccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCccCcch
Q 039291 235 -------------------DEHSLP-----EIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGVDE 282 (362)
Q Consensus 235 -------------------~~~~~~-----~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~~~~~~ 282 (362)
.....+ ......+++++++|.+||+.||.+|+++.+++.||||++...
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~~~~~ 308 (345)
T cd07877 237 PGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 308 (345)
T ss_pred CCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhhhcCC
Confidence 000000 111235788999999999999999999999999999987543
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=307.16 Aligned_cols=260 Identities=23% Similarity=0.380 Sum_probs=197.7
Q ss_pred CCCceee-cceecccCceEEEEEEECCCCCCCCceeeeechhhhh-----------------hHHHHHHHHHHHHcCCCC
Q 039291 4 DGTSWFR-GRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVSA-----------------SASLQKEKEVFDNLNGCP 65 (362)
Q Consensus 4 ~~~~y~~-~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~~~-----------------~~~~~~E~~il~~l~~h~ 65 (362)
..+||.. .+.||+|+||+||+|+++.++. .+++|...... ...+.+|+.+++.++ |+
T Consensus 6 ~~~ry~~~~~~ig~G~~g~vy~~~~~~~~~----~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~ 80 (335)
T PTZ00024 6 ISERYIQKGAHLGEGTYGKVEKAYDTLTGK----IVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIK-HE 80 (335)
T ss_pred cccchhhhhhcccCCCceeEEEEEECCCCC----eEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCC-Cc
Confidence 3577865 5889999999999999987765 45555543221 124678999999998 89
Q ss_pred cccccccceeeecCCCceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEE
Q 039291 66 FVLECFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILL 145 (362)
Q Consensus 66 ~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill 145 (362)
||+++++.+.. ...+++||||+. ++|.+++.. ...+++..+..++.|++.||+|||+.||+|+||||+||++
T Consensus 81 ~iv~~~~~~~~-----~~~~~lv~e~~~-~~l~~~l~~--~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill 152 (335)
T PTZ00024 81 NIMGLVDVYVE-----GDFINLVMDIMA-SDLKKVVDR--KIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFI 152 (335)
T ss_pred ceeeeeEEEec-----CCcEEEEEeccc-cCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEE
Confidence 99999987642 235789999997 599999875 3459999999999999999999999999999999999999
Q ss_pred eecCCCceEEEEeecCCcccccccc------------cCCCCCCccCCCCccCchhhccc-cCCCcchHHHHHHHHHHHH
Q 039291 146 VATQSGKFVAKIADLGVAKRSRHCK------------RQKFDPSMRGTPLYLAPETVVQH-MQEAPSDIWALGCVVLEML 212 (362)
Q Consensus 146 ~~~~~~~~~~kl~Dfgla~~~~~~~------------~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~l~ 212 (362)
+.++.++|+|||++....... .........++..|+|||.+.+. .++.++|+|||||++|+|+
T Consensus 153 ----~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~ 228 (335)
T PTZ00024 153 ----NSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELL 228 (335)
T ss_pred ----CCCCCEEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHH
Confidence 777889999999987554110 01111234578899999998764 4688999999999999999
Q ss_pred hCCCCCccCCCCCHHH-HHHHHcCCCC--C--------------------CCCCccCCHHHHHHHHHHhccCCCCCCCHH
Q 039291 213 SGRQAWVVKEDCSIDQ-LFSIIGDEHS--L--------------------PEIPSRVSKEARDFLRRCFVRKPAFRFTAE 269 (362)
Q Consensus 213 ~g~~pf~~~~~~~~~~-~~~~~~~~~~--~--------------------~~~~~~~~~~~~~li~~~l~~~p~~R~s~~ 269 (362)
+|.+||...+...... +......... + .......+.++.++|.+||+.+|++||+++
T Consensus 229 tg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~ 308 (335)
T PTZ00024 229 TGKPLFPGENEIDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAK 308 (335)
T ss_pred hCCCCCCCCCHHHHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHH
Confidence 9999996554321111 1111110000 0 011234578899999999999999999999
Q ss_pred HHhcCCCccCc
Q 039291 270 MLLDDPFVKGV 280 (362)
Q Consensus 270 ~~l~~p~~~~~ 280 (362)
+++.||||+..
T Consensus 309 ~~l~~~~~~~~ 319 (335)
T PTZ00024 309 EALKHEYFKSD 319 (335)
T ss_pred HHhcCcccCCC
Confidence 99999999765
|
|
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=299.28 Aligned_cols=253 Identities=28% Similarity=0.451 Sum_probs=196.5
Q ss_pred eeecceecccCceEEEEEEECCCCCCCCceeeeechhhh----hhHHHHHHHHHHHHcCCCCcccccccceeeecCCCce
Q 039291 8 WFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVS----ASASLQKEKEVFDNLNGCPFVLECFGEEITMGENGEM 83 (362)
Q Consensus 8 y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~~----~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~~~~ 83 (362)
|.+.+.||+|++|+||+|++..++. .+++|..... ......+|+..++++.+|+|++++++.+.. ..
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~----~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~-----~~ 71 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGE----LVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRE-----ND 71 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCc----EEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhc-----CC
Confidence 6789999999999999999987765 4566654322 233456799999999889999999997653 33
Q ss_pred EEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEeecCCc
Q 039291 84 AYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVA 163 (362)
Q Consensus 84 ~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Dfgla 163 (362)
..++||||+ +++|.+++....+..+++..+..++.|++.+|.|||++|++|+||+|.||++ +.++.++|+|||++
T Consensus 72 ~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i----~~~~~~~l~d~~~~ 146 (283)
T cd07830 72 ELYFVFEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLV----SGPEVVKIADFGLA 146 (283)
T ss_pred cEEEEEecC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEE----cCCCCEEEeecccc
Confidence 467999999 7799998887544568999999999999999999999999999999999999 77888999999998
Q ss_pred ccccccccCCCCCCccCCCCccCchhhcc-ccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHHcCCC-----
Q 039291 164 KRSRHCKRQKFDPSMRGTPLYLAPETVVQ-HMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEH----- 237 (362)
Q Consensus 164 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~----- 237 (362)
........ .....++..|+|||++.+ ..++.++|+||||+++++|++|++||......+............
T Consensus 147 ~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 223 (283)
T cd07830 147 REIRSRPP---YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDW 223 (283)
T ss_pred eeccCCCC---cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhh
Confidence 75543211 134568899999998854 457899999999999999999999996553221111111100000
Q ss_pred ------------CC--------CCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCc
Q 039291 238 ------------SL--------PEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFV 277 (362)
Q Consensus 238 ------------~~--------~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~ 277 (362)
.. .......+.+++++|++||..+|++||++++++.||||
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~~ 283 (283)
T cd07830 224 PEGYKLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF 283 (283)
T ss_pred hhHhhhhccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhCCCC
Confidence 00 01112236889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-40 Score=293.63 Aligned_cols=244 Identities=21% Similarity=0.354 Sum_probs=197.4
Q ss_pred CCCceeecceecccCceEEEEEEECCCCCCCCceeeeechhhh-hhHHHHHHHHHHHHcCCCCcccccccceeeecCCCc
Q 039291 4 DGTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVS-ASASLQKEKEVFDNLNGCPFVLECFGEEITMGENGE 82 (362)
Q Consensus 4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~~-~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~~~ 82 (362)
+.++|.+.+.||+|+||.||++... + ..+++|..... ....+.+|+.++++++ |||++++++.+.. +
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~--~----~~~~iK~~~~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~---~-- 71 (254)
T cd05083 4 NLQKLTLGEIIGEGEFGAVLQGEYT--G----QKVAVKNIKCDVTAQAFLEETAVMTKLH-HKNLVRLLGVILH---N-- 71 (254)
T ss_pred cHHHceeeeeeccCCCCceEecccC--C----CceEEEeecCcchHHHHHHHHHHHHhCC-CCCcCeEEEEEcC---C--
Confidence 3468999999999999999998643 2 24677765433 3456889999999998 8999999886542 1
Q ss_pred eEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEeecCC
Q 039291 83 MAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGV 162 (362)
Q Consensus 83 ~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Dfgl 162 (362)
.++++|||+.+++|.+++.......+++..+..++.|++.||.|||+.|++||||||+||++ +.++.++|+|||+
T Consensus 72 -~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili----~~~~~~kl~Dfg~ 146 (254)
T cd05083 72 -GLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILV----SEDGVAKVSDFGL 146 (254)
T ss_pred -CcEEEEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEE----cCCCcEEECCCcc
Confidence 25799999999999999987555568999999999999999999999999999999999999 7777899999999
Q ss_pred cccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHh-CCCCCccCCCCCHHHHHHHHcCCCCCCC
Q 039291 163 AKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLS-GRQAWVVKEDCSIDQLFSIIGDEHSLPE 241 (362)
Q Consensus 163 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 241 (362)
+....... .....+..|+|||.+.+..++.++|+|||||++|+|++ |..||... ...+....+..... +.
T Consensus 147 ~~~~~~~~-----~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~---~~~~~~~~~~~~~~-~~ 217 (254)
T cd05083 147 ARVGSMGV-----DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKM---SLKEVKECVEKGYR-ME 217 (254)
T ss_pred ceeccccC-----CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccC---CHHHHHHHHhCCCC-CC
Confidence 87543211 12334567999999988889999999999999999998 99999544 34444444444332 23
Q ss_pred CCccCCHHHHHHHHHHhccCCCCCCCHHHHhc
Q 039291 242 IPSRVSKEARDFLRRCFVRKPAFRFTAEMLLD 273 (362)
Q Consensus 242 ~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~ 273 (362)
.+..++.++.+++.+||..+|++||++++++.
T Consensus 218 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 249 (254)
T cd05083 218 PPEGCPADVYVLMTSCWETEPKKRPSFHKLRE 249 (254)
T ss_pred CCCcCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 45678899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=306.49 Aligned_cols=258 Identities=23% Similarity=0.352 Sum_probs=200.5
Q ss_pred CCCceeecceecccCceEEEEEEECCCCCCCCceeeeechh-----hhhhHHHHHHHHHHHHcCCCCcccccccceeeec
Q 039291 4 DGTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAE-----VSASASLQKEKEVFDNLNGCPFVLECFGEEITMG 78 (362)
Q Consensus 4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~-----~~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~ 78 (362)
.+++|.+.+.||+|+||.||+|.++.++. .+++|... ......+.+|+.+++.++ ||||+++++.+...
T Consensus 8 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~----~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~- 81 (328)
T cd07856 8 ITNRYVDLQPVGMGAFGLVCSARDQLTGQ----NVAIKKIMKPFSTPVLAKRTYRELKLLKHLR-HENIISLSDIFISP- 81 (328)
T ss_pred cccceEEEEeecccCCeEEEEEEECCCCC----EEEEEEecccccccchhHHHHHHHHHHHhcC-CCCeeeEeeeEecC-
Confidence 46889999999999999999999988876 44555432 223456788999999998 89999998876421
Q ss_pred CCCceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEe
Q 039291 79 ENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIA 158 (362)
Q Consensus 79 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~ 158 (362)
...+++++||+ +++|.+++.. .++++..+..++.|++.||.|||++||+||||+|+||++ +.++.++|+
T Consensus 82 ---~~~~~lv~e~~-~~~L~~~~~~---~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili----~~~~~~~l~ 150 (328)
T cd07856 82 ---LEDIYFVTELL-GTDLHRLLTS---RPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILI----NENCDLKIC 150 (328)
T ss_pred ---CCcEEEEeehh-ccCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeE----CCCCCEEeC
Confidence 22467999998 5689888864 458999999999999999999999999999999999999 777889999
Q ss_pred ecCCcccccccccCCCCCCccCCCCccCchhhcc-ccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHH--------
Q 039291 159 DLGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQ-HMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQL-------- 229 (362)
Q Consensus 159 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~-------- 229 (362)
|||++...... .....++..|+|||++.+ ..++.++|+|||||++|+|++|++||...+.......
T Consensus 151 dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~ 225 (328)
T cd07856 151 DFGLARIQDPQ-----MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTP 225 (328)
T ss_pred ccccccccCCC-----cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence 99998643321 124567889999998866 5688999999999999999999999965432111100
Q ss_pred ----H------------HHHcCCCCC--CCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCccCcchh
Q 039291 230 ----F------------SIIGDEHSL--PEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGVDEE 283 (362)
Q Consensus 230 ----~------------~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~~~~~~~ 283 (362)
. ......... ......++.+++++|++||+.+|++||++++++.||||......
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~~~~~ 297 (328)
T cd07856 226 PDDVINTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPYHDP 297 (328)
T ss_pred CHHHHHhccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCccccccCC
Confidence 0 000000000 01123467899999999999999999999999999999776544
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-40 Score=300.87 Aligned_cols=262 Identities=24% Similarity=0.359 Sum_probs=199.3
Q ss_pred CCCceeecceecccCceEEEEEEECCCCCCCCceeeeechhh-----hhhHHHHHHHHHHHHcCCCCcccccccceeeec
Q 039291 4 DGTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEV-----SASASLQKEKEVFDNLNGCPFVLECFGEEITMG 78 (362)
Q Consensus 4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~-----~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~ 78 (362)
.-++|.+.+.||+|+||.||+|.++.++. .+++|.... .....+.+|+.++++++ ||||+++++++....
T Consensus 5 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~----~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~-h~~i~~~~~~~~~~~ 79 (302)
T cd07864 5 CVDKFDIIGQIGEGTYGQVYKARDKDTGE----LVALKKVRLDNEKEGFPITAIREIKILRQLN-HRNIVNLKEIVTDKQ 79 (302)
T ss_pred hhhhhheeeeecccCCEEEEEEEECCCCc----EEEEEEEeecccccCchHHHHHHHHHHHhCC-CCCeeeeeheecCcc
Confidence 35789999999999999999999988775 445555432 23345678999999998 999999998765322
Q ss_pred -----CCCceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCce
Q 039291 79 -----ENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKF 153 (362)
Q Consensus 79 -----~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~ 153 (362)
......+++|+||+++ ++..++... ...+++..++.++.|++.||.|||+.||+|+||||+||++ +.++
T Consensus 80 ~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili----~~~~ 153 (302)
T cd07864 80 DALDFKKDKGAFYLVFEYMDH-DLMGLLESG-LVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILL----NNKG 153 (302)
T ss_pred hhhhccccCCcEEEEEcccCc-cHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE----CCCC
Confidence 0122367899999986 777777653 3469999999999999999999999999999999999999 7788
Q ss_pred EEEEeecCCcccccccccCCCCCCccCCCCccCchhhcc-ccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHH
Q 039291 154 VAKIADLGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQ-HMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSI 232 (362)
Q Consensus 154 ~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~ 232 (362)
.+||+|||++.......... .....++..|+|||++.+ ..++.++|||||||++++|++|++||...+.......+..
T Consensus 154 ~~kl~dfg~~~~~~~~~~~~-~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~ 232 (302)
T cd07864 154 QIKLADFGLARLYNSEESRP-YTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISR 232 (302)
T ss_pred cEEeCcccccccccCCcccc-cccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Confidence 89999999987554322211 122346788999998875 3578899999999999999999999965433222212222
Q ss_pred HcCCCC---CC----------------------CCCccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCc
Q 039291 233 IGDEHS---LP----------------------EIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFV 277 (362)
Q Consensus 233 ~~~~~~---~~----------------------~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~ 277 (362)
...... ++ .....++..+.+++.+||..||.+||++.+++.||||
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 302 (302)
T cd07864 233 LCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPWL 302 (302)
T ss_pred HhCCCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcCCCC
Confidence 111110 00 0122468999999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-40 Score=289.83 Aligned_cols=248 Identities=27% Similarity=0.508 Sum_probs=201.8
Q ss_pred ceeecceecccCceEEEEEEECCCCCCCCceeeeechhhh---hhHHHHHHHHHHHHcCCCCcccccccceeeecCCCce
Q 039291 7 SWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVS---ASASLQKEKEVFDNLNGCPFVLECFGEEITMGENGEM 83 (362)
Q Consensus 7 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~~---~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~~~~ 83 (362)
.|...+.||+|++|.||+|.+..++. .+++|..... ....+.+|+.+++.++ |++++++++.+... .
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~----~~~~k~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~-----~ 70 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGK----EVAIKVIKLESKEKKEKIINEIQILKKCK-HPNIVKYYGSYLKK-----D 70 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCc----EEEEEEecccchhHHHHHHHHHHHHHhCC-CCCEeEEEEEEecC-----C
Confidence 37889999999999999999987664 5666665433 4567889999999999 99999998866432 3
Q ss_pred EEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEeecCCc
Q 039291 84 AYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVA 163 (362)
Q Consensus 84 ~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Dfgla 163 (362)
..++++||+++++|.+++.... ..+++..+..++.|++.||.|||++|++|+||+|+||++ +.++.++|+|||.+
T Consensus 71 ~~~l~~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i----~~~~~~~l~d~~~~ 145 (253)
T cd05122 71 ELWIVMEFCSGGSLKDLLKSTN-QTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILL----TSDGEVKLIDFGLS 145 (253)
T ss_pred eEEEEEecCCCCcHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEE----ccCCeEEEeecccc
Confidence 4679999999999999998742 469999999999999999999999999999999999999 67788999999998
Q ss_pred ccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHHcCCCCCCCCC
Q 039291 164 KRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEHSLPEIP 243 (362)
Q Consensus 164 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (362)
........ .....++..|+|||.+.+...+.++|+||||+++++|++|..||...+. ......... ...+..+
T Consensus 146 ~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~---~~~~~~~~~-~~~~~~~ 218 (253)
T cd05122 146 AQLSDTKA---RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPP---MKALFKIAT-NGPPGLR 218 (253)
T ss_pred cccccccc---ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCch---HHHHHHHHh-cCCCCcC
Confidence 76554321 2356689999999999988889999999999999999999999964432 222112211 2222233
Q ss_pred cc--CCHHHHHHHHHHhccCCCCCCCHHHHhcCCC
Q 039291 244 SR--VSKEARDFLRRCFVRKPAFRFTAEMLLDDPF 276 (362)
Q Consensus 244 ~~--~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~ 276 (362)
.. ++.++.++|.+||..||++|||+.+++.|||
T Consensus 219 ~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~~~ 253 (253)
T cd05122 219 NPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKHPF 253 (253)
T ss_pred cccccCHHHHHHHHHHccCChhhCCCHHHHhcCCC
Confidence 22 4899999999999999999999999999998
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=300.64 Aligned_cols=260 Identities=18% Similarity=0.292 Sum_probs=195.2
Q ss_pred CCCceeecceecccCceEEEEEEECCCCCC------------CCceeeeechhhh----hhHHHHHHHHHHHHcCCCCcc
Q 039291 4 DGTSWFRGRVIGQGSFGCVFIAKPKSNSSF------------LPPLMAVKSAEVS----ASASLQKEKEVFDNLNGCPFV 67 (362)
Q Consensus 4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~------------~~~~~~~K~~~~~----~~~~~~~E~~il~~l~~h~~i 67 (362)
..++|++.+.||+|+||.||+|.+...... -...+++|..... ....+.+|+.+++.++ |+||
T Consensus 3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~-~~~i 81 (296)
T cd05095 3 PRKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLK-DPNI 81 (296)
T ss_pred ChhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCC-CCCc
Confidence 357899999999999999999976542211 1135677766432 3456889999999998 8999
Q ss_pred cccccceeeecCCCceEEEEEEEecCCCCHHHHHHHhcC---------CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCC
Q 039291 68 LECFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNG---------NGLPEKDVRHFTRCILEGIGHIHDSGYVHCDV 138 (362)
Q Consensus 68 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~---------~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dl 138 (362)
+++++.+... ...+++|||+.+++|.+++..... ..+++.++..++.|++.||+|||+.|++|+||
T Consensus 82 ~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl 156 (296)
T cd05095 82 IRLLAVCITS-----DPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDL 156 (296)
T ss_pred ceEEEEEecC-----CccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccC
Confidence 9999876432 236799999999999999976321 23778899999999999999999999999999
Q ss_pred CCCCEEEeecCCCceEEEEeecCCcccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHh--CCC
Q 039291 139 KPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLS--GRQ 216 (362)
Q Consensus 139 kp~Nill~~~~~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~--g~~ 216 (362)
||+|||+ +.++.++|+|||+++...............++..|+|||+..+..++.++|+|||||++|||++ |..
T Consensus 157 kp~Nili----~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~ 232 (296)
T cd05095 157 ATRNCLV----GKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQ 232 (296)
T ss_pred ChheEEE----cCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCC
Confidence 9999999 6677899999999875433221111123345678999999888889999999999999999998 678
Q ss_pred CCccCCCCCHHHHH-HHHc--CCCCCCCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhc
Q 039291 217 AWVVKEDCSIDQLF-SIIG--DEHSLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLD 273 (362)
Q Consensus 217 pf~~~~~~~~~~~~-~~~~--~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~ 273 (362)
||............ .... ........+..++..+.+|+.+||+.||++||++.++++
T Consensus 233 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~ 292 (296)
T cd05095 233 PYSQLSDEQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHA 292 (296)
T ss_pred CccccChHHHHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 88543322211111 1010 011111234567899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=307.09 Aligned_cols=256 Identities=23% Similarity=0.369 Sum_probs=197.8
Q ss_pred CCceeecceecccCceEEEEEEECCCCCCCCceeeeechhh-----hhhHHHHHHHHHHHHcCCCCcccccccceeeecC
Q 039291 5 GTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEV-----SASASLQKEKEVFDNLNGCPFVLECFGEEITMGE 79 (362)
Q Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~-----~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~ 79 (362)
.++|.+.+.||+|+||.||+|+++.++. .+++|.... .....+.+|+.+++.+. ||||+++++.+.....
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~----~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~ 88 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGE----KVAIKKLSRPFQSEIFAKRAYRELTLLKHMQ-HENVIGLLDVFTSAVS 88 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCc----EEEEEEecCccccccchhHHHHHHHHHHhcC-CCCccchhheeccccc
Confidence 4789999999999999999999987775 455554422 22345778999999998 9999999987653221
Q ss_pred -CCceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEe
Q 039291 80 -NGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIA 158 (362)
Q Consensus 80 -~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~ 158 (362)
.....+++|+||+.. +|..++. ..+++..+..++.|++.||.|||++|++||||||+||++ +.++.++|+
T Consensus 89 ~~~~~~~~lv~e~~~~-~l~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll----~~~~~~kL~ 159 (342)
T cd07879 89 GDEFQDFYLVMPYMQT-DLQKIMG----HPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAV----NEDCELKIL 159 (342)
T ss_pred CCCCceEEEEeccccc-CHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE----CCCCCEEEe
Confidence 122346799999964 7766542 358999999999999999999999999999999999999 777889999
Q ss_pred ecCCcccccccccCCCCCCccCCCCccCchhhcc-ccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHHcCC-
Q 039291 159 DLGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQ-HMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDE- 236 (362)
Q Consensus 159 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~- 236 (362)
|||+++..... .....++..|+|||++.+ ..++.++|+|||||++|+|++|+.||.+.+. ...+..+...
T Consensus 160 dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~---~~~~~~~~~~~ 231 (342)
T cd07879 160 DFGLARHADAE-----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDY---LDQLTQILKVT 231 (342)
T ss_pred eCCCCcCCCCC-----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHHhc
Confidence 99998754321 124568899999999876 4688899999999999999999999975432 1111111000
Q ss_pred --------------------CCCCC--------CCccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCccCcch
Q 039291 237 --------------------HSLPE--------IPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGVDE 282 (362)
Q Consensus 237 --------------------~~~~~--------~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~~~~~~ 282 (362)
...+. .....+.++.+||.+||+.||++||++++++.||||+....
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~ 305 (342)
T cd07879 232 GVPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRD 305 (342)
T ss_pred CCCCHHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhccc
Confidence 00011 11246788999999999999999999999999999987653
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-40 Score=290.88 Aligned_cols=249 Identities=27% Similarity=0.457 Sum_probs=205.0
Q ss_pred ceeecceecccCceEEEEEEECCCCCCCCceeeeechh-----hhhhHHHHHHHHHHHHcCCCCcccccccceeeecCCC
Q 039291 7 SWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAE-----VSASASLQKEKEVFDNLNGCPFVLECFGEEITMGENG 81 (362)
Q Consensus 7 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~-----~~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~~ 81 (362)
+|.+.+.||+|+||.||+++++.+++ .+++|... ......+.+|+.+++.++ |+||+++++.+..
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~----~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~----- 70 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQ----FYALKEVDLGSMSQKEREDAVNEIRILASVN-HPNIISYKEAFLD----- 70 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCC----EEEEEEEehhhccHHHHHHHHHHHHHHHhCC-CCCchhhhhhhcc-----
Confidence 58999999999999999999988775 44555433 233456778999999999 9999999887653
Q ss_pred ceEEEEEEEecCCCCHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEee
Q 039291 82 EMAYNLLLEYAAGGTLGDLIEKCN--GNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIAD 159 (362)
Q Consensus 82 ~~~~~lv~e~~~~~~L~~~l~~~~--~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~D 159 (362)
...+++||||+++++|.+++.... ...+++..++.++.|++.||.|||+.|++|+||+|.||++ +.++.++|+|
T Consensus 71 ~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~----~~~~~~kl~d 146 (256)
T cd08530 71 GNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILL----VANDLVKIGD 146 (256)
T ss_pred CCEEEEEehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEE----ecCCcEEEee
Confidence 245779999999999999986632 2458999999999999999999999999999999999999 5677899999
Q ss_pred cCCcccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHHcCCCCC
Q 039291 160 LGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEHSL 239 (362)
Q Consensus 160 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 239 (362)
||++...... ......++..|+|||.+.+..++.++|+||||+++++|++|+.||... +...+...+.. ...
T Consensus 147 ~g~~~~~~~~----~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~---~~~~~~~~~~~-~~~ 218 (256)
T cd08530 147 LGISKVLKKN----MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEAR---SMQDLRYKVQR-GKY 218 (256)
T ss_pred ccchhhhccC----CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCC---CHHHHHHHHhc-CCC
Confidence 9998766543 223456889999999999888899999999999999999999999654 33344333333 344
Q ss_pred CCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCc
Q 039291 240 PEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFV 277 (362)
Q Consensus 240 ~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~ 277 (362)
+..+...+.++++++.+||..+|++||++.+++.||++
T Consensus 219 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~p~~ 256 (256)
T cd08530 219 PPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILASPAV 256 (256)
T ss_pred CCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcCCCC
Confidence 55666789999999999999999999999999999974
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-40 Score=295.21 Aligned_cols=252 Identities=19% Similarity=0.331 Sum_probs=192.8
Q ss_pred ceecccCceEEEEEEECCCC--CCCCceeeeechhh----hhhHHHHHHHHHHHHcCCCCcccccccceeeecCCCceEE
Q 039291 12 RVIGQGSFGCVFIAKPKSNS--SFLPPLMAVKSAEV----SASASLQKEKEVFDNLNGCPFVLECFGEEITMGENGEMAY 85 (362)
Q Consensus 12 ~~lG~G~~g~V~~a~~~~~~--~~~~~~~~~K~~~~----~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~~~~~~ 85 (362)
+.||+|+||.||+|+++... ..-...+++|.... .....+.+|+.+++.++ ||||+++++.+.. ....
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~-----~~~~ 74 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFN-HPNIVKLLGVCLL-----NEPQ 74 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcC-CCCeeeEeeeecC-----CCCe
Confidence 46999999999999986543 11113455555432 34556889999999998 9999999987642 2236
Q ss_pred EEEEEecCCCCHHHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecC-CCceEEEEee
Q 039291 86 NLLLEYAAGGTLGDLIEKCN-----GNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQ-SGKFVAKIAD 159 (362)
Q Consensus 86 ~lv~e~~~~~~L~~~l~~~~-----~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~-~~~~~~kl~D 159 (362)
++||||+++++|.+++.... ...+++..+..++.|++.||.|||+.+++|+||||+||++..++ +....++|+|
T Consensus 75 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~d 154 (269)
T cd05044 75 YIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGD 154 (269)
T ss_pred EEEEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECC
Confidence 79999999999999997532 23488999999999999999999999999999999999994432 1223799999
Q ss_pred cCCcccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHh-CCCCCccCCCCCHHHHHHHHcCCCC
Q 039291 160 LGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLS-GRQAWVVKEDCSIDQLFSIIGDEHS 238 (362)
Q Consensus 160 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~ 238 (362)
||++................++..|+|||++.+..++.++|||||||++|+|++ |..||... ...+....+....
T Consensus 155 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~---~~~~~~~~~~~~~- 230 (269)
T cd05044 155 FGLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPAL---NNQEVLQHVTAGG- 230 (269)
T ss_pred cccccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCccc---CHHHHHHHHhcCC-
Confidence 999875543222222223446788999999998889999999999999999998 99999543 2334444443332
Q ss_pred CCCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhc
Q 039291 239 LPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLD 273 (362)
Q Consensus 239 ~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~ 273 (362)
....+..++..+.++|.+||..+|.+||+++++++
T Consensus 231 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 265 (269)
T cd05044 231 RLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQE 265 (269)
T ss_pred ccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 23445678899999999999999999999999875
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-41 Score=307.92 Aligned_cols=257 Identities=21% Similarity=0.321 Sum_probs=193.4
Q ss_pred cceeccc--CceEEEEEEECCCCCCCCceeeeechhh-----hhhHHHHHHHHHHHHcCCCCcccccccceeeecCCCce
Q 039291 11 GRVIGQG--SFGCVFIAKPKSNSSFLPPLMAVKSAEV-----SASASLQKEKEVFDNLNGCPFVLECFGEEITMGENGEM 83 (362)
Q Consensus 11 ~~~lG~G--~~g~V~~a~~~~~~~~~~~~~~~K~~~~-----~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~~~~ 83 (362)
...||+| +||+||+|++..+++ .|++|.... ...+.+.+|+.+++.++ ||||+++++++.. ..
T Consensus 3 ~~~ig~g~~~~~~v~~a~~~~~~~----~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~-h~niv~~~~~~~~-----~~ 72 (328)
T cd08226 3 QVEIGRGFCNLTSVYLARHTPTGT----LVTVRITDLENCTEEHLKALQNEVVLSHFFR-HPNIMTSWTVFTT-----GS 72 (328)
T ss_pred HHHhCCcccCceeEEEEEEcCCCc----EEEEEEeccccCCHHHHHHHHHHHHHHHhCC-CCCcceEeeeEec-----CC
Confidence 3567777 999999999988776 455555432 23466788999998888 8999999997653 23
Q ss_pred EEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEeecCCc
Q 039291 84 AYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVA 163 (362)
Q Consensus 84 ~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Dfgla 163 (362)
.+++||||+.+++|.+++.......+++..+..++.|++.||+|||+.||+||||||+||++ +..+.++++||+.+
T Consensus 73 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill----~~~~~~~~~~~~~~ 148 (328)
T cd08226 73 WLWVISPFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILI----SGDGLVSLSGLSHL 148 (328)
T ss_pred ceEEEEecccCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE----eCCCcEEEechHHH
Confidence 47799999999999999987555569999999999999999999999999999999999999 66678999999865
Q ss_pred ccccccccC-----CCCCCccCCCCccCchhhccc--cCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHHcCC
Q 039291 164 KRSRHCKRQ-----KFDPSMRGTPLYLAPETVVQH--MQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDE 236 (362)
Q Consensus 164 ~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 236 (362)
......... .......++..|+|||++.+. .++.++|||||||++|+|++|.+||..... .......+...
T Consensus 149 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~--~~~~~~~~~~~ 226 (328)
T cd08226 149 YSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLR--TQMLLQKLKGP 226 (328)
T ss_pred hhhhccCccccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcCh--HHHHHHHhcCC
Confidence 322211110 001112356679999999763 478899999999999999999999964321 12222221111
Q ss_pred CC--------------------------------------------CCCCCccCCHHHHHHHHHHhccCCCCCCCHHHHh
Q 039291 237 HS--------------------------------------------LPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLL 272 (362)
Q Consensus 237 ~~--------------------------------------------~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l 272 (362)
.. ....+..++.++++||++||..||++|||+.+++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l 306 (328)
T cd08226 227 PYSPLDITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLL 306 (328)
T ss_pred CCCCccccccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHh
Confidence 00 0011223567899999999999999999999999
Q ss_pred cCCCccCcchh
Q 039291 273 DDPFVKGVDEE 283 (362)
Q Consensus 273 ~~p~~~~~~~~ 283 (362)
.||||+.+.+.
T Consensus 307 ~~~~~~~~~~~ 317 (328)
T cd08226 307 SHAFFKQVKEQ 317 (328)
T ss_pred hCHHHHHHHHh
Confidence 99999876554
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-41 Score=290.69 Aligned_cols=267 Identities=26% Similarity=0.409 Sum_probs=221.4
Q ss_pred CCCceeecceecccCceEEEEEEECCCCCCCCceeeeechhh--hhhHHHHHHHHHHHHcCCCCcccccccceeeecCCC
Q 039291 4 DGTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEV--SASASLQKEKEVFDNLNGCPFVLECFGEEITMGENG 81 (362)
Q Consensus 4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~--~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~~ 81 (362)
.-+.|.+.++||+|+|.+|.+++.+.+.+.++.++..|.+.. +..+-.+.|..+......+|.+|-++..+. .
T Consensus 248 ~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfq-----t 322 (593)
T KOG0695|consen 248 GLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQ-----T 322 (593)
T ss_pred ccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhc-----c
Confidence 346789999999999999999999999875555554444322 233457789999999999999999887653 3
Q ss_pred ceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEeecC
Q 039291 82 EMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLG 161 (362)
Q Consensus 82 ~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Dfg 161 (362)
+..+++|.||++||+|--.++. .++++++.++.+..+|+.||.|||++|||+||||..|||+ +..+++||.|+|
T Consensus 323 esrlffvieyv~ggdlmfhmqr--qrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvll----daeghikltdyg 396 (593)
T KOG0695|consen 323 ESRLFFVIEYVNGGDLMFHMQR--QRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLL----DAEGHIKLTDYG 396 (593)
T ss_pred cceEEEEEEEecCcceeeehhh--hhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEE----ccCCceeecccc
Confidence 4557799999999999888877 4459999999999999999999999999999999999999 999999999999
Q ss_pred CcccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHhCCCCCccCC----CC-CHHHHHHHHcCC
Q 039291 162 VAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKE----DC-SIDQLFSIIGDE 236 (362)
Q Consensus 162 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~----~~-~~~~~~~~~~~~ 236 (362)
+.+.... ......+++|||.|.|||++.+..|+..+|+|+|||+++||+.|+.||..-. +. ....+++.|...
T Consensus 397 mcke~l~--~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilek 474 (593)
T KOG0695|consen 397 MCKEGLG--PGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEK 474 (593)
T ss_pred hhhcCCC--CCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhh
Confidence 9875443 3344568999999999999999999999999999999999999999996421 22 233455655444
Q ss_pred CCCCCCCccCCHHHHHHHHHHhccCCCCCC------CHHHHhcCCCccCcchhhh
Q 039291 237 HSLPEIPSRVSKEARDFLRRCFVRKPAFRF------TAEMLLDDPFVKGVDEELS 285 (362)
Q Consensus 237 ~~~~~~~~~~~~~~~~li~~~l~~~p~~R~------s~~~~l~~p~~~~~~~~~~ 285 (362)
.. .+|..++-.+..+++..|.+||.+|. ...++..|+||+.++|+..
T Consensus 475 qi--riprslsvkas~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~idwd~l 527 (593)
T KOG0695|consen 475 QI--RIPRSLSVKASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRSIDWDLL 527 (593)
T ss_pred cc--cccceeehhhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhhhCCHHHH
Confidence 32 46778888999999999999999996 4789999999999999864
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-41 Score=329.98 Aligned_cols=257 Identities=25% Similarity=0.402 Sum_probs=195.8
Q ss_pred ceeecceecccCceEEEEEEECCCCCCCC-ceeeeechhhhhhHHHHHHHHHHHHcCCCCcccccccceeeecCC-----
Q 039291 7 SWFRGRVIGQGSFGCVFIAKPKSNSSFLP-PLMAVKSAEVSASASLQKEKEVFDNLNGCPFVLECFGEEITMGEN----- 80 (362)
Q Consensus 7 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~~-~~~~~K~~~~~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~----- 80 (362)
.|...+.||+||||.||+++++-.|..+| +++.++. .......+.+|+..|.+|+ |||||++|..++.....
T Consensus 480 DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~-s~~~~skI~rEVk~LArLn-HpNVVRYysAWVEs~~~~~~~e 557 (1351)
T KOG1035|consen 480 DFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA-SDKLYSKILREVKLLARLN-HPNVVRYYSAWVESTAELTVLE 557 (1351)
T ss_pred hhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch-HHHHHHHHHHHHHHHhhcC-CcceeeeehhhhccCCcccccc
Confidence 46678999999999999999998876543 2333333 4456667899999999999 99999999866221000
Q ss_pred --------------------------------------------------------------------------------
Q 039291 81 -------------------------------------------------------------------------------- 80 (362)
Q Consensus 81 -------------------------------------------------------------------------------- 80 (362)
T Consensus 558 i~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e 637 (1351)
T KOG1035|consen 558 IVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSE 637 (1351)
T ss_pred ccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccC
Confidence
Q ss_pred ---------------------Cc--------eEEEEEEEecCCCCHHHHHHHhcCCCC--CHHHHHHHHHHHHHHHHHHH
Q 039291 81 ---------------------GE--------MAYNLLLEYAAGGTLGDLIEKCNGNGL--PEKDVRHFTRCILEGIGHIH 129 (362)
Q Consensus 81 ---------------------~~--------~~~~lv~e~~~~~~L~~~l~~~~~~~l--~~~~~~~i~~ql~~~l~yLH 129 (362)
.+ ..+|+-||||+...|.++++.. .+ ....+|++++||++||.|+|
T Consensus 638 ~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N---~~~~~~d~~wrLFreIlEGLaYIH 714 (1351)
T KOG1035|consen 638 GSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRN---HFNSQRDEAWRLFREILEGLAYIH 714 (1351)
T ss_pred CccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhc---ccchhhHHHHHHHHHHHHHHHHHH
Confidence 01 5688999999987777777652 24 48899999999999999999
Q ss_pred hCCceeCCCCCCCEEEeecCCCceEEEEeecCCccccc----------------ccccCCCCCCccCCCCccCchhhccc
Q 039291 130 DSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSR----------------HCKRQKFDPSMRGTPLYLAPETVVQH 193 (362)
Q Consensus 130 ~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Dfgla~~~~----------------~~~~~~~~~~~~gt~~y~aPE~~~~~ 193 (362)
++|||||||||.||++ +....|||+|||+|+... ........++.+||..|+|||++.+.
T Consensus 715 ~~giIHRDLKP~NIFL----d~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~ 790 (1351)
T KOG1035|consen 715 DQGIIHRDLKPRNIFL----DSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDT 790 (1351)
T ss_pred hCceeeccCCcceeEE----cCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccc
Confidence 9999999999999999 788889999999998611 01111233578899999999999875
Q ss_pred c---CCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHHcCCCCCCCC---CccCCHHHHHHHHHHhccCCCCCCC
Q 039291 194 M---QEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEHSLPEI---PSRVSKEARDFLRRCFVRKPAFRFT 267 (362)
Q Consensus 194 ~---~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~li~~~l~~~p~~R~s 267 (362)
. |+.|+||||||+||+||+. ||... ..-...+..+. ...+|.. +...-+.-..+|++||+.||++|||
T Consensus 791 ~~~~Yn~KiDmYSLGIVlFEM~y---PF~Ts--MERa~iL~~LR-~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~kRPt 864 (1351)
T KOG1035|consen 791 SSNKYNSKIDMYSLGIVLFEMLY---PFGTS--MERASILTNLR-KGSIPEPADFFDPEHPEEASLIRWLLSHDPSKRPT 864 (1351)
T ss_pred ccccccchhhhHHHHHHHHHHhc---cCCch--HHHHHHHHhcc-cCCCCCCcccccccchHHHHHHHHHhcCCCccCCC
Confidence 4 9999999999999999987 56322 22233333333 2223322 2223356779999999999999999
Q ss_pred HHHHhcCCCcc
Q 039291 268 AEMLLDDPFVK 278 (362)
Q Consensus 268 ~~~~l~~p~~~ 278 (362)
|.++|.+.||.
T Consensus 865 A~eLL~s~llp 875 (1351)
T KOG1035|consen 865 ATELLNSELLP 875 (1351)
T ss_pred HHHHhhccCCC
Confidence 99999999998
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-41 Score=313.27 Aligned_cols=246 Identities=23% Similarity=0.313 Sum_probs=203.2
Q ss_pred CCceeecceecccCceEEEEEEECCCCCCCCceeeeechhhhhhHHHHHHHHHHHHcCCCCcccccccceeeecCCCceE
Q 039291 5 GTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVSASASLQKEKEVFDNLNGCPFVLECFGEEITMGENGEMA 84 (362)
Q Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~~~~~ 84 (362)
...|.+...+|.|+|+.|..+.++.++... ++|++... .....+|+.++....+||||+++++++. +...
T Consensus 321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~----~vkii~~~-~~~~~~e~~~~~~~~~h~niv~~~~v~~-----~~~~ 390 (612)
T KOG0603|consen 321 TESYEFREELGEGSFSAVKYCESSPTDQEP----AVKIISKR-ADDNQDEIPISLLVRDHPNIVKSHDVYE-----DGKE 390 (612)
T ss_pred chhhccccccCCCCccceeeeeccccccch----hheecccc-ccccccccchhhhhcCCCcceeecceec-----CCce
Confidence 467888888999999999999999887644 55554433 3335678888888888999999998763 3445
Q ss_pred EEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEeecCCcc
Q 039291 85 YNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAK 164 (362)
Q Consensus 85 ~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Dfgla~ 164 (362)
.++|||.+.|+-|.+.+.... .....+..|++||+.|+.|||++|+|||||||+|||+. +..++++|+|||.++
T Consensus 391 ~~~v~e~l~g~ell~ri~~~~---~~~~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~---~~~g~lrltyFG~a~ 464 (612)
T KOG0603|consen 391 IYLVMELLDGGELLRRIRSKP---EFCSEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLD---GSAGHLRLTYFGFWS 464 (612)
T ss_pred eeeeehhccccHHHHHHHhcc---hhHHHHHHHHHHHHHHHHHHHhcCeeecCCChhheeec---CCCCcEEEEEechhh
Confidence 779999999998888777622 33378889999999999999999999999999999993 366789999999987
Q ss_pred cccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHHcCCCCCCCCCc
Q 039291 165 RSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEHSLPEIPS 244 (362)
Q Consensus 165 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (362)
..... ....+-|..|.|||++....|+.++||||||++||+|++|+.||...... .++...+.. +.+..
T Consensus 465 ~~~~~-----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~--~ei~~~i~~----~~~s~ 533 (612)
T KOG0603|consen 465 ELERS-----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG--IEIHTRIQM----PKFSE 533 (612)
T ss_pred hCchh-----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch--HHHHHhhcC----Ccccc
Confidence 65542 23556789999999999999999999999999999999999999765543 455554432 33447
Q ss_pred cCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCc
Q 039291 245 RVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFV 277 (362)
Q Consensus 245 ~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~ 277 (362)
.+|.++++||++||+.||.+|+++.+++.||||
T Consensus 534 ~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w~ 566 (612)
T KOG0603|consen 534 CVSDEAKDLLQQLLQVDPALRLGADEIGAHPWF 566 (612)
T ss_pred ccCHHHHHHHHHhccCChhhCcChhhhccCcch
Confidence 899999999999999999999999999999999
|
|
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=303.92 Aligned_cols=254 Identities=24% Similarity=0.342 Sum_probs=190.1
Q ss_pred ecceecccCceEEEEEEECCCCCCCCceeeeechh-----hhhhHHHHHHHHHHHHcCCCCcccccccceeeecCCCceE
Q 039291 10 RGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAE-----VSASASLQKEKEVFDNLNGCPFVLECFGEEITMGENGEMA 84 (362)
Q Consensus 10 ~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~-----~~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~~~~~ 84 (362)
+++.+|.| |.||.++.+.++. .+++|... ......+.+|+.+++.++ |+||+++++.+.. ...
T Consensus 6 i~~~~~~~--~~v~~~~~~~~~~----~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~-h~~i~~~~~~~~~-----~~~ 73 (314)
T cd08216 6 IGKCFEDL--MIVHLAKHKPTNT----LVAVKKINLDSCSKEDLKLLQQEIITSRQLQ-HPNILPYVTSFIV-----DSE 73 (314)
T ss_pred hhHhhcCC--ceEEEEEecCCCC----EEEEEEEeccccchhHHHHHHHHHHHHHhcC-Ccchhhhhheeec-----CCe
Confidence 34444444 5566666666655 45555532 334567899999999998 8999999987643 234
Q ss_pred EEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEeecCCcc
Q 039291 85 YNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAK 164 (362)
Q Consensus 85 ~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Dfgla~ 164 (362)
++++|||+++++|.+++.......+++..+..++.|++.||+|||+++|+||||||+||++ +.++.++|+|||.+.
T Consensus 74 ~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili----~~~~~~kl~d~~~~~ 149 (314)
T cd08216 74 LYVVSPLMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILL----SGDGKVVLSGLRYSV 149 (314)
T ss_pred EEEEEeccCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEE----ecCCceEEecCccce
Confidence 6799999999999999987555669999999999999999999999999999999999999 667789999999886
Q ss_pred ccccccc-----CCCCCCccCCCCccCchhhccc--cCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHHcCC-
Q 039291 165 RSRHCKR-----QKFDPSMRGTPLYLAPETVVQH--MQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDE- 236 (362)
Q Consensus 165 ~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~- 236 (362)
....... ........++..|+|||++.+. .++.++|+|||||++|+|++|..||..... .......+...
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~--~~~~~~~~~~~~ 227 (314)
T cd08216 150 SMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPA--TQMLLEKVRGTV 227 (314)
T ss_pred eeccccccccccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHhccC
Confidence 4432211 1112344578889999998763 578899999999999999999999964332 12222221100
Q ss_pred ------CCCC------------------------CCCccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCccCcc
Q 039291 237 ------HSLP------------------------EIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGVD 281 (362)
Q Consensus 237 ------~~~~------------------------~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~~~~~ 281 (362)
...+ .....++.++.+|+.+||..||++|||++++++||||+...
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~~~~ 302 (314)
T cd08216 228 PCLLDKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQCK 302 (314)
T ss_pred ccccccCchhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHhhhc
Confidence 0000 01122456789999999999999999999999999998765
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-40 Score=299.81 Aligned_cols=249 Identities=29% Similarity=0.445 Sum_probs=198.5
Q ss_pred cceecccCceEEEEEEECCCCCCCCceeeeechh---hhhhHHHHHHHHHHHHcCCCCcccccccceeeecCCCceEEEE
Q 039291 11 GRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAE---VSASASLQKEKEVFDNLNGCPFVLECFGEEITMGENGEMAYNL 87 (362)
Q Consensus 11 ~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~---~~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~~~~~~~l 87 (362)
...||+|+||.||+|.++.++. .+++|... ......+.+|+.+++.++ |+|++++++.+.. ....++
T Consensus 25 ~~~lg~g~~g~v~~~~~~~~~~----~v~iK~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~-----~~~~~l 94 (292)
T cd06657 25 FIKIGEGSTGIVCIATVKSSGK----LVAVKKMDLRKQQRRELLFNEVVIMRDYQ-HENVVEMYNSYLV-----GDELWV 94 (292)
T ss_pred HHHcCCCCCeEEEEEEEcCCCe----EEEEEEecccchhHHHHHHHHHHHHHhcC-CcchhheeeEEEe-----CCEEEE
Confidence 4679999999999999988775 45555432 234456888999999998 8999999987643 234779
Q ss_pred EEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEeecCCccccc
Q 039291 88 LLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSR 167 (362)
Q Consensus 88 v~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Dfgla~~~~ 167 (362)
+|||+++++|.+++.. ..+++..++.++.|++.||+|||+.|++|+||+|+||++ +.++.++|+|||++....
T Consensus 95 v~e~~~~~~L~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv----~~~~~~~l~dfg~~~~~~ 167 (292)
T cd06657 95 VMEFLEGGALTDIVTH---TRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILL----THDGRVKLSDFGFCAQVS 167 (292)
T ss_pred EEecCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE----CCCCCEEEcccccceecc
Confidence 9999999999998754 358999999999999999999999999999999999999 777889999999886544
Q ss_pred ccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHHcCCC-CCCCCCccC
Q 039291 168 HCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEH-SLPEIPSRV 246 (362)
Q Consensus 168 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~~ 246 (362)
.... ......|+..|+|||.+.+..++.++|+||+|+++|+|++|..||..... .+....+.... ........+
T Consensus 168 ~~~~--~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~---~~~~~~~~~~~~~~~~~~~~~ 242 (292)
T cd06657 168 KEVP--RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP---LKAMKMIRDNLPPKLKNLHKV 242 (292)
T ss_pred cccc--cccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHhhCCcccCCcccC
Confidence 3211 11345689999999999888889999999999999999999999965432 22222222111 111123457
Q ss_pred CHHHHHHHHHHhccCCCCCCCHHHHhcCCCccCcc
Q 039291 247 SKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGVD 281 (362)
Q Consensus 247 ~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~~~~~ 281 (362)
+.++.+++.+||..+|.+||++.+++.||||....
T Consensus 243 ~~~l~~li~~~l~~~P~~R~~~~~ll~~~~~~~~~ 277 (292)
T cd06657 243 SPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAG 277 (292)
T ss_pred CHHHHHHHHHHHhCCcccCcCHHHHhcChHHhccC
Confidence 89999999999999999999999999999997654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-40 Score=294.82 Aligned_cols=247 Identities=24% Similarity=0.382 Sum_probs=184.7
Q ss_pred ceecccCceEEEEEEECCCCCCCCceeeeechhhh----hhHHHHHHHHHHHHcCCCCcccccccceeeecCCCceEEEE
Q 039291 12 RVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVS----ASASLQKEKEVFDNLNGCPFVLECFGEEITMGENGEMAYNL 87 (362)
Q Consensus 12 ~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~~----~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~~~~~~~l 87 (362)
+.||+|+||+||+|...... ....+++|..... ....+.+|+.+++.++ |+||+++++.+.. ...+++
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~--~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~-h~nii~~~~~~~~-----~~~~~l 72 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGM--SKARVVVKELRASATPDEQLLFLQEVQPYRELN-HPNVLQCLGQCIE-----SIPYLL 72 (269)
T ss_pred CcCCccCCceEEEEEEecCC--CCeEEEEeecCccCChHHHHHHHHHHHHHHhCC-CCCcceEEEEECC-----CCceEE
Confidence 46999999999999764432 2245677754322 3345778999999998 9999999986642 234779
Q ss_pred EEEecCCCCHHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEeecCCcc
Q 039291 88 LLEYAAGGTLGDLIEKCNG---NGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAK 164 (362)
Q Consensus 88 v~e~~~~~~L~~~l~~~~~---~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Dfgla~ 164 (362)
||||+++|+|.+++..... ..+++..+..++.||+.||+|||++||+||||||+|||+ +.++.+||+|||++.
T Consensus 73 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill----~~~~~~kl~dfg~~~ 148 (269)
T cd05042 73 VLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQL----TADLSVKIGDYGLAL 148 (269)
T ss_pred EEEeCCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEe----cCCCcEEEecccccc
Confidence 9999999999999976432 235688899999999999999999999999999999999 777889999999986
Q ss_pred cccccccCCCCCCccCCCCccCchhhcc-------ccCCCcchHHHHHHHHHHHHh-CCCCCccCCCCCHHHHHHHHcC-
Q 039291 165 RSRHCKRQKFDPSMRGTPLYLAPETVVQ-------HMQEAPSDIWALGCVVLEMLS-GRQAWVVKEDCSIDQLFSIIGD- 235 (362)
Q Consensus 165 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~- 235 (362)
...............++..|+|||++.. ..++.++|||||||++|+|++ |..||..... ...+...+..
T Consensus 149 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~--~~~~~~~~~~~ 226 (269)
T cd05042 149 EQYPEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSD--EQVLKQVVREQ 226 (269)
T ss_pred ccccchheeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCH--HHHHHHHhhcc
Confidence 4332211111123446778999999753 346789999999999999999 7888854322 2222222221
Q ss_pred --CCCCCCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhc
Q 039291 236 --EHSLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLD 273 (362)
Q Consensus 236 --~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~ 273 (362)
....+.++..++..+.+++..|| .||++||+++++++
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~ 265 (269)
T cd05042 227 DIKLPKPQLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHE 265 (269)
T ss_pred CccCCCCcccccCCHHHHHHHHHHh-cCcccccCHHHHHH
Confidence 11223455678899999999998 59999999999875
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=289.68 Aligned_cols=251 Identities=22% Similarity=0.363 Sum_probs=202.4
Q ss_pred eeecceecccCceEEEEEEECCCCCCCCceeeeechhhh----hhHHHHHHHHHHHHcCCCCcccccccceeeecCCCce
Q 039291 8 WFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVS----ASASLQKEKEVFDNLNGCPFVLECFGEEITMGENGEM 83 (362)
Q Consensus 8 y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~~----~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~~~~ 83 (362)
+.+++.||+|+||.||+|++...+......+++|..... ....+..|+.+++.++ |+||+++++.+... .
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~-----~ 74 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLD-HPNIVKLLGVCTEE-----E 74 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcC-CCchheEEEEEcCC-----C
Confidence 357899999999999999998765333346777776533 3557889999999996 99999999866432 3
Q ss_pred EEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEeecCCc
Q 039291 84 AYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVA 163 (362)
Q Consensus 84 ~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Dfgla 163 (362)
.++++|||+++++|.+++.......+++..+..++.|++.||.|||+.|++|+||||+||++ +..+.++|+|||++
T Consensus 75 ~~~~i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~----~~~~~~~l~dfg~~ 150 (258)
T smart00219 75 PLMIVMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLV----GENLVVKISDFGLS 150 (258)
T ss_pred eeEEEEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEE----ccCCeEEEcccCCc
Confidence 57799999999999999986433339999999999999999999999999999999999999 77779999999998
Q ss_pred ccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHh-CCCCCccCCCCCHHHHHHHHcCCCCCCCC
Q 039291 164 KRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLS-GRQAWVVKEDCSIDQLFSIIGDEHSLPEI 242 (362)
Q Consensus 164 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 242 (362)
........... ....++..|+|||.+.+..++.++|+||+|+++++|++ |.+||... ........+..... +..
T Consensus 151 ~~~~~~~~~~~-~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~---~~~~~~~~~~~~~~-~~~ 225 (258)
T smart00219 151 RDLYDDDYYKK-KGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGM---SNEEVLEYLKKGYR-LPK 225 (258)
T ss_pred eeccccccccc-ccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCC---CHHHHHHHHhcCCC-CCC
Confidence 76554311111 12337789999999988889999999999999999998 88888543 44455555544443 334
Q ss_pred CccCCHHHHHHHHHHhccCCCCCCCHHHHhc
Q 039291 243 PSRVSKEARDFLRRCFVRKPAFRFTAEMLLD 273 (362)
Q Consensus 243 ~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~ 273 (362)
+..++.++.+++.+||..+|++|||+.++++
T Consensus 226 ~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~ 256 (258)
T smart00219 226 PENCPPEIYKLMLQCWAEDPEDRPTFSELVE 256 (258)
T ss_pred CCcCCHHHHHHHHHHCcCChhhCcCHHHHHh
Confidence 5668999999999999999999999999885
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-40 Score=297.48 Aligned_cols=259 Identities=18% Similarity=0.226 Sum_probs=186.2
Q ss_pred CCCCCceeecceecccCceEEEEEEECCCCCCCCceeeeechhhhhh--------------HHHHHHHHHHHHcCCCCcc
Q 039291 2 DSDGTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVSAS--------------ASLQKEKEVFDNLNGCPFV 67 (362)
Q Consensus 2 ~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~~~~--------------~~~~~E~~il~~l~~h~~i 67 (362)
|+.+++|.+.+.||+|+||+||+|.+..++. ....+++|....... .....+...+..+. |+++
T Consensus 8 ~i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~-~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~-h~~i 85 (294)
T PHA02882 8 DITGKEWKIDKLIGCGGFGCVYETQCASDHC-INNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNID-HLGI 85 (294)
T ss_pred ccCCCceEEeeEEecCCCceEEEEEEcCCcc-cccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCC-CCCC
Confidence 6778999999999999999999999877621 112344443221110 01112222334445 8999
Q ss_pred cccccceeeecCCCceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEee
Q 039291 68 LECFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVA 147 (362)
Q Consensus 68 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~ 147 (362)
+++++...... ......++++|++. .++.++++.. ...++..+..++.|++.||+|||+++|+||||||+|||+
T Consensus 86 ~~~~~~~~~~~-~~~~~~~~~~~~~~-~~~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill-- 159 (294)
T PHA02882 86 PKYYGCGSFKR-CRMYYRFILLEKLV-ENTKEIFKRI--KCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMV-- 159 (294)
T ss_pred CcEEEeeeEec-CCceEEEEEEehhc-cCHHHHHHhh--ccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE--
Confidence 99887544322 22234467888875 4777777652 336889999999999999999999999999999999999
Q ss_pred cCCCceEEEEeecCCcccccccccC-----CCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHhCCCCCccCC
Q 039291 148 TQSGKFVAKIADLGVAKRSRHCKRQ-----KFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKE 222 (362)
Q Consensus 148 ~~~~~~~~kl~Dfgla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~ 222 (362)
+.++.++|+|||+|+........ .......||+.|+|||++.+..++.++|||||||++|+|++|.+||....
T Consensus 160 --~~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~ 237 (294)
T PHA02882 160 --DGNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFG 237 (294)
T ss_pred --cCCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccc
Confidence 67778999999999765322111 11123569999999999999999999999999999999999999997653
Q ss_pred CCCH-H-----HHHHHHcCCCCCCCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhc
Q 039291 223 DCSI-D-----QLFSIIGDEHSLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLD 273 (362)
Q Consensus 223 ~~~~-~-----~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~ 273 (362)
.... . .....+..... ....+++++.++++.||..+|++||+++++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~ 291 (294)
T PHA02882 238 HNGNLIHAAKCDFIKRLHEGKI---KIKNANKFIYDFIECVTKLSYEEKPDYDALIK 291 (294)
T ss_pred cchHHHHHhHHHHHHHhhhhhh---ccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 2211 1 11122222111 12346889999999999999999999999875
|
|
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-40 Score=296.09 Aligned_cols=252 Identities=27% Similarity=0.450 Sum_probs=197.5
Q ss_pred eeecceecccCceEEEEEEECCCCCCCCceeeeechhhh-----hhHHHHHHHHHHHHcCCCCcccccccceeeecCCCc
Q 039291 8 WFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVS-----ASASLQKEKEVFDNLNGCPFVLECFGEEITMGENGE 82 (362)
Q Consensus 8 y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~~-----~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~~~ 82 (362)
|.+.+.||+|++|.||+|++..+++ .+++|..... ....+.+|+.+++.++ |+||+++++.+.. .
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~----~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~-----~ 70 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGE----IVAIKKIKLRFESEGIPKTALREIKLLKELN-HPNIIKLLDVFRH-----K 70 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCc----EEEEEEeccccccchhHHHHHHHHHHHHHhc-CCCcchHHHhhcc-----C
Confidence 6778999999999999999987765 4555554322 3456788999999998 9999999987643 2
Q ss_pred eEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEeecCC
Q 039291 83 MAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGV 162 (362)
Q Consensus 83 ~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Dfgl 162 (362)
..+++|+||+++ +|.+++.... ..+++..+..++.|++.||.|||++||+|+||||+||++ +.++.++|+|||.
T Consensus 71 ~~~~~v~e~~~~-~l~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili----~~~~~~~l~df~~ 144 (283)
T cd05118 71 GDLYLVFEFMDT-DLYKLIKDRQ-RGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLI----NTEGVLKLADFGL 144 (283)
T ss_pred CCEEEEEeccCC-CHHHHHHhhc-ccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEE----CCCCcEEEeeeee
Confidence 347799999975 8888887633 569999999999999999999999999999999999999 7778899999999
Q ss_pred cccccccccCCCCCCccCCCCccCchhhccc-cCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHH-HHHcCC----
Q 039291 163 AKRSRHCKRQKFDPSMRGTPLYLAPETVVQH-MQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLF-SIIGDE---- 236 (362)
Q Consensus 163 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~-~~~~~~---- 236 (362)
+....... .......++..|+|||.+.+. .++.++|+||||+++|+|++|+.||...+..+..... ..+...
T Consensus 145 ~~~~~~~~--~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~ 222 (283)
T cd05118 145 ARSFGSPV--RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEV 222 (283)
T ss_pred eEecCCCc--ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHh
Confidence 87665432 112345688899999998876 7889999999999999999999999654431111111 110000
Q ss_pred --------------------CCCCCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCc
Q 039291 237 --------------------HSLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFV 277 (362)
Q Consensus 237 --------------------~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~ 277 (362)
...+.....++.+++++|.+||..||.+||++.+++.||||
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~~ 283 (283)
T cd05118 223 WPKFTSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283 (283)
T ss_pred cccchhhhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCCCC
Confidence 00011223468899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-40 Score=294.11 Aligned_cols=247 Identities=23% Similarity=0.393 Sum_probs=184.6
Q ss_pred ceecccCceEEEEEEECCCCCCCCceeeeechhhh----hhHHHHHHHHHHHHcCCCCcccccccceeeecCCCceEEEE
Q 039291 12 RVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVS----ASASLQKEKEVFDNLNGCPFVLECFGEEITMGENGEMAYNL 87 (362)
Q Consensus 12 ~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~~----~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~~~~~~~l 87 (362)
+.||+|+||.||+|++..... ...+++|..... ....+.+|+.++++++ ||||+++++.+.. ...+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~--~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~-----~~~~~l 72 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYT--PAQVVVKELRVSASVQEQMKFLEEAQPYRSLQ-HSNLLQCLGQCTE-----VTPYLL 72 (269)
T ss_pred CcccccCCceEEEEEEcCCCC--ceEEEEEecCCCCChHHHHHHHHHHHHHHhCC-CCCEeeEEEEEcC-----CCCcEE
Confidence 469999999999998754322 235677765432 3346788999999998 9999999886542 234679
Q ss_pred EEEecCCCCHHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEeecCCcc
Q 039291 88 LLEYAAGGTLGDLIEKCNG---NGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAK 164 (362)
Q Consensus 88 v~e~~~~~~L~~~l~~~~~---~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Dfgla~ 164 (362)
||||+++|+|.+++..... ..+++..+..++.|++.||+|||+.|++||||||+||++ +..+.++|+|||+++
T Consensus 73 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~----~~~~~~kL~dfg~~~ 148 (269)
T cd05087 73 VMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLL----TADLTVKIGDYGLSH 148 (269)
T ss_pred EEECCCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEE----cCCCcEEECCccccc
Confidence 9999999999999975322 246778888999999999999999999999999999999 777889999999986
Q ss_pred cccccccCCCCCCccCCCCccCchhhccc-------cCCCcchHHHHHHHHHHHHh-CCCCCccCCCCCHHHHHHHHcC-
Q 039291 165 RSRHCKRQKFDPSMRGTPLYLAPETVVQH-------MQEAPSDIWALGCVVLEMLS-GRQAWVVKEDCSIDQLFSIIGD- 235 (362)
Q Consensus 165 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-------~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~- 235 (362)
...............|+..|+|||++.+. .++.++|+||||+++|+|++ |..||...... ......+..
T Consensus 149 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~--~~~~~~~~~~ 226 (269)
T cd05087 149 NKYKEDYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDE--QVLTYTVREQ 226 (269)
T ss_pred cccCcceeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChH--HHHHHHhhcc
Confidence 44322211222345578889999998642 35789999999999999996 99999644322 111111111
Q ss_pred --CCCCCCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhc
Q 039291 236 --EHSLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLD 273 (362)
Q Consensus 236 --~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~ 273 (362)
....+......+..+.+++++|+ .+|++|||+++++.
T Consensus 227 ~~~~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~ 265 (269)
T cd05087 227 QLKLPKPRLKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHL 265 (269)
T ss_pred cCCCCCCccCCCCChHHHHHHHHHh-cCcccCCCHHHHHH
Confidence 11223333456788999999998 68999999999874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=297.45 Aligned_cols=250 Identities=27% Similarity=0.425 Sum_probs=196.8
Q ss_pred ceeecceecccCceEEEEEEECCCCCCCCceeeeechhh------hhhHHHHHHHHHHHHcCCCCcccccccceeeecCC
Q 039291 7 SWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEV------SASASLQKEKEVFDNLNGCPFVLECFGEEITMGEN 80 (362)
Q Consensus 7 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~------~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~ 80 (362)
.|...+.||+|+||+||+|++..++. .+++|.... .....+.+|+.+++.++ |||++++++.+..
T Consensus 22 ~~~~~~~lg~g~~g~v~~~~~~~~~~----~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~---- 92 (313)
T cd06633 22 IFVGLHEIGHGSFGAVYFATNSHTNE----VVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLK-HPNTIEYKGCYLK---- 92 (313)
T ss_pred HhhcceeeccCCCeEEEEEEECCCCc----EEEEEEEeccccCchHHHHHHHHHHHHHHhCC-CCCCccEEEEEEe----
Confidence 46667889999999999999987775 455555431 23346788999999998 8999999987643
Q ss_pred CceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEeec
Q 039291 81 GEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADL 160 (362)
Q Consensus 81 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Df 160 (362)
....++||||+. ++|.+++... ..++++..+..++.|++.||.|||++|++|+||+|+||++ +.++.++|+||
T Consensus 93 -~~~~~lv~e~~~-~~l~~~l~~~-~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili----~~~~~~kL~df 165 (313)
T cd06633 93 -EHTAWLVMEYCL-GSASDLLEVH-KKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILL----TEPGQVKLADF 165 (313)
T ss_pred -CCEEEEEEecCC-CCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEE----CCCCCEEEeec
Confidence 234679999996 4788877653 4569999999999999999999999999999999999999 67778999999
Q ss_pred CCcccccccccCCCCCCccCCCCccCchhhc---cccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHHcCCC
Q 039291 161 GVAKRSRHCKRQKFDPSMRGTPLYLAPETVV---QHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEH 237 (362)
Q Consensus 161 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 237 (362)
|++..... .....|+..|+|||++. ...++.++|+|||||++|+|++|.+||...+. ......+....
T Consensus 166 g~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~---~~~~~~~~~~~ 236 (313)
T cd06633 166 GSASKSSP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA---MSALYHIAQND 236 (313)
T ss_pred CCCcccCC------CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh---HHHHHHHHhcC
Confidence 99753321 12456899999999985 35678899999999999999999999965432 22222222222
Q ss_pred CCCCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCccCcc
Q 039291 238 SLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGVD 281 (362)
Q Consensus 238 ~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~~~~~ 281 (362)
........++..+++|+.+||+.+|.+||++.+++.||||+...
T Consensus 237 ~~~~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~~~~~~~~ 280 (313)
T cd06633 237 SPTLQSNEWTDSFRGFVDYCLQKIPQERPASAELLRHDFVRRDR 280 (313)
T ss_pred CCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCcccCCCc
Confidence 22222345778899999999999999999999999999998643
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-40 Score=295.84 Aligned_cols=255 Identities=21% Similarity=0.371 Sum_probs=196.2
Q ss_pred eeecceecccCceEEEEEEECCCCCCCCceeeeechhhh-----hhHHHHHHHHHHHHcCCCCcccccccceeeecCCCc
Q 039291 8 WFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVS-----ASASLQKEKEVFDNLNGCPFVLECFGEEITMGENGE 82 (362)
Q Consensus 8 y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~~-----~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~~~ 82 (362)
|.+.+.||+|+||.||+|++..+++ .+++|..... ....+.+|+.+++.++ |+|++++++.+... ..
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~----~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~---~~ 72 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGE----LVALKKIRMENEKEGFPITAIREIKLLQKLR-HPNIVRLKEIVTSK---GK 72 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCe----EEEEEEEecccccccchHHHHHHHHHHHhcc-CCCeeeheeeEecC---CC
Confidence 6788999999999999999988775 4455554332 3345778999999999 99999999876532 12
Q ss_pred eEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEeecCC
Q 039291 83 MAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGV 162 (362)
Q Consensus 83 ~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Dfgl 162 (362)
...++||||+++ +|.+++... ...+++..++.++.|++.||+|||+.|++|+||||+||++ +.++.++|+|||+
T Consensus 73 ~~~~lv~e~~~~-~l~~~~~~~-~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~----~~~~~~~l~d~g~ 146 (287)
T cd07840 73 GSIYMVFEYMDH-DLTGLLDSP-EVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILI----NNDGVLKLADFGL 146 (287)
T ss_pred CcEEEEeccccc-cHHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEE----cCCCCEEEccccc
Confidence 457799999975 899888753 2469999999999999999999999999999999999999 7788899999999
Q ss_pred cccccccccCCCCCCccCCCCccCchhhcc-ccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHHcCCC---C
Q 039291 163 AKRSRHCKRQKFDPSMRGTPLYLAPETVVQ-HMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEH---S 238 (362)
Q Consensus 163 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~---~ 238 (362)
+......... ......++..|+|||.+.+ ..++.++||||||+++|+|++|+.||................... .
T Consensus 147 ~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~ 225 (287)
T cd07840 147 ARPYTKRNSA-DYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDEN 225 (287)
T ss_pred eeeccCCCcc-cccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhh
Confidence 9766543221 1123457888999998775 357889999999999999999999996543211111111100000 0
Q ss_pred CCC-----------------------CCccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCc
Q 039291 239 LPE-----------------------IPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFV 277 (362)
Q Consensus 239 ~~~-----------------------~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~ 277 (362)
++. +...++.++.+++++||..+|.+||++.+++.||||
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~~ 287 (287)
T cd07840 226 WPGVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF 287 (287)
T ss_pred ccccccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCcCC
Confidence 000 011138899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-40 Score=292.08 Aligned_cols=244 Identities=16% Similarity=0.196 Sum_probs=183.8
Q ss_pred ceecccCceEEEEEEECCCCC--------CCCceeeeechhhh---hhHHHHHHHHHHHHcCCCCcccccccceeeecCC
Q 039291 12 RVIGQGSFGCVFIAKPKSNSS--------FLPPLMAVKSAEVS---ASASLQKEKEVFDNLNGCPFVLECFGEEITMGEN 80 (362)
Q Consensus 12 ~~lG~G~~g~V~~a~~~~~~~--------~~~~~~~~K~~~~~---~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~ 80 (362)
+.||+|+||.||+|+...... ....++++|..... ....+.+|+.+++.++ ||||+++++++...
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~-hp~iv~~~~~~~~~--- 76 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVS-HKHIVLLYGVCVRD--- 76 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCC-CCCEeeEEEEEecC---
Confidence 468999999999998543221 22346777765433 3346778889999998 89999999876431
Q ss_pred CceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCC---CceEEEE
Q 039291 81 GEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQS---GKFVAKI 157 (362)
Q Consensus 81 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~---~~~~~kl 157 (362)
...+++|||+++++|..++... ...+++..+..++.|++.||+|||++||+||||||+|||+..+.. ....+++
T Consensus 77 --~~~~lv~e~~~~~~l~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l 153 (262)
T cd05077 77 --VENIMVEEFVEFGPLDLFMHRK-SDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKL 153 (262)
T ss_pred --CCCEEEEecccCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEe
Confidence 2356999999999999888653 345999999999999999999999999999999999999953221 1234899
Q ss_pred eecCCcccccccccCCCCCCccCCCCccCchhhc-cccCCCcchHHHHHHHHHHHH-hCCCCCccCCCCCHHHHHHHHcC
Q 039291 158 ADLGVAKRSRHCKRQKFDPSMRGTPLYLAPETVV-QHMQEAPSDIWALGCVVLEML-SGRQAWVVKEDCSIDQLFSIIGD 235 (362)
Q Consensus 158 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~~l~-~g~~pf~~~~~~~~~~~~~~~~~ 235 (362)
+|||++...... ....++..|+|||++. +..++.++|||||||++|+|+ .|..||..... .+.......
T Consensus 154 ~d~g~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~---~~~~~~~~~ 224 (262)
T cd05077 154 SDPGIPITVLSR------QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTL---AEKERFYEG 224 (262)
T ss_pred CCCCCCccccCc------ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcch---hHHHHHHhc
Confidence 999998644321 2345788999999887 467889999999999999998 58888854322 222221111
Q ss_pred CCCCCCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhcC
Q 039291 236 EHSLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDD 274 (362)
Q Consensus 236 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~ 274 (362)
.. ......+.++.+||.+||..||++||++.+++.+
T Consensus 225 ~~---~~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~ 260 (262)
T cd05077 225 QC---MLVTPSCKELADLMTHCMNYDPNQRPFFRAIMRD 260 (262)
T ss_pred Cc---cCCCCChHHHHHHHHHHcCCChhhCcCHHHHHHh
Confidence 11 1222346789999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=287.90 Aligned_cols=242 Identities=21% Similarity=0.318 Sum_probs=190.8
Q ss_pred ceecccCceEEEEEEECCCCCCCCceeeeechhh----hhhHHHHHHHHHHHHcCCCCcccccccceeeecCCCceEEEE
Q 039291 12 RVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEV----SASASLQKEKEVFDNLNGCPFVLECFGEEITMGENGEMAYNL 87 (362)
Q Consensus 12 ~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~----~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~~~~~~~l 87 (362)
+.||+|+||.||+|.+.. +. .+++|.... .....+.+|++++++++ |+||+++++.+.. ....++
T Consensus 1 ~~lg~g~~g~v~~~~~~~-~~----~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~-----~~~~~~ 69 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKG-NT----EVAVKTCRSTLPPDLKRKFLQEAEILKQYD-HPNIVKLIGVCVQ-----KQPIYI 69 (251)
T ss_pred CccccCCCceEEEEEEeC-CC----cEEEEeccccCCHHHHHHHHHHHHHHHhCC-CCCeEEEEEEEec-----CCCeEE
Confidence 579999999999999877 54 456665432 24457889999999998 8999999886542 224679
Q ss_pred EEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEeecCCccccc
Q 039291 88 LLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSR 167 (362)
Q Consensus 88 v~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Dfgla~~~~ 167 (362)
||||+.|++|.+++... ...+++..+..++.|++.||.|||+++++||||||+||++ +.++.++|+|||++....
T Consensus 70 v~e~~~~~~l~~~l~~~-~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili----~~~~~~~l~d~g~~~~~~ 144 (251)
T cd05041 70 VMELVPGGSLLTFLRKK-KNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLV----GENNVLKISDFGMSREEE 144 (251)
T ss_pred EEEcCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEE----cCCCcEEEeecccccccc
Confidence 99999999999999763 3458999999999999999999999999999999999999 777889999999987544
Q ss_pred ccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHh-CCCCCccCCCCCHHHHHHHHcCCCCCCCCCccC
Q 039291 168 HCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLS-GRQAWVVKEDCSIDQLFSIIGDEHSLPEIPSRV 246 (362)
Q Consensus 168 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (362)
............++..|+|||.+.+..++.++|+|||||++|+|++ |..||.... .......+..... ...+..+
T Consensus 145 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~---~~~~~~~~~~~~~-~~~~~~~ 220 (251)
T cd05041 145 GGIYTVSDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMS---NQQTRERIESGYR-MPAPQLC 220 (251)
T ss_pred CCcceeccccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCC---HHHHHHHHhcCCC-CCCCccC
Confidence 2111111112234567999999988889999999999999999999 888885543 2333333333222 2345678
Q ss_pred CHHHHHHHHHHhccCCCCCCCHHHHhc
Q 039291 247 SKEARDFLRRCFVRKPAFRFTAEMLLD 273 (362)
Q Consensus 247 ~~~~~~li~~~l~~~p~~R~s~~~~l~ 273 (362)
+.++.+++.+||..+|++||++.++++
T Consensus 221 ~~~~~~li~~~l~~~p~~Rp~~~ell~ 247 (251)
T cd05041 221 PEEIYRLMLQCWAYDPENRPSFSEIYN 247 (251)
T ss_pred CHHHHHHHHHHhccChhhCcCHHHHHH
Confidence 899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=286.78 Aligned_cols=241 Identities=29% Similarity=0.482 Sum_probs=198.9
Q ss_pred ecccCceEEEEEEECCCCCCCCceeeeechhhh------hhHHHHHHHHHHHHcCCCCcccccccceeeecCCCceEEEE
Q 039291 14 IGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVS------ASASLQKEKEVFDNLNGCPFVLECFGEEITMGENGEMAYNL 87 (362)
Q Consensus 14 lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~~------~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~~~~~~~l 87 (362)
||+|+||.||++.+..+++ .+++|..... ....+..|+.+++.++ |+||+++++.+. .....++
T Consensus 1 lg~G~~~~v~~~~~~~~~~----~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~-----~~~~~~~ 70 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGK----LYAMKVLKKKKIIKRKEVEHTLTERNILSRIN-HPFIVKLHYAFQ-----TEEKLYL 70 (250)
T ss_pred CCCCCceEEEEEEECCCCc----EEEEEEeehhhhcchHHHHHHHHHHHHHHHcC-CCcHHHHHHHee-----cCCeeEE
Confidence 7999999999999987665 4555544322 3456889999999999 999999987653 2345789
Q ss_pred EEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEeecCCccccc
Q 039291 88 LLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSR 167 (362)
Q Consensus 88 v~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Dfgla~~~~ 167 (362)
+|||+++++|.+++... ..+++..+..++.|++.||.|||+.+++|+||+|+||++ +..+.++|+|||++....
T Consensus 71 v~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~----~~~~~~~l~d~~~~~~~~ 144 (250)
T cd05123 71 VLEYAPGGELFSHLSKE--GRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILL----DADGHIKLTDFGLAKELS 144 (250)
T ss_pred EEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEE----cCCCcEEEeecCcceecc
Confidence 99999999999999863 459999999999999999999999999999999999999 677789999999987654
Q ss_pred ccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHHcCCCCCCCCCccCC
Q 039291 168 HCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEHSLPEIPSRVS 247 (362)
Q Consensus 168 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (362)
... .......++..|+|||.+.+...+.++|+||||+++|+|++|..||...+ ..+....+.. ....++..++
T Consensus 145 ~~~--~~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~---~~~~~~~~~~--~~~~~~~~~~ 217 (250)
T cd05123 145 SEG--SRTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAED---RKEIYEKILK--DPLRFPEFLS 217 (250)
T ss_pred cCC--CcccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCC---HHHHHHHHhc--CCCCCCCCCC
Confidence 321 12235668899999999988888999999999999999999999995443 2444444433 2234666789
Q ss_pred HHHHHHHHHHhccCCCCCCCH---HHHhcCCCc
Q 039291 248 KEARDFLRRCFVRKPAFRFTA---EMLLDDPFV 277 (362)
Q Consensus 248 ~~~~~li~~~l~~~p~~R~s~---~~~l~~p~~ 277 (362)
.++.+++++||..||++||++ ++++.||||
T Consensus 218 ~~l~~~i~~~l~~~p~~R~~~~~~~~l~~~~~f 250 (250)
T cd05123 218 PEARDLISGLLQKDPTKRLGSGGAEEIKAHPFF 250 (250)
T ss_pred HHHHHHHHHHhcCCHhhCCCcccHHHHHhCCCC
Confidence 999999999999999999999 999999998
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=286.70 Aligned_cols=241 Identities=20% Similarity=0.320 Sum_probs=190.0
Q ss_pred ceecccCceEEEEEEECCCCCCCCceeeeechhh----hhhHHHHHHHHHHHHcCCCCcccccccceeeecCCCceEEEE
Q 039291 12 RVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEV----SASASLQKEKEVFDNLNGCPFVLECFGEEITMGENGEMAYNL 87 (362)
Q Consensus 12 ~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~----~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~~~~~~~l 87 (362)
+.||+|+||.||+|.... +. .+++|.... .....+.+|+.+++.++ ||||+++++.+.. ....++
T Consensus 1 ~~ig~g~~g~vy~~~~~~-~~----~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~-----~~~~~l 69 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKD-KT----PVAVKTCKEDLPQELKIKFLSEARILKQYD-HPNIVKLIGVCTQ-----RQPIYI 69 (250)
T ss_pred CccCCCCCceEEEEEecC-Cc----EEEEEecCCcCCHHHHHHHHHHHHHHHhCC-CCCcCeEEEEEec-----CCccEE
Confidence 479999999999998654 32 466665432 23346788999999997 9999999986642 224679
Q ss_pred EEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEeecCCccccc
Q 039291 88 LLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSR 167 (362)
Q Consensus 88 v~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Dfgla~~~~ 167 (362)
||||+++++|.+++... ...+++..+..++.|++.+|.|||++|++|+||||+||++ +.++.++|+|||++....
T Consensus 70 v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili----~~~~~~~l~d~g~~~~~~ 144 (250)
T cd05085 70 VMELVPGGDFLSFLRKK-KDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLV----GENNVLKISDFGMSRQED 144 (250)
T ss_pred EEECCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEE----cCCCeEEECCCccceecc
Confidence 99999999999998753 3458999999999999999999999999999999999999 777789999999986543
Q ss_pred ccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHh-CCCCCccCCCCCHHHHHHHHcCCCCCCCCCccC
Q 039291 168 HCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLS-GRQAWVVKEDCSIDQLFSIIGDEHSLPEIPSRV 246 (362)
Q Consensus 168 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (362)
..... ......++..|+|||++.+..++.++||||||+++|++++ |..||... ........+.... ....+..+
T Consensus 145 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~---~~~~~~~~~~~~~-~~~~~~~~ 219 (250)
T cd05085 145 DGIYS-SSGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGM---TNQQAREQVEKGY-RMSCPQKC 219 (250)
T ss_pred ccccc-cCCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCC---CHHHHHHHHHcCC-CCCCCCCC
Confidence 22111 1112234667999999988889999999999999999998 99999544 3333333443332 23455678
Q ss_pred CHHHHHHHHHHhccCCCCCCCHHHHhc
Q 039291 247 SKEARDFLRRCFVRKPAFRFTAEMLLD 273 (362)
Q Consensus 247 ~~~~~~li~~~l~~~p~~R~s~~~~l~ 273 (362)
+.++.+++.+||..+|++||++.++++
T Consensus 220 ~~~~~~li~~~l~~~p~~Rp~~~~l~~ 246 (250)
T cd05085 220 PDDVYKVMQRCWDYKPENRPKFSELQK 246 (250)
T ss_pred CHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=289.85 Aligned_cols=247 Identities=22% Similarity=0.335 Sum_probs=189.9
Q ss_pred ceecccCceEEEEEEECCCCCCCCceeeeechhh----hhhHHHHHHHHHHHHcCCCCcccccccceeeecCCCceEEEE
Q 039291 12 RVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEV----SASASLQKEKEVFDNLNGCPFVLECFGEEITMGENGEMAYNL 87 (362)
Q Consensus 12 ~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~----~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~~~~~~~l 87 (362)
+.||+|+||.||+|.+...+. ....+++|.... .....+.+|+.+++.++ ||||+++++.+.. .....++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~-~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~----~~~~~~l 74 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDG-QKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFS-HPNVLSLLGICLP----SEGSPLV 74 (262)
T ss_pred CcccccCCceEEEEEEecCCC-ceEEEEEEecCccCCHHHHHHHHHHHHHHccCC-CCCcceEEEEeec----CCCCcEE
Confidence 479999999999999764332 224677776532 23456778999999998 9999999885542 1223569
Q ss_pred EEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEeecCCccccc
Q 039291 88 LLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSR 167 (362)
Q Consensus 88 v~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Dfgla~~~~ 167 (362)
+|||+.+++|.+++... ...+++..+..++.|++.||.|||+.+++||||||+|||+ +..+.+||+|||+++...
T Consensus 75 v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili----~~~~~~kl~dfg~~~~~~ 149 (262)
T cd05058 75 VLPYMKHGDLRNFIRSE-THNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCML----DESFTVKVADFGLARDIY 149 (262)
T ss_pred EEecCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEE----cCCCcEEECCcccccccc
Confidence 99999999999999763 2346788889999999999999999999999999999999 677789999999987543
Q ss_pred cccc--CCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHhC-CCCCccCCCCCHHHHHHHHcCCCCCCCCCc
Q 039291 168 HCKR--QKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSG-RQAWVVKEDCSIDQLFSIIGDEHSLPEIPS 244 (362)
Q Consensus 168 ~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (362)
.... ........++..|+|||.+.+..++.++|||||||++|||++| .+||... +..++...+..... +..+.
T Consensus 150 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~---~~~~~~~~~~~~~~-~~~~~ 225 (262)
T cd05058 150 DKEYYSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV---DSFDITVYLLQGRR-LLQPE 225 (262)
T ss_pred CCcceeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCC---CHHHHHHHHhcCCC-CCCCC
Confidence 2111 0111233467789999999888899999999999999999995 5666432 33444444433322 23455
Q ss_pred cCCHHHHHHHHHHhccCCCCCCCHHHHhc
Q 039291 245 RVSKEARDFLRRCFVRKPAFRFTAEMLLD 273 (362)
Q Consensus 245 ~~~~~~~~li~~~l~~~p~~R~s~~~~l~ 273 (362)
.++..+.+++.+||..+|++||++.+++.
T Consensus 226 ~~~~~~~~li~~cl~~~p~~Rp~~~~il~ 254 (262)
T cd05058 226 YCPDPLYEVMLSCWHPKPEMRPTFSELVS 254 (262)
T ss_pred cCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 67899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=288.94 Aligned_cols=242 Identities=18% Similarity=0.260 Sum_probs=187.4
Q ss_pred ceecccCceEEEEEEECCCC------CCCCceeeeechhhhh--hHHHHHHHHHHHHcCCCCcccccccceeeecCCCce
Q 039291 12 RVIGQGSFGCVFIAKPKSNS------SFLPPLMAVKSAEVSA--SASLQKEKEVFDNLNGCPFVLECFGEEITMGENGEM 83 (362)
Q Consensus 12 ~~lG~G~~g~V~~a~~~~~~------~~~~~~~~~K~~~~~~--~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~~~~ 83 (362)
+.||+|+||.||+|.+..++ ......+++|...... ...+.+|+.+++.++ ||||+++++.+.. .
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~------~ 73 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLS-HKHLVKLYGVCVR------D 73 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhhHHHHHHHHHHHHcCC-CcchhheeeEEec------C
Confidence 47999999999999998766 3333466777654332 567889999999998 9999999987653 1
Q ss_pred EEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecC---CCceEEEEeec
Q 039291 84 AYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQ---SGKFVAKIADL 160 (362)
Q Consensus 84 ~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~---~~~~~~kl~Df 160 (362)
..++||||+++++|.+++.... ..+++..+..++.||+.||.|||++||+||||||+||++.... .....++|+||
T Consensus 74 ~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Df 152 (259)
T cd05037 74 ENIMVEEYVKFGPLDVFLHREK-NNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDP 152 (259)
T ss_pred CcEEEEEcCCCCcHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCC
Confidence 2569999999999999998733 2689999999999999999999999999999999999994322 11227999999
Q ss_pred CCcccccccccCCCCCCccCCCCccCchhhccc--cCCCcchHHHHHHHHHHHHh-CCCCCccCCCCCHHHHHHHHcCCC
Q 039291 161 GVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQH--MQEAPSDIWALGCVVLEMLS-GRQAWVVKEDCSIDQLFSIIGDEH 237 (362)
Q Consensus 161 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~ 237 (362)
|++..... .....++..|+|||++.+. .++.++|||||||++|+|++ |..||...... ..........
T Consensus 153 g~a~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~---~~~~~~~~~~ 223 (259)
T cd05037 153 GIPITVLS------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSS---EKERFYQDQH 223 (259)
T ss_pred Cccccccc------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCch---hHHHHHhcCC
Confidence 99875443 1234577889999999876 78899999999999999999 57787554322 2212221222
Q ss_pred CCCCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhc
Q 039291 238 SLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLD 273 (362)
Q Consensus 238 ~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~ 273 (362)
.. +.....++.+++.+||..+|.+||++.++++
T Consensus 224 ~~---~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 256 (259)
T cd05037 224 RL---PMPDCAELANLINQCWTYDPTKRPSFRAILR 256 (259)
T ss_pred CC---CCCCchHHHHHHHHHhccChhhCCCHHHHHH
Confidence 11 2223479999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=297.29 Aligned_cols=252 Identities=28% Similarity=0.422 Sum_probs=198.5
Q ss_pred CCCceeecceecccCceEEEEEEECCCCCCCCceeeeechhh------hhhHHHHHHHHHHHHcCCCCcccccccceeee
Q 039291 4 DGTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEV------SASASLQKEKEVFDNLNGCPFVLECFGEEITM 77 (362)
Q Consensus 4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~------~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~ 77 (362)
...+|...+.||+|+||.||+|+++.++. .+++|.... .....+.+|+++++.++ |+|++++++.+..
T Consensus 13 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~----~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~- 86 (308)
T cd06634 13 PEKLFSDLREIGHGSFGAVYFARDVRNSE----VVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR-HPNTIQYRGCYLR- 86 (308)
T ss_pred cHHHHHHHHheeeCCCEEEEEEEEcCCCc----EEEEEEEecccccChHHHHHHHHHHHHHHhCC-CCCcccEEEEEEc-
Confidence 34568888999999999999999988765 345554321 23345778999999998 8999999987653
Q ss_pred cCCCceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEE
Q 039291 78 GENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKI 157 (362)
Q Consensus 78 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl 157 (362)
...+++||||+. ++|.+++... ..++++..+..++.|++.||.|||+.+++||||||+||++ +.++.++|
T Consensus 87 ----~~~~~lv~e~~~-~~l~~~~~~~-~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~----~~~~~~kl 156 (308)
T cd06634 87 ----EHTAWLVMEYCL-GSASDLLEVH-KKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILL----SEPGLVKL 156 (308)
T ss_pred ----CCeeEEEEEccC-CCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEE----CCCCcEEE
Confidence 234679999997 5888877653 3558999999999999999999999999999999999999 66788999
Q ss_pred eecCCcccccccccCCCCCCccCCCCccCchhhc---cccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHHc
Q 039291 158 ADLGVAKRSRHCKRQKFDPSMRGTPLYLAPETVV---QHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIG 234 (362)
Q Consensus 158 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~ 234 (362)
+|||++..... .....|+..|+|||++. ...++.++|||||||++|+|++|..||...+ .......+.
T Consensus 157 ~dfg~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~---~~~~~~~~~ 227 (308)
T cd06634 157 GDFGSASIMAP------ANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN---AMSALYHIA 227 (308)
T ss_pred CCcccceeecC------cccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCcccc---HHHHHHHHh
Confidence 99999865432 12456889999999985 3457889999999999999999999985432 222222222
Q ss_pred CCCCCCCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCccCc
Q 039291 235 DEHSLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGV 280 (362)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~~~~ 280 (362)
...........++..+++||++||..+|++||++++++.|||+...
T Consensus 228 ~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~~ 273 (308)
T cd06634 228 QNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRE 273 (308)
T ss_pred hcCCCCcCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCcccccc
Confidence 2222222334688999999999999999999999999999999764
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=297.29 Aligned_cols=250 Identities=27% Similarity=0.419 Sum_probs=198.1
Q ss_pred CceeecceecccCceEEEEEEECCCCCCCCceeeeechhh------hhhHHHHHHHHHHHHcCCCCcccccccceeeecC
Q 039291 6 TSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEV------SASASLQKEKEVFDNLNGCPFVLECFGEEITMGE 79 (362)
Q Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~------~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~ 79 (362)
..|...+.||+|+||.||+|++..++. .+++|.... .....+.+|+.+++.++ |||++++++.+..
T Consensus 25 ~~f~~~~~lg~G~~~~v~~~~~~~~~~----~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~--- 96 (317)
T cd06635 25 KLFTDLREIGHGSFGAVYFARDVRTNE----VVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIK-HPNSIEYKGCYLR--- 96 (317)
T ss_pred hhhhhhheeccCCCeEEEEEEEcCCCc----EEEEEEEecCCCCchHHHHHHHHHHHHHHhCC-CCCEEEEEEEEee---
Confidence 347888999999999999999988765 455555431 23346788999999998 8999999987643
Q ss_pred CCceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEee
Q 039291 80 NGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIAD 159 (362)
Q Consensus 80 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~D 159 (362)
....++||||+.| +|.+++... ..++++..+..++.|++.||.|||++||+||||+|+||++ +.++.++|+|
T Consensus 97 --~~~~~lv~e~~~g-~l~~~~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~----~~~~~~kl~d 168 (317)
T cd06635 97 --EHTAWLVMEYCLG-SASDLLEVH-KKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILL----TEPGQVKLAD 168 (317)
T ss_pred --CCeEEEEEeCCCC-CHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEE----CCCCCEEEec
Confidence 2346799999975 888777653 4569999999999999999999999999999999999999 7778899999
Q ss_pred cCCcccccccccCCCCCCccCCCCccCchhhc---cccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHHcCC
Q 039291 160 LGVAKRSRHCKRQKFDPSMRGTPLYLAPETVV---QHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDE 236 (362)
Q Consensus 160 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 236 (362)
||++..... .....|+..|+|||++. ...++.++|+|||||++|+|++|..||.... .......+...
T Consensus 169 fg~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~---~~~~~~~~~~~ 239 (317)
T cd06635 169 FGSASIASP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN---AMSALYHIAQN 239 (317)
T ss_pred CCCccccCC------cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCcc---HHHHHHHHHhc
Confidence 998764332 12456889999999974 3567889999999999999999999986432 22222222222
Q ss_pred CCCCCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCccCc
Q 039291 237 HSLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGV 280 (362)
Q Consensus 237 ~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~~~~ 280 (362)
...+.....++..+++++.+||+.+|.+||++.+++.|+|+...
T Consensus 240 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~ 283 (317)
T cd06635 240 ESPTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRE 283 (317)
T ss_pred cCCCCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhcc
Confidence 22222344678899999999999999999999999999998654
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-39 Score=286.63 Aligned_cols=249 Identities=19% Similarity=0.339 Sum_probs=196.9
Q ss_pred CCCceeecceecccCceEEEEEEECCCCCCCCceeeeechhhh--hhHHHHHHHHHHHHcCCCCcccccccceeeecCCC
Q 039291 4 DGTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVS--ASASLQKEKEVFDNLNGCPFVLECFGEEITMGENG 81 (362)
Q Consensus 4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~~--~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~~ 81 (362)
+..+|.+.+.||+|+||.||+|.+.... .+++|..... ....+.+|++++++++ ||+++++++.+..
T Consensus 2 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~-----~~~~k~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~----- 70 (256)
T cd05112 2 HPSELTLVQEIGSGQFGLVWLGYWLEKR-----KVAIKTIREGAMSEEDFIEEAQVMMKLS-HPKLVQLYGVCTE----- 70 (256)
T ss_pred ChhHeEEEeeecCcccceEEEEEEeCCC-----eEEEEECCCCCCCHHHHHHHHHHHHhCC-CCCeeeEEEEEcc-----
Confidence 3468999999999999999999886432 4566655432 2356889999999998 8999999886532
Q ss_pred ceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEeecC
Q 039291 82 EMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLG 161 (362)
Q Consensus 82 ~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Dfg 161 (362)
...++++|||+.+++|.+++... ...+++..++.++.|++.||.|||+.+++|+||||+||++ +.++.++|+|||
T Consensus 71 ~~~~~~v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i----~~~~~~~l~d~g 145 (256)
T cd05112 71 RSPICLVFEFMEHGCLSDYLRAQ-RGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLV----GENQVVKVSDFG 145 (256)
T ss_pred CCceEEEEEcCCCCcHHHHHHhC-ccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEE----cCCCeEEECCCc
Confidence 23467999999999999999763 3458999999999999999999999999999999999999 777789999999
Q ss_pred CcccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHh-CCCCCccCCCCCHHHHHHHHcCCCCCC
Q 039291 162 VAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLS-GRQAWVVKEDCSIDQLFSIIGDEHSLP 240 (362)
Q Consensus 162 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 240 (362)
++......... ......++..|+|||++.+..++.++|+||||+++|+|++ |..||... ........+......
T Consensus 146 ~~~~~~~~~~~-~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~---~~~~~~~~~~~~~~~- 220 (256)
T cd05112 146 MTRFVLDDQYT-SSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENR---SNSEVVETINAGFRL- 220 (256)
T ss_pred ceeecccCccc-ccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcC---CHHHHHHHHhCCCCC-
Confidence 98754322111 1112335678999999998889999999999999999998 99999543 334444444333221
Q ss_pred CCCccCCHHHHHHHHHHhccCCCCCCCHHHHhc
Q 039291 241 EIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLD 273 (362)
Q Consensus 241 ~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~ 273 (362)
..+...+.++.+|+.+||..+|++||++.++++
T Consensus 221 ~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~ 253 (256)
T cd05112 221 YKPRLASQSVYELMQHCWKERPEDRPSFSLLLH 253 (256)
T ss_pred CCCCCCCHHHHHHHHHHcccChhhCCCHHHHHH
Confidence 234457899999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=290.38 Aligned_cols=244 Identities=18% Similarity=0.298 Sum_probs=188.0
Q ss_pred ceecccCceEEEEEEECCCCC---CCCceeeeechhhh---hhHHHHHHHHHHHHcCCCCcccccccceeeecCCCceEE
Q 039291 12 RVIGQGSFGCVFIAKPKSNSS---FLPPLMAVKSAEVS---ASASLQKEKEVFDNLNGCPFVLECFGEEITMGENGEMAY 85 (362)
Q Consensus 12 ~~lG~G~~g~V~~a~~~~~~~---~~~~~~~~K~~~~~---~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~~~~~~ 85 (362)
+.||+|+||.||+|.++..+. .....+++|..... ..+.+..|+.+++.+. ||||+++++.+... ...
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~-h~~iv~~~~~~~~~-----~~~ 74 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLS-HKHLVLNYGVCVCG-----DES 74 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCC-CCChhheeeEEEeC-----CCc
Confidence 469999999999999866542 23456677765432 3356788999999998 89999999876532 235
Q ss_pred EEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCC----CceEEEEeecC
Q 039291 86 NLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQS----GKFVAKIADLG 161 (362)
Q Consensus 86 ~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~----~~~~~kl~Dfg 161 (362)
++||||+++|+|.+++... +..+++..+..++.||+.||+|||++||+||||||+||++..++. ....++++|||
T Consensus 75 ~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g 153 (258)
T cd05078 75 IMVQEYVKFGSLDTYLKKN-KNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPG 153 (258)
T ss_pred EEEEecCCCCcHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEecccc
Confidence 6999999999999999763 335899999999999999999999999999999999999954321 12347999999
Q ss_pred CcccccccccCCCCCCccCCCCccCchhhcc-ccCCCcchHHHHHHHHHHHHhCC-CCCccCCCCCHHHHHHHHcCCCCC
Q 039291 162 VAKRSRHCKRQKFDPSMRGTPLYLAPETVVQ-HMQEAPSDIWALGCVVLEMLSGR-QAWVVKEDCSIDQLFSIIGDEHSL 239 (362)
Q Consensus 162 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~l~~g~-~pf~~~~~~~~~~~~~~~~~~~~~ 239 (362)
++...... ....++..|+|||++.+ ..++.++|||||||++|+|++|. +||... +............
T Consensus 154 ~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~---~~~~~~~~~~~~~-- 222 (258)
T cd05078 154 ISITVLPK------EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSAL---DSQKKLQFYEDRH-- 222 (258)
T ss_pred cccccCCc------hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhc---cHHHHHHHHHccc--
Confidence 98644321 23568889999999986 45789999999999999999984 665432 2222222222222
Q ss_pred CCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhcC
Q 039291 240 PEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDD 274 (362)
Q Consensus 240 ~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~ 274 (362)
.++...+.++.+++.+||+.||++|||+++++..
T Consensus 223 -~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 256 (258)
T cd05078 223 -QLPAPKWTELANLINQCMDYEPDFRPSFRAIIRD 256 (258)
T ss_pred -cCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHh
Confidence 3455577899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=292.54 Aligned_cols=259 Identities=21% Similarity=0.333 Sum_probs=201.8
Q ss_pred CCceeecceecccCceEEEEEEECCCCCCCCceeeeechhhh----hhHHHHHHHHHHHHcCCCCcccccccceeeecCC
Q 039291 5 GTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVS----ASASLQKEKEVFDNLNGCPFVLECFGEEITMGEN 80 (362)
Q Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~~----~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~ 80 (362)
...|.+.+.||+|+||.||+|+....+......+++|..... ....+.+|+++++.+. |+||+++++.+.. .
T Consensus 3 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~-~~~i~~~~~~~~~---~ 78 (284)
T cd05038 3 KRHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLD-HENIVKYKGVCEK---P 78 (284)
T ss_pred hhhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCC-CCChheEEeeeec---C
Confidence 467888999999999999999976553333456777776533 3457889999999997 8999999886532 2
Q ss_pred CceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEeec
Q 039291 81 GEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADL 160 (362)
Q Consensus 81 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Df 160 (362)
....++++|||+++++|.+++.... ..+++..+..++.||+.||+|||++|++|+||||+||++ +.++.++|+||
T Consensus 79 ~~~~~~lv~e~~~~~~l~~~l~~~~-~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~----~~~~~~~l~df 153 (284)
T cd05038 79 GGRSLRLIMEYLPSGSLRDYLQRHR-DQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILV----ESEDLVKISDF 153 (284)
T ss_pred CCCceEEEEecCCCCCHHHHHHhCc-cccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEE----cCCCCEEEccc
Confidence 2345779999999999999997633 359999999999999999999999999999999999999 77788999999
Q ss_pred CCcccccccccC-CCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHhCCCCCccCCCCC------------HH
Q 039291 161 GVAKRSRHCKRQ-KFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCS------------ID 227 (362)
Q Consensus 161 gla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~------------~~ 227 (362)
|++......... .......++..|+|||.+.+..++.++|+||||+++++|++|..||....... ..
T Consensus 154 g~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~ 233 (284)
T cd05038 154 GLAKVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVT 233 (284)
T ss_pred ccccccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHH
Confidence 999765522111 11112345667999999988889999999999999999999999985432211 22
Q ss_pred HHHHHHcCCCCCCCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhc
Q 039291 228 QLFSIIGDEHSLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLD 273 (362)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~ 273 (362)
.+...+...... ..+..++.++.+++.+||..+|++||++.+++.
T Consensus 234 ~~~~~~~~~~~~-~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05038 234 RLLELLKEGERL-PRPPSCPDEVYDLMKLCWEAEPQDRPSFADLIL 278 (284)
T ss_pred HHHHHHHcCCcC-CCCccCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 233333333222 234567889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=291.29 Aligned_cols=243 Identities=17% Similarity=0.240 Sum_probs=184.9
Q ss_pred eecccCceEEEEEEECCCC--------------------CCCCceeeeechhhh---hhHHHHHHHHHHHHcCCCCcccc
Q 039291 13 VIGQGSFGCVFIAKPKSNS--------------------SFLPPLMAVKSAEVS---ASASLQKEKEVFDNLNGCPFVLE 69 (362)
Q Consensus 13 ~lG~G~~g~V~~a~~~~~~--------------------~~~~~~~~~K~~~~~---~~~~~~~E~~il~~l~~h~~i~~ 69 (362)
.||+|+||.||+|....++ ......+++|..... ....+.+|+.+++.++ ||||++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~-h~niv~ 80 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVS-HIHLAF 80 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCC-CCCeee
Confidence 6999999999999753321 111245777776543 2345778888999998 899999
Q ss_pred cccceeeecCCCceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecC
Q 039291 70 CFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQ 149 (362)
Q Consensus 70 ~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~ 149 (362)
+++++... ...++||||+++++|..++... .+.+++..+..++.|++.||+|||++||+||||||+|||+....
T Consensus 81 ~~~~~~~~-----~~~~lv~ey~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~ 154 (274)
T cd05076 81 VHGVCVRG-----SENIMVEEFVEHGPLDVCLRKE-KGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLG 154 (274)
T ss_pred EEEEEEeC-----CceEEEEecCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccC
Confidence 99976532 2356999999999999988753 34689999999999999999999999999999999999995422
Q ss_pred ---CCceEEEEeecCCcccccccccCCCCCCccCCCCccCchhhcc-ccCCCcchHHHHHHHHHHHH-hCCCCCccCCCC
Q 039291 150 ---SGKFVAKIADLGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQ-HMQEAPSDIWALGCVVLEML-SGRQAWVVKEDC 224 (362)
Q Consensus 150 ---~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~l~-~g~~pf~~~~~~ 224 (362)
.....++++|||++...... ....++..|+|||.+.+ ..++.++|||||||++|||+ +|..||......
T Consensus 155 ~~~~~~~~~kl~d~g~~~~~~~~------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~ 228 (274)
T cd05076 155 LAEGTSPFIKLSDPGVSFTALSR------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPS 228 (274)
T ss_pred cccCccceeeecCCccccccccc------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChH
Confidence 22345899999987543221 12357888999998875 56789999999999999985 699999654332
Q ss_pred CHHHHHHHHcCCCCCCCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhcC
Q 039291 225 SIDQLFSIIGDEHSLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDD 274 (362)
Q Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~ 274 (362)
. ......... ..+...+.++.++|.+||..+|++||++++++++
T Consensus 229 ~---~~~~~~~~~---~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~ 272 (274)
T cd05076 229 E---KERFYEKKH---RLPEPSCKELATLISQCLTYEPTQRPSFRTILRD 272 (274)
T ss_pred H---HHHHHHhcc---CCCCCCChHHHHHHHHHcccChhhCcCHHHHHHh
Confidence 2 222222222 2334456789999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=315.97 Aligned_cols=269 Identities=22% Similarity=0.258 Sum_probs=177.8
Q ss_pred CCCceeecceecccCceEEEEEEECCCCCCCCceeeeechhhhhhHHHHHHHHHHHHcCCCCcccccccceee-ecCCCc
Q 039291 4 DGTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVSASASLQKEKEVFDNLNGCPFVLECFGEEIT-MGENGE 82 (362)
Q Consensus 4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~-~~~~~~ 82 (362)
..++|.+.+.||+|+||.||+|++..++......+++|............+.. ++... +.++..+...+.. ......
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~e~~~~e~-l~~~~-~~~~~~~~~~~~~~~~~~~~ 207 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAVEIWMNER-VRRAC-PNSCADFVYGFLEPVSSKKE 207 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchhHHHHHHH-HHhhc-hhhHHHHHHhhhcccccccC
Confidence 45789999999999999999999988743444578888765332222111111 12222 2222222221111 111233
Q ss_pred eEEEEEEEecCCCCHHHHHHHhcC------------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEE
Q 039291 83 MAYNLLLEYAAGGTLGDLIEKCNG------------------NGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNIL 144 (362)
Q Consensus 83 ~~~~lv~e~~~~~~L~~~l~~~~~------------------~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nil 144 (362)
..+++|+||+.+++|.+++..... ....+..+..++.||+.||.|||++||+||||||+|||
T Consensus 208 ~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDLKP~NIL 287 (566)
T PLN03225 208 DEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVKPQNII 287 (566)
T ss_pred CceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcCCHHHEE
Confidence 457799999999999999875321 01224457789999999999999999999999999999
Q ss_pred EeecCCCceEEEEeecCCcccccccccCCCCCCccCCCCccCchhhccc----------------------cCCCcchHH
Q 039291 145 LVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQH----------------------MQEAPSDIW 202 (362)
Q Consensus 145 l~~~~~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~~~~~Diw 202 (362)
+. +..+.+||+|||+|+...... ........+|+.|+|||.+... .++.++|||
T Consensus 288 l~---~~~~~~KL~DFGlA~~l~~~~-~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVw 363 (566)
T PLN03225 288 FS---EGSGSFKIIDLGAAADLRVGI-NYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIY 363 (566)
T ss_pred Ee---CCCCcEEEEeCCCcccccccc-ccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccH
Confidence 93 235689999999997544321 2223467899999999976432 233456999
Q ss_pred HHHHHHHHHHhCCCCCccCCCCCHHHHHHHHcCCC-------------CCC------CCCccCCHHHHHHHHHHhccCCC
Q 039291 203 ALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEH-------------SLP------EIPSRVSKEARDFLRRCFVRKPA 263 (362)
Q Consensus 203 slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~-------------~~~------~~~~~~~~~~~~li~~~l~~~p~ 263 (362)
||||+||||+++..++.. ....+...+.... ..+ .+....+....+||.+||..||+
T Consensus 364 SlGviL~el~~~~~~~~~----~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~ 439 (566)
T PLN03225 364 SAGLIFLQMAFPNLRSDS----NLIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGR 439 (566)
T ss_pred HHHHHHHHHHhCcCCCch----HHHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCcc
Confidence 999999999997665421 1222211111100 000 00111234566899999999999
Q ss_pred CCCCHHHHhcCCCccCcch
Q 039291 264 FRFTAEMLLDDPFVKGVDE 282 (362)
Q Consensus 264 ~R~s~~~~l~~p~~~~~~~ 282 (362)
+|||+.++|+||||+....
T Consensus 440 kR~ta~e~L~Hpff~~~~~ 458 (566)
T PLN03225 440 QRISAKAALAHPYFDREGL 458 (566)
T ss_pred cCCCHHHHhCCcCcCCCCc
Confidence 9999999999999987543
|
|
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-39 Score=288.42 Aligned_cols=246 Identities=22% Similarity=0.386 Sum_probs=183.6
Q ss_pred ceecccCceEEEEEEECCCCCCCCceeeeechh----hhhhHHHHHHHHHHHHcCCCCcccccccceeeecCCCceEEEE
Q 039291 12 RVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAE----VSASASLQKEKEVFDNLNGCPFVLECFGEEITMGENGEMAYNL 87 (362)
Q Consensus 12 ~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~----~~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~~~~~~~l 87 (362)
+.||+|+||+||+|+....+.. ..+++|... ......+.+|+.+++.++ ||||+++++.+.. ...+++
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~--~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~-h~~iv~~~~~~~~-----~~~~~l 72 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGV--ARVVVKELKANASSKEQNEFLQQGDPYRILQ-HPNILQCLGQCVE-----AIPYLL 72 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCc--ceEEEEEecCCCChHHHHHHHHHHHHHhccC-CcchhheEEEecC-----CCccEE
Confidence 4699999999999986544321 234444432 224467889999999998 9999999987653 234679
Q ss_pred EEEecCCCCHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEeecCCccc
Q 039291 88 LLEYAAGGTLGDLIEKCN--GNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKR 165 (362)
Q Consensus 88 v~e~~~~~~L~~~l~~~~--~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Dfgla~~ 165 (362)
||||+++|+|.+++.... ...+++..++.++.|++.||+|||+.+++||||||+|||+ +.++.++|+|||++..
T Consensus 73 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~----~~~~~~~l~Dfg~~~~ 148 (268)
T cd05086 73 VFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFL----TSDLTVKVGDYGIGPS 148 (268)
T ss_pred EEecCCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEE----cCCccEEecccccccc
Confidence 999999999999997632 2346778889999999999999999999999999999999 7778899999999864
Q ss_pred ccccccCCCCCCccCCCCccCchhhcc-------ccCCCcchHHHHHHHHHHHHh-CCCCCccCCCCCHHHHHHHH-cC-
Q 039291 166 SRHCKRQKFDPSMRGTPLYLAPETVVQ-------HMQEAPSDIWALGCVVLEMLS-GRQAWVVKEDCSIDQLFSII-GD- 235 (362)
Q Consensus 166 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~-~~- 235 (362)
..............|+..|+|||++.. ..++.++|||||||++|||++ |..||.... ..+.+..+ ..
T Consensus 149 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~---~~~~~~~~~~~~ 225 (268)
T cd05086 149 RYKEDYIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLS---DREVLNHVIKDQ 225 (268)
T ss_pred cCcchhhhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCC---HHHHHHHHHhhc
Confidence 322111112234568899999998853 234678999999999999997 577875432 22222222 11
Q ss_pred --CCCCCCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhc
Q 039291 236 --EHSLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLD 273 (362)
Q Consensus 236 --~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~ 273 (362)
....+.++..++..+.+++..|| .+|++||+++++++
T Consensus 226 ~~~~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~ 264 (268)
T cd05086 226 QVKLFKPQLELPYSERWYEVLQFCW-LSPEKRATAEEVHR 264 (268)
T ss_pred ccccCCCccCCCCcHHHHHHHHHHh-hCcccCCCHHHHHH
Confidence 11234455567899999999999 68999999999875
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=292.10 Aligned_cols=252 Identities=25% Similarity=0.436 Sum_probs=196.0
Q ss_pred eeecceecccCceEEEEEEECCCCCCCCceeeeechhh-----hhhHHHHHHHHHHHHcCCCCcccccccceeeecCCCc
Q 039291 8 WFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEV-----SASASLQKEKEVFDNLNGCPFVLECFGEEITMGENGE 82 (362)
Q Consensus 8 y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~-----~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~~~ 82 (362)
|...+.||+|++|.||+|++..+++ .+++|.... .....+..|+.+++.++ |+|++++++.+.. .
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~----~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~-----~ 70 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGE----IVALKKIRLDNEEEGIPSTALREISLLKELK-HPNIVKLLDVIHT-----E 70 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCc----EEEEEEeccccccccccHHHHHHHHHHHhcC-CCCHHHHHhhhhc-----C
Confidence 6778999999999999999988775 455555432 23355778999999998 9999999987643 2
Q ss_pred eEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEeecCC
Q 039291 83 MAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGV 162 (362)
Q Consensus 83 ~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Dfgl 162 (362)
..+++|+||++ ++|.+++.... ..+++..+..++.|++.||.|||++||+|+||+|+||++ +.++.++|+|||+
T Consensus 71 ~~~~~v~e~~~-~~l~~~i~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~----~~~~~~~l~d~g~ 144 (282)
T cd07829 71 RKLYLVFEYCD-MDLKKYLDKRP-GPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILI----NRDGVLKLADFGL 144 (282)
T ss_pred CceEEEecCcC-cCHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEE----cCCCCEEEecCCc
Confidence 35779999997 59999998742 459999999999999999999999999999999999999 7788899999999
Q ss_pred cccccccccCCCCCCccCCCCccCchhhccc-cCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHH-HHHHHc------
Q 039291 163 AKRSRHCKRQKFDPSMRGTPLYLAPETVVQH-MQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQ-LFSIIG------ 234 (362)
Q Consensus 163 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~-~~~~~~------ 234 (362)
+........ ......++..|+|||.+.+. .++.++|+|||||++++|++|.+||.......... +.....
T Consensus 145 ~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 222 (282)
T cd07829 145 ARAFGIPLR--TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEES 222 (282)
T ss_pred ccccCCCcc--ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHH
Confidence 876543222 11234567889999998876 78899999999999999999999996543211110 111000
Q ss_pred ---------CCCCCCC--------CCccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCc
Q 039291 235 ---------DEHSLPE--------IPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFV 277 (362)
Q Consensus 235 ---------~~~~~~~--------~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~ 277 (362)
.....+. ....++.++.++|.+||..||++||++.+++.||||
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~~ 282 (282)
T cd07829 223 WPGVTKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282 (282)
T ss_pred HHhhcccccccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhCcCC
Confidence 0000111 112347889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=285.19 Aligned_cols=229 Identities=24% Similarity=0.345 Sum_probs=182.5
Q ss_pred cCceEEEEEEECCCCCCCCceeeeechhhhhhHHHHHHHHHHHHcCCCCcccccccceeeecCCCceEEEEEEEecCCCC
Q 039291 17 GSFGCVFIAKPKSNSSFLPPLMAVKSAEVSASASLQKEKEVFDNLNGCPFVLECFGEEITMGENGEMAYNLLLEYAAGGT 96 (362)
Q Consensus 17 G~~g~V~~a~~~~~~~~~~~~~~~K~~~~~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~~ 96 (362)
|.+|.||+|+++.+++ .+++|...... ...+|...+.... ||||+++++.+.. ...++++|||++|++
T Consensus 4 g~~~~v~~~~~~~~~~----~~~~K~i~~~~--~~~~~~~~~~~~~-~~~i~~~~~~~~~-----~~~~~lv~e~~~~~~ 71 (237)
T cd05576 4 GVIDKVLLVMDTRTQQ----TFILKGLRKSS--EYSRERLTIIPHC-VPNMVCLHKYIVS-----EDSVFLVLQHAEGGK 71 (237)
T ss_pred cccceEEEEEEccCCc----EEEEEeecchh--hhhhHHHHHHhcC-CCceeehhhheec-----CCeEEEEEecCCCCC
Confidence 8999999999998876 45666654332 2334555555555 8999999987642 235779999999999
Q ss_pred HHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEeecCCcccccccccCCCCC
Q 039291 97 LGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDP 176 (362)
Q Consensus 97 L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Dfgla~~~~~~~~~~~~~ 176 (362)
|.+++... ..+++..+..++.|++.||+|||++||+||||||+||++ +.++.++++|||++...... ..
T Consensus 72 L~~~l~~~--~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~----~~~~~~~l~df~~~~~~~~~-----~~ 140 (237)
T cd05576 72 LWSHISKF--LNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILL----DDRGHIQLTYFSRWSEVEDS-----CD 140 (237)
T ss_pred HHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEE----cCCCCEEEecccchhccccc-----cc
Confidence 99999763 359999999999999999999999999999999999999 77778999999987654332 12
Q ss_pred CccCCCCccCchhhccccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHHcCCCCCCCCCccCCHHHHHHHHH
Q 039291 177 SMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEHSLPEIPSRVSKEARDFLRR 256 (362)
Q Consensus 177 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 256 (362)
...++..|+|||.+.+..++.++|+||+|+++|+|++|..||...... + .......++..++..++++|.+
T Consensus 141 ~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~--------~-~~~~~~~~~~~~~~~~~~li~~ 211 (237)
T cd05576 141 GEAVENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSG--------I-NTHTTLNIPEWVSEEARSLLQQ 211 (237)
T ss_pred cCCcCccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchh--------c-ccccccCCcccCCHHHHHHHHH
Confidence 345677899999998888899999999999999999999887432110 0 0111123556789999999999
Q ss_pred HhccCCCCCCCH-----HHHhcCCCc
Q 039291 257 CFVRKPAFRFTA-----EMLLDDPFV 277 (362)
Q Consensus 257 ~l~~~p~~R~s~-----~~~l~~p~~ 277 (362)
||+.||++|+++ +++++||||
T Consensus 212 ~l~~dp~~R~~~~~~~~~~~~~h~~~ 237 (237)
T cd05576 212 LLQFNPTERLGAGVAGVEDIKSHPFF 237 (237)
T ss_pred HccCCHHHhcCCCccchHHHHcCCCC
Confidence 999999999985 999999997
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-39 Score=286.73 Aligned_cols=256 Identities=20% Similarity=0.352 Sum_probs=196.2
Q ss_pred eeecceecccCceEEEEEEECCCCCCCCceeeeechhh-----hhhHHHHHHHHHHHHcCCCCcccccccceeeecCCC-
Q 039291 8 WFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEV-----SASASLQKEKEVFDNLNGCPFVLECFGEEITMGENG- 81 (362)
Q Consensus 8 y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~-----~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~~- 81 (362)
|.+.+.||+|+||.||+|.++..+. ....+++|.... ...+.+.+|+.++++++ ||||+++++.........
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~-~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~~ 78 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDG-SFQKVAVKMLKADIFSSSDIEEFLREAACMKEFD-HPNVIKLIGVSLRSRAKGR 78 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCC-CceEEEEEEeccccCChHHHHHHHHHHHHHhcCC-CCCcceEEEEEccCCCCCc
Confidence 6788999999999999998764321 123667775432 23456789999999998 899999998765432221
Q ss_pred ceEEEEEEEecCCCCHHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEE
Q 039291 82 EMAYNLLLEYAAGGTLGDLIEKCN----GNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKI 157 (362)
Q Consensus 82 ~~~~~lv~e~~~~~~L~~~l~~~~----~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl 157 (362)
....++++||+.+|+|.+++.... ...+++..+..++.|++.||+|||+.||+||||||+||++ +.++.+||
T Consensus 79 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili----~~~~~~kl 154 (273)
T cd05074 79 LPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCML----NENMTVCV 154 (273)
T ss_pred ccceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEE----cCCCCEEE
Confidence 123468899999999998875421 1247899999999999999999999999999999999999 67778999
Q ss_pred eecCCcccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHh-CCCCCccCCCCCHHHHHHHHcCC
Q 039291 158 ADLGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLS-GRQAWVVKEDCSIDQLFSIIGDE 236 (362)
Q Consensus 158 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~ 236 (362)
+|||+++...............++..|++||.+.+..++.++|||||||++|+|++ |.+||... +.......+...
T Consensus 155 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~---~~~~~~~~~~~~ 231 (273)
T cd05074 155 ADFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGV---ENSEIYNYLIKG 231 (273)
T ss_pred CcccccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCC---CHHHHHHHHHcC
Confidence 99999876543222222223345678999999998889999999999999999999 88998543 334444444333
Q ss_pred CCCCCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhc
Q 039291 237 HSLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLD 273 (362)
Q Consensus 237 ~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~ 273 (362)
.. ...+...+..+.+++.+||..+|++||++.+++.
T Consensus 232 ~~-~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~ 267 (273)
T cd05074 232 NR-LKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRD 267 (273)
T ss_pred Cc-CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 22 2334567899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=285.12 Aligned_cols=248 Identities=20% Similarity=0.352 Sum_probs=195.7
Q ss_pred ceeecceecccCceEEEEEEECC-CCCCCCceeeeechh-------------hhhhHHHHHHHHHHHHcCCCCccccccc
Q 039291 7 SWFRGRVIGQGSFGCVFIAKPKS-NSSFLPPLMAVKSAE-------------VSASASLQKEKEVFDNLNGCPFVLECFG 72 (362)
Q Consensus 7 ~y~~~~~lG~G~~g~V~~a~~~~-~~~~~~~~~~~K~~~-------------~~~~~~~~~E~~il~~l~~h~~i~~~~~ 72 (362)
.|.+.+.||+|+||.||+|+++. ++. .+++|... ......+.+|+.++.+.-.||||+++++
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~----~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~ 76 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQN----LLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYK 76 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCc----eeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEe
Confidence 48889999999999999999987 333 45555432 1233446678888877555999999998
Q ss_pred ceeeecCCCceEEEEEEEecCCCCHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHh-CCceeCCCCCCCEEEeecC
Q 039291 73 EEITMGENGEMAYNLLLEYAAGGTLGDLIEKC--NGNGLPEKDVRHFTRCILEGIGHIHD-SGYVHCDVKPDNILLVATQ 149 (362)
Q Consensus 73 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~l~~~~~~~i~~ql~~~l~yLH~-~~ivH~Dlkp~Nill~~~~ 149 (362)
.+.. ....+++|||++|++|.+++... ....+++..++.++.|++.||.|||+ .|++|+||+|.||++
T Consensus 77 ~~~~-----~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~---- 147 (269)
T cd08528 77 TFLE-----NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIML---- 147 (269)
T ss_pred eEcc-----CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEE----
Confidence 6642 33577999999999999988652 33469999999999999999999996 789999999999999
Q ss_pred CCceEEEEeecCCcccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHH
Q 039291 150 SGKFVAKIADLGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQL 229 (362)
Q Consensus 150 ~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~ 229 (362)
+..+.++|+|||++....... ......|+..|+|||.+.+..++.++|+||||+++|+|++|..||... +....
T Consensus 148 ~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~---~~~~~ 221 (269)
T cd08528 148 GEDDKVTITDFGLAKQKQPES---KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYST---NMLSL 221 (269)
T ss_pred CCCCcEEEecccceeeccccc---ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCccccc---CHHHH
Confidence 777889999999987654322 223566899999999999888999999999999999999999999533 33333
Q ss_pred HHHHcCCCCCCCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhc
Q 039291 230 FSIIGDEHSLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLD 273 (362)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~ 273 (362)
...+......+.....++.++.+++.+||..||++||++.++..
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~ 265 (269)
T cd08528 222 ATKIVEAVYEPLPEGMYSEDVTDVITSCLTPDAEARPDIIQVSA 265 (269)
T ss_pred HHHHhhccCCcCCcccCCHHHHHHHHHHCCCCCccCCCHHHHHH
Confidence 33433333333333367899999999999999999999999865
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-40 Score=306.21 Aligned_cols=254 Identities=22% Similarity=0.309 Sum_probs=211.9
Q ss_pred ceeecceecccCceEEEEEEECCCCCCCCceeeeechhhh----hhHHHHHHHHHHHHcCCCCcccccccceeeecCCCc
Q 039291 7 SWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVS----ASASLQKEKEVFDNLNGCPFVLECFGEEITMGENGE 82 (362)
Q Consensus 7 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~~----~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~~~ 82 (362)
+-.+.++||+|.||+|++|.++..+.. ...||+|++... ....|.+|+.+|.+|+ |+|++++|++...
T Consensus 111 ~i~l~e~LG~GsFgvV~rg~Wt~psgk-~V~VAVKclr~d~l~~~mddflrEas~M~~L~-H~hliRLyGvVl~------ 182 (1039)
T KOG0199|consen 111 QIKLYELLGEGSFGVVKRGTWTQPSGK-HVNVAVKCLRDDSLNAIMDDFLREASHMLKLQ-HPHLIRLYGVVLD------ 182 (1039)
T ss_pred HHHHHHHhcCcceeeEeeccccCCCCc-EEeEEEEeccCCccchhHHHHHHHHHHHHhcc-CcceeEEeeeecc------
Confidence 345678999999999999999865432 257899987643 5678999999999999 9999999998763
Q ss_pred eEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEeecCC
Q 039291 83 MAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGV 162 (362)
Q Consensus 83 ~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Dfgl 162 (362)
..+.+|+|.++.|+|.+.|++.....|.......|+.||+.|+.||.++++|||||...|+|+ .....|||+||||
T Consensus 183 qp~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlll----asprtVKI~DFGL 258 (1039)
T KOG0199|consen 183 QPAMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLL----ASPRTVKICDFGL 258 (1039)
T ss_pred chhhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhhee----cccceeeeecccc
Confidence 235599999999999999998666779999999999999999999999999999999999999 6677899999999
Q ss_pred cccccccccCCCCC-CccCCCCccCchhhccccCCCcchHHHHHHHHHHHHh-CCCCCccCCCCCHHHHHHHHcCCCCCC
Q 039291 163 AKRSRHCKRQKFDP-SMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLS-GRQAWVVKEDCSIDQLFSIIGDEHSLP 240 (362)
Q Consensus 163 a~~~~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 240 (362)
.+..+......... ...-...|+|||.+....++.++|+|++||+||||++ |.-||.+. ...++++++..+..++
T Consensus 259 mRaLg~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~---~g~qIL~~iD~~erLp 335 (1039)
T KOG0199|consen 259 MRALGENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGC---RGIQILKNIDAGERLP 335 (1039)
T ss_pred eeccCCCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCC---CHHHHHHhccccccCC
Confidence 98776544333221 2223445999999999999999999999999999999 88999655 5667777777666655
Q ss_pred CCCccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCC
Q 039291 241 EIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPF 276 (362)
Q Consensus 241 ~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~ 276 (362)
-|+.++.++.+++..||..+|+.|||+..|.+.-+
T Consensus 336 -RPk~csedIY~imk~cWah~paDRptFsair~~~~ 370 (1039)
T KOG0199|consen 336 -RPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDLV 370 (1039)
T ss_pred -CCCCChHHHHHHHHHhccCCccccccHHHHHHhHH
Confidence 47889999999999999999999999988865433
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-39 Score=295.49 Aligned_cols=248 Identities=20% Similarity=0.351 Sum_probs=200.5
Q ss_pred eecceecccCceEEEEEEECCCCCCCCceeeeechh----hhhhHHHHHHHHHHHHcCCCCcccccccceeeecCCCceE
Q 039291 9 FRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAE----VSASASLQKEKEVFDNLNGCPFVLECFGEEITMGENGEMA 84 (362)
Q Consensus 9 ~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~----~~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~~~~~ 84 (362)
.+.+.||+|.||.||.|....-.+--..-||+|..+ ....+.|..|+.+|+++. ||||++++|++.. ..
T Consensus 392 tl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfd-HphIikLIGv~~e------~P 464 (974)
T KOG4257|consen 392 TLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFD-HPHIIKLIGVCVE------QP 464 (974)
T ss_pred cHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCC-Ccchhheeeeeec------cc
Confidence 345789999999999998765422223457777654 346778999999999999 9999999998863 23
Q ss_pred EEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEeecCCcc
Q 039291 85 YNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAK 164 (362)
Q Consensus 85 ~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Dfgla~ 164 (362)
.++|||.++-|.|+.|++.. +..++..+...+..||+.||.|||+..+|||||...|||+ .....|||+|||+++
T Consensus 465 ~WivmEL~~~GELr~yLq~n-k~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLV----sSp~CVKLaDFGLSR 539 (974)
T KOG4257|consen 465 MWIVMELAPLGELREYLQQN-KDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILV----SSPQCVKLADFGLSR 539 (974)
T ss_pred eeEEEecccchhHHHHHHhc-cccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheee----cCcceeeecccchhh
Confidence 56999999999999999874 4459999999999999999999999999999999999999 777789999999998
Q ss_pred cccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHh-CCCCCccCCCCCHHHHHHHHcCCCCCCCCC
Q 039291 165 RSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLS-GRQAWVVKEDCSIDQLFSIIGDEHSLPEIP 243 (362)
Q Consensus 165 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (362)
......-... ....-..-|||||.+.-+.++.++|||.|||++||++. |..||.+-...+. +-.+.++..+ .+|
T Consensus 540 ~~ed~~yYka-S~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDV---I~~iEnGeRl-P~P 614 (974)
T KOG4257|consen 540 YLEDDAYYKA-SRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDV---IGHIENGERL-PCP 614 (974)
T ss_pred hccccchhhc-cccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccce---EEEecCCCCC-CCC
Confidence 7665332222 12223445999999999999999999999999999887 9999987654332 2223334444 468
Q ss_pred ccCCHHHHHHHHHHhccCCCCCCCHHHHhc
Q 039291 244 SRVSKEARDFLRRCFVRKPAFRFTAEMLLD 273 (362)
Q Consensus 244 ~~~~~~~~~li~~~l~~~p~~R~s~~~~l~ 273 (362)
+.+|+.+..|+.+||..+|.+||++.++..
T Consensus 615 ~nCPp~LYslmskcWayeP~kRPrftei~~ 644 (974)
T KOG4257|consen 615 PNCPPALYSLMSKCWAYEPSKRPRFTEIKA 644 (974)
T ss_pred CCCChHHHHHHHHHhccCcccCCcHHHHHH
Confidence 899999999999999999999999888654
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=278.15 Aligned_cols=260 Identities=22% Similarity=0.309 Sum_probs=202.4
Q ss_pred CCceeecceecccCceEEEEEEECCCCCCCCceeeeec-hhhhhhHHHHHHHHHHHHcCCCCcccccccceeeec-CCCc
Q 039291 5 GTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKS-AEVSASASLQKEKEVFDNLNGCPFVLECFGEEITMG-ENGE 82 (362)
Q Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~-~~~~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~-~~~~ 82 (362)
..||...+.+|.|+. .|..|-|.-.+..++.+..... ......++.++|...+..++ |+||++++.++.... ....
T Consensus 16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~-~~nii~l~n~ftP~~~l~~~ 93 (369)
T KOG0665|consen 16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVN-HKNIISLLNVFTPQKTLEEF 93 (369)
T ss_pred eeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhc-ccceeeeeeccCccccHHHH
Confidence 368999999999999 7888888777654432222221 23446788999999999999 899999999775521 1223
Q ss_pred eEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEeecCC
Q 039291 83 MAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGV 162 (362)
Q Consensus 83 ~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Dfgl 162 (362)
..+|+|||++. .+|.+.+.. .++..++.+++.|+++|++|||+.||+||||||+||++ +..+.+||.|||+
T Consensus 94 ~e~y~v~e~m~-~nl~~vi~~----elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv----~~~~~lKi~dfg~ 164 (369)
T KOG0665|consen 94 QEVYLVMELMD-ANLCQVILM----ELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVV----NSDCTLKILDFGL 164 (369)
T ss_pred HhHHHHHHhhh-hHHHHHHHH----hcchHHHHHHHHHHHHHHHHHHhcceeecccCccccee----cchhheeeccchh
Confidence 45679999996 499998873 28999999999999999999999999999999999999 8889999999999
Q ss_pred cccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHHcC-------
Q 039291 163 AKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGD------- 235 (362)
Q Consensus 163 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~------- 235 (362)
|+..... -..+.++.|+.|.|||++.+-.+...+||||+||++.||++|...|.+.+..+ +..+.+..
T Consensus 165 ar~e~~~---~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~id--Q~~ki~~~lgtpd~~ 239 (369)
T KOG0665|consen 165 ARTEDTD---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHID--QWNKIIEQLGTPDPS 239 (369)
T ss_pred hcccCcc---cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHH--HHHHHHHHhcCCCHH
Confidence 9765532 34467889999999999999889999999999999999999999997654322 21111110
Q ss_pred ------------------------CCCCCC--C------CccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCccCc
Q 039291 236 ------------------------EHSLPE--I------PSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGV 280 (362)
Q Consensus 236 ------------------------~~~~~~--~------~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~~~~ 280 (362)
...+|. + ++.-...+++++.+||..||++|.+++++|.|||++-|
T Consensus 240 F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~~vw 316 (369)
T KOG0665|consen 240 FMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYIKVW 316 (369)
T ss_pred HHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCeeeee
Confidence 000110 0 01123568999999999999999999999999999833
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=289.31 Aligned_cols=260 Identities=24% Similarity=0.409 Sum_probs=205.7
Q ss_pred CCceeecceecccCceEEEEEEECCCCCCCCceeeeechhh----------hhhHHHHHHHHHHHHcCCCCcccccccce
Q 039291 5 GTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEV----------SASASLQKEKEVFDNLNGCPFVLECFGEE 74 (362)
Q Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~----------~~~~~~~~E~~il~~l~~h~~i~~~~~~~ 74 (362)
+.||-++.+||+|+|+.||+|-|...+.+ ||+|+-.. +.-+...+|.+|.+.|. ||.||++|+++
T Consensus 462 n~RYLlLhLLGrGGFSEVyKAFDl~EqRY----vAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLD-HpRIVKlYDyf 536 (775)
T KOG1151|consen 462 NDRYLLLHLLGRGGFSEVYKAFDLTEQRY----VAVKIHQLNKNWRDEKKENYHKHACREYRIHKELD-HPRIVKLYDYF 536 (775)
T ss_pred HHHHHHHHHhccccHHHHHHhcccchhhe----eeEeeehhccchhhHhhhhHHHHHHHHHhhhhccC-cceeeeeeeee
Confidence 57899999999999999999999877754 56665321 12345678999999999 99999999987
Q ss_pred eeecCCCceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC--CceeCCCCCCCEEEeecCCCc
Q 039291 75 ITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDS--GYVHCDVKPDNILLVATQSGK 152 (362)
Q Consensus 75 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~--~ivH~Dlkp~Nill~~~~~~~ 152 (362)
... ...+|-|+|||+|.+|.-||+.. +.+++.+++.|+.||+.||.||.+. -|||-||||.|||+... +.-
T Consensus 537 slD----tdsFCTVLEYceGNDLDFYLKQh--klmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~G-tac 609 (775)
T KOG1151|consen 537 SLD----TDSFCTVLEYCEGNDLDFYLKQH--KLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNG-TAC 609 (775)
T ss_pred eec----cccceeeeeecCCCchhHHHHhh--hhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecC-ccc
Confidence 642 23488999999999999999873 4599999999999999999999975 59999999999999643 456
Q ss_pred eEEEEeecCCcccccccccC-----CCCCCccCCCCccCchhhccc----cCCCcchHHHHHHHHHHHHhCCCCCccCCC
Q 039291 153 FVAKIADLGVAKRSRHCKRQ-----KFDPSMRGTPLYLAPETVVQH----MQEAPSDIWALGCVVLEMLSGRQAWVVKED 223 (362)
Q Consensus 153 ~~~kl~Dfgla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~----~~~~~~DiwslG~il~~l~~g~~pf~~~~~ 223 (362)
|.+||.||||++.+...... .......||.+|++||.+.-. ..+.++||||+|||+|.++.|+.||-...
T Consensus 610 GeIKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnq- 688 (775)
T KOG1151|consen 610 GEIKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQ- 688 (775)
T ss_pred ceeEeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCch-
Confidence 78999999999976543322 223456799999999988743 45789999999999999999999994321
Q ss_pred CCHHHHH---HHHc-CCCCCCCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCccC
Q 039291 224 CSIDQLF---SIIG-DEHSLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKG 279 (362)
Q Consensus 224 ~~~~~~~---~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~~~ 279 (362)
....++ .++. .+..+|.- +.++.+++.||++||...-+.|..+.++-.||||..
T Consensus 689 -sQQdILqeNTIlkAtEVqFP~K-PvVsseAkaFIRRCLaYRKeDR~DV~qLA~dpyllP 746 (775)
T KOG1151|consen 689 -SQQDILQENTILKATEVQFPPK-PVVSSEAKAFIRRCLAYRKEDRIDVQQLACDPYLLP 746 (775)
T ss_pred -hHHHHHhhhchhcceeccCCCC-CccCHHHHHHHHHHHHhhhhhhhhHHHHccCccccc
Confidence 111111 1121 23334433 458999999999999999999999999999999854
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=291.32 Aligned_cols=245 Identities=19% Similarity=0.347 Sum_probs=208.7
Q ss_pred eeecceecccCceEEEEEEECCCCCCCCceeeeechhhh--hhHHHHHHHHHHHHcCCCCcccccccceeeecCCCceEE
Q 039291 8 WFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVS--ASASLQKEKEVFDNLNGCPFVLECFGEEITMGENGEMAY 85 (362)
Q Consensus 8 y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~~--~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~~~~~~ 85 (362)
-....+||.|.||.||.|.+++-. ..||+|.++.. ....|..|+.+|+.++ |||+|+++++|.. +..+
T Consensus 269 ItMkhKLGGGQYGeVYeGvWKkys----lTvAVKtLKEDtMeveEFLkEAAvMKeik-HpNLVqLLGVCT~-----EpPF 338 (1157)
T KOG4278|consen 269 ITMKHKLGGGQYGEVYEGVWKKYS----LTVAVKTLKEDTMEVEEFLKEAAVMKEIK-HPNLVQLLGVCTH-----EPPF 338 (1157)
T ss_pred eeeeeccCCCcccceeeeeeeccc----eeeehhhhhhcchhHHHHHHHHHHHHhhc-CccHHHHhhhhcc-----CCCe
Confidence 344568999999999999998754 46788887654 5577999999999999 9999999999864 2347
Q ss_pred EEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEeecCCccc
Q 039291 86 NLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKR 165 (362)
Q Consensus 86 ~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Dfgla~~ 165 (362)
|||.||+..|+|.+||+.+++..++.....+++-||..|++||..+++|||||...|+|+ .++..||++||||++.
T Consensus 339 YIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLV----gEnhiVKvADFGLsRl 414 (1157)
T KOG4278|consen 339 YIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLV----GENHIVKVADFGLSRL 414 (1157)
T ss_pred EEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccc----cccceEEeeccchhhh
Confidence 799999999999999999988889999999999999999999999999999999999999 8888999999999997
Q ss_pred ccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHh-CCCCCccCCCCCHHHHHHHHcCCCCCCCCCc
Q 039291 166 SRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLS-GRQAWVVKEDCSIDQLFSIIGDEHSLPEIPS 244 (362)
Q Consensus 166 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (362)
+........ .......-|.|||-+....++.++|||+|||+|||+.| |..||.+- +..+.+..+..+..+. -|.
T Consensus 415 MtgDTYTAH-AGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGi---dlSqVY~LLEkgyRM~-~Pe 489 (1157)
T KOG4278|consen 415 MTGDTYTAH-AGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGI---DLSQVYGLLEKGYRMD-GPE 489 (1157)
T ss_pred hcCCceecc-cCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCc---cHHHHHHHHhcccccc-CCC
Confidence 765322211 12224566999999999999999999999999999998 88899554 5666777776666654 478
Q ss_pred cCCHHHHHHHHHHhccCCCCCCCHHHH
Q 039291 245 RVSKEARDFLRRCFVRKPAFRFTAEML 271 (362)
Q Consensus 245 ~~~~~~~~li~~~l~~~p~~R~s~~~~ 271 (362)
.+++.+.+|++.||++.|..||+++++
T Consensus 490 GCPpkVYeLMraCW~WsPsDRPsFaei 516 (1157)
T KOG4278|consen 490 GCPPKVYELMRACWNWSPSDRPSFAEI 516 (1157)
T ss_pred CCCHHHHHHHHHHhcCCcccCccHHHH
Confidence 899999999999999999999999886
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=290.42 Aligned_cols=254 Identities=20% Similarity=0.292 Sum_probs=206.0
Q ss_pred CCceeecceecccCceEEEEEEECCCCCCCCceeeeechhhh----hhHHHHHHHHHHHHcCCCCcccccccceeeecCC
Q 039291 5 GTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVS----ASASLQKEKEVFDNLNGCPFVLECFGEEITMGEN 80 (362)
Q Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~~----~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~ 80 (362)
.++-.+++.||+|-||.|.++.... +.+||+|+++.. ....|.+|+++|.+|+ ||||++++++++..
T Consensus 537 Rs~L~~~ekiGeGqFGEVhLCeveg-----~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLk-hPNIveLvGVC~~D--- 607 (807)
T KOG1094|consen 537 RSRLRFKEKIGEGQFGEVHLCEVEG-----PLKVAVKILRPDATKNARNDFLKEIKILSRLK-HPNIVELLGVCVQD--- 607 (807)
T ss_pred hhheehhhhhcCcccceeEEEEecC-----ceEEEEeecCcccchhHHHHHHHHHHHHhccC-CCCeeEEEeeeecC---
Confidence 4566788999999999999998665 468999998654 4467899999999996 99999999998753
Q ss_pred CceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEeec
Q 039291 81 GEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADL 160 (362)
Q Consensus 81 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Df 160 (362)
..+|+|+||+++|+|.+++.++....+.-.....|+.||+.|++||.+.++|||||.+.|+|+ ++++++||+||
T Consensus 608 --ePicmI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv----~~e~~iKiadf 681 (807)
T KOG1094|consen 608 --DPLCMITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLV----DGEFTIKIADF 681 (807)
T ss_pred --CchHHHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceee----cCcccEEecCc
Confidence 248899999999999999998644334555666799999999999999999999999999999 99999999999
Q ss_pred CCcccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHh--CCCCCccCCCCCHHHHHHHHcCC--
Q 039291 161 GVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLS--GRQAWVVKEDCSIDQLFSIIGDE-- 236 (362)
Q Consensus 161 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~--g~~pf~~~~~~~~~~~~~~~~~~-- 236 (362)
|+++..............+-...|||+|.+.-+.+++++|+|+||++|||+++ ...||....+.+..+-...+...
T Consensus 682 gmsR~lysg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~ 761 (807)
T KOG1094|consen 682 GMSRNLYSGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQG 761 (807)
T ss_pred ccccccccCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCC
Confidence 99986655444444344556788999999999999999999999999999866 56788554443333322222222
Q ss_pred -CCCCCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhc
Q 039291 237 -HSLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLD 273 (362)
Q Consensus 237 -~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~ 273 (362)
...+..|.-++..+.+++.+||..+-.+||+++++-.
T Consensus 762 ~~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~ 799 (807)
T KOG1094|consen 762 RQVVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHL 799 (807)
T ss_pred cceeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHH
Confidence 2234556778999999999999999999999999754
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-37 Score=292.27 Aligned_cols=271 Identities=17% Similarity=0.191 Sum_probs=186.1
Q ss_pred CCCceeecceecccCceEEEEEEECCCCC------------CCCceeeeechhhhh-----------------hHHHHHH
Q 039291 4 DGTSWFRGRVIGQGSFGCVFIAKPKSNSS------------FLPPLMAVKSAEVSA-----------------SASLQKE 54 (362)
Q Consensus 4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~------------~~~~~~~~K~~~~~~-----------------~~~~~~E 54 (362)
..++|.+.++||+|+||+||+|.+...+. ...+.|++|.+.... ......|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 46789999999999999999997643321 122468888764221 1223357
Q ss_pred HHHHHHcCCCCc----ccccccceeeecCC---CceEEEEEEEecCCCCHHHHHHHhcC---------------------
Q 039291 55 KEVFDNLNGCPF----VLECFGEEITMGEN---GEMAYNLLLEYAAGGTLGDLIEKCNG--------------------- 106 (362)
Q Consensus 55 ~~il~~l~~h~~----i~~~~~~~~~~~~~---~~~~~~lv~e~~~~~~L~~~l~~~~~--------------------- 106 (362)
+.++.++.+++. ++++++++.....+ .....+|||||+++++|.+++....+
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 777777874432 35555554332111 12335799999999999999874211
Q ss_pred -CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEeecCCcccccccccCCCCCCccCCCCcc
Q 039291 107 -NGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMRGTPLYL 185 (362)
Q Consensus 107 -~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~ 185 (362)
..+++..++.++.|++.+|.|||+.+|+||||||+|||+ +.++.+||+|||++......... ......+|+.|+
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl----~~~~~~kL~DFGla~~~~~~~~~-~~~~g~~tp~Y~ 377 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLV----TVDGQVKIIDFGAAVDMCTGINF-NPLYGMLDPRYS 377 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEE----CCCCcEEEEeCcCccccccCCcc-CccccCCCccee
Confidence 124677899999999999999999999999999999999 77778999999998654332111 111234588999
Q ss_pred Cchhhcccc--------------------C--CCcchHHHHHHHHHHHHhCCC-CCccCCCC--------CHHHHHHHHc
Q 039291 186 APETVVQHM--------------------Q--EAPSDIWALGCVVLEMLSGRQ-AWVVKEDC--------SIDQLFSIIG 234 (362)
Q Consensus 186 aPE~~~~~~--------------------~--~~~~DiwslG~il~~l~~g~~-pf~~~~~~--------~~~~~~~~~~ 234 (362)
|||++.... + ..+.|+||+||++|+|++|.. ||...... .....++...
T Consensus 378 aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~ 457 (507)
T PLN03224 378 PPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYK 457 (507)
T ss_pred ChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhc
Confidence 999886422 1 124799999999999999875 66422111 1111111221
Q ss_pred CCCCCCCCCccCCHHHHHHHHHHhccCC---CCCCCHHHHhcCCCccC
Q 039291 235 DEHSLPEIPSRVSKEARDFLRRCFVRKP---AFRFTAEMLLDDPFVKG 279 (362)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~li~~~l~~~p---~~R~s~~~~l~~p~~~~ 279 (362)
............+..+++|+.+||..+| .+|+|++++|+||||..
T Consensus 458 ~~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~~ 505 (507)
T PLN03224 458 GQKYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFLP 505 (507)
T ss_pred ccCCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcCC
Confidence 1111112345578999999999999866 68999999999999964
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-39 Score=289.50 Aligned_cols=260 Identities=23% Similarity=0.390 Sum_probs=205.4
Q ss_pred CCCCceeecceecccCceEEEEEEECCCCCCCCceeeeechhhhhh--HHHHHHHHHHHHcCC-----CCccccccccee
Q 039291 3 SDGTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVSAS--ASLQKEKEVFDNLNG-----CPFVLECFGEEI 75 (362)
Q Consensus 3 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~~~~--~~~~~E~~il~~l~~-----h~~i~~~~~~~~ 75 (362)
.-+++|.+....|+|-|++|..|++...++ -||+|++..+.. +.-++|++||++|+. .-++++++..+.
T Consensus 429 ~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~----~vAiKIIRnNE~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~ 504 (752)
T KOG0670|consen 429 LLDSRYEVQGYTGKGVFSTVVRARDQARGQ----EVAIKIIRNNEVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFK 504 (752)
T ss_pred hhcceeEEEeccccceeeeeeeccccCCCC----eeEEEEeecchHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhh
Confidence 457899999999999999999999988776 678888764422 345689999999983 235667766553
Q ss_pred eecCCCceEEEEEEEecCCCCHHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceE
Q 039291 76 TMGENGEMAYNLLLEYAAGGTLGDLIEKCNG-NGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFV 154 (362)
Q Consensus 76 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~ 154 (362)
+ .+.+|||+|.+. .+|.++|++++. .+|....++.|+.||..||..|...||+|.||||.|||++ ....+
T Consensus 505 h-----knHLClVFE~Ls-lNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVN---E~k~i 575 (752)
T KOG0670|consen 505 H-----KNHLCLVFEPLS-LNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVN---ESKNI 575 (752)
T ss_pred h-----cceeEEEehhhh-chHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEec---cCcce
Confidence 2 456999999994 699999998754 3589999999999999999999999999999999999993 45578
Q ss_pred EEEeecCCcccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHHc
Q 039291 155 AKIADLGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIG 234 (362)
Q Consensus 155 ~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~ 234 (362)
+||||||.|....... .+.+.-+..|.|||++.|..|++..|+||+||+||||.||+..|.+....+...++--+.
T Consensus 576 LKLCDfGSA~~~~ene----itPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~K 651 (752)
T KOG0670|consen 576 LKLCDFGSASFASENE----ITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELK 651 (752)
T ss_pred eeeccCcccccccccc----ccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhc
Confidence 9999999987655422 134556788999999999999999999999999999999999998876655444332221
Q ss_pred CC-------------------------------------------------------CCCCCCCccCCHHHHHHHHHHhc
Q 039291 235 DE-------------------------------------------------------HSLPEIPSRVSKEARDFLRRCFV 259 (362)
Q Consensus 235 ~~-------------------------------------------------------~~~~~~~~~~~~~~~~li~~~l~ 259 (362)
.. ..+|.-...+-..+++||.+||.
T Consensus 652 Gk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~ 731 (752)
T KOG0670|consen 652 GKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLI 731 (752)
T ss_pred CCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhc
Confidence 00 00010011122568899999999
Q ss_pred cCCCCCCCHHHHhcCCCccC
Q 039291 260 RKPAFRFTAEMLLDDPFVKG 279 (362)
Q Consensus 260 ~~p~~R~s~~~~l~~p~~~~ 279 (362)
.||++|.|..++|.||||.+
T Consensus 732 LdP~KRit~nqAL~HpFi~~ 751 (752)
T KOG0670|consen 732 LDPEKRITVNQALKHPFITE 751 (752)
T ss_pred cChhhcCCHHHHhcCCcccC
Confidence 99999999999999999964
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=274.47 Aligned_cols=260 Identities=22% Similarity=0.333 Sum_probs=203.9
Q ss_pred eeecceecccCceEEEEEEECCCCCCCCceeeeechh-----hhhhHHHHHHHHHHHHcCCCCcccccccceeeecCCCc
Q 039291 8 WFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAE-----VSASASLQKEKEVFDNLNGCPFVLECFGEEITMGENGE 82 (362)
Q Consensus 8 y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~-----~~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~~~ 82 (362)
-+..+-||.|+||+||.+.|...++ .+++|++. ....+++.+|+++|.-++ |.|+...++.......+-.
T Consensus 55 i~PDRPIGYGAFGVVWsVTDPRdgr----rvalkK~pnvfq~L~s~krvFre~kmLcfFk-HdNVLSaLDILQPph~dfF 129 (449)
T KOG0664|consen 55 IQPDRPIGYGAFGVVWSVTDPRSGK----RVALKKMPNVFQNLASCKRVFREIKMLSSFR-HDNVLSLLDILQPANPSFF 129 (449)
T ss_pred CCCCCcccccceeEEEeccCCCCcc----chhHhhcchHHHHHHHHHHHHHHHHHHHhhc-cccHHHHHHhcCCCCchHH
Confidence 3456889999999999999988775 56776653 236678899999999998 8999988886654333333
Q ss_pred eEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEeecCC
Q 039291 83 MAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGV 162 (362)
Q Consensus 83 ~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Dfgl 162 (362)
..+|++.|.+.. +|..+|-. ..+++.+.++-+++||++||+|||+.+|.||||||.|+|+ +.+..+||||||+
T Consensus 130 qEiYV~TELmQS-DLHKIIVS--PQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLV----NSNCvLKICDFGL 202 (449)
T KOG0664|consen 130 QELYVLTELMQS-DLHKIIVS--PQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLV----NSNCILKICDFGL 202 (449)
T ss_pred HHHHHHHHHHHh-hhhheecc--CCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEe----ccCceEEeccccc
Confidence 346688888865 78777765 4569999999999999999999999999999999999999 8999999999999
Q ss_pred cccccccccCCCCCCccCCCCccCchhhcc-ccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHHc-------
Q 039291 163 AKRSRHCKRQKFDPSMRGTPLYLAPETVVQ-HMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIG------- 234 (362)
Q Consensus 163 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~------- 234 (362)
++.-.......+ +..+-|-.|+|||++.+ +.|+.+.||||+|||+.||+..+..|...+.....+++..+.
T Consensus 203 ARvee~d~~~hM-TqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~Ea 281 (449)
T KOG0664|consen 203 ARTWDQRDRLNM-THEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEA 281 (449)
T ss_pred ccccchhhhhhh-HHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHH
Confidence 987665444443 44566889999999997 478999999999999999999999997665433333332221
Q ss_pred --------------CCCCCCCCC--------ccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCccCc
Q 039291 235 --------------DEHSLPEIP--------SRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGV 280 (362)
Q Consensus 235 --------------~~~~~~~~~--------~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~~~~ 280 (362)
.....|+++ .+-..+...++.++|..||++|.+.++++.|++..+.
T Consensus 282 Mr~ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~e~ 349 (449)
T KOG0664|consen 282 MKYACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLEEG 349 (449)
T ss_pred HHHHhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccccccc
Confidence 112222222 1334678899999999999999999999999998664
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=271.19 Aligned_cols=260 Identities=23% Similarity=0.360 Sum_probs=203.3
Q ss_pred CceeecceecccCceEEEEEEECCCCCCCCceeeeechhh----hhhHHHHHHHHHHHHcCCCCcccccccceeeecCCC
Q 039291 6 TSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEV----SASASLQKEKEVFDNLNGCPFVLECFGEEITMGENG 81 (362)
Q Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~----~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~~ 81 (362)
..-+....||.|+||+|++-.++.+|+ .+|+|.+.. ....++..|.....+-..+||||++|+.....+.
T Consensus 64 ~~Lqdlg~iG~G~fG~V~KM~hk~sg~----~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGd-- 137 (361)
T KOG1006|consen 64 DNLQDLGEIGNGAFGTVNKMLHKPSGK----LMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGD-- 137 (361)
T ss_pred chHHHHHHhcCCcchhhhhhhcCccCc----EEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCc--
Confidence 334556789999999999999998875 677777543 3456788888888888889999999998765432
Q ss_pred ceEEEEEEEecCCCCHHHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHHH-hCCceeCCCCCCCEEEeecCCCceEEEE
Q 039291 82 EMAYNLLLEYAAGGTLGDLIEK---CNGNGLPEKDVRHFTRCILEGIGHIH-DSGYVHCDVKPDNILLVATQSGKFVAKI 157 (362)
Q Consensus 82 ~~~~~lv~e~~~~~~L~~~l~~---~~~~~l~~~~~~~i~~ql~~~l~yLH-~~~ivH~Dlkp~Nill~~~~~~~~~~kl 157 (362)
.++.||.+. .+|..+.+. .....++|..+-.|....+.||.||. ...|||||+||+|||+ +..|.|||
T Consensus 138 ---cWiCMELMd-~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILl----dr~G~vKL 209 (361)
T KOG1006|consen 138 ---CWICMELMD-ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILL----DRHGDVKL 209 (361)
T ss_pred ---eeeeHHHHh-hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEE----ecCCCEee
Confidence 458899995 477655432 23456999999999999999999997 4799999999999999 88999999
Q ss_pred eecCCcccccccccCCCCCCccCCCCccCchhhcc--ccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHHcC
Q 039291 158 ADLGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQ--HMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGD 235 (362)
Q Consensus 158 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~ 235 (362)
||||++......... +.-.|-..|||||.+.. ..|+.++|+||||++|||+.||+.|+...+. ..+++......
T Consensus 210 CDFGIcGqLv~SiAk---T~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s-vfeql~~Vv~g 285 (361)
T KOG1006|consen 210 CDFGICGQLVDSIAK---TVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS-VFEQLCQVVIG 285 (361)
T ss_pred ecccchHhHHHHHHh---hhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH-HHHHHHHHHcC
Confidence 999997654432222 34458889999999984 4689999999999999999999999977654 33444444433
Q ss_pred CCCCCCCCc---cCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCccCcchh
Q 039291 236 EHSLPEIPS---RVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGVDEE 283 (362)
Q Consensus 236 ~~~~~~~~~---~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~~~~~~~ 283 (362)
.+..-..+. ..+..++.+|.-||.+|-+.||...+++++||++....+
T Consensus 286 dpp~l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~~fyr~y~~~ 336 (361)
T KOG1006|consen 286 DPPILLFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKFPFYRMYAVE 336 (361)
T ss_pred CCCeecCcccccccCHHHHHHHHHHhhcccccCcchhhhhcCchhhhhhhc
Confidence 332222222 378999999999999999999999999999999765443
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=279.87 Aligned_cols=252 Identities=25% Similarity=0.396 Sum_probs=202.2
Q ss_pred ceeecceecccCceEEEEEEECCCCCCCCceeeeechhhhhhHHHHHHHHHHHHcC-CCCcccccccceeeecCCCceEE
Q 039291 7 SWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVSASASLQKEKEVFDNLN-GCPFVLECFGEEITMGENGEMAY 85 (362)
Q Consensus 7 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~~~~~~~~~E~~il~~l~-~h~~i~~~~~~~~~~~~~~~~~~ 85 (362)
.-.+.++||+|.||.||+|...+ +.||+|++.....+.++.|..|++... .|+||+++++...... .....|
T Consensus 211 pl~l~eli~~Grfg~V~KaqL~~------~~VAVKifp~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t-~~~~ey 283 (534)
T KOG3653|consen 211 PLQLLELIGRGRFGCVWKAQLDN------RLVAVKIFPEQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGT-ADRMEY 283 (534)
T ss_pred chhhHHHhhcCccceeehhhccC------ceeEEEecCHHHHHHHHhHHHHHhccCccchhHHHhhchhccCC-ccccce
Confidence 34567889999999999998776 379999999999999999999998764 5999999998654322 224457
Q ss_pred EEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---------CceeCCCCCCCEEEeecCCCceEEE
Q 039291 86 NLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDS---------GYVHCDVKPDNILLVATQSGKFVAK 156 (362)
Q Consensus 86 ~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~---------~ivH~Dlkp~Nill~~~~~~~~~~k 156 (362)
.||++|.+.|+|.+||.. ..+++....+++..+++||+|||+. .|+|||||..|||+ ..++...
T Consensus 284 wLVt~fh~kGsL~dyL~~---ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLv----K~DlTcc 356 (534)
T KOG3653|consen 284 WLVTEFHPKGSLCDYLKA---NTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLV----KNDLTCC 356 (534)
T ss_pred eEEeeeccCCcHHHHHHh---ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEE----ccCCcEE
Confidence 799999999999999987 3499999999999999999999973 59999999999999 8888999
Q ss_pred EeecCCcccccccccCCCCCCccCCCCccCchhhccccC-C-----CcchHHHHHHHHHHHHhCCC------------CC
Q 039291 157 IADLGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQ-E-----APSDIWALGCVVLEMLSGRQ------------AW 218 (362)
Q Consensus 157 l~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~-----~~~DiwslG~il~~l~~g~~------------pf 218 (362)
|+|||||..........-....+||..|||||++.+... . .+.||||+|.+||||++... ||
T Consensus 357 IaDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpf 436 (534)
T KOG3653|consen 357 IADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPF 436 (534)
T ss_pred eeccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCch
Confidence 999999998876655555556899999999999986422 1 35799999999999998643 33
Q ss_pred cc--CCCCCHHHHHHHHcCCCCCCCCCcc-----CCHHHHHHHHHHhccCCCCCCCHHHHh
Q 039291 219 VV--KEDCSIDQLFSIIGDEHSLPEIPSR-----VSKEARDFLRRCFVRKPAFRFTAEMLL 272 (362)
Q Consensus 219 ~~--~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~li~~~l~~~p~~R~s~~~~l 272 (362)
+. ......+++...+......|.++.. -..-+++.++.||+.||+.|.|+.=+.
T Consensus 437 e~evG~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~ 497 (534)
T KOG3653|consen 437 EAEVGNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVE 497 (534)
T ss_pred hHHhcCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHH
Confidence 31 1233455565555555555655532 235688999999999999999986554
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-38 Score=297.81 Aligned_cols=261 Identities=26% Similarity=0.374 Sum_probs=205.8
Q ss_pred eeecceecccCce-EEEEEEECCCCCCCCceeeeechhhhhhHHHHHHHHHHHHcCCCCcccccccceeeecCCCceEEE
Q 039291 8 WFRGRVIGQGSFG-CVFIAKPKSNSSFLPPLMAVKSAEVSASASLQKEKEVFDNLNGCPFVLECFGEEITMGENGEMAYN 86 (362)
Q Consensus 8 y~~~~~lG~G~~g-~V~~a~~~~~~~~~~~~~~~K~~~~~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~~~~~~~ 86 (362)
|...+.+|.|+-| .||+|...+. .||+|.+-.+..+.+++|+..|+.=..||||+++|+.. .++.+.|
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~ye~R------~VAVKrll~e~~~~A~rEi~lL~eSD~H~NviRyyc~E-----~d~qF~Y 579 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVYEGR------EVAVKRLLEEFFDFAQREIQLLQESDEHPNVIRYYCSE-----QDRQFLY 579 (903)
T ss_pred eccHHHcccCCCCcEEEEEeeCCc------eehHHHHhhHhHHHHHHHHHHHHhccCCCceEEEEeec-----cCCceEE
Confidence 4456789999987 5778877654 68999998888888999999999999999999999743 4566788
Q ss_pred EEEEecCCCCHHHHHHHh-cCCC-CCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeec-CCCceEEEEeecCCc
Q 039291 87 LLLEYAAGGTLGDLIEKC-NGNG-LPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVAT-QSGKFVAKIADLGVA 163 (362)
Q Consensus 87 lv~e~~~~~~L~~~l~~~-~~~~-l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~-~~~~~~~kl~Dfgla 163 (362)
+..|.|. .+|.++++.. .... ......+.++.|++.||++||+.+||||||||+||||... .+....++|+|||++
T Consensus 580 IalELC~-~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfgls 658 (903)
T KOG1027|consen 580 IALELCA-CSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLS 658 (903)
T ss_pred EEehHhh-hhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEecccccc
Confidence 9999996 4999999873 1111 1224568899999999999999999999999999999654 344588999999999
Q ss_pred ccccccccC-CCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHhC-CCCCccCCCCCHHHHHHHHcCCCCCCC
Q 039291 164 KRSRHCKRQ-KFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSG-RQAWVVKEDCSIDQLFSIIGDEHSLPE 241 (362)
Q Consensus 164 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~ 241 (362)
+........ .......||-+|+|||++.......++||||+||++|+.++| ..||... ......++.....+..
T Consensus 659 Kkl~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~----~~R~~NIl~~~~~L~~ 734 (903)
T KOG1027|consen 659 KKLAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDS----LERQANILTGNYTLVH 734 (903)
T ss_pred cccCCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCch----HHhhhhhhcCccceee
Confidence 876543322 223467799999999999998888899999999999999996 8999422 3333344444444433
Q ss_pred CCccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCccCcchhh
Q 039291 242 IPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGVDEEL 284 (362)
Q Consensus 242 ~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~~~~~~~~ 284 (362)
+...-..++++||.+|+..+|..||+|.++|.||+|-.....+
T Consensus 735 L~~~~d~eA~dLI~~ml~~dP~~RPsa~~VL~HPlFW~~ekrL 777 (903)
T KOG1027|consen 735 LEPLPDCEAKDLISRMLNPDPQLRPSATDVLNHPLFWDSEKRL 777 (903)
T ss_pred eccCchHHHHHHHHHhcCCCcccCCCHHHHhCCCccCChHHHH
Confidence 3332333899999999999999999999999999997665443
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=297.61 Aligned_cols=253 Identities=21% Similarity=0.362 Sum_probs=211.9
Q ss_pred CCCceeecceecccCceEEEEEEECCCCCCCCceeeeechh----hhhhHHHHHHHHHHHHcCCCCcccccccceeeecC
Q 039291 4 DGTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAE----VSASASLQKEKEVFDNLNGCPFVLECFGEEITMGE 79 (362)
Q Consensus 4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~----~~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~ 79 (362)
+-+--.+.++||.|.||+||+|+.+..++.. .-||||.++ ......|..|+.||-++. ||||+++.++...
T Consensus 627 d~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre-~~VAIKTLK~GytekqrrdFL~EAsIMGQFd-HPNIIrLEGVVTk--- 701 (996)
T KOG0196|consen 627 DPSCVKIEKVIGAGEFGEVCSGRLKLPGKRE-ITVAIKTLKAGYTEKQRRDFLSEASIMGQFD-HPNIIRLEGVVTK--- 701 (996)
T ss_pred ChhheEEEEEEecccccceecccccCCCCcc-eeEEEeeeccCccHHHHhhhhhhhhhcccCC-CCcEEEEEEEEec---
Confidence 3445577899999999999999998776433 567888765 446677999999999999 9999999997642
Q ss_pred CCceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEee
Q 039291 80 NGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIAD 159 (362)
Q Consensus 80 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~D 159 (362)
.....+|.||+++|+|..+|+... +.|+..+..-+++.|+.|++||.+++.|||||...|||+ +.+..+|++|
T Consensus 702 --s~PvMIiTEyMENGsLDsFLR~~D-GqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILV----NsnLvCKVsD 774 (996)
T KOG0196|consen 702 --SKPVMIITEYMENGSLDSFLRQND-GQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILV----NSNLVCKVSD 774 (996)
T ss_pred --CceeEEEhhhhhCCcHHHHHhhcC-CceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheee----ccceEEEecc
Confidence 334669999999999999999866 459999999999999999999999999999999999999 9999999999
Q ss_pred cCCcccccccccCCCCCCccC--CCCccCchhhccccCCCcchHHHHHHHHHHHHh-CCCCCccCCCCCHHHHHHHHcCC
Q 039291 160 LGVAKRSRHCKRQKFDPSMRG--TPLYLAPETVVQHMQEAPSDIWALGCVVLEMLS-GRQAWVVKEDCSIDQLFSIIGDE 236 (362)
Q Consensus 160 fgla~~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~ 236 (362)
|||++.......... ++.-| ...|.|||.+..+.++.++||||+|++|||.++ |..||-.. .-.+.++.+.++
T Consensus 775 FGLSRvledd~~~~y-tt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdm---SNQdVIkaIe~g 850 (996)
T KOG0196|consen 775 FGLSRVLEDDPEAAY-TTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDM---SNQDVIKAIEQG 850 (996)
T ss_pred ccceeecccCCCccc-cccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCccccc---chHHHHHHHHhc
Confidence 999996654331211 11112 356999999999999999999999999999776 99998433 445667778888
Q ss_pred CCCCCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhc
Q 039291 237 HSLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLD 273 (362)
Q Consensus 237 ~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~ 273 (362)
..+|. |.++|..+-+|+..||++|-.+||.+.+++.
T Consensus 851 yRLPp-PmDCP~aL~qLMldCWqkdR~~RP~F~qiV~ 886 (996)
T KOG0196|consen 851 YRLPP-PMDCPAALYQLMLDCWQKDRNRRPKFAQIVS 886 (996)
T ss_pred cCCCC-CCCCcHHHHHHHHHHHHHHhhcCCCHHHHHH
Confidence 88775 6789999999999999999999999999876
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-37 Score=272.61 Aligned_cols=254 Identities=24% Similarity=0.364 Sum_probs=208.8
Q ss_pred CceeecceecccCceEEEEEEECCCCCCCCceeeeechhhhhhHHHHHHHHHHHHc-CCCCcccccccceeeecCCCceE
Q 039291 6 TSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVSASASLQKEKEVFDNL-NGCPFVLECFGEEITMGENGEMA 84 (362)
Q Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~~~~~~~~~E~~il~~l-~~h~~i~~~~~~~~~~~~~~~~~ 84 (362)
++-.+.+.||+|.||+||+|++++. .||+|++.....+.+.+|.+|++.. -.|+||..+++.-.. +.+....
T Consensus 211 rqI~L~e~IGkGRyGEVwrG~wrGe------~VAVKiF~srdE~SWfrEtEIYqTvmLRHENILgFIaaD~~-~~gs~TQ 283 (513)
T KOG2052|consen 211 RQIVLQEIIGKGRFGEVWRGRWRGE------DVAVKIFSSRDERSWFRETEIYQTVMLRHENILGFIAADNK-DNGSWTQ 283 (513)
T ss_pred heeEEEEEecCccccceeeccccCC------ceEEEEecccchhhhhhHHHHHHHHHhccchhhhhhhcccc-CCCceEE
Confidence 4567889999999999999999875 5899999998999999999998863 249999999986543 3355566
Q ss_pred EEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC--------CceeCCCCCCCEEEeecCCCceEEE
Q 039291 85 YNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDS--------GYVHCDVKPDNILLVATQSGKFVAK 156 (362)
Q Consensus 85 ~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~--------~ivH~Dlkp~Nill~~~~~~~~~~k 156 (362)
++||.+|.+.|||.|+|.. ..++.....+++..++.||+|||-. .|.|||||..|||+ ..++.+.
T Consensus 284 LwLvTdYHe~GSL~DyL~r---~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILV----Kkn~~C~ 356 (513)
T KOG2052|consen 284 LWLVTDYHEHGSLYDYLNR---NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILV----KKNGTCC 356 (513)
T ss_pred EEEeeecccCCcHHHHHhh---ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEE----ccCCcEE
Confidence 8899999999999999987 4599999999999999999999963 59999999999999 8889999
Q ss_pred EeecCCccccccccc--CCCCCCccCCCCccCchhhccccC------CCcchHHHHHHHHHHHHhC----------CCCC
Q 039291 157 IADLGVAKRSRHCKR--QKFDPSMRGTPLYLAPETVVQHMQ------EAPSDIWALGCVVLEMLSG----------RQAW 218 (362)
Q Consensus 157 l~Dfgla~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~------~~~~DiwslG~il~~l~~g----------~~pf 218 (362)
|+|+|||........ .......+||..|||||++...-. -..+||||||.++||+... ++||
T Consensus 357 IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Py 436 (513)
T KOG2052|consen 357 IADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPY 436 (513)
T ss_pred EeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCc
Confidence 999999986655421 122346789999999999986422 2358999999999999763 4688
Q ss_pred cc--CCCCCHHHHHHHHcCCCCCCCCCccCC-----HHHHHHHHHHhccCCCCCCCHHHHhc
Q 039291 219 VV--KEDCSIDQLFSIIGDEHSLPEIPSRVS-----KEARDFLRRCFVRKPAFRFTAEMLLD 273 (362)
Q Consensus 219 ~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~li~~~l~~~p~~R~s~~~~l~ 273 (362)
.. ..+...+++...+......|.+|.... ..+..+++.||..||.-|.|+-.+.+
T Consensus 437 yd~Vp~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKK 498 (513)
T KOG2052|consen 437 YDVVPSDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKK 498 (513)
T ss_pred ccCCCCCCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHH
Confidence 64 456677888888888888888776544 44668899999999999999877654
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=258.85 Aligned_cols=239 Identities=31% Similarity=0.548 Sum_probs=194.3
Q ss_pred CceEEEEEEECCCCCCCCceeeeechhhhh----hHHHHHHHHHHHHcCCCCcccccccceeeecCCCceEEEEEEEecC
Q 039291 18 SFGCVFIAKPKSNSSFLPPLMAVKSAEVSA----SASLQKEKEVFDNLNGCPFVLECFGEEITMGENGEMAYNLLLEYAA 93 (362)
Q Consensus 18 ~~g~V~~a~~~~~~~~~~~~~~~K~~~~~~----~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~ 93 (362)
+||.||+|++..+++ .+++|...... ...+.+|++.+++++ |+|++++++.+... ...++++||+.
T Consensus 1 ~~g~v~~~~~~~~~~----~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~-~~~i~~~~~~~~~~-----~~~~l~~e~~~ 70 (244)
T smart00220 1 SFGKVYLARDKKTGK----LVAIKVIKKEKIKKKRERILREISILKKLK-HPNIVRLYDVFEDE-----DKLYLVMEYCD 70 (244)
T ss_pred CceEEEEEEECCCCc----EEEEEEecccccccHHHHHHHHHHHHHhCC-CCcHHHHHhheeeC-----CEEEEEEeCCC
Confidence 589999999988765 45666654322 577889999999996 99999999876532 34679999999
Q ss_pred CCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEeecCCcccccccccCC
Q 039291 94 GGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQK 173 (362)
Q Consensus 94 ~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Dfgla~~~~~~~~~~ 173 (362)
+++|.+++.... .+++..+..++.+++.++.|||+.+++|+||+|.||++ +.++.++|+|||.+.......
T Consensus 71 ~~~L~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~----~~~~~~~l~d~~~~~~~~~~~--- 141 (244)
T smart00220 71 GGDLFDLLKKRG--RLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILL----DEDGHVKLADFGLARQLDPGG--- 141 (244)
T ss_pred CCCHHHHHHhcc--CCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEE----CCCCcEEEccccceeeecccc---
Confidence 999999997633 38999999999999999999999999999999999999 667889999999987655432
Q ss_pred CCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHHcCCCCCCCCCcc-CCHHHHH
Q 039291 174 FDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEHSLPEIPSR-VSKEARD 252 (362)
Q Consensus 174 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 252 (362)
......++..|++||.+.+..++.++|+||||+++++|++|..||... .+.......+............ ++.++.+
T Consensus 142 ~~~~~~~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 219 (244)
T smart00220 142 LLTTFVGTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGD--DQLLELFKKIGKPKPPFPPPEWKISPEAKD 219 (244)
T ss_pred ccccccCCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCC--CcHHHHHHHHhccCCCCccccccCCHHHHH
Confidence 223566889999999998888899999999999999999999999542 2344444444433322221111 8899999
Q ss_pred HHHHHhccCCCCCCCHHHHhcCCCc
Q 039291 253 FLRRCFVRKPAFRFTAEMLLDDPFV 277 (362)
Q Consensus 253 li~~~l~~~p~~R~s~~~~l~~p~~ 277 (362)
++.+||..+|++||++.++++||||
T Consensus 220 ~i~~~l~~~p~~Rp~~~~~~~~~~~ 244 (244)
T smart00220 220 LIRKLLVKDPEKRLTAEEALQHPFF 244 (244)
T ss_pred HHHHHccCCchhccCHHHHhhCCCC
Confidence 9999999999999999999999997
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=285.97 Aligned_cols=249 Identities=20% Similarity=0.304 Sum_probs=210.5
Q ss_pred eeecceecccCceEEEEEEECCCCCCCCceeeeechhh----hhhHHHHHHHHHHHHcCCCCcccccccceeeecCCCce
Q 039291 8 WFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEV----SASASLQKEKEVFDNLNGCPFVLECFGEEITMGENGEM 83 (362)
Q Consensus 8 y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~----~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~~~~ 83 (362)
....++||+|+||+||+|.+--.++.+.+.|++|.+.. +....+..|+.+|.+|. |||++++++++....
T Consensus 698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masld-Hpnl~RLLgvc~~s~----- 771 (1177)
T KOG1025|consen 698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLD-HPNLLRLLGVCMLST----- 771 (1177)
T ss_pred hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCC-CchHHHHhhhcccch-----
Confidence 45578999999999999999877888889999998643 35678999999999999 999999999886432
Q ss_pred EEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEeecCCc
Q 039291 84 AYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVA 163 (362)
Q Consensus 84 ~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Dfgla 163 (362)
+-||++|+++|.|.++++..+ ..+-......|..||++|+.|||++++|||||-..|||+ ..-..+||.|||+|
T Consensus 772 -~qlvtq~mP~G~LlDyvr~hr-~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLV----ksP~hvkitdfgla 845 (1177)
T KOG1025|consen 772 -LQLVTQLMPLGCLLDYVREHR-DNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLV----KSPNHVKITDFGLA 845 (1177)
T ss_pred -HHHHHHhcccchHHHHHHHhh-ccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheee----cCCCeEEEEecchh
Confidence 458999999999999999854 458899999999999999999999999999999999999 66778999999999
Q ss_pred ccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHh-CCCCCccCCCCCHHHHHHHHcCCCCCCCC
Q 039291 164 KRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLS-GRQAWVVKEDCSIDQLFSIIGDEHSLPEI 242 (362)
Q Consensus 164 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 242 (362)
+...............-.+.|||-|.+....|+.++|||||||++||++| |..|+.+.. ..++-..+.....+ +.
T Consensus 846 ~ll~~d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~---~~eI~dlle~geRL-sq 921 (1177)
T KOG1025|consen 846 KLLAPDEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIP---AEEIPDLLEKGERL-SQ 921 (1177)
T ss_pred hccCcccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCC---HHHhhHHHhccccC-CC
Confidence 97776554444334444566999999999999999999999999999999 999996664 44444444445554 35
Q ss_pred CccCCHHHHHHHHHHhccCCCCCCCHHHHh
Q 039291 243 PSRVSKEARDFLRRCFVRKPAFRFTAEMLL 272 (362)
Q Consensus 243 ~~~~~~~~~~li~~~l~~~p~~R~s~~~~l 272 (362)
|+.++.++..++.+||..|++.||+++++.
T Consensus 922 PpiCtiDVy~~mvkCwmid~~~rp~fkel~ 951 (1177)
T KOG1025|consen 922 PPICTIDVYMVMVKCWMIDADSRPTFKELA 951 (1177)
T ss_pred CCCccHHHHHHHHHHhccCcccCccHHHHH
Confidence 778999999999999999999999988764
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=290.39 Aligned_cols=255 Identities=25% Similarity=0.408 Sum_probs=204.5
Q ss_pred CceeecceecccCceEEEEEEECCCCC---CCCceeeeechhh----hhhHHHHHHHHHHHHcCCCCcccccccceeeec
Q 039291 6 TSWFRGRVIGQGSFGCVFIAKPKSNSS---FLPPLMAVKSAEV----SASASLQKEKEVFDNLNGCPFVLECFGEEITMG 78 (362)
Q Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~---~~~~~~~~K~~~~----~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~ 78 (362)
.+..+.+.||+|+||.|++|..+.-.. .....||+|.... ...+.+..|+++|+.+.+|+||+.+++.+..
T Consensus 296 ~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~-- 373 (609)
T KOG0200|consen 296 ENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQ-- 373 (609)
T ss_pred hhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeecc--
Confidence 334566799999999999998543221 2246788887653 3456789999999999999999999998764
Q ss_pred CCCceEEEEEEEecCCCCHHHHHHHhc------C--------CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEE
Q 039291 79 ENGEMAYNLLLEYAAGGTLGDLIEKCN------G--------NGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNIL 144 (362)
Q Consensus 79 ~~~~~~~~lv~e~~~~~~L~~~l~~~~------~--------~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nil 144 (362)
...+++|+||+..|+|..+++..+ . ..++..+...++.||+.|++||++..+|||||-..|||
T Consensus 374 ---~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRNVL 450 (609)
T KOG0200|consen 374 ---DGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARNVL 450 (609)
T ss_pred ---CCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhhEE
Confidence 334779999999999999998854 0 13889999999999999999999999999999999999
Q ss_pred EeecCCCceEEEEeecCCcccccccccCCCCCCccC--CCCccCchhhccccCCCcchHHHHHHHHHHHHh-CCCCCccC
Q 039291 145 LVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMRG--TPLYLAPETVVQHMQEAPSDIWALGCVVLEMLS-GRQAWVVK 221 (362)
Q Consensus 145 l~~~~~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~ 221 (362)
+ ..+..+||+|||+|+.......... ....| ...|||||.+....++.++||||+|++|||+++ |..||.+-
T Consensus 451 i----~~~~~~kIaDFGlar~~~~~~~y~~-~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~ 525 (609)
T KOG0200|consen 451 I----TKNKVIKIADFGLARDHYNKDYYRT-KSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGI 525 (609)
T ss_pred e----cCCCEEEEccccceeccCCCCceEe-cCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCC
Confidence 9 7778999999999985443222211 11222 233999999999999999999999999999999 88898652
Q ss_pred CCCCHHHHHHHHcCCCCCCCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhc
Q 039291 222 EDCSIDQLFSIIGDEHSLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLD 273 (362)
Q Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~ 273 (362)
.....++..+..+..+ ..|..++.++.++++.||+.+|++||++.++.+
T Consensus 526 --~~~~~l~~~l~~G~r~-~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~ 574 (609)
T KOG0200|consen 526 --PPTEELLEFLKEGNRM-EQPEHCSDEIYDLMKSCWNADPEDRPTFSECVE 574 (609)
T ss_pred --CcHHHHHHHHhcCCCC-CCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHH
Confidence 1244556666666554 457889999999999999999999999999876
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-36 Score=266.67 Aligned_cols=266 Identities=26% Similarity=0.407 Sum_probs=201.4
Q ss_pred CCCceeecceecccCceEEEEEEECCCCCCCCceeeeechhh-hhhHHHHHHHHHHHHcCCCCcccccccceeeecCCCc
Q 039291 4 DGTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEV-SASASLQKEKEVFDNLNGCPFVLECFGEEITMGENGE 82 (362)
Q Consensus 4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~-~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~~~ 82 (362)
..+.|.++..||+|+|++||+|.+... ..-..+|++|.+.. +.-.++..|+++|..+.++.||+++.+.+...
T Consensus 34 ~~~~~~~v~kigeGsFssv~~a~~~~~-~~~~~~valk~i~~ts~p~ri~~El~~L~~~gG~~ni~~~~~~~rnn----- 107 (418)
T KOG1167|consen 34 ISNAYKVVNKIGEGSFSSVYKATDIEQ-DTKRRYVALKAIYRTSSPSRILNELEMLYRLGGSDNIIKLNGCFRNN----- 107 (418)
T ss_pred hhhhhhhhccccccchhhhhhhhHhhh-ccccceEeeeecccccCchHHHHHHHHHHHhccchhhhcchhhhccC-----
Confidence 346788999999999999999988762 22235788888654 35567999999999999999999999866432
Q ss_pred eEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEeecCC
Q 039291 83 MAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGV 162 (362)
Q Consensus 83 ~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Dfgl 162 (362)
...++|+||++..+..+++.. ++...++.+++.++.||.++|.+|||||||||+|+|.+ ...+.-.|+|||+
T Consensus 108 d~v~ivlp~~~H~~f~~l~~~-----l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n---~~t~rg~LvDFgL 179 (418)
T KOG1167|consen 108 DQVAIVLPYFEHDRFRDLYRS-----LSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYN---RRTQRGVLVDFGL 179 (418)
T ss_pred CeeEEEecccCccCHHHHHhc-----CCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccc---cccCCceEEechh
Confidence 235699999999999999876 88999999999999999999999999999999999994 4445678999999
Q ss_pred cccccccc------c------------------------------------CCCCCCccCCCCccCchhhcc-ccCCCcc
Q 039291 163 AKRSRHCK------R------------------------------------QKFDPSMRGTPLYLAPETVVQ-HMQEAPS 199 (362)
Q Consensus 163 a~~~~~~~------~------------------------------------~~~~~~~~gt~~y~aPE~~~~-~~~~~~~ 199 (362)
|....... . ........||++|+|||++.. ...+.++
T Consensus 180 A~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~Qttai 259 (418)
T KOG1167|consen 180 AQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAI 259 (418)
T ss_pred HHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCcc
Confidence 97211000 0 000113459999999999986 4678899
Q ss_pred hHHHHHHHHHHHHhCCCCCccCCC-C-CHHHHHHHHc-----------CC------CC----------------------
Q 039291 200 DIWALGCVVLEMLSGRQAWVVKED-C-SIDQLFSIIG-----------DE------HS---------------------- 238 (362)
Q Consensus 200 DiwslG~il~~l~~g~~pf~~~~~-~-~~~~~~~~~~-----------~~------~~---------------------- 238 (362)
||||.|||+..++++..||....+ . .+.++..+.+ .. ..
T Consensus 260 Diws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~ 339 (418)
T KOG1167|consen 260 DIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKS 339 (418)
T ss_pred ceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccc
Confidence 999999999999999999864322 1 1222222211 00 00
Q ss_pred -----CCCCC-ccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCccCcchh
Q 039291 239 -----LPEIP-SRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGVDEE 283 (362)
Q Consensus 239 -----~~~~~-~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~~~~~~~ 283 (362)
..... ...+..+.+|+.+||+.||.+|+|++++|+||||....+.
T Consensus 340 ~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~~~~~~ 390 (418)
T KOG1167|consen 340 RQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPFFDEADRT 390 (418)
T ss_pred cccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcCcCCcchhhh
Confidence 00011 1134578899999999999999999999999999865443
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-35 Score=304.27 Aligned_cols=240 Identities=21% Similarity=0.269 Sum_probs=179.7
Q ss_pred ceeecceecccCceEEEEEEECCCCCCCCceeeeechhhhhhHHHHHHHHHHHHcCCCCcccccccceeeecCCCceEEE
Q 039291 7 SWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVSASASLQKEKEVFDNLNGCPFVLECFGEEITMGENGEMAYN 86 (362)
Q Consensus 7 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~~~~~~~ 86 (362)
.|...+.||+|+||.||+|+++.++. .|++|...... .....|++++++++ ||||+++++++... ..++
T Consensus 691 ~~~~~~~ig~G~~g~Vy~~~~~~~~~----~vavK~~~~~~-~~~~~~~~~l~~l~-HpnIv~~~~~~~~~-----~~~~ 759 (968)
T PLN00113 691 SLKEENVISRGKKGASYKGKSIKNGM----QFVVKEINDVN-SIPSSEIADMGKLQ-HPNIVKLIGLCRSE-----KGAY 759 (968)
T ss_pred hCCcccEEccCCCeeEEEEEECCCCc----EEEEEEccCCc-cccHHHHHHHhhCC-CCCcceEEEEEEcC-----CCCE
Confidence 35566789999999999999877664 56777664322 22346788999998 99999999987532 2367
Q ss_pred EEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCceeCCCCCCCEEEeecCCCceEEEEeecCCc
Q 039291 87 LLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIH---DSGYVHCDVKPDNILLVATQSGKFVAKIADLGVA 163 (362)
Q Consensus 87 lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH---~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Dfgla 163 (362)
+||||+++|+|.++++. +++..+..++.|++.||+||| +.+|+||||||+||++ +.+...++. ||.+
T Consensus 760 lv~Ey~~~g~L~~~l~~-----l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~----~~~~~~~~~-~~~~ 829 (968)
T PLN00113 760 LIHEYIEGKNLSEVLRN-----LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIII----DGKDEPHLR-LSLP 829 (968)
T ss_pred EEEeCCCCCcHHHHHhc-----CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEE----CCCCceEEE-eccc
Confidence 99999999999999964 899999999999999999999 6799999999999999 555556554 6654
Q ss_pred ccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHhCCCCCccCCC--CCHHHHHHHHcCCC----
Q 039291 164 KRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKED--CSIDQLFSIIGDEH---- 237 (362)
Q Consensus 164 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~--~~~~~~~~~~~~~~---- 237 (362)
..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||..... ....+..+......
T Consensus 830 ~~~~~------~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 903 (968)
T PLN00113 830 GLLCT------DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDM 903 (968)
T ss_pred ccccc------CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhh
Confidence 32221 1234688999999999998999999999999999999999999854321 11222111111000
Q ss_pred -CCCCC------CccCCHHHHHHHHHHhccCCCCCCCHHHHhc
Q 039291 238 -SLPEI------PSRVSKEARDFLRRCFVRKPAFRFTAEMLLD 273 (362)
Q Consensus 238 -~~~~~------~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~ 273 (362)
..+.+ +.....++.+++.+||+.||++||++.++++
T Consensus 904 ~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~ 946 (968)
T PLN00113 904 WIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLK 946 (968)
T ss_pred eeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHH
Confidence 00111 1122345778999999999999999999986
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-35 Score=246.59 Aligned_cols=254 Identities=19% Similarity=0.338 Sum_probs=199.1
Q ss_pred CceeecceecccCceEEEEEEECCCCCCCCceeeeechhh--hhhHHHHHHHHHHHHcCCCCcccccccceeeecCCCce
Q 039291 6 TSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEV--SASASLQKEKEVFDNLNGCPFVLECFGEEITMGENGEM 83 (362)
Q Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~--~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~~~~ 83 (362)
+.|.+.+.||+|.||.+-+|+++.++. .+++|.... ...+.+++|..---.|.+|.||+.-|++... ...
T Consensus 24 d~y~I~k~lgeG~FgkIlL~eHr~s~t----~ivlKavp~p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFq----t~d 95 (378)
T KOG1345|consen 24 DVYTINKQLGEGRFGKILLAEHRQSKT----RIVLKAVPRPQTTQADFVREFHYSFFLSPHQHIIDTYEVAFQ----TSD 95 (378)
T ss_pred hhhhHHHHhcccceeeEEeeeccCCce----EEEeeccCcchhhHHHHHHHhccceeeccchhhhHHHHHHhh----cCc
Confidence 579999999999999999999999875 667777643 3567789999888888899999999987653 233
Q ss_pred EEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEeecCCc
Q 039291 84 AYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVA 163 (362)
Q Consensus 84 ~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Dfgla 163 (362)
+|.++|||++.|+|..-+.. .++-|.....++.||+.|+.|+|++++||||||.+|||+...+. ..|||||||++
T Consensus 96 ~YvF~qE~aP~gdL~snv~~---~GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df--~rvKlcDFG~t 170 (378)
T KOG1345|consen 96 AYVFVQEFAPRGDLRSNVEA---AGIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADF--YRVKLCDFGLT 170 (378)
T ss_pred eEEEeeccCccchhhhhcCc---ccccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCc--cEEEeeecccc
Confidence 67899999999999987765 44899999999999999999999999999999999999987543 47999999998
Q ss_pred ccccccccCCCCCCccCCCCccCchhhccc-----cCCCcchHHHHHHHHHHHHhCCCCCccCCC--CCHHHHHHHHc-C
Q 039291 164 KRSRHCKRQKFDPSMRGTPLYLAPETVVQH-----MQEAPSDIWALGCVVLEMLSGRQAWVVKED--CSIDQLFSIIG-D 235 (362)
Q Consensus 164 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DiwslG~il~~l~~g~~pf~~~~~--~~~~~~~~~~~-~ 235 (362)
+..+..... .--+..|.+||++... ...+.+|+|.||+++|.+++|++||+.... ....+..+... .
T Consensus 171 ~k~g~tV~~-----~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk 245 (378)
T KOG1345|consen 171 RKVGTTVKY-----LEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRK 245 (378)
T ss_pred cccCceehh-----hhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhccc
Confidence 765543222 2246679999987632 346789999999999999999999984422 22333333332 2
Q ss_pred CCCCCCCCccCCHHHHHHHHHHhccCCCCCC---CHHHHhcCCCc
Q 039291 236 EHSLPEIPSRVSKEARDFLRRCFVRKPAFRF---TAEMLLDDPFV 277 (362)
Q Consensus 236 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~---s~~~~l~~p~~ 277 (362)
....|.....+++.+.++.++-|..+++.|. +++.....-|.
T Consensus 246 ~~~~P~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w~ 290 (378)
T KOG1345|consen 246 NPALPKKFNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCLWK 290 (378)
T ss_pred CccCchhhcccCHHHHHHHHHhcCCcccccchhHHHHHHHHHHHH
Confidence 3345555567899999999999999999994 45555555554
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=275.24 Aligned_cols=259 Identities=26% Similarity=0.408 Sum_probs=210.4
Q ss_pred CCceeecceecccCceEEEEEEECCCCCCCCceeeeechhhhhhHHHHHHHHHHHHcCCCCcccccccceeeecCCCceE
Q 039291 5 GTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVSASASLQKEKEVFDNLNGCPFVLECFGEEITMGENGEMA 84 (362)
Q Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~~~~~ 84 (362)
.++|.....+|.|.||.||+|+|+.+++-.+ ...+|.........++.|+-+++.-. ||||+.+++.+... ..
T Consensus 14 ~ddyellqrvgsgTygdvyKaRd~~s~elaa-vkvVkLep~dd~~~iqqei~~~~dc~-h~nivay~gsylr~-----dk 86 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKARDKRSGELAA-VKVVKLEPGDDFSGIQQEIGMLRDCR-HPNIVAYFGSYLRR-----DK 86 (829)
T ss_pred ccchhheeeecCCcccchhhhcccccCchhh-heeeeccCCccccccccceeeeecCC-CcChHHHHhhhhhh-----cC
Confidence 3679999999999999999999999886442 33445555556777889999999988 99999999976532 23
Q ss_pred EEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEeecCCcc
Q 039291 85 YNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAK 164 (362)
Q Consensus 85 ~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Dfgla~ 164 (362)
+.+.||||.||+|.+..+. .+++++.++.+..+..+.||+|||++|=+|||||-.||++ ++.+.+|++|||.+.
T Consensus 87 lwicMEycgggslQdiy~~--TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanill----td~gDvklaDfgvsa 160 (829)
T KOG0576|consen 87 LWICMEYCGGGSLQDIYHV--TGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILL----TDEGDVKLADFGVSA 160 (829)
T ss_pred cEEEEEecCCCcccceeee--cccchhHHHHHHHhhhhccchhhhcCCcccccccccceee----cccCceeecccCchh
Confidence 5699999999999998875 6789999999999999999999999999999999999999 788889999999998
Q ss_pred cccccccCCCCCCccCCCCccCchhhc---cccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHHcCCCCCC-
Q 039291 165 RSRHCKRQKFDPSMRGTPLYLAPETVV---QHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEHSLP- 240 (362)
Q Consensus 165 ~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~- 240 (362)
.+.....+. .++.||+.|||||+.. ...|...+|+|++|+...|+-.-++|-..... ...++-..+.....|
T Consensus 161 qitati~Kr--ksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhp--mr~l~LmTkS~~qpp~ 236 (829)
T KOG0576|consen 161 QITATIAKR--KSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHP--MRALFLMTKSGFQPPT 236 (829)
T ss_pred hhhhhhhhh--hcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccch--HHHHHHhhccCCCCCc
Confidence 776543332 5789999999999875 45789999999999999999888887643322 222222222333322
Q ss_pred -CCCccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCccCc
Q 039291 241 -EIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGV 280 (362)
Q Consensus 241 -~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~~~~ 280 (362)
..+...++.+-+|++.+|..+|.+||+++.+|.|||+...
T Consensus 237 lkDk~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~~ 277 (829)
T KOG0576|consen 237 LKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT 277 (829)
T ss_pred ccCCccchHHHHHHHHHHhcCCCccCCChhhheeceeeccc
Confidence 2334678899999999999999999999999999998764
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-35 Score=266.65 Aligned_cols=195 Identities=25% Similarity=0.371 Sum_probs=163.2
Q ss_pred CceeecceecccCceEEEEEEECCCCCCCCceeeeechhhh-----------hhHHHHHHHHHHHHcC--CCCccccccc
Q 039291 6 TSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVS-----------ASASLQKEKEVFDNLN--GCPFVLECFG 72 (362)
Q Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~~-----------~~~~~~~E~~il~~l~--~h~~i~~~~~ 72 (362)
..|...+.+|+|+||.|++|.++.++. .|.+|.+.++ ....+-.|+.||..|+ .|+||+++++
T Consensus 561 s~yttlq~lG~GAyGkV~lai~K~n~~----eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLd 636 (772)
T KOG1152|consen 561 SDYTTLQPLGEGAYGKVNLAIHKENNY----EVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLD 636 (772)
T ss_pred ccceeeeeccccccceEEEeeecccce----EEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhh
Confidence 358999999999999999999998854 4555554332 2233557999999998 4789999999
Q ss_pred ceeeecCCCceEEEEEEEec-CCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCC
Q 039291 73 EEITMGENGEMAYNLLLEYA-AGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSG 151 (362)
Q Consensus 73 ~~~~~~~~~~~~~~lv~e~~-~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~ 151 (362)
++. ++.+|||+||.. +|.+|+++|+. +..++|.++..|+.|++.|+++||+.||||||||-+||.+ +.
T Consensus 637 fFE-----ddd~yyl~te~hg~gIDLFd~IE~--kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenviv----d~ 705 (772)
T KOG1152|consen 637 FFE-----DDDYYYLETEVHGEGIDLFDFIEF--KPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIV----DS 705 (772)
T ss_pred eee-----cCCeeEEEecCCCCCcchhhhhhc--cCccchHHHHHHHHHHHhccccccccCceecccccccEEE----ec
Confidence 763 345688999975 45699999987 4459999999999999999999999999999999999999 99
Q ss_pred ceEEEEeecCCcccccccccCCCCCCccCCCCccCchhhccccC-CCcchHHHHHHHHHHHHhCCCCCc
Q 039291 152 KFVAKIADLGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQ-EAPSDIWALGCVVLEMLSGRQAWV 219 (362)
Q Consensus 152 ~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~~l~~g~~pf~ 219 (362)
+|.+||+|||.|....... -..++||..|.|||++.+..| +..-|||++|++||.++....||.
T Consensus 706 ~g~~klidfgsaa~~ksgp----fd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 706 NGFVKLIDFGSAAYTKSGP----FDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred CCeEEEeeccchhhhcCCC----cceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 9999999999986554321 246899999999999999876 667899999999999999988885
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-34 Score=229.74 Aligned_cols=209 Identities=22% Similarity=0.371 Sum_probs=163.2
Q ss_pred CceeecceecccCceEEEEEEECCCCCCCCceeeeech----hhhhhHHHHHHHHHHHHcCCCCcccccccceeeecCCC
Q 039291 6 TSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSA----EVSASASLQKEKEVFDNLNGCPFVLECFGEEITMGENG 81 (362)
Q Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~----~~~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~~ 81 (362)
+....+..||+|+||.|-+-++..+|. .+|+|.. +.+..+++.+|+.+..+-..+|.+|.+|+.....+
T Consensus 46 d~L~~i~elGrGayG~vekmrh~~sg~----imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~reg--- 118 (282)
T KOG0984|consen 46 DDLVGIEELGRGAYGVVEKMRHIQSGT----IMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREG--- 118 (282)
T ss_pred hhhhhhhhhcCCccchhhheeeccCCe----EEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccc---
Confidence 344456789999999999999998885 5666654 34456677888888777777999999999654322
Q ss_pred ceEEEEEEEecCCCCHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHh-CCceeCCCCCCCEEEeecCCCceEEEEe
Q 039291 82 EMAYNLLLEYAAGGTLGDLIEKC--NGNGLPEKDVRHFTRCILEGIGHIHD-SGYVHCDVKPDNILLVATQSGKFVAKIA 158 (362)
Q Consensus 82 ~~~~~lv~e~~~~~~L~~~l~~~--~~~~l~~~~~~~i~~ql~~~l~yLH~-~~ivH~Dlkp~Nill~~~~~~~~~~kl~ 158 (362)
..++.||.+. .+|..+..+. .++.++|..+-+|+..++.||.|||+ ..+||||+||+|||+ +..|.||+|
T Consensus 119 --dvwIcME~M~-tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLI----n~~GqVKiC 191 (282)
T KOG0984|consen 119 --DVWICMELMD-TSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILI----NYDGQVKIC 191 (282)
T ss_pred --cEEEeHHHhh-hhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEE----ccCCcEEEc
Confidence 2568999996 4887665542 45679999999999999999999997 589999999999999 999999999
Q ss_pred ecCCcccccccccCCCCCCccCCCCccCchhhcc----ccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHH
Q 039291 159 DLGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQ----HMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSII 233 (362)
Q Consensus 159 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~ 233 (362)
|||++......... +...|-..|||||.+.. ..|+-++||||||++++||.+++.||.... .+-+.++.+
T Consensus 192 DFGIsG~L~dSiAk---t~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~--tpF~qLkqv 265 (282)
T KOG0984|consen 192 DFGISGYLVDSIAK---TMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWG--TPFQQLKQV 265 (282)
T ss_pred ccccceeehhhhHH---HHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccC--CHHHHHHHH
Confidence 99998654432211 12457778999998873 478899999999999999999999996443 344444443
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.6e-31 Score=233.22 Aligned_cols=257 Identities=15% Similarity=0.269 Sum_probs=206.5
Q ss_pred CCCceeecceecccCceEEEEEEECCCCCCCC-ceeeeechhhh----hhHHHHHHHHHHHHcCCCCcccccccceeeec
Q 039291 4 DGTSWFRGRVIGQGSFGCVFIAKPKSNSSFLP-PLMAVKSAEVS----ASASLQKEKEVFDNLNGCPFVLECFGEEITMG 78 (362)
Q Consensus 4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~-~~~~~K~~~~~----~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~ 78 (362)
...|++...++-+|.||.||.|+++....+.. ..+.+|..+.. ....+..|...+..+. |||+....++.+..+
T Consensus 282 ~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~s-H~nll~V~~V~ie~~ 360 (563)
T KOG1024|consen 282 QRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGAS-HPNLLSVLGVSIEDY 360 (563)
T ss_pred hhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCc-CCCccceeEEEeecc
Confidence 34577888899999999999998876544333 24555554433 4456778888888888 999999999887533
Q ss_pred CCCceEEEEEEEecCCCCHHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCc
Q 039291 79 ENGEMAYNLLLEYAAGGTLGDLIEKCNG------NGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGK 152 (362)
Q Consensus 79 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~------~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~ 152 (362)
. .-++++.+..-|+|..+++.+++ +.++-.+...++.|++.|++|||++|+||.||...|+++ ++.
T Consensus 361 ~----~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvI----dd~ 432 (563)
T KOG1024|consen 361 A----TPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVI----DDQ 432 (563)
T ss_pred C----cceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhccee----hhh
Confidence 2 23478888888999999985432 237778888999999999999999999999999999999 889
Q ss_pred eEEEEeecCCcccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHh-CCCCCccCCCCCHHHHHH
Q 039291 153 FVAKIADLGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLS-GRQAWVVKEDCSIDQLFS 231 (362)
Q Consensus 153 ~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~ 231 (362)
..|||+|=.+++...+..-.-.....-....||+||.+....|+.++|+|||||+||||+| |+.|+ -+.++.++..
T Consensus 433 LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~Py---aeIDPfEm~~ 509 (563)
T KOG1024|consen 433 LQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPY---AEIDPFEMEH 509 (563)
T ss_pred eeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCc---cccCHHHHHH
Confidence 9999999999986554332222222234567999999999999999999999999999999 89998 4557888888
Q ss_pred HHcCCCCCCCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhc
Q 039291 232 IIGDEHSLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLD 273 (362)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~ 273 (362)
.++.+..+. -|..+|+++..++--||...|++||+.+++..
T Consensus 510 ylkdGyRla-QP~NCPDeLf~vMacCWallpeeRPsf~Qlv~ 550 (563)
T KOG1024|consen 510 YLKDGYRLA-QPFNCPDELFTVMACCWALLPEERPSFSQLVI 550 (563)
T ss_pred HHhccceec-CCCCCcHHHHHHHHHHHhcCcccCCCHHHHHH
Confidence 888877765 47789999999999999999999999998764
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=6e-32 Score=275.92 Aligned_cols=208 Identities=17% Similarity=0.216 Sum_probs=146.9
Q ss_pred CcccccccceeeecCC--CceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCC
Q 039291 65 PFVLECFGEEITMGEN--GEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDN 142 (362)
Q Consensus 65 ~~i~~~~~~~~~~~~~--~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~N 142 (362)
+||+++++.+.....+ ....+++++|++ +++|.+++... ...+++.+++.++.||+.||.|||++||+||||||+|
T Consensus 33 ~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDlKP~N 110 (793)
T PLN00181 33 DYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP-DRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNVRPSC 110 (793)
T ss_pred HHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc-cccccHHHHHHHHHHHHHHHHHHHhCCeeeccCCchh
Confidence 5666666654221111 112355788887 56999999752 3559999999999999999999999999999999999
Q ss_pred EEEeec---------------CCCceEEEEeecCCcccccccccC--------------CCCCCccCCCCccCchhhccc
Q 039291 143 ILLVAT---------------QSGKFVAKIADLGVAKRSRHCKRQ--------------KFDPSMRGTPLYLAPETVVQH 193 (362)
Q Consensus 143 ill~~~---------------~~~~~~~kl~Dfgla~~~~~~~~~--------------~~~~~~~gt~~y~aPE~~~~~ 193 (362)
||+... .+..+.+|++|||+++........ ......+||+.|||||++.+.
T Consensus 111 iLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~ 190 (793)
T PLN00181 111 FVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEEDNGS 190 (793)
T ss_pred EEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhhhccC
Confidence 999421 123455778888887642210000 000124689999999999998
Q ss_pred cCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHHcCCCCCCCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhc
Q 039291 194 MQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEHSLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLD 273 (362)
Q Consensus 194 ~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~ 273 (362)
.++.++|||||||+||||++|.+|+.... ..+..+.... .+...........+++.+||..+|.+||++.+++.
T Consensus 191 ~~~~~sDVwSlGviL~ELl~~~~~~~~~~-----~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~L~~~P~~Rps~~eil~ 264 (793)
T PLN00181 191 SSNCASDVYRLGVLLFELFCPVSSREEKS-----RTMSSLRHRV-LPPQILLNWPKEASFCLWLLHPEPSCRPSMSELLQ 264 (793)
T ss_pred CCCchhhhhhHHHHHHHHhhCCCchhhHH-----HHHHHHHHhh-cChhhhhcCHHHHHHHHHhCCCChhhCcChHHHhh
Confidence 99999999999999999999988874221 1111111111 11111112456778999999999999999999999
Q ss_pred CCCccCc
Q 039291 274 DPFVKGV 280 (362)
Q Consensus 274 ~p~~~~~ 280 (362)
||||...
T Consensus 265 h~~~~~~ 271 (793)
T PLN00181 265 SEFINEP 271 (793)
T ss_pred chhhhhh
Confidence 9999764
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-30 Score=221.22 Aligned_cols=209 Identities=32% Similarity=0.582 Sum_probs=176.7
Q ss_pred ecccCceEEEEEEECCCCCCCCceeeeechhhhh----hHHHHHHHHHHHHcCCCCcccccccceeeecCCCceEEEEEE
Q 039291 14 IGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVSA----SASLQKEKEVFDNLNGCPFVLECFGEEITMGENGEMAYNLLL 89 (362)
Q Consensus 14 lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~~~----~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~~~~~~~lv~ 89 (362)
||+|++|.||++.+..+++ .+++|...... ...+.+|+..++.+. |++++++++..... ...++++
T Consensus 1 l~~g~~~~v~~~~~~~~~~----~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~-~~~i~~~~~~~~~~-----~~~~~~~ 70 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGK----KVAIKIIKKEDSSSLLEELLREIEILKKLN-HPNIVKLYGVFEDE-----NHLYLVM 70 (215)
T ss_pred CCcCCceEEEEEEecCCCc----EEEEEEeccccchhHHHHHHHHHHHHHhcC-CCCeeeEeeeeecC-----CeEEEEE
Confidence 6899999999999987554 56777765543 367899999999998 69999998866432 3467999
Q ss_pred EecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCC-ceEEEEeecCCcccccc
Q 039291 90 EYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSG-KFVAKIADLGVAKRSRH 168 (362)
Q Consensus 90 e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~-~~~~kl~Dfgla~~~~~ 168 (362)
|++.|++|.+++.... ..+++..++.++.+++.++.+||+.|++|+||+|.||++ +. ...++|+|||.+.....
T Consensus 71 e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~----~~~~~~~~l~d~~~~~~~~~ 145 (215)
T cd00180 71 EYCEGGSLKDLLKENE-GKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILL----DSDNGKVKLADFGLSKLLTS 145 (215)
T ss_pred ecCCCCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEE----eCCCCcEEEecCCceEEccC
Confidence 9999999999998632 358999999999999999999999999999999999999 55 67899999999875544
Q ss_pred cccCCCCCCccCCCCccCchhhccc-cCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHHcCCCCCCCCCccCC
Q 039291 169 CKRQKFDPSMRGTPLYLAPETVVQH-MQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEHSLPEIPSRVS 247 (362)
Q Consensus 169 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (362)
... ......+...|++||.+... ..+.++|+|++|+++++|
T Consensus 146 ~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l------------------------------------ 187 (215)
T cd00180 146 DKS--LLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL------------------------------------ 187 (215)
T ss_pred Ccc--hhhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH------------------------------------
Confidence 221 12345588899999999876 788999999999999999
Q ss_pred HHHHHHHHHHhccCCCCCCCHHHHhcCC
Q 039291 248 KEARDFLRRCFVRKPAFRFTAEMLLDDP 275 (362)
Q Consensus 248 ~~~~~li~~~l~~~p~~R~s~~~~l~~p 275 (362)
..+.+++.+|+..+|++||++.++++++
T Consensus 188 ~~~~~~l~~~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 188 PELKDLIRKMLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence 6888999999999999999999999874
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-29 Score=231.55 Aligned_cols=259 Identities=20% Similarity=0.236 Sum_probs=194.1
Q ss_pred ceeecceecccCceEEEEEEECCCCCCCCceeeeechhhh---hhHHHHHHHHHHHHcCC---CCcccccccceeeecCC
Q 039291 7 SWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVS---ASASLQKEKEVFDNLNG---CPFVLECFGEEITMGEN 80 (362)
Q Consensus 7 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~~---~~~~~~~E~~il~~l~~---h~~i~~~~~~~~~~~~~ 80 (362)
+|.+.+.||+|+||.||+|.+...+ ...+++|..... ....+..|..++..+.. .+++..+++... .
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~---~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~----~ 91 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEK---NKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGR----S 91 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCC---CeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEecc----C
Confidence 8999999999999999999988765 124455544332 11268899999999983 345555554332 2
Q ss_pred CceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecC-CCceEEEEee
Q 039291 81 GEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQ-SGKFVAKIAD 159 (362)
Q Consensus 81 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~-~~~~~~kl~D 159 (362)
...+.++||+.+ |.+|.++......+.++..++..++.|++.+|++||+.|++||||||+|++++... .....+.|.|
T Consensus 92 ~~~~~~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llD 170 (322)
T KOG1164|consen 92 TEDFNFIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLD 170 (322)
T ss_pred CCceeEEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEe
Confidence 333456899998 78999999776657799999999999999999999999999999999999996442 2236799999
Q ss_pred cCCcc--cccccccC------CCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHH
Q 039291 160 LGVAK--RSRHCKRQ------KFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFS 231 (362)
Q Consensus 160 fgla~--~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~ 231 (362)
||+++ .+...... .....++||..|+++.+..+...+.+.|+||++.++.+++.|.+||...........+.
T Consensus 171 fGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~ 250 (322)
T KOG1164|consen 171 FGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFE 250 (322)
T ss_pred cCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHH
Confidence 99998 33222111 11235679999999999999999999999999999999999999997655443333333
Q ss_pred HHcCCCCCCCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhc
Q 039291 232 IIGDEHSLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLD 273 (362)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~ 273 (362)
...............+.++..+...+-..+...+|....+..
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~ 292 (322)
T KOG1164|consen 251 KDPRKLLTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAE 292 (322)
T ss_pred HHhhhhccccccCCChHHHHHHHHHhhccCCcCCCCHHHHHH
Confidence 333332222233445678888888887789999998877765
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-29 Score=217.65 Aligned_cols=253 Identities=25% Similarity=0.377 Sum_probs=202.5
Q ss_pred CCceeecceecccCceEEEEEEECCCCCCCCceeeeechh-hhhhHHHHHHHHHHHHcCCCCcccccccceeeecCCCce
Q 039291 5 GTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAE-VSASASLQKEKEVFDNLNGCPFVLECFGEEITMGENGEM 83 (362)
Q Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~-~~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~~~~ 83 (362)
|-.|.++++||+|+||+++.|++.-+++ .||||-.. ......+..|.+.++.|.+.++|...|- .+.++..
T Consensus 27 G~hyrVGkKIGeGsFG~lf~G~Nl~nne----~VAIKfEPrkS~APQLrdEYr~YKlL~g~~GIP~vYY----FGqeG~~ 98 (449)
T KOG1165|consen 27 GPHYRVGKKIGEGSFGVLFLGKNLYNNE----PVAIKFEPRKSEAPQLRDEYRTYKLLGGTEGIPQVYY----FGQEGKY 98 (449)
T ss_pred cccceeccccccCcceeeecccccccCc----eEEEEeccccCCcchHHHHHHHHHHHcCCCCCCceee----eccccch
Confidence 5589999999999999999999888876 56777643 2345568889999999999999976653 2334444
Q ss_pred EEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecC-CCceEEEEeecCC
Q 039291 84 AYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQ-SGKFVAKIADLGV 162 (362)
Q Consensus 84 ~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~-~~~~~~kl~Dfgl 162 (362)
. .||+|.+ |.+|.|++.-+. +.|+..++..++.|++.-++|+|++.+|+|||||+|+||+-.. .....+.++|||+
T Consensus 99 N-iLVidLL-GPSLEDLFD~Cg-R~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGm 175 (449)
T KOG1165|consen 99 N-ILVIDLL-GPSLEDLFDLCG-RRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGM 175 (449)
T ss_pred h-hhhhhhh-CcCHHHHHHHhc-CcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccc
Confidence 4 3899999 889999999875 4599999999999999999999999999999999999996443 3345789999999
Q ss_pred cccccccccCCCC-----CCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHHcCCC
Q 039291 163 AKRSRHCKRQKFD-----PSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEH 237 (362)
Q Consensus 163 a~~~~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 237 (362)
|+.+......... .+..||..||+-....++..+.+.|+-|||.++++++.|.+||.+-......+.+.+|+...
T Consensus 176 AK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~K 255 (449)
T KOG1165|consen 176 AKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETK 255 (449)
T ss_pred hhhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhcccc
Confidence 9988776544332 46789999999999999999999999999999999999999999988888888888887665
Q ss_pred CCCC---CCccCCHHHHHHHHHHhccCCCCCCCH
Q 039291 238 SLPE---IPSRVSKEARDFLRRCFVRKPAFRFTA 268 (362)
Q Consensus 238 ~~~~---~~~~~~~~~~~li~~~l~~~p~~R~s~ 268 (362)
.... +...+|.++...++-.-..+-.+-|..
T Consensus 256 r~T~i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDY 289 (449)
T KOG1165|consen 256 RSTPIEVLCEGFPEEFATYLRYVRRLDFFETPDY 289 (449)
T ss_pred ccCCHHHHHhcCHHHHHHHHHHHHhcCcccCCCH
Confidence 4322 223456666666555545555555554
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.6e-30 Score=215.16 Aligned_cols=162 Identities=24% Similarity=0.315 Sum_probs=127.8
Q ss_pred CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEeecCCcccccccccCCC
Q 039291 95 GTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKF 174 (362)
Q Consensus 95 ~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Dfgla~~~~~~~~~~~ 174 (362)
|+|.+++... +.++++..++.++.|++.||.|||+++ ||+|||+ +.++.+++ ||++......
T Consensus 1 GsL~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~----~~~~~~~~--fG~~~~~~~~----- 62 (176)
T smart00750 1 VSLADILEVR-GRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILL----TWDGLLKL--DGSVAFKTPE----- 62 (176)
T ss_pred CcHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeE----cCccceee--ccceEeeccc-----
Confidence 6899999863 456999999999999999999999998 9999999 77788888 9998755431
Q ss_pred CCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHHcCC-C-CCC---CCCccCCH-
Q 039291 175 DPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDE-H-SLP---EIPSRVSK- 248 (362)
Q Consensus 175 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~-~-~~~---~~~~~~~~- 248 (362)
...||+.|+|||++.+..++.++|||||||++|||++|+.||...... ......+... . ..+ ..+..++.
T Consensus 63 --~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 138 (176)
T smart00750 63 --QSRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEEREL--SAILEILLNGMPADDPRDRSNLESVSAA 138 (176)
T ss_pred --cCCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchh--cHHHHHHHHHhccCCccccccHHHHHhh
Confidence 235899999999999999999999999999999999999999644321 1211111111 1 100 11223343
Q ss_pred -HHHHHHHHHhccCCCCCCCHHHHhcCCCcc
Q 039291 249 -EARDFLRRCFVRKPAFRFTAEMLLDDPFVK 278 (362)
Q Consensus 249 -~~~~li~~~l~~~p~~R~s~~~~l~~p~~~ 278 (362)
++++++.+||..+|++||++.+++.|+|+.
T Consensus 139 ~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~ 169 (176)
T smart00750 139 RSFADFMRVCASRLPQRREAANHYLAHCRAL 169 (176)
T ss_pred hhHHHHHHHHHhcccccccCHHHHHHHHHHH
Confidence 699999999999999999999999999874
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-31 Score=257.88 Aligned_cols=261 Identities=24% Similarity=0.356 Sum_probs=195.0
Q ss_pred eecceecccCceEEEEEEECCCCCCCC-ceeeee---chhhh-hhHHHHHHHHHHHHcCCCCcccccccceeeecCCCce
Q 039291 9 FRGRVIGQGSFGCVFIAKPKSNSSFLP-PLMAVK---SAEVS-ASASLQKEKEVFDNLNGCPFVLECFGEEITMGENGEM 83 (362)
Q Consensus 9 ~~~~~lG~G~~g~V~~a~~~~~~~~~~-~~~~~K---~~~~~-~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~~~~ 83 (362)
.....+|.|++|.|+.+......+... +.+.++ ..... ....+..|..+-..|. |+|++...........
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~-h~~~~e~l~~~~~~~~---- 395 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLS-HPNIIETLDIVQEIDG---- 395 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeeccccc-CCchhhhHHHHhhccc----
Confidence 347889999999888887665444222 222322 11111 1112555666666677 8998777765543222
Q ss_pred EEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEeecCCc
Q 039291 84 AYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVA 163 (362)
Q Consensus 84 ~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Dfgla 163 (362)
+.-.||||++ +|+.++.. ...+....+..++.||+.|++|+|+.||.|||+|++|+++ ...+.+||+|||.+
T Consensus 396 -~~~~mE~~~~-Dlf~~~~~--~~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~----~~~g~lki~Dfg~~ 467 (601)
T KOG0590|consen 396 -ILQSMEYCPY-DLFSLVMS--NGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLV----TENGILKIIDFGAA 467 (601)
T ss_pred -chhhhhcccH-HHHHHHhc--ccccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEE----ecCCceEEeecCcc
Confidence 2244999999 99999986 3459999999999999999999999999999999999999 88889999999999
Q ss_pred ccccccccC--CCCCCccCCCCccCchhhccccCCC-cchHHHHHHHHHHHHhCCCCCccCCCCCHHH--HHH--HHcCC
Q 039291 164 KRSRHCKRQ--KFDPSMRGTPLYLAPETVVQHMQEA-PSDIWALGCVVLEMLSGRQAWVVKEDCSIDQ--LFS--IIGDE 236 (362)
Q Consensus 164 ~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~-~~DiwslG~il~~l~~g~~pf~~~~~~~~~~--~~~--~~~~~ 236 (362)
....-.... ......+|+..|+|||++.+..|++ ..||||.|++++.|++|+.||......+... ... .....
T Consensus 468 ~vf~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~ 547 (601)
T KOG0590|consen 468 SVFRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIF 547 (601)
T ss_pred eeeccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccc
Confidence 866655554 5556789999999999999988876 5799999999999999999997654433221 000 00011
Q ss_pred CCCCCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCccCcch
Q 039291 237 HSLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGVDE 282 (362)
Q Consensus 237 ~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~~~~~~ 282 (362)
.....+...++.+.+.+|.+||+++|.+|.|++++++++||+.+..
T Consensus 548 ~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~i~~ 593 (601)
T KOG0590|consen 548 EGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILNDEWIRSIEC 593 (601)
T ss_pred cChHHHHHhchhhHHHHHHHHccCChhheecHHHHhhChHhhhcce
Confidence 1112334568889999999999999999999999999999998753
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.6e-29 Score=215.65 Aligned_cols=212 Identities=31% Similarity=0.513 Sum_probs=169.6
Q ss_pred eeecceecccCceEEEEEEECCCCCCCCceeeeechhhh----hhHHHHHHHHHHHHcCCCCcccccccceeeecCCCce
Q 039291 8 WFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVS----ASASLQKEKEVFDNLNGCPFVLECFGEEITMGENGEM 83 (362)
Q Consensus 8 y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~~----~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~~~~ 83 (362)
|.+.+.||+|++|.||+|++..++. .+++|..... ..+.+.+|++.+++++ |+|++++++.... ..
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~----~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~-~~~i~~~~~~~~~-----~~ 70 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGE----LVAVKVLKKEKTEKQREEFLREIRILKKLK-HPNIVKLYGVFED-----PE 70 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCc----EEEEEeeccccchHHHHHHHHHHHHHHhCC-CCChhhheeeeec-----CC
Confidence 5678999999999999999987664 5666665543 4567889999999997 8999999886542 23
Q ss_pred EEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEeecCCc
Q 039291 84 AYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVA 163 (362)
Q Consensus 84 ~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Dfgla 163 (362)
.+++++|++++++|.+++..... .+++..+..++.|++.++.+||+.+++|+||+|.||++ +..+.++|+|||++
T Consensus 71 ~~~~v~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v----~~~~~~~l~d~g~~ 145 (225)
T smart00221 71 PLYLVMEYCEGGDLFDYLRKKGG-KLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILL----GMDGLVKLADFGLA 145 (225)
T ss_pred ceEEEEeccCCCCHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE----cCCCCEEEeeCcee
Confidence 46799999999999999987322 18999999999999999999999999999999999999 66688999999998
Q ss_pred ccccccccCCCCCCccCCCCccCchhh-ccccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHHcCC
Q 039291 164 KRSRHCKRQKFDPSMRGTPLYLAPETV-VQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDE 236 (362)
Q Consensus 164 ~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 236 (362)
......... ......++..|++||.+ ....++.++|+|+||+++++|++|+.||... ..+...+.+.+...
T Consensus 146 ~~~~~~~~~-~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~-~~~~~~~~~~~~~~ 217 (225)
T smart00221 146 RFIHRDLAA-LLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSGE-GEFTSLLSDVWSFG 217 (225)
T ss_pred eEecCcccc-cccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCcccc-chhHHHHHHHHhcC
Confidence 766543211 22345688899999998 5667788999999999999999999999441 22344555555443
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-28 Score=204.42 Aligned_cols=255 Identities=21% Similarity=0.273 Sum_probs=198.1
Q ss_pred CCCceeecceecccCceEEEEEEECCCCCCCCceeeeechhhh-hhHHHHHHHHHHHHcCCCCcccccccceeeecCCCc
Q 039291 4 DGTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVS-ASASLQKEKEVFDNLNGCPFVLECFGEEITMGENGE 82 (362)
Q Consensus 4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~~-~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~~~ 82 (362)
.+++|.+++.||.|+||.+|+|....+|+ .||+|..... .-..+..|.++.+.|++...|..+..+.. + .
T Consensus 13 v~gky~lvrkiGsGSFGdIy~~~~i~~ge----~VAiK~Es~~a~hpqL~yEskvY~iL~~g~GiP~i~~y~~----e-~ 83 (341)
T KOG1163|consen 13 VGGKYKLVRKIGSGSFGDIYLGISITSGE----EVAIKLESSKAKHPQLLYESKVYRILQGGVGIPHIRHYGT----E-K 83 (341)
T ss_pred eccceEEEEeecCCchhheeeeeeccCCc----eEEEEeecccCCCcchhHHHHHHHHhccCCCCchhhhhcc----c-c
Confidence 46899999999999999999999998887 5677664433 22347789999999997777765554332 2 2
Q ss_pred eEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEeecCC
Q 039291 83 MAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGV 162 (362)
Q Consensus 83 ~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Dfgl 162 (362)
.+-.+|||.+ |.+|.+++.-+.+ .|+..++..++-|++.-++|+|.+++|||||||+|+|++-.. ....+.++|||+
T Consensus 84 ~ynvlVMdLL-GPsLEdLfnfC~R-~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgr-h~~kl~LIDFGL 160 (341)
T KOG1163|consen 84 DYNVLVMDLL-GPSLEDLFNFCSR-RFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGR-HCNKLYLIDFGL 160 (341)
T ss_pred ccceeeeecc-CccHHHHHHHHhh-hhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeecccc-ccceEEEEeccc
Confidence 2335999999 8899999988754 499999999999999999999999999999999999996542 234589999999
Q ss_pred cccccccccCC-----CCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHHcCCC
Q 039291 163 AKRSRHCKRQK-----FDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEH 237 (362)
Q Consensus 163 a~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 237 (362)
|+.+....... ......||..|.+-....+...+.+.|+-|+|.+|.++..|.+||++-......+...+|....
T Consensus 161 aKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK 240 (341)
T KOG1163|consen 161 AKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKK 240 (341)
T ss_pred hhhhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhh
Confidence 99776544332 2346789999999888888888999999999999999999999999876666666666554332
Q ss_pred C---CCCCCccCCHHHHHHHHHHhccCCCCCCCHHH
Q 039291 238 S---LPEIPSRVSKEARDFLRRCFVRKPAFRFTAEM 270 (362)
Q Consensus 238 ~---~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~ 270 (362)
. ...+....|.++.-.+.-|-..--++-|....
T Consensus 241 ~s~~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~y 276 (341)
T KOG1163|consen 241 MSTPIEVLCKGFPAEFAMYLNYCRGLGFEEKPDYMY 276 (341)
T ss_pred cCCCHHHHhCCCcHHHHHHHHHHhhcCCCCCCcHHH
Confidence 1 12233567888888888887666666665443
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.6e-28 Score=227.88 Aligned_cols=242 Identities=26% Similarity=0.392 Sum_probs=192.2
Q ss_pred eecccCceEEEEEEECCCCCCCCceeeeechhh-----hhhHHHHHHHHHHHHcCCCCcccccccceeeecCCCceEEEE
Q 039291 13 VIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEV-----SASASLQKEKEVFDNLNGCPFVLECFGEEITMGENGEMAYNL 87 (362)
Q Consensus 13 ~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~-----~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~~~~~~~l 87 (362)
.+|+|+||.|++++... +......+++|.... .....-..|..++...+.+|.++++.-.+. .+...++
T Consensus 1 vlg~g~~gkvfLvrk~~-g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafq-----t~~kl~l 74 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAG-GADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQ-----TDGKLYL 74 (612)
T ss_pred CCCcCCCcchHHHHHhc-cccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeec-----cccchhH
Confidence 47999999999986432 222222333333221 111245568888999998999998876553 3344779
Q ss_pred EEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEeecCCccccc
Q 039291 88 LLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSR 167 (362)
Q Consensus 88 v~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Dfgla~~~~ 167 (362)
++++..||+|...+.. ...+++...+.+...++.+++++|+.+|+|||+|++||++ +.+|++++.|||+++..-
T Consensus 75 ~ld~~rgg~lft~l~~--~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enill----d~~Ghi~~tdfglske~v 148 (612)
T KOG0603|consen 75 ILDFLRGGDLFTRLSK--EVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLL----LLEGHIKLTDFGLSKEAV 148 (612)
T ss_pred hhhhcccchhhhcccc--CCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceee----cccCccccCCchhhhHhH
Confidence 9999999999988876 3458999999999999999999999999999999999999 999999999999987655
Q ss_pred ccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHHcCCCCCCCCCccCC
Q 039291 168 HCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEHSLPEIPSRVS 247 (362)
Q Consensus 168 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (362)
... ..|||..|||||++. ....++|.||+|+++++|++|..||.. +....|.... +.+|..++
T Consensus 149 ~~~------~~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~-------~~~~~Il~~~--~~~p~~l~ 211 (612)
T KOG0603|consen 149 KEK------IACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG-------DTMKRILKAE--LEMPRELS 211 (612)
T ss_pred hhh------hcccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch-------HHHHHHhhhc--cCCchhhh
Confidence 322 128999999999997 688889999999999999999999965 3333333211 24667899
Q ss_pred HHHHHHHHHHhccCCCCCC-----CHHHHhcCCCccCcchh
Q 039291 248 KEARDFLRRCFVRKPAFRF-----TAEMLLDDPFVKGVDEE 283 (362)
Q Consensus 248 ~~~~~li~~~l~~~p~~R~-----s~~~~l~~p~~~~~~~~ 283 (362)
..+++++..++..+|..|. .+.+++.|+||..+.|.
T Consensus 212 ~~a~~~~~~l~~r~p~nrLg~~~~~~~eik~h~f~~~i~~~ 252 (612)
T KOG0603|consen 212 AEARSLFRQLFKRNPENRLGAGPDGVDEIKQHEFFQSIDWN 252 (612)
T ss_pred HHHHHHHHHHHhhCHHHHhccCcchhHHHhccchheeeeHh
Confidence 9999999999999999997 35899999999999888
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.1e-25 Score=203.86 Aligned_cols=257 Identities=28% Similarity=0.468 Sum_probs=195.6
Q ss_pred eeecceecccCceEEEEEEECCCCCCCCceeeeechhh----h--hhHHHHHHHHHHHHcCCCCcccccccceeeecCCC
Q 039291 8 WFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEV----S--ASASLQKEKEVFDNLNGCPFVLECFGEEITMGENG 81 (362)
Q Consensus 8 y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~----~--~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~~ 81 (362)
|.+.+.||.|+||.||++.+. ..+++|.+.. . ....+.+|+.++..+.++++++++++.+..
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~-------~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~----- 69 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR-------KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQD----- 69 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec-------cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEec-----
Confidence 788999999999999999988 2345554332 2 366788999999999966689998886622
Q ss_pred ceEEEEEEEecCCCCHHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCce-EEEEee
Q 039291 82 EMAYNLLLEYAAGGTLGDLIEKCNG-NGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKF-VAKIAD 159 (362)
Q Consensus 82 ~~~~~lv~e~~~~~~L~~~l~~~~~-~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~-~~kl~D 159 (362)
....+++++++.++++.+++..... ..+++..+..++.|++.++.|+|+.+++|||+||+||++ +... .++++|
T Consensus 70 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~----~~~~~~~~l~d 145 (384)
T COG0515 70 EGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILL----DRDGRVVKLID 145 (384)
T ss_pred CCEEEEEEecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeee----cCCCCeEEEec
Confidence 1226799999999999977765321 259999999999999999999999999999999999999 6666 799999
Q ss_pred cCCcccccccccCC----CCCCccCCCCccCchhhcc---ccCCCcchHHHHHHHHHHHHhCCCCCccCCCC-CHHHHHH
Q 039291 160 LGVAKRSRHCKRQK----FDPSMRGTPLYLAPETVVQ---HMQEAPSDIWALGCVVLEMLSGRQAWVVKEDC-SIDQLFS 231 (362)
Q Consensus 160 fgla~~~~~~~~~~----~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~-~~~~~~~ 231 (362)
||++.......... ......||..|+|||.+.+ .......|+||+|++++++++|..||...... .......
T Consensus 146 fg~~~~~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~ 225 (384)
T COG0515 146 FGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLK 225 (384)
T ss_pred cCcceecCCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHH
Confidence 99997554432221 2357789999999999987 57888999999999999999999997655431 1233333
Q ss_pred HHcCCCC---CCCCCccC----CHHHHHHHHHHhccCCCCCCCHHHHhcCCCccCc
Q 039291 232 IIGDEHS---LPEIPSRV----SKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGV 280 (362)
Q Consensus 232 ~~~~~~~---~~~~~~~~----~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~~~~ 280 (362)
.+..... ........ ...+.+++.+++..+|..|.+..+...+++....
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~~~~ 281 (384)
T COG0515 226 IILELPTPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHL 281 (384)
T ss_pred HHHhcCCcccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhchHhhCc
Confidence 3322221 11111111 2578999999999999999999998888665443
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.1e-26 Score=210.16 Aligned_cols=163 Identities=17% Similarity=0.136 Sum_probs=122.1
Q ss_pred CCCceeecceecccCceEEEEEEECC-CCCCCCceeeeechh--------hhhhHHHHHHHHHHHHcCCCCcccc-cccc
Q 039291 4 DGTSWFRGRVIGQGSFGCVFIAKPKS-NSSFLPPLMAVKSAE--------VSASASLQKEKEVFDNLNGCPFVLE-CFGE 73 (362)
Q Consensus 4 ~~~~y~~~~~lG~G~~g~V~~a~~~~-~~~~~~~~~~~K~~~--------~~~~~~~~~E~~il~~l~~h~~i~~-~~~~ 73 (362)
-.++|.+.+.||+|+||+||+|.++. ++. .+++|... ......+.+|+++|++|+ |+|++. ++..
T Consensus 16 ~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~----~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~-h~~iv~~l~~~ 90 (365)
T PRK09188 16 LSARFVETAVLKRDVFSTVERGYFAGDPGT----ARAVRRRVSEVPWWSKPLARHLAAREIRALKTVR-GIGVVPQLLAT 90 (365)
T ss_pred ccCCceEccEEeecCcEEEEEEEEcCCCCe----EEEEEEecccccccccHHHHHHHHHHHHHHHhcc-CCCCCcEEEEc
Confidence 45789999999999999999999876 443 34666532 123456889999999999 777764 4321
Q ss_pred eeeecCCCceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCC-CCCCEEEeecCCCc
Q 039291 74 EITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDV-KPDNILLVATQSGK 152 (362)
Q Consensus 74 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dl-kp~Nill~~~~~~~ 152 (362)
+ ..++||||++|++|.. +.. .. ...++.|++.+|.|||++||+|||| ||+|||+ +.+
T Consensus 91 ----~-----~~~LVmE~~~G~~L~~-~~~-----~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv----~~~ 148 (365)
T PRK09188 91 ----G-----KDGLVRGWTEGVPLHL-ARP-----HG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLM----GPD 148 (365)
T ss_pred ----C-----CcEEEEEccCCCCHHH-hCc-----cc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEE----cCC
Confidence 1 2579999999999963 211 11 1467899999999999999999999 9999999 666
Q ss_pred eEEEEeecCCcccccccccCCC------CCCccCCCCccCchhhccc
Q 039291 153 FVAKIADLGVAKRSRHCKRQKF------DPSMRGTPLYLAPETVVQH 193 (362)
Q Consensus 153 ~~~kl~Dfgla~~~~~~~~~~~------~~~~~gt~~y~aPE~~~~~ 193 (362)
+.+||+|||+|+.......... .....++..|+|||.+...
T Consensus 149 ~~ikLiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~ 195 (365)
T PRK09188 149 GEAAVIDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR 195 (365)
T ss_pred CCEEEEECccceecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence 7899999999986543221111 1356688899999998743
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.92 E-value=2e-25 Score=218.50 Aligned_cols=226 Identities=26% Similarity=0.470 Sum_probs=169.5
Q ss_pred CCceeecceecccCceEEEEEEECCCCCCCCceeeeechhhhhhHHHHHHHHHHHHcCCCCcccccccceeeecCCCceE
Q 039291 5 GTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVSASASLQKEKEVFDNLNGCPFVLECFGEEITMGENGEMA 84 (362)
Q Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~~~~~ 84 (362)
.+.|..+|+|-.|+||-||+++++.+.+. +++|+.+.+ -|++ ||..+-+ + .
T Consensus 82 e~df~~IklisngAygavylvrh~~trqr----fa~kiNkq~---------lilR------nilt~a~-------n---p 132 (1205)
T KOG0606|consen 82 ESDFNTIKLISNGAYGAVYLVRHKETRQR----FAMKINKQN---------LILR------NILTFAG-------N---P 132 (1205)
T ss_pred ccccceeEeeccCCCCceeeeeccccccc----hhhcccccc---------hhhh------ccccccC-------C---c
Confidence 46788999999999999999999987653 455443222 1122 1222211 0 0
Q ss_pred EEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEeecCCcc
Q 039291 85 YNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAK 164 (362)
Q Consensus 85 ~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Dfgla~ 164 (362)
+ .| |+-..+++.. ++++... +.+++|||+.||+|||+||+|.+| ..-+++|+.|||+++
T Consensus 133 f-vv------gDc~tllk~~--g~lPvdm--------vla~Eylh~ygivhrdlkpdnllI----T~mGhiKlTDfgLsk 191 (1205)
T KOG0606|consen 133 F-VV------GDCATLLKNI--GPLPVDM--------VLAVEYLHSYGIVHRDLKPDNLLI----TSMGHIKLTDFGLSK 191 (1205)
T ss_pred c-ee------chhhhhcccC--CCCcchh--------hHHhHhhccCCeecCCCCCCccee----eecccccccchhhhh
Confidence 1 22 5666666652 2344332 789999999999999999999999 888999999999987
Q ss_pred cccccc-------------cCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHH
Q 039291 165 RSRHCK-------------RQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFS 231 (362)
Q Consensus 165 ~~~~~~-------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~ 231 (362)
...... ..-.....+||+.|.|||++....|+..+|+|++|+|+||++.|+.||.++ .+++++.
T Consensus 192 ~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGd---tpeelfg 268 (1205)
T KOG0606|consen 192 KGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGD---TPEELFG 268 (1205)
T ss_pred hhhhhccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCC---CHHHHHh
Confidence 432211 011123568999999999999999999999999999999999999999655 4555554
Q ss_pred H-HcCCCCCCCCCccCCHHHHHHHHHHhccCCCCCC---CHHHHhcCCCccCcchh
Q 039291 232 I-IGDEHSLPEIPSRVSKEARDFLRRCFVRKPAFRF---TAEMLLDDPFVKGVDEE 283 (362)
Q Consensus 232 ~-~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~---s~~~~l~~p~~~~~~~~ 283 (362)
. +.....+|+-....+++++++|.++|+.+|..|. .+-++..|+||+..+|.
T Consensus 269 ~visd~i~wpE~dea~p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~~LDw~ 324 (1205)
T KOG0606|consen 269 QVISDDIEWPEEDEALPPEAQDLIEQLLRQNPLCRLGTGGALEVKQHGFFQLLDWK 324 (1205)
T ss_pred hhhhhhccccccCcCCCHHHHHHHHHHHHhChHhhcccchhhhhhhccceeecccc
Confidence 4 4445556666677889999999999999999996 57889999999998877
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.4e-24 Score=189.25 Aligned_cols=201 Identities=23% Similarity=0.339 Sum_probs=155.0
Q ss_pred cCCCCcccccccceeee----------------------cCCCceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHH
Q 039291 61 LNGCPFVLECFGEEITM----------------------GENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFT 118 (362)
Q Consensus 61 l~~h~~i~~~~~~~~~~----------------------~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~ 118 (362)
|..|||||+++..+... +......+|+||..++. +|.+++.. ...+....+-++
T Consensus 272 La~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~---~~~s~r~~~~~l 347 (598)
T KOG4158|consen 272 LAKHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWT---RHRSYRTGRVIL 347 (598)
T ss_pred cCCCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhc---CCCchHHHHHHH
Confidence 34699999988766431 11235568899999975 99999976 348889999999
Q ss_pred HHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEeecCCcccccccc-cCCC---CCCccCCCCccCchhhcccc
Q 039291 119 RCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCK-RQKF---DPSMRGTPLYLAPETVVQHM 194 (362)
Q Consensus 119 ~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Dfgla~~~~~~~-~~~~---~~~~~gt~~y~aPE~~~~~~ 194 (362)
.|+++|+.|||.+||.|||+|.+|||+--++|+-..+.|+|||.+--..... .-.+ .-..-|.-.-||||+....+
T Consensus 348 aQlLEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~P 427 (598)
T KOG4158|consen 348 AQLLEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVP 427 (598)
T ss_pred HHHHHHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCC
Confidence 9999999999999999999999999998887888889999999764222100 0000 11334788899999987432
Q ss_pred ------CCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHHcCCCCCCCCCccCCHHHHHHHHHHhccCCCCCCCH
Q 039291 195 ------QEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEHSLPEIPSRVSKEARDFLRRCFVRKPAFRFTA 268 (362)
Q Consensus 195 ------~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~ 268 (362)
.-.++|.|+.|.+-||++....||+...+...+... -++..+|.+|..+++.+++++..+|+.||++|++.
T Consensus 428 Gp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~---Yqe~qLPalp~~vpp~~rqlV~~lL~r~pskRvsp 504 (598)
T KOG4158|consen 428 GPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRT---YQESQLPALPSRVPPVARQLVFDLLKRDPSKRVSP 504 (598)
T ss_pred CCceeeccchhhhhhhhhhHHHHhccCCcccccchheechhh---hhhhhCCCCcccCChHHHHHHHHHhcCCccccCCc
Confidence 135789999999999999999999875443332221 34556788899999999999999999999999974
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.4e-24 Score=187.47 Aligned_cols=241 Identities=21% Similarity=0.269 Sum_probs=146.4
Q ss_pred CceeecceecccCceEEEEEEECCCCCCCCceeeeechh--hhhhHHHHHHHHHHHHcCC---------CCcccccccce
Q 039291 6 TSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAE--VSASASLQKEKEVFDNLNG---------CPFVLECFGEE 74 (362)
Q Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~--~~~~~~~~~E~~il~~l~~---------h~~i~~~~~~~ 74 (362)
.....++.||.|+++.||.+.+..+++.++.++..-... ....+.+.+|.-....+.+ |-.++..++..
T Consensus 12 r~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~ 91 (288)
T PF14531_consen 12 RTLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLL 91 (288)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEE
T ss_pred eEEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEE
Confidence 345668999999999999999999987544333222221 1233445555543333222 11222222222
Q ss_pred ee--------ecCCCce----EEEEEEEecCCCCHHHHHHHh---cCC--CCCHHHHHHHHHHHHHHHHHHHhCCceeCC
Q 039291 75 IT--------MGENGEM----AYNLLLEYAAGGTLGDLIEKC---NGN--GLPEKDVRHFTRCILEGIGHIHDSGYVHCD 137 (362)
Q Consensus 75 ~~--------~~~~~~~----~~~lv~e~~~~~~L~~~l~~~---~~~--~l~~~~~~~i~~ql~~~l~yLH~~~ivH~D 137 (362)
.. ...+... .++++|+-+. ++|.+++... ... .+.......+..|+++.+++||+.|++|+|
T Consensus 92 ~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~-~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgd 170 (288)
T PF14531_consen 92 RIPGKPPFFERGPGQSIYWVLNRFLLMPRAQ-GDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGD 170 (288)
T ss_dssp EETTS-SEEEECETTEEEEEESEEEEEE--S-EEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST
T ss_pred EEcCCCcceecCCCCccceeehhhhccchhh-hcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEecc
Confidence 11 1111111 2367888885 5998876542 111 122333455669999999999999999999
Q ss_pred CCCCCEEEeecCCCceEEEEeecCCcccccccccCCCCCCccCCCCccCchhhccc--------cCCCcchHHHHHHHHH
Q 039291 138 VKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQH--------MQEAPSDIWALGCVVL 209 (362)
Q Consensus 138 lkp~Nill~~~~~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--------~~~~~~DiwslG~il~ 209 (362)
|||+|+++ +.+|.++|+||+.....+..... ...+..|.+||..... .++.+.|.|+||+++|
T Consensus 171 i~~~nfll----~~~G~v~Lg~F~~~~r~g~~~~~-----~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly 241 (288)
T PF14531_consen 171 IKPENFLL----DQDGGVFLGDFSSLVRAGTRYRC-----SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLY 241 (288)
T ss_dssp -SGGGEEE-----TTS-EEE--GGGEEETTEEEEG-----GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHH
T ss_pred cceeeEEE----cCCCCEEEcChHHHeecCceeec-----cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHH
Confidence 99999999 88899999999987655542221 2345779999977543 4678899999999999
Q ss_pred HHHhCCCCCccCCCCCHHHHHHHHcCCCCCCCCCccCCHHHHHHHHHHhccCCCCC
Q 039291 210 EMLSGRQAWVVKEDCSIDQLFSIIGDEHSLPEIPSRVSKEARDFLRRCFVRKPAFR 265 (362)
Q Consensus 210 ~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R 265 (362)
.|.+|..||......... ...+..+. ++|..++.||..+|+.||++|
T Consensus 242 ~lWC~~lPf~~~~~~~~~--------~~~f~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 242 SLWCGRLPFGLSSPEADP--------EWDFSRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp HHHHSS-STCCCGGGSTS--------GGGGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred HHHHccCCCCCCCccccc--------cccchhcC-CcCHHHHHHHHHHccCCcccC
Confidence 999999999644221111 01334555 899999999999999999987
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.8e-24 Score=210.83 Aligned_cols=240 Identities=23% Similarity=0.257 Sum_probs=171.2
Q ss_pred ceeecceecccCceEEEEEEECCCCCCCCceeeeechhhhhhHH---HHHHHHHHHHcCCCCcccccccceeeecCCCce
Q 039291 7 SWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVSASAS---LQKEKEVFDNLNGCPFVLECFGEEITMGENGEM 83 (362)
Q Consensus 7 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~~~~~~---~~~E~~il~~l~~h~~i~~~~~~~~~~~~~~~~ 83 (362)
.|...+.||.+.|=+|.+|++.. |. ++.||.+|....-..+. ..+|++ ..+..+||++.+..+.+. +.
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~e-G~-vVvKVFvk~~p~~sL~~~~qrL~~ik--~~l~~~pn~lPfqk~~~t-----~k 94 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDRE-GL-VVVKVFVKQDPTISLRPFKQRLEEIK--FALMKAPNCLPFQKVLVT-----DK 94 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCC-ce-EEEEEEeccCCCCCchHHHHHHHHHH--HHhhcCCcccchHHHHHh-----hH
Confidence 67889999999999999999876 33 44566666543322222 333444 344558999887765432 23
Q ss_pred EEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEeecCCc
Q 039291 84 AYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVA 163 (362)
Q Consensus 84 ~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Dfgla 163 (362)
..|||-+|... +|.|.+..+ .-+...+.+.|+.||+.||.-||..||+|+|||.+|||+ ..=.-+.|+||...
T Consensus 95 AAylvRqyvkh-nLyDRlSTR--PFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILi----TSWNW~~LtDFAsF 167 (1431)
T KOG1240|consen 95 AAYLVRQYVKH-NLYDRLSTR--PFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILI----TSWNWLYLTDFASF 167 (1431)
T ss_pred HHHHHHHHHhh-hhhhhhccc--hHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEE----eeechhhhhccccc
Confidence 35688888865 899988762 237888999999999999999999999999999999999 43345889999877
Q ss_pred ccccccccCCCCC-----CccCCCCccCchhhcccc-----------CCCcchHHHHHHHHHHHHh-CCCCCccC-----
Q 039291 164 KRSRHCKRQKFDP-----SMRGTPLYLAPETVVQHM-----------QEAPSDIWALGCVVLEMLS-GRQAWVVK----- 221 (362)
Q Consensus 164 ~~~~~~~~~~~~~-----~~~gt~~y~aPE~~~~~~-----------~~~~~DiwslG~il~~l~~-g~~pf~~~----- 221 (362)
+...-........ +...-.+|.|||.+.... .+++=||||+||+++||++ |++||.-.
T Consensus 168 KPtYLPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQL~aY 247 (1431)
T KOG1240|consen 168 KPTYLPEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQLLAY 247 (1431)
T ss_pred CCccCCCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHHHHhH
Confidence 6443322222111 122334699999887422 3566799999999999988 78888311
Q ss_pred ---CCCCHHHHHHHHcCCCCCCCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhcC
Q 039291 222 ---EDCSIDQLFSIIGDEHSLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDD 274 (362)
Q Consensus 222 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~ 274 (362)
+..+.++.+..| -+..++.+|..|++.||++|.+|++.|+.
T Consensus 248 r~~~~~~~e~~Le~I------------ed~~~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 248 RSGNADDPEQLLEKI------------EDVSLRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred hccCccCHHHHHHhC------------cCccHHHHHHHHHccCchhccCHHHHHHh
Confidence 122333333332 23478999999999999999999999885
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.1e-23 Score=178.51 Aligned_cols=174 Identities=17% Similarity=0.111 Sum_probs=127.0
Q ss_pred CCCceeecceecccCceEEEEEEECCCCCCCCceeeeechhhh------hhHH------HHHHHHHHHHcCCCCcccccc
Q 039291 4 DGTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVS------ASAS------LQKEKEVFDNLNGCPFVLECF 71 (362)
Q Consensus 4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~~------~~~~------~~~E~~il~~l~~h~~i~~~~ 71 (362)
-+++|...+.||.|+||.||++.+ ..+ .+++|...+. .... +.+|+..+.++. |++|..+.
T Consensus 29 l~~~y~~~~~l~~~~f~~v~l~~~-~~~-----~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~-~~GI~~~~ 101 (232)
T PRK10359 29 LSYNIKTIKVFRNIDDTKVSLIDT-DYG-----KYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVR-SEGLASLN 101 (232)
T ss_pred hhCceEEEEEecCCCceEEEEEec-CCC-----cEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHH-HCCCCcce
Confidence 368999999999999999999765 322 4677776432 1112 578999999997 89998888
Q ss_pred cceeeecCC---CceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeec
Q 039291 72 GEEITMGEN---GEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVAT 148 (362)
Q Consensus 72 ~~~~~~~~~---~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~ 148 (362)
+........ .....+++|||++|.+|.++.. +++. ...+++.+|..||+.|++|||+||+||++
T Consensus 102 d~~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~------~~~~----~~~~i~~~l~~lH~~gi~H~Dikp~Nili--- 168 (232)
T PRK10359 102 DFYLLAERKTLRYAHTYIMLIEYIEGVELNDMPE------ISED----VKAKIKASIESLHQHGMVSGDPHKGNFIV--- 168 (232)
T ss_pred EeeeecccccccccCCeEEEEEEECCccHHHhhh------ccHH----HHHHHHHHHHHHHHcCCccCCCChHHEEE---
Confidence 765432111 1223679999999999988732 3332 45699999999999999999999999999
Q ss_pred CCCceEEEEeecCCcccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHh
Q 039291 149 QSGKFVAKIADLGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLS 213 (362)
Q Consensus 149 ~~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~ 213 (362)
+.++ ++|+|||........... ..++....++.++|+||||+++..+..
T Consensus 169 -~~~g-i~liDfg~~~~~~e~~a~--------------d~~vler~y~~~~di~~lg~~~~~~~~ 217 (232)
T PRK10359 169 -SKNG-LRIIDLSGKRCTAQRKAK--------------DRIDLERHYGIKNEIKDLGYYLLIYKK 217 (232)
T ss_pred -eCCC-EEEEECCCcccccchhhH--------------HHHHHHhHhcccccccceeEeehHHHH
Confidence 5555 999999987644321111 113445567789999999999876643
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.1e-23 Score=178.16 Aligned_cols=243 Identities=15% Similarity=0.252 Sum_probs=187.0
Q ss_pred eecceecccCceEEEEEEECCCCCCCCceeeeechhhhhhHHHHHHHHHHHHcCCCCcccccccceeeecCCCceEEEEE
Q 039291 9 FRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVSASASLQKEKEVFDNLNGCPFVLECFGEEITMGENGEMAYNLL 88 (362)
Q Consensus 9 ~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~~~~~~~lv 88 (362)
.+..+|.+...|+.|+|++.++. .+++...+........+.+..|.-.|+-+. ||||..+++.+ +....+.+|
T Consensus 193 nl~tkl~e~hsgelwrgrwqgnd-ivakil~vr~~t~risrdfneefp~lrifs-hpnilpvlgac-----nsppnlv~i 265 (448)
T KOG0195|consen 193 NLITKLAESHSGELWRGRWQGND-IVAKILNVREVTARISRDFNEEFPALRIFS-HPNILPVLGAC-----NSPPNLVII 265 (448)
T ss_pred hhhhhhccCCCcccccccccCcc-hhhhhhhhhhcchhhcchhhhhCcceeeec-CCchhhhhhhc-----cCCCCceEe
Confidence 34567889999999999998864 334444444444445667888888888887 99999999876 334557799
Q ss_pred EEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--ceeCCCCCCCEEEeecCCCceEEEEeecCCcccc
Q 039291 89 LEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSG--YVHCDVKPDNILLVATQSGKFVAKIADLGVAKRS 166 (362)
Q Consensus 89 ~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~--ivH~Dlkp~Nill~~~~~~~~~~kl~Dfgla~~~ 166 (362)
..|++.|+|..++....+...+..++.+++.++++|++|||+.. |----|....+++ +++.+.+|. .+-+++.
T Consensus 266 sq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmi----dedltaris-mad~kfs 340 (448)
T KOG0195|consen 266 SQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMI----DEDLTARIS-MADTKFS 340 (448)
T ss_pred eeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEe----cchhhhhee-cccceee
Confidence 99999999999999866666889999999999999999999864 3344678889999 777666553 1112211
Q ss_pred cccccCCCCCCccCCCCccCchhhccccCC---CcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHHcCCCCCCCCC
Q 039291 167 RHCKRQKFDPSMRGTPLYLAPETVVQHMQE---APSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEHSLPEIP 243 (362)
Q Consensus 167 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~---~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (362)
..+ ....-.+.||+||.+...+.+ .++|+|||+++||||.|...||... .+.+.--++.-+...+.+|
T Consensus 341 fqe------~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadl---spmecgmkialeglrv~ip 411 (448)
T KOG0195|consen 341 FQE------VGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADL---SPMECGMKIALEGLRVHIP 411 (448)
T ss_pred eec------cccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccC---CchhhhhhhhhccccccCC
Confidence 111 123357889999999876554 4689999999999999999999543 4455555555567777899
Q ss_pred ccCCHHHHHHHHHHhccCCCCCCCHHHHh
Q 039291 244 SRVSKEARDFLRRCFVRKPAFRFTAEMLL 272 (362)
Q Consensus 244 ~~~~~~~~~li~~~l~~~p~~R~s~~~~l 272 (362)
+.++..+..|+.-|+..||.+||.++++.
T Consensus 412 pgis~hm~klm~icmnedpgkrpkfdmiv 440 (448)
T KOG0195|consen 412 PGISRHMNKLMNICMNEDPGKRPKFDMIV 440 (448)
T ss_pred CCccHHHHHHHHHHhcCCCCcCCCcceeh
Confidence 99999999999999999999999887764
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.5e-22 Score=168.35 Aligned_cols=186 Identities=16% Similarity=0.133 Sum_probs=133.2
Q ss_pred eeecceecccCceEEEEEEECCCCCCCCceeeeechhhh-------hhHHHHHHHHHHHHcCCCCcccccccceeeecCC
Q 039291 8 WFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVS-------ASASLQKEKEVFDNLNGCPFVLECFGEEITMGEN 80 (362)
Q Consensus 8 y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~~-------~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~ 80 (362)
..+...|++|+||+|+.+...+ .+++.+..... ....+.+|+++|++|.+++++.++++..
T Consensus 4 ~~~~~~l~~~~f~~v~~~~~~~------~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~~------ 71 (218)
T PRK12274 4 PAVNEPLKSDTFGRILLVRGGE------RKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHWD------ 71 (218)
T ss_pred cccceeecCCCcceEEEeecCC------ceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEEc------
Confidence 3467899999999999876522 24454443222 2235789999999998888898887631
Q ss_pred CceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCC-CCCCEEEeecCCCceEEEEee
Q 039291 81 GEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDV-KPDNILLVATQSGKFVAKIAD 159 (362)
Q Consensus 81 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dl-kp~Nill~~~~~~~~~~kl~D 159 (362)
..+++|||+.|.+|.+.+.. . ...++.|++.+|.++|++||+|||| ||+|||+ +.++.++|+|
T Consensus 72 ---~~~lvmeyI~G~~L~~~~~~--------~-~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv----~~~g~i~LID 135 (218)
T PRK12274 72 ---GRHLDRSYLAGAAMYQRPPR--------G-DLAYFRAARRLLQQLHRCGVAHNDLAKEANWLV----QEDGSPAVID 135 (218)
T ss_pred ---CEEEEEeeecCccHHhhhhh--------h-hHHHHHHHHHHHHHHHHCcCccCCCCCcceEEE----cCCCCEEEEE
Confidence 14699999999998654321 1 1357889999999999999999999 7999999 6667799999
Q ss_pred cCCcccccccccC----CC-------CCCccCCCCccCchhhccc-cCC-CcchHHHHHHHHHHHHhCCCCCccC
Q 039291 160 LGVAKRSRHCKRQ----KF-------DPSMRGTPLYLAPETVVQH-MQE-APSDIWALGCVVLEMLSGRQAWVVK 221 (362)
Q Consensus 160 fgla~~~~~~~~~----~~-------~~~~~gt~~y~aPE~~~~~-~~~-~~~DiwslG~il~~l~~g~~pf~~~ 221 (362)
||+|......... .. ..-...++.|++|+.-.-- ..+ ...++++.|+.+|.++|+..++...
T Consensus 136 FG~A~~~~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~ 210 (218)
T PRK12274 136 FQLAVRGNPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWED 210 (218)
T ss_pred CCCceecCCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcccc
Confidence 9999854432210 00 0012267788888754321 222 4568889999999999999886543
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.8e-22 Score=201.15 Aligned_cols=203 Identities=26% Similarity=0.323 Sum_probs=155.5
Q ss_pred CCCCCceeecceecccCceEEEEEEECCCCCCCCceeeeechhhhhhHHHHHHHHHHHHcC--CCCcccccccceeeecC
Q 039291 2 DSDGTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVSASASLQKEKEVFDNLN--GCPFVLECFGEEITMGE 79 (362)
Q Consensus 2 ~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~~~~~~~~~E~~il~~l~--~h~~i~~~~~~~~~~~~ 79 (362)
...|..|.|.+.||+|+||+||+|...+ + +++|+|.-.+...=.++-=.+++.+|+ ..+-|.++....+. .
T Consensus 694 ~~~~~~~~I~~e~G~g~y~~vy~a~~~~-~----~~~alK~e~P~~~WEfYI~~q~~~RLk~~~~~~~~~~~~a~~~--~ 766 (974)
T KOG1166|consen 694 EVGGEKFCISKEIGEGSYGSVYVATHSN-G----KLVALKVEKPPNPWEFYICLQVMERLKPQMLPSIMHISSAHVF--Q 766 (974)
T ss_pred eecceeEEEEeeeccccceEEEEeecCC-C----cEEEEEeecCCCceeeeehHHHHHhhchhhhcchHHHHHHHcc--C
Confidence 3568899999999999999999999877 3 588999866543322332333444444 12334444433322 1
Q ss_pred CCceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeec---CCCceEEE
Q 039291 80 NGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVAT---QSGKFVAK 156 (362)
Q Consensus 80 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~---~~~~~~~k 156 (362)
+ .-+||+||.+.|+|.+++.. .+.+++..+..+..|++..+++||..+|||+||||+|+||... +.+..-++
T Consensus 767 ~---~S~lv~ey~~~Gtlld~~N~--~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~ 841 (974)
T KOG1166|consen 767 N---ASVLVSEYSPYGTLLDLINT--NKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLY 841 (974)
T ss_pred C---cceeeeeccccccHHHhhcc--CCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceE
Confidence 1 13489999999999999984 5569999999999999999999999999999999999999532 23345699
Q ss_pred EeecCCcccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHhCCC
Q 039291 157 IADLGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQ 216 (362)
Q Consensus 157 l~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~ 216 (362)
|+|||-|-...-......-...++|-.+-.+|...|+.+++.+|.|.|+.+++.|+.|+.
T Consensus 842 lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 842 LIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred EEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence 999999875554333323356778999999999999999999999999999999999964
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.7e-22 Score=168.68 Aligned_cols=136 Identities=18% Similarity=0.139 Sum_probs=100.5
Q ss_pred cceecccCceEEEEEEECCCCCCCCceeeeechhhh-----h-------h-----------------HHHHHHHHHHHHc
Q 039291 11 GRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVS-----A-------S-----------------ASLQKEKEVFDNL 61 (362)
Q Consensus 11 ~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~~-----~-------~-----------------~~~~~E~~il~~l 61 (362)
...||+|++|.||+|.+. +|+ .|++|..... . . ....+|++++.++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~----~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 76 (190)
T cd05147 2 NGCISTGKEANVYHATTA-NGE----ERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRL 76 (190)
T ss_pred CCccccccceEEEEEECC-CCC----EEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHH
Confidence 578999999999999986 565 4566654321 0 0 1223599999999
Q ss_pred CCCCcccccccceeeecCCCceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH-HhCCceeCCCCC
Q 039291 62 NGCPFVLECFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHI-HDSGYVHCDVKP 140 (362)
Q Consensus 62 ~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yL-H~~~ivH~Dlkp 140 (362)
. ++++...... ... . .++||||++|+++...+.. ..++++..+..++.|++.+|.|| |+.||+||||||
T Consensus 77 ~-~~~v~~p~~~--~~~---~--~~iVmE~i~g~~l~~~~~~--~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP 146 (190)
T cd05147 77 V-TAGIPCPEPI--LLK---S--HVLVMEFIGDDGWAAPRLK--DAPLSESKARELYLQVIQIMRILYQDCRLVHADLSE 146 (190)
T ss_pred H-HCCCCCCcEE--Eec---C--CEEEEEEeCCCCCcchhhh--cCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCH
Confidence 7 5665333221 111 1 2599999998877655433 34699999999999999999999 799999999999
Q ss_pred CCEEEeecCCCceEEEEeecCCcccc
Q 039291 141 DNILLVATQSGKFVAKIADLGVAKRS 166 (362)
Q Consensus 141 ~Nill~~~~~~~~~~kl~Dfgla~~~ 166 (362)
+|||+ +. +.++|+|||+|...
T Consensus 147 ~NIli----~~-~~v~LiDFG~a~~~ 167 (190)
T cd05147 147 YNLLY----HD-GKLYIIDVSQSVEH 167 (190)
T ss_pred HHEEE----EC-CcEEEEEccccccC
Confidence 99999 32 46999999998643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.8e-21 Score=166.12 Aligned_cols=142 Identities=15% Similarity=0.226 Sum_probs=106.0
Q ss_pred eecceecccCceEEEEEEECCCCCCCCceeeeechhhh---hhHHHHHHHHHHHHcC----CCCcccccccceeeecCCC
Q 039291 9 FRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVS---ASASLQKEKEVFDNLN----GCPFVLECFGEEITMGENG 81 (362)
Q Consensus 9 ~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~~---~~~~~~~E~~il~~l~----~h~~i~~~~~~~~~~~~~~ 81 (362)
.-.+.||+|+||.||. +..++. + ++|..... ..+.+.+|+.+++.|. .||||+++++++.+.. ..
T Consensus 5 ~~~~~LG~G~~~~Vy~--hp~~~~----k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~-g~ 76 (210)
T PRK10345 5 SEQSPLGTGRHRKCYA--HPEDAQ----R-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDC-GT 76 (210)
T ss_pred CCcceecCCCceEEEE--CCCCcC----e-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCC-CC
Confidence 3467899999999995 554433 2 35544322 4567899999999995 2899999999775432 11
Q ss_pred ceEEEEEEEe--cCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHH-HHHHhCCceeCCCCCCCEEEeecCCCceEEEEe
Q 039291 82 EMAYNLLLEY--AAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGI-GHIHDSGYVHCDVKPDNILLVATQSGKFVAKIA 158 (362)
Q Consensus 82 ~~~~~lv~e~--~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l-~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~ 158 (362)
...+.+|+|| +.+++|.++++. ..+++. ..++.|++.++ +|||+++|+||||||+|||+...++++..++|+
T Consensus 77 g~v~~~I~e~~G~~~~tL~~~l~~---~~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~Li 151 (210)
T PRK10345 77 GYVYDVIADFDGKPSITLTEFAEQ---CRYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVC 151 (210)
T ss_pred eEEEEEEecCCCCcchhHHHHHHc---ccccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEE
Confidence 2334478999 557999999965 236666 35678888888 999999999999999999996544456689999
Q ss_pred ecCCc
Q 039291 159 DLGVA 163 (362)
Q Consensus 159 Dfgla 163 (362)
||+.+
T Consensus 152 Dg~G~ 156 (210)
T PRK10345 152 DNIGE 156 (210)
T ss_pred ECCCC
Confidence 96544
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.7e-21 Score=165.18 Aligned_cols=138 Identities=21% Similarity=0.146 Sum_probs=102.5
Q ss_pred ecceecccCceEEEEEEECCCCCCCCceeeeechhhhh-----------------------------hHHHHHHHHHHHH
Q 039291 10 RGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVSA-----------------------------SASLQKEKEVFDN 60 (362)
Q Consensus 10 ~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~~~-----------------------------~~~~~~E~~il~~ 60 (362)
+.+.||+|++|.||+|.+. +|+ .|++|...... .....+|...+.+
T Consensus 1 ~~~~ig~G~~~~Vy~a~~~-~g~----~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~ 75 (190)
T cd05145 1 INGCISTGKEANVYHARTG-DGE----ELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKR 75 (190)
T ss_pred CCceeecCCCcEEEEEEcC-CCC----EEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHH
Confidence 3678999999999999987 555 45555543220 1223578899999
Q ss_pred cCCCCcccccccceeeecCCCceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCceeCCCC
Q 039291 61 LNGCPFVLECFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHD-SGYVHCDVK 139 (362)
Q Consensus 61 l~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~-~~ivH~Dlk 139 (362)
+. ++++........ . . .++||||++|+++...... ..++++..+..++.|++.++.++|+ .||+|||||
T Consensus 76 l~-~~~i~~p~~~~~--~-~----~~lVmE~~~g~~~~~~~l~--~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlk 145 (190)
T cd05145 76 LY-EAGVPVPEPILL--K-K----NVLVMEFIGDDGSPAPRLK--DVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLS 145 (190)
T ss_pred HH-hCCCCCceEEEe--c-C----CEEEEEEecCCCchhhhhh--hccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCC
Confidence 98 677643333221 1 1 2599999998865443222 2458899999999999999999999 999999999
Q ss_pred CCCEEEeecCCCceEEEEeecCCccccc
Q 039291 140 PDNILLVATQSGKFVAKIADLGVAKRSR 167 (362)
Q Consensus 140 p~Nill~~~~~~~~~~kl~Dfgla~~~~ 167 (362)
|+|||+ + ++.++|+|||++....
T Consensus 146 P~NIll----~-~~~~~liDFG~a~~~~ 168 (190)
T cd05145 146 EYNILY----H-DGKPYIIDVSQAVELD 168 (190)
T ss_pred hhhEEE----E-CCCEEEEEcccceecC
Confidence 999999 4 4679999999986544
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.2e-23 Score=205.25 Aligned_cols=262 Identities=24% Similarity=0.363 Sum_probs=204.0
Q ss_pred CCceeecceecccCceEEEEEEECCCCCCCCceeeeechhh-----hhhHHHHHHHHHHHHcCCCCcccccccceeeecC
Q 039291 5 GTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEV-----SASASLQKEKEVFDNLNGCPFVLECFGEEITMGE 79 (362)
Q Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~-----~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~ 79 (362)
...|.+.+.||+|+|+.|-++......+. .++.|.... ........|..+-+.+.+|+|++.+++...
T Consensus 19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~---~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~---- 91 (601)
T KOG0590|consen 19 NSQYKLSRSIGKGSFSSSALASNSRDPES---SSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSS---- 91 (601)
T ss_pred cccccccccccccccchhhhhhhcCCCcc---eeeccCCCCCCCccchhhhcCccccccccccccccccccCCccC----
Confidence 57899999999999999999987655442 334443322 233445568888888888999999988653
Q ss_pred CCceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH-hCCceeCCCCCCCEEEeecCCCce-EEEE
Q 039291 80 NGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIH-DSGYVHCDVKPDNILLVATQSGKF-VAKI 157 (362)
Q Consensus 80 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH-~~~ivH~Dlkp~Nill~~~~~~~~-~~kl 157 (362)
....++++++|..|+++.+.+........+...+..++.|+..++.|+| ..++.||||||+|.++ +..+ ..++
T Consensus 92 -~~~~~~~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l----~~s~~~l~~ 166 (601)
T KOG0590|consen 92 -SPRSYLLSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLL----DESGSALKI 166 (601)
T ss_pred -CCcccccccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchh----ccCCCcccC
Confidence 3445679999999999999884322225888889999999999999999 9999999999999999 6666 8999
Q ss_pred eecCCcccccc-cccCCCCCCccC-CCCccCchhhccc-cCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHHc
Q 039291 158 ADLGVAKRSRH-CKRQKFDPSMRG-TPLYLAPETVVQH-MQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIG 234 (362)
Q Consensus 158 ~Dfgla~~~~~-~~~~~~~~~~~g-t~~y~aPE~~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~ 234 (362)
+|||+|..+.. ..........+| ++.|+|||...+. ......|+||.|+++.-+++|..||......+... .....
T Consensus 167 ~df~~At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~-~~~~~ 245 (601)
T KOG0590|consen 167 ADFGLATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRY-SSWKS 245 (601)
T ss_pred CCchhhccccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccc-eeecc
Confidence 99999997776 444444456678 9999999999885 55778899999999999999999997654433211 11111
Q ss_pred C-CCCCCCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCccC
Q 039291 235 D-EHSLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKG 279 (362)
Q Consensus 235 ~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~~~ 279 (362)
. .......+..++....+++.+++..+|..|.+.+++..+||+..
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~ 291 (601)
T KOG0590|consen 246 NKGRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKLDNWLSS 291 (601)
T ss_pred cccccccCccccCChhhhhcccccccCCchhccccccccccccccc
Confidence 1 11123345678899999999999999999999999999999977
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.4e-22 Score=186.23 Aligned_cols=215 Identities=20% Similarity=0.218 Sum_probs=151.3
Q ss_pred HHHHHHHHHHHHcCCCCcccccc--cce-eeecCC---CceEEEEEEEecCCCCHHHHHHHh-cCCCCCHHHHHHHHHHH
Q 039291 49 ASLQKEKEVFDNLNGCPFVLECF--GEE-ITMGEN---GEMAYNLLLEYAAGGTLGDLIEKC-NGNGLPEKDVRHFTRCI 121 (362)
Q Consensus 49 ~~~~~E~~il~~l~~h~~i~~~~--~~~-~~~~~~---~~~~~~lv~e~~~~~~L~~~l~~~-~~~~l~~~~~~~i~~ql 121 (362)
....+++-.+....+|++.+.+- ... .....+ ...++|+.|++|...+|.++|... .....+......++.|+
T Consensus 289 ~~~~r~~~~l~~~~~~~~s~~~d~~~s~~~~~~~~~v~~~~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~ 368 (516)
T KOG1033|consen 289 KYTFRQLGVLVDSSHSNRSILEDLRPSLFESSKRNKVGKKVYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQI 368 (516)
T ss_pred hhhhhhhhheeccccCCcccccCCCCchhhhccccccccccchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhh
Confidence 34455666665556566554332 000 000111 123478999999999999999742 23347788899999999
Q ss_pred HHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEeecCCcccccccc----cCCCCCCccCCCCccCchhhccccCCC
Q 039291 122 LEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCK----RQKFDPSMRGTPLYLAPETVVQHMQEA 197 (362)
Q Consensus 122 ~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Dfgla~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~ 197 (362)
+.|++| +|.+|+|+||.||+. ..+..+||.|||+........ .....+...||..||+||.+.+..|+.
T Consensus 369 ~~~~~y---k~~ihrdlkp~nif~----~~d~q~kIgDFgl~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~ 441 (516)
T KOG1033|consen 369 APAVEY---KGLIHRDLKPSNIFF----SDDDQLKIGDFGLVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSE 441 (516)
T ss_pred ccchhh---ccchhhhcccccccc----ccchhhhhhhhhheeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhh
Confidence 999999 999999999999999 666689999999998666544 111224677999999999999999999
Q ss_pred cchHHHHHHHHHHHHhC-CCCCccCCCCCHHHHHHHHcCCCCCCCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCC
Q 039291 198 PSDIWALGCVVLEMLSG-RQAWVVKEDCSIDQLFSIIGDEHSLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPF 276 (362)
Q Consensus 198 ~~DiwslG~il~~l~~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~ 276 (362)
++||||||+||+|++.- ...+ .-...+..+..+...|.+..+. ++-..|+.+||...|.+||++.+.--|+|
T Consensus 442 kvdIyaLGlil~EL~~~f~T~~------er~~t~~d~r~g~ip~~~~~d~-p~e~~ll~~lls~~p~~RP~~~~~~~~~~ 514 (516)
T KOG1033|consen 442 KVDIYALGLILAELLIQFSTQF------ERIATLTDIRDGIIPPEFLQDY-PEEYTLLQQLLSPSPEERPSAIEVALHEF 514 (516)
T ss_pred hcchhhHHHHHHHHHHHhccHH------HHHHhhhhhhcCCCChHHhhcC-cHHHHHHHHhcCCCcccCchHHHHhhhhh
Confidence 99999999999999982 2222 1122233333333322333333 35568999999999999997777666665
Q ss_pred c
Q 039291 277 V 277 (362)
Q Consensus 277 ~ 277 (362)
.
T Consensus 515 ~ 515 (516)
T KOG1033|consen 515 L 515 (516)
T ss_pred c
Confidence 4
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.82 E-value=8.1e-20 Score=159.59 Aligned_cols=142 Identities=22% Similarity=0.144 Sum_probs=104.9
Q ss_pred CCceeecceecccCceEEEEEE-ECCCCCCCCceeeeechhhh---------------------------hhHHHHHHHH
Q 039291 5 GTSWFRGRVIGQGSFGCVFIAK-PKSNSSFLPPLMAVKSAEVS---------------------------ASASLQKEKE 56 (362)
Q Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~-~~~~~~~~~~~~~~K~~~~~---------------------------~~~~~~~E~~ 56 (362)
|.-|.+.+.||+|++|.||+|. +..++. .|++|..... ....+.+|+.
T Consensus 27 ~~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~----~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~ 102 (237)
T smart00090 27 GILSAIGGCISTGKEANVYHALDFDGSGK----ERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFR 102 (237)
T ss_pred CchHHhCCeeccCcceeEEEEEecCCCCc----EEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHH
Confidence 4468899999999999999998 555554 4566654321 1123568999
Q ss_pred HHHHcCCC-CcccccccceeeecCCCceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC-ce
Q 039291 57 VFDNLNGC-PFVLECFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSG-YV 134 (362)
Q Consensus 57 il~~l~~h-~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~-iv 134 (362)
++.++.++ ..+.+++. . . ..++||||++|++|...... ...+....+..++.|++.+|.+||+.| |+
T Consensus 103 ~L~~L~~~~i~~p~~~~---~-~-----~~~lV~E~~~g~~L~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~g~ii 171 (237)
T smart00090 103 NLQRLYEAGVPVPKPIA---W-R-----RNVLVMEFIGGDGLPAPRLK--DVEPEEEEEFELYDDILEEMRKLYKEGELV 171 (237)
T ss_pred HHHHHHhcCCCCCeeeE---e-c-----CceEEEEEecCCcccccccc--cCCcchHHHHHHHHHHHHHHHHHHhcCCEE
Confidence 99999731 12222222 1 1 13699999999888765432 334777778899999999999999999 99
Q ss_pred eCCCCCCCEEEeecCCCceEEEEeecCCcccc
Q 039291 135 HCDVKPDNILLVATQSGKFVAKIADLGVAKRS 166 (362)
Q Consensus 135 H~Dlkp~Nill~~~~~~~~~~kl~Dfgla~~~ 166 (362)
||||||+||++ + .+.++|+|||.+...
T Consensus 172 H~Dikp~NIli----~-~~~i~LiDFg~a~~~ 198 (237)
T smart00090 172 HGDLSEYNILV----H-DGKVVIIDVSQSVEL 198 (237)
T ss_pred eCCCChhhEEE----E-CCCEEEEEChhhhcc
Confidence 99999999999 4 457999999987543
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=3.7e-19 Score=166.58 Aligned_cols=204 Identities=20% Similarity=0.308 Sum_probs=156.0
Q ss_pred HHcCCCCcccccccceeeecCCCceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCc-eeCC
Q 039291 59 DNLNGCPFVLECFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGY-VHCD 137 (362)
Q Consensus 59 ~~l~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~i-vH~D 137 (362)
+.+. |.|+.++++..+.. ..++.|.+||..|+|.+.+.. ....++......++++++.||.|||..-| .|+.
T Consensus 2 ~~l~-h~n~~~f~g~~~~~-----~~~~~i~~~c~rGsl~D~i~~-~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~ 74 (484)
T KOG1023|consen 2 RQLD-HDNLNKFIGASVDG-----PEMIVIWEYCSRGSLLDILSN-EDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGA 74 (484)
T ss_pred cccc-hhhhhhheeeEecC-----CceEEEEeeecCccHHhHHhc-cccCccHHHHHHHHHHHHHHHHHHhcCcceeeee
Confidence 4566 89999999988743 346799999999999999987 44569999999999999999999998765 9999
Q ss_pred CCCCCEEEeecCCCceEEEEeecCCcccccccccCCCCCCccCCCCccCchhhcccc-------CCCcchHHHHHHHHHH
Q 039291 138 VKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHM-------QEAPSDIWALGCVVLE 210 (362)
Q Consensus 138 lkp~Nill~~~~~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-------~~~~~DiwslG~il~~ 210 (362)
++..|+++ +....+||.|||+.................-...|.|||.+.+.. .+.+.|+||+|++++|
T Consensus 75 l~s~nClv----d~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~e 150 (484)
T KOG1023|consen 75 LKSSNCLV----DSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYE 150 (484)
T ss_pred ecccccee----eeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHH
Confidence 99999999 999999999999986553211111112223455699999998642 3567899999999999
Q ss_pred HHhCCCCCccC-CCCCHHHHHHHHcC---CCCCCCCCc--cCCHHHHHHHHHHhccCCCCCCCHHHHhc
Q 039291 211 MLSGRQAWVVK-EDCSIDQLFSIIGD---EHSLPEIPS--RVSKEARDFLRRCFVRKPAFRFTAEMLLD 273 (362)
Q Consensus 211 l~~g~~pf~~~-~~~~~~~~~~~~~~---~~~~~~~~~--~~~~~~~~li~~~l~~~p~~R~s~~~~l~ 273 (362)
+++...||... ...+..+++..+.. ....|.+.. ...+++..++..||..+|.+||+++++-.
T Consensus 151 i~~r~~~~~~~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~ 219 (484)
T KOG1023|consen 151 ILFRSGPFDLRNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRS 219 (484)
T ss_pred HHhccCccccccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHh
Confidence 99999999753 22233455544443 224444442 45567999999999999999999887643
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.77 E-value=5.1e-18 Score=146.32 Aligned_cols=132 Identities=19% Similarity=0.223 Sum_probs=99.9
Q ss_pred cceecccCceEEEEEEECCCCCCCCceeeeechhh-----------hhhHHHHHHHHHHHHcCCCCcccccccceeeecC
Q 039291 11 GRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEV-----------SASASLQKEKEVFDNLNGCPFVLECFGEEITMGE 79 (362)
Q Consensus 11 ~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~-----------~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~ 79 (362)
.+.||+|++|.||+|.+.+. .+++|.... .....+.+|+.++..+. ++++.....++...
T Consensus 1 ~~~l~~G~~~~vy~~~~~~~------~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-~~~i~~p~~~~~~~-- 71 (211)
T PRK14879 1 MKLIKRGAEAEIYLGDFLGI------KAVIKWRIPKRYRHPELDERIRRERTRREARIMSRAR-KAGVNVPAVYFVDP-- 71 (211)
T ss_pred CcccccCceEEEEEEeeCCC------ceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHH-HCCCCCCeEEEEeC--
Confidence 36799999999999987332 344443211 01245778999999998 67765544433221
Q ss_pred CCceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEee
Q 039291 80 NGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIAD 159 (362)
Q Consensus 80 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~D 159 (362)
...+++|||++|++|.+++... .. ....++.+++.+|.++|+.|++|+|++|.|||+ + .+.++|+|
T Consensus 72 ---~~~~lv~e~~~G~~L~~~~~~~-----~~-~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~----~-~~~~~liD 137 (211)
T PRK14879 72 ---ENFIIVMEYIEGEPLKDLINSN-----GM-EELELSREIGRLVGKLHSAGIIHGDLTTSNMIL----S-GGKIYLID 137 (211)
T ss_pred ---CCCEEEEEEeCCcCHHHHHHhc-----cH-HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEE----E-CCCEEEEE
Confidence 1246999999999999998752 22 888999999999999999999999999999999 4 45689999
Q ss_pred cCCccc
Q 039291 160 LGVAKR 165 (362)
Q Consensus 160 fgla~~ 165 (362)
||++..
T Consensus 138 f~~a~~ 143 (211)
T PRK14879 138 FGLAEF 143 (211)
T ss_pred CCcccC
Confidence 998764
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.77 E-value=3.7e-18 Score=167.02 Aligned_cols=139 Identities=17% Similarity=0.220 Sum_probs=103.0
Q ss_pred CceeecceecccCceEEEEEEECCCCCCCCceeeeechhh------hhhHHHHHHHHHHHHcCCCCcccccccceeeecC
Q 039291 6 TSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEV------SASASLQKEKEVFDNLNGCPFVLECFGEEITMGE 79 (362)
Q Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~------~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~ 79 (362)
..|...+.||+|+||+||+|.+......+ ++...|.... .....+.+|+++++.+. |++++....+...
T Consensus 333 ~~~~~~~~iG~G~~g~Vy~~~~~~~~~v~-k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-~~~i~~p~~~~~~--- 407 (535)
T PRK09605 333 RRKIPDHLIGKGAEADIKKGEYLGRDAVI-KERVPKGYRHPELDERLRTERTRAEARLLSEAR-RAGVPTPVIYDVD--- 407 (535)
T ss_pred cccCccceeccCCcEEEEEEeecCcccee-EEEecccccchhHHHHHHHHHHHHHHHHHHhhc-ccCCCeeEEEEEe---
Confidence 34567899999999999999876654322 2222222111 12356789999999998 7887665443322
Q ss_pred CCceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEee
Q 039291 80 NGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIAD 159 (362)
Q Consensus 80 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~D 159 (362)
....++||||++|++|.+++. ....++.|++.+|.|||+.|++||||||+|||+ + ++.++|+|
T Consensus 408 --~~~~~lv~E~~~g~~L~~~l~----------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl----~-~~~~~liD 470 (535)
T PRK09605 408 --PEEKTIVMEYIGGKDLKDVLE----------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIV----R-DDRLYLID 470 (535)
T ss_pred --CCCCEEEEEecCCCcHHHHHH----------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEE----E-CCcEEEEe
Confidence 112469999999999999885 246789999999999999999999999999999 2 23589999
Q ss_pred cCCcccc
Q 039291 160 LGVAKRS 166 (362)
Q Consensus 160 fgla~~~ 166 (362)
||+++..
T Consensus 471 FGla~~~ 477 (535)
T PRK09605 471 FGLGKYS 477 (535)
T ss_pred CcccccC
Confidence 9998643
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.76 E-value=5.8e-18 Score=144.63 Aligned_cols=128 Identities=21% Similarity=0.283 Sum_probs=93.6
Q ss_pred eecccCceEEEEEEECCCCCCCCceeeeechhh-----------hhhHHHHHHHHHHHHcCCCCcccccccceeeecCCC
Q 039291 13 VIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEV-----------SASASLQKEKEVFDNLNGCPFVLECFGEEITMGENG 81 (362)
Q Consensus 13 ~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~-----------~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~~ 81 (362)
+||+|++|.||+|...+ . .+++|.... ....++.+|++++..+. ++++.........
T Consensus 1 ~ig~G~~~~vy~~~~~~--~----~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-~~~i~~p~~~~~~----- 68 (199)
T TIGR03724 1 LIAKGAEAIIYLGDFLG--L----KAVIKERVPKSYRHPELDERIRRERTRNEARLLSRAR-KAGVNTPVVYDVD----- 68 (199)
T ss_pred CCCCCceEEEEEeecCC--c----cEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHH-HCCCCCCEEEEEE-----
Confidence 48999999999998543 2 344443211 12355778999999998 4554333222221
Q ss_pred ceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEeecC
Q 039291 82 EMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLG 161 (362)
Q Consensus 82 ~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Dfg 161 (362)
....++||||++|++|.+++... . . .++.|++.+|.+||+.|++|+|++|.||++ + .+.++++|||
T Consensus 69 ~~~~~lv~e~~~g~~l~~~~~~~--~-~------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~----~-~~~~~liDfg 134 (199)
T TIGR03724 69 PDNKTIVMEYIEGKPLKDVIEEG--N-D------ELLREIGRLVGKLHKAGIVHGDLTTSNIIV----R-DDKLYLIDFG 134 (199)
T ss_pred CCCCEEEEEEECCccHHHHHhhc--H-H------HHHHHHHHHHHHHHHCCeecCCCCcceEEE----E-CCcEEEEECC
Confidence 11246999999999999887651 1 1 789999999999999999999999999999 4 5679999999
Q ss_pred Ccccc
Q 039291 162 VAKRS 166 (362)
Q Consensus 162 la~~~ 166 (362)
++...
T Consensus 135 ~a~~~ 139 (199)
T TIGR03724 135 LGKYS 139 (199)
T ss_pred CCcCC
Confidence 98643
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.75 E-value=8.5e-18 Score=143.49 Aligned_cols=136 Identities=23% Similarity=0.177 Sum_probs=100.7
Q ss_pred CCceeecceecccCceEEEEEEECCCCCCCCceeeeechhhh-------------------------hhHHHHHHHHHHH
Q 039291 5 GTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVS-------------------------ASASLQKEKEVFD 59 (362)
Q Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~~-------------------------~~~~~~~E~~il~ 59 (362)
+..|.+.+.||+|+||.||+|... ++. .+++|..... ......+|..++.
T Consensus 14 ~~~~~~~~~i~~G~~g~Vy~~~~~-~g~----~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 88 (198)
T cd05144 14 GVVESLGNQIGVGKESDVYLALDP-DGN----PVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALK 88 (198)
T ss_pred CchhhcCCccccCcceEEEEEEcC-CCC----EEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHH
Confidence 345889999999999999999875 343 4566642211 1123567888888
Q ss_pred HcCCCCc--ccccccceeeecCCCceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCC
Q 039291 60 NLNGCPF--VLECFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCD 137 (362)
Q Consensus 60 ~l~~h~~--i~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~D 137 (362)
.+. +++ +...++. ...++||||++|++|..+... .....++.+++.++.++|+.||+|||
T Consensus 89 ~l~-~~~i~v~~~~~~---------~~~~lv~e~~~g~~L~~~~~~--------~~~~~~~~~i~~~l~~lh~~gi~H~D 150 (198)
T cd05144 89 ALY-EEGFPVPKPIDW---------NRHAVVMEYIDGVELYRVRVL--------EDPEEVLDEILEEIVKAYKHGIIHGD 150 (198)
T ss_pred HHH-HcCCCCCceeec---------CCceEEEEEeCCcchhhcccc--------ccHHHHHHHHHHHHHHHHHCCCCcCC
Confidence 887 443 3333221 123699999999998765431 34567889999999999999999999
Q ss_pred CCCCCEEEeecCCCceEEEEeecCCccccc
Q 039291 138 VKPDNILLVATQSGKFVAKIADLGVAKRSR 167 (362)
Q Consensus 138 lkp~Nill~~~~~~~~~~kl~Dfgla~~~~ 167 (362)
|||+||++ +.++.++|+|||++....
T Consensus 151 l~p~Nill----~~~~~~~liDfg~~~~~~ 176 (198)
T cd05144 151 LSEFNILV----DDDEKIYIIDWPQMVSTD 176 (198)
T ss_pred CCcccEEE----cCCCcEEEEECCccccCC
Confidence 99999999 667789999999985443
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.73 E-value=7e-18 Score=166.11 Aligned_cols=266 Identities=23% Similarity=0.322 Sum_probs=195.4
Q ss_pred CCceeecceecccCceEEEEEEECCCCCCCCceeeeechh--hhhhHHHHHHHHHHHHcCCCCcccccccceeeecCCCc
Q 039291 5 GTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAE--VSASASLQKEKEVFDNLNGCPFVLECFGEEITMGENGE 82 (362)
Q Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~--~~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~~~ 82 (362)
-+.+.+.+-+-+|+++.+..++-..++......+-.+... ......+..+-.++-.. ++|.++..+.-+. -.
T Consensus 803 ~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p-~~P~v~~~~~s~~-----~r 876 (1205)
T KOG0606|consen 803 PDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITP-RSPAVVRSFPSFP-----CR 876 (1205)
T ss_pred CccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccC-CCCceecccCCCC-----CC
Confidence 3456677788899999999998887774333222222211 11122222333222222 2566665543311 12
Q ss_pred eEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEeecCC
Q 039291 83 MAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGV 162 (362)
Q Consensus 83 ~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Dfgl 162 (362)
...+|+++|+.|++|...++. .+..++.-++.++..+..+++|||...++|||++|.|++. ...+..++.|||.
T Consensus 877 sP~~L~~~~~~~~~~~Skl~~--~~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~----~~~gh~~l~~~~t 950 (1205)
T KOG0606|consen 877 SPLPLVGHYLNGGDLPSKLHN--SGCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLI----AYDGHRPLTDFGT 950 (1205)
T ss_pred CCcchhhHHhccCCchhhhhc--CCCcccccccchhHHHHhhhhccccchhhcccccccchhh----cccCCcccCcccc
Confidence 346699999999999999987 3458888899999999999999999999999999999999 8888899999984
Q ss_pred ccccccc---------------------c------cC--CCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHh
Q 039291 163 AKRSRHC---------------------K------RQ--KFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLS 213 (362)
Q Consensus 163 a~~~~~~---------------------~------~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~ 213 (362)
....+-. . .. .......||+.|.+||.+.+......+|+|++|++++|.++
T Consensus 951 ~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~ 1030 (1205)
T KOG0606|consen 951 LSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLT 1030 (1205)
T ss_pred ccccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhc
Confidence 3211100 0 00 11234569999999999999999999999999999999999
Q ss_pred CCCCCccCCCCCHHHHHHHHc-CCCCCCCCCccCCHHHHHHHHHHhccCCCCCCCHH---HHhcCCCccCcchhhh
Q 039291 214 GRQAWVVKEDCSIDQLFSIIG-DEHSLPEIPSRVSKEARDFLRRCFVRKPAFRFTAE---MLLDDPFVKGVDEELS 285 (362)
Q Consensus 214 g~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~---~~l~~p~~~~~~~~~~ 285 (362)
|.+||.. ....+.++.+. ....+|.-+...+.++++++.++|..+|.+|..+. ++..|+||+.+.|+..
T Consensus 1031 g~pp~na---~tpq~~f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~~~~e~k~~~~~~~~~~~~l 1103 (1205)
T KOG0606|consen 1031 GIPPFNA---ETPQQIFENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAKGAAEVKGHPFFQDVDWENL 1103 (1205)
T ss_pred CCCCCCC---cchhhhhhccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcccccccccCCccCCCCcccc
Confidence 9999943 35556665554 34466777788999999999999999999999877 8999999999988854
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.69 E-value=4.4e-16 Score=136.33 Aligned_cols=136 Identities=18% Similarity=0.197 Sum_probs=96.4
Q ss_pred cceec-ccCceEEEEEEECCCCCCCCceeeeechh----------------hhhhHHHHHHHHHHHHcCCCCcc--cccc
Q 039291 11 GRVIG-QGSFGCVFIAKPKSNSSFLPPLMAVKSAE----------------VSASASLQKEKEVFDNLNGCPFV--LECF 71 (362)
Q Consensus 11 ~~~lG-~G~~g~V~~a~~~~~~~~~~~~~~~K~~~----------------~~~~~~~~~E~~il~~l~~h~~i--~~~~ 71 (362)
...|| .|+.|+||.+...+ + .+++|... ......+.+|+.++..|. ++++ +..+
T Consensus 36 ~~~lg~~~g~gtv~~v~~~~-~-----~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~-~~gi~vP~pl 108 (239)
T PRK01723 36 ARVVGSAKGRGTTWFVQTPG-V-----NWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLY-EAGLPVPRPI 108 (239)
T ss_pred CceeecCCCCccEEEEEeCC-c-----eEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHH-hCCCCCceeE
Confidence 45788 89999999987753 2 23443321 112356788999999998 5554 5555
Q ss_pred cceeeecCCCceEEEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCC
Q 039291 72 GEEITMGENGEMAYNLLLEYAAG-GTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQS 150 (362)
Q Consensus 72 ~~~~~~~~~~~~~~~lv~e~~~~-~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~ 150 (362)
+...... ......++|||+++| .+|.+++.. .++++.. +.|++.+|.+||++||+||||||.|||+ +
T Consensus 109 ~~~~~~~-~~~~~~~lV~e~l~G~~~L~~~l~~---~~l~~~~----~~~i~~~l~~lH~~GI~HrDlkp~NILv----~ 176 (239)
T PRK01723 109 AARVVRH-GLFYRADILIERIEGARDLVALLQE---APLSEEQ----WQAIGQLIARFHDAGVYHADLNAHNILL----D 176 (239)
T ss_pred eeeeeec-CcceeeeEEEEecCCCCCHHHHHhc---CCCCHHH----HHHHHHHHHHHHHCCCCCCCCCchhEEE----c
Confidence 4432211 111122599999997 689988864 3466543 5789999999999999999999999999 5
Q ss_pred CceEEEEeecCCccc
Q 039291 151 GKFVAKIADLGVAKR 165 (362)
Q Consensus 151 ~~~~~kl~Dfgla~~ 165 (362)
.++.++|+|||.+..
T Consensus 177 ~~~~v~LIDfg~~~~ 191 (239)
T PRK01723 177 PDGKFWLIDFDRGEL 191 (239)
T ss_pred CCCCEEEEECCCccc
Confidence 556799999998753
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.67 E-value=2.6e-16 Score=132.99 Aligned_cols=135 Identities=23% Similarity=0.224 Sum_probs=90.8
Q ss_pred ecceecccCceEEEEEEECCCCCCCCceeeeechhhhh-----hHH----------------------HHHHHHHHHHcC
Q 039291 10 RGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVSA-----SAS----------------------LQKEKEVFDNLN 62 (362)
Q Consensus 10 ~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~~~-----~~~----------------------~~~E~~il~~l~ 62 (362)
+++.||+|+||+||+|.+. +++ .+++|...... ... ...|...+..+.
T Consensus 1 ~~~~lg~G~~g~Vy~a~~~-~~~----~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~ 75 (187)
T cd05119 1 VGGPIGTGKEADVYLALDG-DGE----PVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLY 75 (187)
T ss_pred CCcccccccceeEEEEECC-CCC----EEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHH
Confidence 3578999999999999987 444 46666543210 010 134566666665
Q ss_pred CCC-cccccccceeeecCCCceEEEEEEEecCCCCHH-HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCceeCCCC
Q 039291 63 GCP-FVLECFGEEITMGENGEMAYNLLLEYAAGGTLG-DLIEKCNGNGLPEKDVRHFTRCILEGIGHIHD-SGYVHCDVK 139 (362)
Q Consensus 63 ~h~-~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~-~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~-~~ivH~Dlk 139 (362)
++. .+.+++.. ...++||||++|+.+. ..+.... .. ..++.++.+++.++.++|. .||+|+|||
T Consensus 76 ~~~~~~~~~~~~---------~~~~lv~e~~~g~~~~~~~l~~~~---~~-~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~ 142 (187)
T cd05119 76 EAGVPVPKPIDL---------NRHVLVMEFIGGDGIPAPRLKDVR---LL-EDPEELYDQILELMRKLYREAGLVHGDLS 142 (187)
T ss_pred HcCCCCCceEec---------CCCEEEEEEeCCCCccChhhhhhh---hc-ccHHHHHHHHHHHHHHHhhccCcCcCCCC
Confidence 321 12333221 1146999999985443 1222211 11 6788999999999999999 999999999
Q ss_pred CCCEEEeecCCCceEEEEeecCCccccc
Q 039291 140 PDNILLVATQSGKFVAKIADLGVAKRSR 167 (362)
Q Consensus 140 p~Nill~~~~~~~~~~kl~Dfgla~~~~ 167 (362)
|+||++ + ++.++|+|||.+....
T Consensus 143 p~Nili----~-~~~~~liDfg~a~~~~ 165 (187)
T cd05119 143 EYNILV----D-DGKVYIIDVPQAVEID 165 (187)
T ss_pred hhhEEE----E-CCcEEEEECccccccc
Confidence 999999 4 5679999999985443
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.62 E-value=2.9e-15 Score=121.43 Aligned_cols=131 Identities=20% Similarity=0.245 Sum_probs=101.3
Q ss_pred ecceecccCceEEEEEEECCCCCCCCceeeeechhhhh-hHHHHHHHHHHHHcCCC-CcccccccceeeecCCCceEEEE
Q 039291 10 RGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVSA-SASLQKEKEVFDNLNGC-PFVLECFGEEITMGENGEMAYNL 87 (362)
Q Consensus 10 ~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~~~-~~~~~~E~~il~~l~~h-~~i~~~~~~~~~~~~~~~~~~~l 87 (362)
+.+.||+|.++.||++...+ ..+++|...... ...+.+|+.+++.+.++ .++.+++.... . ....++
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~------~~~~iK~~~~~~~~~~~~~e~~~~~~l~~~~~~~p~~~~~~~----~-~~~~~~ 70 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD------EDYVLKINPSREKGADREREVAILQLLARKGLPVPKVLASGE----S-DGWSYL 70 (155)
T ss_pred cceecccccccceEEEEecC------CeEEEEecCCCCchhHHHHHHHHHHHHHHcCCCCCeEEEEcC----C-CCccEE
Confidence 56889999999999999765 246666654432 35688999999999854 56666655332 1 134679
Q ss_pred EEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCCCCEEEeecCCCceEEEEeecCCcc
Q 039291 88 LLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDS---GYVHCDVKPDNILLVATQSGKFVAKIADLGVAK 164 (362)
Q Consensus 88 v~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~---~ivH~Dlkp~Nill~~~~~~~~~~kl~Dfgla~ 164 (362)
+|||+.|+.+..+ +......++.+++.+|.++|.. +++|+|++|.||++ +..+.++++|||.+.
T Consensus 71 v~e~~~g~~~~~~---------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~----~~~~~~~l~Df~~~~ 137 (155)
T cd05120 71 LMEWIEGETLDEV---------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILV----DDGKILGIIDWEYAG 137 (155)
T ss_pred EEEecCCeecccC---------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEE----ECCcEEEEEeccccc
Confidence 9999998777643 4566678899999999999985 79999999999999 556789999999875
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.62 E-value=1.1e-15 Score=143.67 Aligned_cols=254 Identities=22% Similarity=0.241 Sum_probs=186.5
Q ss_pred Cceeecceecc--cCceEEEEEEE--CCCCCCCCceeeeech----h-hhhhHHHHHHHHHHHHcCCCCcccccccceee
Q 039291 6 TSWFRGRVIGQ--GSFGCVFIAKP--KSNSSFLPPLMAVKSA----E-VSASASLQKEKEVFDNLNGCPFVLECFGEEIT 76 (362)
Q Consensus 6 ~~y~~~~~lG~--G~~g~V~~a~~--~~~~~~~~~~~~~K~~----~-~~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~ 76 (362)
..+.+...+|. |.+|.||.++. +.... .+++|.- . .....+-.+|..-.+.++.|++.++.+..+.
T Consensus 114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~----~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e- 188 (524)
T KOG0601|consen 114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPH----KFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWE- 188 (524)
T ss_pred hhcccccccccCCCCCceeecccCCcccCCc----ccccccccCCCCCccccccccchhhcccccCccccccccCcccc-
Confidence 45677888999 99999999987 54444 4444441 1 2234445678888888888999998666543
Q ss_pred ecCCCceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHH----HHHHHHhCCceeCCCCCCCEEEeecCCCc
Q 039291 77 MGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILE----GIGHIHDSGYVHCDVKPDNILLVATQSGK 152 (362)
Q Consensus 77 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~----~l~yLH~~~ivH~Dlkp~Nill~~~~~~~ 152 (362)
+....++-+|+|. .+|..+... ...-+++..++.++.+... ||.++|+.+++|-|+||.||++ ..+
T Consensus 189 ----~~~~lfiqtE~~~-~sl~~~~~~-~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~----~~~ 258 (524)
T KOG0601|consen 189 ----GSGILFIQTELCG-ESLQSYCHT-PCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFT----TSD 258 (524)
T ss_pred ----cCCcceeeecccc-chhHHhhhc-ccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheec----ccc
Confidence 2334567888885 688777765 2344889999999999999 9999999999999999999999 555
Q ss_pred -eEEEEeecCCcccccccccCCC---CCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHH
Q 039291 153 -FVAKIADLGVAKRSRHCKRQKF---DPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQ 228 (362)
Q Consensus 153 -~~~kl~Dfgla~~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~ 228 (362)
...+++|||+........-... .....|...|++||... .-++...|++++|.++.+-.++..+..........+
T Consensus 259 ~~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~-~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~ 337 (524)
T KOG0601|consen 259 WTSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLN-GLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQ 337 (524)
T ss_pred cceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhc-cccchHhhhcchhhhhHhhHhhcccccCCCCCCccc
Confidence 7899999999886665431111 11225788899999775 458889999999999999998876654432222222
Q ss_pred HHHHHcCCCCCCCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCccC
Q 039291 229 LFSIIGDEHSLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKG 279 (362)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~~~ 279 (362)
+- ......++....+.++...+..|++.+|-.|++++.++.++++..
T Consensus 338 ~r----~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s 384 (524)
T KOG0601|consen 338 LR----QGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHS 384 (524)
T ss_pred cc----cccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccc
Confidence 21 111222334456777888999999999999999999999998864
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.53 E-value=6.3e-15 Score=128.52 Aligned_cols=211 Identities=17% Similarity=0.214 Sum_probs=145.1
Q ss_pred HHHcCCCCcccccccceeeecCCCceEEEEEEEecCCCCHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhC--Cc
Q 039291 58 FDNLNGCPFVLECFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCN--GNGLPEKDVRHFTRCILEGIGHIHDS--GY 133 (362)
Q Consensus 58 l~~l~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~l~~~~~~~i~~ql~~~l~yLH~~--~i 133 (362)
+..+- |.||++++.++......+.....++.||+..|+|.++|++.. ...+......+|+-||+.||.|||+- -|
T Consensus 121 llqlv-HsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~Ppi 199 (458)
T KOG1266|consen 121 LLQLV-HSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPI 199 (458)
T ss_pred HHHHH-HHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCcc
Confidence 33444 788999999877665545556678999999999999998743 34588899999999999999999975 59
Q ss_pred eeCCCCCCCEEEeecCCCceEEEEeecCCccccccc--ccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHH
Q 039291 134 VHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHC--KRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEM 211 (362)
Q Consensus 134 vH~Dlkp~Nill~~~~~~~~~~kl~Dfgla~~~~~~--~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l 211 (362)
+|+++....|++ ..++.+|+.--.-....... ..........+-++|.|||.=..-..+.++|||+||.+..+|
T Consensus 200 ihgnlTc~tifi----q~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlem 275 (458)
T KOG1266|consen 200 IHGNLTCDTIFI----QHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEM 275 (458)
T ss_pred ccCCcchhheee----cCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHH
Confidence 999999999999 66777776422111100000 000001123467889999965555567789999999999999
Q ss_pred HhCCCC-CccCCCCCHHHHHHHHcCCCCCCCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCccCcc
Q 039291 212 LSGRQA-WVVKEDCSIDQLFSIIGDEHSLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGVD 281 (362)
Q Consensus 212 ~~g~~p-f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~~~~~ 281 (362)
..+..- -........++......... -..--++++.+||+-.|+.||++.+++.||..-++.
T Consensus 276 ailEiq~tnseS~~~~ee~ia~~i~~l--------en~lqr~~i~kcl~~eP~~rp~ar~llfHpllfeVh 338 (458)
T KOG1266|consen 276 AILEIQSTNSESKVEVEENIANVIIGL--------ENGLQRGSITKCLEGEPNGRPDARLLLFHPLLFEVH 338 (458)
T ss_pred HHheeccCCCcceeehhhhhhhheeec--------cCccccCcCcccccCCCCCCcchhhhhcCceeeecc
Confidence 887653 21122222222222211100 112235789999999999999999999999876653
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.48 E-value=3.2e-13 Score=128.31 Aligned_cols=140 Identities=19% Similarity=0.219 Sum_probs=91.2
Q ss_pred cceecccCceEEEEEEECCCCCCCCceeeeechhhhhhHH----------------------------------------
Q 039291 11 GRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVSASAS---------------------------------------- 50 (362)
Q Consensus 11 ~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~~~~~~---------------------------------------- 50 (362)
.+.||.|++|.||+|+.++ |+ .|++|...+...+.
T Consensus 122 ~~plasaSigQVh~A~l~~-G~----~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~ 196 (437)
T TIGR01982 122 EKPLAAASIAQVHRARLVD-GK----EVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRR 196 (437)
T ss_pred CcceeeeehhheEEEEecC-CC----EEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHH
Confidence 4679999999999999865 43 57777654432222
Q ss_pred ---HHHHHHHHHHcC----CCCcccccccceeeecCCCceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHH
Q 039291 51 ---LQKEKEVFDNLN----GCPFVLECFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILE 123 (362)
Q Consensus 51 ---~~~E~~il~~l~----~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~ 123 (362)
+.+|+..+.++. +++++ .+-.++... ...-+|||||++|++|.++...... ..+ ...++.+++.
T Consensus 197 Eldf~~Ea~n~~~~~~~~~~~~~v-~vP~v~~~~----~~~~vLvmE~i~G~~L~~~~~~~~~-~~~---~~~ia~~~~~ 267 (437)
T TIGR01982 197 ELDLRREAANASELGENFKNDPGV-YVPEVYWDR----TSERVLTMEWIDGIPLSDIAALDEA-GLD---RKALAENLAR 267 (437)
T ss_pred HHCHHHHHHHHHHHHHhcCCCCCE-EeCCEehhh----cCCceEEEEeECCcccccHHHHHhc-CCC---HHHHHHHHHH
Confidence 223444443332 23333 111111111 1124599999999999987754211 132 3345566665
Q ss_pred -HHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEeecCCcccccc
Q 039291 124 -GIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRH 168 (362)
Q Consensus 124 -~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Dfgla~~~~~ 168 (362)
.+..+|..|++|+|+||.||++ +.++.++++|||++.....
T Consensus 268 ~~l~ql~~~g~~H~D~hPgNilv----~~~g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 268 SFLNQVLRDGFFHADLHPGNIFV----LKDGKIIALDFGIVGRLSE 309 (437)
T ss_pred HHHHHHHhCCceeCCCCcccEEE----CCCCcEEEEeCCCeeECCH
Confidence 4688999999999999999999 6677899999999875543
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.40 E-value=1.1e-12 Score=108.84 Aligned_cols=126 Identities=16% Similarity=0.070 Sum_probs=90.2
Q ss_pred cceecccCceEEEEEEECCCCCCCCceeeeechhhhh--hHHHHHHHHHHHHcCCCCcccccccceeeecCCCceEEEEE
Q 039291 11 GRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVSA--SASLQKEKEVFDNLNGCPFVLECFGEEITMGENGEMAYNLL 88 (362)
Q Consensus 11 ~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~~~--~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~~~~~~~lv 88 (362)
++.|+.|..+.||+++..+ ..+++|...... ...+.+|+.+++.+.+...+.+++... . .. .++|
T Consensus 3 ~~~l~~G~~~~vy~~~~~~------~~~~lK~~~~~~~~~~~~~~E~~~l~~l~~~~~~P~~~~~~-----~-~~-~~lv 69 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVAN------KKYVVRIPGNGTELLINRENEAENSKLAAEAGIGPKLYYFD-----P-ET-GVLI 69 (170)
T ss_pred eeecCCcccCceEEEEECC------eEEEEEeCCCCcccccCHHHHHHHHHHHHHhCCCCceEEEe-----C-CC-CeEE
Confidence 5788999999999998652 257777764432 234678999999987433333443321 1 11 2489
Q ss_pred EEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCc-----eeCCCCCCCEEEeecCCCceEEEEeecCCc
Q 039291 89 LEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGY-----VHCDVKPDNILLVATQSGKFVAKIADLGVA 163 (362)
Q Consensus 89 ~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~i-----vH~Dlkp~Nill~~~~~~~~~~kl~Dfgla 163 (362)
|||++|.++.+. . . ....++.+++.+|..||..++ +|+|++|.||++ + .+.++++|||.+
T Consensus 70 ~e~i~G~~l~~~--~-----~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~----~-~~~~~liDf~~a 134 (170)
T cd05151 70 TEFIEGSELLTE--D-----F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLL----D-DGRLWLIDWEYA 134 (170)
T ss_pred EEecCCCccccc--c-----c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEE----E-CCeEEEEecccc
Confidence 999999887643 0 1 123456899999999999885 999999999999 4 345899999986
Q ss_pred c
Q 039291 164 K 164 (362)
Q Consensus 164 ~ 164 (362)
.
T Consensus 135 ~ 135 (170)
T cd05151 135 G 135 (170)
T ss_pred c
Confidence 4
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.39 E-value=2.3e-12 Score=124.05 Aligned_cols=77 Identities=19% Similarity=0.294 Sum_probs=53.6
Q ss_pred EEEEEEecCCCCHHHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEeec
Q 039291 85 YNLLLEYAAGGTLGDLIEKCNGN----GLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADL 160 (362)
Q Consensus 85 ~~lv~e~~~~~~L~~~l~~~~~~----~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Df 160 (362)
-+|||||+.|+.+.++-.-...+ .+.+..+..++.|++ ..|++|+|+||.||++..++...+.++++||
T Consensus 236 ~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qif-------~~GffHaDpHPGNIlv~~~g~~~~~i~llDF 308 (537)
T PRK04750 236 TVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQVF-------RDGFFHADMHPGNIFVSYDPPENPRYIALDF 308 (537)
T ss_pred ceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHHH-------hCCeeeCCCChHHeEEecCCCCCCeEEEEec
Confidence 35999999999998753211111 244444555555554 5999999999999999543333448999999
Q ss_pred CCcccccc
Q 039291 161 GVAKRSRH 168 (362)
Q Consensus 161 gla~~~~~ 168 (362)
|++.....
T Consensus 309 Givg~l~~ 316 (537)
T PRK04750 309 GIVGSLNK 316 (537)
T ss_pred ceEEECCH
Confidence 99875543
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.37 E-value=1.7e-11 Score=116.90 Aligned_cols=146 Identities=19% Similarity=0.288 Sum_probs=112.1
Q ss_pred hHHHHHHHHHHHHcCCCCcccccccceeeecCCCceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHH
Q 039291 48 SASLQKEKEVFDNLNGCPFVLECFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGH 127 (362)
Q Consensus 48 ~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~y 127 (362)
.....+-++.|+.|+ ||||+++++.... ...+|||+|.+. .|..+++. +....+...+.||+.||.+
T Consensus 53 ~~~~~~A~k~lKtlR-HP~Il~yL~t~e~-----~~~~ylvTErV~--Pl~~~lk~-----l~~~~v~~Gl~qIl~AL~F 119 (690)
T KOG1243|consen 53 TELAKRAVKRLKTLR-HPNILSYLDTTEE-----EGTLYLVTERVR--PLETVLKE-----LGKEEVCLGLFQILAALSF 119 (690)
T ss_pred hHHHHHHHHHhhhcc-Cchhhhhhhhhcc-----cCceEEEeeccc--cHHHHHHH-----hHHHHHHHHHHHHHHHHHH
Confidence 455677888899999 9999999986543 225789999994 89999987 5588888999999999999
Q ss_pred HH-hCCceeCCCCCCCEEEeecCCCceEEEEeecCCcccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHH
Q 039291 128 IH-DSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGC 206 (362)
Q Consensus 128 LH-~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ 206 (362)
|| +.+++|++|....|++ +..|..||++|.++........ ......---.|..|+.+.... -..|.|-|||
T Consensus 120 L~~d~~lvHgNv~~~SVfV----n~~GeWkLggle~v~~~~~~~~--~~~~~~~~~s~~~P~~~~~s~--~s~D~~~Lg~ 191 (690)
T KOG1243|consen 120 LNDDCNLVHGNVCKDSVFV----NESGEWKLGGLELVSKASGFNA--PAKSLYLIESFDDPEEIDPSE--WSIDSWGLGC 191 (690)
T ss_pred HhccCCeeeccEeeeeEEE----cCCCcEEEeeeEEEeccccCCc--ccccchhhhcccChhhcCccc--cchhhhhHHH
Confidence 97 6789999999999999 8889999999998754443221 011112222356666543322 3469999999
Q ss_pred HHHHHHhC
Q 039291 207 VVLEMLSG 214 (362)
Q Consensus 207 il~~l~~g 214 (362)
++++++.|
T Consensus 192 li~el~ng 199 (690)
T KOG1243|consen 192 LIEELFNG 199 (690)
T ss_pred HHHHHhCc
Confidence 99999999
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.37 E-value=6.2e-13 Score=125.17 Aligned_cols=247 Identities=21% Similarity=0.190 Sum_probs=170.3
Q ss_pred CceeecceecccCceEEEEEEECCCCCCCCceeeeechh-----hhhhHHHHHHHHHHHHcCCCCcccccccceeeecCC
Q 039291 6 TSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAE-----VSASASLQKEKEVFDNLNGCPFVLECFGEEITMGEN 80 (362)
Q Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~-----~~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~ 80 (362)
.+|..+..||.|.|+.|+....+..+. .+++.|... ......-..|..+...++-|.+++..+..+....
T Consensus 265 ~df~~v~~i~~~~~~~~~~~~~r~~~~---~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r-- 339 (524)
T KOG0601|consen 265 TDFGLVSKISDGNFSSVFKVSKRPEGD---CIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLR-- 339 (524)
T ss_pred CCcceeEEccCCccccceeeeecCCCC---ceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccc--
Confidence 467888999999999999987552332 244554432 2233344567777778887888888776554322
Q ss_pred CceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEeec
Q 039291 81 GEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADL 160 (362)
Q Consensus 81 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Df 160 (362)
..|+-.|||+++++...+.- ...+++...+.+..|++.++.++|++.++|+|+||+||++..+ .+..++.||
T Consensus 340 ---~~~ip~e~~~~~s~~l~~~~--~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~---~~~~~~~~~ 411 (524)
T KOG0601|consen 340 ---QGYIPLEFCEGGSSSLRSVT--SQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISND---GFFSKLGDF 411 (524)
T ss_pred ---cccCchhhhcCcchhhhhHH--HHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccc---hhhhhcccc
Confidence 24488999999988765532 2348999999999999999999999999999999999999421 277889999
Q ss_pred CCcccccccccCCCCCCccCCCCc-cCchhhccccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHHcCCCCC
Q 039291 161 GVAKRSRHCKRQKFDPSMRGTPLY-LAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEHSL 239 (362)
Q Consensus 161 gla~~~~~~~~~~~~~~~~gt~~y-~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 239 (362)
|.++....... .....+..| .+++......+..+.|++|||.-+.+.+++.+.-.. .... ..+. ....
T Consensus 412 ~~~t~~~~~~~----~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~--~~~~----~~i~-~~~~ 480 (524)
T KOG0601|consen 412 GCWTRLAFSSG----VFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSES--GVQS----LTIR-SGDT 480 (524)
T ss_pred ccccccceecc----cccccccccccchhhccccccccccccccccccccccccCcccCcc--cccc----eeee-cccc
Confidence 98864221110 111233334 245555566888999999999999999998753211 1011 1111 1222
Q ss_pred CCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCc
Q 039291 240 PEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFV 277 (362)
Q Consensus 240 ~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~ 277 (362)
+..+. ...++..+.+.+...++..|+.+.++..|.-|
T Consensus 481 p~~~~-~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~ 517 (524)
T KOG0601|consen 481 PNLPG-LKLQLQVLLKVMINPDRKRRPSAVELSLHSEF 517 (524)
T ss_pred cCCCc-hHHhhhhhhhhhcCCccccchhhhhhcccchh
Confidence 33333 33788899999999999999999988877654
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.33 E-value=1.7e-11 Score=102.97 Aligned_cols=140 Identities=15% Similarity=0.186 Sum_probs=92.9
Q ss_pred cceecccCceEEEEEEECCC--CCCCCceeeeechhhh-------------------------hhHHH----HHHHHHHH
Q 039291 11 GRVIGQGSFGCVFIAKPKSN--SSFLPPLMAVKSAEVS-------------------------ASASL----QKEKEVFD 59 (362)
Q Consensus 11 ~~~lG~G~~g~V~~a~~~~~--~~~~~~~~~~K~~~~~-------------------------~~~~~----~~E~~il~ 59 (362)
...||.|--+.||.|..... +..-...+|+|..... ....+ .+|.+.|+
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 45799999999999986531 0001124556542110 11122 37999999
Q ss_pred HcCCC-CcccccccceeeecCCCceEEEEEEEecCCCCHH-HHHHHhcCCCCCHHHHHHHHHHHHHHHHHH-HhCCceeC
Q 039291 60 NLNGC-PFVLECFGEEITMGENGEMAYNLLLEYAAGGTLG-DLIEKCNGNGLPEKDVRHFTRCILEGIGHI-HDSGYVHC 136 (362)
Q Consensus 60 ~l~~h-~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~-~~l~~~~~~~l~~~~~~~i~~ql~~~l~yL-H~~~ivH~ 136 (362)
++... -++..+++. . .-++||||+.+..+. ..++. ..+++..+..+..|++.+|..| |+.|+||+
T Consensus 82 rl~~~Gv~vP~pi~~----~-----~~~lvME~Ig~~~~~~~~Lkd---~~~~~~~~~~i~~~i~~~l~~l~H~~glVHG 149 (197)
T cd05146 82 RMQKAGIPCPEVVVL----K-----KHVLVMSFIGDDQVPAPKLKD---AKLNDEEMKNAYYQVLSMMKQLYKECNLVHA 149 (197)
T ss_pred HHHHcCCCCCeEEEe----c-----CCEEEEEEcCCCCccchhhhc---cccCHHHHHHHHHHHHHHHHHHHHhCCeecC
Confidence 98742 234444432 1 135899999765442 22322 2366677788899999999999 89999999
Q ss_pred CCCCCCEEEeecCCCceEEEEeecCCccccc
Q 039291 137 DVKPDNILLVATQSGKFVAKIADLGVAKRSR 167 (362)
Q Consensus 137 Dlkp~Nill~~~~~~~~~~kl~Dfgla~~~~ 167 (362)
||++.||++. . +.+.|+|||.+....
T Consensus 150 DLs~~NIL~~----~-~~v~iIDF~qav~~~ 175 (197)
T cd05146 150 DLSEYNMLWH----D-GKVWFIDVSQSVEPT 175 (197)
T ss_pred CCCHHHEEEE----C-CcEEEEECCCceeCC
Confidence 9999999993 2 358999999876444
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.31 E-value=4.3e-11 Score=96.99 Aligned_cols=149 Identities=19% Similarity=0.192 Sum_probs=99.4
Q ss_pred ecceecccCceEEEEEEECCCCCCCCceeeeechh-----h-hhhHHHHHHHHHHHHcCCCCcccccccceeeecCCCce
Q 039291 10 RGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAE-----V-SASASLQKEKEVFDNLNGCPFVLECFGEEITMGENGEM 83 (362)
Q Consensus 10 ~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~-----~-~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~~~~ 83 (362)
....|-+|+-+.|+++.+..... +.+....|... . -...+..+|+++|.++... .|.-..-++++..
T Consensus 11 ~l~likQGAEArv~~~~~~Ge~~-iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~-GI~~P~l~~~D~~----- 83 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFSGEAA-IIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRAL-GIPAPRLIFIDTY----- 83 (229)
T ss_pred cceeeeccceeeEeeeccCCcee-EEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHh-CCCCceEEEEecC-----
Confidence 56789999999999998876431 11222222221 1 1445677899998887621 2211111122111
Q ss_pred EEEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEeecCC
Q 039291 84 AYNLLLEYAAG-GTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGV 162 (362)
Q Consensus 84 ~~~lv~e~~~~-~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Dfgl 162 (362)
.-.++|||++| .++.+++...-.......-...++.++-+.+.-||.++|||+||..+||++... +....+.++|||+
T Consensus 84 ~~~i~ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~-~~~~~~~lIdfgl 162 (229)
T KOG3087|consen 84 GGQIYMEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSD-GNQITPILIDFGL 162 (229)
T ss_pred CCeEEEEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecC-CCcCceEEEeecc
Confidence 12489999987 478888877544434444447889999999999999999999999999999654 3444568999999
Q ss_pred cccc
Q 039291 163 AKRS 166 (362)
Q Consensus 163 a~~~ 166 (362)
+...
T Consensus 163 s~~s 166 (229)
T KOG3087|consen 163 SSVS 166 (229)
T ss_pred hhcc
Confidence 8544
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.27 E-value=5.2e-11 Score=96.90 Aligned_cols=133 Identities=20% Similarity=0.255 Sum_probs=87.1
Q ss_pred ceecccCceEEEEEEECCCCCCCCceeee-echhhh------hhHHHHHHHHHHHHcCCCCcccccccceeeecCCCceE
Q 039291 12 RVIGQGSFGCVFIAKPKSNSSFLPPLMAV-KSAEVS------ASASLQKEKEVFDNLNGCPFVLECFGEEITMGENGEMA 84 (362)
Q Consensus 12 ~~lG~G~~g~V~~a~~~~~~~~~~~~~~~-K~~~~~------~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~~~~~ 84 (362)
..+++|+-+.++.+.+.+.. ++.|..+ |..... ...+-.+|++++.++.. -.|.-..-+.+. ...
T Consensus 2 ~~i~~GAEa~i~~~~~~g~~--av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~-~GV~~P~v~dvD-----~~~ 73 (204)
T COG3642 2 DLIKQGAEAIIYLTDFLGLP--AVVKERIPKRYRHPELDEKLRRERTRREARILAKARE-AGVPVPIVYDVD-----PDN 73 (204)
T ss_pred chhhCCcceeEEeeeccCcc--eEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHH-cCCCCCeEEEEc-----CCC
Confidence 46889999999999664432 1112222 222111 23456689999888763 222211111111 112
Q ss_pred EEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEeecCCcc
Q 039291 85 YNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAK 164 (362)
Q Consensus 85 ~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Dfgla~ 164 (362)
..++|||++|..|.+.+... . ..++..+-.-+.-||..||+|+||.++||++. +.. +.++||||+.
T Consensus 74 ~~I~me~I~G~~lkd~l~~~-----~----~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~----~~~-i~~IDfGLg~ 139 (204)
T COG3642 74 GLIVMEYIEGELLKDALEEA-----R----PDLLREVGRLVGKLHKAGIVHGDLTTSNIILS----GGR-IYFIDFGLGE 139 (204)
T ss_pred CEEEEEEeCChhHHHHHHhc-----c----hHHHHHHHHHHHHHHhcCeecCCCccceEEEe----CCc-EEEEECCccc
Confidence 34899999999999888762 1 34566677777889999999999999999994 322 8999999986
Q ss_pred cc
Q 039291 165 RS 166 (362)
Q Consensus 165 ~~ 166 (362)
..
T Consensus 140 ~s 141 (204)
T COG3642 140 FS 141 (204)
T ss_pred cc
Confidence 43
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.20 E-value=1e-11 Score=118.80 Aligned_cols=158 Identities=17% Similarity=0.275 Sum_probs=116.8
Q ss_pred HHHHHHHHHHh-CCceeCCCCCCCEEEeecCCCceEEEEeecCCccccccccc-----C--CCCCCccCCCCccCchhhc
Q 039291 120 CILEGIGHIHD-SGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKR-----Q--KFDPSMRGTPLYLAPETVV 191 (362)
Q Consensus 120 ql~~~l~yLH~-~~ivH~Dlkp~Nill~~~~~~~~~~kl~Dfgla~~~~~~~~-----~--~~~~~~~gt~~y~aPE~~~ 191 (362)
+++.|+.|+|. .++||++|.|++|.+ +.++.+||+.|+.+........ . .......-...|.|||++.
T Consensus 107 ~v~dgl~flh~sAk~VH~ni~p~~i~~----na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~ 182 (700)
T KOG2137|consen 107 NVADGLAFLHRSAKVVHGNIQPEAIVV----NANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLL 182 (700)
T ss_pred cccchhhhhccCcceeecccchhheee----ccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhc
Confidence 34489999995 689999999999999 8888899999998754433111 1 1112233566799999999
Q ss_pred cccCCCcchHHHHHHHHHHHH-hCCCCCccCCCCCHHHHHHHHcCCCCCCCCCccCCHHHHHHHHHHhccCCCCCCCHHH
Q 039291 192 QHMQEAPSDIWALGCVVLEML-SGRQAWVVKEDCSIDQLFSIIGDEHSLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEM 270 (362)
Q Consensus 192 ~~~~~~~~DiwslG~il~~l~-~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~ 270 (362)
+...+.++|++|+||.+|.+. .|+.-+................ +-........++.++++=+.+++..++..||++..
T Consensus 183 ~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~-~~~~~~~s~~~p~el~~~l~k~l~~~~~~rp~~~~ 261 (700)
T KOG2137|consen 183 GTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLL-NAGAFGYSNNLPSELRESLKKLLNGDSAVRPTLDL 261 (700)
T ss_pred cccccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhccc-ccccccccccCcHHHHHHHHHHhcCCcccCcchhh
Confidence 988899999999999999998 4555554443333322222221 22222345779999999999999999999999999
Q ss_pred HhcCCCccCcch
Q 039291 271 LLDDPFVKGVDE 282 (362)
Q Consensus 271 ~l~~p~~~~~~~ 282 (362)
++.-|||....-
T Consensus 262 l~~~~ff~D~~~ 273 (700)
T KOG2137|consen 262 LLSIPFFSDPGL 273 (700)
T ss_pred hhcccccCCchh
Confidence 999999987543
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.11 E-value=4e-09 Score=98.06 Aligned_cols=216 Identities=17% Similarity=0.167 Sum_probs=147.3
Q ss_pred CceEEEEEEECCCCCCCCceeeeech---hhhhhHHHHHHHHHHHHcCCCCcccccccceeeecCCCceEEEEEEEecCC
Q 039291 18 SFGCVFIAKPKSNSSFLPPLMAVKSA---EVSASASLQKEKEVFDNLNGCPFVLECFGEEITMGENGEMAYNLLLEYAAG 94 (362)
Q Consensus 18 ~~g~V~~a~~~~~~~~~~~~~~~K~~---~~~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~ 94 (362)
--.+.|++..+.+|.. +.+|.. +.........-.++++++. |+|+|++..++.... ..+..+++|++|+++
T Consensus 288 ~~~Ttyk~~s~~DG~~----YvLkRlhg~r~~~~nk~t~lve~wkkl~-h~NvV~frevf~t~t-F~D~SlvlvYDYyP~ 361 (655)
T KOG3741|consen 288 FSITTYKATSNVDGNA----YVLKRLHGDRDQSTNKDTSLVEAWKKLC-HTNVVPFREVFLTYT-FGDLSLVLVYDYYPS 361 (655)
T ss_pred ccceeEeeeeccCCce----eeeeeeccccccCcccchHHHHHHHHhc-cCceeehhhhhhhhc-cCcceEEEEEecCCC
Confidence 3467888887777764 344444 2222222334567899999 999999999887443 345568899999886
Q ss_pred -CCHHHHHHHh-------------cCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEeec
Q 039291 95 -GTLGDLIEKC-------------NGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADL 160 (362)
Q Consensus 95 -~~L~~~l~~~-------------~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Df 160 (362)
++|.++.-.. .+.+.+|..+|.++.||..||.++|+.|+.-+-|.|.+|++ .++..++|...
T Consensus 362 s~TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv----~G~~RIriS~C 437 (655)
T KOG3741|consen 362 SPTLYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILV----TGKMRIRISGC 437 (655)
T ss_pred CchHHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEe----eCcceEEEecc
Confidence 4666654321 12247889999999999999999999999999999999999 77767888887
Q ss_pred CCcccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHH-HHHHcCCCCC
Q 039291 161 GVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQL-FSIIGDEHSL 239 (362)
Q Consensus 161 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~-~~~~~~~~~~ 239 (362)
|+........ + |-+ .--.+-|.=.||.+++.|.||..--. ......+. ...
T Consensus 438 ~i~Dvl~~d~---------~-------~~l---e~~Qq~D~~~lG~ll~aLAt~~~ns~--~~d~~~~s~~~~------- 489 (655)
T KOG3741|consen 438 GIMDVLQEDP---------T-------EPL---ESQQQNDLRDLGLLLLALATGTENSN--RTDSTQSSHLTR------- 489 (655)
T ss_pred cceeeecCCC---------C-------cch---hHHhhhhHHHHHHHHHHHhhcccccc--cccchHHHHHHH-------
Confidence 7654332211 0 111 11235688899999999999964211 11111111 222
Q ss_pred CCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhcC
Q 039291 240 PEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDD 274 (362)
Q Consensus 240 ~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~ 274 (362)
+....+.+++++|.-+...+++. -++.+++.+
T Consensus 490 --I~~~yS~D~rn~v~yl~s~~~~~-ksI~~llp~ 521 (655)
T KOG3741|consen 490 --ITTTYSTDLRNVVEYLESLNFRE-KSIQDLLPM 521 (655)
T ss_pred --hhhhhhHHHHHHHHHHHhcCccc-ccHHHHHHH
Confidence 23457889999999998888886 567776654
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.11 E-value=3.2e-09 Score=94.15 Aligned_cols=114 Identities=16% Similarity=0.106 Sum_probs=80.7
Q ss_pred HHHHHHHHHHHcCCCCcc--cccccceeeecCCCceEEEEEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHH
Q 039291 50 SLQKEKEVFDNLNGCPFV--LECFGEEITMGENGEMAYNLLLEYAAGG-TLGDLIEKCNGNGLPEKDVRHFTRCILEGIG 126 (362)
Q Consensus 50 ~~~~E~~il~~l~~h~~i--~~~~~~~~~~~~~~~~~~~lv~e~~~~~-~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~ 126 (362)
.+.+|...+.+|.. -+| ..++.+...........-++|+|++++. +|.+++......+.+......++.+++..+.
T Consensus 74 ~a~rE~~~l~~L~~-~GIptP~pVa~~e~~~~~~~~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~ 152 (268)
T PRK15123 74 GADREWRAIHRLHE-VGVDTMTGVAFGERGSNPATRTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVR 152 (268)
T ss_pred HHHHHHHHHHHHHH-cCCCCCCeeEEEEecCCCccceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHH
Confidence 37789888888752 222 2222222111111112245899999886 8999986543345677888899999999999
Q ss_pred HHHhCCceeCCCCCCCEEEeec---CCCceEEEEeecCCcc
Q 039291 127 HIHDSGYVHCDVKPDNILLVAT---QSGKFVAKIADLGVAK 164 (362)
Q Consensus 127 yLH~~~ivH~Dlkp~Nill~~~---~~~~~~~kl~Dfgla~ 164 (362)
-||..||+|+|+++.|||+..+ .++...+.++||+.+.
T Consensus 153 ~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~ 193 (268)
T PRK15123 153 DMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQ 193 (268)
T ss_pred HHHHCcCccCCCChhhEEEeccccCCCCCceEEEEECCccc
Confidence 9999999999999999999531 1335679999999874
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.05 E-value=1.3e-09 Score=94.27 Aligned_cols=140 Identities=17% Similarity=0.240 Sum_probs=96.7
Q ss_pred cceecccCceEEEEEEECCCCCCCCceeeeechhhh----hhHHHHHHHHHHHHcCCC-CcccccccceeeecCCCceEE
Q 039291 11 GRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVS----ASASLQKEKEVFDNLNGC-PFVLECFGEEITMGENGEMAY 85 (362)
Q Consensus 11 ~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~~----~~~~~~~E~~il~~l~~h-~~i~~~~~~~~~~~~~~~~~~ 85 (362)
.+.||.|..+.||++...+ + ..+++|..... ....+.+|.++++.+..+ ..+.+++...... ......
T Consensus 3 ~~~l~~G~~n~~~~v~~~~-g----~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~--~~~~~~ 75 (223)
T cd05154 3 VRQLSGGQSNLTYLLTAGG-G----RRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDP--SVLGTP 75 (223)
T ss_pred ceecCCCccceEEEEEecC-C----cceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCC--CccCCc
Confidence 3678999999999998754 2 24566665432 345688999999999853 2244444332111 001234
Q ss_pred EEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh-----------------------------------
Q 039291 86 NLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHD----------------------------------- 130 (362)
Q Consensus 86 ~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~----------------------------------- 130 (362)
++||||++|.++.+.+.. ..+++.....++.+++.+|..||+
T Consensus 76 ~~v~e~i~G~~l~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 152 (223)
T cd05154 76 FYVMERVDGRVLRDRLLR---PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTD 152 (223)
T ss_pred eEEEEEeCCEecCCCCCC---CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhccc
Confidence 699999999888765431 236777777777788888877773
Q ss_pred ---------------------CCceeCCCCCCCEEEeecCCC--ceEEEEeecCCcc
Q 039291 131 ---------------------SGYVHCDVKPDNILLVATQSG--KFVAKIADLGVAK 164 (362)
Q Consensus 131 ---------------------~~ivH~Dlkp~Nill~~~~~~--~~~~kl~Dfgla~ 164 (362)
..++|+|+++.||++ +. .+.+.|+||+.+.
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~----~~~~~~~~~iID~e~~~ 205 (223)
T cd05154 153 EPPAMERLLRWLEAHLPADSRPGLVHGDYRLGNVLF----HPDEPRVVAVLDWELAT 205 (223)
T ss_pred ccHHHHHHHHHHHhhCCCCCCcEEEECCCCcccEEE----cCCCCcEEEEEeccccc
Confidence 246899999999999 44 5678999999874
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.00 E-value=1.3e-08 Score=87.14 Aligned_cols=113 Identities=23% Similarity=0.314 Sum_probs=82.4
Q ss_pred hHHHHHHHHHHHHcCCCCc--ccccccceeeecCCCceEEEEEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHH
Q 039291 48 SASLQKEKEVFDNLNGCPF--VLECFGEEITMGENGEMAYNLLLEYAAGG-TLGDLIEKCNGNGLPEKDVRHFTRCILEG 124 (362)
Q Consensus 48 ~~~~~~E~~il~~l~~h~~--i~~~~~~~~~~~~~~~~~~~lv~e~~~~~-~L~~~l~~~~~~~l~~~~~~~i~~ql~~~ 124 (362)
..+..+|...+..|.. -+ +.+.+++..... ......++|+|+++|. +|.+++..... ++......++.+++..
T Consensus 55 ~~ra~~E~~~~~~L~~-~Gi~tP~pva~~~~r~-~~~~~s~lite~l~~~~~L~~~~~~~~~--~~~~~~~~ll~~l~~~ 130 (206)
T PF06293_consen 55 RSRAKREWRNLQRLRE-AGIPTPEPVAYGERRK-GGGYRSYLITEALPGAQDLRDLLQQWEQ--LDPSQRRELLRALARL 130 (206)
T ss_pred chHHHHHHHHHHHHHH-cCCCCCcEEEEEEEcC-CCceeEEEEEEeCCCcccHHHHHHhhcc--cchhhHHHHHHHHHHH
Confidence 3457788888777762 22 333443332211 1123456999999984 79999986333 7778889999999999
Q ss_pred HHHHHhCCceeCCCCCCCEEEeecCCCceEEEEeecCCccc
Q 039291 125 IGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKR 165 (362)
Q Consensus 125 l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Dfgla~~ 165 (362)
+.-||+.||+|+|+++.|||+..++ +...+.++||+.++.
T Consensus 131 i~~lH~~gi~H~Dl~~~NILv~~~~-~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 131 IAKLHDAGIYHGDLNPSNILVDPDD-GQYRFYLIDLDRMRF 170 (206)
T ss_pred HHHHHHCcCCCCCCCcccEEEeCCC-CceeEEEEcchhcee
Confidence 9999999999999999999995443 345899999997653
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.99 E-value=1.1e-08 Score=93.17 Aligned_cols=255 Identities=14% Similarity=0.162 Sum_probs=155.8
Q ss_pred CCCCCceeecceecccCceEEEEEEECCCCCCCCceeeeechhhhhhHHHHHHHHHHHHcCCCCccccccc--ceeeecC
Q 039291 2 DSDGTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVSASASLQKEKEVFDNLNGCPFVLECFG--EEITMGE 79 (362)
Q Consensus 2 ~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~~~~~~~~~E~~il~~l~~h~~i~~~~~--~~~~~~~ 79 (362)
|..+.--..++.||+|+-+.+|-.-.-... +.|+..+-...- -..-...|...-.||-+-.-+. .....+.
T Consensus 7 ~~~ge~i~~gr~LgqGgea~ly~l~e~~d~---VAKIYh~Pppa~----~aqk~a~la~~p~~p~~~~rvaWPqa~L~G~ 79 (637)
T COG4248 7 DVYGEPIPPGRPLGQGGEADLYTLGEVRDQ---VAKIYHAPPPAA----QAQKVAELAATPDAPLLNYRVAWPQATLHGG 79 (637)
T ss_pred cccCcccCCCccccCCccceeeecchhhch---hheeecCCCchH----HHHHHHHhccCCCCcchhhhhcccHHHhhCC
Confidence 344555567899999999999976433221 223444332211 1122233444444554432111 0011233
Q ss_pred CCceEEEEEEEecCCCC-HHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceE
Q 039291 80 NGEMAYNLLLEYAAGGT-LGDLIEKC----NGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFV 154 (362)
Q Consensus 80 ~~~~~~~lv~e~~~~~~-L~~~l~~~----~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~ 154 (362)
+....+-+.|..+.|.. +..+++.. ....++++.+.+.++.|+.+.+-||..|-+-+|+.++|+|+ ++.+.
T Consensus 80 ~~~~~iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lV----sd~~~ 155 (637)
T COG4248 80 RRGKVIGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLV----SDDSK 155 (637)
T ss_pred CccceeEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceee----ecCce
Confidence 44444668888887752 23333221 11237899999999999999999999999999999999999 77777
Q ss_pred EEEeecCCcccccccccCCCCCCccCCCCccCchhhc-----cccCCCcchHHHHHHHHHHHHhC-CCCCccCC----CC
Q 039291 155 AKIADLGVAKRSRHCKRQKFDPSMRGTPLYLAPETVV-----QHMQEAPSDIWALGCVVLEMLSG-RQAWVVKE----DC 224 (362)
Q Consensus 155 ~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~~l~~g-~~pf~~~~----~~ 224 (362)
|.|+|=...... .........+|...|.+||.-. +...+...|.|.||+++++++.| +.||.+-. ..
T Consensus 156 V~LVdsDsfqi~---~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap 232 (637)
T COG4248 156 VVLVDSDSFQIN---ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAP 232 (637)
T ss_pred EEEEcccceeec---cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCC
Confidence 888874432211 1122223567999999999765 33446678999999999999986 89996531 11
Q ss_pred CHHH-HHHH-------HcCCC---CCCCCC-ccCCHHHHHHHHHHhccC--CCCCCCHHH
Q 039291 225 SIDQ-LFSI-------IGDEH---SLPEIP-SRVSKEARDFLRRCFVRK--PAFRFTAEM 270 (362)
Q Consensus 225 ~~~~-~~~~-------~~~~~---~~~~~~-~~~~~~~~~li~~~l~~~--p~~R~s~~~ 270 (362)
.+.+ .+.. ..... ..-++| .-+++++.-|..+|+..- +.-|||++.
T Consensus 233 ~p~E~~Ia~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~a 292 (637)
T COG4248 233 NPLETDIAHGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKA 292 (637)
T ss_pred CcchhhhhcceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHH
Confidence 1222 1100 00011 111122 346789999999999764 568999865
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.97 E-value=2.2e-09 Score=89.88 Aligned_cols=100 Identities=27% Similarity=0.324 Sum_probs=65.9
Q ss_pred HHHHHHHHHHHHcCCCC-cccccccceeeecCCCceEEEEEEEecC--CCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHH
Q 039291 49 ASLQKEKEVFDNLNGCP-FVLECFGEEITMGENGEMAYNLLLEYAA--GGTLGDLIEKCNGNGLPEKDVRHFTRCILEGI 125 (362)
Q Consensus 49 ~~~~~E~~il~~l~~h~-~i~~~~~~~~~~~~~~~~~~~lv~e~~~--~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l 125 (362)
....+|.+.|.++.... ++.+++.+. . -+|||||++ |..+..+... .++......++.+++..+
T Consensus 53 ~~~~~E~~~L~~l~~~Gv~vP~p~~~~----~-----~~ivME~I~~~G~~~~~l~~~----~~~~~~~~~~~~~il~~~ 119 (188)
T PF01163_consen 53 EWAKKEFRNLKRLYEAGVPVPKPYDYN----R-----NVIVMEYIGEDGVPLPRLKDV----DLSPEEPKELLEEILEEI 119 (188)
T ss_dssp HHHHHHHHHHHHCCCTT-SS--EEEEE----T-----TEEEEE--EETTEEGGCHHHC----GGGGSTHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHCCccCCcEEEEe----C-----CEEEEEecCCCccchhhHHhc----cccchhHHHHHHHHHHHH
Confidence 45778999999998542 455554321 1 249999998 6666554432 133556777888888866
Q ss_pred HH-HHhCCceeCCCCCCCEEEeecCCCceEEEEeecCCcccc
Q 039291 126 GH-IHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRS 166 (362)
Q Consensus 126 ~y-LH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Dfgla~~~ 166 (362)
.. +|+.||+|+||.+.||++ +++ .+.|+|||.+...
T Consensus 120 ~~~~~~~givHGDLs~~NIlv----~~~-~~~iIDf~qav~~ 156 (188)
T PF01163_consen 120 IKMLHKAGIVHGDLSEYNILV----DDG-KVYIIDFGQAVDS 156 (188)
T ss_dssp HHHHHCTTEEESS-STTSEEE----ETT-CEEE--GTTEEET
T ss_pred HHHHHhcCceecCCChhhEEe----ecc-eEEEEecCcceec
Confidence 55 589999999999999999 443 5999999987544
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.91 E-value=1.2e-08 Score=88.15 Aligned_cols=132 Identities=23% Similarity=0.190 Sum_probs=96.7
Q ss_pred eeecceecccCceEEEEEEECCCCCCCCceeeeechhh-------------------------hhhHHHHHHHHHHHHcC
Q 039291 8 WFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEV-------------------------SASASLQKEKEVFDNLN 62 (362)
Q Consensus 8 y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~-------------------------~~~~~~~~E~~il~~l~ 62 (362)
+.++..||-|--+.||.|.+...+ ++++|.-.. -.....++|.++|.+|.
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~~g~-----~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~ 167 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDPKGR-----KVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLY 167 (304)
T ss_pred HhhccccccCccceEEEEECCCCC-----EEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhh
Confidence 467899999999999999987543 566663110 03345789999999998
Q ss_pred CC-CcccccccceeeecCCCceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCC
Q 039291 63 GC-PFVLECFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPD 141 (362)
Q Consensus 63 ~h-~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~ 141 (362)
.. -.|.+.++.- .-++|||+++|..|...- ++...+..++..|++-+.-+-..|+||+|+.+-
T Consensus 168 ~~G~~VP~P~~~n---------RHaVvMe~ieG~eL~~~r-------~~~en~~~il~~il~~~~~~~~~GiVHGDlSef 231 (304)
T COG0478 168 PEGVKVPKPIAWN---------RHAVVMEYIEGVELYRLR-------LDVENPDEILDKILEEVRKAYRRGIVHGDLSEF 231 (304)
T ss_pred hcCCCCCCccccc---------cceeeeehcccceeeccc-------CcccCHHHHHHHHHHHHHHHHHcCccccCCchh
Confidence 44 3555555422 235899999996665322 345556667777777777666999999999999
Q ss_pred CEEEeecCCCceEEEEeecCCcc
Q 039291 142 NILLVATQSGKFVAKIADLGVAK 164 (362)
Q Consensus 142 Nill~~~~~~~~~~kl~Dfgla~ 164 (362)
||++ ++++.+.++||--+.
T Consensus 232 NIlV----~~dg~~~vIDwPQ~v 250 (304)
T COG0478 232 NILV----TEDGDIVVIDWPQAV 250 (304)
T ss_pred eEEE----ecCCCEEEEeCcccc
Confidence 9999 777789999998654
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.89 E-value=6.3e-08 Score=81.73 Aligned_cols=141 Identities=16% Similarity=0.129 Sum_probs=99.3
Q ss_pred ecccCceEEEEEEECCCCCCCCceeeeechh---------hhhhHHHHHHHHHHHHcCC--CCcccccccceeeecCCCc
Q 039291 14 IGQGSFGCVFIAKPKSNSSFLPPLMAVKSAE---------VSASASLQKEKEVFDNLNG--CPFVLECFGEEITMGENGE 82 (362)
Q Consensus 14 lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~---------~~~~~~~~~E~~il~~l~~--h~~i~~~~~~~~~~~~~~~ 82 (362)
-|+||.+-|+.....+. .+.+|... +.....+.+|...+..|.. .| +.++.. .........
T Consensus 26 ~~rgG~SgV~r~~~~g~------~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvP-VP~pvf-~~~~k~~~~ 97 (216)
T PRK09902 26 YRRNGMSGVQCVERNGK------KLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVI-VPKIVF-GEAVKIEGE 97 (216)
T ss_pred cCCCCcceEEEEEeCCc------EEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCC-CCccce-eeeeccCCc
Confidence 46688888998875543 35555432 4466789999999998872 23 333331 111111223
Q ss_pred eEEEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEeecC
Q 039291 83 MAYNLLLEYAAG-GTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLG 161 (362)
Q Consensus 83 ~~~~lv~e~~~~-~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Dfg 161 (362)
..-+||+|-+.| .+|.+++....-.+.++.....++.+++..+.-||+.|+.|+|+-+.||++... ++..+.++||.
T Consensus 98 ~rA~LVTe~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~--g~~~v~lIDlE 175 (216)
T PRK09902 98 WRALLVTEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTE--GKAEAGFLDLE 175 (216)
T ss_pred eEEEEEEEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCC--CCeeEEEEEhh
Confidence 345589997753 588888876444457888888999999999999999999999999999999432 23459999998
Q ss_pred Ccc
Q 039291 162 VAK 164 (362)
Q Consensus 162 la~ 164 (362)
-++
T Consensus 176 k~r 178 (216)
T PRK09902 176 KSR 178 (216)
T ss_pred ccc
Confidence 765
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.81 E-value=1.7e-07 Score=79.49 Aligned_cols=139 Identities=19% Similarity=0.238 Sum_probs=85.4
Q ss_pred CCceeecceecccCceEEEEEEECCCCCCCCceeeeechhhhhhH------------HHHHHHHHHHHcC--CCCccccc
Q 039291 5 GTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVSASA------------SLQKEKEVFDNLN--GCPFVLEC 70 (362)
Q Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~~~~~------------~~~~E~~il~~l~--~h~~i~~~ 70 (362)
+++|...+.+-......|.+..-.+ .++.+|........ ...+++..+.++. +......+
T Consensus 30 ~~~~~~~kv~k~~~r~~ValIei~~------~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~ 103 (229)
T PF06176_consen 30 DNNYKIIKVFKNTKRNYVALIEIDG------KKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADP 103 (229)
T ss_pred hCCceEEEeecCCCccEEEEEEECC------cEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccc
Confidence 4566777777776666666654433 25677776543221 1223333333332 23333333
Q ss_pred ccceeeecCCCceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCC
Q 039291 71 FGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQS 150 (362)
Q Consensus 71 ~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~ 150 (362)
+.+..-....-...++++|||++|..|.++.. +++. +...+++++.-||+.|++|+|..|.|+++ .
T Consensus 104 yl~~ekk~~~~~~~~~ll~EYIeG~~l~d~~~------i~e~----~~~ki~~~ikqlH~~G~~HGD~hpgNFlv----~ 169 (229)
T PF06176_consen 104 YLAAEKKIFRYTSSYVLLMEYIEGVELNDIED------IDED----LAEKIVEAIKQLHKHGFYHGDPHPGNFLV----S 169 (229)
T ss_pred eeeeeeeeccceeEEEEEEEEecCeecccchh------cCHH----HHHHHHHHHHHHHHcCCccCCCCcCcEEE----E
Confidence 33332222233344668999999988876542 3332 44567788999999999999999999999 4
Q ss_pred CceEEEEeecCCcc
Q 039291 151 GKFVAKIADLGVAK 164 (362)
Q Consensus 151 ~~~~~kl~Dfgla~ 164 (362)
+++ ++++||+..+
T Consensus 170 ~~~-i~iID~~~k~ 182 (229)
T PF06176_consen 170 NNG-IRIIDTQGKR 182 (229)
T ss_pred CCc-EEEEECcccc
Confidence 333 8999998654
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=98.57 E-value=2.5e-07 Score=93.90 Aligned_cols=208 Identities=20% Similarity=0.248 Sum_probs=139.4
Q ss_pred HHHHHHHHHHcCCCCcccccccceeeecCCCceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh
Q 039291 51 LQKEKEVFDNLNGCPFVLECFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHD 130 (362)
Q Consensus 51 ~~~E~~il~~l~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~ 130 (362)
...|...+.++. |+|++.++.+.......+ ....+..++|...++...++. -+..+..+.+.+..++++||.|+|+
T Consensus 229 ~E~e~~~l~k~~-~~n~~~~~~~~le~~~~g-~~~~v~~~~~s~~~~~~~~q~--v~~i~~~~~r~~~~~~~~GL~~~h~ 304 (1351)
T KOG1035|consen 229 TEIELESLSKIA-HDNLGGYFVYGLERLFRG-IVLDVLQEICSKVELRSLLQS--VGSIPLETLRILHQKLLEGLAYLHS 304 (1351)
T ss_pred HHHHHHHHHhhc-cccccceeEEeehhhcch-HHHHHHHhhcCccchHHHHhh--ccccCHHHHHHHHHHHhhhHHHHHH
Confidence 445666677777 899999887665432222 123356789999999999987 4458999999999999999999999
Q ss_pred CCceeCCCCCCCEEEeecCCCceEEEEe--ecCCcccccccccCCCCCCccCCCCccCchhhccccCCCc--chHHHHHH
Q 039291 131 SGYVHCDVKPDNILLVATQSGKFVAKIA--DLGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAP--SDIWALGC 206 (362)
Q Consensus 131 ~~ivH~Dlkp~Nill~~~~~~~~~~kl~--Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~--~DiwslG~ 206 (362)
....|.-+...-..- ...++.+.+.+. ||+.+......... ....-+..+.++|......+..+ .|+|.+|.
T Consensus 305 ~~l~~v~L~~s~~~~-~~~~~e~~~~~sl~~~~ss~~l~d~~~~---~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgl 380 (1351)
T KOG1035|consen 305 LSLEHVVLSASSSKE-STVDGEGVVAISLSDFDSSKPLPDNEKS---FSDLLAEIRNADEDLKENTAKKSRLTDLWCLGL 380 (1351)
T ss_pred hccceeEEecccccc-cccCccceeecchhhhcccccCCCcccc---hhhcCccccccccccccccchhhhhhHHHHHHH
Confidence 854444333321111 112455666666 88877655443222 23445666888888877666554 69999999
Q ss_pred HHHHHHhCCCCCccCCCCCHHHHHHHHcCCCCCCCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCccCc
Q 039291 207 VVLEMLSGRQAWVVKEDCSIDQLFSIIGDEHSLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGV 280 (362)
Q Consensus 207 il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~~~~ 280 (362)
.+..+..|..+-... ..... -.+........+.+.+|+..++++|+++.+++.|+|.+..
T Consensus 381 l~~~~~~~~~i~~~~-----~~~~~---------~l~~~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~~f~~~~ 440 (1351)
T KOG1035|consen 381 LLLQLSQGEDISEKS-----AVPVS---------LLDVLSTSELLDALPKCLDEDSEERLSALELLTHPFLRFP 440 (1351)
T ss_pred HHhhhhhcCcccccc-----cchhh---------hhccccchhhhhhhhhhcchhhhhccchhhhhhchhcccc
Confidence 999998876432100 00000 0111122277889999999999999999999999998653
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.47 E-value=1.7e-06 Score=75.27 Aligned_cols=81 Identities=21% Similarity=0.203 Sum_probs=55.2
Q ss_pred cceecccCceEEEEEEECCCCCCCCceeeeechhhh-hhHHHHHHHHHHHHcCCCC-cccccccceeeecCCCceEEEEE
Q 039291 11 GRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVS-ASASLQKEKEVFDNLNGCP-FVLECFGEEITMGENGEMAYNLL 88 (362)
Q Consensus 11 ~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~~-~~~~~~~E~~il~~l~~h~-~i~~~~~~~~~~~~~~~~~~~lv 88 (362)
++.|+.|..+.||++...+ + .+++|..... ....+.+|..+++.|..+. .+.+++.... ........+++
T Consensus 2 i~~l~~G~~n~~~~v~~~~-~-----~~vlK~~~~~~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~--~~~~~~~~~~~ 73 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD-G-----RYVLKFYRPPDAAERLRREAAVLRQLAEHGIPVPRVLAFDT--SDEFNGFPYLL 73 (239)
T ss_dssp EEEEEESSSSEEEEEEETT-S-----EEEEEEESSHHHHHHHHHHHHHHHHHHHTTSBS--EEEEEE--ETEETSEEEEE
T ss_pred CccCCCCCeeeEEEEEECC-c-----EEEEEEeCCCCCHHHHHHHHHHHHHHHhcCCCCceEEeecc--cccccccceEE
Confidence 4689999999999999777 4 4677776544 5667889999999887442 2444443221 11222236799
Q ss_pred EEecCCCCHHH
Q 039291 89 LEYAAGGTLGD 99 (362)
Q Consensus 89 ~e~~~~~~L~~ 99 (362)
|++++|..+..
T Consensus 74 ~~~i~g~~~~~ 84 (239)
T PF01636_consen 74 MEYIPGRPLDD 84 (239)
T ss_dssp EEEESSEEHHH
T ss_pred EEEeccccccc
Confidence 99999988777
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.39 E-value=2.9e-06 Score=81.75 Aligned_cols=140 Identities=20% Similarity=0.238 Sum_probs=86.7
Q ss_pred ceecccCceEEEEEEECCCCCCCCceeeeechhhhhhHH-----------------------------------------
Q 039291 12 RVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVSASAS----------------------------------------- 50 (362)
Q Consensus 12 ~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~~~~~~----------------------------------------- 50 (362)
.-|+.++-|.||+|+.+. | ..||+|...+.....
T Consensus 131 ~PiAsASIaQVH~A~L~s-G----~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~E 205 (517)
T COG0661 131 EPIASASIAQVHRAVLKS-G----EEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREE 205 (517)
T ss_pred CchhhhhHhhheeEEecC-C----CEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHH
Confidence 568899999999999987 3 368888754432221
Q ss_pred --HHHHHHHHHHcC----CCCcccccccceeeecCCCceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHH
Q 039291 51 --LQKEKEVFDNLN----GCPFVLECFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEG 124 (362)
Q Consensus 51 --~~~E~~il~~l~----~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~ 124 (362)
+.+|+..+.++. +.+++. +-.++... ...-.|+|||++|..+.+...... ..++...+...+.++.
T Consensus 206 lDy~~EA~n~~~~~~nf~~~~~v~-VP~V~we~----t~~~VLtmE~i~Gi~i~d~~~l~~-~g~d~k~ia~~~~~~f-- 277 (517)
T COG0661 206 LDYRREAANAERFRENFKDDPDVY-VPKVYWEY----TTRRVLTMEWIDGIKISDIAALKS-AGIDRKELAELLVRAF-- 277 (517)
T ss_pred hCHHHHHHHHHHHHHHcCCCCCeE-eceeehhc----cCCcEEEEEeeCCEecccHHHHHh-cCCCHHHHHHHHHHHH--
Confidence 223444444332 233331 11111111 111249999999999988753322 3366444433332221
Q ss_pred HHHHHhCCceeCCCCCCCEEEeecCCCceEEEEeecCCcccccc
Q 039291 125 IGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRH 168 (362)
Q Consensus 125 l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Dfgla~~~~~ 168 (362)
+..+=..|++|.|..|.||++ +.++.+.+.|||+......
T Consensus 278 ~~q~~~dgffHaDpHpGNi~v----~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 278 LRQLLRDGFFHADPHPGNILV----RSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred HHHHHhcCccccCCCccceEE----ecCCcEEEEcCcceecCCH
Confidence 234445899999999999999 7778899999999865544
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.33 E-value=6.6e-06 Score=71.45 Aligned_cols=72 Identities=14% Similarity=0.142 Sum_probs=44.5
Q ss_pred ceecccCceEEEEEEECCCCCCCCceeeeechhhh-hhHHHHHHHHHHHHcCCCCc-ccccccceeeecCCCceEEEEEE
Q 039291 12 RVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVS-ASASLQKEKEVFDNLNGCPF-VLECFGEEITMGENGEMAYNLLL 89 (362)
Q Consensus 12 ~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~~-~~~~~~~E~~il~~l~~h~~-i~~~~~~~~~~~~~~~~~~~lv~ 89 (362)
..||+|..+.||+.. .+ .+++|..... ....+.+|.++++.+....- +.+.+.+.. . ...+.+||
T Consensus 7 ~~i~~G~t~~~y~~~---~~-----~~VlR~~~~~~~~~~i~~E~~~l~~l~~~glpvP~~~~~~~----~-~~~~glv~ 73 (226)
T TIGR02172 7 TQTGEGGNGESYTHK---TG-----KWMLKLYNPGFDKETIKREFDASRKVFSLGIPTPHPFDLVE----D-GGRLGLIY 73 (226)
T ss_pred eeecCCCCcceeEec---CC-----CEEEEeCCCCCCHHHHHHHHHHHHHHHHcCCCCCceEEEEe----c-CCeeeeee
Confidence 678999999999842 22 2345544332 34457899999999874322 334443221 1 22256899
Q ss_pred EecCCCC
Q 039291 90 EYAAGGT 96 (362)
Q Consensus 90 e~~~~~~ 96 (362)
|+++|.+
T Consensus 74 e~i~G~~ 80 (226)
T TIGR02172 74 ELIVGKR 80 (226)
T ss_pred eecCCcc
Confidence 9999863
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.27 E-value=8.6e-08 Score=91.53 Aligned_cols=238 Identities=19% Similarity=0.167 Sum_probs=149.1
Q ss_pred cceecccCceEEEEEEECCCCCCCCceeeeechhhhhhHHHHHHHHHHHHcCCCCc-ccccccceeeecCCCceEEEEEE
Q 039291 11 GRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVSASASLQKEKEVFDNLNGCPF-VLECFGEEITMGENGEMAYNLLL 89 (362)
Q Consensus 11 ~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~~~~~~~~~E~~il~~l~~h~~-i~~~~~~~~~~~~~~~~~~~lv~ 89 (362)
.-.+++|+++++++.+...+.. ...+-+... -...-++++|.+++ ||| .+..++ ..+.+....+.+
T Consensus 247 fh~fvK~altknpKkRptaekl-----L~h~fvs~~--l~~rl~~eLLdK~n-~P~~~v~~~~-----d~~~E~~~~i~~ 313 (829)
T KOG0576|consen 247 FHNFVKGALTKNPKKRPTAEKL-----LQHPFVSQT--LSRRLAIELLDKVN-NPNPVVRYLE-----DYDGEDYLWIPM 313 (829)
T ss_pred HHHHHHHHhcCCCccCCChhhh-----eeceeeccc--hhhHHHHHHHHHcc-CCCCcccccc-----cCCcccccchhh
Confidence 4557899999999998776642 234433333 33456788899999 788 433332 234455667899
Q ss_pred EecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEeecCCcccccc
Q 039291 90 EYAAGG-TLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRH 168 (362)
Q Consensus 90 e~~~~~-~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Dfgla~~~~~ 168 (362)
+++.++ +....... ..-.+.+-+...+.+.-+++++|+|+.-=+|+| ||+..+ ...+..||+.......
T Consensus 314 ~i~s~~rs~~~~~~~-se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s~-----~~~~~~~~~v~~~L~~ 383 (829)
T KOG0576|consen 314 RICSTGRSSALEMTV-SEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGSE-----EEVKLLDFAVPPQLTR 383 (829)
T ss_pred hhhcCCccccccCCh-hhHhhhhhhhhhhhhhhcccccccccccccCcc----cccccc-----cccccccccCCcccCc
Confidence 999887 22221111 011244556666777788899999998779999 888732 4588999998865554
Q ss_pred cccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHHcCCCCCCCCCc--cC
Q 039291 169 CKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEHSLPEIPS--RV 246 (362)
Q Consensus 169 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~--~~ 246 (362)
.. ......+|+.++|||+.....+....|.|++|+--.++--|-+|-.... .. ...+.....-+.+.. ..
T Consensus 384 ~~---~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~~P~----~~-~~~~g~~p~s~~L~~~~aw 455 (829)
T KOG0576|consen 384 TM---KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRSSPP----AV-LPMIGNGPNSPMLTDKSAW 455 (829)
T ss_pred cc---ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCCCCc----cc-cCCCCCCCCccccchhhhc
Confidence 32 3356789999999999999999999999999987677766666542210 00 000111110000000 00
Q ss_pred C-HHHHHHHHHHhccCCCCCCCHHHHhcCCCccC
Q 039291 247 S-KEARDFLRRCFVRKPAFRFTAEMLLDDPFVKG 279 (362)
Q Consensus 247 ~-~~~~~li~~~l~~~p~~R~s~~~~l~~p~~~~ 279 (362)
+ ..-+++...|+..-|..|+....++.|.+|.+
T Consensus 456 ~~~~~~~~~~~~~~g~P~~pkv~mgacfsKvfng 489 (829)
T KOG0576|consen 456 SPVFHRDFPAPCLNGLPPTPKVHMGACFSKVFNG 489 (829)
T ss_pred CcccccCCcccccCCCCCCCcchhhHHHHHHhcc
Confidence 1 11113566677777777777777776655544
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.20 E-value=8.2e-06 Score=66.41 Aligned_cols=126 Identities=23% Similarity=0.289 Sum_probs=86.2
Q ss_pred ecceecccCceEEEEEEECCCCCCCCceeeeechh-hhhhHHHHHHHHHHHHcCCCCcccccccceeeecCCCceEEEEE
Q 039291 10 RGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAE-VSASASLQKEKEVFDNLNGCPFVLECFGEEITMGENGEMAYNLL 88 (362)
Q Consensus 10 ~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~-~~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~~~~~~~lv 88 (362)
..+.||+|..|.||++.++.. .+++|... ......+..|+++|..+++...-.++|.+ +. -.+.
T Consensus 26 v~~~L~KG~~s~Vyl~~~~~~------~~a~Kvrr~ds~r~~l~kEakiLeil~g~~~~p~vy~y----g~-----~~i~ 90 (201)
T COG2112 26 VEKELAKGTTSVVYLGEWRGG------EVALKVRRRDSPRRNLEKEAKILEILAGEGVTPEVYFY----GE-----DFIR 90 (201)
T ss_pred hhhhhhcccccEEEEeeccCc------eEEEEEecCCcchhhHHHHHHHHHHhhhcCCCceEEEe----ch-----hhhh
Confidence 358899999999999998764 46666654 34567799999999999853333333332 11 1256
Q ss_pred EEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCC-CC-CEEEeecCCCceEEEEeecCCcc
Q 039291 89 LEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVK-PD-NILLVATQSGKFVAKIADLGVAK 164 (362)
Q Consensus 89 ~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlk-p~-Nill~~~~~~~~~~kl~Dfgla~ 164 (362)
|||+.|..|.++-.. .+. +-+..+++.---|-..||-|..|. |. ||++ +. ..+.|+||..|+
T Consensus 91 me~i~G~~L~~~~~~-----~~r----k~l~~vlE~a~~LD~~GI~H~El~~~~k~vlv----~~-~~~~iIDFd~At 154 (201)
T COG2112 91 MEYIDGRPLGKLEIG-----GDR----KHLLRVLEKAYKLDRLGIEHGELSRPWKNVLV----ND-RDVYIIDFDSAT 154 (201)
T ss_pred hhhhcCcchhhhhhc-----ccH----HHHHHHHHHHHHHHHhccchhhhcCCceeEEe----cC-CcEEEEEccchh
Confidence 999999888765543 122 233445566555778899999997 43 5555 22 258999999886
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.19 E-value=1.9e-05 Score=75.93 Aligned_cols=81 Identities=25% Similarity=0.351 Sum_probs=56.9
Q ss_pred EEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEeecCCcc
Q 039291 85 YNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAK 164 (362)
Q Consensus 85 ~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Dfgla~ 164 (362)
-.|+|||++|..+.++-.- ....++...+..-+.+... .-|=..|++|+|-.|.||++..+...+..+.+.|||+..
T Consensus 277 RVLtME~~~G~~i~Dl~~i-~~~gi~~~~i~~~l~~~~~--~qIf~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~ 353 (538)
T KOG1235|consen 277 RVLTMEYVDGIKINDLDAI-DKRGISPHDILNKLVEAYL--EQIFKTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYA 353 (538)
T ss_pred eEEEEEecCCccCCCHHHH-HHcCCCHHHHHHHHHHHHH--HHHHhcCCccCCCCCCcEEEecCCCCCccEEEEcccccc
Confidence 3499999999988665322 2334777655544443322 234457899999999999997665567889999999986
Q ss_pred cccc
Q 039291 165 RSRH 168 (362)
Q Consensus 165 ~~~~ 168 (362)
....
T Consensus 354 ~is~ 357 (538)
T KOG1235|consen 354 VISH 357 (538)
T ss_pred cccH
Confidence 5544
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.14 E-value=2.4e-05 Score=68.91 Aligned_cols=77 Identities=21% Similarity=0.139 Sum_probs=47.4
Q ss_pred eecccCc-eEEEEEEECCCCCCCCceeeeechhhhhhHHHHHHHHHHHHcCCCCcccccccceeeecCCCceEEEEEEEe
Q 039291 13 VIGQGSF-GCVFIAKPKSNSSFLPPLMAVKSAEVSASASLQKEKEVFDNLNGCPFVLECFGEEITMGENGEMAYNLLLEY 91 (362)
Q Consensus 13 ~lG~G~~-g~V~~a~~~~~~~~~~~~~~~K~~~~~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~ 91 (362)
.|-.|.. ..||++...+ . .+.+|.........+.+|+++++.+..+--+.+++.... .. ...++|||+
T Consensus 5 ~~~~g~~~~~v~~~~~~~-~-----~~~vk~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~----~~-~~~~lv~e~ 73 (244)
T cd05150 5 RVTEGQSGATVYRLDGKN-P-----GLYLKIAPSGPTYELEREAERLRWLAGKLPVPEVIDYGS----DD-GRAWLLTSA 73 (244)
T ss_pred ecCCCCCcCeEEEEcCCC-C-----cEEEEecCCCcccchHHHHHHHHHHHhcCCCCeEEEEEe----cC-CccEEEEEe
Confidence 3444555 7889996533 2 466776654334567789999999875533444443221 11 124589999
Q ss_pred cCCCCHHHH
Q 039291 92 AAGGTLGDL 100 (362)
Q Consensus 92 ~~~~~L~~~ 100 (362)
++|.+|...
T Consensus 74 i~G~~l~~~ 82 (244)
T cd05150 74 VPGVPAAAL 82 (244)
T ss_pred eCCccHhHh
Confidence 999877643
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.12 E-value=6.5e-05 Score=63.19 Aligned_cols=99 Identities=20% Similarity=0.235 Sum_probs=77.9
Q ss_pred HHHHHHHHHcCCCCcccccccceeeecCCCceEEEEEEEecCCCCHHHH---HHHhcCCCCCHHHHHHHHHHHHHHHHHH
Q 039291 52 QKEKEVFDNLNGCPFVLECFGEEITMGENGEMAYNLLLEYAAGGTLGDL---IEKCNGNGLPEKDVRHFTRCILEGIGHI 128 (362)
Q Consensus 52 ~~E~~il~~l~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~---l~~~~~~~l~~~~~~~i~~ql~~~l~yL 128 (362)
..|.-+++.+.+.+++.+++|.+-. .++.||...+++... +.. -...++..+.+|+.++++.+.+|
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG~---------~~v~E~~~~~~~~~~~~~l~~--~~~~~w~~R~~iA~~lL~~l~~l 75 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCGR---------FYVVEYVGAGSLYGIYRPLSQ--FLQSPWEQRAKIALQLLELLEEL 75 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECCC---------EEEEEeecCcccccccccccc--ccccCHHHHHHHHHHHHHHHHHH
Confidence 3578889999977899999997731 368999987766421 111 11268999999999999999999
Q ss_pred Hh---CCceeCCCCCCCEEEeecCCCceEEEEeecCCccc
Q 039291 129 HD---SGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKR 165 (362)
Q Consensus 129 H~---~~ivH~Dlkp~Nill~~~~~~~~~~kl~Dfgla~~ 165 (362)
+. ..+.-.|++++|+-+ +.++.+|++|...+..
T Consensus 76 ~~~~~~~~~lcDv~~~nfgv----~~~~~lk~iDld~v~~ 111 (188)
T PF12260_consen 76 DHGPLGFFYLCDVSPDNFGV----NDDGRLKLIDLDDVFV 111 (188)
T ss_pred hcCCCCcEEEeecchHHeEE----eCCCcEEEEechhcch
Confidence 87 458889999999999 6777899999987643
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.12 E-value=3.1e-05 Score=66.65 Aligned_cols=133 Identities=22% Similarity=0.193 Sum_probs=84.3
Q ss_pred eecccCceEEEEEEECCCCCCCCceeeeechhhhhh---------------------------HHHHHHHHHHHHcCC-C
Q 039291 13 VIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVSAS---------------------------ASLQKEKEVFDNLNG-C 64 (362)
Q Consensus 13 ~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~~~~---------------------------~~~~~E~~il~~l~~-h 64 (362)
.|..|--+.||+|..... ..+++|+...... .=..+|...|+++.. +
T Consensus 55 ~istGKEA~Vy~a~~~~~-----~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAG 129 (268)
T COG1718 55 CISTGKEANVYLAETGDG-----RYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAG 129 (268)
T ss_pred eecCCcceEEEeeccCCC-----ceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcC
Confidence 567788889999976432 2466666432200 012357777777652 1
Q ss_pred CcccccccceeeecCCCceEEEEEEEecCCCCH-HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCceeCCCCCCC
Q 039291 65 PFVLECFGEEITMGENGEMAYNLLLEYAAGGTL-GDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHD-SGYVHCDVKPDN 142 (362)
Q Consensus 65 ~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L-~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~-~~ivH~Dlkp~N 142 (362)
-.+.+.+... . -.|||||+..... .-.|+ .-++...++..+..++++.+.-|-. .++||+||+.-|
T Consensus 130 VrvP~Pi~~~--------~-nVLvMEfIg~~g~pAP~Lk---Dv~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyN 197 (268)
T COG1718 130 VRVPEPIAFR--------N-NVLVMEFIGDDGLPAPRLK---DVPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYN 197 (268)
T ss_pred CCCCCceeec--------C-CeEEEEeccCCCCCCCCcc---cCCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhh
Confidence 2333333321 1 2389999965311 11111 1224444788899999999987765 999999999999
Q ss_pred EEEeecCCCceEEEEeecCCccccc
Q 039291 143 ILLVATQSGKFVAKIADLGVAKRSR 167 (362)
Q Consensus 143 ill~~~~~~~~~~kl~Dfgla~~~~ 167 (362)
||+ . .+.+.|+|||-|....
T Consensus 198 iL~----~-~~~p~iID~~QaV~~~ 217 (268)
T COG1718 198 ILV----H-DGEPYIIDVSQAVTID 217 (268)
T ss_pred eEE----E-CCeEEEEECccccccC
Confidence 999 4 5569999999875443
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.99 E-value=6.6e-05 Score=77.64 Aligned_cols=82 Identities=13% Similarity=0.139 Sum_probs=50.2
Q ss_pred cceecccCceEEEEEEECCCCCCCCceeeeechhh----hhhHHHHHHHHHHHHcCCCCcc--cccccceeeecCCCceE
Q 039291 11 GRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEV----SASASLQKEKEVFDNLNGCPFV--LECFGEEITMGENGEMA 84 (362)
Q Consensus 11 ~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~----~~~~~~~~E~~il~~l~~h~~i--~~~~~~~~~~~~~~~~~ 84 (362)
.+.|+.|.++.+|+......+. ...+++|.... .....+.+|.++|+.|..|+++ .+++..+... .....
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~--~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~--~v~G~ 118 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGS--VKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDA--SVIGT 118 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCc--ceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCC--CcCCC
Confidence 5778999999999987654321 12344444322 1234688999999999755554 4444432211 11122
Q ss_pred EEEEEEecCCCC
Q 039291 85 YNLLLEYAAGGT 96 (362)
Q Consensus 85 ~~lv~e~~~~~~ 96 (362)
.++||||++|..
T Consensus 119 ~flVME~v~G~~ 130 (822)
T PLN02876 119 AFYIMEYLEGRI 130 (822)
T ss_pred ceEEEEecCCcc
Confidence 458999999864
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.99 E-value=0.00019 Score=60.77 Aligned_cols=130 Identities=22% Similarity=0.324 Sum_probs=85.3
Q ss_pred cceecccCceEEEEEEECCCCCCCCceeeeechhhh-------------------hhHHHHHHHHHHHHcC-----CCCc
Q 039291 11 GRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVS-------------------ASASLQKEKEVFDNLN-----GCPF 66 (362)
Q Consensus 11 ~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~~-------------------~~~~~~~E~~il~~l~-----~h~~ 66 (362)
...||+|+.-.||.--+..+ ..+|..... ..+...+|+.-...+. .+.+
T Consensus 6 ~~~i~~G~~R~cy~HP~dp~-------~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~ 78 (199)
T PF10707_consen 6 SDLIAQGGERDCYQHPDDPN-------LCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSH 78 (199)
T ss_pred CcccccCCCceEEECCCCCC-------eEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccc
Confidence 46799999999998643332 133332222 2455667777666555 2567
Q ss_pred ccccccceeeecCCCceEEEEEEEecCC------CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCC
Q 039291 67 VLECFGEEITMGENGEMAYNLLLEYAAG------GTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKP 140 (362)
Q Consensus 67 i~~~~~~~~~~~~~~~~~~~lv~e~~~~------~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp 140 (362)
|.+++|...+. ....+|+|.+.. .+|.++++. ..+++ .... .|-+-.+||-+++|+.+|++|
T Consensus 79 i~r~~G~veT~-----~G~Glv~e~I~d~dG~~s~TL~~~l~~---~~~~~-~~~~---~L~~f~~~l~~~~Iv~~dl~~ 146 (199)
T PF10707_consen 79 IPRFYGFVETN-----LGLGLVVELIRDADGNISPTLEDYLKE---GGLTE-ELRQ---ALDEFKRYLLDHHIVIRDLNP 146 (199)
T ss_pred cccEeEEEecC-----CceEEEEEEEECCCCCcCccHHHHHHc---CCccH-HHHH---HHHHHHHHHHHcCCeecCCCc
Confidence 88888865432 224577776543 367888854 33666 3333 333445788999999999999
Q ss_pred CCEEEeecCCCceEEEEee
Q 039291 141 DNILLVATQSGKFVAKIAD 159 (362)
Q Consensus 141 ~Nill~~~~~~~~~~kl~D 159 (362)
.||++....++...+.|+|
T Consensus 147 ~NIv~~~~~~~~~~lvlID 165 (199)
T PF10707_consen 147 HNIVVQRRDSGEFRLVLID 165 (199)
T ss_pred ccEEEEecCCCceEEEEEe
Confidence 9999988776666788888
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.95 E-value=0.00014 Score=61.18 Aligned_cols=129 Identities=21% Similarity=0.288 Sum_probs=89.3
Q ss_pred CCceeecceecccCc-eEEEEEEECCCCCCCCceeeeechhh------------------------hhhHHHHHHHHHHH
Q 039291 5 GTSWFRGRVIGQGSF-GCVFIAKPKSNSSFLPPLMAVKSAEV------------------------SASASLQKEKEVFD 59 (362)
Q Consensus 5 ~~~y~~~~~lG~G~~-g~V~~a~~~~~~~~~~~~~~~K~~~~------------------------~~~~~~~~E~~il~ 59 (362)
+..++.++.||.|.- |.||+++..+. .+|+|.... ....-+..|.+...
T Consensus 36 ~~~I~flefLg~g~~~~~V~kv~I~g~------~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfg 109 (207)
T PF13095_consen 36 GDDIEFLEFLGHGSHDGYVFKVEIDGR------IYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFG 109 (207)
T ss_pred CCcEeeeeecCCCCceeEEEEEEECCe------EEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhH
Confidence 467888999999999 99999987664 456665100 01224678888887
Q ss_pred HcCC--CCcc--cccccceeeecC-------------CCceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHH
Q 039291 60 NLNG--CPFV--LECFGEEITMGE-------------NGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCIL 122 (362)
Q Consensus 60 ~l~~--h~~i--~~~~~~~~~~~~-------------~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~ 122 (362)
+|+. +.++ ++++++.....+ .....+.||-||.+... .+.... +.+|.
T Consensus 110 RLke~~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~-----------~~~~~~----~~~~~ 174 (207)
T PF13095_consen 110 RLKEAGREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP-----------PLQIRD----IPQML 174 (207)
T ss_pred HHHhccccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc-----------ccchhH----HHHHH
Confidence 7763 3445 899987654310 11234557888876533 133333 45677
Q ss_pred HHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEeecCCc
Q 039291 123 EGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVA 163 (362)
Q Consensus 123 ~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Dfgla 163 (362)
+-+.-+|..||+-+|+++.|..= -+|+|||.+
T Consensus 175 ~dl~~~~k~gI~~~Dv~~~ny~~---------G~lvDfs~~ 206 (207)
T PF13095_consen 175 RDLKILHKLGIVPRDVKPRNYRG---------GKLVDFSSS 206 (207)
T ss_pred HHHHHHHHCCeeeccCccccccC---------CEEEecccC
Confidence 77889999999999999999874 479999964
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=97.95 E-value=1.7e-06 Score=90.10 Aligned_cols=209 Identities=14% Similarity=-0.004 Sum_probs=140.4
Q ss_pred HHHHcCCCCcccccccceeeecCCCceEEEEEEEecCCCCHHHHHHHhc-C-CCCCHHHHHHHHHHHHHHHHHHHhC---
Q 039291 57 VFDNLNGCPFVLECFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCN-G-NGLPEKDVRHFTRCILEGIGHIHDS--- 131 (362)
Q Consensus 57 il~~l~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~-~~l~~~~~~~i~~ql~~~l~yLH~~--- 131 (362)
.++.+. |+++...+..... ... ...+..++|+.+|.+++.|-+.. . ..+++.-+...-.+.+.+..-+|+.
T Consensus 1282 e~~~~~-h~~~~~~p~rI~p-s~s--~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tnl 1357 (2724)
T KOG1826|consen 1282 ELREAK-HYLTEVDPLRIPP-SES--TEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTNL 1357 (2724)
T ss_pred hhhhhh-ceeeecccccCCC-CCC--hHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcccC
Confidence 344455 7888766654332 222 22347999999999999886521 1 2244444444444447777777764
Q ss_pred --CceeCCCCCCCEEEeecCCCceEEEEeecCCcccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHH
Q 039291 132 --GYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVL 209 (362)
Q Consensus 132 --~ivH~Dlkp~Nill~~~~~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ 209 (362)
-.+|+++|+-|.++ ..+.+++++++|+.+...+ .........+++.|++|++...-.++.++|+|..|+-+|
T Consensus 1358 g~T~v~~~Lkf~lpmI----Vtny~v~~gk~gLdKIknp--~~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly 1431 (2724)
T KOG1826|consen 1358 GNTNVSKSLKFTLPMI----VTNYNVKLGKGGLDKIKNP--VLSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLY 1431 (2724)
T ss_pred Cccchhhhhhhhccce----ecCCcccccccccccccCc--hHhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHH
Confidence 27899999999999 6777899999999872222 222224567888999999888778888899999999999
Q ss_pred HHHhCCCCCccCCCCCHHHHHHHHcCCCCCCCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCccC
Q 039291 210 EMLSGRQAWVVKEDCSIDQLFSIIGDEHSLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKG 279 (362)
Q Consensus 210 ~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~~~ 279 (362)
....|..+|... .....+.+.++....+++...|.++......+|-+.-..||.....+.-+.|.-
T Consensus 1432 ~rs~~n~~fi~f----lq~~Lkgiidn~tf~sIe~l~pgdaNve~~~~Ll~K~~~rp~q~isls~d~~a~ 1497 (2724)
T KOG1826|consen 1432 LRSDGNAYFIFF----LQPALKGIIDNHTFFSIEKLKPGDANVEALHRLLWKYMERPGQYISLSRDHFAV 1497 (2724)
T ss_pred HHhcccHHHHHH----HHHHHcCcccccccccccccCCCcccHHHHHHHHHHhhhcchhhhhcccccccc
Confidence 999998877321 112222333444444555555566666666667777788998888887766643
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.86 E-value=0.00015 Score=63.47 Aligned_cols=30 Identities=23% Similarity=0.482 Sum_probs=24.7
Q ss_pred CCceeCCCCCCCEEEeecCCCceEEEEeecCCcc
Q 039291 131 SGYVHCDVKPDNILLVATQSGKFVAKIADLGVAK 164 (362)
Q Consensus 131 ~~ivH~Dlkp~Nill~~~~~~~~~~kl~Dfgla~ 164 (362)
.+++|+|+.+.||++ ++....-|+||+.+.
T Consensus 164 ~~l~HGD~~~~Nvlv----~~~~i~giIDw~~a~ 193 (235)
T cd05155 164 PVWFHGDLAPGNLLV----QDGRLSAVIDFGCLG 193 (235)
T ss_pred ceEEeCCCCCCcEEE----ECCCEEEEEeCcccC
Confidence 358999999999999 555566799999763
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.77 E-value=4.7e-05 Score=67.96 Aligned_cols=133 Identities=16% Similarity=0.190 Sum_probs=91.4
Q ss_pred CCceeecceecccCceEEEEEEECCCCCCCCceeeeechhh----------h---------------hhHHHHHHHHHHH
Q 039291 5 GTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEV----------S---------------ASASLQKEKEVFD 59 (362)
Q Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~----------~---------------~~~~~~~E~~il~ 59 (362)
+.=+.++..||-|--+.||.+.+...+. .++|.-.. . ..-...+|...|+
T Consensus 91 ~~v~svGnqIGVGKESDIY~v~d~~G~~-----~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmk 165 (465)
T KOG2268|consen 91 GSVESVGNQIGVGKESDIYVVADEEGNP-----LILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMK 165 (465)
T ss_pred chhhhhccccccccccceEEEecCCCCc-----hhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHH
Confidence 3457789999999999999998875432 33432110 0 1123568999999
Q ss_pred HcCCCCc-ccccccceeeecCCCceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCC
Q 039291 60 NLNGCPF-VLECFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDV 138 (362)
Q Consensus 60 ~l~~h~~-i~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dl 138 (362)
.|..|.. |.+.++.. .-|+|||++.|..|.+.-+- .+.. .+...+..-+--|-.+|+||+|.
T Consensus 166 aL~e~gfpVPkpiD~~---------RH~Vvmelv~g~Pl~~v~~v-----~d~~---~ly~~lm~~Iv~la~~GlIHgDF 228 (465)
T KOG2268|consen 166 ALYERGFPVPKPIDHN---------RHCVVMELVDGYPLRQVRHV-----EDPP---TLYDDLMGLIVRLANHGLIHGDF 228 (465)
T ss_pred HHHHcCCCCCCccccc---------ceeeHHHhhcccceeeeeec-----CChH---HHHHHHHHHHHHHHHcCceeccc
Confidence 9986543 33343322 24699999999888765432 3333 34445555567788999999999
Q ss_pred CCCCEEEeecCCCceEEEEeecCCc
Q 039291 139 KPDNILLVATQSGKFVAKIADLGVA 163 (362)
Q Consensus 139 kp~Nill~~~~~~~~~~kl~Dfgla 163 (362)
.--||++ .+...++++||--.
T Consensus 229 NEFNimv----~dd~~i~vIDFPQm 249 (465)
T KOG2268|consen 229 NEFNIMV----KDDDKIVVIDFPQM 249 (465)
T ss_pred chheeEE----ecCCCEEEeechHh
Confidence 9999999 66677999999743
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.68 E-value=0.00073 Score=61.28 Aligned_cols=80 Identities=15% Similarity=0.086 Sum_probs=51.3
Q ss_pred ecceecccCceEEEEEEECCCCCCCCceeeeechhhh-hhHHHHHHHHHHHHcCCC--CcccccccceeeecCCCceEEE
Q 039291 10 RGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVS-ASASLQKEKEVFDNLNGC--PFVLECFGEEITMGENGEMAYN 86 (362)
Q Consensus 10 ~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~~-~~~~~~~E~~il~~l~~h--~~i~~~~~~~~~~~~~~~~~~~ 86 (362)
-.+.||+|..+.||.....+. . +.+|..... ....+.+|...|+.|... -.+.++++.+... .....-+
T Consensus 18 ~~~~i~~G~~~~vy~~~~~~~-~-----~~~k~~~~~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~--~~~g~~~ 89 (297)
T PRK10593 18 RVECISEQPYAALWALYDSQG-N-----PMPLMARSFSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHE--QSPGPDV 89 (297)
T ss_pred eeeecCCccceeEEEEEcCCC-C-----EEEEEecccccchHHHHHHHHHHHHccCCCCCcCcEEEEeccC--CcCCCeE
Confidence 356899999999999975443 2 333433221 345788999999999754 2456666543221 1112246
Q ss_pred EEEEecCCCCH
Q 039291 87 LLLEYAAGGTL 97 (362)
Q Consensus 87 lv~e~~~~~~L 97 (362)
+|||+++|.++
T Consensus 90 LVmE~i~G~~~ 100 (297)
T PRK10593 90 LLLERLRGVSV 100 (297)
T ss_pred EEEeccCCEec
Confidence 99999998754
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.59 E-value=0.00033 Score=62.13 Aligned_cols=132 Identities=17% Similarity=0.184 Sum_probs=72.0
Q ss_pred eecccCceEEEEEEECCCCCCCCceeeeechhhhhh---HHHHHHHHHHHHcCCCCcccccccceeeecCCCceEEEEEE
Q 039291 13 VIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVSAS---ASLQKEKEVFDNLNGCPFVLECFGEEITMGENGEMAYNLLL 89 (362)
Q Consensus 13 ~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~~~~---~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~~~~~~~lv~ 89 (362)
.+..|-.+.+|+.... +. ++.+|....... -...+|..+++.+..+....+++.. .. -.+||
T Consensus 3 ~~~~G~tn~~y~~~~~--~~----~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~----~~-----~~~v~ 67 (256)
T TIGR02721 3 TLSGGLTNRSWRIEHP--GI----SFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILV----NE-----HWLLV 67 (256)
T ss_pred cCCCcCcCCeEEEEeC--Cc----cEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEE----eC-----CEEEE
Confidence 4567888899988632 22 455565432211 1357899999999754322333221 11 13899
Q ss_pred EecCCCCHH--------------HHHHHhcC-----CCCCHH-HHHHHHHHH---------HHHHHHHHh--------CC
Q 039291 90 EYAAGGTLG--------------DLIEKCNG-----NGLPEK-DVRHFTRCI---------LEGIGHIHD--------SG 132 (362)
Q Consensus 90 e~~~~~~L~--------------~~l~~~~~-----~~l~~~-~~~~i~~ql---------~~~l~yLH~--------~~ 132 (362)
||++|..+. +.+.+... .+++.. .+..+..++ ...+..+-. ..
T Consensus 68 e~i~G~~~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 147 (256)
T TIGR02721 68 EWLEGEVITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLA 147 (256)
T ss_pred EeccCcccccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCe
Confidence 999986643 11221111 112211 122222222 111222221 25
Q ss_pred ceeCCCCCCCEEEeecCCCceEEEEeecCCcc
Q 039291 133 YVHCDVKPDNILLVATQSGKFVAKIADLGVAK 164 (362)
Q Consensus 133 ivH~Dlkp~Nill~~~~~~~~~~kl~Dfgla~ 164 (362)
++|+|+.|.||++ ++++ +.|+||+.|.
T Consensus 148 l~H~Dl~~~Nil~----~~~~-~~lIDwE~a~ 174 (256)
T TIGR02721 148 PLHMDVHAYNLVV----TPQG-LKLIDWEYAS 174 (256)
T ss_pred eecCCCCcCcEEE----eCCC-CEEEeccccC
Confidence 8999999999999 4444 6899999874
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.41 E-value=0.0012 Score=59.80 Aligned_cols=145 Identities=15% Similarity=0.091 Sum_probs=79.8
Q ss_pred ecceecccCceEEEEEEECCCCCCCCceeeeechhhhhhHHHHHHHHHHHHcCCCC-cccccccceee-ecCCCceEEEE
Q 039291 10 RGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVSASASLQKEKEVFDNLNGCP-FVLECFGEEIT-MGENGEMAYNL 87 (362)
Q Consensus 10 ~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~~~~~~~~~E~~il~~l~~h~-~i~~~~~~~~~-~~~~~~~~~~l 87 (362)
-.+.|..|....+|+....+ + .+++|.........+..|+.++..|..+. .+.+++...-. .........++
T Consensus 18 ~i~~i~~G~~n~~y~v~~~~-~-----~~vLr~~~~~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~ 91 (296)
T cd05153 18 SFEGISAGIENTNYFVTTDS-G-----RYVLTLFEKVSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAA 91 (296)
T ss_pred heecccCccccceEEEEeCC-C-----cEEEEEcCCCChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEE
Confidence 35678888889999986543 2 35566654444556778899888886332 23333321000 00001123468
Q ss_pred EEEecCCCCHHH-----------HHHH---hc-CCCC--------CHHHH----------HHHHHHHHHHHHHHHh----
Q 039291 88 LLEYAAGGTLGD-----------LIEK---CN-GNGL--------PEKDV----------RHFTRCILEGIGHIHD---- 130 (362)
Q Consensus 88 v~e~~~~~~L~~-----------~l~~---~~-~~~l--------~~~~~----------~~i~~ql~~~l~yLH~---- 130 (362)
|+++++|..+.. .+.+ .. .... .+... ......+..++.++..
T Consensus 92 l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~ 171 (296)
T cd05153 92 LVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPS 171 (296)
T ss_pred EEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhh
Confidence 999999876421 1111 00 0000 00000 0011112334444443
Q ss_pred ---CCceeCCCCCCCEEEeecCCCceEEEEeecCCcc
Q 039291 131 ---SGYVHCDVKPDNILLVATQSGKFVAKIADLGVAK 164 (362)
Q Consensus 131 ---~~ivH~Dlkp~Nill~~~~~~~~~~kl~Dfgla~ 164 (362)
.+++|+|+.|.||++ +++..+.|+||+.+.
T Consensus 172 ~~~~~l~HgD~~~~Nil~----~~~~~~~iIDfe~a~ 204 (296)
T cd05153 172 DLPRGVIHADLFRDNVLF----DGDELSGVIDFYFAC 204 (296)
T ss_pred cCCCcCCccCcCcccEEE----eCCceEEEeehhhhc
Confidence 479999999999999 666667899999763
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.32 E-value=0.0013 Score=57.31 Aligned_cols=74 Identities=16% Similarity=0.181 Sum_probs=45.3
Q ss_pred cceecccCceEEEEEEECC-CCCCCCceeeeechhhhhh--HHHHHHHHHHHHcCCCCcccccccceeeecCCCceEEEE
Q 039291 11 GRVIGQGSFGCVFIAKPKS-NSSFLPPLMAVKSAEVSAS--ASLQKEKEVFDNLNGCPFVLECFGEEITMGENGEMAYNL 87 (362)
Q Consensus 11 ~~~lG~G~~g~V~~a~~~~-~~~~~~~~~~~K~~~~~~~--~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~~~~~~~l 87 (362)
++.|..|-...+|++.... .+ ..+.+|....... ....+|..+++.+..+....+++... .+ .+
T Consensus 3 i~~l~gG~tN~~~~v~~~~~~~----~~~vlR~~~~~~~~~~d~~~E~~~~~~l~~~gl~P~v~~~~----~~-----~~ 69 (235)
T cd05157 3 FKRFTGGITNKLVKVSNKEDNQ----DAVLVRVYGNKTELIIDRERELRIHKLLSKHGLAPKLYATF----QN-----GL 69 (235)
T ss_pred EEEcCCcccceEEEEEcCCCCC----CeEEEEEccCCccceecHHHHHHHHHHHHhCCCCCeEEEEe----CC-----cE
Confidence 4678889999999997553 12 2455665443221 22357899999887544344443211 11 27
Q ss_pred EEEecCCCCH
Q 039291 88 LLEYAAGGTL 97 (362)
Q Consensus 88 v~e~~~~~~L 97 (362)
+|||++|.++
T Consensus 70 l~e~i~G~~l 79 (235)
T cd05157 70 IYEFIPGRTL 79 (235)
T ss_pred EEEeeCCCcC
Confidence 9999998765
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.30 E-value=0.0035 Score=58.87 Aligned_cols=75 Identities=19% Similarity=0.194 Sum_probs=48.2
Q ss_pred cceecccCceEEEEEEECCCCCCCCceeeeechh----------hhhhHHHHHHHHHHHHcCCC--Ccccccccceeeec
Q 039291 11 GRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAE----------VSASASLQKEKEVFDNLNGC--PFVLECFGEEITMG 78 (362)
Q Consensus 11 ~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~----------~~~~~~~~~E~~il~~l~~h--~~i~~~~~~~~~~~ 78 (362)
.+.||.|.+..||++.+.+.++ .+.+|... +...++...|.+.|+.+... ..+.+++.+
T Consensus 31 ~~elggGn~N~VyrV~~~~g~~----svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~----- 101 (401)
T PRK09550 31 AREIGDGNLNLVFRVSDTEGGK----SVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY----- 101 (401)
T ss_pred eeEcCCCceEEEEEEEeCCCCe----EEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE-----
Confidence 4689999999999999865432 35666532 12345677889998887533 234444432
Q ss_pred CCCceEEEEEEEecCCCC
Q 039291 79 ENGEMAYNLLLEYAAGGT 96 (362)
Q Consensus 79 ~~~~~~~~lv~e~~~~~~ 96 (362)
+... .++|||++++..
T Consensus 102 -D~~~-~~lVME~L~~~~ 117 (401)
T PRK09550 102 -DEEL-AVTVMEDLSDHK 117 (401)
T ss_pred -CCCC-CEEEEecCCCcc
Confidence 1122 359999998744
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.23 E-value=0.006 Score=55.63 Aligned_cols=145 Identities=17% Similarity=0.186 Sum_probs=76.7
Q ss_pred eecceecccCceEEEEEEECCCCCCCCceeeeechhhh-hhHHHHHHHHHHHHcCCCC-cccccccceee-ecCCCceEE
Q 039291 9 FRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVS-ASASLQKEKEVFDNLNGCP-FVLECFGEEIT-MGENGEMAY 85 (362)
Q Consensus 9 ~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~~-~~~~~~~E~~il~~l~~h~-~i~~~~~~~~~-~~~~~~~~~ 85 (362)
...+.++.|....+|++... ++ .+.+|..... ..+.+..|..++..|..+. .+.+++...-. .........
T Consensus 25 ~~i~~~~~G~~n~~y~v~t~-~~-----~~vLK~~~~~~~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~ 98 (307)
T TIGR00938 25 LSLKGIAEGVENSNYLLTTD-VG-----RYILTLYEKRVKAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKP 98 (307)
T ss_pred eeccccCCccccceEEEEeC-CC-----cEEEEEecCCCCHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeE
Confidence 34677888888999998643 33 2445544321 2345667788888775221 13333331100 000011235
Q ss_pred EEEEEecCCCCHH-----------HHHHHhc--CCCCC--------HHH-----HH----------HHHHHHHHHHHHHH
Q 039291 86 NLLLEYAAGGTLG-----------DLIEKCN--GNGLP--------EKD-----VR----------HFTRCILEGIGHIH 129 (362)
Q Consensus 86 ~lv~e~~~~~~L~-----------~~l~~~~--~~~l~--------~~~-----~~----------~i~~ql~~~l~yLH 129 (362)
+++++|++|..+. ..+.... ...++ ... .. .....+...++++.
T Consensus 99 ~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~ 178 (307)
T TIGR00938 99 ACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLD 178 (307)
T ss_pred EEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHH
Confidence 6899999985431 1111100 00010 000 00 00112333455554
Q ss_pred h-------CCceeCCCCCCCEEEeecCCCceEEEEeecCCc
Q 039291 130 D-------SGYVHCDVKPDNILLVATQSGKFVAKIADLGVA 163 (362)
Q Consensus 130 ~-------~~ivH~Dlkp~Nill~~~~~~~~~~kl~Dfgla 163 (362)
. .+++|+|+.+.||++ +.++.+.|+||+.+
T Consensus 179 ~~~~~~~~~~l~HgD~~~~Nvl~----~~~~~~~vIDfd~~ 215 (307)
T TIGR00938 179 KFWPRDLPRGVIHADLFPDNVLF----DGDSVKGVIDFYFA 215 (307)
T ss_pred hhhhhcCCCccCCCCCCcCcEEE----ECCceEEEeecccc
Confidence 2 689999999999999 55556789999976
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.20 E-value=0.0068 Score=55.56 Aligned_cols=30 Identities=30% Similarity=0.482 Sum_probs=25.1
Q ss_pred CCceeCCCCCCCEEEeecCCCceEEEEeecCCcc
Q 039291 131 SGYVHCDVKPDNILLVATQSGKFVAKIADLGVAK 164 (362)
Q Consensus 131 ~~ivH~Dlkp~Nill~~~~~~~~~~kl~Dfgla~ 164 (362)
.++||+|+.|.||++ +++...-|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~----~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 187 RGVIHADLFRDNVLF----EGDRLSGFIDFYFAC 216 (319)
T ss_pred cccCCCCCCCCcEEE----ECCceEEEEeccccc
Confidence 489999999999999 555556899999863
|
|
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.17 E-value=0.00069 Score=64.18 Aligned_cols=172 Identities=19% Similarity=0.254 Sum_probs=100.4
Q ss_pred hhHHHHHHHHHHHHcCCCCcccccccceeeecCCCceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHH
Q 039291 47 ASASLQKEKEVFDNLNGCPFVLECFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIG 126 (362)
Q Consensus 47 ~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~ 126 (362)
....+.-...+++.+. |+|....++... .......+|||++ +.+|.+++.... +-... +
T Consensus 25 ~s~~ilgr~~~lktl~-~~~l~~yl~~~r----~~~~r~IVV~e~~-~~Sled~~~~~~---l~~~s-------~----- 83 (725)
T KOG1093|consen 25 NSIQILGRFQYLKSLQ-HDNLCQYLDFSR----GKHERVIVVMEHY-TMSLEDILKTGN---LKDES-------L----- 83 (725)
T ss_pred cHHHHhhhhHHHHhhc-CccceeeEeeec----CccceEEEEehhh-ccchHHHHHhcc---cchhh-------h-----
Confidence 3444667778899999 899877766432 2222366899999 569999987622 11111 0
Q ss_pred HHHhCCceeCCCCCCCEEEeecCCCceEEEEeecCCcccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHH
Q 039291 127 HIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGC 206 (362)
Q Consensus 127 yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~ 206 (362)
+ .+++.| .|++ +.+| -++..+ ....| +++||||+|.
T Consensus 84 -~-~~~~~~-----~~~~-----------~~td-~~~t~~---------~~~~~----------------pKsdVwsl~~ 119 (725)
T KOG1093|consen 84 -L-AHGVLH-----LNII-----------YITD-HFLTKY---------PSPIG----------------PKSDVWSLGF 119 (725)
T ss_pred -c-ccccce-----ehhh-----------hccc-cccccC---------CCCCC----------------cchhhhhHHH
Confidence 0 222222 2222 2333 111000 01111 3999999999
Q ss_pred HHHHHHhCCCCCccCCCCCHHHHHHHHcCCCC-CC------CCCccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCccC
Q 039291 207 VVLEMLSGRQAWVVKEDCSIDQLFSIIGDEHS-LP------EIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKG 279 (362)
Q Consensus 207 il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~-~~------~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~~~ 279 (362)
++.++.-|...|.........+.+.+...... .. .+-..++....++..+|+-..|..||...++.+++-|.+
T Consensus 120 i~~el~L~~~l~~~~~~s~~l~~i~k~~~~d~~~~~~a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~~k~~i~~e 199 (725)
T KOG1093|consen 120 IILELYLGISLEAELTESEYLEILLKYYTDDQELLSTAMEHLIQLLADKKRLPLLKKCLWLEPIIRPLPMELSKRCSFTE 199 (725)
T ss_pred HHHHHHHhhHHHHHHHHHHHHHHHHHhccCchhHHHHHHHHHHHHhhhHhHHHHhccCCccccccccchhHHhcCccHHH
Confidence 99999998766533222222222111110000 00 112246777889999999999999999999999998877
Q ss_pred cchh
Q 039291 280 VDEE 283 (362)
Q Consensus 280 ~~~~ 283 (362)
+-..
T Consensus 200 v~~~ 203 (725)
T KOG1093|consen 200 VYKD 203 (725)
T ss_pred HHhh
Confidence 6433
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.72 E-value=0.011 Score=53.61 Aligned_cols=32 Identities=22% Similarity=0.313 Sum_probs=25.9
Q ss_pred CceeCCCCCCCEEEeecCCCceEEEEeecCCccccc
Q 039291 132 GYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSR 167 (362)
Q Consensus 132 ~ivH~Dlkp~Nill~~~~~~~~~~kl~Dfgla~~~~ 167 (362)
.++|+|+.+.|+++ +....+-+.||+++....
T Consensus 199 ~lvHGD~~~gNlii----~~~~~~gVlDwe~~~lGD 230 (321)
T COG3173 199 VLVHGDYRPGNLII----DPGRPTGVLDWELATLGD 230 (321)
T ss_pred eeeeCCcccCCEEE----eCCCeeEEEeccccccCC
Confidence 48999999999999 444448899999986443
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=96.71 E-value=0.02 Score=51.38 Aligned_cols=29 Identities=34% Similarity=0.444 Sum_probs=23.6
Q ss_pred CceeCCCCCCCEEEeecCCC-ceEEEEeecCCcc
Q 039291 132 GYVHCDVKPDNILLVATQSG-KFVAKIADLGVAK 164 (362)
Q Consensus 132 ~ivH~Dlkp~Nill~~~~~~-~~~~kl~Dfgla~ 164 (362)
.++|+|+++.|||+ +. ....-|+||+.+.
T Consensus 186 ~lvHGD~~~~Nilv----~~~~~~~gviDWe~a~ 215 (276)
T cd05152 186 VLVHGDLHPGHILI----DEDARVTGLIDWTEAK 215 (276)
T ss_pred eeEeCCCCCCcEEE----eCCCCEEEEECcHhcc
Confidence 48999999999999 44 3446799999874
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=96.71 E-value=0.013 Score=53.13 Aligned_cols=79 Identities=19% Similarity=0.132 Sum_probs=45.9
Q ss_pred cceecccCceEEEEEEECCC--CCCCCceeeeechhhh--hhHHHHHHHHHHHHcCCCCcccccccceeeecCCCceEEE
Q 039291 11 GRVIGQGSFGCVFIAKPKSN--SSFLPPLMAVKSAEVS--ASASLQKEKEVFDNLNGCPFVLECFGEEITMGENGEMAYN 86 (362)
Q Consensus 11 ~~~lG~G~~g~V~~a~~~~~--~~~~~~~~~~K~~~~~--~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~~~~~~~ 86 (362)
++.|..|--..+|++..... .+.....+.+|..... ......+|.+++..+.......+++... .+ .
T Consensus 3 i~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~~~~~r~~E~~~~~~l~~~g~~P~~~~~~----~~-----~ 73 (302)
T cd05156 3 VSKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVELLIDRERELVVFARLSERNLGPKLYGIF----PN-----G 73 (302)
T ss_pred EEEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCcceechHHHHHHHHHHHhCCCCCceEEEe----CC-----C
Confidence 45677788889999875431 0111235566665432 2234678988999887543333333321 11 2
Q ss_pred EEEEecCCCCHH
Q 039291 87 LLLEYAAGGTLG 98 (362)
Q Consensus 87 lv~e~~~~~~L~ 98 (362)
+|+||++|..+.
T Consensus 74 ~v~e~i~G~~l~ 85 (302)
T cd05156 74 RIEEFIPSRTLT 85 (302)
T ss_pred chhheeCCCcCC
Confidence 589999887653
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=96.57 E-value=0.014 Score=53.79 Aligned_cols=73 Identities=19% Similarity=0.181 Sum_probs=44.0
Q ss_pred ceecccCceEEEEEEECCCCCCCCceeeeechhh----------hhhHHHHHHHHHHHHcCCC-C-cccccccceeeecC
Q 039291 12 RVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEV----------SASASLQKEKEVFDNLNGC-P-FVLECFGEEITMGE 79 (362)
Q Consensus 12 ~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~----------~~~~~~~~E~~il~~l~~h-~-~i~~~~~~~~~~~~ 79 (362)
+.||.|...-||++.+...+. -+.+|...+ -...+...|...|+..... | .+.++|.+
T Consensus 1 ~EigdGnlN~VfrV~~~~g~~----svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~------ 70 (370)
T TIGR01767 1 QEVGDGNLNLVFHVYDQEGDR----AAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF------ 70 (370)
T ss_pred CcCCCCceEEEEEEEcCCCCe----eEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE------
Confidence 468999999999999754322 345554221 1335567888888887642 3 34444332
Q ss_pred CCceEEEEEEEecCCC
Q 039291 80 NGEMAYNLLLEYAAGG 95 (362)
Q Consensus 80 ~~~~~~~lv~e~~~~~ 95 (362)
+... ..+|||+++..
T Consensus 71 D~e~-~~~vMEdL~~~ 85 (370)
T TIGR01767 71 DTEM-AVTVMEDLSHH 85 (370)
T ss_pred cccc-ceehHhhCccc
Confidence 2222 34899998553
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.55 E-value=0.025 Score=51.91 Aligned_cols=134 Identities=17% Similarity=0.155 Sum_probs=86.9
Q ss_pred cceecccCceEEEEEEECCCCCCCCceeeeechhhh-----------------------------hhHHHHHHHHHHHHc
Q 039291 11 GRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVS-----------------------------ASASLQKEKEVFDNL 61 (362)
Q Consensus 11 ~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~~-----------------------------~~~~~~~E~~il~~l 61 (362)
-..|..|--+.||.|....... +|+|+.+.. ..-=...|++-|++|
T Consensus 149 nGCiSTGKEANVYHat~~dG~~-----~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl 223 (520)
T KOG2270|consen 149 NGCISTGKEANVYHATEEDGSE-----FAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRL 223 (520)
T ss_pred ccccccCccceeEeeecCCCce-----EEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHH
Confidence 3567788889999997665433 555553211 001134688888888
Q ss_pred CCCCcccccccceeeecCCCceEEEEEEEecCCCCH-HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH-HhCCceeCCCC
Q 039291 62 NGCPFVLECFGEEITMGENGEMAYNLLLEYAAGGTL-GDLIEKCNGNGLPEKDVRHFTRCILEGIGHI-HDSGYVHCDVK 139 (362)
Q Consensus 62 ~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L-~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yL-H~~~ivH~Dlk 139 (362)
+ .-.|.-.-. ... . . -.|||+|+..... .-.|+ .-.++...+..+-.|++..+.-| |..++||.||.
T Consensus 224 ~-~aGIP~PeP-IlL-k----~-hVLVM~FlGrdgw~aPkLK---d~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLS 292 (520)
T KOG2270|consen 224 N-NAGIPCPEP-ILL-K----N-HVLVMEFLGRDGWAAPKLK---DASLSTSKARELYQQCVRIMRRLYQKCRLVHADLS 292 (520)
T ss_pred H-hcCCCCCCc-eee-e----c-ceEeeeeccCCCCcCcccc---cccCChHHHHHHHHHHHHHHHHHHHHhceeccchh
Confidence 7 333322211 111 1 1 2489999953221 12222 23488888999999999998877 56799999999
Q ss_pred CCCEEEeecCCCceEEEEeecCCccc
Q 039291 140 PDNILLVATQSGKFVAKIADLGVAKR 165 (362)
Q Consensus 140 p~Nill~~~~~~~~~~kl~Dfgla~~ 165 (362)
--|+|+ . .|.+.|+|.+-+..
T Consensus 293 EfN~Ly----h-dG~lyiIDVSQSVE 313 (520)
T KOG2270|consen 293 EFNLLY----H-DGKLYIIDVSQSVE 313 (520)
T ss_pred hhhheE----E-CCEEEEEEcccccc
Confidence 999999 3 35689999887643
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=96.20 E-value=0.023 Score=52.65 Aligned_cols=144 Identities=15% Similarity=0.136 Sum_probs=77.6
Q ss_pred eecceecccCceEEEEEEECCCCCCCCceeeeechhhhhh--HHHHHHHHHHHHcCCCCcccccccceeeecCCCceEEE
Q 039291 9 FRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVSAS--ASLQKEKEVFDNLNGCPFVLECFGEEITMGENGEMAYN 86 (362)
Q Consensus 9 ~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~~~~--~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~~~~~~~ 86 (362)
.-++.|-.|-...+|++............+.++....... -...+|..+++.+..+..-.++++.+ .+ .
T Consensus 39 ~~i~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~idR~~E~~~~~~l~~~gl~P~~~~~~----~~-----g 109 (344)
T PLN02236 39 LQVIPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFFDRDDEIRTFECMSRHGQGPRLLGRF----PN-----G 109 (344)
T ss_pred EEEEEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeeechHHHHHHHHHHHHcCCCCceEEEE----CC-----c
Confidence 3445666688899999875432221224566776543321 12357888888887543334444422 11 1
Q ss_pred EEEEecCCCCHHH--------------HHHHhcCCC------C-CHHHHHHHHHHH-----------------HHHHHHH
Q 039291 87 LLLEYAAGGTLGD--------------LIEKCNGNG------L-PEKDVRHFTRCI-----------------LEGIGHI 128 (362)
Q Consensus 87 lv~e~~~~~~L~~--------------~l~~~~~~~------l-~~~~~~~i~~ql-----------------~~~l~yL 128 (362)
.|.+|++|.+|.. .+.+..... . ....+..++.++ ...+..|
T Consensus 110 ~v~efi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L 189 (344)
T PLN02236 110 RVEEFIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLL 189 (344)
T ss_pred eEEEeeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHH
Confidence 5789988766531 111110101 1 122333333221 1111111
Q ss_pred ----H----hCCceeCCCCCCCEEEeecCCCceEEEEeecCCcc
Q 039291 129 ----H----DSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAK 164 (362)
Q Consensus 129 ----H----~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Dfgla~ 164 (362)
. ...++|+|+++.|||+. +.++.+.++||..+.
T Consensus 190 ~~~~~~~~~~~~~cH~Dl~~~Nil~~---~~~~~~~lID~Eya~ 230 (344)
T PLN02236 190 EKELSGDDQEIGFCHNDLQYGNIMID---EETRAITIIDYEYAS 230 (344)
T ss_pred HHHhcccCCCceEEeCCCCcCcEEEe---CCCCcEEEEeehhcc
Confidence 1 23689999999999993 223569999999763
|
|
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.79 E-value=0.078 Score=49.82 Aligned_cols=80 Identities=14% Similarity=0.121 Sum_probs=46.4
Q ss_pred ecceecccCceEEEEEEECCCC--CCCCceeeeechhhh--hhHHHHHHHHHHHHcCCCCcccccccceeeecCCCceEE
Q 039291 10 RGRVIGQGSFGCVFIAKPKSNS--SFLPPLMAVKSAEVS--ASASLQKEKEVFDNLNGCPFVLECFGEEITMGENGEMAY 85 (362)
Q Consensus 10 ~~~~lG~G~~g~V~~a~~~~~~--~~~~~~~~~K~~~~~--~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~~~~~~ 85 (362)
.++.|..|--..+|++...... .+..+.|.+...... ..-.-.+|..+++.|..+..-.++++.+. -
T Consensus 54 ~i~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~~~~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~---------~ 124 (383)
T PTZ00384 54 EIKKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSSTYNSLVIDNDLQYNIAKLLGDNNFGPKIIGRFG---------D 124 (383)
T ss_pred EEEEeCCcccceEEEEEecCCCCCccccceEEEEeccCCCceEeccHHHHHHHHHHHhCCCCCeEEEecC---------C
Confidence 3456667888999999754332 222233444432111 11123578899998885555555555331 1
Q ss_pred EEEEEecCCCCHH
Q 039291 86 NLLLEYAAGGTLG 98 (362)
Q Consensus 86 ~lv~e~~~~~~L~ 98 (362)
.+|.||++|..|.
T Consensus 125 g~l~efIeGr~l~ 137 (383)
T PTZ00384 125 FTIQEWVEGNTMG 137 (383)
T ss_pred EEEEEEeccccCC
Confidence 3899999987653
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=95.73 E-value=0.12 Score=48.64 Aligned_cols=72 Identities=17% Similarity=0.214 Sum_probs=44.2
Q ss_pred ecceecccCceEEEEEEECCCCCCCCceeeeechh-----h-----hhhHHHHHHHHHHHHcCCC--Ccccccccceeee
Q 039291 10 RGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAE-----V-----SASASLQKEKEVFDNLNGC--PFVLECFGEEITM 77 (362)
Q Consensus 10 ~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~-----~-----~~~~~~~~E~~il~~l~~h--~~i~~~~~~~~~~ 77 (362)
..+.||.|....||+..+.. + .+.+|... . -...+...|...|+.+... ..+.+++.+..
T Consensus 36 ~~~eiggGn~N~VyrV~~~~-~-----svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de-- 107 (418)
T PLN02756 36 KIKEVGDGNLNFVYIVVSSS-G-----SFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR-- 107 (418)
T ss_pred eEEEcCCCceeeEEEEEcCC-c-----cEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--
Confidence 36789999999999998743 2 24555433 1 1344556777888776532 24555554321
Q ss_pred cCCCceEEEEEEEecCC
Q 039291 78 GENGEMAYNLLLEYAAG 94 (362)
Q Consensus 78 ~~~~~~~~~lv~e~~~~ 94 (362)
+. .+++||++++
T Consensus 108 ----d~-~vlvME~L~~ 119 (418)
T PLN02756 108 ----TM-ALIGMRYLEP 119 (418)
T ss_pred ----CC-CEEEEeecCC
Confidence 12 3489999977
|
|
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=95.73 E-value=0.051 Score=46.41 Aligned_cols=87 Identities=21% Similarity=0.256 Sum_probs=59.1
Q ss_pred hhHHHHHHHHHHHHcCCCCcccccccceeeecCCCceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHH
Q 039291 47 ASASLQKEKEVFDNLNGCPFVLECFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIG 126 (362)
Q Consensus 47 ~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~ 126 (362)
...-+..+.+++.++.+ |+++.. +....+-+|.|+|-.... .. .-.+.. =+.+|.
T Consensus 101 ~~~~y~nky~v~ArmhG---ilrL~N-------Dn~~~yGvIlE~Cy~~~i-----------~~---~N~i~a-gi~~L~ 155 (308)
T PF07387_consen 101 NDALYFNKYRVFARMHG---ILRLKN-------DNNYKYGVILERCYKIKI-----------NF---SNFITA-GIKDLM 155 (308)
T ss_pred chhhhhhhhhHHHHhhh---eeEeec-------CCCceeEEEEeeccCccc-----------ch---hHHHHH-hHHHHH
Confidence 34556778888888765 555542 344557799999953211 11 111111 145677
Q ss_pred HHHh--CCceeCCCCCCCEEEeecCCCceEEEEeecCC
Q 039291 127 HIHD--SGYVHCDVKPDNILLVATQSGKFVAKIADLGV 162 (362)
Q Consensus 127 yLH~--~~ivH~Dlkp~Nill~~~~~~~~~~kl~Dfgl 162 (362)
-.|+ .+.+|+|-.|+|||- ++.|.+||.|-+.
T Consensus 156 ~fH~~~~~~lHGD~np~NiM~----D~~G~lKlVDP~~ 189 (308)
T PF07387_consen 156 DFHSENQHCLHGDCNPDNIMC----DKFGYLKLVDPVC 189 (308)
T ss_pred HhhccCCCeecCCCChhheee----cCCCCEEecChhh
Confidence 7884 579999999999999 9999999999774
|
The function of this family is unknown. |
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=95.59 E-value=0.039 Score=49.67 Aligned_cols=74 Identities=18% Similarity=0.086 Sum_probs=43.3
Q ss_pred cceecccCceEEEEEEECCCCCCCCceeeeechhhhhhHHHHHHHHHHHHcCC--CCcccccccceeeecCCCceEEEEE
Q 039291 11 GRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVSASASLQKEKEVFDNLNG--CPFVLECFGEEITMGENGEMAYNLL 88 (362)
Q Consensus 11 ~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~~~~~~~~~E~~il~~l~~--h~~i~~~~~~~~~~~~~~~~~~~lv 88 (362)
.+.|+.|....+|.... ++ ..+.+|.........+..|..-|+.|.. --.+.+.++..... +. -+||
T Consensus 22 ~~~v~GG~i~~a~~~~~--~~----~~~FvK~~~~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~---~~--~fLl 90 (288)
T PF03881_consen 22 IEPVSGGDINEAYRLDT--DG----GSYFVKVNSESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYD---DD--AFLL 90 (288)
T ss_dssp EEEE--SSSSEEEEEET--TS-----EEEEEEEEGGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-S---SC--CEEE
T ss_pred eEecCCCChhheEEEEC--CC----ccEEEEecChhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeec---CC--ceEE
Confidence 56789999999999872 22 2578887776666778999999999952 23455555543221 11 2599
Q ss_pred EEecCCC
Q 039291 89 LEYAAGG 95 (362)
Q Consensus 89 ~e~~~~~ 95 (362)
|||++.+
T Consensus 91 le~l~~~ 97 (288)
T PF03881_consen 91 LEFLEMG 97 (288)
T ss_dssp EE-----
T ss_pred EEeecCC
Confidence 9999876
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >KOG1236 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.57 E-value=0.062 Score=50.04 Aligned_cols=62 Identities=19% Similarity=0.324 Sum_probs=45.9
Q ss_pred EEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHH-HHHhCCceeCCCCCCCEEEeecCC
Q 039291 86 NLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIG-HIHDSGYVHCDVKPDNILLVATQS 150 (362)
Q Consensus 86 ~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~-yLH~~~ivH~Dlkp~Nill~~~~~ 150 (362)
.++=+|..|.++..++... ..++.....++.-.+.|+. -|--.+++|.|+.|.||++...+.
T Consensus 321 vl~E~~~~Gl~v~~~v~~~---~~pe~l~kkva~lg~~AllkMl~vDNFvHaDlHPGNVlirf~~t 383 (565)
T KOG1236|consen 321 VLVETYERGLSVLRFVKWK---SQPEALVKKVAKLGVNALLKMLIVDNFVHADLHPGNVLIRFNKT 383 (565)
T ss_pred eeeeeccccccHHhhhhcc---cChHHHHHHHHHHHHHHHHHHHHhhcceecccCCCcEEEEecCC
Confidence 3666788888999888762 2556666677776666653 455678999999999999965543
|
|
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=95.47 E-value=0.043 Score=51.34 Aligned_cols=73 Identities=19% Similarity=0.250 Sum_probs=45.6
Q ss_pred cceecccCceEEEEEEECCCCCCCCceeeeechh---------hhhhHHHHHHHHHHHHcCC-CC-cccccccceeeecC
Q 039291 11 GRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAE---------VSASASLQKEKEVFDNLNG-CP-FVLECFGEEITMGE 79 (362)
Q Consensus 11 ~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~---------~~~~~~~~~E~~il~~l~~-h~-~i~~~~~~~~~~~~ 79 (362)
.+.||.|.-.-||++.+...+. -+.+|... +-...+...|.+.|+.+.. .| .+.++|.+
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~----svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~------ 103 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNI----SVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF------ 103 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCc----eEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE------
Confidence 5789999999999999843222 34555422 1244667788999988764 23 34444432
Q ss_pred CCceEEEEEEEecCC
Q 039291 80 NGEMAYNLLLEYAAG 94 (362)
Q Consensus 80 ~~~~~~~lv~e~~~~ 94 (362)
+... ..+|||+++.
T Consensus 104 D~e~-~~~vMEdL~~ 117 (409)
T PRK12396 104 DSVM-NCCVMEDLSD 117 (409)
T ss_pred CcHH-hhHHHHhCcc
Confidence 2222 3489999864
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=95.36 E-value=0.059 Score=49.43 Aligned_cols=105 Identities=13% Similarity=0.187 Sum_probs=69.3
Q ss_pred CCceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC-CceeCCCCCCCEEEeecCCCceEEEEe
Q 039291 80 NGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDS-GYVHCDVKPDNILLVATQSGKFVAKIA 158 (362)
Q Consensus 80 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~-~ivH~Dlkp~Nill~~~~~~~~~~kl~ 158 (362)
++..+.|++|++. |++|. .++. -...++..++.+.+..+.-+..+ .+-|||+...|||+ + +|+|-|+
T Consensus 296 de~~y~yl~~kdh-gt~is-~ik~-----~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLI----d-~GnvtLI 363 (488)
T COG5072 296 DETLYLYLHFKDH-GTPIS-IIKA-----DRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILI----D-EGNVTLI 363 (488)
T ss_pred CCceEEEEEEecC-Cceee-eeec-----ccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceee----e-cCceEEE
Confidence 4456677888887 55554 2222 45678888899888887777654 68899999999999 7 7889999
Q ss_pred ecCCcccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHH
Q 039291 159 DLGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWAL 204 (362)
Q Consensus 159 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diwsl 204 (362)
||-+++...... .+.....--|-.+.| .-+...|||-+
T Consensus 364 DfklsRl~~~q~-------~isy~rldhp~lF~G-~dd~QFeIYrl 401 (488)
T COG5072 364 DFKLSRLSYSQG-------IISYNRLDHPDLFNG-VDDYQFEIYRL 401 (488)
T ss_pred EeeeeecccCCc-------eeeccccCchhhhcC-ccceeeeHHHH
Confidence 999998433211 111112223444443 33666777753
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=94.46 E-value=0.16 Score=46.76 Aligned_cols=77 Identities=14% Similarity=0.129 Sum_probs=42.0
Q ss_pred cceecccCceEEEEEEECCCCCCCCceeeeechhhhhh--HHHHHHHHHHHHcCCCCcccccccceeeecCCCceEEEEE
Q 039291 11 GRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVSAS--ASLQKEKEVFDNLNGCPFVLECFGEEITMGENGEMAYNLL 88 (362)
Q Consensus 11 ~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~~~~--~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~~~~~~~lv 88 (362)
++.|..|=-..+|++...+... -...+.++....... -...+|..+++.+..+..-.++++.. .+ - +|
T Consensus 19 i~~l~gGlTN~~~~v~~~~~~~-~~~~~v~Ri~g~~t~~~IdR~~E~~il~~l~~~gl~P~~l~~~----~~----G-~i 88 (330)
T PLN02421 19 VERISGGITNLLLKVSVKEENG-NEVSVTVRLFGPNTDYVIDRERELQAIKYLSAAGFGAKLLGVF----GN----G-MI 88 (330)
T ss_pred EEEeCCcccceEEEEEecCCCC-CCceEEEEEecCCcCeEechHHHHHHHHHHHhcCCCCceeEEe----CC----c-Ee
Confidence 4556668888899887543211 012455665433211 12357888888887543333443322 11 1 57
Q ss_pred EEecCCCCH
Q 039291 89 LEYAAGGTL 97 (362)
Q Consensus 89 ~e~~~~~~L 97 (362)
.+|++|..|
T Consensus 89 ~~fi~g~~l 97 (330)
T PLN02421 89 QSFINARTL 97 (330)
T ss_pred ehhhcCCCC
Confidence 888877654
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=93.76 E-value=0.14 Score=46.68 Aligned_cols=28 Identities=29% Similarity=0.395 Sum_probs=23.3
Q ss_pred CCceeCCCCCCCEEEeecCCCceEEEEeecCCc
Q 039291 131 SGYVHCDVKPDNILLVATQSGKFVAKIADLGVA 163 (362)
Q Consensus 131 ~~ivH~Dlkp~Nill~~~~~~~~~~kl~Dfgla 163 (362)
.+++|+|+.+.||++ +. +.+.|+||+.+
T Consensus 187 ~~liHgD~~~~Nil~----~~-~~i~lIDfd~~ 214 (313)
T TIGR02906 187 RGFCHQDYAYHNILL----KD-NEVYVIDFDYC 214 (313)
T ss_pred CceEcCCCCcccEEE----eC-CcEEEEECccc
Confidence 578999999999999 44 34789999965
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >PF05445 Pox_ser-thr_kin: Poxvirus serine/threonine protein kinase; InterPro: IPR008790 This family of proteins contain poxvirus serine/threonine protein kinases, which are essential for phosphorylation of virion proteins during virion assembly | Back alignment and domain information |
|---|
Probab=93.65 E-value=0.069 Score=48.56 Aligned_cols=59 Identities=20% Similarity=0.252 Sum_probs=37.6
Q ss_pred CHHHHHHHHHHHHHHHHHHH----hCCceeCCCCCCCEEEeecCC--------------CceEEEEeecCCcccccc
Q 039291 110 PEKDVRHFTRCILEGIGHIH----DSGYVHCDVKPDNILLVATQS--------------GKFVAKIADLGVAKRSRH 168 (362)
Q Consensus 110 ~~~~~~~i~~ql~~~l~yLH----~~~ivH~Dlkp~Nill~~~~~--------------~~~~~kl~Dfgla~~~~~ 168 (362)
-..-++.++.|++.-.--+- ...++|-||||+|||+..++. +.-.++|-||.+|....-
T Consensus 273 ~~~YvkfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiFds~~~i~I~~~~~~~vF~Epi~~~LnDFDfSqv~~i 349 (434)
T PF05445_consen 273 NVEYVKFIFLQIALLYIKIYELPCCTNFLHVDLKPDNILIFDSKEPIRIKFGNRNYVFKEPIRCCLNDFDFSQVANI 349 (434)
T ss_pred HHHHHHHHHHHHHHHHeeeecCCCcceeeecccCcCcEEEecCCCceEEEECCeEEEecccceeeecccCHHHhccc
Confidence 34567778888754331121 346999999999999976532 112346778887765443
|
; GO: 0004672 protein kinase activity, 0005524 ATP binding |
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=93.21 E-value=1.2 Score=47.64 Aligned_cols=34 Identities=26% Similarity=0.350 Sum_probs=25.0
Q ss_pred CCceeCCCCCCCEEEeecCCCceEEEEeecCCccc
Q 039291 131 SGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKR 165 (362)
Q Consensus 131 ~~ivH~Dlkp~Nill~~~~~~~~~~kl~Dfgla~~ 165 (362)
.++||+|+.+.|||+..+.+. ...-|+|||-+..
T Consensus 203 ~~vIHgDln~~NiLv~~~~~~-~isGiIDFgDa~~ 236 (1013)
T PRK06148 203 AQVIHNDANDYNILVDADDGE-RISGLIDFGDAVH 236 (1013)
T ss_pred cceECCCCCcccEEEcCCCCc-ceEEEEECccccc
Confidence 579999999999999432211 3445999998753
|
|
| >PHA03111 Ser/Thr kinase; Provisional | Back alignment and domain information |
|---|
Probab=92.91 E-value=0.23 Score=45.03 Aligned_cols=39 Identities=26% Similarity=0.304 Sum_probs=29.2
Q ss_pred CHHHHHHHHHHHHHHHHHHH----hCCceeCCCCCCCEEEeec
Q 039291 110 PEKDVRHFTRCILEGIGHIH----DSGYVHCDVKPDNILLVAT 148 (362)
Q Consensus 110 ~~~~~~~i~~ql~~~l~yLH----~~~ivH~Dlkp~Nill~~~ 148 (362)
-..-++.++.|++.-.-.+- ...++|-||||.|||+..+
T Consensus 277 ~~~YikfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiFds 319 (444)
T PHA03111 277 LVEYIKFIFLQIALLYIKIYELPCCDNFLHVDLKPDNILIFDS 319 (444)
T ss_pred HHHHHHHHHHHHHHHHHhhhcCCCcceeeeccCCCCcEEEecC
Confidence 45667888888876553442 2469999999999999765
|
|
| >smart00587 CHK ZnF_C4 abd HLH domain containing kinases domain | Back alignment and domain information |
|---|
Probab=92.19 E-value=0.32 Score=41.11 Aligned_cols=35 Identities=14% Similarity=0.122 Sum_probs=25.4
Q ss_pred hCCceeCCCCCCCEEEeecCC-CceEEEEeecCCcc
Q 039291 130 DSGYVHCDVKPDNILLVATQS-GKFVAKIADLGVAK 164 (362)
Q Consensus 130 ~~~ivH~Dlkp~Nill~~~~~-~~~~~kl~Dfgla~ 164 (362)
...++|+|+.+.||++..+++ ....+.++||..+.
T Consensus 119 ~~vl~HgD~~~~N~~~~~~~~~~~~~~~liDfq~~~ 154 (196)
T smart00587 119 FNVLNHGDLWANNIMFKYDDEGKPEDVALIDFQLSH 154 (196)
T ss_pred ceEEeeCCCCccceeeccCCCCCccceEEEecccCC
Confidence 346899999999999953221 11258899999863
|
subfamily of choline kinases |
| >COG0510 ycfN Thiamine kinase and related kinases [Coenzyme transport and metabolism] | Back alignment and domain information |
|---|
Probab=92.04 E-value=0.29 Score=43.68 Aligned_cols=46 Identities=22% Similarity=0.233 Sum_probs=33.0
Q ss_pred HHHHHHHHHHHHHHHhC--CceeCCCCCCCEEEeecCCCceEEEEeecCCcc
Q 039291 115 RHFTRCILEGIGHIHDS--GYVHCDVKPDNILLVATQSGKFVAKIADLGVAK 164 (362)
Q Consensus 115 ~~i~~ql~~~l~yLH~~--~ivH~Dlkp~Nill~~~~~~~~~~kl~Dfgla~ 164 (362)
...+..+-.++.-.+.. -++|+|+.|+|++. ++.+.++|+||.-|.
T Consensus 135 ~~~~~~l~~~l~~~~~~~~v~cH~Dl~~~N~l~----t~~~~l~LIDWEyAg 182 (269)
T COG0510 135 RKKLKELRRALEEVPKDDLVPCHNDLNPGNLLL----TDKGGLFLIDWEYAG 182 (269)
T ss_pred HHHHHHHHHHhhhcCCCceeeecCCCCccceEE----cCCCcEEEEecccCC
Confidence 33444444444444433 58999999999999 666779999998764
|
|
| >COG3231 Aph Aminoglycoside phosphotransferase [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=91.96 E-value=1.4 Score=37.84 Aligned_cols=106 Identities=25% Similarity=0.277 Sum_probs=70.2
Q ss_pred eeeechhhhhhHHHHHHHHHHHHcCC----CCcccccccceeeecCCCceEEEEEEEecCCCCHHHHHHHhcCCCCCHHH
Q 039291 38 MAVKSAEVSASASLQKEKEVFDNLNG----CPFVLECFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKD 113 (362)
Q Consensus 38 ~~~K~~~~~~~~~~~~E~~il~~l~~----h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~ 113 (362)
+.+|+......+.+..|+..++=+.+ +|.|+.+.+ +.. .-+|+|+-++|.++...-.. ++...
T Consensus 46 ~~~k~~~~~~~a~L~~Ea~RlrWla~~~l~~P~V~~~~~-------~~~-~~wLl~salpG~~~s~~~~~-----~~p~r 112 (266)
T COG3231 46 LYLKIASSGPAAELEGEAARLRWLAGQGLGCPRVLGLED-------DAD-QAWLLMSALPGEDASHPRYA-----LDPKR 112 (266)
T ss_pred eEEEEecCcchhhhhhHHHHHHHhcccCCCCCceEeecc-------Ccc-hhHHhhhhcCCCcccchhhc-----CCHHH
Confidence 56677666667778899998886652 455543322 122 23589999999887654322 33333
Q ss_pred HHHHHHHHHHHHHHHHhC----------------------------------------------------------Ccee
Q 039291 114 VRHFTRCILEGIGHIHDS----------------------------------------------------------GYVH 135 (362)
Q Consensus 114 ~~~i~~ql~~~l~yLH~~----------------------------------------------------------~ivH 135 (362)
.+--|+++|..||+. -+.|
T Consensus 113 ---~v~~la~aLR~LH~l~~~aCPFd~rl~~rl~~a~~r~~a~~vdesdfd~e~qgr~~~El~d~L~~~rp~~edLVv~H 189 (266)
T COG3231 113 ---AVPLLAEALRRLHELPVEACPFDRRLARRLAKARARVRAGLVDESDFDEERQGRTAEELFDELEARRPAVEDLVVTH 189 (266)
T ss_pred ---HHHHHHHHHHHHhcCChhhCCcchHHHHHHHHHHHHHhccCCChhhcChhhcCCCHHHHHHHHHhcCCchhhceeec
Confidence 234466677777764 2789
Q ss_pred CCCCCCCEEEeecCCCceEEEEeecCCc
Q 039291 136 CDVKPDNILLVATQSGKFVAKIADLGVA 163 (362)
Q Consensus 136 ~Dlkp~Nill~~~~~~~~~~kl~Dfgla 163 (362)
+|-..-|+++ ++...--++|+|-.
T Consensus 190 GDACLPN~i~----d~~rf~GfIDlGrl 213 (266)
T COG3231 190 GDACLPNFIL----DGWRFSGFIDLGRL 213 (266)
T ss_pred CcccCcceEe----cCCceEEeeecCcc
Confidence 9999999999 66666678888865
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 362 | ||||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 2e-20 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-20 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 2e-20 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-20 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 3e-20 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 3e-20 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 5e-20 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 3e-19 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 3e-19 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 4e-19 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 2e-18 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 2e-18 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-18 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 2e-18 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 2e-18 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 2e-18 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 3e-18 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 3e-18 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 3e-18 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 3e-18 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 3e-18 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 3e-18 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 3e-18 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 3e-18 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 5e-18 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 5e-18 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 5e-18 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 5e-18 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-18 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 6e-18 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 6e-18 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-18 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 1e-17 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-17 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-17 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 1e-17 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 1e-17 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 1e-17 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 1e-17 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 1e-17 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 1e-17 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 1e-17 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 1e-17 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-17 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 1e-17 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 1e-17 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 1e-17 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 2e-17 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 2e-17 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 2e-17 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 2e-17 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-17 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 3e-17 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 3e-17 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 4e-17 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 4e-17 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 4e-17 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 5e-17 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 5e-17 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 5e-17 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 5e-17 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 5e-17 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 5e-17 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 5e-17 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 5e-17 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 5e-17 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 6e-17 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 6e-17 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 6e-17 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 7e-17 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 7e-17 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 7e-17 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 7e-17 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 9e-17 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-16 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 1e-16 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 1e-16 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 1e-16 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-16 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 1e-16 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 1e-16 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 1e-16 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 1e-16 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 1e-16 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 1e-16 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 1e-16 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 1e-16 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 1e-16 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 2e-16 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 2e-16 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 2e-16 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 2e-16 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-16 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 2e-16 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 2e-16 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 3e-16 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 3e-16 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 3e-16 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 3e-16 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 3e-16 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 3e-16 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 3e-16 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 3e-16 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 4e-16 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 4e-16 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 5e-16 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 5e-16 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 5e-16 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 5e-16 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 5e-16 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 6e-16 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 7e-16 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 7e-16 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 8e-16 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 9e-16 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 9e-16 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 1e-15 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 1e-15 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-15 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 1e-15 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 1e-15 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 1e-15 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 2e-15 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 2e-15 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 2e-15 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 2e-15 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 2e-15 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 2e-15 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 2e-15 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-15 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 3e-15 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 3e-15 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 3e-15 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 3e-15 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 3e-15 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 3e-15 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 3e-15 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 3e-15 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 3e-15 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 4e-15 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 4e-15 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 4e-15 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 4e-15 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 4e-15 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 4e-15 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 4e-15 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 5e-15 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 5e-15 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 5e-15 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 5e-15 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 5e-15 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 5e-15 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 5e-15 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 5e-15 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 5e-15 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 6e-15 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 6e-15 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 7e-15 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 7e-15 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 7e-15 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 7e-15 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 8e-15 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 8e-15 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 8e-15 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 9e-15 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 1e-14 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 1e-14 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 1e-14 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 1e-14 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 1e-14 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 2e-14 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 2e-14 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 2e-14 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 2e-14 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 2e-14 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 2e-14 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 2e-14 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 2e-14 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 2e-14 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 2e-14 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 3e-14 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 3e-14 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 3e-14 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 3e-14 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 3e-14 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 3e-14 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 3e-14 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 3e-14 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 3e-14 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 4e-14 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 5e-14 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 5e-14 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 5e-14 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 7e-14 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 8e-14 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 1e-13 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 1e-13 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 1e-13 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 1e-13 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 1e-13 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 1e-13 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 2e-13 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 2e-13 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 2e-13 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 2e-13 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 2e-13 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 2e-13 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 2e-13 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 2e-13 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 2e-13 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 2e-13 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 2e-13 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 2e-13 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 2e-13 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 2e-13 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 2e-13 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 2e-13 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-13 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 2e-13 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-13 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 2e-13 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 2e-13 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 3e-13 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 3e-13 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 3e-13 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 3e-13 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 4e-13 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 4e-13 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 5e-13 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 5e-13 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 5e-13 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 5e-13 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 6e-13 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 6e-13 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 6e-13 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 6e-13 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 6e-13 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 7e-13 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 7e-13 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 7e-13 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 7e-13 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 7e-13 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 7e-13 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 7e-13 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 7e-13 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 8e-13 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 8e-13 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 8e-13 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 8e-13 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 8e-13 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 9e-13 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 9e-13 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 1e-12 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 1e-12 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 1e-12 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-12 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 1e-12 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-12 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 1e-12 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 1e-12 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 1e-12 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 1e-12 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 1e-12 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 1e-12 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 1e-12 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 2e-12 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 2e-12 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 2e-12 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 2e-12 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 2e-12 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 2e-12 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 2e-12 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 2e-12 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 2e-12 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 2e-12 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 3e-12 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 3e-12 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 3e-12 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 3e-12 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 3e-12 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 3e-12 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 3e-12 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-12 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 3e-12 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 3e-12 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 4e-12 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 4e-12 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 4e-12 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 4e-12 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 4e-12 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 4e-12 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 4e-12 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 4e-12 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 5e-12 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 6e-12 | ||
| 1how_A | 373 | The X-Ray Crystal Structure Of Sky1p, An Sr Protein | 6e-12 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 6e-12 | ||
| 1q8y_A | 373 | The Structure Of The Yeast Sr Protein Kinase, Sky1p | 7e-12 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 7e-12 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 8e-12 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 8e-12 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 9e-12 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 1e-11 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 1e-11 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 1e-11 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 1e-11 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 1e-11 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 2e-11 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 2e-11 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 2e-11 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 2e-11 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 3e-11 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 3e-11 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 3e-11 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 3e-11 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 3e-11 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 4e-11 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 4e-11 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 4e-11 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 4e-11 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 4e-11 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 4e-11 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 5e-11 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 5e-11 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 5e-11 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 5e-11 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 5e-11 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 6e-11 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 6e-11 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 6e-11 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 6e-11 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 6e-11 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 7e-11 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 7e-11 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 7e-11 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 7e-11 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 7e-11 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 8e-11 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 8e-11 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 8e-11 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 8e-11 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 8e-11 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 8e-11 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 8e-11 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 8e-11 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 9e-11 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 9e-11 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 9e-11 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 9e-11 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 9e-11 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 9e-11 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 9e-11 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 9e-11 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 1e-10 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 1e-10 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 1e-10 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 1e-10 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 1e-10 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 1e-10 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 1e-10 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 1e-10 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 1e-10 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-10 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 1e-10 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 1e-10 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 1e-10 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 1e-10 | ||
| 1eh4_A | 298 | Binary Complex Of Casein Kinase-1 From S. Pombe Wit | 1e-10 | ||
| 2csn_A | 297 | Binary Complex Of Casein Kinase-1 With Cki7 Length | 1e-10 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 1e-10 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 1e-10 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 2e-10 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-10 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 2e-10 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 2e-10 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 2e-10 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 2e-10 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 2e-10 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 2e-10 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 3e-10 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 3e-10 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 3e-10 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 3e-10 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-10 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 3e-10 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 3e-10 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 3e-10 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-10 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 3e-10 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 3e-10 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 3e-10 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 4e-10 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 4e-10 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-10 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 4e-10 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 4e-10 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 4e-10 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-10 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 4e-10 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 4e-10 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 4e-10 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 5e-10 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 5e-10 | ||
| 4hni_A | 296 | Crystal Structure Of Ck1e In Complex With Pf4800567 | 5e-10 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 5e-10 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 5e-10 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 5e-10 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 5e-10 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 6e-10 | ||
| 3uys_A | 296 | Crystal Structure Of Apo Human Ck1d Length = 296 | 6e-10 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 6e-10 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 6e-10 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 6e-10 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 6e-10 | ||
| 1ckj_A | 317 | Casein Kinase I Delta Truncation Mutant Containing | 6e-10 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 6e-10 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 6e-10 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 6e-10 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 6e-10 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 6e-10 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 6e-10 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 6e-10 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 7e-10 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 7e-10 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 7e-10 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 7e-10 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 7e-10 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 7e-10 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 7e-10 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 7e-10 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 7e-10 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 7e-10 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 7e-10 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 7e-10 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 7e-10 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 7e-10 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 7e-10 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 7e-10 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 7e-10 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 7e-10 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 8e-10 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 8e-10 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 8e-10 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 8e-10 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 8e-10 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 8e-10 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 8e-10 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 8e-10 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 8e-10 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 8e-10 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 8e-10 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 8e-10 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 8e-10 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 9e-10 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 9e-10 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 9e-10 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 9e-10 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 9e-10 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 9e-10 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 9e-10 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 9e-10 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 9e-10 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 9e-10 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 9e-10 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 9e-10 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 9e-10 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 9e-10 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 9e-10 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 9e-10 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 9e-10 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 9e-10 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 9e-10 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 9e-10 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 9e-10 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 1e-09 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 1e-09 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 1e-09 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 1e-09 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 1e-09 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 1e-09 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 1e-09 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 1e-09 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 1e-09 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 1e-09 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 1e-09 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 1e-09 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 1e-09 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-09 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 1e-09 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-09 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 1e-09 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 1e-09 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 1e-09 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 1e-09 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 1e-09 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 1e-09 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 1e-09 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 1e-09 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 1e-09 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 1e-09 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 2e-09 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 2e-09 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 2e-09 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 2e-09 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 2e-09 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 2e-09 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 2e-09 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 2e-09 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 2e-09 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 2e-09 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 2e-09 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 2e-09 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 2e-09 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 2e-09 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 2e-09 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 2e-09 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 2e-09 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 2e-09 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-09 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 2e-09 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 2e-09 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 2e-09 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 2e-09 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 2e-09 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 2e-09 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 2e-09 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 2e-09 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 2e-09 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 2e-09 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 2e-09 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 2e-09 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 2e-09 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 2e-09 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 2e-09 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-09 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 2e-09 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 2e-09 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 2e-09 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 2e-09 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 2e-09 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 2e-09 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 3e-09 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 3e-09 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 3e-09 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 3e-09 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 3e-09 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 3e-09 | ||
| 3sv0_A | 483 | Crystal Structure Of Casein Kinase-1 Like Protein I | 3e-09 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 3e-09 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 3e-09 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 3e-09 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 3e-09 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 3e-09 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 3e-09 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 3e-09 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-09 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 3e-09 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 4e-09 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-09 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 4e-09 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 4e-09 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 4e-09 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-09 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 4e-09 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 5e-09 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 5e-09 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 5e-09 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 5e-09 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 6e-09 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 6e-09 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 6e-09 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 6e-09 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 6e-09 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 6e-09 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 6e-09 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 6e-09 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 7e-09 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 7e-09 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 7e-09 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 7e-09 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 7e-09 | ||
| 3nr9_A | 368 | Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length | 8e-09 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 9e-09 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-09 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 9e-09 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 1e-08 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-08 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 1e-08 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-08 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 1e-08 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-08 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-08 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 1e-08 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 1e-08 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-08 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 1e-08 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 1e-08 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 1e-08 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 2e-08 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 2e-08 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 2e-08 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 2e-08 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 2e-08 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 2e-08 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 2e-08 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-08 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 2e-08 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 2e-08 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 2e-08 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 2e-08 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 2e-08 | ||
| 2cmw_A | 310 | Structure Of Human Casein Kinase 1 Gamma-1 In Compl | 2e-08 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 3e-08 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 3e-08 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 3e-08 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 3e-08 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 3e-08 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 3e-08 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 3e-08 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 4e-08 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 4e-08 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 4e-08 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 4e-08 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 4e-08 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 4e-08 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 4e-08 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 5e-08 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 5e-08 | ||
| 3llt_A | 360 | Crystal Structure Of Pf14_0431, Kinase Domain Lengt | 5e-08 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 5e-08 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-08 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 5e-08 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 5e-08 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 5e-08 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 5e-08 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 6e-08 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 6e-08 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 6e-08 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 6e-08 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 7e-08 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 7e-08 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 7e-08 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 7e-08 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 7e-08 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 7e-08 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 7e-08 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 7e-08 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 7e-08 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 7e-08 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 7e-08 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 7e-08 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 7e-08 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 7e-08 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-08 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 8e-08 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 8e-08 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 8e-08 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 8e-08 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 8e-08 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 8e-08 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 8e-08 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 9e-08 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 9e-08 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 9e-08 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 9e-08 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 9e-08 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 1e-07 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 1e-07 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-07 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 1e-07 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-07 | ||
| 2c47_A | 313 | Structure Of Casein Kinase 1 Gamma 2 Length = 313 | 1e-07 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 1e-07 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 2e-07 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 2e-07 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 2e-07 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 2e-07 | ||
| 3kga_A | 299 | Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe | 2e-07 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 2e-07 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 2e-07 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 2e-07 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 2e-07 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 3e-07 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 3e-07 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 3e-07 | ||
| 2eu9_A | 355 | Crystal Structure Of Clk3 Length = 355 | 3e-07 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 3e-07 | ||
| 2exe_A | 357 | Crystal Structure Of The Phosphorylated Clk3 Length | 3e-07 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 3e-07 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 3e-07 | ||
| 2wu6_A | 381 | Crystal Structure Of The Human Clk3 In Complex With | 3e-07 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 3e-07 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 3e-07 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 4e-07 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 4e-07 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 4e-07 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 4e-07 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 5e-07 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 5e-07 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 5e-07 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 5e-07 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 5e-07 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 5e-07 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 5e-07 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 5e-07 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 5e-07 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 5e-07 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 5e-07 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 5e-07 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 5e-07 | ||
| 4hgl_A | 330 | Crystal Structure Of Ck1g3 With Compound 1 Length = | 5e-07 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 5e-07 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 5e-07 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 6e-07 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 6e-07 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 6e-07 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 6e-07 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 6e-07 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 6e-07 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 6e-07 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 7e-07 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 7e-07 | ||
| 2pzi_A | 681 | Crystal Structure Of Protein Kinase Pkng From Mycob | 8e-07 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 8e-07 | ||
| 3e3b_X | 339 | Crystal Structure Of Catalytic Subunit Of Human Pro | 9e-07 | ||
| 3ofm_A | 350 | Structure Of A Human Ck2alpha Prime, The Paralog Is | 9e-07 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 1e-06 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-06 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-06 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 1e-06 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 1e-06 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 1e-06 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 1e-06 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-06 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 1e-06 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 1e-06 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 1e-06 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 1e-06 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 1e-06 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 1e-06 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 1e-06 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 1e-06 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 1e-06 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 1e-06 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 1e-06 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 2e-06 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 2e-06 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 2e-06 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 2e-06 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 2e-06 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 2e-06 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 2e-06 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 2e-06 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 2e-06 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 2e-06 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 2e-06 | ||
| 2chl_A | 351 | Structure Of Casein Kinase 1 Gamma 3 Length = 351 | 2e-06 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-06 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-06 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 2e-06 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 2e-06 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 2e-06 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 2e-06 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 2e-06 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 2e-06 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 2e-06 | ||
| 2izr_A | 330 | Structure Of Casein Kinase Gamma 3 In Complex With | 2e-06 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 2e-06 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 2e-06 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 2e-06 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 2e-06 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 2e-06 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-06 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 2e-06 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 3e-06 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 3e-06 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 3e-06 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 3e-06 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 3e-06 | ||
| 3gni_B | 389 | Structure Of Strad And Mo25 Length = 389 | 3e-06 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 3e-06 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 3e-06 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 3e-06 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 3e-06 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 3e-06 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 3e-06 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 3e-06 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 3e-06 | ||
| 3u87_A | 349 | Structure Of A Chimeric Construct Of Human Ck2alpha | 3e-06 | ||
| 2wtk_B | 373 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 3e-06 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 3e-06 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 3e-06 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 3e-06 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 3e-06 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 3e-06 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 3e-06 | ||
| 2zjw_A | 340 | Crystal Structure Of Human Ck2 Alpha Complexed With | 3e-06 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 3e-06 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 3e-06 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 3e-06 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 3e-06 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 3e-06 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 3e-06 | ||
| 1jwh_A | 337 | Crystal Structure Of Human Protein Kinase Ck2 Holoe | 3e-06 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 3e-06 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 4e-06 | ||
| 2r7i_A | 335 | Crystal Structure Of Catalytic Subunit Of Protein K | 4e-06 | ||
| 3q9w_A | 336 | Crystal Structure Of Human Ck2 Alpha In Complex Wit | 4e-06 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 4e-06 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 4e-06 | ||
| 3bqc_A | 335 | High Ph-Value Crystal Structure Of Emodin In Comple | 4e-06 | ||
| 3h30_A | 334 | Crystal Structure Of The Catalytic Subunit Of Human | 4e-06 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 4e-06 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 4e-06 | ||
| 1pjk_A | 334 | Crystal Structure Of A C-terminal Deletion Mutant O | 4e-06 | ||
| 4dgl_C | 335 | Crystal Structure Of The Ck2 Tetrameric Holoenzyme | 4e-06 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 4e-06 | ||
| 3nga_A | 333 | Human Ck2 Catalytic Domain In Complex With Cx-4945 | 4e-06 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 4e-06 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 4e-06 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 4e-06 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 4e-06 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 4e-06 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 4e-06 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 4e-06 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 5e-06 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 5e-06 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 5e-06 | ||
| 2x7g_A | 389 | Structure Of Human Serine-Arginine-Rich Protein-Spe | 5e-06 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 5e-06 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 5e-06 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 5e-06 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 5e-06 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 5e-06 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 5e-06 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 5e-06 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 5e-06 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 6e-06 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 6e-06 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 6e-06 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 6e-06 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 6e-06 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 6e-06 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 6e-06 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 6e-06 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 6e-06 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 6e-06 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 6e-06 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 7e-06 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 7e-06 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 7e-06 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 7e-06 | ||
| 3q04_A | 328 | Crystal Structure Of The Apo-Form Of Human Ck2 Alph | 8e-06 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 8e-06 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 8e-06 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 8e-06 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 8e-06 | ||
| 3mb6_A | 331 | Human Ck2 Catalytic Domain In Complex With A Difura | 8e-06 | ||
| 3nsz_A | 330 | Human Ck2 Catalytic Domain In Complex With Amppn Le | 9e-06 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 9e-06 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 1e-05 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 1e-05 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 1e-05 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 1e-05 | ||
| 2lav_A | 361 | Nmr Solution Structure Of Human Vaccinia-Related Ki | 1e-05 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 1e-05 | ||
| 2kty_A | 368 | Solution Structure Of Human Vaccinia Related Kinase | 1e-05 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 1e-05 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-05 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 1e-05 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 2e-05 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 2e-05 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 2e-05 | ||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 2e-05 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 2e-05 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 2e-05 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 2e-05 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 2e-05 | ||
| 3op5_A | 364 | Human Vaccinia-Related Kinase 1 Length = 364 | 2e-05 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 2e-05 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 2e-05 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 3e-05 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 4e-05 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 4e-05 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 4e-05 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 4e-05 | ||
| 1x8b_A | 289 | Structure Of Human Wee1a Kinase: Kinase Domain Comp | 4e-05 | ||
| 1z57_A | 339 | Crystal Structure Of Human Clk1 In Complex With 10z | 5e-05 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 5e-05 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 5e-05 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 5e-05 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 5e-05 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 5e-05 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 5e-05 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 6e-05 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 6e-05 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 6e-05 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 6e-05 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 7e-05 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 8e-05 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 8e-05 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 9e-05 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 9e-05 | ||
| 1wbp_A | 397 | Srpk1 Bound To 9mer Docking Motif Peptide Length = | 9e-05 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 1e-04 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 1e-04 | ||
| 3beg_A | 381 | Crystal Structure Of Sr Protein Kinase 1 Complexed | 1e-04 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-04 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 1e-04 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 1e-04 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 1e-04 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 1e-04 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 1e-04 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 1e-04 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 1e-04 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 1e-04 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 1e-04 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-04 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 1e-04 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 1e-04 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-04 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 1e-04 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-04 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-04 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 1e-04 | ||
| 2pvh_A | 352 | Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri | 2e-04 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 2e-04 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-04 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 2e-04 | ||
| 4anm_A | 335 | Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | 2e-04 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 2e-04 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 2e-04 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 2e-04 | ||
| 1ds5_A | 332 | Dimeric Crystal Structure Of The Alpha Subunit In C | 2e-04 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 2e-04 | ||
| 2qc6_A | 332 | Protein Kinase Ck2 In Complex With Dbc Length = 332 | 2e-04 | ||
| 3pvg_A | 331 | Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C | 2e-04 | ||
| 1daw_A | 327 | Crystal Structure Of A Binary Complex Of Protein Ki | 2e-04 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 2e-04 | ||
| 1m2p_A | 325 | Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra | 2e-04 | ||
| 4dgm_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 2e-04 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 2e-04 | ||
| 4dgn_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 2e-04 | ||
| 3kxg_A | 327 | Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun | 2e-04 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 2e-04 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 2e-04 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-04 | ||
| 2vag_A | 339 | Crystal Structure Of Di-Phosphorylated Human Clk1 I | 3e-04 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 3e-04 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 3e-04 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 3e-04 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 3e-04 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 3e-04 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-04 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 3e-04 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 3e-04 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 3e-04 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 3e-04 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 3e-04 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 3e-04 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 4e-04 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 4e-04 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 4e-04 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 4e-04 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 4e-04 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 4e-04 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 4e-04 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 4e-04 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 4e-04 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 5e-04 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 5e-04 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 5e-04 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 5e-04 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 5e-04 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 5e-04 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 6e-04 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 6e-04 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 6e-04 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 6e-04 | ||
| 2v62_A | 345 | Structure Of Vaccinia-Related Kinase 2 Length = 345 | 6e-04 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 6e-04 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 6e-04 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 7e-04 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 7e-04 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 8e-04 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 9e-04 |
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|1EH4|A Chain A, Binary Complex Of Casein Kinase-1 From S. Pombe With An Atp Competitive Inhibitor, Ic261 Length = 298 | Back alignment and structure |
|
| >pdb|2CSN|A Chain A, Binary Complex Of Casein Kinase-1 With Cki7 Length = 297 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|4HNI|A Chain A, Crystal Structure Of Ck1e In Complex With Pf4800567 Length = 296 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3UYS|A Chain A, Crystal Structure Of Apo Human Ck1d Length = 296 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|1CKJ|A Chain A, Casein Kinase I Delta Truncation Mutant Containing Residues 1-317 Complex With Bound Tungstate Length = 317 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3SV0|A Chain A, Crystal Structure Of Casein Kinase-1 Like Protein In Plant Length = 483 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|2CMW|A Chain A, Structure Of Human Casein Kinase 1 Gamma-1 In Complex With 2-(2-Hydroxyethylamino)-6-(3-Chloroanilino)-9- Isopropylpurine (Casp Target) Length = 310 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2C47|A Chain A, Structure Of Casein Kinase 1 Gamma 2 Length = 313 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|4HGL|A Chain A, Crystal Structure Of Ck1g3 With Compound 1 Length = 330 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|2CHL|A Chain A, Structure Of Casein Kinase 1 Gamma 3 Length = 351 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|2IZR|A Chain A, Structure Of Casein Kinase Gamma 3 In Complex With Inhibitor Length = 330 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349 | Back alignment and structure |
|
| >pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334 | Back alignment and structure |
|
| >pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|2X7G|A Chain A, Structure Of Human Serine-Arginine-Rich Protein-Specific Kinase 2 (Srpk2) Bound To Purvalanol B Length = 389 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331 | Back alignment and structure |
|
| >pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2LAV|A Chain A, Nmr Solution Structure Of Human Vaccinia-Related Kinase 1 Length = 361 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|2KTY|A Chain A, Solution Structure Of Human Vaccinia Related Kinase-1 Length = 368 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3OP5|A Chain A, Human Vaccinia-Related Kinase 1 Length = 364 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289 | Back alignment and structure |
|
| >pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|1WBP|A Chain A, Srpk1 Bound To 9mer Docking Motif Peptide Length = 397 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|3BEG|A Chain A, Crystal Structure Of Sr Protein Kinase 1 Complexed To Its Substrate AsfSF2 Length = 381 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332 | Back alignment and structure |
|
| >pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331 | Back alignment and structure |
|
| >pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325 | Back alignment and structure |
|
| >pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326 | Back alignment and structure |
|
| >pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2V62|A Chain A, Structure Of Vaccinia-Related Kinase 2 Length = 345 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 222 bits (568), Expect = 6e-71
Identities = 80/286 (27%), Positives = 133/286 (46%), Gaps = 29/286 (10%)
Query: 2 DSDGTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVSASAS---LQKEKEVF 58
D + V+G+G++G V+ + SN +A+K S L +E +
Sbjct: 18 DYEYDENGDRVVLGKGTYGIVYAGRDLSNQVR----IAIKEIPERDSRYSQPLHEEIALH 73
Query: 59 DNLNGCPFVLECFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNG-LPEKDVRHF 117
+L +++ G + +E GG+L L+ G E+ + +
Sbjct: 74 KHLK-HKNIVQYLGSFSE-----NGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFY 127
Query: 118 TRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPS 177
T+ ILEG+ ++HD+ VH D+K DN+L + T SG V KI+D G +KR +
Sbjct: 128 TKQILEGLKYLHDNQIVHRDIKGDNVL-INTYSG--VLKISDFGTSKRLAGINPCT--ET 182
Query: 178 MRGTPLYLAPETVVQHMQ--EAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSI--- 232
GT Y+APE + + + +DIW+LGC ++EM +G+ + + + +
Sbjct: 183 FTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPF-----YELGEPQAAMFK 237
Query: 233 IGDEHSLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVK 278
+G PEIP +S EA+ F+ +CF P R A LL D F+K
Sbjct: 238 VGMFKVHPEIPESMSAEAKAFILKCFEPDPDKRACANDLLVDEFLK 283
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 214 bits (546), Expect = 4e-67
Identities = 69/280 (24%), Positives = 111/280 (39%), Gaps = 23/280 (8%)
Query: 3 SDGTSWFRGR-VIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVSASASLQKEKEVFDNL 61
+ W + +G+GSFG V K K AVK +V +E L
Sbjct: 54 REEVHWMTHQPRVGRGSFGEVHRMKDKQTGF----QCAVK--KVRLEVFRVEELVACAGL 107
Query: 62 NGCPFVLECFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCI 121
+ P ++ +G N+ +E GG+LG LI++ LPE ++
Sbjct: 108 S-SPRIVPLYGAVRE-----GPWVNIFMELLEGGSLGQLIKQMGC--LPEDRALYYLGQA 159
Query: 122 LEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKR---SRHCKRQKFDPSM 178
LEG+ ++H +H DVK DN+LL + G + D G A K +
Sbjct: 160 LEGLEYLHTRRILHGDVKADNVLL--SSDGSRA-ALCDFGHALCLQPDGLGKSLLTGDYI 216
Query: 179 RGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEHS 238
GT ++APE V+ +A DIW+ C++L ML+G W + I +
Sbjct: 217 PGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPL--CLKIASEPPP 274
Query: 239 LPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVK 278
+ EIP + ++ ++P R +A L
Sbjct: 275 IREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKA 314
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 195 bits (499), Expect = 2e-60
Identities = 68/303 (22%), Positives = 120/303 (39%), Gaps = 37/303 (12%)
Query: 5 GTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVK-----SAEVSASASLQKEKEVFD 59
G + + IG G VF + + A+K A+ S + E +
Sbjct: 27 GRIYSILKQIGSGGSSKVFQVLNEKKQ-----IYAIKYVNLEEADNQTLDSYRNEIAYLN 81
Query: 60 NLNG-CPFVLECFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFT 118
L ++ + EIT +++E L ++K + + + + +
Sbjct: 82 KLQQHSDKIIRLYDYEITDQY-----IYMVMECG-NIDLNSWLKK-KKS-IDPWERKSYW 133
Query: 119 RCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSM 178
+ +LE + IH G VH D+KP N L+V + K+ D G+A + + S
Sbjct: 134 KNMLEAVHTIHQHGIVHSDLKPANFLIV-----DGMLKLIDFGIANQMQPDTTSVVKDSQ 188
Query: 179 RGTPLYLAPETVVQHMQE-----------APSDIWALGCVVLEMLSGRQAWVVKEDCSID 227
GT Y+ PE + SD+W+LGC++ M G+ + + I
Sbjct: 189 VGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN-QIS 247
Query: 228 QLFSIIGDEHSLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGVDEELSRE 287
+L +II H E P K+ +D L+ C R P R + LL P+V+ +++
Sbjct: 248 KLHAIIDPNHE-IEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQM 306
Query: 288 LEG 290
+G
Sbjct: 307 AKG 309
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 196 bits (499), Expect = 4e-60
Identities = 69/314 (21%), Positives = 123/314 (39%), Gaps = 37/314 (11%)
Query: 5 GTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVK-----SAEVSASASLQKEKEVFD 59
G + + IG G VF + + A+K A+ S + E +
Sbjct: 8 GRIYSILKQIGSGGSSKVFQVLNEKKQ-----IYAIKYVNLEEADNQTLDSYRNEIAYLN 62
Query: 60 NLNG-CPFVLECFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFT 118
L ++ + EIT +++E L ++K + + + + +
Sbjct: 63 KLQQHSDKIIRLYDYEITDQY-----IYMVMECG-NIDLNSWLKK-KKS-IDPWERKSYW 114
Query: 119 RCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSM 178
+ +LE + IH G VH D+KP N L+V + K+ D G+A + + S
Sbjct: 115 KNMLEAVHTIHQHGIVHSDLKPANFLIV-----DGMLKLIDFGIANQMQPDTTSVVKDSQ 169
Query: 179 RGTPLYLAPETVVQHMQE-----------APSDIWALGCVVLEMLSGRQAWVVKEDCSID 227
GT Y+ PE + SD+W+LGC++ M G+ + + I
Sbjct: 170 VGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN-QIS 228
Query: 228 QLFSIIGDEHSLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGVDEELSRE 287
+L +II H E P K+ +D L+ C R P R + LL P+V+ +++
Sbjct: 229 KLHAIIDPNHE-IEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQM 287
Query: 288 LEGDYSQGEVTLSN 301
+G + + L
Sbjct: 288 AKGTTEEMKYVLGQ 301
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 196 bits (500), Expect = 1e-59
Identities = 71/326 (21%), Positives = 125/326 (38%), Gaps = 38/326 (11%)
Query: 5 GTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVK-----SAEVSASASLQKEKEVFD 59
G + + IG G VF + + A+K A+ S + E +
Sbjct: 55 GRIYSILKQIGSGGSSKVFQVLNEKKQ-----IYAIKYVNLEEADNQTLDSYRNEIAYLN 109
Query: 60 NLNG-CPFVLECFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFT 118
L ++ + EIT +++E L ++K + + + + +
Sbjct: 110 KLQQHSDKIIRLYDYEITDQY-----IYMVMECG-NIDLNSWLKK-KKS-IDPWERKSYW 161
Query: 119 RCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSM 178
+ +LE + IH G VH D+KP N L+V + K+ D G+A + + S
Sbjct: 162 KNMLEAVHTIHQHGIVHSDLKPANFLIV-----DGMLKLIDFGIANQMQPDTTSVVKDSQ 216
Query: 179 RGTPLYLAPETVVQHMQE-----------APSDIWALGCVVLEMLSGRQAWVVKEDCSID 227
G Y+ PE + SD+W+LGC++ M G+ + + I
Sbjct: 217 VGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIIN-QIS 275
Query: 228 QLFSIIGDEHSLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGVDEELSRE 287
+L +II H E P K+ +D L+ C R P R + LL P+V+ +++
Sbjct: 276 KLHAIIDPNHE-IEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQM 334
Query: 288 LEGDYSQGEVTLSNADAESCSPECIS 313
+G + + L SP I
Sbjct: 335 AKGTTEEMKYVLGQ-LVGLNSPNSIL 359
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 190 bits (484), Expect = 2e-58
Identities = 65/284 (22%), Positives = 119/284 (41%), Gaps = 23/284 (8%)
Query: 1 MDSDGTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVS--ASASLQKEKEVF 58
M +DG IG+GSF V+ + +A + + Q+ KE
Sbjct: 21 MSNDGRFLKFDIEIGRGSFKTVYKGLDTETTVE----VAWCELQDRKLTKSERQRFKEEA 76
Query: 59 DNLNGC--PFVLECFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRH 116
+ L G P ++ + + + + L+ E GTL +++ + K +R
Sbjct: 77 EMLKGLQHPNIVRFYDSWESTVKGKK-CIVLVTELMTSGTLKTYLKRFKV--MKIKVLRS 133
Query: 117 FTRCILEGIGHIHDSGY--VHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKF 174
+ R IL+G+ +H +H D+K DNI + +G KI DLG+A KR F
Sbjct: 134 WCRQILKGLQFLHTRTPPIIHRDLKCDNIF-ITGPTG--SVKIGDLGLAT----LKRASF 186
Query: 175 DPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIG 234
++ GTP ++APE + E+ D++A G +LEM + + E + Q++ +
Sbjct: 187 AKAVIGTPEFMAPEMYEEKYDES-VDVYAFGMCMLEMATSEYPY--SECQNAAQIYRRVT 243
Query: 235 DEHSLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVK 278
E ++ + C + R++ + LL+ F +
Sbjct: 244 SGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ 287
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 189 bits (482), Expect = 3e-58
Identities = 68/305 (22%), Positives = 104/305 (34%), Gaps = 52/305 (17%)
Query: 1 MDSDGTS-WFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVK-----SAEVSASASLQKE 54
M S T+ + IG G FG VF + + + A+K A + +E
Sbjct: 5 MKSRYTTEFHELEKIGSGEFGSVFKCVKRLDGC----IYAIKRSKKPLAGSVDEQNALRE 60
Query: 55 KEVFDNLNGCPFVLECFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNG--LPEK 112
L V+ F E+ M + EY GG+L D I + E
Sbjct: 61 VYAHAVLGQHSHVVRYFSAWA---EDDHM--LIQNEYCNGGSLADAISENYRIMSYFKEA 115
Query: 113 DVRHFTRCILEGIGHIHDSGYVHCDVKPDNILL---------------VATQSGKFVAKI 157
+++ + G+ +IH VH D+KP NI + S K + KI
Sbjct: 116 ELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKI 175
Query: 158 ADLGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAP----SDIWALGCVVLEMLS 213
DLG R G +LA E V+Q + +DI+AL V+
Sbjct: 176 GDLGHV------TRISSPQVEEGDSRFLANE-VLQ--ENYTHLPKADIFALALTVVCAAG 226
Query: 214 GRQAWVVKEDCSIDQLFSIIGDEHSLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLD 273
+ I LP IP +S+E + L+ P R +A L+
Sbjct: 227 AEPLP------RNGDQWHEIRQGR-LPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVK 279
Query: 274 DPFVK 278
+
Sbjct: 280 HSVLL 284
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 187 bits (478), Expect = 3e-57
Identities = 74/278 (26%), Positives = 103/278 (37%), Gaps = 30/278 (10%)
Query: 6 TSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVK-----SAEVSASASLQKEKEVFDN 60
S+ R +G GS+G VF + K + L AVK A E +
Sbjct: 57 QSFQRLSRLGHGSYGEVFKVRSKEDGR----LYAVKRSMSPFRGPKDRARKLAEVGSHEK 112
Query: 61 LNGCPFVLECFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRC 120
+ P + E G + L E G +L E G LPE V + R
Sbjct: 113 VGQHPCCVRLEQAWE---EGGIL--YLQTELC-GPSLQQHCEA-WGASLPEAQVWGYLRD 165
Query: 121 ILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMRG 180
L + H+H G VH DVKP NI L G K+ D G+ G
Sbjct: 166 TLLALAHLHSQGLVHLDVKPANIFL--GPRG--RCKLGDFGLLV---ELGTAGAGEVQEG 218
Query: 181 TPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEHSLP 240
P Y+APE ++Q +D+++LG +LE+ + QL P
Sbjct: 219 DPRYMAPE-LLQGSYGTAADVFSLGLTILEVACNMELP--HGGEGWQQLRQGY----LPP 271
Query: 241 EIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVK 278
E + +S E R L P R TAE LL P ++
Sbjct: 272 EFTAGLSSELRSVLVMMLEPDPKLRATAEALLALPVLR 309
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 181 bits (461), Expect = 3e-54
Identities = 77/340 (22%), Positives = 135/340 (39%), Gaps = 37/340 (10%)
Query: 10 RGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVSASA-------SLQKEKEVFDNLN 62
R + IG+GSFG + K + +K E++ S ++E V N+
Sbjct: 28 RLQKIGEGSFGKAILVKSTEDGRQY----VIK--EINISRMSSKEREESRREVAVLANMK 81
Query: 63 GCPFVLECFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCIL 122
P +++ G ++++Y GG L I G E + + I
Sbjct: 82 -HPNIVQYRESFEENGS-----LYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQIC 135
Query: 123 EGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMRGTP 182
+ H+HD +H D+K NI L T+ G ++ D G+A+ + + GTP
Sbjct: 136 LALKHVHDRKILHRDIKSQNIFL--TKDG--TVQLGDFGIARVLNS--TVELARACIGTP 189
Query: 183 LYLAPETVVQHMQ-EAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFS-IIGDEHSLP 240
YL+PE + ++ SDIWALGCV+ E+ + + A+ E S+ L II P
Sbjct: 190 YYLSPE-ICENKPYNNKSDIWALGCVLYELCTLKHAF---EAGSMKNLVLKIISGSF--P 243
Query: 241 EIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGVDEELSRELEGDYSQGEVTLS 300
+ S + R + + F R P R + +L+ F+ E+ T S
Sbjct: 244 PVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEKGFIAKRIEKFLSPQLIAEEFCLKTFS 303
Query: 301 NADAESCSPECISFIPLEANSSLSSWGSAQRTNEGSTITV 340
++ + P +S+S + + T + +
Sbjct: 304 KFGSQPIPAKR----PASGQNSISVMPAQKITKPAAKYGI 339
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 172 bits (437), Expect = 1e-51
Identities = 63/292 (21%), Positives = 107/292 (36%), Gaps = 39/292 (13%)
Query: 10 RGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVS-ASASLQKEKEVFDNLNGCPFV- 67
+IG G FG VF AK + + +K V + ++E + L+ +
Sbjct: 15 EIELIGSGGFGQVFKAKHRIDGK----TYVIK--RVKYNNEKAEREVKALAKLD-HVNIV 67
Query: 68 --LECFGEEITMGENGEMAYN--------LLLEYAAGGTLGDLIEKCNGNGLPEKDVRHF 117
C+ E + + +E+ GTL IEK G L +
Sbjct: 68 HYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALEL 127
Query: 118 TRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKR-SRHCKRQKFDP 176
I +G+ +IH ++ D+KP NI L + KI D G+ KR +
Sbjct: 128 FEQITKGVDYIHSKKLINRDLKPSNIFL--VDTK--QVKIGDFGLVTSLKNDGKRTRS-- 181
Query: 177 SMRGTPLYLAPETVVQHMQ-EAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGD 235
+GT Y++PE + D++ALG ++ E+L V + F+ + D
Sbjct: 182 --KGTLRYMSPE-QISSQDYGKEVDLYALGLILAELL-----HVCDTAFETSKFFTDLRD 233
Query: 236 EHSLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGVDEELSRE 287
I K+ + L++ +KP R +L V E +
Sbjct: 234 ----GIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEKNER 281
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 172 bits (437), Expect = 3e-51
Identities = 69/278 (24%), Positives = 124/278 (44%), Gaps = 27/278 (9%)
Query: 10 RGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVSASAS------LQKEKEVFDNLNG 63
+ IG+G F V+ A + +A+K ++ KE ++ LN
Sbjct: 36 IEKKIGRGQFSEVYRAACLLDGV----PVALKKVQIFDLMDAKARADCIKEIDLLKQLN- 90
Query: 64 CPFVLECFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKC--NGNGLPEKDVRHFTRCI 121
P V++ + I E+ E+ N++LE A G L +I+ +PE+ V + +
Sbjct: 91 HPNVIKYYASFI---EDNEL--NIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQL 145
Query: 122 LEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMRGT 181
+ H+H +H D+KP N+ + T +G V K+ DLG+ + + S+ GT
Sbjct: 146 CSALEHMHSRRVMHRDIKPANVFI--TATG--VVKLGDLGLGRFFSS--KTTAAHSLVGT 199
Query: 182 PLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEHSLPE 241
P Y++PE + ++ SDIW+LGC++ EM + + + + ++ L I ++ P
Sbjct: 200 PYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPF-YGDKMNLYSLCKKI-EQCDYPP 257
Query: 242 IPS-RVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVK 278
+PS S+E R + C P R + D
Sbjct: 258 LPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRM 295
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 167 bits (424), Expect = 1e-49
Identities = 70/284 (24%), Positives = 115/284 (40%), Gaps = 36/284 (12%)
Query: 10 RGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVSASASLQKEKE-------VFDNLN 62
IG GS+G + KS+ ++ K E+ + + EK+ + L
Sbjct: 10 VLYTIGTGSYGRCQKIRRKSDGK----ILVWK--ELDYGSMTEAEKQMLVSEVNLLRELK 63
Query: 63 GCPFVLECFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNG--LPEKDVRHFTRC 120
P ++ + + I N +++EY GG L +I K L E+ V
Sbjct: 64 -HPNIVRYY-DRIIDRTNTT--LYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQ 119
Query: 121 ILEGIGHIHDSGY-----VHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFD 175
+ + H +H D+KP N+ L GK K+ D G+A+ H F
Sbjct: 120 LTLALKECHRRSDGGHTVLHRDLKPANVFL----DGKQNVKLGDFGLARILNH--DTSFA 173
Query: 176 PSMRGTPLYLAPETVVQHMQ-EAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIG 234
+ GTP Y++PE + M SDIW+LGC++ E+ + + S +L I
Sbjct: 174 KTFVGTPYYMSPE-QMNRMSYNEKSDIWSLGCLLYELCALMPPFTAF---SQKELAGKI- 228
Query: 235 DEHSLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVK 278
E IP R S E + + R K R + E +L++P +
Sbjct: 229 REGKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLIL 272
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 170 bits (432), Expect = 2e-49
Identities = 61/286 (21%), Positives = 110/286 (38%), Gaps = 22/286 (7%)
Query: 7 SWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVSASASLQKEKEVFDNLNGCPF 66
S+ V+G G+ G + N AVK + +E ++ + P
Sbjct: 25 SFCPKDVLGHGAEGTIVYRGMFDNRDV-----AVKRILPECFSFADREVQLLRESDEHPN 79
Query: 67 VLECFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIG 126
V+ F E + +E TL + +E+ + + G+
Sbjct: 80 VIRYFCTEKD-----RQFQYIAIELC-AATLQEYVEQ-KDFAHLGLEPITLLQQTTSGLA 132
Query: 127 HIHDSGYVHCDVKPDNILLVAT-QSGKFVAKIADLGVAKR-SRHCKRQKFDPSMRGTPLY 184
H+H VH D+KP NIL+ GK A I+D G+ K+ + + GT +
Sbjct: 133 HLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGW 192
Query: 185 LAPETVVQHMQEAPS---DIWALGCVVLEMLS-GRQAWVVKEDCSIDQLFSIIGDEH-SL 239
+APE + + +E P+ DI++ GCV ++S G + Q ++G
Sbjct: 193 IAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPF---GKSLQRQANILLGACSLDC 249
Query: 240 PEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGVDEELS 285
AR+ + + P R +A+ +L PF ++++L
Sbjct: 250 LHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWSLEKQLQ 295
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 166 bits (423), Expect = 3e-49
Identities = 68/305 (22%), Positives = 112/305 (36%), Gaps = 43/305 (14%)
Query: 11 GRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVSAS--ASLQKEKEVFDNLNGCPFVL 68
V+GQG+FG V A+ +S A+K + +++ E + +LN +V+
Sbjct: 11 IAVLGQGAFGQVVKARNALDSR----YYAIKKIRHTEEKLSTILSEVMLLASLN-HQYVV 65
Query: 69 ---ECFGEEITMGENGEMAYN-----LLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRC 120
+ E + + +EY GTL DLI N N + R
Sbjct: 66 RYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLN-QQRDEYWRLFRQ 124
Query: 121 ILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMR- 179
ILE + +IH G +H D+KP NI + +S KI D G+AK S
Sbjct: 125 ILEALSYIHSQGIIHRDLKPMNIFI--DESRN--VKIGDFGLAKNVHRSLDILKLDSQNL 180
Query: 180 -----------GTPLYLAPETVVQHMQE--APSDIWALGCVVLEMLSGRQAWVVKEDCSI 226
GT +Y+A E V+ D+++LG + EM+
Sbjct: 181 PGSSDNLTSAIGTAMYVATE-VLDGTGHYNEKIDMYSLGIIFFEMIYPFST-----GMER 234
Query: 227 DQLFSII--GDEHSLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVK-GVDEE 283
+ + P+ K + +R P R A LL+ ++ +E
Sbjct: 235 VNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPVKHQDE 294
Query: 284 LSREL 288
+ +E
Sbjct: 295 VIKEA 299
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 160 bits (407), Expect = 9e-47
Identities = 68/284 (23%), Positives = 105/284 (36%), Gaps = 35/284 (12%)
Query: 11 GRVIGQGSFGCVFIAKPKSNSSFLPPLMAVK---SAEVSASASLQKEKEVFDNLNGCPFV 67
+ +G+G F V + + + F A+K E Q+E ++ N P +
Sbjct: 34 IQKLGEGGFSYVDLVEGLHDGHFY----ALKRILCHEQQDREEAQREADMHRLFN-HPNI 88
Query: 68 LECFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKC--NGNGLPEKDVRHFTRCILEGI 125
L + A+ LLL + GTL + IE+ GN L E + I G+
Sbjct: 89 LRLVAYCLRERGAKHEAW-LLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGL 147
Query: 126 GHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRH-------CKRQKFDPSM 178
IH GY H D+KP NILL G+ + DLG ++ + +
Sbjct: 148 EAIHAKGYAHRDLKPTNILL--GDEGQP--VLMDLGSMNQACIHVEGSRQALTLQDWAAQ 203
Query: 179 RGTPLYLAPETVVQHMQEAP----SDIWALGCVVLEMLSGR---QAWVVKEDCSIDQLFS 231
R T Y APE + +D+W+LGCV+ M+ G D +
Sbjct: 204 RCTISYRAPE-LFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDM----VFQKGDSVAL 258
Query: 232 IIGDEHSLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDP 275
+ ++ S+P R S L P R +LL
Sbjct: 259 AVQNQLSIP-QSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQL 301
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 159 bits (403), Expect = 2e-46
Identities = 53/295 (17%), Positives = 99/295 (33%), Gaps = 39/295 (13%)
Query: 10 RGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVSASA----SLQKEKEVFDNLNGCP 65
+ +G+G FG VF AK K + A+K + + +E + L P
Sbjct: 9 PIQCLGRGGFGVVFEAKNKVDDC----NYAIKRIRLPNRELAREKVMREVKALAKLE-HP 63
Query: 66 FV---LECFGEEITMGENGEMAYNLLL----EYAAGGTLGDLIEKCNGNGLPEKD-VRHF 117
+ + E+ T + + + L + L D + E+ H
Sbjct: 64 GIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHI 123
Query: 118 TRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKR----------SR 167
I E + +H G +H D+KP NI T V K+ D G+
Sbjct: 124 FLQIAEAVEFLHSKGLMHRDLKPSNIFF--TMDD--VVKVGDFGLVTAMDQDEEEQTVLT 179
Query: 168 HCKRQKFDPSMRGTPLYLAPETVVQHMQ-EAPSDIWALGCVVLEMLSGRQAWVVKEDCSI 226
GT LY++PE + DI++LG ++ E+L
Sbjct: 180 PMPAYARHTGQVGTKLYMSPE-QIHGNSYSHKVDIFSLGLILFELLYPFST-----QMER 233
Query: 227 DQLFSIIGDEHSLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGVD 281
+ + + P + ++ ++ P R A ++++ + +D
Sbjct: 234 VRTLTDV-RNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLD 287
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 3e-42
Identities = 61/305 (20%), Positives = 110/305 (36%), Gaps = 48/305 (15%)
Query: 8 WFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVK----SAEVSASASLQKEKEVFDNLNG 63
W ++GQG+ VF + K L A+K + + +E EV LN
Sbjct: 11 WLLSDILGQGATANVFRGRHKKTGD----LFAIKVFNNISFLRPVDVQMREFEVLKKLNH 66
Query: 64 CPFVLECFGEEITMGENGEMAYNLLLEYAAGGTLGD-LIEKCNGNGLPEKDVRHFTRCIL 122
+++ F I L++E+ G+L L E N GLPE + R ++
Sbjct: 67 -KNIVKLF--AIEEETTTRHKV-LIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVV 122
Query: 123 EGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMRGTP 182
G+ H+ ++G VH ++KP NI+ V + G+ V K+ D G A R + + S+ GT
Sbjct: 123 GGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA---RELEDDEQFVSLYGTE 179
Query: 183 LYLAPETVVQHMQEAPS--------DIWALGCVVLEMLSGRQAWVVKEDCSIDQ--LFSI 232
YL P+ + + D+W++G +G + E ++ ++ I
Sbjct: 180 EYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKI 239
Query: 233 IGDEHSL----------------------PEIPSRVSKEARDFLRRCFVRKPAFRFTAEM 270
I + S + + L + +
Sbjct: 240 ITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQ 299
Query: 271 LLDDP 275
+
Sbjct: 300 FFAET 304
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 9e-41
Identities = 64/309 (20%), Positives = 111/309 (35%), Gaps = 55/309 (17%)
Query: 11 GRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVSASASLQKEKEVFDNLNGCPFVLEC 70
+++G GS G V AVK + E ++ + P V+
Sbjct: 20 EKILGYGSSGTVVFQGSFQGRPV-----AVKRMLIDFCDIALMEIKLLTESDDHPNVIRY 74
Query: 71 FGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKC-----NGNGLPEKDVRHFTRCILEGI 125
+ E T + + LE L DL+E N E + R I G+
Sbjct: 75 YCSETT-----DRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGV 128
Query: 126 GHIHDSGYVHCDVKPDNILL---------VATQSGKFVAKIADLGVAKRSRHCKRQKFDP 176
H+H +H D+KP NIL+ T + I+D G+ K+ + F
Sbjct: 129 AHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDS-GQSSFRT 187
Query: 177 SMR---GTPLYLAPETVVQHMQEAPS-------DIWALGCVVLEMLSG----------RQ 216
++ GT + APE + + DI+++GCV +LS R+
Sbjct: 188 NLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE 247
Query: 217 AWVVKEDCSIDQLFSIIGDEHSLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPF 276
+ +++ S+D++ + + EA D + + P R TA +L P
Sbjct: 248 SNIIRGIFSLDEMKCLHDRS---------LIAEATDLISQMIDHDPLKRPTAMKVLRHPL 298
Query: 277 VKGVDEELS 285
++L
Sbjct: 299 FWPKSKKLE 307
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 2e-40
Identities = 61/304 (20%), Positives = 110/304 (36%), Gaps = 48/304 (15%)
Query: 8 WFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVK----SAEVSASASLQKEKEVFDNLNG 63
W ++GQG+ VF + K L A+K + + +E EV LN
Sbjct: 11 WLLSDILGQGATANVFRGRHKKTGD----LFAIKVFNNISFLRPVDVQMREFEVLKKLN- 65
Query: 64 CPFVLECFGEEITMGENGEMAYNLLLEYAAGGTLGD-LIEKCNGNGLPEKDVRHFTRCIL 122
+++ F I L++E+ G+L L E N GLPE + R ++
Sbjct: 66 HKNIVKLF--AIEEETTTRHKV-LIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVV 122
Query: 123 EGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMRGTP 182
G+ H+ ++G VH ++KP NI+ V + G+ V K+ D G A R + + S+ GT
Sbjct: 123 GGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA---RELEDDEQFVSLYGTE 179
Query: 183 LYLAPETVVQHMQEAPS--------DIWALGCVVLEMLSGRQAWVVKEDCSIDQ--LFSI 232
YL P+ + + D+W++G +G + E ++ ++ I
Sbjct: 180 EYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKI 239
Query: 233 IGDEHSLP----------------------EIPSRVSKEARDFLRRCFVRKPAFRFTAEM 270
I + S + + L + +
Sbjct: 240 ITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQ 299
Query: 271 LLDD 274
+
Sbjct: 300 FFAE 303
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 1e-38
Identities = 58/288 (20%), Positives = 105/288 (36%), Gaps = 38/288 (13%)
Query: 11 GRVIGQGSFGCVFIAKPKSNSSFLPPLMAVK---SAEVSASASLQKEKEVFDNLNGCPFV 67
RV+ +G F V+ A+ + A+K S E + ++ +E L+G P +
Sbjct: 33 RRVLAEGGFAFVYEAQDVGSGR----EYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNI 88
Query: 68 LECFGEEITMGE---NGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEG 124
++ E G+ + LL E G + L + + L V
Sbjct: 89 VQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRA 148
Query: 125 IGHIHDSG--YVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPS----- 177
+ H+H +H D+K +N+LL + G K+ D G A H +
Sbjct: 149 VQHMHRQKPPIIHRDLKVENLLL--SNQGTI--KLCDFGSATTISHYPDYSWSAQRRALV 204
Query: 178 -----MRGTPLYLAPETVVQHMQEAP----SDIWALGCVVLEMLSGRQAWVVKEDCSIDQ 228
TP+Y PE ++ P DIWALGC++ + + + ED +
Sbjct: 205 EEEITRNTTPMYRTPE-IIDLYSNFPIGEKQDIWALGCILYLLCFRQHPF---EDGAK-- 258
Query: 229 LFSIIGDEHSLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPF 276
I+ ++S+P ++ +R P R + ++
Sbjct: 259 -LRIVNGKYSIPPHDTQ-YTVFHSLIRAMLQVNPEERLSIAEVVHQLQ 304
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 2e-38
Identities = 71/293 (24%), Positives = 128/293 (43%), Gaps = 36/293 (12%)
Query: 11 GRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKS------AEVSASASLQKEKEVFDNLNGC 64
GR +G+G FG V++A+ K + L A+K + L++E E+ +L
Sbjct: 14 GRPLGKGKFGNVYLAREKQSKFIL----ALKVLFKAQLEKAGVEHQLRREVEIQSHLRH- 68
Query: 65 PFVLECFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEG 124
P +L +G + Y L+LEYA GT+ ++K + E+ + +
Sbjct: 69 PNILRLYG---YF-HDATRVY-LILEYAPLGTVYRELQKLSK--FDEQRTATYITELANA 121
Query: 125 IGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMRGTPLY 184
+ + H +H D+KP+N+LL +G+ KIAD G + + +R + GT Y
Sbjct: 122 LSYCHSKRVIHRDIKPENLLL--GSAGEL--KIADFGWSVHAPSSRRT----DLCGTLDY 173
Query: 185 LAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSII--GDEHSLPEI 242
L PE + M + D+W+LG + E L G+ + E + + + I +
Sbjct: 174 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPF---EANTYQETYKRISRVE----FTF 226
Query: 243 PSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDP-FVKGVDEELSRELEGDYSQ 294
P V++ ARD + R P+ R +L+ P + + + + S+
Sbjct: 227 PDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSKPSNCQNKESASK 279
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 2e-38
Identities = 47/317 (14%), Positives = 77/317 (24%), Gaps = 57/317 (17%)
Query: 10 RGRVIGQGSFGCVFIAKPKS----------NSSFLPPLMAVKSA--EVSASASLQKEKEV 57
RG V+GQ A + + PP A+K EV L+ K
Sbjct: 77 RGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQ 136
Query: 58 FDNLNGCPFVLEC----------FGEEITMGENGEMAYNLLLEYAAGGTLGDLIEK---- 103
F+ + + L L E
Sbjct: 137 KQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSH 196
Query: 104 -CNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGV 162
L T ++ + +H G VH ++P +I+L Q G +
Sbjct: 197 SSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVL--DQRGG--VFLTGFEH 252
Query: 163 AKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAP-----------SDIWALGCVVLEM 211
R + + PE + + D WALG V+ +
Sbjct: 253 LVRDGA------RVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWI 306
Query: 212 LSGRQAWVVKEDCSIDQLFSIIGDEHSLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEML 271
+ I + + R L R
Sbjct: 307 WCADLPI---TKDAALGGSEWIF------RSCKNIPQPVRALLEGFLRYPKEDRLLPLQA 357
Query: 272 LDDPFVKGVDEELSREL 288
++ P + + ELS L
Sbjct: 358 METPEYEQLRTELSAAL 374
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 2e-38
Identities = 66/300 (22%), Positives = 133/300 (44%), Gaps = 33/300 (11%)
Query: 11 GRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKS-----AEVSASASLQKEKEVFDNLNGCP 65
+ +G G++G V + + K A+K S+++ L +E V L+ P
Sbjct: 42 VKKLGSGAYGEVLLCRDKVTHVER----AIKIIRKTSVSTSSNSKLLEEVAVLKLLDH-P 96
Query: 66 FVLECFG--EEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILE 123
+++ + E+ + Y L++E GG L D I E D + +L
Sbjct: 97 NIMKLYDFFED-------KRNYYLVMECYKGGELFDEIIHRMK--FNEVDAAVIIKQVLS 147
Query: 124 GIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMRGTPL 183
G+ ++H VH D+KP+N+LL ++ + KI D G+ S + QK GT
Sbjct: 148 GVTYLHKHNIVHRDLKPENLLL-ESKEKDALIKIVDFGL---SAVFENQKKMKERLGTAY 203
Query: 184 YLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLF-SIIGDEHSLPEI 242
Y+APE V++ + D+W++G ++ +L+G + + D ++ + +++
Sbjct: 204 YIAPE-VLRKKYDEKCDVWSIGVILFILLAGYPPFGGQTD---QEILRKVEKGKYTFDSP 259
Query: 243 P-SRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGVDEELSRELEGDYSQGEVTLSN 301
VS+ A+D +++ R +A+ L+ P++K + + +E + + N
Sbjct: 260 EWKNVSEGAKDLIKQMLQFDSQRRISAQQALEHPWIKEMCSK--KESGIELPSLANAIEN 317
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 5e-38
Identities = 74/301 (24%), Positives = 133/301 (44%), Gaps = 35/301 (11%)
Query: 11 GRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKS------AEVSASASLQKEKEVFDNLNGC 64
RV+G+GSFG V + K K AVK + + SL +E ++ L+
Sbjct: 31 QRVLGKGSFGEVILCKDKITGQEC----AVKVISKRQVKQKTDKESLLREVQLLKQLDH- 85
Query: 65 PFVLECFG--EEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCIL 122
P +++ + E+ + + L+ E GG L D I E D R +L
Sbjct: 86 PNIMKLYEFFED-------KGYFYLVGEVYTGGELFDEIISRKR--FSEVDAARIIRQVL 136
Query: 123 EGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMRGTP 182
GI ++H + VH D+KP+N+LL ++S +I D G+ S H + K GT
Sbjct: 137 SGITYMHKNKIVHRDLKPENLLL-ESKSKDANIRIIDFGL---STHFEASKKMKDKIGTA 192
Query: 183 LYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLF-SIIGDEHSLPE 241
Y+APE V+ + D+W+ G ++ +LSG + + + + +++
Sbjct: 193 YYIAPE-VLHGTYDEKCDVWSTGVILYILLSGCPPFNGANE---YDILKKVEKGKYTFEL 248
Query: 242 IP-SRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGVDEELSRELEGDYSQGEVTLS 300
+VS+ A+D +R+ P+ R +A LD +++ +E ++ D + +
Sbjct: 249 PQWKKVSESAKDLIRKMLTYVPSMRISARDALDHEWIQTYTKE---QISVDVPSLDNAIL 305
Query: 301 N 301
N
Sbjct: 306 N 306
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 7e-38
Identities = 69/293 (23%), Positives = 132/293 (45%), Gaps = 39/293 (13%)
Query: 8 WFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVSAS--ASLQKEKEVFDNLNGCP 65
+ ++G G++G V+ + L A+K +V+ +++E + +
Sbjct: 26 FELVELVGNGTYGQVYKGRHVKTGQ----LAAIKVMDVTGDEEEEIKQEINMLKKYSHHR 81
Query: 66 FVLECFG---EEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCIL 122
+ +G ++ G + ++ L++E+ G++ DLI+ GN L E+ + + R IL
Sbjct: 82 NIATYYGAFIKKNPPGMDDQLW--LVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREIL 139
Query: 123 EGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAK--RSRHCKRQKFDPSMRG 180
G+ H+H +H D+K N+LL T++ + K+ D GV+ +R + G
Sbjct: 140 RGLSHLHQHKVIHRDIKGQNVLL--TENAE--VKLVDFGVSAQLDRTVGRRN----TFIG 191
Query: 181 TPLYLAPETVVQHMQEAPS------DIWALGCVVLEMLSGRQAWVVKEDCSID---QLFS 231
TP ++APE V+ + + D+W+LG +EM G C + LF
Sbjct: 192 TPYWMAPE-VIACDENPDATYDFKSDLWSLGITAIEMAEGAPPL-----CDMHPMRALFL 245
Query: 232 IIGDEHSLPEI-PSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGVDEE 283
I + P + + SK+ + F+ C V+ + R E L+ PF++ E
Sbjct: 246 IP--RNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQPNE 296
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 1e-37
Identities = 67/285 (23%), Positives = 117/285 (41%), Gaps = 20/285 (7%)
Query: 11 GRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVSASASLQKEKEVFDNLNGCPFVLEC 70
+ +G+GSF K ++ AVK A+ QKE G P +++
Sbjct: 16 DKPLGEGSFSICRKCVHKKSNQAF----AVKIISKRMEANTQKEITALKLCEGHPNIVKL 71
Query: 71 FGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHD 130
+ + + L++E GG L + I+K + E + + R ++ + H+HD
Sbjct: 72 HE----VFHDQLHTF-LVMELLNGGELFERIKK-KKH-FSETEASYIMRKLVSAVSHMHD 124
Query: 131 SGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMRGTPLYLAPETV 190
G VH D+KP+N+L ++ KI D G A+ + P T Y APE +
Sbjct: 125 VGVVHRDLKPENLLF-TDENDNLEIKIIDFGFARLKPPDNQPLKTPC--FTLHYAAPELL 181
Query: 191 VQHMQEAPSDIWALGCVVLEMLSG----RQAWVVKEDCSIDQLFSIIGD-EHSLPEIP-S 244
Q+ + D+W+LG ++ MLSG + S ++ I + S
Sbjct: 182 NQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWK 241
Query: 245 RVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGVDEELSRELE 289
VS+EA+D ++ P R L + +++ + S L
Sbjct: 242 NVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGSQLSSNPLM 286
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 2e-37
Identities = 54/337 (16%), Positives = 106/337 (31%), Gaps = 80/337 (23%)
Query: 10 RGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVK--------------SAEVSASASLQKEK 55
+ +G+G FG VF AK K + A+K EV A A L+
Sbjct: 10 PIQCMGRGGFGVVFEAKNKVDDCNY----AIKRIRLPNRELAREKVMREVKALAKLEHPG 65
Query: 56 EV-------------FDNLNGCPFVLECFGEEITMGENGEMAYN---------------- 86
V + ++ + + + A +
Sbjct: 66 IVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVG 125
Query: 87 ------------LLLEYAAGGTLGDLIEKCNGNGLPEKD-VRHFTRCILEGIGHIHDSGY 133
+ ++ L D + + E H I E + +H G
Sbjct: 126 QLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGL 185
Query: 134 VHCDVKPDNILLVATQSGKFVAKIADLGVAKR-SRHCKRQKFDPSMR---------GTPL 183
+H D+KP NI + V K+ D G+ + + Q M GT L
Sbjct: 186 MHRDLKPSNIFF----TMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKL 241
Query: 184 YLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEHSLPEIP 243
Y++PE + + DI++LG ++ E+L ++ + + P +
Sbjct: 242 YMSPEQIHGNNYSHKVDIFSLGLILFELLYSFST-----QMERVRIITDV-RNLKFPLLF 295
Query: 244 SRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGV 280
++ + ++ P R A ++++ + +
Sbjct: 296 TQKYPQEHMMVQDMLSPSPTERPEATDIIENAIFENL 332
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 2e-37
Identities = 60/281 (21%), Positives = 107/281 (38%), Gaps = 19/281 (6%)
Query: 13 VIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVSASASLQKEKEVFDNLNGCPFVLECFG 72
V+G G G V + A+K + S ++E + +G P ++
Sbjct: 36 VLGLGVNGKVLECFHRRTGQKC----ALKL--LYDSPKARQEVDHHWQASGGPHIVCILD 89
Query: 73 --EEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHD 130
E +G+ +++E GG L I++ E++ R I I +H
Sbjct: 90 VYEN---MHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHS 146
Query: 131 SGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMRGTPLYLAPETV 190
H DVKP+N+L ++ V K+ D G AK + + TP Y+APE +
Sbjct: 147 HNIAHRDVKPENLLY-TSKEKDAVLKLTDFGFAK---ETTQNALQ-TPCYTPYYVAPEVL 201
Query: 191 VQHMQEAPSDIWALGCVVLEMLSGRQA-WVVKEDCSIDQLFSIIGD-EHSLPEIP-SRVS 247
+ D+W+LG ++ +L G + + I ++ P S VS
Sbjct: 202 GPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPEWSEVS 261
Query: 248 KEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGVDEELSREL 288
++A+ +R P R T ++ P++ L
Sbjct: 262 EDAKQLIRLLLKTDPTERLTITQFMNHPWINQSMVVPQTPL 302
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 5e-37
Identities = 64/278 (23%), Positives = 116/278 (41%), Gaps = 31/278 (11%)
Query: 11 GRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVSASA----SLQKEKEVFDNLNGCPF 66
R +G G+FG V + + +S+ +K+ S ++ E EV +L+ P
Sbjct: 27 KRKLGSGAFGDVHLVEERSSGLER----VIKTINKDRSQVPMEQIEAEIEVLKSLDH-PN 81
Query: 67 VLECFG--EEITMGENGEMAYNLLLEYAAGGTLGDLI-EKCNGNG-LPEKDVRHFTRCIL 122
+++ F E+ +++E GG L + I L E V + ++
Sbjct: 82 IIKIFEVFED-------YHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMM 134
Query: 123 EGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMRGTP 182
+ + H VH D+KP+NIL S KI D G+A+ + + + GT
Sbjct: 135 NALAYFHSQHVVHKDLKPENILF-QDTSPHSPIKIIDFGLAELFKSDEHST---NAAGTA 190
Query: 183 LYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQA-WVVKEDCSIDQLF-SIIGDEHSLP 240
LY+APE V + DIW+ G V+ +L+G S++++ E +
Sbjct: 191 LYMAPE-VFKRDVTFKCDIWSAGVVMYFLLTGCLPFT----GTSLEEVQQKATYKEPNYA 245
Query: 241 EIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVK 278
++ +A D L++ + P R +A +L + K
Sbjct: 246 VECRPLTPQAVDLLKQMLTKDPERRPSAAQVLHHEWFK 283
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 8e-37
Identities = 70/301 (23%), Positives = 129/301 (42%), Gaps = 35/301 (11%)
Query: 11 GRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKS-----AEVSASASLQKEKEVFDNLNGCP 65
++G+GSFG V K + AVK A+ ++++ +E E+ L+ P
Sbjct: 27 VCMLGKGSFGEVLKCKDRITQQEY----AVKVINKASAKNKDTSTILREVELLKKLDH-P 81
Query: 66 FVLECFG--EEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILE 123
+++ F E+ ++ ++ E GG L D I K E D + +
Sbjct: 82 NIMKLFEILED-------SSSFYIVGELYTGGELFDEIIKRKR--FSEHDAARIIKQVFS 132
Query: 124 GIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMRGTPL 183
GI ++H VH D+KP+NILL ++ KI D G+ S ++ GT
Sbjct: 133 GITYMHKHNIVHRDLKPENILL-ESKEKDCDIKIIDFGL---STCFQQNTKMKDRIGTAY 188
Query: 184 YLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQA-WVVKEDCSIDQLF-SIIGDEHSLPE 241
Y+APE V++ + D+W+ G ++ +LSG + + + + +++
Sbjct: 189 YIAPE-VLRGTYDEKCDVWSAGVILYILLSGTPPFY----GKNEYDILKRVETGKYAFDL 243
Query: 242 IP-SRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGVDEELSRELEGDYSQGEVTLS 300
+S +A+D +R+ P+ R TA L+ P+++ E D E ++
Sbjct: 244 PQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYSSE--TPTISDLPSLESAMT 301
Query: 301 N 301
N
Sbjct: 302 N 302
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 9e-37
Identities = 77/290 (26%), Positives = 122/290 (42%), Gaps = 39/290 (13%)
Query: 9 FRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVSAS-----ASLQKEKEVFDNLNG 63
+ +G+G F V KS A K + A + E V +
Sbjct: 32 LTSKELGRGKFAVVRQCISKSTGQEY----AAKFLKKRRRGQDCRAEILHEIAVLELAKS 87
Query: 64 CPFVLECFG--EEITMGENGEMAYNLLLEYAAGGTLGDLI-EKCNGNGLPEKDVRHFTRC 120
CP V+ E L+LEYAAGG + L + + E DV +
Sbjct: 88 CPRVINLHEVYEN-------TSEIILILEYAAGGEIFSLCLPELAEM-VSENDVIRLIKQ 139
Query: 121 ILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPS--M 178
ILEG+ ++H + VH D+KP NILL ++ KI D G+++ K + +
Sbjct: 140 ILEGVYYLHQNNIVHLDLKPQNILL-SSIYPLGDIKIVDFGMSR--------KIGHACEL 190
Query: 179 R---GTPLYLAPETVVQHMQEAPSDIWALGCVVL-EMLSGRQAWVVKEDCSIDQLFSIIG 234
R GTP YLAPE + +D+W +G ++ +L+ +V +++ +I
Sbjct: 191 REIMGTPEYLAPEILNYDPITTATDMWNIG-IIAYMLLTHTSPFVGEDNQET--YLNISQ 247
Query: 235 DEHSLPEIP-SRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGVDEE 283
E S VS+ A DF++ V+ P R TAE+ L +++ D E
Sbjct: 248 VNVDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQWDFE 297
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 1e-36
Identities = 70/281 (24%), Positives = 119/281 (42%), Gaps = 16/281 (5%)
Query: 11 GRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVSASASLQKEKEVFDNLNGCPFVLEC 70
IG GS+ K+ + AVK + S +E E+ P ++
Sbjct: 27 KEDIGVGSYSVCKRCIHKATNMEF----AVKIIDKSKR-DPTEEIEILLRYGQHPNIITL 81
Query: 71 FGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHD 130
++G+ Y ++ E GG L D I + E++ I + + ++H
Sbjct: 82 KDVY----DDGKYVY-VVTELMKGGELLDKILR-QKF-FSEREASAVLFTITKTVEYLHA 134
Query: 131 SGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMRGTPLYLAPETV 190
G VH D+KP NIL V +I D G AK+ R P T ++APE +
Sbjct: 135 QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPC--YTANFVAPEVL 192
Query: 191 VQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGD-EHSLPEIP-SRVSK 248
+ +A DIW+LG ++ ML+G + D + +++ + IG + SL + VS
Sbjct: 193 ERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWNSVSD 252
Query: 249 EARDFLRRCFVRKPAFRFTAEMLLDDPFVKGVDEELSRELE 289
A+D + + P R TA ++L P++ D+ +L
Sbjct: 253 TAKDLVSKMLHVDPHQRLTAALVLRHPWIVHWDQLPQYQLN 293
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 1e-36
Identities = 66/276 (23%), Positives = 120/276 (43%), Gaps = 35/276 (12%)
Query: 11 GRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKS------AEVSASASLQKEKEVFDNLNGC 64
GR +G+G FG V++A+ K N + A+K + L++E E+ +L
Sbjct: 19 GRPLGKGKFGNVYLAREKQNKFIM----ALKVLFKSQLEKEGVEHQLRREIEIQSHLR-H 73
Query: 65 PFVLECFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEG 124
P +L + + + Y L+LE+A G L ++K E+ F + +
Sbjct: 74 PNILRMYN---YF-HDRKRIY-LMLEFAPRGELYKELQKHGR--FDEQRSATFMEELADA 126
Query: 125 IGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMRGTPLY 184
+ + H+ +H D+KP+N+L+ K KIAD G + + +R+ +M GT Y
Sbjct: 127 LHYCHERKVIHRDIKPENLLMGY----KGELKIADFGWSVHAPSLRRR----TMCGTLDY 178
Query: 185 LAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSII--GDEHSLPEI 242
L PE + + D+W G + E L G + + S + I D +
Sbjct: 179 LPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPF---DSPSHTETHRRIVNVD----LKF 231
Query: 243 PSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVK 278
P +S ++D + + P R + +++ P+VK
Sbjct: 232 PPFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVK 267
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 134 bits (338), Expect = 1e-36
Identities = 78/281 (27%), Positives = 126/281 (44%), Gaps = 50/281 (17%)
Query: 14 IGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVSAS---ASLQKEKEVFDNLNGCPFVLEC 70
IG+GS G V +A+ K + +AVK ++ L E + + V+E
Sbjct: 53 IGEGSTGIVCLAREKHSGR----QVAVKMMDLRKQQRRELLFNEVVIMRDYQ-HFNVVEM 107
Query: 71 FGEEITMGENGEMAYNL--LLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHI 128
+ + E L L+E+ GG L D++ + L E+ + +L+ + ++
Sbjct: 108 YKSYLVGEE-------LWVLMEFLQGGALTDIVSQVR---LNEEQIATVCEAVLQALAYL 157
Query: 129 HDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKR--SRHCKRQKFDPSMRGTPLYLA 186
H G +H D+K D+ILL T G+ K++D G + KR+ S+ GTP ++A
Sbjct: 158 HAQGVIHRDIKSDSILL--TLDGR--VKLSDFGFCAQISKDVPKRK----SLVGTPYWMA 209
Query: 187 PETVVQHMQEAPSDIWALGCVVLEMLSGR---------QAWVVKEDCSIDQLFSIIGDEH 237
PE + + + DIW+LG +V+EM+ G QA + +
Sbjct: 210 PEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQA-----------MKRLRDSPP 258
Query: 238 SLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVK 278
+ +VS RDFL R VR P R TA+ LLD PF+
Sbjct: 259 PKLKNSHKVSPVLRDFLERMLVRDPQERATAQELLDHPFLL 299
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 2e-36
Identities = 72/287 (25%), Positives = 117/287 (40%), Gaps = 62/287 (21%)
Query: 14 IGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVSAS---ASLQKEKEVFDNLNGCPFVLEC 70
IGQG+ G V+ A + +A++ + + E V P ++
Sbjct: 28 IGQGASGTVYTAMDVATGQ----EVAIRQMNLQQQPKKELIINEILVMRENK-NPNIVNY 82
Query: 71 FGEEITMGENGEMAYN------LLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEG 124
+Y +++EY AGG+L D++ + + E + R L+
Sbjct: 83 LD-----------SYLVGDELWVVMEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQA 128
Query: 125 IGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKR--SRHCKRQKFDPSMRGTP 182
+ +H + +H D+K DNILL G K+ D G + KR +M GTP
Sbjct: 129 LEFLHSNQVIHRDIKSDNILL--GMDGS--VKLTDFGFCAQITPEQSKRS----TMVGTP 180
Query: 183 LYLAPETVVQHMQEAPSDIWALGCVVLEMLSGR---------QAWVVKEDCSIDQLFSII 233
++APE V + DIW+LG + +EM+ G +A L+ I
Sbjct: 181 YWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA-----------LYLI- 228
Query: 234 GDEHSLPEI--PSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVK 278
+ PE+ P ++S RDFL RC R +A+ LL F+K
Sbjct: 229 -ATNGTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHQFLK 274
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 5e-36
Identities = 59/287 (20%), Positives = 122/287 (42%), Gaps = 41/287 (14%)
Query: 13 VIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVSASAS----LQKEKEVFDNLNGCPFVL 68
+G G+ G V+ + + ++AVK S + + + +V + CP+++
Sbjct: 32 EMGSGTCGQVWKMRFRKTGH----VIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIV 87
Query: 69 ECFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHI 128
+CFG T N ++ + +E + ++K +PE+ + T I++ + ++
Sbjct: 88 QCFG---TFITNTDVF--IAMELMGTCA--EKLKKRMQGPIPERILGKMTVAIVKALYYL 140
Query: 129 HDS-GYVHCDVKPDNILLVATQSGKFVAKIADLGVAKR-SRHCKRQKFDPSMRGTPLYLA 186
+ G +H DVKP NILL + G+ K+ D G++ R + + G Y+A
Sbjct: 141 KEKHGVIHRDVKPSNILL--DERGQ--IKLCDFGISGRLVDDKAKDRS----AGCAAYMA 192
Query: 187 PETVVQHMQEA------PSDIWALGCVVLEMLSGR---QAWVVKEDCSIDQLFSII-GDE 236
PE + +D+W+LG ++E+ +G+ + + L ++ +
Sbjct: 193 PE-RIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNC----KTDFEVLTKVLQEEP 247
Query: 237 HSLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGVDEE 283
LP S + + F++ C + R LL+ F+K +
Sbjct: 248 PLLPG-HMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRYETL 293
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 6e-36
Identities = 63/277 (22%), Positives = 110/277 (39%), Gaps = 31/277 (11%)
Query: 11 GRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKS---AEVSASASLQKEKEVFDNLNGCPFV 67
IG+GS+G V IA K A K V ++E E+ +L+ P +
Sbjct: 14 ENTIGRGSWGEVKIAVQKGTRIRR----AAKKIPKYFVEDVDRFKQEIEIMKSLDH-PNI 68
Query: 68 LECFG--EEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGI 125
+ + E+ L++E GG L + + E D + +L +
Sbjct: 69 IRLYETFED-------NTDIYLVMELCTGGELFERVVH-KRV-FRESDAARIMKDVLSAV 119
Query: 126 GHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMRGTPLYL 185
+ H H D+KP+N L T S K+ D G+A R + K + + GTP Y+
Sbjct: 120 AYCHKLNVAHRDLKPENFLF-LTDSPDSPLKLIDFGLAARFKPGKMMR---TKVGTPYYV 175
Query: 186 APETVVQHMQEAPSDIWALGCVVLEMLSGRQA-WVVKEDCSIDQLF-SIIGDEHSLPEIP 243
+P+ V++ + D W+ G ++ +L G + ++ I + PE
Sbjct: 176 SPQ-VLEGLYGPECDEWSAGVMMYVLLCGYPPFS----APTDSEVMLKIREGTFTFPEKD 230
Query: 244 -SRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKG 279
VS +A +RR + P R T+ L+ + +
Sbjct: 231 WLNVSPQAESLIRRLLTKSPKQRITSLQALEHEWFEK 267
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 133 bits (335), Expect = 7e-36
Identities = 40/315 (12%), Positives = 80/315 (25%), Gaps = 49/315 (15%)
Query: 10 RGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVSASAS------LQKEKEVFDNLNG 63
+ G VF+ + A+K + A S L + L G
Sbjct: 66 LVEPLRVGDRSVVFLVRDVERLEDF----ALKVFTMGAENSRSELERLHEATFAAARLLG 121
Query: 64 --------------CPFVLECFGE----EITMGENGEMAYNLLLEY-AAGGTLGDLIEKC 104
+ + +++ G++ N LL AA L L
Sbjct: 122 ESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTL 181
Query: 105 -----NGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIAD 159
+ T ++ ++ G VH PDN+ + G+ + D
Sbjct: 182 DFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFI--MPDGR--LMLGD 237
Query: 160 LGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQE--APSDIWALGCVVLEMLSGR-- 215
+ + P+ Y E + + W LG + +
Sbjct: 238 VSALWK-----VGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLP 292
Query: 216 --QAWVVKEDCSIDQLFSIIGDEHSLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLD 273
+ + G + + + + + R R ++
Sbjct: 293 FGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME 352
Query: 274 DPFVKGVDEELSREL 288
P + E+S L
Sbjct: 353 TPEFLQLQNEISSSL 367
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 9e-36
Identities = 60/286 (20%), Positives = 112/286 (39%), Gaps = 38/286 (13%)
Query: 13 VIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVSASAS----LQKEKEVFDNLNGCPFVL 68
+G+G++G V + + +MAVK + ++ L + ++ CPF +
Sbjct: 14 ELGRGAYGVVEKMRHVPSGQ----IMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTV 69
Query: 69 ECFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNG-LPEKDVRHFTRCILEGIGH 127
+G + G++ + +E + + +PE + I++ + H
Sbjct: 70 TFYG---ALFREGDVW--ICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEH 124
Query: 128 IHDSGYV-HCDVKPDNILLVATQSGKFVAKIADLGVAKR-SRHCKRQKFDPSMRGTPLYL 185
+H V H DVKP N+L+ G+ K+ D G++ + G Y+
Sbjct: 125 LHSKLSVIHRDVKPSNVLI--NALGQ--VKMCDFGISGYLVDDVAKDID----AGCKPYM 176
Query: 186 APETVVQHMQEAP----SDIWALGCVVLEMLSGR---QAWVVKEDCSIDQLFSII-GDEH 237
APE + + + SDIW+LG ++E+ R +W QL ++
Sbjct: 177 APERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSW----GTPFQQLKQVVEEPSP 232
Query: 238 SLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGVDEE 283
LP + S E DF +C + R T L+ PF + +
Sbjct: 233 QLP--ADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTLHESK 276
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 1e-35
Identities = 61/287 (21%), Positives = 111/287 (38%), Gaps = 24/287 (8%)
Query: 11 GRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVSASASLQKEKEVFDNLNGCPFVLEC 70
+V+G G G V K A+K + ++E E+ + CP ++
Sbjct: 67 SQVLGLGINGKVLQIFNKRTQEKF----ALKM--LQDCPKARREVELHWRASQCPHIVRI 120
Query: 71 FG--EEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHI 128
E + G +++E GG L I+ E++ + I E I ++
Sbjct: 121 VDVYENLYAGRK---CLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYL 177
Query: 129 HDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMR---GTPLYL 185
H H DVKP+N+L ++ + K+ D G AK + S+ TP Y+
Sbjct: 178 HSINIAHRDVKPENLLY-TSKRPNAILKLTDFGFAKETTS------HNSLTTPCYTPYYV 230
Query: 186 APETVVQHMQEAPSDIWALGCVVLEMLSGRQA-WVVKEDCSIDQLFSIIGD-EHSLPEIP 243
APE + + D+W+LG ++ +L G + + + I ++ P
Sbjct: 231 APEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPE 290
Query: 244 -SRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGVDEELSRELE 289
S VS+E + +R +P R T ++ P++ + L
Sbjct: 291 WSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLH 337
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 2e-35
Identities = 63/308 (20%), Positives = 109/308 (35%), Gaps = 38/308 (12%)
Query: 8 WFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVK----SAEVSASASLQKEKEVFDNLNG 63
W +G G FG V + +A+K E ++ LN
Sbjct: 16 WEMKERLGTGGFGYVLRWIHQDTGE----QVAIKQCRQELSPKNRERWCLEIQIMKKLN- 70
Query: 64 CPFV---LECFGEEITMGENGEMAYNLLLEYAAGGTLGDLI-EKCNGNGLPEKDVRHFTR 119
P V E + + ++ L +EY GG L + + N GL E +R
Sbjct: 71 HPNVVSAREVP-DGLQKLAPNDLPL-LAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLS 128
Query: 120 CILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMR 179
I + ++H++ +H D+KP+NI+L KI DLG ++ + +
Sbjct: 129 DISSALRYLHENRIIHRDLKPENIVLQPGPQRLIH-KIIDLGY---AKELDQGELCTEFV 184
Query: 180 GTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGR---------QAWVVKEDCSIDQLF 230
GT YLAPE + Q D W+ G + E ++G W K ++
Sbjct: 185 GTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHI 244
Query: 231 SIIGDEHSLPEIPSRV----------SKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGV 280
+ D + S + + + +L+ + R T + + +
Sbjct: 245 VVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQAL 304
Query: 281 DEELSREL 288
D LS +L
Sbjct: 305 DSILSLKL 312
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 2e-35
Identities = 65/287 (22%), Positives = 119/287 (41%), Gaps = 36/287 (12%)
Query: 13 VIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVSASAS----LQKEKEVFDNLNGCPFVL 68
IG+G++G V K + +MAVK + L + +V + CP+++
Sbjct: 29 EIGRGAYGSVNKMVHKPSGQ----IMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIV 84
Query: 69 ECFGEEITMGENGEMAYNLLLEYAAGGTLGDL--IEKCNGNGLPEKDVRHFTRCILEGIG 126
+ +G G+ + +E + + + +PE+ + T ++ +
Sbjct: 85 QFYGALFREGD-----CWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALN 139
Query: 127 HIHDSGYV-HCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMRGTPLYL 185
H+ ++ + H D+KP NILL +SG K+ D G++ + + D G Y+
Sbjct: 140 HLKENLKIIHRDIKPSNILL--DRSGN--IKLCDFGISGQLVDSIAKTRDA---GCRPYM 192
Query: 186 APETVVQHMQEAP----SDIWALGCVVLEMLSGR---QAWVVKEDCSIDQLFSII-GDEH 237
APE + SD+W+LG + E+ +GR W + DQL ++ GD
Sbjct: 193 APERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKW----NSVFDQLTQVVKGDPP 248
Query: 238 SLPEIPSRV-SKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGVDEE 283
L R S +F+ C + + R + LL PF+ +E
Sbjct: 249 QLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILMYEER 295
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 2e-35
Identities = 77/287 (26%), Positives = 127/287 (44%), Gaps = 58/287 (20%)
Query: 12 RVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVSASAS-LQKEKEVFDNLNGCPFVLEC 70
+G+GS+G V+ A K ++A+K V + + KE + + P V++
Sbjct: 35 EKLGEGSYGSVYKAIHKETGQ----IVAIKQVPVESDLQEIIKEISIMQQCD-SPHVVKY 89
Query: 71 FGEEITMGENGEMAYN------LLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEG 124
+G +Y +++EY G++ D+I N L E ++ + L+G
Sbjct: 90 YG-----------SYFKNTDLWIVMEYCGAGSVSDIIRLRNK-TLTEDEIATILQSTLKG 137
Query: 125 IGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKR--SRHCKRQKFDPSMRGTP 182
+ ++H +H D+K NILL G AK+AD GVA + KR ++ GTP
Sbjct: 138 LEYLHFMRKIHRDIKAGNILL--NTEGH--AKLADFGVAGQLTDTMAKRN----TVIGTP 189
Query: 183 LYLAPETVVQHMQEAPSDIWALGCVVLEMLSGR---------QAWVVKEDCSIDQLFSII 233
++APE + + +DIW+LG +EM G+ +A +F I
Sbjct: 190 FWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRA-----------IFMI- 237
Query: 234 GDEHSLPEI--PSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVK 278
+ P P S DF+++C V+ P R TA LL PFV+
Sbjct: 238 -PTNPPPTFRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQHPFVR 283
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 2e-35
Identities = 76/290 (26%), Positives = 130/290 (44%), Gaps = 53/290 (18%)
Query: 12 RVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVSAS---ASLQKEKEVFDNLNGCPFVL 68
+G G+FG V+ AK K + L A K E + E E+ + P+++
Sbjct: 25 GELGDGAFGKVYKAKNKETGA----LAAAKVIETKSEEELEDYIVEIEILATCD-HPYIV 79
Query: 69 ECFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHI 128
+ G +G++ +++E+ GG + ++ + + GL E ++ R +LE + +
Sbjct: 80 KLLG---AYYHDGKLW--IMIEFCPGGAVDAIMLELDR-GLTEPQIQVVCRQMLEALNFL 133
Query: 129 HDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKR--SRHCKRQKFDPSMRGTPLYLA 186
H +H D+K N+L+ T G ++AD GV+ + KR S GTP ++A
Sbjct: 134 HSKRIIHRDLKAGNVLM--TLEGD--IRLADFGVSAKNLKTLQKRD----SFIGTPYWMA 185
Query: 187 PETV-VQHMQEAP----SDIWALGCVVLEMLSGR---------QAWVVKEDCSIDQLFSI 232
PE V + M++ P +DIW+LG ++EM + L I
Sbjct: 186 PEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRV-----------LLKI 234
Query: 233 IGDEHSLPEI--PSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGV 280
+ P + PS+ S E RDFL+ + P R +A LL+ PFV +
Sbjct: 235 A--KSDPPTLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSI 282
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 2e-35
Identities = 73/297 (24%), Positives = 131/297 (44%), Gaps = 31/297 (10%)
Query: 11 GRVIGQGSFGCVFIAKPKSNSSFL-------PPLMAVKSAEVSASASLQKEKEVFDNLNG 63
+ +G G+ G V +A + + + E + +++ E E+ LN
Sbjct: 140 SKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNH 199
Query: 64 CPFVLECFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILE 123
P +++ Y ++LE GG L D + L E + + +L
Sbjct: 200 -PCIIKIKNFFDAE------DYYIVLELMEGGELFDKV--VGNKRLKEATCKLYFYQMLL 250
Query: 124 GIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMRGTPL 183
+ ++H++G +H D+KP+N+LL + + + KI D G +K ++ GTP
Sbjct: 251 AVQYLHENGIIHRDLKPENVLLSSQEEDCLI-KITDFGHSK---ILGETSLMRTLCGTPT 306
Query: 184 YLAPETVVQHMQEA---PSDIWALGCVVLEMLSGRQA-WVVKEDCSIDQLFSII--GDEH 237
YLAPE +V D W+LG ++ LSG E + L I G +
Sbjct: 307 YLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFS---EHRTQVSLKDQITSGKYN 363
Query: 238 SLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGVDEELSRELEGDYSQ 294
+PE+ + VS++A D +++ V P RFT E L P+++ DE++ R+ + S+
Sbjct: 364 FIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQ--DEDMKRKFQDLLSE 418
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 131 bits (330), Expect = 3e-35
Identities = 53/285 (18%), Positives = 93/285 (32%), Gaps = 33/285 (11%)
Query: 11 GRVIGQGSFGCVFIAKPKSNSSFLP-PLMAVK---SAEVSASASLQKEKEVFDNLNGCPF 66
++G+G+F V+ A + +K A + E F
Sbjct: 70 HHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMF 129
Query: 67 V--LECFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKC---NGNGLPEKDVRHFTRCI 121
+ + +NG L+ E + GTL + I +P+ V F +
Sbjct: 130 MKFYSAH-----LFQNG---SVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRM 181
Query: 122 LEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVA-------KIADLGVAKRSRHCKRQKF 174
L I +HD +H D+KPDN +L + + DLG + + +
Sbjct: 182 LYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTI 241
Query: 175 DPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKED--CSIDQLFSI 232
+ T + E + D + + V ML G V E C + LF
Sbjct: 242 FTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRR 301
Query: 233 IGDE-------HSLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEM 270
+ H + IP + D LR+ + +T ++
Sbjct: 302 LPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKI 346
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 3e-35
Identities = 66/331 (19%), Positives = 110/331 (33%), Gaps = 69/331 (20%)
Query: 13 VIGQG--SFGCVFIAKPKSNSSFLPPLMAVK-----SAEVSASASLQKEKEVFDNLNGCP 65
VIG+G V +A+ K + V+ + LQ E V N P
Sbjct: 32 VIGKGFEDLMTVNLARYKPTGE----YVTVRRINLEACSNEMVTFLQGELHVSKLFN-HP 86
Query: 66 FVLECFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGI 125
++ T + E+ ++ + A G+ DLI +G+ E + + + +L+ +
Sbjct: 87 NIVPYRA---TFIADNEL--WVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKAL 141
Query: 126 GHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVA-----KRSRHCKRQKFDPSMRG 180
+IH GYVH VK +IL+ + GK ++ L R F
Sbjct: 142 DYIHHMGYVHRSVKASHILI--SVDGK--VYLSGLRSNLSMISHGQRQRVVHDFPKYSVK 197
Query: 181 TPLYLAPETVVQHMQE--APSDIWALGCVVLEMLSGR----------------------- 215
+L+PE + Q++Q A SDI+++G E+ +G
Sbjct: 198 VLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCL 257
Query: 216 ------------------QAWVVKEDCSIDQLFSIIGDEHSLPEIPSRVSKEARDFLRRC 257
A D + S F+ +C
Sbjct: 258 LDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQC 317
Query: 258 FVRKPAFRFTAEMLLDDPFVKGVDEELSREL 288
R P R +A LL+ F K + S L
Sbjct: 318 LQRNPDARPSASTLLNHSFFKQIKRRASEAL 348
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 4e-35
Identities = 69/286 (24%), Positives = 118/286 (41%), Gaps = 33/286 (11%)
Query: 11 GRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKS---------AEVSASASLQKEKEVFDNL 61
G +G G F V + KS A K + +++E + +
Sbjct: 17 GEELGSGQFAIVKKCREKSTGLEY----AAKFIKKRQSRASRRGVSREEIEREVSILRQV 72
Query: 62 NGCPFVLECFG--EEITMGENGEMAYNLLLEYAAGGTLGD-LIEKCNGNGLPEKDVRHFT 118
V+ E L+LE +GG L D L +K L E++ F
Sbjct: 73 LH-HNVITLHDVYEN-------RTDVVLILELVSGGELFDFLAQK---ESLSEEEATSFI 121
Query: 119 RCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSM 178
+ IL+G+ ++H H D+KP+NI+L+ K+ D G+A K ++
Sbjct: 122 KQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFK---NI 178
Query: 179 RGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEHS 238
GTP ++APE V +D+W++G + +LSG ++ L +I +
Sbjct: 179 FGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQET--LANITSVSYD 236
Query: 239 LPEIP-SRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGVDEE 283
E S S+ A+DF+R+ V++ R T + L P++ VD +
Sbjct: 237 FDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDNQ 282
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 5e-35
Identities = 76/279 (27%), Positives = 134/279 (48%), Gaps = 45/279 (16%)
Query: 13 VIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVSAS----ASLQKEKEVFDNLNGCPFVL 68
IG+GSFG VF ++A+K ++ + +Q+E V + P+V
Sbjct: 29 KIGKGSFGEVFKGIDNRTQK----VVAIKIIDLEEAEDEIEDIQQEITVLSQCD-SPYVT 83
Query: 69 ECFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHI 128
+ +G + ++ ++ +++EY GG+ DL+E L E + R IL+G+ ++
Sbjct: 84 KYYG---SYLKDTKLW--IIMEYLGGGSALDLLEP---GPLDETQIATILREILKGLDYL 135
Query: 129 HDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKR--SRHCKRQKFDPSMRGTPLYLA 186
H +H D+K N+LL ++ G+ K+AD GVA + KR + GTP ++A
Sbjct: 136 HSEKKIHRDIKAANVLL--SEHGE--VKLADFGVAGQLTDTQIKRN----TFVGTPFWMA 187
Query: 187 PETVVQHMQEAPSDIWALGCVVLEMLSGR-------QAWVVKEDCSIDQLFSIIGDEHSL 239
PE + Q ++ +DIW+LG +E+ G V LF I +++
Sbjct: 188 PEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKV---------LFLIP--KNNP 236
Query: 240 PEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVK 278
P + SK ++F+ C ++P+FR TA+ LL F+
Sbjct: 237 PTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFIL 275
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 5e-35
Identities = 60/285 (21%), Positives = 118/285 (41%), Gaps = 29/285 (10%)
Query: 11 GRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVSAS--ASLQKEKEVFDNLNGCPFVL 68
+G+G FG V S+ K +V + ++KE + + +L
Sbjct: 10 AEDLGRGEFGIVHRCVETSSKKTY----MAKFVKVKGTDQVLVKKEISILNIA-RHRNIL 64
Query: 69 ECFG--EEITMGENGEMAYNLLLEYAAGGTLGD-LIEKCNGNGLPEKDVRHFTRCILEGI 125
E ++ E+ +G + + + L E+++ + + E +
Sbjct: 65 HLHESFES-------MEELVMIFEFISGLDIFERINTS--AFELNEREIVSYVHQVCEAL 115
Query: 126 GHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMRGTPLYL 185
+H H D++P+NI+ +S KI + G A++ + + + P Y
Sbjct: 116 QFLHSHNIGHFDIRPENIIYQTRRSSTI--KIIEFGQARQLKPGDNFRL---LFTAPEYY 170
Query: 186 APETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFS-IIGDEHSLPEIP- 243
APE + +D+W+LG +V +LSG ++ + + Q+ I+ E++ E
Sbjct: 171 APEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETN---QQIIENIMNAEYTFDEEAF 227
Query: 244 SRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGVDEELSREL 288
+S EA DF+ R V++ R TA L P++K E +S ++
Sbjct: 228 KEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQKIERVSTKV 272
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 8e-35
Identities = 63/296 (21%), Positives = 116/296 (39%), Gaps = 44/296 (14%)
Query: 11 GRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKS----------------AEVSASASLQKE 54
R +G G++G V + K K+ S A+K + E
Sbjct: 41 VRKLGSGAYGEVLLCKEKNGHSEK----AIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNE 96
Query: 55 KEVFDNLNGCPFVLECFG--EEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEK 112
+ +L+ P +++ F E+ + + L+ E+ GG L + I + E
Sbjct: 97 ISLLKSLDH-PNIIKLFDVFED-------KKYFYLVTEFYEGGELFEQIINRHK--FDEC 146
Query: 113 DVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQ 172
D + + IL GI ++H VH D+KP+NILL ++ KI D G+ S +
Sbjct: 147 DAANIMKQILSGICYLHKHNIVHRDIKPENILL-ENKNSLLNIKIVDFGL---SSFFSKD 202
Query: 173 KFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQA-WVVKEDCSIDQLF- 230
GT Y+APE V++ D+W+ G ++ +L G + +
Sbjct: 203 YKLRDRLGTAYYIAPE-VLKKKYNEKCDVWSCGVIMYILLCGYPPFG----GQNDQDIIK 257
Query: 231 SIIGDEHSLPEIP-SRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGVDEELS 285
+ ++ +S EA++ ++ R TAE L+ ++K ++
Sbjct: 258 KVEKGKYYFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYANNIN 313
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 129 bits (325), Expect = 3e-34
Identities = 69/285 (24%), Positives = 123/285 (43%), Gaps = 26/285 (9%)
Query: 11 GRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVSAS---ASLQKEKEVFDNLNGCPFV 67
+G G+FG V K+ K +++ E + + L+ P +
Sbjct: 56 LEELGSGAFGVVHRCVEKATGRVF----VAKFINTPYPLDKYTVKNEISIMNQLHH-PKL 110
Query: 68 LECFG--EEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGI 125
+ E+ + L+LE+ +GG L D I + E +V ++ R EG+
Sbjct: 111 INLHDAFED-------KYEMVLILEFLSGGELFDRIAA-EDYKMSEAEVINYMRQACEGL 162
Query: 126 GHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMRGTPLYL 185
H+H+ VH D+KP+NI+ ++ KI D G+A + + K T +
Sbjct: 163 KHMHEHSIVHLDIKPENIMCETKKASSV--KIIDFGLATKLNPDEIVK---VTTATAEFA 217
Query: 186 APETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEHSLPEIP-S 244
APE V + +D+WA+G + +LSG + ++D L ++ + E S
Sbjct: 218 APEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLET--LQNVKRCDWEFDEDAFS 275
Query: 245 RVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGVDEELSRELE 289
VS EA+DF++ ++P R T L+ P++KG L+ +
Sbjct: 276 SVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHSNLTSRIP 320
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 4e-34
Identities = 65/284 (22%), Positives = 122/284 (42%), Gaps = 39/284 (13%)
Query: 12 RVIGQGSFGCVFIAKPKSNSSFLPPLMAVKS------AEVSASASLQKEKEVFDNLNGCP 65
R IG+GSFG V I + + A+K E + ++ KE ++ L P
Sbjct: 21 RAIGKGSFGKVCIVQKNDTKK----MYAMKYMNKQKCVERNEVRNVFKELQIMQGLE-HP 75
Query: 66 FVLE---CFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCIL 122
F++ F ++ E + ++++ GG L +++ E+ V+ F ++
Sbjct: 76 FLVNLWYSF-------QDEEDMF-MVVDLLLGGDLRYHLQQNVH--FKEETVKLFICELV 125
Query: 123 EGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMRGTP 182
+ ++ + +H D+KPDNILL + G I D +A + +M GT
Sbjct: 126 MALDYLQNQRIIHRDMKPDNILL--DEHGH--VHITDFNIAAMLPRETQIT---TMAGTK 178
Query: 183 LYLAPETVVQHMQEA----PSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEHS 238
Y+APE + + A D W+LG E+L GR+ + ++ S ++ E +
Sbjct: 179 PYMAPE-MFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTF--ETT 235
Query: 239 LPEIPSRVSKEARDFLRRCFVRKPAFRF-TAEMLLDDPFVKGVD 281
+ PS S+E L++ P RF + + P++ ++
Sbjct: 236 VVTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQNFPYMNDIN 279
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 129 bits (324), Expect = 4e-34
Identities = 50/333 (15%), Positives = 82/333 (24%), Gaps = 46/333 (13%)
Query: 10 RGRVIGQGSFGCVFIAKPKS----------NSSFLPPLMAVKSA--EVSASASLQKEKEV 57
RG V+GQ A + + PP A+K EV L+ K
Sbjct: 82 RGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQ 141
Query: 58 FDNLNGCPFVLEC----------FGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGN 107
F+ + + L L E +
Sbjct: 142 KQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSH 201
Query: 108 G-----LPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGV 162
L T ++ + +H G VH ++P +I+L Q G +
Sbjct: 202 SSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVL--DQRGG--VFLTGFEH 257
Query: 163 AKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQE-----APSDIWALGCVVLEMLSGRQA 217
R P A + D W LG + +
Sbjct: 258 LVRDGASAVSPIGRGF-APPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLP 316
Query: 218 WVVKEDCSIDQLFSIIGDEHSLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFV 277
+ I ++P+ R L R ++ P
Sbjct: 317 NTDDAALGGSEW--IFRSCKNIPQ-------PVRALLEGFLRYPKEDRLLPLQAMETPEY 367
Query: 278 KGVDEELSRELEGDYSQGEVTLSNADAESCSPE 310
+ + ELS L + GE T S + +
Sbjct: 368 EQLRTELSAALPLYQTDGEPTREGGAPPSGTSQ 400
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 5e-34
Identities = 78/287 (27%), Positives = 117/287 (40%), Gaps = 56/287 (19%)
Query: 12 RVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVSASAS------LQKEKEVFDNLNGCP 65
R IG GSFG V+ A+ NS ++A+K S S + KE L P
Sbjct: 60 REIGHGSFGAVYFARDVRNSE----VVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR-HP 114
Query: 66 FVLECFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGI 125
++ G L++EY G DL+E L E ++ T L+G+
Sbjct: 115 NTIQYRG---CYLREHTAW--LVMEYCLGSAS-DLLEVHKK-PLQEVEIAAVTHGALQGL 167
Query: 126 GHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMRGTPLYL 185
++H +H DVK NILL ++ G K+ D G A S S GTP ++
Sbjct: 168 AYLHSHNMIHRDVKAGNILL--SEPGL--VKLGDFGSA--SIMAPAN----SFVGTPYWM 217
Query: 186 APETVVQHMQEAP----SDIWALGCVVLEMLSGR---------QAWVVKEDCSIDQLFSI 232
APE V+ M E D+W+LG +E+ + A L+ I
Sbjct: 218 APE-VILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA-----------LYHI 265
Query: 233 IGDEHSLPEI-PSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVK 278
++ P + S+ R+F+ C + P R T+E+LL FV
Sbjct: 266 A--QNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVL 310
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 6e-34
Identities = 67/277 (24%), Positives = 116/277 (41%), Gaps = 31/277 (11%)
Query: 11 GRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKS---AEVSASASLQKEKEVFDNLNGCPFV 67
V+G G+F VF+ K + A+K + +SL+ E V + +
Sbjct: 14 MEVLGSGAFSEVFLVKQRLTGKLF----ALKCIKKSPAFRDSSLENEIAVLKKIKH-ENI 68
Query: 68 LECFG--EEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGI 125
+ E Y L+++ +GG L D I + G EKD + +L +
Sbjct: 69 VTLEDIYES-------TTHYYLVMQLVSGGELFDRILE-RGV-YTEKDASLVIQQVLSAV 119
Query: 126 GHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMRGTPLYL 185
++H++G VH D+KP+N+L T I D G++K + + GTP Y+
Sbjct: 120 KYLHENGIVHRDLKPENLLY-LTPEENSKIMITDFGLSK---MEQNGIMS-TACGTPGYV 174
Query: 186 APETVVQHMQEAPSDIWALGCVVLEMLSGRQA-WVVKEDCSIDQLFS-IIGDEHSLPEIP 243
APE + Q D W++G + +L G + + + +LF I +
Sbjct: 175 APEVLAQKPYSKAVDCWSIGVITYILLCGYPPFY----EETESKLFEKIKEGYYEFESPF 230
Query: 244 -SRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKG 279
+S+ A+DF+ + P R+T E L P++ G
Sbjct: 231 WDDISESAKDFICHLLEKDPNERYTCEKALSHPWIDG 267
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 6e-34
Identities = 63/333 (18%), Positives = 111/333 (33%), Gaps = 77/333 (23%)
Query: 11 GRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKS--------AEVSASASLQKEKEVFDNLN 62
IGQGS+G V +A + A+K ++ E + L+
Sbjct: 31 KGAIGQGSYGVVRVAIENQTRAIR----AIKIMNKNKIRQINPKDVERIKTEVRLMKKLH 86
Query: 63 GCPFVLECFG--EEITMGENGEMAYNLLLEYAAGGTLGDLIEK----------------- 103
P + + E+ E L++E GG L D +
Sbjct: 87 H-PNIARLYEVYED-------EQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQ 138
Query: 104 ---------------------CNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDN 142
EK + + R I + ++H+ G H D+KP+N
Sbjct: 139 ICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPEN 198
Query: 143 ILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMR---GTPLYLAPETVVQHMQEA-- 197
L +S + K+ D G++K + M GTP ++APE V+ E+
Sbjct: 199 FLFSTNKSFEI--KLVDFGLSKEFYKLNNGE-YYGMTTKAGTPYFVAPE-VLNTTNESYG 254
Query: 198 -PSDIWALGCVVLEMLSGRQA-WVVKEDCSIDQLF-SIIGDEHSLPEIP-SRVSKEARDF 253
D W+ G ++ +L G + ++ + + +S ARD
Sbjct: 255 PKCDAWSAGVLLHLLLMGAVPFP----GVNDADTISQVLNKKLCFENPNYNVLSPLARDL 310
Query: 254 LRRCFVRKPAFRFTAEMLLDDPFVKGVDEELSR 286
L R RF A L P++ +++ +
Sbjct: 311 LSNLLNRNVDERFDAMRALQHPWISQFSDKIYK 343
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 7e-34
Identities = 75/287 (26%), Positives = 122/287 (42%), Gaps = 41/287 (14%)
Query: 11 GRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVSASASLQK------EKEVFDNLNGC 64
G+++G+GSF V +A+ + S A+K E K E++V L+
Sbjct: 35 GKILGEGSFSTVVLARELATSRE----YAIKILEKRHIIKENKVPYVTRERDVMSRLD-H 89
Query: 65 PFVLE---CFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCI 121
PF ++ F ++ E Y L YA G L I K E R +T I
Sbjct: 90 PFFVKLYFTF-------QDDEKLY-FGLSYAKNGELLKYIRKIGS--FDETCTRFYTAEI 139
Query: 122 LEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMRGT 181
+ + ++H G +H D+KP+NILL + +I D G AK +Q S GT
Sbjct: 140 VSALEYLHGKGIIHRDLKPENILL--NEDMH--IQITDFGTAKVLSPESKQARANSFVGT 195
Query: 182 PLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLF-SIIGDEHSLP 240
Y++PE + + SD+WALGC++ ++++G + + +F II E
Sbjct: 196 AQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF---RAGNEYLIFQKIIKLE---Y 249
Query: 241 EIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDD------PFVKGVD 281
+ P + +ARD + + V R E + PF + V
Sbjct: 250 DFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVT 296
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 7e-34
Identities = 71/295 (24%), Positives = 120/295 (40%), Gaps = 33/295 (11%)
Query: 11 GRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKS--------AEVSASASLQKEKEVFDNLN 62
VIG+G F V + AVK + ++ L++E + L
Sbjct: 29 CEVIGKGPFSVVRRCINRETGQQF----AVKIVDVAKFTSSPGLSTEDLKREASICHMLK 84
Query: 63 GCPFVLECFG--EEITMGENGEMAYNLLLEYAAGGTLGDLI--EKCNGNGLPEKDVRHFT 118
P ++E + ++ E+ G L I G E H+
Sbjct: 85 H-PHIVELLETYSS-------DGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYM 136
Query: 119 RCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSM 178
R ILE + + HD+ +H DVKP +LL A++ K+ GVA + +
Sbjct: 137 RQILEALRYCHDNNIIHRDVKPHCVLL-ASKENSAPVKLGGFGVAI--QLGESGLVAGGR 193
Query: 179 RGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLF-SIIGDEH 237
GTP ++APE V + P D+W G ++ +LSG + + ++LF II ++
Sbjct: 194 VGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK----ERLFEGIIKGKY 249
Query: 238 SLPEIP-SRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGVDEELSRELEGD 291
+ S +S+ A+D +RR + PA R T L+ P++K D + +
Sbjct: 250 KMNPRQWSHISESAKDLVRRMLMLDPAERITVYEALNHPWLKERDRYAYKIHLPE 304
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 2e-33
Identities = 71/300 (23%), Positives = 117/300 (39%), Gaps = 43/300 (14%)
Query: 9 FRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKS---AEVSASASLQKEKEVFDNLNGCP 65
+ V+G+G+ V S AVK + + +E E+ G
Sbjct: 16 LQEDVLGEGAHARVQTCINLITSQ----EYAVKIIEKQPGHIRSRVFREVEMLYQCQGHR 71
Query: 66 FVLECFG--EEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILE 123
VLE EE E + L+ E GG++ I K + E + + +
Sbjct: 72 NVLELIEFFEE-------EDRFYLVFEKMRGGSILSHIHK-RRH-FNELEASVVVQDVAS 122
Query: 124 GIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAK--RSRHCKRQKFDPSMR-- 179
+ +H+ G H D+KP+NIL + KI D + + P +
Sbjct: 123 ALDFLHNKGIAHRDLKPENILC-EHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTP 181
Query: 180 -GTPLYLAPETVVQHMQEAPS-----DIWALGCVVLEMLSG----------RQAWVVKED 223
G+ Y+APE V +EA D+W+LG ++ +LSG W E
Sbjct: 182 CGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEA 241
Query: 224 CSIDQ--LFSIIGD-EHSLPEIP-SRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKG 279
C Q LF I + ++ P+ + +S A+D + + VR R +A +L P+V+G
Sbjct: 242 CPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQG 301
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 2e-33
Identities = 67/278 (24%), Positives = 125/278 (44%), Gaps = 31/278 (11%)
Query: 11 GRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKS-----AEVSASASLQKEKEVFDNLNGCP 65
++G+GSFG V K + AVK A+ ++++ +E E+ L+ P
Sbjct: 27 VCMLGKGSFGEVLKCKDRITQQEY----AVKVINKASAKNKDTSTILREVELLKKLDH-P 81
Query: 66 FVLECFG--EEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILE 123
+++ F E+ ++ ++ E GG L D I K E D + +
Sbjct: 82 NIMKLFEILED-------SSSFYIVGELYTGGELFDEIIK-RKR-FSEHDAARIIKQVFS 132
Query: 124 GIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMRGTPL 183
GI ++H VH D+KP+NILL ++ KI D G++ + + K GT
Sbjct: 133 GITYMHKHNIVHRDLKPENILL-ESKEKDCDIKIIDFGLSTCFQQNTKMK---DRIGTAY 188
Query: 184 YLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLF-SIIGDEHSLPEI 242
Y+APE V++ + D+W+ G ++ +LSG + K + + + +++
Sbjct: 189 YIAPE-VLRGTYDEKCDVWSAGVILYILLSGTPPFYGKNE---YDILKRVETGKYAFDLP 244
Query: 243 P-SRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKG 279
+S +A+D +R+ P+ R TA L+ P+++
Sbjct: 245 QWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQK 282
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 2e-33
Identities = 63/286 (22%), Positives = 115/286 (40%), Gaps = 51/286 (17%)
Query: 10 RGRVIGQGSFGCVFIAK-PKSNSSFLPPLMAVKSAEVSASASLQKEK---------EVFD 59
RGR +G+G F F + F A K + + L K +
Sbjct: 19 RGRFLGKGGFAKCFEISDADTKEVF-----AGK---IVPKSLLLKPHQREKMSMEISIHR 70
Query: 60 NLNGCPFVL---ECFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRH 116
+L V+ F E+ + + ++LE +L +L ++ L E + R+
Sbjct: 71 SLA-HQHVVGFHGFF-------EDNDFVF-VVLELCRRRSLLELHKRRKA--LTEPEARY 119
Query: 117 FTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDP 176
+ R I+ G ++H + +H D+K N+ L + KI D G+A + + D
Sbjct: 120 YLRQIVLGCQYLHRNRVIHRDLKLGNLFL----NEDLEVKIGDFGLATKVEY------DG 169
Query: 177 SMR----GTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSI 232
+ GTP Y+APE + + D+W++GC++ +L G+ + E + + +
Sbjct: 170 ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPF---ETSCLKETYLR 226
Query: 233 IGDEHSLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVK 278
I IP ++ A +++ P R T LL+D F
Sbjct: 227 IKKNEY--SIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFT 270
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 2e-33
Identities = 71/286 (24%), Positives = 116/286 (40%), Gaps = 39/286 (13%)
Query: 12 RVIGQGSFGCVFIAKPKSNSSFLPPLMAVKS------AEVSASASLQKEKEVFDNLNGCP 65
RV+G+G FG V + ++ + A K + A EK++ + +N
Sbjct: 190 RVLGKGGFGEVCACQVRATGK----MYACKKLEKKRIKKRKGEAMALNEKQILEKVN-SR 244
Query: 66 FVLE---CFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCIL 122
FV+ + E + L+L GG L I G PE + I
Sbjct: 245 FVVSLAYAY-------ETKDALC-LVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEIC 296
Query: 123 EGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMRGTP 182
G+ +H V+ D+KP+NILL G +I+DLG+A + K GT
Sbjct: 297 CGLEDLHRERIVYRDLKPENILL--DDHGH--IRISDLGLAVHVPEGQTIK---GRVGTV 349
Query: 183 LYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVV-KEDCSIDQLF-SIIGDEHSLP 240
Y+APE V D WALGC++ EM++G+ + K+ +++ +
Sbjct: 350 GYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVP---E 406
Query: 241 EIPSRVSKEARDFLRRCFVRKPAFRF-----TAEMLLDDPFVKGVD 281
E R S +AR + + PA R +A + + P K ++
Sbjct: 407 EYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKKLN 452
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 2e-33
Identities = 74/286 (25%), Positives = 120/286 (41%), Gaps = 33/286 (11%)
Query: 11 GRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKS---------AEVSASASLQKEKEVFDNL 61
G +G G F V + KS A K + +++E + +
Sbjct: 16 GEELGSGQFAVVKKCREKSTGLQY----AAKFIKKRRTKSSRRGVSREDIEREVSILKEI 71
Query: 62 NGCPFVLECFG--EEITMGENGEMAYNLLLEYAAGGTLGD-LIEKCNGNGLPEKDVRHFT 118
P V+ E + L+LE AGG L D L EK L E++ F
Sbjct: 72 Q-HPNVITLHEVYEN-------KTDVILILELVAGGELFDFLAEK---ESLTEEEATEFL 120
Query: 119 RCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSM 178
+ IL G+ ++H H D+KP+NI+L+ K KI D G+A + K ++
Sbjct: 121 KQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFK---NI 177
Query: 179 RGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEHS 238
GTP ++APE V +D+W++G + +LSG ++ L ++ +
Sbjct: 178 FGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQET--LANVSAVNYE 235
Query: 239 LPEIP-SRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGVDEE 283
+ S S A+DF+RR V+ P R T + L P++K D +
Sbjct: 236 FEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQ 281
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 4e-33
Identities = 69/319 (21%), Positives = 128/319 (40%), Gaps = 72/319 (22%)
Query: 13 VIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVSASAS----LQKEKEVFDNLNGCPFVL 68
+G G+ G VF K + +MA K + + + +E +V N P+++
Sbjct: 40 ELGAGNGGVVFKVSHKPSGL----VMARKLIHLEIKPAIRNQIIRELQVLHECN-SPYIV 94
Query: 69 ECFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHI 128
+G +GE+ ++ +E+ GG+L +++K +PE+ + + +++G+ ++
Sbjct: 95 GFYG---AFYSDGEI--SICMEHMDGGSLDQVLKK--AGRIPEQILGKVSIAVIKGLTYL 147
Query: 129 HDSGYV-HCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMR----GTPL 183
+ + H DVKP NIL+ G+ K+ D GV+ + SM GT
Sbjct: 148 REKHKIMHRDVKPSNILV--NSRGE--IKLCDFGVSGQ--------LIDSMANSFVGTRS 195
Query: 184 YLAPETVVQHMQEAPSDIWALGCVVLEMLSGR---------------------------- 215
Y++PE + SDIW++G ++EM GR
Sbjct: 196 YMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPP 255
Query: 216 --------QAWVVKEDCSIDQLFSI---IGDEHSLPEIPSRVSKEARDFLRRCFVRKPAF 264
+ +F + I +E S E +DF+ +C ++ PA
Sbjct: 256 RPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAE 315
Query: 265 RFTAEMLLDDPFVKGVDEE 283
R + L+ F+K D E
Sbjct: 316 RADLKQLMVHAFIKRSDAE 334
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 5e-33
Identities = 62/283 (21%), Positives = 116/283 (40%), Gaps = 45/283 (15%)
Query: 10 RGRVIGQGSFGCVFIAK-PKSNSSFLPPLMAVKS------AEVSASASLQKEKEVFDNLN 62
RGR +G+G F F + F A K + + E + +L
Sbjct: 45 RGRFLGKGGFAKCFEISDADTKEVF-----AGKIVPKSLLLKPHQREKMSMEISIHRSLA 99
Query: 63 GCPFVL---ECFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTR 119
V+ F E+ + + ++LE +L +L ++ L E + R++ R
Sbjct: 100 H-QHVVGFHGFF-------EDNDFVF-VVLELCRRRSLLELHKRRKA--LTEPEARYYLR 148
Query: 120 CILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMR 179
I+ G ++H + +H D+K N+ L + KI D G+A + + D +
Sbjct: 149 QIVLGCQYLHRNRVIHRDLKLGNLFL----NEDLEVKIGDFGLATKVEY------DGERK 198
Query: 180 ----GTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGD 235
GTP Y+APE + + D+W++GC++ +L G+ + E + + + I
Sbjct: 199 KVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPF---ETSCLKETYLRI-- 253
Query: 236 EHSLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVK 278
+ + IP ++ A +++ P R T LL+D F
Sbjct: 254 KKNEYSIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFT 296
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 5e-33
Identities = 68/301 (22%), Positives = 119/301 (39%), Gaps = 65/301 (21%)
Query: 13 VIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVSAS----ASLQKEKEVFDNLNGCPFVL 68
VIG G+ V A +A+K + L KE + + P ++
Sbjct: 22 VIGSGATAVVQAAYCAPKKE----KVAIKRINLEKCQTSMDELLKEIQAMSQCH-HPNIV 76
Query: 69 ECFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNG------LPEKDVRHFTRCIL 122
+ + E+ L+++ +GG++ D+I+ G L E + R +L
Sbjct: 77 SYYT---SFVVKDELW--LVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVL 131
Query: 123 EGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVA-------KRSRHCKRQKFD 175
EG+ ++H +G +H DVK NILL + G +IAD GV+ +R+ R+
Sbjct: 132 EGLEYLHKNGQIHRDVKAGNILL--GEDGS--VQIADFGVSAFLATGGDITRNKVRK--- 184
Query: 176 PSMRGTPLYLAPETVVQHMQE--APSDIWALGCVVLEMLSGR---------QAWVVKEDC 224
+ GTP ++APE V++ ++ +DIW+ G +E+ +G +
Sbjct: 185 -TFVGTPCWMAPE-VMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKV------- 235
Query: 225 SIDQLFSI-------IGDEHSLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFV 277
L + E+ + K R + C + P R TA LL F
Sbjct: 236 ----LMLTLQNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFF 291
Query: 278 K 278
+
Sbjct: 292 Q 292
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 5e-33
Identities = 69/286 (24%), Positives = 119/286 (41%), Gaps = 33/286 (11%)
Query: 11 GRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKS---------AEVSASASLQKEKEVFDNL 61
G +G G F V + KS A K +++E + +
Sbjct: 17 GEELGSGQFAIVKKCREKSTGLEY----AAKFIKKRQSRASRRGVCREEIEREVSILRQV 72
Query: 62 NGCPFVLECFG--EEITMGENGEMAYNLLLEYAAGGTLGD-LIEKCNGNGLPEKDVRHFT 118
P ++ E L+LE +GG L D L +K L E++ F
Sbjct: 73 L-HPNIITLHDVYEN-------RTDVVLILELVSGGELFDFLAQK---ESLSEEEATSFI 121
Query: 119 RCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSM 178
+ IL+G+ ++H H D+KP+NI+L+ K+ D G+A K ++
Sbjct: 122 KQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFK---NI 178
Query: 179 RGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEHS 238
GTP ++APE V +D+W++G + +LSG ++ L +I +
Sbjct: 179 FGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQET--LANITAVSYD 236
Query: 239 LPEIP-SRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGVDEE 283
E S+ S+ A+DF+R+ V++ R T + L P++ VD +
Sbjct: 237 FDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDTQ 282
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 8e-33
Identities = 70/290 (24%), Positives = 125/290 (43%), Gaps = 54/290 (18%)
Query: 8 WFRGRVIGQGSFGCVFIAK-PKSNSSFLPPLMAVKSAEVSASASLQKEK---------EV 57
+ G ++G+GSF V+ A+ + A+K + ++ K ++
Sbjct: 13 FKVGNLLGKGSFAGVYRAESIHTGLEV-----AIK---MIDKKAMYKAGMVQRVQNEVKI 64
Query: 58 FDNLNGCPFVL---ECFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDV 114
L P +L F E+ Y L+LE G + + K E +
Sbjct: 65 HCQLKH-PSILELYNYF-------EDSNYVY-LVLEMCHNGEMNRYL-KNRVKPFSENEA 114
Query: 115 RHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKF 174
RHF I+ G+ ++H G +H D+ N+LL + KIAD G+A + +
Sbjct: 115 RHFMHQIITGMLYLHSHGILHRDLTLSNLLL----TRNMNIKIADFGLATQLKM------ 164
Query: 175 DPSMR-----GTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQL 229
P + GTP Y++PE + SD+W+LGC+ +L GR + + ++
Sbjct: 165 -PHEKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPF---DTDTVKNT 220
Query: 230 FS-IIGDEHSLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVK 278
+ ++ ++ +PS +S EA+D + + R PA R + +LD PF+
Sbjct: 221 LNKVVLADYE---MPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDHPFMS 267
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 9e-33
Identities = 71/291 (24%), Positives = 113/291 (38%), Gaps = 32/291 (10%)
Query: 11 GRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVSA-----SASLQKEKEVFDNLNGCP 65
+G+G+F V K+ A K L++E + L P
Sbjct: 34 KEELGKGAFSVVRRCVHKTTGLEF----AAKIINTKKLSARDFQKLEREARICRKLQH-P 88
Query: 66 FVLECFG--EEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILE 123
++ +E E + L+ + GG L + I E D H + ILE
Sbjct: 89 NIVRLHDSIQE-------ESFHYLVFDLVTGGELFEDIVA-REF-YSEADASHCIQQILE 139
Query: 124 GIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMRGTPL 183
I + H +G VH ++KP+N+LL + G V K+AD G+ + + GTP
Sbjct: 140 SIAYCHSNGIVHRNLKPENLLLASKAKGAAV-KLADFGL---AIEVNDSEAWHGFAGTPG 195
Query: 184 YLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQA-WVVKEDCSIDQLF-SIIGDEHSLPE 241
YL+PE + + P DIWA G ++ +L G W D +L+ I + P
Sbjct: 196 YLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFW----DEDQHRLYAQIKAGAYDYPS 251
Query: 242 IP-SRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGVDEELSRELEGD 291
V+ EA+ + P R TA+ L P++ + S D
Sbjct: 252 PEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNRERVASAIHRQD 302
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 1e-32
Identities = 70/298 (23%), Positives = 117/298 (39%), Gaps = 47/298 (15%)
Query: 11 GRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKS---------AEVSASASLQKEKEVFDNL 61
G +G G F V + K A K + +++E + +
Sbjct: 10 GEELGSGQFAIVRKCRQKGTGKEY----AAKFIKKRRLSSSRRGVSREEIEREVNILREI 65
Query: 62 NGCPFVLECFG--EEITMGENGEMAYNLLLEYAAGGTLGD-LIEKCNGNGLPEKDVRHFT 118
P ++ E + L+LE +GG L D L EK L E + F
Sbjct: 66 RH-PNIITLHDIFEN-------KTDVVLILELVSGGELFDFLAEK---ESLTEDEATQFL 114
Query: 119 RCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSM 178
+ IL+G+ ++H H D+KP+NI+L+ K+ D G+A + K ++
Sbjct: 115 KQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFK---NI 171
Query: 179 RGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCS------IDQLFS- 231
GTP ++APE V +D+W++G + +LSG S + +
Sbjct: 172 FGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG---------ASPFLGETKQETLTN 222
Query: 232 IIGDEHSLPEIP-SRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGVDEELSREL 288
I + E S S+ A+DF+RR V+ P R T L+ ++K + R
Sbjct: 223 ISAVNYDFDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRRRNVRGE 280
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 1e-32
Identities = 70/282 (24%), Positives = 111/282 (39%), Gaps = 32/282 (11%)
Query: 11 GRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKS-----AEVSASASLQKEKEVFDNLNGCP 65
+G+G+F V K+ A K L++E + L P
Sbjct: 11 KEELGKGAFSVVRRCVHKTTGLEF----AAKIINTKKLSARDFQKLEREARICRKLQH-P 65
Query: 66 FVLECFG--EEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILE 123
++ +E E + L+ + GG L + I E D H + ILE
Sbjct: 66 NIVRLHDSIQE-------ESFHYLVFDLVTGGELFEDIVA-REF-YSEADASHCIQQILE 116
Query: 124 GIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMRGTPL 183
I + H +G VH ++KP+N+LL + G V K+AD G+A + GTP
Sbjct: 117 SIAYCHSNGIVHRNLKPENLLLASKAKGAAV-KLADFGLAI---EVNDSEAWHGFAGTPG 172
Query: 184 YLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQA-WVVKEDCSIDQLF-SIIGDEHSLPE 241
YL+PE + + P DIWA G ++ +L G W D +L+ I + P
Sbjct: 173 YLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFW----DEDQHRLYAQIKAGAYDYPS 228
Query: 242 IP-SRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGVDE 282
V+ EA+ + P R TA+ L P++ +
Sbjct: 229 PEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNRER 270
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 1e-32
Identities = 73/288 (25%), Positives = 126/288 (43%), Gaps = 37/288 (12%)
Query: 11 GRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKS-----------AEVSASASLQKEKEVFD 59
+ +G G+ G V +A + + A+K E + +++ E E+
Sbjct: 15 SKTLGSGACGEVKLAFERKTCKKV----AIKIISKRKFAIGSAREADPALNVETEIEILK 70
Query: 60 NLNGCPFVLECFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTR 119
LN P +++ Y ++LE GG L D + N L E + +
Sbjct: 71 KLNH-PCIIKIKNFFDAE------DYYIVLELMEGGELFDKVVG-NKR-LKEATCKLYFY 121
Query: 120 CILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMR 179
+L + ++H++G +H D+KP+N+LL + + + KI D G +K ++
Sbjct: 122 QMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLI-KITDFGHSK---ILGETSLMRTLC 177
Query: 180 GTPLYLAPETVVQHMQEA---PSDIWALGCVVLEMLSGRQA-WVVKEDCSIDQLFSII-- 233
GTP YLAPE +V D W+LG ++ LSG E + L I
Sbjct: 178 GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFS---EHRTQVSLKDQITS 234
Query: 234 GDEHSLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGVD 281
G + +PE+ + VS++A D +++ V P RFT E L P+++ D
Sbjct: 235 GKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDED 282
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 2e-32
Identities = 72/274 (26%), Positives = 120/274 (43%), Gaps = 25/274 (9%)
Query: 11 GRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVSASASLQKEKEVFDNLNGCPFVLEC 70
+G+G+ V+ K K + K+ + ++ E V L+ P +++
Sbjct: 58 ESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKI---VRTEIGVLLRLS-HPNIIKL 113
Query: 71 FG--EEITMGENGEMAYNLLLEYAAGGTLGDLI-EKCNGNGLPEKDVRHFTRCILEGIGH 127
E +L+LE GG L D I EK E+D + ILE + +
Sbjct: 114 KEIFET-------PTEISLVLELVTGGELFDRIVEK---GYYSERDAADAVKQILEAVAY 163
Query: 128 IHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMRGTPLYLAP 187
+H++G VH D+KP+N+L AT + KIAD G++K + Q ++ GTP Y AP
Sbjct: 164 LHENGIVHRDLKPENLLY-ATPAPDAPLKIADFGLSK---IVEHQVLMKTVCGTPGYCAP 219
Query: 188 ETVVQHMQEAPSDIWALGCVVLEMLSGRQA-WVVKEDCSIDQLFSIIGDEHSLPEIP-SR 245
E + D+W++G + +L G + + + D + + I+ E+
Sbjct: 220 EILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFR--RILNCEYYFISPWWDE 277
Query: 246 VSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKG 279
VS A+D +R+ V P R T L P+V G
Sbjct: 278 VSLNAKDLVRKLIVLDPKKRLTTFQALQHPWVTG 311
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 3e-32
Identities = 61/313 (19%), Positives = 108/313 (34%), Gaps = 56/313 (17%)
Query: 11 GRVIGQGSFGCVFIAK-----------PKSN---SSFLPPLMAVKSAEVSASASLQKEKE 56
R + QG F + + + KS K + S + E +
Sbjct: 36 IRTLNQGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQ 95
Query: 57 VFDNLNGCPFVLECFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKC------NGNGLP 110
+ ++ + L C G + N + Y ++ EY ++ E +P
Sbjct: 96 IITDIKN-EYCLTCEG---II-TNYDEVY-IIYEYMENDSILKFDEYFFVLDKNYTCFIP 149
Query: 111 EKDVRHFTRCILEGIGHIHDS-GYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHC 169
+ ++ + +L +IH+ H DVKP NIL+ K++D G ++
Sbjct: 150 IQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILM----DKNGRVKLSDFGESEYMVDK 205
Query: 170 KRQKFDPSMRGTPLYLAPETVVQHMQE--APSDIWALGCVVLEMLSGRQAWVVKEDCSID 227
K + RGT ++ PE A DIW+LG + M + S+
Sbjct: 206 KIK----GSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPF--SLKISLV 259
Query: 228 QLFSII-----------------GDEHSLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEM 270
+LF+ I + +S E DFL+ + PA R T+E
Sbjct: 260 ELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSED 319
Query: 271 LLDDPFVKGVDEE 283
L ++ + E
Sbjct: 320 ALKHEWLADTNIE 332
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 3e-32
Identities = 67/296 (22%), Positives = 110/296 (37%), Gaps = 47/296 (15%)
Query: 11 GRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVSASA------------SLQKEKEVF 58
++G+G V K AVK +V+ + KE ++
Sbjct: 22 KEILGRGVSSVVRRCIHKPTCKEY----AVKIIDVTGGGSFSAEEVQELREATLKEVDIL 77
Query: 59 DNLNGCPFVLECFG--EEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRH 116
++G P +++ E + L+ + G L D + + L EK+ R
Sbjct: 78 RKVSGHPNIIQLKDTYET-------NTFFFLVFDLMKKGELFDYLTE-KVT-LSEKETRK 128
Query: 117 FTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDP 176
R +LE I +H VH D+KP+NILL K+ D G + +
Sbjct: 129 IMRALLEVICALHKLNIVHRDLKPENILL----DDDMNIKLTDFGFSC---QLDPGEKLR 181
Query: 177 SMRGTPLYLAPETVVQHMQEA------PSDIWALGCVVLEMLSGRQA-WVVKEDCSIDQL 229
+ GTP YLAPE + M + D+W+ G ++ +L+G W +
Sbjct: 182 EVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFW----HRKQMLM 237
Query: 230 F-SIIGDEHSLPEIP-SRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGVDEE 283
I+ + S +D + R V +P R+TAE L PF + E
Sbjct: 238 LRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYVVE 293
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 126 bits (317), Expect = 3e-32
Identities = 57/279 (20%), Positives = 119/279 (42%), Gaps = 22/279 (7%)
Query: 11 GRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVSASA---SLQKEKEVFDNLNGCPFV 67
+G G+FG V ++ + A K + +++KE + L P +
Sbjct: 162 HEELGTGAFGVVHRVTERATGNNF----AAKFVMTPHESDKETVRKEIQTMSVLRH-PTL 216
Query: 68 LECFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGH 127
+ E ++ E+ +GG L + + + + E + + R + +G+ H
Sbjct: 217 VNLHDAFEDDNE-----MVMIYEFMSGGELFEKVADEHNK-MSEDEAVEYMRQVCKGLCH 270
Query: 128 IHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMRGTPLYLAP 187
+H++ YVH D+KP+NI+ +S + K+ D G+ + K GT + AP
Sbjct: 271 MHENNYVHLDLKPENIMFTTKRSNEL--KLIDFGLTAHLDPKQSVK---VTTGTAEFAAP 325
Query: 188 ETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEHSLPEIP-SRV 246
E +D+W++G + +LSG + + D L ++ + ++ + S +
Sbjct: 326 EVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDET--LRNVKSCDWNMDDSAFSGI 383
Query: 247 SKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGVDEELS 285
S++ +DF+R+ + P R T L+ P++ +
Sbjct: 384 SEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGR 422
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 5e-32
Identities = 57/284 (20%), Positives = 105/284 (36%), Gaps = 39/284 (13%)
Query: 11 GRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVSASASLQKEKEVFDNLNGCPFVLEC 70
+V+G G G V K A+K + ++E E+ + CP ++
Sbjct: 23 SQVLGLGINGKVLQIFNKRTQEKF----ALKM--LQDCPKARREVELHWRASQCPHIVRI 76
Query: 71 FG--EEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHI 128
E + G +++E GG L I+ E++ + I E I ++
Sbjct: 77 VDVYENLYAGRK---CLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYL 133
Query: 129 HDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMRGTPLYLAPE 188
H H DVKP+N+L ++ + K+ D G AK + +K+D S
Sbjct: 134 HSINIAHRDVKPENLLY-TSKRPNAILKLTDFGFAKETT---GEKYDKS----------- 178
Query: 189 TVVQHMQEAPSDIWALGCVVLEMLSGRQA-WVVKEDCSIDQLFSIIGD-EHSLPEIP-SR 245
D+W+LG ++ +L G + + + I ++ P S
Sbjct: 179 ----------CDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSE 228
Query: 246 VSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGVDEELSRELE 289
VS+E + +R +P R T ++ P++ + L
Sbjct: 229 VSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLH 272
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 6e-32
Identities = 72/276 (26%), Positives = 127/276 (46%), Gaps = 26/276 (9%)
Query: 10 RGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVSASA---SLQKEKEVFDNLNGCPF 66
+ ++G G FG V + + L A K + ++ E V + L+
Sbjct: 93 KTEILGGGRFGQVHKCEETATGLKL----AAKIIKTRGMKDKEEVKNEISVMNQLDH-AN 147
Query: 67 VLECFG--EEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEG 124
+++ + E + L++EY GG L D I L E D F + I EG
Sbjct: 148 LIQLYDAFES-------KNDIVLVMEYVDGGELFDRI-IDESYNLTELDTILFMKQICEG 199
Query: 125 IGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMRGTPLY 184
I H+H +H D+KP+NIL V + + KI D G+A+R + ++ K GTP +
Sbjct: 200 IRHMHQMYILHLDLKPENILCVNRDAKQI--KIIDFGLARRYKPREKLK---VNFGTPEF 254
Query: 185 LAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEHSLPEIP- 243
LAPE V P+D+W++G + +LSG ++ D L +I+ L +
Sbjct: 255 LAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAET--LNNILACRWDLEDEEF 312
Query: 244 SRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKG 279
+S+EA++F+ + +++ ++R +A L P++
Sbjct: 313 QDISEEAKEFISKLLIKEKSWRISASEALKHPWLSD 348
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 9e-32
Identities = 72/306 (23%), Positives = 115/306 (37%), Gaps = 36/306 (11%)
Query: 1 MDSDGTSWFR-----GRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKS-----AEVSASAS 50
M + + F +G+G+F V A
Sbjct: 1 MATITCTRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEY----AAMIINTKKLSARDHQK 56
Query: 51 LQKEKEVFDNLNGCPFVLECFG--EEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNG 108
L++E + L P ++ E E + L+ + GG L + I
Sbjct: 57 LEREARICRLLKH-PNIVRLHDSISE-------EGHHYLIFDLVTGGELFEDIVA-REY- 106
Query: 109 LPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRH 168
E D H + ILE + H H G VH ++KP+N+LL + G V K+AD G+A
Sbjct: 107 YSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAV-KLADFGLAIEVEG 165
Query: 169 CKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQA-WVVKEDCSID 227
++ F GTP YL+PE + + P D+WA G ++ +L G W D
Sbjct: 166 EQQAWFG--FAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFW----DEDQH 219
Query: 228 QLF-SIIGDEHSLPEIP-SRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGVDEELS 285
+L+ I + P V+ EA+D + + P+ R TA L P++ S
Sbjct: 220 RLYQQIKAGAYDFPSPEWDTVTPEAKDLINKMLTINPSKRITAAEALKHPWISHRSTVAS 279
Query: 286 RELEGD 291
+
Sbjct: 280 CMHRQE 285
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 1e-31
Identities = 70/274 (25%), Positives = 118/274 (43%), Gaps = 47/274 (17%)
Query: 12 RVIGQGSFGCVFIAKPKSNSSFLPPLMAVKS------AEVSASASLQKEKEVFDNLNGCP 65
RVIG+GS+ V + + K + A+K + +Q EK VF+ + P
Sbjct: 15 RVIGRGSYAKVLLVRLKKTDR----IYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHP 70
Query: 66 FVLE---CFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCIL 122
F++ CF + + ++EY GG L +++ LPE+ R ++ I
Sbjct: 71 FLVGLHSCF-------QTESRLF-FVIEYVNGGDLMFHMQRQRK--LPEEHARFYSAEIS 120
Query: 123 EGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMR--- 179
+ ++H+ G ++ D+K DN+LL G + K+ D G+ CK
Sbjct: 121 LALNYLHERGIIYRDLKLDNVLL--DSEG-HI-KLTDYGM------CKEGLRPGDTTSTF 170
Query: 180 -GTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGR------QAWVVKEDCSIDQLF-S 231
GTP Y+APE + D WALG ++ EM++GR + + + D LF
Sbjct: 171 CGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQV 230
Query: 232 IIGDEHSLPEIPSRVSKEARDFLRRCFVRKPAFR 265
I+ + IP +S +A L+ + P R
Sbjct: 231 ILEKQ---IRIPRSLSVKAASVLKSFLNKDPKER 261
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 2e-31
Identities = 64/288 (22%), Positives = 113/288 (39%), Gaps = 40/288 (13%)
Query: 12 RVIGQGSFGCVFIAKPKSNSSFLPPLMAVKS------AEVSASASLQKEKEVFDNLNGCP 65
RV+G+G FG VF + K+ L A K + EK++ ++
Sbjct: 191 RVLGRGGFGEVFACQMKATGK----LYACKKLNKKRLKKRKGYQGAMVEKKILAKVH-SR 245
Query: 66 FVLE---CFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGN--GLPEKDVRHFTRC 120
F++ F E L++ GG + I + + G E +T
Sbjct: 246 FIVSLAYAF-------ETKTDLC-LVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQ 297
Query: 121 ILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMRG 180
I+ G+ H+H ++ D+KP+N+LL G +I+DLG+A Q G
Sbjct: 298 IVSGLEHLHQRNIIYRDLKPENVLL--DDDGN--VRISDLGLAV--ELKAGQTKTKGYAG 351
Query: 181 TPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVV-KEDCSIDQLF-SIIGDEHS 238
TP ++APE ++ + D +ALG + EM++ R + E +L ++
Sbjct: 352 TPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQA-- 409
Query: 239 LPEIPSRVSKEARDFLRRCFVRKPAFRF-----TAEMLLDDPFVKGVD 281
P + S ++DF + P R + + L P + +
Sbjct: 410 -VTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDIS 456
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 3e-31
Identities = 69/274 (25%), Positives = 118/274 (43%), Gaps = 47/274 (17%)
Query: 12 RVIGQGSFGCVFIAKPKSNSSFLPPLMAVKS------AEVSASASLQKEKEVFDNLNGCP 65
RVIG+GS+ V + + K + A++ + +Q EK VF+ + P
Sbjct: 58 RVIGRGSYAKVLLVRLKKTDR----IYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHP 113
Query: 66 FVLE---CFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCIL 122
F++ CF + + ++EY GG L +++ LPE+ R ++ I
Sbjct: 114 FLVGLHSCF-------QTESRLF-FVIEYVNGGDLMFHMQRQRK--LPEEHARFYSAEIS 163
Query: 123 EGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMR--- 179
+ ++H+ G ++ D+K DN+LL G + K+ D G+ CK
Sbjct: 164 LALNYLHERGIIYRDLKLDNVLL--DSEG-HI-KLTDYGM------CKEGLRPGDTTSTF 213
Query: 180 -GTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGR------QAWVVKEDCSIDQLF-S 231
GTP Y+APE + D WALG ++ EM++GR + + + D LF
Sbjct: 214 CGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQV 273
Query: 232 IIGDEHSLPEIPSRVSKEARDFLRRCFVRKPAFR 265
I+ + IP +S +A L+ + P R
Sbjct: 274 ILEKQ---IRIPRSLSVKAASVLKSFLNKDPKER 304
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 3e-31
Identities = 84/306 (27%), Positives = 136/306 (44%), Gaps = 57/306 (18%)
Query: 12 RVIGQGSFGCVFIAKPKSNSSFLPPLMAVKS------AEVSASASLQKEKEVFDNLNGCP 65
+VIG+G+F V + K K + A+K + + ++E++V N +
Sbjct: 67 KVIGRGAFSEVAVVKMKQTGQ----VYAMKIMNKWDMLKRGEVSCFREERDVLVNGD-RR 121
Query: 66 FVLE---CFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCIL 122
++ + F ++ Y L++EY GG L L+ K G +P + R + I+
Sbjct: 122 WITQLHFAF-------QDENYLY-LVMEYYVGGDLLTLLSKF-GERIPAEMARFYLAEIV 172
Query: 123 EGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMR--- 179
I +H GYVH D+KPDNILL + G ++AD G C + + D ++R
Sbjct: 173 MAIDSVHRLGYVHRDIKPDNILL--DRCGH--IRLADFGS------CLKLRADGTVRSLV 222
Query: 180 --GTPLYLAPETVVQHMQEAPS--------DIWALGCVVLEMLSGRQAWVVKEDCSIDQL 229
GTP YL+PE ++Q + P D WALG EM G+ + S +
Sbjct: 223 AVGTPDYLSPE-ILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPF---YADSTAET 278
Query: 230 FS-IIGDEHSL--PEIPSRVSKEARDFLRRCFVRKPAFRFT---AEMLLDDPFVKGVDEE 283
+ I+ + L P + V +EARDF++R + P R A PF G+D +
Sbjct: 279 YGKIVHYKEHLSLPLVDEGVPEEARDFIQR-LLCPPETRLGRGGAGDFRTHPFFFGLDWD 337
Query: 284 LSRELE 289
R+
Sbjct: 338 GLRDSV 343
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 3e-31
Identities = 79/291 (27%), Positives = 127/291 (43%), Gaps = 39/291 (13%)
Query: 12 RVIGQGSFGCVFIAKPKSNSSFLPPLMAVKS---AEVSAS---ASLQKEKEVFDNLNGCP 65
+++G+GSFG VF+A+ K + A+K+ V EK V P
Sbjct: 23 KMLGKGSFGKVFLAEFKKTNQ----FFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHP 78
Query: 66 FVLE---CFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCIL 122
F+ F + E + ++EY GG L I+ C+ + I+
Sbjct: 79 FLTHMFCTF-------QTKENLF-FVMEYLNGGDLMYHIQSCHK--FDLSRATFYAAEII 128
Query: 123 EGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMRGTP 182
G+ +H G V+ D+K DNILL + G + KIAD G+ K + + GTP
Sbjct: 129 LGLQFLHSKGIVYRDLKLDNILL--DKDG-HI-KIADFGMCK--ENMLGDAKTNTFCGTP 182
Query: 183 LYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLF-SIIGDEHSLPE 241
Y+APE ++ D W+ G ++ EML G+ + ++LF SI D P
Sbjct: 183 DYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPF---HGQDEEELFHSIRMDN---PF 236
Query: 242 IPSRVSKEARDFLRRCFVRKPAFRFTA-EMLLDDPFVKGVDEE--LSRELE 289
P + KEA+D L + FVR+P R + P + ++ E +E++
Sbjct: 237 YPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREINWEELERKEID 287
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 8e-31
Identities = 81/332 (24%), Positives = 137/332 (41%), Gaps = 29/332 (8%)
Query: 11 GRVIGQGSFGCVFIAKPKSNSSFLPPLMAVK----SAEVSASASLQKEKEVFDNLNGCPF 66
+ +G+G++G V +A + +AVK V +++KE + LN
Sbjct: 12 VQTLGEGAYGEVQLAVNRVTEE----AVAVKIVDMKRAVDCPENIKKEICINKMLNH-EN 66
Query: 67 VLECFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIG 126
V++ + G + Y L LEY +GG L D I G+PE D + F ++ G+
Sbjct: 67 VVKFY-GHR---REGNIQY-LFLEYCSGGELFDRI--EPDIGMPEPDAQRFFHQLMAGVV 119
Query: 127 HIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMRGTPLYLA 186
++H G H D+KP+N+LL + KI+D G+A R+ R++ M GT Y+A
Sbjct: 120 YLHGIGITHRDIKPENLLL----DERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVA 175
Query: 187 PETVVQHMQ--EAPSDIWALGCVVL-EMLSGRQAWVVKEDCSIDQLFSIIGDEHSLPEIP 243
PE +++ + P D+W+ G +VL ML+G W D S + + L
Sbjct: 176 PE-LLKRREFHAEPVDVWSCG-IVLTAMLAGELPWDQPSD-SCQEYSDWKEKKTYLNP-W 231
Query: 244 SRVSKEARDFLRRCFVRKPAFRFTAEMLLDDP-FVKGVDEELSRELEGDYSQGEVTLSNA 302
++ L + V P+ R T + D + K + + R E S
Sbjct: 232 KKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLKKGAKRPRVTSGGVSESP-SGF 290
Query: 303 DAESCSPECISFIPLEANSSLSSWGSAQRTNE 334
S S + + + S W +
Sbjct: 291 SKHIQSNLDFSPVNSASRTPGSGWSKEHHHHH 322
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 116 bits (294), Expect = 1e-30
Identities = 74/286 (25%), Positives = 127/286 (44%), Gaps = 32/286 (11%)
Query: 11 GRVIGQGSFGCVFIAKPKSNSSFLPPLMAVK----SAEVSASASLQKEKEVFDNLNGCPF 66
+ +G+G++G V +A + +AVK V +++KE + LN
Sbjct: 12 VQTLGEGAYGEVQLAVNRVTEE----AVAVKIVDMKRAVDCPENIKKEICINKMLNH-EN 66
Query: 67 VLECFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIG 126
V++ + G + Y L LEY +GG L D I G+PE D + F ++ G+
Sbjct: 67 VVKFY-GHR---REGNIQY-LFLEYCSGGELFDRI--EPDIGMPEPDAQRFFHQLMAGVV 119
Query: 127 HIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMRGTPLYLA 186
++H G H D+KP+N+LL + KI+D G+A R+ R++ M GT Y+A
Sbjct: 120 YLHGIGITHRDIKPENLLL----DERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVA 175
Query: 187 PETVVQHMQ--EAPSDIWALGCVVL-EMLSGRQAWVVKEDCS--IDQLFSIIGDEHSLPE 241
PE +++ + P D+W+ G +VL ML+G W + S + + L
Sbjct: 176 PE-LLKRREFHAEPVDVWSCG-IVLTAMLAGELPW---DQPSDSCQEYSDWKEKKTYLNP 230
Query: 242 IPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDP-FVKGVDEELSR 286
++ L + V P+ R T + D + K + + R
Sbjct: 231 -WKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLKKGAKR 275
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 4e-30
Identities = 61/296 (20%), Positives = 113/296 (38%), Gaps = 44/296 (14%)
Query: 11 GRVIGQGSFGCVFIAK-PKSNSSF----LPPLMAVKSAEVSASASLQKEKEVFDNLNGCP 65
IG+GS+G V +A N+ + L ++ A + +
Sbjct: 18 KDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPR 77
Query: 66 FVLECFGEEIT----------------MGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGL 109
+E +EI + + E ++ E G + ++ L
Sbjct: 78 GPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL---KPL 134
Query: 110 PEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHC 169
E R + + +++GI ++H +H D+KP N+L+ KIAD GV S
Sbjct: 135 SEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLV----GEDGHIKIADFGV---SNEF 187
Query: 170 KRQKFDPSMR---GTPLYLAPETVVQHMQE---APSDIWALGCVVLEMLSGRQAWVVKED 223
K D + GTP ++APE++ + + D+WA+G + + G+ + D
Sbjct: 188 KGS--DALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPF---MD 242
Query: 224 CSIDQLFS-IIGDEHSLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVK 278
I L S I P+ P ++++ +D + R + P R + P+V
Sbjct: 243 ERIMCLHSKIKSQALEFPDQPD-IAEDLKDLITRMLDKNPESRIVVPEIKLHPWVT 297
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 5e-30
Identities = 65/288 (22%), Positives = 116/288 (40%), Gaps = 43/288 (14%)
Query: 12 RVIGQGSFGCVFIAKPKSNSSFLPPLMAVKS------AEVSASASLQKEKEVFDNLNG-- 63
R+IG+G FG V+ + + A+K E+ + ++
Sbjct: 195 RIIGRGGFGEVYGCRKADTGK----MYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD 250
Query: 64 CPFVLE---CFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRC 120
CPF++ F + +L+ GG L + + E D+R +
Sbjct: 251 CPFIVCMSYAF-------HTPDKLS-FILDLMNGGDLHYHLSQHGV--FSEADMRFYAAE 300
Query: 121 ILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMRG 180
I+ G+ H+H+ V+ D+KP NILL + G +I+DLG+A K + G
Sbjct: 301 IILGLEHMHNRFVVYRDLKPANILL--DEHGH--VRISDLGLACDFSKKKPH----ASVG 352
Query: 181 TPLYLAPETVVQHMQEAPS-DIWALGCVVLEMLSGRQAWVVKEDCSIDQLF-SIIGDEHS 238
T Y+APE + + + S D ++LGC++ ++L G + + ++ +
Sbjct: 353 THGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMA-- 410
Query: 239 LPEIPSRVSKEARDFLRRCFVRKPAFRF-----TAEMLLDDPFVKGVD 281
E+P S E R L R R A+ + + PF + +D
Sbjct: 411 -VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLD 457
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 6e-30
Identities = 79/298 (26%), Positives = 131/298 (43%), Gaps = 43/298 (14%)
Query: 12 RVIGQGSFGCVFIAKPKSNSSF-----LPPLMAVKSAEVSASASLQKEKEVFDNLNGCPF 66
+VIG+G+FG V + K K+ L +K AE A ++E++V N + +
Sbjct: 80 KVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAET---ACFREERDVLVNGD-SKW 135
Query: 67 VLE---CFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILE 123
+ F ++ Y L+++Y GG L L+ K LPE+ R + ++
Sbjct: 136 ITTLHYAF-------QDDNNLY-LVMDYYVGGDLLTLLSKFEDR-LPEEMARFYLAEMVI 186
Query: 124 GIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMRGTPL 183
I +H YVH D+KPDNIL+ +G ++AD G + + GTP
Sbjct: 187 AIDSVHQLHYVHRDIKPDNILM--DMNGH--IRLADFGSCLKLMEDGTVQSS-VAVGTPD 241
Query: 184 YLAPETVVQHMQEAPS------DIWALGCVVLEMLSGRQAWVVKEDCSIDQLFS-IIGDE 236
Y++PE ++Q M+ D W+LG + EML G + S+ + + I+ +
Sbjct: 242 YISPE-ILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPF---YAESLVETYGKIMNHK 297
Query: 237 HSL--PEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLD---DPFVKGVDEELSRELE 289
P + VS+ A+D +RR + R + D PF G+D + R E
Sbjct: 298 ERFQFPTQVTDVSENAKDLIRR-LICSREHRLGQNGIEDFKKHPFFSGIDWDNIRNCE 354
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 8e-30
Identities = 65/295 (22%), Positives = 105/295 (35%), Gaps = 56/295 (18%)
Query: 11 GRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKS-----------AEVSASASLQKEKEVFD 59
VIG+G V ++ AVK + ++E +
Sbjct: 99 KDVIGRGVSSVVRRCVHRATGHEF----AVKIMEVTAERLSPEQLEEVREATRRETHILR 154
Query: 60 NLNGCPFVLECFG--EEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHF 117
+ G P ++ E L+ + G L D + + L EK+ R
Sbjct: 155 QVAGHPHIITLIDSYES-------SSFMFLVFDLMRKGELFDYLTE-KVA-LSEKETRSI 205
Query: 118 TRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPS 177
R +LE + +H + VH D+KP+NILL +++D G + +P
Sbjct: 206 MRSLLEAVSFLHANNIVHRDLKPENILL----DDNMQIRLSDFGFSC--------HLEPG 253
Query: 178 MR-----GTPLYLAPETVVQHMQEA------PSDIWALGCVVLEMLSGRQA-WVVKEDCS 225
+ GTP YLAPE + M E D+WA G ++ +L+G W
Sbjct: 254 EKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFW----HRR 309
Query: 226 IDQLF-SIIGDEHSLPEIP-SRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVK 278
+ I+ ++ S +D + R P R TAE L PF +
Sbjct: 310 QILMLRMIMEGQYQFSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQHPFFE 364
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 1e-29
Identities = 67/270 (24%), Positives = 112/270 (41%), Gaps = 49/270 (18%)
Query: 12 RVIGQGSFGCVFIAKPKSNSSFLPPLMAVKS---------AEVSASASLQKEKEVFDNLN 62
+++G+G+FG V + + K+ A+K EV A E V N
Sbjct: 11 KLLGKGTFGKVILVREKATGR----YYAMKILRKEVIIAKDEV---AHTVTESRVLQNTR 63
Query: 63 GCPFVLE---CFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTR 119
PF+ F + + ++EYA GG L + + E+ R +
Sbjct: 64 -HPFLTALKYAF-------QTHDRLC-FVMEYANGGELFFHLSRERV--FTEERARFYGA 112
Query: 120 CILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMR 179
I+ + ++H V+ D+K +N++L + G + KI D G+ K +M+
Sbjct: 113 EIVSALEYLHSRDVVYRDIKLENLML--DKDG-HI-KITDFGLCKEG-----ISDGATMK 163
Query: 180 ---GTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLF-SIIGD 235
GTP YLAPE + + D W LG V+ EM+ GR + + ++LF I+ +
Sbjct: 164 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF---YNQDHERLFELILME 220
Query: 236 EHSLPEIPSRVSKEARDFLRRCFVRKPAFR 265
E P +S EA+ L + P R
Sbjct: 221 E---IRFPRTLSPEAKSLLAGLLKKDPKQR 247
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 1e-29
Identities = 71/264 (26%), Positives = 114/264 (43%), Gaps = 36/264 (13%)
Query: 12 RVIGQGSFGCVFIAKPKSNSSFLPPLMAVKS------AEVSASASLQKEKEVFDNLNGCP 65
RV+G+GSFG V +A+ K L AVK + EK + P
Sbjct: 29 RVLGKGSFGKVMLARVKETGD----LYAVKVLKKDVILQDDDVECTMTEKRILSLARNHP 84
Query: 66 FVLE---CFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCIL 122
F+ + CF + + + ++E+ GG L I+K E R + I+
Sbjct: 85 FLTQLFCCF-------QTPDRLF-FVMEFVNGGDLMFHIQKSRR--FDEARARFYAAEII 134
Query: 123 EGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMRGTP 182
+ +HD G ++ D+K DN+LL G K+AD G+ K + GTP
Sbjct: 135 SALMFLHDKGIIYRDLKLDNVLL--DHEG-HC-KLADFGMCK--EGICNGVTTATFCGTP 188
Query: 183 LYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLF-SIIGDEHSLPE 241
Y+APE + + + D WA+G ++ EML G + E + D LF +I+ DE
Sbjct: 189 DYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPF---EAENEDDLFEAILNDE---VV 242
Query: 242 IPSRVSKEARDFLRRCFVRKPAFR 265
P+ + ++A L+ + P R
Sbjct: 243 YPTWLHEDATGILKSFMTKNPTMR 266
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 1e-29
Identities = 71/264 (26%), Positives = 108/264 (40%), Gaps = 36/264 (13%)
Query: 12 RVIGQGSFGCVFIAKPKSNSSFLPPLMAVKS---AEVSAS---ASLQKEKEVFDNLNGCP 65
V+G+GSFG V +++ K L AVK V EK V P
Sbjct: 26 MVLGKGSFGKVMLSERKGTDE----LYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPP 81
Query: 66 FVLE---CFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCIL 122
F+ + CF + + Y ++EY GG L I++ E + I
Sbjct: 82 FLTQLHSCF-------QTMDRLY-FVMEYVNGGDLMYHIQQVGR--FKEPHAVFYAAEIA 131
Query: 123 EGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMRGTP 182
G+ + G ++ D+K DN++L G + KIAD G+ K + + GTP
Sbjct: 132 IGLFFLQSKGIIYRDLKLDNVML--DSEG-HI-KIADFGMCKEN--IWDGVTTKTFCGTP 185
Query: 183 LYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLF-SIIGDEHSLPE 241
Y+APE + D WA G ++ EML+G+ + E D+LF SI+
Sbjct: 186 DYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPF---EGEDEDELFQSIMEHN---VA 239
Query: 242 IPSRVSKEARDFLRRCFVRKPAFR 265
P +SKEA + + P R
Sbjct: 240 YPKSMSKEAVAICKGLMTKHPGKR 263
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 2e-29
Identities = 66/284 (23%), Positives = 116/284 (40%), Gaps = 40/284 (14%)
Query: 12 RVIGQGSFGCVFIAKPKSNSSFLPPLMAVKS------AEVSASASLQKEKEVFDNLNGCP 65
+VIG+GSFG V +A+ K+ F AVK + + E+ V P
Sbjct: 44 KVIGKGSFGKVLLARHKAEEVFY----AVKVLQKKAILKKKEEKHIMSERNVLLKNVKHP 99
Query: 66 FVLE---CFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCIL 122
F++ F + + Y +L+Y GG L +++ E R + I
Sbjct: 100 FLVGLHFSF-------QTADKLY-FVLDYINGGELFYHLQRERC--FLEPRARFYAAEIA 149
Query: 123 EGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMRGTP 182
+G++H V+ D+KP+NILL G + + D G+ K + + + GTP
Sbjct: 150 SALGYLHSLNIVYRDLKPENILL--DSQG-HI-VLTDFGLCK--ENIEHNSTTSTFCGTP 203
Query: 183 LYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLF-SIIGDEHSLPE 241
YLAPE + + + D W LG V+ EML G + + +++ +I+ +
Sbjct: 204 EYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPF---YSRNTAEMYDNILNKP---LQ 257
Query: 242 IPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDD----PFVKGVD 281
+ ++ AR L + R A+ + F ++
Sbjct: 258 LKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFFSLIN 301
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 2e-29
Identities = 62/293 (21%), Positives = 112/293 (38%), Gaps = 50/293 (17%)
Query: 11 GRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVSASASLQKEKEVFDNLNGC--PFVL 68
V +G FGCV+ A+ + +AVK + S Q E EV+ +L G +L
Sbjct: 29 LEVKARGRFGCVWKAQLLNEY------VAVKIFPIQDKQSWQNEYEVY-SLPGMKHENIL 81
Query: 69 ECFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHI 128
+ G E G + ++ L+ + G+L D + N + ++ H + G+ ++
Sbjct: 82 QFIGAEKR-GTSVDVDLWLITAFHEKGSLSDFL---KANVVSWNELCHIAETMARGLAYL 137
Query: 129 HDS----------GYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSM 178
H+ H D+K N+LL A IAD G+A + K
Sbjct: 138 HEDIPGLKDGHKPAISHRDIKSKNVLL----KNNLTACIADFGLALKFEAGKSAGDTHGQ 193
Query: 179 RGTPLYLAPETVVQHMQEAP-----SDIWALGCVVLEMLSGRQAW-------------VV 220
GT Y+APE + + D++A+G V+ E+ S A +
Sbjct: 194 VGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEI 253
Query: 221 KEDCSIDQLFSIIGDEHSLPEIPSRVSKEA-----RDFLRRCFVRKPAFRFTA 268
+ S++ + ++ + P + K A + + C+ R +A
Sbjct: 254 GQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSA 306
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 5e-29
Identities = 67/295 (22%), Positives = 129/295 (43%), Gaps = 50/295 (16%)
Query: 12 RVIGQGSFGCVFIAKPKSNSSFLPPLMAVKS-------AEVSASASLQKEKEVFDNLNGC 64
+V+G G++G VF+ + K + L A+K + + + E++V +++
Sbjct: 60 KVLGTGAYGKVFLVR-KISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQS 118
Query: 65 PFVLE---CFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCI 121
PF++ F + + L+L+Y GG L + + E +V+ + I
Sbjct: 119 PFLVTLHYAF-------QTETKLH-LILDYINGGELFTHLSQRER--FTEHEVQIYVGEI 168
Query: 122 LEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMR-- 179
+ + H+H G ++ D+K +NILL +G + D G+ K D + R
Sbjct: 169 VLALEHLHKLGIIYRDIKLENILL--DSNGH--VVLTDFGL------SKEFVADETERAY 218
Query: 180 ---GTPLYLAPETVVQHMQEAPS---DIWALGCVVLEMLSGRQA-WVVKEDCSIDQLF-S 231
GT Y+AP+ +V+ D W+LG ++ E+L+G V E S ++
Sbjct: 219 DFCGTIEYMAPD-IVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRR 277
Query: 232 IIGDEHSLPEIPSRVSKEARDFLRRCFVRKPAFRF-----TAEMLLDDPFVKGVD 281
I+ E P P +S A+D ++R ++ P R A+ + + F + ++
Sbjct: 278 ILKSE---PPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKIN 329
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 2e-28
Identities = 62/293 (21%), Positives = 108/293 (36%), Gaps = 48/293 (16%)
Query: 11 GRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVSASASLQKEKEVFDNLNGC-PFVLE 69
+G+G +G V+ + + +AVK S +E E+++ + +L
Sbjct: 13 LECVGKGRYGEVWRGSWQGEN------VAVKIFSSRDEKSWFRETELYNTVMLRHENILG 66
Query: 70 CFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIH 129
++T + L+ Y G+L D ++ L I G+ H+H
Sbjct: 67 FIASDMT-SRHSSTQLWLITHYHEMGSLYDYLQL---TTLDTVSCLRIVLSIASGLAHLH 122
Query: 130 DSGY--------VHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSM--R 179
+ H D+K NIL+ IADLG+A Q +
Sbjct: 123 IEIFGTQGKPAIAHRDLKSKNILV----KKNGQCCIADLGLAVMHSQSTNQLDVGNNPRV 178
Query: 180 GTPLYLAPE----TVVQHMQEA--PSDIWALGCVVLEMLSGRQAW------------VVK 221
GT Y+APE T+ ++ DIWA G V+ E+ + VV
Sbjct: 179 GTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVP 238
Query: 222 EDCSIDQLFSIIGDEHSLPEIPSRVSKEA-----RDFLRRCFVRKPAFRFTAE 269
D S + + ++ + P IP+R + ++ C+ + P+ R TA
Sbjct: 239 NDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTAL 291
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 2e-28
Identities = 73/288 (25%), Positives = 115/288 (39%), Gaps = 47/288 (16%)
Query: 12 RVIGQGSFGCVFIAKPKSNSSFLPPLMAVKS---------AEVSASASLQKEKEVFDNLN 62
V+G+GSFG V +++ K L AVK +V EK V
Sbjct: 347 MVLGKGSFGKVMLSERKGTDE----LYAVKILKKDVVIQDDDV---ECTMVEKRVLALPG 399
Query: 63 GCPFVLE---CFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTR 119
PF+ + CF + + Y ++EY GG L I++ E +
Sbjct: 400 KPPFLTQLHSCF-------QTMDRLY-FVMEYVNGGDLMYHIQQVGR--FKEPHAVFYAA 449
Query: 120 CILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMR 179
I G+ + G ++ D+K DN++L G + KIAD G+ K + +
Sbjct: 450 EIAIGLFFLQSKGIIYRDLKLDNVML--DSEG-HI-KIADFGMCK--ENIWDGVTTKTFC 503
Query: 180 GTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLF-SIIGDEHS 238
GTP Y+APE + D WA G ++ EML+G+ + E D+LF SI+
Sbjct: 504 GTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPF---EGEDEDELFQSIMEHN-- 558
Query: 239 LPEIPSRVSKEARDFLRRCFVRKPAFRF-----TAEMLLDDPFVKGVD 281
P +SKEA + + P R + + F + +D
Sbjct: 559 -VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYID 605
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 2e-28
Identities = 61/293 (20%), Positives = 108/293 (36%), Gaps = 48/293 (16%)
Query: 11 GRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVSASASLQKEKEVFDNLN-GCPFVLE 69
+ IG+G +G V++ K + +AVK + AS +E E++ + +L
Sbjct: 42 VKQIGKGRYGEVWMGKWRGEK------VAVKVFFTTEEASWFRETEIYQTVLMRHENILG 95
Query: 70 CFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIH 129
+ G L+ +Y G+L D + L K + + G+ H+H
Sbjct: 96 FIAAD-IKGTGSWTQLYLITDYHENGSLYDYL---KSTTLDAKSMLKLAYSSVSGLCHLH 151
Query: 130 DSGY--------VHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSM--R 179
+ H D+K NIL+ IADLG+A + + P
Sbjct: 152 TEIFSTQGKPAIAHRDLKSKNILV----KKNGTCCIADLGLAVKFISDTNEVDIPPNTRV 207
Query: 180 GTPLYLAPE--TVVQHMQEAPS----DIWALGCVVLEMLSG----------RQAW--VVK 221
GT Y+ PE + S D+++ G ++ E+ + + +V
Sbjct: 208 GTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVP 267
Query: 222 EDCSIDQLFSIIGDEHSLPEIPSRVSKEA-----RDFLRRCFVRKPAFRFTAE 269
D S + + I+ + P P+R S + + C+ PA R TA
Sbjct: 268 SDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTAL 320
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 3e-28
Identities = 58/213 (27%), Positives = 93/213 (43%), Gaps = 39/213 (18%)
Query: 78 GENGEMAYNLLLEYAAGGTLGDLIEKCNGNG-LPEKDVRHFTRCILEGIGHIHDSGYVHC 136
E + Y L++EY G TL + IE +G L +FT IL+GI H HD VH
Sbjct: 80 DEEDDCYY-LVMEYIEGPTLSEYIES---HGPLSVDTAINFTNQILDGIKHAHDMRIVHR 135
Query: 137 DVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQE 196
D+KP NIL+ + KI D G+AK + + + GT Y +PE +
Sbjct: 136 DIKPQNILI--DSNKT--LKIFDFGIAKALSETSLTQTNHVL-GTVQYFSPEQAKGEATD 190
Query: 197 APSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGD----------EHSLPEIPS-- 244
+DI+++G V+ EML G F+ G+ + S+P + +
Sbjct: 191 ECTDIYSIGIVLYEMLVGEPP------------FN--GETAVSIAIKHIQDSVPNVTTDV 236
Query: 245 --RVSKEARDFLRRCFVRKPAFRF-TAEMLLDD 274
+ + + + R + A R+ T + + DD
Sbjct: 237 RKDIPQSLSNVILRATEKDKANRYKTIQEMKDD 269
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 3e-28
Identities = 62/279 (22%), Positives = 115/279 (41%), Gaps = 31/279 (11%)
Query: 11 GRVIGQGSFGCVFIAKPKSNSSFLPPLMAVK-------SAEVSASASLQKEKEVFDNLNG 63
G ++G+GS+G V AVK + A+++KE ++ L
Sbjct: 10 GDLLGEGSYGKVKEVLDSETLC----RRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRH 65
Query: 64 CPFVLECFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILE 123
V++ ++ E + Y +++EY G + ++++ P + +++
Sbjct: 66 -KNVIQLV--DVLYNEEKQKMY-MVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLID 120
Query: 124 GIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMRGTPL 183
G+ ++H G VH D+KP N+LL + KI+ LGVA+ + +G+P
Sbjct: 121 GLEYLHSQGIVHKDIKPGNLLL----TTGGTLKISALGVAEALHPFAADDTCRTSQGSPA 176
Query: 184 YLAPETVVQHMQE---APSDIWALGCVVL-EMLSGRQAWVVKEDCSIDQLFSIIGDEHSL 239
+ PE + + DIW+ G V L + +G + E +I +LF IG
Sbjct: 177 FQPPE-IANGLDTFSGFKVDIWSAG-VTLYNITTGLYPF---EGDNIYKLFENIGKGS-- 229
Query: 240 PEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVK 278
IP D L+ +PA RF+ + + +
Sbjct: 230 YAIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFR 268
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 4e-28
Identities = 79/292 (27%), Positives = 129/292 (44%), Gaps = 54/292 (18%)
Query: 12 RVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVSASASLQK-------------EKEVF 58
+V+GQGSFG VF+ K K + S L A+K L+K E+++
Sbjct: 30 KVLGQGSFGKVFLVK-KISGSDARQLYAMKV--------LKKATLKVRDRVRTKMERDIL 80
Query: 59 DNLNGCPFVLE---CFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVR 115
+N PF+++ F + Y L+L++ GG L + K E+DV+
Sbjct: 81 VEVN-HPFIVKLHYAF-------QTEGKLY-LILDFLRGGDLFTRLSKEVM--FTEEDVK 129
Query: 116 HFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFD 175
+ + + H+H G ++ D+KP+NILL + G K+ D G++K S +K
Sbjct: 130 FYLAELALALDHLHSLGIIYRDLKPENILL--DEEGH--IKLTDFGLSKES--IDHEKKA 183
Query: 176 PSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLF-SIIG 234
S GT Y+APE V + +D W+ G ++ EML+G + + + I+
Sbjct: 184 YSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPF---QGKDRKETMTMILK 240
Query: 235 DEHSLPEIPSRVSKEARDFLRRCFVRKPAFRF-----TAEMLLDDPFVKGVD 281
+ +P +S EA+ LR F R PA R E + F +D
Sbjct: 241 AK---LGMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFSTID 289
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 5e-28
Identities = 65/295 (22%), Positives = 111/295 (37%), Gaps = 67/295 (22%)
Query: 11 GRVIGQGSFGCVFIAKPKSNSSFLPPLMAVK---------SAEVSASASLQKEKEVFDNL 61
G ++G G FG V+ S++ +A+K E+ + E + +
Sbjct: 48 GPLLGSGGFGSVYSGIRVSDNL----PVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 103
Query: 62 N-GCPFVLECFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNG-LPEKDVRHFTR 119
+ G V+ + E + L+LE DL + G L E+ R F
Sbjct: 104 SSGFSGVIRLL-DWF---ERPDSFV-LILERPEPV--QDLFDFITERGALQEELARSFFW 156
Query: 120 CILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMR 179
+LE + H H+ G +H D+K +NIL+ + K+ D G K +
Sbjct: 157 QVLEAVRHCHNCGVLHRDIKDENILI---DLNRGELKLIDFGS---GALLKDTVYTDFD- 209
Query: 180 GTPLYLAPETVVQHMQEAPS-DIWALGCVVL-EMLSGRQAWVVKEDCSIDQLFSIIGDEH 237
GT +Y PE + H S +W+LG ++L +M+ G
Sbjct: 210 GTRVYSPPEWIRYHRYHGRSAAVWSLG-ILLYDMVCGD---------------------- 246
Query: 238 SLP------------EIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGV 280
+P RVS E + +R C +P+ R T E + + P+++ V
Sbjct: 247 -IPFEHDEEIIRGQVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV 300
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 8e-28
Identities = 66/265 (24%), Positives = 109/265 (41%), Gaps = 38/265 (14%)
Query: 12 RVIGQGSFGCVFIAKPKSNSSFLPPLMAVKS---AEVSAS---ASLQKEKEVFDNLNGCP 65
+++G+G+FG V + K K+ A+K + A A E V N P
Sbjct: 154 KLLGKGTFGKVILVKEKATGR----YYAMKILKKEVIVAKDEVAHTLTENRVLQNSR-HP 208
Query: 66 FVLE---CFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCIL 122
F+ F + + ++EYA GG L + + E R + I+
Sbjct: 209 FLTALKYSF-------QTHDRLC-FVMEYANGGELFFHLSRE--RVFSEDRARFYGAEIV 258
Query: 123 EGIGHIH-DSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMRGT 181
+ ++H + V+ D+K +N++L + G KI D G+ K K + GT
Sbjct: 259 SALDYLHSEKNVVYRDLKLENLML--DKDGH--IKITDFGLCK--EGIKDGATMKTFCGT 312
Query: 182 PLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLF-SIIGDEHSLP 240
P YLAPE + + D W LG V+ EM+ GR + + ++LF I+ +E
Sbjct: 313 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF---YNQDHEKLFELILMEE---I 366
Query: 241 EIPSRVSKEARDFLRRCFVRKPAFR 265
P + EA+ L + P R
Sbjct: 367 RFPRTLGPEAKSLLSGLLKKDPKQR 391
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 8e-28
Identities = 66/265 (24%), Positives = 118/265 (44%), Gaps = 35/265 (13%)
Query: 12 RVIGQGSFGCVFIAKPKSNSSFLPPLMAVKS-------AEVSASASLQKEKEVFDNLNGC 64
RV+G+G +G VF + K + + A+K +A + E+ + + +
Sbjct: 23 RVLGKGGYGKVFQVR-KVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVK-H 80
Query: 65 PFVLE---CFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCI 121
PF+++ F + G Y L+LEY +GG L +E+ E + I
Sbjct: 81 PFIVDLIYAF-------QTGGKLY-LILEYLSGGELFMQLEREGI--FMEDTACFYLAEI 130
Query: 122 LEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMRGT 181
+GH+H G ++ D+KP+NI+L G K+ D G+ K S + GT
Sbjct: 131 SMALGHLHQKGIIYRDLKPENIML--NHQGH--VKLTDFGLCKES--IHDGTVTHTFCGT 184
Query: 182 PLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLF-SIIGDEHSLP 240
Y+APE +++ D W+LG ++ +ML+G + + + I+ +
Sbjct: 185 IEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPF---TGENRKKTIDKILKCK---L 238
Query: 241 EIPSRVSKEARDFLRRCFVRKPAFR 265
+P +++EARD L++ R A R
Sbjct: 239 NLPPYLTQEARDLLKKLLKRNAASR 263
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 1e-27
Identities = 73/289 (25%), Positives = 119/289 (41%), Gaps = 50/289 (17%)
Query: 11 GRVIGQGSFGCVFIA---------------KPKSNSSFLPPLMAVKSAEVSASASLQKEK 55
+ IG+G+F V +A K + N + L L EV L
Sbjct: 20 LKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFR----EVRIMKILNH-- 73
Query: 56 EVFDNLNGCPFVLECFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVR 115
P +++ F E I E + Y L++EYA+GG + D + +G + EK+ R
Sbjct: 74 ---------PNIVKLF-EVI---ETEKTLY-LIMEYASGGEVFDYLVA-HG-RMKEKEAR 117
Query: 116 HFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFD 175
R I+ + + H VH D+K +N+LL KIAD G S
Sbjct: 118 SKFRQIVSAVQYCHQKRIVHRDLKAENLLL----DADMNIKIADFG---FSNEFTVGGKL 170
Query: 176 PSMRGTPLYLAPETVVQHMQEAP-SDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIG 234
+ G P Y APE + P D+W+LG ++ ++SG + + ++ +L +
Sbjct: 171 DAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPF---DGQNLKELRERV- 226
Query: 235 DEHSLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGVDEE 283
IP +S + + L+R V P R T E ++ D ++ EE
Sbjct: 227 -LRGKYRIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKDRWINAGHEE 274
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 1e-27
Identities = 51/219 (23%), Positives = 87/219 (39%), Gaps = 40/219 (18%)
Query: 72 GEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNG-LPEKDVRHFTRCILEGIGHIHD 130
GE G + Y +++EY G TL D++ G + K + + H
Sbjct: 81 GEA--ETPAGPLPY-IVMEYVDGVTLRDIVHT---EGPMTPKRAIEVIADACQALNFSHQ 134
Query: 131 SGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMR-GTPLYLAPET 189
+G +H DVKP NI++ + + K+ D G+A+ + GT YL+PE
Sbjct: 135 NGIIHRDVKPANIMI--SATNA--VKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQ 190
Query: 190 VVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGD-------EH----- 237
+A SD+++LGCV+ E+L+G F+ GD +H
Sbjct: 191 ARGDSVDARSDVYSLGCVLYEVLTGEPP------------FT--GDSPVSVAYQHVREDP 236
Query: 238 -SLPEIPSRVSKEARDFLRRCFVRKPAFRF-TAEMLLDD 274
+S + + + + P R+ TA + D
Sbjct: 237 IPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRAD 275
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 2e-27
Identities = 61/293 (20%), Positives = 105/293 (35%), Gaps = 48/293 (16%)
Query: 11 GRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVSASASLQKEKEVFDNLN-GCPFVLE 69
IG+G FG V+ K + +AVK S +E E++ + +L
Sbjct: 47 QESIGKGRFGEVWRGKWRGEE------VAVKIFSSREERSWFREAEIYQTVMLRHENILG 100
Query: 70 CFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIH 129
+ L+ +Y G+L D + + + + + G+ H+H
Sbjct: 101 FIAADNKD-NGTWTQLWLVSDYHEHGSLFDYLNR---YTVTVEGMIKLALSTASGLAHLH 156
Query: 130 DSGY--------VHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPS--MR 179
H D+K NIL+ IADLG+A R
Sbjct: 157 MEIVGTQGKPAIAHRDLKSKNILV----KKNGTCCIADLGLAVRHDSATDTIDIAPNHRV 212
Query: 180 GTPLYLAPE----TVVQHMQEA--PSDIWALGCVVLEMLSGRQAW------------VVK 221
GT Y+APE ++ E+ +DI+A+G V E+ +V
Sbjct: 213 GTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVP 272
Query: 222 EDCSIDQLFSIIGDEHSLPEIPSR-----VSKEARDFLRRCFVRKPAFRFTAE 269
D S++++ ++ ++ P IP+R + +R C+ A R TA
Sbjct: 273 SDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTAL 325
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 3e-27
Identities = 46/205 (22%), Positives = 77/205 (37%), Gaps = 31/205 (15%)
Query: 71 FGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHD 130
F E + + Y +++EY G +L G LP + + IL + ++H
Sbjct: 147 FVEHTDRHGDP-VGY-IVMEYVGGQSLKRSK----GQKLPVAEAIAYLLEILPALSYLHS 200
Query: 131 SGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMRGTPLYLAPETV 190
G V+ D+KP+NI+L Q K+ DLG R + GTP + APE +
Sbjct: 201 IGLVYNDLKPENIMLTEEQ-----LKLIDLGAVSRINS------FGYLYGTPGFQAPE-I 248
Query: 191 VQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEHSLPEIPSRVSKEA 250
V+ +DI+ +G + + + + ++ + +
Sbjct: 249 VRTGPTVATDIYTVGRTLAALTLDLPTRN-------GRYVDGLPEDDPVLKTYDSY---- 297
Query: 251 RDFLRRCFVRKPAFRFT--AEMLLD 273
LRR P RFT EM
Sbjct: 298 GRLLRRAIDPDPRQRFTTAEEMSAQ 322
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 6e-27
Identities = 63/227 (27%), Positives = 104/227 (45%), Gaps = 20/227 (8%)
Query: 87 LLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLV 146
+++EYA+GG L + I CN E + R F + +L G+ + H H D+K +N LL
Sbjct: 93 IIMEYASGGELYERI--CNAGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLD 150
Query: 147 ATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAP-SDIWALG 205
+ + + KI D G +K S + K S GTP Y+APE +++ + +D+W+ G
Sbjct: 151 GSPAPRL--KICDFGYSKSSVLHSQPK---STVGTPAYIAPEVLLRQEYDGKIADVWSCG 205
Query: 206 CVVL-EMLSGRQAWVVKEDCSIDQLF-----SIIGDEHSLPEIPSRVSKEARDFLRRCFV 259
V L ML G + ED + + I+ ++S+P+ R+S E + R FV
Sbjct: 206 -VTLYVMLVGAYPF---EDPEEPRDYRKTIQRILSVKYSIPD-DIRISPECCHLISRIFV 260
Query: 260 RKPAFRFTAEMLLDDP-FVKGVDEELSRELEGDYSQGEVTLSNADAE 305
PA R + + F+K + +L E E +
Sbjct: 261 ADPATRISIPEIKTHSWFLKNLPADLMNESNTGSQFQEPEQPMQSLD 307
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 8e-27
Identities = 52/270 (19%), Positives = 107/270 (39%), Gaps = 34/270 (12%)
Query: 11 GRVIGQGSFGCVFIAKPKSNSS------FLPPLMAVKSAEVSASASLQKEKEVFDNLNGC 64
+ IG+G FG V + + S + ++ + Q+E + NLN
Sbjct: 24 EKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLN-H 82
Query: 65 PFVLECFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEG 124
P +++ +G + +++E+ G L + + + I G
Sbjct: 83 PNIVKLYG--LMHN-----PPRMVMEFVPCGDLYHRLLD-KAHPIKWSVKLRLMLDIALG 134
Query: 125 IGHIHDSGY--VHCDVKPDNILLVAT-QSGKFVAKIADLGVAKRSRHCKRQKFDPSMRGT 181
I ++ + VH D++ NI L + ++ AK+AD G++++S H + G
Sbjct: 135 IEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHSVS-----GLLGN 189
Query: 182 PLYLAPETVVQHMQEAP----SDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSI--IGD 235
++APE +E +D ++ ++ +L+G + ++ S ++ I I +
Sbjct: 190 FQWMAPE--TIGAEEESYTEKADTYSFAMILYTILTGEGPF---DEYSYGKIKFINMIRE 244
Query: 236 EHSLPEIPSRVSKEARDFLRRCFVRKPAFR 265
E P IP R+ + C+ P R
Sbjct: 245 EGLRPTIPEDCPPRLRNVIELCWSGDPKKR 274
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 1e-26
Identities = 48/307 (15%), Positives = 98/307 (31%), Gaps = 59/307 (19%)
Query: 11 GRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVSASASLQKEKEVFD--NLNGCPFVL 68
+IG+G +G V+ +AVK + + EK ++ + +
Sbjct: 18 LELIGRGRYGAVYKGSLDERP------VAVKVFSFANRQNFINEKNIYRVPLME-HDNIA 70
Query: 69 ECFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHI 128
+ + +G M Y L++EY G+L + + + G+ ++
Sbjct: 71 RFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSL---HTSDWVSSCRLAHSVTRGLAYL 127
Query: 129 HDS---------GYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDP--- 176
H H D+ N+L+ I+D G++ R + +
Sbjct: 128 HTELPRGDHYKPAISHRDLNSRNVLV----KNDGTCVISDFGLSMRLTGNRLVRPGEEDN 183
Query: 177 ---SMRGTPLYLAPE-------TVVQHMQEAPSDIWALGCVVLEMLSGRQ---------- 216
S GT Y+APE D++ALG + E+
Sbjct: 184 AAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPE 243
Query: 217 -----AWVVKEDCSIDQLFSIIGDEHSLPEIPSRVSKEA------RDFLRRCFVRKPAFR 265
V + + + ++ E P+ P + + ++ + C+ + R
Sbjct: 244 YQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEAR 303
Query: 266 FTAEMLL 272
TA+
Sbjct: 304 LTAQXAE 310
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 3e-26
Identities = 68/304 (22%), Positives = 110/304 (36%), Gaps = 76/304 (25%)
Query: 11 GRVIGQGSFGCVFIAKPKSNSSFLPPLMAVK---------SAEVSASASLQKEKEVFDNL 61
G ++G+G FG VF ++ +A+K + +S S + E + +
Sbjct: 36 GPLLGKGGFGTVFAGHRLTDRL----QVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKV 91
Query: 62 NGCPFV------LECFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNG-LPEKDV 114
L+ F E E L+LE DL + G L E
Sbjct: 92 GAGGGHPGVIRLLDWF-------ETQEGFM-LVLERPLPA--QDLFDYITEKGPLGEGPS 141
Query: 115 RHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKF 174
R F ++ I H H G VH D+K +NIL+ + AK+ D G + +
Sbjct: 142 RCFFGQVVAAIQHCHSRGVVHRDIKDENILI---DLRRGCAKLIDFGS---GALLHDEPY 195
Query: 175 DPSMRGTPLYLAPETVVQHMQEAPS-DIWALGCVVL-EMLSGRQAWVVKEDCSIDQLFSI 232
GT +Y PE + +H A +W+LG ++L +M+ G
Sbjct: 196 TDFD-GTRVYSPPEWISRHQYHALPATVWSLG-ILLYDMVCGD----------------- 236
Query: 233 IGDEHSLP------------EIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDP-FVKG 279
+P P+ VS + +RRC KP+ R + E +L DP
Sbjct: 237 ------IPFERDQEILEAELHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTP 290
Query: 280 VDEE 283
++
Sbjct: 291 AEDV 294
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 4e-26
Identities = 79/299 (26%), Positives = 134/299 (44%), Gaps = 47/299 (15%)
Query: 12 RVIGQGSFGCVFIAKPKSNSSF-----LPPLMAVKSAEVSASASLQKEKEVFDNLNGCPF 66
+VIG+G+FG V + + KS L +K ++ A +E+++ N P+
Sbjct: 75 KVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDS---AFFWEERDIMAFAN-SPW 130
Query: 67 VLE---CFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILE 123
V++ F ++ Y +++EY GG L +L+ +PEK R +T ++
Sbjct: 131 VVQLFYAF-------QDDRYLY-MVMEYMPGGDLVNLMSN---YDVPEKWARFYTAEVVL 179
Query: 124 GIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMRGTPL 183
+ IH G++H DVKPDN+LL +SG K+AD G + + D + GTP
Sbjct: 180 ALDAIHSMGFIHRDVKPDNMLL--DKSGH--LKLADFGTCMKMNKEGMVRCD-TAVGTPD 234
Query: 184 YLAPETVVQHMQEAPS-----DIWALGCVVLEMLSGRQAWVVKEDCSIDQLFS-IIGDEH 237
Y++PE V++ D W++G + EML G + S+ +S I+ ++
Sbjct: 235 YISPE-VLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF---YADSLVGTYSKIMNHKN 290
Query: 238 SLPEIPS--RVSKEARDFLRRCFVRKPAFRFT---AEMLLDDPFVKGVD--EELSRELE 289
SL P +SKEA++ + F+ R E + F K E R+
Sbjct: 291 SLT-FPDDNDISKEAKNLICA-FLTDREVRLGRNGVEEIKRHLFFKNDQWAWETLRDTV 347
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 8e-26
Identities = 59/262 (22%), Positives = 111/262 (42%), Gaps = 33/262 (12%)
Query: 11 GRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEV-SASASLQKEKEVFDNLNGCPFVLE 69
V+G+G+FG V AK ++ +A+K E S + E +N P +++
Sbjct: 13 EEVVGRGAFGVVCKAKWRAKD------VAIKQIESESERKAFIVELRQLSRVN-HPNIVK 65
Query: 70 CFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNG-LPEKDVRHFTRCILEGIGHI 128
+G + L++EYA GG+L +++ + +G+ ++
Sbjct: 66 LYGACLN-------PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYL 118
Query: 129 HDS---GYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMRGTPLYL 185
H +H D+KP N+LLV +G V KI D G A C Q + +G+ ++
Sbjct: 119 HSMQPKALIHRDLKPPNLLLV---AGGTVLKICDFGTA-----CDIQTHMTNNKGSAAWM 170
Query: 186 APETVVQHMQ--EAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEHSLPEIP 243
APE V + E D+++ G ++ E+++ R+ + E + P +
Sbjct: 171 APE-VFEGSNYSEK-CDVFSWGIILWEVITRRKPF--DEIGGPAFRIMWAVHNGTRPPLI 226
Query: 244 SRVSKEARDFLRRCFVRKPAFR 265
+ K + RC+ + P+ R
Sbjct: 227 KNLPKPIESLMTRCWSKDPSQR 248
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 2e-25
Identities = 64/330 (19%), Positives = 116/330 (35%), Gaps = 47/330 (14%)
Query: 11 GRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVSASASLQKEKEVFDNLNGCPFVLEC 70
+G G+FG V+ A K + + VK ++KEK + D P + +
Sbjct: 29 MSPLGSGAFGFVWTAVDKEKNK----EVVVKF--------IKKEKVLEDCWIEDPKLGKV 76
Query: 71 FGEEITMG--------------ENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRH 116
E + EN ++ ++ +G L I++ + L E +
Sbjct: 77 TLEIAILSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDR-HPR-LDEPLASY 134
Query: 117 FTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDP 176
R ++ +G++ +H D+K +NI++ + F K+ D G A + + F
Sbjct: 135 IFRQLVSAVGYLRLKDIIHRDIKDENIVI----AEDFTIKLIDFGSAAYLE--RGKLFYT 188
Query: 177 SMRGTPLYLAPETVVQHMQEAP-SDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGD 235
GT Y APE ++ + P ++W+LG + ++ + +L +
Sbjct: 189 FC-GTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPF--------CELEETVEA 239
Query: 236 EHSLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGVDEELSRELEGDYSQG 295
P VSKE + P R T E L+ DP+V E +
Sbjct: 240 AIH---PPYLVSKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQPVNLADYTWEEVFRVN 296
Query: 296 EVTLSNADAESCSPECISFIPLEANSSLSS 325
+ A S S + L
Sbjct: 297 KPESGVLSAASLEMGNRSLSDVAQAQELCG 326
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 3e-25
Identities = 59/280 (21%), Positives = 106/280 (37%), Gaps = 60/280 (21%)
Query: 11 GRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVSASASLQKEKEVFDNLNGCPFVLEC 70
G+ IG GSFG V+ K + +AVK + + P L+
Sbjct: 29 GQRIGSGSFGTVYKGKWHGD-------VAVK---------------MLNVTAPTPQQLQA 66
Query: 71 FGEEITMGENGEMAY----NLLL--------------EYAAGGTLGDLIEKCNGNGLPEK 112
F E+ + + N+LL ++ G +L + + K
Sbjct: 67 FKNEVGV-----LRKTRHVNILLFMGYSTAPQLAIVTQWCEGSSLYHHLHA-SETKFEMK 120
Query: 113 DVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQ 172
+ R G+ ++H +H D+K +NI L KI D G+A
Sbjct: 121 KLIDIARQTARGMDYLHAKSIIHRDLKSNNIFL----HEDNTVKIGDFGLATEKSRWSGS 176
Query: 173 KFDPSMRGTPLYLAPETVVQHMQEAP----SDIWALGCVVLEMLSGRQAWVVKEDCSIDQ 228
+ G+ L++APE V++ P SD++A G V+ E+++G+ + + DQ
Sbjct: 177 HQFEQLSGSILWMAPE-VIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPY--SNINNRDQ 233
Query: 229 LFSIIGDEH---SLPEIPSRVSKEARDFLRRCFVRKPAFR 265
+ ++G L ++ S K + + C +K R
Sbjct: 234 IIEMVGRGSLSPDLSKVRSNCPKRMKRLMAECLKKKRDER 273
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 7e-25
Identities = 66/276 (23%), Positives = 105/276 (38%), Gaps = 62/276 (22%)
Query: 12 RVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVSASASLQK--------------EKEV 57
+ +G GSFG V + K K + + A+K L K EK +
Sbjct: 47 KTLGTGSFGRVMLVKHKESGNH----YAMKI--------LDKQKVVKLKQIEHTLNEKRI 94
Query: 58 FDNLNGCPFVLECFGEEITMGENGEMAYNL--LLEYAAGGTLGDLIEKCNGNGLPEKDVR 115
+N PF+++ NL ++EY AGG + + + E R
Sbjct: 95 LQAVN-FPFLVKLEFSFKD-------NSNLYMVMEYVAGGEMFSHLRRIGR--FSEPHAR 144
Query: 116 HFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRH-----CK 170
+ I+ ++H ++ D+KP+N+L+ Q G ++ D G AKR + C
Sbjct: 145 FYAAQIVLTFEYLHSLDLIYRDLKPENLLI--DQQGY--IQVTDFGFAKRVKGRTWTLC- 199
Query: 171 RQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLF 230
GTP LAPE ++ D WALG ++ EM +G + Q++
Sbjct: 200 ---------GTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF---FADQPIQIY 247
Query: 231 SIIGDEHSLPEIPSRVSKEARDFLRRCFVRKPAFRF 266
I PS S + +D LR RF
Sbjct: 248 EKIVSGK--VRFPSHFSSDLKDLLRNLLQVDLTKRF 281
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 8e-25
Identities = 67/298 (22%), Positives = 118/298 (39%), Gaps = 71/298 (23%)
Query: 12 RVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVSASASLQK--------------EKEV 57
R +G GSFG V + + + N + A+K L+K E+ +
Sbjct: 12 RTLGTGSFGRVHLIRSRHNGRY----YAMKV--------LKKEIVVRLKQVEHTNDERLM 59
Query: 58 FDNLNGCPFVLE---CFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDV 114
+ PF++ F ++ + + ++++Y GG L L+ K P
Sbjct: 60 LSIVT-HPFIIRMWGTF-------QDAQQIF-MIMDYIEGGELFSLLRKSQR--FPNPVA 108
Query: 115 RHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRH-----C 169
+ + + + ++H ++ D+KP+NILL ++G KI D G AK C
Sbjct: 109 KFYAAEVCLALEYLHSKDIIYRDLKPENILL--DKNGH--IKITDFGFAKYVPDVTYTLC 164
Query: 170 KRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQL 229
GTP Y+APE V D W+ G ++ EML+G + D + +
Sbjct: 165 ----------GTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPF---YDSNTMKT 211
Query: 230 F-SIIGDEHSLPEIPSRVSKEARDFLRRCFVRKPAFRF-----TAEMLLDDPFVKGVD 281
+ I+ E P +++ +D L R R + R E + + P+ K V
Sbjct: 212 YEKILNAE---LRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVV 266
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 1e-24
Identities = 44/205 (21%), Positives = 73/205 (35%), Gaps = 25/205 (12%)
Query: 78 GENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCD 137
GE Y + + G L ++ + L R I + H +G H D
Sbjct: 103 GEIDGQLY-VDMRLINGVDLAAMLRR--QGPLAPPRAVAIVRQIGSALDAAHAAGATHRD 159
Query: 138 VKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSM------RGTPLYLAPETVV 191
VKP+NIL+ + A + D G+A D + GT Y+APE
Sbjct: 160 VKPENILV--SADDF--AYLVDFGIA-------SATTDEKLTQLGNTVGTLYYMAPERFS 208
Query: 192 QHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDE-HSLPEIPSRVSKEA 250
+ +DI+AL CV+ E L+G + + + + + I + +
Sbjct: 209 ESHATYRADIYALTCVLYECLTGSPPY---QGDQLSVMGAHINQAIPRPSTVRPGIPVAF 265
Query: 251 RDFLRRCFVRKPAFRF-TAEMLLDD 274
+ R + P R+ T L
Sbjct: 266 DAVIARGMAKNPEDRYVTCGDLSAA 290
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 99.6 bits (249), Expect = 2e-24
Identities = 43/272 (15%), Positives = 89/272 (32%), Gaps = 48/272 (17%)
Query: 11 GRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVS-----ASASLQKEKEVFDNL---N 62
+ + G ++ + + N + VK +V S +E N
Sbjct: 15 LTKLNENHSGELWKGRWQGND------IVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPN 68
Query: 63 GCPFVLECFGEEITMGENGEMAYNLLL--EYAAGGTLGDLIEKCNGNGLPEKDVRHFTRC 120
P + C A + L + G+L +++ + + + F
Sbjct: 69 VLPVLGAC---------QSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALD 119
Query: 121 ILEGIGHIHDSGY--VHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSM 178
+ G+ +H + ++++ A+I+ V P
Sbjct: 120 MARGMAFLHTLEPLIPRHALNSRSVMI----DEDMTARISMADVK-------FSFQSPGR 168
Query: 179 RGTPLYLAPETVVQHMQEAP----SDIWALGCVVL-EMLSGRQAWVVKEDCSIDQLFSII 233
P ++APE +Q E +D+W+ V+L E+++ + D S ++ +
Sbjct: 169 MYAPAWVAPE-ALQKKPEDTNRRSADMWSFA-VLLWELVTREVPF---ADLSNMEIGMKV 223
Query: 234 GDEHSLPEIPSRVSKEARDFLRRCFVRKPAFR 265
E P IP +S ++ C PA R
Sbjct: 224 ALEGLRPTIPPGISPHVSKLMKICMNEDPAKR 255
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 99.6 bits (249), Expect = 3e-24
Identities = 66/283 (23%), Positives = 114/283 (40%), Gaps = 47/283 (16%)
Query: 11 GRVIGQGSFGCVFIAKPKSNSSFLPPLMAVK------SAEVSASASLQKEKEVFDNLNGC 64
G +G G+FG V I + + +AVK + +++E +
Sbjct: 16 GDTLGVGTFGKVKIGEHQLTGH----KVAVKILNRQKIRSLDVVGKIKREIQNLKLFRH- 70
Query: 65 PFVLECFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNG-LPEKDVRHFTRCILE 123
P +++ + + I + +++EY +GG L D I K +G + E + R + IL
Sbjct: 71 PHIIKLY-QVI---STPTDFF-MVMEYVSGGELFDYICK---HGRVEEMEARRLFQQILS 122
Query: 124 GIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRH-------CKRQKFDP 176
+ + H VH D+KP+N+LL AKIAD G++ C
Sbjct: 123 AVDYCHRHMVVHRDLKPENVLL----DAHMNAKIADFGLSNMMSDGEFLRTSC------- 171
Query: 177 SMRGTPLYLAPETVVQHMQEAP-SDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGD 235
G+P Y APE + + P DIW+ G ++ +L G + +D + LF I
Sbjct: 172 ---GSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPF---DDEHVPTLFKKIRG 225
Query: 236 EHSLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVK 278
IP +++ L P R T + + + + K
Sbjct: 226 GV--FYIPEYLNRSVATLLMHMLQVDPLKRATIKDIREHEWFK 266
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 99.7 bits (249), Expect = 4e-24
Identities = 57/265 (21%), Positives = 110/265 (41%), Gaps = 33/265 (12%)
Query: 11 GRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVS-----ASASLQKEKEVFDNLNGCP 65
IG GSFG V A+ + +AVK +E + L P
Sbjct: 42 KEKIGAGSFGTVHRAEWHGSD------VAVKILMEQDFHAERVNEFLREVAIMKRLRH-P 94
Query: 66 FVLECFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCN-GNGLPEKDVRHFTRCILEG 124
++ G +++ EY + G+L L+ K L E+ + +G
Sbjct: 95 NIVLFMG--AVTQPP---NLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKG 149
Query: 125 IGHIHDSGY--VHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMRGTP 182
+ ++H+ VH ++K N+L+ K+ K+ D G+++ S GTP
Sbjct: 150 MNYLHNRNPPIVHRNLKSPNLLV----DKKYTVKVCDFGLSRLKASTFLSSK--SAAGTP 203
Query: 183 LYLAPETVVQHMQ--EAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEHSLP 240
++APE V++ E SD+++ G ++ E+ + +Q W + + Q+ + +G +
Sbjct: 204 EWMAPE-VLRDEPSNEK-SDVYSFGVILWELATLQQPW---GNLNPAQVVAAVGFKCKRL 258
Query: 241 EIPSRVSKEARDFLRRCFVRKPAFR 265
EIP ++ + + C+ +P R
Sbjct: 259 EIPRNLNPQVAAIIEGCWTNEPWKR 283
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 4e-24
Identities = 77/333 (23%), Positives = 127/333 (38%), Gaps = 83/333 (24%)
Query: 12 RVIGQGSFGCVFIAKPKSNSSFLPPLMAVK---SAEVSASASLQKEKEVFDNLN------ 62
R +G G F V++AK N++ +A+K +V A+ + E ++ +N
Sbjct: 25 RKLGWGHFSTVWLAKDMVNNTH----VAMKIVRGDKVYTEAA-EDEIKLLQRVNDADNTK 79
Query: 63 ----GCPFVLECFGEEITMGENGE---MAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVR 115
G +L+ G NG M + +L G L LI+K G+P V+
Sbjct: 80 EDSMGANHILKLLDHFNHKGPNGVHVVMVFEVL-----GENLLALIKKYEHRGIPLIYVK 134
Query: 116 HFTRCILEGIGHIHDS-GYVHCDVKPDNILLVAT--QSGKFVAKIADLGVAKRSRHCKRQ 172
++ +L G+ ++H G +H D+KP+N+L+ KIADLG A C
Sbjct: 135 QISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNA-----CWYD 189
Query: 173 KFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGR-------QAWVVKEDCS 225
+ + T Y +PE ++ +DIW+ C++ E+++G K+D
Sbjct: 190 EHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDD-- 247
Query: 226 IDQLFSII------------------------GD------------EHSLPEIPSRVSKE 249
D + II G E L E E
Sbjct: 248 -DHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDE 306
Query: 250 AR---DFLRRCFVRKPAFRFTAEMLLDDPFVKG 279
A+ DFL P R A L++ P++K
Sbjct: 307 AKEISDFLSPMLQLDPRKRADAGGLVNHPWLKD 339
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 98.8 bits (247), Expect = 1e-23
Identities = 62/236 (26%), Positives = 94/236 (39%), Gaps = 54/236 (22%)
Query: 96 TLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVA 155
T+ D +E NGL + V+ + I+ GIG H +H D+KP+NIL+ +QSG V
Sbjct: 109 TILDDLELFP-NGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILV--SQSG--VV 163
Query: 156 KIADLGVAKRSRHCKRQKFDPSMRGTPL-----YLAPETVVQHMQEAPS-DIWALGCVVL 209
K+ D G A R P Y APE +V ++ + D+WA+GC+V
Sbjct: 164 KLCDFGFA-------RTLAAPGEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVT 216
Query: 210 EMLSGRQAWVVKEDCSIDQLFSII---G--DEHSLPEIPS-------------------- 244
EM G + D IDQL+ I+ G
Sbjct: 217 EMFMGEPLFPGDSD--IDQLYHIMMCLGNLIPRHQELFNKNPVFAGVRLPEIKEREPLER 274
Query: 245 ---RVSKEARDFLRRCFVRKPAFRFTAEMLL------DDPFVKGVDEELSRELEGD 291
++S+ D ++C P R LL D F + +EL +++ D
Sbjct: 275 RYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQMDGFAERFSQELQLKVQKD 330
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 98.6 bits (246), Expect = 1e-23
Identities = 52/284 (18%), Positives = 99/284 (34%), Gaps = 63/284 (22%)
Query: 11 GRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVSASASLQKEKEVFDNLNGCPFVLEC 70
G +IG+G FG V+ + +A++ + D L+
Sbjct: 38 GELIGKGRFGQVYHGRWHGE-------VAIR---------------LIDIERDNEDQLKA 75
Query: 71 FGEEIT-------------MG---ENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDV 114
F E+ MG +A ++ G TL ++ L
Sbjct: 76 FKREVMAYRQTRHENVVLFMGACMSPPHLA--IITSLCKGRTLYSVVRD-AKIVLDVNKT 132
Query: 115 RHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKF 174
R + I++G+G++H G +H D+K N+ I D G+ S + +
Sbjct: 133 RQIAQEIVKGMGYLHAKGILHKDLKSKNVFY-----DNGKVVITDFGLFSISGVLQAGRR 187
Query: 175 DPSMR---GTPLYLAPETVVQHMQEAP----------SDIWALGCVVLEMLSGRQAWVVK 221
+ +R G +LAPE +++ + SD++ALG + E+ + +
Sbjct: 188 EDKLRIQNGWLCHLAPE-IIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPF--- 243
Query: 222 EDCSIDQLFSIIGDEHSLPEIPSRVSKEARDFLRRCFVRKPAFR 265
+ + + +G + KE D L C+ + R
Sbjct: 244 KTQPAEAIIWQMGTGMKPNLSQIGMGKEISDILLFCWAFEQEER 287
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 96.9 bits (242), Expect = 5e-23
Identities = 57/221 (25%), Positives = 83/221 (37%), Gaps = 48/221 (21%)
Query: 96 TLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVA 155
T+ +++ G+PE V+ T L+ + H +H DVKP+NIL+ + V
Sbjct: 87 TVLHELDRYQ-RGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILI----TKHSVI 141
Query: 156 KIADLGVAKRSRHCKRQKFDPSMRGTPL-----YLAPETVVQHMQEAPS-DIWALGCVVL 209
K+ D G A R PS Y +PE +V Q P D+WA+GCV
Sbjct: 142 KLCDFGFA-------RLLTGPSDYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFA 194
Query: 210 EMLSGRQAWVVKEDCSIDQL---FSIIG--DEHSLPEIPS-------------------- 244
E+LSG W +DQL +G +
Sbjct: 195 ELLSGVPLW--PGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGVKIPDPEDMEPLEL 252
Query: 245 ---RVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGVDE 282
+S A L+ C P R T E LL P+ + + E
Sbjct: 253 KFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIRE 293
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 97.0 bits (242), Expect = 7e-23
Identities = 73/290 (25%), Positives = 118/290 (40%), Gaps = 49/290 (16%)
Query: 11 GRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKS------AEVSASASLQKEKEVFDNLNGC 64
+G+GSFG V +A +A+K + +++E L
Sbjct: 14 RETLGEGSFGKVKLATHYKTQQ----KVALKFISRQLLKKSDMHMRVEREISYLKLLRH- 68
Query: 65 PFVLECFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNG-LPEKDVRHFTRCILE 123
P +++ + + I +++EYA GG L D I + + E + R F + I+
Sbjct: 69 PHIIKLY-DVI---TTPTDIV-MVIEYA-GGELFDYIVE---KKRMTEDEGRRFFQQIIC 119
Query: 124 GIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRH-------CKRQKFDP 176
I + H VH D+KP+N+LL KIAD G++ C
Sbjct: 120 AIEYCHRHKIVHRDLKPENLLL----DDNLNVKIADFGLSNIMTDGNFLKTSC------- 168
Query: 177 SMRGTPLYLAPETVVQHMQEAP-SDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGD 235
G+P Y APE + + P D+W+ G V+ ML GR + +D I LF +
Sbjct: 169 ---GSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPF---DDEFIPNLFKKVNS 222
Query: 236 EHSLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDP-FVKGVDEEL 284
+P +S A+ +RR V P R T + + DP F + + L
Sbjct: 223 CV--YVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRDPWFNVNLPDYL 270
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 98.3 bits (245), Expect = 8e-23
Identities = 72/283 (25%), Positives = 120/283 (42%), Gaps = 47/283 (16%)
Query: 11 GRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKS---AEVSASASLQK-EKEVFDNLNGC-- 64
G +G G+FG V + K + +AVK ++ + + K +E+ NL
Sbjct: 21 GDTLGVGTFGKVKVGKHELTGH----KVAVKILNRQKIRSLDVVGKIRREI-QNLKLFRH 75
Query: 65 PFVLECFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNG-LPEKDVRHFTRCILE 123
P +++ + + I + +++EY +GG L D I K NG L EK+ R + IL
Sbjct: 76 PHIIKLY-QVI---STPSDIF-MVMEYVSGGELFDYICK---NGRLDEKESRRLFQQILS 127
Query: 124 GIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRH-------CKRQKFDP 176
G+ + H VH D+KP+N+LL AKIAD G++ C
Sbjct: 128 GVDYCHRHMVVHRDLKPENVLL----DAHMNAKIADFGLSNMMSDGEFLRTSC------- 176
Query: 177 SMRGTPLYLAPETVVQHMQEAP-SDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGD 235
G+P Y APE + + P DIW+ G ++ +L G + +D + LF I
Sbjct: 177 ---GSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPF---DDDHVPTLFKKI-- 228
Query: 236 EHSLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVK 278
+ P ++ L+ P R T + + + + K
Sbjct: 229 CDGIFYTPQYLNPSVISLLKHMLQVDPMKRATIKDIREHEWFK 271
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 97.9 bits (244), Expect = 8e-23
Identities = 82/379 (21%), Positives = 135/379 (35%), Gaps = 63/379 (16%)
Query: 12 RVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVSASASLQKEKEVFDNLNGCPFV--LE 69
+VIG GSFG V+ AK + L+A+K +E ++ L+ C V
Sbjct: 60 KVIGNGSFGVVYQAKLCDSGE----LVAIKKVLQDKRFKN-RELQIMRKLDHCNIVRLRY 114
Query: 70 CFGEEITMGENGEMAY-NLLLEYAAGGTLGDLIEKCN--GNGLPEKDVRHFTRCILEGIG 126
F + GE + Y NL+L+Y T+ + + LP V+ + + +
Sbjct: 115 FF---YSSGEKKDEVYLNLVLDYV-PETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 170
Query: 127 HIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMRG---TPL 183
+IH G H D+KP N+LL V K+ D G AK+ +
Sbjct: 171 YIHSFGICHRDIKPQNLLL---DPDTAVLKLCDFGSAKQLVR------GEPNVSYICSRY 221
Query: 184 YLAPETVVQHMQEAPS-DIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIG-------- 234
Y APE + S D+W+ GCV+ E+L G+ + D +DQL II
Sbjct: 222 YRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF--PGDSGVDQLVEIIKVLGTPTRE 279
Query: 235 ---------DEHSLPEIP---------SRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPF 276
E P+I R EA R P R T F
Sbjct: 280 QIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSF 339
Query: 277 VKGVDEELSRELEG-------DYSQGEVTLSNADAESCSPECISFIPLEANSSLSSWGSA 329
+ + + G +++ E++ + A P A++ ++ ++
Sbjct: 340 FDELRDPNVKLPNGRDTPALFNFTTQELSSNPPLATILIPPHARIQA-AASTPTNATAAS 398
Query: 330 QRTNEGSTITVKELSSNPT 348
T S++ +
Sbjct: 399 DANTGDRGQTNNAASASAS 417
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 94.9 bits (237), Expect = 2e-22
Identities = 70/311 (22%), Positives = 117/311 (37%), Gaps = 76/311 (24%)
Query: 14 IGQGSFGCVFIAKPKSNSSFLPPLMAVK----------SAEVSASA----SLQKEKEVFD 59
IG G++G V+ A+ + F+ A+K + S +L + E F+
Sbjct: 17 IGVGAYGTVYKARDPHSGHFV----ALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFE 72
Query: 60 NLNGCPFVLECFGEEITMGENGEMAYNLLL--EYAAGGTLGDLIEKCNGNGLPEKDVRHF 117
+ N V+ ++ + + L E+ L ++K GLP + ++
Sbjct: 73 HPN----VVRLM--DVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDL 125
Query: 118 TRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPS 177
R L G+ +H + VH D+KP+NIL+ T G K+AD G+A+ +
Sbjct: 126 MRQFLRGLDFLHANCIVHRDLKPENILV--TSGG--TVKLADFGLARI--------YSYQ 173
Query: 178 MRGTPL-----YLAPETVVQHMQEAPSDIWALGCVVLEMLSGR---QAWVVKEDCSIDQL 229
M TP+ Y APE ++Q P D+W++GC+ EM + + DQL
Sbjct: 174 MALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCG-----NSEADQL 228
Query: 230 ---FSIIG--DEHSLPEIPS-------------------RVSKEARDFLRRCFVRKPAFR 265
F +IG E P S + + L P R
Sbjct: 229 GKIFDLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKR 288
Query: 266 FTAEMLLDDPF 276
+A L +
Sbjct: 289 ISAFRALQHSY 299
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 1e-21
Identities = 74/314 (23%), Positives = 110/314 (35%), Gaps = 84/314 (26%)
Query: 12 RVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVSASA-------SLQKE---------K 55
+VIG GSFG VF AK + A+K +V + + K
Sbjct: 46 KVIGNGSFGVVFQAKLVESDEV-----AIK--KVLQDKRFKNRELQIMRIVKHPNVVDLK 98
Query: 56 EVFDNLNGCPFVLECFGEEITMGENGEMAY-NLLLEYAAGGTLGDLIEKCN--GNGLPEK 112
F + G+ + + NL+LEY T+ +P
Sbjct: 99 AFF----------------YSNGDKKDEVFLNLVLEYV-PETVYRASRHYAKLKQTMPML 141
Query: 113 DVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQ 172
++ + +L + +IH G H D+KP N+LL V K+ D G AK
Sbjct: 142 LIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPP---SGVLKLIDFGSAKILIA---- 194
Query: 173 KFDPSMRG---TPLYLAPETVVQHMQEAPS-DIWALGCVVLEMLSGRQAWVVKEDCSIDQ 228
+ Y APE + + DIW+ GCV+ E++ G+ + + IDQ
Sbjct: 195 --GEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQP--LFPGESGIDQ 250
Query: 229 LFSIIG-----------------DEHSLPEIPS---------RVSKEARDFLRRCFVRKP 262
L II EH P+I R +A D + R P
Sbjct: 251 LVEIIKVLGTPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTP 310
Query: 263 AFRFTAEMLLDDPF 276
+ R TA L PF
Sbjct: 311 SARLTAIEALCHPF 324
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 1e-21
Identities = 59/236 (25%), Positives = 98/236 (41%), Gaps = 28/236 (11%)
Query: 11 GRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVSASAS-LQKEKEVFDNLNGCPFV-- 67
GR IG GSFG +++ + + A+K V L E +++ + G +
Sbjct: 14 GRKIGSGSFGDIYLGTDIAAGEEV----AIKLECVKTKHPQLHIESKIYKMMQGGVGIPT 69
Query: 68 LECFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGH 127
+ G E G+ M LL G +L DL C+ K V ++ I +
Sbjct: 70 IRWCGAE---GDYNVMVMELL-----GPSLEDLFNFCSRK-FSLKTVLLLADQMISRIEY 120
Query: 128 IHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKR-----SRHCKRQKFDPSMRGTP 182
IH ++H DVKPDN L+ + G V I D G+AK+ + + + ++ GT
Sbjct: 121 IHSKNFIHRDVKPDNFLMGLGKKGNLVYII-DFGLAKKYRDARTHQHIPYRENKNLTGTA 179
Query: 183 LYLAPETVVQHMQEAPS---DIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGD 235
Y + T H+ S D+ +LG V++ G W + + Q + I +
Sbjct: 180 RYASINT---HLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISE 232
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 2e-21
Identities = 53/217 (24%), Positives = 89/217 (41%), Gaps = 49/217 (22%)
Query: 97 LGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAK 156
L ++K G+P + ++ +L G+ +H VH D+KP NIL+ T SG K
Sbjct: 105 LTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILV--TSSG--QIK 160
Query: 157 IADLGVAKRSRHCKRQKFDPSMRGTPL-----YLAPETVVQHMQEAPSDIWALGCVVLEM 211
+AD G+A+ + M T + Y APE ++Q P D+W++GC+ EM
Sbjct: 161 LADFGLARI--------YSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEM 212
Query: 212 LSGR---QAWVVKEDCSIDQL---FSIIG--DEHSLPEIPS------------------- 244
+ + +DQL +IG E P +
Sbjct: 213 FRRKPLFRG-----SSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVT 267
Query: 245 RVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGVD 281
+ + +D L +C PA R +A L P+ + ++
Sbjct: 268 DIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLE 304
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 93.3 bits (232), Expect = 2e-21
Identities = 71/368 (19%), Positives = 122/368 (33%), Gaps = 81/368 (22%)
Query: 12 RVIGQGSFGCVFIAKPKSNSS-------FLPP--------------------LMAVKSAE 44
+ +G GSFG V + P L+
Sbjct: 13 KTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNRELDIMKVLDHVNIIKLVDYFYTT 72
Query: 45 VSASASLQKEKEVFDNLNGCPFVLECFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKC 104
+ + + L G + + + + + N+++EY TL +++
Sbjct: 73 GDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYV-PDTLHKVLKSF 131
Query: 105 NGNG--LPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGV 162
+G +P + + + +G IH G H D+KP N+L+ + K+ D G
Sbjct: 132 IRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSK---DNTLKLCDFGS 188
Query: 163 AKRSRHCKRQKFDPSMRGTP-----LYLAPETVVQHMQEAPS-DIWALGCVVLEMLSGRQ 216
AK K PS Y APE ++ + PS D+W++GCV E++ G+
Sbjct: 189 AK--------KLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKP 240
Query: 217 AWVVKEDCSIDQLFSIIG-----------------DEHSLPEI---------PSRVSKEA 250
+ + SIDQL II E P + P A
Sbjct: 241 --LFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLA 298
Query: 251 RDFLRRCFVRKPAFRFTAEMLLDDPFVKGVDEELSRELEGDYSQGEVTLSNADAESCSPE 310
D L + +P R + PF + L R + + ++ P+
Sbjct: 299 IDLLEQILRYEPDLRINPYEAMAHPFF----DHL-RNSYESEVKNNSNFPHGVNQNI-PQ 352
Query: 311 CISFIPLE 318
+F P E
Sbjct: 353 LFNFSPYE 360
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 90.5 bits (225), Expect = 6e-21
Identities = 62/238 (26%), Positives = 105/238 (44%), Gaps = 30/238 (12%)
Query: 11 GRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVSASAS-LQKEKEVFDNLNGCPFV-- 67
GR IG+GSFG +F N+ + A+K + A L+ E + L GC +
Sbjct: 15 GRRIGEGSFGVIFEGTNLLNNQQV----AIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPN 70
Query: 68 LECFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGH 127
+ FG+E G + + +LL G +L DL++ C K V + +L +
Sbjct: 71 VYYFGQE---GLHNVLVIDLL-----GPSLEDLLDLCGRK-FSVKTVAMAAKQMLARVQS 121
Query: 128 IHDSGYVHCDVKPDNILL--VATQSGKFVAKIADLGVAKRSRHCKRQK-----FDPSMRG 180
IH+ V+ D+KPDN L+ +++ + + D G+ K R ++ ++ G
Sbjct: 122 IHEKSLVYRDIKPDNFLIGRPNSKNANMIYVV-DFGMVKFYRDPVTKQHIPYREKKNLSG 180
Query: 181 TPLYLAPETVVQHMQEAPS---DIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGD 235
T Y++ T H+ S D+ ALG V + L G W + + Q + IG+
Sbjct: 181 TARYMSINT---HLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGE 235
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 1e-20
Identities = 59/274 (21%), Positives = 107/274 (39%), Gaps = 46/274 (16%)
Query: 11 GRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVSAS-------ASLQKEKEVFDNL-- 61
+IG G FG V+ A + +AVK+A ++++E ++F L
Sbjct: 12 EEIIGIGGFGKVYRAFWIGDE------VAVKAARHDPDEDISQTIENVRQEAKLFAMLKH 65
Query: 62 -NGCPFVLECFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRC 120
N C E L++E+A GG L ++ +G +P + ++
Sbjct: 66 PNIIALRGVCLKEP---------NLCLVMEFARGGPLNRVL---SGKRIPPDILVNWAVQ 113
Query: 121 ILEGIGHIHDSGY---VHCDVKPDNILL----VATQSGKFVAKIADLGVAKRSRHCKRQK 173
I G+ ++HD +H D+K NIL+ + KI D G+A+ +
Sbjct: 114 IARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR----EWHRT 169
Query: 174 FDPSMRGTPLYLAPETVVQHMQ--EAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFS 231
S G ++APE V++ + SD+W+ G ++ E+L+G + +
Sbjct: 170 TKMSAAGAYAWMAPE-VIRASMFSKG-SDVWSYGVLLWELLTGEVPF---RGIDGLAVAY 224
Query: 232 IIGDEHSLPEIPSRVSKEARDFLRRCFVRKPAFR 265
+ IPS + + C+ P R
Sbjct: 225 GVAMNKLALPIPSTCPEPFAKLMEDCWNPDPHSR 258
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 90.2 bits (224), Expect = 2e-20
Identities = 44/244 (18%), Positives = 83/244 (34%), Gaps = 40/244 (16%)
Query: 2 DSDGTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLM----AVK----------SAEVSA 47
D G W + + G ++ A P S + ++K
Sbjct: 38 DKSGRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQ 97
Query: 48 SASLQKEKEVFDNLNGCPFV----LECFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEK 103
A+ + + L P + FG + Y L+ + G +L ++
Sbjct: 98 RAAKPLQVNKWKKLYSTPLLAIPTCMGFGVH-------QDKYRFLVLPSLGRSLQSALDV 150
Query: 104 CNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVA 163
+ L E+ V +L+ + +H++ YVH +V +NI + + +A G A
Sbjct: 151 SPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVT--LAGYGFA 208
Query: 164 KR----SRHCKRQKFDP--SMRGTPLYLAPETVVQHMQEAPS---DIWALGCVVLEMLSG 214
R +H G +++ + H PS D+ +LG +L+ L G
Sbjct: 209 FRYCPSGKH-VAYVEGSRSPHEGDLEFISMDL---HKGCGPSRRSDLQSLGYCMLKWLYG 264
Query: 215 RQAW 218
W
Sbjct: 265 FLPW 268
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 91.2 bits (226), Expect = 2e-20
Identities = 56/219 (25%), Positives = 94/219 (42%), Gaps = 28/219 (12%)
Query: 11 GRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVSASAS-LQKEKEVFDNLNGCPFV-- 67
GR IG GSFG +++ + + A+K V L E +++ L G +
Sbjct: 12 GRKIGSGSFGEIYLGTNIQTNEEV----AIKLENVKTKHPQLLYESKIYRILQGGTGIPN 67
Query: 68 LECFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGH 127
+ FG E G+ + +LL G +L DL C+ L K V ++ +
Sbjct: 68 VRWFGVE---GDYNVLVMDLL-----GPSLEDLFNFCSRK-LSLKTVLMLADQMINRVEF 118
Query: 128 IHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKR-----SRHCKRQKFDPSMRGTP 182
+H ++H D+KPDN L+ + V I D G+AK+ + + + ++ GT
Sbjct: 119 VHSKSFLHRDIKPDNFLMGLGRRANQVYII-DFGLAKKYRDTSTHQHIPYRENKNLTGTA 177
Query: 183 LYLAPETVVQHMQEAPS---DIWALGCVVLEMLSGRQAW 218
Y + T H+ S D+ +LG V++ L G W
Sbjct: 178 RYASVNT---HLGIEQSRRDDLESLGYVLMYFLRGSLPW 213
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 90.0 bits (223), Expect = 3e-20
Identities = 76/369 (20%), Positives = 119/369 (32%), Gaps = 125/369 (33%)
Query: 14 IGQGSFGCVFIAKPKSNSSFLPPLMAVK---SAEVSASASLQKEKEVFDNLN-------G 63
+G G F V+++ F+ A+K SAE +L E + ++
Sbjct: 45 LGWGHFSTVWLSWDIQGKKFV----AMKVVKSAEHYTETALD-EIRLLKSVRNSDPNDPN 99
Query: 64 CPFV---LECFGEEITMGENGE---MAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHF 117
V L+ F +I+ G NG M + +L G L I K N GLP V+
Sbjct: 100 REMVVQLLDDF--KIS-GVNGTHICMVFEVL-----GHHLLKWIIKSNYQGLPLPCVKKI 151
Query: 118 TRCILEGIGHIH-DSGYVHCDVKPDNILLVATQ--------------------------- 149
+ +L+G+ ++H +H D+KP+NILL +
Sbjct: 152 IQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVS 211
Query: 150 ------------------SGKFVAKIADLGVAKRSRHCKRQKFDPSMRGTPLYLAPETVV 191
+ K KIADLG A C K T Y + E ++
Sbjct: 212 TAPATAGNFLVNPLEPKNAEKLKVKIADLGNA-----CWVHKHFTEDIQTRQYRSLEVLI 266
Query: 192 QHMQEAPSDIWALGCVVLEMLSGR-----------------------------QAWVVKE 222
P+DIW+ C+ E+ +G + +V
Sbjct: 267 GSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAG 326
Query: 223 DCSIDQLFSIIGDEHSLPEIPSRVSKEAR---------------DFLRRCFVRKPAFRFT 267
S + F+ GD + ++ E DFL P R T
Sbjct: 327 KYS-KEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRAT 385
Query: 268 AEMLLDDPF 276
A L P+
Sbjct: 386 AAECLRHPW 394
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 5e-20
Identities = 43/237 (18%), Positives = 82/237 (34%), Gaps = 57/237 (24%)
Query: 99 DLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIA 158
++I + N NG +D++ + IL+ + ++ H D+KP+NILL K + +
Sbjct: 124 EIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVR 183
Query: 159 DLGVAKRSRHCKRQK------------FDPSMRGTPL----YLAPETVVQHMQEAPSDIW 202
+ K+ + + + F G+ + Y APE ++ + SD+W
Sbjct: 184 RVTDGKKIQIYRTKSTGIKLIDFGCATFKSDYHGSIINTRQYRAPEVILNLGWDVSSDMW 243
Query: 203 ALGCVVLEMLSG-----------------------------------------RQAWVVK 221
+ GCV+ E+ +G + +
Sbjct: 244 SFGCVLAELYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLA 303
Query: 222 EDCSIDQLFSIIGDEHSLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVK 278
+ + SI + LP + DFL P R + LL F++
Sbjct: 304 WPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQIDPTLRPSPAELLKHKFLE 360
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 89.0 bits (221), Expect = 8e-20
Identities = 39/127 (30%), Positives = 59/127 (46%), Gaps = 27/127 (21%)
Query: 99 DLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIA 158
+LI+K G VR F IL+ + +H + +HCD+KP+NILL Q G+ K+
Sbjct: 187 ELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLK--QQGRSGIKVI 244
Query: 159 DLGVAKR----------SRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVV 208
D G + SR Y APE ++ P D+W+LGC++
Sbjct: 245 DFGSSCYEHQRVYTYIQSRF---------------YRAPEVILGARYGMPIDMWSLGCIL 289
Query: 209 LEMLSGR 215
E+L+G
Sbjct: 290 AELLTGY 296
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 87.2 bits (217), Expect = 1e-19
Identities = 70/340 (20%), Positives = 126/340 (37%), Gaps = 96/340 (28%)
Query: 3 SDGTSWFRGRV--------IGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVSASASLQKE 54
+F+G + +G+G++G V+ AK ++A+K + L E
Sbjct: 10 GRENLYFQGLMEKYQKLEKVGEGTYGVVYKAKDSQGR-----IVALK--RIR----LDAE 58
Query: 55 KEVFDNLNGCPF--------VLECFGE------EITMGENGEMAYNLLLEYAAGGTLGDL 100
E G P + E ++ E L+ E+ L +
Sbjct: 59 DE------GIPSTAIREISLLKELHHPNIVSLIDVIHSER---CLTLVFEFMEKD-LKKV 108
Query: 101 IEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADL 160
+++ GL + ++ + +L G+ H H +H D+KP N+L+ G K+AD
Sbjct: 109 LDENKT-GLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLI--NSDG--ALKLADF 163
Query: 161 GVAKRSRHCKRQKFDPSMRGTPL-----YLAPETVVQHMQEAPS-DIWALGCVVLEMLSG 214
G+A R P T Y AP+ ++ + + S DIW++GC+ EM++G
Sbjct: 164 GLA-------RAFGIPVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITG 216
Query: 215 R---QAWVVKEDCSIDQL---FSIIG--DEHSLPEIPS---------------------- 244
+ DQL FSI+G + P++
Sbjct: 217 KPLFPG-----VTDDDQLPKIFSILGTPNPREWPQVQELPLWKQRTFQVFEKKPWSSIIP 271
Query: 245 RVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGVDEEL 284
+E D L P R +A ++ P+ K +D ++
Sbjct: 272 GFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDLDPQI 311
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 4e-19
Identities = 55/203 (27%), Positives = 87/203 (42%), Gaps = 46/203 (22%)
Query: 109 LPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRH 168
E+ +++ +L+G+ +IH +G VH D+KP N+ + KI D G+A+
Sbjct: 123 FSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNED----CELKILDFGLAR---- 174
Query: 169 CKRQKFDPSMRG---TPLYLAPETVVQHMQEAPS-DIWALGCVVLEMLSGRQAWVVKEDC 224
D M G T Y APE ++ M + DIW++GC++ EML+G+ + K
Sbjct: 175 ----HADAEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKT--LFKGKD 228
Query: 225 SIDQLFSI--------------IGDEH------SLPEIPSR--------VSKEARDFLRR 256
+DQL I + D+ SLP+ P + S +A D L +
Sbjct: 229 YLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEK 288
Query: 257 CFVRKPAFRFTAEMLLDDPFVKG 279
R TA L PF +
Sbjct: 289 MLELDVDKRLTAAQALTHPFFEP 311
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 86.4 bits (214), Expect = 5e-19
Identities = 55/237 (23%), Positives = 88/237 (37%), Gaps = 26/237 (10%)
Query: 2 DSDGTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVSASASLQKEKEVFDNL 61
D +W G IGQG FGC+++A S+ S V E S + L E + +
Sbjct: 31 DMAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRA 90
Query: 62 NGCPFVLECFGEEITMG------------ENGEMAYNLLLEYAAGGTLGDLIEKCNGNGL 109
+ + + +Y ++ G L + E
Sbjct: 91 AKPEQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANAKR-F 149
Query: 110 PEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHC 169
K V + IL+ + +IH+ YVH D+K N+LL + + D G+A R
Sbjct: 150 SRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVY--LVDYGLAYRYCPE 207
Query: 170 KRQK---FDP--SMRGTPLYLAPETVVQHMQEAPS---DIWALGCVVLEMLSGRQAW 218
K DP GT + + + H APS D+ LG +++ L+G W
Sbjct: 208 GVHKAYAADPKRCHDGTIEFTSIDA---HNGVAPSRRGDLEILGYCMIQWLTGHLPW 261
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 85.2 bits (211), Expect = 8e-19
Identities = 50/237 (21%), Positives = 89/237 (37%), Gaps = 29/237 (12%)
Query: 2 DSDGTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVSASASLQKEKEVFDNL 61
D +G W G+ IG G FG +++A P + VK E + L E + + +
Sbjct: 33 DMEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDAR-HVVK-VEYQENGPLFSELKFYQRV 90
Query: 62 NGCPFVLECFGEEIT------------MGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGL 109
+ + + + E +Y ++ G L + +
Sbjct: 91 AKKDCIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQKISGQNGT--F 148
Query: 110 PEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHC 169
+ V +L+ + +IH++ YVH D+K N+LL + +AD G++ R
Sbjct: 149 KKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVY--LADYGLSYRYCPN 206
Query: 170 KRQK---FDP--SMRGTPLYLAPETVVQHMQEAPS---DIWALGCVVLEMLSGRQAW 218
K +P GT + + + H A S D+ LG +L L G+ W
Sbjct: 207 GNHKQYQENPRKGHNGTIEFTSLDA---HKGVALSRRSDVEILGYCMLRWLCGKLPW 260
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 85.5 bits (212), Expect = 9e-19
Identities = 45/254 (17%), Positives = 78/254 (30%), Gaps = 89/254 (35%)
Query: 99 DLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVA--- 155
+ +++ N P VRH + + +H++ H D+KP+NIL V ++
Sbjct: 110 EFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHK 169
Query: 156 ------------KIADLGVAK----------RSRHCKRQKFDPSMRGTPLYLAPETVVQH 193
++AD G A +RH Y PE +++
Sbjct: 170 SCEEKSVKNTSIRVADFGSATFDHEHHTTIVATRH---------------YRPPEVILEL 214
Query: 194 MQEAPSDIWALGCVVLEMLSGR---QAWVVKEDCSIDQLFSIIG---------------- 234
P D+W++GC++ E G Q + + L +
Sbjct: 215 GWAQPCDVWSIGCILFEYYRGFTLFQT-----HENREHLVMMEKILGPIPSHMIHRTRKQ 269
Query: 235 ----DEHSLPEIPSRVSKEAR---------------------DFLRRCFVRKPAFRFTAE 269
+ + S + + D +RR PA R T
Sbjct: 270 KYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLA 329
Query: 270 MLLDDPFVKGVDEE 283
L PF G+ E
Sbjct: 330 EALLHPFFAGLTPE 343
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 1e-18
Identities = 67/347 (19%), Positives = 113/347 (32%), Gaps = 87/347 (25%)
Query: 12 RVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVSASASLQKEKEVFDNLNGCPFVLECF 71
R I GS+G V +A+K V + S + + + C VL
Sbjct: 28 RFISSGSYGAVCAGVDSEGIP-----VAIK--RVFNTVSDGRTVNILSDSFLCKRVLR-- 78
Query: 72 GEEITM--------------------GENGEMAYNLLLEYAAGGTLGDL--IEKCNGNGL 109
EI + Y L+ E T DL + +
Sbjct: 79 --EIRLLNHFHHPNILGLRDIFVHFEEPAMHKLY-LVTELM--RT--DLAQVIHDQRIVI 131
Query: 110 PEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHC 169
+ +++F IL G+ +H++G VH D+ P NILL I D +A+
Sbjct: 132 SPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADN----NDITICDFNLAREDTA- 186
Query: 170 KRQKFDPSMRG---TPLYLAPETVVQHMQEAPS-DIWALGCVVLEMLSGRQAWVVKEDCS 225
D + Y APE V+Q D+W+ GCV+ EM + + + +
Sbjct: 187 -----DANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKA--LFRGSTF 239
Query: 226 IDQL---FSIIGD------------------EHSLPEIPSR--------VSKEARDFLRR 256
+QL ++G +SL +P+R A D + +
Sbjct: 240 YNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAK 299
Query: 257 CFVRKPAFRFTAEMLLDDPFVKGV----DEELSRELEGDYSQGEVTL 299
P R + E L P+ + + D + + +
Sbjct: 300 MLEFNPQRRISTEQALRHPYFESLFDPLDLTEGLSERFHFDESVTDV 346
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 84.1 bits (209), Expect = 1e-18
Identities = 47/212 (22%), Positives = 82/212 (38%), Gaps = 45/212 (21%)
Query: 97 LGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAK 156
L + CNG L + V+ F +L+G+G H +H D+KP N+L+ + K
Sbjct: 87 LKKYFDSCNG-DLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLI----NRNGELK 141
Query: 157 IADLGVAKRSRHCKRQKFDPSMRGTPL-----YLAPETVVQHMQEAPS-DIWALGCVVLE 210
+A+ G+A R P + Y P+ + + S D+W+ GC+ E
Sbjct: 142 LANFGLA-------RAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAE 194
Query: 211 MLSGRQAWVVKEDCSIDQL---FSIIG--DEHSLPEIPS--------------------- 244
+ + + + + DQL F ++G E P +
Sbjct: 195 LANAGRP-LFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVP 253
Query: 245 RVSKEARDFLRRCFVRKPAFRFTAEMLLDDPF 276
+++ RD L+ P R +AE L P+
Sbjct: 254 KLNATGRDLLQNLLKCNPVQRISAEEALQHPY 285
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 1e-18
Identities = 51/203 (25%), Positives = 87/203 (42%), Gaps = 46/203 (22%)
Query: 109 LPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRH 168
L E ++ +L+G+ +IH +G +H D+KP N+ + + KI D G+A+
Sbjct: 125 LGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAV----NEDCELKILDFGLAR---- 176
Query: 169 CKRQKFDPSMRG---TPLYLAPETVVQHMQEAPS-DIWALGCVVLEMLSGRQAWVVKEDC 224
+ D M G T Y APE ++ M+ + DIW++GC++ EM++G+ + K
Sbjct: 177 ----QADSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKT--LFKGSD 230
Query: 225 SIDQLFSI--------------IGDEH------SLPEIPSR--------VSKEARDFLRR 256
+DQL I + + LPE+ + S A + L +
Sbjct: 231 HLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEK 290
Query: 257 CFVRKPAFRFTAEMLLDDPFVKG 279
V R TA L P+ +
Sbjct: 291 MLVLDAEQRVTAGEALAHPYFES 313
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 1e-18
Identities = 55/279 (19%), Positives = 93/279 (33%), Gaps = 46/279 (16%)
Query: 9 FRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVSASASLQKE--KEV-----FDNL 61
G V+G+G FG + +M +K Q+ KEV ++
Sbjct: 13 IHGEVLGKGCFGQAIKVTHRETG----EVMVMKELI-RFDEETQRTFLKEVKVMRCLEHP 67
Query: 62 NGCPFVLECFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCI 121
N F+ + N + EY GGTL +I+ + P F + I
Sbjct: 68 NVLKFIGVL-----YKDKR----LNFITEYIKGGTLRGIIKS-MDSQYPWSQRVSFAKDI 117
Query: 122 LEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDP----- 176
G+ ++H +H D+ N L+ +AD G+A+ K Q
Sbjct: 118 ASGMAYLHSMNIIHRDLNSHNCLV----RENKNVVVADFGLARLMVDEKTQPEGLRSLKK 173
Query: 177 -------SMRGTPLYLAPETVVQHMQ--EAPSDIWALGCVVLEMLSGRQAWVVKEDCSID 227
++ G P ++APE ++ E D+++ G V+ E++ A D
Sbjct: 174 PDRKKRYTVVGNPYWMAPE-MINGRSYDEK-VDVFSFGIVLCEIIGRVNAD---PDYLPR 228
Query: 228 QLFSIIGDEHSL-PEIPSRVSKEARDFLRRCFVRKPAFR 265
+ + L P RC P R
Sbjct: 229 TMDFGLNVRGFLDRYCPPNCPPSFFPITVRCCDLDPEKR 267
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 2e-18
Identities = 54/212 (25%), Positives = 80/212 (37%), Gaps = 46/212 (21%)
Query: 99 DLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIA 158
DL L + V+ IL G+ +IH + +H D+KP N+ + KI
Sbjct: 119 DLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCE----LKIL 174
Query: 159 DLGVAKRSRHCKRQKFDPSMRG---TPLYLAPETVVQHMQEAPS-DIWALGCVVLEMLSG 214
D G+A+ M G T Y APE ++ M + DIW++GC++ E+L+G
Sbjct: 175 DFGLAR--------HTADEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 226
Query: 215 RQAWVVKEDCSIDQLFSI--------------IGDEH------SLPEIPSR--------V 246
R + IDQL I I E SL ++P
Sbjct: 227 RT--LFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGA 284
Query: 247 SKEARDFLRRCFVRKPAFRFTAEMLLDDPFVK 278
+ A D L + V R TA L +
Sbjct: 285 NPLAVDLLEKMLVLDSDKRITAAQALAHAYFA 316
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 84.2 bits (209), Expect = 2e-18
Identities = 52/217 (23%), Positives = 85/217 (39%), Gaps = 51/217 (23%)
Query: 97 LGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILL-VATQSGKFVA 155
L ++K + + ++ F ++ G+ H +H D+KP N+LL V+ S V
Sbjct: 119 LKKYMDKNPD--VSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVL 176
Query: 156 KIADLGVAKRSRHCKRQKFDPSMRGTPL-----YLAPETVVQHMQEAPS-DIWALGCVVL 209
KI D G+A R P + T Y PE ++ + S DIW++ C+
Sbjct: 177 KIGDFGLA-------RAFGIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWA 229
Query: 210 EMLSGR---QAWVVKEDCSIDQL---FSIIG--DEH------SLPE-------------- 241
EML D IDQL F ++G D+ +LP+
Sbjct: 230 EMLMKTPLFPG-----DSEIDQLFKIFEVLGLPDDTTWPGVTALPDWKQSFPKFRGKTLK 284
Query: 242 --IPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPF 276
+ + + E D L P R +A+ L+ P+
Sbjct: 285 RVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPY 321
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 84.8 bits (210), Expect = 2e-18
Identities = 31/119 (26%), Positives = 55/119 (46%), Gaps = 9/119 (7%)
Query: 99 DLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDS--GYVHCDVKPDNILLVATQSGKFVAK 156
DL+ N G+ R F + + + + +HCD+KP+NILL + K
Sbjct: 144 DLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLC--NPKRSAIK 201
Query: 157 IADLGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGR 215
I D G + C+ + + Y +PE ++ + D+W+LGC+++EM +G
Sbjct: 202 IVDFGSS-----CQLGQRIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGE 255
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 83.3 bits (207), Expect = 2e-18
Identities = 53/215 (24%), Positives = 87/215 (40%), Gaps = 52/215 (24%)
Query: 97 LGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAK 156
L L++ C G GL + F +L GI + HD +H D+KP N+L+ + G+ K
Sbjct: 86 LKKLLDVCEG-GLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLI--NREGEL--K 140
Query: 157 IADLGVAKRSRHCKRQKFDPSMRGTPL-----YLAPETVVQHMQEAPS-DIWALGCVVLE 210
IAD G+A R P + T Y AP+ ++ + + + DIW++GC+ E
Sbjct: 141 IADFGLA-------RAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAE 193
Query: 211 MLSGR---QAWVVKEDCSIDQL---FSIIG--DEHSLPEIPS------------------ 244
M++G DQL F I+G + + P +
Sbjct: 194 MVNGTPLFPG-----VSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWES 248
Query: 245 ---RVSKEARDFLRRCFVRKPAFRFTAEMLLDDPF 276
+ + D L + P R TA+ L+ +
Sbjct: 249 FLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAY 283
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 84.0 bits (208), Expect = 2e-18
Identities = 55/238 (23%), Positives = 100/238 (42%), Gaps = 30/238 (12%)
Query: 11 GRVIGQGSFGCVFIAKPKSNSSFLPPLMAVK-SAEVSASASLQKEKEVFDNLNGCPFV-- 67
G+ IG G+FG + + K + ++ A+K S + L E + L +
Sbjct: 14 GKKIGCGNFGELRLGKNLYTNEYV----AIKLEPMKSRAPQLHLEYRFYKQLGSGDGIPQ 69
Query: 68 LECFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGH 127
+ FG G+ M LL G +L DL + C+ K V ++ + +
Sbjct: 70 VYYFGPC---GKYNAMVLELL-----GPSLEDLFDLCDRT-FSLKTVLMIAIQLISRMEY 120
Query: 128 IHDSGYVHCDVKPDNILL--VATQSGKFVAKIADLGVAKRSRHCKRQK-----FDPSMRG 180
+H ++ DVKP+N L+ ++ + + I D +AK + +K S+ G
Sbjct: 121 VHSKNLIYRDVKPENFLIGRPGNKTQQVIHII-DFALAKEYIDPETKKHIPYREHKSLTG 179
Query: 181 TPLYLAPETVVQHMQEAPS---DIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGD 235
T Y++ T H+ + S D+ ALG + + L G W + ++ + + IGD
Sbjct: 180 TARYMSINT---HLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGD 234
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 82.5 bits (204), Expect = 4e-18
Identities = 23/198 (11%), Positives = 47/198 (23%), Gaps = 44/198 (22%)
Query: 78 GENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCD 137
++ E+ GG+L ++ + + + H +G
Sbjct: 100 VHTRAGGL-VVAEWIRGGSLQEVADT----SPSPVGAIRAMQSLAAAADAAHRAGVALSI 154
Query: 138 VKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEA 197
P + + + G +A +
Sbjct: 155 DHPSRVRV--SIDGD--VVLAYPA----------------------TMPDAN-------P 181
Query: 198 PSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEHSLPEIPSR----VSKEARDF 253
DI +G + +L R W + E L D P P+ + +
Sbjct: 182 QDDIRGIGASLYALLVNR--WPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQISAV 239
Query: 254 LRRCFVRKPAFRFTAEML 271
R R + +L
Sbjct: 240 AARSVQGDGGIRSASTLL 257
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 81.9 bits (203), Expect = 1e-17
Identities = 51/224 (22%), Positives = 87/224 (38%), Gaps = 53/224 (23%)
Query: 97 LGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAK 156
L ++ C GN + +V+ F +L G+ + H +H D+KP N+L+ + + K
Sbjct: 86 LKQYLDDC-GNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLI----NERGELK 140
Query: 157 IADLGVAKRSRHCKRQKFDPSMRGTPL-----YLAPETVVQHMQEAPS-DIWALGCVVLE 210
+AD G+A R K P+ Y P+ ++ + D+W +GC+ E
Sbjct: 141 LADFGLA-------RAKSIPTKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYE 193
Query: 211 MLSGR---QAWVVKEDCSIDQL---FSIIG--DEHSLPEIPS------------------ 244
M +GR +QL F I+G E + P I S
Sbjct: 194 MATGRPLFPG-----STVEEQLHFIFRILGTPTEETWPGILSNEEFKTYNYPKYRAEALL 248
Query: 245 ----RVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGVDEEL 284
R+ + D L + + R +AE + PF + E +
Sbjct: 249 SHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGERI 292
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 81.9 bits (203), Expect = 1e-17
Identities = 51/219 (23%), Positives = 91/219 (41%), Gaps = 44/219 (20%)
Query: 99 DLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIA 158
DL + L + +++F L + +H S +H D+KP N+L+ + K+
Sbjct: 99 DLHRVISTQMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCD----LKVC 154
Query: 159 DLGVAKRSRHCKRQKFDPSMRGTPL--------YLAPETVVQHMQEAPS-DIWALGCVVL 209
D G+A+ +P+ + + + Y APE ++ + + + D+W+ GC++
Sbjct: 155 DFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILA 214
Query: 210 EMLSGRQAWVVKEDCSIDQL---FSIIG----DE--------------HSLPEIPSR--- 245
E+ R + QL F IIG D SLP P+
Sbjct: 215 ELFLRRP--IFPGRDYRHQLLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLE 272
Query: 246 -----VSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKG 279
V+ + D L+R V PA R TA+ L+ P+++
Sbjct: 273 KMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQT 311
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 2e-17
Identities = 64/329 (19%), Positives = 101/329 (30%), Gaps = 100/329 (30%)
Query: 12 RVIGQGSFGCVFIAKPKSNSS-------FLPPLMA------------------VKSAEVS 46
R+ GQG+FG V + K KS P V+
Sbjct: 29 RMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVLHHPNIVQLQSYF 88
Query: 47 ASASLQKEKEVFDNLNGCPFVLECFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNG 106
+ + ++++ N+ V+E + + + Y
Sbjct: 89 YTLGERDRRDIYLNV-----VMEYVPDTL---------HRCCRNYYR-----------RQ 123
Query: 107 NGLPEKDVRHFTRCILEGIGHIHDS--GYVHCDVKPDNILLVATQSGKFVAKIADLGVAK 164
P ++ F ++ IG +H H D+KP N +LV G K+ D G AK
Sbjct: 124 VAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHN-VLVNEADG--TLKLCDFGSAK 180
Query: 165 RSRHCKRQKFDPSMRGTP-----LYLAPETVVQHMQEAPS-DIWALGCVVLEMLSGRQAW 218
K PS Y APE + + + DIW++GC+ EM+ G
Sbjct: 181 --------KLSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEP-- 230
Query: 219 VVKEDCSIDQLFSIIG-----------------DEHSLPEIP------------SRVSKE 249
+ + D S QL I+ + L + +KE
Sbjct: 231 IFRGDNSAGQLHEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKE 290
Query: 250 ARDFLRRCFVRKPAFRFTAEMLLDDPFVK 278
A D L P R L P+
Sbjct: 291 AYDLLSALLQYLPEERMKPYEALCHPYFD 319
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 80.8 bits (200), Expect = 2e-17
Identities = 51/217 (23%), Positives = 81/217 (37%), Gaps = 48/217 (22%)
Query: 99 DLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIA 158
DL L E+ R F +L G+ +IH + +H D+KP N+ + V KI
Sbjct: 107 DLANVLEQGPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDL---VLKIG 163
Query: 159 DLGVAKRSRHCKRQKFDPSMRGTPL--------YLAPETVVQHMQEAPS-DIWALGCVVL 209
D G+A R L Y +P ++ + D+WA GC+
Sbjct: 164 DFGLA-------RIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFA 216
Query: 210 EMLSGRQAWVVKEDCSIDQL---FSIIG---DE-------------HSLPEIPSR----- 245
EML+G+ + ++Q+ I +E + P +
Sbjct: 217 EMLTGKTLF--AGAHELEQMQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQL 274
Query: 246 ---VSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKG 279
+S+EA DFL + P R TAE L P++
Sbjct: 275 LPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSI 311
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 80.0 bits (198), Expect = 5e-17
Identities = 66/316 (20%), Positives = 117/316 (37%), Gaps = 72/316 (22%)
Query: 12 RVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVSASASLQKEKEVF------DNLNGCP 65
R +G+G + VF A +N+ + VK + K+K++ +NL G P
Sbjct: 42 RKLGRGKYSEVFEAINITNNE----KVVVKILK------PVKKKKIKREIKILENLRGGP 91
Query: 66 FVLECFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGI 125
++ +I L+ E+ L + L + D+R + IL+ +
Sbjct: 92 NIITLA--DIVKDPVSRTPA-LVFEHVNNTDFKQLYQT-----LTDYDIRFYMYEILKAL 143
Query: 126 GHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMRG---TP 182
+ H G +H DVKP N+++ K ++ D G+A H ++ +
Sbjct: 144 DYCHSMGIMHRDVKPHNVMIDHEH-RKL--RLIDWGLA-EFYHPGQE-----YNVRVASR 194
Query: 183 LYLAPETVVQHMQEAPS-DIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSI--------- 232
+ PE +V + S D+W+LGC++ M+ ++ + D DQL I
Sbjct: 195 YFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDN-YDQLVRIAKVLGTEDL 253
Query: 233 ------IGDE------HSLPEIPSR-------------VSKEARDFLRRCFVRKPAFRFT 267
E L + VS EA DFL + R T
Sbjct: 254 YDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLT 313
Query: 268 AEMLLDDPFVKGVDEE 283
A ++ P+ V ++
Sbjct: 314 AREAMEHPYFYTVVKD 329
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 79.2 bits (196), Expect = 1e-16
Identities = 44/255 (17%), Positives = 75/255 (29%), Gaps = 89/255 (34%)
Query: 99 DLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVA--- 155
D I++ +R I + + +H + H D+KP+NIL V + +
Sbjct: 105 DFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKI 164
Query: 156 ------------KIADLGVAK----------RSRHCKRQKFDPSMRGTPLYLAPETVVQH 193
K+ D G A +RH Y APE ++
Sbjct: 165 KRDERTLINPDIKVVDFGSATYDDEHHSTLVSTRH---------------YRAPEVILAL 209
Query: 194 MQEAPSDIWALGCVVLEMLSGR---QAWVVKEDCSIDQLFSIIG---------------- 234
P D+W++GC+++E G S + L +
Sbjct: 210 GWSQPCDVWSIGCILIEYYLGFTVFPT-----HDSKEHLAMMERILGPLPKHMIQKTRKR 264
Query: 235 -----DEHSLPEIPS------RVSKEARD--------------FLRRCFVRKPAFRFTAE 269
D E S R K ++ +++ PA R T
Sbjct: 265 KYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLR 324
Query: 270 MLLDDPFVKGVDEEL 284
L PF + + +
Sbjct: 325 EALKHPFFDLLKKSI 339
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 79.5 bits (196), Expect = 1e-16
Identities = 72/341 (21%), Positives = 115/341 (33%), Gaps = 101/341 (29%)
Query: 9 FRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVSASASLQKEKEVFDNLNGCPFVL 68
+ G +G+G++G V+ AK K A+K Q E L
Sbjct: 24 YEGCKVGRGTYGHVYKAKRKDGKD--DKDYALK----------QIEGTGISMSACREIAL 71
Query: 69 --ECFGEEIT-----MGENGEMAYNLLLEYAAGGTLGDLIEKCNGNG-------LPEKDV 114
E + + + LL +YA L +I+ + LP V
Sbjct: 72 LRELKHPNVISLQKVFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMV 130
Query: 115 RHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKF 174
+ IL+GI ++H + +H D+KP NIL++ + KIAD+G A R
Sbjct: 131 KSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFA-------RLFN 183
Query: 175 DPSMRGTPL--------YLAPE---------TVVQHMQEAPSDIWALGCVVLEMLSGR-- 215
P L Y APE + DIWA+GC+ E+L+
Sbjct: 184 SPLKPLADLDPVVVTFWYRAPELLLGARHYTKAI--------DIWAIGCIFAELLTSEPI 235
Query: 216 -----QAWVVKEDCSIDQL---FSIIG--------DEHSLPEIPS--------------- 244
+ DQL F+++G D +PE +
Sbjct: 236 FHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSL 295
Query: 245 ---------RVSKEARDFLRRCFVRKPAFRFTAEMLLDDPF 276
+ +A L++ P R T+E + DP+
Sbjct: 296 IKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPY 336
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 78.9 bits (195), Expect = 2e-16
Identities = 54/210 (25%), Positives = 77/210 (36%), Gaps = 50/210 (23%)
Query: 107 NGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRS 166
L + +F IL G+ +IH + +H D+KP N+LL T KI D G+A
Sbjct: 123 QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTT----CDLKICDFGLA--- 175
Query: 167 RHCKRQKFDPSMRGTPL--------YLAPETVVQHMQEAPS-DIWALGCVVLEMLSGRQA 217
R L Y APE ++ S DIW++GC++ EMLS R
Sbjct: 176 ----RVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPI 231
Query: 218 WVVKEDCSIDQLFSI--------------IGDEH------SLPEIPSR--------VSKE 249
+ K +DQL I I + SLP +
Sbjct: 232 FPGKH--YLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSK 289
Query: 250 ARDFLRRCFVRKPAFRFTAEMLLDDPFVKG 279
A D L + P R E L P+++
Sbjct: 290 ALDLLDKMLTFNPHKRIEVEQALAHPYLEQ 319
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 78.0 bits (193), Expect = 2e-16
Identities = 49/222 (22%), Positives = 80/222 (36%), Gaps = 67/222 (30%)
Query: 97 LGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAK 156
L +I+ + L ++ + L+G+ ++H +H D+KP+N+LL V K
Sbjct: 98 LEVIIKDNSL-VLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLL----DENGVLK 152
Query: 157 IADLGVAKRSRHCKRQKFDPSMRGTPL-----YLAPE---------TVVQHMQEAPSDIW 202
+AD G+A + P+ T Y APE V D+W
Sbjct: 153 LADFGLA-------KSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGV--------DMW 197
Query: 203 ALGCVVLEMLSGR---QAWVVKEDCSIDQL---FSIIG--------------DEHSLPEI 242
A+GC++ E+L D +DQL F +G D +
Sbjct: 198 AVGCILAELLLRVPFLPG-----DSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSF 252
Query: 243 P--------SRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPF 276
P S + D ++ F+ P R TA L +
Sbjct: 253 PGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKY 294
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 78.2 bits (193), Expect = 3e-16
Identities = 46/211 (21%), Positives = 79/211 (37%), Gaps = 48/211 (22%)
Query: 108 GLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSR 167
L + + + +L GI H+H +G +H D+KP NI++ + KI D G+A R
Sbjct: 123 ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSD----CTLKILDFGLA---R 175
Query: 168 HCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSID 227
T Y APE ++ + DIW++GC++ EM+ G + + ID
Sbjct: 176 TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTD--HID 233
Query: 228 QL---FSIIG---DE-------------HSLPEIPSR--------------------VSK 248
Q +G E + P+ +
Sbjct: 234 QWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKAS 293
Query: 249 EARDFLRRCFVRKPAFRFTAEMLLDDPFVKG 279
+ARD L + V + R + + L P++
Sbjct: 294 QARDLLSKMLVIDASKRISVDEALQHPYINV 324
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 7e-16
Identities = 67/324 (20%), Positives = 113/324 (34%), Gaps = 95/324 (29%)
Query: 14 IGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVSASASLQKEKEVFDNLNGCPF------- 66
IGQG+FG VF A+ + +A+K ++ EKE G P
Sbjct: 25 IGQGTFGEVFKARHRKTGQ----KVALKKVL------MENEKE------GFPITALREIK 68
Query: 67 ------------VLECFGEEITMGENGEMAYNLLLEYA----AGGTLGDLIEKCNGNGLP 110
++E + + + + L+ ++ AG L+
Sbjct: 69 ILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAG-----LLSNVLVK-FT 122
Query: 111 EKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCK 170
+++ + +L G+ +IH + +H D+K N+L+ T+ G V K+AD G+A R
Sbjct: 123 LSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLI--TRDG--VLKLADFGLA---RAFS 175
Query: 171 RQKFDPSMRGTPL-----YLAPETVVQHMQEAPS-DIWALGCVVLEMLSGR---QAWVVK 221
K R T Y PE ++ P D+W GC++ EM + Q
Sbjct: 176 LAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQG---- 231
Query: 222 EDCSIDQLFSII---G--DEHSLPEI---------------PSRV---------SKEARD 252
+ QL I G P + +V A D
Sbjct: 232 -NTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALD 290
Query: 253 FLRRCFVRKPAFRFTAEMLLDDPF 276
+ + V PA R ++ L+ F
Sbjct: 291 LIDKLLVLDPAQRIDSDDALNHDF 314
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 77.2 bits (190), Expect = 8e-16
Identities = 47/211 (22%), Positives = 80/211 (37%), Gaps = 48/211 (22%)
Query: 108 GLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSR 167
L + + + +L GI H+H +G +H D+KP NI++ + + KI D G+A R
Sbjct: 160 ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCT----LKILDFGLA---R 212
Query: 168 HCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSID 227
T Y APE ++ + DIW++GC++ EM+ + + ID
Sbjct: 213 TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKI--LFPGRDYID 270
Query: 228 QL---FSIIG---DE-------------HSLPEIPSR--------------------VSK 248
Q +G E + P+ +
Sbjct: 271 QWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKAS 330
Query: 249 EARDFLRRCFVRKPAFRFTAEMLLDDPFVKG 279
+ARD L + V PA R + + L P++
Sbjct: 331 QARDLLSKMLVIDPAKRISVDDALQHPYINV 361
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 76.1 bits (188), Expect = 8e-16
Identities = 47/220 (21%), Positives = 81/220 (36%), Gaps = 56/220 (25%)
Query: 97 LGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAK 156
+ GL V++F +L+G+ H++ +H D+KP N+L+ + G K
Sbjct: 93 MDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLI--NKRG--QLK 148
Query: 157 IADLGVAKRSRHCKRQKFDPSMRGTPL-----YLAPETVVQHMQEAPS-DIWALGCVVLE 210
+ D G+A R P + Y AP+ ++ + S DIW+ GC++ E
Sbjct: 149 LGDFGLA-------RAFGIPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAE 201
Query: 211 MLSGR---QAWVVKEDCSIDQL---FSIIG--DEHSLPEI-------------------- 242
M++G+ +QL F I+G +E P +
Sbjct: 202 MITGKPLFPG-----TNDEEQLKLIFDIMGTPNESLWPSVTKLPKYNPNIQQRPPRDLRQ 256
Query: 243 ------PSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPF 276
+ DFL P R +A+ L P+
Sbjct: 257 VLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPW 296
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 69.5 bits (171), Expect = 1e-13
Identities = 57/236 (24%), Positives = 85/236 (36%), Gaps = 70/236 (29%)
Query: 12 RVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVSASASLQKEKEVFDNLNGCPFVLECF 71
+IG G FG V+ + + +A+K S Q +E F
Sbjct: 45 FLIGHGVFGKVYKGVLRDGA-----KVALK---RRTPESSQGIEE--------------F 82
Query: 72 GEEITM----------------GENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVR 115
EI E EM L+ +Y G L + G+ LP +
Sbjct: 83 ETEIETLSFCRHPHLVSLIGFCDERNEMI--LIYKYMENGNLKRHL---YGSDLPTMSMS 137
Query: 116 HFTR---CI--LEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCK 170
R CI G+ ++H +H DVK NILL FV KI D G++
Sbjct: 138 WEQRLEICIGAARGLHYLHTRAIIHRDVKSINILL----DENFVPKITDFGIS------- 186
Query: 171 RQKFDPSM---------RGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQA 217
K + +GT Y+ PE ++ SD+++ G V+ E+L R A
Sbjct: 187 --KKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSA 240
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 4e-13
Identities = 47/238 (19%), Positives = 83/238 (34%), Gaps = 70/238 (29%)
Query: 106 GNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKR 165
N L ++ +++ I ++H G +H D+KP NILL A K+AD G+++
Sbjct: 103 ANILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECH----VKVADFGLSRS 158
Query: 166 SRHCKRQKFDPSMRGTPLYLAPETVVQHMQE--------AP------------SDIWALG 205
+ +R + + + + + AP D+W+LG
Sbjct: 159 FVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLG 218
Query: 206 CVVLEMLSGRQAWVVKEDCSIDQL---FSIIG---DE--------------HSLPEIPSR 245
C++ E+L G+ + +++QL +I +E SL E
Sbjct: 219 CILGEILCGKP--IFPGSSTMNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEI 276
Query: 246 ------------------------VSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKG 279
++EA D L + P R +A L PFV
Sbjct: 277 RQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRISANDALKHPFVSI 334
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 67.5 bits (165), Expect = 1e-12
Identities = 51/251 (20%), Positives = 84/251 (33%), Gaps = 81/251 (32%)
Query: 106 GNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKR 165
L E+ ++ +L G IH+SG +H D+KP N LL + K+ D G+A R
Sbjct: 123 PIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLL----NQDCSVKVCDFGLA-R 177
Query: 166 SRHCKRQKFDPSMRGTPL---------------------YLAPETVVQHMQEAPS-DIWA 203
+ + ++ + Y APE ++ S DIW+
Sbjct: 178 TINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWS 237
Query: 204 LGCVVLEMLSGRQAWVVKEDC--------------------------SIDQL---FSIIG 234
GC+ E+L+ Q+ + + DQL F+IIG
Sbjct: 238 TGCIFAELLNMLQSHINDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIG 297
Query: 235 ---DE--------------HSLPEIPSR--------VSKEARDFLRRCFVRKPAFRFTAE 269
++ P +S + + L P R T +
Sbjct: 298 TPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDGINLLESMLKFNPNKRITID 357
Query: 270 MLLDDPFVKGV 280
LD P++K V
Sbjct: 358 QALDHPYLKDV 368
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 64.8 bits (158), Expect = 1e-11
Identities = 45/210 (21%), Positives = 87/210 (41%), Gaps = 29/210 (13%)
Query: 11 GRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKS--AEVSASASLQKEKEVFDNLNGCPFVL 68
+GQG FG V++ + +A+K+ + + +E +V L ++
Sbjct: 189 EVKLGQGCFGEVWMGTWNGTTR-----VAIKTLKPGTMSPEAFLQEAQVMKKLR-HEKLV 242
Query: 69 ECFG---EEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGI 125
+ + EE ++ EY + G+L D ++ G L + I G+
Sbjct: 243 QLYAVVSEEPIY---------IVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGM 293
Query: 126 GHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMRGT-PL- 183
++ YVH D++ NIL+ V K+AD G+A R + ++ P+
Sbjct: 294 AYVERMNYVHRDLRAANILV----GENLVCKVADFGLA---RLIEDNEYTARQGAKFPIK 346
Query: 184 YLAPETVVQHMQEAPSDIWALGCVVLEMLS 213
+ APE + SD+W+ G ++ E+ +
Sbjct: 347 WTAPEAALYGRFTIKSDVWSFGILLTELTT 376
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 64.5 bits (157), Expect = 1e-11
Identities = 46/258 (17%), Positives = 78/258 (30%), Gaps = 87/258 (33%)
Query: 106 GNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVA-- 163
L E ++ +L G+ ++H +G +H D+KP N L+ Q K+ D G+A
Sbjct: 150 PVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLV--NQDCSV--KVCDFGLART 205
Query: 164 ----KRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQE--------APS------------ 199
+ + + + + + AP
Sbjct: 206 VDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAI 265
Query: 200 DIWALGCVVLEMLSGRQAWV-----------------------------VKEDCSIDQL- 229
D+W++GC+ E+L+ + V + DQL
Sbjct: 266 DVWSIGCIFAELLNMIKENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLN 325
Query: 230 --FSIIG--DEHSLPEIPS-----------------------RVSKEARDFLRRCFVRKP 262
F+I+G E + + S +A L+R V P
Sbjct: 326 VIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERFPASSADAIHLLKRMLVFNP 385
Query: 263 AFRFTAEMLLDDPFVKGV 280
R T L PF K V
Sbjct: 386 NKRITINECLAHPFFKEV 403
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 63.6 bits (155), Expect = 2e-11
Identities = 63/305 (20%), Positives = 110/305 (36%), Gaps = 37/305 (12%)
Query: 11 GRVIGQGSFGCVF--IAKPKSNSSFLPPLMAVKS----AEVSASASLQKEKEVFDNLNGC 64
VIG+G FGCV+ AVKS ++ + E + + +
Sbjct: 94 NEVIGRGHFGCVYHGTLLDNDGK---KIHCAVKSLNRITDIGEVSQFLTEGIIMKDFS-H 149
Query: 65 PFVLECFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEG 124
P VL G E + ++L Y G L + I + KD+ F + +G
Sbjct: 150 PNVLSLLG-ICLRSEGSPL---VVLPYMKHGDLRNFIRN-ETHNPTVKDLIGFGLQVAKG 204
Query: 125 IGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMRGTPLY 184
+ + +VH D+ N +L KF K+AD G+ +R ++FD T
Sbjct: 205 MKFLASKKFVHRDLAARNCML----DEKFTVKVADFGL---ARDMYDKEFDSVHNKTGAK 257
Query: 185 L-----APETVVQHMQEAPSDIWALGCVVLEMLS-GRQAWVVKEDCSIDQLFSIIGDEHS 238
L A E++ SD+W+ G ++ E+++ G + D + + +
Sbjct: 258 LPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPY---PDVNTFDITVYLLQGRR 314
Query: 239 LPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGVDEELSRELEGDYSQGEVT 298
L + P + + +C+ K R + L V + S + Y T
Sbjct: 315 LLQ-PEYCPDPLYEVMLKCWHPKAEMRPSFSEL-----VSRISAIFSTFIGEHYVHVNAT 368
Query: 299 LSNAD 303
N
Sbjct: 369 YVNVK 373
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 64.1 bits (156), Expect = 2e-11
Identities = 45/210 (21%), Positives = 87/210 (41%), Gaps = 29/210 (13%)
Query: 11 GRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKS--AEVSASASLQKEKEVFDNLNGCPFVL 68
+GQG FG V++ + +A+K+ + + +E +V L ++
Sbjct: 272 EVKLGQGCFGEVWMGTWNGTTR-----VAIKTLKPGTMSPEAFLQEAQVMKKLR-HEKLV 325
Query: 69 ECFG---EEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGI 125
+ + EE ++ EY + G+L D ++ G L + I G+
Sbjct: 326 QLYAVVSEEPIY---------IVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGM 376
Query: 126 GHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMRGT-PL- 183
++ YVH D++ NIL+ V K+AD G+A R + ++ P+
Sbjct: 377 AYVERMNYVHRDLRAANILV----GENLVCKVADFGLA---RLIEDNEYTARQGAKFPIK 429
Query: 184 YLAPETVVQHMQEAPSDIWALGCVVLEMLS 213
+ APE + SD+W+ G ++ E+ +
Sbjct: 430 WTAPEAALYGRFTIKSDVWSFGILLTELTT 459
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 62.2 bits (152), Expect = 4e-11
Identities = 60/239 (25%), Positives = 97/239 (40%), Gaps = 57/239 (23%)
Query: 3 SDGTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKS-AEVSASASLQKEKEVFDN- 60
+ G +G+G FG V+ K N++ + AVK A + + + +++ FD
Sbjct: 28 DERPISVGGNKMGEGGFGVVY--KGYVNNTTV----AVKKLAAMVDITTEELKQQ-FDQE 80
Query: 61 --------------LNGCPFVLECFGEEITMGENGEMAYNLLL--EYAAGGTLGD-LIEK 103
L G + +L L Y G+L D L
Sbjct: 81 IKVMAKCQHENLVELLGF-----SSDGD-----------DLCLVYVYMPNGSLLDRLSCL 124
Query: 104 CNGNGLPEKDVRHFTRC-ILEGI--G--HIHDSGYVHCDVKPDNILLVATQSGKFVAKIA 158
L RC I +G G +H++ ++H D+K NILL F AKI+
Sbjct: 125 DGTPPLSWH-----MRCKIAQGAANGINFLHENHHIHRDIKSANILL----DEAFTAKIS 175
Query: 159 DLGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQA 217
D G+A+ S + + GT Y+APE + + SDI++ G V+LE+++G A
Sbjct: 176 DFGLARASEKFAQTVMTSRIVGTTAYMAPEALRGEITPK-SDIYSFGVVLLEIITGLPA 233
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 61.9 bits (151), Expect = 5e-11
Identities = 51/222 (22%), Positives = 90/222 (40%), Gaps = 36/222 (16%)
Query: 11 GRVIGQGSFGCVF--IAKPKSNSSFLPPLMAVKS----AEVSASASLQKEKEVFDNLNGC 64
RVIG+G FG V+ ++ + A+KS E+ + +E + LN
Sbjct: 26 DRVIGKGHFGVVYHGEYIDQAQNRI---QCAIKSLSRITEMQQVEAFLREGLLMRGLN-H 81
Query: 65 PFVLECFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEG 124
P VL G + E +LL Y G L I + KD+ F + G
Sbjct: 82 PNVLALIG-IMLPPEGLPH---VLLPYMCHGDLLQFI-RSPQRNPTVKDLISFGLQVARG 136
Query: 125 IGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAK--------RSRHCKRQKFDP 176
+ ++ + +VH D+ N +L F K+AD G+A+ + + +
Sbjct: 137 MEYLAEQKFVHRDLAARNCML----DESFTVKVADFGLARDILDREYYSVQQHRHARL-- 190
Query: 177 SMRGTPL-YLAPETVVQHMQEAPSDIWALGCVVLEMLS-GRQ 216
P+ + A E++ + SD+W+ G ++ E+L+ G
Sbjct: 191 -----PVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAP 227
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 61.9 bits (151), Expect = 5e-11
Identities = 60/322 (18%), Positives = 113/322 (35%), Gaps = 53/322 (16%)
Query: 11 GRVIGQGSFGCVFIAKPKSNSSFLPPLM-AVKSAEVSASAS----LQKEKEVFDNLNGCP 65
R +GQGSFG V+ K P A+K+ +AS E V N C
Sbjct: 30 SRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFN-CH 88
Query: 66 FVLECFG----EEITMGENGEMAYNLLLEYAAGGTL--------GDLIEKCNGNGLPEKD 113
V+ G + T+ +++E G L +
Sbjct: 89 HVVRLLGVVSQGQPTL---------VIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSK 139
Query: 114 VRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQK 173
+ I +G+ +++ + +VH D+ N ++ + F KI D G+ R
Sbjct: 140 MIQMAGEIADGMAYLNANKFVHRDLAARNCMV----AEDFTVKIGDFGMT---RDIYETD 192
Query: 174 FDPSMRGTPL---YLAPETVVQHMQEAPSDIWALGCVVL-EMLS-GRQAWVVKEDCSIDQ 228
+ L +++PE++ + SD+W+ G VVL E+ + Q + + S +Q
Sbjct: 193 YYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFG-VVLWEIATLAEQPY---QGLSNEQ 248
Query: 229 LFSIIGDEHSLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGVDEELSREL 288
+ + + L P + +R C+ P R + ++ + E+
Sbjct: 249 VLRFVMEGGLLD-KPDNCPDMLFELMRMCWQYNPKMRPSFLEII---------SSIKEEM 298
Query: 289 EGDYSQGEVTLSNADAESCSPE 310
E + + S + E
Sbjct: 299 EPGFREVSFYYSEENKLPEPEE 320
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 62.1 bits (151), Expect = 7e-11
Identities = 51/292 (17%), Positives = 115/292 (39%), Gaps = 38/292 (13%)
Query: 11 GRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKS--AEVSASASLQKEKEVFDNLNGCPFVL 68
+G G +G V+ K S +AVK+ + KE V + P ++
Sbjct: 225 KHKLGGGQYGEVYEGVWKKYSL----TVAVKTLKEDTMEVEEFLKEAAVMKEIK-HPNLV 279
Query: 69 E----CFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEG 124
+ C E ++ E+ G L D + +CN + + + I
Sbjct: 280 QLLGVCTREPPFY---------IITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSA 330
Query: 125 IGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMRGT-PL 183
+ ++ ++H ++ N L+ + K+AD G++ R + P+
Sbjct: 331 MEYLEKKNFIHRNLAARNCLV----GENHLVKVADFGLS---RLMTGDTYTAHAGAKFPI 383
Query: 184 -YLAPETVVQHMQEAPSDIWALGCVVLEMLS-GRQAWVVKEDCSIDQLFSIIGDEHSLPE 241
+ APE++ + SD+WA G ++ E+ + G + + Q++ ++ ++ +
Sbjct: 384 KWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY---PGIDLSQVYELLEKDYRME- 439
Query: 242 IPSRVSKEARDFLRRCFVRKPAFRFTAEML---LDDPFVK-GVDEELSRELE 289
P ++ + +R C+ P+ R + + + F + + +E+ +EL
Sbjct: 440 RPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKELG 491
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 60.7 bits (148), Expect = 1e-10
Identities = 49/218 (22%), Positives = 86/218 (39%), Gaps = 28/218 (12%)
Query: 11 GRVIGQGSFGCVF--IAKPKSNSSFLPPLMAVKS----AEVSASASLQKEKEVFDNLNGC 64
VIG+G FGCV+ AVKS ++ + E + + +
Sbjct: 30 NEVIGRGHFGCVYHGTLLDNDGK---KIHCAVKSLNRITDIGEVSQFLTEGIIMKDFS-H 85
Query: 65 PFVLECFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEG 124
P VL G E + ++L Y G L + I + KD+ F + +G
Sbjct: 86 PNVLSLLG-ICLRSEGSPL---VVLPYMKHGDLRNFIRN-ETHNPTVKDLIGFGLQVAKG 140
Query: 125 IGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMRGTPLY 184
+ ++ +VH D+ N +L KF K+AD G+ +R +++ T
Sbjct: 141 MKYLASKKFVHRDLAARNCML----DEKFTVKVADFGL---ARDMYDKEYYSVHNKTGAK 193
Query: 185 L-----APETVVQHMQEAPSDIWALGCVVLEMLS-GRQ 216
L A E++ SD+W+ G ++ E+++ G
Sbjct: 194 LPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 231
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 2e-10
Identities = 60/273 (21%), Positives = 114/273 (41%), Gaps = 29/273 (10%)
Query: 11 GRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKS----AEVSASASLQKEKEVFDNLNGCPF 66
R +G+G FG V + + +AVKS + + A L+KE E+ NL
Sbjct: 26 IRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLY-HEN 84
Query: 67 VLECFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIG 126
+++ G I + G L++E+ G+L + + K N N + K + I +G+
Sbjct: 85 IVKYKG--ICTEDGGNGIK-LIMEFLPSGSLKEYLPK-NKNKINLKQQLKYAVQICKGMD 140
Query: 127 HIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMRG-TPL-Y 184
++ YVH D+ N+L+ + KI D G+ ++ ++ + +P+ +
Sbjct: 141 YLGSRQYVHRDLAARNVLV----ESEHQVKIGDFGLT-KAIETDKEYYTVKDDRDSPVFW 195
Query: 185 LAPETVVQHMQEAPSDIWALGCVVLEMLS-GRQAWVVKEDCSID-----------QLFSI 232
APE ++Q SD+W+ G + E+L+ +L +
Sbjct: 196 YAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNT 255
Query: 233 IGDEHSLPEIPSRVSKEARDFLRRCFVRKPAFR 265
+ + LP P E +R+C+ +P+ R
Sbjct: 256 LKEGKRLPC-PPNCPDEVYQLMRKCWEFQPSNR 287
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 60.7 bits (148), Expect = 2e-10
Identities = 45/222 (20%), Positives = 90/222 (40%), Gaps = 42/222 (18%)
Query: 11 GRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVSASASLQ----KEKEVFDNLNGCPF 66
G IG+G+FG VF + +++++ L+AVKS + L+ +E + + P
Sbjct: 119 GEQIGRGNFGEVFSGRLRADNT----LVAVKSCRETLPPDLKAKFLQEARILKQYS-HPN 173
Query: 67 VLECFG----EEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCIL 122
++ G ++ +++E GG + G L K +
Sbjct: 174 IVRLIGVCTQKQPIY---------IVMELVQGGDFLTFLRT-EGARLRVKTLLQMVGDAA 223
Query: 123 EGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKR------SRHCKRQKFDP 176
G+ ++ +H D+ N L+ + K V KI+D G+++ + ++
Sbjct: 224 AGMEYLESKCCIHRDLAARNCLV----TEKNVLKISDFGMSREEADGVYAASGGLRQV-- 277
Query: 177 SMRGTPL-YLAPETVVQHMQEAPSDIWALGCVVLEMLS-GRQ 216
P+ + APE + + SD+W+ G ++ E S G
Sbjct: 278 -----PVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGAS 314
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 3e-10
Identities = 56/282 (19%), Positives = 104/282 (36%), Gaps = 36/282 (12%)
Query: 11 GRVIGQGSFGCVFIAKPKSNSSFLPPLM-AVKSAEVSASAS----LQKEKEVFDNLNGCP 65
R +G G+FG V+ + + PL AVK+ S E + N
Sbjct: 35 IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFN-HQ 93
Query: 66 FVLECFG----EEITMGENGEMAYNLLLEYAAGGTLGDLIEKC-----NGNGLPEKDVRH 116
++ C G +L+E AGG L + + + L D+ H
Sbjct: 94 NIVRCIGVSLQSLPRF---------ILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLH 144
Query: 117 FTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDP 176
R I G ++ ++ ++H D+ N L + VAKI D G+A R R +
Sbjct: 145 VARDIACGCQYLEENHFIHRDIAARNCL-LTCPGPGRVAKIGDFGMA---RDIYRASYYR 200
Query: 177 SMRGTPL---YLAPETVVQHMQEAPSDIWALGCVVLEMLS-GRQAWVVKEDCSIDQLFSI 232
L ++ PE ++ + + +D W+ G ++ E+ S G + S ++
Sbjct: 201 KGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPY---PSKSNQEVLEF 257
Query: 233 IGDEHSLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDD 274
+ + P + +C+ +P R ++L+
Sbjct: 258 VTSGGRMD-PPKNCPGPVYRIMTQCWQHQPEDRPNFAIILER 298
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 59.7 bits (145), Expect = 3e-10
Identities = 54/279 (19%), Positives = 108/279 (38%), Gaps = 43/279 (15%)
Query: 11 GRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKS----AEVSASASLQKEKEVFDNLNGCPF 66
R +G+G FG V + + ++AVK+ A + ++E ++ L
Sbjct: 36 IRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLY-HEH 94
Query: 67 VLECFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIG 126
+++ G L++EY G+L D + + + + + F + I EG+
Sbjct: 95 IIKYKG--CCEDAGAASLQ-LVMEYVPLGSLRDYLPR---HSIGLAQLLLFAQQICEGMA 148
Query: 127 HIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCK-------RQKFDPSMR 179
++H Y+H D+ N+LL + KI D G+AK
Sbjct: 149 YLHAQHYIHRDLAARNVLL----DNDRLVKIGDFGLAKAVPEGHEYYRVREDGDS----- 199
Query: 180 GTPL-YLAPETVVQHMQEAPSDIWALGCVVLEMLS-GRQAWVVKEDC-----------SI 226
P+ + APE + ++ SD+W+ G + E+L+ + ++
Sbjct: 200 --PVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTV 257
Query: 227 DQLFSIIGDEHSLPEIPSRVSKEARDFLRRCFVRKPAFR 265
+L ++ LP P + E ++ C+ + +FR
Sbjct: 258 LRLTELLERGERLPR-PDKCPAEVYHLMKNCWETEASFR 295
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 59.7 bits (145), Expect = 3e-10
Identities = 56/273 (20%), Positives = 100/273 (36%), Gaps = 36/273 (13%)
Query: 11 GRVIGQGSFGCVFIAKPKSNSSFLPPLM-AVKSAEVSASAS----LQKEKEVFDNLNGCP 65
R +G G+FG V+ + + PL AVK+ S E + N
Sbjct: 76 IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFN-HQ 134
Query: 66 FVLECFG----EEITMGENGEMAYNLLLEYAAGGTLGDLIEKC-----NGNGLPEKDVRH 116
++ C G +LLE AGG L + + + L D+ H
Sbjct: 135 NIVRCIGVSLQSLPRF---------ILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLH 185
Query: 117 FTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDP 176
R I G ++ ++ ++H D+ N L+ VAKI D G+A R R +
Sbjct: 186 VARDIACGCQYLEENHFIHRDIAARNC-LLTCPGPGRVAKIGDFGMA---RDIYRAGYYR 241
Query: 177 SMRGTPL---YLAPETVVQHMQEAPSDIWALGCVVLEMLS-GRQAWVVKEDCSIDQLFSI 232
L ++ PE ++ + + +D W+ G ++ E+ S G + S ++
Sbjct: 242 KGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPY---PSKSNQEVLEF 298
Query: 233 IGDEHSLPEIPSRVSKEARDFLRRCFVRKPAFR 265
+ + P + +C+ +P R
Sbjct: 299 VTSGGRMD-PPKNCPGPVYRIMTQCWQHQPEDR 330
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 5e-10
Identities = 58/313 (18%), Positives = 113/313 (36%), Gaps = 45/313 (14%)
Query: 11 GRVIGQGSFGCVFIAKPKSNSSFLPPLMAVK-----SAEVSASASLQKEKEVFDNLNGCP 65
GR++G+G FG V A+ K +AVK S +E + P
Sbjct: 28 GRMLGKGEFGSVREAQLKQEDG-SFVKVAVKMLKADIIASSDIEEFLREAACMKEFD-HP 85
Query: 66 FVLE----CFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKC----NGNGLPEKDVRHF 117
V + M ++L + G L + N LP + + F
Sbjct: 86 HVAKLVGVSLRSRAKGRLPIPM---VILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRF 142
Query: 118 TRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCK---RQKF 174
I G+ ++ ++H D+ N +L + +AD G++ R + RQ
Sbjct: 143 MVDIACGMEYLSSRNFIHRDLAARNCML----AEDMTVCVADFGLS-RKIYSGDYYRQG- 196
Query: 175 DPSMRGTPL---YLAPETVVQHMQEAPSDIWALGCVVLEMLS-GRQAWVVKEDCSIDQLF 230
+ L +LA E++ ++ SD+WA G + E+++ G+ + +++
Sbjct: 197 ----CASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPY---AGIENAEIY 249
Query: 231 SIIGDEHSLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGVDEELSRELEG 290
+ + + L P +E D + +C+ P R + L + E + L
Sbjct: 250 NYLIGGNRLK-QPPECMEEVYDLMYQCWSADPKQRPSFTCLRMEL------ENILGHLSV 302
Query: 291 DYSQGEVTLSNAD 303
+ + N +
Sbjct: 303 LSTSQDPLYINIE 315
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 58.8 bits (143), Expect = 6e-10
Identities = 42/220 (19%), Positives = 83/220 (37%), Gaps = 24/220 (10%)
Query: 11 GRVIGQGSFGCVFIAKPKSNSSFLPPLMAVK-----SAEVSASASLQKEKEVFDNLNGCP 65
G+++G+G FG V K +AVK ++ E + + P
Sbjct: 39 GKILGEGEFGSVMEGNLK-QEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFS-HP 96
Query: 66 FVLECFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKC----NGNGLPEKDVRHFTRCI 121
V+ G I M G ++L + G L + +P + + F I
Sbjct: 97 NVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDI 156
Query: 122 LEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMRGT 181
G+ ++ + ++H D+ N +L +AD G++ + + R
Sbjct: 157 ALGMEYLSNRNFLHRDLAARNCML----RDDMTVCVADFGLS---KKIYSGDYYRQGRIA 209
Query: 182 PL---YLAPETVVQHMQEAPSDIWALGCVVL-EMLS-GRQ 216
+ ++A E++ + + SD+WA G V + E+ + G
Sbjct: 210 KMPVKWIAIESLADRVYTSKSDVWAFG-VTMWEIATRGMT 248
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 59.1 bits (143), Expect = 8e-10
Identities = 51/267 (19%), Positives = 100/267 (37%), Gaps = 37/267 (13%)
Query: 11 GRVIGQGSFGCVF--IAKPKSNSSFLPPLMAVK----SAEVSASASLQKEKEVFDNLNGC 64
GR IG+G FG V I N + +A+K S +E +
Sbjct: 395 GRCIGEGQFGDVHQGIYMSPENPAMA---VAIKTCKNCTSDSVREKFLQEALTMRQFD-H 450
Query: 65 PFVLECFG---EEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCI 121
P +++ G E +++E G L ++ L + + +
Sbjct: 451 PHIVKLIGVITENPVW---------IIMELCTLGELRSFLQV-RKFSLDLASLILYAYQL 500
Query: 122 LEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMRG- 180
+ ++ +VH D+ N+L+ S K+ D G SR+ + + + +G
Sbjct: 501 STALAYLESKRFVHRDIAARNVLV----SSNDCVKLGDFG---LSRYMEDSTYYKASKGK 553
Query: 181 TPL-YLAPETVVQHMQEAPSDIWALGCVVLEMLS-GRQAWVVKEDCSIDQLFSIIGDEHS 238
P+ ++APE++ + SD+W G + E+L G + + + + + I +
Sbjct: 554 LPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPF---QGVKNNDVIGRIENGER 610
Query: 239 LPEIPSRVSKEARDFLRRCFVRKPAFR 265
LP P + +C+ P+ R
Sbjct: 611 LPM-PPNCPPTLYSLMTKCWAYDPSRR 636
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 58.6 bits (142), Expect = 1e-09
Identities = 51/215 (23%), Positives = 93/215 (43%), Gaps = 32/215 (14%)
Query: 11 GRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKS--AEVSASASLQKEKEVFDNLNGCPFVL 68
+ +G G FG V++A ++ +AVK+ + + E V L ++
Sbjct: 193 EKKLGAGQFGEVWMATYNKHTK-----VAVKTMKPGSMSVEAFLAEANVMKTLQ-HDKLV 246
Query: 69 ECFG---EEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGI 125
+ +E ++ E+ A G+L D ++ G+ P + F+ I EG+
Sbjct: 247 KLHAVVTKEPIY---------IITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGM 297
Query: 126 GHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMRGTPL-- 183
I Y+H D++ NIL+ S V KIAD G+A R + ++ G
Sbjct: 298 AFIEQRNYIHRDLRAANILV----SASLVCKIADFGLA---RVIEDNEYTAR-EGAKFPI 349
Query: 184 -YLAPETVVQHMQEAPSDIWALGCVVLEMLS-GRQ 216
+ APE + SD+W+ G +++E+++ GR
Sbjct: 350 KWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRI 384
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 57.7 bits (140), Expect = 1e-09
Identities = 44/207 (21%), Positives = 90/207 (43%), Gaps = 13/207 (6%)
Query: 11 GRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKS---AEVSASASLQKEKEVFDNLNGCPFV 67
+ +G+G+FG V + + ++AVK + ++E E+ +L +
Sbjct: 15 LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQ-HDNI 73
Query: 68 LECFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGH 127
++ G + L++EY G+L D ++K + + + +T I +G+ +
Sbjct: 74 VKYKG--VCYSAGRRNLK-LIMEYLPYGSLRDYLQK-HKERIDHIKLLQYTSQICKGMEY 129
Query: 128 IHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMRGTPL-YLA 186
+ Y+H D+ NIL+ + KI D G+ K K +P+ + A
Sbjct: 130 LGTKRYIHRDLATRNILV----ENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYA 185
Query: 187 PETVVQHMQEAPSDIWALGCVVLEMLS 213
PE++ + SD+W+ G V+ E+ +
Sbjct: 186 PESLTESKFSVASDVWSFGVVLYELFT 212
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 2e-09
Identities = 44/207 (21%), Positives = 90/207 (43%), Gaps = 13/207 (6%)
Query: 11 GRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKS---AEVSASASLQKEKEVFDNLNGCPFV 67
+ +G+G+FG V + + ++AVK + ++E E+ +L +
Sbjct: 46 LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQ-HDNI 104
Query: 68 LECFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGH 127
++ G + L++EY G+L D ++K + + + +T I +G+ +
Sbjct: 105 VKYKG--VCYSAGRRNLK-LIMEYLPYGSLRDYLQK-HKERIDHIKLLQYTSQICKGMEY 160
Query: 128 IHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMRGTPL-YLA 186
+ Y+H D+ NIL+ + KI D G+ K K +P+ + A
Sbjct: 161 LGTKRYIHRDLATRNILV----ENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYA 216
Query: 187 PETVVQHMQEAPSDIWALGCVVLEMLS 213
PE++ + SD+W+ G V+ E+ +
Sbjct: 217 PESLTESKFSVASDVWSFGVVLYELFT 243
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 3e-09
Identities = 50/210 (23%), Positives = 92/210 (43%), Gaps = 26/210 (12%)
Query: 11 GRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKS-AEVSASASLQKEKEVFDNLNGCPFVLE 69
+ IG+G FG V + + N +AVK + + + E V L +++
Sbjct: 198 LQTIGKGEFGDVMLGDYRGNK------VAVKCIKNDATAQAFLAEASVMTQLR-HSNLVQ 250
Query: 70 CFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIH 129
G I + G ++ EY A G+L D + + L + F+ + E + ++
Sbjct: 251 LLGV-IVEEKGGLY---IVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE 306
Query: 130 DSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQ--KFDPSMRGTPLYLAP 187
+ +VH D+ N+L+ S VAK++D G+ + + K P ++ T AP
Sbjct: 307 GNNFVHRDLAARNVLV----SEDNVAKVSDFGLT-KEASSTQDTGKL-P-VKWT----AP 355
Query: 188 ETVVQHMQEAPSDIWALGCVVLEMLS-GRQ 216
E + + SD+W+ G ++ E+ S GR
Sbjct: 356 EALREKKFSTKSDVWSFGILLWEIYSFGRV 385
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 56.1 bits (136), Expect = 3e-09
Identities = 52/210 (24%), Positives = 93/210 (44%), Gaps = 26/210 (12%)
Query: 11 GRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVSASAS-LQKEKEVFDNLNGCPFVLE 69
+ IG+G FG V + + N +AVK + A+A E V L +++
Sbjct: 26 LQTIGKGEFGDVMLGDYRGNK------VAVKCIKNDATAQAFLAEASVMTQLR-HSNLVQ 78
Query: 70 CFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIH 129
G I + G ++ EY A G+L D + + L + F+ + E + ++
Sbjct: 79 LLGV-IVEEKGGLY---IVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE 134
Query: 130 DSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQ--KFDPSMRGTPLYLAP 187
+ +VH D+ N+L+ S VAK++D G+ + + K P ++ T AP
Sbjct: 135 GNNFVHRDLAARNVLV----SEDNVAKVSDFGLT-KEASSTQDTGKL-P-VKWT----AP 183
Query: 188 ETVVQHMQEAPSDIWALGCVVLEMLS-GRQ 216
E + + SD+W+ G ++ E+ S GR
Sbjct: 184 EALREKKFSTKSDVWSFGILLWEIYSFGRV 213
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 5e-09
Identities = 63/290 (21%), Positives = 106/290 (36%), Gaps = 48/290 (16%)
Query: 11 GRVIGQGSFGCVFIAKPKSNSSFLPPLM-AVKS---AEVSASASLQKEKEVFDNLNGCPF 66
+G+G+FG VF+A+ + ++ AVK+ A SA Q+E E+ L
Sbjct: 46 KWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQ-HQH 104
Query: 67 VLECFG----EEITMGENGEMAYNLLLEYAAGGTL-------------GDLIEKCNGNGL 109
++ FG + ++ EY G L E L
Sbjct: 105 IVRFFGVCTEGRPLL---------MVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPL 155
Query: 110 PEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHC 169
+ + G+ ++ +VH D+ N L+ V KI D G+ SR
Sbjct: 156 GLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLV----GQGLVVKIGDFGM---SRDI 208
Query: 170 KRQKFDPSMRGTPL---YLAPETVVQHMQEAPSDIWALGCVVL-EMLS-GRQAWVVKEDC 224
+ T L ++ PE+++ SD+W+ G VVL E+ + G+Q W
Sbjct: 209 YSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFG-VVLWEIFTYGKQPW---YQL 264
Query: 225 SIDQLFSIIGDEHSLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDD 274
S + I L P E +R C+ R+P R + + +
Sbjct: 265 SNTEAIDCITQGRELE-RPRACPPEVYAIMRGCWQREPQQRHSIKDVHAR 313
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 56.1 bits (136), Expect = 5e-09
Identities = 26/92 (28%), Positives = 44/92 (47%), Gaps = 21/92 (22%)
Query: 134 VHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPS--------MRGTPLYL 185
+H DVK NILL +F A + D G+A K +RGT ++
Sbjct: 156 IHRDVKAANILL----DEEFEAVVGDFGLA---------KLMDYKDTHVTTAVRGTIGHI 202
Query: 186 APETVVQHMQEAPSDIWALGCVVLEMLSGRQA 217
APE + +D++ G ++LE+++G++A
Sbjct: 203 APEYLSTGKSSEKTDVFGYGVMLLELITGQRA 234
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 5e-09
Identities = 65/302 (21%), Positives = 119/302 (39%), Gaps = 46/302 (15%)
Query: 11 GRVIGQGSFGCVFIAKPKSNSSFLPPLM---AVKSAEVSASAS----LQKEKEVFDNLNG 63
G+ +G+G FG V +A+ P AVK + A+ L E E+ +
Sbjct: 86 GKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 145
Query: 64 CPFVLECFGEEITMGENGEMAYNLLLEYAAGGTL--------------GDLIEKCNGNGL 109
++ G Y +++EYA+ G L I + +
Sbjct: 146 HKNIINLLG----ACTQDGPLY-VIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 200
Query: 110 PEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHC 169
KD+ T + G+ ++ +H D+ N+L+ + V KIAD G+A R
Sbjct: 201 TFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLV----TENNVMKIADFGLA---RDI 253
Query: 170 KRQKFDPSMRGTPL---YLAPETVVQHMQEAPSDIWALGCVVL-EMLS-GRQAWVVKEDC 224
+ L ++APE + + SD+W+ G V++ E+ + G +
Sbjct: 254 NNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFG-VLMWEIFTLGGSPY---PGI 309
Query: 225 SIDQLFSIIGDEHSLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEML---LDDPFVKGVD 281
+++LF ++ + H + P+ + E +R C+ P+ R T + L LD +
Sbjct: 310 PVEELFKLLKEGHRMD-KPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTN 368
Query: 282 EE 283
EE
Sbjct: 369 EE 370
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 7e-09
Identities = 49/207 (23%), Positives = 95/207 (45%), Gaps = 13/207 (6%)
Query: 11 GRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVSASAS---LQKEKEVFDNLNGCPFV 67
+G+G+FG V + + L+AVK + S Q+E ++ L+ F+
Sbjct: 28 ISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALH-SDFI 86
Query: 68 LECFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGH 127
++ G ++ G + L++EY G L D +++ + L + ++ I +G+ +
Sbjct: 87 VKYRG--VSYGPGRQSLR-LVMEYLPSGCLRDFLQR-HRARLDASRLLLYSSQICKGMEY 142
Query: 128 IHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMRGTPL-YLA 186
+ VH D+ NIL+ + KIAD G+AK K +P+ + A
Sbjct: 143 LGSRRCVHRDLAARNILV----ESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYA 198
Query: 187 PETVVQHMQEAPSDIWALGCVVLEMLS 213
PE++ ++ SD+W+ G V+ E+ +
Sbjct: 199 PESLSDNIFSRQSDVWSFGVVLYELFT 225
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 55.1 bits (133), Expect = 1e-08
Identities = 65/320 (20%), Positives = 123/320 (38%), Gaps = 46/320 (14%)
Query: 11 GRVIGQGSFGCVFIAKPKSNSSFLPPLM---AVK----SAEVSASASLQKEKEVFDNLNG 63
G+ +G+G+FG V +A+ P + AVK A + L E E+ +
Sbjct: 74 GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 133
Query: 64 CPFVLECFGEEITMGENGEMAYNLLLEYAAGGTL--------------GDLIEKCNGNGL 109
++ G Y +++EYA+ G L L
Sbjct: 134 HKNIINLLG----ACTQDGPLY-VIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 188
Query: 110 PEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHC 169
KD+ + G+ ++ +H D+ N+L+ + V KIAD G+A R
Sbjct: 189 SSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLV----TEDNVMKIADFGLA---RDI 241
Query: 170 KRQKFDPSMRGTPL---YLAPETVVQHMQEAPSDIWALGCVVL-EMLS-GRQAWVVKEDC 224
+ L ++APE + + SD+W+ G V+L E+ + G +
Sbjct: 242 HHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFG-VLLWEIFTLGGSPY---PGV 297
Query: 225 SIDQLFSIIGDEHSLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEML---LDDPFVKGVD 281
+++LF ++ + H + + PS + E +R C+ P+ R T + L LD +
Sbjct: 298 PVEELFKLLKEGHRM-DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSN 356
Query: 282 EELSRELEGDYSQGEVTLSN 301
+E+ + ++ +
Sbjct: 357 QEMGYYHHHHHHDYDIPTTE 376
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 54.6 bits (132), Expect = 1e-08
Identities = 51/229 (22%), Positives = 89/229 (38%), Gaps = 34/229 (14%)
Query: 11 GRVIGQGSFGCVFIAKPKSNSSFLPPLM-AVKSAEVSASAS----LQKEKEVFDNLNGCP 65
G+ +G+G+FG V A AVK + A+ S L E ++ ++
Sbjct: 32 GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 91
Query: 66 FVLECFGEEITMGENGEMAYNLLLEYAAGGTLGD--------------LIEKCNGNGLPE 111
V+ G T + G +++E+ G L E + L
Sbjct: 92 NVVNLLGA-CT--KPGGPLM-VIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTL 147
Query: 112 KDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKR 171
+ + ++ + +G+ + +H D+ NILL S K V KI D G+A R +
Sbjct: 148 EHLICYSFQVAKGMEFLASRKCIHRDLAARNILL----SEKNVVKICDFGLA---RDIYK 200
Query: 172 QKFDPSMRGTPL---YLAPETVVQHMQEAPSDIWALGCVVLEMLS-GRQ 216
L ++APET+ + SD+W+ G ++ E+ S G
Sbjct: 201 DPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGAS 249
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 54.5 bits (132), Expect = 1e-08
Identities = 64/282 (22%), Positives = 111/282 (39%), Gaps = 49/282 (17%)
Query: 11 GRVIGQGSFGCVFIAKPKSNSSFLPPLM-AVKS---AEVSASASLQKEKEVFDNLNGCPF 66
R +G+G+FG VF+A+ + S ++ AVK+ ++A Q+E E+ NL
Sbjct: 20 KRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQ-HEH 78
Query: 67 VLECFG----EEITMGENGEMAYNLLLEYAAGGTL--------------GDLIEKCNGNG 108
+++ +G + + ++ EY G L D +
Sbjct: 79 IVKFYGVCGDGDPLI---------MVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGE 129
Query: 109 LPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRH 168
L + H I G+ ++ +VH D+ N L+ + KI D G SR
Sbjct: 130 LGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLV----GANLLVKIGDFG---MSRD 182
Query: 169 CKRQKFDPSMRGTPL---YLAPETVVQHMQEAPSDIWALGCVVL-EMLS-GRQAWVVKED 223
+ T L ++ PE+++ SD+W+ G V+L E+ + G+Q W
Sbjct: 183 VYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFG-VILWEIFTYGKQPW---FQ 238
Query: 224 CSIDQLFSIIGDEHSLPEIPSRVSKEARDFLRRCFVRKPAFR 265
S ++ I L P KE D + C+ R+P R
Sbjct: 239 LSNTEVIECITQGRVLE-RPRVCPKEVYDVMLGCWQREPQQR 279
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 54.2 bits (131), Expect = 2e-08
Identities = 66/304 (21%), Positives = 120/304 (39%), Gaps = 50/304 (16%)
Query: 11 GRVIGQGSFGCVFIAKPKSNSSFLPPLM---AVK----SAEVSASASLQKEKEVFDNLNG 63
G+ +G+G+FG V +A+ P AVK A + L E E+ +
Sbjct: 40 GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 99
Query: 64 CPFVLECFGEEITMGENGEMAYNLLLEYAAGGTL--------------GDLIEKCNGNGL 109
++ G Y +++EYA+ G L I + +
Sbjct: 100 HKNIINLLG----ACTQDGPLY-VIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 110 PEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHC 169
KD+ T + G+ ++ +H D+ N+L+ + V KIAD G+A+
Sbjct: 155 TFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLV----TENNVMKIADFGLAR----- 205
Query: 170 KRQKFDPSMRGTPLYL-----APETVVQHMQEAPSDIWALGCVVL-EMLS-GRQAWVVKE 222
D + T L APE + + SD+W+ G V++ E+ + G +
Sbjct: 206 DINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFG-VLMWEIFTLGGSPY---P 261
Query: 223 DCSIDQLFSIIGDEHSLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEML---LDDPFVKG 279
+++LF ++ + H + + P+ + E +R C+ P+ R T + L LD
Sbjct: 262 GIPVEELFKLLKEGHRM-DKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLT 320
Query: 280 VDEE 283
+EE
Sbjct: 321 TNEE 324
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 53.4 bits (129), Expect = 2e-08
Identities = 48/218 (22%), Positives = 87/218 (39%), Gaps = 38/218 (17%)
Query: 11 GRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVSASAS--LQKEKEVFDNLNGCPFVL 68
+G G FG V++ ++ +AVKS + + + E + L ++
Sbjct: 18 VERLGAGQFGEVWMGYYNGHTK-----VAVKSLKQGSMSPDAFLAEANLMKQLQ-HQRLV 71
Query: 69 ECFG---EEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGI 125
+ +E ++ EY G+L D ++ +G L + I EG+
Sbjct: 72 RLYAVVTQEPIY---------IITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGM 122
Query: 126 GHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMRG----- 180
I + Y+H D++ NIL+ S KIAD G+A R + ++
Sbjct: 123 AFIEERNYIHRDLRAANILV----SDTLSCKIADFGLA---RLIEDNEYTAREGAKFPIK 175
Query: 181 -TPLYLAPETVVQHMQEAPSDIWALGCVVLEMLS-GRQ 216
T APE + SD+W+ G ++ E+++ GR
Sbjct: 176 WT----APEAINYGTFTIKSDVWSFGILLTEIVTHGRI 209
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 4e-08
Identities = 43/218 (19%), Positives = 88/218 (40%), Gaps = 29/218 (13%)
Query: 11 GRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVSASASLQ----KEKEVFDNLNGCPF 66
+VIG G FG V+ K++S +A+K+ + + + E + +
Sbjct: 49 QKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFS-HHN 107
Query: 67 VLECFG----EEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCIL 122
++ G + M ++ EY G L + + + R I
Sbjct: 108 IIRLEGVISKYKPMM---------IITEYMENGALDKFLRE-KDGEFSVLQLVGMLRGIA 157
Query: 123 EGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMRGTP 182
G+ ++ + YVH D+ NIL+ + V K++D G+++ + + G
Sbjct: 158 AGMKYLANMNYVHRDLAARNILV----NSNLVCKVSDFGLSRVLE--DDPEATYTTSGGK 211
Query: 183 L---YLAPETVVQHMQEAPSDIWALGCVVLEMLS-GRQ 216
+ + APE + + SD+W+ G V+ E+++ G +
Sbjct: 212 IPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGER 249
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 53.4 bits (129), Expect = 4e-08
Identities = 53/246 (21%), Positives = 85/246 (34%), Gaps = 71/246 (28%)
Query: 11 GRVIGQGSFGCVFIAKPKSNSSFLPPLM-AVK----SAEVSASASLQKEKEV---FD--- 59
G+ +G G+FG V A L AVK +A +L E ++
Sbjct: 51 GKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHE 110
Query: 60 ---NLNGCPFVLECFGEEITMGENGEMAYNLLLEYAAGGTL------------GDLIEKC 104
NL G C + ++ EY G L D
Sbjct: 111 NIVNLLGA-----CTHGGPVL---------VITEYCCYGDLLNFLRRKSRVLETDPAFAI 156
Query: 105 NGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAK 164
+ +D+ HF+ + +G+ + +H DV N+LL + VAKI D G+A
Sbjct: 157 ANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLL----TNGHVAKIGDFGLA- 211
Query: 165 RSRHCKRQKFDPSMRGTPLYL------------APETVVQHMQEAPSDIWALGCVVL-EM 211
R + Y+ APE++ + SD+W+ G ++L E+
Sbjct: 212 ------RD-----IMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYG-ILLWEI 259
Query: 212 LS-GRQ 216
S G
Sbjct: 260 FSLGLN 265
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 53.4 bits (129), Expect = 4e-08
Identities = 55/236 (23%), Positives = 95/236 (40%), Gaps = 55/236 (23%)
Query: 11 GRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVSASASLQKE--------KEVFD--- 59
VIG+G+FG V A+ K + + A+K + AS ++ ++
Sbjct: 30 QDVIGEGNFGQVLKARIKKDGLRMD--AAIKRMKEYASKDDHRDFAGELEVLCKLGHHPN 87
Query: 60 --NLNGCPFVLECFGEEITMGENGEMAYNLLLEYAAGGTL--------------GDLIEK 103
NL G C L +EYA G L I
Sbjct: 88 IINLLGA-----CEHRGYLY---------LAIEYAPHGNLLDFLRKSRVLETDPAFAIAN 133
Query: 104 CNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVA 163
+ L + + HF + G+ ++ ++H D+ NIL+ +VAKIAD G++
Sbjct: 134 STASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILV----GENYVAKIADFGLS 189
Query: 164 KRSRHCKRQKFDPSMRGTPL-YLAPETVVQHMQEAPSDIWALGCVVL-EMLS-GRQ 216
R + +K +M P+ ++A E++ + SD+W+ G V+L E++S G
Sbjct: 190 -RGQEVYVKK---TMGRLPVRWMAIESLNYSVYTTNSDVWSYG-VLLWEIVSLGGT 240
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 6e-08
Identities = 67/291 (23%), Positives = 112/291 (38%), Gaps = 58/291 (19%)
Query: 11 GRVIGQGSFGCVFIAKPKSNSSFLPPLM-AVKSAEVSASAS----LQKEKEVFDNLNGCP 65
R IG+G+FG VF A+ + P M AVK + ASA Q+E + + P
Sbjct: 52 VRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFD-NP 110
Query: 66 FVLE----CFGEEITMGENGEMAYNLLLEYAAGGTL----------------------GD 99
+++ C + LL EY A G L
Sbjct: 111 NIVKLLGVCAVGKPMC---------LLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRA 161
Query: 100 LIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIAD 159
+ L + R + G+ ++ + +VH D+ N L+ V KIAD
Sbjct: 162 RVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLV----GENMVVKIAD 217
Query: 160 LGVAKRSRHCKRQKFDPSMRGTPL---YLAPETVVQHMQEAPSDIWALGCVVL-EMLS-G 214
G+ SR+ + + + ++ PE++ + SD+WA G VVL E+ S G
Sbjct: 218 FGL---SRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYG-VVLWEIFSYG 273
Query: 215 RQAWVVKEDCSIDQLFSIIGDEHSLPEIPSRVSKEARDFLRRCFVRKPAFR 265
Q + + +++ + D + L P E + +R C+ + PA R
Sbjct: 274 LQPY---YGMAHEEVIYYVRDGNIL-ACPENCPLELYNLMRLCWSKLPADR 320
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 52.6 bits (127), Expect = 6e-08
Identities = 53/240 (22%), Positives = 87/240 (36%), Gaps = 55/240 (22%)
Query: 11 GRVIGQGSFGCVFIAKPKSNSSFLPPLM-AVK----SAEVSASASLQKEKEV---FD--- 59
G+ +G G+FG V A + AVK SA ++ +L E +V
Sbjct: 28 GKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHM 87
Query: 60 ---NLNGCPFVLECFGEEITMGENGEMAYNLLLEYAAGGTL----------------GDL 100
NL G C T+ ++ EY G L
Sbjct: 88 NIVNLLGA-----CTIGGPTL---------VITEYCCYGDLLNFLRRKRDSFICSKTSPA 133
Query: 101 IEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADL 160
I + + L +D+ F+ + +G+ + +H D+ NILL + + KI D
Sbjct: 134 IMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILL----THGRITKICDF 189
Query: 161 GVAKRSRHCKRQKFDPSMRGTPL---YLAPETVVQHMQEAPSDIWALGCVVLEMLS-GRQ 216
G+A R K L ++APE++ + SD+W+ G + E+ S G
Sbjct: 190 GLA---RDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSS 246
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 7e-08
Identities = 53/246 (21%), Positives = 89/246 (36%), Gaps = 62/246 (25%)
Query: 11 GRVIGQGSFGCVFIAKPKSNSSFLPPLM-AVKSAEVSASASLQKE--------KEVFDNL 61
G+V+G G+FG V A S + AVK + A +S ++ ++ +
Sbjct: 50 GKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHE 109
Query: 62 N-----GCPFVLECFGEEITMGENGEMAYNLLLEYAAGGTL------------------- 97
N G C L+ EY G L
Sbjct: 110 NIVNLLGA-----CTLSGPIY---------LIFEYCCYGDLLNYLRSKREKFSEDEIEYE 155
Query: 98 --GDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVA 155
L E+ + N L +D+ F + +G+ + VH D+ N+L+ + V
Sbjct: 156 NQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLV----THGKVV 211
Query: 156 KIADLGVAKRSRHCKRQKFDPSMRGTPL---YLAPETVVQHMQEAPSDIWALGCVVL-EM 211
KI D G+A R L ++APE++ + + SD+W+ G ++L E+
Sbjct: 212 KICDFGLA---RDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYG-ILLWEI 267
Query: 212 LS-GRQ 216
S G
Sbjct: 268 FSLGVN 273
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 9e-08
Identities = 38/220 (17%), Positives = 87/220 (39%), Gaps = 29/220 (13%)
Query: 11 GRVIGQGSFGCVF--IAKPKSNSSFLPPLM-AVK---SAEVSASASLQKEKEVFDNLNGC 64
+GQG+F +F + + + L +K A + S S + + L+
Sbjct: 13 NESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLS-H 71
Query: 65 PFVLECFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEG 124
++ +G + G+ L+ E+ G+L ++K N N + + +
Sbjct: 72 KHLVLNYG----VCVCGDENI-LVQEFVKFGSLDTYLKK-NKNCINILWKLEVAKQLAAA 125
Query: 125 IGHIHDSGYVHCDVKPDNILLVATQSGKF----VAKIADLGVAKRSRHCKRQKFDPSMRG 180
+ + ++ +H +V NILL+ + K K++D G++ +
Sbjct: 126 MHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGIS-------ITVLPKDILQ 178
Query: 181 TPL-YLAPETVVQHMQE--APSDIWALGCVVLEMLS-GRQ 216
+ ++ PE +++ + +D W+ G + E+ S G +
Sbjct: 179 ERIPWVPPE-CIENPKNLNLATDKWSFGTTLWEICSGGDK 217
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 50.7 bits (122), Expect = 2e-07
Identities = 42/215 (19%), Positives = 82/215 (38%), Gaps = 30/215 (13%)
Query: 11 GRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKS--AEVSASASLQKEKEVFDNLNGCPFVL 68
+G G +G V+ K S + AVK+ + KE V + P ++
Sbjct: 18 KHKLGGGQYGEVYEGVWKKYSLTV----AVKTLKEDTMEVEEFLKEAAVMKEIK-HPNLV 72
Query: 69 E----CFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEG 124
+ C E ++ E+ G L D + +CN + + + I
Sbjct: 73 QLLGVCTREPPFY---------IITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSA 123
Query: 125 IGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMRGT-PL 183
+ ++ ++H D+ N L+ + K+AD G++ R + P+
Sbjct: 124 MEYLEKKNFIHRDLAARNCLV----GENHLVKVADFGLS---RLMTGDTYTAHAGAKFPI 176
Query: 184 -YLAPETVVQHMQEAPSDIWALGCVVLEMLS-GRQ 216
+ APE++ + SD+WA G ++ E+ + G
Sbjct: 177 KWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMS 211
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 51.1 bits (123), Expect = 2e-07
Identities = 48/228 (21%), Positives = 93/228 (40%), Gaps = 51/228 (22%)
Query: 11 GRVIGQGSFGCVF--IAKPKSNSSFLPPLMAVKSAEVSASASLQKE--KEV-----FD-- 59
+V+G G+FG V+ + P+ +P +A+K + S KE E D
Sbjct: 20 IKVLGSGAFGTVYKGLWIPEGEKVKIP--VAIKELREATSPKANKEILDEAYVMASVDNP 77
Query: 60 ---NLNGCPFVLECFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRH 116
L G C + L+ + G L D + + + + + + + +
Sbjct: 78 HVCRLLGI-----CLTSTV-------Q---LITQLMPFGCLLDYVRE-HKDNIGSQYLLN 121
Query: 117 FTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAK------RSRHCK 170
+ I +G+ ++ D VH D+ N+L+ KI D G+AK + H +
Sbjct: 122 WCVQIAKGMNYLEDRRLVHRDLAARNVLV----KTPQHVKITDFGLAKLLGAEEKEYHAE 177
Query: 171 RQKFDPSMRGTPL-YLAPETVVQHMQEAPSDIWALGCVVLEMLS-GRQ 216
K P+ ++A E+++ + SD+W+ G V E+++ G +
Sbjct: 178 GGKV-------PIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSK 218
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 3e-07
Identities = 48/218 (22%), Positives = 91/218 (41%), Gaps = 30/218 (13%)
Query: 11 GRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVSASASLQ----KEKEVFDNLNGCPF 66
+V+G G FG V + K S + A+K+ +V + + E + + P
Sbjct: 50 DKVVGAGEFGEVCSGRLKLPSKKEISV-AIKTLKVGYTEKQRRDFLGEASIMGQFD-HPN 107
Query: 67 VLECFG----EEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCIL 122
++ G + M ++ EY G+L + K + + R I
Sbjct: 108 IIRLEGVVTKSKPVM---------IVTEYMENGSLDSFLRK-HDAQFTVIQLVGMLRGIA 157
Query: 123 EGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMRGTP 182
G+ ++ D GYVH D+ NIL+ + V K++D G+ + + + RG
Sbjct: 158 SGMKYLSDMGYVHRDLAARNILI----NSNLVCKVSDFGLGRVLE--DDPEAAYTTRGGK 211
Query: 183 L---YLAPETVVQHMQEAPSDIWALGCVVLEMLS-GRQ 216
+ + +PE + + SD+W+ G V+ E++S G +
Sbjct: 212 IPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGER 249
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 49.9 bits (120), Expect = 4e-07
Identities = 45/218 (20%), Positives = 89/218 (40%), Gaps = 33/218 (15%)
Query: 11 GRVIGQGSFGCVF--IAKPKSNSSFLPPLMAVKSAEVSASASLQ----KEKEVFDNLNGC 64
GR IG+G FG V I N + +A+K+ + S S++ +E +
Sbjct: 20 GRCIGEGQFGDVHQGIYMSPENPALA---VAIKTCKNCTSDSVREKFLQEALTMRQFD-H 75
Query: 65 PFVLECFG---EEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCI 121
P +++ G E +++E G L ++ L + + +
Sbjct: 76 PHIVKLIGVITENPVW---------IIMELCTLGELRSFLQV-RKYSLDLASLILYAYQL 125
Query: 122 LEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMRGT 181
+ ++ +VH D+ N+L+ S K+ D G SR+ + + + +G
Sbjct: 126 STALAYLESKRFVHRDIAARNVLV----SSNDCVKLGDFG---LSRYMEDSTYYKASKGK 178
Query: 182 -PL-YLAPETVVQHMQEAPSDIWALGCVVLEMLS-GRQ 216
P+ ++APE++ + SD+W G + E+L G +
Sbjct: 179 LPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVK 216
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 51.0 bits (121), Expect = 4e-07
Identities = 64/400 (16%), Positives = 112/400 (28%), Gaps = 119/400 (29%)
Query: 33 FLPPLMA---VKSAEVSASASLQKE--KEVF---DNLNGCPFVLECF---GEEIT---MG 78
F + K + + L KE + D ++G + EE+ +
Sbjct: 25 FEDAFVDNFDCKDVQDMPKSILSKEEIDHIIMSKDAVSGTLRLFWTLLSKQEEMVQKFVE 84
Query: 79 ENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHF--TRCILEGIGHIHDSGYVHC 136
E + Y L+ + + P R + R L + V
Sbjct: 85 EVLRINYKFLMS--------PIKTEQRQ---PSMMTRMYIEQRDRLYNDNQVFAKYNV-S 132
Query: 137 DVKPDNIL---LVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQH 193
++P L L+ + K V LG K +A + + +
Sbjct: 133 RLQPYLKLRQALLELRPAKNVLIDGVLGSGKTW------------------VALDVCLSY 174
Query: 194 MQEA--PSDI-WA-LGCV-----VLEMLSGRQAWVVKEDCSIDQLFSIIGDEHSLPEIPS 244
+ I W L VLEML Q + + D + I
Sbjct: 175 KVQCKMDFKIFWLNLKNCNSPETVLEML---QKLLYQIDPNWTSR------SDHSSNIKL 225
Query: 245 RVSKEARDFLRRCFVRKP------------------AFRFTAEMLL--------D----- 273
R+ + LRR KP AF + ++LL D
Sbjct: 226 RIH-SIQAELRRLLKSKPYENCLLVLLNVQNAKAWNAFNLSCKILLTTRFKQVTDFLSAA 284
Query: 274 -------DPFVKGVDEELSRELEGDYSQGEVTLSNAD----AESCSPECISFIPLEANSS 322
D + + + L Y + D + +P +S I
Sbjct: 285 TTTHISLDHHSMTLTPDEVKSLLLKY----LDCRPQDLPREVLTTNPRRLSIIAESIRDG 340
Query: 323 LSSWGSAQRTNEGSTITVKELSSN---PTVFCRSF--FAI 357
L++W + + N T+ E S N P + + F ++
Sbjct: 341 LATWDNWKHVNCDKLTTIIESSLNVLEPAEYRKMFDRLSV 380
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 49.5 bits (119), Expect = 6e-07
Identities = 57/283 (20%), Positives = 97/283 (34%), Gaps = 50/283 (17%)
Query: 11 GRVIGQGSFGCVFIAKPKSNSSFLPPLM-AVK----SAEVSASASLQKEKEVFDNLNGCP 65
+G+ FG V+ + A+K AE + E + L P
Sbjct: 14 MEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQ-HP 72
Query: 66 FVLECFG----EEITMGENGEMAYNLLLEYAAGGTL--------------GDLIEKCNGN 107
V+ G ++ ++ Y + G L ++ +
Sbjct: 73 NVVCLLGVVTKDQPLS---------MIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKS 123
Query: 108 GLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSR 167
L D H I G+ ++ VH D+ N+L+ K KI+DLG+ R
Sbjct: 124 ALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLV----YDKLNVKISDLGL---FR 176
Query: 168 HCKRQKFDPSMRGTPL---YLAPETVVQHMQEAPSDIWALGCVVL-EMLS-GRQAWVVKE 222
+ + + L ++APE ++ SDIW+ G VVL E+ S G Q +
Sbjct: 177 EVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYG-VVLWEVFSYGLQPY---C 232
Query: 223 DCSIDQLFSIIGDEHSLPEIPSRVSKEARDFLRRCFVRKPAFR 265
S + +I + LP P + C+ P+ R
Sbjct: 233 GYSNQDVVEMIRNRQVLPC-PDDCPAWVYALMIECWNEFPSRR 274
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 49.6 bits (119), Expect = 6e-07
Identities = 42/219 (19%), Positives = 84/219 (38%), Gaps = 32/219 (14%)
Query: 11 GRVIGQGSFGCVF--IAKPKSNSSFLPPLMAVKSAEVSASASLQ----KEKEVFDNLNGC 64
++IG G G V + +A+K+ + + + E + +
Sbjct: 54 EKIIGSGDSGEVCYGRLRVPGQRDVP---VAIKALKAGYTERQRRDFLSEASIMGQFD-H 109
Query: 65 PFVLE----CFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRC 120
P ++ + M ++ EY G+L + + + R
Sbjct: 110 PNIIRLEGVVTRGRLAM---------IVTEYMENGSLDTFLRT-HDGQFTIMQLVGMLRG 159
Query: 121 ILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMRG 180
+ G+ ++ D GYVH D+ N+L+ V K++D G++ R + G
Sbjct: 160 VGAGMRYLSDLGYVHRDLAARNVLV----DSNLVCKVSDFGLS-RVLEDDPDAAYTTTGG 214
Query: 181 T-PL-YLAPETVVQHMQEAPSDIWALGCVVLEMLS-GRQ 216
P+ + APE + + SD+W+ G V+ E+L+ G +
Sbjct: 215 KIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGER 253
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 49.1 bits (118), Expect = 7e-07
Identities = 46/216 (21%), Positives = 84/216 (38%), Gaps = 34/216 (15%)
Query: 11 GRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKS--AEVSASASLQKEKEVFDNLNGCPFVL 68
+ +G G FG V + K K +AVK + +E + L+ P ++
Sbjct: 13 LKELGSGQFGVVKLGKWKGQYD-----VAVKMIKEGSMSEDEFFQEAQTMMKLS-HPKLV 66
Query: 69 E----CFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEG 124
+ C E ++ EY + G L + + +G GL + + EG
Sbjct: 67 KFYGVCSKEYPIY---------IVTEYISNGCLLNYLRS-HGKGLEPSQLLEMCYDVCEG 116
Query: 125 IGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMRGTPL- 183
+ + ++H D+ N L+ K++D G+ R+ ++ S GT
Sbjct: 117 MAFLESHQFIHRDLAARNCLV----DRDLCVKVSDFGMT---RYVLDDQYVSS-VGTKFP 168
Query: 184 --YLAPETVVQHMQEAPSDIWALGCVVLEMLS-GRQ 216
+ APE + SD+WA G ++ E+ S G+
Sbjct: 169 VKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKM 204
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 49.2 bits (118), Expect = 7e-07
Identities = 51/242 (21%), Positives = 92/242 (38%), Gaps = 54/242 (22%)
Query: 11 GRVIGQGSFGCVFIAKPKSNSSFLPPLM-AVK----SAEVSASASLQKEKEVFDNLNGCP 65
G+ +G+G FG V A AVK +A S L E V + P
Sbjct: 28 GKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQV-NHP 86
Query: 66 FVLECFG----EEITMGENGEMAYNLLLEYAAGGTL----------------------GD 99
V++ +G + + L++EYA G+L
Sbjct: 87 HVIKLYGACSQDGPLL---------LIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSS 137
Query: 100 LIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIAD 159
++ + L D+ F I +G+ ++ + VH D+ NIL+ + KI+D
Sbjct: 138 SLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILV----AEGRKMKISD 193
Query: 160 LGVAKRSRHCKRQKFDPSMRGTPL---YLAPETVVQHMQEAPSDIWALGCVVL-EMLS-G 214
G++ R + + ++A E++ H+ SD+W+ G V+L E+++ G
Sbjct: 194 FGLS---RDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFG-VLLWEIVTLG 249
Query: 215 RQ 216
Sbjct: 250 GN 251
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 49.2 bits (118), Expect = 8e-07
Identities = 46/218 (21%), Positives = 89/218 (40%), Gaps = 38/218 (17%)
Query: 11 GRVIGQGSFGCVF--IAKPKSNSSFLPPLMAVKSAEVSASASLQKE--KEV-----FD-- 59
+V+G G FG V + P+ S +P + +K E + + + D
Sbjct: 18 LKVLGSGVFGTVHKGVWIPEGESIKIP--VCIKVIEDKSGRQSFQAVTDHMLAIGSLDHA 75
Query: 60 ---NLNGCPFVLECFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRH 116
L G C G + + + +Y G+L D + + G L + + +
Sbjct: 76 HIVRLLGL-----CPGSSLQL----------VTQYLPLGSLLDHVRQHRGA-LGPQLLLN 119
Query: 117 FTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDP 176
+ I +G+ ++ + G VH ++ N+LL ++AD GVA ++
Sbjct: 120 WGVQIAKGMYYLEEHGMVHRNLAARNVLL----KSPSQVQVADFGVA-DLLPPDDKQLLY 174
Query: 177 SMRGTPL-YLAPETVVQHMQEAPSDIWALGCVVLEMLS 213
S TP+ ++A E++ SD+W+ G V E+++
Sbjct: 175 SEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMT 212
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 1e-06
Identities = 46/225 (20%), Positives = 92/225 (40%), Gaps = 50/225 (22%)
Query: 10 RGRVIGQGSFGCVF--IAKPKSNSSFLPPLMAVKSAEVSASASLQKE--KEV-----FD- 59
+ +V+G G+FG V+ + P+ +P +A+K + S KE E D
Sbjct: 19 KIKVLGSGAFGTVYKGLWIPEGEKVKIP--VAIKELREATSPKANKEILDEAYVMASVDN 76
Query: 60 ----NLNGCPFVLECFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVR 115
L G C + + + + G L D + + + + + + +
Sbjct: 77 PHVCRLLGI-----CLTSTVQL----------ITQLMPFGCLLDYVRE-HKDNIGSQYLL 120
Query: 116 HFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAK------RSRHC 169
++ I +G+ ++ D VH D+ N+L+ KI D G+AK + H
Sbjct: 121 NWCVQIAKGMNYLEDRRLVHRDLAARNVLV----KTPQHVKITDFGLAKLLGAEEKEYHA 176
Query: 170 KRQKFDPSMRGTPL-YLAPETVVQHMQEAPSDIWALGCVVLEMLS 213
+ K P+ ++A E+++ + SD+W+ G V E+++
Sbjct: 177 EGGKV-------PIKWMALESILHRIYTHQSDVWSYGVTVWELMT 214
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 48.4 bits (115), Expect = 2e-06
Identities = 48/226 (21%), Positives = 89/226 (39%), Gaps = 44/226 (19%)
Query: 9 FRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVSASASLQKE--KEV-----FDNL 61
+G G+FG V + + +A+K + + +E +E DN
Sbjct: 339 IADIELGCGNFGSVRQGVYRMRKKQID--VAIKVLKQGTEKADTEEMMREAQIMHQLDNP 396
Query: 62 NGCPFVLECFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCI 121
+ C E + + ++E A GG L + +P +V +
Sbjct: 397 YIVRLIGVCQAEALML----------VMEMAGGGPLHKFLVG-KREEIPVSNVAELLHQV 445
Query: 122 LEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAK---------RSRHCKRQ 172
G+ ++ + +VH ++ N+LLV + AKI+D G++K +R
Sbjct: 446 SMGMKYLEEKNFVHRNLAARNVLLVN----RHYAKISDFGLSKALGADDSYYTARS--AG 499
Query: 173 KFDPSMRGTPL-YLAPETVVQHMQEAPSDIWALGCVVLEMLS-GRQ 216
K+ PL + APE + + SD+W+ G + E LS G++
Sbjct: 500 KW-------PLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQK 538
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 46.8 bits (112), Expect = 4e-06
Identities = 41/215 (19%), Positives = 83/215 (38%), Gaps = 32/215 (14%)
Query: 11 GRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKS--AEVSASASLQKEKEVFDNLNGCPFVL 68
+ IG G FG V + + +A+K+ + +E EV L+ P ++
Sbjct: 13 VQEIGSGQFGLVHLGYWLNKDK-----VAIKTIREGAMSEEDFIEEAEVMMKLS-HPKLV 66
Query: 69 E----CFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEG 124
+ C + L+ E+ G L D + + + + EG
Sbjct: 67 QLYGVCLEQAPIC---------LVTEFMEHGCLSDYLRT-QRGLFAAETLLGMCLDVCEG 116
Query: 125 IGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMRGT-PL 183
+ ++ ++ +H D+ N L+ V K++D G+ R ++ S P+
Sbjct: 117 MAYLEEACVIHRDLAARNCLV----GENQVIKVSDFGMT---RFVLDDQYTSSTGTKFPV 169
Query: 184 -YLAPETVVQHMQEAPSDIWALGCVVLEMLS-GRQ 216
+ +PE + SD+W+ G ++ E+ S G+
Sbjct: 170 KWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKI 204
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 47.2 bits (112), Expect = 4e-06
Identities = 28/111 (25%), Positives = 50/111 (45%), Gaps = 10/111 (9%)
Query: 106 GNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKR 165
+ L + + ++ + +G+ + +H D+ NILL S K V KI D G+A
Sbjct: 187 KDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILL----SEKNVVKICDFGLA-- 240
Query: 166 SRHCKRQKFDPSMRGTPL---YLAPETVVQHMQEAPSDIWALGCVVLEMLS 213
R + L ++APET+ + SD+W+ G ++ E+ S
Sbjct: 241 -RDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 290
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 41.1 bits (96), Expect = 4e-04
Identities = 24/132 (18%), Positives = 45/132 (34%), Gaps = 9/132 (6%)
Query: 11 GRVIGQGSFGCVFIAKPK-----SNSSFLPPLMAVKSAEVSASASLQKEKEVFDNLNGCP 65
G+ +G+G+FG V A + + M + A S +L E ++ ++
Sbjct: 27 GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 86
Query: 66 FVLECFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGI 125
V+ G G +++E+ G L + +P K R + +
Sbjct: 87 NVVNLLGACTKPGG----PLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYV 142
Query: 126 GHIHDSGYVHCD 137
G I D
Sbjct: 143 GAIPVDLKRRLD 154
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 46.4 bits (111), Expect = 5e-06
Identities = 48/216 (22%), Positives = 96/216 (44%), Gaps = 29/216 (13%)
Query: 11 GRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVSASASLQ----KEKEVFDNLNGCPF 66
R++G+G FG V+ ++ + AVK+ + + + E + NL+ P
Sbjct: 17 NRILGEGFFGEVYEGVYTNHKGEKINV-AVKTCKKDCTLDNKEKFMSEAVIMKNLD-HPH 74
Query: 67 VLECFG---EEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILE 123
+++ G EE T +++E G LG +E+ N N L + ++ I +
Sbjct: 75 IVKLIGIIEEEPTW---------IIMELYPYGELGHYLER-NKNSLKVLTLVLYSLQICK 124
Query: 124 GIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMRGT-P 182
+ ++ VH D+ NIL+ + K+ D G+ SR+ + + + + P
Sbjct: 125 AMAYLESINCVHRDIAVRNILV----ASPECVKLGDFGL---SRYIEDEDYYKASVTRLP 177
Query: 183 L-YLAPETVVQHMQEAPSDIWALGCVVLEMLS-GRQ 216
+ +++PE++ SD+W + E+LS G+Q
Sbjct: 178 IKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQ 213
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 46.5 bits (111), Expect = 5e-06
Identities = 45/226 (19%), Positives = 90/226 (39%), Gaps = 44/226 (19%)
Query: 9 FRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVSASASLQKEKEVFDNLNGCPFVL 68
+ +G G+FG V + +AVK + A+ K++
Sbjct: 20 LEDKELGSGNFGTVKKGYYQMKKVVKT--VAVKILKNEANDPALKDE------------- 64
Query: 69 ECFGEEI-TMGE-------------NGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDV 114
E M + E L++E A G L +++ + +K++
Sbjct: 65 --LLAEANVMQQLDNPYIVRMIGICEAESWM-LVMEMAELGPLNKYLQQ--NRHVKDKNI 119
Query: 115 RHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKF 174
+ G+ ++ +S +VH D+ N+LL + AKI+D G++K R + +
Sbjct: 120 IELVHQVSMGMKYLEESNFVHRDLAARNVLL----VTQHYAKISDFGLSKALR--ADENY 173
Query: 175 DPSMRGT--PL-YLAPETVVQHMQEAPSDIWALGCVVLEMLS-GRQ 216
+ P+ + APE + + + SD+W+ G ++ E S G++
Sbjct: 174 YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQK 219
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 45.7 bits (109), Expect = 9e-06
Identities = 48/221 (21%), Positives = 88/221 (39%), Gaps = 44/221 (19%)
Query: 14 IGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVSASASLQKE--KEV-----FDNLNGCPF 66
+G G+FG V + + +A+K + + +E +E DN
Sbjct: 18 LGCGNFGSVRQGVYRMRKKQID--VAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRL 75
Query: 67 VLECFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIG 126
+ C E + + ++E A GG L + +P +V + G+
Sbjct: 76 IGVCQAEALML----------VMEMAGGGPLHKFLVG-KREEIPVSNVAELLHQVSMGMK 124
Query: 127 HIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAK---------RSRHCKRQKFDPS 177
++ + +VH D+ N+LL + AKI+D G++K +R K+
Sbjct: 125 YLEEKNFVHRDLAARNVLL----VNRHYAKISDFGLSKALGADDSYYTARS--AGKW--- 175
Query: 178 MRGTPL-YLAPETVVQHMQEAPSDIWALGCVVLEMLS-GRQ 216
PL + APE + + SD+W+ G + E LS G++
Sbjct: 176 ----PLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQK 212
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 45.3 bits (108), Expect = 1e-05
Identities = 41/215 (19%), Positives = 90/215 (41%), Gaps = 32/215 (14%)
Query: 11 GRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKS--AEVSASASLQKEKEVFDNLNGCPFVL 68
+ +G G FG V K + +A+K + +E +V NL+ ++
Sbjct: 29 LKELGTGQFGVVKYGKWRGQYD-----VAIKMIKEGSMSEDEFIEEAKVMMNLS-HEKLV 82
Query: 69 E----CFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEG 124
+ C + ++ EY A G L + + + + + + + + E
Sbjct: 83 QLYGVCTKQRPIF---------IITEYMANGCLLNYL-REMRHRFQTQQLLEMCKDVCEA 132
Query: 125 IGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMRGT-PL 183
+ ++ ++H D+ N L+ + + V K++D G++ R+ ++ S+ P+
Sbjct: 133 MEYLESKQFLHRDLAARNCLV----NDQGVVKVSDFGLS---RYVLDDEYTSSVGSKFPV 185
Query: 184 -YLAPETVVQHMQEAPSDIWALGCVVLEMLS-GRQ 216
+ PE ++ + SDIWA G ++ E+ S G+
Sbjct: 186 RWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKM 220
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 42.6 bits (99), Expect = 1e-04
Identities = 27/185 (14%), Positives = 46/185 (24%), Gaps = 42/185 (22%)
Query: 14 IGQGSFGCVFIAK-----------PKSNSSFLPPLMAVKSAEVSASASLQKEKEV--FDN 60
IG+G FG VF + E+ + KE + +
Sbjct: 28 IGEGVFGEVFQTIADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEV 87
Query: 61 LNGCPFVLECFGEEITMGENGE------MAYN-------------------LLLEYAAGG 95
N + G YN ++LE+ GG
Sbjct: 88 CNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGG 147
Query: 96 TLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDS-GYVHCDVKPDNILLVATQSGKFV 154
+E+ + + + S + H D+ N+LL T K
Sbjct: 148 I---DLEQMRTKLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLLKKTSLKKLH 204
Query: 155 AKIAD 159
+
Sbjct: 205 YTLNG 209
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 41.8 bits (99), Expect = 2e-04
Identities = 44/226 (19%), Positives = 81/226 (35%), Gaps = 39/226 (17%)
Query: 10 RGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVSASASLQKEKEVFDNLNGCPFVLE 69
+G GSFG V + + S + AVK + + + +
Sbjct: 22 LLEKLGDGSFGVVRRGEWDAPSGKTVSV-AVKCLKPDVLSQPEAMDD------------- 67
Query: 70 CFGEEI-TMGE-------------NGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVR 115
F E+ M ++ E A G+L D + K + +
Sbjct: 68 -FIREVNAMHSLDHRNLIRLYGVVLTPPMK-MVTELAPLGSLLDRLRK-HQGHFLLGTLS 124
Query: 116 HFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFD 175
+ + EG+G++ ++H D+ N+LL + + + KI D G+ R+ +
Sbjct: 125 RYAVQVAEGMGYLESKRFIHRDLAARNLLL----ATRDLVKIGDFGLM-RALPQNDDHYV 179
Query: 176 PSMRG-TPL-YLAPETVVQHMQEAPSDIWALGCVVLEMLS-GRQAW 218
P + APE++ SD W G + EM + G++ W
Sbjct: 180 MQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPW 225
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 362 | |||
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 100.0 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.95 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.92 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.86 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.74 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.39 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.2 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 99.18 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.05 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.79 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.61 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.52 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.29 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.24 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.1 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.94 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 97.88 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 97.82 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.52 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.35 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.33 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.32 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.22 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.19 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.9 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 96.84 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 96.71 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.48 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.33 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.41 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 93.1 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 92.13 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 89.34 |
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-66 Score=464.28 Aligned_cols=259 Identities=27% Similarity=0.455 Sum_probs=222.4
Q ss_pred CceeecceecccCceEEEEEEECCCCCCCCceeeeechhh------hhhHHHHHHHHHHHHcCCCCcccccccceeeecC
Q 039291 6 TSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEV------SASASLQKEKEVFDNLNGCPFVLECFGEEITMGE 79 (362)
Q Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~------~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~ 79 (362)
++|.+++.||+|+||+||+|+++.+++ .||+|.+.. ...+.+.+|+++|++|+ ||||+++++++..
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~----~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~-HpnIv~l~~~~~~--- 103 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSR----EYAIKILEKRHIIKENKVPYVTRERDVMSRLD-HPFFVKLYFTFQD--- 103 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCC----EEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCC-CTTBCCEEEEEEC---
T ss_pred cccEEEEEEecccCeEEEEEEECCCCC----EEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCC-CCCCCeEEEEEEe---
Confidence 469999999999999999999999886 456665432 24467899999999998 9999999997642
Q ss_pred CCceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEee
Q 039291 80 NGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIAD 159 (362)
Q Consensus 80 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~D 159 (362)
...+|+|||||+||+|.+++++. +.+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|
T Consensus 104 --~~~~yivmEy~~gG~L~~~i~~~--~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl----~~~g~vKl~D 175 (311)
T 4aw0_A 104 --DEKLYFGLSYAKNGELLKYIRKI--GSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILL----NEDMHIQITD 175 (311)
T ss_dssp --SSEEEEEECCCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE----CTTSCEEECC
T ss_pred --CCEEEEEEecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEE----cCCCCEEEEE
Confidence 33578999999999999999874 459999999999999999999999999999999999999 8888999999
Q ss_pred cCCcccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHHcCCCCC
Q 039291 160 LGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEHSL 239 (362)
Q Consensus 160 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 239 (362)
||+|+............+.+||+.|||||++.+..|+.++|||||||+||+|++|++||.+. +..+++..+....
T Consensus 176 FGla~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~---~~~~~~~~i~~~~-- 250 (311)
T 4aw0_A 176 FGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAG---NEGLIFAKIIKLE-- 250 (311)
T ss_dssp CTTCEECCTTTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCS---SHHHHHHHHHHTC--
T ss_pred cCCceecCCCCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC---CHHHHHHHHHcCC--
Confidence 99998765444444446789999999999999999999999999999999999999999654 4556665554433
Q ss_pred CCCCccCCHHHHHHHHHHhccCCCCCCCHHH------HhcCCCccCcchhhh
Q 039291 240 PEIPSRVSKEARDFLRRCFVRKPAFRFTAEM------LLDDPFVKGVDEELS 285 (362)
Q Consensus 240 ~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~------~l~~p~~~~~~~~~~ 285 (362)
..+|..+++++++||.+||+.||++|+|++| +++||||++++|+..
T Consensus 251 ~~~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~~~~~i~~Hp~F~~idw~~l 302 (311)
T 4aw0_A 251 YDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENL 302 (311)
T ss_dssp CCCCTTCCHHHHHHHHHHSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCCTTG
T ss_pred CCCCcccCHHHHHHHHHHccCCHhHCcChHHHcCCHHHHCCCCcCCCCHHHh
Confidence 2467789999999999999999999999987 589999999988643
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-65 Score=464.64 Aligned_cols=255 Identities=25% Similarity=0.420 Sum_probs=212.8
Q ss_pred CceeecceecccCceEEEEEEECCCCCCCCceeeeechh-----hhhhHHHHHHHHHHHHcCCCCcccccccceeeecCC
Q 039291 6 TSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAE-----VSASASLQKEKEVFDNLNGCPFVLECFGEEITMGEN 80 (362)
Q Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~-----~~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~ 80 (362)
++|.+++.||+|+||+||+|+++.+++ .||+|.+. ....+.+.+|+++|++|+ |||||++++++..
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~----~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~-HpnIV~~~~~~~~---- 94 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGR----QYVIKEINISRMSSKEREESRREVAVLANMK-HPNIVQYRESFEE---- 94 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCC----EEEEEEEECTTSCHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEEE----
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCC----EEEEEEEehHHCCHHHHHHHHHHHHHHHHCC-CCCCCcEEEEEEE----
Confidence 589999999999999999999999886 45665542 234567899999999998 9999999997753
Q ss_pred CceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEeec
Q 039291 81 GEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADL 160 (362)
Q Consensus 81 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Df 160 (362)
...+|||||||+||+|.++|....+..+++..++.|+.||+.||+|||++|||||||||+|||+ +.++.+||+||
T Consensus 95 -~~~~yiVmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl----~~~g~vKl~DF 169 (350)
T 4b9d_A 95 -NGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFL----TKDGTVQLGDF 169 (350)
T ss_dssp -TTEEEEEEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEE----CTTCCEEECST
T ss_pred -CCEEEEEEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEE----CCCCCEEEccc
Confidence 2347899999999999999987666678999999999999999999999999999999999999 78889999999
Q ss_pred CCcccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHHcCCCCCC
Q 039291 161 GVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEHSLP 240 (362)
Q Consensus 161 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 240 (362)
|+|+....... .....+||+.|||||++.+..|+.++|||||||+||||++|++||.+. +..+++..+.... .+
T Consensus 170 Gla~~~~~~~~--~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~---~~~~~~~~i~~~~-~~ 243 (350)
T 4b9d_A 170 GIARVLNSTVE--LARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAG---SMKNLVLKIISGS-FP 243 (350)
T ss_dssp TEESCCCHHHH--HHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCS---SHHHHHHHHHHTC-CC
T ss_pred ccceeecCCcc--cccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc---CHHHHHHHHHcCC-CC
Confidence 99986543211 123568999999999999999999999999999999999999999654 4555555554443 34
Q ss_pred CCCccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCccCc
Q 039291 241 EIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGV 280 (362)
Q Consensus 241 ~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~~~~ 280 (362)
.++..+|+++++||.+||+.||++|||++++++||||++.
T Consensus 244 ~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~~ 283 (350)
T 4b9d_A 244 PVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEKGFIAKR 283 (350)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHTT
T ss_pred CCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCHHhhcC
Confidence 5677899999999999999999999999999999999753
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-63 Score=444.09 Aligned_cols=256 Identities=23% Similarity=0.369 Sum_probs=215.6
Q ss_pred CCce-eecceecccCceEEEEEEECCCCCCCCceeeeechh-----hhhhHHHHHHHHHHHHcCCCCcccccccceeeec
Q 039291 5 GTSW-FRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAE-----VSASASLQKEKEVFDNLNGCPFVLECFGEEITMG 78 (362)
Q Consensus 5 ~~~y-~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~-----~~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~ 78 (362)
++|| .+.+.||+|+||+||+|+++.++. .||+|.+. ......+.+|+++|++|+ |||||++++++....
T Consensus 24 ~gr~~~~~~~iG~G~fg~Vy~a~~~~~~~----~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~-HpnIV~~~~~~~~~~ 98 (290)
T 3fpq_A 24 DGRFLKFDIEIGRGSFKTVYKGLDTETTV----EVAWCELQDRKLTKSERQRFKEEAEMLKGLQ-HPNIVRFYDSWESTV 98 (290)
T ss_dssp TSSEEEEEEEEEECSSEEEEEEEETTTCC----EEEEEEEEGGGSCHHHHHHHHHHHHHHHTCC-CTTBCCEEEEEEEEE
T ss_pred CCceEEeeeEEecCcCcEEEEEEECCCCe----EEEEEEEchhhCCHHHHHHHHHHHHHHHhCC-CCCCCcEEEEEeecc
Confidence 4566 678899999999999999998876 45555442 334567899999999998 999999999775433
Q ss_pred CCCceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--ceeCCCCCCCEEEeecCC-CceEE
Q 039291 79 ENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSG--YVHCDVKPDNILLVATQS-GKFVA 155 (362)
Q Consensus 79 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~--ivH~Dlkp~Nill~~~~~-~~~~~ 155 (362)
.....+|||||||+||+|.+++.+. +++++..++.|+.||+.||+|||++| ||||||||+|||+ + .++.+
T Consensus 99 -~~~~~~~lvmEy~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl----~~~~g~v 171 (290)
T 3fpq_A 99 -KGKKCIVLVTELMTSGTLKTYLKRF--KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFI----TGPTGSV 171 (290)
T ss_dssp -TTEEEEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEE----SSTTSCE
T ss_pred -CCCcEEEEEEeCCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeE----ECCCCCE
Confidence 3345678999999999999999873 45999999999999999999999998 9999999999999 5 36789
Q ss_pred EEeecCCcccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHHcC
Q 039291 156 KIADLGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGD 235 (362)
Q Consensus 156 kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~ 235 (362)
||+|||+|+.... ....+.+||+.|||||++.+ .|+.++|||||||+||||++|++||... .....+...+..
T Consensus 172 Kl~DFGla~~~~~----~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~--~~~~~~~~~i~~ 244 (290)
T 3fpq_A 172 KIGDLGLATLKRA----SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSEC--QNAAQIYRRVTS 244 (290)
T ss_dssp EECCTTGGGGCCT----TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTC--SSHHHHHHHHTT
T ss_pred EEEeCcCCEeCCC----CccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCC--CcHHHHHHHHHc
Confidence 9999999975432 22346789999999998865 5999999999999999999999999643 356677777776
Q ss_pred CCCCCCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCccC
Q 039291 236 EHSLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKG 279 (362)
Q Consensus 236 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~~~ 279 (362)
....+.++..+++++++||.+||..||++|||++++++||||++
T Consensus 245 ~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~Hp~~~~ 288 (290)
T 3fpq_A 245 GVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE 288 (290)
T ss_dssp TCCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred CCCCCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccC
Confidence 66555667778999999999999999999999999999999975
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-63 Score=454.34 Aligned_cols=253 Identities=28% Similarity=0.430 Sum_probs=215.4
Q ss_pred CceeecceecccCceEEEEEEECCCCCCCCceeeeechh---hhhhHHHHHHHHHHHHcCCCCcccccccceeeecCCCc
Q 039291 6 TSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAE---VSASASLQKEKEVFDNLNGCPFVLECFGEEITMGENGE 82 (362)
Q Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~---~~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~~~ 82 (362)
..|.+.+.||+|+||+||+|+++.+++ .||+|.+. ....+.+.+|+.+|+.|+ |||||++++++.. .
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~----~vAiK~i~~~~~~~~~~~~~Ei~il~~l~-HpnIV~l~~~~~~-----~ 143 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGK----LVAVKKMDLRKQQRRELLFNEVVIMRDYQ-HENVVEMYNSYLV-----G 143 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCC----EEEEEEEEGGGCSSGGGGHHHHHHHHHCC-CTTBCCEEEEEEE-----T
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCC----EEEEEEEecCchhHHHHHHHHHHHHHhCC-CCCCCcEEEEEEE-----C
Confidence 469999999999999999999999886 55666543 234556889999999998 9999999998754 2
Q ss_pred eEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEeecCC
Q 039291 83 MAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGV 162 (362)
Q Consensus 83 ~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Dfgl 162 (362)
..+|||||||+||+|.+++.. +++++..++.|+.||+.||+|||++|||||||||+|||+ +.++.+||+|||+
T Consensus 144 ~~~~ivmEy~~gg~L~~~l~~---~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl----~~~g~vKl~DFGl 216 (346)
T 4fih_A 144 DELWVVMEFLEGGALTDIVTH---TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILL----THDGRVKLSDFGF 216 (346)
T ss_dssp TEEEEEECCCTTEEHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE----CTTCCEEECCCTT
T ss_pred CEEEEEEeCCCCCcHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEE----CCCCCEEEecCcC
Confidence 347899999999999999976 359999999999999999999999999999999999999 8888999999999
Q ss_pred cccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHHcCC-CCCCC
Q 039291 163 AKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDE-HSLPE 241 (362)
Q Consensus 163 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~-~~~~~ 241 (362)
|+...... ......+||+.|||||++.+..|+.++|||||||++|||++|++||.+. +..+++..+... .....
T Consensus 217 a~~~~~~~--~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~---~~~~~~~~i~~~~~~~~~ 291 (346)
T 4fih_A 217 CAQVSKEV--PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNE---PPLKAMKMIRDNLPPRLK 291 (346)
T ss_dssp CEECCSSS--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTS---CHHHHHHHHHHSSCCCCS
T ss_pred ceecCCCC--CcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc---CHHHHHHHHHcCCCCCCC
Confidence 98665422 2235688999999999999999999999999999999999999999654 445555554433 22233
Q ss_pred CCccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCccCc
Q 039291 242 IPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGV 280 (362)
Q Consensus 242 ~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~~~~ 280 (362)
.+..+++++++||.+||..||++|||++|+++||||++.
T Consensus 292 ~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~Hp~~~~~ 330 (346)
T 4fih_A 292 NLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKA 330 (346)
T ss_dssp CGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGC
T ss_pred ccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhcCC
Confidence 456799999999999999999999999999999999764
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-63 Score=448.02 Aligned_cols=260 Identities=30% Similarity=0.434 Sum_probs=211.3
Q ss_pred CCceeecceecccCceEEEEEEECCCCCCCCceeeeechhh-----hhhHHHHHHHHHHHHcCCCCcccccccceeeecC
Q 039291 5 GTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEV-----SASASLQKEKEVFDNLNGCPFVLECFGEEITMGE 79 (362)
Q Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~-----~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~ 79 (362)
-++|.+++.||+|+||+||+|++..++ .....||+|.+.. .....+.+|+++|++|+ ||||+++++++..
T Consensus 23 p~~Y~i~~~lG~G~fg~Vy~a~~~~~~-~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~-HpnIv~l~~~~~~--- 97 (304)
T 3ubd_A 23 PSQFELLKVLGQGSFGKVFLVKKISGS-DARQLYAMKVLKKATLKVRDRVRTKMERDILVEVN-HPFIVKLHYAFQT--- 97 (304)
T ss_dssp GGGEEEEEEEECGGGCEEEEEEECSST-TTTCEEEEEEEESEEEEEEECC------CCCCCCC-CTTEECEEEEEEE---
T ss_pred ccccEEEEEEecCCCeEEEEEEEccCC-CCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCC-CCCCCeEEEEEEE---
Confidence 368999999999999999999985422 1124567776532 23346889999999998 9999999997753
Q ss_pred CCceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEee
Q 039291 80 NGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIAD 159 (362)
Q Consensus 80 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~D 159 (362)
...+|+|||||+||+|.+++.+. +.+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|
T Consensus 98 --~~~~~ivmEy~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl----~~~g~vKl~D 169 (304)
T 3ubd_A 98 --EGKLYLILDFLRGGDLFTRLSKE--VMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILL----DEEGHIKLTD 169 (304)
T ss_dssp --TTEEEEEECCCTTCEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEE----CTTSCEEEES
T ss_pred --CCEEEEEEEcCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEE----cCCCCEEecc
Confidence 23578999999999999999873 459999999999999999999999999999999999999 8888999999
Q ss_pred cCCcccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHHcCCCCC
Q 039291 160 LGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEHSL 239 (362)
Q Consensus 160 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 239 (362)
||+|+..... .....+.+||+.|||||++.+..|+.++|||||||+||||++|++||.+. +..+++..+....
T Consensus 170 FGla~~~~~~--~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~---~~~~~~~~i~~~~-- 242 (304)
T 3ubd_A 170 FGLSKESIDH--EKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGK---DRKETMTMILKAK-- 242 (304)
T ss_dssp SEEEEC-------CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCS---SHHHHHHHHHHCC--
T ss_pred cccceeccCC--CccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCc---CHHHHHHHHHcCC--
Confidence 9999865432 22334678999999999999999999999999999999999999999654 4555555554332
Q ss_pred CCCCccCCHHHHHHHHHHhccCCCCCCC-----HHHHhcCCCccCcchhh
Q 039291 240 PEIPSRVSKEARDFLRRCFVRKPAFRFT-----AEMLLDDPFVKGVDEEL 284 (362)
Q Consensus 240 ~~~~~~~~~~~~~li~~~l~~~p~~R~s-----~~~~l~~p~~~~~~~~~ 284 (362)
+.+|..+|+++++||.+||+.||++||| ++++++||||+.++|+.
T Consensus 243 ~~~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~Hp~f~~idw~~ 292 (304)
T 3ubd_A 243 LGMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFSTIDWNK 292 (304)
T ss_dssp CCCCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTSGGGTTCCHHH
T ss_pred CCCCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcCccccCCCHHH
Confidence 3467789999999999999999999998 47999999999998764
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-63 Score=438.33 Aligned_cols=249 Identities=25% Similarity=0.433 Sum_probs=199.5
Q ss_pred CceeecceecccCceEEEEEEECCCCCCCCceeeeechh------hhhhHHHHHHHHHHHHcCCCCcccccccceeeecC
Q 039291 6 TSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAE------VSASASLQKEKEVFDNLNGCPFVLECFGEEITMGE 79 (362)
Q Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~------~~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~ 79 (362)
++|.+++.||+|+||+||+|+++.+++ .||+|.+. ......+.+|+.+|++++ ||||+++++++..
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~----~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~~~~~~~~--- 84 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQ----KVALKIINKKVLAKSDMQGRIEREISYLRLLR-HPHIIKLYDVIKS--- 84 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCC----EEEEEEEECC------CHHHHHHHHHHHHHCC-CTTBCCEEEEEEC---
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCC----EEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCC-CCCCCeEEEEEEE---
Confidence 579999999999999999999998886 45555542 223456889999999998 9999999997642
Q ss_pred CCceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEee
Q 039291 80 NGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIAD 159 (362)
Q Consensus 80 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~D 159 (362)
...+|+||||| +|+|.+++.. .+++++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|
T Consensus 85 --~~~~~ivmEy~-~g~L~~~l~~--~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl----~~~~~vkl~D 155 (275)
T 3hyh_A 85 --KDEIIMVIEYA-GNELFDYIVQ--RDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLL----DEHLNVKIAD 155 (275)
T ss_dssp --SSEEEEEEECC-CEEHHHHHHH--SCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEE----CTTCCEEECC
T ss_pred --CCEEEEEEeCC-CCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEE----CCCCCEEEee
Confidence 33578999999 6799999987 4569999999999999999999999999999999999999 7888999999
Q ss_pred cCCcccccccccCCCCCCccCCCCccCchhhccccC-CCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHHcCCCC
Q 039291 160 LGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQ-EAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEHS 238 (362)
Q Consensus 160 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 238 (362)
||+|+..... ....+.+||+.|||||++.+..+ +.++||||+||++|+|++|++||.+. +..+++..+....
T Consensus 156 FGla~~~~~~---~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~---~~~~~~~~i~~~~- 228 (275)
T 3hyh_A 156 FGLSNIMTDG---NFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDE---SIPVLFKNISNGV- 228 (275)
T ss_dssp SSCC------------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCS---SHHHHHHHHHHTC-
T ss_pred cCCCeecCCC---CccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCC---CHHHHHHHHHcCC-
Confidence 9999765432 22246789999999999998876 57999999999999999999999543 4566666654433
Q ss_pred CCCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCccC
Q 039291 239 LPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKG 279 (362)
Q Consensus 239 ~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~~~ 279 (362)
+.+|..+|+++++||.+||+.||++|||++++++||||+.
T Consensus 229 -~~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~hpw~k~ 268 (275)
T 3hyh_A 229 -YTLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQDDWFKV 268 (275)
T ss_dssp -CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHCHHHHT
T ss_pred -CCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHcCccccc
Confidence 3467789999999999999999999999999999999964
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-62 Score=456.54 Aligned_cols=253 Identities=28% Similarity=0.429 Sum_probs=215.8
Q ss_pred CceeecceecccCceEEEEEEECCCCCCCCceeeeechh---hhhhHHHHHHHHHHHHcCCCCcccccccceeeecCCCc
Q 039291 6 TSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAE---VSASASLQKEKEVFDNLNGCPFVLECFGEEITMGENGE 82 (362)
Q Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~---~~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~~~ 82 (362)
+.|.+++.||+|+||+||+|+++.+++ .||+|.+. ....+.+.+|+.+|+.|+ |||||++++++.. .
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~----~vAiK~i~~~~~~~~~~~~~Ei~il~~l~-HpnIV~l~~~~~~-----~ 220 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGK----LVAVKKMDLRKQQRRELLFNEVVIMRDYQ-HENVVEMYNSYLV-----G 220 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCC----EEEEEEEESTTCSSGGGHHHHHHHHHHCC-CTTBCCEEEEEEE-----T
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCC----EEEEEEEeccchhHHHHHHHHHHHHHhCC-CCCCCceEEEEEE-----C
Confidence 569999999999999999999999886 55666543 234566889999999998 9999999998754 2
Q ss_pred eEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEeecCC
Q 039291 83 MAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGV 162 (362)
Q Consensus 83 ~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Dfgl 162 (362)
..+|||||||+||+|.++++. +++++..++.|+.||+.||+|||++|||||||||+|||+ +.++.+||+|||+
T Consensus 221 ~~~~iVmEy~~gG~L~~~i~~---~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl----~~~g~vKl~DFGl 293 (423)
T 4fie_A 221 DELWVVMEFLEGGALTDIVTH---TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILL----THDGRVKLSDFGF 293 (423)
T ss_dssp TEEEEEEECCTTEEHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEE----CTTCCEEECCCTT
T ss_pred CEEEEEEeCCCCCcHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEE----cCCCCEEEecCcc
Confidence 347899999999999999975 349999999999999999999999999999999999999 8888999999999
Q ss_pred cccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHHcCCC-CCCC
Q 039291 163 AKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEH-SLPE 241 (362)
Q Consensus 163 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~-~~~~ 241 (362)
|+...... ......+||+.|||||++.+..|+.++|||||||++|||++|++||.+. +..+++..+.... ....
T Consensus 294 a~~~~~~~--~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~---~~~~~~~~i~~~~~~~~~ 368 (423)
T 4fie_A 294 CAQVSKEV--PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNE---PPLKAMKMIRDNLPPRLK 368 (423)
T ss_dssp CEECCSSC--CCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTS---CHHHHHHHHHHSCCCCCS
T ss_pred ceECCCCC--ccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc---CHHHHHHHHHcCCCCCCc
Confidence 98665422 2235789999999999999999999999999999999999999999654 4445555544332 2233
Q ss_pred CCccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCccCc
Q 039291 242 IPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGV 280 (362)
Q Consensus 242 ~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~~~~ 280 (362)
.+..+++++++||.+||..||++|||++|+|+||||++.
T Consensus 369 ~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~Hp~~~~~ 407 (423)
T 4fie_A 369 NLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKA 407 (423)
T ss_dssp CTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGC
T ss_pred ccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHHhcCC
Confidence 456799999999999999999999999999999999764
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-61 Score=440.60 Aligned_cols=256 Identities=27% Similarity=0.373 Sum_probs=209.6
Q ss_pred CceeecceecccCceEEEEEEECCCCCCCCceeeeechhhhhhHHHHHHHHHHHHcCCCCcccccccceeeecCCCceEE
Q 039291 6 TSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVSASASLQKEKEVFDNLNGCPFVLECFGEEITMGENGEMAY 85 (362)
Q Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~~~~~~ 85 (362)
+.|.+.+.||+|+||+||+|+++.+++ .||+|.+..+.. ..+|+.+|+.|+ |||||++++++.. ...+
T Consensus 58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~----~vAiK~i~~~~~--~~~E~~il~~l~-HpnIV~l~~~~~~-----~~~~ 125 (336)
T 4g3f_A 58 HWMTHQPRVGRGSFGEVHRMKDKQTGF----QCAVKKVRLEVF--RVEELVACAGLS-SPRIVPLYGAVRE-----GPWV 125 (336)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCC----EEEEEEEETTTC--CTHHHHTTTTCC-CTTBCCEEEEEEE-----TTEE
T ss_pred hheEeCcEeccCCCeEEEEEEECCCCC----EEEEEEECHHHh--HHHHHHHHHhCC-CCCCCcEEEEEEE-----CCEE
Confidence 568889999999999999999999875 678887654322 357999999998 9999999997653 2357
Q ss_pred EEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCce-EEEEeecCCcc
Q 039291 86 NLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKF-VAKIADLGVAK 164 (362)
Q Consensus 86 ~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~-~~kl~Dfgla~ 164 (362)
|||||||+||+|.++++.. +++++..++.|+.||+.||+|||++|||||||||+|||+ +.++ .+||+|||+|+
T Consensus 126 ~ivmEy~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl----~~~g~~vKl~DFGla~ 199 (336)
T 4g3f_A 126 NIFMELLEGGSLGQLIKQM--GCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLL----SSDGSRAALCDFGHAL 199 (336)
T ss_dssp EEEECCCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEE----CTTSCCEEECCCTTCE
T ss_pred EEEEeccCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEE----eCCCCEEEEeeCCCCe
Confidence 8999999999999999874 459999999999999999999999999999999999999 6665 59999999998
Q ss_pred cccccccC---CCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHHcCCCCCCC
Q 039291 165 RSRHCKRQ---KFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEHSLPE 241 (362)
Q Consensus 165 ~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 241 (362)
........ ......+||+.|||||++.+..|+.++|||||||+||||++|++||.......... ...........
T Consensus 200 ~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~--~i~~~~~~~~~ 277 (336)
T 4g3f_A 200 CLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCL--KIASEPPPIRE 277 (336)
T ss_dssp EC------------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHH--HHHHSCCGGGG
T ss_pred EccCCCcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHH--HHHcCCCCchh
Confidence 65432211 12234689999999999999999999999999999999999999997654433222 22223333445
Q ss_pred CCccCCHHHHHHHHHHhccCCCCCCCHHHH-------------hcCCCccCcc
Q 039291 242 IPSRVSKEARDFLRRCFVRKPAFRFTAEML-------------LDDPFVKGVD 281 (362)
Q Consensus 242 ~~~~~~~~~~~li~~~l~~~p~~R~s~~~~-------------l~~p~~~~~~ 281 (362)
++..+++++++||.+||+.||++|||+.|+ ++|||+.+..
T Consensus 278 ~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw~~~~~ 330 (336)
T 4g3f_A 278 IPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPWKGEYK 330 (336)
T ss_dssp SCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCSSSSCC
T ss_pred cCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCCCcCCCC
Confidence 778899999999999999999999999997 5788887653
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-59 Score=438.84 Aligned_cols=266 Identities=23% Similarity=0.351 Sum_probs=212.0
Q ss_pred CCceeecceecccCceEEEEEEECCCCCCCCceeeeechhh-----hhhHHHHHHHHHHHHcCCCCcccccccceeeec-
Q 039291 5 GTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEV-----SASASLQKEKEVFDNLNGCPFVLECFGEEITMG- 78 (362)
Q Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~-----~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~- 78 (362)
+++|.+++.||+|+||+||+|+++.+++ .||+|.+.. .....+.+|+++|+.|+ ||||+++++++....
T Consensus 53 ~~~Y~~~~~lG~G~fG~V~~a~~~~t~~----~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~ 127 (398)
T 4b99_A 53 GDEYEIIETIGNGAYGVVSSARRRLTGQ----QVAIKKIPNAFDVVTNAKRTLRELKILKHFK-HDNIIAIKDILRPTVP 127 (398)
T ss_dssp CSSEEEEEEEEECSSCEEEEEEETTTCC----EEEEEEETTTTSSHHHHHHHHHHHHHHHHCC-CTTBCCEEEECCCSSC
T ss_pred CCCeEEEEEEecccCeEEEEEEECCCCC----EEEEEEECccccchHHHHHHHHHHHHHHhcC-CCCcceEeeeeecccc
Confidence 5789999999999999999999999886 567776532 24456889999999998 999999999765421
Q ss_pred CCCceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEe
Q 039291 79 ENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIA 158 (362)
Q Consensus 79 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~ 158 (362)
......+|||||||+ |+|.+++.. .+++++..++.++.||+.||+|||++|||||||||+|||+ +.++.+||+
T Consensus 128 ~~~~~~~~ivmE~~~-g~L~~~i~~--~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~----~~~~~~Ki~ 200 (398)
T 4b99_A 128 YGEFKSVYVVLDLME-SDLHQIIHS--SQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLV----NENCELKIG 200 (398)
T ss_dssp TTTCCCEEEEEECCS-EEHHHHHTS--SSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE----CTTCCEEEC
T ss_pred cccCCEEEEEEeCCC-CCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCcccccc----CCCCCEEEe
Confidence 123345789999996 689999976 4569999999999999999999999999999999999999 888899999
Q ss_pred ecCCccccccc--ccCCCCCCccCCCCccCchhhccc-cCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHHcC
Q 039291 159 DLGVAKRSRHC--KRQKFDPSMRGTPLYLAPETVVQH-MQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGD 235 (362)
Q Consensus 159 Dfgla~~~~~~--~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~ 235 (362)
|||+|+..... .........+||+.|||||++.+. .++.++||||+|||+|||++|++||.+.+..+....+.....
T Consensus 201 DFGla~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g 280 (398)
T 4b99_A 201 DFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLG 280 (398)
T ss_dssp CCTTCBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHC
T ss_pred ecceeeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcC
Confidence 99999865432 122334578999999999998875 569999999999999999999999976643322222222111
Q ss_pred CCC------------------CC--------CCCccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCccCcch
Q 039291 236 EHS------------------LP--------EIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGVDE 282 (362)
Q Consensus 236 ~~~------------------~~--------~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~~~~~~ 282 (362)
... ++ .+...+++++++||.+||..||++|+|++++|+||||++...
T Consensus 281 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~ 353 (398)
T 4b99_A 281 TPSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKYHD 353 (398)
T ss_dssp CCCGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTTTCC
T ss_pred CCChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCcCCC
Confidence 110 00 012347899999999999999999999999999999987643
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-60 Score=427.29 Aligned_cols=262 Identities=19% Similarity=0.300 Sum_probs=198.0
Q ss_pred ceeecceecccCceEEEEEEECCCCCCCCceeeeechh----hhhhHHHHHHHHHHHHcCCCCcccccccceeeecC---
Q 039291 7 SWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAE----VSASASLQKEKEVFDNLNGCPFVLECFGEEITMGE--- 79 (362)
Q Consensus 7 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~----~~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~--- 79 (362)
+|.+++.||+|+||+||+|+++.+++ .||+|.+. ....+.+.+|+++|++|+ ||||+++++.+.....
T Consensus 6 dy~~~~~lG~G~fg~V~~a~~~~~~~----~vAiK~i~~~~~~~~~~~~~~E~~il~~l~-HpnIV~~~~~~~~~~~~~~ 80 (299)
T 4g31_A 6 DFEPIQCLGRGGFGVVFEAKNKVDDC----NYAIKRIRLPNRELAREKVMREVKALAKLE-HPGIVRYFNAWLEKNTTEK 80 (299)
T ss_dssp HEEEEEEEEECC--EEEEEEETTTCC----EEEEEEEEECSSHHHHHHHHHHHHHHTTCC-CTTBCCEEEEEEEEC----
T ss_pred hCEEeeEEecCCCeEEEEEEECCCCC----EEEEEEEeccCCHHHHHHHHHHHHHHHhCC-CCCCCeEEEEEEecCcccc
Confidence 58999999999999999999998886 45555542 334567889999999998 9999999998765332
Q ss_pred ----CCceEEEEEEEecCCCCHHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceE
Q 039291 80 ----NGEMAYNLLLEYAAGGTLGDLIEKCNG-NGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFV 154 (362)
Q Consensus 80 ----~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~ 154 (362)
.....+|+|||||+||+|.+++..... ...++..++.++.||+.||+|||++|||||||||+|||+ +.++.
T Consensus 81 ~~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl----~~~~~ 156 (299)
T 4g31_A 81 LQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFF----TMDDV 156 (299)
T ss_dssp ------CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE----CTTCC
T ss_pred ccccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEE----CCCCc
Confidence 123457899999999999999986322 124567789999999999999999999999999999999 77889
Q ss_pred EEEeecCCcccccccccCC----------CCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHhCCCCCccCCCC
Q 039291 155 AKIADLGVAKRSRHCKRQK----------FDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDC 224 (362)
Q Consensus 155 ~kl~Dfgla~~~~~~~~~~----------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~ 224 (362)
+||+|||+|+......... .....+||+.|||||++.+..|+.++|||||||++|||++ ||....
T Consensus 157 vKl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~-- 231 (299)
T 4g31_A 157 VKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQM-- 231 (299)
T ss_dssp EEECCCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHH--
T ss_pred EEEccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCcc--
Confidence 9999999998654422211 1235689999999999999999999999999999999996 774321
Q ss_pred CHHHHHHHHcCCCCCCCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCccCcchh
Q 039291 225 SIDQLFSIIGDEHSLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGVDEE 283 (362)
Q Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~~~~~~~ 283 (362)
+....+..+... ..|..+...++++.+||.+||+.||++|||+.++++||||+++++.
T Consensus 232 ~~~~~~~~~~~~-~~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~~~~~~p 289 (299)
T 4g31_A 232 ERVRTLTDVRNL-KFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFP 289 (299)
T ss_dssp HHHHHHHHHHTT-CCCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGCCC---
T ss_pred HHHHHHHHHhcC-CCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCCCCCC
Confidence 122333333332 3333445567888999999999999999999999999999987543
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-59 Score=423.11 Aligned_cols=261 Identities=21% Similarity=0.400 Sum_probs=213.1
Q ss_pred CCCceeecceecccCceEEEEEEECCCC-CCCCceeeeechhh---hhhHHHHHHHHHHHHcCCCCcccccccceeeecC
Q 039291 4 DGTSWFRGRVIGQGSFGCVFIAKPKSNS-SFLPPLMAVKSAEV---SASASLQKEKEVFDNLNGCPFVLECFGEEITMGE 79 (362)
Q Consensus 4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~-~~~~~~~~~K~~~~---~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~ 79 (362)
..++|.+++.||+|+||+||+|++.... ......||+|.+.. ...+.+.+|+++|++|+ |||||++++++..
T Consensus 11 ~r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~-HpnIV~l~g~~~~--- 86 (299)
T 4asz_A 11 KRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQ-HEHIVKFYGVCVE--- 86 (299)
T ss_dssp CGGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCC-CTTBCCEEEEECS---
T ss_pred CHHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCC-CCCCccEEEEEee---
Confidence 4568999999999999999999986431 22235678887643 34567899999999998 9999999998753
Q ss_pred CCceEEEEEEEecCCCCHHHHHHHhc-----------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeec
Q 039291 80 NGEMAYNLLLEYAAGGTLGDLIEKCN-----------GNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVAT 148 (362)
Q Consensus 80 ~~~~~~~lv~e~~~~~~L~~~l~~~~-----------~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~ 148 (362)
...+++|||||+||+|.++|+... ...+++.++..++.|++.||.|||+++||||||||+|||+
T Consensus 87 --~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl--- 161 (299)
T 4asz_A 87 --GDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLV--- 161 (299)
T ss_dssp --SSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---
T ss_pred --CCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEE---
Confidence 234779999999999999997632 2469999999999999999999999999999999999999
Q ss_pred CCCceEEEEeecCCcccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHh-CCCCCccCCCCCHH
Q 039291 149 QSGKFVAKIADLGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLS-GRQAWVVKEDCSID 227 (362)
Q Consensus 149 ~~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~ 227 (362)
+.++.+||+|||+|+...............||+.|||||++.+..++.++|||||||+||||+| |+.||... +..
T Consensus 162 -~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~---~~~ 237 (299)
T 4asz_A 162 -GENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQL---SNN 237 (299)
T ss_dssp -CGGGCEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTS---CHH
T ss_pred -CCCCcEEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCC---CHH
Confidence 8888999999999986554333333345679999999999999999999999999999999998 89999654 455
Q ss_pred HHHHHHcCCCCCCCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCccCc
Q 039291 228 QLFSIIGDEHSLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGV 280 (362)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~~~~ 280 (362)
+++..+..... +..|..+|+++.+|+.+||+.||++|||+.++. +|++.+
T Consensus 238 ~~~~~i~~~~~-~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~--~~L~~~ 287 (299)
T 4asz_A 238 EVIECITQGRV-LQRPRTCPQEVYELMLGCWQREPHMRKNIKGIH--TLLQNL 287 (299)
T ss_dssp HHHHHHHHTCC-CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH--HHHHHH
T ss_pred HHHHHHHcCCC-CCCCccchHHHHHHHHHHcCCChhHCcCHHHHH--HHHHHH
Confidence 66666554443 456788999999999999999999999999994 455443
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-58 Score=428.73 Aligned_cols=261 Identities=25% Similarity=0.339 Sum_probs=202.4
Q ss_pred CCceeecceecccCceEEEEEEECCCCCCCCceeeeechhhh-hhHHHHHHHHHHHHcCCCCcccccccceeeecCCCce
Q 039291 5 GTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVS-ASASLQKEKEVFDNLNGCPFVLECFGEEITMGENGEM 83 (362)
Q Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~~-~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~~~~ 83 (362)
.++|.+++.||+|+||+||+|+++... ....+||+|.+... ....+.+|+++|+.+.+||||+++++++.. ..
T Consensus 20 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~-~~~~~vAiK~i~~~~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~-----~~ 93 (361)
T 4f9c_A 20 SNVFKIEDKIGEGTFSSVYLATAQLQV-GPEEKIALKHLIPTSHPIRIAAELQCLTVAGGQDNVMGVKYCFRK-----ND 93 (361)
T ss_dssp GGTCEEEEEEEECSSEEEEEEEEEBTT-SCEEEEEEEEECTTSCHHHHHHHHHHHHHTCSBTTBCCCSEEEEE-----TT
T ss_pred cCcEEEEEEEecccCcEEEEEEEcccC-CCCCEEEEEEEccccCHHHHHHHHHHHHHhcCCCCCceEEEEEEE-----CC
Confidence 478999999999999999999875321 11247788865433 445688999999999889999999987643 23
Q ss_pred EEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEeecCCc
Q 039291 84 AYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVA 163 (362)
Q Consensus 84 ~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Dfgla 163 (362)
.+|+|||||+||+|.+++.. +++.+++.++.||+.||+|||++||+||||||+|||+. ...+.+||+|||+|
T Consensus 94 ~~~lvmE~~~g~~L~~~~~~-----l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~---~~~~~~kl~DFGla 165 (361)
T 4f9c_A 94 HVVIAMPYLEHESFLDILNS-----LSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYN---RRLKKYALVDFGLA 165 (361)
T ss_dssp EEEEEEECCCCCCHHHHHTT-----CCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEE---TTTTEEEECCCTTC
T ss_pred EEEEEEeCCCcccHHHHHcC-----CCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEe---CCCCeEEECcCCCC
Confidence 57899999999999999853 99999999999999999999999999999999999993 22368999999999
Q ss_pred cccccccc--------------------------CCCCCCccCCCCccCchhhccc-cCCCcchHHHHHHHHHHHHhCCC
Q 039291 164 KRSRHCKR--------------------------QKFDPSMRGTPLYLAPETVVQH-MQEAPSDIWALGCVVLEMLSGRQ 216 (362)
Q Consensus 164 ~~~~~~~~--------------------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~l~~g~~ 216 (362)
+....... .......+||+.|+|||++.+. .++.++||||+||++|||++|+.
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~ 245 (361)
T 4f9c_A 166 QGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRY 245 (361)
T ss_dssp EECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCS
T ss_pred cccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCC
Confidence 75432211 1112356899999999999875 58999999999999999999999
Q ss_pred CCccCCCCCHHHHHHHH-------------------------------------cC-CC-------------CCCCCCcc
Q 039291 217 AWVVKEDCSIDQLFSII-------------------------------------GD-EH-------------SLPEIPSR 245 (362)
Q Consensus 217 pf~~~~~~~~~~~~~~~-------------------------------------~~-~~-------------~~~~~~~~ 245 (362)
||....+ +..++.... .. .. .....+..
T Consensus 246 Pf~~~~~-~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~ 324 (361)
T 4f9c_A 246 PFYKASD-DLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNE 324 (361)
T ss_dssp SSSCCSS-HHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTT
T ss_pred CCCCCCC-HHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhcccccccccccccccccccccccccc
Confidence 9964432 122211110 00 00 00112346
Q ss_pred CCHHHHHHHHHHhccCCCCCCCHHHHhcCCCccCc
Q 039291 246 VSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGV 280 (362)
Q Consensus 246 ~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~~~~ 280 (362)
+++++++||++||+.||++|+|++|+|+||||+++
T Consensus 325 is~~a~DLl~~lL~~dP~~R~ta~eaL~Hp~f~~i 359 (361)
T 4f9c_A 325 VPDEAYDLLDKLLDLNPASRITAEEALLHPFFKDM 359 (361)
T ss_dssp CCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGTTC
T ss_pred CCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCC
Confidence 88999999999999999999999999999999876
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-58 Score=415.34 Aligned_cols=249 Identities=20% Similarity=0.331 Sum_probs=199.8
Q ss_pred CCCceeecceecccCceEEEEEEECCCCCCCCceeeeechh-----hhhhHHHHHHHHHHHHcCCCCcccccccceeeec
Q 039291 4 DGTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAE-----VSASASLQKEKEVFDNLNGCPFVLECFGEEITMG 78 (362)
Q Consensus 4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~-----~~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~ 78 (362)
.-+++.+++.||+|+||+||+|+++++ ||+|.++ ....+.+.+|+.+|++|+ |||||++++++.
T Consensus 34 ~~~~l~l~~~iG~G~fG~Vy~~~~~~~-------vAvK~~~~~~~~~~~~~~f~~E~~il~~l~-HpNIV~l~g~~~--- 102 (307)
T 3omv_A 34 EASEVMLSTRIGSGSFGTVYKGKWHGD-------VAVKILKVVDPTPEQFQAFRNEVAVLRKTR-HVNILLFMGYMT--- 102 (307)
T ss_dssp CTTSCCEEEECCCCSSSEEEEEESSSE-------EEEEECCCSSCCHHHHHHHHHHHHHHTTCC-CTTBCCEEEEEC---
T ss_pred cHHHeEEeeEEeeCCCcEEEEEEECCc-------EEEEEEEecCCCHHHHHHHHHHHHHHHhCC-CCCEeeEEEEEE---
Confidence 456788899999999999999986542 4555543 334567899999999998 999999998653
Q ss_pred CCCceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEe
Q 039291 79 ENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIA 158 (362)
Q Consensus 79 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~ 158 (362)
+ . .++||||||+||+|.+++... ..++++.++..|+.|++.||+|||+++||||||||+|||+ +.++.+||+
T Consensus 103 -~-~-~~~iVmEy~~gGsL~~~l~~~-~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl----~~~~~~Ki~ 174 (307)
T 3omv_A 103 -K-D-NLAIVTQWCEGSSLYKHLHVQ-ETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFL----HEGLTVKIG 174 (307)
T ss_dssp -S-S-SCEEEEECCSSCBHHHHHHTS-CCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEE----ETTEEEEEC
T ss_pred -C-C-eEEEEEEcCCCCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEE----CCCCcEEEe
Confidence 1 1 267999999999999999763 3569999999999999999999999999999999999999 788999999
Q ss_pred ecCCcccccccccCCCCCCccCCCCccCchhhcc---ccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHHcC
Q 039291 159 DLGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQ---HMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGD 235 (362)
Q Consensus 159 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~ 235 (362)
|||+|+..............+||+.|||||++.+ ..|+.++|||||||+||||+||+.||...+ ....+...+..
T Consensus 175 DFGla~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~--~~~~~~~~~~~ 252 (307)
T 3omv_A 175 DFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHIN--NRDQIIFMVGR 252 (307)
T ss_dssp CCSSCBC------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCC--CHHHHHHHHHT
T ss_pred eccCceecccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCC--hHHHHHHHHhc
Confidence 9999986654333333456789999999999974 358899999999999999999999996543 34444445544
Q ss_pred CCC---CCCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhc
Q 039291 236 EHS---LPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLD 273 (362)
Q Consensus 236 ~~~---~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~ 273 (362)
... .+.++..+++++.+|+.+||+.||++|||+.++++
T Consensus 253 ~~~~p~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~ 293 (307)
T 3omv_A 253 GYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILS 293 (307)
T ss_dssp TCCCCCSTTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHH
T ss_pred CCCCCCcccccccchHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 433 34566789999999999999999999999998865
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-59 Score=427.55 Aligned_cols=260 Identities=20% Similarity=0.281 Sum_probs=215.5
Q ss_pred CCCceeecceecccCceEEEEEEECCCCCCCC-ceeeeechhhh----hhHHHHHHHHHHHHcCCCCcccccccceeeec
Q 039291 4 DGTSWFRGRVIGQGSFGCVFIAKPKSNSSFLP-PLMAVKSAEVS----ASASLQKEKEVFDNLNGCPFVLECFGEEITMG 78 (362)
Q Consensus 4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~-~~~~~K~~~~~----~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~ 78 (362)
..++|.+++.||+|+||+||+|+++..+...+ +.||+|.+... ..+.+.+|+.+|+++.||||||++++++...
T Consensus 62 ~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~- 140 (353)
T 4ase_A 62 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP- 140 (353)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCT-
T ss_pred cHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEec-
Confidence 45789999999999999999999887654433 57889886532 3456889999999999889999999977532
Q ss_pred CCCceEEEEEEEecCCCCHHHHHHHhc--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEE
Q 039291 79 ENGEMAYNLLLEYAAGGTLGDLIEKCN--------------GNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNIL 144 (362)
Q Consensus 79 ~~~~~~~~lv~e~~~~~~L~~~l~~~~--------------~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nil 144 (362)
...+++|||||++|+|.++|+... ...+++..+..++.||+.||+|||+++||||||||+|||
T Consensus 141 ---~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~NIL 217 (353)
T 4ase_A 141 ---GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNIL 217 (353)
T ss_dssp ---TSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEE
T ss_pred ---CCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCcccee
Confidence 234679999999999999998632 234899999999999999999999999999999999999
Q ss_pred EeecCCCceEEEEeecCCcccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHh-CCCCCccCCC
Q 039291 145 LVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLS-GRQAWVVKED 223 (362)
Q Consensus 145 l~~~~~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~ 223 (362)
+ +.++++||+|||+|+..............+||+.|||||++.+..|+.++|||||||+||||+| |..||.+...
T Consensus 218 l----~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~ 293 (353)
T 4ase_A 218 L----SEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI 293 (353)
T ss_dssp E----CGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred e----CCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCH
Confidence 9 8888999999999986654333323345779999999999999999999999999999999998 9999965432
Q ss_pred CCHHHHHHHHcCCCCCCCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhcC
Q 039291 224 CSIDQLFSIIGDEHSLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDD 274 (362)
Q Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~ 274 (362)
...+...+.... .+..|..+++++.+|+.+||+.||++|||+.++++|
T Consensus 294 --~~~~~~~i~~g~-~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~ 341 (353)
T 4ase_A 294 --DEEFCRRLKEGT-RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 341 (353)
T ss_dssp --SHHHHHHHHHTC-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred --HHHHHHHHHcCC-CCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 233334443333 345677899999999999999999999999999986
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-58 Score=447.37 Aligned_cols=261 Identities=24% Similarity=0.380 Sum_probs=217.8
Q ss_pred CCCCceeecceecccCceEEEEEEECCCCCCCCceeeeechhhh------hhHHHHHHHHH---HHHcCCCCcccccccc
Q 039291 3 SDGTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVS------ASASLQKEKEV---FDNLNGCPFVLECFGE 73 (362)
Q Consensus 3 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~~------~~~~~~~E~~i---l~~l~~h~~i~~~~~~ 73 (362)
.+-++|.+++.||+|+||+||+|+++.+++ .+|+|.+... ......+|..+ ++.++ ||||+++++.
T Consensus 186 ~slddf~i~k~LG~G~fG~V~la~~~~tg~----~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~-HP~IV~l~~~ 260 (689)
T 3v5w_A 186 LTMNDFSVHRIIGRGGFGEVYGCRKADTGK----MYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD-CPFIVCMSYA 260 (689)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCC----EEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSC-CTTBCCEEEE
T ss_pred CchHHeEEEEEEecccCeEEEEEEECCCCC----EEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCC-CCCEeEEEEE
Confidence 345789999999999999999999999886 4566654322 22334455444 44455 9999999987
Q ss_pred eeeecCCCceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCce
Q 039291 74 EITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKF 153 (362)
Q Consensus 74 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~ 153 (362)
+.. ...+|+|||||+||+|.++|... +.+++..++.|+.||+.||+|||++|||||||||+|||+ +.++
T Consensus 261 f~~-----~~~lylVmEy~~GGdL~~~l~~~--~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILl----d~~G 329 (689)
T 3v5w_A 261 FHT-----PDKLSFILDLMNGGDLHYHLSQH--GVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILL----DEHG 329 (689)
T ss_dssp EEC-----SSEEEEEECCCCSCBHHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEE----CTTS
T ss_pred EEE-----CCEEEEEEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEE----eCCC
Confidence 643 34588999999999999999874 459999999999999999999999999999999999999 8889
Q ss_pred EEEEeecCCcccccccccCCCCCCccCCCCccCchhhcc-ccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHH
Q 039291 154 VAKIADLGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQ-HMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSI 232 (362)
Q Consensus 154 ~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~ 232 (362)
++||+|||+|+..... ...+.+||+.|||||++.+ ..|+.++|||||||+||||++|.+||.+....+..++...
T Consensus 330 ~vKL~DFGlA~~~~~~----~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~ 405 (689)
T 3v5w_A 330 HVRISDLGLACDFSKK----KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRM 405 (689)
T ss_dssp CEEECCCTTCEECSSC----CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHH
T ss_pred CEEecccceeeecCCC----CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHh
Confidence 9999999999865432 2346789999999999974 5799999999999999999999999987766666666655
Q ss_pred HcCCCCCCCCCccCCHHHHHHHHHHhccCCCCCCC-----HHHHhcCCCccCcchhhh
Q 039291 233 IGDEHSLPEIPSRVSKEARDFLRRCFVRKPAFRFT-----AEMLLDDPFVKGVDEELS 285 (362)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s-----~~~~l~~p~~~~~~~~~~ 285 (362)
+.... +.+|..+|+++++||.+||..||.+|++ ++++++||||++++|+..
T Consensus 406 i~~~~--~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~idW~~l 461 (689)
T 3v5w_A 406 TLTMA--VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMV 461 (689)
T ss_dssp HHHCC--CCCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGGGTTCCHHHH
T ss_pred hcCCC--CCCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcCccccCCCHHHH
Confidence 54332 3467789999999999999999999998 799999999999999854
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-58 Score=417.45 Aligned_cols=257 Identities=22% Similarity=0.349 Sum_probs=203.4
Q ss_pred CCCceeecceecccCceEEEEEEECCC-CCCCCceeeeechhh---hhhHHHHHHHHHHHHcCCCCcccccccceeeecC
Q 039291 4 DGTSWFRGRVIGQGSFGCVFIAKPKSN-SSFLPPLMAVKSAEV---SASASLQKEKEVFDNLNGCPFVLECFGEEITMGE 79 (362)
Q Consensus 4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~-~~~~~~~~~~K~~~~---~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~ 79 (362)
...++.+.++||+|+||+||+|+++.. .......||+|.+.. ...+.+.+|+++|++|+ |||||++++++..
T Consensus 39 ~~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~-HpnIV~l~g~~~~--- 114 (329)
T 4aoj_A 39 KRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQ-HQHIVRFFGVCTE--- 114 (329)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCC-CTTBCCEEEEECS---
T ss_pred CHHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCC-CCCCCcEEEEEEE---
Confidence 345788899999999999999997642 122234678887643 34567899999999998 9999999998753
Q ss_pred CCceEEEEEEEecCCCCHHHHHHHhc-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEe
Q 039291 80 NGEMAYNLLLEYAAGGTLGDLIEKCN-------------GNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLV 146 (362)
Q Consensus 80 ~~~~~~~lv~e~~~~~~L~~~l~~~~-------------~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~ 146 (362)
...+|||||||++|+|.++++... ..++++.++..|+.|++.||.|||+++||||||||+|||+
T Consensus 115 --~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl- 191 (329)
T 4aoj_A 115 --GRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLV- 191 (329)
T ss_dssp --SSSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE-
T ss_pred --CCEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEE-
Confidence 234779999999999999997632 2459999999999999999999999999999999999999
Q ss_pred ecCCCceEEEEeecCCcccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHh-CCCCCccCCCCC
Q 039291 147 ATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLS-GRQAWVVKEDCS 225 (362)
Q Consensus 147 ~~~~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~ 225 (362)
+.++.+||+|||+|+..............+||+.|||||++.+..++.++|||||||+||||+| |+.||... .
T Consensus 192 ---~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~---~ 265 (329)
T 4aoj_A 192 ---GQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQL---S 265 (329)
T ss_dssp ---ETTTEEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSS---C
T ss_pred ---CCCCcEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCC---C
Confidence 7888999999999986654433333446779999999999999999999999999999999999 99999654 4
Q ss_pred HHHHHHHHcCCCCCCCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhcC
Q 039291 226 IDQLFSIIGDEHSLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDD 274 (362)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~ 274 (362)
..+++..+.... .+..|..+++++.+|+.+||+.||++|||+.+++.+
T Consensus 266 ~~~~~~~i~~g~-~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~ 313 (329)
T 4aoj_A 266 NTEAIDCITQGR-ELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHAR 313 (329)
T ss_dssp HHHHHHHHHHTC-CCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHH
T ss_pred HHHHHHHHHcCC-CCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 455555554443 345678899999999999999999999999999763
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-58 Score=414.32 Aligned_cols=257 Identities=20% Similarity=0.279 Sum_probs=212.7
Q ss_pred CCCceeecceecccCceEEEEEEECCCC-CCCCceeeeechhhh----hhHHHHHHHHHHHHcCCCCcccccccceeeec
Q 039291 4 DGTSWFRGRVIGQGSFGCVFIAKPKSNS-SFLPPLMAVKSAEVS----ASASLQKEKEVFDNLNGCPFVLECFGEEITMG 78 (362)
Q Consensus 4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~-~~~~~~~~~K~~~~~----~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~ 78 (362)
.-..+.+.+.||+|+||+||+|+..... ......||+|.+... ..+.+.+|+.++++|+ |||||++++++..
T Consensus 24 ~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~-HpNIV~l~g~~~~-- 100 (308)
T 4gt4_A 24 SLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQ-HPNVVCLLGVVTK-- 100 (308)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCC-CTTBCCEEEEECS--
T ss_pred CHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCC-CCCCCCcceEEEE--
Confidence 3457788999999999999999975421 112347888876432 3467899999999998 9999999998753
Q ss_pred CCCceEEEEEEEecCCCCHHHHHHHhc--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEE
Q 039291 79 ENGEMAYNLLLEYAAGGTLGDLIEKCN--------------GNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNIL 144 (362)
Q Consensus 79 ~~~~~~~~lv~e~~~~~~L~~~l~~~~--------------~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nil 144 (362)
...+++|||||++|+|.++|.... ...+++..+..++.|++.||+|||+++||||||||+|||
T Consensus 101 ---~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NIL 177 (308)
T 4gt4_A 101 ---DQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVL 177 (308)
T ss_dssp ---SSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEE
T ss_pred ---CCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceE
Confidence 223679999999999999997532 235899999999999999999999999999999999999
Q ss_pred EeecCCCceEEEEeecCCcccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHh-CCCCCccCCC
Q 039291 145 LVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLS-GRQAWVVKED 223 (362)
Q Consensus 145 l~~~~~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~ 223 (362)
+ ++++.+||+|||+|+..............+||+.|||||++.+..++.++|||||||+||||+| |..||.+.
T Consensus 178 l----~~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~-- 251 (308)
T 4gt4_A 178 V----YDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGY-- 251 (308)
T ss_dssp E----CGGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTC--
T ss_pred E----CCCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCC--
Confidence 9 8888999999999987655444444456789999999999999999999999999999999998 89999654
Q ss_pred CCHHHHHHHHcCCCCCCCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhcC
Q 039291 224 CSIDQLFSIIGDEHSLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDD 274 (362)
Q Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~ 274 (362)
...++...+...... ..|..++.++.+|+.+||+.||++|||+.+++++
T Consensus 252 -~~~~~~~~i~~~~~~-~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~ 300 (308)
T 4gt4_A 252 -SNQDVVEMIRNRQVL-PCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSR 300 (308)
T ss_dssp -CHHHHHHHHHTTCCC-CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred -CHHHHHHHHHcCCCC-CCcccchHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 456666666655543 4678899999999999999999999999999764
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-56 Score=434.53 Aligned_cols=258 Identities=21% Similarity=0.369 Sum_probs=215.3
Q ss_pred CceeecceecccCceEEEEEEECCCCCCCCceeeeechh---hhhhHHHHHHHHHHHHcCCCCcccccccceeeecCCCc
Q 039291 6 TSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAE---VSASASLQKEKEVFDNLNGCPFVLECFGEEITMGENGE 82 (362)
Q Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~---~~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~~~ 82 (362)
++|.+++.||+|+||+||+|+++.+++. +|+|.+. ......+.+|+.+|+.|+ ||||+++++++.. .
T Consensus 157 ~~Y~i~~~lG~G~fg~V~~~~~~~tg~~----~AiK~i~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~-----~ 226 (573)
T 3uto_A 157 DHYDIHEELGTGAFGVVHRVTERATGNN----FAAKFVMTPHESDKETVRKEIQTMSVLR-HPTLVNLHDAFED-----D 226 (573)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCE----EEEEEEECCSHHHHHHHHHHHHHHHHTC-CTTBCCEEEEEEC-----S
T ss_pred cccEEEEEEeeccCeEEEEEEECCCCCE----EEEEEEeccchhhHHHHHHHHHHHHhCC-CCCCCeEEEEEEE-----C
Confidence 5799999999999999999999999864 5555432 334567889999999998 9999999997642 3
Q ss_pred eEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEeecCC
Q 039291 83 MAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGV 162 (362)
Q Consensus 83 ~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Dfgl 162 (362)
..+|+|||||+||+|.++|... .+.+++..++.++.||+.||+|||++||+||||||+|||+.. +..+.+||+|||+
T Consensus 227 ~~~~iv~E~~~gg~L~~~i~~~-~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~--~~~~~vKl~DFG~ 303 (573)
T 3uto_A 227 NEMVMIYEFMSGGELFEKVADE-HNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTT--KRSNELKLIDFGL 303 (573)
T ss_dssp SEEEEEEECCCCCBHHHHHTCT-TSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESS--SSCCCEEECCCSS
T ss_pred CEEEEEEeecCCCcHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccC--CCCCCEEEeeccc
Confidence 4578999999999999999652 346999999999999999999999999999999999999932 2346899999999
Q ss_pred cccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHHcCCCC-C-C
Q 039291 163 AKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEHS-L-P 240 (362)
Q Consensus 163 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~-~-~ 240 (362)
|+...... .....+||+.|||||++.+..|+.++|||||||++|+|++|.+||.+. +..+++..+..... + +
T Consensus 304 a~~~~~~~---~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~---~~~~~~~~i~~~~~~~~~ 377 (573)
T 3uto_A 304 TAHLDPKQ---SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGE---NDDETLRNVKSCDWNMDD 377 (573)
T ss_dssp CEECCTTS---EEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCS---SHHHHHHHHHTTCCCCCS
T ss_pred eeEccCCC---ceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc---CHHHHHHHHHhCCCCCCc
Confidence 98765422 223568999999999999999999999999999999999999999654 44555555544332 2 2
Q ss_pred CCCccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCccCcch
Q 039291 241 EIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGVDE 282 (362)
Q Consensus 241 ~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~~~~~~ 282 (362)
..+..+++++++||++||..||++|||+.++|+||||+...+
T Consensus 378 ~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~Hpw~~~~~~ 419 (573)
T 3uto_A 378 SAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNA 419 (573)
T ss_dssp GGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTSCCCC
T ss_pred ccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcCcCCCCC
Confidence 334578999999999999999999999999999999987543
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-54 Score=388.44 Aligned_cols=253 Identities=24% Similarity=0.328 Sum_probs=199.2
Q ss_pred CceeecceecccCceEEEEEEECCCCCCCCceeeeechhhhhhHHHHHHHHHH--HHcCCCCcccccccceeeecCCCce
Q 039291 6 TSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVSASASLQKEKEVF--DNLNGCPFVLECFGEEITMGENGEM 83 (362)
Q Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~~~~~~~~~E~~il--~~l~~h~~i~~~~~~~~~~~~~~~~ 83 (362)
.+|.+.+.||+|+||+||+|++++ ..||+|.+.......+.+|.+++ .+++ ||||+++++++.... ....
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~~g------~~VAvK~l~~~~~~~~~~e~Ei~~~~~l~-HpNIv~l~g~~~~~~-~~~~ 74 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKWRG------EEVAVKIFSSREERSWFREAEIYQTVMLR-HENILGFIAADNKDN-GTWT 74 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETT------EEEEEEEECGGGHHHHHHHHHHHTSTTCC-CTTBCCEEEEEEEEC-SSSE
T ss_pred cEEEEEEEEeeCCCeEEEEEEECC------EEEEEEEECccchhhHHHHHHHHHHhcCC-CCCCCcEEEEEEecC-CCce
Confidence 579999999999999999999853 36899988766666666555554 5676 999999999876533 2234
Q ss_pred EEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC--------CceeCCCCCCCEEEeecCCCceEE
Q 039291 84 AYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDS--------GYVHCDVKPDNILLVATQSGKFVA 155 (362)
Q Consensus 84 ~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~--------~ivH~Dlkp~Nill~~~~~~~~~~ 155 (362)
.+|||||||+||+|.++++. .++++..+..++.|++.||+|||++ +||||||||+|||+ +.++++
T Consensus 75 ~~~lV~Ey~~~gsL~~~l~~---~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl----~~~~~~ 147 (303)
T 3hmm_A 75 QLWLVSDYHEHGSLFDYLNR---YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILV----KKNGTC 147 (303)
T ss_dssp EEEEEEECCTTCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEE----CTTSCE
T ss_pred EEEEEecCCCCCcHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEE----CCCCCE
Confidence 57899999999999999976 3599999999999999999999987 99999999999999 888999
Q ss_pred EEeecCCcccccccccC--CCCCCccCCCCccCchhhccc------cCCCcchHHHHHHHHHHHHhCCCCCccCC-----
Q 039291 156 KIADLGVAKRSRHCKRQ--KFDPSMRGTPLYLAPETVVQH------MQEAPSDIWALGCVVLEMLSGRQAWVVKE----- 222 (362)
Q Consensus 156 kl~Dfgla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~------~~~~~~DiwslG~il~~l~~g~~pf~~~~----- 222 (362)
||+|||+|+........ ......+||+.|||||++.+. .++.++|||||||+||||+||.+||....
T Consensus 148 Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p 227 (303)
T 3hmm_A 148 CIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLP 227 (303)
T ss_dssp EECCCTTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCT
T ss_pred EEEeCCCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCcccccccc
Confidence 99999999865543221 122356799999999999764 36778999999999999999987664321
Q ss_pred -------CCCHHHHHHHHcCCCCCCCCCcc-----CCHHHHHHHHHHhccCCCCCCCHHHHhc
Q 039291 223 -------DCSIDQLFSIIGDEHSLPEIPSR-----VSKEARDFLRRCFVRKPAFRFTAEMLLD 273 (362)
Q Consensus 223 -------~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~li~~~l~~~p~~R~s~~~~l~ 273 (362)
.....++...+......|.+|.. .+..+.+|+.+||+.||++|||+.++++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~ 290 (303)
T 3hmm_A 228 YYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKK 290 (303)
T ss_dssp TTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHH
T ss_pred chhcccccchHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHH
Confidence 22345566666555555666543 2357889999999999999999999986
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-53 Score=391.22 Aligned_cols=260 Identities=28% Similarity=0.442 Sum_probs=214.3
Q ss_pred CCCceeecceecccCceEEEEEEECCCCCCCCceeeeechhh------hhhHHHHHHHHHHHHcCCCCcccccccceeee
Q 039291 4 DGTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEV------SASASLQKEKEVFDNLNGCPFVLECFGEEITM 77 (362)
Q Consensus 4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~------~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~ 77 (362)
.-++|.+++.||+|+||+||+|+++.+++ .+|+|.+.. .....+.+|..+++.+.+||||+++++.+..
T Consensus 21 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~----~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~- 95 (353)
T 3txo_A 21 GIDNFEFIRVLGKGSFGKVMLARVKETGD----LYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQT- 95 (353)
T ss_dssp --CCEEEEEEEEEETTEEEEEEEETTTCC----EEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEEC-
T ss_pred chhheEEEEEEeeCCCEEEEEEEEcCCCC----EEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEe-
Confidence 34689999999999999999999998876 456665432 2445678999999999779999999987642
Q ss_pred cCCCceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEE
Q 039291 78 GENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKI 157 (362)
Q Consensus 78 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl 157 (362)
...+|+||||++||+|.+++... +.+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||
T Consensus 96 ----~~~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl----~~~g~ikL 165 (353)
T 3txo_A 96 ----PDRLFFVMEFVNGGDLMFHIQKS--RRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLL----DHEGHCKL 165 (353)
T ss_dssp ----SSEEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE----CTTSCEEE
T ss_pred ----CCEEEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEE----CCCCCEEE
Confidence 23478999999999999999874 459999999999999999999999999999999999999 88889999
Q ss_pred eecCCcccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHHcCCC
Q 039291 158 ADLGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEH 237 (362)
Q Consensus 158 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 237 (362)
+|||+++..... .......+||+.|+|||++.+..++.++|||||||++|+|++|.+||... +..++...+....
T Consensus 166 ~DFG~a~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~---~~~~~~~~i~~~~ 240 (353)
T 3txo_A 166 ADFGMCKEGICN--GVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAE---NEDDLFEAILNDE 240 (353)
T ss_dssp CCCTTCBCSCC-----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCS---SHHHHHHHHHHCC
T ss_pred ccccceeecccC--CccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCC---CHHHHHHHHHcCC
Confidence 999999754332 22234678999999999999999999999999999999999999999654 4455555554332
Q ss_pred CCCCCCccCCHHHHHHHHHHhccCCCCCCCH------HHHhcCCCccCcchhhh
Q 039291 238 SLPEIPSRVSKEARDFLRRCFVRKPAFRFTA------EMLLDDPFVKGVDEELS 285 (362)
Q Consensus 238 ~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~------~~~l~~p~~~~~~~~~~ 285 (362)
..+|..++.++++||++||..||.+||++ ++++.||||+.+.|+..
T Consensus 241 --~~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~hp~f~~~~w~~l 292 (353)
T 3txo_A 241 --VVYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFFKEIDWAQL 292 (353)
T ss_dssp --CCCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTSGGGTTCCHHHH
T ss_pred --CCCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhCCcccCCCHHHH
Confidence 24566799999999999999999999998 89999999999988753
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-52 Score=390.95 Aligned_cols=263 Identities=27% Similarity=0.433 Sum_probs=216.9
Q ss_pred CCCceeecceecccCceEEEEEEECCCCCCCCceeeeechhh------hhhHHHHHHHHHHHHcCCCCcccccccceeee
Q 039291 4 DGTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEV------SASASLQKEKEVFDNLNGCPFVLECFGEEITM 77 (362)
Q Consensus 4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~------~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~ 77 (362)
.-++|.+++.||+|+||+||+|+++.+++. +|+|.+.. .....+.+|..++.++.+||||+++++.+..
T Consensus 50 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~----~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~- 124 (396)
T 4dc2_A 50 GLQDFDLLRVIGRGSYAKVLLVRLKKTDRI----YAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQT- 124 (396)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEE----EEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEEC-
T ss_pred ChhHcEEEEEEeeCCCeEEEEEEECCCCCE----EEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEE-
Confidence 346899999999999999999999988764 45554432 2334578999999998679999999987642
Q ss_pred cCCCceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEE
Q 039291 78 GENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKI 157 (362)
Q Consensus 78 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl 157 (362)
...+++||||++||+|.+++... +.+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||
T Consensus 125 ----~~~~~lV~E~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl----~~~g~ikL 194 (396)
T 4dc2_A 125 ----ESRLFFVIEYVNGGDLMFHMQRQ--RKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLL----DSEGHIKL 194 (396)
T ss_dssp ----SSEEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE----CTTSCEEE
T ss_pred ----CCEEEEEEEcCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEE----CCCCCEEE
Confidence 33578999999999999999874 459999999999999999999999999999999999999 88889999
Q ss_pred eecCCcccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHhCCCCCccCCC------CCHHHHHH
Q 039291 158 ADLGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKED------CSIDQLFS 231 (362)
Q Consensus 158 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~------~~~~~~~~ 231 (362)
+|||+++..... .......+||+.|+|||++.+..++.++|||||||++|||++|++||..... .....+..
T Consensus 195 ~DFGla~~~~~~--~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~ 272 (396)
T 4dc2_A 195 TDYGMCKEGLRP--GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQ 272 (396)
T ss_dssp CCCTTCBCCCCT--TCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHH
T ss_pred eecceeeecccC--CCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHH
Confidence 999999753322 2223467899999999999999999999999999999999999999964321 22333444
Q ss_pred HHcCCCCCCCCCccCCHHHHHHHHHHhccCCCCCCCH------HHHhcCCCccCcchhhh
Q 039291 232 IIGDEHSLPEIPSRVSKEARDFLRRCFVRKPAFRFTA------EMLLDDPFVKGVDEELS 285 (362)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~------~~~l~~p~~~~~~~~~~ 285 (362)
.+.... ..+|..++.++++||++||..||.+|+++ ++++.||||+.+.|+..
T Consensus 273 ~i~~~~--~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~i~w~~l 330 (396)
T 4dc2_A 273 VILEKQ--IRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDMM 330 (396)
T ss_dssp HHHHCC--CCCCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTTCCHHHH
T ss_pred HHhccc--cCCCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccccCCCHHHH
Confidence 443322 34667899999999999999999999985 79999999999988754
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-52 Score=381.75 Aligned_cols=259 Identities=25% Similarity=0.372 Sum_probs=218.3
Q ss_pred CCCceeecceecccCceEEEEEEECCCCCCCCceeeeechhh------hhhHHHHHHHHHHHHcCCCCcccccccceeee
Q 039291 4 DGTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEV------SASASLQKEKEVFDNLNGCPFVLECFGEEITM 77 (362)
Q Consensus 4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~------~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~ 77 (362)
+-++|.+++.||+|+||+||+|+++.+++ .+|+|.+.. .....+.+|+.+++.++ ||||+++++.+..
T Consensus 3 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~----~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~l~~~~~~- 76 (337)
T 1o6l_A 3 TMNDFDYLKLLGKGTFGKVILVREKATGR----YYAMKILRKEVIIAKDEVAHTVTESRVLQNTR-HPFLTALKYAFQT- 76 (337)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCC----EEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCC-CTTBCCEEEEEEC-
T ss_pred ChHHeEEEEEEecCCCeEEEEEEECCCCC----EEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCC-CCcCcceEEEEEe-
Confidence 45789999999999999999999998876 456665432 24456889999999998 9999999987643
Q ss_pred cCCCceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEE
Q 039291 78 GENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKI 157 (362)
Q Consensus 78 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl 157 (362)
...+|+||||++||+|.+++... +.+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||
T Consensus 77 ----~~~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll----~~~g~vkL 146 (337)
T 1o6l_A 77 ----HDRLCFVMEYANGGELFFHLSRE--RVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLML----DKDGHIKI 146 (337)
T ss_dssp ----SSEEEEEEECCTTCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE----CTTSCEEE
T ss_pred ----CCEEEEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEE----CCCCCEEE
Confidence 23578999999999999999873 459999999999999999999999999999999999999 78889999
Q ss_pred eecCCcccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHHcCCC
Q 039291 158 ADLGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEH 237 (362)
Q Consensus 158 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 237 (362)
+|||+++...... ......+||+.|+|||++.+..++.++|||||||++|||++|..||... +...+...+....
T Consensus 147 ~DFG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~---~~~~~~~~i~~~~ 221 (337)
T 1o6l_A 147 TDFGLCKEGISDG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ---DHERLFELILMEE 221 (337)
T ss_dssp CCCTTCBCSCCTT--CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCS---SHHHHHHHHHHCC
T ss_pred eeccchhhcccCC--CcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCC---CHHHHHHHHHcCC
Confidence 9999997543321 2224678999999999999999999999999999999999999999654 3445554443322
Q ss_pred CCCCCCccCCHHHHHHHHHHhccCCCCCC-----CHHHHhcCCCccCcchhhh
Q 039291 238 SLPEIPSRVSKEARDFLRRCFVRKPAFRF-----TAEMLLDDPFVKGVDEELS 285 (362)
Q Consensus 238 ~~~~~~~~~~~~~~~li~~~l~~~p~~R~-----s~~~~l~~p~~~~~~~~~~ 285 (362)
..+|..+++++++||.+||..||++|| +++++++||||+.+.|...
T Consensus 222 --~~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h~~f~~~~~~~~ 272 (337)
T 1o6l_A 222 --IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDV 272 (337)
T ss_dssp --CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCHHHH
T ss_pred --CCCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcCCCcCCCCHHHH
Confidence 245677999999999999999999999 8999999999999988743
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-52 Score=381.69 Aligned_cols=253 Identities=26% Similarity=0.385 Sum_probs=213.2
Q ss_pred CCceeecceecccCceEEEEEEECCCCCCCCceeeeechh-----hhhhHHHHHHHHHHHHcCCCCcccccccceeeecC
Q 039291 5 GTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAE-----VSASASLQKEKEVFDNLNGCPFVLECFGEEITMGE 79 (362)
Q Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~-----~~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~ 79 (362)
-++|.+++.||+|+||.||+|++..+++ .|++|... ......+.+|+++++.++ ||||+++++++..
T Consensus 14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~----~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~--- 85 (328)
T 3fe3_A 14 IGNYRLLKTIGKGNFAKVKLARHILTGR----EVAIKIIDKTQLNPTSLQKLFREVRIMKILN-HPNIVKLFEVIET--- 85 (328)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCC----EEEEEEEEGGGSCHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEEC---
T ss_pred cCCEEEEEEEeeCCCEEEEEEEECCCCC----EEEEEEEEhhcCCHHHHHHHHHHHHHHHhCC-CCCEeeEEEEEEE---
Confidence 3689999999999999999999988876 56666543 234566889999999998 9999999987642
Q ss_pred CCceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEee
Q 039291 80 NGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIAD 159 (362)
Q Consensus 80 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~D 159 (362)
...+++||||++|++|.+++... +++++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|
T Consensus 86 --~~~~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll----~~~~~~kl~D 157 (328)
T 3fe3_A 86 --EKTLYLIMEYASGGEVFDYLVAH--GRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLL----DADMNIKIAD 157 (328)
T ss_dssp --SSEEEEEECCCTTCBHHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE----CTTSCEEECS
T ss_pred --CCEEEEEEECCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEE----cCCCCEEEee
Confidence 23477999999999999999874 459999999999999999999999999999999999999 7888899999
Q ss_pred cCCcccccccccCCCCCCccCCCCccCchhhccccCC-CcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHHcCCCC
Q 039291 160 LGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQE-APSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEHS 238 (362)
Q Consensus 160 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 238 (362)
||++....... .....+||+.|+|||++.+..+. .++|||||||++|+|++|+.||.+. +..++...+....
T Consensus 158 FG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~---~~~~~~~~i~~~~- 230 (328)
T 3fe3_A 158 FGFSNEFTVGG---KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQ---NLKELRERVLRGK- 230 (328)
T ss_dssp TTCCGGGSSSC---GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCS---SHHHHHHHHHHCC-
T ss_pred ccCceecCCCC---ccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCC---CHHHHHHHHHhCC-
Confidence 99997654322 22456899999999999987765 7899999999999999999999654 4455555443332
Q ss_pred CCCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCccCcc
Q 039291 239 LPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGVD 281 (362)
Q Consensus 239 ~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~~~~~ 281 (362)
..+|..+++++.+||++||..||.+|||++++++||||+...
T Consensus 231 -~~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~~ 272 (328)
T 3fe3_A 231 -YRIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKDRWINAGH 272 (328)
T ss_dssp -CCCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTCTTTTTTC
T ss_pred -CCCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcCHhhcCCC
Confidence 245667899999999999999999999999999999998654
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-51 Score=385.94 Aligned_cols=262 Identities=23% Similarity=0.369 Sum_probs=222.5
Q ss_pred CCCCceeecceecccCceEEEEEEECCCCCCCCceeeeechhh------hhhHHHHHHHHHHHHcCCCCcccccccceee
Q 039291 3 SDGTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEV------SASASLQKEKEVFDNLNGCPFVLECFGEEIT 76 (362)
Q Consensus 3 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~------~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~ 76 (362)
+.-++|.+++.||+|+||.||+|+++.+++ .+|+|.+.. .....+.+|+.+++.++ ||||+++++.+..
T Consensus 12 v~~~~y~i~~~LG~G~fG~V~~~~~~~~~~----~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~-hp~Iv~l~~~~~~ 86 (384)
T 4fr4_A 12 VNFDHFEILRAIGKGSFGKVCIVQKNDTKK----MYAMKYMNKQKCVERNEVRNVFKELQIMQGLE-HPFLVNLWYSFQD 86 (384)
T ss_dssp CCGGGEEEEEEEECCTTCCEEEEEETTTCC----EEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCC-CTTBCCEEEEEEC
T ss_pred CChHHeEEEEEEeeCCCeEEEEEEECCCCC----EEEEEEEehhhcccHHHHHHHHHHHHHHHhCC-CCCCCcEEEEEEe
Confidence 455799999999999999999999998876 456665432 23466889999999998 9999999987642
Q ss_pred ecCCCceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEE
Q 039291 77 MGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAK 156 (362)
Q Consensus 77 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~k 156 (362)
...+|+||||+.||+|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+|
T Consensus 87 -----~~~~~lv~e~~~gg~L~~~l~~--~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll----~~~g~vk 155 (384)
T 4fr4_A 87 -----EEDMFMVVDLLLGGDLRYHLQQ--NVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILL----DEHGHVH 155 (384)
T ss_dssp -----SSEEEEEECCCTTEEHHHHHHT--TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE----CTTSCEE
T ss_pred -----CCEEEEEEecCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEE----CCCCCEE
Confidence 2347899999999999999986 4569999999999999999999999999999999999999 8888999
Q ss_pred EeecCCcccccccccCCCCCCccCCCCccCchhhcc---ccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHH
Q 039291 157 IADLGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQ---HMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSII 233 (362)
Q Consensus 157 l~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~ 233 (362)
|+|||+++..... ......+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.........++...+
T Consensus 156 L~DFG~a~~~~~~---~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~ 232 (384)
T 4fr4_A 156 ITDFNIAAMLPRE---TQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTF 232 (384)
T ss_dssp ECCCTTCEECCTT---CCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHH
T ss_pred EeccceeeeccCC---CceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHH
Confidence 9999999765432 22246789999999999974 45899999999999999999999999877666776666655
Q ss_pred cCCCCCCCCCccCCHHHHHHHHHHhccCCCCCCC-HHHHhcCCCccCcchhhh
Q 039291 234 GDEHSLPEIPSRVSKEARDFLRRCFVRKPAFRFT-AEMLLDDPFVKGVDEELS 285 (362)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s-~~~~l~~p~~~~~~~~~~ 285 (362)
... ...++..++.++.+||.+||..||.+||+ +++++.||||+.+.|+..
T Consensus 233 ~~~--~~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~hp~f~~~~w~~~ 283 (384)
T 4fr4_A 233 ETT--VVTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQNFPYMNDINWDAV 283 (384)
T ss_dssp HHC--CCCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHTSGGGTTCCHHHH
T ss_pred hhc--ccCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHcChhhhcCCHHHH
Confidence 433 23456789999999999999999999998 999999999999988744
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-52 Score=399.27 Aligned_cols=271 Identities=27% Similarity=0.416 Sum_probs=222.1
Q ss_pred CCCCceeecceecccCceEEEEEEECCCCCCCCceeeeechhhh------hhHHHHHHHHHHHHcCCCCcccccccceee
Q 039291 3 SDGTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVS------ASASLQKEKEVFDNLNGCPFVLECFGEEIT 76 (362)
Q Consensus 3 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~~------~~~~~~~E~~il~~l~~h~~i~~~~~~~~~ 76 (362)
...++|.+++.||+|+||+||+|+++.+++ .+|+|.+... ....+.+|..++..++ ||||+++++.+..
T Consensus 71 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~----~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~-hp~Iv~l~~~~~~ 145 (437)
T 4aw2_A 71 LHREDFEILKVIGRGAFGEVAVVKLKNADK----VFAMKILNKWEMLKRAETACFREERDVLVNGD-SKWITTLHYAFQD 145 (437)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTE----EEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSC-TTTBCCEEEEEEC
T ss_pred CChhheEEEEEEEeCCCEEEEEEEEcCCCc----EEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCC-CCCEEEEEEEEee
Confidence 456789999999999999999999998875 5566655331 2334889999999997 9999999987642
Q ss_pred ecCCCceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEE
Q 039291 77 MGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAK 156 (362)
Q Consensus 77 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~k 156 (362)
...+|+||||++||+|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+|
T Consensus 146 -----~~~~~lV~Ey~~gg~L~~~l~~~-~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl----~~~g~vk 215 (437)
T 4aw2_A 146 -----DNNLYLVMDYYVGGDLLTLLSKF-EDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILM----DMNGHIR 215 (437)
T ss_dssp -----SSEEEEEECCCTTCBHHHHHHTT-TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE----CTTSCEE
T ss_pred -----CCEEEEEEecCCCCcHHHHHHHc-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeE----cCCCCEE
Confidence 33578999999999999999863 3459999999999999999999999999999999999999 8888999
Q ss_pred EeecCCcccccccccCCCCCCccCCCCccCchhhc-----cccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHH
Q 039291 157 IADLGVAKRSRHCKRQKFDPSMRGTPLYLAPETVV-----QHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFS 231 (362)
Q Consensus 157 l~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~ 231 (362)
|+|||+++....... ......+||+.|+|||++. ...++.++|||||||++|||++|++||... +..+...
T Consensus 216 L~DFGla~~~~~~~~-~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~---~~~~~~~ 291 (437)
T 4aw2_A 216 LADFGSCLKLMEDGT-VQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAE---SLVETYG 291 (437)
T ss_dssp ECCCTTCEECCTTSC-EECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCS---SHHHHHH
T ss_pred EcchhhhhhcccCCC-cccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCC---ChhHHHH
Confidence 999999976543222 1223568999999999997 457899999999999999999999999654 3444444
Q ss_pred HHcC---CCCCCCCCccCCHHHHHHHHHHhccCCCC--CCCHHHHhcCCCccCcchhhhhhhhCCC
Q 039291 232 IIGD---EHSLPEIPSRVSKEARDFLRRCFVRKPAF--RFTAEMLLDDPFVKGVDEELSRELEGDY 292 (362)
Q Consensus 232 ~~~~---~~~~~~~~~~~~~~~~~li~~~l~~~p~~--R~s~~~~l~~p~~~~~~~~~~~~~~~~~ 292 (362)
.+.. ...+|.....+++++++||++||..+|++ |++++++++||||++++|+..+....++
T Consensus 292 ~i~~~~~~~~~p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~~i~w~~l~~~~~p~ 357 (437)
T 4aw2_A 292 KIMNHKERFQFPTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSGIDWDNIRNCEAPY 357 (437)
T ss_dssp HHHTHHHHCCCCSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGTTCCTTTGGGSCCSC
T ss_pred hhhhccccccCCcccccCCHHHHHHHHHHhcccccccCCCCHHHHhCCCccCCCCHHHHhhCCCCC
Confidence 4432 23445555669999999999999988888 9999999999999999988765554444
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-52 Score=384.26 Aligned_cols=261 Identities=28% Similarity=0.449 Sum_probs=218.8
Q ss_pred CCCCceeecceecccCceEEEEEEECCCCCCCCceeeeechhh------hhhHHHHHHHHHHHHcCCCCcccccccceee
Q 039291 3 SDGTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEV------SASASLQKEKEVFDNLNGCPFVLECFGEEIT 76 (362)
Q Consensus 3 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~------~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~ 76 (362)
..-++|.+++.||+|+||+||+|+++.+++ .+|+|.... .....+.+|..++..+.+||||+++++.+..
T Consensus 14 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~----~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~ 89 (345)
T 1xjd_A 14 LKIEDFILHKMLGKGSFGKVFLAEFKKTNQ----FFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQT 89 (345)
T ss_dssp --CTTEEEEEEEEECSSSEEEEEEETTTTE----EEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred CChHHeEEEEEEeeCCCeEEEEEEECCCCC----EEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEe
Confidence 345799999999999999999999998875 566665543 2345678899999988669999999987642
Q ss_pred ecCCCceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEE
Q 039291 77 MGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAK 156 (362)
Q Consensus 77 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~k 156 (362)
...+|+||||++||+|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+|
T Consensus 90 -----~~~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll----~~~g~vk 158 (345)
T 1xjd_A 90 -----KENLFFVMEYLNGGDLMYHIQSC--HKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILL----DKDGHIK 158 (345)
T ss_dssp -----SSEEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE----CTTSCEE
T ss_pred -----CCEEEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEE----CCCCCEE
Confidence 23578999999999999999874 459999999999999999999999999999999999999 7888999
Q ss_pred EeecCCcccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHHcCC
Q 039291 157 IADLGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDE 236 (362)
Q Consensus 157 l~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 236 (362)
|+|||+++...... ......+||+.|+|||++.+..++.++|||||||++|+|++|..||... +..++...+...
T Consensus 159 L~DFG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~---~~~~~~~~i~~~ 233 (345)
T 1xjd_A 159 IADFGMCKENMLGD--AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQ---DEEELFHSIRMD 233 (345)
T ss_dssp ECCCTTCBCCCCTT--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS---SHHHHHHHHHHC
T ss_pred EeEChhhhhcccCC--CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCC---CHHHHHHHHHhC
Confidence 99999997543221 2224678999999999999999999999999999999999999999654 445555555333
Q ss_pred CCCCCCCccCCHHHHHHHHHHhccCCCCCCCHH-HHhcCCCccCcchhhh
Q 039291 237 HSLPEIPSRVSKEARDFLRRCFVRKPAFRFTAE-MLLDDPFVKGVDEELS 285 (362)
Q Consensus 237 ~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~-~~l~~p~~~~~~~~~~ 285 (362)
. +.++..++.++++||.+||..||++||++. +++.||||+.+.|+..
T Consensus 234 ~--~~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~hp~f~~~~w~~l 281 (345)
T 1xjd_A 234 N--PFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREINWEEL 281 (345)
T ss_dssp C--CCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTTCCHHHH
T ss_pred C--CCCCcccCHHHHHHHHHHhcCCHhHcCCChHHHHcCccccCCCHHHH
Confidence 2 345677999999999999999999999998 9999999999988744
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-51 Score=372.54 Aligned_cols=257 Identities=26% Similarity=0.422 Sum_probs=213.3
Q ss_pred CCCceeecceecccCceEEEEEEECCCCCCCCceeeeechh---hhhhHHHHHHHHHHHHcCCCCcccccccceeeecCC
Q 039291 4 DGTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAE---VSASASLQKEKEVFDNLNGCPFVLECFGEEITMGEN 80 (362)
Q Consensus 4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~---~~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~ 80 (362)
..++|.+.+.||+|+||+||+|++..++. .|++|... ......+.+|+.+++.++ ||||+++++.+..
T Consensus 18 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~----~vaiK~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~---- 88 (297)
T 3fxz_A 18 PKKKYTRFEKIGQGASGTVYTAMDVATGQ----EVAIRQMNLQQQPKKELIINEILVMRENK-NPNIVNYLDSYLV---- 88 (297)
T ss_dssp GGGTBCCCEEEEEETTEEEEEEEBTTTCC----EEEEEEEEGGGCSCHHHHHHHHHHHHHCC-CTTBCCEEEEEEE----
T ss_pred hhhceeeeeeeccCCCeEEEEEEECCCCc----EEEEEEeecccccHHHHHHHHHHHHhcCC-CCCCCeEeEEEEE----
Confidence 45789999999999999999999988875 55666543 234566889999999998 8999999997653
Q ss_pred CceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEeec
Q 039291 81 GEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADL 160 (362)
Q Consensus 81 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Df 160 (362)
...+++||||++|++|.+++.. ..+++..++.++.|++.||.|||++||+||||||+|||+ +.++.+||+||
T Consensus 89 -~~~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~----~~~~~~kl~Df 160 (297)
T 3fxz_A 89 -GDELWVVMEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILL----GMDGSVKLTDF 160 (297)
T ss_dssp -TTEEEEEEECCTTCBHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE----CTTCCEEECCC
T ss_pred -CCEEEEEEECCCCCCHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEE----CCCCCEEEeeC
Confidence 2247799999999999999986 349999999999999999999999999999999999999 77888999999
Q ss_pred CCcccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHHcCCCCCC
Q 039291 161 GVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEHSLP 240 (362)
Q Consensus 161 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 240 (362)
|++........ ......||+.|+|||++.+..++.++|||||||++|+|++|..||...+. ...............
T Consensus 161 g~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~--~~~~~~~~~~~~~~~ 236 (297)
T 3fxz_A 161 GFCAQITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP--LRALYLIATNGTPEL 236 (297)
T ss_dssp TTCEECCSTTC--CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH--HHHHHHHHHHCSCCC
T ss_pred CCceecCCccc--ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHhCCCCCC
Confidence 99876554322 22456799999999999999999999999999999999999999965432 222222222222233
Q ss_pred CCCccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCccCcc
Q 039291 241 EIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGVD 281 (362)
Q Consensus 241 ~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~~~~~ 281 (362)
..+..++..+++||.+||..||++|||+.++++||||+...
T Consensus 237 ~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~~ 277 (297)
T 3fxz_A 237 QNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHQFLKIAK 277 (297)
T ss_dssp SCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred CCccccCHHHHHHHHHHccCChhHCcCHHHHhhChhhcccC
Confidence 45678999999999999999999999999999999997653
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-52 Score=382.98 Aligned_cols=260 Identities=27% Similarity=0.364 Sum_probs=218.1
Q ss_pred CCCceeecceecccCceEEEEEEECCCCCCCCceeeeechhh------hhhHHHHHHHHHHHHcCCCCcccccccceeee
Q 039291 4 DGTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEV------SASASLQKEKEVFDNLNGCPFVLECFGEEITM 77 (362)
Q Consensus 4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~------~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~ 77 (362)
.-++|.+++.||+|+||+||+|+++.+++ .+|+|.... .....+.+|..++..+.+||+|+++++.+..
T Consensus 18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~----~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~- 92 (353)
T 2i0e_A 18 KLTDFNFLMVLGKGSFGKVMLSERKGTDE----LYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQT- 92 (353)
T ss_dssp -CTTEEEEEEEEEETTEEEEEEEETTEEE----EEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEEC-
T ss_pred chHHcEEEEEEeeCCCEEEEEEEECCCCC----EEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEc-
Confidence 34789999999999999999999998775 566666533 2345678899999998779999999987642
Q ss_pred cCCCceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEE
Q 039291 78 GENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKI 157 (362)
Q Consensus 78 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl 157 (362)
...+|+||||++||+|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||
T Consensus 93 ----~~~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll----~~~g~vkL 162 (353)
T 2i0e_A 93 ----MDRLYFVMEYVNGGDLMYHIQQV--GRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVML----DSEGHIKI 162 (353)
T ss_dssp ----SSEEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE----CTTSCEEE
T ss_pred ----CCEEEEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEE----cCCCcEEE
Confidence 23578999999999999999874 459999999999999999999999999999999999999 88889999
Q ss_pred eecCCcccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHHcCCC
Q 039291 158 ADLGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEH 237 (362)
Q Consensus 158 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 237 (362)
+|||+++...... ......+||+.|+|||++.+..++.++|||||||++|||++|++||... +..++...+....
T Consensus 163 ~DFG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~---~~~~~~~~i~~~~ 237 (353)
T 2i0e_A 163 ADFGMCKENIWDG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGE---DEDELFQSIMEHN 237 (353)
T ss_dssp CCCTTCBCCCCTT--CCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCS---SHHHHHHHHHHCC
T ss_pred EeCCcccccccCC--cccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCC---CHHHHHHHHHhCC
Confidence 9999997543221 2224678999999999999999999999999999999999999999654 4455555554332
Q ss_pred CCCCCCccCCHHHHHHHHHHhccCCCCCCC-----HHHHhcCCCccCcchhhh
Q 039291 238 SLPEIPSRVSKEARDFLRRCFVRKPAFRFT-----AEMLLDDPFVKGVDEELS 285 (362)
Q Consensus 238 ~~~~~~~~~~~~~~~li~~~l~~~p~~R~s-----~~~~l~~p~~~~~~~~~~ 285 (362)
..+|..++.++++||.+||..||.+||+ +++++.||||+.+.|+..
T Consensus 238 --~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h~~f~~~~w~~l 288 (353)
T 2i0e_A 238 --VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEKL 288 (353)
T ss_dssp --CCCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTSGGGTTCCHHHH
T ss_pred --CCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCccccCCCHHHH
Confidence 2456789999999999999999999994 699999999999988754
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-51 Score=380.03 Aligned_cols=263 Identities=27% Similarity=0.436 Sum_probs=217.1
Q ss_pred CCCceeecceecccCceEEEEEEECCCCCCCCceeeeechhh------hhhHHHHHHHHHHHHcCCCCcccccccceeee
Q 039291 4 DGTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEV------SASASLQKEKEVFDNLNGCPFVLECFGEEITM 77 (362)
Q Consensus 4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~------~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~ 77 (362)
.-++|.+++.||+|+||+||+|+++.+++ .+++|.... .....+.+|..+++++.+||||+++++.+..
T Consensus 7 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~----~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~- 81 (345)
T 3a8x_A 7 GLQDFDLLRVIGRGSYAKVLLVRLKKTDR----IYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQT- 81 (345)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTE----EEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC-
T ss_pred chhheEEEEEEEecCCeEEEEEEECCCCC----EEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEe-
Confidence 45789999999999999999999998876 455555432 2345678999999998669999999987642
Q ss_pred cCCCceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEE
Q 039291 78 GENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKI 157 (362)
Q Consensus 78 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl 157 (362)
...+|+||||++||+|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||
T Consensus 82 ----~~~~~lv~e~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll----~~~g~~kL 151 (345)
T 3a8x_A 82 ----ESRLFFVIEYVNGGDLMFHMQRQ--RKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLL----DSEGHIKL 151 (345)
T ss_dssp ----SSEEEEEECCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE----CTTSCEEE
T ss_pred ----CCEEEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEE----CCCCCEEE
Confidence 23578999999999999999874 459999999999999999999999999999999999999 78889999
Q ss_pred eecCCcccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHhCCCCCccCCC------CCHHHHHH
Q 039291 158 ADLGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKED------CSIDQLFS 231 (362)
Q Consensus 158 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~------~~~~~~~~ 231 (362)
+|||+++...... ......+||+.|+|||++.+..++.++|||||||++|+|++|..||..... .....+..
T Consensus 152 ~DFG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~ 229 (345)
T 3a8x_A 152 TDYGMCKEGLRPG--DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQ 229 (345)
T ss_dssp CCGGGCBCSCCTT--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHH
T ss_pred EeccccccccCCC--CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHH
Confidence 9999997543221 222467899999999999999999999999999999999999999964221 22333444
Q ss_pred HHcCCCCCCCCCccCCHHHHHHHHHHhccCCCCCCCH------HHHhcCCCccCcchhhh
Q 039291 232 IIGDEHSLPEIPSRVSKEARDFLRRCFVRKPAFRFTA------EMLLDDPFVKGVDEELS 285 (362)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~------~~~l~~p~~~~~~~~~~ 285 (362)
.+.... ..+|..++.++++||.+||..||.+||++ ++++.||||+.+.|+..
T Consensus 230 ~i~~~~--~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~~~w~~~ 287 (345)
T 3a8x_A 230 VILEKQ--IRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDMM 287 (345)
T ss_dssp HHHHCC--CCCCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGTTCCHHHH
T ss_pred HHHcCC--CCCCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccCCCCHHHH
Confidence 443222 24567899999999999999999999985 89999999999988743
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-51 Score=374.39 Aligned_cols=256 Identities=24% Similarity=0.405 Sum_probs=216.6
Q ss_pred CCCceeecceecccCceEEEEEEECCCCCCCCceeeeechhh------hhhHHHHHHHHHHHHcCCCCcccccccceeee
Q 039291 4 DGTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEV------SASASLQKEKEVFDNLNGCPFVLECFGEEITM 77 (362)
Q Consensus 4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~------~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~ 77 (362)
.-++|.+++.||+|+||+||+|+++.+++ .+++|.... .....+.+|+.+++.++ ||||+++++.+..
T Consensus 4 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~----~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~Iv~~~~~~~~- 77 (318)
T 1fot_A 4 SLQDFQILRTLGTGSFGRVHLIRSRHNGR----YYAMKVLKKEIVVRLKQVEHTNDERLMLSIVT-HPFIIRMWGTFQD- 77 (318)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCC----EEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCC-BTTBCCEEEEEEC-
T ss_pred ChHHcEEEEEEeeCCCEEEEEEEECCCCC----EEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCC-CCCCceEeEEEEe-
Confidence 44789999999999999999999998876 456665432 23456788999999997 9999999987642
Q ss_pred cCCCceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEE
Q 039291 78 GENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKI 157 (362)
Q Consensus 78 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl 157 (362)
...+|+||||++||+|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||
T Consensus 78 ----~~~~~lv~e~~~gg~L~~~l~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll----~~~g~~kL 147 (318)
T 1fot_A 78 ----AQQIFMIMDYIEGGELFSLLRK--SQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILL----DKNGHIKI 147 (318)
T ss_dssp ----SSEEEEEECCCCSCBHHHHHHH--TSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEE----CTTSCEEE
T ss_pred ----CCEEEEEEeCCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEE----cCCCCEEE
Confidence 2357899999999999999987 4459999999999999999999999999999999999999 78889999
Q ss_pred eecCCcccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHHcCCC
Q 039291 158 ADLGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEH 237 (362)
Q Consensus 158 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 237 (362)
+|||+++.... .....+||+.|+|||++.+..++.++|||||||++|+|++|..||... +.......+....
T Consensus 148 ~Dfg~a~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~---~~~~~~~~i~~~~ 219 (318)
T 1fot_A 148 TDFGFAKYVPD-----VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDS---NTMKTYEKILNAE 219 (318)
T ss_dssp CCCSSCEECSS-----CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCS---SHHHHHHHHHHCC
T ss_pred eecCcceecCC-----ccccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCC---CHHHHHHHHHhCC
Confidence 99999976543 123568999999999999999999999999999999999999999654 3444444443322
Q ss_pred CCCCCCccCCHHHHHHHHHHhccCCCCCC-----CHHHHhcCCCccCcchhhh
Q 039291 238 SLPEIPSRVSKEARDFLRRCFVRKPAFRF-----TAEMLLDDPFVKGVDEELS 285 (362)
Q Consensus 238 ~~~~~~~~~~~~~~~li~~~l~~~p~~R~-----s~~~~l~~p~~~~~~~~~~ 285 (362)
..++..++.++++||.+||..||++|+ +++++++||||+.+.|+..
T Consensus 220 --~~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~hp~f~~~~~~~~ 270 (318)
T 1fot_A 220 --LRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVWEKL 270 (318)
T ss_dssp --CCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSCCHHHH
T ss_pred --CCCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcCccccCCCHHHH
Confidence 245667899999999999999999999 8999999999999988754
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-52 Score=380.31 Aligned_cols=258 Identities=28% Similarity=0.447 Sum_probs=210.5
Q ss_pred CCceeecceecccCceEEEEEEECCCCCCCCceeeeechh----hhhhHHHHHHHHHHHHcCCCCcccccccceeeecCC
Q 039291 5 GTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAE----VSASASLQKEKEVFDNLNGCPFVLECFGEEITMGEN 80 (362)
Q Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~----~~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~ 80 (362)
-++|.+++.||+|+||+||+|+++.+++ .+++|... ......+.+|+.+++.++ ||||+++++++..
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~----~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~---- 76 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEE----AVAVKIVDMKRAVDCPENIKKEICINKMLN-HENVVKFYGHRRE---- 76 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCC----EEEEEEEECC-------CHHHHHHHHHHCC-CTTBCCEEEEEEC----
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCc----EEEEEEEEcccccchHHHHHHHHHHHHhCC-CCCCCeEEEEEec----
Confidence 4789999999999999999999998876 45666543 223466889999999998 9999999987642
Q ss_pred CceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEeec
Q 039291 81 GEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADL 160 (362)
Q Consensus 81 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Df 160 (362)
...+++||||++|++|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+||
T Consensus 77 -~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll----~~~~~~kl~Df 149 (323)
T 3tki_A 77 -GNIQYLFLEYCSGGELFDRIEP--DIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLL----DERDNLKISDF 149 (323)
T ss_dssp -SSEEEEEEECCTTEEGGGGSBT--TTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE----CTTCCEEECCC
T ss_pred -CCeEEEEEEcCCCCcHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEE----eCCCCEEEEEe
Confidence 2346799999999999999875 4459999999999999999999999999999999999999 77888999999
Q ss_pred CCcccccccccCCCCCCccCCCCccCchhhccccC-CCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHHcCCCCC
Q 039291 161 GVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQ-EAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEHSL 239 (362)
Q Consensus 161 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 239 (362)
|+++...............||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.......... .........
T Consensus 150 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~--~~~~~~~~~ 227 (323)
T 3tki_A 150 GLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEY--SDWKEKKTY 227 (323)
T ss_dssp TTCEECEETTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHH--HHHHTTCTT
T ss_pred eccceeccCCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHH--HHHhccccc
Confidence 99986654333333346789999999999987765 778999999999999999999997655433222 222222222
Q ss_pred CCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCccCc
Q 039291 240 PEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGV 280 (362)
Q Consensus 240 ~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~~~~ 280 (362)
......++.++.+||.+||..||++|||++++++||||+..
T Consensus 228 ~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~ 268 (323)
T 3tki_A 228 LNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKP 268 (323)
T ss_dssp STTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCC
T ss_pred CCccccCCHHHHHHHHHHccCChhhCcCHHHHhhChhhccc
Confidence 23346789999999999999999999999999999999764
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-51 Score=382.54 Aligned_cols=265 Identities=24% Similarity=0.386 Sum_probs=213.7
Q ss_pred CCceeecceecccCceEEEEEEECCCCCCCCceeeeechhhh-----hhHHHHHHHHHHHHcCCCCcccccccceeeecC
Q 039291 5 GTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVS-----ASASLQKEKEVFDNLNGCPFVLECFGEEITMGE 79 (362)
Q Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~~-----~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~ 79 (362)
.++|.+++.||+|+||+||+|+++.++..++.++..|..... ....+.+|+.+++.++ ||||+++++++..
T Consensus 11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~--- 86 (361)
T 2yab_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVL-HPNIITLHDVYEN--- 86 (361)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCC-CTTBCCEEEEEEC---
T ss_pred hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCC-CcCCCcEEEEEEe---
Confidence 468999999999999999999999888644333333222111 2356889999999998 9999999987642
Q ss_pred CCceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEee
Q 039291 80 NGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIAD 159 (362)
Q Consensus 80 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~D 159 (362)
...+++||||++||+|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||+..++.....+||+|
T Consensus 87 --~~~~~lv~e~~~gg~L~~~l~~--~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~D 162 (361)
T 2yab_A 87 --RTDVVLILELVSGGELFDFLAQ--KESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLID 162 (361)
T ss_dssp --SSEEEEEEECCCSCBHHHHHTT--CSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECC
T ss_pred --CCEEEEEEEcCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEe
Confidence 3357899999999999999976 456999999999999999999999999999999999999943322223799999
Q ss_pred cCCcccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHHcCCCC-
Q 039291 160 LGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEHS- 238 (362)
Q Consensus 160 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~- 238 (362)
||++....... .....+||+.|+|||++.+..++.++|||||||++|+|++|.+||.+. +..+.+..+.....
T Consensus 163 FG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~---~~~~~~~~i~~~~~~ 236 (361)
T 2yab_A 163 FGLAHEIEDGV---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGD---TKQETLANITAVSYD 236 (361)
T ss_dssp CSSCEECCTTC---CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCS---SHHHHHHHHHTTCCC
T ss_pred cCCceEcCCCC---ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCC---CHHHHHHHHHhcCCC
Confidence 99998655422 224567999999999999989999999999999999999999999654 34455555443322
Q ss_pred C-CCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCccCcchh
Q 039291 239 L-PEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGVDEE 283 (362)
Q Consensus 239 ~-~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~~~~~~~ 283 (362)
+ +..+..++.++++||.+||..||.+|||+.++++||||+...+.
T Consensus 237 ~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~~~ 282 (361)
T 2yab_A 237 FDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDTQ 282 (361)
T ss_dssp CCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTSCSSHH
T ss_pred CCchhccCCCHHHHHHHHHHCCCChhHCcCHHHHhcCcCcCCCchh
Confidence 1 12235689999999999999999999999999999999987654
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-52 Score=382.64 Aligned_cols=261 Identities=24% Similarity=0.311 Sum_probs=217.5
Q ss_pred CceeecceecccCceEEEEEEECCCCCCCCceeeeechhhhhhHHHHHHHHHHHHcCCCCcccccccceeeecCCCceEE
Q 039291 6 TSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVSASASLQKEKEVFDNLNGCPFVLECFGEEITMGENGEMAY 85 (362)
Q Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~~~~~~ 85 (362)
++|.+++.||+|+||+||+|+++.+++ .+++|...... ....+|++++.++.+||||+++++++.. ...+
T Consensus 22 ~~y~~~~~lG~G~~g~V~~~~~~~~~~----~~avK~~~~~~-~~~~~E~~~l~~~~~hp~iv~~~~~~~~-----~~~~ 91 (342)
T 2qr7_A 22 DGYEVKEDIGVGSYSVCKRCIHKATNM----EFAVKIIDKSK-RDPTEEIEILLRYGQHPNIITLKDVYDD-----GKYV 91 (342)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTE----EEEEEEEETTT-CCCHHHHHHHHHHTTSTTBCCEEEEEEC-----SSEE
T ss_pred ccEEEEEEEeeCCCEEEEEEEECCCCC----EEEEEEEEccc-CChHHHHHHHHHhcCCCCcCeEEEEEEc-----CCEE
Confidence 579999999999999999999998875 56777765432 2356799999999779999999987642 3357
Q ss_pred EEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEeecCCccc
Q 039291 86 NLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKR 165 (362)
Q Consensus 86 ~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Dfgla~~ 165 (362)
|+||||++||+|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||+...+...+.+||+|||+++.
T Consensus 92 ~lv~E~~~gg~L~~~i~~--~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~ 169 (342)
T 2qr7_A 92 YVVTELMKGGELLDKILR--QKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQ 169 (342)
T ss_dssp EEEECCCCSCBHHHHHHT--CTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEE
T ss_pred EEEEeCCCCCcHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCccc
Confidence 899999999999999976 456999999999999999999999999999999999999954434445699999999986
Q ss_pred ccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHHcCCCCC--CCCC
Q 039291 166 SRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEHSL--PEIP 243 (362)
Q Consensus 166 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~--~~~~ 243 (362)
...... .....+||+.|+|||++.+..++.++|||||||++|+|++|..||.........++...+...... ...+
T Consensus 170 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~ 247 (342)
T 2qr7_A 170 LRAENG--LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYW 247 (342)
T ss_dssp CBCTTC--CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCCCSTTT
T ss_pred CcCCCC--ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcccCcccc
Confidence 554222 224567999999999999888999999999999999999999999876666677776666543322 2234
Q ss_pred ccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCccCc
Q 039291 244 SRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGV 280 (362)
Q Consensus 244 ~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~~~~ 280 (362)
..++.++++||++||..||++||++.++++||||..+
T Consensus 248 ~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~ 284 (342)
T 2qr7_A 248 NSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVHW 284 (342)
T ss_dssp TTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHTG
T ss_pred ccCCHHHHHHHHHHCCCChhHCcCHHHHhcCCeecCc
Confidence 6789999999999999999999999999999999764
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-52 Score=390.65 Aligned_cols=265 Identities=29% Similarity=0.418 Sum_probs=215.5
Q ss_pred CCCCceeecceecccCceEEEEEEECCCCCCCCceeeeechhh------hhhHHHHHHHHHHHHcCCCCcccccccceee
Q 039291 3 SDGTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEV------SASASLQKEKEVFDNLNGCPFVLECFGEEIT 76 (362)
Q Consensus 3 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~------~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~ 76 (362)
...++|.+++.||+|+||+||+|+++.+++ .+|+|.+.. .....+.+|..++..++ ||||+++++.+..
T Consensus 58 ~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~----~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~-hp~Iv~l~~~~~~ 132 (412)
T 2vd5_A 58 LQRDDFEILKVIGRGAFSEVAVVKMKQTGQ----VYAMKIMNKWDMLKRGEVSCFREERDVLVNGD-RRWITQLHFAFQD 132 (412)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCC----EEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSC-TTTBCCEEEEEEC
T ss_pred CChhhEEEEEEEeeCCCeEEEEEEECCCCC----EEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcC-CCCeeeEEEEEee
Confidence 456789999999999999999999998876 556665532 23345789999999998 9999999987642
Q ss_pred ecCCCceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEE
Q 039291 77 MGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAK 156 (362)
Q Consensus 77 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~k 156 (362)
...+|+||||++||+|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+|
T Consensus 133 -----~~~~~lVmE~~~gg~L~~~l~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl----d~~g~vk 202 (412)
T 2vd5_A 133 -----ENYLYLVMEYYVGGDLLTLLSKFG-ERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILL----DRCGHIR 202 (412)
T ss_dssp -----SSEEEEEECCCCSCBHHHHHHHHS-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE----CTTSCEE
T ss_pred -----CCEEEEEEcCCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeee----cCCCCEE
Confidence 335789999999999999998743 469999999999999999999999999999999999999 8888999
Q ss_pred EeecCCcccccccccCCCCCCccCCCCccCchhhc-------cccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHH
Q 039291 157 IADLGVAKRSRHCKRQKFDPSMRGTPLYLAPETVV-------QHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQL 229 (362)
Q Consensus 157 l~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~ 229 (362)
|+|||+++....... ......+||+.|+|||++. ...++.++|||||||++|||++|+.||... +..+.
T Consensus 203 L~DFGla~~~~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~---~~~~~ 278 (412)
T 2vd5_A 203 LADFGSCLKLRADGT-VRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYAD---STAET 278 (412)
T ss_dssp ECCCTTCEECCTTSC-EECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCS---SHHHH
T ss_pred EeechhheeccCCCc-cccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCC---CHHHH
Confidence 999999976543221 1123568999999999998 356899999999999999999999999654 34444
Q ss_pred HHHHcC---CCCCCCCCccCCHHHHHHHHHHhccCCCCC---CCHHHHhcCCCccCcchhhhhh
Q 039291 230 FSIIGD---EHSLPEIPSRVSKEARDFLRRCFVRKPAFR---FTAEMLLDDPFVKGVDEELSRE 287 (362)
Q Consensus 230 ~~~~~~---~~~~~~~~~~~~~~~~~li~~~l~~~p~~R---~s~~~~l~~p~~~~~~~~~~~~ 287 (362)
+..+.. ...+|..+..++.++++||++||. +|.+| +++++++.||||+.+.|+....
T Consensus 279 ~~~i~~~~~~~~~p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff~~i~w~~l~~ 341 (412)
T 2vd5_A 279 YGKIVHYKEHLSLPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFFGLDWDGLRD 341 (412)
T ss_dssp HHHHHTHHHHCCCC----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGGTTCCSTTSTT
T ss_pred HHHHHhcccCcCCCccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCcCCCCHHHHhh
Confidence 444432 233454556799999999999999 99998 5899999999999998875443
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-51 Score=386.40 Aligned_cols=259 Identities=27% Similarity=0.425 Sum_probs=214.2
Q ss_pred CCCCceeecceecccCceEEEEEEECCCCCCCCceeeeechhh------hhhHHHHHHHHHHHHcCCCCcccccccceee
Q 039291 3 SDGTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEV------SASASLQKEKEVFDNLNGCPFVLECFGEEIT 76 (362)
Q Consensus 3 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~------~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~ 76 (362)
...++|.+++.||+|+||+||+|+++.+++ .+|+|.+.. .....+.+|+.+++.++ ||||+++++.+..
T Consensus 66 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~----~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~-hp~Iv~l~~~~~~ 140 (410)
T 3v8s_A 66 MKAEDYEVVKVIGRGAFGEVQLVRHKSTRK----VYAMKLLSKFEMIKRSDSAFFWEERDIMAFAN-SPWVVQLFYAFQD 140 (410)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCC----EEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCC-CTTBCCEEEEEEC
T ss_pred cCccccEEEEEEEcCCCEEEEEEEECCCCc----EEEEEEEehhhhhhhHHHHHHHHHHHHHHhCC-CCCCCeEEEEEEE
Confidence 345789999999999999999999998876 456665432 23345789999999998 9999999987642
Q ss_pred ecCCCceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEE
Q 039291 77 MGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAK 156 (362)
Q Consensus 77 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~k 156 (362)
...+|+||||++||+|.++++. ..+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+|
T Consensus 141 -----~~~~~lV~E~~~gg~L~~~l~~---~~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl----~~~g~ik 208 (410)
T 3v8s_A 141 -----DRYLYMVMEYMPGGDLVNLMSN---YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLL----DKSGHLK 208 (410)
T ss_dssp -----SSEEEEEECCCTTEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE----CTTSCEE
T ss_pred -----CCEEEEEEeCCCCCcHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeE----CCCCCEE
Confidence 3357899999999999999976 349999999999999999999999999999999999999 8888999
Q ss_pred EeecCCcccccccccCCCCCCccCCCCccCchhhcccc----CCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHH
Q 039291 157 IADLGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHM----QEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSI 232 (362)
Q Consensus 157 l~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~ 232 (362)
|+|||+++....... ......+||+.|+|||++.+.. ++.++|||||||++|||++|++||... +.......
T Consensus 209 L~DFG~a~~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~---~~~~~~~~ 284 (410)
T 3v8s_A 209 LADFGTCMKMNKEGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYAD---SLVGTYSK 284 (410)
T ss_dssp ECCCTTCEECCTTSE-EECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCS---SHHHHHHH
T ss_pred EeccceeEeeccCCc-ccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCC---ChhhHHHH
Confidence 999999976543221 1224678999999999998765 788999999999999999999999654 44555555
Q ss_pred HcCC---CCCCCCCccCCHHHHHHHHHHhccCCCC--CCCHHHHhcCCCccCcchh
Q 039291 233 IGDE---HSLPEIPSRVSKEARDFLRRCFVRKPAF--RFTAEMLLDDPFVKGVDEE 283 (362)
Q Consensus 233 ~~~~---~~~~~~~~~~~~~~~~li~~~l~~~p~~--R~s~~~~l~~p~~~~~~~~ 283 (362)
+... ..+|. +..++.++++||.+||..+|.+ |++++++++||||+++.|.
T Consensus 285 i~~~~~~~~~p~-~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~~~~w~ 339 (410)
T 3v8s_A 285 IMNHKNSLTFPD-DNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQWA 339 (410)
T ss_dssp HHTHHHHCCCCT-TCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSGGGCCSSCC
T ss_pred HHhccccccCCC-cccccHHHHHHHHHHccChhhhCCCCCHHHHhcCccccCCCHH
Confidence 5432 22222 3468999999999999999988 9999999999999998664
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-50 Score=370.18 Aligned_cols=259 Identities=22% Similarity=0.385 Sum_probs=207.7
Q ss_pred CCceeecceecccCceEEEEEEECCCCCCCCceeeeechhhh-----hhHHHHHHHHHHHHcCCCCcccccccceeeecC
Q 039291 5 GTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVS-----ASASLQKEKEVFDNLNGCPFVLECFGEEITMGE 79 (362)
Q Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~~-----~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~ 79 (362)
.++|.+++.||+|+||+||+|++.. ++ .+++|..... ....+.+|+.++++++ ||||+++++++..
T Consensus 20 ~~~y~~~~~lG~G~~g~V~~~~~~~-~~----~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~--- 90 (311)
T 3niz_A 20 MEKYQKLEKVGEGTYGVVYKAKDSQ-GR----IVALKRIRLDAEDEGIPSTAIREISLLKELH-HPNIVSLIDVIHS--- 90 (311)
T ss_dssp SCEEEEEEEEEECSSCEEEEEEETT-SC----EEEEEEEC------CHHHHHHHHHHHHHHCC-CTTBCCEEEEECC---
T ss_pred HhhhHhhhhccCCCCeEEEEEEECC-CC----EEEEEEEecccccchhhHHHHHHHHHHHHcC-CCCEeeeeeEEcc---
Confidence 5799999999999999999999865 33 5677765422 3356889999999998 9999999987642
Q ss_pred CCceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEee
Q 039291 80 NGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIAD 159 (362)
Q Consensus 80 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~D 159 (362)
...+++||||+++ +|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|
T Consensus 91 --~~~~~lv~e~~~~-~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~----~~~~~~kl~D 162 (311)
T 3niz_A 91 --ERCLTLVFEFMEK-DLKKVLDEN-KTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLI----NSDGALKLAD 162 (311)
T ss_dssp --SSCEEEEEECCSE-EHHHHHHTC-TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE----CTTCCEEECC
T ss_pred --CCEEEEEEcCCCC-CHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEE----CCCCCEEEcc
Confidence 3347799999985 888888763 3559999999999999999999999999999999999999 7788899999
Q ss_pred cCCcccccccccCCCCCCccCCCCccCchhhcc-ccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHHcCCCC
Q 039291 160 LGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQ-HMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEHS 238 (362)
Q Consensus 160 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 238 (362)
||+++...... .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+....+....+........
T Consensus 163 fg~a~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~ 240 (311)
T 3niz_A 163 FGLARAFGIPV--RSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPN 240 (311)
T ss_dssp CTTCEETTSCC--C---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCC
T ss_pred CcCceecCCCc--ccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCC
Confidence 99998654322 12234678999999999986 5689999999999999999999999987665554443333222111
Q ss_pred CC-------------------------CCCccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCccCcch
Q 039291 239 LP-------------------------EIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGVDE 282 (362)
Q Consensus 239 ~~-------------------------~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~~~~~~ 282 (362)
.. .+...+++++.+||.+||..||++|||++++++||||+.+..
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~ 309 (311)
T 3niz_A 241 PREWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDLDP 309 (311)
T ss_dssp TTTSGGGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTSCT
T ss_pred hHHhhhhhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCcccccCCc
Confidence 11 112346789999999999999999999999999999998754
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-51 Score=370.09 Aligned_cols=267 Identities=24% Similarity=0.390 Sum_probs=208.9
Q ss_pred CCCCceeecceecccCceEEEEEEECCCCCCCCceeeeechhhh--------hhHHHHHHHHHHHHcC--CCCccccccc
Q 039291 3 SDGTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVS--------ASASLQKEKEVFDNLN--GCPFVLECFG 72 (362)
Q Consensus 3 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~~--------~~~~~~~E~~il~~l~--~h~~i~~~~~ 72 (362)
...++|.+++.||+|+||+||+|+++.+++ .|++|..... ....+.+|+.+++.+. .||||+++++
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~----~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~ 81 (308)
T 3g33_A 6 MATSRYEPVAEIGVGAYGTVYKARDPHSGH----FVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMD 81 (308)
T ss_dssp ----CCEEEEEECCSSSCCEEEEECTTTCC----EEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEE
T ss_pred ccccceEEEEEEecCCCeEEEEEEECCCCc----EEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeee
Confidence 456899999999999999999999988775 5666665321 1345778888888776 4999999999
Q ss_pred ceeeecCCCceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCc
Q 039291 73 EEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGK 152 (362)
Q Consensus 73 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~ 152 (362)
++..........+++||||+. ++|.+++.......+++..++.++.||+.||+|||++||+||||||+|||+ +.+
T Consensus 82 ~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~----~~~ 156 (308)
T 3g33_A 82 VCATSRTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILV----TSG 156 (308)
T ss_dssp EEEECCSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEE----CTT
T ss_pred eeeccCCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE----cCC
Confidence 887655455556889999997 599999988655569999999999999999999999999999999999999 778
Q ss_pred eEEEEeecCCcccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHH-HH
Q 039291 153 FVAKIADLGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQL-FS 231 (362)
Q Consensus 153 ~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~-~~ 231 (362)
+.+||+|||+++..... .......||+.|+|||++.+..++.++|||||||++|+|++|++||........... ..
T Consensus 157 ~~~kl~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~ 233 (308)
T 3g33_A 157 GTVKLADFGLARIYSYQ---MALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFD 233 (308)
T ss_dssp SCEEECSCSCTTTSTTC---CCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHH
T ss_pred CCEEEeeCccccccCCC---cccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 88999999999765432 222456799999999999999999999999999999999999999966543222221 12
Q ss_pred HHcCCC--CCC-------------------CCCccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCccCcc
Q 039291 232 IIGDEH--SLP-------------------EIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGVD 281 (362)
Q Consensus 232 ~~~~~~--~~~-------------------~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~~~~~ 281 (362)
.+.... .++ .....++.++.+||.+||..||++|||+.++++||||+...
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~~~~~ 304 (308)
T 3g33_A 234 LIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKDE 304 (308)
T ss_dssp HHCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC----
T ss_pred HhCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCccccCCC
Confidence 211110 000 01235789999999999999999999999999999998643
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-51 Score=395.12 Aligned_cols=260 Identities=22% Similarity=0.328 Sum_probs=199.7
Q ss_pred CceeecceecccCceEEEEEEECCCCCCCCceeeeechh-----hhhhHHHHHHHHHHHHcCCCCcccccccceeeecC-
Q 039291 6 TSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAE-----VSASASLQKEKEVFDNLNGCPFVLECFGEEITMGE- 79 (362)
Q Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~-----~~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~- 79 (362)
++|.+++.||+|+||+||+|+++.+++ .||+|.+. ......+.+|+.+++.++ ||||+++++++.....
T Consensus 62 ~~y~~~~~lG~G~~g~V~~a~~~~~~~----~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~~~ 136 (464)
T 3ttj_A 62 KRYQNLKPIGSGAQGIVCAAYDAVLDR----NVAIKKLSRPFQNQTHAKRAYRELVLMKCVN-HKNIISLLNVFTPQKTL 136 (464)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTE----EEEEEEEESGGGSHHHHHHHHHHHHHHHHCC-CTTBCCCSEEECSCCST
T ss_pred CCeEEEEEeecCCCeEEEEEEECCCCC----EEEEEEECccccChHHHHHHHHHHHHHHhCC-CCCCCcEEEEEccCCcc
Confidence 689999999999999999999998875 45666553 334567889999999998 9999999997754321
Q ss_pred CCceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEee
Q 039291 80 NGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIAD 159 (362)
Q Consensus 80 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~D 159 (362)
+....+|+||||+++ +|.+.+.. .+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|
T Consensus 137 ~~~~~~~lv~E~~~~-~l~~~~~~----~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll----~~~~~~kl~D 207 (464)
T 3ttj_A 137 EEFQDVYLVMELMDA-NLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV----KSDCTLKILD 207 (464)
T ss_dssp TTCCEEEEEEECCSE-EHHHHHTS----CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE----CTTSCEEECC
T ss_pred ccCCeEEEEEeCCCC-CHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEE----eCCCCEEEEE
Confidence 223457899999976 57666643 39999999999999999999999999999999999999 7888999999
Q ss_pred cCCcccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHH-HHHc----
Q 039291 160 LGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLF-SIIG---- 234 (362)
Q Consensus 160 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~-~~~~---- 234 (362)
||+++..... ......+||+.|+|||++.+..++.++|||||||++|+|++|++||.+.+..+....+ ..++
T Consensus 208 FG~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~ 284 (464)
T 3ttj_A 208 FGLARTAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCP 284 (464)
T ss_dssp CCCC-----C---CCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCH
T ss_pred EEeeeecCCC---cccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCH
Confidence 9999865432 2234678999999999999999999999999999999999999999765432211111 1111
Q ss_pred ---------------CCCCCCC------CCcc-----------CCHHHHHHHHHHhccCCCCCCCHHHHhcCCCccCcch
Q 039291 235 ---------------DEHSLPE------IPSR-----------VSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGVDE 282 (362)
Q Consensus 235 ---------------~~~~~~~------~~~~-----------~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~~~~~~ 282 (362)
....... ++.. .++++++||.+||..||++|||++++++||||+.+..
T Consensus 285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~~~~~~ 364 (464)
T 3ttj_A 285 EFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYD 364 (464)
T ss_dssp HHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGGCC
T ss_pred HHHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChhhhhccC
Confidence 0000000 0000 1567999999999999999999999999999987543
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-51 Score=377.06 Aligned_cols=256 Identities=24% Similarity=0.371 Sum_probs=217.8
Q ss_pred CCCceeecceecccCceEEEEEEECCCCCCCCceeeeechhh------hhhHHHHHHHHHHHHcCCCCcccccccceeee
Q 039291 4 DGTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEV------SASASLQKEKEVFDNLNGCPFVLECFGEEITM 77 (362)
Q Consensus 4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~------~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~ 77 (362)
.-++|.+++.||+|+||.||+|+++.+++ .+++|.+.. .....+.+|+.+++.++ ||||+++++.+..
T Consensus 39 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~----~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~- 112 (350)
T 1rdq_E 39 QLDQFDRIKTLGTGSFGRVMLVKHKESGN----HYAMKILDKQKVVKLKQIEHTLNEKRILQAVN-FPFLVKLEFSFKD- 112 (350)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCC----EEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCC-CTTBCCEEEEEEC-
T ss_pred CHHHCEEEEEeecCcCcEEEEEEECCCCC----EEEEEEEEhHHhccHHHHHHHHHHHHHHHhCC-CCCCCeEEEEEEc-
Confidence 34789999999999999999999998876 556665432 23456889999999997 9999999887642
Q ss_pred cCCCceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEE
Q 039291 78 GENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKI 157 (362)
Q Consensus 78 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl 157 (362)
...+|+||||++||+|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||
T Consensus 113 ----~~~~~lv~e~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll----~~~g~~kL 182 (350)
T 1rdq_E 113 ----NSNLYMVMEYVAGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLI----DQQGYIQV 182 (350)
T ss_dssp ----SSEEEEEEECCTTCBHHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE----CTTSCEEE
T ss_pred ----CCEEEEEEcCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEE----CCCCCEEE
Confidence 23578999999999999999874 459999999999999999999999999999999999999 78889999
Q ss_pred eecCCcccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHHcCCC
Q 039291 158 ADLGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEH 237 (362)
Q Consensus 158 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 237 (362)
+|||+++..... ....+||+.|+|||++.+..++.++|||||||++|+|++|.+||... +..++...+....
T Consensus 183 ~DFg~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~---~~~~~~~~i~~~~ 254 (350)
T 1rdq_E 183 TDFGFAKRVKGR-----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFAD---QPIQIYEKIVSGK 254 (350)
T ss_dssp CCCTTCEECSSC-----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS---SHHHHHHHHHHCC
T ss_pred cccccceeccCC-----cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCC---CHHHHHHHHHcCC
Confidence 999999765431 23568999999999999999999999999999999999999999654 4455555554332
Q ss_pred CCCCCCccCCHHHHHHHHHHhccCCCCCCC-----HHHHhcCCCccCcchhhh
Q 039291 238 SLPEIPSRVSKEARDFLRRCFVRKPAFRFT-----AEMLLDDPFVKGVDEELS 285 (362)
Q Consensus 238 ~~~~~~~~~~~~~~~li~~~l~~~p~~R~s-----~~~~l~~p~~~~~~~~~~ 285 (362)
..+|..++.++++||.+||..||.+||+ +++++.||||+.++|...
T Consensus 255 --~~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h~~f~~~~w~~~ 305 (350)
T 1rdq_E 255 --VRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAI 305 (350)
T ss_dssp --CCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTCCHHHH
T ss_pred --CCCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhCcCcCCCCHHHH
Confidence 2456779999999999999999999998 999999999999988743
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-50 Score=370.17 Aligned_cols=259 Identities=26% Similarity=0.435 Sum_probs=206.2
Q ss_pred CCCCceeecceecccCceEEEEEEEC---CCCCCCCceeeeechhh-------hhhHHHHHHHHHHHHcCCCCccccccc
Q 039291 3 SDGTSWFRGRVIGQGSFGCVFIAKPK---SNSSFLPPLMAVKSAEV-------SASASLQKEKEVFDNLNGCPFVLECFG 72 (362)
Q Consensus 3 ~~~~~y~~~~~lG~G~~g~V~~a~~~---~~~~~~~~~~~~K~~~~-------~~~~~~~~E~~il~~l~~h~~i~~~~~ 72 (362)
...++|.+++.||+|+||+||+|++. .++ ..+++|.... .....+.+|+.+++.++ ||||+++++
T Consensus 14 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~----~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~ 88 (327)
T 3a62_A 14 IRPECFELLRVLGKGGYGKVFQVRKVTGANTG----KIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVK-HPFIVDLIY 88 (327)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEECSSTTTT----CEEEEEEECCC--------------HHHHHHHCC-CTTBCCEEE
T ss_pred CCHHHeEEEEEEEeCCCEEEEEEEEeccCCCC----cEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCC-CCCccceeE
Confidence 45678999999999999999999985 344 3566666532 23455778999999998 999999998
Q ss_pred ceeeecCCCceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCc
Q 039291 73 EEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGK 152 (362)
Q Consensus 73 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~ 152 (362)
.+.. ...+++||||++|++|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||+ +.+
T Consensus 89 ~~~~-----~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill----~~~ 157 (327)
T 3a62_A 89 AFQT-----GGKLYLILEYLSGGELFMQLERE--GIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIML----NHQ 157 (327)
T ss_dssp EEEC-----SSCEEEEEECCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEE----CTT
T ss_pred EEEc-----CCEEEEEEeCCCCCcHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEE----CCC
Confidence 7643 23477999999999999999873 459999999999999999999999999999999999999 778
Q ss_pred eEEEEeecCCcccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHH
Q 039291 153 FVAKIADLGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSI 232 (362)
Q Consensus 153 ~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~ 232 (362)
+.+||+|||+++...... ......+||+.|+|||++.+..++.++|||||||++|+|++|..||... +.......
T Consensus 158 ~~~kl~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~---~~~~~~~~ 232 (327)
T 3a62_A 158 GHVKLTDFGLCKESIHDG--TVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGE---NRKKTIDK 232 (327)
T ss_dssp SCEEECCCSCC------------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCS---SHHHHHHH
T ss_pred CcEEEEeCCcccccccCC--ccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCC---CHHHHHHH
Confidence 899999999987543321 2224567999999999999989999999999999999999999999654 33444444
Q ss_pred HcCCCCCCCCCccCCHHHHHHHHHHhccCCCCCC-----CHHHHhcCCCccCcchhh
Q 039291 233 IGDEHSLPEIPSRVSKEARDFLRRCFVRKPAFRF-----TAEMLLDDPFVKGVDEEL 284 (362)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~-----s~~~~l~~p~~~~~~~~~ 284 (362)
+.... ..++..++.++++||.+||..||++|| ++++++.||||+.+.++.
T Consensus 233 i~~~~--~~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f~~~~~~~ 287 (327)
T 3a62_A 233 ILKCK--LNLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHINWEE 287 (327)
T ss_dssp HHHTC--CCCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGGGSSCCHHH
T ss_pred HHhCC--CCCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCCcccCCCHHH
Confidence 33222 245667899999999999999999999 889999999999988764
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-50 Score=385.02 Aligned_cols=261 Identities=23% Similarity=0.342 Sum_probs=209.8
Q ss_pred CceeecceecccCceEEEEEEECCCCCCCCceeeeec-hhhhhhHHHHHHHHHHHHcCCCCcccccccceeeecCCCceE
Q 039291 6 TSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKS-AEVSASASLQKEKEVFDNLNGCPFVLECFGEEITMGENGEMA 84 (362)
Q Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~-~~~~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~~~~~ 84 (362)
++|.+++.||+|+||+||+|.++.++..++.++..+. ........+.+|+.+++.++ ||||+++++.+.. ...
T Consensus 11 ~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~-----~~~ 84 (444)
T 3soa_A 11 EEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLK-HPNIVRLHDSISE-----EGH 84 (444)
T ss_dssp HHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCC-BTTBCCEEEEEEC-----SSE
T ss_pred CCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCC-CcCCCeEEEEEEE-----CCE
Confidence 5899999999999999999999988864433322221 22334567889999999998 9999999987642 335
Q ss_pred EEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEeecCCcc
Q 039291 85 YNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAK 164 (362)
Q Consensus 85 ~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Dfgla~ 164 (362)
+++||||+.||+|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||+... ..++.+||+|||++.
T Consensus 85 ~~lv~E~~~gg~L~~~i~~--~~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~-~~~~~vkL~DFG~a~ 161 (444)
T 3soa_A 85 HYLIFDLVTGGELFEDIVA--REYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASK-LKGAAVKLADFGLAI 161 (444)
T ss_dssp EEEEECCCBCCBHHHHHHH--CSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBS-STTCCEEECCCSSCB
T ss_pred EEEEEEeCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecc-CCCCcEEEccCceeE
Confidence 7799999999999999987 4569999999999999999999999999999999999999432 145789999999997
Q ss_pred cccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHHcCCC-CC-CCC
Q 039291 165 RSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEH-SL-PEI 242 (362)
Q Consensus 165 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~-~~-~~~ 242 (362)
...... .......||+.|+|||++.+..++.++|||||||++|+|++|.+||... +...+...+.... .+ ...
T Consensus 162 ~~~~~~--~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~---~~~~~~~~i~~~~~~~~~~~ 236 (444)
T 3soa_A 162 EVEGEQ--QAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDE---DQHRLYQQIKAGAYDFPSPE 236 (444)
T ss_dssp CCCTTC--CBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCS---SHHHHHHHHHHTCCCCCTTT
T ss_pred EecCCC--ceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCc---cHHHHHHHHHhCCCCCCccc
Confidence 665422 2224578999999999999989999999999999999999999999654 3444444443322 22 223
Q ss_pred CccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCccCc
Q 039291 243 PSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGV 280 (362)
Q Consensus 243 ~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~~~~ 280 (362)
+..+++++++||.+||..||++|||+.++++||||+..
T Consensus 237 ~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~hp~~~~~ 274 (444)
T 3soa_A 237 WDTVTPEAKDLINKMLTINPSKRITAAEALKHPWISHR 274 (444)
T ss_dssp TTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSCTTHHH
T ss_pred cccCCHHHHHHHHHHcCCChhHCCCHHHHhcCccccCC
Confidence 35789999999999999999999999999999999753
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-50 Score=370.58 Aligned_cols=261 Identities=25% Similarity=0.337 Sum_probs=196.7
Q ss_pred Cceeec---ceecccCceEEEEEEECCCCCCCCceeeeechhhhhhHHHHHHHHHHHHcCCCCcccccccceeeecCCCc
Q 039291 6 TSWFRG---RVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVSASASLQKEKEVFDNLNGCPFVLECFGEEITMGENGE 82 (362)
Q Consensus 6 ~~y~~~---~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~~~ 82 (362)
++|.+. +.||+|+||+||+|+++.+++ .+++|.........+.+|+.+++.+.+||||+++++++.. .
T Consensus 8 ~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~----~vavK~~~~~~~~~~~~e~~~l~~l~~h~niv~~~~~~~~-----~ 78 (325)
T 3kn6_A 8 QHYDLDLKDKPLGEGSFSICRKCVHKKSNQ----AFAVKIISKRMEANTQKEITALKLCEGHPNIVKLHEVFHD-----Q 78 (325)
T ss_dssp HHEEECTTSCCSEEETTEEEEEEEETTTCC----EEEEEEEEGGGHHHHHHHHHHHHHTTTCTTBCCEEEEEEC-----S
T ss_pred hccccccCCCccccCCCeEEEEEEECCCCC----EEEEEEEChhhhhhHHHHHHHHHHhcCCCCeeEEEEEEEc-----C
Confidence 356664 889999999999999998775 6788887777777889999999999989999999997642 2
Q ss_pred eEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEeecCC
Q 039291 83 MAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGV 162 (362)
Q Consensus 83 ~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Dfgl 162 (362)
..+++||||++||+|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||+..+ +....+||+|||+
T Consensus 79 ~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~-~~~~~~kl~Dfg~ 155 (325)
T 3kn6_A 79 LHTFLVMELLNGGELFERIKK--KKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDE-NDNLEIKIIDFGF 155 (325)
T ss_dssp SEEEEEECCCCSCBHHHHHHH--CSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC-----CEEEECCCTT
T ss_pred CEEEEEEEccCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecC-CCcccEEEecccc
Confidence 346799999999999999987 4569999999999999999999999999999999999999432 2234799999999
Q ss_pred cccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHhCCCCCccCCC----CCHHHHHHHHcCCCC
Q 039291 163 AKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKED----CSIDQLFSIIGDEHS 238 (362)
Q Consensus 163 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~----~~~~~~~~~~~~~~~ 238 (362)
++...... ......+||+.|+|||++.+..++.++|||||||++|+|++|..||...+. ....++...+.....
T Consensus 156 a~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~ 233 (325)
T 3kn6_A 156 ARLKPPDN--QPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDF 233 (325)
T ss_dssp CEECCC------------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCC
T ss_pred ceecCCCC--CcccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCC
Confidence 97554322 222456789999999999999999999999999999999999999976432 234556666654432
Q ss_pred CCC--CCccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCccCc
Q 039291 239 LPE--IPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGV 280 (362)
Q Consensus 239 ~~~--~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~~~~ 280 (362)
... .+..+++++++||.+||..||++|||+.+++.||||+..
T Consensus 234 ~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~~~ 277 (325)
T 3kn6_A 234 SFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDG 277 (325)
T ss_dssp CCCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCGGGCTT
T ss_pred CCCcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcChhhccC
Confidence 211 123589999999999999999999999999999999764
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-51 Score=382.67 Aligned_cols=262 Identities=22% Similarity=0.334 Sum_probs=199.1
Q ss_pred CceeecceecccCceEEEEEEECCCCCCCCceeeeechh-----hhhhHHHHHHHHHHHHcCCCCcccccccceeeecCC
Q 039291 6 TSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAE-----VSASASLQKEKEVFDNLNGCPFVLECFGEEITMGEN 80 (362)
Q Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~-----~~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~ 80 (362)
++|.+++.||+|+||+||+|.++.+++ .||+|.+. ......+.+|+.+++.+.+||||+++++++.. .
T Consensus 9 ~~y~~~~~lG~G~~g~V~~~~~~~~~~----~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~---~ 81 (388)
T 3oz6_A 9 RKYELVKKLGKGAYGIVWKSIDRRTGE----VVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRA---D 81 (388)
T ss_dssp TTEEEEEC-------CEEEEEETTTCC----EEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC---T
T ss_pred CceEEEEEeeeCCCeEEEEEEECCCCC----EEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEec---C
Confidence 689999999999999999999998876 45666542 33456678999999999989999999997653 2
Q ss_pred CceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEeec
Q 039291 81 GEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADL 160 (362)
Q Consensus 81 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Df 160 (362)
....+|+||||++ ++|.+++.. ..+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+||
T Consensus 82 ~~~~~~lv~e~~~-~~L~~~~~~---~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll----~~~~~~kl~DF 153 (388)
T 3oz6_A 82 NDRDVYLVFDYME-TDLHAVIRA---NILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILL----NAECHVKVADF 153 (388)
T ss_dssp TSSCEEEEEECCS-EEHHHHHHH---TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE----CTTCCEEECCC
T ss_pred CCCEEEEEecccC-cCHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEE----cCCCCEEecCC
Confidence 2335789999997 599999976 359999999999999999999999999999999999999 78889999999
Q ss_pred CCcccccccc-------------------cCCCCCCccCCCCccCchhhcc-ccCCCcchHHHHHHHHHHHHhCCCCCcc
Q 039291 161 GVAKRSRHCK-------------------RQKFDPSMRGTPLYLAPETVVQ-HMQEAPSDIWALGCVVLEMLSGRQAWVV 220 (362)
Q Consensus 161 gla~~~~~~~-------------------~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~ 220 (362)
|+|+...... ........+||+.|+|||++.+ ..++.++|||||||++|+|++|++||.+
T Consensus 154 G~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~ 233 (388)
T 3oz6_A 154 GLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPG 233 (388)
T ss_dssp TTCEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred cccccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCC
Confidence 9997653211 1112245689999999999987 5789999999999999999999999976
Q ss_pred CCCCCHHHHHHHHcCCC-----------------------------CCCC-------------CCccCCHHHHHHHHHHh
Q 039291 221 KEDCSIDQLFSIIGDEH-----------------------------SLPE-------------IPSRVSKEARDFLRRCF 258 (362)
Q Consensus 221 ~~~~~~~~~~~~~~~~~-----------------------------~~~~-------------~~~~~~~~~~~li~~~l 258 (362)
.+.......+......+ .... .+..+++++.+||.+||
T Consensus 234 ~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L 313 (388)
T 3oz6_A 234 SSTMNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLL 313 (388)
T ss_dssp SSHHHHHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHC
T ss_pred CCHHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhh
Confidence 54322211111110000 0000 01257899999999999
Q ss_pred ccCCCCCCCHHHHhcCCCccCcch
Q 039291 259 VRKPAFRFTAEMLLDDPFVKGVDE 282 (362)
Q Consensus 259 ~~~p~~R~s~~~~l~~p~~~~~~~ 282 (362)
..||++|||++++++||||+.+..
T Consensus 314 ~~dP~~R~t~~e~l~Hp~~~~~~~ 337 (388)
T 3oz6_A 314 QFNPNKRISANDALKHPFVSIFHN 337 (388)
T ss_dssp CSSGGGSCCHHHHTTSTTTTTTCC
T ss_pred ccCcccCCCHHHHhCCHHHHHhcC
Confidence 999999999999999999987644
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-50 Score=378.00 Aligned_cols=259 Identities=25% Similarity=0.397 Sum_probs=207.8
Q ss_pred CCCceeecceecccCceEEEEEEECCCCCCCCceeeeechhhh------hhHHHHHHHHHH-HHcCCCCcccccccceee
Q 039291 4 DGTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVS------ASASLQKEKEVF-DNLNGCPFVLECFGEEIT 76 (362)
Q Consensus 4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~~------~~~~~~~E~~il-~~l~~h~~i~~~~~~~~~ 76 (362)
.-++|.+++.||+|+||+||+|+++.++. .+++|.+... ....+.+|..++ +.++ ||||+++++.+..
T Consensus 36 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~----~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~-hp~Iv~l~~~~~~ 110 (373)
T 2r5t_A 36 KPSDFHFLKVIGKGSFGKVLLARHKAEEV----FYAVKVLQKKAILKKKEEKHIMSERNVLLKNVK-HPFLVGLHFSFQT 110 (373)
T ss_dssp CGGGEEEEEEEECCTTCEEEEEEETTTCC----EEEEEEEEGGGBC-------------CCBCCCC-CTTBCCEEEEEEC
T ss_pred ChhheEEEEEEeeCCCeEEEEEEEcCCCC----EEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCC-CCCCCCEEEEEEe
Confidence 34689999999999999999999998876 4555554322 234456676664 4455 9999999987642
Q ss_pred ecCCCceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEE
Q 039291 77 MGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAK 156 (362)
Q Consensus 77 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~k 156 (362)
...+|+||||++||+|.+++... +.+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+|
T Consensus 111 -----~~~~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll----~~~g~ik 179 (373)
T 2r5t_A 111 -----ADKLYFVLDYINGGELFYHLQRE--RCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILL----DSQGHIV 179 (373)
T ss_dssp -----SSEEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE----CTTSCEE
T ss_pred -----CCEEEEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEE----CCCCCEE
Confidence 23578999999999999999873 459999999999999999999999999999999999999 8888999
Q ss_pred EeecCCcccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHHcCC
Q 039291 157 IADLGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDE 236 (362)
Q Consensus 157 l~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 236 (362)
|+|||+++..... .......+||+.|+|||++.+..++.++|||||||++|||++|..||... +..++...+...
T Consensus 180 L~DFG~a~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~---~~~~~~~~i~~~ 254 (373)
T 2r5t_A 180 LTDFGLCKENIEH--NSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSR---NTAEMYDNILNK 254 (373)
T ss_dssp ECCCCBCGGGBCC--CCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCS---BHHHHHHHHHHS
T ss_pred EeeCccccccccC--CCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCC---CHHHHHHHHHhc
Confidence 9999999754332 22335678999999999999999999999999999999999999999654 445555555433
Q ss_pred CCCCCCCccCCHHHHHHHHHHhccCCCCCCCH----HHHhcCCCccCcchhhh
Q 039291 237 HSLPEIPSRVSKEARDFLRRCFVRKPAFRFTA----EMLLDDPFVKGVDEELS 285 (362)
Q Consensus 237 ~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~----~~~l~~p~~~~~~~~~~ 285 (362)
. ..++..++.++++||.+||..||.+|+++ .+++.||||+.+.|+..
T Consensus 255 ~--~~~~~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~i~~h~~f~~~~w~~l 305 (373)
T 2r5t_A 255 P--LQLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFFSLINWDDL 305 (373)
T ss_dssp C--CCCCSSSCHHHHHHHHHHTCSSGGGSTTTTTTHHHHHTSGGGTTCCHHHH
T ss_pred c--cCCCCCCCHHHHHHHHHHcccCHHhCCCCCCCHHHHhCCccccCCCHHHH
Confidence 2 24567799999999999999999999986 69999999999988753
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-50 Score=376.22 Aligned_cols=265 Identities=22% Similarity=0.284 Sum_probs=210.2
Q ss_pred CCCCceeecceeccc--CceEEEEEEECCCCCCCCceeeeechh-----hhhhHHHHHHHHHHHHcCCCCccccccccee
Q 039291 3 SDGTSWFRGRVIGQG--SFGCVFIAKPKSNSSFLPPLMAVKSAE-----VSASASLQKEKEVFDNLNGCPFVLECFGEEI 75 (362)
Q Consensus 3 ~~~~~y~~~~~lG~G--~~g~V~~a~~~~~~~~~~~~~~~K~~~-----~~~~~~~~~E~~il~~l~~h~~i~~~~~~~~ 75 (362)
..+++|.+++.||+| +||+||+|+++.+++ .|++|.+. ......+.+|+.+++.++ ||||+++++++.
T Consensus 22 ~~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~----~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~ 96 (389)
T 3gni_B 22 PEGGCYELLTVIGKGFEDLMTVNLARYKPTGE----YVTVRRINLEACSNEMVTFLQGELHVSKLFN-HPNIVPYRATFI 96 (389)
T ss_dssp CCGGGEEEEEEEEEETTTTEEEEEEEETTTCC----EEEEEEEEGGGSCHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEE
T ss_pred CCCCcEEEEecccCCcCCceEEEEEEEcCCCC----EEEEEEecccccChHHHHHHHHHHHHHHhCC-CCCCCcEeEEEE
Confidence 467899999999999 999999999998876 55666543 234466888999999998 999999999775
Q ss_pred eecCCCceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEE
Q 039291 76 TMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVA 155 (362)
Q Consensus 76 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~ 155 (362)
. ...+++||||+++++|.+++.......+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+
T Consensus 97 ~-----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll----~~~~~~ 167 (389)
T 3gni_B 97 A-----DNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILI----SVDGKV 167 (389)
T ss_dssp E-----TTEEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE----CTTCCE
T ss_pred E-----CCEEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE----cCCCCE
Confidence 3 2347899999999999999988655679999999999999999999999999999999999999 778899
Q ss_pred EEeecCCcccccccc-----cCCCCCCccCCCCccCchhhcc--ccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHH
Q 039291 156 KIADLGVAKRSRHCK-----RQKFDPSMRGTPLYLAPETVVQ--HMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQ 228 (362)
Q Consensus 156 kl~Dfgla~~~~~~~-----~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~ 228 (362)
||+|||++....... .........||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...+......
T Consensus 168 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~ 247 (389)
T 3gni_B 168 YLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLL 247 (389)
T ss_dssp EECCGGGCEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHH
T ss_pred EEcccccceeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHH
Confidence 999999986443221 1112234579999999999987 578999999999999999999999997654433221
Q ss_pred HHHHHcCC-------------------------------------------CCCCCCCccCCHHHHHHHHHHhccCCCCC
Q 039291 229 LFSIIGDE-------------------------------------------HSLPEIPSRVSKEARDFLRRCFVRKPAFR 265 (362)
Q Consensus 229 ~~~~~~~~-------------------------------------------~~~~~~~~~~~~~~~~li~~~l~~~p~~R 265 (362)
..+... ......+..+++++++||.+||+.||++|
T Consensus 248 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R 325 (389)
T 3gni_B 248 --EKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDAR 325 (389)
T ss_dssp --HC--------------------------------------------------------CCHHHHHHHHHHTCSCTTTS
T ss_pred --HHhcCCCCccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccC
Confidence 111000 00012345688999999999999999999
Q ss_pred CCHHHHhcCCCccCcchh
Q 039291 266 FTAEMLLDDPFVKGVDEE 283 (362)
Q Consensus 266 ~s~~~~l~~p~~~~~~~~ 283 (362)
||+.++++||||+.+.+.
T Consensus 326 pta~ell~hp~f~~~~~~ 343 (389)
T 3gni_B 326 PSASTLLNHSFFKQIKRR 343 (389)
T ss_dssp CCHHHHTTSGGGGGC---
T ss_pred CCHHHHhcCHHHHHHhhc
Confidence 999999999999887543
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-50 Score=374.36 Aligned_cols=261 Identities=26% Similarity=0.357 Sum_probs=202.0
Q ss_pred CCCCceeecceecccCceEEEEEEECCCCCCCCceeeeechhh--hhhHHHHHHHHHHHHcCCCCcccccccceeeecCC
Q 039291 3 SDGTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEV--SASASLQKEKEVFDNLNGCPFVLECFGEEITMGEN 80 (362)
Q Consensus 3 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~--~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~ 80 (362)
...++|.+++.||+|+||+||+|+++.+++ .||+|.... .....+.+|+.+++.++ ||||+++++++..
T Consensus 17 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~----~vavK~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~---- 87 (361)
T 3uc3_A 17 HDSDRYDFVKDIGSGNFGVARLMRDKLTKE----LVAVKYIERGAAIDENVQREIINHRSLR-HPNIVRFKEVILT---- 87 (361)
T ss_dssp CCTTTEEEEEEESSSTTSSEEEEEETTTCC----EEEEEEEESSTTSCHHHHHHHHHHHHCC-CTTBCCEEEEEEC----
T ss_pred CCCCcEEEEEEeccCCCEEEEEEEECCCCc----EEEEEEEecCccccHHHHHHHHHHHhCC-CCCCCcEEEEEee----
Confidence 356899999999999999999999998875 566666543 23466889999999998 9999999997653
Q ss_pred CceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEeec
Q 039291 81 GEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADL 160 (362)
Q Consensus 81 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Df 160 (362)
...+++||||+.||+|.+++... +++++..++.++.||+.||.|||++||+||||||+|||+.. +..+.+||+||
T Consensus 88 -~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~--~~~~~~kl~Df 162 (361)
T 3uc3_A 88 -PTHLAIIMEYASGGELYERICNA--GRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDG--SPAPRLKICDF 162 (361)
T ss_dssp -SSEEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECS--SSSCCEEECCC
T ss_pred -CCEEEEEEEeCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcC--CCCceEEEeec
Confidence 23477999999999999999773 45999999999999999999999999999999999999932 22334999999
Q ss_pred CCcccccccccCCCCCCccCCCCccCchhhccccCCCc-chHHHHHHHHHHHHhCCCCCccCCC-CCHHHHHHHHcCCCC
Q 039291 161 GVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAP-SDIWALGCVVLEMLSGRQAWVVKED-CSIDQLFSIIGDEHS 238 (362)
Q Consensus 161 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~il~~l~~g~~pf~~~~~-~~~~~~~~~~~~~~~ 238 (362)
|+++..... .......||+.|+|||++.+..++.+ +|||||||++|+|++|+.||..... .........+.....
T Consensus 163 g~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~ 239 (361)
T 3uc3_A 163 GYSKSSVLH---SQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKY 239 (361)
T ss_dssp CCC------------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCC
T ss_pred Ccccccccc---CCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCC
Confidence 998743322 12235679999999999988777655 8999999999999999999976543 334455554443332
Q ss_pred CCCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCccCc
Q 039291 239 LPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGV 280 (362)
Q Consensus 239 ~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~~~~ 280 (362)
.......+++++++||.+||..||++|||+.++++||||...
T Consensus 240 ~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~ 281 (361)
T 3uc3_A 240 SIPDDIRISPECCHLISRIFVADPATRISIPEIKTHSWFLKN 281 (361)
T ss_dssp CCCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTSHHHHTT
T ss_pred CCCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhCcchhcC
Confidence 222234689999999999999999999999999999999553
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-50 Score=388.68 Aligned_cols=268 Identities=25% Similarity=0.359 Sum_probs=196.8
Q ss_pred CCceeecceecccCceEEEEEEECCCCCCCCceeeeechh-----hhhhHHHHHHHHHHHHcCCCCcccccccceeeecC
Q 039291 5 GTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAE-----VSASASLQKEKEVFDNLNGCPFVLECFGEEITMGE 79 (362)
Q Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~-----~~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~ 79 (362)
.++|.+++.||+|+||+||+|+++.+++ .||+|.+. ....+.+.+|+.+|+.++ ||||+++++++.....
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~----~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~ 126 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKR----VVAIKKILRVFEDLIDCKRILREIAILNRLN-HDHVVKVLDIVIPKDV 126 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--C----EEEEEEECSTTSSHHHHHHHHHHHHHHHHCC-CTTBCCEEEECCCSCT
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCc----EEEEEEechhhcCHHHHHHHHHHHHHHHhCC-CCCCCceEEEEecCCc
Confidence 4789999999999999999999998876 55666542 234567889999999998 9999999998765443
Q ss_pred CCceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEee
Q 039291 80 NGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIAD 159 (362)
Q Consensus 80 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~D 159 (362)
+....+|+||||+. ++|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|
T Consensus 127 ~~~~~~~lv~e~~~-~~L~~~~~~--~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl----~~~~~~kl~D 199 (458)
T 3rp9_A 127 EKFDELYVVLEIAD-SDFKKLFRT--PVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLV----NQDCSVKVCD 199 (458)
T ss_dssp TTCCCEEEEECCCS-EEHHHHHHS--SCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE----CTTCCEEECC
T ss_pred ccCceEEEEEeccc-cchhhhccc--CCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEE----CCCCCEeecc
Confidence 44456789999985 699999976 4569999999999999999999999999999999999999 8888999999
Q ss_pred cCCcccccccccC-------------------------CCCCCccCCCCccCchhhc-cccCCCcchHHHHHHHHHHHHh
Q 039291 160 LGVAKRSRHCKRQ-------------------------KFDPSMRGTPLYLAPETVV-QHMQEAPSDIWALGCVVLEMLS 213 (362)
Q Consensus 160 fgla~~~~~~~~~-------------------------~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~~l~~ 213 (362)
||+++........ ......+||+.|+|||++. +..++.++|||||||+||||++
T Consensus 200 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~ellt 279 (458)
T 3rp9_A 200 FGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLN 279 (458)
T ss_dssp CTTCBCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHT
T ss_pred cccchhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHH
Confidence 9999865422111 1224567899999999874 5679999999999999999998
Q ss_pred -----------CCCCCccCCCCC------------------HHH---HHHHHcC-------------------------C
Q 039291 214 -----------GRQAWVVKEDCS------------------IDQ---LFSIIGD-------------------------E 236 (362)
Q Consensus 214 -----------g~~pf~~~~~~~------------------~~~---~~~~~~~-------------------------~ 236 (362)
|.++|.+..... ..+ ++..++. .
T Consensus 280 g~~~~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~ 359 (458)
T 3rp9_A 280 MIKENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREG 359 (458)
T ss_dssp TSTTTCSSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCC
T ss_pred hccccccccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCC
Confidence 666675543100 011 1111110 0
Q ss_pred CCCCCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCccCcchhh
Q 039291 237 HSLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGVDEEL 284 (362)
Q Consensus 237 ~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~~~~~~~~ 284 (362)
..+......++.++.+||++||..||++|||++++|+||||+.+.+..
T Consensus 360 ~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~~~~~~ 407 (458)
T 3rp9_A 360 TDLAERFPASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEVRIAE 407 (458)
T ss_dssp CCGGGGSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTCCGG
T ss_pred CCHHHHCCCCCHHHHHHHHHHhccCccccCCHHHHhcCHhhhhcCCCc
Confidence 001112245689999999999999999999999999999999986653
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-50 Score=368.55 Aligned_cols=263 Identities=21% Similarity=0.347 Sum_probs=193.6
Q ss_pred CCCceeecceecccCceEEEEEEECCCCCCCCceeeeechh----hhhhHHHHHHHHHHHHcCCCCcccccccceeeecC
Q 039291 4 DGTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAE----VSASASLQKEKEVFDNLNGCPFVLECFGEEITMGE 79 (362)
Q Consensus 4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~----~~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~ 79 (362)
..++|.+++.||+|+||+||+|+++.++. .|++|... ......+.+|+.++++++ ||||+++++++..
T Consensus 3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~----~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~--- 74 (317)
T 2pmi_A 3 SSSQFKQLEKLGNGTYATVYKGLNKTTGV----YVALKEVKLDSEEGTPSTAIREISLMKELK-HENIVRLYDVIHT--- 74 (317)
T ss_dssp ----------------CEEEEEECSSSCC----EEEEEEEECCSTTCSCHHHHHHHHHHTTCC-BTTBCCEEEEECC---
T ss_pred cccceeEeeEECCCCCEEEEEEEECCCCc----EEEEEEeecccccccHHHHHHHHHHHHhcC-CCCcceEEEEEEE---
Confidence 35799999999999999999999988775 45666543 223466889999999998 9999999987642
Q ss_pred CCceEEEEEEEecCCCCHHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEE
Q 039291 80 NGEMAYNLLLEYAAGGTLGDLIEKCNG----NGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVA 155 (362)
Q Consensus 80 ~~~~~~~lv~e~~~~~~L~~~l~~~~~----~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~ 155 (362)
...+++||||++ ++|.+++..... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+
T Consensus 75 --~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~----~~~~~~ 147 (317)
T 2pmi_A 75 --ENKLTLVFEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLI----NKRGQL 147 (317)
T ss_dssp --TTEEEEEEECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE----CTTCCE
T ss_pred --CCeEEEEEEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEE----cCCCCE
Confidence 335789999998 599999876431 359999999999999999999999999999999999999 778889
Q ss_pred EEeecCCcccccccccCCCCCCccCCCCccCchhhcc-ccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHHc
Q 039291 156 KIADLGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQ-HMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIG 234 (362)
Q Consensus 156 kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~ 234 (362)
||+|||+++...... .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.........+....
T Consensus 148 kl~Dfg~~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~ 225 (317)
T 2pmi_A 148 KLGDFGLARAFGIPV--NTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIM 225 (317)
T ss_dssp EECCCSSCEETTSCC--CCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHH
T ss_pred EECcCccceecCCCc--ccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHh
Confidence 999999997654321 22235679999999999986 468999999999999999999999997654322222211111
Q ss_pred CCCC-----------------------------CCCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCccCcchh
Q 039291 235 DEHS-----------------------------LPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGVDEE 283 (362)
Q Consensus 235 ~~~~-----------------------------~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~~~~~~~ 283 (362)
.... .+..+..++.++++||.+||..||++|||++++++||||++....
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~ 303 (317)
T 2pmi_A 226 GTPNESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEYYHH 303 (317)
T ss_dssp CSCCTTTCGGGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCC-
T ss_pred CCCChhHhhhhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhhhcccch
Confidence 1100 001123578899999999999999999999999999999876544
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-50 Score=400.88 Aligned_cols=259 Identities=26% Similarity=0.361 Sum_probs=220.6
Q ss_pred CCceeecceecccCceEEEEEEECCCCCCCCceeeeechhh------hhhHHHHHHHHHHHHcCCCCcccccccceeeec
Q 039291 5 GTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEV------SASASLQKEKEVFDNLNGCPFVLECFGEEITMG 78 (362)
Q Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~------~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~ 78 (362)
-++|.+++.||+|+||+||+|+++.+++ .+|+|.+.. .....+..|..++..+.+||+|+.+++.+.
T Consensus 340 ~~~f~~~~~LG~G~fG~V~~~~~~~~~~----~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~--- 412 (674)
T 3pfq_A 340 LTDFNFLMVLGKGSFGKVMLSERKGTDE----LYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQ--- 412 (674)
T ss_dssp CTTEEEEEESSBTTTBCEEEEEESSSCC----EEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECB---
T ss_pred ccceEEEEEEccCCCEEEEEEEECCCCc----EEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEE---
Confidence 4679999999999999999999998876 456665432 244567889999999988999999988653
Q ss_pred CCCceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEe
Q 039291 79 ENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIA 158 (362)
Q Consensus 79 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~ 158 (362)
....+|+||||++||+|.++++.. +.+++..++.|+.||+.||+|||++||+||||||+|||+ +.++.+||+
T Consensus 413 --~~~~~~lV~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl----~~~g~ikL~ 484 (674)
T 3pfq_A 413 --TMDRLYFVMEYVNGGDLMYHIQQV--GRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVML----DSEGHIKIA 484 (674)
T ss_dssp --CSSEEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEE----CSSSCEEEC
T ss_pred --eCCEEEEEEeCcCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEE----cCCCcEEEe
Confidence 233578999999999999999874 459999999999999999999999999999999999999 888899999
Q ss_pred ecCCcccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHHcCCCC
Q 039291 159 DLGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEHS 238 (362)
Q Consensus 159 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 238 (362)
|||+++...... ......+||+.|+|||++.+..++.++|||||||+||||++|.+||.+. +..+++..+....
T Consensus 485 DFGla~~~~~~~--~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~---~~~~~~~~i~~~~- 558 (674)
T 3pfq_A 485 DFGMCKENIWDG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGE---DEDELFQSIMEHN- 558 (674)
T ss_dssp CCTTCEECCCTT--CCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCS---SHHHHHHHHHSSC-
T ss_pred ecceeeccccCC--cccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCC---CHHHHHHHHHhCC-
Confidence 999998543322 2234678999999999999999999999999999999999999999654 4556666665443
Q ss_pred CCCCCccCCHHHHHHHHHHhccCCCCCCCH-----HHHhcCCCccCcchhhh
Q 039291 239 LPEIPSRVSKEARDFLRRCFVRKPAFRFTA-----EMLLDDPFVKGVDEELS 285 (362)
Q Consensus 239 ~~~~~~~~~~~~~~li~~~l~~~p~~R~s~-----~~~l~~p~~~~~~~~~~ 285 (362)
..+|..++.++++||++||..||++|+++ +++++||||+.++|+..
T Consensus 559 -~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h~ff~~i~w~~l 609 (674)
T 3pfq_A 559 -VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEKL 609 (674)
T ss_dssp -CCCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSSGGGSSCCHHHH
T ss_pred -CCCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcCccccCCCHHHH
Confidence 34667899999999999999999999997 99999999999998754
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-50 Score=392.76 Aligned_cols=264 Identities=27% Similarity=0.398 Sum_probs=221.5
Q ss_pred CCCCceeecceecccCceEEEEEEECCCCCCCCceeeeechhh------hhhHHHHHHHHHHHHcCCCCcccccccceee
Q 039291 3 SDGTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEV------SASASLQKEKEVFDNLNGCPFVLECFGEEIT 76 (362)
Q Consensus 3 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~------~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~ 76 (362)
...++|.+.+.||+|+||.||+|+++.+++ .+|+|.+.. .....+.+|+.+|+.++ ||||+++++.+..
T Consensus 181 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~----~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~-hp~Iv~l~~~~~~ 255 (576)
T 2acx_A 181 VTKNTFRQYRVLGKGGFGEVCACQVRATGK----MYACKKLEKKRIKKRKGEAMALNEKQILEKVN-SRFVVSLAYAYET 255 (576)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCC----EEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCC-CTTBCCEEEEEEC
T ss_pred ccccceEEEEEEeeCCCEEEEEEEECCCCC----EEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcC-CCCEeeEEEEEee
Confidence 456889999999999999999999998876 556665432 23456789999999998 9999999886642
Q ss_pred ecCCCceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEE
Q 039291 77 MGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAK 156 (362)
Q Consensus 77 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~k 156 (362)
...+|+||||++||+|.+++.......+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+|
T Consensus 256 -----~~~l~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILl----d~~g~vK 326 (576)
T 2acx_A 256 -----KDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILL----DDHGHIR 326 (576)
T ss_dssp -----SSEEEEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE----CTTSCEE
T ss_pred -----CCEEEEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEE----eCCCCeE
Confidence 2357899999999999999987555569999999999999999999999999999999999999 7888999
Q ss_pred EeecCCcccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHhCCCCCccCCCC-CHHHHHHHHcC
Q 039291 157 IADLGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDC-SIDQLFSIIGD 235 (362)
Q Consensus 157 l~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~-~~~~~~~~~~~ 235 (362)
|+|||+++...... .....+||+.|+|||++.+..++.++|||||||++|+|++|.+||...... ....+...+..
T Consensus 327 L~DFGla~~~~~~~---~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~ 403 (576)
T 2acx_A 327 ISDLGLAVHVPEGQ---TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKE 403 (576)
T ss_dssp ECCCTTCEECCTTC---CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHH
T ss_pred EEecccceecccCc---cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhc
Confidence 99999997654322 113468999999999999989999999999999999999999999765432 34445444433
Q ss_pred CCCCCCCCccCCHHHHHHHHHHhccCCCCCC-----CHHHHhcCCCccCcchhhh
Q 039291 236 EHSLPEIPSRVSKEARDFLRRCFVRKPAFRF-----TAEMLLDDPFVKGVDEELS 285 (362)
Q Consensus 236 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~-----s~~~~l~~p~~~~~~~~~~ 285 (362)
. ...++..++.++++||.+||..||.+|| +++++++||||+.+.|+..
T Consensus 404 ~--~~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~HpfF~~i~w~~l 456 (576)
T 2acx_A 404 V--PEEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKKLNFKRL 456 (576)
T ss_dssp C--CCCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTSGGGTTCCHHHH
T ss_pred c--cccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhChhhccCCHHHH
Confidence 2 2345678999999999999999999999 7999999999999988743
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-50 Score=385.70 Aligned_cols=259 Identities=25% Similarity=0.378 Sum_probs=208.6
Q ss_pred CCCceeecceecccCceEEEEEEECCCCCCCCceeeeechhhh------hhHHHHHHHHHHHHcCCCCcccccccceeee
Q 039291 4 DGTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVS------ASASLQKEKEVFDNLNGCPFVLECFGEEITM 77 (362)
Q Consensus 4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~~------~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~ 77 (362)
..++|.+++.||+|+||.||+|+++.++. .||+|.+... ....+.+|+.+++.++ ||||+++++.+..
T Consensus 146 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~----~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~l~~~~~~- 219 (446)
T 4ejn_A 146 TMNEFEYLKLLGKGTFGKVILVKEKATGR----YYAMKILKKEVIVAKDEVAHTLTENRVLQNSR-HPFLTALKYSFQT- 219 (446)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCC----EEEEEEEEHHHHC-------------CCCCCS-CTTSCCEEEEEEE-
T ss_pred ChHHcEEeEEEeeCcCEEEEEEEEcCCCC----EEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCC-CCeEeeEEEEEee-
Confidence 34789999999999999999999998876 5666665432 3345678999999998 9999999987653
Q ss_pred cCCCceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCceeCCCCCCCEEEeecCCCceEEE
Q 039291 78 GENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHD-SGYVHCDVKPDNILLVATQSGKFVAK 156 (362)
Q Consensus 78 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~-~~ivH~Dlkp~Nill~~~~~~~~~~k 156 (362)
...+++||||++||+|.+++... ..+++..++.++.||+.||+|||+ +||+||||||+|||+ +.++.+|
T Consensus 220 ----~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll----~~~~~~k 289 (446)
T 4ejn_A 220 ----HDRLCFVMEYANGGELFFHLSRE--RVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLML----DKDGHIK 289 (446)
T ss_dssp ----TTEEEEEECCCSSCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEE----CSSSCEE
T ss_pred ----CCEEEEEEeeCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEE----CCCCCEE
Confidence 22478999999999999999873 459999999999999999999998 999999999999999 7788899
Q ss_pred EeecCCcccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHHcCC
Q 039291 157 IADLGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDE 236 (362)
Q Consensus 157 l~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 236 (362)
|+|||+++...... ......+||+.|+|||++.+..++.++|||||||++|+|++|+.||... +...+...+...
T Consensus 290 l~DFG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~---~~~~~~~~i~~~ 364 (446)
T 4ejn_A 290 ITDFGLCKEGIKDG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ---DHEKLFELILME 364 (446)
T ss_dssp ECCCCCCCTTCC-------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCS---SHHHHHHHHHHC
T ss_pred EccCCCceeccCCC--cccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCC---CHHHHHHHHHhC
Confidence 99999997543321 2224678999999999999999999999999999999999999999654 344444444332
Q ss_pred CCCCCCCccCCHHHHHHHHHHhccCCCCCC-----CHHHHhcCCCccCcchhhh
Q 039291 237 HSLPEIPSRVSKEARDFLRRCFVRKPAFRF-----TAEMLLDDPFVKGVDEELS 285 (362)
Q Consensus 237 ~~~~~~~~~~~~~~~~li~~~l~~~p~~R~-----s~~~~l~~p~~~~~~~~~~ 285 (362)
. ..++..+++++.+||.+||..||.+|| +++++++||||+++.++..
T Consensus 365 ~--~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~hp~f~~~~~~~~ 416 (446)
T 4ejn_A 365 E--IRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGIVWQHV 416 (446)
T ss_dssp C--CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCHHHH
T ss_pred C--CCCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhCccccCCCHHHH
Confidence 2 235677999999999999999999999 9999999999999887643
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-50 Score=372.61 Aligned_cols=260 Identities=24% Similarity=0.384 Sum_probs=204.5
Q ss_pred CCCCCceeecceecccCceEEEEEEECCCCCCCCceeeeechh-----hhhhHHHHHHHHHHHHcCCC-Cccccccccee
Q 039291 2 DSDGTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAE-----VSASASLQKEKEVFDNLNGC-PFVLECFGEEI 75 (362)
Q Consensus 2 ~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~-----~~~~~~~~~E~~il~~l~~h-~~i~~~~~~~~ 75 (362)
++.+++|.+++.||+|+||+||+|.+.. +. .+|+|... ....+.+.+|+.+++.+.+| |||+++++++.
T Consensus 5 ~~~~~~y~i~~~lG~G~~g~Vy~~~~~~-~~----~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~ 79 (343)
T 3dbq_A 5 SVKGRIYSILKQIGSGGSSKVFQVLNEK-KQ----IYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEI 79 (343)
T ss_dssp ESSSCEEEEEEEESCCSSEEEEEEECTT-SC----EEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEE
T ss_pred eeecCEEEEEEEEecCCCeEEEEEEeCC-CC----EEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEe
Confidence 4678999999999999999999999854 33 56777543 23446788999999999854 99999998764
Q ss_pred eecCCCceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEE
Q 039291 76 TMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVA 155 (362)
Q Consensus 76 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~ 155 (362)
. ...+++||| +.+++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||+ + ++.+
T Consensus 80 ~-----~~~~~lv~e-~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll----~-~~~~ 146 (343)
T 3dbq_A 80 T-----DQYIYMVME-CGNIDLNSWLKK--KKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLI----V-DGML 146 (343)
T ss_dssp C-----SSEEEEEEC-CCSEEHHHHHHH--SCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE----E-TTEE
T ss_pred e-----CCEEEEEEe-CCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEE----E-CCcE
Confidence 2 235779999 557899999987 4569999999999999999999999999999999999999 3 3469
Q ss_pred EEeecCCcccccccccCCCCCCccCCCCccCchhhcc-----------ccCCCcchHHHHHHHHHHHHhCCCCCccCCCC
Q 039291 156 KIADLGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQ-----------HMQEAPSDIWALGCVVLEMLSGRQAWVVKEDC 224 (362)
Q Consensus 156 kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~ 224 (362)
||+|||+++..............+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||....
T Consensus 147 kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~-- 224 (343)
T 3dbq_A 147 KLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII-- 224 (343)
T ss_dssp EECCCSSSCCC------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCC--
T ss_pred EEeecccccccCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhh--
Confidence 9999999986654433333346789999999999975 667889999999999999999999996432
Q ss_pred CHHHHHHHHcCCCCCCCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCccCcc
Q 039291 225 SIDQLFSIIGDEHSLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGVD 281 (362)
Q Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~~~~~ 281 (362)
........+........++...+.++.+||.+||..||.+|||+.++++||||+...
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~ 281 (343)
T 3dbq_A 225 NQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQT 281 (343)
T ss_dssp SHHHHHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSCC
T ss_pred hHHHHHHHHhcCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCccccccC
Confidence 233333333333444456677889999999999999999999999999999997643
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-50 Score=366.54 Aligned_cols=254 Identities=22% Similarity=0.350 Sum_probs=203.2
Q ss_pred CCceeecceecccCceEEEEEEECCCCCCCCceeeeechhhh-----------------------------hhHHHHHHH
Q 039291 5 GTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVS-----------------------------ASASLQKEK 55 (362)
Q Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~~-----------------------------~~~~~~~E~ 55 (362)
-++|.+.+.||+|+||+||+|+++.++. .|++|..... ..+.+.+|+
T Consensus 12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~----~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~ 87 (298)
T 2zv2_A 12 LNQYTLKDEIGKGSYGVVKLAYNENDNT----YYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEI 87 (298)
T ss_dssp ETTEEEEEEEEC--CCEEEEEEETTTTE----EEEEEEEECC-------------------------------CHHHHHH
T ss_pred ecceEEEeEEeecCCEEEEEEEECCCCc----EEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHH
Confidence 4789999999999999999999988876 4555554321 134588999
Q ss_pred HHHHHcCCCCcccccccceeeecCCCceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcee
Q 039291 56 EVFDNLNGCPFVLECFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVH 135 (362)
Q Consensus 56 ~il~~l~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH 135 (362)
.++++++ ||||+++++++.. .....+++||||+++++|.+++. ..++++..++.++.||+.||.|||++||+|
T Consensus 88 ~~l~~l~-h~~iv~~~~~~~~---~~~~~~~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH 160 (298)
T 2zv2_A 88 AILKKLD-HPNVVKLVEVLDD---PNEDHLYMVFELVNQGPVMEVPT---LKPLSEDQARFYFQDLIKGIEYLHYQKIIH 160 (298)
T ss_dssp HHHHTCC-CTTBCCEEEEEEC---SSSSEEEEEEECCTTCBSCCSSC---SSCCCHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred HHHHhCC-CCCCCeEEEEEEc---CCCCEEEEEEecCCCCcHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHHCCeec
Confidence 9999998 9999999987653 12345789999999999987653 356999999999999999999999999999
Q ss_pred CCCCCCCEEEeecCCCceEEEEeecCCcccccccccCCCCCCccCCCCccCchhhcccc---CCCcchHHHHHHHHHHHH
Q 039291 136 CDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHM---QEAPSDIWALGCVVLEML 212 (362)
Q Consensus 136 ~Dlkp~Nill~~~~~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~DiwslG~il~~l~ 212 (362)
|||||+|||+ +.++.+||+|||+++....... ......||+.|+|||++.+.. ++.++|||||||++|+|+
T Consensus 161 ~Dlkp~Nil~----~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~ 234 (298)
T 2zv2_A 161 RDIKPSNLLV----GEDGHIKIADFGVSNEFKGSDA--LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFV 234 (298)
T ss_dssp CCCCGGGEEE----CTTSCEEECCCTTCEECSSSSC--EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHH
T ss_pred cCCCHHHEEE----CCCCCEEEecCCCccccccccc--cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHH
Confidence 9999999999 7778899999999976543221 123567999999999998654 377899999999999999
Q ss_pred hCCCCCccCCCCCHHHHHHHHcCCCCCCCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCcc
Q 039291 213 SGRQAWVVKEDCSIDQLFSIIGDEHSLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVK 278 (362)
Q Consensus 213 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~~ 278 (362)
+|..||... ....+...+............++.++++||.+||..||++|||+.++++||||+
T Consensus 235 ~g~~pf~~~---~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp~~~ 297 (298)
T 2zv2_A 235 FGQCPFMDE---RIMCLHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVT 297 (298)
T ss_dssp HSSCSSCCS---SHHHHHHHHHHCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTCHHHH
T ss_pred HCCCCCCCc---cHHHHHHHHhcccCCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhcCcccc
Confidence 999999644 334444443332222223356899999999999999999999999999999985
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-50 Score=372.67 Aligned_cols=251 Identities=27% Similarity=0.416 Sum_probs=207.9
Q ss_pred CCceeecceecccCceEEEEEEECCCCCCCCceeeeechhhh------hhHHHHHHHHHHHHcCCCCcccccccceeeec
Q 039291 5 GTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVS------ASASLQKEKEVFDNLNGCPFVLECFGEEITMG 78 (362)
Q Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~~------~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~ 78 (362)
-++|.+++.||+|+||+||+|++..++. .|++|..... ....+.+|+.+++.++ ||||+++++++..
T Consensus 8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~----~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~-- 80 (336)
T 3h4j_B 8 IGPYIIRETLGEGSFGKVKLATHYKTQQ----KVALKFISRQLLKKSDMHMRVEREISYLKLLR-HPHIIKLYDVITT-- 80 (336)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCC----EEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCC-CTTBCCEEEEEEC--
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCC----EEEEEEEehHHccchhHHHHHHHHHHHHHhCC-CCCCCeEEEEEEe--
Confidence 3789999999999999999999988875 5666665322 2356889999999998 9999999987643
Q ss_pred CCCceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEe
Q 039291 79 ENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIA 158 (362)
Q Consensus 79 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~ 158 (362)
...+++||||+ +|+|.+++... +.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+
T Consensus 81 ---~~~~~lv~E~~-~g~l~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll----~~~~~~kl~ 150 (336)
T 3h4j_B 81 ---PTDIVMVIEYA-GGELFDYIVEK--KRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLL----DDNLNVKIA 150 (336)
T ss_dssp ---SSEEEEEECCC-CEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEE----CTTCCEEEC
T ss_pred ---CCEEEEEEECC-CCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEE----cCCCCEEEE
Confidence 23477999999 67999998773 459999999999999999999999999999999999999 788889999
Q ss_pred ecCCcccccccccCCCCCCccCCCCccCchhhccccC-CCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHHcCCC
Q 039291 159 DLGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQ-EAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEH 237 (362)
Q Consensus 159 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 237 (362)
|||++....... .....+||+.|+|||++.+..+ +.++|||||||++|+|++|..||....... +...+ ..
T Consensus 151 DFG~s~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~---~~~~i--~~ 222 (336)
T 3h4j_B 151 DFGLSNIMTDGN---FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPN---LFKKV--NS 222 (336)
T ss_dssp CSSCTBTTTTSB---TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTT---CBCCC--CS
T ss_pred EeccceeccCCc---ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHH---HHHHH--Hc
Confidence 999997654322 2245679999999999988766 789999999999999999999996543221 11111 11
Q ss_pred CCCCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCccCc
Q 039291 238 SLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGV 280 (362)
Q Consensus 238 ~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~~~~ 280 (362)
....+|..+++++++||++||..||.+|||++++++||||+..
T Consensus 223 ~~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~ 265 (336)
T 3h4j_B 223 CVYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRDPWFNVN 265 (336)
T ss_dssp SCCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTCHHHHTT
T ss_pred CCCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhChhhccC
Confidence 2234567789999999999999999999999999999999753
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-50 Score=374.42 Aligned_cols=259 Identities=28% Similarity=0.428 Sum_probs=209.8
Q ss_pred CceeecceecccCceEEEEEEECCCCCCCCceeeeechhhh--------hhHHHHHHHHHHHHcCCCCcccccccceeee
Q 039291 6 TSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVS--------ASASLQKEKEVFDNLNGCPFVLECFGEEITM 77 (362)
Q Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~~--------~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~ 77 (362)
++|.+++.||+|+||+||+|+++.+++ .+++|..... ..+.+.+|+.+++.++ ||||+++++++..
T Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~~~~~----~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~- 97 (351)
T 3c0i_A 24 DVYELCEVIGKGPFSVVRRCINRETGQ----QFAVKIVDVAKFTSSPGLSTEDLKREASICHMLK-HPHIVELLETYSS- 97 (351)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCC----EEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCC-CTTBCCEEEEEEE-
T ss_pred cceEEeeEEeeCCCEEEEEEEECCCCC----EEEEEEEEhhhccccccchHHHHHHHHHHHHhCC-CCCCCcEEEEEEe-
Confidence 579999999999999999999998875 5677765322 3466889999999998 9999999987653
Q ss_pred cCCCceEEEEEEEecCCCCHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEE
Q 039291 78 GENGEMAYNLLLEYAAGGTLGDLIEKCN--GNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVA 155 (362)
Q Consensus 78 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~ 155 (362)
...+++||||++|++|.+++.... +..+++..++.++.||+.||.|||++||+||||||+|||+..+ +....+
T Consensus 98 ----~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~-~~~~~v 172 (351)
T 3c0i_A 98 ----DGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASK-ENSAPV 172 (351)
T ss_dssp ----TTEEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSS-STTCCE
T ss_pred ----CCEEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecC-CCCCcE
Confidence 234789999999999998886532 3458999999999999999999999999999999999999432 223459
Q ss_pred EEeecCCcccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHHcC
Q 039291 156 KIADLGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGD 235 (362)
Q Consensus 156 kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~ 235 (362)
||+|||++....... ......+||+.|+|||++.+..++.++|||||||++|+|++|..||.... ..+...+..
T Consensus 173 kl~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~----~~~~~~i~~ 246 (351)
T 3c0i_A 173 KLGGFGVAIQLGESG--LVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK----ERLFEGIIK 246 (351)
T ss_dssp EECCCTTCEECCTTS--CBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSH----HHHHHHHHH
T ss_pred EEecCcceeEecCCC--eeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcH----HHHHHHHHc
Confidence 999999997665422 22345679999999999999899999999999999999999999996542 233333322
Q ss_pred CC-CC-CCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCccCcc
Q 039291 236 EH-SL-PEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGVD 281 (362)
Q Consensus 236 ~~-~~-~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~~~~~ 281 (362)
.. .. +..+..++.++++||.+||..||++|||+.++++||||+...
T Consensus 247 ~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~~~ 294 (351)
T 3c0i_A 247 GKYKMNPRQWSHISESAKDLVRRMLMLDPAERITVYEALNHPWLKERD 294 (351)
T ss_dssp TCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTHH
T ss_pred CCCCCCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcChhhcCCc
Confidence 22 11 112246899999999999999999999999999999998653
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-50 Score=366.57 Aligned_cols=261 Identities=26% Similarity=0.418 Sum_probs=211.1
Q ss_pred CCceeecceecccCceEEEEEEECCCCCCCCceeeeechhhh---------hhHHHHHHHHHHHHcCCCCccccccccee
Q 039291 5 GTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVS---------ASASLQKEKEVFDNLNGCPFVLECFGEEI 75 (362)
Q Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~~---------~~~~~~~E~~il~~l~~h~~i~~~~~~~~ 75 (362)
.++|.+++.||+|+||+||+|+++.++.. +++|..... ....+.+|+.+++.++ ||||+++++++.
T Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~----~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~ 84 (326)
T 2y0a_A 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQ----YAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ-HPNVITLHEVYE 84 (326)
T ss_dssp HHHEEEEEEEECCSSEEEEEEEETTTCCE----EEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCC-CTTBCCEEEEEE
T ss_pred ccceEeceEEeeCCCeEEEEEEECCCCcE----EEEEEEEccccccccchhhHHHHHHHHHHHHhCC-CCCCCcEEEEEE
Confidence 36799999999999999999999988764 455543221 3466889999999998 999999998764
Q ss_pred eecCCCceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEE
Q 039291 76 TMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVA 155 (362)
Q Consensus 76 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~ 155 (362)
. ...+++||||++|++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||+..+......+
T Consensus 85 ~-----~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~ 157 (326)
T 2y0a_A 85 N-----KTDVILILELVAGGELFDFLAE--KESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRI 157 (326)
T ss_dssp C-----SSEEEEEEECCCSCBHHHHHTT--SSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCE
T ss_pred e-----CCEEEEEEEcCCCCCHHHHHHh--cCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCE
Confidence 2 2347799999999999999976 45699999999999999999999999999999999999994333233379
Q ss_pred EEeecCCcccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHHcC
Q 039291 156 KIADLGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGD 235 (362)
Q Consensus 156 kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~ 235 (362)
||+|||+++...... ......||+.|+|||++.+..++.++|||||||++|+|++|..||.... ..+....+..
T Consensus 158 kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~---~~~~~~~~~~ 231 (326)
T 2y0a_A 158 KIIDFGLAHKIDFGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT---KQETLANVSA 231 (326)
T ss_dssp EECCCTTCEECCTTS---CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSS---HHHHHHHHHH
T ss_pred EEEECCCCeECCCCC---ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCC---HHHHHHHHHh
Confidence 999999997664322 1235679999999999998899999999999999999999999996543 3333333322
Q ss_pred -CCCC-CCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCccCcchh
Q 039291 236 -EHSL-PEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGVDEE 283 (362)
Q Consensus 236 -~~~~-~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~~~~~~~ 283 (362)
.... +..+..++..+++||.+||..||++|||+.++++||||+.....
T Consensus 232 ~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~~ 281 (326)
T 2y0a_A 232 VNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQ 281 (326)
T ss_dssp TCCCCCHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTSCCSHH
T ss_pred cCCCcCccccccCCHHHHHHHHHHccCChhhCCCHHHHhcCCCccCCcch
Confidence 1111 11234688999999999999999999999999999999886544
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-50 Score=378.08 Aligned_cols=262 Identities=22% Similarity=0.354 Sum_probs=203.2
Q ss_pred Cceeec-ceecccCceEEEEEEECCCCCCCCceeeeechhhhhhHHHHHHHHHHHHcCCCCcccccccceeeecCCCceE
Q 039291 6 TSWFRG-RVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVSASASLQKEKEVFDNLNGCPFVLECFGEEITMGENGEMA 84 (362)
Q Consensus 6 ~~y~~~-~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~~~~~ 84 (362)
++|.+. +.||+|+||+||+|+++.+++ .|++|.+.. ...+.+|+.++.++.+||||+++++++.... .+...
T Consensus 61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~----~vAiK~~~~--~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~-~~~~~ 133 (400)
T 1nxk_A 61 DDYKVTSQVLGLGINGKVLQIFNKRTQE----KFALKMLQD--CPKARREVELHWRASQCPHIVRIVDVYENLY-AGRKC 133 (400)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCC----EEEEEEEEC--SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEE-TTEEE
T ss_pred ccceeccceeeeccCeEEEEEEECCCCC----EEEEEEeCc--chhHHHHHHHHHHhcCCCCcceEeEEEeecc-cCCcE
Confidence 456665 799999999999999998875 677777642 3457789999877777999999999775433 23456
Q ss_pred EEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEeecCCcc
Q 039291 85 YNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAK 164 (362)
Q Consensus 85 ~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Dfgla~ 164 (362)
+|+||||++||+|.+++.......+++..++.++.||+.||.|||++||+||||||+|||+... ..++.+||+|||+++
T Consensus 134 ~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~-~~~~~~kl~DFG~a~ 212 (400)
T 1nxk_A 134 LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSK-RPNAILKLTDFGFAK 212 (400)
T ss_dssp EEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSS-STTCCEEECCCTTCE
T ss_pred EEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecC-CCCccEEEEeccccc
Confidence 7899999999999999987544569999999999999999999999999999999999999321 126789999999997
Q ss_pred cccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHhCCCCCccCCCCC----HHHHHHHHcCCCCCC
Q 039291 165 RSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCS----IDQLFSIIGDEHSLP 240 (362)
Q Consensus 165 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~----~~~~~~~~~~~~~~~ 240 (362)
...... .....+||+.|+|||++.+..++.++|||||||++|+|++|..||....... ....+. .....++
T Consensus 213 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~--~~~~~~~ 287 (400)
T 1nxk_A 213 ETTSHN---SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIR--MGQYEFP 287 (400)
T ss_dssp ECC--------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHH--HTCCCCC
T ss_pred ccCCCC---ccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHH--cCcccCC
Confidence 554321 2245779999999999999999999999999999999999999997654322 112211 1122222
Q ss_pred -CCCccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCccCc
Q 039291 241 -EIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGV 280 (362)
Q Consensus 241 -~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~~~~ 280 (362)
..+..++.++++||++||..||++|||+.++++||||...
T Consensus 288 ~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~ 328 (400)
T 1nxk_A 288 NPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 328 (400)
T ss_dssp TTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHTT
T ss_pred CcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccCC
Confidence 2235689999999999999999999999999999999753
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-50 Score=387.28 Aligned_cols=265 Identities=23% Similarity=0.376 Sum_probs=220.2
Q ss_pred CCCCceeecceecccCceEEEEEEECCCCCCCCceeeeechhh------hhhHHHHHHHHHHHHcCCCCcccccccceee
Q 039291 3 SDGTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEV------SASASLQKEKEVFDNLNGCPFVLECFGEEIT 76 (362)
Q Consensus 3 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~------~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~ 76 (362)
...++|.+.+.||+|+||+||+|+++.+++ .+++|.+.. .....+.+|+.++++++ ||||+++++.+..
T Consensus 182 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~----~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~-hp~Iv~l~~~~~~ 256 (543)
T 3c4z_A 182 MGEDWFLDFRVLGRGGFGEVFACQMKATGK----LYACKKLNKKRLKKRKGYQGAMVEKKILAKVH-SRFIVSLAYAFET 256 (543)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEETTTCC----EEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCC-CTTBCCEEEEEEC
T ss_pred CChhheEEEEEEeeCCCeEEEEEEECCCCc----EEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcC-CCCEeeEEEEEee
Confidence 455789999999999999999999998876 556665532 23356789999999998 9999999886642
Q ss_pred ecCCCceEEEEEEEecCCCCHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceE
Q 039291 77 MGENGEMAYNLLLEYAAGGTLGDLIEKCN--GNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFV 154 (362)
Q Consensus 77 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~ 154 (362)
...+|+||||++||+|.+++.... ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.
T Consensus 257 -----~~~l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl----~~~g~ 327 (543)
T 3c4z_A 257 -----KTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLL----DDDGN 327 (543)
T ss_dssp -----SSEEEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE----CTTSC
T ss_pred -----CCEEEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEE----eCCCC
Confidence 234789999999999999997643 3469999999999999999999999999999999999999 88889
Q ss_pred EEEeecCCcccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHhCCCCCccCCC-CCHHHHHHHH
Q 039291 155 AKIADLGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKED-CSIDQLFSII 233 (362)
Q Consensus 155 ~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~-~~~~~~~~~~ 233 (362)
+||+|||+++....... .....+||+.|+|||++.+..++.++|||||||++|||++|.+||..... ....++...+
T Consensus 328 vkL~DFGla~~~~~~~~--~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i 405 (543)
T 3c4z_A 328 VRISDLGLAVELKAGQT--KTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRV 405 (543)
T ss_dssp EEECCCTTCEECCTTCC--CBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHH
T ss_pred EEEeecceeeeccCCCc--ccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHH
Confidence 99999999986543221 22356899999999999999999999999999999999999999976533 2344555544
Q ss_pred cCCCCCCCCCccCCHHHHHHHHHHhccCCCCCCC-----HHHHhcCCCccCcchhhh
Q 039291 234 GDEHSLPEIPSRVSKEARDFLRRCFVRKPAFRFT-----AEMLLDDPFVKGVDEELS 285 (362)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s-----~~~~l~~p~~~~~~~~~~ 285 (362)
.... ..+|..++.++++||.+||..||++||+ +++++.||||+.+.|...
T Consensus 406 ~~~~--~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~i~w~~l 460 (543)
T 3c4z_A 406 LEQA--VTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDISWRQL 460 (543)
T ss_dssp HHCC--CCCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGGTTCCHHHH
T ss_pred hhcc--cCCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcCccccCCCHHHH
Confidence 3322 2456789999999999999999999995 589999999999988743
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-50 Score=372.34 Aligned_cols=256 Identities=25% Similarity=0.377 Sum_probs=209.8
Q ss_pred CceeecceecccCceEEEEEEECCCCCCCCceeeeechh-----hhhhHHHHHHHHHHHHcCCCCcccccccceeeecCC
Q 039291 6 TSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAE-----VSASASLQKEKEVFDNLNGCPFVLECFGEEITMGEN 80 (362)
Q Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~-----~~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~ 80 (362)
++|.+++.||+|+||.||+|+++.++. .+++|... ......+.+|+.+++.|+ ||||+++++++..
T Consensus 29 ~~y~~~~~lG~G~~g~V~~~~~~~~~~----~~avK~~~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~~~~~~~~---- 99 (362)
T 2bdw_A 29 DNYDVKEELGKGAFSVVRRCVHKTTGL----EFAAKIINTKKLSARDFQKLEREARICRKLQ-HPNIVRLHDSIQE---- 99 (362)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCC----EEEEEEEETTTCCHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEEC----
T ss_pred cCeEEeeEEecCCCeEEEEEEECCCCC----EEEEEEEEcccCCHHHHHHHHHHHHHHHhCC-CCCCCeEEEEEEe----
Confidence 479999999999999999999998876 45666543 234466889999999998 9999999987642
Q ss_pred CceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEeec
Q 039291 81 GEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADL 160 (362)
Q Consensus 81 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Df 160 (362)
...+++||||+.||+|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||+..+ +..+.+||+||
T Consensus 100 -~~~~~lv~e~~~gg~L~~~l~~--~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~-~~~~~~kl~Df 175 (362)
T 2bdw_A 100 -ESFHYLVFDLVTGGELFEDIVA--REFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASK-AKGAAVKLADF 175 (362)
T ss_dssp -SSEEEEEECCCCSCBHHHHHTT--CSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCS-STTCCEEECCC
T ss_pred -CCEEEEEEecCCCCCHHHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecC-CCCCCEEEeec
Confidence 2346799999999999999976 4569999999999999999999999999999999999999432 12356999999
Q ss_pred CCcccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHHcCCC-CC
Q 039291 161 GVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEH-SL 239 (362)
Q Consensus 161 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~-~~ 239 (362)
|++....... ......||+.|+|||++.+..++.++|||||||++|+|++|.+||... +...+...+.... ..
T Consensus 176 G~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~---~~~~~~~~i~~~~~~~ 249 (362)
T 2bdw_A 176 GLAIEVNDSE---AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDE---DQHRLYAQIKAGAYDY 249 (362)
T ss_dssp TTCBCCTTCC---SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCS---SHHHHHHHHHHTCCCC
T ss_pred CcceEecCCc---ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCC---CHHHHHHHHHhCCCCC
Confidence 9997655321 223567999999999999989999999999999999999999999654 3344444443322 22
Q ss_pred C-CCCccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCccCc
Q 039291 240 P-EIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGV 280 (362)
Q Consensus 240 ~-~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~~~~ 280 (362)
+ ..+..+++++++||.+||..||++||++.++++||||...
T Consensus 250 ~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~ 291 (362)
T 2bdw_A 250 PSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNR 291 (362)
T ss_dssp CTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTSHHHHTH
T ss_pred CcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcccCCC
Confidence 2 2235689999999999999999999999999999999753
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-50 Score=369.31 Aligned_cols=258 Identities=22% Similarity=0.343 Sum_probs=210.7
Q ss_pred CCceeecceecccCceEEEEEEECCCCCCCCceeeeechhh--hhhHHHHHHHHHHHHcCCCCcccccccceeeecCCCc
Q 039291 5 GTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEV--SASASLQKEKEVFDNLNGCPFVLECFGEEITMGENGE 82 (362)
Q Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~--~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~~~ 82 (362)
.++|.+++.||+|+||+||+|+++.++. .+++|.... .....+.+|+.+++.++ ||||+++++.+.. .
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~----~~a~K~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~-----~ 73 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKK----TYMAKFVKVKGTDQVLVKKEISILNIAR-HRNILHLHESFES-----M 73 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTE----EEEEEEECCCTHHHHHHHHHHHHHHHSC-CTTBCCEEEEEEE-----T
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCc----EEEEEEEecCcccHHHHHHHHHHHHhCC-CCCCCeEeEEEec-----C
Confidence 4799999999999999999999998875 456665432 24456889999999998 9999999997643 2
Q ss_pred eEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEeecCC
Q 039291 83 MAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGV 162 (362)
Q Consensus 83 ~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Dfgl 162 (362)
..+++||||++|++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||+.. +.++.+||+|||+
T Consensus 74 ~~~~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~--~~~~~~kl~Dfg~ 150 (321)
T 1tki_A 74 EELVMIFEFISGLDIFERINTS-AFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQT--RRSSTIKIIEFGQ 150 (321)
T ss_dssp TEEEEEECCCCCCBHHHHHTSS-SCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESS--SSCCCEEECCCTT
T ss_pred CEEEEEEEeCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcc--CCCCCEEEEECCC
Confidence 3478999999999999999752 346999999999999999999999999999999999999932 1267899999999
Q ss_pred cccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHHcCCCC-CC-
Q 039291 163 AKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEHS-LP- 240 (362)
Q Consensus 163 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~-~~- 240 (362)
+........ .....||+.|+|||++.+..++.++|||||||++|+|++|..||.... ..+....+..... ++
T Consensus 151 a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~---~~~~~~~i~~~~~~~~~ 224 (321)
T 1tki_A 151 ARQLKPGDN---FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAET---NQQIIENIMNAEYTFDE 224 (321)
T ss_dssp CEECCTTCE---EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSS---HHHHHHHHHHTCCCCCH
T ss_pred CeECCCCCc---cccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCC---HHHHHHHHHcCCCCCCh
Confidence 976543221 134679999999999998889999999999999999999999996543 3444444432222 11
Q ss_pred CCCccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCccCcc
Q 039291 241 EIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGVD 281 (362)
Q Consensus 241 ~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~~~~~ 281 (362)
..+..++.++++||.+||..||.+|||+.++++||||++..
T Consensus 225 ~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~ 265 (321)
T 1tki_A 225 EAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQKI 265 (321)
T ss_dssp HHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHSCG
T ss_pred hhhccCCHHHHHHHHHHcCCChhHCcCHHHHhcChhhccCc
Confidence 12246899999999999999999999999999999997653
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-49 Score=359.99 Aligned_cols=255 Identities=22% Similarity=0.387 Sum_probs=203.2
Q ss_pred CceeecceecccCceEEEEEEECCCCCCCCceeeeechh-----hhhhHHHHHHHHHHHHcCCCCcccccccceeeecCC
Q 039291 6 TSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAE-----VSASASLQKEKEVFDNLNGCPFVLECFGEEITMGEN 80 (362)
Q Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~-----~~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~ 80 (362)
++|.+++.||+|+||+||+|+++.+++ .+++|... ......+.+|+.++++++ ||||+++++++..
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~----~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~---- 72 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHE----IVALKRVRLDDDDEGVPSSALREICLLKELK-HKNIVRLHDVLHS---- 72 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCC----EEEEEEEESSCSSTTHHHHHHHHHHHHTTCC-CTTBCCEEEEEEE----
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCc----eEEEEeeeccCCcCCcchHHHHHHHHHhcCC-CCCEeeEEeEEEe----
Confidence 589999999999999999999998876 45666543 223466889999999998 9999999997653
Q ss_pred CceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEeec
Q 039291 81 GEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADL 160 (362)
Q Consensus 81 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Df 160 (362)
...+++||||+.+ +|.+++... .+.+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+||
T Consensus 73 -~~~~~lv~e~~~~-~l~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~----~~~~~~kl~Df 145 (292)
T 3o0g_A 73 -DKKLTLVFEFCDQ-DLKKYFDSC-NGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLI----NRNGELKLANF 145 (292)
T ss_dssp -TTEEEEEEECCSE-EHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE----CTTSCEEECCC
T ss_pred -CCEEEEEEecCCC-CHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE----cCCCCEEEeec
Confidence 2347799999976 676666553 4569999999999999999999999999999999999999 77888999999
Q ss_pred CCcccccccccCCCCCCccCCCCccCchhhcccc-CCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHHc---CC
Q 039291 161 GVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHM-QEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIG---DE 236 (362)
Q Consensus 161 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~---~~ 236 (362)
|+++..... ........||+.|+|||++.+.. ++.++|||||||++|+|++|..||.... +.......+. ..
T Consensus 146 g~~~~~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~--~~~~~~~~i~~~~~~ 221 (292)
T 3o0g_A 146 GLARAFGIP--VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGN--DVDDQLKRIFRLLGT 221 (292)
T ss_dssp TTCEECCSC--CSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCS--SHHHHHHHHHHHHCC
T ss_pred ccceecCCc--cccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCC--CHHHHHHHHHHHhCC
Confidence 999765432 22224567899999999998765 7999999999999999999888864332 2223222221 00
Q ss_pred ------------------------CCCCCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCccCc
Q 039291 237 ------------------------HSLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGV 280 (362)
Q Consensus 237 ------------------------~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~~~~ 280 (362)
.........++.++++||.+||+.||++|||++++++||||+.+
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~ 289 (292)
T 3o0g_A 222 PTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDF 289 (292)
T ss_dssp CCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTC
T ss_pred CChhhhhhhcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCcccccC
Confidence 01112234578999999999999999999999999999999875
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-50 Score=360.80 Aligned_cols=256 Identities=23% Similarity=0.390 Sum_probs=198.9
Q ss_pred CceeecceecccCceEEEEEEECCCCCCCCceeeeechhh-----hhhHHHHHHHHHHHHcCCCCcccccccceeeecCC
Q 039291 6 TSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEV-----SASASLQKEKEVFDNLNGCPFVLECFGEEITMGEN 80 (362)
Q Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~-----~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~ 80 (362)
++|.+++.||+|+||+||+|++. +++ .+++|.... .....+.+|+.++++++ ||||+++++++..
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~-~~~----~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~---- 71 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNN-YGE----TFALKKIRLEKEDEGIPSTTIREISILKELK-HSNIVKLYDVIHT---- 71 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEET-TSC----EEEEEEECCSSGGGCCCHHHHHHHHGGGGCC-CTTBCCEEEEEEC----
T ss_pred ccchhhhhcccCCCEEEEEEEcC-CCC----EEEEEEEeccccccccchhHHHHHHHHHhcC-CCCEeeeeeEEcc----
Confidence 58999999999999999999984 343 466665432 23366889999999998 9999999997643
Q ss_pred CceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEeec
Q 039291 81 GEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADL 160 (362)
Q Consensus 81 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Df 160 (362)
...+++||||+.+ +|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+||
T Consensus 72 -~~~~~lv~e~~~~-~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~----~~~~~~kl~Df 144 (288)
T 1ob3_A 72 -KKRLVLVFEHLDQ-DLKKLLDVC-EGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLI----NREGELKIADF 144 (288)
T ss_dssp -SSCEEEEEECCSE-EHHHHHHTS-TTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE----CTTSCEEECCT
T ss_pred -CCeEEEEEEecCC-CHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE----cCCCCEEEeEC
Confidence 2347799999986 999998763 3569999999999999999999999999999999999999 77888999999
Q ss_pred CCcccccccccCCCCCCccCCCCccCchhhccc-cCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHH-HHHHHcCCC-
Q 039291 161 GVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQH-MQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQ-LFSIIGDEH- 237 (362)
Q Consensus 161 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~-~~~~~~~~~- 237 (362)
|+++....... ......||+.|+|||++.+. .++.++|||||||++|+|++|..||.......... +........
T Consensus 145 g~~~~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 222 (288)
T 1ob3_A 145 GLARAFGIPVR--KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNS 222 (288)
T ss_dssp THHHHHCC-----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCT
T ss_pred ccccccCcccc--ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCCh
Confidence 99976543211 12345789999999999764 58999999999999999999999996543222111 111111100
Q ss_pred -C---------------------CCCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCccCc
Q 039291 238 -S---------------------LPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGV 280 (362)
Q Consensus 238 -~---------------------~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~~~~ 280 (362)
. +......++.++.+||.+||..||++|||++++++||||++.
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~ 287 (288)
T 1ob3_A 223 KNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKEN 287 (288)
T ss_dssp TTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC-
T ss_pred hhchhhhcccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhc
Confidence 0 011224578999999999999999999999999999999753
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-49 Score=370.30 Aligned_cols=259 Identities=24% Similarity=0.374 Sum_probs=206.6
Q ss_pred CCceeecceecccCceEEEEEEECCCCCCCCceeeeechh--hhhhHHHHHHHHHHHHcC----CCCcccccccceeeec
Q 039291 5 GTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAE--VSASASLQKEKEVFDNLN----GCPFVLECFGEEITMG 78 (362)
Q Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~--~~~~~~~~~E~~il~~l~----~h~~i~~~~~~~~~~~ 78 (362)
+++|.+++.||+|+||+||+|++..++. .|++|... ........+|+.+++.+. .||||+++++.+...
T Consensus 34 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~----~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~- 108 (360)
T 3llt_A 34 NNAFLVIRKMGDGTFGRVLLCQHIDNKK----YYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYY- 108 (360)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTCC----EEEEEEECSCHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEET-
T ss_pred cCEEEEEEEEcccCCeEEEEEEECCCCe----EEEEEEeccchhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeEC-
Confidence 5799999999999999999999988775 56777654 334556788999999997 589999999977542
Q ss_pred CCCceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecC---------
Q 039291 79 ENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQ--------- 149 (362)
Q Consensus 79 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~--------- 149 (362)
..+++||||+ +++|.+++.......+++..++.++.||+.||+|||++||+||||||+|||+....
T Consensus 109 ----~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~~~~ 183 (360)
T 3llt_A 109 ----DHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVR 183 (360)
T ss_dssp ----TEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEEEEEE
T ss_pred ----CeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccccccchh
Confidence 2478999999 88999999886656799999999999999999999999999999999999993210
Q ss_pred ------------CCceEEEEeecCCcccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHhCCCC
Q 039291 150 ------------SGKFVAKIADLGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQA 217 (362)
Q Consensus 150 ------------~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~p 217 (362)
...+.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|+|++|+.|
T Consensus 184 ~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~p 258 (360)
T 3llt_A 184 RVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY-----HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLL 258 (360)
T ss_dssp CTTTCCEEEEEEESCCCEEECCCTTCEETTSC-----CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCS
T ss_pred cccccccccccccCCCCEEEEeccCceecCCC-----CcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCC
Confidence 12677999999999754331 2356799999999999999999999999999999999999999
Q ss_pred CccCCCCCHHHHHHHHcCCC------------------------CCCC-----------------CCccCCHHHHHHHHH
Q 039291 218 WVVKEDCSIDQLFSIIGDEH------------------------SLPE-----------------IPSRVSKEARDFLRR 256 (362)
Q Consensus 218 f~~~~~~~~~~~~~~~~~~~------------------------~~~~-----------------~~~~~~~~~~~li~~ 256 (362)
|...+.......+....... .+|. .+...++.+.+||.+
T Consensus 259 f~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 338 (360)
T 3llt_A 259 FRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYS 338 (360)
T ss_dssp CCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHH
T ss_pred CCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHH
Confidence 97654322222222211100 0000 011134778899999
Q ss_pred HhccCCCCCCCHHHHhcCCCcc
Q 039291 257 CFVRKPAFRFTAEMLLDDPFVK 278 (362)
Q Consensus 257 ~l~~~p~~R~s~~~~l~~p~~~ 278 (362)
||+.||++|||++++++||||+
T Consensus 339 ~L~~dP~~Rpta~elL~hp~f~ 360 (360)
T 3llt_A 339 ILQIDPTLRPSPAELLKHKFLE 360 (360)
T ss_dssp HCCSSGGGSCCHHHHTTSGGGC
T ss_pred HhcCChhhCCCHHHHhcCcccC
Confidence 9999999999999999999995
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-49 Score=377.56 Aligned_cols=268 Identities=26% Similarity=0.372 Sum_probs=205.1
Q ss_pred CCceeecceecccCceEEEEEEECCCCCCCCceeeeechhh-----hhhHHHHHHHHHHHHcCCCCcccccccceeeecC
Q 039291 5 GTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEV-----SASASLQKEKEVFDNLNGCPFVLECFGEEITMGE 79 (362)
Q Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~-----~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~ 79 (362)
.++|.+++.||+|+||+||+|+++.+++ .||+|.+.. ...+.+.+|+.+|+.++ ||||+++++++.....
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~----~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~ 99 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEK----NVAIKKVNRMFEDLIDCKRILREITILNRLK-SDYIIRLYDLIIPDDL 99 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTE----EEEEEEECSTTTSHHHHHHHHHHHHHHHHCC-CTTBCCEEEECCCSCT
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCc----EEEEEEeCchhcChHHHHHHHHHHHHHHHcC-CCCcceEEEEEecCCC
Confidence 5899999999999999999999998875 566665532 34467889999999998 9999999997765433
Q ss_pred CCceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEee
Q 039291 80 NGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIAD 159 (362)
Q Consensus 80 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~D 159 (362)
.....+|+||||+. ++|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|
T Consensus 100 ~~~~~~~lv~e~~~-~~L~~~~~~--~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl----~~~~~~kL~D 172 (432)
T 3n9x_A 100 LKFDELYIVLEIAD-SDLKKLFKT--PIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLL----NQDCSVKVCD 172 (432)
T ss_dssp TTCCCEEEEEECCS-EEHHHHHHS--SCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE----CTTCCEEECC
T ss_pred CcCCeEEEEEecCC-cCHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEE----CCCCCEEEcc
Confidence 33345789999996 599999976 4569999999999999999999999999999999999999 7888999999
Q ss_pred cCCcccccccccC--------------------CCCCCccCCCCccCchhhc-cccCCCcchHHHHHHHHHHHHhCCC--
Q 039291 160 LGVAKRSRHCKRQ--------------------KFDPSMRGTPLYLAPETVV-QHMQEAPSDIWALGCVVLEMLSGRQ-- 216 (362)
Q Consensus 160 fgla~~~~~~~~~--------------------~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~~l~~g~~-- 216 (362)
||+++........ ......+||+.|+|||++. +..++.++|||||||++|||++|..
T Consensus 173 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~ 252 (432)
T 3n9x_A 173 FGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSH 252 (432)
T ss_dssp CTTCEEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTT
T ss_pred CCCcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccc
Confidence 9999865433211 1235678999999999864 5679999999999999999998543
Q ss_pred ---------CCccCCCCC---------------HHH---HHHHH--------------------cCCCCCCC-----CCc
Q 039291 217 ---------AWVVKEDCS---------------IDQ---LFSII--------------------GDEHSLPE-----IPS 244 (362)
Q Consensus 217 ---------pf~~~~~~~---------------~~~---~~~~~--------------------~~~~~~~~-----~~~ 244 (362)
+|.+.+... ..+ ++..+ ........ ...
T Consensus 253 ~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 332 (432)
T 3n9x_A 253 INDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYP 332 (432)
T ss_dssp CSSGGGCCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHST
T ss_pred ccccccccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCC
Confidence 343322100 011 11111 11111111 113
Q ss_pred cCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCccCcchhh
Q 039291 245 RVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGVDEEL 284 (362)
Q Consensus 245 ~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~~~~~~~~ 284 (362)
.+++++.+||++||..||++|||++++++||||+.+.+..
T Consensus 333 ~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~~~ 372 (432)
T 3n9x_A 333 SISDDGINLLESMLKFNPNKRITIDQALDHPYLKDVRKKK 372 (432)
T ss_dssp TSCHHHHHHHHHHSCSSTTTSCCHHHHHTCGGGTTTCCTT
T ss_pred CCCHHHHHHHHHHhcCCcccCCCHHHHhcChhhhhccCcc
Confidence 5899999999999999999999999999999999886653
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-49 Score=369.87 Aligned_cols=265 Identities=22% Similarity=0.294 Sum_probs=212.2
Q ss_pred CCceeecceecccCceEEEEEEECCCCCCCCceeeeechh----hhhhHHHHHHHHHHHHcCCCCcccccccceeeecCC
Q 039291 5 GTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAE----VSASASLQKEKEVFDNLNGCPFVLECFGEEITMGEN 80 (362)
Q Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~----~~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~ 80 (362)
+++|.+++.||+|+||.||+|++..++. .|++|... ......+.+|++++++++ ||||+++++++......
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~----~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~ 100 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKV----RVAIKKISPFEHQTYCQRTLREIKILLRFR-HENIIGINDIIRAPTIE 100 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTE----EEEEEEECCTTCHHHHHHHHHHHHHHHHCC-CTTBCCCCEEECCSSTT
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCe----EEEEEEeccccCcHHHHHHHHHHHHHHhcC-CCCCccceeEEecCCcc
Confidence 5799999999999999999999988775 56666653 234467889999999998 99999999977654333
Q ss_pred CceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEeec
Q 039291 81 GEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADL 160 (362)
Q Consensus 81 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Df 160 (362)
....+++||||+.+ +|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+||
T Consensus 101 ~~~~~~iv~e~~~~-~L~~~l~~---~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~----~~~~~~kl~Df 172 (364)
T 3qyz_A 101 QMKDVYIVQDLMET-DLYKLLKT---QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLL----NTTCDLKICDF 172 (364)
T ss_dssp TCCCEEEEEECCSE-EHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE----CTTCCEEECCC
T ss_pred ccceEEEEEcccCc-CHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEE----CCCCCEEEEeC
Confidence 34457899999975 99999976 359999999999999999999999999999999999999 77888999999
Q ss_pred CCcccccccccC-CCCCCccCCCCccCchhhcc-ccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHHcCCC-
Q 039291 161 GVAKRSRHCKRQ-KFDPSMRGTPLYLAPETVVQ-HMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEH- 237 (362)
Q Consensus 161 gla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~- 237 (362)
|++......... ......+||+.|+|||++.+ ..++.++|||||||++|+|++|++||.+....+....+.......
T Consensus 173 g~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~ 252 (364)
T 3qyz_A 173 GLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPS 252 (364)
T ss_dssp TTCEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCC
T ss_pred cceEecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCC
Confidence 999866543222 12345689999999998765 458999999999999999999999997665443332222111110
Q ss_pred -------------------------CCCCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCccCcch
Q 039291 238 -------------------------SLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGVDE 282 (362)
Q Consensus 238 -------------------------~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~~~~~~ 282 (362)
.+..+...++.++.+||.+||..||++|||+.++++||||+....
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~~ 322 (364)
T 3qyz_A 253 QEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD 322 (364)
T ss_dssp HHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTTCC
T ss_pred HHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhhccC
Confidence 001122457899999999999999999999999999999988643
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-50 Score=368.55 Aligned_cols=260 Identities=19% Similarity=0.314 Sum_probs=205.4
Q ss_pred CceeecceecccCceEEEEEEECCCCCCCCceeeeechh----hhhhHHHHHHHHHHHHcCCCCcccccccceeeecC--
Q 039291 6 TSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAE----VSASASLQKEKEVFDNLNGCPFVLECFGEEITMGE-- 79 (362)
Q Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~----~~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~-- 79 (362)
++|.+++.||+|+||.||+|+++.++. .||+|... ....+.+.+|+.++++++ ||||+++++.+.....
T Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~----~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~ 80 (332)
T 3qd2_B 6 TDFEPIQCMGRGGFGVVFEAKNKVDDC----NYAIKRIRLPNRELAREKVMREVKALAKLE-HPGIVRYFNAWLETPPEK 80 (332)
T ss_dssp HHEEEEEEEECC-CSEEEEEEETTTCC----EEEEEEEECCSTTTHHHHHHHHHHHHTSCC-CTTBCCEEEEEEECCSCH
T ss_pred hcCceeeEecCCCCeEEEEEEEcCCCc----EEEEEEeecCCchhHHHHHHHHHHHHHhCC-CCCEeeEEEEEEEeccch
Confidence 579999999999999999999998775 55666543 335567899999999998 9999999997754321
Q ss_pred --------------------------------------------------CCceEEEEEEEecCCCCHHHHHHHhcC-CC
Q 039291 80 --------------------------------------------------NGEMAYNLLLEYAAGGTLGDLIEKCNG-NG 108 (362)
Q Consensus 80 --------------------------------------------------~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~ 108 (362)
.....+++|||||+|++|.+++..... ..
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~ 160 (332)
T 3qd2_B 81 WQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLED 160 (332)
T ss_dssp HHHHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGG
T ss_pred hhhhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccc
Confidence 112347899999999999999987322 22
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEeecCCcccccccccC----------CCCCCc
Q 039291 109 LPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQ----------KFDPSM 178 (362)
Q Consensus 109 l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Dfgla~~~~~~~~~----------~~~~~~ 178 (362)
.++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++........ ......
T Consensus 161 ~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll----~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (332)
T 3qd2_B 161 REHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFF----TMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQ 236 (332)
T ss_dssp SCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE----CTTCCEEECCCTTCEECSCC--------------CCCSC
T ss_pred hhhHHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEE----eCCCCEEEeecCcccccccchhhcccccccccccccccc
Confidence 5667799999999999999999999999999999999 77789999999999866543211 122356
Q ss_pred cCCCCccCchhhccccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHHcCCCCCCCCCccCCHHHHHHHHHHh
Q 039291 179 RGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEHSLPEIPSRVSKEARDFLRRCF 258 (362)
Q Consensus 179 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 258 (362)
.||+.|+|||++.+..++.++|||||||++|+|++|..|+.. .......+.. ...+..+...++++.+||.+||
T Consensus 237 ~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~-----~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l 310 (332)
T 3qd2_B 237 VGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQME-----RVRIITDVRN-LKFPLLFTQKYPQEHMMVQDML 310 (332)
T ss_dssp C-CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHH-----HHHHHHHHHT-TCCCHHHHHHCHHHHHHHHHHH
T ss_pred CCCcCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhH-----HHHHHHHhhc-cCCCcccccCChhHHHHHHHHc
Confidence 799999999999999999999999999999999998776521 1222222222 2333334567789999999999
Q ss_pred ccCCCCCCCHHHHhcCCCccCc
Q 039291 259 VRKPAFRFTAEMLLDDPFVKGV 280 (362)
Q Consensus 259 ~~~p~~R~s~~~~l~~p~~~~~ 280 (362)
..||++|||++++++||||+++
T Consensus 311 ~~~p~~Rps~~~~l~~~~f~~~ 332 (332)
T 3qd2_B 311 SPSPTERPEATDIIENAIFENL 332 (332)
T ss_dssp CSSGGGSCCHHHHHHSTTCCCC
T ss_pred cCCCCcCCCHHHHhhchhhhcC
Confidence 9999999999999999999864
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-50 Score=366.81 Aligned_cols=262 Identities=23% Similarity=0.361 Sum_probs=199.6
Q ss_pred CCCceeecceecccCceEEEEEEECCCCCCCCceeeeechhhh-----hhHHHHHHHHHHHHcCCCCcccccccceeeec
Q 039291 4 DGTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVS-----ASASLQKEKEVFDNLNGCPFVLECFGEEITMG 78 (362)
Q Consensus 4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~~-----~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~ 78 (362)
.-++|.+++.||+|+||+||+|+++.+++ .|++|..... ....+.+|+.++++++ ||||+++++++..
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~----~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~-- 104 (329)
T 3gbz_A 32 SIDRYRRITKLGEGTYGEVYKAIDTVTNE----TVAIKRIRLEHEEEGVPGTAIREVSLLKELQ-HRNIIELKSVIHH-- 104 (329)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTTE----EEEEEECCCCC--------CHHHHHHGGGCC-CTTBCCEEEEEEE--
T ss_pred chhhEEEEEEEEecCCeEEEEEEECCCCc----eEEEEEEcccccccccchhHHHHHHHHHHcC-CCCcceEEEEEec--
Confidence 34689999999999999999999988875 5677765422 2345679999999998 9999999987653
Q ss_pred CCCceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecC-CCceEEEE
Q 039291 79 ENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQ-SGKFVAKI 157 (362)
Q Consensus 79 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~-~~~~~~kl 157 (362)
...+++||||++| +|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||+..++ +..+.+||
T Consensus 105 ---~~~~~lv~e~~~~-~L~~~~~~--~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl 178 (329)
T 3gbz_A 105 ---NHRLHLIFEYAEN-DLKKYMDK--NPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKI 178 (329)
T ss_dssp ---TTEEEEEEECCSE-EHHHHHHH--CTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEE
T ss_pred ---CCEEEEEEecCCC-CHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEE
Confidence 2347799999985 99999987 34599999999999999999999999999999999999996544 45567999
Q ss_pred eecCCcccccccccCCCCCCccCCCCccCchhhccc-cCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHHc--
Q 039291 158 ADLGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQH-MQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIG-- 234 (362)
Q Consensus 158 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~-- 234 (362)
+|||+++...... .......||+.|+|||++.+. .++.++|||||||++|+|++|..||...... ..+.....
T Consensus 179 ~Dfg~a~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~--~~~~~~~~~~ 254 (329)
T 3gbz_A 179 GDFGLARAFGIPI--RQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEI--DQLFKIFEVL 254 (329)
T ss_dssp CCTTHHHHHC-------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHHHH
T ss_pred CcCCCccccCCcc--cccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHH--HHHHHHHHHh
Confidence 9999997654322 122356789999999999874 5899999999999999999999999655332 22222211
Q ss_pred CCCC---C-------------CC---------CCccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCccCcch
Q 039291 235 DEHS---L-------------PE---------IPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGVDE 282 (362)
Q Consensus 235 ~~~~---~-------------~~---------~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~~~~~~ 282 (362)
.... + +. ++..++.++++||.+||..||++|||++++++||||+...+
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~ 327 (329)
T 3gbz_A 255 GLPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHNDF 327 (329)
T ss_dssp CCCCTTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSSCS
T ss_pred CCCchhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCcccCCCCC
Confidence 1000 0 00 01127899999999999999999999999999999998754
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-49 Score=354.11 Aligned_cols=259 Identities=23% Similarity=0.373 Sum_probs=215.4
Q ss_pred CCCCCceeecceecccCceEEEEEEECCCCCCCCceeeeechh-----hhhhHHHHHHHHHHHHcCCCCcccccccceee
Q 039291 2 DSDGTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAE-----VSASASLQKEKEVFDNLNGCPFVLECFGEEIT 76 (362)
Q Consensus 2 ~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~-----~~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~ 76 (362)
+..+..|.+.+.||+|+||+||+|.+..++. .+++|... ......+.+|+.+++.++ ||||+++++.+..
T Consensus 22 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~----~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~ 96 (290)
T 1t4h_A 22 SNDGRFLKFDIEIGRGSFKTVYKGLDTETTV----EVAWCELQDRKLTKSERQRFKEEAEMLKGLQ-HPNIVRFYDSWES 96 (290)
T ss_dssp CTTSCEEEEEEEEEECSSEEEEEEEETTTCC----EEEEEEEEGGGSCHHHHHHHHHHHHHHTTCC-CTTBCCEEEEEEE
T ss_pred ccCceeEEeeeeccCCCCeEEEEeEecCCce----EEEEEEecchhhCHHHHHHHHHHHHHHHhCC-CCCeeeeeeeecc
Confidence 4567889999999999999999999988875 44555432 334567889999999998 9999999997654
Q ss_pred ecCCCceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--ceeCCCCCCCEEEeecCC-Cce
Q 039291 77 MGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSG--YVHCDVKPDNILLVATQS-GKF 153 (362)
Q Consensus 77 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~--ivH~Dlkp~Nill~~~~~-~~~ 153 (362)
.. .....+++||||+++++|.+++... ..+++..++.++.||+.||.|||++| |+||||||+|||+ + .++
T Consensus 97 ~~-~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~----~~~~~ 169 (290)
T 1t4h_A 97 TV-KGKKCIVLVTELMTSGTLKTYLKRF--KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFI----TGPTG 169 (290)
T ss_dssp ES-SSCEEEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEE----SSTTS
T ss_pred cc-CCCceEEEEEEecCCCCHHHHHHHc--cCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEE----ECCCC
Confidence 43 3345678999999999999999874 45999999999999999999999999 9999999999999 5 567
Q ss_pred EEEEeecCCcccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHH
Q 039291 154 VAKIADLGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSII 233 (362)
Q Consensus 154 ~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~ 233 (362)
.+||+|||++...... ......||+.|+|||++.+ .++.++|||||||++|+|++|..||... .........+
T Consensus 170 ~~kl~Dfg~~~~~~~~----~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~--~~~~~~~~~~ 242 (290)
T 1t4h_A 170 SVKIGDLGLATLKRAS----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSEC--QNAAQIYRRV 242 (290)
T ss_dssp CEEECCTTGGGGCCTT----SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTC--SSHHHHHHHH
T ss_pred CEEEeeCCCccccccc----ccccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCc--CcHHHHHHHH
Confidence 8999999998644332 2234579999999998864 5899999999999999999999999643 3455666666
Q ss_pred cCCCCCCCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCccC
Q 039291 234 GDEHSLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKG 279 (362)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~~~ 279 (362)
.........+...++++.+||.+||..||.+|||+.++++||||++
T Consensus 243 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~f~~ 288 (290)
T 1t4h_A 243 TSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE 288 (290)
T ss_dssp TTTCCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred hccCCccccCCCCCHHHHHHHHHHccCChhhCCCHHHHhhCccccc
Confidence 6555555566778899999999999999999999999999999975
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-49 Score=368.84 Aligned_cols=261 Identities=21% Similarity=0.369 Sum_probs=203.8
Q ss_pred CCceeecceecccCceEEEEEEECCCCCCCCceeeeechh-----hhhhHHHHHHHHHHHHcCCCCcccccccceeeecC
Q 039291 5 GTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAE-----VSASASLQKEKEVFDNLNGCPFVLECFGEEITMGE 79 (362)
Q Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~-----~~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~ 79 (362)
.++|.+++.||+|+||.||+|+++.+++ .|++|... ......+.+|+.+++.++ ||||+++++++.....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~----~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~~ 98 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGA----KVAIKKLYRPFQSELFAKRAYRELRLLKHMR-HENVIGLLDVFTPDET 98 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCC----EEEEEECSSTTSSHHHHHHHHHHHHHHHHCC-BTTBCCCSEEECSCSS
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCC----EEEEEEeCccccCHHHHHHHHHHHHHHHhCC-CcCCCCceeeEecCCc
Confidence 4789999999999999999999988875 56777652 223466889999999998 9999999997754211
Q ss_pred -CCceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEe
Q 039291 80 -NGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIA 158 (362)
Q Consensus 80 -~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~ 158 (362)
.....+|+||||+ +++|.++++. ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+
T Consensus 99 ~~~~~~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll----~~~~~~kl~ 170 (367)
T 1cm8_A 99 LDDFTDFYLVMPFM-GTDLGKLMKH---EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAV----NEDCELKIL 170 (367)
T ss_dssp TTTCCCCEEEEECC-SEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE----CTTCCEEEC
T ss_pred cccCceEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEE----cCCCCEEEE
Confidence 1123467999999 7899999976 359999999999999999999999999999999999999 778889999
Q ss_pred ecCCcccccccccCCCCCCccCCCCccCchhhcc-ccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHH-HHHcC-
Q 039291 159 DLGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQ-HMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLF-SIIGD- 235 (362)
Q Consensus 159 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~-~~~~~- 235 (362)
|||+++..... ....+||+.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+..+....+ .....
T Consensus 171 Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~ 245 (367)
T 1cm8_A 171 DFGLARQADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTP 245 (367)
T ss_dssp CCTTCEECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCC
T ss_pred eeecccccccc-----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence 99999865431 245679999999999987 67899999999999999999999999765432211111 11100
Q ss_pred ------------------------CCCCCCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCccCcchh
Q 039291 236 ------------------------EHSLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGVDEE 283 (362)
Q Consensus 236 ------------------------~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~~~~~~~ 283 (362)
...+..+...+++++.+||.+||..||++|||++++++||||+.....
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~~~ 317 (367)
T 1cm8_A 246 PAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDT 317 (367)
T ss_dssp CHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC--
T ss_pred CHHHHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhhcCC
Confidence 111223345679999999999999999999999999999999887554
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-49 Score=374.23 Aligned_cols=259 Identities=24% Similarity=0.386 Sum_probs=204.2
Q ss_pred CCCceeecceecccCceEEEEEEECCCCCCCCceeeeechh-----hhhhHHHHHHHHHHHHcCC-CCcccccccceeee
Q 039291 4 DGTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAE-----VSASASLQKEKEVFDNLNG-CPFVLECFGEEITM 77 (362)
Q Consensus 4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~-----~~~~~~~~~E~~il~~l~~-h~~i~~~~~~~~~~ 77 (362)
.+++|.+++.||+|+||+||+|.+.. +. .+++|.+. ......+.+|+.++++|.+ ||||+++++++..
T Consensus 54 ~~~~y~~~~~LG~G~fg~Vy~~~~~~-~~----~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~- 127 (390)
T 2zmd_A 54 KGRIYSILKQIGSGGSSKVFQVLNEK-KQ----IYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEIT- 127 (390)
T ss_dssp TTEEEEEEEEEECCSSEEEEEEECTT-CC----EEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC-
T ss_pred cCCceEEEEEEccCCCeEEEEEEcCC-CC----EEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEec-
Confidence 45679999999999999999999865 43 56666543 2345678899999999985 7999999987653
Q ss_pred cCCCceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEE
Q 039291 78 GENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKI 157 (362)
Q Consensus 78 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl 157 (362)
...+++||| +.+++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||+ +. +.+||
T Consensus 128 ----~~~~~lv~E-~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll----~~-~~~kl 195 (390)
T 2zmd_A 128 ----DQYIYMVME-CGNIDLNSWLKK--KKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLI----VD-GMLKL 195 (390)
T ss_dssp ----SSEEEEEEE-CCSEEHHHHHHH--CSSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEE----SS-SCEEE
T ss_pred ----CCEEEEEEe-cCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEE----EC-CeEEE
Confidence 224789999 567899999987 3469999999999999999999999999999999999999 32 56999
Q ss_pred eecCCcccccccccCCCCCCccCCCCccCchhhcc-----------ccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCH
Q 039291 158 ADLGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQ-----------HMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSI 226 (362)
Q Consensus 158 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~ 226 (362)
+|||+++..............+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.... ..
T Consensus 196 ~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~--~~ 273 (390)
T 2zmd_A 196 IDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII--NQ 273 (390)
T ss_dssp CCCSSSCCC---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCC--CH
T ss_pred EecCccccccCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhh--HH
Confidence 99999986654333333346789999999999875 368889999999999999999999996432 23
Q ss_pred HHHHHHHcCCCCCCCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCccCcch
Q 039291 227 DQLFSIIGDEHSLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGVDE 282 (362)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~~~~~~ 282 (362)
...+..+........++...+.++.+||.+||..||.+|||+.++++||||+....
T Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~~~ 329 (390)
T 2zmd_A 274 ISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTH 329 (390)
T ss_dssp HHHHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSCC-
T ss_pred HHHHHHHhCccccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhCcCccccCc
Confidence 33333333333334456667899999999999999999999999999999986543
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-49 Score=369.34 Aligned_cols=259 Identities=26% Similarity=0.366 Sum_probs=197.5
Q ss_pred CCceeecceecccCceEEEEEEECCCCCCCCceeeeechhhh-hhHHHHHHHHHHHHcCCCCcccccccceeeecCCCce
Q 039291 5 GTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVS-ASASLQKEKEVFDNLNGCPFVLECFGEEITMGENGEM 83 (362)
Q Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~~-~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~~~~ 83 (362)
.++|.+.+.||+|+||+||+|+++.+++ .|++|..... ..+.+.+|+.++++++ ||||+++++++.. ..
T Consensus 52 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~----~vavK~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~-----~~ 121 (349)
T 2w4o_A 52 SDFFEVESELGRGATSIVYRCKQKGTQK----PYALKVLKKTVDKKIVRTEIGVLLRLS-HPNIIKLKEIFET-----PT 121 (349)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCC----EEEEEEEEC----------CHHHHHCC-CTTBCCEEEEEEC-----SS
T ss_pred cCcEEEeeEEeeCCCEEEEEEEECCCCc----EEEEEEeccchhHHHHHHHHHHHHhCC-CCCCcceeeeEec-----CC
Confidence 4679999999999999999999988775 5666665433 3456788999999998 9999999987642 23
Q ss_pred EEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEeecCCc
Q 039291 84 AYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVA 163 (362)
Q Consensus 84 ~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Dfgla 163 (362)
.+++||||++|++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||+... +.++.+||+|||++
T Consensus 122 ~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~-~~~~~~kl~Dfg~a 198 (349)
T 2w4o_A 122 EISLVLELVTGGELFDRIVE--KGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATP-APDAPLKIADFGLS 198 (349)
T ss_dssp EEEEEECCCCSCBHHHHHTT--CSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSS-STTCCEEECCCC--
T ss_pred eEEEEEEeCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecC-CCCCCEEEccCccc
Confidence 47799999999999999976 4559999999999999999999999999999999999999321 23678999999999
Q ss_pred ccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHHcCCCC--CCC
Q 039291 164 KRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEHS--LPE 241 (362)
Q Consensus 164 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~--~~~ 241 (362)
+..... .......||+.|+|||++.+..++.++|||||||++|+|++|..||.... ....+...+..... .+.
T Consensus 199 ~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~--~~~~~~~~i~~~~~~~~~~ 273 (349)
T 2w4o_A 199 KIVEHQ---VLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDER--GDQFMFRRILNCEYYFISP 273 (349)
T ss_dssp -----------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTT--CHHHHHHHHHTTCCCCCTT
T ss_pred cccCcc---cccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCc--ccHHHHHHHHhCCCccCCc
Confidence 765432 12235679999999999999899999999999999999999999996543 23334444433221 223
Q ss_pred CCccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCccCcc
Q 039291 242 IPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGVD 281 (362)
Q Consensus 242 ~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~~~~~ 281 (362)
.+..++.++++||.+||..||++|||+.++++||||....
T Consensus 274 ~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~ 313 (349)
T 2w4o_A 274 WWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQHPWVTGKA 313 (349)
T ss_dssp TTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTTSTT
T ss_pred hhhhCCHHHHHHHHHHccCChhhCcCHHHHhcCcccCCCc
Confidence 3457899999999999999999999999999999998654
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-50 Score=367.36 Aligned_cols=263 Identities=29% Similarity=0.400 Sum_probs=209.5
Q ss_pred CCceeec-ceecccCceEEEEEEECCCCCCCCceeeeechh-----hhhhHHHHHHHHHHHHcCCCCcccccccceeeec
Q 039291 5 GTSWFRG-RVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAE-----VSASASLQKEKEVFDNLNGCPFVLECFGEEITMG 78 (362)
Q Consensus 5 ~~~y~~~-~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~-----~~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~ 78 (362)
+++|.+. +.||+|+||+||+|+++.+++ .+++|... ......+.+|+.+++.+.+||||+++++++..
T Consensus 27 ~~~y~~~~~~lG~G~~g~V~~~~~~~~~~----~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~-- 100 (327)
T 3lm5_A 27 NNFYILTSKELGRGKFAVVRQCISKSTGQ----EYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYEN-- 100 (327)
T ss_dssp HHHEEEEEEEEEEETTEEEEEEEETTTCC----EEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEEC--
T ss_pred hhEEeeccceeCCCCCeEEEEEEECCCCC----EEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEe--
Confidence 3578887 899999999999999998876 45555443 22356788999999999989999999987642
Q ss_pred CCCceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEe
Q 039291 79 ENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIA 158 (362)
Q Consensus 79 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~ 158 (362)
...+++||||+.|++|.+++.......+++..++.++.||+.||.|||++||+||||||+|||+... ...+.+||+
T Consensus 101 ---~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~-~~~~~~kL~ 176 (327)
T 3lm5_A 101 ---TSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSI-YPLGDIKIV 176 (327)
T ss_dssp ---SSEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCB-TTBCCEEEC
T ss_pred ---CCeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecC-CCCCcEEEe
Confidence 2347799999999999999866445679999999999999999999999999999999999999321 126789999
Q ss_pred ecCCcccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHHc--CC
Q 039291 159 DLGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIG--DE 236 (362)
Q Consensus 159 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~--~~ 236 (362)
|||+++....... .....||+.|+|||++.+..++.++|||||||++|+|++|..||...+. ......+. ..
T Consensus 177 Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~---~~~~~~i~~~~~ 250 (327)
T 3lm5_A 177 DFGMSRKIGHACE---LREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDN---QETYLNISQVNV 250 (327)
T ss_dssp CGGGCEEC------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHHTCC
T ss_pred eCccccccCCccc---cccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc---hHHHHHHHhccc
Confidence 9999986543221 2346799999999999999999999999999999999999999965533 23222221 12
Q ss_pred CCCCCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCccCcchh
Q 039291 237 HSLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGVDEE 283 (362)
Q Consensus 237 ~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~~~~~~~ 283 (362)
...+..+..++..+++||.+||..||++|||++++++||||+.+.++
T Consensus 251 ~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~~~~~~~~~ 297 (327)
T 3lm5_A 251 DYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQWDFE 297 (327)
T ss_dssp CCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTCGGGCCCCTT
T ss_pred ccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCCHhhcccccc
Confidence 22233446789999999999999999999999999999999987654
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-50 Score=368.42 Aligned_cols=260 Identities=22% Similarity=0.365 Sum_probs=200.9
Q ss_pred CceeecceecccCceEEEEEEECCCCCCCCceeeeechhhhh----hHHHHHHHHHHHHcCCCCcccccccceeeecCCC
Q 039291 6 TSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVSA----SASLQKEKEVFDNLNGCPFVLECFGEEITMGENG 81 (362)
Q Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~~~----~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~~ 81 (362)
++|.+++.||+|+||+||+|+++.+++ .+++|...... ...+.+|+.+++.++ ||||+++++++..
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~----~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~----- 71 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDN----LVALKEIRLEHEEGAPCTAIREVSLLKDLK-HANIVTLHDIIHT----- 71 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCC----EEEEEEECC------CCCCCCCHHHHSCCC-CTTBCCEEEEEEC-----
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCc----EEEEEEEecccccccchhHHHHHHHHHhcC-CCCCCeeeeEEee-----
Confidence 589999999999999999999988775 56777654322 224557999999998 9999999987643
Q ss_pred ceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEeecC
Q 039291 82 EMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLG 161 (362)
Q Consensus 82 ~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Dfg 161 (362)
...+++||||+++ +|.+++... +..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||
T Consensus 72 ~~~~~lv~e~~~~-~l~~~~~~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~----~~~~~~kl~Dfg 145 (324)
T 3mtl_A 72 EKSLTLVFEYLDK-DLKQYLDDC-GNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLI----NERGELKLADFG 145 (324)
T ss_dssp SSCEEEEEECCSE-EHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEE----CTTCCEEECSSS
T ss_pred CCEEEEEeccccc-CHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEE----CCCCCEEEccCc
Confidence 2346799999974 999998874 4469999999999999999999999999999999999999 777889999999
Q ss_pred CcccccccccCCCCCCccCCCCccCchhhcc-ccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHHcCCCCCC
Q 039291 162 VAKRSRHCKRQKFDPSMRGTPLYLAPETVVQ-HMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEHSLP 240 (362)
Q Consensus 162 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 240 (362)
++....... .......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.........+..........
T Consensus 146 ~a~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 223 (324)
T 3mtl_A 146 LARAKSIPT--KTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEE 223 (324)
T ss_dssp EEECC--------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTT
T ss_pred ccccccCCc--cccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChH
Confidence 997554321 22235578999999999986 568999999999999999999999997654322222222221111111
Q ss_pred C-------------------------CCccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCccCcchh
Q 039291 241 E-------------------------IPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGVDEE 283 (362)
Q Consensus 241 ~-------------------------~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~~~~~~~ 283 (362)
. ....++.++++||.+||+.||++|||++++++||||..+.+.
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~ 291 (324)
T 3mtl_A 224 TWPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGER 291 (324)
T ss_dssp TSTTGGGCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCST
T ss_pred hchhhhcchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhcccc
Confidence 1 113478999999999999999999999999999999876544
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-49 Score=356.68 Aligned_cols=257 Identities=24% Similarity=0.378 Sum_probs=202.9
Q ss_pred CCceeecceecccCceEEEEEEECCCCCCCCceeeeechh----hhhhHHHHHHHHHHHHcCCCCcccccccceeeecCC
Q 039291 5 GTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAE----VSASASLQKEKEVFDNLNGCPFVLECFGEEITMGEN 80 (362)
Q Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~----~~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~ 80 (362)
+++|.+.+.||+|+||+||+|+++.++. .+++|... ....+.+.+|++++++++ ||||+++++++..
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~----~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~---- 91 (285)
T 3is5_A 21 DDLFIFKRKLGSGAFGDVHLVEERSSGL----ERVIKTINKDRSQVPMEQIEAEIEVLKSLD-HPNIIKIFEVFED---- 91 (285)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCC----EEEEEEEEGGGCCSCHHHHHHHHHHHHTCC-CTTBCCEEEEEEC----
T ss_pred hhheeecceeccCCCeEEEEEEEccCCc----eEEEEEeeccccchhHHHHHHHHHHHHhCC-CchHHhHHHheec----
Confidence 3689999999999999999999988875 44555543 234567889999999998 8999999987642
Q ss_pred CceEEEEEEEecCCCCHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEe
Q 039291 81 GEMAYNLLLEYAAGGTLGDLIEKC--NGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIA 158 (362)
Q Consensus 81 ~~~~~~lv~e~~~~~~L~~~l~~~--~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~ 158 (362)
...+++||||+++++|.+++... .+..+++..++.++.||+.||.|||++||+||||||+||++..+ +..+.+||+
T Consensus 92 -~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~-~~~~~~kl~ 169 (285)
T 3is5_A 92 -YHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDT-SPHSPIKII 169 (285)
T ss_dssp -SSEEEEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSS-STTCCEEEC
T ss_pred -CCeEEEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecC-CCCCCEEEE
Confidence 23477999999999999988653 24569999999999999999999999999999999999999432 334679999
Q ss_pred ecCCcccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHHc-CCC
Q 039291 159 DLGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIG-DEH 237 (362)
Q Consensus 159 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~-~~~ 237 (362)
|||++....... ......||+.|+|||++. ..++.++|||||||++|+|++|+.||.... .......+. ...
T Consensus 170 Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~---~~~~~~~~~~~~~ 242 (285)
T 3is5_A 170 DFGLAELFKSDE---HSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTS---LEEVQQKATYKEP 242 (285)
T ss_dssp CCCCCCC-------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHHHCCC
T ss_pred eeecceecCCcc---cCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCC---HHHHHhhhccCCc
Confidence 999997554322 224567999999999886 468899999999999999999999996543 333333222 222
Q ss_pred CCCCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCccC
Q 039291 238 SLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKG 279 (362)
Q Consensus 238 ~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~~~ 279 (362)
..+.....+++++.+||.+||..||++|||+.++++||||++
T Consensus 243 ~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~f~~ 284 (285)
T 3is5_A 243 NYAVECRPLTPQAVDLLKQMLTKDPERRPSAAQVLHHEWFKQ 284 (285)
T ss_dssp CCCC--CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGGC
T ss_pred ccccccCcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHhhc
Confidence 223333457899999999999999999999999999999975
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-49 Score=361.82 Aligned_cols=259 Identities=24% Similarity=0.370 Sum_probs=209.4
Q ss_pred CCceeecceecccCceEEEEEEECCCCCCCCceeeeechhhhhhHHHHHHHHHHHHcCCCCcccccccceeeecCCCceE
Q 039291 5 GTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVSASASLQKEKEVFDNLNGCPFVLECFGEEITMGENGEMA 84 (362)
Q Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~~~~~ 84 (362)
.++|.+++.||+|+||+||+|++..+++ .+++|.......+.+.+|+.+++++.+||||+++++++.. .....
T Consensus 35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~----~vavK~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~---~~~~~ 107 (330)
T 3nsz_A 35 QDDYQLVRKLGRGKYSEVFEAINITNNE----KVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKD---PVSRT 107 (330)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCC----EEEEEEECSCCHHHHHHHHHHHHHHTTSTTBCCEEEEEEC---TTTCC
T ss_pred CCceEEEEEecccCCeEEEEEEECCCCc----EEEEEEecccchHHHHHHHHHHHHcCCCCCEEEeeeeecc---CCCCc
Confidence 5789999999999999999999988775 6788887777778899999999999989999999987653 22334
Q ss_pred EEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCc-eEEEEeecCCc
Q 039291 85 YNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGK-FVAKIADLGVA 163 (362)
Q Consensus 85 ~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~-~~~kl~Dfgla 163 (362)
.++||||+.+++|.++++. +++..++.++.||+.||+|||++||+||||||+|||+ +.+ ..+||+|||++
T Consensus 108 ~~lv~e~~~~~~l~~~~~~-----~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~----~~~~~~~kl~Dfg~a 178 (330)
T 3nsz_A 108 PALVFEHVNNTDFKQLYQT-----LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMI----DHEHRKLRLIDWGLA 178 (330)
T ss_dssp EEEEEECCCCCCHHHHGGG-----CCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE----ETTTTEEEECCCTTC
T ss_pred eEEEEeccCchhHHHHHHh-----CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEE----cCCCCEEEEEeCCCc
Confidence 6799999999999998864 9999999999999999999999999999999999999 433 38999999999
Q ss_pred ccccccccCCCCCCccCCCCccCchhhcc-ccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHH----------
Q 039291 164 KRSRHCKRQKFDPSMRGTPLYLAPETVVQ-HMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSI---------- 232 (362)
Q Consensus 164 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~---------- 232 (362)
+....... .....||+.|+|||++.+ ..++.++|||||||++|+|++|..||..... ....+...
T Consensus 179 ~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~-~~~~l~~~~~~~~~~~~~ 254 (330)
T 3nsz_A 179 EFYHPGQE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHD-NYDQLVRIAKVLGTEDLY 254 (330)
T ss_dssp EECCTTCC---CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSS-HHHHHHHHHHHHCHHHHH
T ss_pred eEcCCCCc---cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCc-hHHHHHHHHHhcCCchhh
Confidence 76543222 235679999999999987 6789999999999999999999999954322 11111110
Q ss_pred --HcCC-C---------------------CCCCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCccCcchh
Q 039291 233 --IGDE-H---------------------SLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGVDEE 283 (362)
Q Consensus 233 --~~~~-~---------------------~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~~~~~~~ 283 (362)
+... . .....+..+++++++||.+||..||++|||++++++||||+.+.++
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~~~ 329 (330)
T 3nsz_A 255 DYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVKD 329 (330)
T ss_dssp HHHHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGGTTCC--
T ss_pred hHHHHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCccHhhhccC
Confidence 0000 0 0011223379999999999999999999999999999999987653
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-49 Score=377.03 Aligned_cols=263 Identities=27% Similarity=0.398 Sum_probs=206.8
Q ss_pred CceeecceecccCceEEEEEEECCCCCCCCceeeeechhhhhhHHHHHHHHHHHHcCCCCcccccccceeeecC-CCceE
Q 039291 6 TSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVSASASLQKEKEVFDNLNGCPFVLECFGEEITMGE-NGEMA 84 (362)
Q Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~-~~~~~ 84 (362)
.+|.+++.||+|+||+||+|+++.+++ .|++|.+... .....+|+++|+.|+ ||||+++++++..... .....
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~----~vaiK~~~~~-~~~~~~E~~il~~l~-hpniv~l~~~~~~~~~~~~~~~ 127 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGE----LVAIKKVLQD-KRFKNRELQIMRKLD-HCNIVRLRYFFYSSGEKKDEVY 127 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCC----EEEEEEEECC-TTSCCHHHHHHHTCC-CTTBCCEEEEEEEEETTTTEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCc----EEEEEEeccc-chhHHHHHHHHHHcC-CCCccceeeEEeccCCCCccee
Confidence 479999999999999999999988775 5677765432 233458999999998 9999999988765443 33456
Q ss_pred EEEEEEecCCCCHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEeecCC
Q 039291 85 YNLLLEYAAGGTLGDLIEKC--NGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGV 162 (362)
Q Consensus 85 ~~lv~e~~~~~~L~~~l~~~--~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Dfgl 162 (362)
+++||||+++ +|.+++... ....+++..++.++.||+.||.|||++||+||||||+|||+. .+.+.+||+|||+
T Consensus 128 ~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~---~~~~~~kl~DFG~ 203 (420)
T 1j1b_A 128 LNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLD---PDTAVLKLCDFGS 203 (420)
T ss_dssp EEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEE---TTTTEEEECCCTT
T ss_pred EEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEe---CCCCeEEeccchh
Confidence 7799999986 777666542 345699999999999999999999999999999999999993 2346789999999
Q ss_pred cccccccccCCCCCCccCCCCccCchhhccc-cCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHHc-------
Q 039291 163 AKRSRHCKRQKFDPSMRGTPLYLAPETVVQH-MQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIG------- 234 (362)
Q Consensus 163 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~------- 234 (362)
++...... .....+||+.|+|||++.+. .++.++|||||||++|||++|++||.+.+. ..++...+.
T Consensus 204 a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~--~~~l~~i~~~lg~p~~ 278 (420)
T 1j1b_A 204 AKQLVRGE---PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSG--VDQLVEIIKVLGTPTR 278 (420)
T ss_dssp CEECCTTC---CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSH--HHHHHHHHHHHCSCCH
T ss_pred hhhcccCC---CceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHHHhCCCCH
Confidence 98654322 12356799999999999765 789999999999999999999999976542 222222211
Q ss_pred ----------CCCCCCC---------CCccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCccCcchh
Q 039291 235 ----------DEHSLPE---------IPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGVDEE 283 (362)
Q Consensus 235 ----------~~~~~~~---------~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~~~~~~~ 283 (362)
....++. ++..++.++++||.+||..||.+|||+.+++.||||+.+.+.
T Consensus 279 ~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~ 346 (420)
T 1j1b_A 279 EQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRDP 346 (420)
T ss_dssp HHHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGCT
T ss_pred HHHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhcccccc
Confidence 0111121 234578999999999999999999999999999999876543
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-49 Score=360.78 Aligned_cols=266 Identities=24% Similarity=0.343 Sum_probs=201.3
Q ss_pred CCceeec-ceecccCceEEEEEEECCCCCCCCceeeeechhh---hhhHHHHHHHHHHHHcCCCCcccccccceeeecCC
Q 039291 5 GTSWFRG-RVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEV---SASASLQKEKEVFDNLNGCPFVLECFGEEITMGEN 80 (362)
Q Consensus 5 ~~~y~~~-~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~---~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~ 80 (362)
.++|.+. +.||+|+||+||+|+++.+++ .|++|.... .....+.+|+.+++++.+||||+++++++..
T Consensus 11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~----~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~---- 82 (316)
T 2ac3_A 11 EDVYQLQEDVLGEGAHARVQTCINLITSQ----EYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEE---- 82 (316)
T ss_dssp TTSCEECCCCCCCCSSEEEEEEECSSSCC----EEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEE----
T ss_pred ceeEEecCceecCCceEEEEEEEEcCCCc----EEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEee----
Confidence 4678885 889999999999999988775 456665432 2456788999999997779999999997653
Q ss_pred CceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEeec
Q 039291 81 GEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADL 160 (362)
Q Consensus 81 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Df 160 (362)
...+++||||++|++|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||+..+ +....+||+||
T Consensus 83 -~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~-~~~~~~kl~Df 158 (316)
T 2ac3_A 83 -EDRFYLVFEKMRGGSILSHIHKR--RHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHP-NQVSPVKICDF 158 (316)
T ss_dssp -TTEEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCS-SSSCSEEECCT
T ss_pred -CCEEEEEEEcCCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccC-CCcCceEEEEc
Confidence 23578999999999999999874 459999999999999999999999999999999999999322 11234999999
Q ss_pred CCccccccccc-----CCCCCCccCCCCccCchhhcc-----ccCCCcchHHHHHHHHHHHHhCCCCCccCCCCC-----
Q 039291 161 GVAKRSRHCKR-----QKFDPSMRGTPLYLAPETVVQ-----HMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCS----- 225 (362)
Q Consensus 161 gla~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~----- 225 (362)
|++........ .......+||+.|+|||++.+ ..++.++|||||||++|+|++|+.||......+
T Consensus 159 g~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~ 238 (316)
T 2ac3_A 159 DLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDR 238 (316)
T ss_dssp TCCC-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC--
T ss_pred cCccccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccc
Confidence 99875432111 111124569999999999975 568899999999999999999999997654322
Q ss_pred -------HHHHHHHHcCCC-CCCC-CCccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCccCcch
Q 039291 226 -------IDQLFSIIGDEH-SLPE-IPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGVDE 282 (362)
Q Consensus 226 -------~~~~~~~~~~~~-~~~~-~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~~~~~~ 282 (362)
...+...+.... .++. ....++.++++||.+||..||++|||++++++||||++...
T Consensus 239 ~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~~ 304 (316)
T 2ac3_A 239 GEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAP 304 (316)
T ss_dssp --CCHHHHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTTCC----
T ss_pred cccchhHHHHHHHHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcChhhcCCCC
Confidence 222333333222 1111 11358899999999999999999999999999999987643
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-49 Score=379.49 Aligned_cols=252 Identities=26% Similarity=0.408 Sum_probs=212.4
Q ss_pred CCceeecceecccCceEEEEEEECCCCCCCCceeeeechhhh------hhHHHHHHHHHHHHcCCCCcccccccceeeec
Q 039291 5 GTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVS------ASASLQKEKEVFDNLNGCPFVLECFGEEITMG 78 (362)
Q Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~~------~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~ 78 (362)
-++|.+++.||+|+||+||+|+++.+++ .|++|..... ....+.+|+.+++.++ ||||+++++++..
T Consensus 15 ~~~Y~l~~~LG~G~fg~V~~a~~~~~g~----~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~-HpnIv~l~~~~~~-- 87 (476)
T 2y94_A 15 IGHYILGDTLGVGTFGKVKVGKHELTGH----KVAVKILNRQKIRSLDVVGKIRREIQNLKLFR-HPHIIKLYQVIST-- 87 (476)
T ss_dssp ETTEEEEEEEECCSSSCEEEEEETTTCC----EEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCC-CTTBCCEEEEEEC--
T ss_pred ecCEEEEEEEeeCCCeEEEEEEECCCCC----EEEEEEEEhhhccCHHHHHHHHHHHHHHHhCC-CCCCCcEEEEEEE--
Confidence 4789999999999999999999998875 5677765432 3456889999999998 9999999987643
Q ss_pred CCCceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEe
Q 039291 79 ENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIA 158 (362)
Q Consensus 79 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~ 158 (362)
...+++||||++||+|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+
T Consensus 88 ---~~~~~lv~E~~~gg~L~~~l~~--~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll----~~~~~vkL~ 158 (476)
T 2y94_A 88 ---PSDIFMVMEYVSGGELFDYICK--NGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLL----DAHMNAKIA 158 (476)
T ss_dssp ---SSEEEEEEECCSSEEHHHHTTS--SSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEE----CTTCCEEEC
T ss_pred ---CCEEEEEEeCCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEE----ecCCCeEEE
Confidence 2347899999999999999975 4569999999999999999999999999999999999999 778889999
Q ss_pred ecCCcccccccccCCCCCCccCCCCccCchhhccccC-CCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHHcCCC
Q 039291 159 DLGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQ-EAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEH 237 (362)
Q Consensus 159 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 237 (362)
|||++...... ......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||... ....+...+....
T Consensus 159 DFG~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~---~~~~~~~~i~~~~ 232 (476)
T 2y94_A 159 DFGLSNMMSDG---EFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDD---HVPTLFKKICDGI 232 (476)
T ss_dssp CCSSCEECCTT---CCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCS---SSHHHHHHHHTTC
T ss_pred eccchhhcccc---ccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCC---CHHHHHHHHhcCC
Confidence 99999865432 12245689999999999998765 68999999999999999999999644 3344555554433
Q ss_pred CCCCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCccCc
Q 039291 238 SLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGV 280 (362)
Q Consensus 238 ~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~~~~ 280 (362)
...+..+++++.+||.+||..||++|||+.++++||||+..
T Consensus 233 --~~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~hp~~~~~ 273 (476)
T 2y94_A 233 --FYTPQYLNPSVISLLKHMLQVDPMKRATIKDIREHEWFKQD 273 (476)
T ss_dssp --CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHTT
T ss_pred --cCCCccCCHHHHHHHHHHcCCCchhCcCHHHHHhCHHhhhc
Confidence 24566789999999999999999999999999999999753
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-49 Score=373.86 Aligned_cols=267 Identities=23% Similarity=0.415 Sum_probs=207.0
Q ss_pred CCCCCCceeecceecccCceEEEEEEECCCCCCCCceeeeechhhhhhHHHHHHHHHHHHcCCCCcccccccceeeecC-
Q 039291 1 MDSDGTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVSASASLQKEKEVFDNLNGCPFVLECFGEEITMGE- 79 (362)
Q Consensus 1 ~~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~- 79 (362)
++...++|.+++.||+|+||+||+|+++.+++ .||+|..... .....+|+.+++.++ ||||+++++++.....
T Consensus 2 l~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~----~vAiK~~~~~-~~~~~~E~~il~~l~-hpnIv~l~~~~~~~~~~ 75 (383)
T 3eb0_A 2 LETSSKKYSLGKTLGTGSFGIVCEVFDIESGK----RFALKKVLQD-PRYKNRELDIMKVLD-HVNIIKLVDYFYTTGDE 75 (383)
T ss_dssp ----CTTEEEEEEEECC-CEEEEEEEETTTCC----EEEEEEEECC-TTSCCHHHHHHTTCC-CTTBCCEEEEEEEC---
T ss_pred CccccceEEEEEEEEeccCEEEEEEEECCCCC----EEEEEEEecC-cchHHHHHHHHHHcC-CCCccchhheeeecCcc
Confidence 35678899999999999999999999988875 5677765433 233458999999998 9999999998755332
Q ss_pred --------------------------------CCceEEEEEEEecCCCCHHHHHHH--hcCCCCCHHHHHHHHHHHHHHH
Q 039291 80 --------------------------------NGEMAYNLLLEYAAGGTLGDLIEK--CNGNGLPEKDVRHFTRCILEGI 125 (362)
Q Consensus 80 --------------------------------~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~l~~~~~~~i~~ql~~~l 125 (362)
.....+++||||+++ +|.+.+.. ..+..+++..++.++.||+.||
T Consensus 76 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL 154 (383)
T 3eb0_A 76 EPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAV 154 (383)
T ss_dssp ----------------------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHH
Confidence 234457899999985 88887764 2346699999999999999999
Q ss_pred HHHHhCCceeCCCCCCCEEEeecCCCceEEEEeecCCcccccccccCCCCCCccCCCCccCchhhccc-cCCCcchHHHH
Q 039291 126 GHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQH-MQEAPSDIWAL 204 (362)
Q Consensus 126 ~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Diwsl 204 (362)
.|||++||+||||||+|||+. ..++.+||+|||+++...... ......||+.|+|||++.+. .++.++||||+
T Consensus 155 ~~LH~~gi~H~Dikp~Nil~~---~~~~~~kl~Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~Diwsl 228 (383)
T 3eb0_A 155 GFIHSLGICHRDIKPQNLLVN---SKDNTLKLCDFGSAKKLIPSE---PSVAYICSRFYRAPELMLGATEYTPSIDLWSI 228 (383)
T ss_dssp HHHHTTTEECSCCCGGGEEEE---TTTTEEEECCCTTCEECCTTS---CCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHH
T ss_pred HHHHHCcCccCccCHHHEEEc---CCCCcEEEEECCCCcccCCCC---CCcCcccCCCccCHHHhcCCCCCCcchhhhhH
Confidence 999999999999999999993 246789999999998654322 22356789999999998875 48999999999
Q ss_pred HHHHHHHHhCCCCCccCCCCCHHHHHHHHc--C---------------CCCCCC---------CCccCCHHHHHHHHHHh
Q 039291 205 GCVVLEMLSGRQAWVVKEDCSIDQLFSIIG--D---------------EHSLPE---------IPSRVSKEARDFLRRCF 258 (362)
Q Consensus 205 G~il~~l~~g~~pf~~~~~~~~~~~~~~~~--~---------------~~~~~~---------~~~~~~~~~~~li~~~l 258 (362)
||++|+|++|++||.+.... ..+...+. . ...++. ++..++.++.+||.+||
T Consensus 229 G~il~ell~g~~pf~~~~~~--~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L 306 (383)
T 3eb0_A 229 GCVFGELILGKPLFSGETSI--DQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQIL 306 (383)
T ss_dssp HHHHHHHHHSSCSSCCSSHH--HHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHC
T ss_pred HHHHHHHHhCCCCCCCCChH--HHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHc
Confidence 99999999999999765432 22222211 0 011111 34558899999999999
Q ss_pred ccCCCCCCCHHHHhcCCCccCcch
Q 039291 259 VRKPAFRFTAEMLLDDPFVKGVDE 282 (362)
Q Consensus 259 ~~~p~~R~s~~~~l~~p~~~~~~~ 282 (362)
..||++|||+.++++||||+.+..
T Consensus 307 ~~dP~~R~t~~e~l~hp~f~~~~~ 330 (383)
T 3eb0_A 307 RYEPDLRINPYEAMAHPFFDHLRN 330 (383)
T ss_dssp CSSGGGSCCHHHHHTSGGGHHHHH
T ss_pred cCChhhCCCHHHHhcCHHHHHHHh
Confidence 999999999999999999987654
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-49 Score=371.11 Aligned_cols=257 Identities=25% Similarity=0.368 Sum_probs=209.8
Q ss_pred CceeecceecccCceEEEEEEECCCCCCCCceeeeechhh---hhhHHHHHHHHHHHHcCCCCcccccccceeeecCCCc
Q 039291 6 TSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEV---SASASLQKEKEVFDNLNGCPFVLECFGEEITMGENGE 82 (362)
Q Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~---~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~~~ 82 (362)
++|.+++.||+|+||+||+|.++.+++ .+++|.... .....+.+|+.+++.++ ||||+++++++.. .
T Consensus 51 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~----~~a~K~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~~~~~~~~-----~ 120 (387)
T 1kob_A 51 DYYDILEELGSGAFGVVHRCVEKATGR----VFVAKFINTPYPLDKYTVKNEISIMNQLH-HPKLINLHDAFED-----K 120 (387)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCC----EEEEEEEECCSHHHHHHHHHHHHHHTTCC-STTBCCEEEEEEC-----S
T ss_pred cceEEEEEEecCCCEEEEEEEECCCCC----EEEEEEecccchhhHHHHHHHHHHHHhCC-CcCCCeEEEEEEe-----C
Confidence 579999999999999999999998876 445554432 24456889999999998 9999999987642 2
Q ss_pred eEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEeecCC
Q 039291 83 MAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGV 162 (362)
Q Consensus 83 ~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Dfgl 162 (362)
..+++||||+.|++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||+.. +..+.+||+|||+
T Consensus 121 ~~~~lv~E~~~gg~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~--~~~~~vkL~DFG~ 197 (387)
T 1kob_A 121 YEMVLILEFLSGGELFDRIAAE-DYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCET--KKASSVKIIDFGL 197 (387)
T ss_dssp SEEEEEEECCCCCBHHHHTTCT-TCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESS--TTCCCEEECCCTT
T ss_pred CEEEEEEEcCCCCcHHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEec--CCCCceEEEeccc
Confidence 3477999999999999998752 346999999999999999999999999999999999999932 2346799999999
Q ss_pred cccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHHcCC--CCCC
Q 039291 163 AKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDE--HSLP 240 (362)
Q Consensus 163 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~--~~~~ 240 (362)
++...... ......||+.|+|||++.+..++.++|||||||++|+|++|..||...+ ..+....+... ...+
T Consensus 198 a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~---~~~~~~~i~~~~~~~~~ 271 (387)
T 1kob_A 198 ATKLNPDE---IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGED---DLETLQNVKRCDWEFDE 271 (387)
T ss_dssp CEECCTTS---CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSS---HHHHHHHHHHCCCCCCS
T ss_pred ceecCCCc---ceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCC---HHHHHHHHHhCCCCCCc
Confidence 98654321 1234579999999999999899999999999999999999999996543 33333333222 1223
Q ss_pred CCCccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCccCcc
Q 039291 241 EIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGVD 281 (362)
Q Consensus 241 ~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~~~~~ 281 (362)
..+..++.++++||.+||..||++|||+.++++||||+...
T Consensus 272 ~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 312 (387)
T 1kob_A 272 DAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDH 312 (387)
T ss_dssp STTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSCC
T ss_pred cccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCccccCCc
Confidence 34457899999999999999999999999999999998754
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-49 Score=376.57 Aligned_cols=259 Identities=27% Similarity=0.438 Sum_probs=199.6
Q ss_pred CceeecceecccCceEEEEEEECCCCCCCCceeeeechhhh-----------hhHHHHHHHHHHHHcCCCCcccccccce
Q 039291 6 TSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVS-----------ASASLQKEKEVFDNLNGCPFVLECFGEE 74 (362)
Q Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~~-----------~~~~~~~E~~il~~l~~h~~i~~~~~~~ 74 (362)
++|.+.+.||+|+||+||+|.++.+++ .+|+|.+... ....+.+|+.+|++++ ||||+++++++
T Consensus 135 ~~y~~~~~LG~G~~g~V~~a~~~~~~~----~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~ 209 (419)
T 3i6u_A 135 DEYIMSKTLGSGACGEVKLAFERKTCK----KVAIRIISKRKFAIGSAREADPALNVETEIEILKKLN-HPCIIKIKNFF 209 (419)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCC----EEEEEEEEGGGGTTC--------CCHHHHHHHHHHCC-CTTBCCCCEEE
T ss_pred ccEEEEeEEeeCCCeEEEEEEECCCCc----EEEEEEEEechhcccccccchhHHHHHHHHHHHHhCC-CCCEeeEEEEE
Confidence 689999999999999999999998876 4566654322 1234789999999998 99999999865
Q ss_pred eeecCCCceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceE
Q 039291 75 ITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFV 154 (362)
Q Consensus 75 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~ 154 (362)
. . . .+++||||+++++|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||+... +....
T Consensus 210 ~----~-~-~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~-~~~~~ 280 (419)
T 3i6u_A 210 D----A-E-DYYIVLELMEGGELFDKVVG--NKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQ-EEDCL 280 (419)
T ss_dssp E----S-S-EEEEEEECCTTCBGGGGTSS--SCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSS-SSSCC
T ss_pred e----c-C-ceEEEEEcCCCCcHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecC-CCcce
Confidence 2 1 2 26799999999999998875 4569999999999999999999999999999999999999432 23456
Q ss_pred EEEeecCCcccccccccCCCCCCccCCCCccCchhhcc---ccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHH
Q 039291 155 AKIADLGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQ---HMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFS 231 (362)
Q Consensus 155 ~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~ 231 (362)
+||+|||+++..... ......+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||........ +..
T Consensus 281 ~kl~DFG~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~--~~~ 355 (419)
T 3i6u_A 281 IKITDFGHSKILGET---SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS--LKD 355 (419)
T ss_dssp EEECCSSTTTSCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCC--HHH
T ss_pred EEEeecccceecCCC---ccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHH--HHH
Confidence 999999999865432 22245779999999999864 5677899999999999999999999975433221 222
Q ss_pred HHcCC--CCCCCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCccCcchh
Q 039291 232 IIGDE--HSLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGVDEE 283 (362)
Q Consensus 232 ~~~~~--~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~~~~~~~ 283 (362)
.+... ...+..+..++.++.+||.+||..||++|||++++++||||+.....
T Consensus 356 ~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~~~ 409 (419)
T 3i6u_A 356 QITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDEDMK 409 (419)
T ss_dssp HHHTTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCCHHHH
T ss_pred HHhcCCCCCCchhhcccCHHHHHHHHHHccCChhHCcCHHHHhCCcccCChhHH
Confidence 22222 12222335689999999999999999999999999999999876543
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-48 Score=357.94 Aligned_cols=268 Identities=24% Similarity=0.422 Sum_probs=211.0
Q ss_pred CCCCceeecceecccCceEEEEEEECCCCCCCCceeeeechhh--hhhHHHHHHHHHHHHcCCCCcccccccceeeecC-
Q 039291 3 SDGTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEV--SASASLQKEKEVFDNLNGCPFVLECFGEEITMGE- 79 (362)
Q Consensus 3 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~--~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~- 79 (362)
...++|.+++.||+|+||.||+|++..+++ .+++|.... .....+.+|+.+++++.+||||+++++.+.....
T Consensus 21 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~----~vaiK~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~ 96 (326)
T 2x7f_A 21 DPAGIFELVELVGNGTYGQVYKGRHVKTGQ----LAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPP 96 (326)
T ss_dssp CCTTTEEEEEEEEEETTEEEEEEEETTTCC----EEEEEEEECCSSTTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--
T ss_pred CCCCcEEEEEEeccCCCEEEEEEEECCCCC----eEEEEEEecCcccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCc
Confidence 356899999999999999999999988775 566666532 3456788999999999779999999998765321
Q ss_pred CCceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEee
Q 039291 80 NGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIAD 159 (362)
Q Consensus 80 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~D 159 (362)
.....+++||||+++++|.+++.......+++..++.++.||+.||.|||++||+|+||||+||++ +.++.+||+|
T Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~----~~~~~~kl~D 172 (326)
T 2x7f_A 97 GMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLL----TENAEVKLVD 172 (326)
T ss_dssp CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEE----CTTCCEEECC
T ss_pred cccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEE----cCCCCEEEee
Confidence 113457899999999999999987655679999999999999999999999999999999999999 7788899999
Q ss_pred cCCcccccccccCCCCCCccCCCCccCchhhc-----cccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHHc
Q 039291 160 LGVAKRSRHCKRQKFDPSMRGTPLYLAPETVV-----QHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIG 234 (362)
Q Consensus 160 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~ 234 (362)
||++........ ......||+.|+|||++. +..++.++|||||||++|+|++|..||.... .......+.
T Consensus 173 fg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~---~~~~~~~~~ 247 (326)
T 2x7f_A 173 FGVSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMH---PMRALFLIP 247 (326)
T ss_dssp CTTTC---------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSC---HHHHHHHHH
T ss_pred CcCceecCcCcc--ccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCc---HHHHHHHhh
Confidence 999876543211 123567999999999997 4568899999999999999999999995442 333333333
Q ss_pred CCCCCCCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCccCcchh
Q 039291 235 DEHSLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGVDEE 283 (362)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~~~~~~~ 283 (362)
........+..++..+++||.+||..||.+||++.++++||||+....+
T Consensus 248 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~~~ 296 (326)
T 2x7f_A 248 RNPAPRLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQPNE 296 (326)
T ss_dssp HSCCCCCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSHHHHCCTTH
T ss_pred cCccccCCccccCHHHHHHHHHHhccChhhCCCHHHHhhChHHhhCccc
Confidence 3333333456789999999999999999999999999999999886544
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-49 Score=357.47 Aligned_cols=249 Identities=27% Similarity=0.359 Sum_probs=200.8
Q ss_pred CceeecceecccCceEEEEEEECCCCCCCCceeeeechh-----hhhhHHHHHHHHHHHHcCCCCcccccccceeeecCC
Q 039291 6 TSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAE-----VSASASLQKEKEVFDNLNGCPFVLECFGEEITMGEN 80 (362)
Q Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~-----~~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~ 80 (362)
++|.+.+.||+|+||+||+|+++.++. .||+|... .........|+..+..+..||||+++++++..
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~----~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~---- 128 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDGR----LYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEE---- 128 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTSC----EEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE----
T ss_pred hheeeeheeccCCCeEEEEEEECCCCe----EEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEe----
Confidence 679999999999999999999998775 56666542 22334556677777777669999999997643
Q ss_pred CceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEeec
Q 039291 81 GEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADL 160 (362)
Q Consensus 81 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Df 160 (362)
...+++||||+ +++|.+++... +..+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+||
T Consensus 129 -~~~~~lv~e~~-~~~L~~~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll----~~~~~~kl~DF 201 (311)
T 3p1a_A 129 -GGILYLQTELC-GPSLQQHCEAW-GASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFL----GPRGRCKLGDF 201 (311)
T ss_dssp -TTEEEEEEECC-CCBHHHHHHHH-CSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE----CGGGCEEECCC
T ss_pred -CCEEEEEEecc-CCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEE----CCCCCEEEccc
Confidence 23477999999 66999988774 4569999999999999999999999999999999999999 77888999999
Q ss_pred CCcccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHHcCCCCCC
Q 039291 161 GVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEHSLP 240 (362)
Q Consensus 161 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 240 (362)
|++....... ......||+.|+|||++.+ .++.++|||||||++|+|++|..|+... .....+......+
T Consensus 202 G~a~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~------~~~~~~~~~~~~~ 271 (311)
T 3p1a_A 202 GLLVELGTAG---AGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGG------EGWQQLRQGYLPP 271 (311)
T ss_dssp TTCEECC---------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSH------HHHHHHTTTCCCH
T ss_pred eeeeecccCC---CCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCc------cHHHHHhccCCCc
Confidence 9987654322 2235669999999999876 6899999999999999999997666432 1223333333333
Q ss_pred CCCccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCccC
Q 039291 241 EIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKG 279 (362)
Q Consensus 241 ~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~~~ 279 (362)
.++..++.++.+||.+||..||++|||++++++||||++
T Consensus 272 ~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~ 310 (311)
T 3p1a_A 272 EFTAGLSSELRSVLVMMLEPDPKLRATAEALLALPVLRQ 310 (311)
T ss_dssp HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGSC
T ss_pred ccccCCCHHHHHHHHHHcCCChhhCcCHHHHHhCccccC
Confidence 455678999999999999999999999999999999975
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-48 Score=357.03 Aligned_cols=262 Identities=23% Similarity=0.371 Sum_probs=209.5
Q ss_pred CCCCceeecceecccCceEEEEEEECCCCCCCCceeeeechhh----hhhHHHHHHHHHHHHcCCCCcccccccceeeec
Q 039291 3 SDGTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEV----SASASLQKEKEVFDNLNGCPFVLECFGEEITMG 78 (362)
Q Consensus 3 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~----~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~ 78 (362)
+.+++|.+++.||+|+||+||+|+++.+++ .|++|.... ...+.+.+|++++++++ ||||+++++++..
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~----~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~-- 78 (319)
T 4euu_A 6 TSNHLWLLSDILGQGATANVFRGRHKKTGD----LFAIKVFNNISFLRPVDVQMREFEVLKKLN-HKNIVKLFAIEEE-- 78 (319)
T ss_dssp CSSEEEEEEEEEEECSSEEEEEEEETTTCC----EEEEEEECGGGGGSCHHHHHHHHHHHHHCC-CTTBCCEEEEEEC--
T ss_pred CCCCCEEEEEEecCCCCeEEEEEEECCCCc----EEEEEEeccccccchHHHHHHHHHHHHhcC-CCCcceEEEEeec--
Confidence 457899999999999999999999998875 566666542 34466789999999998 9999999987643
Q ss_pred CCCceEEEEEEEecCCCCHHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEE
Q 039291 79 ENGEMAYNLLLEYAAGGTLGDLIEKCNG-NGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKI 157 (362)
Q Consensus 79 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl 157 (362)
.....+++||||+++++|.+++..... ..+++..++.++.||+.||.|||++||+||||||+|||+...++..+.+||
T Consensus 79 -~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL 157 (319)
T 4euu_A 79 -TTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKL 157 (319)
T ss_dssp -TTTCCEEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEE
T ss_pred -CCCceEEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEE
Confidence 223356799999999999999986432 339999999999999999999999999999999999999777677889999
Q ss_pred eecCCcccccccccCCCCCCccCCCCccCchhhc--------cccCCCcchHHHHHHHHHHHHhCCCCCccCCC--CCHH
Q 039291 158 ADLGVAKRSRHCKRQKFDPSMRGTPLYLAPETVV--------QHMQEAPSDIWALGCVVLEMLSGRQAWVVKED--CSID 227 (362)
Q Consensus 158 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~--~~~~ 227 (362)
+|||+++....... .....||+.|+|||++. +..++.++|||||||++|+|++|+.||..... ....
T Consensus 158 ~Dfg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~ 234 (319)
T 4euu_A 158 TDFGAARELEDDEQ---FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKE 234 (319)
T ss_dssp CCCTTCEECCTTCC---BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHH
T ss_pred ccCCCceecCCCCc---eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHH
Confidence 99999986554222 13567999999999987 46788999999999999999999999964332 1222
Q ss_pred HHHHHHcCCC----------------------CCCCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhcCC
Q 039291 228 QLFSIIGDEH----------------------SLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDP 275 (362)
Q Consensus 228 ~~~~~~~~~~----------------------~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p 275 (362)
.+...+...+ ....++..++..+.+||.+||+.||++|||++++++||
T Consensus 235 ~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~ 304 (319)
T 4euu_A 235 VMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAET 304 (319)
T ss_dssp HHHHHHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHH
T ss_pred HHHHHhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhcc
Confidence 2322222111 00123345667899999999999999999999999986
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-49 Score=351.96 Aligned_cols=259 Identities=27% Similarity=0.453 Sum_probs=211.2
Q ss_pred CceeecceecccCceEEEEEEECCCCCCCCceeeeechhh----hhhHHHHHHHHHHHHcCCCCcccccccceeeecCCC
Q 039291 6 TSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEV----SASASLQKEKEVFDNLNGCPFVLECFGEEITMGENG 81 (362)
Q Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~----~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~~ 81 (362)
++|.+++.||+|+||.||+|+++.+++ .+++|.... .....+.+|+.+++.++ ||||+++++.+..
T Consensus 7 ~~y~~~~~lg~G~~g~V~~~~~~~~~~----~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~----- 76 (276)
T 2yex_A 7 EDWDLVQTLGEGAYGEVQLAVNRVTEE----AVAVKIVDMKRAVDCPENIKKEICINKMLN-HENVVKFYGHRRE----- 76 (276)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTCC----EEEEEEEEGGGCTTHHHHHHHHHHHHHTCC-CTTBCCEEEEEEE-----
T ss_pred cceEEEEEeecCCCcEEEEEEECCCCc----EEEEEEeeeccchhhhHHHHHHHHHHHhcC-CCCceeeeeEEEc-----
Confidence 579999999999999999999988775 456665432 34467889999999998 9999999987643
Q ss_pred ceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEeecC
Q 039291 82 EMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLG 161 (362)
Q Consensus 82 ~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Dfg 161 (362)
...+++||||+++++|.+++.. ...+++..++.++.|++.||.|||++||+||||||+||++ +.++.+||+|||
T Consensus 77 ~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~----~~~~~~kl~dfg 150 (276)
T 2yex_A 77 GNIQYLFLEYCSGGELFDRIEP--DIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLL----DERDNLKISDFG 150 (276)
T ss_dssp TTEEEEEEECCTTEEGGGGSBT--TTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE----CTTCCEEECCCT
T ss_pred CCEEEEEEEecCCCcHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEE----ccCCCEEEeeCC
Confidence 2346799999999999998865 3459999999999999999999999999999999999999 777889999999
Q ss_pred CcccccccccCCCCCCccCCCCccCchhhccccC-CCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHHcCCCCCC
Q 039291 162 VAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQ-EAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEHSLP 240 (362)
Q Consensus 162 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 240 (362)
++................||+.|+|||++.+..+ +.++||||||+++|+|++|..||......... ...........
T Consensus 151 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~--~~~~~~~~~~~ 228 (276)
T 2yex_A 151 LATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE--YSDWKEKKTYL 228 (276)
T ss_dssp TCEECEETTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHH--HHHHHTTCTTS
T ss_pred CccccCCCcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHH--HHHhhhccccc
Confidence 9976554333333345679999999999987665 67899999999999999999999765543322 22222222222
Q ss_pred CCCccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCccCcch
Q 039291 241 EIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGVDE 282 (362)
Q Consensus 241 ~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~~~~~~ 282 (362)
..+..++.++.+||.+||..||++|||++++++||||+....
T Consensus 229 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~ 270 (276)
T 2yex_A 229 NPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLK 270 (276)
T ss_dssp TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCCCC
T ss_pred CchhhcCHHHHHHHHHHCCCCchhCCCHHHHhcCccccChhh
Confidence 234578999999999999999999999999999999987543
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-48 Score=356.08 Aligned_cols=252 Identities=29% Similarity=0.440 Sum_probs=208.4
Q ss_pred ceeecceecccCceEEEEEEECCCCCCCCceeeeechhh---hhhHHHHHHHHHHHHcCCCCcccccccceeeecCCCce
Q 039291 7 SWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEV---SASASLQKEKEVFDNLNGCPFVLECFGEEITMGENGEM 83 (362)
Q Consensus 7 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~---~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~~~~ 83 (362)
.|...+.||+|+||.||+|+++.++. .|++|.... ...+.+.+|+.+++.++ ||||+++++.+... .
T Consensus 46 ~~~~~~~lg~G~~g~V~~a~~~~~g~----~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~-----~ 115 (321)
T 2c30_A 46 LLDSYVKIGEGSTGIVCLAREKHSGR----QVAVKMMDLRKQQRRELLFNEVVIMRDYQ-HFNVVEMYKSYLVG-----E 115 (321)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCC----EEEEEEEETTTCCSHHHHHHHHHHHTTCC-CTTBCCEEEEEEET-----T
T ss_pred hhhccEEeccCCCeEEEEEEECCCCc----EEEEEEEeccchhHHHHHHHHHHHHHhCC-CCCcceEEEEEEEC-----C
Confidence 47788899999999999999987775 567776532 24466889999999998 99999999876532 2
Q ss_pred EEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEeecCCc
Q 039291 84 AYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVA 163 (362)
Q Consensus 84 ~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Dfgla 163 (362)
.+++||||++|++|.+++.. ..+++..+..++.|++.||.|||++||+||||||+|||+ +.++.+||+|||++
T Consensus 116 ~~~lv~e~~~~~~L~~~l~~---~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll----~~~~~~kl~Dfg~~ 188 (321)
T 2c30_A 116 ELWVLMEFLQGGALTDIVSQ---VRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILL----TLDGRVKLSDFGFC 188 (321)
T ss_dssp EEEEEECCCCSCBHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE----CTTCCEEECCCTTC
T ss_pred EEEEEEecCCCCCHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE----CCCCcEEEeeeeee
Confidence 46799999999999999864 459999999999999999999999999999999999999 77788999999998
Q ss_pred ccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHHcCCC-CCCCC
Q 039291 164 KRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEH-SLPEI 242 (362)
Q Consensus 164 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~-~~~~~ 242 (362)
........ ......||+.|+|||++.+..++.++|||||||++|+|++|+.||... ...+....+.... .....
T Consensus 189 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~---~~~~~~~~~~~~~~~~~~~ 263 (321)
T 2c30_A 189 AQISKDVP--KRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSD---SPVQAMKRLRDSPPPKLKN 263 (321)
T ss_dssp EECCSSSC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTS---CHHHHHHHHHHSSCCCCTT
T ss_pred eecccCcc--ccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC---CHHHHHHHHhcCCCCCcCc
Confidence 76554222 224567999999999999989999999999999999999999999654 3333333332222 11223
Q ss_pred CccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCccCc
Q 039291 243 PSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGV 280 (362)
Q Consensus 243 ~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~~~~ 280 (362)
+..++++++++|.+||..||++|||+.++++||||...
T Consensus 264 ~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~ 301 (321)
T 2c30_A 264 SHKVSPVLRDFLERMLVRDPQERATAQELLDHPFLLQT 301 (321)
T ss_dssp GGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGGGC
T ss_pred cccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhccC
Confidence 45689999999999999999999999999999999764
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-48 Score=350.26 Aligned_cols=261 Identities=25% Similarity=0.357 Sum_probs=211.6
Q ss_pred CCCceeecceecccCceEEEEEEECCCCCCCCceeeeechh-----hhhhHHHHHHHHHHHHcCCCCcccccccceeeec
Q 039291 4 DGTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAE-----VSASASLQKEKEVFDNLNGCPFVLECFGEEITMG 78 (362)
Q Consensus 4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~-----~~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~ 78 (362)
-.++|.+++.||+|+||.||+|.++.++. .+++|... ......+.+|+.++++++ ||||+++++.+..
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~----~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~-- 76 (284)
T 3kk8_A 4 FSDNYDVKEELGKGAFSVVRRCVHKTTGL----EFAAKIINTKKLSARDFQKLEREARICRKLQ-HPNIVRLHDSIQE-- 76 (284)
T ss_dssp TTTTEEEEEEEEEETTEEEEEEEETTTCC----EEEEEEEEGGGCCHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEEC--
T ss_pred hhhhhhhhhhhcCcCCeEEEEEEEcCCCc----eEEEEEeecccCCHHHHHHHHHHHHHHHHcC-CCCcCeEEEEEEc--
Confidence 36899999999999999999999998876 45555543 234466889999999998 9999999987642
Q ss_pred CCCceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEe
Q 039291 79 ENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIA 158 (362)
Q Consensus 79 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~ 158 (362)
....++||||+++++|.+++... ..+++..++.++.|++.||.|||++||+||||||+||++..+ +..+.+||+
T Consensus 77 ---~~~~~~v~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~-~~~~~~kl~ 150 (284)
T 3kk8_A 77 ---ESFHYLVFDLVTGGELFEDIVAR--EFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASK-AKGAAVKLA 150 (284)
T ss_dssp ---SSEEEEEECCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSS-STTCCEEEC
T ss_pred ---CCEEEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecC-CCCCcEEEe
Confidence 23467999999999999988774 459999999999999999999999999999999999999432 223459999
Q ss_pred ecCCcccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHHcCCC-
Q 039291 159 DLGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEH- 237 (362)
Q Consensus 159 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~- 237 (362)
|||++........ .....||+.|+|||++.+..++.++||||||+++|+|++|..||.... .......+....
T Consensus 151 Dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~---~~~~~~~~~~~~~ 224 (284)
T 3kk8_A 151 DFGLAIEVNDSEA---WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDED---QHRLYAQIKAGAY 224 (284)
T ss_dssp CCTTCEECCSSCB---CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHHHTCC
T ss_pred eceeeEEcccCcc---ccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCc---hhHHHHHHHhccc
Confidence 9999976543222 235679999999999999999999999999999999999999996543 333333332222
Q ss_pred C-CCCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCccCcchh
Q 039291 238 S-LPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGVDEE 283 (362)
Q Consensus 238 ~-~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~~~~~~~ 283 (362)
. .......+++++.+||.+||..||++|||+.++++||||++..+.
T Consensus 225 ~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~~ 271 (284)
T 3kk8_A 225 DYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNRERV 271 (284)
T ss_dssp CCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTSHHHHSCCCG
T ss_pred cCCchhhcccCHHHHHHHHHHcccChhhCCCHHHHhcCccccCChhH
Confidence 1 122235689999999999999999999999999999999876443
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-49 Score=366.99 Aligned_cols=264 Identities=23% Similarity=0.416 Sum_probs=209.8
Q ss_pred CCCCceeecceecccCceEEEEEEECCCCCCCCceeeeechhhhhhHHHHHHHHHHHHcCCCCcccccccceeeecCCCc
Q 039291 3 SDGTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVSASASLQKEKEVFDNLNGCPFVLECFGEEITMGENGE 82 (362)
Q Consensus 3 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~~~ 82 (362)
...++|.+.+.||+|+||+||+|+++.++..++.++..+.........+.+|+.+++.++ ||||+++++++.. .
T Consensus 30 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~-----~ 103 (360)
T 3eqc_A 30 LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECN-SPYIVGFYGAFYS-----D 103 (360)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCC-CTTBCCEEEEEEE-----T
T ss_pred cccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCC-CCCEEEEeEEEEE-----C
Confidence 457899999999999999999999998876443333332223445567889999999998 9999999997653 2
Q ss_pred eEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC-CceeCCCCCCCEEEeecCCCceEEEEeecC
Q 039291 83 MAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDS-GYVHCDVKPDNILLVATQSGKFVAKIADLG 161 (362)
Q Consensus 83 ~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~-~ivH~Dlkp~Nill~~~~~~~~~~kl~Dfg 161 (362)
..+++||||++|++|.+++... ..+++..+..++.|++.||.|||+. ||+||||||+|||+ +.++.+||+|||
T Consensus 104 ~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~----~~~~~~kl~Dfg 177 (360)
T 3eqc_A 104 GEISICMEHMDGGSLDQVLKKA--GRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILV----NSRGEIKLCDFG 177 (360)
T ss_dssp TEEEEEECCCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEE----CTTCCEEECCCC
T ss_pred CEEEEEEECCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEE----CCCCCEEEEECC
Confidence 2477999999999999999874 3599999999999999999999996 99999999999999 778889999999
Q ss_pred CcccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHH--------------
Q 039291 162 VAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSID-------------- 227 (362)
Q Consensus 162 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~-------------- 227 (362)
++...... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||...+.....
T Consensus 178 ~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 253 (360)
T 3eqc_A 178 VSGQLIDS----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAET 253 (360)
T ss_dssp CCHHHHHH----C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC----------
T ss_pred CCcccccc----cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCC
Confidence 98755332 123567999999999999999999999999999999999999999654321111
Q ss_pred -------------------------HHHHHHcCCCCCCCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCccCcch
Q 039291 228 -------------------------QLFSIIGDEHSLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGVDE 282 (362)
Q Consensus 228 -------------------------~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~~~~~~ 282 (362)
+....+............++.++++||.+||..||++|||++++++||||+...+
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~ 333 (360)
T 3eqc_A 254 PPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDA 333 (360)
T ss_dssp --------------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHHHHH
T ss_pred CCCcccCCCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHhhcchH
Confidence 1111221122222223457899999999999999999999999999999987544
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-49 Score=358.88 Aligned_cols=260 Identities=27% Similarity=0.437 Sum_probs=202.1
Q ss_pred CceeecceecccCceEEEEEEECCCCCCCCceeeeechh-----hhhhHHHHHHHHHHHHcCCCCcccccccceeeecCC
Q 039291 6 TSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAE-----VSASASLQKEKEVFDNLNGCPFVLECFGEEITMGEN 80 (362)
Q Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~-----~~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~ 80 (362)
++|.+++.||+|+||+||+|+++.++. .+++|... ....+.+.+|+.++++++ ||||+++++++..
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~----~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~---- 73 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQ----IVAIKKFLESEDDPVIKKIALREIRMLKQLK-HPNLVNLLEVFRR---- 73 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCC----EEEEEEECCCCC-HHHHHHHHHHHHHHHHCC-CTTBCCEEEEEEE----
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCc----EEEEEEeeccccchHHHHHHHHHHHHHHhCC-CCCccchhheeec----
Confidence 689999999999999999999998876 45666432 223456789999999999 9999999997643
Q ss_pred CceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEeec
Q 039291 81 GEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADL 160 (362)
Q Consensus 81 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Df 160 (362)
...+++||||+++++|.+++.. ...+++..++.++.|++.||.|||++||+||||||+||++ +.++.+||+||
T Consensus 74 -~~~~~lv~e~~~~~~l~~~~~~--~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~----~~~~~~kl~Df 146 (311)
T 4agu_A 74 -KRRLHLVFEYCDHTVLHELDRY--QRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILI----TKHSVIKLCDF 146 (311)
T ss_dssp -TTEEEEEEECCSEEHHHHHHHT--SSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE----CTTSCEEECCC
T ss_pred -CCeEEEEEEeCCCchHHHHHhh--hcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEE----cCCCCEEEeeC
Confidence 2346799999999999998876 4559999999999999999999999999999999999999 77888999999
Q ss_pred CCcccccccccCCCCCCccCCCCccCchhhcc-ccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHHcCC---
Q 039291 161 GVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQ-HMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDE--- 236 (362)
Q Consensus 161 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~--- 236 (362)
|++....... .......||+.|+|||++.+ ..++.++|||||||++|+|++|.+||......+...........
T Consensus 147 g~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 224 (311)
T 4agu_A 147 GFARLLTGPS--DYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIP 224 (311)
T ss_dssp TTCEECC--------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCH
T ss_pred CCchhccCcc--cccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccc
Confidence 9997654322 22235679999999999986 56799999999999999999999999765432222222211110
Q ss_pred --------------CCCCC---------CCccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCccCcchh
Q 039291 237 --------------HSLPE---------IPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGVDEE 283 (362)
Q Consensus 237 --------------~~~~~---------~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~~~~~~~ 283 (362)
...+. ....++.++.+||.+||..||++|||++++++||||+++.+.
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~ 294 (311)
T 4agu_A 225 RHQQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIREI 294 (311)
T ss_dssp HHHHHHHTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGTTCC--
T ss_pred ccccccccccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChHHHhccCH
Confidence 01111 013578899999999999999999999999999999987654
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-48 Score=357.48 Aligned_cols=262 Identities=24% Similarity=0.383 Sum_probs=212.0
Q ss_pred CCceeecceecccCceEEEEEEECCCCCCCCceeeeechhhh---------hhHHHHHHHHHHHHcCCCCccccccccee
Q 039291 5 GTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVS---------ASASLQKEKEVFDNLNGCPFVLECFGEEI 75 (362)
Q Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~~---------~~~~~~~E~~il~~l~~h~~i~~~~~~~~ 75 (362)
.++|.+++.||+|+||.||+|+++.++. .+++|..... ....+.+|+.+++.++ ||||+++++++.
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~----~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~ 85 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGL----EYAAKFIKKRQSRASRRGVSREEIEREVSILRQVL-HHNVITLHDVYE 85 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCC----EEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCC-CTTBCCEEEEEE
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCe----EEEEEEEecccccccccchhHHHHHHHHHHHHhCC-CCCcceEEEEEe
Confidence 3679999999999999999999998876 4455544321 2466889999999998 999999998764
Q ss_pred eecCCCceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEE
Q 039291 76 TMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVA 155 (362)
Q Consensus 76 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~ 155 (362)
. ...+++||||++|++|.+++.. ...+++..++.++.|++.||.|||++||+||||||+||++..++.....+
T Consensus 86 ~-----~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~ 158 (321)
T 2a2a_A 86 N-----RTDVVLILELVSGGELFDFLAQ--KESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHI 158 (321)
T ss_dssp C-----SSEEEEEECCCCSCBHHHHHHT--CSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCE
T ss_pred c-----CCEEEEEEEcCCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCE
Confidence 2 2347799999999999999976 45699999999999999999999999999999999999994322222279
Q ss_pred EEeecCCcccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHHcC
Q 039291 156 KIADLGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGD 235 (362)
Q Consensus 156 kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~ 235 (362)
||+|||++....... ......||+.|+|||++.+..++.++|||||||++|+|++|..||... ...+....+..
T Consensus 159 kl~Dfg~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~---~~~~~~~~i~~ 232 (321)
T 2a2a_A 159 KLIDFGLAHEIEDGV---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGD---TKQETLANITS 232 (321)
T ss_dssp EECCCTTCEECCTTC---CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCS---SHHHHHHHHHT
T ss_pred EEccCccceecCccc---cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCC---CHHHHHHHHHh
Confidence 999999997655422 123567999999999999889999999999999999999999999654 33444444433
Q ss_pred CCC-C-CCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCccCcchhh
Q 039291 236 EHS-L-PEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGVDEEL 284 (362)
Q Consensus 236 ~~~-~-~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~~~~~~~~ 284 (362)
... . +..+..++..+++||.+||..||++|||+.+++.||||....+..
T Consensus 233 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~hp~~~~~~~~~ 283 (321)
T 2a2a_A 233 VSYDFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDNQQ 283 (321)
T ss_dssp TCCCCCHHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHSTTTSCSSHHH
T ss_pred cccccChhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhcCccccCCCccc
Confidence 221 1 112246889999999999999999999999999999999876553
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-48 Score=363.38 Aligned_cols=265 Identities=24% Similarity=0.397 Sum_probs=212.7
Q ss_pred CCceeecceecccCceEEEEEEECCCCCCCCceeeeechhh-------hhhHHHHHHHHHHHHcCCCCcccccccceeee
Q 039291 5 GTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEV-------SASASLQKEKEVFDNLNGCPFVLECFGEEITM 77 (362)
Q Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~-------~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~ 77 (362)
.++|.+++.||+|+||+||+|++... ......+++|.+.. .....+.+|+.+++.+.+||||+++++.+..
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~- 130 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISG-HDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT- 130 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSS-TTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEE-
T ss_pred ccceEEEEEeccCCCEEEEEEEEccc-CCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEee-
Confidence 37899999999999999999998531 11124667776532 2345577899999999779999999886643
Q ss_pred cCCCceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEE
Q 039291 78 GENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKI 157 (362)
Q Consensus 78 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl 157 (362)
...+++||||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||
T Consensus 131 ----~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll----~~~~~~kl 200 (355)
T 1vzo_A 131 ----ETKLHLILDYINGGELFTHLSQR--ERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILL----DSNGHVVL 200 (355)
T ss_dssp ----TTEEEEEECCCCSCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE----CTTSCEEE
T ss_pred ----CceEEEEeecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE----CCCCcEEE
Confidence 22477999999999999999874 459999999999999999999999999999999999999 77889999
Q ss_pred eecCCcccccccccCCCCCCccCCCCccCchhhcc--ccCCCcchHHHHHHHHHHHHhCCCCCccCCCC-CHHHHHHHHc
Q 039291 158 ADLGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQ--HMQEAPSDIWALGCVVLEMLSGRQAWVVKEDC-SIDQLFSIIG 234 (362)
Q Consensus 158 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~-~~~~~~~~~~ 234 (362)
+|||+++........ .....+||+.|+|||++.+ ..++.++|||||||++|+|++|..||...... ....+...+.
T Consensus 201 ~DfG~a~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~ 279 (355)
T 1vzo_A 201 TDFGLSKEFVADETE-RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRIL 279 (355)
T ss_dssp SCSSEEEECCGGGGG-GGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHH
T ss_pred eeCCCCeecccCCCC-cccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHh
Confidence 999999765432222 2235679999999999986 35788999999999999999999999755332 3344444332
Q ss_pred CCCCCCCCCccCCHHHHHHHHHHhccCCCCCC-----CHHHHhcCCCccCcchhh
Q 039291 235 DEHSLPEIPSRVSKEARDFLRRCFVRKPAFRF-----TAEMLLDDPFVKGVDEEL 284 (362)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~-----s~~~~l~~p~~~~~~~~~ 284 (362)
.. .+.++..++..+++||.+||..||++|| +++++++||||+.+.+..
T Consensus 280 ~~--~~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~~~~~~ 332 (355)
T 1vzo_A 280 KS--EPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINWDD 332 (355)
T ss_dssp HC--CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCCHHH
T ss_pred cc--CCCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhcCChhH
Confidence 22 2345678999999999999999999999 999999999999987764
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-48 Score=351.01 Aligned_cols=253 Identities=26% Similarity=0.432 Sum_probs=208.2
Q ss_pred CCCCceeecceecccCceEEEEEEECCCCCCCCceeeeechhh------hhhHHHHHHHHHHHHcCCCCcccccccceee
Q 039291 3 SDGTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEV------SASASLQKEKEVFDNLNGCPFVLECFGEEIT 76 (362)
Q Consensus 3 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~------~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~ 76 (362)
..-++|.+++.||+|+||+||+|+++.++. .+++|.... .....+.+|+.++++++ ||||+++++++..
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~----~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~ 80 (279)
T 3fdn_A 6 WALEDFEIGRPLGKGKFGNVYLAREKQSKF----ILALKVLFKAQLEKAGVEHQLRREVEIQSHLR-HPNILRLYGYFHD 80 (279)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCC----EEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCC-CTTBCCEEEEEEC
T ss_pred eecccEEEeeEEecCCCeEEEEEEEccCCc----EEEEEEEeccccchhhHHHHHHHHHHHHHcCC-CCCCcchhheEec
Confidence 345789999999999999999999998875 456665422 23456889999999999 9999999987642
Q ss_pred ecCCCceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEE
Q 039291 77 MGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAK 156 (362)
Q Consensus 77 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~k 156 (362)
...+++||||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+||++ +.++.++
T Consensus 81 -----~~~~~lv~e~~~~~~l~~~l~~~--~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili----~~~~~~~ 149 (279)
T 3fdn_A 81 -----ATRVYLILEYAPLGTVYRELQKL--SKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLL----GSAGELK 149 (279)
T ss_dssp -----SSEEEEEECCCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEE----CTTSCEE
T ss_pred -----CCEEEEEEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEE----cCCCCEE
Confidence 23477999999999999999874 459999999999999999999999999999999999999 7788899
Q ss_pred EeecCCcccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHHcCC
Q 039291 157 IADLGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDE 236 (362)
Q Consensus 157 l~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 236 (362)
|+|||++...... ......||+.|+|||++.+..++.++||||||+++|+|++|..||... ...+....+...
T Consensus 150 l~Dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~---~~~~~~~~~~~~ 222 (279)
T 3fdn_A 150 IADFGWSVHAPSS----RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN---TYQETYKRISRV 222 (279)
T ss_dssp ECSCCEESCC------------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCS---SHHHHHHHHHHT
T ss_pred EEeccccccCCcc----cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCC---cHHHHHHHHHhC
Confidence 9999998644332 123567999999999999999999999999999999999999999644 344444443322
Q ss_pred CCCCCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCccCc
Q 039291 237 HSLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGV 280 (362)
Q Consensus 237 ~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~~~~ 280 (362)
. ...+..++.++++||.+||..||++|||+.++++||||+..
T Consensus 223 ~--~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h~~~~~~ 264 (279)
T 3fdn_A 223 E--FTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITAN 264 (279)
T ss_dssp C--CCCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHCHHHHHH
T ss_pred C--CCCCCcCCHHHHHHHHHHhccChhhCCCHHHHhhCccccCC
Confidence 2 23556789999999999999999999999999999999653
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-49 Score=369.91 Aligned_cols=264 Identities=26% Similarity=0.396 Sum_probs=204.5
Q ss_pred CCceeecceecccCceEEEEEEECCCCCCCCceeeeechhhhhhHHHHHHHHHHHHcCCCCcccccccceeeecC-CCce
Q 039291 5 GTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVSASASLQKEKEVFDNLNGCPFVLECFGEEITMGE-NGEM 83 (362)
Q Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~-~~~~ 83 (362)
..+|.+++.||+|+||+||+|++..++. +++|..... .....+|+.+++.++ ||||+++++++..... ....
T Consensus 39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~-----~aikk~~~~-~~~~~~E~~il~~l~-h~niv~l~~~~~~~~~~~~~~ 111 (394)
T 4e7w_A 39 EIAYTNCKVIGNGSFGVVFQAKLVESDE-----VAIKKVLQD-KRFKNRELQIMRIVK-HPNVVDLKAFFYSNGDKKDEV 111 (394)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTEE-----EEEEEEECC-TTSCCHHHHHHHTCC-CTTBCCEEEEEEEESSSSSCE
T ss_pred cceEEEeEEEeeCCCeEEEEEEECCCCe-----EEEEEEecC-cchHHHHHHHHHhCC-CCCcceEEEEEEecCCCCCce
Confidence 4589999999999999999999987764 455544322 222347999999998 9999999998876543 3455
Q ss_pred EEEEEEEecCCCCHHHHHHH--hcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCC-CceEEEEeec
Q 039291 84 AYNLLLEYAAGGTLGDLIEK--CNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQS-GKFVAKIADL 160 (362)
Q Consensus 84 ~~~lv~e~~~~~~L~~~l~~--~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~-~~~~~kl~Df 160 (362)
++++||||++++ +.+.+.. .....+++..++.++.||+.||.|||++||+||||||+|||+ + .++.+||+||
T Consensus 112 ~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill----~~~~~~~kL~DF 186 (394)
T 4e7w_A 112 FLNLVLEYVPET-VYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLL----DPPSGVLKLIDF 186 (394)
T ss_dssp EEEEEEECCSEE-HHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE----ETTTTEEEECCC
T ss_pred EEEEEeeccCcc-HHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEE----cCCCCcEEEeeC
Confidence 678999999874 4443332 124569999999999999999999999999999999999999 5 6778999999
Q ss_pred CCcccccccccCCCCCCccCCCCccCchhhccc-cCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHH-HHHHHcC---
Q 039291 161 GVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQH-MQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQ-LFSIIGD--- 235 (362)
Q Consensus 161 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~-~~~~~~~--- 235 (362)
|+++....... .....||+.|+|||++.+. .++.++|||||||++|+|++|++||.+.+..+... +......
T Consensus 187 G~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~ 263 (394)
T 4e7w_A 187 GSAKILIAGEP---NVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSR 263 (394)
T ss_dssp TTCEECCTTCC---CCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCH
T ss_pred CCcccccCCCC---CcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCH
Confidence 99986543222 2356799999999999765 58999999999999999999999997654322111 1111110
Q ss_pred -----------CCCCCC---------CCccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCccCcchh
Q 039291 236 -----------EHSLPE---------IPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGVDEE 283 (362)
Q Consensus 236 -----------~~~~~~---------~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~~~~~~~ 283 (362)
...++. ++..+++++.+||.+||..||.+|||+.+++.||||+++.+.
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~ 331 (394)
T 4e7w_A 264 EQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELRTG 331 (394)
T ss_dssp HHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTTTSS
T ss_pred HHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhhccc
Confidence 111111 233588999999999999999999999999999999987654
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-48 Score=369.69 Aligned_cols=269 Identities=26% Similarity=0.364 Sum_probs=192.6
Q ss_pred Cceee-cceecccCceEEEEEEECCCCCCCCceeeeechhhh-hhHHHHHHHHHHHHcCCCCcccccccceeeecCCCce
Q 039291 6 TSWFR-GRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVS-ASASLQKEKEVFDNLNGCPFVLECFGEEITMGENGEM 83 (362)
Q Consensus 6 ~~y~~-~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~~-~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~~~~ 83 (362)
+.|.+ +++||+|+||+||+|+++.+.. ...+|+|.+... ....+.+|+.+|++|+ ||||+++++++.. ....
T Consensus 20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~--~~~vaiK~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~---~~~~ 93 (405)
T 3rgf_A 20 DLFEYEGCKVGRGTYGHVYKAKRKDGKD--DKDYALKQIEGTGISMSACREIALLRELK-HPNVISLQKVFLS---HADR 93 (405)
T ss_dssp HHEECSSCCCC-----EEEEEEESSSSC--CCCEEEEECSSSSCCHHHHHHHHHHHHCC-CTTBCCCCEEEEE---TTTT
T ss_pred hhhhhcCcEeeecCCeEEEEEEEccCCC--CeEEEEEEECCCCCCHHHHHHHHHHHhcC-CCCeeeEeeEEec---CCCC
Confidence 45776 6789999999999999764321 236788876543 3456889999999998 9999999997753 2234
Q ss_pred EEEEEEEecCCCCHHHHHHHhc-------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEE
Q 039291 84 AYNLLLEYAAGGTLGDLIEKCN-------GNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAK 156 (362)
Q Consensus 84 ~~~lv~e~~~~~~L~~~l~~~~-------~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~k 156 (362)
.+++||||+.+ +|.+++.... ...+++..++.++.||+.||.|||++||+||||||+|||+...++..+.+|
T Consensus 94 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~k 172 (405)
T 3rgf_A 94 KVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVK 172 (405)
T ss_dssp EEEEEEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTTCEE
T ss_pred eEEEEEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCCcEE
Confidence 57899999975 8888886422 124999999999999999999999999999999999999976556678899
Q ss_pred EeecCCccccccccc-CCCCCCccCCCCccCchhhccc-cCCCcchHHHHHHHHHHHHhCCCCCccCCCC-------CHH
Q 039291 157 IADLGVAKRSRHCKR-QKFDPSMRGTPLYLAPETVVQH-MQEAPSDIWALGCVVLEMLSGRQAWVVKEDC-------SID 227 (362)
Q Consensus 157 l~Dfgla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~-------~~~ 227 (362)
|+|||+++....... .......+||+.|+|||++.+. .++.++|||||||++|+|++|.+||.+.... ...
T Consensus 173 l~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~ 252 (405)
T 3rgf_A 173 IADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHD 252 (405)
T ss_dssp ECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHH
T ss_pred EEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHH
Confidence 999999986543211 1222456799999999999874 5899999999999999999999999754331 112
Q ss_pred HH---HHHHcCCCC--CCC------------------------------CCccCCHHHHHHHHHHhccCCCCCCCHHHHh
Q 039291 228 QL---FSIIGDEHS--LPE------------------------------IPSRVSKEARDFLRRCFVRKPAFRFTAEMLL 272 (362)
Q Consensus 228 ~~---~~~~~~~~~--~~~------------------------------~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l 272 (362)
.+ +..+..... ++. .....+.++.+||.+||..||.+|||++++|
T Consensus 253 ~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L 332 (405)
T 3rgf_A 253 QLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAM 332 (405)
T ss_dssp HHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred HHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHh
Confidence 22 222211100 000 0011267899999999999999999999999
Q ss_pred cCCCccCcc
Q 039291 273 DDPFVKGVD 281 (362)
Q Consensus 273 ~~p~~~~~~ 281 (362)
+||||....
T Consensus 333 ~hp~f~~~~ 341 (405)
T 3rgf_A 333 QDPYFLEDP 341 (405)
T ss_dssp TSGGGTSSS
T ss_pred cChhhccCC
Confidence 999998754
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-48 Score=349.47 Aligned_cols=257 Identities=23% Similarity=0.359 Sum_probs=208.0
Q ss_pred CCceeecceecccCceEEEEEEECCCCCCCCceeeeechh---hhhhHHHHHHHHHHHHcCCCCcccccccceeeecCCC
Q 039291 5 GTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAE---VSASASLQKEKEVFDNLNGCPFVLECFGEEITMGENG 81 (362)
Q Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~---~~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~~ 81 (362)
.++|.+.+.||+|+||+||+|+++.++. .+++|... ....+.+.+|+.++++++ ||||+++++.+..
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~----~~a~k~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~----- 77 (277)
T 3f3z_A 8 NQYYTLENTIGRGSWGEVKIAVQKGTRI----RRAAKKIPKYFVEDVDRFKQEIEIMKSLD-HPNIIRLYETFED----- 77 (277)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCC----EEEEEEEEGGGCSCHHHHHHHHHHHHTCC-CTTBCCEEEEEEC-----
T ss_pred hhhEEeeeEEeecCCEEEEEEEeCCCCc----EEEEEeehhhccchHHHHHHHHHHHHhCC-CCCEeeEEEEEec-----
Confidence 4689999999999999999999998875 45555543 234567889999999997 9999999987642
Q ss_pred ceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEeecC
Q 039291 82 EMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLG 161 (362)
Q Consensus 82 ~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Dfg 161 (362)
...+++||||+++++|.+++... ..+++..++.++.|++.||.|||++||+||||||+||++..+ +.++.++|+|||
T Consensus 78 ~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~-~~~~~~~l~Dfg 154 (277)
T 3f3z_A 78 NTDIYLVMELCTGGELFERVVHK--RVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTD-SPDSPLKLIDFG 154 (277)
T ss_dssp SSEEEEEEECCCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSS-STTCCEEECCCT
T ss_pred CCeEEEEEeccCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecC-CCCCcEEEEecc
Confidence 23477999999999999999873 459999999999999999999999999999999999999542 455679999999
Q ss_pred CcccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHHcCCC-CCC
Q 039291 162 VAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEH-SLP 240 (362)
Q Consensus 162 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~-~~~ 240 (362)
++....... ......||+.|+|||++.+. ++.++||||||+++|+|++|..||.... ..+....+.... ..+
T Consensus 155 ~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~---~~~~~~~~~~~~~~~~ 227 (277)
T 3f3z_A 155 LAARFKPGK---MMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPT---DSEVMLKIREGTFTFP 227 (277)
T ss_dssp TCEECCTTS---CBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHHHCCCCCC
T ss_pred cceeccCcc---chhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCC---HHHHHHHHHhCCCCCC
Confidence 997654322 22356799999999998764 8999999999999999999999996543 333333333222 111
Q ss_pred C-CCccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCccCcc
Q 039291 241 E-IPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGVD 281 (362)
Q Consensus 241 ~-~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~~~~~ 281 (362)
. ....+++++.+||.+||..||++|||+.++++||||++..
T Consensus 228 ~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~~ 269 (277)
T 3f3z_A 228 EKDWLNVSPQAESLIRRLLTKSPKQRITSLQALEHEWFEKQL 269 (277)
T ss_dssp HHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHHHH
T ss_pred chhhhcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhccc
Confidence 1 1125899999999999999999999999999999997643
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-48 Score=349.33 Aligned_cols=255 Identities=23% Similarity=0.390 Sum_probs=212.1
Q ss_pred CCCCceeecceecccCceEEEEEEECCCCCCCCceeeeechh------hhhhHHHHHHHHHHHHcCCCCcccccccceee
Q 039291 3 SDGTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAE------VSASASLQKEKEVFDNLNGCPFVLECFGEEIT 76 (362)
Q Consensus 3 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~------~~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~ 76 (362)
...++|.+++.||+|+||.||+|+++.+++. +++|... ....+.+.+|+.+++.++ ||||+++++++..
T Consensus 12 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~----~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~ 86 (294)
T 2rku_A 12 RSRRRYVRGRFLGKGGFAKCFEISDADTKEV----FAGKIVPKSLLLKPHQREKMSMEISIHRSLA-HQHVVGFHGFFED 86 (294)
T ss_dssp TTTEEEEEEEEEEEETTEEEEEEEETTTCCE----EEEEEEEGGGCCSHHHHHHHHHHHHHHHTCC-CTTBCCEEEEEEC
T ss_pred CcccceEEEEEEeecCCEEEEEEEECCCCce----EEEEEechhhccCHHHHHHHHHHHHHHHhCC-CCCEeeeeeeecc
Confidence 4568999999999999999999999988764 4555432 234567889999999997 9999999987642
Q ss_pred ecCCCceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEE
Q 039291 77 MGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAK 156 (362)
Q Consensus 77 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~k 156 (362)
...+++||||+++++|.+++... ..+++..++.++.|++.||.|||++||+||||||+||++ +.++.+|
T Consensus 87 -----~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~----~~~~~~k 155 (294)
T 2rku_A 87 -----NDFVFVVLELCRRRSLLELHKRR--KALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFL----NEDLEVK 155 (294)
T ss_dssp -----SSEEEEEEECCTTCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE----CTTCCEE
T ss_pred -----CCEEEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEE----cCCCCEE
Confidence 23477999999999999998773 459999999999999999999999999999999999999 7788899
Q ss_pred EeecCCcccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHHcCC
Q 039291 157 IADLGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDE 236 (362)
Q Consensus 157 l~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 236 (362)
|+|||++........ ......||+.|+|||++.+..++.++||||||+++|+|++|..||... ...+....+...
T Consensus 156 l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~---~~~~~~~~~~~~ 230 (294)
T 2rku_A 156 IGDFGLATKVEYDGE--RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETS---CLKETYLRIKKN 230 (294)
T ss_dssp ECCCTTCEECCSTTC--CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCS---SHHHHHHHHHTT
T ss_pred EEeccCceecccCcc--ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCC---CHHHHHHHHhhc
Confidence 999999976543222 123567999999999999888999999999999999999999999644 333443343332
Q ss_pred CCCCCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCccCc
Q 039291 237 HSLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGV 280 (362)
Q Consensus 237 ~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~~~~ 280 (362)
. ..++..++..+.++|.+||..||++|||++++++||||...
T Consensus 231 ~--~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~~~~~~~ 272 (294)
T 2rku_A 231 E--YSIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSG 272 (294)
T ss_dssp C--CCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTS
T ss_pred c--CCCccccCHHHHHHHHHHcccChhhCcCHHHHhhChheecC
Confidence 2 24566789999999999999999999999999999999653
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-48 Score=347.41 Aligned_cols=256 Identities=27% Similarity=0.440 Sum_probs=188.0
Q ss_pred CCCceeecceecccCceEEEEEEECCCCCCCCceeeeechhhh------hhHHHHHHHHHHHHcCCCCcccccccceeee
Q 039291 4 DGTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVS------ASASLQKEKEVFDNLNGCPFVLECFGEEITM 77 (362)
Q Consensus 4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~~------~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~ 77 (362)
.-++|.+++.||+|+||.||+|++..++. .+++|..... ....+.+|+.+++.++ ||||+++++++..
T Consensus 9 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~----~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~- 82 (278)
T 3cok_A 9 KIEDFKVGNLLGKGSFAGVYRAESIHTGL----EVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLK-HPSILELYNYFED- 82 (278)
T ss_dssp SGGGEEEEEEEEECSSEEEEEEEETTTCC----EEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBC-CTTBCCEEEEEEC-
T ss_pred ccccceeeeeecCCCceEEEEEEEccCCc----eEEEEEeehhhhhhhhHHHHHHHHHHHHHhCC-CCCeEeEEEEEcc-
Confidence 34689999999999999999999987775 5677765432 2366889999999998 9999999987642
Q ss_pred cCCCceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEE
Q 039291 78 GENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKI 157 (362)
Q Consensus 78 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl 157 (362)
...+++||||+++++|.+++... ..++++..++.++.|++.||.|||++||+||||||+||++ +.++.+||
T Consensus 83 ----~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili----~~~~~~kl 153 (278)
T 3cok_A 83 ----SNYVYLVLEMCHNGEMNRYLKNR-VKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLL----TRNMNIKI 153 (278)
T ss_dssp ----SSEEEEEEECCTTEEHHHHHHTC-SSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEE----CTTCCEEE
T ss_pred ----CCeEEEEEecCCCCcHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE----cCCCCEEE
Confidence 23577999999999999999863 3569999999999999999999999999999999999999 77888999
Q ss_pred eecCCcccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHHcCCC
Q 039291 158 ADLGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEH 237 (362)
Q Consensus 158 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 237 (362)
+|||++......... .....||+.|+|||++.+..++.++||||||+++|+|++|+.||....... ....+...
T Consensus 154 ~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~~~~~~~~- 227 (278)
T 3cok_A 154 ADFGLATQLKMPHEK--HYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKN---TLNKVVLA- 227 (278)
T ss_dssp CCCTTCEECC------------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC--------CCSS-
T ss_pred EeecceeeccCCCCc--ceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHH---HHHHHhhc-
Confidence 999999765432222 234679999999999998889999999999999999999999997554322 22222111
Q ss_pred CCCCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCccCcc
Q 039291 238 SLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGVD 281 (362)
Q Consensus 238 ~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~~~~~ 281 (362)
....+..++.++.+||.+||..||++|||+.++++||||....
T Consensus 228 -~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~ 270 (278)
T 3cok_A 228 -DYEMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDHPFMSRNS 270 (278)
T ss_dssp -CCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSTTTC---
T ss_pred -ccCCccccCHHHHHHHHHHcccCHhhCCCHHHHhcCccccCCC
Confidence 1235567899999999999999999999999999999997643
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-48 Score=357.19 Aligned_cols=254 Identities=23% Similarity=0.387 Sum_probs=211.2
Q ss_pred CCCceeecceecccCceEEEEEEECCCCCCCCceeeeechh------hhhhHHHHHHHHHHHHcCCCCcccccccceeee
Q 039291 4 DGTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAE------VSASASLQKEKEVFDNLNGCPFVLECFGEEITM 77 (362)
Q Consensus 4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~------~~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~ 77 (362)
..++|.+++.||+|+||.||+|++..+++. +++|... ......+.+|+.+++.++ ||||+++++++..
T Consensus 39 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~----~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~- 112 (335)
T 2owb_A 39 SRRRYVRGRFLGKGGFAKCFEISDADTKEV----FAGKIVPKSLLLKPHQREKMSMEISIHRSLA-HQHVVGFHGFFED- 112 (335)
T ss_dssp TTEEEEEEEEEEEETTEEEEEEEETTTCCE----EEEEEEEGGGCCSHHHHHHHHHHHHHHHTCC-CTTBCCEEEEEEC-
T ss_pred cCCceEEEEEEeeCCCeEEEEEEECCCCCE----EEEEEechhhhcCHHHHHHHHHHHHHHHhCC-CCCCCeEEEEEec-
Confidence 467999999999999999999999988764 4555432 234567889999999998 9999999987642
Q ss_pred cCCCceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEE
Q 039291 78 GENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKI 157 (362)
Q Consensus 78 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl 157 (362)
...+++||||+.+++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||
T Consensus 113 ----~~~~~lv~e~~~~~~L~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~----~~~~~~kl 182 (335)
T 2owb_A 113 ----NDFVFVVLELCRRRSLLELHKRR--KALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFL----NEDLEVKI 182 (335)
T ss_dssp ----SSEEEEEECCCTTCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE----CTTCCEEE
T ss_pred ----CCeEEEEEecCCCCCHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEE----cCCCCEEE
Confidence 23577999999999999999873 459999999999999999999999999999999999999 77888999
Q ss_pred eecCCcccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHHcCCC
Q 039291 158 ADLGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEH 237 (362)
Q Consensus 158 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 237 (362)
+|||++........ ......||+.|+|||++.+..++.++|||||||++|+|++|..||.... ..+....+....
T Consensus 183 ~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~---~~~~~~~~~~~~ 257 (335)
T 2owb_A 183 GDFGLATKVEYDGE--RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSC---LKETYLRIKKNE 257 (335)
T ss_dssp CCCTTCEECCSTTC--CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSS---HHHHHHHHHHTC
T ss_pred eeccCceecccCcc--cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCC---HHHHHHHHhcCC
Confidence 99999976543222 1235679999999999999889999999999999999999999996542 333333332221
Q ss_pred CCCCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCccCc
Q 039291 238 SLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGV 280 (362)
Q Consensus 238 ~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~~~~ 280 (362)
..++..++.++.+||.+||..||++||++.++++||||...
T Consensus 258 --~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~~~~~~~ 298 (335)
T 2owb_A 258 --YSIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSG 298 (335)
T ss_dssp --CCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTS
T ss_pred --CCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccCC
Confidence 23556789999999999999999999999999999999653
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-49 Score=363.87 Aligned_cols=263 Identities=23% Similarity=0.343 Sum_probs=204.5
Q ss_pred CceeecceecccCceEEEEEEECCCCCCCCceeeeechhh--------hhhHHHHHHHHHHHHcCCCCcccccccceeee
Q 039291 6 TSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEV--------SASASLQKEKEVFDNLNGCPFVLECFGEEITM 77 (362)
Q Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~--------~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~ 77 (362)
++|.+++.||+|+||+||+|+++.++. .+++|.... ...+.+.+|+.++++++ ||||+++++++..
T Consensus 26 ~~y~~~~~lG~G~~g~V~~~~~~~~~~----~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~- 99 (345)
T 3hko_A 26 KKYHLKGAIGQGSYGVVRVAIENQTRA----IRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLH-HPNIARLYEVYED- 99 (345)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCC----EEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCC-CTTBCCEEEEEEC-
T ss_pred hheeecceeeecCCeEEEEEEECCCCc----eEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCC-CCCcceeehhhcc-
Confidence 689999999999999999999988875 456665432 34467889999999998 9999999997642
Q ss_pred cCCCceEEEEEEEecCCCCHHHHHHHhc--------------------------------------CCCCCHHHHHHHHH
Q 039291 78 GENGEMAYNLLLEYAAGGTLGDLIEKCN--------------------------------------GNGLPEKDVRHFTR 119 (362)
Q Consensus 78 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~--------------------------------------~~~l~~~~~~~i~~ 119 (362)
...+++||||++||+|.+++.... ...+++..++.++.
T Consensus 100 ----~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 175 (345)
T 3hko_A 100 ----EQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMR 175 (345)
T ss_dssp ----SSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHH
T ss_pred ----CCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHH
Confidence 335789999999999999985210 11246888999999
Q ss_pred HHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEeecCCcccccccccCC--CCCCccCCCCccCchhhcc--ccC
Q 039291 120 CILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQK--FDPSMRGTPLYLAPETVVQ--HMQ 195 (362)
Q Consensus 120 ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Dfgla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~--~~~ 195 (362)
||+.||.|||++||+||||||+|||+.. +....+||+|||++.......... ......||+.|+|||++.+ ..+
T Consensus 176 qi~~~l~~LH~~~ivH~Dlkp~NIll~~--~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ 253 (345)
T 3hko_A 176 QIFSALHYLHNQGICHRDIKPENFLFST--NKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESY 253 (345)
T ss_dssp HHHHHHHHHHHTTEECCCCCGGGEEESC--SSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCC
T ss_pred HHHHHHHHHHHCCccccCCChhhEEEec--CCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCC
Confidence 9999999999999999999999999932 222379999999998654322211 2245679999999999975 678
Q ss_pred CCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHH-cCCCCCC-CCCccCCHHHHHHHHHHhccCCCCCCCHHHHhc
Q 039291 196 EAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSII-GDEHSLP-EIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLD 273 (362)
Q Consensus 196 ~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~-~~~~~~~-~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~ 273 (362)
+.++|||||||++|+|++|+.||.... ..+....+ ......+ .....+++++++||.+||..||.+||++.++++
T Consensus 254 ~~~~DiwslG~il~el~~g~~pf~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~ 330 (345)
T 3hko_A 254 GPKCDAWSAGVLLHLLLMGAVPFPGVN---DADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQ 330 (345)
T ss_dssp CTHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHH
T ss_pred CcHHHHHHHHHHHHHHHHCCCCCCCCC---hHHHHHHHHhcccccCCcccccCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence 899999999999999999999996543 23333333 2222221 122358999999999999999999999999999
Q ss_pred CCCccCcchh
Q 039291 274 DPFVKGVDEE 283 (362)
Q Consensus 274 ~p~~~~~~~~ 283 (362)
||||++..+.
T Consensus 331 hp~~~~~~~~ 340 (345)
T 3hko_A 331 HPWISQFSDK 340 (345)
T ss_dssp SHHHHTTSSC
T ss_pred ChhhccChHh
Confidence 9999876544
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-48 Score=358.60 Aligned_cols=265 Identities=21% Similarity=0.290 Sum_probs=206.0
Q ss_pred CCceeecceecccCceEEEEEEECCCCCCCCceeeeechhh-----hhhHHHHHHHHHHHHcCCCCcccccccceeeecC
Q 039291 5 GTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEV-----SASASLQKEKEVFDNLNGCPFVLECFGEEITMGE 79 (362)
Q Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~-----~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~ 79 (362)
-++|.+++.||+|+||+||+|+++.+++ .|++|.... .....+.+|+.+++.++ ||||+++++++.....
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~----~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~ 90 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQ----KVALKKVLMENEKEGFPITALREIKILQLLK-HENVVNLIEICRTKAS 90 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCC----EEEEEECCCSSCSSSSCHHHHHHHHHHHHCC-CTTBCCEEEEEEEC--
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCC----EEEEEEEecccccccchHHHHHHHHHHHhcc-CCCcccHhheeecccc
Confidence 4789999999999999999999988875 566665422 23446789999999998 9999999997764321
Q ss_pred ---CCceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEE
Q 039291 80 ---NGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAK 156 (362)
Q Consensus 80 ---~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~k 156 (362)
.....+++||||+.+ +|.+.+... ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+|
T Consensus 91 ~~~~~~~~~~lv~e~~~~-~l~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~----~~~~~~k 164 (351)
T 3mi9_A 91 PYNRCKGSIYLVFDFCEH-DLAGLLSNV-LVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLI----TRDGVLK 164 (351)
T ss_dssp ------CEEEEEEECCSE-EHHHHHHCT-TSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE----CTTSCEE
T ss_pred ccccCCceEEEEEeccCC-CHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEE----cCCCCEE
Confidence 113457899999975 888877653 3459999999999999999999999999999999999999 7788899
Q ss_pred EeecCCccccccccc--CCCCCCccCCCCccCchhhcc-ccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHH
Q 039291 157 IADLGVAKRSRHCKR--QKFDPSMRGTPLYLAPETVVQ-HMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSII 233 (362)
Q Consensus 157 l~Dfgla~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~ 233 (362)
|+|||+++....... ........||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.........+...
T Consensus 165 l~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~ 244 (351)
T 3mi9_A 165 LADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQL 244 (351)
T ss_dssp ECCCTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHH
T ss_pred EccchhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH
Confidence 999999976543221 122245678999999999986 46799999999999999999999999765433332333222
Q ss_pred cCCCCCCCCCc---------------------------cCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCccCc
Q 039291 234 GDEHSLPEIPS---------------------------RVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGV 280 (362)
Q Consensus 234 ~~~~~~~~~~~---------------------------~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~~~~ 280 (362)
.........+. ..++++++||.+||..||++|||++++++||||...
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~ 318 (351)
T 3mi9_A 245 CGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSD 318 (351)
T ss_dssp HCCCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGSS
T ss_pred hCCCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCcCCC
Confidence 22211111111 027789999999999999999999999999999764
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-48 Score=364.81 Aligned_cols=258 Identities=26% Similarity=0.419 Sum_probs=203.6
Q ss_pred ceee--cceecccCceEEEEEEECCCCCCCCceeeeechhh---hhhHHHHHHHHHHHHcCCCCcccccccceeeecCCC
Q 039291 7 SWFR--GRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEV---SASASLQKEKEVFDNLNGCPFVLECFGEEITMGENG 81 (362)
Q Consensus 7 ~y~~--~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~---~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~~ 81 (362)
.|.+ .+.||+|+||.||+|+++.++. .+++|.... ...+.+.+|+.++++++ ||||+++++++..
T Consensus 88 ~~~~~~~~~lG~G~~g~Vy~a~~~~~g~----~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~----- 157 (373)
T 2x4f_A 88 FYTVSKTEILGGGRFGQVHKCEETATGL----KLAAKIIKTRGMKDKEEVKNEISVMNQLD-HANLIQLYDAFES----- 157 (373)
T ss_dssp TEEEEEEEECC-----CEEEEEETTTCC----EEEEEEEECCSHHHHHHHHHHHHHHTTCC-CTTBCCEEEEEEC-----
T ss_pred ceeeecceEEecCcCEEEEEEEEcCCCc----EEEEEEEcccccccHHHHHHHHHHHHhCC-CCCCCeEEEEEEE-----
Confidence 3444 6789999999999999988875 456665433 34567889999999998 9999999987643
Q ss_pred ceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEeecC
Q 039291 82 EMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLG 161 (362)
Q Consensus 82 ~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Dfg 161 (362)
...+++||||+++++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||+.. +..+.+||+|||
T Consensus 158 ~~~~~lv~E~~~~~~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~--~~~~~~kl~DFG 234 (373)
T 2x4f_A 158 KNDIVLVMEYVDGGELFDRIIDE-SYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVN--RDAKQIKIIDFG 234 (373)
T ss_dssp SSEEEEEEECCTTCEEHHHHHHT-GGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEE--TTTTEEEECCCS
T ss_pred CCEEEEEEeCCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEec--CCCCcEEEEeCC
Confidence 23477999999999999988763 345999999999999999999999999999999999999954 345679999999
Q ss_pred CcccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHHc-CCCCC-
Q 039291 162 VAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIG-DEHSL- 239 (362)
Q Consensus 162 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~-~~~~~- 239 (362)
+++....... .....||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+ ..+....+. .....
T Consensus 235 ~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~---~~~~~~~i~~~~~~~~ 308 (373)
T 2x4f_A 235 LARRYKPREK---LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDN---DAETLNNILACRWDLE 308 (373)
T ss_dssp SCEECCTTCB---CCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSS---HHHHHHHHHHTCCCSC
T ss_pred CceecCCccc---cccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHHhccCCCC
Confidence 9986654222 234579999999999998889999999999999999999999996553 233333322 22211
Q ss_pred CCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCccCcchh
Q 039291 240 PEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGVDEE 283 (362)
Q Consensus 240 ~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~~~~~~~ 283 (362)
+.....+++++++||.+||..||.+|||+.++++||||+.....
T Consensus 309 ~~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~hp~~~~~~~~ 352 (373)
T 2x4f_A 309 DEEFQDISEEAKEFISKLLIKEKSWRISASEALKHPWLSDHKLH 352 (373)
T ss_dssp SGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHCHHHH
T ss_pred hhhhccCCHHHHHHHHHHcCCChhhCCCHHHHhcCcCcCCCchh
Confidence 12234689999999999999999999999999999999886544
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-48 Score=378.46 Aligned_cols=257 Identities=25% Similarity=0.376 Sum_probs=207.0
Q ss_pred CCceeecceecccCceEEEEEEECCCCCCCCceeeeechhh----------------hhhHHHHHHHHHHHHcCCCCccc
Q 039291 5 GTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEV----------------SASASLQKEKEVFDNLNGCPFVL 68 (362)
Q Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~----------------~~~~~~~~E~~il~~l~~h~~i~ 68 (362)
+++|.+++.||+|+||+||+|+++.++.. +|+|.... ...+.+.+|+.++++++ ||||+
T Consensus 35 ~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~----~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv 109 (504)
T 3q5i_A 35 GESYFKVRKLGSGAYGEVLLCKEKNGHSE----KAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLD-HPNII 109 (504)
T ss_dssp GGTEEEEEEEEC--CEEEEEEEETTTCCE----EEEEEEEC----------------CTHHHHHHHHHHHHTCC-CTTBC
T ss_pred ccceEEEeEecccCCeEEEEEEECCCCcE----EEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCC-CCCCC
Confidence 57899999999999999999999988764 45554322 23456889999999998 99999
Q ss_pred ccccceeeecCCCceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeec
Q 039291 69 ECFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVAT 148 (362)
Q Consensus 69 ~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~ 148 (362)
++++++.. ...+++|||||+||+|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||+..+
T Consensus 110 ~~~~~~~~-----~~~~~lv~e~~~gg~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~ 182 (504)
T 3q5i_A 110 KLFDVFED-----KKYFYLVTEFYEGGELFEQIINR--HKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENK 182 (504)
T ss_dssp CEEEEEEC-----SSEEEEEEECCTTCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESST
T ss_pred eEEEEEEc-----CCEEEEEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecC
Confidence 99997642 33578999999999999999773 459999999999999999999999999999999999999332
Q ss_pred CCCceEEEEeecCCcccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHH
Q 039291 149 QSGKFVAKIADLGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQ 228 (362)
Q Consensus 149 ~~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~ 228 (362)
+....+||+|||++....... .....+||+.|+|||++.+ .++.++|||||||++|+|++|.+||.+. ...+
T Consensus 183 -~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~---~~~~ 254 (504)
T 3q5i_A 183 -NSLLNIKIVDFGLSSFFSKDY---KLRDRLGTAYYIAPEVLKK-KYNEKCDVWSCGVIMYILLCGYPPFGGQ---NDQD 254 (504)
T ss_dssp -TCCSSEEECCCTTCEECCTTS---CBCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCS---SHHH
T ss_pred -CCCccEEEEECCCCEEcCCCC---ccccccCCcCCCCHHHhcc-CCCchHHHHHHHHHHHHHHhCCCCCCCC---CHHH
Confidence 122369999999997665422 2235679999999999874 6899999999999999999999999654 3445
Q ss_pred HHHHHcCCCCCCC--CCccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCccCcc
Q 039291 229 LFSIIGDEHSLPE--IPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGVD 281 (362)
Q Consensus 229 ~~~~~~~~~~~~~--~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~~~~~ 281 (362)
+...+........ .+..+++++++||.+||..||.+|||++++++||||+...
T Consensus 255 ~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~ 309 (504)
T 3q5i_A 255 IIKKVEKGKYYFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYA 309 (504)
T ss_dssp HHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHTC
T ss_pred HHHHHHcCCCCCCccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhhch
Confidence 5555443332211 1246899999999999999999999999999999997654
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-49 Score=366.07 Aligned_cols=261 Identities=21% Similarity=0.320 Sum_probs=191.2
Q ss_pred CCceeecceecccCceEEEEEEECCCCCCCCceeeeechhh-----hhhHHHHHHHHHHHHcCCCCcccccccceeeecC
Q 039291 5 GTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEV-----SASASLQKEKEVFDNLNGCPFVLECFGEEITMGE 79 (362)
Q Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~-----~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~ 79 (362)
.++|.+++.||+|+||.||+|+++.++. .|++|.... .....+.+|+.+++.++ ||||+++++++.....
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~----~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~~ 102 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGL----RVAVKKLSRPFQSIIHAKRTYRELRLLKHMK-HENVIGLLDVFTPARS 102 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTE----EEEEEECSSTTSSHHHHHHHHHHHHHHHHCC-CTTBCCCSEEECSCSS
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCC----EEEEEEeCccccCHHHHHHHHHHHHHHHhCC-CCCCCcEEEEEecCCc
Confidence 4789999999999999999999988875 567776532 24567889999999998 9999999997653211
Q ss_pred -CCceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEe
Q 039291 80 -NGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIA 158 (362)
Q Consensus 80 -~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~ 158 (362)
.....+++|+|++ +++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+
T Consensus 103 ~~~~~~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll----~~~~~~kL~ 174 (367)
T 2fst_X 103 LEEFNDVYLVTHLM-GADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV----NEDCELKIL 174 (367)
T ss_dssp GGGCCCCEEEEECC-CEECC--------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE----CTTCCEEEC
T ss_pred cccCCeEEEEeccc-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEE----CCCCCEEEe
Confidence 1123467999999 6799998875 459999999999999999999999999999999999999 778889999
Q ss_pred ecCCcccccccccCCCCCCccCCCCccCchhhcc-ccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHHcCC-
Q 039291 159 DLGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQ-HMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDE- 236 (362)
Q Consensus 159 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~- 236 (362)
|||+++..... .....||+.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+..+....+......
T Consensus 175 DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p 249 (367)
T 2fst_X 175 DFGLARHTADE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTP 249 (367)
T ss_dssp C--------------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSC
T ss_pred ecccccccccc-----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence 99999764431 235679999999999987 67899999999999999999999999765432221111111100
Q ss_pred --------------------CCCC-----CCCccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCccCcchh
Q 039291 237 --------------------HSLP-----EIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGVDEE 283 (362)
Q Consensus 237 --------------------~~~~-----~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~~~~~~~ 283 (362)
...+ .....+++++.+||.+||..||++|||+.+++.||||+.....
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~~~~~~ 321 (367)
T 2fst_X 250 GAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDP 321 (367)
T ss_dssp CHHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCG
T ss_pred CHHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhhhccCC
Confidence 0011 1123468999999999999999999999999999999886544
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-48 Score=377.99 Aligned_cols=255 Identities=25% Similarity=0.402 Sum_probs=208.3
Q ss_pred CceeecceecccCceEEEEEEECCCCCCCCceeeeechh-----hhhhHHHHHHHHHHHHcCCCCcccccccceeeecCC
Q 039291 6 TSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAE-----VSASASLQKEKEVFDNLNGCPFVLECFGEEITMGEN 80 (362)
Q Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~-----~~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~ 80 (362)
++|.+++.||+|+||+||+|+++.++. .||+|.+. ......+.+|+.++++++ ||||+++++++..
T Consensus 22 ~~y~~~~~lG~G~~g~V~~~~~~~~~~----~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~---- 92 (486)
T 3mwu_A 22 ERYNIVCMLGKGSFGEVLKCKDRITQQ----EYAVKVINKASAKNKDTSTILREVELLKKLD-HPNIMKLFEILED---- 92 (486)
T ss_dssp HHEEEEEEEECCSSSEEEEEEETTTCC----EEEEEEEEHHHHBCSCHHHHHHHHHHHHHCC-CTTBCCEEEEEEC----
T ss_pred cceEEeEEEeecCCEEEEEEEECCCCC----EEEEEEEecccccchHHHHHHHHHHHHHhCC-CCCcCeEEEEEEc----
Confidence 589999999999999999999998875 45666543 224567889999999998 9999999987642
Q ss_pred CceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEeec
Q 039291 81 GEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADL 160 (362)
Q Consensus 81 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Df 160 (362)
...+++|||||.|++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||+... +..+.+||+||
T Consensus 93 -~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~-~~~~~~kl~Df 168 (486)
T 3mwu_A 93 -SSSFYIVGELYTGGELFDEIIKR--KRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESK-EKDCDIKIIDF 168 (486)
T ss_dssp -SSEEEEEECCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSS-STTCCEEECSC
T ss_pred -CCEEEEEEEcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecC-CCCCCEEEEEC
Confidence 33578999999999999998774 459999999999999999999999999999999999999432 23467999999
Q ss_pred CCcccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHHcCCCCCC
Q 039291 161 GVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEHSLP 240 (362)
Q Consensus 161 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 240 (362)
|+++...... .....+||+.|+|||++.+ .++.++|||||||++|+|++|.+||.+. ...++...+.......
T Consensus 169 g~a~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~---~~~~~~~~i~~~~~~~ 241 (486)
T 3mwu_A 169 GLSTCFQQNT---KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGK---NEYDILKRVETGKYAF 241 (486)
T ss_dssp SCTTTBCCC-------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCS---SHHHHHHHHHHTCCCS
T ss_pred CcCeECCCCC---ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCC---CHHHHHHHHHhCCCCC
Confidence 9997654322 2235679999999999876 5899999999999999999999999654 3344444443333222
Q ss_pred C--CCccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCccCc
Q 039291 241 E--IPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGV 280 (362)
Q Consensus 241 ~--~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~~~~ 280 (362)
. .+..+++++++||.+||..||.+|||+.++++||||+..
T Consensus 242 ~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~~ 283 (486)
T 3mwu_A 242 DLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKY 283 (486)
T ss_dssp CSGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHCHHHHHT
T ss_pred CCcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCHhhccC
Confidence 2 235689999999999999999999999999999999764
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-48 Score=376.48 Aligned_cols=257 Identities=23% Similarity=0.377 Sum_probs=206.2
Q ss_pred CceeecceecccCceEEEEEEECCCCCCCCceeeeechh-----hhhhHHHHHHHHHHHHcCCCCcccccccceeeecCC
Q 039291 6 TSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAE-----VSASASLQKEKEVFDNLNGCPFVLECFGEEITMGEN 80 (362)
Q Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~-----~~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~ 80 (362)
++|.+++.||+|+||+||+|+++.++.. +++|... ......+.+|+.+++.++ ||||+++++++..
T Consensus 37 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~----~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~---- 107 (494)
T 3lij_A 37 EMYQRVKKLGSGAYGEVLLCRDKVTHVE----RAIKIIRKTSVSTSSNSKLLEEVAVLKLLD-HPNIMKLYDFFED---- 107 (494)
T ss_dssp HHEEEEEEEECC---EEEEEEETTTCCE----EEEEEEEC-----CTTHHHHHHHHHHTTCC-CTTBCCEEEEEEC----
T ss_pred cCeEEeeEEecCCCEEEEEEEECCCCcE----EEEEEEeccccCchHHHHHHHHHHHHHhCC-CCCCCeEEEEEEe----
Confidence 3799999999999999999999988764 4555432 234567889999999998 9999999997642
Q ss_pred CceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEeec
Q 039291 81 GEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADL 160 (362)
Q Consensus 81 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Df 160 (362)
...+++|||||.||+|.+++... .++++..++.++.||+.||.|||++||+||||||+|||+... +..+.+||+||
T Consensus 108 -~~~~~lv~e~~~~g~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~-~~~~~~kl~Df 183 (494)
T 3lij_A 108 -KRNYYLVMECYKGGELFDEIIHR--MKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESK-EKDALIKIVDF 183 (494)
T ss_dssp -SSEEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCS-STTCCEEECCC
T ss_pred -CCEEEEEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCC-CCCCcEEEEEC
Confidence 33478999999999999988773 459999999999999999999999999999999999999432 23456999999
Q ss_pred CCcccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHHcCCCCCC
Q 039291 161 GVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEHSLP 240 (362)
Q Consensus 161 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 240 (362)
|++....... .....+||+.|+|||++. ..++.++|||||||++|+|++|.+||.+. ...++...+.......
T Consensus 184 G~a~~~~~~~---~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~---~~~~~~~~i~~~~~~~ 256 (494)
T 3lij_A 184 GLSAVFENQK---KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQ---TDQEILRKVEKGKYTF 256 (494)
T ss_dssp TTCEECBTTB---CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCS---SHHHHHHHHHHTCCCC
T ss_pred CCCeECCCCc---cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCC---CHHHHHHHHHhCCCCC
Confidence 9997665422 224567999999999986 46899999999999999999999999654 3444444443332221
Q ss_pred --CCCccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCccCcch
Q 039291 241 --EIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGVDE 282 (362)
Q Consensus 241 --~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~~~~~~ 282 (362)
..+..+++++++||.+||..||.+|||+.++++||||+....
T Consensus 257 ~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~~ 300 (494)
T 3lij_A 257 DSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEHPWIKEMCS 300 (494)
T ss_dssp CSGGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHHHHH
T ss_pred CchhcccCCHHHHHHHHHHCCCChhhCccHHHHhcCcccccCcc
Confidence 223468999999999999999999999999999999987543
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-48 Score=361.89 Aligned_cols=258 Identities=22% Similarity=0.373 Sum_probs=210.9
Q ss_pred CCCceeecceecccCceEEEEEEECCCCC---CCCceeeeechhh----hhhHHHHHHHHHHHHcCCCCcccccccceee
Q 039291 4 DGTSWFRGRVIGQGSFGCVFIAKPKSNSS---FLPPLMAVKSAEV----SASASLQKEKEVFDNLNGCPFVLECFGEEIT 76 (362)
Q Consensus 4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~---~~~~~~~~K~~~~----~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~ 76 (362)
..++|.+++.||+|+||+||+|++...+. .....|++|.... .....+.+|+.+++.+.+||||+++++.+..
T Consensus 79 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 158 (370)
T 2psq_A 79 PRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 158 (370)
T ss_dssp CGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECS
T ss_pred cHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEcc
Confidence 45789999999999999999999854321 2234688887643 2445688999999999669999999997642
Q ss_pred ecCCCceEEEEEEEecCCCCHHHHHHHhcC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCC
Q 039291 77 MGENGEMAYNLLLEYAAGGTLGDLIEKCNG--------------NGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDN 142 (362)
Q Consensus 77 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--------------~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~N 142 (362)
...+|+||||++||+|.+++..... ..+++..+..++.||+.||.|||++||+||||||+|
T Consensus 159 -----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~N 233 (370)
T 2psq_A 159 -----DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARN 233 (370)
T ss_dssp -----SSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGG
T ss_pred -----CCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhh
Confidence 2236799999999999999987431 348999999999999999999999999999999999
Q ss_pred EEEeecCCCceEEEEeecCCcccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHh-CCCCCccC
Q 039291 143 ILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLS-GRQAWVVK 221 (362)
Q Consensus 143 ill~~~~~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~ 221 (362)
||+ +.++.+||+|||+++...............+|+.|+|||++.+..++.++|||||||++|||++ |..||...
T Consensus 234 Ill----~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~ 309 (370)
T 2psq_A 234 VLV----TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI 309 (370)
T ss_dssp EEE----CTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred EEE----CCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCC
Confidence 999 7888999999999986554333333345567889999999999999999999999999999999 99999654
Q ss_pred CCCCHHHHHHHHcCCCCCCCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhcC
Q 039291 222 EDCSIDQLFSIIGDEHSLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDD 274 (362)
Q Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~ 274 (362)
. ..++...+.... .+..+..++.++.++|.+||..||++||++.+++++
T Consensus 310 ~---~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~ 358 (370)
T 2psq_A 310 P---VEELFKLLKEGH-RMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 358 (370)
T ss_dssp C---GGGHHHHHHTTC-CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred C---HHHHHHHHhcCC-CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 3 344444444433 345677899999999999999999999999999873
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-48 Score=358.82 Aligned_cols=261 Identities=23% Similarity=0.373 Sum_probs=200.9
Q ss_pred CCCCceeecceecccCceEEEEEEECCCCCCCCceeeeechhhh--------hhHHHHHHHHHHHHcCCCCcccccccce
Q 039291 3 SDGTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVS--------ASASLQKEKEVFDNLNGCPFVLECFGEE 74 (362)
Q Consensus 3 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~~--------~~~~~~~E~~il~~l~~h~~i~~~~~~~ 74 (362)
...++|.+++.||+|+||.||+|+++.+++ .+++|..... ....+.+|+.+++.++ ||||+++++++
T Consensus 7 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~----~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~ 81 (346)
T 1ua2_A 7 SRAKRYEKLDFLGEGQFATVYKARDKNTNQ----IVAIKKIKLGHRSEAKDGINRTALREIKLLQELS-HPNIIGLLDAF 81 (346)
T ss_dssp ------CEEEEEEEETTEEEEEEECSSCCS----EEEEEEC------------CTHHHHHHHHHHHCC-CTTBCCEEEEE
T ss_pred HHhcccEEEeEEeecCCEEEEEEEECCCCc----EEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCC-CCCCCeEEEEE
Confidence 456899999999999999999999988775 5677765422 1245789999999998 99999999876
Q ss_pred eeecCCCceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceE
Q 039291 75 ITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFV 154 (362)
Q Consensus 75 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~ 154 (362)
.. ...+++||||+++ +|.+++.. ....+++..++.++.|++.||.|||++||+||||||+|||+ +.++.
T Consensus 82 ~~-----~~~~~lv~e~~~~-~l~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~----~~~~~ 150 (346)
T 1ua2_A 82 GH-----KSNISLVFDFMET-DLEVIIKD-NSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLL----DENGV 150 (346)
T ss_dssp CC-----TTCCEEEEECCSE-EHHHHHTT-CCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE----CTTCC
T ss_pred ee-----CCceEEEEEcCCC-CHHHHHHh-cCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEE----cCCCC
Confidence 42 2236799999986 89888876 33469999999999999999999999999999999999999 77889
Q ss_pred EEEeecCCcccccccccCCCCCCccCCCCccCchhhccc-cCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHH-HHHH
Q 039291 155 AKIADLGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQH-MQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQ-LFSI 232 (362)
Q Consensus 155 ~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~-~~~~ 232 (362)
+||+|||+++...... .......||+.|+|||++.+. .++.++|||||||++|+|++|.+||.+........ ++..
T Consensus 151 ~kl~Dfg~a~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~ 228 (346)
T 1ua2_A 151 LKLADFGLAKSFGSPN--RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFET 228 (346)
T ss_dssp EEECCCGGGSTTTSCC--CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHH
T ss_pred EEEEecccceeccCCc--ccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHH
Confidence 9999999997654322 222456799999999999764 58899999999999999999999996553221111 1111
Q ss_pred HcCC--CCCC---------------CC-----CccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCccCcc
Q 039291 233 IGDE--HSLP---------------EI-----PSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGVD 281 (362)
Q Consensus 233 ~~~~--~~~~---------------~~-----~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~~~~~ 281 (362)
.... ..++ .. ...++.++++||.+||..||++|||+.++++||||+...
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~~~~ 299 (346)
T 1ua2_A 229 LGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRP 299 (346)
T ss_dssp HCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSS
T ss_pred cCCCChhhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhhcCC
Confidence 1110 0011 11 145679999999999999999999999999999998653
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-49 Score=361.10 Aligned_cols=245 Identities=22% Similarity=0.318 Sum_probs=204.2
Q ss_pred CceeecceecccCceEEEEEEECCCCCCCCceeeeechhhh-----------hhHHHHHHHHHHHHcCCCCcccccccce
Q 039291 6 TSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVS-----------ASASLQKEKEVFDNLNGCPFVLECFGEE 74 (362)
Q Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~~-----------~~~~~~~E~~il~~l~~h~~i~~~~~~~ 74 (362)
++|.+++.||+|+||+||+|+++.++. .|++|..... ....+.+|+.++++++ ||||+++++++
T Consensus 24 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~----~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~Iv~~~~~~ 98 (335)
T 3dls_A 24 QKYSTMSPLGSGAFGFVWTAVDKEKNK----EVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVE-HANIIKVLDIF 98 (335)
T ss_dssp HHEEEEEECSSSSSCSEEEEEETTTTE----EEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCC-CTTBCCEEEEE
T ss_pred cceEEEeEEEecCCEEEEEEEECCCCc----EEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCC-CCCEeeEEEEE
Confidence 689999999999999999999988875 4566654322 3345778999999997 99999999876
Q ss_pred eeecCCCceEEEEEEEecCCC-CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCce
Q 039291 75 ITMGENGEMAYNLLLEYAAGG-TLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKF 153 (362)
Q Consensus 75 ~~~~~~~~~~~~lv~e~~~~~-~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~ 153 (362)
.. ...+++||||+.+| +|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++
T Consensus 99 ~~-----~~~~~lv~e~~~~g~~l~~~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll----~~~~ 167 (335)
T 3dls_A 99 EN-----QGFFQLVMEKHGSGLDLFAFIDR--HPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVI----AEDF 167 (335)
T ss_dssp EC-----SSEEEEEEECCTTSCBHHHHHHT--CCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE----CTTS
T ss_pred ee-----CCEEEEEEEeCCCCccHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEE----cCCC
Confidence 42 33577999999776 99999986 4469999999999999999999999999999999999999 7788
Q ss_pred EEEEeecCCcccccccccCCCCCCccCCCCccCchhhccccC-CCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHH
Q 039291 154 VAKIADLGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQ-EAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSI 232 (362)
Q Consensus 154 ~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~ 232 (362)
.+||+|||++....... ......||+.|+|||++.+..+ +.++|||||||++|+|++|..||......
T Consensus 168 ~~kL~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~-------- 236 (335)
T 3dls_A 168 TIKLIDFGSAAYLERGK---LFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET-------- 236 (335)
T ss_dssp CEEECCCTTCEECCTTC---CBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG--------
T ss_pred cEEEeecccceECCCCC---ceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH--------
Confidence 89999999997654322 2235679999999999988776 78899999999999999999999643210
Q ss_pred HcCCCCCCCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCccCc
Q 039291 233 IGDEHSLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGV 280 (362)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~~~~ 280 (362)
.......+..++.++.+||.+||..||++|||++++++||||+..
T Consensus 237 ---~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~~ 281 (335)
T 3dls_A 237 ---VEAAIHPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQP 281 (335)
T ss_dssp ---TTTCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHCTTTTCC
T ss_pred ---HhhccCCCcccCHHHHHHHHHHccCChhhCcCHHHHhcCccccCC
Confidence 111123355689999999999999999999999999999999764
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-48 Score=352.65 Aligned_cols=267 Identities=25% Similarity=0.426 Sum_probs=212.4
Q ss_pred CCCceeecceecccCceEEEEEEEC-CCCCCCCceeeeechhh-----hhhHHHHHHHHHHHHcC--CCCccccccccee
Q 039291 4 DGTSWFRGRVIGQGSFGCVFIAKPK-SNSSFLPPLMAVKSAEV-----SASASLQKEKEVFDNLN--GCPFVLECFGEEI 75 (362)
Q Consensus 4 ~~~~y~~~~~lG~G~~g~V~~a~~~-~~~~~~~~~~~~K~~~~-----~~~~~~~~E~~il~~l~--~h~~i~~~~~~~~ 75 (362)
.+++|.+++.||+|+||+||+|++. .++. .|++|.... .....+.+|+.+++.+. .||||+++++++.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~----~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~ 84 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGR----FVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCT 84 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTE----EEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEE
T ss_pred chhceeeeeeecccccEEEEEEEecCCCCE----EEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeee
Confidence 3588999999999999999999996 4443 456665432 12345778998888874 4999999999876
Q ss_pred eecCCCceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEE
Q 039291 76 TMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVA 155 (362)
Q Consensus 76 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~ 155 (362)
....+....+++||||+. ++|.+++.......+++..++.++.||+.||.|||++||+||||||+||++ +.++.+
T Consensus 85 ~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili----~~~~~~ 159 (326)
T 1blx_A 85 VSRTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILV----TSSGQI 159 (326)
T ss_dssp EEECSSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE----CTTCCE
T ss_pred ecccCCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEE----cCCCCE
Confidence 544445667889999998 599999988655669999999999999999999999999999999999999 778889
Q ss_pred EEeecCCcccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHH-HHHHHc
Q 039291 156 KIADLGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQ-LFSIIG 234 (362)
Q Consensus 156 kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~-~~~~~~ 234 (362)
||+|||++....... ......||+.|+|||++.+..++.++|||||||++|+|++|..||.......... +.....
T Consensus 160 kl~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~ 236 (326)
T 1blx_A 160 KLADFGLARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIG 236 (326)
T ss_dssp EECSCCSCCCCCGGG---GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC
T ss_pred EEecCcccccccCCC---CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcC
Confidence 999999997654322 1235679999999999999899999999999999999999999996553321111 111111
Q ss_pred CC---------------------CCCCCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCccCcch
Q 039291 235 DE---------------------HSLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGVDE 282 (362)
Q Consensus 235 ~~---------------------~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~~~~~~ 282 (362)
.. .....+...++.++++||.+||..||++|||+.+++.||||+...+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~ 305 (326)
T 1blx_A 237 LPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLER 305 (326)
T ss_dssp CCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCCC
T ss_pred CCCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCccccccch
Confidence 00 0111234568999999999999999999999999999999987643
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-48 Score=359.10 Aligned_cols=253 Identities=25% Similarity=0.382 Sum_probs=206.7
Q ss_pred CceeecceecccCceEEEEEEECCCCCCCCceeeeechhhh-----------hhHHHHHHHHHHHHcCCCCcccccccce
Q 039291 6 TSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVS-----------ASASLQKEKEVFDNLNGCPFVLECFGEE 74 (362)
Q Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~~-----------~~~~~~~E~~il~~l~~h~~i~~~~~~~ 74 (362)
++|.+.+.||+|+||.||+|+++.+++ .|++|..... ....+.+|+.+++++.+||||+++++++
T Consensus 94 ~~y~~~~~lg~G~~g~Vy~a~~~~~g~----~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~ 169 (365)
T 2y7j_A 94 QKYDPKDVIGRGVSSVVRRCVHRATGH----EFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSY 169 (365)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCC----EEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred hhcccceEEecCCCEEEEEEEECCCCc----EEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEE
Confidence 479999999999999999999987775 5666654322 2456789999999996699999999866
Q ss_pred eeecCCCceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceE
Q 039291 75 ITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFV 154 (362)
Q Consensus 75 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~ 154 (362)
.. ...+++||||++|++|.+++... ..+++..++.++.||+.||.|||+.||+||||||+|||+ +.++.
T Consensus 170 ~~-----~~~~~lv~e~~~g~~L~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~----~~~~~ 238 (365)
T 2y7j_A 170 ES-----SSFMFLVFDLMRKGELFDYLTEK--VALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILL----DDNMQ 238 (365)
T ss_dssp EB-----SSEEEEEECCCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE----CTTCC
T ss_pred ee-----CCEEEEEEEeCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE----CCCCC
Confidence 42 33577999999999999999863 459999999999999999999999999999999999999 78889
Q ss_pred EEEeecCCcccccccccCCCCCCccCCCCccCchhhccc------cCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHH
Q 039291 155 AKIADLGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQH------MQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQ 228 (362)
Q Consensus 155 ~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~ 228 (362)
++|+|||++....... ......||+.|+|||++.+. .++.++|||||||++|+|++|..||... ....
T Consensus 239 ikl~DfG~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~---~~~~ 312 (365)
T 2y7j_A 239 IRLSDFGFSCHLEPGE---KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHR---RQIL 312 (365)
T ss_dssp EEECCCTTCEECCTTC---CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCS---SHHH
T ss_pred EEEEecCcccccCCCc---ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCC---CHHH
Confidence 9999999987655322 12356799999999998743 5788999999999999999999999654 3334
Q ss_pred HHHHHcCCCCCCC--CCccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCccC
Q 039291 229 LFSIIGDEHSLPE--IPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKG 279 (362)
Q Consensus 229 ~~~~~~~~~~~~~--~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~~~ 279 (362)
....+........ .+..++.++.+||.+||..||++|||+.++++||||+.
T Consensus 313 ~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~f~r 365 (365)
T 2y7j_A 313 MLRMIMEGQYQFSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQHPFFER 365 (365)
T ss_dssp HHHHHHHTCCCCCHHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCC
T ss_pred HHHHHHhCCCCCCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCcccCC
Confidence 4444332222111 12467899999999999999999999999999999963
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-49 Score=365.05 Aligned_cols=261 Identities=20% Similarity=0.278 Sum_probs=209.2
Q ss_pred CCCCceeecceecccCceEEEEEEECCCC-CCCCceeeeechhh----hhhHHHHHHHHHHHHcCCCCcccccccceeee
Q 039291 3 SDGTSWFRGRVIGQGSFGCVFIAKPKSNS-SFLPPLMAVKSAEV----SASASLQKEKEVFDNLNGCPFVLECFGEEITM 77 (362)
Q Consensus 3 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~-~~~~~~~~~K~~~~----~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~ 77 (362)
...++|.+++.||+|+||.||+|++...+ ......|++|.... ...+.+.+|+++++++.+||||+++++++..
T Consensus 19 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~- 97 (359)
T 3vhe_A 19 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTK- 97 (359)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred ccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeeeeec-
Confidence 45789999999999999999999965422 12235778887643 2345688999999999879999999997643
Q ss_pred cCCCceEEEEEEEecCCCCHHHHHHHhcC---------------------------------------------------
Q 039291 78 GENGEMAYNLLLEYAAGGTLGDLIEKCNG--------------------------------------------------- 106 (362)
Q Consensus 78 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--------------------------------------------------- 106 (362)
....+++||||++||+|.+++.....
T Consensus 98 ---~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 174 (359)
T 3vhe_A 98 ---PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLS 174 (359)
T ss_dssp ---TTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC---------------------------------------------
T ss_pred ---CCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccc
Confidence 22336799999999999999987432
Q ss_pred -------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEeecCCcccccccccCC
Q 039291 107 -------------NGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQK 173 (362)
Q Consensus 107 -------------~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Dfgla~~~~~~~~~~ 173 (362)
..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++.........
T Consensus 175 ~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll----~~~~~~kl~Dfg~a~~~~~~~~~~ 250 (359)
T 3vhe_A 175 DVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILL----SEKNVVKICDFGLARDIYKDPDYV 250 (359)
T ss_dssp ---------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE----CGGGCEEECCCGGGSCTTSCTTCE
T ss_pred hhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEE----cCCCcEEEEeccceeeecccccch
Confidence 128999999999999999999999999999999999999 778889999999998654433333
Q ss_pred CCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHh-CCCCCccCCCCCHHHHHHHHcCCCCCCCCCccCCHHHHH
Q 039291 174 FDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLS-GRQAWVVKEDCSIDQLFSIIGDEHSLPEIPSRVSKEARD 252 (362)
Q Consensus 174 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 252 (362)
......||+.|+|||++.+..++.++|||||||++|+|++ |..||....... .....+.. ...+..+..+++++.+
T Consensus 251 ~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~--~~~~~~~~-~~~~~~~~~~~~~l~~ 327 (359)
T 3vhe_A 251 RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE--EFCRRLKE-GTRMRAPDYTTPEMYQ 327 (359)
T ss_dssp EC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH--HHHHHHHH-TCCCCCCTTCCHHHHH
T ss_pred hccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhH--HHHHHHHc-CCCCCCCCCCCHHHHH
Confidence 3345678999999999999999999999999999999998 999997654322 22222222 2233456778999999
Q ss_pred HHHHHhccCCCCCCCHHHHhcC
Q 039291 253 FLRRCFVRKPAFRFTAEMLLDD 274 (362)
Q Consensus 253 li~~~l~~~p~~R~s~~~~l~~ 274 (362)
+|.+||..||.+|||+.++++|
T Consensus 328 li~~~l~~dP~~Rps~~ell~~ 349 (359)
T 3vhe_A 328 TMLDCWHGEPSQRPTFSELVEH 349 (359)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHccCChhhCCCHHHHHHH
Confidence 9999999999999999999875
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-47 Score=346.36 Aligned_cols=258 Identities=25% Similarity=0.369 Sum_probs=210.3
Q ss_pred CCceeecceecccCceEEEEEEECCCCCCCCceeeeechhh------------hhhHHHHHHHHHHHHcCCCCccccccc
Q 039291 5 GTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEV------------SASASLQKEKEVFDNLNGCPFVLECFG 72 (362)
Q Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~------------~~~~~~~~E~~il~~l~~h~~i~~~~~ 72 (362)
.++|.+.+.||+|+||.||+|+++.+++ .+++|.... .....+.+|+.+++++.+||||+++++
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~----~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~ 91 (298)
T 1phk_A 16 YENYEPKEILGRGVSSVVRRCIHKPTCK----EYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKD 91 (298)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTE----EEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEE
T ss_pred hhccceeeeecCCCceEEEEEEEcCcCc----eEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeee
Confidence 4789999999999999999999988875 566666432 234567899999999987999999998
Q ss_pred ceeeecCCCceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCc
Q 039291 73 EEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGK 152 (362)
Q Consensus 73 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~ 152 (362)
++.. ...+++||||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+||++ +.+
T Consensus 92 ~~~~-----~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~----~~~ 160 (298)
T 1phk_A 92 TYET-----NTFFFLVFDLMKKGELFDYLTEK--VTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILL----DDD 160 (298)
T ss_dssp EEEC-----SSEEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE----CTT
T ss_pred eecc-----CCeEEEEEeccCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEE----cCC
Confidence 7642 33577999999999999999873 459999999999999999999999999999999999999 778
Q ss_pred eEEEEeecCCcccccccccCCCCCCccCCCCccCchhhc------cccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCH
Q 039291 153 FVAKIADLGVAKRSRHCKRQKFDPSMRGTPLYLAPETVV------QHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSI 226 (362)
Q Consensus 153 ~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~ 226 (362)
+.+||+|||++....... ......||+.|+|||++. ...++.++||||||+++|+|++|..||.... .
T Consensus 161 ~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~---~ 234 (298)
T 1phk_A 161 MNIKLTDFGFSCQLDPGE---KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRK---Q 234 (298)
T ss_dssp CCEEECCCTTCEECCTTC---CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS---H
T ss_pred CcEEEecccchhhcCCCc---ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCcc---H
Confidence 889999999997654322 123567999999999986 3467889999999999999999999996543 3
Q ss_pred HHHHHHHcCCC-CCC-CCCccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCccCcchh
Q 039291 227 DQLFSIIGDEH-SLP-EIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGVDEE 283 (362)
Q Consensus 227 ~~~~~~~~~~~-~~~-~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~~~~~~~ 283 (362)
......+.... ..+ .....++.++.+||.+||..||++|||+.++++||||++...+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~ 293 (298)
T 1phk_A 235 MLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYVVE 293 (298)
T ss_dssp HHHHHHHHHTCCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTTC--
T ss_pred HHHHHHHhcCCcccCcccccccCHHHHHHHHHHccCCcccCCCHHHHHhChHhhhccch
Confidence 33333332222 111 2235689999999999999999999999999999999887654
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-48 Score=367.16 Aligned_cols=257 Identities=24% Similarity=0.365 Sum_probs=203.2
Q ss_pred CCceeecceecccCceEEEEEEECCCCCCCCceeeeechhhh--hhHHHHHHHHHHHHcC-----CCCcccccccceeee
Q 039291 5 GTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVS--ASASLQKEKEVFDNLN-----GCPFVLECFGEEITM 77 (362)
Q Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~~--~~~~~~~E~~il~~l~-----~h~~i~~~~~~~~~~ 77 (362)
.++|.+++.||+|+||+||+|++..++. .||+|.+... ....+.+|+.+++.+. .|+||+++++.+..
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~----~vAvK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~- 170 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQ----HVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTF- 170 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEETTTTE----EEEEEEECSCHHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEE-
T ss_pred cCcEEEEEEcccCccEEEEEEEECCCCc----EEEEEEECCccchHHHHHHHHHHHHHHhhccccCCcCEEEEEeeccc-
Confidence 4689999999999999999999988775 6777776433 3456778999998884 36799999887643
Q ss_pred cCCCceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceE--E
Q 039291 78 GENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFV--A 155 (362)
Q Consensus 78 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~--~ 155 (362)
...+++||||+. ++|.+++.......+++..++.++.||+.||+|||++||+||||||+|||+ +.++. +
T Consensus 171 ----~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl----~~~~~~~v 241 (429)
T 3kvw_A 171 ----RNHICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILL----KQQGRSGI 241 (429)
T ss_dssp ----TTEEEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEE----SSTTSCCE
T ss_pred ----CCeEEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEE----ccCCCcce
Confidence 234789999996 599999988665669999999999999999999999999999999999999 55544 9
Q ss_pred EEeecCCcccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHHcC
Q 039291 156 KIADLGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGD 235 (362)
Q Consensus 156 kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~ 235 (362)
||+|||++..... .....+||+.|+|||++.+..++.++|||||||++|+|++|.+||.+.+..+....+.....
T Consensus 242 kL~DFG~a~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~ 316 (429)
T 3kvw_A 242 KVIDFGSSCYEHQ-----RVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLG 316 (429)
T ss_dssp EECCCTTCEETTC-----CCCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHC
T ss_pred EEeecccceecCC-----cccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcC
Confidence 9999999965432 12356799999999999999999999999999999999999999976543222111111100
Q ss_pred ------------------CCCCCC------------------------------------CCccCCHHHHHHHHHHhccC
Q 039291 236 ------------------EHSLPE------------------------------------IPSRVSKEARDFLRRCFVRK 261 (362)
Q Consensus 236 ------------------~~~~~~------------------------------------~~~~~~~~~~~li~~~l~~~ 261 (362)
....+. ++...++++.+||.+||+.|
T Consensus 317 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~d 396 (429)
T 3kvw_A 317 MPSQKLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWD 396 (429)
T ss_dssp CCCHHHHHTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSS
T ss_pred CCCHHHHHhhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCC
Confidence 000000 11234788999999999999
Q ss_pred CCCCCCHHHHhcCCCccCc
Q 039291 262 PAFRFTAEMLLDDPFVKGV 280 (362)
Q Consensus 262 p~~R~s~~~~l~~p~~~~~ 280 (362)
|++|||++++++||||+..
T Consensus 397 P~~Rpta~e~L~Hpw~~~~ 415 (429)
T 3kvw_A 397 PAVRMTPGQALRHPWLRRR 415 (429)
T ss_dssp TTTSCCHHHHHTSTTTC--
T ss_pred hhhCCCHHHHhCChhhccC
Confidence 9999999999999999864
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-48 Score=355.45 Aligned_cols=255 Identities=19% Similarity=0.303 Sum_probs=206.9
Q ss_pred CCCceeecceecccCceEEEEEEECCCCCCCCceeeeechhh----hhhHHHHHHHHHHHHcCCCCcccccccceeeecC
Q 039291 4 DGTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEV----SASASLQKEKEVFDNLNGCPFVLECFGEEITMGE 79 (362)
Q Consensus 4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~----~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~ 79 (362)
..++|.+++.||+|+||+||+|++..++..++.++++|.... .....+.+|+.++++++ ||||+++++++..
T Consensus 13 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~--- 88 (327)
T 3poz_A 13 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD-NPHVCRLLGICLT--- 88 (327)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCC-BTTBCCEEEEEES---
T ss_pred CHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCC-CCCEeEEEEEEec---
Confidence 468999999999999999999999998888888899998643 34467889999999998 9999999997753
Q ss_pred CCceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEee
Q 039291 80 NGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIAD 159 (362)
Q Consensus 80 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~D 159 (362)
. ..++|+||+.+|+|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|
T Consensus 89 -~--~~~~v~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll----~~~~~~kl~D 160 (327)
T 3poz_A 89 -S--TVQLITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLV----KTPQHVKITD 160 (327)
T ss_dssp -S--SEEEEEECCTTCBHHHHHHHS-TTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE----EETTEEEECC
T ss_pred -C--CeEEEEEecCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEE----CCCCCEEEcc
Confidence 1 156899999999999999873 3569999999999999999999999999999999999999 6667899999
Q ss_pred cCCcccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHh-CCCCCccCCCCCHHHHHHHHcCCCC
Q 039291 160 LGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLS-GRQAWVVKEDCSIDQLFSIIGDEHS 238 (362)
Q Consensus 160 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~ 238 (362)
||+++...............||+.|+|||++.+..++.++|||||||++|+|++ |..||...... ++...+.....
T Consensus 161 fg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~---~~~~~~~~~~~ 237 (327)
T 3poz_A 161 FGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS---EISSILEKGER 237 (327)
T ss_dssp TTHHHHHTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG---GHHHHHHTTCC
T ss_pred CcceeEccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHH---HHHHHHHcCCC
Confidence 999986654433333345567889999999999999999999999999999999 99999765443 33333333332
Q ss_pred CCCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhcC
Q 039291 239 LPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDD 274 (362)
Q Consensus 239 ~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~ 274 (362)
...+..++.++.+++.+||..||++||++.+++++
T Consensus 238 -~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 272 (327)
T 3poz_A 238 -LPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIE 272 (327)
T ss_dssp -CCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHH
T ss_pred -CCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 23466789999999999999999999999999875
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-48 Score=357.68 Aligned_cols=266 Identities=21% Similarity=0.346 Sum_probs=207.8
Q ss_pred CCCceeecceecccCceEEEEEEECCCCCCCCceeeeechh----hhhhHHHHHHHHHHHHcCCCCcccccccceeeecC
Q 039291 4 DGTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAE----VSASASLQKEKEVFDNLNGCPFVLECFGEEITMGE 79 (362)
Q Consensus 4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~----~~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~ 79 (362)
-.++|.+++.||+|+||+||+|+++.+++ .|++|... ......+.+|+.++++++ ||||+++++++.....
T Consensus 9 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~----~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~ 83 (353)
T 2b9h_A 9 ISSDFQLKSLLGEGAYGVVCSATHKPTGE----IVAIKKIEPFDKPLFALRTLREIKILKHFK-HENIITIFNIQRPDSF 83 (353)
T ss_dssp SCTTEEEEEEEEECSSEEEEEEEETTTTE----EEEEEEECCCSSHHHHHHHHHHHHHHHHCC-CTTBCCEEEECCCSCS
T ss_pred cccceEEeeEEcCCCCeEEEEEEECCCCc----EEEEEeecccccchHHHHHHHHHHHHHhCc-CCCcCCeeeeeccccc
Confidence 46899999999999999999999988775 56666543 234456789999999998 9999999987654333
Q ss_pred CCceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEee
Q 039291 80 NGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIAD 159 (362)
Q Consensus 80 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~D 159 (362)
.....+++||||+. ++|.+++.. ..+++..++.++.|++.||.|||++||+||||||+|||+ +.++.+||+|
T Consensus 84 ~~~~~~~lv~e~~~-~~L~~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~----~~~~~~kl~D 155 (353)
T 2b9h_A 84 ENFNEVYIIQELMQ-TDLHRVIST---QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLI----NSNCDLKVCD 155 (353)
T ss_dssp TTCCCEEEEECCCS-EEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE----CTTCCEEECC
T ss_pred CccceEEEEEeccC-ccHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEE----cCCCcEEEEe
Confidence 33456789999997 599999876 359999999999999999999999999999999999999 7788899999
Q ss_pred cCCcccccccccCC--------CCCCccCCCCccCchhhcc-ccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHH
Q 039291 160 LGVAKRSRHCKRQK--------FDPSMRGTPLYLAPETVVQ-HMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLF 230 (362)
Q Consensus 160 fgla~~~~~~~~~~--------~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~ 230 (362)
||++.......... ......||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+.......+
T Consensus 156 fg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~ 235 (353)
T 2b9h_A 156 FGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLI 235 (353)
T ss_dssp CTTCEECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH
T ss_pred cccccccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHH
Confidence 99998654322111 1224578999999998865 67899999999999999999999999765422111111
Q ss_pred HH-HcCC---------------------CCCC-----CCCccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCccCcch
Q 039291 231 SI-IGDE---------------------HSLP-----EIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGVDE 282 (362)
Q Consensus 231 ~~-~~~~---------------------~~~~-----~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~~~~~~ 282 (362)
.. .... ...+ ..+..+++++.+||.+||..||++|||+.++++||||+...+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~ 314 (353)
T 2b9h_A 236 FGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYHD 314 (353)
T ss_dssp HHHHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCC
T ss_pred HHHhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccccccCC
Confidence 11 1110 0000 112468899999999999999999999999999999987654
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-49 Score=378.90 Aligned_cols=256 Identities=27% Similarity=0.396 Sum_probs=210.4
Q ss_pred CceeecceecccCceEEEEEEECCCCCCCCceeeeechh------hhhhHHHHHHHHHHHHcCCCCcccccccceeeecC
Q 039291 6 TSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAE------VSASASLQKEKEVFDNLNGCPFVLECFGEEITMGE 79 (362)
Q Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~------~~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~ 79 (362)
++|.+.+.||+|+||+||+|+++.+++ .+++|... ......+.+|+.++++++ ||||+++++++..
T Consensus 26 ~~y~~~~~lg~G~~g~V~~~~~~~~~~----~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~--- 97 (484)
T 3nyv_A 26 DRYKGQRVLGKGSFGEVILCKDKITGQ----ECAVKVISKRQVKQKTDKESLLREVQLLKQLD-HPNIMKLYEFFED--- 97 (484)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCC----EEEEEEEETTTCCBSSCHHHHHHHHHHHTTCC-CTTBCCEEEEEEC---
T ss_pred CceEEeeEEecCCCEEEEEEEECCCCC----EEEEEEEEhhhcccchHHHHHHHHHHHHHhCC-CCCCCcEEEEEEe---
Confidence 589999999999999999999998876 45666542 234567889999999998 9999999987642
Q ss_pred CCceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEee
Q 039291 80 NGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIAD 159 (362)
Q Consensus 80 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~D 159 (362)
...+++||||+.|++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||+... +..+.+||+|
T Consensus 98 --~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~-~~~~~~kl~D 172 (484)
T 3nyv_A 98 --KGYFYLVGEVYTGGELFDEIIS--RKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESK-SKDANIRIID 172 (484)
T ss_dssp --SSEEEEEECCCCSCBHHHHHHT--CSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSS-STTCCEEECC
T ss_pred --CCEEEEEEecCCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecC-CCCCcEEEEe
Confidence 3357899999999999999976 4569999999999999999999999999999999999999432 3457799999
Q ss_pred cCCcccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHHcCCCCC
Q 039291 160 LGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEHSL 239 (362)
Q Consensus 160 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 239 (362)
||+++...... .....+||+.|+|||++.+ .++.++|||||||++|+|++|.+||.+. +..+....+......
T Consensus 173 fg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~---~~~~~~~~i~~~~~~ 245 (484)
T 3nyv_A 173 FGLSTHFEASK---KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGA---NEYDILKKVEKGKYT 245 (484)
T ss_dssp TTHHHHBCCCC---SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCS---SHHHHHHHHHHCCCC
T ss_pred eeeeEEccccc---ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCC---CHHHHHHHHHcCCCC
Confidence 99997654322 1134579999999999876 6899999999999999999999999654 344444444433322
Q ss_pred CC--CCccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCccCcc
Q 039291 240 PE--IPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGVD 281 (362)
Q Consensus 240 ~~--~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~~~~~ 281 (362)
.. .+..+++++++||.+||..||.+|||+.++++||||+...
T Consensus 246 ~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h~~~~~~~ 289 (484)
T 3nyv_A 246 FELPQWKKVSESAKDLIRKMLTYVPSMRISARDALDHEWIQTYT 289 (484)
T ss_dssp CCSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHHHT
T ss_pred CCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhhChhhcccc
Confidence 22 2356899999999999999999999999999999997653
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-48 Score=346.37 Aligned_cols=252 Identities=25% Similarity=0.410 Sum_probs=210.9
Q ss_pred CCCceeecceecccCceEEEEEEECCCCCCCCceeeeechhhh------hhHHHHHHHHHHHHcCCCCcccccccceeee
Q 039291 4 DGTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVS------ASASLQKEKEVFDNLNGCPFVLECFGEEITM 77 (362)
Q Consensus 4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~~------~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~ 77 (362)
.-++|.+++.||+|+||.||+|++..++. .+++|..... ....+.+|+.+++.++ ||||+++++++..
T Consensus 12 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~----~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~- 85 (284)
T 2vgo_A 12 TIDDFDIGRPLGKGKFGNVYLAREKQNKF----IMALKVLFKSQLEKEGVEHQLRREIEIQSHLR-HPNILRMYNYFHD- 85 (284)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTE----EEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCC-CTTBCCEEEEEEC-
T ss_pred hhhhceeeheecCCCCeEEEEEEEcCCCc----EEEEEEEcccccchHHHHHHHHHHHHHHhcCC-CCCEeeEEEEEEc-
Confidence 45789999999999999999999988765 5666665322 3456889999999998 9999999987642
Q ss_pred cCCCceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEE
Q 039291 78 GENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKI 157 (362)
Q Consensus 78 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl 157 (362)
...+++||||+++++|.+++... ..+++..++.++.|++.||.|||++||+||||||+||++ +.++.++|
T Consensus 86 ----~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~----~~~~~~kl 155 (284)
T 2vgo_A 86 ----RKRIYLMLEFAPRGELYKELQKH--GRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLM----GYKGELKI 155 (284)
T ss_dssp ----SSEEEEEECCCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEE----CTTCCEEE
T ss_pred ----CCEEEEEEEeCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEE----cCCCCEEE
Confidence 23577999999999999999874 359999999999999999999999999999999999999 77788999
Q ss_pred eecCCcccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHHcCCC
Q 039291 158 ADLGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEH 237 (362)
Q Consensus 158 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 237 (362)
+|||++....... .....||+.|+|||++.+..++.++||||||+++|+|++|..||.... .......+....
T Consensus 156 ~Dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~---~~~~~~~~~~~~ 228 (284)
T 2vgo_A 156 ADFGWSVHAPSLR----RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPS---HTETHRRIVNVD 228 (284)
T ss_dssp CCCTTCEECSSSC----BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSS---HHHHHHHHHTTC
T ss_pred ecccccccCcccc----cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCC---HhHHHHHHhccc
Confidence 9999986554321 134679999999999999899999999999999999999999996543 333333333222
Q ss_pred CCCCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCccCc
Q 039291 238 SLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGV 280 (362)
Q Consensus 238 ~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~~~~ 280 (362)
..++..++.+++++|.+||..||.+||++.++++||||+..
T Consensus 229 --~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h~~~~~~ 269 (284)
T 2vgo_A 229 --LKFPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKAN 269 (284)
T ss_dssp --CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTCHHHHHH
T ss_pred --cCCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhCHHHHhh
Confidence 24567789999999999999999999999999999999743
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-48 Score=349.89 Aligned_cols=259 Identities=22% Similarity=0.368 Sum_probs=211.4
Q ss_pred CCceeecceecccCceEEEEEEECCCCCCCCceeeeechhh-------hhhHHHHHHHHHHHHcCCCCcccccccceeee
Q 039291 5 GTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEV-------SASASLQKEKEVFDNLNGCPFVLECFGEEITM 77 (362)
Q Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~-------~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~ 77 (362)
.++|.+++.||+|+||.||+|.+..++. .+++|.... .....+.+|+.+++.++ ||||+++++++..
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~----~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~- 77 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLC----RRAVKILKKKKLRRIPNGEANVKKEIQLLRRLR-HKNVIQLVDVLYN- 77 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCC----EEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCC-CTTBCCEEEEEEC-
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCc----EEEEEEeccccccccchhHHHHHHHHHHHHhcC-CCCeeEEEEEEEc-
Confidence 4789999999999999999999988775 566666532 23467889999999998 9999999987642
Q ss_pred cCCCceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEE
Q 039291 78 GENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKI 157 (362)
Q Consensus 78 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl 157 (362)
.....+++||||+.++ |.+++.......+++..++.++.||+.||.|||++||+||||||+||++ +.++.+||
T Consensus 78 --~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~----~~~~~~kl 150 (305)
T 2wtk_C 78 --EEKQKMYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLL----TTGGTLKI 150 (305)
T ss_dssp --C---CEEEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE----CTTCCEEE
T ss_pred --CCCCeEEEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEE----cCCCcEEe
Confidence 2234577999999875 8888887666779999999999999999999999999999999999999 77888999
Q ss_pred eecCCcccccccccCCCCCCccCCCCccCchhhcccc--CCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHHcC
Q 039291 158 ADLGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHM--QEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGD 235 (362)
Q Consensus 158 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~ 235 (362)
+|||++................||+.|+|||++.+.. ++.++||||||+++|+|++|..||... +..+....+..
T Consensus 151 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~---~~~~~~~~i~~ 227 (305)
T 2wtk_C 151 SALGVAEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGD---NIYKLFENIGK 227 (305)
T ss_dssp CCCTTCEECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCS---SHHHHHHHHHH
T ss_pred eccccccccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCc---hHHHHHHHHhc
Confidence 9999997655433333334567999999999998643 477999999999999999999999644 44455444433
Q ss_pred CCCCCCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCccCcc
Q 039291 236 EHSLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGVD 281 (362)
Q Consensus 236 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~~~~~ 281 (362)
.. ..++..++.++.+||.+||..||.+|||+.++++||||+...
T Consensus 228 ~~--~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~ 271 (305)
T 2wtk_C 228 GS--YAIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKH 271 (305)
T ss_dssp CC--CCCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSHHHHSCC
T ss_pred CC--CCCCCccCHHHHHHHHHHccCChhhCCCHHHHhcCcccccCC
Confidence 32 245667899999999999999999999999999999997643
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-48 Score=351.33 Aligned_cols=252 Identities=23% Similarity=0.375 Sum_probs=199.4
Q ss_pred CCCCCCceeecceecccCceEEEEEEECCCCCCCCceeeeechh-----hhhhHHHHHHHHHHHHcCCCCccccccccee
Q 039291 1 MDSDGTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAE-----VSASASLQKEKEVFDNLNGCPFVLECFGEEI 75 (362)
Q Consensus 1 ~~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~-----~~~~~~~~~E~~il~~l~~h~~i~~~~~~~~ 75 (362)
+++..++|.+++.||+|+||+||+|++.+. .+++|... ....+.+.+|+.++++++ ||||+++++.+.
T Consensus 32 ~~i~~~~y~i~~~lG~G~~g~V~~~~~~~~------~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~ 104 (309)
T 3p86_A 32 MDIPWCDLNIKEKIGAGSFGTVHRAEWHGS------DVAVKILMEQDFHAERVNEFLREVAIMKRLR-HPNIVLFMGAVT 104 (309)
T ss_dssp CBCCGGGEEEEEEEEECSSEEEEEEEETTE------EEEEEEECCCCCSHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEC
T ss_pred ccCChhHceeeeEeecCCCeEEEEEEECCC------cEEEEEecCCCCCHHHHHHHHHHHHHHHhCC-CCCEeeEEEEEE
Confidence 356778999999999999999999987532 46666643 234456889999999998 999999998764
Q ss_pred eecCCCceEEEEEEEecCCCCHHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCC--ceeCCCCCCCEEEeecCCCc
Q 039291 76 TMGENGEMAYNLLLEYAAGGTLGDLIEKCNG-NGLPEKDVRHFTRCILEGIGHIHDSG--YVHCDVKPDNILLVATQSGK 152 (362)
Q Consensus 76 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~l~~~~~~~i~~ql~~~l~yLH~~~--ivH~Dlkp~Nill~~~~~~~ 152 (362)
. ...+++||||+++++|.+++..... ..+++..++.++.|++.||+|||++| |+||||||+|||+ +.+
T Consensus 105 ~-----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll----~~~ 175 (309)
T 3p86_A 105 Q-----PPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLV----DKK 175 (309)
T ss_dssp S-----TTCCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEE----CTT
T ss_pred E-----CCceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEE----eCC
Confidence 2 2236799999999999999976321 23999999999999999999999999 9999999999999 788
Q ss_pred eEEEEeecCCcccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHH
Q 039291 153 FVAKIADLGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSI 232 (362)
Q Consensus 153 ~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~ 232 (362)
+.+||+|||+++...... .......||+.|+|||++.+..++.++|||||||++|+|++|..||... ...+....
T Consensus 176 ~~~kL~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~---~~~~~~~~ 250 (309)
T 3p86_A 176 YTVKVCDFGLSRLKASTF--LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNL---NPAQVVAA 250 (309)
T ss_dssp CCEEECCCC-------------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTS---CHHHHHHH
T ss_pred CcEEECCCCCCccccccc--cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC---CHHHHHHH
Confidence 899999999997544321 1223567999999999999999999999999999999999999999544 44455444
Q ss_pred HcCCCCCCCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhc
Q 039291 233 IGDEHSLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLD 273 (362)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~ 273 (362)
+........++..+++++.+||.+||..||.+|||+.++++
T Consensus 251 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~ 291 (309)
T 3p86_A 251 VGFKCKRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMD 291 (309)
T ss_dssp HHHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHhcCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 44344445677889999999999999999999999999986
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-49 Score=367.91 Aligned_cols=265 Identities=13% Similarity=0.090 Sum_probs=192.4
Q ss_pred CceeecceecccCceEEEEEEECCCCCCCCceeeeechhh------hhhHHHHHHHHHHHHcC-CCCccccccccee---
Q 039291 6 TSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEV------SASASLQKEKEVFDNLN-GCPFVLECFGEEI--- 75 (362)
Q Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~------~~~~~~~~E~~il~~l~-~h~~i~~~~~~~~--- 75 (362)
.+|.+++.||+|+||+||+|+++.+++ .+|+|.+.. .....+.+|+.+++.|. .||||++++..+.
T Consensus 62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~----~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~ 137 (371)
T 3q60_A 62 RKLKLVEPLRVGDRSVVFLVRDVERLE----DFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPS 137 (371)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTTE----EEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCC
T ss_pred eeeeeeeeccCCCCEEEEEEEECCCCc----eeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeee
Confidence 459999999999999999999988875 556665433 34456778866665554 4999887553332
Q ss_pred ----eecC--------C----CceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHH------HHHHHHHHHHHHHHHhCCc
Q 039291 76 ----TMGE--------N----GEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDV------RHFTRCILEGIGHIHDSGY 133 (362)
Q Consensus 76 ----~~~~--------~----~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~------~~i~~ql~~~l~yLH~~~i 133 (362)
..+. + ....+|+||||++ ++|.+++..... .+.+..+ ..++.||+.||+|||++||
T Consensus 138 d~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~-~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~i 215 (371)
T 3q60_A 138 DAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDF-VYVFRGDEGILALHILTAQLIRLAANLQSKGL 215 (371)
T ss_dssp EEEEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHH-SCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred hheecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhcc-ccchhhhhhhhhHHHHHHHHHHHHHHHHHCCC
Confidence 1110 0 0145789999998 799999987432 3555555 6777999999999999999
Q ss_pred eeCCCCCCCEEEeecCCCceEEEEeecCCcccccccccCCCCCCccCCCCccCchhhcc--ccCCCcchHHHHHHHHHHH
Q 039291 134 VHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQ--HMQEAPSDIWALGCVVLEM 211 (362)
Q Consensus 134 vH~Dlkp~Nill~~~~~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~~l 211 (362)
+||||||+|||+ +.++.+||+|||+++...... ....+|+.|+|||++.+ ..++.++|||||||++|+|
T Consensus 216 vHrDikp~NIll----~~~~~~kL~DFG~a~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~el 286 (371)
T 3q60_A 216 VHGHFTPDNLFI----MPDGRLMLGDVSALWKVGTRG-----PASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRV 286 (371)
T ss_dssp EETTCSGGGEEE----CTTSCEEECCGGGEEETTCEE-----EGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHH
T ss_pred ccCcCCHHHEEE----CCCCCEEEEecceeeecCCCc-----cCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHH
Confidence 999999999999 778889999999998654321 13457799999999987 6899999999999999999
Q ss_pred HhCCCCCccCCCCCHHHHH----HHHcCCCCCCCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCccCcchhhh
Q 039291 212 LSGRQAWVVKEDCSIDQLF----SIIGDEHSLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGVDEELS 285 (362)
Q Consensus 212 ~~g~~pf~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~~~~~~~~~ 285 (362)
++|+.||............ ............+..+++++.+||.+||..||++|||+.++++||||+++.+...
T Consensus 287 ltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~~~ 364 (371)
T 3q60_A 287 WCLFLPFGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQLQNEIS 364 (371)
T ss_dssp HHSSCSTTBCCTTCTTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHHHHHHHHHHH
T ss_pred HhCCCCCCCcCcccccchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHHHHHHHHHHh
Confidence 9999999765322111000 0000011111223478999999999999999999999999999999998877654
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-48 Score=347.18 Aligned_cols=253 Identities=25% Similarity=0.336 Sum_probs=202.9
Q ss_pred CceeecceecccCceEEEEEEECCCCCCCCceeeeechh-----hhhhHHHHHHHHHHHHcCCCCcccccccceeeecCC
Q 039291 6 TSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAE-----VSASASLQKEKEVFDNLNGCPFVLECFGEEITMGEN 80 (362)
Q Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~-----~~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~ 80 (362)
++|.+++.||+|+||+||+|+++.++. .+++|... ......+.+|+.++..+.+||||+++++++..
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~----~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~---- 82 (289)
T 1x8b_A 11 TEFHELEKIGSGEFGSVFKCVKRLDGC----IYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAE---- 82 (289)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCC----EEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEE----
T ss_pred chhhhhhhhcCCCceEEEEEEEcCCCc----eEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeec----
Confidence 689999999999999999999988775 45666543 23456688999999999669999999997643
Q ss_pred CceEEEEEEEecCCCCHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecC---------
Q 039291 81 GEMAYNLLLEYAAGGTLGDLIEKCN--GNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQ--------- 149 (362)
Q Consensus 81 ~~~~~~lv~e~~~~~~L~~~l~~~~--~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~--------- 149 (362)
...+++||||++|++|.+++.... ...+++..++.++.||+.||.|||++||+||||||+|||+..+.
T Consensus 83 -~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~ 161 (289)
T 1x8b_A 83 -DDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEG 161 (289)
T ss_dssp -TTEEEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC------------
T ss_pred -CCeEEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCccccccc
Confidence 224779999999999999998642 25699999999999999999999999999999999999994322
Q ss_pred ------CCceEEEEeecCCcccccccccCCCCCCccCCCCccCchhhccc-cCCCcchHHHHHHHHHHHHhCCCCCccCC
Q 039291 150 ------SGKFVAKIADLGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQH-MQEAPSDIWALGCVVLEMLSGRQAWVVKE 222 (362)
Q Consensus 150 ------~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~ 222 (362)
.....+||+|||++...... ....||+.|+|||++.+. .++.++|||||||++|+|++|.+++....
T Consensus 162 ~~~~~~~~~~~~kl~Dfg~~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~ 235 (289)
T 1x8b_A 162 DEDDWASNKVMFKIGDLGHVTRISSP------QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGD 235 (289)
T ss_dssp --------CCCEEECCCTTCEETTCS------CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSH
T ss_pred ccccccCCceEEEEcccccccccCCc------cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchh
Confidence 14457999999998765432 234599999999999875 56679999999999999999998763321
Q ss_pred CCCHHHHHHHHcCCCCCCCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCccCc
Q 039291 223 DCSIDQLFSIIGDEHSLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGV 280 (362)
Q Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~~~~ 280 (362)
....+. ....+.++..++.++.+||.+||..||++|||+.++++||||+..
T Consensus 236 ------~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 286 (289)
T 1x8b_A 236 ------QWHEIR-QGRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSA 286 (289)
T ss_dssp ------HHHHHH-TTCCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTTC---
T ss_pred ------HHHHHH-cCCCCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhChHhhhh
Confidence 112222 233456777899999999999999999999999999999999764
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-48 Score=347.09 Aligned_cols=260 Identities=23% Similarity=0.379 Sum_probs=193.9
Q ss_pred CCCCCCceeecceecccCceEEEEEEECCCCCCCCceeeeechhh----hhhHHHHHHHHH-HHHcCCCCccccccccee
Q 039291 1 MDSDGTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEV----SASASLQKEKEV-FDNLNGCPFVLECFGEEI 75 (362)
Q Consensus 1 ~~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~----~~~~~~~~E~~i-l~~l~~h~~i~~~~~~~~ 75 (362)
+++..++|.+++.||+|+||+||+|++..+++ .+++|.... ........|... ++.++ ||||+++++.+.
T Consensus 2 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~----~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~-h~~iv~~~~~~~ 76 (290)
T 3fme_A 2 MEVKADDLEPIMELGRGAYGVVEKMRHVPSGQ----IMAVKRIRATVNSQEQKRLLMDLDISMRTVD-CPFTVTFYGALF 76 (290)
T ss_dssp CCCCGGGEEEEEEEEECSSEEEEEEEETTTTE----EEEEEEEC---CHHHHHHHHHHHHHHHTTCC-CTTBCCEEEEEE
T ss_pred CcccHHhhhhHHhcCCCCCeEEEEEEecCCCe----EEEEEEeecccCcHHHHHHHHHHHHHHHhCC-CCeEEEEeeeee
Confidence 46778999999999999999999999988775 566665532 222333444444 55555 999999999765
Q ss_pred eecCCCceEEEEEEEecCCCCHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhC-CceeCCCCCCCEEEeecCCCc
Q 039291 76 TMGENGEMAYNLLLEYAAGGTLGDLIEKC--NGNGLPEKDVRHFTRCILEGIGHIHDS-GYVHCDVKPDNILLVATQSGK 152 (362)
Q Consensus 76 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~l~~~~~~~i~~ql~~~l~yLH~~-~ivH~Dlkp~Nill~~~~~~~ 152 (362)
. ...+++||||++| +|.+++... .+..+++..++.++.||+.||.|||++ ||+||||||+||++ +.+
T Consensus 77 ~-----~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~----~~~ 146 (290)
T 3fme_A 77 R-----EGDVWICMELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLI----NAL 146 (290)
T ss_dssp C-----SSSEEEEEECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEE----CTT
T ss_pred c-----cCCEEEEEehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEE----CCC
Confidence 3 2236799999975 888877652 345699999999999999999999998 99999999999999 777
Q ss_pred eEEEEeecCCcccccccccCCCCCCccCCCCccCchhh----ccccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHH
Q 039291 153 FVAKIADLGVAKRSRHCKRQKFDPSMRGTPLYLAPETV----VQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQ 228 (362)
Q Consensus 153 ~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~ 228 (362)
+.+||+|||++........ .....||+.|+|||++ .+..++.++|||||||++|+|++|..||..... ....
T Consensus 147 ~~~kl~Dfg~~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-~~~~ 222 (290)
T 3fme_A 147 GQVKMCDFGISGYLVDDVA---KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGT-PFQQ 222 (290)
T ss_dssp CCEEBCCC------------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSC-HHHH
T ss_pred CCEEEeecCCccccccccc---ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCc-hHHH
Confidence 8899999999976544222 1345799999999996 456788999999999999999999999964322 2223
Q ss_pred HHHHHcCCCCCCCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCccCc
Q 039291 229 LFSIIGDEHSLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGV 280 (362)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~~~~ 280 (362)
+...+. .......+..++.++.+||.+||..||++|||+.++++||||+..
T Consensus 223 ~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~~ 273 (290)
T 3fme_A 223 LKQVVE-EPSPQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTLH 273 (290)
T ss_dssp HHHHHH-SCCCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHH
T ss_pred HHHHhc-cCCCCcccccCCHHHHHHHHHHhhcChhhCcCHHHHHhCcccccC
Confidence 333332 222223345689999999999999999999999999999999753
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-48 Score=363.20 Aligned_cols=263 Identities=24% Similarity=0.354 Sum_probs=205.3
Q ss_pred CCceeecceecccCceEEEEEEECCCCCCCCceeeeechhh--hhhHHHHHHHHHHHHcCC-------CCccccccccee
Q 039291 5 GTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEV--SASASLQKEKEVFDNLNG-------CPFVLECFGEEI 75 (362)
Q Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~--~~~~~~~~E~~il~~l~~-------h~~i~~~~~~~~ 75 (362)
.++|.+++.||+|+||+||+|++..+++ .||+|.... .....+.+|+.+++.+.+ |+||+++++.+.
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~----~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~ 111 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKK----FVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFK 111 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTE----EEEEEEECSCHHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEE
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCe----EEEEEEEecCCcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeeccee
Confidence 4789999999999999999999988775 567776543 234668899999999863 788999999776
Q ss_pred eecCCCceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC-CceeCCCCCCCEEEeecC-----
Q 039291 76 TMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDS-GYVHCDVKPDNILLVATQ----- 149 (362)
Q Consensus 76 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~-~ivH~Dlkp~Nill~~~~----- 149 (362)
..+. ....+++||||+ +++|.+++.......+++..++.++.||+.||.|||++ ||+||||||+|||+..++
T Consensus 112 ~~~~-~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~~~~~~ 189 (397)
T 1wak_A 112 ISGV-NGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRR 189 (397)
T ss_dssp EEET-TEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCHHHHHH
T ss_pred ecCC-CCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccchhhhh
Confidence 4432 345678999999 56777777665556799999999999999999999998 999999999999994221
Q ss_pred ----------------------------------------CCceEEEEeecCCcccccccccCCCCCCccCCCCccCchh
Q 039291 150 ----------------------------------------SGKFVAKIADLGVAKRSRHCKRQKFDPSMRGTPLYLAPET 189 (362)
Q Consensus 150 ----------------------------------------~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~ 189 (362)
.....+||+|||++...... .....||+.|+|||+
T Consensus 190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~-----~~~~~gt~~y~aPE~ 264 (397)
T 1wak_A 190 LAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-----FTEDIQTRQYRSLEV 264 (397)
T ss_dssp HHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC-----SCSCCSCGGGCCHHH
T ss_pred hhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc-----CccCCCCCcccCChh
Confidence 01137999999999765432 234579999999999
Q ss_pred hccccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCH----HH---HHHHHcCCC------------------CC-----
Q 039291 190 VVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSI----DQ---LFSIIGDEH------------------SL----- 239 (362)
Q Consensus 190 ~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~----~~---~~~~~~~~~------------------~~----- 239 (362)
+.+..++.++|||||||++|+|++|+.||........ .. +........ ..
T Consensus 265 ~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 344 (397)
T 1wak_A 265 LIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITK 344 (397)
T ss_dssp HHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCC
T ss_pred hcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccc
Confidence 9999999999999999999999999999976543221 11 111111100 00
Q ss_pred -------------CCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCcc
Q 039291 240 -------------PEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVK 278 (362)
Q Consensus 240 -------------~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~~ 278 (362)
...+...+.++++||.+||..||++|||++++++||||+
T Consensus 345 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~ 396 (397)
T 1wak_A 345 LKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWLN 396 (397)
T ss_dssp CCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGGGG
T ss_pred cCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCcccc
Confidence 012334567889999999999999999999999999996
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-47 Score=354.59 Aligned_cols=251 Identities=28% Similarity=0.427 Sum_probs=205.6
Q ss_pred CceeecceecccCceEEEEEEECCCCCCCCceeeeechh------hhhhHHHHHHHHHHHHcCCCCcccccccceeeecC
Q 039291 6 TSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAE------VSASASLQKEKEVFDNLNGCPFVLECFGEEITMGE 79 (362)
Q Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~------~~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~ 79 (362)
++|.+.+.||+|+||+||+|++..++. .|++|... ......+.+|+.++++++ ||||+++++++..
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~----~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~--- 125 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSE----VVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR-HPNTIQYRGCYLR--- 125 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTE----EEEEEEEESCSSCHHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEEE---
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCe----EEEEEEEccccccchHHHHHHHHHHHHHHhCC-CCCEeeEEEEEEE---
Confidence 569999999999999999999988775 56666543 223456889999999998 9999999997653
Q ss_pred CCceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEee
Q 039291 80 NGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIAD 159 (362)
Q Consensus 80 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~D 159 (362)
...+++||||+. |+|.+++... ..++++..++.++.|++.||.|||++||+||||||+|||+ +.++.+||+|
T Consensus 126 --~~~~~lv~e~~~-g~l~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll----~~~~~~kL~D 197 (348)
T 1u5q_A 126 --EHTAWLVMEYCL-GSASDLLEVH-KKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILL----SEPGLVKLGD 197 (348)
T ss_dssp --TTEEEEEEECCS-EEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEE----ETTTEEEECC
T ss_pred --CCeEEEEEecCC-CCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEE----CCCCCEEEee
Confidence 234679999997 5888888653 4569999999999999999999999999999999999999 6778899999
Q ss_pred cCCcccccccccCCCCCCccCCCCccCchhhc---cccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHHcCC
Q 039291 160 LGVAKRSRHCKRQKFDPSMRGTPLYLAPETVV---QHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDE 236 (362)
Q Consensus 160 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 236 (362)
||++...... ....||+.|+|||++. +..++.++|||||||++|+|++|..||.... .......+...
T Consensus 198 fG~a~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~---~~~~~~~~~~~ 268 (348)
T 1u5q_A 198 FGSASIMAPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN---AMSALYHIAQN 268 (348)
T ss_dssp CTTCBSSSSB------CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC---HHHHHHHHHHS
T ss_pred ccCceecCCC------CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC---hHHHHHHHHhc
Confidence 9999755421 3467999999999985 4678999999999999999999999996543 23333333223
Q ss_pred CCCCCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCccCcc
Q 039291 237 HSLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGVD 281 (362)
Q Consensus 237 ~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~~~~~ 281 (362)
......+..++..+++||.+||..||++|||++++++||||....
T Consensus 269 ~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~~~~~~~ 313 (348)
T 1u5q_A 269 ESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRER 313 (348)
T ss_dssp CCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHSCC
T ss_pred CCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHhhChhhhccC
Confidence 333334567899999999999999999999999999999996643
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-48 Score=354.82 Aligned_cols=260 Identities=27% Similarity=0.445 Sum_probs=204.7
Q ss_pred CceeecceecccCceEEEEEEECCCCCCCCceeeeechhhh-----------hhHHHHHHHHHHHHcCCCCcccccccce
Q 039291 6 TSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVS-----------ASASLQKEKEVFDNLNGCPFVLECFGEE 74 (362)
Q Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~~-----------~~~~~~~E~~il~~l~~h~~i~~~~~~~ 74 (362)
++|.+++.||+|+||.||+|+++.++. .|++|..... ....+.+|+.++++++ ||||+++++++
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~----~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~ 84 (322)
T 2ycf_A 10 DEYIMSKTLGSGACGEVKLAFERKTCK----KVAIKIISKRKFAIGSAREADPALNVETEIEILKKLN-HPCIIKIKNFF 84 (322)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTE----EEEEEEECC---------------CHHHHHHHHHHCC-CTTBCCEEEEE
T ss_pred hceeEeeEEecCCCEEEEEEEEcCCCc----EEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCC-CCCCceEeeEE
Confidence 689999999999999999999988775 5666654321 2245789999999998 99999999865
Q ss_pred eeecCCCceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceE
Q 039291 75 ITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFV 154 (362)
Q Consensus 75 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~ 154 (362)
.. .. +++||||+++++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||+..+ +....
T Consensus 85 ~~----~~--~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~-~~~~~ 155 (322)
T 2ycf_A 85 DA----ED--YYIVLELMEGGELFDKVVG--NKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQ-EEDCL 155 (322)
T ss_dssp ES----SS--EEEEEECCTTEETHHHHST--TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSS-SSSCC
T ss_pred cC----Cc--eEEEEecCCCCcHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecC-CCCCe
Confidence 32 11 6799999999999999875 4569999999999999999999999999999999999999432 12345
Q ss_pred EEEeecCCcccccccccCCCCCCccCCCCccCchhhc---cccCCCcchHHHHHHHHHHHHhCCCCCccCCCC-CHHHHH
Q 039291 155 AKIADLGVAKRSRHCKRQKFDPSMRGTPLYLAPETVV---QHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDC-SIDQLF 230 (362)
Q Consensus 155 ~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~-~~~~~~ 230 (362)
+||+|||++........ .....||+.|+|||++. ...++.++|||||||++|+|++|..||...... ......
T Consensus 156 ~kl~Dfg~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~ 232 (322)
T 2ycf_A 156 IKITDFGHSKILGETSL---MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQI 232 (322)
T ss_dssp EEECCCTTCEECCCCHH---HHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHH
T ss_pred EEEccCccceecccccc---cccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHH
Confidence 99999999976543211 12456999999999975 456889999999999999999999999754332 222222
Q ss_pred HHHcCCCCCCCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCccCcchh
Q 039291 231 SIIGDEHSLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGVDEE 283 (362)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~~~~~~~ 283 (362)
.. ......+..+..++.++.+||.+||..||++||++.++++||||+.....
T Consensus 233 ~~-~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h~~~~~~~~~ 284 (322)
T 2ycf_A 233 TS-GKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDEDMK 284 (322)
T ss_dssp HH-TCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGCCHHHH
T ss_pred Hh-CccccCchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhhCcCcCCHHHH
Confidence 21 11122223335689999999999999999999999999999999886543
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-49 Score=367.44 Aligned_cols=256 Identities=16% Similarity=0.120 Sum_probs=197.1
Q ss_pred CCCceeecceecccCceEEEEEEECCCCCCCCceeeeechh------hhhhHHHHHHHHHHHHcC--CCCccccccccee
Q 039291 4 DGTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAE------VSASASLQKEKEVFDNLN--GCPFVLECFGEEI 75 (362)
Q Consensus 4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~------~~~~~~~~~E~~il~~l~--~h~~i~~~~~~~~ 75 (362)
..++|.+++.||+|+||+||+|+++.+++ .||+|.+. ....+.+.+|+.+++.+. .||||+++++.+.
T Consensus 71 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~----~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~ 146 (377)
T 3byv_A 71 RPRTLVRGTVLGQEDPYAYLEATDQETGE----SFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFI 146 (377)
T ss_dssp CCEEEEEEEEEEEETTEEEEEEEC-CCCC----EEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBC
T ss_pred CCceEEEcceeecCCCEEEEEEEECCCCc----EEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhh
Confidence 46889999999999999999999987775 55666543 234567889996665554 4999999985332
Q ss_pred e-------ec---------CCCce---EEEEEEEecCCCCHHHHHHHhcCCCCCH-------HHHHHHHHHHHHHHHHHH
Q 039291 76 T-------MG---------ENGEM---AYNLLLEYAAGGTLGDLIEKCNGNGLPE-------KDVRHFTRCILEGIGHIH 129 (362)
Q Consensus 76 ~-------~~---------~~~~~---~~~lv~e~~~~~~L~~~l~~~~~~~l~~-------~~~~~i~~ql~~~l~yLH 129 (362)
. .. .+... ..|+||||+ +|+|.+++..... +++ ..++.++.||+.||+|||
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~--~~~~~~~l~~~~~~~i~~qi~~aL~~LH 223 (377)
T 3byv_A 147 FPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLS--HSSTHKSLVHHARLQLTLQVIRLLASLH 223 (377)
T ss_dssp CCSEEEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHH--TTTTTHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred hhhhhhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccc--cccccccccHHHHHHHHHHHHHHHHHHH
Confidence 1 10 00110 267999999 5799999987432 444 888889999999999999
Q ss_pred hCCceeCCCCCCCEEEeecCCCceEEEEeecCCcccccccccCCCCCCccCCCCccCchhhccc-----------cCCCc
Q 039291 130 DSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQH-----------MQEAP 198 (362)
Q Consensus 130 ~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~ 198 (362)
++||+||||||+|||+ +.++.+||+|||+++..... .....| +.|+|||++.+. .++.+
T Consensus 224 ~~~ivHrDikp~NIll----~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~ 293 (377)
T 3byv_A 224 HYGLVHTYLRPVDIVL----DQRGGVFLTGFEHLVRDGAR-----VVSSVS-RGFEPPELEARRATISYHRDRRTLMTFS 293 (377)
T ss_dssp HTTEECSCCCGGGEEE----CTTCCEEECCGGGCEETTCE-----EECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHH
T ss_pred hCCeecCCCCHHHEEE----cCCCCEEEEechhheecCCc-----ccCCCC-cCccChhhhcccccccccccccccCChh
Confidence 9999999999999999 77789999999999754321 134567 999999999987 89999
Q ss_pred chHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHHcCCCCCCCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCcc
Q 039291 199 SDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEHSLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVK 278 (362)
Q Consensus 199 ~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~~ 278 (362)
+|||||||++|+|++|+.||....... ....+ ...+..+++++.+||.+||..||++|||+.++++||||+
T Consensus 294 ~DvwSlG~il~elltg~~Pf~~~~~~~---~~~~~------~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~ 364 (377)
T 3byv_A 294 FDAWALGLVIYWIWCADLPITKDAALG---GSEWI------FRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYE 364 (377)
T ss_dssp HHHHHHHHHHHHHHHSSCCC------C---CSGGG------GSSCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHTSHHHH
T ss_pred hhHHHHHHHHHHHHHCCCCCccccccc---chhhh------hhhccCCCHHHHHHHHHHcCCCchhCCCHHHHhhChHHH
Confidence 999999999999999999996543211 11111 112356899999999999999999999999999999998
Q ss_pred Ccchhhh
Q 039291 279 GVDEELS 285 (362)
Q Consensus 279 ~~~~~~~ 285 (362)
.+.....
T Consensus 365 ~~~~~~~ 371 (377)
T 3byv_A 365 QLRTELS 371 (377)
T ss_dssp HHHHHHH
T ss_pred HHHHHHH
Confidence 8766543
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-48 Score=361.72 Aligned_cols=265 Identities=20% Similarity=0.332 Sum_probs=212.8
Q ss_pred CCCCceeecceecccCceEEEEEEECCCC-CCCCceeeeechh----hhhhHHHHHHHHHHHHcCCCCcccccccceeee
Q 039291 3 SDGTSWFRGRVIGQGSFGCVFIAKPKSNS-SFLPPLMAVKSAE----VSASASLQKEKEVFDNLNGCPFVLECFGEEITM 77 (362)
Q Consensus 3 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~-~~~~~~~~~K~~~----~~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~ 77 (362)
...++|.+++.||+|+||+||+|++...+ ......|++|... ......+.+|+.++++++ ||||+++++++..
T Consensus 68 ~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~- 145 (367)
T 3l9p_A 68 VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFN-HQNIVRCIGVSLQ- 145 (367)
T ss_dssp CCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCC-CTTBCCEEEEECS-
T ss_pred cCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCC-CCCCCeEEEEEec-
Confidence 34678999999999999999999965431 2233578888763 334556889999999998 9999999997642
Q ss_pred cCCCceEEEEEEEecCCCCHHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCc
Q 039291 78 GENGEMAYNLLLEYAAGGTLGDLIEKCNG-----NGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGK 152 (362)
Q Consensus 78 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-----~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~ 152 (362)
....++||||++||+|.+++..... ..+++..++.++.||+.||.|||++||+||||||+|||+..+ ...
T Consensus 146 ----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~-~~~ 220 (367)
T 3l9p_A 146 ----SLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCP-GPG 220 (367)
T ss_dssp ----SSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCS-STT
T ss_pred ----CCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecC-CCC
Confidence 2235699999999999999987542 349999999999999999999999999999999999999322 134
Q ss_pred eEEEEeecCCcccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHh-CCCCCccCCCCCHHHHHH
Q 039291 153 FVAKIADLGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLS-GRQAWVVKEDCSIDQLFS 231 (362)
Q Consensus 153 ~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~ 231 (362)
..+||+|||+++...............||+.|+|||++.+..++.++|||||||++|+|++ |..||... ...++..
T Consensus 221 ~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~---~~~~~~~ 297 (367)
T 3l9p_A 221 RVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSK---SNQEVLE 297 (367)
T ss_dssp CCEEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC---CHHHHHH
T ss_pred ceEEECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC---CHHHHHH
Confidence 5699999999986544333333345678999999999999999999999999999999998 99999554 4555555
Q ss_pred HHcCCCCCCCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCcc
Q 039291 232 IIGDEHSLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVK 278 (362)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~~ 278 (362)
.+..... +..+..++.++.+||.+||..||++|||+.+++++.++.
T Consensus 298 ~i~~~~~-~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~ 343 (367)
T 3l9p_A 298 FVTSGGR-MDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYC 343 (367)
T ss_dssp HHHTTCC-CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred HHHcCCC-CCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence 5554443 345677899999999999999999999999999987653
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-47 Score=351.53 Aligned_cols=254 Identities=20% Similarity=0.309 Sum_probs=205.9
Q ss_pred CCCceeecceecccCceEEEEEEECCCCCCCCceeeeechhh----hhhHHHHHHHHHHHHcCCCCcccccccceeeecC
Q 039291 4 DGTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEV----SASASLQKEKEVFDNLNGCPFVLECFGEEITMGE 79 (362)
Q Consensus 4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~----~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~ 79 (362)
..++|.+++.||+|+||+||+|++..++..++.++++|.... .....+.+|+.+++.++ ||||+++++++..
T Consensus 13 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~--- 88 (327)
T 3lzb_A 13 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD-NPHVCRLLGICLT--- 88 (327)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCC-BTTBCCCCEEEES---
T ss_pred CHhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCC-CCCeeEEEEEEec---
Confidence 468999999999999999999999999988888889987642 35567889999999998 9999999997653
Q ss_pred CCceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEee
Q 039291 80 NGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIAD 159 (362)
Q Consensus 80 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~D 159 (362)
. ..++|+||+.+|+|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|
T Consensus 89 -~--~~~~v~~~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~----~~~~~~kL~D 160 (327)
T 3lzb_A 89 -S--TVQLITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLV----KTPQHVKITD 160 (327)
T ss_dssp -S--SEEEEECCCSSCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE----EETTEEEECC
T ss_pred -C--CceEEEEecCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEE----cCCCCEEEcc
Confidence 1 156899999999999999874 3469999999999999999999999999999999999999 6667899999
Q ss_pred cCCcccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHh-CCCCCccCCCCCHHHHHHHHcCCCC
Q 039291 160 LGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLS-GRQAWVVKEDCSIDQLFSIIGDEHS 238 (362)
Q Consensus 160 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~ 238 (362)
||+++...............||+.|+|||++.+..++.++|||||||++|+|++ |..||...... ++...+.....
T Consensus 161 fG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~---~~~~~~~~~~~ 237 (327)
T 3lzb_A 161 FGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS---EISSILEKGER 237 (327)
T ss_dssp TTC----------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG---GHHHHHHTTCC
T ss_pred CcceeEccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHH---HHHHHHHcCCC
Confidence 999986654433333345567889999999999999999999999999999999 99999765443 33333433333
Q ss_pred CCCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhc
Q 039291 239 LPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLD 273 (362)
Q Consensus 239 ~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~ 273 (362)
...+..++.++.++|.+||..||.+||++.++++
T Consensus 238 -~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 271 (327)
T 3lzb_A 238 -LPQPPICTIDVYMIMRKCWMIDADSRPKFRELII 271 (327)
T ss_dssp -CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -CCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 3346678999999999999999999999999987
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-48 Score=351.41 Aligned_cols=254 Identities=24% Similarity=0.354 Sum_probs=198.1
Q ss_pred CCCceeecceecccCceEEEEEEECCCCCCCCceeeeechh------hhhhHHHHHHHHHHHHcCCCCcccccccceeee
Q 039291 4 DGTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAE------VSASASLQKEKEVFDNLNGCPFVLECFGEEITM 77 (362)
Q Consensus 4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~------~~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~ 77 (362)
-+++|.+++.||+|+||+||+|++..++. .+++|... ....+.+.+|+.++++++ ||||+++++++..
T Consensus 9 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~----~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-hp~iv~~~~~~~~- 82 (294)
T 4eqm_A 9 INERYKIVDKLGGGGMSTVYLAEDTILNI----KVAIKAIFIPPREKEETLKRFEREVHNSSQLS-HQNIVSMIDVDEE- 82 (294)
T ss_dssp EETTEEEEEEEEEETTEEEEEEEETTTCS----EEEEEEEECCSSCCHHHHHHHHHHHHHHTTCC-BTTBCCEEEEEEC-
T ss_pred hhccEEEEEEEccCCCEEEEEEEECCCCC----eEEEEEeccCccccHHHHHHHHHHHHHHhcCC-CCCCceEEEeeee-
Confidence 35799999999999999999999988775 55666542 234567889999999998 9999999987542
Q ss_pred cCCCceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEE
Q 039291 78 GENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKI 157 (362)
Q Consensus 78 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl 157 (362)
...+++||||++|++|.+++... +++++..++.++.|++.||.|||++||+||||||+||++ +.++.+||
T Consensus 83 ----~~~~~lv~e~~~g~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~----~~~~~~kl 152 (294)
T 4eqm_A 83 ----DDCYYLVMEYIEGPTLSEYIESH--GPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILI----DSNKTLKI 152 (294)
T ss_dssp ----SSEEEEEEECCCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE----CTTSCEEE
T ss_pred ----CCeEEEEEeCCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEE----CCCCCEEE
Confidence 33577999999999999999874 459999999999999999999999999999999999999 77888999
Q ss_pred eecCCcccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHHcCCC
Q 039291 158 ADLGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEH 237 (362)
Q Consensus 158 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 237 (362)
+|||++........ .......||+.|+|||++.+..++.++|||||||++|+|++|+.||..... .......+....
T Consensus 153 ~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~--~~~~~~~~~~~~ 229 (294)
T 4eqm_A 153 FDFGIAKALSETSL-TQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETA--VSIAIKHIQDSV 229 (294)
T ss_dssp CCCSSSTTC--------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCH--HHHHHHHHSSCC
T ss_pred EeCCCccccccccc-cccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCh--HHHHHHHhhccC
Confidence 99999976543221 122356799999999999999999999999999999999999999965432 222233332221
Q ss_pred CC--CCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCC
Q 039291 238 SL--PEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPF 276 (362)
Q Consensus 238 ~~--~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~ 276 (362)
.. ...+..+++.+.++|.+||..||.+||+..+.+.+.|
T Consensus 230 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l 270 (294)
T 4eqm_A 230 PNVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDL 270 (294)
T ss_dssp CCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHH
T ss_pred CCcchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHH
Confidence 11 1234668999999999999999999995444444333
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-48 Score=350.96 Aligned_cols=261 Identities=24% Similarity=0.383 Sum_probs=202.0
Q ss_pred CCCCceeecceecccCceEEEEEEECCCCCCCCceeeeechh-----hhhhHHHHHHHHHHHHcCC-CCcccccccceee
Q 039291 3 SDGTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAE-----VSASASLQKEKEVFDNLNG-CPFVLECFGEEIT 76 (362)
Q Consensus 3 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~-----~~~~~~~~~E~~il~~l~~-h~~i~~~~~~~~~ 76 (362)
..+++|.+++.||+|+||.||+|++.. +. .+++|... ......+.+|+.+++++.+ ||||+++++++..
T Consensus 25 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~-~~----~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~ 99 (313)
T 3cek_A 25 VKGRIYSILKQIGSGGSSKVFQVLNEK-KQ----IYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEIT 99 (313)
T ss_dssp ETTEEEEEEEEEECCSSEEEEEEECTT-CC----EEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEEC
T ss_pred eccceEEEEEEecCCCCEEEEEEEcCC-Cc----EEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeec
Confidence 467899999999999999999999865 33 45666542 3345678899999999985 7999999987643
Q ss_pred ecCCCceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEE
Q 039291 77 MGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAK 156 (362)
Q Consensus 77 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~k 156 (362)
...+++||| +.+++|.+++.. ...+++..++.++.|++.||.|||++||+||||||+|||+ ++ +.+|
T Consensus 100 -----~~~~~lv~e-~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~----~~-~~~k 166 (313)
T 3cek_A 100 -----DQYIYMVME-CGNIDLNSWLKK--KKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLI----VD-GMLK 166 (313)
T ss_dssp -----SSEEEEEEC-CCSEEHHHHHHH--CSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE----ET-TEEE
T ss_pred -----CCEEEEEEe-cCCCcHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEE----EC-CeEE
Confidence 234779999 557899999987 4569999999999999999999999999999999999999 33 5799
Q ss_pred EeecCCcccccccccCCCCCCccCCCCccCchhhcc-----------ccCCCcchHHHHHHHHHHHHhCCCCCccCCCCC
Q 039291 157 IADLGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQ-----------HMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCS 225 (362)
Q Consensus 157 l~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~ 225 (362)
|+|||++................||+.|+|||++.+ ..++.++|||||||++|+|++|..||.... .
T Consensus 167 L~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~--~ 244 (313)
T 3cek_A 167 LIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII--N 244 (313)
T ss_dssp ECCCSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCC--S
T ss_pred EeeccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHH--H
Confidence 999999986654333323345679999999999875 467889999999999999999999996432 2
Q ss_pred HHHHHHHHcCCCCCCCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCccCcchh
Q 039291 226 IDQLFSIIGDEHSLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGVDEE 283 (362)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~~~~~~~ 283 (362)
.......+........++...+.++.++|.+||..||.+||++.++++||||+.....
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~~~~~~ 302 (313)
T 3cek_A 245 QISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHP 302 (313)
T ss_dssp HHHHHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHCC---
T ss_pred HHHHHHHHHhcccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcCccccCCCCc
Confidence 2333333333333345566778999999999999999999999999999999865433
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-48 Score=346.04 Aligned_cols=261 Identities=24% Similarity=0.411 Sum_probs=208.4
Q ss_pred CCceeecceecccCceEEEEEEECCCCCCCCceeeeechhhh---------hhHHHHHHHHHHHHcCCCCccccccccee
Q 039291 5 GTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVS---------ASASLQKEKEVFDNLNGCPFVLECFGEEI 75 (362)
Q Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~~---------~~~~~~~E~~il~~l~~h~~i~~~~~~~~ 75 (362)
.++|.+++.||+|+||+||+|+++.+++. +++|..... ..+.+.+|+.++++++ ||||+++++++.
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~----~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~ 78 (283)
T 3bhy_A 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKE----YAAKFIKKRRLSSSRRGVSREEIEREVNILREIR-HPNIITLHDIFE 78 (283)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCE----EEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCC-CTTBCCEEEEEE
T ss_pred hhhhhhHHhhcccCceEEEEEEEcCCCCe----eehHHhhhccccccccchHHHHHHHHHHHHHhCC-CCCeeehhheec
Confidence 46899999999999999999999987764 455543221 3567889999999998 999999998764
Q ss_pred eecCCCceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEE
Q 039291 76 TMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVA 155 (362)
Q Consensus 76 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~ 155 (362)
. ...+++||||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+||++..++.....+
T Consensus 79 ~-----~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~ 151 (283)
T 3bhy_A 79 N-----KTDVVLILELVSGGELFDFLAEK--ESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRI 151 (283)
T ss_dssp C-----SSEEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCE
T ss_pred C-----CCeEEEEEeecCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCce
Confidence 2 23477999999999999999763 4599999999999999999999999999999999999995433334489
Q ss_pred EEeecCCcccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHHcC
Q 039291 156 KIADLGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGD 235 (362)
Q Consensus 156 kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~ 235 (362)
||+|||++........ .....||+.|+|||++.+..++.++||||||+++|+|++|..||.... ..+....+..
T Consensus 152 kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~---~~~~~~~~~~ 225 (283)
T 3bhy_A 152 KLIDFGIAHKIEAGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGET---KQETLTNISA 225 (283)
T ss_dssp EECCCTTCEECC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSS---HHHHHHHHHT
T ss_pred EEEecccceeccCCCc---ccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcc---hHHHHHHhHh
Confidence 9999999976543221 234569999999999998899999999999999999999999996543 3444444332
Q ss_pred CCC--CCCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCccCcchh
Q 039291 236 EHS--LPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGVDEE 283 (362)
Q Consensus 236 ~~~--~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~~~~~~~ 283 (362)
... .+..+..++..+.+||.+||..||++||++.++++||||+.+.+.
T Consensus 226 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~~ 275 (283)
T 3bhy_A 226 VNYDFDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRRR 275 (283)
T ss_dssp TCCCCCHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHHHC
T ss_pred cccCCcchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHHHHH
Confidence 221 112224678999999999999999999999999999999876443
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-47 Score=358.58 Aligned_cols=267 Identities=24% Similarity=0.387 Sum_probs=210.6
Q ss_pred CCCceeecceecccCceEEEEEEECCCCCCCCceeeeechhhh--hhHHHHHHHHHHHHcCC----------CCcccccc
Q 039291 4 DGTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVS--ASASLQKEKEVFDNLNG----------CPFVLECF 71 (362)
Q Consensus 4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~~--~~~~~~~E~~il~~l~~----------h~~i~~~~ 71 (362)
..++|.+++.||+|+||+||+|+++.++. .|++|..... ....+.+|+.+++++.+ ||||++++
T Consensus 17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~----~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~ 92 (373)
T 1q8y_A 17 KDARYILVRKLGWGHFSTVWLAKDMVNNT----HVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLL 92 (373)
T ss_dssp TTTTEEEEEEEEECSSEEEEEEEETTTTE----EEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCC
T ss_pred cCCeEEEEEeeeecCCeEEEEEEecCCCc----EEEEEEecCCccchhhhhHHHHHHHHhhcccccchhccccchHHHHH
Confidence 45799999999999999999999988775 5677766432 44567899999998873 78999999
Q ss_pred cceeeecCCCceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC-CceeCCCCCCCEEEeecC-
Q 039291 72 GEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDS-GYVHCDVKPDNILLVATQ- 149 (362)
Q Consensus 72 ~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~-~ivH~Dlkp~Nill~~~~- 149 (362)
+.+..... ....+++||||+ +++|.+++.......+++..++.++.||+.||.|||++ ||+||||||+|||+...+
T Consensus 93 ~~~~~~~~-~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~ 170 (373)
T 1q8y_A 93 DHFNHKGP-NGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDS 170 (373)
T ss_dssp EEEEEEET-TEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEET
T ss_pred HHhhccCC-CCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccCC
Confidence 98765432 234678999999 88999999886666799999999999999999999998 999999999999996544
Q ss_pred -CCceEEEEeecCCcccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHhCCCCCccCCCCC---
Q 039291 150 -SGKFVAKIADLGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCS--- 225 (362)
Q Consensus 150 -~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~--- 225 (362)
+..+.+||+|||++...... .....||+.|+|||++.+..++.++|||||||++|+|++|..||.......
T Consensus 171 ~~~~~~~kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~ 245 (373)
T 1q8y_A 171 PENLIQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTK 245 (373)
T ss_dssp TTTEEEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------C
T ss_pred CcCcceEEEcccccccccCCC-----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCC
Confidence 45678999999999765432 234579999999999999999999999999999999999999997543211
Q ss_pred -H---HHHHHHHcCCC------------------------------------CCCCCCccCCHHHHHHHHHHhccCCCCC
Q 039291 226 -I---DQLFSIIGDEH------------------------------------SLPEIPSRVSKEARDFLRRCFVRKPAFR 265 (362)
Q Consensus 226 -~---~~~~~~~~~~~------------------------------------~~~~~~~~~~~~~~~li~~~l~~~p~~R 265 (362)
. .++...+...+ ....++..++.++.+||.+||..||++|
T Consensus 246 ~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R 325 (373)
T 1q8y_A 246 DDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKR 325 (373)
T ss_dssp HHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTC
T ss_pred hHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCcccc
Confidence 1 11111111000 0012334567889999999999999999
Q ss_pred CCHHHHhcCCCccCcc
Q 039291 266 FTAEMLLDDPFVKGVD 281 (362)
Q Consensus 266 ~s~~~~l~~p~~~~~~ 281 (362)
||++++++||||++..
T Consensus 326 pt~~ell~hp~f~~~~ 341 (373)
T 1q8y_A 326 ADAGGLVNHPWLKDTL 341 (373)
T ss_dssp BCHHHHHTCGGGTTCT
T ss_pred CCHHHHhhChhhhccc
Confidence 9999999999998753
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-47 Score=347.03 Aligned_cols=260 Identities=27% Similarity=0.477 Sum_probs=208.0
Q ss_pred CCCceeecceecccCceEEEEEEECCCCCCCCceeeeechhhh-hhHHHHHHHHHHHHcCCCCcccccccceeeecCCCc
Q 039291 4 DGTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVS-ASASLQKEKEVFDNLNGCPFVLECFGEEITMGENGE 82 (362)
Q Consensus 4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~~-~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~~~ 82 (362)
..++|.+.+.||+|+||.||+|+++.++. .+++|..... ....+.+|+.+++.++ ||||+++++.+.. .
T Consensus 27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~----~vaiK~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~-----~ 96 (314)
T 3com_A 27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQ----IVAIKQVPVESDLQEIIKEISIMQQCD-SPHVVKYYGSYFK-----N 96 (314)
T ss_dssp ---CEEEEEECC----CEEEEEEETTTCC----EEEEEEEETTSCCHHHHHHHHHHHTCC-CTTBCCEEEEEEE-----T
T ss_pred chhhhhhheeeccCCCeEEEEEEECCCCC----EEEEEecCchHHHHHHHHHHHHHHhCC-CCCCccEEEEEEe-----C
Confidence 46789999999999999999999988775 5677765433 4567889999999998 9999999987653 2
Q ss_pred eEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEeecCC
Q 039291 83 MAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGV 162 (362)
Q Consensus 83 ~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Dfgl 162 (362)
..+++||||+++++|.+++... ...+++..++.++.||+.||.|||+.||+|+||||+||++ +.++.+||+|||+
T Consensus 97 ~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~----~~~~~~kl~dfg~ 171 (314)
T 3com_A 97 TDLWIVMEYCGAGSVSDIIRLR-NKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILL----NTEGHAKLADFGV 171 (314)
T ss_dssp TEEEEEEECCTTEEHHHHHHHH-TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE----CTTCCEEECCCTT
T ss_pred CEEEEEeecCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEE----CCCCCEEEeeccc
Confidence 2467999999999999999753 4569999999999999999999999999999999999999 7778899999999
Q ss_pred cccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHHcCCCCCCCC
Q 039291 163 AKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEHSLPEI 242 (362)
Q Consensus 163 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 242 (362)
+......... .....||+.|+|||++.+..++.++||||||+++|+|++|..||..... .................
T Consensus 172 ~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~--~~~~~~~~~~~~~~~~~ 247 (314)
T 3com_A 172 AGQLTDTMAK--RNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHP--MRAIFMIPTNPPPTFRK 247 (314)
T ss_dssp CEECBTTBSC--BCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCH--HHHHHHHHHSCCCCCSS
T ss_pred chhhhhhccc--cCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCCh--HHHHHHHhcCCCcccCC
Confidence 9765442221 2356799999999999998999999999999999999999999964432 22222222222222234
Q ss_pred CccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCccCcch
Q 039291 243 PSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGVDE 282 (362)
Q Consensus 243 ~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~~~~~~ 282 (362)
+..++.++.+||.+||..||.+|||+.++++||||+....
T Consensus 248 ~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~~~~~~~~~ 287 (314)
T 3com_A 248 PELWSDNFTDFVKQCLVKSPEQRATATQLLQHPFVRSAKG 287 (314)
T ss_dssp GGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHTCCC
T ss_pred cccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhcCCc
Confidence 5668999999999999999999999999999999987643
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-48 Score=358.28 Aligned_cols=265 Identities=21% Similarity=0.319 Sum_probs=202.5
Q ss_pred CCCceeecceecccCceEEEEEEECCCCCCCCceeeeechhhh--------------hhHHHHHHHHHHHHcCCCCcccc
Q 039291 4 DGTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVS--------------ASASLQKEKEVFDNLNGCPFVLE 69 (362)
Q Consensus 4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~~--------------~~~~~~~E~~il~~l~~h~~i~~ 69 (362)
-.++|.+++.||+|+||.||+|.+.. +. .|++|..... ..+.+.+|+.++++++ ||||++
T Consensus 20 ~~~~y~~~~~lg~G~~g~V~~~~~~~-~~----~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~ 93 (362)
T 3pg1_A 20 MQSPYTVQRFISSGSYGAVCAGVDSE-GI----PVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFH-HPNILG 93 (362)
T ss_dssp TTCSCEEEEEEEEETTEEEEEEECTT-SC----EEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCC-CTTBCC
T ss_pred hccceEEeEEeccCCCEEEEEEECCC-CC----eEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCC-CcCccc
Confidence 35799999999999999999999865 43 5666654221 2367889999999998 999999
Q ss_pred cccceeeecCCCceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecC
Q 039291 70 CFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQ 149 (362)
Q Consensus 70 ~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~ 149 (362)
+++++..........+++||||+. |+|.+++.. ....+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus 94 ~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~---- 167 (362)
T 3pg1_A 94 LRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHD-QRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILL---- 167 (362)
T ss_dssp CSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHC-TTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE----
T ss_pred eeeeEEeccCCCcceEEEEEccCC-CCHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEE----
Confidence 999887655455567889999997 588888875 34469999999999999999999999999999999999999
Q ss_pred CCceEEEEeecCCcccccccccCCCCCCccCCCCccCchhhcc-ccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHH
Q 039291 150 SGKFVAKIADLGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQ-HMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQ 228 (362)
Q Consensus 150 ~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~ 228 (362)
+.++.+||+|||++....... ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||..........
T Consensus 168 ~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~ 244 (362)
T 3pg1_A 168 ADNNDITICDFNLAREDTADA---NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLN 244 (362)
T ss_dssp CTTCCEEECCTTC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH
T ss_pred cCCCCEEEEecCccccccccc---ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 777889999999997544322 2235679999999999987 678999999999999999999999996543211111
Q ss_pred HH-HHHcC------------------CCCC--------CCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCccCcc
Q 039291 229 LF-SIIGD------------------EHSL--------PEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGVD 281 (362)
Q Consensus 229 ~~-~~~~~------------------~~~~--------~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~~~~~ 281 (362)
.+ ..... .... ...+..+++.+.+||.+||..||++|||+.++++||||+.+.
T Consensus 245 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~ 324 (362)
T 3pg1_A 245 KIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESLF 324 (362)
T ss_dssp HHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred HHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCchhhhcc
Confidence 11 11100 0000 012235688999999999999999999999999999999875
Q ss_pred hh
Q 039291 282 EE 283 (362)
Q Consensus 282 ~~ 283 (362)
..
T Consensus 325 ~~ 326 (362)
T 3pg1_A 325 DP 326 (362)
T ss_dssp CG
T ss_pred Cc
Confidence 44
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-48 Score=354.35 Aligned_cols=255 Identities=18% Similarity=0.259 Sum_probs=210.7
Q ss_pred CCCceeecceecccCceEEEEEEECCCCCCCCceeeeechhhh----hhHHHHHHHHHHHHcCCCCcccccccceeeecC
Q 039291 4 DGTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVS----ASASLQKEKEVFDNLNGCPFVLECFGEEITMGE 79 (362)
Q Consensus 4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~~----~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~ 79 (362)
..++|.+++.||+|+||+||+|+++.++..++.++++|..... ....+.+|+.+++.++ ||||+++++++.
T Consensus 11 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~---- 85 (325)
T 3kex_A 11 KETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLD-HAHIVRLLGLCP---- 85 (325)
T ss_dssp CTTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCC-CTTBCCEEEEEC----
T ss_pred CHhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCC-CCCcCeEEEEEc----
Confidence 4689999999999999999999999998888888999876432 3345778999999998 999999998653
Q ss_pred CCceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEee
Q 039291 80 NGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIAD 159 (362)
Q Consensus 80 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~D 159 (362)
...+++||||+.+|+|.+++... ...+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|
T Consensus 86 --~~~~~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~----~~~~~~kl~D 158 (325)
T 3kex_A 86 --GSSLQLVTQYLPLGSLLDHVRQH-RGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLL----KSPSQVQVAD 158 (325)
T ss_dssp --BSSEEEEEECCTTCBSHHHHHSS-GGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEE----SSSSCEEECS
T ss_pred --CCccEEEEEeCCCCCHHHHHHHc-cccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEE----CCCCeEEECC
Confidence 12367999999999999999763 3459999999999999999999999999999999999999 7778899999
Q ss_pred cCCcccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHh-CCCCCccCCCCCHHHHHHHHcCCCC
Q 039291 160 LGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLS-GRQAWVVKEDCSIDQLFSIIGDEHS 238 (362)
Q Consensus 160 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~ 238 (362)
||+++...............||..|+|||++.+..++.++|||||||++|+|++ |..||...... +....+....
T Consensus 159 fg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~---~~~~~~~~~~- 234 (325)
T 3kex_A 159 FGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLA---EVPDLLEKGE- 234 (325)
T ss_dssp CSGGGGSCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTT---HHHHHHHTTC-
T ss_pred CCcccccCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHH---HHHHHHHcCC-
Confidence 999987655444434455678889999999998899999999999999999999 99999765433 3333333332
Q ss_pred CCCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhcC
Q 039291 239 LPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDD 274 (362)
Q Consensus 239 ~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~ 274 (362)
....+..++.++.++|.+||..||.+||++.+++++
T Consensus 235 ~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~ 270 (325)
T 3kex_A 235 RLAQPQICTIDVYMVMVKCWMIDENIRPTFKELANE 270 (325)
T ss_dssp BCCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHH
T ss_pred CCCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 234456688899999999999999999999999885
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-47 Score=348.12 Aligned_cols=260 Identities=26% Similarity=0.446 Sum_probs=208.0
Q ss_pred CCCceeecceecccCceEEEEEEECCCCCCCCceeeeechh---hhhhHHHHHHHHHHHHcCCCCcccccccceeeecCC
Q 039291 4 DGTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAE---VSASASLQKEKEVFDNLNGCPFVLECFGEEITMGEN 80 (362)
Q Consensus 4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~---~~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~ 80 (362)
.+++|.+++.||+|+||.||+|+++.++. .+++|... ......+.+|+.+++.++ ||||+++++.+..
T Consensus 17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~----~~aiK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~---- 87 (302)
T 2j7t_A 17 PNEVWEIVGELGDGAFGKVYKAKNKETGA----LAAAKVIETKSEEELEDYIVEIEILATCD-HPYIVKLLGAYYH---- 87 (302)
T ss_dssp GGGTEEEEEEEECSTTCCEEEEEETTTCC----EEEEEEEC----CCHHHHHHHHHHHHHCC-CTTBCCEEEEEEC----
T ss_pred CccceeecceeccCCCeEEEEEEEcCCCc----EEEEEEecCCCHHHHHHHHHHHHHHhcCC-CCCEeeeeeeeee----
Confidence 35789999999999999999999988775 45666543 234567889999999998 9999999987653
Q ss_pred CceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEeec
Q 039291 81 GEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADL 160 (362)
Q Consensus 81 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Df 160 (362)
...+++||||+++++|.+++... ...+++..++.++.||+.||.|||++|++||||||+||++ +.++.+||+||
T Consensus 88 -~~~~~lv~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~----~~~~~~kl~Df 161 (302)
T 2j7t_A 88 -DGKLWIMIEFCPGGAVDAIMLEL-DRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLM----TLEGDIRLADF 161 (302)
T ss_dssp -C-CEEEEEECCTTEEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEE----CTTSCEEECCC
T ss_pred -CCeEEEEEEeCCCCcHHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEE----CCCCCEEEEEC
Confidence 23477999999999999998763 3459999999999999999999999999999999999999 77788999999
Q ss_pred CCcccccccccCCCCCCccCCCCccCchhhc-----cccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHH-HHHc
Q 039291 161 GVAKRSRHCKRQKFDPSMRGTPLYLAPETVV-----QHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLF-SIIG 234 (362)
Q Consensus 161 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~-~~~~ 234 (362)
|++........ ......||+.|+|||++. +..++.++|||||||++|+|++|..||...+ ..... ....
T Consensus 162 g~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~---~~~~~~~~~~ 236 (302)
T 2j7t_A 162 GVSAKNLKTLQ--KRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELN---PMRVLLKIAK 236 (302)
T ss_dssp HHHHHHHHHHH--C-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSC---HHHHHHHHHH
T ss_pred CCCcccccccc--ccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCC---HHHHHHHHhc
Confidence 99764332111 113457999999999984 5678899999999999999999999996543 33332 2222
Q ss_pred CCCCCCCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCccCcchh
Q 039291 235 DEHSLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGVDEE 283 (362)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~~~~~~~ 283 (362)
........+..++.++.++|.+||..||++|||+.++++||||+...+.
T Consensus 237 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~ 285 (302)
T 2j7t_A 237 SDPPTLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSITSN 285 (302)
T ss_dssp SCCCCCSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTSTTTTTCCCC
T ss_pred cCCcccCCccccCHHHHHHHHHHcccChhhCCCHHHHhcChHHhhhccc
Confidence 2222223456789999999999999999999999999999999987543
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-48 Score=345.28 Aligned_cols=262 Identities=26% Similarity=0.425 Sum_probs=211.9
Q ss_pred CCCCCCceeecceecccCceEEEEEEECCCCCCCCceeeeechh-----hhhhHHHHHHHHHHHHcCCCCccccccccee
Q 039291 1 MDSDGTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAE-----VSASASLQKEKEVFDNLNGCPFVLECFGEEI 75 (362)
Q Consensus 1 ~~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~-----~~~~~~~~~E~~il~~l~~h~~i~~~~~~~~ 75 (362)
|....++|.+++.||+|+||.||+|+++.+++ .+++|... ....+.+.+|+.++++++ ||||+++++.+.
T Consensus 1 ~p~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~----~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~ 75 (279)
T 2w5a_A 1 MPSRAEDYEVLYTIGTGSYGRCQKIRRKSDGK----ILVWKELDYGSMTEAEKQMLVSEVNLLRELK-HPNIVRYYDRII 75 (279)
T ss_dssp --CCGGGEEEEEEEEECSSSEEEEEEETTTCC----EEEEEEEECTTCCHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEE
T ss_pred CCCchhheeeehhccCCCCcEEEEEEECCCCc----EEEEEEEEcccCCHHHHHHHHHHHHHHHhcC-CCCCCeEEEEEe
Confidence 34567899999999999999999999988775 45555542 334567889999999998 999999998665
Q ss_pred eecCCCceEEEEEEEecCCCCHHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC-----ceeCCCCCCCEEEeec
Q 039291 76 TMGENGEMAYNLLLEYAAGGTLGDLIEKCN--GNGLPEKDVRHFTRCILEGIGHIHDSG-----YVHCDVKPDNILLVAT 148 (362)
Q Consensus 76 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~l~~~~~~~i~~ql~~~l~yLH~~~-----ivH~Dlkp~Nill~~~ 148 (362)
.. ....+++||||+++++|.+++.... ...+++..++.++.|++.||.|||+.| |+||||||+||++
T Consensus 76 ~~---~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~--- 149 (279)
T 2w5a_A 76 DR---TNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFL--- 149 (279)
T ss_dssp EG---GGTEEEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEE---
T ss_pred cC---CCceEEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEE---
Confidence 32 2335779999999999999997642 345999999999999999999999999 9999999999999
Q ss_pred CCCceEEEEeecCCcccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHH
Q 039291 149 QSGKFVAKIADLGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQ 228 (362)
Q Consensus 149 ~~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~ 228 (362)
+.++.+||+|||++........ ......||+.|+|||++.+..++.++||||||+++|+|++|..||... ....
T Consensus 150 -~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~---~~~~ 223 (279)
T 2w5a_A 150 -DGKQNVKLGDFGLARILNHDTS--FAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAF---SQKE 223 (279)
T ss_dssp -CSSSCEEECCCCHHHHC---CH--HHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCS---SHHH
T ss_pred -cCCCCEEEecCchheeeccccc--cccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCccc---CHHH
Confidence 7778899999999875543211 112356899999999999888999999999999999999999999654 3344
Q ss_pred HHHHHcCCCCCCCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCccCc
Q 039291 229 LFSIIGDEHSLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGV 280 (362)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~~~~ 280 (362)
+...+... ..+.++..++.++.++|.+||..||++||++.++++|+|+.+-
T Consensus 224 ~~~~i~~~-~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~~ 274 (279)
T 2w5a_A 224 LAGKIREG-KFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLILEH 274 (279)
T ss_dssp HHHHHHHT-CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCGG
T ss_pred HHHHHhhc-ccccCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhhh
Confidence 44444333 2345667899999999999999999999999999999999764
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-48 Score=355.54 Aligned_cols=260 Identities=21% Similarity=0.364 Sum_probs=203.0
Q ss_pred CCceeecceecccCceEEEEEEECCCCCCCCceeeeechhh------hhhHHHHHHHHHHHHcCCCCcccccccceeeec
Q 039291 5 GTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEV------SASASLQKEKEVFDNLNGCPFVLECFGEEITMG 78 (362)
Q Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~------~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~ 78 (362)
.++|.+++.||+|+||+||+|+++.+++ .|++|.... .....+.+|+.++++++ ||||+++++.+....
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~----~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~ 85 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHR----DVAVKVLRADLARDPSFYLRFRREAQNAAALN-HPAIVAVYDTGEAET 85 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTE----EEEEEEECTTTTTSHHHHHHHHHHHTTCCCCC-CTTBCCEEEEEEEEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCc----eEEEEEeCccccCCHHHHHHHHHHHHHHHcCC-CCCcceEEEeeeccC
Confidence 5789999999999999999999988775 567776532 23356789999999998 999999999776543
Q ss_pred CCCceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEe
Q 039291 79 ENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIA 158 (362)
Q Consensus 79 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~ 158 (362)
. ....+|+||||++|++|.+++... +++++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+
T Consensus 86 ~-~~~~~~lv~e~~~g~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~----~~~~~~kl~ 158 (311)
T 3ork_A 86 P-AGPLPYIVMEYVDGVTLRDIVHTE--GPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMI----SATNAVKVM 158 (311)
T ss_dssp T-TEEEEEEEEECCCEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE----ETTSCEEEC
T ss_pred C-CCcccEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEE----cCCCCEEEe
Confidence 2 233457999999999999999873 459999999999999999999999999999999999999 667789999
Q ss_pred ecCCcccccccccC-CCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHH-HHHHcCC
Q 039291 159 DLGVAKRSRHCKRQ-KFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQL-FSIIGDE 236 (362)
Q Consensus 159 Dfgla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~-~~~~~~~ 236 (362)
|||++......... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||.... .... .......
T Consensus 159 Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~---~~~~~~~~~~~~ 235 (311)
T 3ork_A 159 DFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDS---PVSVAYQHVRED 235 (311)
T ss_dssp CCSCC------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS---HHHHHHHHHHCC
T ss_pred eccCcccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC---hHHHHHHHhcCC
Confidence 99999765432221 12234679999999999999999999999999999999999999996543 3333 2333222
Q ss_pred CCCC-CCCccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCccC
Q 039291 237 HSLP-EIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKG 279 (362)
Q Consensus 237 ~~~~-~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~~~ 279 (362)
...+ ..+..++.++.++|.+||..||++||++.+++.|+|++.
T Consensus 236 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~ 279 (311)
T 3ork_A 236 PIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV 279 (311)
T ss_dssp CCCHHHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred CCCcccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHH
Confidence 2211 123458999999999999999999999999999999853
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-47 Score=355.18 Aligned_cols=258 Identities=21% Similarity=0.329 Sum_probs=196.0
Q ss_pred CceeecceecccCceEEEEEEECCCCCCCCceeeeechh-----hhhhHHHHHHHHHHHHcCCCCcccccccceeeecC-
Q 039291 6 TSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAE-----VSASASLQKEKEVFDNLNGCPFVLECFGEEITMGE- 79 (362)
Q Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~-----~~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~- 79 (362)
++|.+++.||+|+||+||+|.++.++. .|++|... ......+.+|+.+++.++ ||||+++++++.....
T Consensus 25 ~~y~~~~~lG~G~~g~V~~~~~~~~~~----~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~ 99 (371)
T 2xrw_A 25 KRYQNLKPIGSGAQGIVCAAYDAILER----NVAIKKLSRPFQNQTHAKRAYRELVLMKCVN-HKNIIGLLNVFTPQKSL 99 (371)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTE----EEEEEEEECTTSSHHHHHHHHHHHHHHHHCC-CTTBCCEEEEECSCCST
T ss_pred hheeEeeeeEecCCEEEEEEEECCCCc----eEEEEEeccccCChHHHHHHHHHHHHHHhcC-CCCccceEEeecccccc
Confidence 689999999999999999999988775 45666543 234466889999999998 9999999997654221
Q ss_pred CCceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEee
Q 039291 80 NGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIAD 159 (362)
Q Consensus 80 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~D 159 (362)
.....+++||||+.+ +|.+++.. .+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|
T Consensus 100 ~~~~~~~lv~e~~~~-~l~~~~~~----~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~----~~~~~~kl~D 170 (371)
T 2xrw_A 100 EEFQDVYIVMELMDA-NLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV----KSDCTLKILD 170 (371)
T ss_dssp TTCCEEEEEEECCSE-EHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE----CTTSCEEECC
T ss_pred ccccceEEEEEcCCC-CHHHHHhh----ccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEE----cCCCCEEEEE
Confidence 223357899999975 78888853 39999999999999999999999999999999999999 7788899999
Q ss_pred cCCcccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHHcCCCCC
Q 039291 160 LGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEHSL 239 (362)
Q Consensus 160 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 239 (362)
||+++..... .......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+. ...+..+......
T Consensus 171 fg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~---~~~~~~i~~~~~~ 244 (371)
T 2xrw_A 171 FGLARTAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDH---IDQWNKVIEQLGT 244 (371)
T ss_dssp CCC-------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH---HHHHHHHHC-CCC
T ss_pred eecccccccc---cccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHHHhCC
Confidence 9999765432 122356799999999999998999999999999999999999999965432 2222222111100
Q ss_pred --------------------CCC--------------C------ccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCccC
Q 039291 240 --------------------PEI--------------P------SRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKG 279 (362)
Q Consensus 240 --------------------~~~--------------~------~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~~~ 279 (362)
+.. + ...+.++++||.+||..||++|||++++++||||+.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~ 324 (371)
T 2xrw_A 245 PCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINV 324 (371)
T ss_dssp CCHHHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHT
T ss_pred CCHHHHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcchhh
Confidence 000 0 012578999999999999999999999999999987
Q ss_pred cchh
Q 039291 280 VDEE 283 (362)
Q Consensus 280 ~~~~ 283 (362)
+...
T Consensus 325 ~~~~ 328 (371)
T 2xrw_A 325 WYDP 328 (371)
T ss_dssp TCCH
T ss_pred hcCc
Confidence 6443
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-48 Score=355.33 Aligned_cols=260 Identities=25% Similarity=0.371 Sum_probs=201.9
Q ss_pred CCCceeecceecccCceEEEEEEECCCCCCCCceeeeechh-----hhhhHHHHHHHHHHHHcCCCCcccccccceeeec
Q 039291 4 DGTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAE-----VSASASLQKEKEVFDNLNGCPFVLECFGEEITMG 78 (362)
Q Consensus 4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~-----~~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~ 78 (362)
.-++|.+++.||+|+||.||+|+++.++. .|++|... ....+.+.+|+.+++.++ ||||+++++++..
T Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~----~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~-- 95 (331)
T 4aaa_A 23 SMEKYENLGLVGEGSYGMVMKCRNKDTGR----IVAIKKFLESDDDKMVKKIAMREIKLLKQLR-HENLVNLLEVCKK-- 95 (331)
T ss_dssp CGGGEEEEEEGGGGTTSSEEEEEETTTCC----EEEEEEEESCSSCHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEEE--
T ss_pred hhhhheeeeEEeecCCEEEEEEEECCCCc----eEEEEEEecCCCchHHHHHHHHHHHHHhhCC-CCCEeeEEEEeec--
Confidence 45789999999999999999999998876 45666542 223455779999999999 9999999997643
Q ss_pred CCCceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEe
Q 039291 79 ENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIA 158 (362)
Q Consensus 79 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~ 158 (362)
...+++||||+++++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+
T Consensus 96 ---~~~~~lv~e~~~~~~l~~~~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~----~~~~~~kl~ 166 (331)
T 4aaa_A 96 ---KKRWYLVFEFVDHTILDDLELF--PNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILV----SQSGVVKLC 166 (331)
T ss_dssp ---TTEEEEEEECCSEEHHHHHHHS--TTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE----CTTSCEEEC
T ss_pred ---CCEEEEEEecCCcchHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEE----cCCCcEEEE
Confidence 2346799999999888887765 3459999999999999999999999999999999999999 777899999
Q ss_pred ecCCcccccccccCCCCCCccCCCCccCchhhccc-cCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHH-HHHc--
Q 039291 159 DLGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQH-MQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLF-SIIG-- 234 (362)
Q Consensus 159 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~-~~~~-- 234 (362)
|||++....... .......||+.|+|||++.+. .++.++|||||||++|+|++|..||............ ....
T Consensus 167 Dfg~~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 244 (331)
T 4aaa_A 167 DFGFARTLAAPG--EVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNL 244 (331)
T ss_dssp CCTTC--------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSC
T ss_pred eCCCceeecCCc--cccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCC
Confidence 999997654322 122356799999999999875 7899999999999999999999999655432111111 1110
Q ss_pred --------------CCCCCCCC---------CccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCccCcc
Q 039291 235 --------------DEHSLPEI---------PSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGVD 281 (362)
Q Consensus 235 --------------~~~~~~~~---------~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~~~~~ 281 (362)
.....+.. ...++.++.+||.+||..||++|||+.++++||||+...
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~ 314 (331)
T 4aaa_A 245 IPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQMDG 314 (331)
T ss_dssp CHHHHHHHHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHGGG
T ss_pred ChhhhhHhhhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchhccCC
Confidence 01111111 135789999999999999999999999999999998653
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-47 Score=349.75 Aligned_cols=255 Identities=18% Similarity=0.316 Sum_probs=207.1
Q ss_pred CCCCceeecceecccCceEEEEEEECCCCCCCCceeeeechhh----hhhHHHHHHHHHHHHcCCCCcccccccceeeec
Q 039291 3 SDGTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEV----SASASLQKEKEVFDNLNGCPFVLECFGEEITMG 78 (362)
Q Consensus 3 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~----~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~ 78 (362)
...++|.+++.||+|+||+||+|+++.+++. ...|++|.... ...+.+.+|+.+++.++ ||||+++++++..
T Consensus 46 ~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~-- 121 (325)
T 3kul_A 46 IEASRIHIEKIIGSGDSGEVCYGRLRVPGQR-DVPVAIKALKAGYTERQRRDFLSEASIMGQFD-HPNIIRLEGVVTR-- 121 (325)
T ss_dssp CCGGGEEEEEEEEETTTEEEEEEEECCTTSC-CEEEEEEEECTTCCHHHHHHHHHHHHHHTTCC-CTTBCCEEEEECG--
T ss_pred cChhHeEEeeEEEeCCCcEEEEEEEecCCCC-CceEEEEecCCCCCHHHHHHHHHHHHHHHhCC-CCCCCcEEEEEEe--
Confidence 4568999999999999999999999876542 23467776543 34567889999999998 9999999987642
Q ss_pred CCCceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEe
Q 039291 79 ENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIA 158 (362)
Q Consensus 79 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~ 158 (362)
...+++||||++|++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+
T Consensus 122 ---~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll----~~~~~~kl~ 193 (325)
T 3kul_A 122 ---GRLAMIVTEYMENGSLDTFLRTH-DGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLV----DSNLVCKVS 193 (325)
T ss_dssp ---GGCCEEEEECCTTCBHHHHHHTT-TTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE----CTTCCEEEC
T ss_pred ---CCccEEEeeCCCCCcHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEE----CCCCCEEEC
Confidence 23467999999999999999763 3469999999999999999999999999999999999999 788899999
Q ss_pred ecCCcccccccccCC-CCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHh-CCCCCccCCCCCHHHHHHHHcCC
Q 039291 159 DLGVAKRSRHCKRQK-FDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLS-GRQAWVVKEDCSIDQLFSIIGDE 236 (362)
Q Consensus 159 Dfgla~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~ 236 (362)
|||+++......... ......+|+.|+|||++.+..++.++|||||||++|+|++ |..||... ...+....+...
T Consensus 194 Dfg~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~---~~~~~~~~~~~~ 270 (325)
T 3kul_A 194 DFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNM---TNRDVISSVEEG 270 (325)
T ss_dssp CCSSCEECC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTS---CHHHHHHHHHTT
T ss_pred CCCcccccccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccC---CHHHHHHHHHcC
Confidence 999998654432111 1223456778999999998899999999999999999999 99999544 445555555544
Q ss_pred CCCCCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhc
Q 039291 237 HSLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLD 273 (362)
Q Consensus 237 ~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~ 273 (362)
... ..+..++.++.+||.+||..||++|||+.++++
T Consensus 271 ~~~-~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~ 306 (325)
T 3kul_A 271 YRL-PAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVS 306 (325)
T ss_dssp CCC-CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCC-CCCCCcCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 333 356779999999999999999999999999986
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-47 Score=347.06 Aligned_cols=256 Identities=26% Similarity=0.431 Sum_probs=208.3
Q ss_pred CCceeecceecccCceEEEEEEECCCCCCCCceeeeechhhh---hhHHHHHHHHHHHHcCCCCcccccccceeeecCCC
Q 039291 5 GTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVS---ASASLQKEKEVFDNLNGCPFVLECFGEEITMGENG 81 (362)
Q Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~~---~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~~ 81 (362)
.++|.+++.||+|+||+||+|+++.+++ .+++|..... ....+.+|+.+++.++ ||||+++++++..
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~----~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~----- 77 (304)
T 2jam_A 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGK----LFALKCIKKSPAFRDSSLENEIAVLKKIK-HENIVTLEDIYES----- 77 (304)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCC----EEEEEEEECC------HHHHHHHHHHHCC-CTTBCCEEEEEEC-----
T ss_pred hccceeeeeccCCCCceEEEEEECCCCC----EEEEEEEecccccchHHHHHHHHHHHhCC-CCCeeehhhhccc-----
Confidence 4689999999999999999999988775 5566655322 3456889999999998 9999999987642
Q ss_pred ceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEeecC
Q 039291 82 EMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLG 161 (362)
Q Consensus 82 ~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Dfg 161 (362)
...+++||||+++++|.+++... +.+++..++.++.|++.||.|||++||+||||||+||++... +.++.++|+|||
T Consensus 78 ~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~-~~~~~~kl~Dfg 154 (304)
T 2jam_A 78 TTHYYLVMQLVSGGELFDRILER--GVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTP-EENSKIMITDFG 154 (304)
T ss_dssp SSEEEEEECCCCSCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSS-STTCCEEBCSCS
T ss_pred CCEEEEEEEcCCCccHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecC-CCCCCEEEccCC
Confidence 23477999999999999999763 459999999999999999999999999999999999999432 355679999999
Q ss_pred CcccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHHcCCC--CC
Q 039291 162 VAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEH--SL 239 (362)
Q Consensus 162 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~--~~ 239 (362)
++...... ......||+.|+|||++.+..++.++|||||||++|+|++|..||... ....+...+.... ..
T Consensus 155 ~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~---~~~~~~~~i~~~~~~~~ 227 (304)
T 2jam_A 155 LSKMEQNG----IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEE---TESKLFEKIKEGYYEFE 227 (304)
T ss_dssp TTCCCCCB----TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTS---CHHHHHHHHHHCCCCCC
T ss_pred cceecCCC----ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCC---CHHHHHHHHHcCCCCCC
Confidence 98654321 223456999999999999888999999999999999999999999654 3344444433222 12
Q ss_pred CCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCccCc
Q 039291 240 PEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGV 280 (362)
Q Consensus 240 ~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~~~~ 280 (362)
...+..++.++.+||.+||..||++|||++++++||||+..
T Consensus 228 ~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~ 268 (304)
T 2jam_A 228 SPFWDDISESAKDFICHLLEKDPNERYTCEKALSHPWIDGN 268 (304)
T ss_dssp TTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHSS
T ss_pred ccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCccccCC
Confidence 23446789999999999999999999999999999999764
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-47 Score=358.70 Aligned_cols=261 Identities=21% Similarity=0.317 Sum_probs=200.1
Q ss_pred CCceeecceecccCceEEEEEEECCCCCCCCceeeeechhhh--hhHHHHHHHHHHHHcCCCCc-----ccccccceeee
Q 039291 5 GTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVS--ASASLQKEKEVFDNLNGCPF-----VLECFGEEITM 77 (362)
Q Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~~--~~~~~~~E~~il~~l~~h~~-----i~~~~~~~~~~ 77 (362)
.++|.+++.||+|+||+||+|+++.+++ .||+|..... ....+.+|+.+++.+.+|++ |+++++.+..
T Consensus 53 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~----~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~- 127 (382)
T 2vx3_A 53 MDRYEIDSLIGKGSFGQVVKAYDRVEQE----WVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMF- 127 (382)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTE----EEEEEEECSSHHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEE-
T ss_pred eeeEEEEEEEeecCCEEEEEEEEcCCCc----EEEEEEEeccHHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeecc-
Confidence 3689999999999999999999988775 5677776432 34567789999999986775 6666655432
Q ss_pred cCCCceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH--hCCceeCCCCCCCEEEeecCCCceEE
Q 039291 78 GENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIH--DSGYVHCDVKPDNILLVATQSGKFVA 155 (362)
Q Consensus 78 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH--~~~ivH~Dlkp~Nill~~~~~~~~~~ 155 (362)
...+++||||+.+ +|.+++.......+++..++.++.|++.||.||| +.||+||||||+|||+.. +..+.+
T Consensus 128 ----~~~~~lv~e~~~~-~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~--~~~~~~ 200 (382)
T 2vx3_A 128 ----RNHLCLVFEMLSY-NLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCN--PKRSAI 200 (382)
T ss_dssp ----TTEEEEEEECCCC-BHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESS--TTSCCE
T ss_pred ----CCceEEEEecCCC-CHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEec--CCCCcE
Confidence 2357899999964 9999998865567999999999999999999999 579999999999999942 345679
Q ss_pred EEeecCCcccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHHcC
Q 039291 156 KIADLGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGD 235 (362)
Q Consensus 156 kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~ 235 (362)
||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|+|++|++||.+.+.......+.....
T Consensus 201 kL~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~ 275 (382)
T 2vx3_A 201 KIVDFGSSCQLGQR-----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLG 275 (382)
T ss_dssp EECCCTTCEETTCC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHC
T ss_pred EEEeccCceecccc-----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Confidence 99999999765431 2356799999999999999999999999999999999999999975533221111111000
Q ss_pred CCC----------------CCC--------------C-Cc----------------------------cCCHHHHHHHHH
Q 039291 236 EHS----------------LPE--------------I-PS----------------------------RVSKEARDFLRR 256 (362)
Q Consensus 236 ~~~----------------~~~--------------~-~~----------------------------~~~~~~~~li~~ 256 (362)
... .+. . +. ..+.++++||.+
T Consensus 276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~ 355 (382)
T 2vx3_A 276 IPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILR 355 (382)
T ss_dssp SCCHHHHTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHH
T ss_pred CCCHHHHHhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHH
Confidence 000 000 0 00 001478999999
Q ss_pred HhccCCCCCCCHHHHhcCCCccCcch
Q 039291 257 CFVRKPAFRFTAEMLLDDPFVKGVDE 282 (362)
Q Consensus 257 ~l~~~p~~R~s~~~~l~~p~~~~~~~ 282 (362)
||+.||++|||++++|+||||+...+
T Consensus 356 mL~~dP~~Rpta~e~L~hp~f~~~~~ 381 (382)
T 2vx3_A 356 MLDYDPKTRIQPYYALQHSFFKKTAD 381 (382)
T ss_dssp HTCSCTTTSCCHHHHTTSGGGCC---
T ss_pred hcCCChhhCCCHHHHhcCcccccCCC
Confidence 99999999999999999999987643
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-47 Score=342.97 Aligned_cols=253 Identities=25% Similarity=0.399 Sum_probs=202.8
Q ss_pred CCCceeecceecccCceEEEEEEECCCCCCCCceeeeechhhh------hhHHHHHHHHHHHHcCCCCcccccccceeee
Q 039291 4 DGTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVS------ASASLQKEKEVFDNLNGCPFVLECFGEEITM 77 (362)
Q Consensus 4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~~------~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~ 77 (362)
..++|.+++.||+|+||.||+|+++.+++ .+++|..... ....+.+|+.+++.++ ||||+++++.+..
T Consensus 9 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~----~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~- 82 (276)
T 2h6d_A 9 KIGHYVLGDTLGVGTFGKVKIGEHQLTGH----KVAVKILNRQKIRSLDVVGKIKREIQNLKLFR-HPHIIKLYQVIST- 82 (276)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTCC----EEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCC-CTTBCCEEEEEEC-
T ss_pred eeccEEEEeeecCCCCeEEEEEEECCCCc----eEEEEEeccccccchhHHHHHHHHHHHHhcCC-CCCEeEEEEEEec-
Confidence 45789999999999999999999987775 5677765332 3456889999999998 9999999987642
Q ss_pred cCCCceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEE
Q 039291 78 GENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKI 157 (362)
Q Consensus 78 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl 157 (362)
...+++||||+++++|.+++... ..+++..++.++.|++.||.|||++||+|+||||+||++ +.++.++|
T Consensus 83 ----~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~----~~~~~~~l 152 (276)
T 2h6d_A 83 ----PTDFFMVMEYVSGGELFDYICKH--GRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLL----DAHMNAKI 152 (276)
T ss_dssp ----SSEEEEEEECCCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEE----CTTSCEEE
T ss_pred ----CCeEEEEEeccCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEE----CCCCCEEE
Confidence 23477999999999999999874 459999999999999999999999999999999999999 77788999
Q ss_pred eecCCcccccccccCCCCCCccCCCCccCchhhccccC-CCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHHcCC
Q 039291 158 ADLGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQ-EAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDE 236 (362)
Q Consensus 158 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 236 (362)
+|||++....... ......||+.|+|||++.+..+ +.++||||||+++|+|++|..||... ........+...
T Consensus 153 ~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~---~~~~~~~~~~~~ 226 (276)
T 2h6d_A 153 ADFGLSNMMSDGE---FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDE---HVPTLFKKIRGG 226 (276)
T ss_dssp CCCCGGGCCCC----------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCS---SHHHHHHHHHHC
T ss_pred eecccccccCCCc---ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCC---cHHHHHHHhhcC
Confidence 9999987654321 2235579999999999987765 58899999999999999999999543 444454444332
Q ss_pred CCCCCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCccCc
Q 039291 237 HSLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGV 280 (362)
Q Consensus 237 ~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~~~~ 280 (362)
. ..++..++.++.++|.+||..||++|||+.++++||||+..
T Consensus 227 ~--~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h~~~~~~ 268 (276)
T 2h6d_A 227 V--FYIPEYLNRSVATLLMHMLQVDPLKRATIKDIREHEWFKQD 268 (276)
T ss_dssp C--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHTT
T ss_pred c--ccCchhcCHHHHHHHHHHccCChhhCCCHHHHHhChhhccC
Confidence 2 23566789999999999999999999999999999999753
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-47 Score=356.16 Aligned_cols=259 Identities=23% Similarity=0.394 Sum_probs=213.9
Q ss_pred CCCCceeecceecccCceEEEEEEECCCCC---CCCceeeeechhh----hhhHHHHHHHHHHHHcCCCCccccccccee
Q 039291 3 SDGTSWFRGRVIGQGSFGCVFIAKPKSNSS---FLPPLMAVKSAEV----SASASLQKEKEVFDNLNGCPFVLECFGEEI 75 (362)
Q Consensus 3 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~---~~~~~~~~K~~~~----~~~~~~~~E~~il~~l~~h~~i~~~~~~~~ 75 (362)
...++|.+++.||+|+||+||+|++...++ .....+++|.... .....+.+|+++++.+..||||+++++.+.
T Consensus 66 i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~ 145 (382)
T 3tt0_A 66 LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT 145 (382)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeec
Confidence 456899999999999999999999865432 2224678887643 244668899999999966999999999764
Q ss_pred eecCCCceEEEEEEEecCCCCHHHHHHHhcC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCC
Q 039291 76 TMGENGEMAYNLLLEYAAGGTLGDLIEKCNG--------------NGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPD 141 (362)
Q Consensus 76 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--------------~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~ 141 (362)
. ...+++||||+++|+|.+++..... ..+++..++.++.||+.||.|||++||+||||||+
T Consensus 146 ~-----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~ 220 (382)
T 3tt0_A 146 Q-----DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAAR 220 (382)
T ss_dssp S-----SSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGG
T ss_pred c-----CCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcc
Confidence 3 2236799999999999999987431 35999999999999999999999999999999999
Q ss_pred CEEEeecCCCceEEEEeecCCcccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHh-CCCCCcc
Q 039291 142 NILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLS-GRQAWVV 220 (362)
Q Consensus 142 Nill~~~~~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~ 220 (362)
|||+ +.++.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|+|++ |..||..
T Consensus 221 NIll----~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~ 296 (382)
T 3tt0_A 221 NVLV----TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPG 296 (382)
T ss_dssp GEEE----CTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred eEEE----cCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Confidence 9999 7778899999999986654433333345667889999999999999999999999999999999 9999954
Q ss_pred CCCCCHHHHHHHHcCCCCCCCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhcC
Q 039291 221 KEDCSIDQLFSIIGDEHSLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDD 274 (362)
Q Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~ 274 (362)
. ...++...+..... +..+..++.++.+||.+||..||++|||+.+++++
T Consensus 297 ~---~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 346 (382)
T 3tt0_A 297 V---PVEELFKLLKEGHR-MDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 346 (382)
T ss_dssp C---CHHHHHHHHHTTCC-CCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred C---CHHHHHHHHHcCCC-CCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 4 45566665554433 34567899999999999999999999999999874
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-47 Score=345.06 Aligned_cols=253 Identities=28% Similarity=0.496 Sum_probs=211.4
Q ss_pred CCceeecceecccCceEEEEEEECCCCCCCCceeeeechh----hhhhHHHHHHHHHHHHcCCCCcccccccceeeecCC
Q 039291 5 GTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAE----VSASASLQKEKEVFDNLNGCPFVLECFGEEITMGEN 80 (362)
Q Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~----~~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~ 80 (362)
..+|.+++.||+|+||.||+|++..++. .+++|... ......+.+|+.+++.++ ||||+++++.+..
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~----~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~---- 91 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQK----VVAIKIIDLEEAEDEIEDIQQEITVLSQCD-SPYVTKYYGSYLK---- 91 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCC----EEEEEEEETTTCSTTHHHHHHHHHHHHHCC-CTTBCCEEEEEEE----
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCc----EEEEEEecccccHHHHHHHHHHHHHHHhCC-CCCEeEEEEEEec----
Confidence 4679999999999999999999988775 45666543 234567899999999997 8999999987653
Q ss_pred CceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEeec
Q 039291 81 GEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADL 160 (362)
Q Consensus 81 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Df 160 (362)
...+++||||+++++|.+++.. .++++..+..++.||+.||.|||++||+||||||+||++ +.++.+||+||
T Consensus 92 -~~~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~----~~~~~~kl~Df 163 (303)
T 3a7i_A 92 -DTKLWIIMEYLGGGSALDLLEP---GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLL----SEHGEVKLADF 163 (303)
T ss_dssp -TTEEEEEEECCTTEEHHHHHTT---SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE----CTTSCEEECCC
T ss_pred -CCeEEEEEEeCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEE----CCCCCEEEeec
Confidence 2247799999999999999864 469999999999999999999999999999999999999 77788999999
Q ss_pred CCcccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHHcCCCCCC
Q 039291 161 GVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEHSLP 240 (362)
Q Consensus 161 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 240 (362)
|++........ ......||+.|+|||++.+..++.++||||||+++|+|++|..||... ........+... ..+
T Consensus 164 g~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~---~~~~~~~~~~~~-~~~ 237 (303)
T 3a7i_A 164 GVAGQLTDTQI--KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSEL---HPMKVLFLIPKN-NPP 237 (303)
T ss_dssp TTCEECBTTBC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTS---CHHHHHHHHHHS-CCC
T ss_pred ccceecCcccc--ccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCc---CHHHHHHHhhcC-CCC
Confidence 99976554221 123567999999999999989999999999999999999999999543 333333333222 234
Q ss_pred CCCccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCccCc
Q 039291 241 EIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGV 280 (362)
Q Consensus 241 ~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~~~~ 280 (362)
.++..++.++.+||.+||..||++|||+.++++||||...
T Consensus 238 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~ 277 (303)
T 3a7i_A 238 TLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFILRN 277 (303)
T ss_dssp CCCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTCHHHHHH
T ss_pred CCccccCHHHHHHHHHHcCCChhhCcCHHHHhhChhhhcC
Confidence 5667889999999999999999999999999999999653
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-47 Score=351.09 Aligned_cols=264 Identities=20% Similarity=0.275 Sum_probs=204.3
Q ss_pred CCCceeecceecccCceEEEEEEEC-CCCCCCCceeeeechhh--hhhHHHHHHHHHHHHcCC-----CCccccccccee
Q 039291 4 DGTSWFRGRVIGQGSFGCVFIAKPK-SNSSFLPPLMAVKSAEV--SASASLQKEKEVFDNLNG-----CPFVLECFGEEI 75 (362)
Q Consensus 4 ~~~~y~~~~~lG~G~~g~V~~a~~~-~~~~~~~~~~~~K~~~~--~~~~~~~~E~~il~~l~~-----h~~i~~~~~~~~ 75 (362)
-+++|.+++.||+|+||+||+|.+. .++ ..|++|.... .....+.+|+.+++.+++ |++++++++.+.
T Consensus 12 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~----~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~ 87 (339)
T 1z57_A 12 LSARYEIVDTLGEGAFGKVVECIDHKAGG----RHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFE 87 (339)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTT----EEEEEEEECSSHHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEE
T ss_pred ccCceEEEEEEecCCCeEEEEEEecCCCC----cEEEEEEEecCCchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccc
Confidence 3579999999999999999999984 344 3577777643 234668899999998872 335788877654
Q ss_pred eecCCCceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCC----
Q 039291 76 TMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSG---- 151 (362)
Q Consensus 76 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~---- 151 (362)
. ...+++||||+ +++|.+++......++++..++.++.||+.||+|||++||+||||||+|||+...+..
T Consensus 88 ~-----~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~ 161 (339)
T 1z57_A 88 H-----HGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYN 161 (339)
T ss_dssp E-----TTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC
T ss_pred c-----CCcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccC
Confidence 2 23578999999 8899999988655579999999999999999999999999999999999999432100
Q ss_pred -----------ceEEEEeecCCcccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHhCCCCCcc
Q 039291 152 -----------KFVAKIADLGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVV 220 (362)
Q Consensus 152 -----------~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~ 220 (362)
++.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|+|++|..||..
T Consensus 162 ~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~ 236 (339)
T 1z57_A 162 PKIKRDERTLINPDIKVVDFGSATYDDEH-----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPT 236 (339)
T ss_dssp ----CEEEEESCCCEEECCCSSCEETTSC-----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred CccccccccccCCCceEeeCcccccCccc-----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCC
Confidence 557999999999754321 2356799999999999998999999999999999999999999976
Q ss_pred CCCCCHHHHHHHHcCCCC-------------------C--------------------CCCCccCCHHHHHHHHHHhccC
Q 039291 221 KEDCSIDQLFSIIGDEHS-------------------L--------------------PEIPSRVSKEARDFLRRCFVRK 261 (362)
Q Consensus 221 ~~~~~~~~~~~~~~~~~~-------------------~--------------------~~~~~~~~~~~~~li~~~l~~~ 261 (362)
.+.......+..+..... + ...+...+.++.+||.+||..|
T Consensus 237 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~d 316 (339)
T 1z57_A 237 HDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYD 316 (339)
T ss_dssp SCHHHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSS
T ss_pred CChHHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcC
Confidence 543222222222211000 0 0011234578999999999999
Q ss_pred CCCCCCHHHHhcCCCccCcch
Q 039291 262 PAFRFTAEMLLDDPFVKGVDE 282 (362)
Q Consensus 262 p~~R~s~~~~l~~p~~~~~~~ 282 (362)
|.+|||+.++++||||+.+.+
T Consensus 317 P~~Rpt~~ell~hp~f~~~~~ 337 (339)
T 1z57_A 317 PAKRITLREALKHPFFDLLKK 337 (339)
T ss_dssp TTTSCCHHHHTTSGGGGGGGC
T ss_pred cccccCHHHHhcCHHHHHHhc
Confidence 999999999999999987654
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-48 Score=350.16 Aligned_cols=264 Identities=24% Similarity=0.385 Sum_probs=189.8
Q ss_pred CCCCceeecceecccCceEEEEEEECCCCCCCCceeeeechhh----hhhHHHHHHHHHHHHcCCCCcccccccceeeec
Q 039291 3 SDGTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEV----SASASLQKEKEVFDNLNGCPFVLECFGEEITMG 78 (362)
Q Consensus 3 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~----~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~ 78 (362)
...++|.+++.||+|+||.||+|.+..+++ .|++|.... ...+.+.+|+.++++++ ||||+++++.+...
T Consensus 12 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~----~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~- 85 (303)
T 2vwi_A 12 INRDDYELQEVIGSGATAVVQAAYCAPKKE----KVAIKRINLEKCQTSMDELLKEIQAMSQCH-HPNIVSYYTSFVVK- 85 (303)
T ss_dssp -CCCCCEEEEECC---CCCEEEEEC----C----EEEEECCC----------------CCCCCC-CTTBCCEEEEEESS-
T ss_pred cchhhhhhhheeccccceEEEEEEECCCCc----EEEEEEEEhhhcchhHHHHHHHHHHHhhcC-CCCEeeEEEEEeec-
Confidence 467899999999999999999999887764 677776543 23456788999999997 99999999876532
Q ss_pred CCCceEEEEEEEecCCCCHHHHHHHh------cCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCc
Q 039291 79 ENGEMAYNLLLEYAAGGTLGDLIEKC------NGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGK 152 (362)
Q Consensus 79 ~~~~~~~~lv~e~~~~~~L~~~l~~~------~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~ 152 (362)
..+++||||++|++|.+++... ....+++..++.++.||+.||.|||++||+||||||+||++ +.+
T Consensus 86 ----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~----~~~ 157 (303)
T 2vwi_A 86 ----DELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILL----GED 157 (303)
T ss_dssp ----SCEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEE----CTT
T ss_pred ----CCcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEE----cCC
Confidence 2367999999999999999752 23459999999999999999999999999999999999999 778
Q ss_pred eEEEEeecCCccccccccc---CCCCCCccCCCCccCchhhcc-ccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHH
Q 039291 153 FVAKIADLGVAKRSRHCKR---QKFDPSMRGTPLYLAPETVVQ-HMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQ 228 (362)
Q Consensus 153 ~~~kl~Dfgla~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~ 228 (362)
+.+||+|||++........ ........||+.|+|||++.+ ..++.++|||||||++|+|++|..||........
T Consensus 158 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-- 235 (303)
T 2vwi_A 158 GSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKV-- 235 (303)
T ss_dssp CCEEECCCHHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGH--
T ss_pred CCEEEEeccchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhH--
Confidence 8899999999875543211 112235679999999999976 5689999999999999999999999976543222
Q ss_pred HHHHHcCCC-------CCCCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCccCcch
Q 039291 229 LFSIIGDEH-------SLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGVDE 282 (362)
Q Consensus 229 ~~~~~~~~~-------~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~~~~~~ 282 (362)
......... ..+.....++.++.++|.+||..||.+||++.++++||||+....
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~ 296 (303)
T 2vwi_A 236 LMLTLQNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKAKN 296 (303)
T ss_dssp HHHHHTSSCCCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTTC-----
T ss_pred HHHHhccCCCccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhChhhhcCCC
Confidence 222222111 112234568899999999999999999999999999999987654
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-47 Score=351.28 Aligned_cols=270 Identities=20% Similarity=0.330 Sum_probs=194.3
Q ss_pred CCCCceeecceecccCceEEEEEEECCCCCCCCceeeeechhh-----hhhHHHHHHHHHHHHcCCCCcccccccceeee
Q 039291 3 SDGTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEV-----SASASLQKEKEVFDNLNGCPFVLECFGEEITM 77 (362)
Q Consensus 3 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~-----~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~ 77 (362)
+..++|.+++.||+|+||+||+|+++.++.. ...+++|.... ...+.+.+|+.++++++ ||||+++++++...
T Consensus 20 i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~ 97 (323)
T 3qup_A 20 IPEQQFTLGRMLGKGEFGSVREAQLKQEDGS-FVKVAVKMLKADIIASSDIEEFLREAACMKEFD-HPHVAKLVGVSLRS 97 (323)
T ss_dssp CC---CEEEEEEEEETTEEEEEEEC--------CEEEEEEC------CHHHHHHHHHHHHHTTCC-CTTBCCCCEEEECC
T ss_pred cChhHeEEeceecccCCeEEEEEEEcccCCc-ceeEEEEEecccccCHHHHHHHHHHHHHHHHCC-CCceehhhceeecc
Confidence 4578999999999999999999998776532 13577776543 34567889999999997 99999999977543
Q ss_pred cCCC-ceEEEEEEEecCCCCHHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCc
Q 039291 78 GENG-EMAYNLLLEYAAGGTLGDLIEKCNG----NGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGK 152 (362)
Q Consensus 78 ~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~----~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~ 152 (362)
.... ....++||||+.+++|.+++..... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.+
T Consensus 98 ~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli----~~~ 173 (323)
T 3qup_A 98 RAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCML----AED 173 (323)
T ss_dssp -------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE----CTT
T ss_pred ccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEE----cCC
Confidence 2211 1223799999999999999976432 259999999999999999999999999999999999999 777
Q ss_pred eEEEEeecCCcccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHh-CCCCCccCCCCCHHHHHH
Q 039291 153 FVAKIADLGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLS-GRQAWVVKEDCSIDQLFS 231 (362)
Q Consensus 153 ~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~ 231 (362)
+.+||+|||+++...............+++.|+|||++.+..++.++|||||||++|+|++ |..||...... +...
T Consensus 174 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~---~~~~ 250 (323)
T 3qup_A 174 MTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENA---EIYN 250 (323)
T ss_dssp SCEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG---GHHH
T ss_pred CCEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChH---HHHH
Confidence 8899999999986654333333334557888999999999999999999999999999999 99999765433 3333
Q ss_pred HHcCCCCCCCCCccCCHHHHHHHHHHhccCCCCCCC-------HHHHhcCCCccCcch
Q 039291 232 IIGDEHSLPEIPSRVSKEARDFLRRCFVRKPAFRFT-------AEMLLDDPFVKGVDE 282 (362)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s-------~~~~l~~p~~~~~~~ 282 (362)
.+.... .+..+..++.++.+||.+||..||++||| +++++.|||+....+
T Consensus 251 ~~~~~~-~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~~~~ 307 (323)
T 3qup_A 251 YLIGGN-RLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLSTSQ 307 (323)
T ss_dssp HHHTTC-CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC--------
T ss_pred HHhcCC-CCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcCCCC
Confidence 333333 23456678999999999999999999999 677888999876533
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-47 Score=352.87 Aligned_cols=265 Identities=23% Similarity=0.352 Sum_probs=193.7
Q ss_pred CceeecceecccCceEEEEEEECCCCCCCCceeeeechhh--hhhHHHHHHHHHHHHcCCCCcccccccceeeecC--CC
Q 039291 6 TSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEV--SASASLQKEKEVFDNLNGCPFVLECFGEEITMGE--NG 81 (362)
Q Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~--~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~--~~ 81 (362)
++|.+++.||+|+||+||+|+++.++. .|++|.... .......+|++.+..++ ||||+++++++..... ..
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~----~vavK~~~~~~~~~~~~~~~~~~l~~l~-h~niv~~~~~~~~~~~~~~~ 97 (360)
T 3e3p_A 23 DRFQVERMAGQGTFGTVQLGKEKSTGM----SVAIKKVIQDPRFRNRELQIMQDLAVLH-HPNIVQLQSYFYTLGERDRR 97 (360)
T ss_dssp TTEEEC----------CEEEEETTTCC----EEEEEEEECCTTCCCHHHHHHHHHHHHC-CTTBCCEEEEEEEECSSCTT
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCC----EEEEEEEecCccccHHHHHHHHHHHhcC-CCCcccHHHhhhcccccccc
Confidence 689999999999999999999988875 566665432 23345667788888888 9999999998766433 23
Q ss_pred ceEEEEEEEecCCCCHHHHHHH--hcCCCCCHHHHHHHHHHHHHHHHHHH--hCCceeCCCCCCCEEEeecCCC-ceEEE
Q 039291 82 EMAYNLLLEYAAGGTLGDLIEK--CNGNGLPEKDVRHFTRCILEGIGHIH--DSGYVHCDVKPDNILLVATQSG-KFVAK 156 (362)
Q Consensus 82 ~~~~~lv~e~~~~~~L~~~l~~--~~~~~l~~~~~~~i~~ql~~~l~yLH--~~~ivH~Dlkp~Nill~~~~~~-~~~~k 156 (362)
...+++||||+.+ +|.+.+.. .....+++..++.++.|++.||.||| ++||+||||||+|||+ +. ++.+|
T Consensus 98 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll----~~~~~~~k 172 (360)
T 3e3p_A 98 DIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLV----NEADGTLK 172 (360)
T ss_dssp CEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEE----ETTTTEEE
T ss_pred ceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEE----eCCCCcEE
Confidence 4457899999986 66555443 23456999999999999999999999 9999999999999999 43 67899
Q ss_pred EeecCCcccccccccCCCCCCccCCCCccCchhhccc-cCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHH-HHHHc
Q 039291 157 IADLGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQH-MQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQL-FSIIG 234 (362)
Q Consensus 157 l~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~-~~~~~ 234 (362)
|+|||+++...... ......||+.|+|||++.+. .++.++|||||||++|+|++|+.||........... .....
T Consensus 173 l~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~ 249 (360)
T 3e3p_A 173 LCDFGSAKKLSPSE---PNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLG 249 (360)
T ss_dssp ECCCTTCBCCCTTS---CCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHC
T ss_pred EeeCCCceecCCCC---CcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcC
Confidence 99999998655322 22356789999999999765 489999999999999999999999976532221111 11110
Q ss_pred C-----------CC---------------CCCCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCccCcchh
Q 039291 235 D-----------EH---------------SLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGVDEE 283 (362)
Q Consensus 235 ~-----------~~---------------~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~~~~~~~ 283 (362)
. .. .++..+...+.++++||.+||+.||.+|||+.++++||||+.+...
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~ 324 (360)
T 3e3p_A 250 CPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELHDP 324 (360)
T ss_dssp CCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGGGCT
T ss_pred CCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccccccCCc
Confidence 0 00 0112223367899999999999999999999999999999887543
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-47 Score=336.71 Aligned_cols=251 Identities=19% Similarity=0.305 Sum_probs=208.1
Q ss_pred CCCCceeecceecccCceEEEEEEECCCCCCCCceeeeechhhh--hhHHHHHHHHHHHHcCCCCcccccccceeeecCC
Q 039291 3 SDGTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVS--ASASLQKEKEVFDNLNGCPFVLECFGEEITMGEN 80 (362)
Q Consensus 3 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~~--~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~ 80 (362)
...++|.+.+.||+|+||+||+|++..++ .+++|..... ..+.+.+|+.++++++ ||||+++++++..
T Consensus 7 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~-----~vavK~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~---- 76 (269)
T 4hcu_A 7 IDPSELTFVQEIGSGQFGLVHLGYWLNKD-----KVAIKTIREGAMSEEDFIEEAEVMMKLS-HPKLVQLYGVCLE---- 76 (269)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTE-----EEEEEEECTTSBCHHHHHHHHHHHHTCC-CTTBCCEEEEECS----
T ss_pred eChhhceeeheecCCCccEEEEEEecCCC-----eEEEEEecccccCHHHHHHHHHHHHhCC-CCCEeeEEEEEec----
Confidence 45689999999999999999999987543 5777776533 3466889999999998 8999999987642
Q ss_pred CceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEeec
Q 039291 81 GEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADL 160 (362)
Q Consensus 81 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Df 160 (362)
...+++||||+++++|.+++... ...+++..++.++.|++.||.|||++||+||||||+||++ +.++.+||+||
T Consensus 77 -~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~----~~~~~~kl~Df 150 (269)
T 4hcu_A 77 -QAPICLVFEFMEHGCLSDYLRTQ-RGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLV----GENQVIKVSDF 150 (269)
T ss_dssp -SSSEEEEEECCTTCBHHHHHHTT-TTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE----CGGGCEEECCT
T ss_pred -CCceEEEEEeCCCCcHHHHHHhc-CcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEE----cCCCCEEeccc
Confidence 23367999999999999999763 3469999999999999999999999999999999999999 77788999999
Q ss_pred CCcccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHh-CCCCCccCCCCCHHHHHHHHcCCCCC
Q 039291 161 GVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLS-GRQAWVVKEDCSIDQLFSIIGDEHSL 239 (362)
Q Consensus 161 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~ 239 (362)
|++......... ......+|+.|+|||++.+..++.++||||||+++|+|++ |..||... ...+....+.... .
T Consensus 151 g~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~---~~~~~~~~~~~~~-~ 225 (269)
T 4hcu_A 151 GMTRFVLDDQYT-SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENR---SNSEVVEDISTGF-R 225 (269)
T ss_dssp TGGGGBCCHHHH-STTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC---CHHHHHHHHHTTC-C
T ss_pred cccccccccccc-cccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCC---CHHHHHHHHhcCc-c
Confidence 999765432221 2234557888999999998899999999999999999999 99999543 4455555554432 2
Q ss_pred CCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhcC
Q 039291 240 PEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDD 274 (362)
Q Consensus 240 ~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~ 274 (362)
+..+..++.++.+++.+||..||++||++.+++++
T Consensus 226 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~ 260 (269)
T 4hcu_A 226 LYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQ 260 (269)
T ss_dssp CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 34566789999999999999999999999999874
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-47 Score=358.72 Aligned_cols=251 Identities=20% Similarity=0.338 Sum_probs=205.6
Q ss_pred CCCceeecceecccCceEEEEEEECCCCCCCCceeeeechhh----hhhHHHHHHHHHHHHcCCCCcccccccceeeecC
Q 039291 4 DGTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEV----SASASLQKEKEVFDNLNGCPFVLECFGEEITMGE 79 (362)
Q Consensus 4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~----~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~ 79 (362)
..++|.+++.||+|+||+||+|+++.++. .|++|.... .....+.+|+.++++++ ||||+++++++..
T Consensus 112 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~----~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~--- 183 (377)
T 3cbl_A 112 NHEDLVLGEQIGRGNFGEVFSGRLRADNT----LVAVKSCRETLPPDLKAKFLQEARILKQYS-HPNIVRLIGVCTQ--- 183 (377)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCC----EEEEEECCTTSCHHHHTTTTHHHHHHTTCC-CTTBCCEEEEECS---
T ss_pred chHHeEEeeEeccCCCCeEEEEEEecCCe----EEEEEEccccCCHHHHHHHHHHHHHHHhCC-CCCEEEEEEEEec---
Confidence 45789999999999999999999987765 567776543 23456789999999998 9999999997642
Q ss_pred CCceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEee
Q 039291 80 NGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIAD 159 (362)
Q Consensus 80 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~D 159 (362)
...+++||||+++|+|.+++... +..+++..+..++.|++.||+|||++||+||||||+|||+ +.++.+||+|
T Consensus 184 --~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~----~~~~~~kl~D 256 (377)
T 3cbl_A 184 --KQPIYIVMELVQGGDFLTFLRTE-GARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLV----TEKNVLKISD 256 (377)
T ss_dssp --SSSCEEEEECCTTCBHHHHHHHH-GGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE----CTTCCEEECC
T ss_pred --CCCcEEEEEcCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEE----cCCCcEEECc
Confidence 22367999999999999999863 3459999999999999999999999999999999999999 7788999999
Q ss_pred cCCcccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHh-CCCCCccCCCCCHHHHHHHHcCCCC
Q 039291 160 LGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLS-GRQAWVVKEDCSIDQLFSIIGDEHS 238 (362)
Q Consensus 160 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~ 238 (362)
||+++...............+++.|+|||++.+..++.++|||||||++|||++ |..||... ...+....+.....
T Consensus 257 fG~s~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~---~~~~~~~~~~~~~~ 333 (377)
T 3cbl_A 257 FGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNL---SNQQTREFVEKGGR 333 (377)
T ss_dssp GGGCEECTTSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTS---CHHHHHHHHHTTCC
T ss_pred CCCceecCCCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC---CHHHHHHHHHcCCC
Confidence 999975443221111122345778999999998889999999999999999998 99999654 34444445544433
Q ss_pred CCCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhc
Q 039291 239 LPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLD 273 (362)
Q Consensus 239 ~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~ 273 (362)
. ..+..++.++.+||.+||..||++|||+.++++
T Consensus 334 ~-~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~ 367 (377)
T 3cbl_A 334 L-PCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQ 367 (377)
T ss_dssp C-CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred C-CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 3 456778999999999999999999999999875
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-47 Score=353.98 Aligned_cols=265 Identities=21% Similarity=0.255 Sum_probs=201.2
Q ss_pred CCCCceeecceecccCceEEEEEEECCCCCC-CCceeeeechhhhhhHHHHHHHHHHHHcCC--------------CCcc
Q 039291 3 SDGTSWFRGRVIGQGSFGCVFIAKPKSNSSF-LPPLMAVKSAEVSASASLQKEKEVFDNLNG--------------CPFV 67 (362)
Q Consensus 3 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~-~~~~~~~K~~~~~~~~~~~~E~~il~~l~~--------------h~~i 67 (362)
..+++|.+++.||+|+||+||+|.++.++.. ....|++|...... ..+.+|+++++++.+ ||||
T Consensus 32 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~i 110 (364)
T 3op5_A 32 MAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDN-GPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGV 110 (364)
T ss_dssp TTCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTC-HHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCS
T ss_pred cCCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccc-hhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCC
Confidence 4678999999999999999999999876432 24578888765432 234555555555443 9999
Q ss_pred cccccceeeecCCCceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEee
Q 039291 68 LECFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVA 147 (362)
Q Consensus 68 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~ 147 (362)
+++++.+.... .....+++||||+ |++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||+..
T Consensus 111 v~~~~~~~~~~-~~~~~~~lv~e~~-g~~L~~~~~~~-~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~ 187 (364)
T 3op5_A 111 PKYWGSGLHDK-NGKSYRFMIMDRF-GSDLQKIYEAN-AKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNY 187 (364)
T ss_dssp CCEEEEEEEEE-TTEEEEEEEEECE-EEEHHHHHHHT-TSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEES
T ss_pred CeEEeeeeecc-CCcceEEEEEeCC-CCCHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEec
Confidence 99999876543 3345678999999 99999999873 356999999999999999999999999999999999999942
Q ss_pred cCCCceEEEEeecCCcccccccccCC-----CCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHhCCCCCccCC
Q 039291 148 TQSGKFVAKIADLGVAKRSRHCKRQK-----FDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKE 222 (362)
Q Consensus 148 ~~~~~~~~kl~Dfgla~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~ 222 (362)
+..+.+||+|||+++......... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||....
T Consensus 188 --~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~ 265 (364)
T 3op5_A 188 --KNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNL 265 (364)
T ss_dssp --SCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGT
T ss_pred --CCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccc
Confidence 156789999999997655432211 1134569999999999999899999999999999999999999997543
Q ss_pred CCCHHHHHHHHcCCCCCCC------CCccCCHHHHHHHHHHhccCCCCCCCHHHHhc
Q 039291 223 DCSIDQLFSIIGDEHSLPE------IPSRVSKEARDFLRRCFVRKPAFRFTAEMLLD 273 (362)
Q Consensus 223 ~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~ 273 (362)
.................+. ....++.++.+++..||..||++||++.++++
T Consensus 266 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~ 322 (364)
T 3op5_A 266 KDPKYVRDSKIRYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRD 322 (364)
T ss_dssp TCHHHHHHHHHHHHHCHHHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred cCHHHHHHHHHHhhhhHHHHHHHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHH
Confidence 3221111111100000000 01457899999999999999999999999876
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-47 Score=342.10 Aligned_cols=263 Identities=23% Similarity=0.335 Sum_probs=202.9
Q ss_pred CceeecceecccCceEEEEEEECCCCCCCCceeeeechhh--hhhHHHHHHHHHHHHcCCCCcccccccceeeec-----
Q 039291 6 TSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEV--SASASLQKEKEVFDNLNGCPFVLECFGEEITMG----- 78 (362)
Q Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~--~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~----- 78 (362)
++|.+++.||+|+||.||+|++..++. .+++|.... .....+.+|+.+++.++ ||||+++++.+....
T Consensus 6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~----~vaiK~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~~~ 80 (303)
T 1zy4_A 6 SDFEEIAVLGQGAFGQVVKARNALDSR----YYAIKKIRHTEEKLSTILSEVMLLASLN-HQYVVRYYAAWLERRNFVKP 80 (303)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCC----EEEEEEEEEEHHHHHHHHHHHHHHTTCC-CTTBCCEEEEEEECCCCCC-
T ss_pred ccchhhheeccCCcEEEEEEEEcCCCe----EEEEEEEeccHHHHHHHHHHHHHHHhcC-chHHHHHHHHHHhhcchhhh
Confidence 589999999999999999999988775 566666532 34567889999999998 999999998765421
Q ss_pred ---CCCceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEE
Q 039291 79 ---ENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVA 155 (362)
Q Consensus 79 ---~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~ 155 (362)
......+++||||+++++|.+++... ...+++..++.++.|++.||.|||++||+||||||+||++ +.++.+
T Consensus 81 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~----~~~~~~ 155 (303)
T 1zy4_A 81 MTAVKKKSTLFIQMEYCENGTLYDLIHSE-NLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFI----DESRNV 155 (303)
T ss_dssp -----CEEEEEEEEECCCSCBHHHHHHHS-CGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE----CTTSCE
T ss_pred hcccccCCceEEEEecCCCCCHHHhhhcc-ccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEE----cCCCCE
Confidence 12355678999999999999999863 3458899999999999999999999999999999999999 777889
Q ss_pred EEeecCCccccccccc------------CCCCCCccCCCCccCchhhccc-cCCCcchHHHHHHHHHHHHhCCCCCccCC
Q 039291 156 KIADLGVAKRSRHCKR------------QKFDPSMRGTPLYLAPETVVQH-MQEAPSDIWALGCVVLEMLSGRQAWVVKE 222 (362)
Q Consensus 156 kl~Dfgla~~~~~~~~------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~ 222 (362)
||+|||++........ ........||+.|+|||++.+. .++.++|||||||++|+|++ ||....
T Consensus 156 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~ 232 (303)
T 1zy4_A 156 KIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGM 232 (303)
T ss_dssp EECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHH
T ss_pred EEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCch
Confidence 9999999975542110 1122356799999999999864 68999999999999999998 553211
Q ss_pred CCCHHHHHHHHcCC--CCCCCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCccCcchh
Q 039291 223 DCSIDQLFSIIGDE--HSLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGVDEE 283 (362)
Q Consensus 223 ~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~~~~~~~ 283 (362)
+.......+... ...+.++...+..++++|.+||..||.+|||+.++++||||+...++
T Consensus 233 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~ 293 (303)
T 1zy4_A 233 --ERVNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPVKHQD 293 (303)
T ss_dssp --HHHHHHHHHHSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSCSCCCCHH
T ss_pred --hHHHHHHhccccccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCCCCcCCCChH
Confidence 122333333221 22234556678899999999999999999999999999999876554
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-47 Score=351.93 Aligned_cols=264 Identities=22% Similarity=0.320 Sum_probs=184.8
Q ss_pred CCceeec-ceecccCceEEEEEEECCCCCCCCceeeeechhhhhhHHHHHHHHHHHHcCCCCcccccccceeeecCCCce
Q 039291 5 GTSWFRG-RVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVSASASLQKEKEVFDNLNGCPFVLECFGEEITMGENGEM 83 (362)
Q Consensus 5 ~~~y~~~-~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~~~~ 83 (362)
.++|.+. +.||+|+||+||+|+++.+++ .|++|..... ....+|+..+.++.+||||+++++++.... ....
T Consensus 27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~----~vavK~~~~~--~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~-~~~~ 99 (336)
T 3fhr_A 27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQ----KCALKLLYDS--PKARQEVDHHWQASGGPHIVCILDVYENMH-HGKR 99 (336)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCC----EEEEEEEESS--HHHHHHHHHHHHHTTSTTBCCEEEEEEEEE-TTEE
T ss_pred cceeEecceeeeeCCCeEEEEEEECCCCC----EEEEEEecCc--HHHHHHHHHHHHhcCCCChHHHHHHHhhcc-CCCc
Confidence 4689995 569999999999999998875 6777776433 233455555444555999999999775433 3345
Q ss_pred EEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEeecCCc
Q 039291 84 AYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVA 163 (362)
Q Consensus 84 ~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Dfgla 163 (362)
.+++||||++||+|.+++.......+++..++.++.||+.||.|||++||+||||||+|||+..+ +..+.+||+|||++
T Consensus 100 ~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~-~~~~~~kl~Dfg~~ 178 (336)
T 3fhr_A 100 CLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSK-EKDAVLKLTDFGFA 178 (336)
T ss_dssp EEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCS-STTCCEEECCCTTC
T ss_pred eEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEec-CCCceEEEeccccc
Confidence 57899999999999999987655679999999999999999999999999999999999999432 23566999999999
Q ss_pred ccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHH-HHHHHcC--CCCCC
Q 039291 164 KRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQ-LFSIIGD--EHSLP 240 (362)
Q Consensus 164 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~-~~~~~~~--~~~~~ 240 (362)
...... ......||+.|+|||++.+..++.++|||||||++|+|++|..||.......... ....+.. .....
T Consensus 179 ~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 254 (336)
T 3fhr_A 179 KETTQN----ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPN 254 (336)
T ss_dssp EEC--------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC---------------------CCCT
T ss_pred eecccc----ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhccccccCc
Confidence 755432 1235678999999999988889999999999999999999999997654332211 1111111 11111
Q ss_pred CCCccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCccCc
Q 039291 241 EIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGV 280 (362)
Q Consensus 241 ~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~~~~ 280 (362)
..+..++.++++||.+||..||++|||+.++++||||++.
T Consensus 255 ~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~ 294 (336)
T 3fhr_A 255 PEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQS 294 (336)
T ss_dssp TTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTG
T ss_pred hhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCcccccc
Confidence 2235689999999999999999999999999999999763
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-47 Score=353.64 Aligned_cols=260 Identities=21% Similarity=0.276 Sum_probs=207.5
Q ss_pred CCCCceeecceecccCceEEEEEEECCCCC-CCCceeeeechhh----hhhHHHHHHHHHHHHcCCCCcccccccceeee
Q 039291 3 SDGTSWFRGRVIGQGSFGCVFIAKPKSNSS-FLPPLMAVKSAEV----SASASLQKEKEVFDNLNGCPFVLECFGEEITM 77 (362)
Q Consensus 3 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~-~~~~~~~~K~~~~----~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~ 77 (362)
...++|.+++.||+|+||+||+|++..... .....|++|.... .....+.+|+.+++++..||||+++++.+..
T Consensus 42 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~- 120 (344)
T 1rjb_A 42 FPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTL- 120 (344)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred cCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEee-
Confidence 456789999999999999999999843221 1234677777543 3456788999999999669999999997643
Q ss_pred cCCCceEEEEEEEecCCCCHHHHHHHhcC---------------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeC
Q 039291 78 GENGEMAYNLLLEYAAGGTLGDLIEKCNG---------------------NGLPEKDVRHFTRCILEGIGHIHDSGYVHC 136 (362)
Q Consensus 78 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~---------------------~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~ 136 (362)
...+++||||+++|+|.+++..... ..+++..++.++.||+.||.|||++||+||
T Consensus 121 ----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~ 196 (344)
T 1rjb_A 121 ----SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHR 196 (344)
T ss_dssp ----SSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEET
T ss_pred ----CCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccC
Confidence 2236799999999999999986432 238999999999999999999999999999
Q ss_pred CCCCCCEEEeecCCCceEEEEeecCCcccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHh-CC
Q 039291 137 DVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLS-GR 215 (362)
Q Consensus 137 Dlkp~Nill~~~~~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~ 215 (362)
||||+|||+ +.++.+||+|||++................||+.|+|||++.+..++.++|||||||++|+|++ |.
T Consensus 197 Dikp~NIll----~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~ 272 (344)
T 1rjb_A 197 DLAARNVLV----THGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGV 272 (344)
T ss_dssp TCSGGGEEE----ETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSC
T ss_pred CCChhhEEE----cCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCC
Confidence 999999999 6777899999999986654333323345668889999999999899999999999999999998 99
Q ss_pred CCCccCCCCCHHHHHHHHcCCCCCCCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhcC
Q 039291 216 QAWVVKEDCSIDQLFSIIGDEHSLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDD 274 (362)
Q Consensus 216 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~ 274 (362)
.||...... ......+.. ...+..+..++.++.+||.+||..||.+|||+.+++++
T Consensus 273 ~p~~~~~~~--~~~~~~~~~-~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 328 (344)
T 1rjb_A 273 NPYPGIPVD--ANFYKLIQN-GFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 328 (344)
T ss_dssp CSSTTCCCS--HHHHHHHHT-TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCcccCCcH--HHHHHHHhc-CCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence 999665432 222233322 23344567789999999999999999999999999985
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-47 Score=352.66 Aligned_cols=260 Identities=22% Similarity=0.353 Sum_probs=201.5
Q ss_pred CCceeecceecccCceEEEEEEECCCCCCCCceeeeechhh-----hhhHHHHHHHHHHHHcCCCCcccccccceeeecC
Q 039291 5 GTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEV-----SASASLQKEKEVFDNLNGCPFVLECFGEEITMGE 79 (362)
Q Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~-----~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~ 79 (362)
.++|.+++.||+|+||+||+|+++.+++ .|++|.... .....+.+|+.+++.++ ||||+++++++.....
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~----~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~ 115 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRSGE----KVAIKKLSRPFQSEIFAKRAYRELLLLKHMQ-HENVIGLLDVFTPASS 115 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTE----EEEEEEECSTTSSHHHHHHHHHHHHHHHHCC-CTTBCCCSEEECSCSS
T ss_pred cccEEEEeEEecCCCeEEEEEEECCCCC----EEEEEEecccccchhHHHHHHHHHHHHHhcC-CCCchhhhhheeccCC
Confidence 3689999999999999999999998875 566666532 23467889999999999 9999999997754221
Q ss_pred C-CceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEe
Q 039291 80 N-GEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIA 158 (362)
Q Consensus 80 ~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~ 158 (362)
. ....+++||||+. ++|.+++. ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+
T Consensus 116 ~~~~~~~~lv~e~~~-~~l~~~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll----~~~~~~kL~ 186 (371)
T 4exu_A 116 LRNFYDFYLVMPFMQ-TDLQKIMG----MEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAV----NEDCELKIL 186 (371)
T ss_dssp STTCCCCEEEEECCC-EEHHHHTT----SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE----CTTCCEEEC
T ss_pred cccceeEEEEEcccc-ccHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEE----CCCCCEEEE
Confidence 1 1122479999997 58887763 349999999999999999999999999999999999999 778889999
Q ss_pred ecCCcccccccccCCCCCCccCCCCccCchhhcc-ccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHH-HHHcC-
Q 039291 159 DLGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQ-HMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLF-SIIGD- 235 (362)
Q Consensus 159 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~-~~~~~- 235 (362)
|||+++..... .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...+.......+ .....
T Consensus 187 Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~ 261 (371)
T 4exu_A 187 DFGLARHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVP 261 (371)
T ss_dssp STTCC-------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred ecCcccccccC-----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Confidence 99999755432 235678999999999987 67899999999999999999999999654321111111 11100
Q ss_pred ----------------------C--CCCCCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCccCcchh
Q 039291 236 ----------------------E--HSLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGVDEE 283 (362)
Q Consensus 236 ----------------------~--~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~~~~~~~ 283 (362)
. ..+...+..+++++++||.+||..||++|||++++++||||+.....
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~ 333 (371)
T 4exu_A 262 GTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRDP 333 (371)
T ss_dssp CHHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTCCG
T ss_pred cHHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCcccccCCCc
Confidence 0 00011224578999999999999999999999999999999876543
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-47 Score=347.67 Aligned_cols=255 Identities=22% Similarity=0.294 Sum_probs=204.4
Q ss_pred CCCceeecceecccCceEEEEEEECCCCCCCCceeeeechhhhh--hHHHHHHHHHHHHcCCCCcccccccceeeecCCC
Q 039291 4 DGTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVSA--SASLQKEKEVFDNLNGCPFVLECFGEEITMGENG 81 (362)
Q Consensus 4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~~~--~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~~ 81 (362)
..++|.+++.||+|+||+||+|++.+ ..||+|...... .....+|+.++++++ ||||+++++++..... .
T Consensus 22 ~~~~y~~~~~lg~G~~g~Vy~~~~~~------~~vavK~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~-~ 93 (322)
T 3soc_A 22 QSMPLQLLEVKARGRFGCVWKAQLLN------EYVAVKIFPIQDKQSWQNEYEVYSLPGMK-HENILQFIGAEKRGTS-V 93 (322)
T ss_dssp TTEEEEEEEEEECSTTCEEEEEEETT------EEEEEEEECGGGHHHHHHHHHHHTSTTCC-CTTBCCEEEEEEEECS-S
T ss_pred chhhchhhheecccCceEEEEEEECC------CEEEEEEeecCchHHHHHHHHHHHHhcCC-CCCchhhcceeccCCC-C
Confidence 46799999999999999999998863 367888765443 334556888899998 9999999998765332 2
Q ss_pred ceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC----------CceeCCCCCCCEEEeecCCC
Q 039291 82 EMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDS----------GYVHCDVKPDNILLVATQSG 151 (362)
Q Consensus 82 ~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~----------~ivH~Dlkp~Nill~~~~~~ 151 (362)
...+++||||+++|+|.++++. ..+++..++.++.|++.||.|||+. ||+||||||+|||+ +.
T Consensus 94 ~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill----~~ 166 (322)
T 3soc_A 94 DVDLWLITAFHEKGSLSDFLKA---NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLL----KN 166 (322)
T ss_dssp SEEEEEEEECCTTCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEE----CT
T ss_pred CceEEEEEecCCCCCHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEE----CC
Confidence 3457899999999999999976 3499999999999999999999999 99999999999999 77
Q ss_pred ceEEEEeecCCcccccccccCCCCCCccCCCCccCchhhcc-----ccCCCcchHHHHHHHHHHHHhCCCCCccCCC---
Q 039291 152 KFVAKIADLGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQ-----HMQEAPSDIWALGCVVLEMLSGRQAWVVKED--- 223 (362)
Q Consensus 152 ~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~il~~l~~g~~pf~~~~~--- 223 (362)
++.+||+|||+++...............||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+..+
T Consensus 167 ~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~ 246 (322)
T 3soc_A 167 NLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYM 246 (322)
T ss_dssp TCCEEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCC
T ss_pred CCeEEEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhc
Confidence 88999999999986655433333345689999999999986 3556788999999999999999999975432
Q ss_pred ----------CCHHHHHHHHcCCCCCCCCCcc-----CCHHHHHHHHHHhccCCCCCCCHHHHhc
Q 039291 224 ----------CSIDQLFSIIGDEHSLPEIPSR-----VSKEARDFLRRCFVRKPAFRFTAEMLLD 273 (362)
Q Consensus 224 ----------~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~li~~~l~~~p~~R~s~~~~l~ 273 (362)
.....+...+......+..+.. .+.++.+||.+||..||++|||+.++++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~ 311 (322)
T 3soc_A 247 LPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGE 311 (322)
T ss_dssp CTTHHHHCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred cchhhhhccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 1333444444444444444332 3456999999999999999999999986
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=340.96 Aligned_cols=259 Identities=24% Similarity=0.356 Sum_probs=208.9
Q ss_pred CCCceeecceecccCceEEEEEEECCCCCCCCceeeeechhh-hhhHHHHHHHHHHHHcCCCCcccccccceeeecCCCc
Q 039291 4 DGTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEV-SASASLQKEKEVFDNLNGCPFVLECFGEEITMGENGE 82 (362)
Q Consensus 4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~-~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~~~ 82 (362)
.+++|.+++.||+|+||+||+|++..++. .|++|.... .....+.+|+.+++.+.+|++++++++++.. .
T Consensus 8 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~----~vavK~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~-----~ 78 (298)
T 1csn_A 8 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQ----QVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQE-----G 78 (298)
T ss_dssp ETTTEEEEEEEEECSSCEEEEEEETTTTE----EEEEEEEECCTTSCCHHHHHHHHHHTTTCTTCCCEEEEEEE-----T
T ss_pred cccceEEEEEEeecCCEEEEEEEECCCCc----EEEEEEeccCCccHHHHHHHHHHHHHhcCCCCCeEEeecCC-----C
Confidence 47899999999999999999999988775 567776532 2445688999999999879999999876532 2
Q ss_pred eEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecC-CCceEEEEeecC
Q 039291 83 MAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQ-SGKFVAKIADLG 161 (362)
Q Consensus 83 ~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~-~~~~~~kl~Dfg 161 (362)
..+++||||+ +++|.+++... +.++++..++.++.||+.||.|||++||+||||||+|||+..+. .....+||+|||
T Consensus 79 ~~~~lv~e~~-~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg 156 (298)
T 1csn_A 79 LHNVLVIDLL-GPSLEDLLDLC-GRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFG 156 (298)
T ss_dssp TEEEEEEECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCT
T ss_pred ceeEEEEEec-CCCHHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECc
Confidence 3467999999 89999999874 34599999999999999999999999999999999999994332 223349999999
Q ss_pred CcccccccccC-----CCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHHcCC
Q 039291 162 VAKRSRHCKRQ-----KFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDE 236 (362)
Q Consensus 162 la~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 236 (362)
+++........ .......||+.|+|||++.+..++.++|||||||++|+|++|+.||.........+....+...
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~ 236 (298)
T 1csn_A 157 MVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEK 236 (298)
T ss_dssp TCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHH
T ss_pred cccccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhh
Confidence 99866543221 1224567999999999999989999999999999999999999999876655555544443221
Q ss_pred ---CCCCCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhc
Q 039291 237 ---HSLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLD 273 (362)
Q Consensus 237 ---~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~ 273 (362)
...+.....++.++.+++.+||..||++||+++++++
T Consensus 237 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~ 276 (298)
T 1csn_A 237 KQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG 276 (298)
T ss_dssp HHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred ccCccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHH
Confidence 1222233468999999999999999999999999876
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-47 Score=347.50 Aligned_cols=259 Identities=23% Similarity=0.356 Sum_probs=209.9
Q ss_pred CCCCCceeecceecccCceEEEEEEECCCC-CCCCceeeeechhh----hhhHHHHHHHHHHHHcCCCCcccccccceee
Q 039291 2 DSDGTSWFRGRVIGQGSFGCVFIAKPKSNS-SFLPPLMAVKSAEV----SASASLQKEKEVFDNLNGCPFVLECFGEEIT 76 (362)
Q Consensus 2 ~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~-~~~~~~~~~K~~~~----~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~ 76 (362)
+...++|.+++.||+|+||.||+|++...+ ......+++|.... ...+.+.+|+.+++.++ ||||+++++.+..
T Consensus 19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~ 97 (314)
T 2ivs_A 19 EFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVN-HPHVIKLYGACSQ 97 (314)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCC-CTTBCCEEEEECS
T ss_pred ccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCC-CCceeeEEEEEec
Confidence 356789999999999999999999985432 12224678887643 24466889999999997 9999999987642
Q ss_pred ecCCCceEEEEEEEecCCCCHHHHHHHhcC----------------------CCCCHHHHHHHHHHHHHHHHHHHhCCce
Q 039291 77 MGENGEMAYNLLLEYAAGGTLGDLIEKCNG----------------------NGLPEKDVRHFTRCILEGIGHIHDSGYV 134 (362)
Q Consensus 77 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~----------------------~~l~~~~~~~i~~ql~~~l~yLH~~~iv 134 (362)
...+++||||+++++|.+++..... ..+++..++.++.||+.||.|||++||+
T Consensus 98 -----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iv 172 (314)
T 2ivs_A 98 -----DGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLV 172 (314)
T ss_dssp -----SSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred -----CCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCc
Confidence 2236799999999999999987432 2389999999999999999999999999
Q ss_pred eCCCCCCCEEEeecCCCceEEEEeecCCcccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHh-
Q 039291 135 HCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLS- 213 (362)
Q Consensus 135 H~Dlkp~Nill~~~~~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~- 213 (362)
||||||+||++ +.++.+||+|||++................+|+.|+|||++.+..++.++|||||||++|+|++
T Consensus 173 H~dikp~NIli----~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~ 248 (314)
T 2ivs_A 173 HRDLAARNILV----AEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTL 248 (314)
T ss_dssp CCCCSGGGEEE----ETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTT
T ss_pred ccccchheEEE----cCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhC
Confidence 99999999999 6777899999999986654333223345567889999999999889999999999999999999
Q ss_pred CCCCCccCCCCCHHHHHHHHcCCCCCCCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhcC
Q 039291 214 GRQAWVVKEDCSIDQLFSIIGDEHSLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDD 274 (362)
Q Consensus 214 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~ 274 (362)
|..||..... ..+...+.... .+..+..++.++.++|.+||..||++||++.+++++
T Consensus 249 g~~p~~~~~~---~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~ 305 (314)
T 2ivs_A 249 GGNPYPGIPP---ERLFNLLKTGH-RMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKD 305 (314)
T ss_dssp SCCSSTTCCG---GGHHHHHHTTC-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCCCCCCH---HHHHHHhhcCC-cCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 9999965543 33444443333 344567899999999999999999999999999874
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-47 Score=349.61 Aligned_cols=264 Identities=24% Similarity=0.370 Sum_probs=200.1
Q ss_pred CCceeecceecccCceEEEEEEECCCCCCCCceeeeechh---hhhhHHHHHHHHHHHHcCCCCcccccccceeeec---
Q 039291 5 GTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAE---VSASASLQKEKEVFDNLNGCPFVLECFGEEITMG--- 78 (362)
Q Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~---~~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~--- 78 (362)
+++|.+++.||+|+||.||+|+++.+++ .|++|... ....+.+.+|+.++++++ ||||+++++++...+
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~----~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~ 84 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDK----RVAIKKIVLTDPQSVKHALREIKIIRRLD-HDNIVKVFEILGPSGSQL 84 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTE----EEEEEEEECCSHHHHHHHHHHHHHHHTCC-CTTBCCEEEEECTTSCBC
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCe----EEEEEEEecCChHHHHHHHHHHHHHHhcC-CCCeeEEEEecccccccc
Confidence 5899999999999999999999998775 55666543 334567889999999998 999999998653211
Q ss_pred ------CCCceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCc
Q 039291 79 ------ENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGK 152 (362)
Q Consensus 79 ------~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~ 152 (362)
......+++||||+. |+|.+++.. +++++..++.++.|++.||+|||++||+||||||+||++. ..+
T Consensus 85 ~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~---~~~ 157 (320)
T 2i6l_A 85 TDDVGSLTELNSVYIVQEYME-TDLANVLEQ---GPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFIN---TED 157 (320)
T ss_dssp CC----CCSCSEEEEEEECCS-EEHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEE---TTT
T ss_pred ccccccccccCceeEEeeccC-CCHHHHhhc---CCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEc---CCC
Confidence 122346789999997 599999864 4699999999999999999999999999999999999993 245
Q ss_pred eEEEEeecCCccccccccc-CCCCCCccCCCCccCchhhcc-ccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHH
Q 039291 153 FVAKIADLGVAKRSRHCKR-QKFDPSMRGTPLYLAPETVVQ-HMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLF 230 (362)
Q Consensus 153 ~~~kl~Dfgla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~ 230 (362)
+.+||+|||+++....... ........+|..|+|||++.+ ..++.++|||||||++|+|++|+.||..... ....
T Consensus 158 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~---~~~~ 234 (320)
T 2i6l_A 158 LVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHE---LEQM 234 (320)
T ss_dssp TEEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH---HHHH
T ss_pred CeEEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCH---HHHH
Confidence 6899999999986543211 112234568999999998876 6789999999999999999999999965532 2222
Q ss_pred HHHcCCC----------------------------CCCCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCccCcch
Q 039291 231 SIIGDEH----------------------------SLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGVDE 282 (362)
Q Consensus 231 ~~~~~~~----------------------------~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~~~~~~ 282 (362)
..+.... .....+..++.++++||.+||..||++|||++++++||||+....
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~ 314 (320)
T 2i6l_A 235 QLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIYSF 314 (320)
T ss_dssp HHHHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHTTCC
T ss_pred HHHHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCcccccccC
Confidence 2111100 001122458999999999999999999999999999999987654
Q ss_pred h
Q 039291 283 E 283 (362)
Q Consensus 283 ~ 283 (362)
.
T Consensus 315 p 315 (320)
T 2i6l_A 315 P 315 (320)
T ss_dssp -
T ss_pred c
Confidence 4
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-47 Score=350.34 Aligned_cols=258 Identities=23% Similarity=0.353 Sum_probs=210.1
Q ss_pred CCCCCceeecceecccCceEEEEEEECCCCC-CCCceeeeechhhh----hhHHHHHHHHHHHHcCCCCcccccccceee
Q 039291 2 DSDGTSWFRGRVIGQGSFGCVFIAKPKSNSS-FLPPLMAVKSAEVS----ASASLQKEKEVFDNLNGCPFVLECFGEEIT 76 (362)
Q Consensus 2 ~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~-~~~~~~~~K~~~~~----~~~~~~~E~~il~~l~~h~~i~~~~~~~~~ 76 (362)
+...++|.+++.||+|+||.||+|++..... .....|++|..... ....+.+|+.++++++ ||||+++++++..
T Consensus 43 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~ 121 (343)
T 1luf_A 43 EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFD-NPNIVKLLGVCAV 121 (343)
T ss_dssp BCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCC-CTTBCCEEEEECS
T ss_pred EecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCC-CCCEEEEEEEEcc
Confidence 3566899999999999999999999875321 11246788876432 3466889999999997 9999999987642
Q ss_pred ecCCCceEEEEEEEecCCCCHHHHHHHhc----------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCce
Q 039291 77 MGENGEMAYNLLLEYAAGGTLGDLIEKCN----------------------GNGLPEKDVRHFTRCILEGIGHIHDSGYV 134 (362)
Q Consensus 77 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----------------------~~~l~~~~~~~i~~ql~~~l~yLH~~~iv 134 (362)
...+++||||+++++|.+++.... ...+++..++.++.||+.||.|||++||+
T Consensus 122 -----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~iv 196 (343)
T 1luf_A 122 -----GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFV 196 (343)
T ss_dssp -----SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCC
T ss_pred -----CCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCee
Confidence 234679999999999999998742 15699999999999999999999999999
Q ss_pred eCCCCCCCEEEeecCCCceEEEEeecCCcccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHh-
Q 039291 135 HCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLS- 213 (362)
Q Consensus 135 H~Dlkp~Nill~~~~~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~- 213 (362)
||||||+|||+ +.++.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|+|++
T Consensus 197 H~Dlkp~NIl~----~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~ 272 (343)
T 1luf_A 197 HRDLATRNCLV----GENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSY 272 (343)
T ss_dssp CSCCSGGGEEE----CGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTT
T ss_pred cCCCCcceEEE----CCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhc
Confidence 99999999999 7788899999999976544333233345668999999999998899999999999999999999
Q ss_pred CCCCCccCCCCCHHHHHHHHcCCCCCCCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhc
Q 039291 214 GRQAWVVKEDCSIDQLFSIIGDEHSLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLD 273 (362)
Q Consensus 214 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~ 273 (362)
|..||... ...+....+.... .+..+..++.++.++|.+||..||++||++.++++
T Consensus 273 g~~p~~~~---~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~ 328 (343)
T 1luf_A 273 GLQPYYGM---AHEEVIYYVRDGN-ILACPENCPLELYNLMRLCWSKLPADRPSFCSIHR 328 (343)
T ss_dssp TCCTTTTS---CHHHHHHHHHTTC-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCcCCCC---ChHHHHHHHhCCC-cCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 99999644 4455555554433 34567789999999999999999999999999986
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-47 Score=350.46 Aligned_cols=265 Identities=21% Similarity=0.293 Sum_probs=203.7
Q ss_pred CCceeecceecccCceEEEEEEECCCCCCCCceeeeechhh--hhhHHHHHHHHHHHHcCCCC-----cccccccceeee
Q 039291 5 GTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEV--SASASLQKEKEVFDNLNGCP-----FVLECFGEEITM 77 (362)
Q Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~--~~~~~~~~E~~il~~l~~h~-----~i~~~~~~~~~~ 77 (362)
.++|.+++.||+|+||+||+|++..++. ..|++|.... .....+.+|+.+++.+.++. +++.+++.+..
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~---~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~- 93 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGK---SQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNF- 93 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTT---EEEEEEEECSCHHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEE-
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCc---eEEEEEEEcccccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeee-
Confidence 5799999999999999999999987763 3567776643 34566888999999987322 26666554432
Q ss_pred cCCCceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecC--------
Q 039291 78 GENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQ-------- 149 (362)
Q Consensus 78 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~-------- 149 (362)
...+++||||+ +++|.+++......++++..++.++.||+.||.|||++||+||||||+|||+....
T Consensus 94 ----~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~~ 168 (355)
T 2eu9_A 94 ----HGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEH 168 (355)
T ss_dssp ----TTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEECCC
T ss_pred ----CCeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeccccccccccc
Confidence 23578999999 66888888775556799999999999999999999999999999999999994321
Q ss_pred -------CCceEEEEeecCCcccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHhCCCCCccCC
Q 039291 150 -------SGKFVAKIADLGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKE 222 (362)
Q Consensus 150 -------~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~ 222 (362)
+..+.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|+|++|..||....
T Consensus 169 ~~~~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 243 (355)
T 2eu9_A 169 KSCEEKSVKNTSIRVADFGSATFDHEH-----HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHE 243 (355)
T ss_dssp -CCCEEEESCCCEEECCCTTCEETTSC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred ccccccccCCCcEEEeecCcccccccc-----ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCC
Confidence 34567999999999754321 235679999999999999899999999999999999999999997654
Q ss_pred CCCHHHHHHHHcCCCC-------------------CC--------------------CCCccCCHHHHHHHHHHhccCCC
Q 039291 223 DCSIDQLFSIIGDEHS-------------------LP--------------------EIPSRVSKEARDFLRRCFVRKPA 263 (362)
Q Consensus 223 ~~~~~~~~~~~~~~~~-------------------~~--------------------~~~~~~~~~~~~li~~~l~~~p~ 263 (362)
.......+..+..... ++ ......+.++.+||.+||..||+
T Consensus 244 ~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~ 323 (355)
T 2eu9_A 244 NREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPA 323 (355)
T ss_dssp HHHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTT
T ss_pred HHHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChh
Confidence 3222222222211100 00 00112346889999999999999
Q ss_pred CCCCHHHHhcCCCccCcchh
Q 039291 264 FRFTAEMLLDDPFVKGVDEE 283 (362)
Q Consensus 264 ~R~s~~~~l~~p~~~~~~~~ 283 (362)
+|||+.++++||||+++.++
T Consensus 324 ~Rpt~~e~l~hp~f~~~~~~ 343 (355)
T 2eu9_A 324 QRITLAEALLHPFFAGLTPE 343 (355)
T ss_dssp TSCCHHHHTTSGGGGGCCHH
T ss_pred hCcCHHHHhcChhhcCCChh
Confidence 99999999999999987654
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-47 Score=349.32 Aligned_cols=254 Identities=22% Similarity=0.285 Sum_probs=205.8
Q ss_pred CCCceeecceecccCceEEEEEEECCCCCCCCceeeeechhh-hhhHHHHHHHHHHHHcCCCCcccccccceeeecCCCc
Q 039291 4 DGTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEV-SASASLQKEKEVFDNLNGCPFVLECFGEEITMGENGE 82 (362)
Q Consensus 4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~-~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~~~ 82 (362)
-+++|.+++.||+|+||+||+|++..+++ .|++|.... .....+.+|+.+++.|.+||||+++++++.. .
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~----~vavK~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~-----~ 77 (330)
T 2izr_A 7 VGPNFRVGKKIGCGNFGELRLGKNLYTNE----YVAIKLEPMKSRAPQLHLEYRFYKQLGSGDGIPQVYYFGPC-----G 77 (330)
T ss_dssp ETTTEEEEEECCC-CTTSEEEEEETTTTE----EEEEEEEETTCSSCCHHHHHHHHHHHCSCTTSCCEEEEEEE-----T
T ss_pred EcCCeEEEEEeeccCCceEEEEEECCCCc----EEEEEEeccccchHHHHHHHHHHHHhhCCCCCCEEEEEEec-----C
Confidence 36899999999999999999999988775 567776543 2345688999999999669999999987643 2
Q ss_pred eEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceE-----EEE
Q 039291 83 MAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFV-----AKI 157 (362)
Q Consensus 83 ~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~-----~kl 157 (362)
..+++||||+ +++|.+++... ...+++..++.++.||+.||+|||++||+||||||+|||+ +.++. +||
T Consensus 78 ~~~~lv~e~~-~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill----~~~~~~~~~~~kl 151 (330)
T 2izr_A 78 KYNAMVLELL-GPSLEDLFDLC-DRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLI----GRPGNKTQQVIHI 151 (330)
T ss_dssp TEEEEEEECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE----CCGGGTCTTSEEE
T ss_pred CccEEEEEeC-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeee----ccCCCCCCceEEE
Confidence 3467999999 89999999874 4569999999999999999999999999999999999999 55555 999
Q ss_pred eecCCcccccccccCC-----CCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHH
Q 039291 158 ADLGVAKRSRHCKRQK-----FDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSI 232 (362)
Q Consensus 158 ~Dfgla~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~ 232 (362)
+|||+++......... ......||+.|+|||++.+..++.++|||||||++|+|++|..||.........+.+..
T Consensus 152 ~DFg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~ 231 (330)
T 2izr_A 152 IDFALAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQK 231 (330)
T ss_dssp CCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHH
T ss_pred EEcccceeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHH
Confidence 9999998654432211 12467899999999999999999999999999999999999999987766666665555
Q ss_pred HcCCCCC---CCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhc
Q 039291 233 IGDEHSL---PEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLD 273 (362)
Q Consensus 233 ~~~~~~~---~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~ 273 (362)
+...... ......++ ++.+++.+||..||.+||+++++.+
T Consensus 232 i~~~~~~~~~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~ 274 (330)
T 2izr_A 232 IGDTKRATPIEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRK 274 (330)
T ss_dssp HHHHHHHSCHHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred HHhhhccCCHHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 4321110 01112244 9999999999999999999999876
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-47 Score=347.52 Aligned_cols=254 Identities=22% Similarity=0.334 Sum_probs=205.3
Q ss_pred CCCceeecceecccCceEEEEEEECCCCCCCCceeeeech---hhhhhHHHHHHHHHHHHcCCCCcccccccceeeecCC
Q 039291 4 DGTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSA---EVSASASLQKEKEVFDNLNGCPFVLECFGEEITMGEN 80 (362)
Q Consensus 4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~---~~~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~ 80 (362)
..++|.+++.||+|+||+||+|.++.++. .+++|.. .....+.+.+|+.++++++ ||||+++++++..
T Consensus 8 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~----~va~K~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~---- 78 (310)
T 3s95_A 8 RPSDLIHGEVLGKGCFGQAIKVTHRETGE----VMVMKELIRFDEETQRTFLKEVKVMRCLE-HPNVLKFIGVLYK---- 78 (310)
T ss_dssp CGGGEEEEEEEECCSSEEEEEEEETTTCC----EEEEEEESCCCHHHHHHHHHHHHHHTTCC-CTTBCCEEEEEEE----
T ss_pred ChhHeeccceecCCCCEEEEEEEECCCCc----EEEEEEeccCCHHHHHHHHHHHHHHHhCC-CcCcccEEEEEec----
Confidence 45799999999999999999999998876 4555543 3445677889999999998 9999999997753
Q ss_pred CceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEeec
Q 039291 81 GEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADL 160 (362)
Q Consensus 81 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Df 160 (362)
...+++||||+++++|.+++... ...+++..+..++.|++.||+|||++||+||||||+|||+ +.++.+||+||
T Consensus 79 -~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~----~~~~~~kl~Df 152 (310)
T 3s95_A 79 -DKRLNFITEYIKGGTLRGIIKSM-DSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLV----RENKNVVVADF 152 (310)
T ss_dssp -TTEEEEEEECCTTCBHHHHHHHC-CTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEE----CTTSCEEECCC
T ss_pred -CCeeEEEEEecCCCcHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEE----CCCCCEEEeec
Confidence 23467999999999999999873 4569999999999999999999999999999999999999 77888999999
Q ss_pred CCcccccccccCC------------CCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHhCCCCCccCCCCC---
Q 039291 161 GVAKRSRHCKRQK------------FDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCS--- 225 (362)
Q Consensus 161 gla~~~~~~~~~~------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~--- 225 (362)
|+++......... ......||+.|+|||++.+..++.++|||||||++|+|++|..||.......
T Consensus 153 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~ 232 (310)
T 3s95_A 153 GLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDF 232 (310)
T ss_dssp TTCEECC--------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTS
T ss_pred ccceecccccccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHH
Confidence 9997654322211 1125679999999999999999999999999999999999999986432211
Q ss_pred ---HHHHHHHHcCCCCCCCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCccCcch
Q 039291 226 ---IDQLFSIIGDEHSLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGVDE 282 (362)
Q Consensus 226 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~~~~~~ 282 (362)
....... ..+..+++++.+++.+||..||++|||+.++++ +++.+..
T Consensus 233 ~~~~~~~~~~--------~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~--~L~~l~~ 282 (310)
T 3s95_A 233 GLNVRGFLDR--------YCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEH--WLETLRM 282 (310)
T ss_dssp SBCHHHHHHH--------TCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHH--HHHHHHH
T ss_pred hhhhhccccc--------cCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH--HHHHHHH
Confidence 1111111 234568889999999999999999999999987 5554433
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-46 Score=335.09 Aligned_cols=253 Identities=21% Similarity=0.327 Sum_probs=207.4
Q ss_pred CCCCCCceeecceecccCceEEEEEEECCCCCCCCceeeeechhhh--hhHHHHHHHHHHHHcCCCCcccccccceeeec
Q 039291 1 MDSDGTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVS--ASASLQKEKEVFDNLNGCPFVLECFGEEITMG 78 (362)
Q Consensus 1 ~~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~~--~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~ 78 (362)
++...++|.+.+.||+|+||+||+|+++.+. .+++|..... ....+.+|+.++++++ ||||+++++++..
T Consensus 3 ~~l~~~~y~~~~~lg~G~~g~V~~~~~~~~~-----~vavK~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~-- 74 (268)
T 3sxs_A 3 MELKREEITLLKELGSGQFGVVKLGKWKGQY-----DVAVKMIKEGSMSEDEFFQEAQTMMKLS-HPKLVKFYGVCSK-- 74 (268)
T ss_dssp TBCCGGGEEEEEEEEEETTEEEEEEEETTTE-----EEEEEEECBTTBCHHHHHHHHHHHHHCC-CTTBCCEEEEECS--
T ss_pred eEechhheeeeeeeccCCCceEEEEEecCce-----eEEEEEeccCCCcHHHHHHHHHHHHhCC-CCCEeeEEEEEcc--
Confidence 3567889999999999999999999887542 4677765433 3466889999999999 8999999987632
Q ss_pred CCCceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEe
Q 039291 79 ENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIA 158 (362)
Q Consensus 79 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~ 158 (362)
...+++||||+++++|.+++... +..+++..++.++.|++.||.|||++||+||||||+||++ +.++.++|+
T Consensus 75 ---~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~----~~~~~~~l~ 146 (268)
T 3sxs_A 75 ---EYPIYIVTEYISNGCLLNYLRSH-GKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLV----DRDLCVKVS 146 (268)
T ss_dssp ---SSSEEEEEECCTTCBHHHHHHHH-GGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEE----CTTCCEEEC
T ss_pred ---CCceEEEEEccCCCcHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEE----CCCCCEEEc
Confidence 23467999999999999999874 3459999999999999999999999999999999999999 788899999
Q ss_pred ecCCcccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHh-CCCCCccCCCCCHHHHHHHHcCCC
Q 039291 159 DLGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLS-GRQAWVVKEDCSIDQLFSIIGDEH 237 (362)
Q Consensus 159 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~ 237 (362)
|||++......... ......+|+.|+|||++.+..++.++||||||+++|+|++ |..||... ........+....
T Consensus 147 Dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~---~~~~~~~~~~~~~ 222 (268)
T 3sxs_A 147 DFGMTRYVLDDQYV-SSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLY---TNSEVVLKVSQGH 222 (268)
T ss_dssp CTTCEEECCTTCEE-ECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTS---CHHHHHHHHHTTC
T ss_pred cCccceecchhhhh-cccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCcccc---ChHHHHHHHHcCC
Confidence 99999765443221 1234456778999999998889999999999999999999 99999544 3344444443333
Q ss_pred CCCCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhcC
Q 039291 238 SLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDD 274 (362)
Q Consensus 238 ~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~ 274 (362)
....+...++++.++|.+||..||++|||+.+++++
T Consensus 223 -~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 258 (268)
T 3sxs_A 223 -RLYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSS 258 (268)
T ss_dssp -CCCCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred -CCCCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 233456689999999999999999999999999875
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-47 Score=346.65 Aligned_cols=260 Identities=21% Similarity=0.308 Sum_probs=208.0
Q ss_pred CCCCceeecceecccCceEEEEEEECCC-CCCCCceeeeechhh----hhhHHHHHHHHHHHHcCCCCcccccccceeee
Q 039291 3 SDGTSWFRGRVIGQGSFGCVFIAKPKSN-SSFLPPLMAVKSAEV----SASASLQKEKEVFDNLNGCPFVLECFGEEITM 77 (362)
Q Consensus 3 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~-~~~~~~~~~~K~~~~----~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~ 77 (362)
...++|.+++.||+|+||+||+|++... .......+++|.... ...+.+.+|+.+++++.+||||+++++.+..
T Consensus 20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~- 98 (313)
T 1t46_A 20 FPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTI- 98 (313)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred cChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEec-
Confidence 4568999999999999999999986431 112234678887643 2446788999999999669999999987643
Q ss_pred cCCCceEEEEEEEecCCCCHHHHHHHhcC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCC
Q 039291 78 GENGEMAYNLLLEYAAGGTLGDLIEKCNG----------------NGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPD 141 (362)
Q Consensus 78 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~----------------~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~ 141 (362)
...+++||||+++|+|.+++..... ..+++..++.++.||+.||.|||++||+||||||+
T Consensus 99 ----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~ 174 (313)
T 1t46_A 99 ----GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAAR 174 (313)
T ss_dssp ----SSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG
T ss_pred ----CCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccc
Confidence 2235799999999999999987432 24899999999999999999999999999999999
Q ss_pred CEEEeecCCCceEEEEeecCCcccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHh-CCCCCcc
Q 039291 142 NILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLS-GRQAWVV 220 (362)
Q Consensus 142 Nill~~~~~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~ 220 (362)
||++ +.++.+||+|||++................||+.|+|||++.+..++.++|||||||++|+|++ |..||..
T Consensus 175 Nil~----~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~ 250 (313)
T 1t46_A 175 NILL----THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPG 250 (313)
T ss_dssp GEEE----ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTT
T ss_pred eEEE----cCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCc
Confidence 9999 6778899999999986655433333345668889999999999899999999999999999999 9999976
Q ss_pred CCCCCHHHHHHHHcCCCCCCCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhcC
Q 039291 221 KEDCSIDQLFSIIGDEHSLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDD 274 (362)
Q Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~ 274 (362)
..... .....+... ..+..+..++.++.++|.+||..||.+|||+.+++++
T Consensus 251 ~~~~~--~~~~~~~~~-~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 301 (313)
T 1t46_A 251 MPVDS--KFYKMIKEG-FRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQL 301 (313)
T ss_dssp CCSSH--HHHHHHHHT-CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ccchh--HHHHHhccC-CCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence 54322 222222222 2233456789999999999999999999999999873
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-46 Score=339.67 Aligned_cols=256 Identities=30% Similarity=0.471 Sum_probs=201.8
Q ss_pred eeecceecccCceEEEEEEECCCCCCCCceeeeechhh---hhhHHHHHHHHHHHHcCCCCcccccccceeeecCCCceE
Q 039291 8 WFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEV---SASASLQKEKEVFDNLNGCPFVLECFGEEITMGENGEMA 84 (362)
Q Consensus 8 y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~---~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~~~~~ 84 (362)
|.....||+|+||.||+|++..++. .|++|.... .....+.+|+.+++.++ ||||+++++++.. ...
T Consensus 24 ~~~~~~lg~G~~g~Vy~~~~~~~~~----~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~-----~~~ 93 (295)
T 2clq_A 24 NGDRVVLGKGTYGIVYAGRDLSNQV----RIAIKEIPERDSRYSQPLHEEIALHKHLK-HKNIVQYLGSFSE-----NGF 93 (295)
T ss_dssp TSSBCEEEECSSSEEEEEEETTTCC----EEEEEEEECCCC---HHHHHHHHHHHTCC-CTTBCCEEEEEEE-----TTE
T ss_pred CCCcEEEeecCcEEEEEEEECCCCe----EEEEEEccCCchHHHHHHHHHHHHHHhCC-CCCEeeEeeEEEe-----CCc
Confidence 3344599999999999999988775 556665432 34566889999999998 9999999987643 224
Q ss_pred EEEEEEecCCCCHHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCC-ceEEEEeecCC
Q 039291 85 YNLLLEYAAGGTLGDLIEKCNG-NGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSG-KFVAKIADLGV 162 (362)
Q Consensus 85 ~~lv~e~~~~~~L~~~l~~~~~-~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~-~~~~kl~Dfgl 162 (362)
+++||||+++++|.+++..... ..+++..++.++.|++.||.|||++||+|+||||+||++ +. ++.+||+|||+
T Consensus 94 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~----~~~~~~~kl~Dfg~ 169 (295)
T 2clq_A 94 IKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLI----NTYSGVLKISDFGT 169 (295)
T ss_dssp EEEEEECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE----ETTTCCEEECCTTT
T ss_pred EEEEEEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEE----ECCCCCEEEeeccc
Confidence 6799999999999999987432 347799999999999999999999999999999999999 44 67899999999
Q ss_pred cccccccccCCCCCCccCCCCccCchhhcccc--CCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHHcCCCCCC
Q 039291 163 AKRSRHCKRQKFDPSMRGTPLYLAPETVVQHM--QEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEHSLP 240 (362)
Q Consensus 163 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 240 (362)
+....... .......||+.|+|||++.+.. ++.++||||||+++|+|++|..||..... ..............+
T Consensus 170 ~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~--~~~~~~~~~~~~~~~ 245 (295)
T 2clq_A 170 SKRLAGIN--PCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGE--PQAAMFKVGMFKVHP 245 (295)
T ss_dssp CEESCC-------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSS--HHHHHHHHHHHCCCC
T ss_pred ccccCCCC--CcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCc--hhHHHHhhccccccc
Confidence 97654322 1223567999999999998643 78899999999999999999999965432 222222221123344
Q ss_pred CCCccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCccCcc
Q 039291 241 EIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGVD 281 (362)
Q Consensus 241 ~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~~~~~ 281 (362)
.++..++.++.+||.+||..||++||++.+++.||||+...
T Consensus 246 ~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~ 286 (295)
T 2clq_A 246 EIPESMSAEAKAFILKCFEPDPDKRACANDLLVDEFLKVSS 286 (295)
T ss_dssp CCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHTSGGGCC--
T ss_pred cccccCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhhcc
Confidence 56778999999999999999999999999999999998654
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-46 Score=348.82 Aligned_cols=258 Identities=22% Similarity=0.347 Sum_probs=210.2
Q ss_pred CCceeecceecccCceEEEEEEECCCCCCCCceeeeechhhhhh--------------------HHHHHHHHHHHHcCCC
Q 039291 5 GTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVSAS--------------------ASLQKEKEVFDNLNGC 64 (362)
Q Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~~~~--------------------~~~~~E~~il~~l~~h 64 (362)
.++|.+++.||+|+||.||+|++ ++ ..|++|....... ..+.+|+.++++++ |
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~--~~----~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h 102 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK--DN----KFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIK-N 102 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE--TT----EEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCC-C
T ss_pred cCceEEEEEEcCCCCeEEEEEEc--CC----ceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCC-C
Confidence 37899999999999999999998 44 3677776543311 77899999999998 9
Q ss_pred CcccccccceeeecCCCceEEEEEEEecCCCCHHHH------HHHhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCceeCC
Q 039291 65 PFVLECFGEEITMGENGEMAYNLLLEYAAGGTLGDL------IEKCNGNGLPEKDVRHFTRCILEGIGHIHD-SGYVHCD 137 (362)
Q Consensus 65 ~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~------l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~-~~ivH~D 137 (362)
|||+++++++.. ...+++||||+++++|.++ +.......+++..++.++.||+.||.|||+ +||+|||
T Consensus 103 ~~i~~~~~~~~~-----~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~d 177 (348)
T 2pml_X 103 EYCLTCEGIITN-----YDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRD 177 (348)
T ss_dssp TTBCCCSEEEES-----SSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCC
T ss_pred CCcceEEEEEee-----CCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecC
Confidence 999999997653 2357799999999999998 654335679999999999999999999999 9999999
Q ss_pred CCCCCEEEeecCCCceEEEEeecCCcccccccccCCCCCCccCCCCccCchhhccc-cCCC-cchHHHHHHHHHHHHhCC
Q 039291 138 VKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQH-MQEA-PSDIWALGCVVLEMLSGR 215 (362)
Q Consensus 138 lkp~Nill~~~~~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~-~~DiwslG~il~~l~~g~ 215 (362)
|||+||++ +.++.+||+|||++...... ......||+.|+|||++.+. .++. ++|||||||++|+|++|.
T Consensus 178 l~p~Nil~----~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~ 249 (348)
T 2pml_X 178 VKPSNILM----DKNGRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNV 249 (348)
T ss_dssp CCGGGEEE----CTTSCEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSS
T ss_pred CChHhEEE----cCCCcEEEeccccccccccc----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCC
Confidence 99999999 77888999999999765432 12356799999999999876 5665 899999999999999999
Q ss_pred CCCccCCCCCHHHHHHHHcCCC-CCCC----------------CCccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCcc
Q 039291 216 QAWVVKEDCSIDQLFSIIGDEH-SLPE----------------IPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVK 278 (362)
Q Consensus 216 ~pf~~~~~~~~~~~~~~~~~~~-~~~~----------------~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~~ 278 (362)
.||..... ..+....+.... ..+. ....++.++.+||.+||..||.+|||+.++++||||+
T Consensus 250 ~pf~~~~~--~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp~f~ 327 (348)
T 2pml_X 250 VPFSLKIS--LVELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLA 327 (348)
T ss_dssp CSSCCSSC--SHHHHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGT
T ss_pred CCCCCCCc--HHHHHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCcccc
Confidence 99975433 234444443332 1111 0156899999999999999999999999999999999
Q ss_pred Ccchhh
Q 039291 279 GVDEEL 284 (362)
Q Consensus 279 ~~~~~~ 284 (362)
...++.
T Consensus 328 ~~~~~~ 333 (348)
T 2pml_X 328 DTNIED 333 (348)
T ss_dssp TCCHHH
T ss_pred CCCHHH
Confidence 887654
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-47 Score=339.95 Aligned_cols=255 Identities=17% Similarity=0.288 Sum_probs=196.0
Q ss_pred CCCCCceeecceecccCceEEEEEEECCCCCCCCceeeeechhh----hhhHHHHHHHHHHHHcCCCCcccccccceeee
Q 039291 2 DSDGTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEV----SASASLQKEKEVFDNLNGCPFVLECFGEEITM 77 (362)
Q Consensus 2 ~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~----~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~ 77 (362)
+...++|.+++.||+|+||+||+|++..++. ....+++|.... .....+.+|+.++++++ ||||+++++++.
T Consensus 11 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~-- 86 (281)
T 1mp8_A 11 EIQRERIELGRCIGEGQFGDVHQGIYMSPEN-PALAVAIKTCKNCTSDSVREKFLQEALTMRQFD-HPHIVKLIGVIT-- 86 (281)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEECCC---CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCC-CTTBCCEEEEEC--
T ss_pred EEehHHeEEEeEeeecCCeeEEEEEEecCCC-CceEEEEEeccccCCHHHHHHHHHHHHHHHhCC-CCccceEEEEEc--
Confidence 4567899999999999999999999876542 124677777543 34456889999999998 999999998652
Q ss_pred cCCCceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEE
Q 039291 78 GENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKI 157 (362)
Q Consensus 78 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl 157 (362)
+ ..+++||||+++++|.+++... ...+++..++.++.|++.||.|||++||+||||||+|||+ +.++.+||
T Consensus 87 --~--~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~----~~~~~~kl 157 (281)
T 1mp8_A 87 --E--NPVWIIMELCTLGELRSFLQVR-KYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLV----SSNDCVKL 157 (281)
T ss_dssp --S--SSCEEEEECCTTEEHHHHHHHT-TTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE----EETTEEEE
T ss_pred --c--CccEEEEecCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEE----CCCCCEEE
Confidence 1 2356999999999999999863 3469999999999999999999999999999999999999 55678999
Q ss_pred eecCCcccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHh-CCCCCccCCCCCHHHHHHHHcCC
Q 039291 158 ADLGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLS-GRQAWVVKEDCSIDQLFSIIGDE 236 (362)
Q Consensus 158 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~ 236 (362)
+|||+++........ ......+|+.|+|||++.+..++.++|||||||++|+|++ |..||...... +....+...
T Consensus 158 ~Dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~---~~~~~i~~~ 233 (281)
T 1mp8_A 158 GDFGLSRYMEDSTYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN---DVIGRIENG 233 (281)
T ss_dssp CC--------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGG---GHHHHHHTT
T ss_pred CccccccccCccccc-ccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHH---HHHHHHHcC
Confidence 999999765432211 1234457788999999998899999999999999999997 99999765433 333333333
Q ss_pred CCCCCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhcC
Q 039291 237 HSLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDD 274 (362)
Q Consensus 237 ~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~ 274 (362)
.. +..+..+++++.++|.+||..||++|||+.+++++
T Consensus 234 ~~-~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 270 (281)
T 1mp8_A 234 ER-LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ 270 (281)
T ss_dssp CC-CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CC-CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 32 34567899999999999999999999999999863
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-47 Score=341.19 Aligned_cols=256 Identities=25% Similarity=0.408 Sum_probs=206.9
Q ss_pred CceeecceecccCceEEEEEEECCCCCCCCceeeeechhh-----hhhHHHHHHHHHHHHcCCCCcccccccceeeecCC
Q 039291 6 TSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEV-----SASASLQKEKEVFDNLNGCPFVLECFGEEITMGEN 80 (362)
Q Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~-----~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~ 80 (362)
++|.+++.||+|+||.||+|+++.+++ .+++|.... .....+.+|+.++++++ ||||+++++.+..
T Consensus 22 ~~y~i~~~lg~G~~g~V~~~~~~~~~~----~valK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~---- 92 (287)
T 2wei_A 22 ERYNIVCMLGKGSFGEVLKCKDRITQQ----EYAVKVINKASAKNKDTSTILREVELLKKLD-HPNIMKLFEILED---- 92 (287)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCC----EEEEEEEEGGGBSSSCHHHHHHHHHHHHTCC-CTTBCCEEEEEEC----
T ss_pred hcceeeEEEcCCCCEEEEEEEEcCCCc----EEEEEEecccccchHHHHHHHHHHHHHHhcc-CCCccEEEEEEeC----
Confidence 589999999999999999999988775 456665432 24567889999999997 9999999987642
Q ss_pred CceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEeec
Q 039291 81 GEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADL 160 (362)
Q Consensus 81 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Df 160 (362)
...+++||||+++++|.+++... ..+++..++.++.||+.||.|||++||+||||||+||++..+ +....+||+||
T Consensus 93 -~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~-~~~~~~kL~Df 168 (287)
T 2wei_A 93 -SSSFYIVGELYTGGELFDEIIKR--KRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESK-EKDCDIKIIDF 168 (287)
T ss_dssp -SSEEEEEECCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCS-STTCCEEECST
T ss_pred -CCeEEEEEEccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecC-CCcccEEEecc
Confidence 23477999999999999988763 359999999999999999999999999999999999999432 22457999999
Q ss_pred CCcccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHHcCCCCCC
Q 039291 161 GVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEHSLP 240 (362)
Q Consensus 161 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 240 (362)
|++....... ......||+.|+|||++.+. ++.++||||||+++|+|++|..||.... .......+.......
T Consensus 169 g~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~---~~~~~~~~~~~~~~~ 241 (287)
T 2wei_A 169 GLSTCFQQNT---KMKDRIGTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPPFYGKN---EYDILKRVETGKYAF 241 (287)
T ss_dssp TGGGTBCCCS---SCSCHHHHHTTCCHHHHTTC-CCTHHHHHHHHHHHHHHHHSSCSSCCSS---HHHHHHHHHHCCCCC
T ss_pred CcceeecCCC---ccccccCcccccChHHhcCC-CCCchhhHhHHHHHHHHHhCCCCCCCCC---HHHHHHHHHcCCCCC
Confidence 9987654321 12345689999999998764 8899999999999999999999996543 334444433332222
Q ss_pred CC--CccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCccCcc
Q 039291 241 EI--PSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGVD 281 (362)
Q Consensus 241 ~~--~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~~~~~ 281 (362)
.. ...++.++.++|.+||..||++|||+.++++||||++..
T Consensus 242 ~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~~~~~~ 284 (287)
T 2wei_A 242 DLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYS 284 (287)
T ss_dssp CSGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHHHC
T ss_pred CchhhhhcCHHHHHHHHHHcccChhhCcCHHHHhcCHHHhccc
Confidence 22 246899999999999999999999999999999997653
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-47 Score=348.72 Aligned_cols=261 Identities=20% Similarity=0.282 Sum_probs=208.5
Q ss_pred CCCCceeecceecccCceEEEEEEECCCC-CCCCceeeeechhh----hhhHHHHHHHHHHHHcCCCCcccccccceeee
Q 039291 3 SDGTSWFRGRVIGQGSFGCVFIAKPKSNS-SFLPPLMAVKSAEV----SASASLQKEKEVFDNLNGCPFVLECFGEEITM 77 (362)
Q Consensus 3 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~-~~~~~~~~~K~~~~----~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~ 77 (362)
...++|.+++.||+|+||+||+|++.... ......+++|.... .....+.+|+.+++++.+||||+++++.+..
T Consensus 24 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~- 102 (316)
T 2xir_A 24 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTK- 102 (316)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECC-
T ss_pred cchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEec-
Confidence 45689999999999999999999875422 12235678887643 2345688999999999879999999987642
Q ss_pred cCCCceEEEEEEEecCCCCHHHHHHHhcC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCE
Q 039291 78 GENGEMAYNLLLEYAAGGTLGDLIEKCNG--------------NGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNI 143 (362)
Q Consensus 78 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--------------~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Ni 143 (362)
....+++||||+++++|.+++..... ..+++..++.++.||+.||.|||++||+||||||+||
T Consensus 103 ---~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Ni 179 (316)
T 2xir_A 103 ---PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNI 179 (316)
T ss_dssp ---TTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred ---CCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccceE
Confidence 22346799999999999999987432 1289999999999999999999999999999999999
Q ss_pred EEeecCCCceEEEEeecCCcccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHh-CCCCCccCC
Q 039291 144 LLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLS-GRQAWVVKE 222 (362)
Q Consensus 144 ll~~~~~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~ 222 (362)
++ +.++.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|+|++ |..||....
T Consensus 180 l~----~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~ 255 (316)
T 2xir_A 180 LL----SEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK 255 (316)
T ss_dssp EE----CGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred EE----CCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccc
Confidence 99 7778899999999976544322222235668899999999999899999999999999999998 999996544
Q ss_pred CCCHHHHHHHHcCCCCCCCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhcC
Q 039291 223 DCSIDQLFSIIGDEHSLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDD 274 (362)
Q Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~ 274 (362)
.. ......+... ..+..+..+++++.++|.+||..||.+|||+.++++|
T Consensus 256 ~~--~~~~~~~~~~-~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 304 (316)
T 2xir_A 256 ID--EEFCRRLKEG-TRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 304 (316)
T ss_dssp CS--HHHHHHHHHT-CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred hh--HHHHHHhccC-ccCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 32 2222222222 2234566789999999999999999999999999985
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-46 Score=339.50 Aligned_cols=256 Identities=23% Similarity=0.349 Sum_probs=207.1
Q ss_pred CCCCceeecceecccCceEEEEEEECCCCCCCCceeeeechhhhhhHHHHHHHHHHHH--cCCCCcccccccceeeecCC
Q 039291 3 SDGTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVSASASLQKEKEVFDN--LNGCPFVLECFGEEITMGEN 80 (362)
Q Consensus 3 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~~~~~~~~~E~~il~~--l~~h~~i~~~~~~~~~~~~~ 80 (362)
.-.++|.+++.||+|+||+||+|++. + ..|++|.........+.+|.+++.. ++ ||||+++++.+.... .
T Consensus 5 ~~~~~y~~~~~lg~G~~g~V~~~~~~--~----~~vavK~~~~~~~~~~~~e~~~~~~~~l~-h~niv~~~~~~~~~~-~ 76 (301)
T 3q4u_A 5 TVARDITLLECVGKGRYGEVWRGSWQ--G----ENVAVKIFSSRDEKSWFRETELYNTVMLR-HENILGFIASDMTSR-H 76 (301)
T ss_dssp CCGGGCEEEEEEEECSSEEEEEEEET--T----EEEEEEEECGGGHHHHHHHHHHHHHTCCC-CTTBCCEEEEEEEEE-T
T ss_pred cccCcEEEEEeeccCCCcEEEEEEEC--C----EEEEEEEeccccchhhHHHHHHHHHhhcc-CcCeeeEEEeecccc-C
Confidence 45689999999999999999999884 2 3689998877777778889888888 55 999999998766543 3
Q ss_pred CceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH--------hCCceeCCCCCCCEEEeecCCCc
Q 039291 81 GEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIH--------DSGYVHCDVKPDNILLVATQSGK 152 (362)
Q Consensus 81 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH--------~~~ivH~Dlkp~Nill~~~~~~~ 152 (362)
....+++||||+++|+|.++++. ..+++..++.++.|++.||+||| ++||+||||||+|||+ +.+
T Consensus 77 ~~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill----~~~ 149 (301)
T 3q4u_A 77 SSTQLWLITHYHEMGSLYDYLQL---TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILV----KKN 149 (301)
T ss_dssp TEEEEEEEECCCTTCBHHHHHTT---CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEE----CTT
T ss_pred CCceeEEehhhccCCCHHHHHhh---cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEE----cCC
Confidence 34557899999999999999964 45999999999999999999999 9999999999999999 778
Q ss_pred eEEEEeecCCcccccccccC--CCCCCccCCCCccCchhhccc------cCCCcchHHHHHHHHHHHHhC----------
Q 039291 153 FVAKIADLGVAKRSRHCKRQ--KFDPSMRGTPLYLAPETVVQH------MQEAPSDIWALGCVVLEMLSG---------- 214 (362)
Q Consensus 153 ~~~kl~Dfgla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~------~~~~~~DiwslG~il~~l~~g---------- 214 (362)
+.+||+|||+++........ .......||+.|+|||++.+. .++.++|||||||++|+|++|
T Consensus 150 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~ 229 (301)
T 3q4u_A 150 GQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDY 229 (301)
T ss_dssp SCEEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCC
T ss_pred CCEEEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccc
Confidence 88999999999755432221 112345799999999999876 445789999999999999999
Q ss_pred CCCCccC--CCCCHHHHHHHHcCCCCCCCCCc-----cCCHHHHHHHHHHhccCCCCCCCHHHHhc
Q 039291 215 RQAWVVK--EDCSIDQLFSIIGDEHSLPEIPS-----RVSKEARDFLRRCFVRKPAFRFTAEMLLD 273 (362)
Q Consensus 215 ~~pf~~~--~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~li~~~l~~~p~~R~s~~~~l~ 273 (362)
..||... ..................+.++. .++.++.+|+.+||..||++|||+.++++
T Consensus 230 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~ 295 (301)
T 3q4u_A 230 KPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKK 295 (301)
T ss_dssp CCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred cccccccCCCCcchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHH
Confidence 8888653 23334445555544444444443 25678999999999999999999999986
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-46 Score=335.24 Aligned_cols=252 Identities=21% Similarity=0.348 Sum_probs=203.6
Q ss_pred CCCCceeecceecccCceEEEEEEECCCCCCCCceeeeechhhh----------hhHHHHHHHHHHHHcCCCCccccccc
Q 039291 3 SDGTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVS----------ASASLQKEKEVFDNLNGCPFVLECFG 72 (362)
Q Consensus 3 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~~----------~~~~~~~E~~il~~l~~h~~i~~~~~ 72 (362)
..+++|.+.+.||+|+||+||+|++..++. .+++|..... ..+.+.+|+.++++++ ||||+++++
T Consensus 16 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~----~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~ 90 (287)
T 4f0f_A 16 LADNEIEYEKQIGKGGFGLVHKGRLVKDKS----VVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLN-HPNIVKLYG 90 (287)
T ss_dssp CCSTTEEEEEECCCCSSSCEEEEEETTTCC----EEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCC-CTTBCCEEE
T ss_pred hhhccceehhccccCCceeEEEEEEcCCce----EEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCC-CCCchhhhe
Confidence 467899999999999999999999988775 5677764321 1167889999999998 999999998
Q ss_pred ceeeecCCCceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--ceeCCCCCCCEEEeecC-
Q 039291 73 EEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSG--YVHCDVKPDNILLVATQ- 149 (362)
Q Consensus 73 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~--ivH~Dlkp~Nill~~~~- 149 (362)
++.. .. ++||||+++++|.+++... ...+++..++.++.|++.||.|||++| |+||||||+|||+..+.
T Consensus 91 ~~~~----~~---~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~ 162 (287)
T 4f0f_A 91 LMHN----PP---RMVMEFVPCGDLYHRLLDK-AHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDE 162 (287)
T ss_dssp EETT----TT---EEEEECCTTCBHHHHHHCT-TSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCT
T ss_pred eecC----CC---eEEEEecCCCCHHHHHhcc-cCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCC
Confidence 6531 11 4899999999999988763 456999999999999999999999999 99999999999994332
Q ss_pred CCceEEEEeecCCcccccccccCCCCCCccCCCCccCchhhc--cccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHH
Q 039291 150 SGKFVAKIADLGVAKRSRHCKRQKFDPSMRGTPLYLAPETVV--QHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSID 227 (362)
Q Consensus 150 ~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~ 227 (362)
+....+||+|||+++..... .....||+.|+|||++. ...++.++|||||||++|+|++|+.||........
T Consensus 163 ~~~~~~kl~Dfg~~~~~~~~-----~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~- 236 (287)
T 4f0f_A 163 NAPVCAKVADFGLSQQSVHS-----VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKI- 236 (287)
T ss_dssp TCSCCEEECCCTTCBCCSSC-----EECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHH-
T ss_pred CCceeEEeCCCCcccccccc-----ccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHH-
Confidence 22234999999999744331 13467999999999984 45678899999999999999999999976544332
Q ss_pred HHHHHHcCCCCCCCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhc
Q 039291 228 QLFSIIGDEHSLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLD 273 (362)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~ 273 (362)
.....+......+.++..+++++.++|.+||..||++|||+.++++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 282 (287)
T 4f0f_A 237 KFINMIREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVK 282 (287)
T ss_dssp HHHHHHHHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHhccCCCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 3333333344555677889999999999999999999999999885
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-47 Score=348.25 Aligned_cols=259 Identities=21% Similarity=0.336 Sum_probs=209.8
Q ss_pred CCCCceeecceecccCceEEEEEEECCCCC-CCCceeeeechhhh----hhHHHHHHHHHHHHcCCCCcccccccceeee
Q 039291 3 SDGTSWFRGRVIGQGSFGCVFIAKPKSNSS-FLPPLMAVKSAEVS----ASASLQKEKEVFDNLNGCPFVLECFGEEITM 77 (362)
Q Consensus 3 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~-~~~~~~~~K~~~~~----~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~ 77 (362)
...++|.+++.||+|+||+||+|.+..++. .....+++|..... ....+.+|+.+++.+..||||+++++++..
T Consensus 43 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~- 121 (333)
T 2i1m_A 43 FPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTH- 121 (333)
T ss_dssp CCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred CCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEec-
Confidence 456789999999999999999999987764 33457888876533 456688999999999669999999987642
Q ss_pred cCCCceEEEEEEEecCCCCHHHHHHHhc------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEE
Q 039291 78 GENGEMAYNLLLEYAAGGTLGDLIEKCN------------GNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILL 145 (362)
Q Consensus 78 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~------------~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill 145 (362)
...+++||||+++|+|.+++.... ...+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus 122 ----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~ 197 (333)
T 2i1m_A 122 ----GGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLL 197 (333)
T ss_dssp ----SSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEE
T ss_pred ----CCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEE
Confidence 223679999999999999997642 3458999999999999999999999999999999999999
Q ss_pred eecCCCceEEEEeecCCcccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHh-CCCCCccCCCC
Q 039291 146 VATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLS-GRQAWVVKEDC 224 (362)
Q Consensus 146 ~~~~~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~ 224 (362)
+.++.+||+|||++................||+.|+|||++.+..++.++|||||||++|+|++ |..||......
T Consensus 198 ----~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~ 273 (333)
T 2i1m_A 198 ----TNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVN 273 (333)
T ss_dssp ----EGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSS
T ss_pred ----CCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchh
Confidence 6778899999999986554333333345667889999999998899999999999999999998 99999654432
Q ss_pred CHHHHHHHHcCCCCCCCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhc
Q 039291 225 SIDQLFSIIGDEHSLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLD 273 (362)
Q Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~ 273 (362)
. .....+... ..+..+..++.++.++|.+||..||.+|||+.++++
T Consensus 274 ~--~~~~~~~~~-~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 319 (333)
T 2i1m_A 274 S--KFYKLVKDG-YQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICS 319 (333)
T ss_dssp H--HHHHHHHHT-CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred H--HHHHHHhcC-CCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence 2 222222212 223345668999999999999999999999999987
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-46 Score=345.39 Aligned_cols=259 Identities=22% Similarity=0.359 Sum_probs=202.4
Q ss_pred CCceeecceecccCceEEEEEEECCCCCCCCceeeeechhh-----hhhHHHHHHHHHHHHcCCCCcccccccceeeecC
Q 039291 5 GTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEV-----SASASLQKEKEVFDNLNGCPFVLECFGEEITMGE 79 (362)
Q Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~-----~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~ 79 (362)
.++|.+.+.||+|+||.||+|+++.+++ .|++|.... .....+.+|+.+++.++ ||||+++++++.....
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~----~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~ 97 (353)
T 3coi_A 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGE----KVAIKKLSRPFQSEIFAKRAYRELLLLKHMQ-HENVIGLLDVFTPASS 97 (353)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTE----EEEEEEESSTTSSHHHHHHHHHHHHHHHHCC-CTTBCCCSEEECSCSS
T ss_pred CceEEEeeeEecCCCeEEEEEEECCCCC----EEEEEEecccccchHHHHHHHHHHHHHHhcC-CCCcccHhheEecccc
Confidence 3689999999999999999999988875 567776532 23456889999999998 9999999987653211
Q ss_pred C-CceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEe
Q 039291 80 N-GEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIA 158 (362)
Q Consensus 80 ~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~ 158 (362)
. ....+++||||+. ++|.+++. ..+++..++.++.||+.||.|||++||+||||||+||++ +.++.+||+
T Consensus 98 ~~~~~~~~lv~e~~~-~~l~~~~~----~~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~----~~~~~~kl~ 168 (353)
T 3coi_A 98 LRNFYDFYLVMPFMQ-TDLQKIMG----LKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAV----NEDCELKIL 168 (353)
T ss_dssp GGGCCCCEEEEECCS-EEGGGTTT----SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEE----CTTCCEEEC
T ss_pred cccceeEEEEecccc-CCHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeE----CCCCcEEEe
Confidence 0 1123579999997 58887764 349999999999999999999999999999999999999 778889999
Q ss_pred ecCCcccccccccCCCCCCccCCCCccCchhhcc-ccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHH-HHHHc--
Q 039291 159 DLGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQ-HMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQL-FSIIG-- 234 (362)
Q Consensus 159 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~-~~~~~-- 234 (362)
|||++...... .....||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+.... .....
T Consensus 169 Dfg~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~ 243 (353)
T 3coi_A 169 DFGLARHADAE-----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVP 243 (353)
T ss_dssp STTCTTC-------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBC
T ss_pred ecccccCCCCC-----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence 99999754431 234578999999999987 6789999999999999999999999975532111111 11100
Q ss_pred -----------------------CCCCCCCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCccCcch
Q 039291 235 -----------------------DEHSLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGVDE 282 (362)
Q Consensus 235 -----------------------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~~~~~~ 282 (362)
....++..+..++.++.+||.+||..||++|||+++++.||||+....
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~~~ 314 (353)
T 3coi_A 244 GTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRD 314 (353)
T ss_dssp CHHHHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTCC
T ss_pred CHHHHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhccC
Confidence 011223344578999999999999999999999999999999987644
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-46 Score=353.50 Aligned_cols=260 Identities=23% Similarity=0.373 Sum_probs=207.1
Q ss_pred CCCCceeecceecccCceEEEEEEECCCCCCCCceeeeechhh----hhhHHHHHHHHHHHHcCCCCcccccccceeeec
Q 039291 3 SDGTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEV----SASASLQKEKEVFDNLNGCPFVLECFGEEITMG 78 (362)
Q Consensus 3 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~----~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~ 78 (362)
+.+++|.+++.||+|+||+||+|+++.+++ .|++|.... ...+.+.+|++++++++ ||||+++++++..
T Consensus 6 ~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~----~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~-- 78 (396)
T 4eut_A 6 TSNHLWLLSDILGQGATANVFRGRHKKTGD----LFAIKVFNNISFLRPVDVQMREFEVLKKLN-HKNIVKLFAIEEE-- 78 (396)
T ss_dssp CSSEEEEEEEEEEECSSEEEEEEEETTTCC----EEEEEEECGGGGGSCHHHHHHHHHHHHHCC-CTTBCCEEEEEEC--
T ss_pred CCCCceEEEEEEEcCCCeEEEEEEECCCCc----EEEEEEeccccccchHHHHHHHHHHHHhcC-CCCCCeEEEeecc--
Confidence 457899999999999999999999998875 566666542 34466789999999998 9999999987643
Q ss_pred CCCceEEEEEEEecCCCCHHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEE
Q 039291 79 ENGEMAYNLLLEYAAGGTLGDLIEKCNG-NGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKI 157 (362)
Q Consensus 79 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl 157 (362)
.....+++||||++||+|.+++..... ..+++..++.++.||+.||+|||++||+||||||+|||+....+..+.+||
T Consensus 79 -~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL 157 (396)
T 4eut_A 79 -TTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKL 157 (396)
T ss_dssp -TTTCCEEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEE
T ss_pred -CCCCeeEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEE
Confidence 223346799999999999999976432 349999999999999999999999999999999999999777677889999
Q ss_pred eecCCcccccccccCCCCCCccCCCCccCchhhcc--------ccCCCcchHHHHHHHHHHHHhCCCCCccCCC--CCHH
Q 039291 158 ADLGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQ--------HMQEAPSDIWALGCVVLEMLSGRQAWVVKED--CSID 227 (362)
Q Consensus 158 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslG~il~~l~~g~~pf~~~~~--~~~~ 227 (362)
+|||+++....... .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||..... ....
T Consensus 158 ~DFG~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~ 234 (396)
T 4eut_A 158 TDFGAARELEDDEQ---FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKE 234 (396)
T ss_dssp CCGGGCEECCCGGG---SSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHH
T ss_pred ecCCCceEccCCCc---cccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHH
Confidence 99999986554322 235679999999999875 5678899999999999999999999975432 2233
Q ss_pred HHHHHHcCCCC----------------------CCCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhc
Q 039291 228 QLFSIIGDEHS----------------------LPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLD 273 (362)
Q Consensus 228 ~~~~~~~~~~~----------------------~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~ 273 (362)
.+...+...+. ...++..++..+.++|.+||..||++||+++++++
T Consensus 235 ~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~ 302 (396)
T 4eut_A 235 VMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFA 302 (396)
T ss_dssp HHHHHHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHH
T ss_pred HHHHHhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHH
Confidence 33333332211 01122445678899999999999999999999855
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-46 Score=344.73 Aligned_cols=260 Identities=22% Similarity=0.372 Sum_probs=210.5
Q ss_pred CCCCCceeecceecccCceEEEEEEECCCCC---CCCceeeeechhh----hhhHHHHHHHHHHHHcCCCCcccccccce
Q 039291 2 DSDGTSWFRGRVIGQGSFGCVFIAKPKSNSS---FLPPLMAVKSAEV----SASASLQKEKEVFDNLNGCPFVLECFGEE 74 (362)
Q Consensus 2 ~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~---~~~~~~~~K~~~~----~~~~~~~~E~~il~~l~~h~~i~~~~~~~ 74 (362)
+...++|.+++.||+|+||+||+|++...+. .....|++|.... .....+.+|+.+++++..||||+++++.+
T Consensus 31 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~ 110 (334)
T 2pvf_A 31 EFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGAC 110 (334)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cCCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEE
Confidence 3467899999999999999999999864321 2235688887653 24456889999999996699999999876
Q ss_pred eeecCCCceEEEEEEEecCCCCHHHHHHHhcC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCC
Q 039291 75 ITMGENGEMAYNLLLEYAAGGTLGDLIEKCNG--------------NGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKP 140 (362)
Q Consensus 75 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--------------~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp 140 (362)
.. ...+++||||+++++|.+++..... ..+++..++.++.||+.||.|||++||+||||||
T Consensus 111 ~~-----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp 185 (334)
T 2pvf_A 111 TQ-----DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAA 185 (334)
T ss_dssp CS-----SSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSG
T ss_pred cc-----CCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCcc
Confidence 42 2346799999999999999986431 2489999999999999999999999999999999
Q ss_pred CCEEEeecCCCceEEEEeecCCcccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHh-CCCCCc
Q 039291 141 DNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLS-GRQAWV 219 (362)
Q Consensus 141 ~Nill~~~~~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~ 219 (362)
+||++ +.++.+||+|||++................+|+.|+|||++.+..++.++|||||||++|+|++ |..||.
T Consensus 186 ~NIll----~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~ 261 (334)
T 2pvf_A 186 RNVLV----TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYP 261 (334)
T ss_dssp GGEEE----CTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred ceEEE----cCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcC
Confidence 99999 7788899999999986654332223344567889999999998889999999999999999999 999996
Q ss_pred cCCCCCHHHHHHHHcCCCCCCCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhcC
Q 039291 220 VKEDCSIDQLFSIIGDEHSLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDD 274 (362)
Q Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~ 274 (362)
.. ...++...+.... .+..+..++.++.++|.+||..||.+|||+.+++++
T Consensus 262 ~~---~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 312 (334)
T 2pvf_A 262 GI---PVEELFKLLKEGH-RMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 312 (334)
T ss_dssp TC---CHHHHHHHHHHTC-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cC---CHHHHHHHHhcCC-CCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 54 4455554444333 234567789999999999999999999999999874
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-47 Score=340.58 Aligned_cols=251 Identities=22% Similarity=0.367 Sum_probs=191.7
Q ss_pred CCCCCceeecceecccCceEEEEEEECCCCCCCCceeeeechh-----hhhhHHHHHHHHHHHHcCCCCcccccccceee
Q 039291 2 DSDGTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAE-----VSASASLQKEKEVFDNLNGCPFVLECFGEEIT 76 (362)
Q Consensus 2 ~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~-----~~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~ 76 (362)
++.+++|.+++.||+|+||+||+|++... +++|... ....+.+.+|+.+++.++ ||||++++++..
T Consensus 20 ei~~~~y~~~~~lG~G~~g~Vy~~~~~~~-------vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~- 90 (289)
T 3og7_A 20 EIPDGQITVGQRIGSGSFGTVYKGKWHGD-------VAVKMLNVTAPTPQQLQAFKNEVGVLRKTR-HVNILLFMGYST- 90 (289)
T ss_dssp BCCTTSCEEEEEEEECSSEEEEEEESSSE-------EEEEEESCSSCCHHHHHHHHHHHHHHTTCC-CTTBCCEEEEEC-
T ss_pred ccCccceeeeeEecCCCCeEEEEEEEcCc-------eEEEEEeccCCCHHHHHHHHHHHHHHHhCC-CCcEEEEEeecc-
Confidence 56789999999999999999999986542 5555543 334567889999999998 999999988432
Q ss_pred ecCCCceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEE
Q 039291 77 MGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAK 156 (362)
Q Consensus 77 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~k 156 (362)
...+++||||+++++|.+++... ...+++..++.++.|++.||.|||++||+||||||+||++ +.++.+|
T Consensus 91 -----~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~----~~~~~~k 160 (289)
T 3og7_A 91 -----APQLAIVTQWCEGSSLYHHLHAS-ETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFL----HEDNTVK 160 (289)
T ss_dssp -----SSSCEEEEECCCEEEHHHHHTTC----CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE----ETTTEEE
T ss_pred -----CCccEEEEEecCCCcHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEE----CCCCCEE
Confidence 12256999999999999999653 3569999999999999999999999999999999999999 6677899
Q ss_pred EeecCCcccccccccCCCCCCccCCCCccCchhhc---cccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHH
Q 039291 157 IADLGVAKRSRHCKRQKFDPSMRGTPLYLAPETVV---QHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSII 233 (362)
Q Consensus 157 l~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~ 233 (362)
|+|||++................||+.|+|||++. +..++.++|||||||++|+|++|+.||.... ....+...+
T Consensus 161 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~--~~~~~~~~~ 238 (289)
T 3og7_A 161 IGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNIN--NRDQIIEMV 238 (289)
T ss_dssp ECCCC------------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCC--CHHHHHHHH
T ss_pred EccceeccccccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccc--hHHHHHHHh
Confidence 99999997655433333334567999999999997 5567889999999999999999999996543 333444333
Q ss_pred cCC---CCCCCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhc
Q 039291 234 GDE---HSLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLD 273 (362)
Q Consensus 234 ~~~---~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~ 273 (362)
... ...+.....+++++.+||.+||..||.+|||+.++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 281 (289)
T 3og7_A 239 GRGSLSPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILA 281 (289)
T ss_dssp HHTSCCCCTTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred cccccCcchhhccccCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 322 2233445678999999999999999999999999886
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-47 Score=341.75 Aligned_cols=262 Identities=19% Similarity=0.298 Sum_probs=202.3
Q ss_pred CCCCCceeecceecccCceEEEEEEECCCCCCCCceeeeechhh---hhhHHHHHHHHHHHHcCCCCcccccccceeeec
Q 039291 2 DSDGTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEV---SASASLQKEKEVFDNLNGCPFVLECFGEEITMG 78 (362)
Q Consensus 2 ~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~---~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~ 78 (362)
+...++|.+++.||+|+||+||+|+....+......|++|.... ...+.+.+|+.++++++ ||||+++++++....
T Consensus 6 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~ 84 (295)
T 3ugc_A 6 QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQ-HDNIVKYKGVCYSAG 84 (295)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCC-CTTBCCEEEEECHHH
T ss_pred cCCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCC-CCCEeeEEEEEecCC
Confidence 35678999999999999999999996433333345778887543 33456889999999998 999999998764322
Q ss_pred CCCceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEe
Q 039291 79 ENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIA 158 (362)
Q Consensus 79 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~ 158 (362)
...+++||||+++++|.+++.... ..+++..+..++.|++.||.|||++||+||||||+|||+ +.++.+||+
T Consensus 85 ---~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~----~~~~~~kl~ 156 (295)
T 3ugc_A 85 ---RRNLKLIMEYLPYGSLRDYLQKHK-ERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILV----ENENRVKIG 156 (295)
T ss_dssp ---HTSCEEEEECCTTCBHHHHHHHCG-GGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE----EETTEEEEC
T ss_pred ---CCceEEEEEeCCCCCHHHHHHhcc-cccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEE----cCCCeEEEc
Confidence 223679999999999999998742 359999999999999999999999999999999999999 666789999
Q ss_pred ecCCcccccccccC-CCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHhCCCCCccCCC----------CC--
Q 039291 159 DLGVAKRSRHCKRQ-KFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKED----------CS-- 225 (362)
Q Consensus 159 Dfgla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~----------~~-- 225 (362)
|||++......... .......++..|+|||++.+..++.++||||||+++|+|++|..||..... ..
T Consensus 157 Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~ 236 (295)
T 3ugc_A 157 DFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQM 236 (295)
T ss_dssp CCCSCC-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHH
T ss_pred cCcccccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccch
Confidence 99999865432211 122344577789999999999999999999999999999999998853211 00
Q ss_pred -HHHHHHHHcCCCCCCCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhc
Q 039291 226 -IDQLFSIIGDEHSLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLD 273 (362)
Q Consensus 226 -~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~ 273 (362)
.......+..... ...+..++.++.+||.+||..||++|||+.++++
T Consensus 237 ~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~ 284 (295)
T 3ugc_A 237 IVFHLIELLKNNGR-LPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 284 (295)
T ss_dssp HHHHHHHHHHTTCC-CCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred hHHHHHHHHhccCc-CCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 0122223333332 3456789999999999999999999999999986
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-46 Score=332.01 Aligned_cols=252 Identities=24% Similarity=0.388 Sum_probs=198.9
Q ss_pred CCCCCCceeecceecccCceEEEEEEECCCCCCCCceeeeechhhh-------hhHHHHHHHHHHHHcCCCCcccccccc
Q 039291 1 MDSDGTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVS-------ASASLQKEKEVFDNLNGCPFVLECFGE 73 (362)
Q Consensus 1 ~~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~~-------~~~~~~~E~~il~~l~~h~~i~~~~~~ 73 (362)
++...++|.+.+.||+|+||+||+|.+.+ ..+++|..... ..+.+.+|+.+++.++ ||||++++++
T Consensus 2 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~------~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~ 74 (271)
T 3dtc_A 2 LEIDFAELTLEEIIGIGGFGKVYRAFWIG------DEVAVKAARHDPDEDISQTIENVRQEAKLFAMLK-HPNIIALRGV 74 (271)
T ss_dssp CBCCTTSEEEEEEEEEETTEEEEEEEETT------EEEEEEEC----------CHHHHHHHHHHHHHCC-CTTBCCEEEE
T ss_pred CccchhheeeeeeeccCCCeEEEEEEEcC------CeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcC-CCCEeeEEEE
Confidence 45678899999999999999999999863 25677765422 2356889999999998 9999999987
Q ss_pred eeeecCCCceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCCCCEEEeecCC
Q 039291 74 EITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSG---YVHCDVKPDNILLVATQS 150 (362)
Q Consensus 74 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~---ivH~Dlkp~Nill~~~~~ 150 (362)
+.. ...+++||||++|++|.+++.. ..+++..++.++.|++.||.|||++| |+||||||+||++.....
T Consensus 75 ~~~-----~~~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~ 146 (271)
T 3dtc_A 75 CLK-----EPNLCLVMEFARGGPLNRVLSG---KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVE 146 (271)
T ss_dssp ECC-----C--CEEEEECCTTEEHHHHHTS---SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCS
T ss_pred Eec-----CCceEEEEEcCCCCCHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccc
Confidence 642 2346799999999999999853 46999999999999999999999999 899999999999943211
Q ss_pred ----CceEEEEeecCCcccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCH
Q 039291 151 ----GKFVAKIADLGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSI 226 (362)
Q Consensus 151 ----~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~ 226 (362)
..+.+||+|||++........ ....||+.|+|||++.+..++.++||||||+++|+|++|+.||... +.
T Consensus 147 ~~~~~~~~~kl~Dfg~~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~---~~ 219 (271)
T 3dtc_A 147 NGDLSNKILKITDFGLAREWHRTTK----MSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGI---DG 219 (271)
T ss_dssp SSCCSSCCEEECCCCC-----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTS---CH
T ss_pred cccccCcceEEccCCcccccccccc----cCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCC---CH
Confidence 267799999999975543221 2457999999999999988999999999999999999999999654 33
Q ss_pred HHHHHHHcCCCCCCCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhcC
Q 039291 227 DQLFSIIGDEHSLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDD 274 (362)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~ 274 (362)
......+.........+..+++++.++|.+||..||.+|||+.+++++
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 267 (271)
T 3dtc_A 220 LAVAYGVAMNKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQ 267 (271)
T ss_dssp HHHHHHHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHhhhcCCCCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHH
Confidence 444444444444556678899999999999999999999999999864
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-46 Score=334.77 Aligned_cols=251 Identities=19% Similarity=0.281 Sum_probs=204.0
Q ss_pred CCCCceeecceecccCceEEEEEEECCCCCCCCceeeeechhhh--hhHHHHHHHHHHHHcCCCCcccccccceeeecCC
Q 039291 3 SDGTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVS--ASASLQKEKEVFDNLNGCPFVLECFGEEITMGEN 80 (362)
Q Consensus 3 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~~--~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~ 80 (362)
...++|.+++.||+|+||+||+|+++.+. .+++|..... ..+.+.+|+.++++++ ||||+++++++..
T Consensus 21 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~-----~vavK~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~---- 90 (283)
T 3gen_A 21 IDPKDLTFLKELGTGQFGVVKYGKWRGQY-----DVAIKMIKEGSMSEDEFIEEAKVMMNLS-HEKLVQLYGVCTK---- 90 (283)
T ss_dssp CCGGGEEEEEECC---CEEEEEEEETTTE-----EEEEEEECTTSBCHHHHHHHHHHHHTCC-CTTBCCEEEEECS----
T ss_pred CCHHHHHhHhhcCCCCCceEEEEEEcCCC-----eEEEEEecCCCCCHHHHHHHHHHHhcCC-CCCEeeEEEEEec----
Confidence 45679999999999999999999887532 4677776533 4566889999999999 9999999987632
Q ss_pred CceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEeec
Q 039291 81 GEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADL 160 (362)
Q Consensus 81 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Df 160 (362)
...+++||||+++++|.+++.... ..+++..++.++.|++.||.|||++||+||||||+||++ +.++.+||+||
T Consensus 91 -~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili----~~~~~~kl~Df 164 (283)
T 3gen_A 91 -QRPIFIITEYMANGCLLNYLREMR-HRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLV----NDQGVVKVSDF 164 (283)
T ss_dssp -SSSEEEEECCCTTCBHHHHHHCGG-GCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEE----CTTSCEEECST
T ss_pred -CCCeEEEEeccCCCcHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEE----cCCCCEEEccc
Confidence 234679999999999999997633 459999999999999999999999999999999999999 77888999999
Q ss_pred CCcccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHh-CCCCCccCCCCCHHHHHHHHcCCCCC
Q 039291 161 GVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLS-GRQAWVVKEDCSIDQLFSIIGDEHSL 239 (362)
Q Consensus 161 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~ 239 (362)
|++......... ......+|+.|+|||++.+..++.++||||||+++|+|++ |+.||... ........+.... .
T Consensus 165 g~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~---~~~~~~~~~~~~~-~ 239 (283)
T 3gen_A 165 GLSRYVLDDEYT-SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERF---TNSETAEHIAQGL-R 239 (283)
T ss_dssp TGGGGBCCHHHH-STTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTS---CHHHHHHHHHTTC-C
T ss_pred cccccccccccc-cccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCcccc---ChhHHHHHHhccc-C
Confidence 999765432222 1234557888999999998889999999999999999998 99999654 3444444444433 2
Q ss_pred CCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhcC
Q 039291 240 PEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDD 274 (362)
Q Consensus 240 ~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~ 274 (362)
...+..+++.+.++|.+||..||++|||+.++++|
T Consensus 240 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 274 (283)
T 3gen_A 240 LYRPHLASEKVYTIMYSCWHEKADERPTFKILLSN 274 (283)
T ss_dssp CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred CCCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence 33456789999999999999999999999999875
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-47 Score=345.38 Aligned_cols=258 Identities=19% Similarity=0.315 Sum_probs=208.7
Q ss_pred CCCCceeecceecccCceEEEEEEECCC-CCCCCceeeeechhhh----hhHHHHHHHHHHHHcCCCCcccccccceeee
Q 039291 3 SDGTSWFRGRVIGQGSFGCVFIAKPKSN-SSFLPPLMAVKSAEVS----ASASLQKEKEVFDNLNGCPFVLECFGEEITM 77 (362)
Q Consensus 3 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~-~~~~~~~~~~K~~~~~----~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~ 77 (362)
...++|.+.+.||+|+||.||+|+++.. .......+++|..... ....+.+|+.+++.++ ||||+++++++..
T Consensus 22 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~- 99 (322)
T 1p4o_A 22 VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFN-CHHVVRLLGVVSQ- 99 (322)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCC-CTTBCCEEEEECS-
T ss_pred chhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcC-CCCEeeeEEEEcc-
Confidence 4568999999999999999999987631 1112246788876432 3456889999999998 9999999987642
Q ss_pred cCCCceEEEEEEEecCCCCHHHHHHHhcC--------CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecC
Q 039291 78 GENGEMAYNLLLEYAAGGTLGDLIEKCNG--------NGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQ 149 (362)
Q Consensus 78 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--------~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~ 149 (362)
...+++||||+++++|.+++..... ..+++..++.++.||+.||.|||++||+||||||+||++
T Consensus 100 ----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli---- 171 (322)
T 1p4o_A 100 ----GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMV---- 171 (322)
T ss_dssp ----SSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEE----
T ss_pred ----CCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEE----
Confidence 2236799999999999999976421 357999999999999999999999999999999999999
Q ss_pred CCceEEEEeecCCcccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHh-CCCCCccCCCCCHHH
Q 039291 150 SGKFVAKIADLGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLS-GRQAWVVKEDCSIDQ 228 (362)
Q Consensus 150 ~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~ 228 (362)
+.++.+||+|||++................||+.|+|||++.+..++.++|||||||++|+|++ |..||... ...+
T Consensus 172 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~---~~~~ 248 (322)
T 1p4o_A 172 AEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGL---SNEQ 248 (322)
T ss_dssp CTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTS---CHHH
T ss_pred cCCCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccC---CHHH
Confidence 7788899999999976544322222234567899999999998889999999999999999999 89999544 4455
Q ss_pred HHHHHcCCCCCCCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhcC
Q 039291 229 LFSIIGDEHSLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDD 274 (362)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~ 274 (362)
....+.... .+..+..++.++.++|.+||..||.+|||+.+++++
T Consensus 249 ~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~ 293 (322)
T 1p4o_A 249 VLRFVMEGG-LLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 293 (322)
T ss_dssp HHHHHHTTC-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHcCC-cCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 555554433 334567899999999999999999999999999875
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-46 Score=347.34 Aligned_cols=263 Identities=17% Similarity=0.241 Sum_probs=201.3
Q ss_pred CCCCCceeecceecccCceEEEEEEECCCCCC----CCceeeeechhhhhhHHHHHHHHHHHHcCCCCcccccccce---
Q 039291 2 DSDGTSWFRGRVIGQGSFGCVFIAKPKSNSSF----LPPLMAVKSAEVSASASLQKEKEVFDNLNGCPFVLECFGEE--- 74 (362)
Q Consensus 2 ~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~----~~~~~~~K~~~~~~~~~~~~E~~il~~l~~h~~i~~~~~~~--- 74 (362)
+..+++|.+++.||+|+||+||+|+++.++.. ....+++|..... ..+.+|+.++++++ ||||+++++..
T Consensus 38 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~--~~~~~E~~~l~~l~-h~niv~~~~~~~~~ 114 (352)
T 2jii_A 38 DKSGRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD--GRLFNEQNFFQRAA-KPLQVNKWKKLYST 114 (352)
T ss_dssp CTTSCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT--STHHHHHHHHHHHC-CHHHHHHHHHHTTC
T ss_pred cccCCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc--chHHHHHHHHHHhc-ccchhhhhhhhccC
Confidence 45679999999999999999999999875211 1246788877543 56889999999998 89998843321
Q ss_pred --------eeecCCCceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEe
Q 039291 75 --------ITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLV 146 (362)
Q Consensus 75 --------~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~ 146 (362)
...+......+++||||+ +++|.+++.......+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus 115 ~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIl~- 192 (352)
T 2jii_A 115 PLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFV- 192 (352)
T ss_dssp TTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGEEE-
T ss_pred CccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEE-
Confidence 011112234578999999 9999999987544679999999999999999999999999999999999999
Q ss_pred ecCCCce--EEEEeecCCcccccccccC-----CCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHhCCCCCc
Q 039291 147 ATQSGKF--VAKIADLGVAKRSRHCKRQ-----KFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWV 219 (362)
Q Consensus 147 ~~~~~~~--~~kl~Dfgla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~ 219 (362)
+.++ .+||+|||+++........ .......||+.|+|||++.+..++.++|||||||++|+|++|+.||.
T Consensus 193 ---~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~ 269 (352)
T 2jii_A 193 ---DPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWT 269 (352)
T ss_dssp ---ETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTG
T ss_pred ---cCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcc
Confidence 5555 8999999999765543221 11234579999999999999899999999999999999999999997
Q ss_pred cCCCCCHHHHHHH---Hc-CCCCCCC---CCccCCHHHHHHHHHHhccCCCCCCCHHHHhc
Q 039291 220 VKEDCSIDQLFSI---IG-DEHSLPE---IPSRVSKEARDFLRRCFVRKPAFRFTAEMLLD 273 (362)
Q Consensus 220 ~~~~~~~~~~~~~---~~-~~~~~~~---~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~ 273 (362)
.... ....+... .. ....+.. ....++.++.+||.+||..||++||++.++++
T Consensus 270 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 329 (352)
T 2jii_A 270 NCLP-NTEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRN 329 (352)
T ss_dssp GGTT-CHHHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred cCCc-CHHHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHH
Confidence 6532 22222221 11 1111110 11357899999999999999999999999986
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-46 Score=345.15 Aligned_cols=251 Identities=24% Similarity=0.391 Sum_probs=206.6
Q ss_pred CCCCceeecceecccCceEEEEEEECCCCCCCCceeeeechhhh---------hhHHHHHHHHHHHHcCC-CCccccccc
Q 039291 3 SDGTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVS---------ASASLQKEKEVFDNLNG-CPFVLECFG 72 (362)
Q Consensus 3 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~~---------~~~~~~~E~~il~~l~~-h~~i~~~~~ 72 (362)
.-.++|.+++.||+|+||.||+|+++.++. .|++|..... ....+.+|+.+++++.+ |+||+++++
T Consensus 40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~----~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~ 115 (320)
T 3a99_A 40 PLESQYQVGPLLGSGGFGSVYSGIRVSDNL----PVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLD 115 (320)
T ss_dssp CCTTTEEEEEECSSSSSCEEEEEEETTTTE----EEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEE
T ss_pred CccCceEEEEEEeeCCCeEEEEEEECCCCc----EEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEE
Confidence 456899999999999999999999988775 5677765432 22456789999999984 799999998
Q ss_pred ceeeecCCCceEEEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCC-
Q 039291 73 EEITMGENGEMAYNLLLEYAAG-GTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQS- 150 (362)
Q Consensus 73 ~~~~~~~~~~~~~~lv~e~~~~-~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~- 150 (362)
++.. ...+++|||++.+ ++|.+++... ..+++..++.++.||+.||.|||++||+||||||+|||+ +
T Consensus 116 ~~~~-----~~~~~lv~e~~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll----~~ 184 (320)
T 3a99_A 116 WFER-----PDSFVLILERPEPVQDLFDFITER--GALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILI----DL 184 (320)
T ss_dssp EEEC-----SSEEEEEEECCSSEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE----ET
T ss_pred EEec-----CCcEEEEEEcCCCCccHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEE----eC
Confidence 7642 2346799999986 8999999873 459999999999999999999999999999999999999 4
Q ss_pred CceEEEEeecCCcccccccccCCCCCCccCCCCccCchhhccccC-CCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHH
Q 039291 151 GKFVAKIADLGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQ-EAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQL 229 (362)
Q Consensus 151 ~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~ 229 (362)
.++.+||+|||++...... ......||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.... ..
T Consensus 185 ~~~~~kL~Dfg~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~-----~~ 255 (320)
T 3a99_A 185 NRGELKLIDFGSGALLKDT----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE-----EI 255 (320)
T ss_dssp TTTEEEECCCTTCEECCSS----CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-----HH
T ss_pred CCCCEEEeeCccccccccc----cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh-----hh
Confidence 5678999999999765432 1234679999999999987665 678999999999999999999995431 11
Q ss_pred HHHHcCCCCCCCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCccCcchh
Q 039291 230 FSIIGDEHSLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGVDEE 283 (362)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~~~~~~~ 283 (362)
.... ...+..++.++.+||.+||..||++|||++++++||||+.....
T Consensus 256 ---~~~~---~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~~~ 303 (320)
T 3a99_A 256 ---IRGQ---VFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLP 303 (320)
T ss_dssp ---HHCC---CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSCCCH
T ss_pred ---hccc---ccccccCCHHHHHHHHHHccCChhhCcCHHHHhcCHhhcCccCc
Confidence 1111 13456789999999999999999999999999999999887543
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-46 Score=356.65 Aligned_cols=270 Identities=22% Similarity=0.312 Sum_probs=213.2
Q ss_pred CCCceeecceecccCceEEEEEEECCCCCCCCceeeeechhh-hhhHHHHHHHHHHHHcCCCCcccccccceeeecCCCc
Q 039291 4 DGTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEV-SASASLQKEKEVFDNLNGCPFVLECFGEEITMGENGE 82 (362)
Q Consensus 4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~-~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~~~ 82 (362)
-+++|.+++.||+|+||.||+|++..+++ .|++|.... .....+.+|+++++.|.+++++..+..+.. ..
T Consensus 5 i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~----~vAvK~~~~~~~~~~~~~E~~il~~L~~~~~i~~i~~~~~-----~~ 75 (483)
T 3sv0_A 5 VGNKFRLGRKIGSGSFGEIYLGTNIQTNE----EVAIKLENVKTKHPQLLYESKIYRILQGGTGIPNVRWFGV-----EG 75 (483)
T ss_dssp ETTTEECCCCCEECSSCEEEEEEETTTCC----EEEEEEEETTCSSCCHHHHHHHHHHTTTSTTCCCEEEEEE-----ET
T ss_pred cCCcEEEEEEEeeCCCEEEEEEEECCCCc----EEEEEEeccccccHHHHHHHHHHHHhcCCCCCCeEEEEEe-----eC
Confidence 36899999999999999999999988775 567776432 233458899999999997777766654332 12
Q ss_pred eEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEeecCC
Q 039291 83 MAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGV 162 (362)
Q Consensus 83 ~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Dfgl 162 (362)
...++||||+ +++|.+++... ...+++..++.|+.||+.||.|||++||+||||||+|||+... +..+.+||+|||+
T Consensus 76 ~~~~lvme~~-g~sL~~ll~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~-~~~~~vkL~DFGl 152 (483)
T 3sv0_A 76 DYNVLVMDLL-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLG-RRANQVYIIDFGL 152 (483)
T ss_dssp TEEEEEEECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCG-GGTTCEEECCCTT
T ss_pred CEEEEEEECC-CCCHHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecC-CCCCeEEEEeCCc
Confidence 3467999999 89999999864 3469999999999999999999999999999999999999432 2456799999999
Q ss_pred cccccccccC-----CCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHHcCCC
Q 039291 163 AKRSRHCKRQ-----KFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEH 237 (362)
Q Consensus 163 a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 237 (362)
++........ .......||+.|+|||++.+..++.++|||||||+||+|++|+.||.........+.+..+....
T Consensus 153 a~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~ 232 (483)
T 3sv0_A 153 AKKYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKK 232 (483)
T ss_dssp CEECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHH
T ss_pred ceeccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhcc
Confidence 9866543221 11236779999999999999999999999999999999999999998766555555444332211
Q ss_pred ---CCCCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhc----------CCCccCcchhhh
Q 039291 238 ---SLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLD----------DPFVKGVDEELS 285 (362)
Q Consensus 238 ---~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~----------~p~~~~~~~~~~ 285 (362)
....++..++.++.+||.+||..+|++||++.++++ ++|+..++|+..
T Consensus 233 ~~~~~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~~~~~~~~~~dW~~~ 293 (483)
T 3sv0_A 233 VATSIEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIREGFQFDYVFDWTIL 293 (483)
T ss_dssp HHSCHHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCCSSCCHHHHH
T ss_pred ccccHHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHHcCCCccCCcCchhh
Confidence 111223467899999999999999999999988754 677777777754
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-46 Score=336.12 Aligned_cols=260 Identities=23% Similarity=0.353 Sum_probs=206.8
Q ss_pred CCCceeecceecccCceEEEEEEECCCCCCCCceeeeechhhh----hhHHHHHHHHHHHHcCCCCcccccccceeeecC
Q 039291 4 DGTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVS----ASASLQKEKEVFDNLNGCPFVLECFGEEITMGE 79 (362)
Q Consensus 4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~~----~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~ 79 (362)
..++|.+++.||+|+||.||+|+....+......+++|..... ....+.+|+.+++.++ ||||+++++++...
T Consensus 19 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~-- 95 (302)
T 4e5w_A 19 EKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLY-HENIVKYKGICTED-- 95 (302)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCC-CTTBCCEEEEEEC---
T ss_pred hhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCC-CCCeeeeeeEEecC--
Confidence 4577999999999999999999965444444567888876533 3467889999999998 99999999876542
Q ss_pred CCceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEee
Q 039291 80 NGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIAD 159 (362)
Q Consensus 80 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~D 159 (362)
....+++||||+++++|.+++... ...+++..++.++.|++.||+|||++||+||||||+||++ +.++.+||+|
T Consensus 96 -~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~----~~~~~~kl~D 169 (302)
T 4e5w_A 96 -GGNGIKLIMEFLPSGSLKEYLPKN-KNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLV----ESEHQVKIGD 169 (302)
T ss_dssp ---CCEEEEEECCTTCBHHHHHHHH-TTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE----EETTEEEECC
T ss_pred -CCceEEEEEEeCCCCcHHHHHHhc-cccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEE----cCCCCEEECc
Confidence 223477999999999999999664 3559999999999999999999999999999999999999 5667899999
Q ss_pred cCCcccccccccC-CCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHhCCCCCccC------------CCCCH
Q 039291 160 LGVAKRSRHCKRQ-KFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVK------------EDCSI 226 (362)
Q Consensus 160 fgla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~------------~~~~~ 226 (362)
||++......... .......||..|+|||++.+..++.++|||||||++|+|++|..|+... .....
T Consensus 170 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~ 249 (302)
T 4e5w_A 170 FGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTV 249 (302)
T ss_dssp CTTCEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHH
T ss_pred ccccccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCH
Confidence 9999865543221 2223566888999999999988999999999999999999999886322 11122
Q ss_pred HHHHHHHcCCCCCCCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhc
Q 039291 227 DQLFSIIGDEHSLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLD 273 (362)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~ 273 (362)
......+..... ...+..+++++.+||.+||..||.+|||+.++++
T Consensus 250 ~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 295 (302)
T 4e5w_A 250 TRLVNTLKEGKR-LPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIE 295 (302)
T ss_dssp HHHHHHHHTTCC-CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHhccCC-CCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence 233333333333 3456789999999999999999999999999885
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-45 Score=352.22 Aligned_cols=247 Identities=21% Similarity=0.321 Sum_probs=205.0
Q ss_pred CCCCceeecceecccCceEEEEEEECCCCCCCCceeeeechhhh-hhHHHHHHHHHHHHcCCCCcccccccceeeecCCC
Q 039291 3 SDGTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVS-ASASLQKEKEVFDNLNGCPFVLECFGEEITMGENG 81 (362)
Q Consensus 3 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~~-~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~~ 81 (362)
...++|.+++.||+|+||+||+|++++ ..|++|..... ..+.+.+|+.+|++++ ||||+++++++.. .
T Consensus 190 i~~~~~~~~~~lG~G~fg~V~~~~~~~------~~vavK~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~----~ 258 (450)
T 1k9a_A 190 LNMKELKLLQTIGKGEFGDVMLGDYRG------NKVAVKCIKNDATAQAFLAEASVMTQLR-HSNLVQLLGVIVE----E 258 (450)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETT------EEEEEEEESSCTTSHHHHHHHHHHHTCC-CTTBCCEEEEEEC----T
T ss_pred cChHHeEEEeeecCcCCeeEEEEEecC------CeEEEEEeCCchHHHHHHHHHHHHHhcc-CCCEEEEEEEEEc----C
Confidence 345789999999999999999999863 26788876543 4567899999999998 9999999997653 2
Q ss_pred ceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEeecC
Q 039291 82 EMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLG 161 (362)
Q Consensus 82 ~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Dfg 161 (362)
...+++||||+++|+|.+++.......+++..+..++.|++.||+|||++||+||||||+|||+ +.++.+||+|||
T Consensus 259 ~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill----~~~~~~kl~DfG 334 (450)
T 1k9a_A 259 KGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLV----SEDNVAKVSDFG 334 (450)
T ss_dssp TSCEEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE----CTTSCEEECCCT
T ss_pred CCceEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEE----CCCCCEEEeeCC
Confidence 2247799999999999999988655558999999999999999999999999999999999999 778899999999
Q ss_pred CcccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHh-CCCCCccCCCCCHHHHHHHHcCCCCCC
Q 039291 162 VAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLS-GRQAWVVKEDCSIDQLFSIIGDEHSLP 240 (362)
Q Consensus 162 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 240 (362)
+++...... ....++..|+|||++.+..++.++|||||||++|||++ |..||........ ...+..... .
T Consensus 335 ~a~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~---~~~i~~~~~-~ 405 (450)
T 1k9a_A 335 LTKEASSTQ-----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV---VPRVEKGYK-M 405 (450)
T ss_dssp TCEECC-----------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTH---HHHHHTTCC-C
T ss_pred Ccccccccc-----cCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH---HHHHHcCCC-C
Confidence 997543211 23357889999999999999999999999999999998 9999976554433 333333332 3
Q ss_pred CCCccCCHHHHHHHHHHhccCCCCCCCHHHHhc
Q 039291 241 EIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLD 273 (362)
Q Consensus 241 ~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~ 273 (362)
..+..+++++.+||.+||..||++|||+.+++.
T Consensus 406 ~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~ 438 (450)
T 1k9a_A 406 DAPDGCPPAVYDVMKNCWHLDAATRPTFLQLRE 438 (450)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 456789999999999999999999999999875
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-46 Score=344.06 Aligned_cols=257 Identities=21% Similarity=0.288 Sum_probs=203.8
Q ss_pred CCCCceeecceecccCceEEEEEEECCCCCCCCceeeeechhh---hhhHHHHHHHHHHHHcCCCCcccccccceeeecC
Q 039291 3 SDGTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEV---SASASLQKEKEVFDNLNGCPFVLECFGEEITMGE 79 (362)
Q Consensus 3 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~---~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~ 79 (362)
...++|.+.+.||+|+||+||+|+++. + ..|++|.... ...+.+.+|+.+++.++ ||||+++++++..
T Consensus 36 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~-~----~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~--- 106 (321)
T 2qkw_B 36 EATNNFDHKFLIGHGVFGKVYKGVLRD-G----AKVALKRRTPESSQGIEEFETEIETLSFCR-HPHLVSLIGFCDE--- 106 (321)
T ss_dssp CCCCCCSCCCCSCBCSSSEEEEEECTT-C----CEEEEEECCSCCSSHHHHHHHHHHGGGSCC-CTTBCCEEEECCC---
T ss_pred HHHhccCccceeecCCCeeEEEEEECC-C----CEEEEEEecccChHHHHHHHHHHHHHHhCC-CCCEeeEEEEEcC---
Confidence 456899999999999999999999753 3 3577776543 34567889999999998 9999999987642
Q ss_pred CCceEEEEEEEecCCCCHHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEE
Q 039291 80 NGEMAYNLLLEYAAGGTLGDLIEKCNG--NGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKI 157 (362)
Q Consensus 80 ~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl 157 (362)
...+++||||+++++|.+++..... ..+++..++.++.|++.||.|||++||+||||||+||++ +.++.+||
T Consensus 107 --~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~----~~~~~~kl 180 (321)
T 2qkw_B 107 --RNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILL----DENFVPKI 180 (321)
T ss_dssp --TTCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEE----CTTCCEEE
T ss_pred --CCeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEE----CCCCCEEE
Confidence 2246799999999999999865332 359999999999999999999999999999999999999 78889999
Q ss_pred eecCCcccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHH----HH
Q 039291 158 ADLGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFS----II 233 (362)
Q Consensus 158 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~----~~ 233 (362)
+|||+++...............||+.|+|||++.+..++.++|||||||++|+|++|+.||............. ..
T Consensus 181 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~ 260 (321)
T 2qkw_B 181 TDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESH 260 (321)
T ss_dssp CCCTTCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHH
T ss_pred eecccccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhcc
Confidence 99999976544333333345679999999999998899999999999999999999999997543322211111 11
Q ss_pred cC--------CCCCCCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhcC
Q 039291 234 GD--------EHSLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDD 274 (362)
Q Consensus 234 ~~--------~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~ 274 (362)
.. ......++...+.++.+++.+||..||++|||+.+++++
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 309 (321)
T 2qkw_B 261 NNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWK 309 (321)
T ss_dssp TTTCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ccccHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 11 111122344566789999999999999999999999875
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-46 Score=355.24 Aligned_cols=264 Identities=23% Similarity=0.317 Sum_probs=198.8
Q ss_pred CCCceeecceecccCceEEEEEEECCCCCCCCceeeeechhhhhhHHHHHHHHHHHHcCCCCcccccccceeeecCCCce
Q 039291 4 DGTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVSASASLQKEKEVFDNLNGCPFVLECFGEEITMGENGEM 83 (362)
Q Consensus 4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~~~~ 83 (362)
.+.+|.+.+.||+|+||+||.... .++ ..||+|.+.......+.+|+.+++.+.+||||+++++.+.. ..
T Consensus 22 ~~~~y~~~~~LG~G~~G~V~~~~~-~~~----~~vAvK~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~-----~~ 91 (432)
T 3p23_A 22 GKISFCPKDVLGHGAEGTIVYRGM-FDN----RDVAVKRILPECFSFADREVQLLRESDEHPNVIRYFCTEKD-----RQ 91 (432)
T ss_dssp TTEEEEEEEEEEECGGGCEEEEEE-SSS----SEEEEEEECTTTEEECHHHHHHHHHSCCCTTBCCEEEEEEE-----TT
T ss_pred ccEEEecCCeeecCcCEEEEEEEE-eCC----eEEEEEEECHHHHHHHHHHHHHHHhccCCCCcCeEEEEEec-----CC
Confidence 456899999999999999764433 333 36888887666566678999999999779999999986542 33
Q ss_pred EEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecC-CCceEEEEeecCC
Q 039291 84 AYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQ-SGKFVAKIADLGV 162 (362)
Q Consensus 84 ~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~-~~~~~~kl~Dfgl 162 (362)
.+|+|||||. |+|.+++... ...+.+..+..++.||+.||.|||++||+||||||+|||+..++ +....+||+|||+
T Consensus 92 ~~~lv~E~~~-g~L~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~ 169 (432)
T 3p23_A 92 FQYIAIELCA-ATLQEYVEQK-DFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGL 169 (432)
T ss_dssp EEEEEEECCS-EEHHHHHHSS-SCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTE
T ss_pred EEEEEEECCC-CCHHHHHHhc-CCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccc
Confidence 4789999996 5999999863 33466667889999999999999999999999999999995432 3455789999999
Q ss_pred cccccccccC-CCCCCccCCCCccCchhhcc---ccCCCcchHHHHHHHHHHHHh-CCCCCccCCCCCHHHHHHHHcCCC
Q 039291 163 AKRSRHCKRQ-KFDPSMRGTPLYLAPETVVQ---HMQEAPSDIWALGCVVLEMLS-GRQAWVVKEDCSIDQLFSIIGDEH 237 (362)
Q Consensus 163 a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~ 237 (362)
++........ .......||+.|+|||++.+ ..++.++|||||||++|+|++ |..||.... ..... .+....
T Consensus 170 a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~---~~~~~-~~~~~~ 245 (432)
T 3p23_A 170 CKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSL---QRQAN-ILLGAC 245 (432)
T ss_dssp EECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTT---THHHH-HHTTCC
T ss_pred eeeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhh---HHHHH-HHhccC
Confidence 9865532211 22245679999999999983 567789999999999999999 999994332 22222 222222
Q ss_pred CCCC--CCccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCccCcchh
Q 039291 238 SLPE--IPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGVDEE 283 (362)
Q Consensus 238 ~~~~--~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~~~~~~~ 283 (362)
..+. .+...+..+++||.+||..||++|||+.++++||||..+.+.
T Consensus 246 ~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~hp~f~~~~~~ 293 (432)
T 3p23_A 246 SLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWSLEKQ 293 (432)
T ss_dssp CCTTSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTSTTTCCHHHH
T ss_pred CccccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHhCccccChHHH
Confidence 2111 123356678999999999999999999999999999987654
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-46 Score=344.17 Aligned_cols=267 Identities=20% Similarity=0.329 Sum_probs=207.2
Q ss_pred CCCCCceeecceecccCceEEEEEEECCC-CCCCCceeeeechh----hhhhHHHHHHHHHHHHcCCCCcccccccceee
Q 039291 2 DSDGTSWFRGRVIGQGSFGCVFIAKPKSN-SSFLPPLMAVKSAE----VSASASLQKEKEVFDNLNGCPFVLECFGEEIT 76 (362)
Q Consensus 2 ~~~~~~y~~~~~lG~G~~g~V~~a~~~~~-~~~~~~~~~~K~~~----~~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~ 76 (362)
+...++|.+++.||+|+||.||+|++... +......|++|... ......+.+|+.++++++ ||||+++++++..
T Consensus 26 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~ 104 (327)
T 2yfx_A 26 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFN-HQNIVRCIGVSLQ 104 (327)
T ss_dssp BCCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCC-CTTBCCEEEEECS
T ss_pred cCChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCC-CCCCCeEEEEEcC
Confidence 35678999999999999999999995432 11223467888763 334567889999999997 9999999987643
Q ss_pred ecCCCceEEEEEEEecCCCCHHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCC
Q 039291 77 MGENGEMAYNLLLEYAAGGTLGDLIEKCNG-----NGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSG 151 (362)
Q Consensus 77 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-----~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~ 151 (362)
...+++||||++|++|.+++..... ..+++..++.++.||+.||.|||++||+||||||+|||+..+ ..
T Consensus 105 -----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~-~~ 178 (327)
T 2yfx_A 105 -----SLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCP-GP 178 (327)
T ss_dssp -----SSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCS-ST
T ss_pred -----CCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecC-CC
Confidence 2235799999999999999987432 348999999999999999999999999999999999999422 13
Q ss_pred ceEEEEeecCCcccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHh-CCCCCccCCCCCHHHHH
Q 039291 152 KFVAKIADLGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLS-GRQAWVVKEDCSIDQLF 230 (362)
Q Consensus 152 ~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~ 230 (362)
...+||+|||++................||+.|+|||++.+..++.++|||||||++|+|++ |..||... ...+..
T Consensus 179 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~---~~~~~~ 255 (327)
T 2yfx_A 179 GRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSK---SNQEVL 255 (327)
T ss_dssp TCCEEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC---CHHHHH
T ss_pred cceEEECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCc---CHHHHH
Confidence 45799999999975543332233345678999999999998899999999999999999998 99999544 344555
Q ss_pred HHHcCCCCCCCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCccC
Q 039291 231 SIIGDEHSLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKG 279 (362)
Q Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~~~ 279 (362)
..+.... .+..+..++..+.++|.+||..||.+||++.+++++.|+..
T Consensus 256 ~~~~~~~-~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~ 303 (327)
T 2yfx_A 256 EFVTSGG-RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT 303 (327)
T ss_dssp HHHHTTC-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHhcCC-CCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHh
Confidence 5544433 23456778999999999999999999999999999887643
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=339.33 Aligned_cols=257 Identities=19% Similarity=0.316 Sum_probs=203.1
Q ss_pred CCCCceeecceecccCceEEEEEEECCCCCCCCceeeeechhh----hhhHHHHHHHHHHHHcCCCCcccccccceeeec
Q 039291 3 SDGTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEV----SASASLQKEKEVFDNLNGCPFVLECFGEEITMG 78 (362)
Q Consensus 3 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~----~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~ 78 (362)
+..++|.+.+.||+|+||+||+|+++.++......|++|.... .....+.+|+.+++.++ ||||+++++.+..
T Consensus 41 i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~-- 117 (333)
T 1mqb_A 41 IHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFS-HHNIIRLEGVISK-- 117 (333)
T ss_dssp CCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCC-CTTBCCEEEEECS--
T ss_pred CChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCC-CCCCCcEEEEEec--
Confidence 4678999999999999999999998876654445688887643 23456889999999998 9999999987632
Q ss_pred CCCceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEe
Q 039291 79 ENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIA 158 (362)
Q Consensus 79 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~ 158 (362)
...+++||||+++++|.+++... ...+++..++.++.||+.||.|||++||+||||||+||++ +.++.+||+
T Consensus 118 ---~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~----~~~~~~kl~ 189 (333)
T 1mqb_A 118 ---YKPMMIITEYMENGALDKFLREK-DGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILV----NSNLVCKVS 189 (333)
T ss_dssp ---SSSEEEEEECCTTEEHHHHHHHT-TTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE----CTTCCEEEC
T ss_pred ---CCCcEEEEeCCCCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEE----CCCCcEEEC
Confidence 23467999999999999999863 3569999999999999999999999999999999999999 778899999
Q ss_pred ecCCcccccccccCC-CCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHh-CCCCCccCCCCCHHHHHHHHcCC
Q 039291 159 DLGVAKRSRHCKRQK-FDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLS-GRQAWVVKEDCSIDQLFSIIGDE 236 (362)
Q Consensus 159 Dfgla~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~ 236 (362)
|||+++......... ......+|+.|+|||++.+..++.++|||||||++|+|++ |..||... ...++...+...
T Consensus 190 Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~---~~~~~~~~~~~~ 266 (333)
T 1mqb_A 190 DFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWEL---SNHEVMKAINDG 266 (333)
T ss_dssp CCCC-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC---CHHHHHHHHHTT
T ss_pred CCCcchhhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccC---CHHHHHHHHHCC
Confidence 999998654322211 1123346788999999998899999999999999999999 99999543 445555555544
Q ss_pred CCCCCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhcC
Q 039291 237 HSLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDD 274 (362)
Q Consensus 237 ~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~ 274 (362)
... ..+..++.++.++|.+||..||++||++.+++++
T Consensus 267 ~~~-~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 303 (333)
T 1mqb_A 267 FRL-PTPMDCPSAIYQLMMQCWQQERARRPKFADIVSI 303 (333)
T ss_dssp CCC-CCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred CcC-CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 333 3456789999999999999999999999999863
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-46 Score=335.55 Aligned_cols=253 Identities=19% Similarity=0.330 Sum_probs=210.0
Q ss_pred CCCCCceeecceecccCceEEEEEEECCCCCCCCceeeeechhhh--hhHHHHHHHHHHHHcCCCCcccccccceeeecC
Q 039291 2 DSDGTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVS--ASASLQKEKEVFDNLNGCPFVLECFGEEITMGE 79 (362)
Q Consensus 2 ~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~~--~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~ 79 (362)
+...++|.+.+.||+|+||+||+|.++.++. .+++|..... ..+.+.+|+.+++.++ ||||+++++++..
T Consensus 9 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~----~vaiK~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~--- 80 (288)
T 3kfa_A 9 EMERTDITMKHKLGGGQYGEVYEGVWKKYSL----TVAVKTLKEDTMEVEEFLKEAAVMKEIK-HPNLVQLLGVCTR--- 80 (288)
T ss_dssp BCCGGGEEEEEESGGGTTCSEEEEEEGGGTE----EEEEEEECSCSTHHHHHHHHHHHHHHCC-CTTBCCEEEEECS---
T ss_pred cccccceeEEeecCCCCceeEEEeEecCCCE----EEEEEecCcCHHHHHHHHHHHHHHHhCC-CCCEeeEEEEEcc---
Confidence 3567899999999999999999999988764 5677765432 4467889999999998 9999999987642
Q ss_pred CCceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEee
Q 039291 80 NGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIAD 159 (362)
Q Consensus 80 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~D 159 (362)
...+++||||++|++|.+++.......+++..++.++.|++.||.|||++||+||||||+||++ +.++.++|+|
T Consensus 81 --~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~----~~~~~~~l~D 154 (288)
T 3kfa_A 81 --EPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLV----GENHLVKVAD 154 (288)
T ss_dssp --SSSEEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEE----CGGGCEEECC
T ss_pred --CCCEEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEE----cCCCCEEEcc
Confidence 2346799999999999999988666779999999999999999999999999999999999999 7778899999
Q ss_pred cCCcccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHh-CCCCCccCCCCCHHHHHHHHcCCCC
Q 039291 160 LGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLS-GRQAWVVKEDCSIDQLFSIIGDEHS 238 (362)
Q Consensus 160 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~ 238 (362)
||++......... ......+|+.|+|||++.+..++.++||||||+++|+|++ |..||...+.. .....+....
T Consensus 155 fg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~---~~~~~~~~~~- 229 (288)
T 3kfa_A 155 FGLSRLMTGDTYT-AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS---QVYELLEKDY- 229 (288)
T ss_dssp CCGGGTSCSSSSE-EETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG---GHHHHHHTTC-
T ss_pred CccceeccCCccc-cccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH---HHHHHHhccC-
Confidence 9999765532211 1234557889999999998899999999999999999999 99999665433 3333333332
Q ss_pred CCCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhc
Q 039291 239 LPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLD 273 (362)
Q Consensus 239 ~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~ 273 (362)
.+..+..+++++.+||.+||..||.+|||+.++++
T Consensus 230 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~ 264 (288)
T 3kfa_A 230 RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ 264 (288)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHH
Confidence 23456778999999999999999999999999976
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=340.04 Aligned_cols=257 Identities=19% Similarity=0.319 Sum_probs=200.5
Q ss_pred CCCCceeecceecccCceEEEEEEECCCCCCCCceeeeechhhhhhHHHHHHHHHHHH--cCCCCcccccccceeeecCC
Q 039291 3 SDGTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVSASASLQKEKEVFDN--LNGCPFVLECFGEEITMGEN 80 (362)
Q Consensus 3 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~~~~~~~~~E~~il~~--l~~h~~i~~~~~~~~~~~~~ 80 (362)
..-++|.+++.||+|+||+||+|++.+ ..|++|.........+..|.+++.. ++ ||||+++++........
T Consensus 10 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~------~~vavK~~~~~~~~~~~~e~~~~~~~~~~-h~~i~~~~~~~~~~~~~ 82 (336)
T 3g2f_A 10 LDLDNLKLLELIGRGRYGAVYKGSLDE------RPVAVKVFSFANRQNFINEKNIYRVPLME-HDNIARFIVGDERVTAD 82 (336)
T ss_dssp CCTTSEEEEEEEEECSSEEEEEEEETT------EEEEEEEEEGGGHHHHHHHHHHHTSTTCC-CTTBCCEEEEEEEECTT
T ss_pred cChHHhheeeecccCCCeEEEEEEECC------eEEEEEEeeccchhhHHHHHHHHHHHhcc-CcchhhheecccccccC
Confidence 456899999999999999999998743 3688888776666666666666543 55 99999999866655556
Q ss_pred CceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---------CceeCCCCCCCEEEeecCCC
Q 039291 81 GEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDS---------GYVHCDVKPDNILLVATQSG 151 (362)
Q Consensus 81 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~---------~ivH~Dlkp~Nill~~~~~~ 151 (362)
....+++||||+++|+|.+++.. ..+++..+..++.||+.||.|||+. ||+||||||+|||+ +.
T Consensus 83 ~~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill----~~ 155 (336)
T 3g2f_A 83 GRMEYLLVMEYYPNGSLXKYLSL---HTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLV----KN 155 (336)
T ss_dssp SCEEEEEEECCCTTCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEE----CT
T ss_pred CCceEEEEEecCCCCcHHHHHhh---cccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEE----cC
Confidence 66678899999999999999976 3368999999999999999999999 99999999999999 77
Q ss_pred ceEEEEeecCCcccccccc------cCCCCCCccCCCCccCchhhcc-------ccCCCcchHHHHHHHHHHHHhCCCCC
Q 039291 152 KFVAKIADLGVAKRSRHCK------RQKFDPSMRGTPLYLAPETVVQ-------HMQEAPSDIWALGCVVLEMLSGRQAW 218 (362)
Q Consensus 152 ~~~~kl~Dfgla~~~~~~~------~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DiwslG~il~~l~~g~~pf 218 (362)
++.+||+|||+++...... .........||+.|+|||++.+ ..++.++|||||||++|||++|..||
T Consensus 156 ~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~ 235 (336)
T 3g2f_A 156 DGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDL 235 (336)
T ss_dssp TSCEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGG
T ss_pred CCcEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcC
Confidence 7889999999997654321 1112235579999999999986 45677899999999999999997776
Q ss_pred ccCCC---------------CCHHHHHHHHcCCCCCCCCCcc------CCHHHHHHHHHHhccCCCCCCCHHHHhc
Q 039291 219 VVKED---------------CSIDQLFSIIGDEHSLPEIPSR------VSKEARDFLRRCFVRKPAFRFTAEMLLD 273 (362)
Q Consensus 219 ~~~~~---------------~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~li~~~l~~~p~~R~s~~~~l~ 273 (362)
..... .........+......+.++.. +++++.+||.+||..||++|||+.++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~ 311 (336)
T 3g2f_A 236 FPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEE 311 (336)
T ss_dssp STTSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred CCccchhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHH
Confidence 43321 1122333333334444444433 4458999999999999999999999965
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-46 Score=338.46 Aligned_cols=263 Identities=19% Similarity=0.321 Sum_probs=200.6
Q ss_pred CCCCCceeecceecccCceEEEEEEECCCCCCCCceeeeechhh-----hhhHHHHHHHHHHHHcCCCCcccccccceee
Q 039291 2 DSDGTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEV-----SASASLQKEKEVFDNLNGCPFVLECFGEEIT 76 (362)
Q Consensus 2 ~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~-----~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~ 76 (362)
...+++|.+++.||+|+||+||+|++...+. ....+++|.... ...+.+.+|+.++++++ ||||+++++++..
T Consensus 30 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~ 107 (313)
T 3brb_A 30 VIDRNLLILGKILGEGEFGSVMEGNLKQEDG-TSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFS-HPNVIRLLGVCIE 107 (313)
T ss_dssp BCCGGGEEEEEEEEC-CCCCEEEEEEECTTS-CEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCC-CTTBCCCCEEEEC
T ss_pred ccCHHHeeeccceeecCCeEEEEEEEeccCC-ceeEEEEEEEeccccchhHHHHHHHHHHHHhcCC-CCCeeeeeEEEee
Confidence 3567899999999999999999998765322 124678887642 23456889999999998 9999999998765
Q ss_pred ecCCCceEEEEEEEecCCCCHHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCc
Q 039291 77 MGENGEMAYNLLLEYAAGGTLGDLIEKC----NGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGK 152 (362)
Q Consensus 77 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~----~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~ 152 (362)
.........++||||+++++|.+++... ....+++..++.++.||+.||.|||++||+||||||+||++ +.+
T Consensus 108 ~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli----~~~ 183 (313)
T 3brb_A 108 MSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCML----RDD 183 (313)
T ss_dssp -------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEE----CTT
T ss_pred ccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEE----cCC
Confidence 4433333567999999999999999542 23569999999999999999999999999999999999999 777
Q ss_pred eEEEEeecCCcccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHh-CCCCCccCCCCCHHHHHH
Q 039291 153 FVAKIADLGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLS-GRQAWVVKEDCSIDQLFS 231 (362)
Q Consensus 153 ~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~ 231 (362)
+.+||+|||++................+++.|+|||++.+..++.++|||||||++|+|++ |..||...... ....
T Consensus 184 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~---~~~~ 260 (313)
T 3brb_A 184 MTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNH---EMYD 260 (313)
T ss_dssp SCEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG---GHHH
T ss_pred CcEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHH---HHHH
Confidence 8899999999976554332222234567889999999999899999999999999999999 99999655432 3333
Q ss_pred HHcCCCCCCCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhcC
Q 039291 232 IIGDEHSLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDD 274 (362)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~ 274 (362)
.+.... .+..+..++.++.++|.+||..||.+|||+.+++.+
T Consensus 261 ~~~~~~-~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 302 (313)
T 3brb_A 261 YLLHGH-RLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQ 302 (313)
T ss_dssp HHHTTC-CCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred HHHcCC-CCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 333332 334567899999999999999999999999999864
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-46 Score=355.96 Aligned_cols=264 Identities=25% Similarity=0.314 Sum_probs=195.3
Q ss_pred CCCceeecceecccCceEEEEEEECCCCCCCCceeeeechhhhhhHHHHHHHHHHHHcCCCCcccccccceeeecCCCce
Q 039291 4 DGTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVSASASLQKEKEVFDNLNGCPFVLECFGEEITMGENGEM 83 (362)
Q Consensus 4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~~~~ 83 (362)
-++.|.+.+.||+|+||+||.+... ++ ..||+|.......+.+.+|+.+++++.+||||+++++.+.. ..
T Consensus 13 l~~~~~~~~~LG~G~~g~V~~~~~~-~g----~~vAvK~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~-----~~ 82 (434)
T 2rio_A 13 LKNLVVSEKILGYGSSGTVVFQGSF-QG----RPVAVKRMLIDFCDIALMEIKLLTESDDHPNVIRYYCSETT-----DR 82 (434)
T ss_dssp CSSCEEEEEEEEECSTTCEEEEEES-SS----SEEEEEEEEGGGHHHHHHHHHHHHHHTTSTTBCCEEEEEEC-----SS
T ss_pred hhheeeccCeEeeCCCeEEEEEEEE-CC----eEEEEEEEcHHHHHHHHHHHHHHHhccCCCCcCeEEEEEec-----CC
Confidence 4577888999999999999876443 33 47888887766667788999999988669999999886532 34
Q ss_pred EEEEEEEecCCCCHHHHHHHhcCCC-----CCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecC---------
Q 039291 84 AYNLLLEYAAGGTLGDLIEKCNGNG-----LPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQ--------- 149 (362)
Q Consensus 84 ~~~lv~e~~~~~~L~~~l~~~~~~~-----l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~--------- 149 (362)
.+++|||||. |+|.+++....... .++..++.++.||+.||+|||++||+||||||+|||+..++
T Consensus 83 ~~~lv~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~ 161 (434)
T 2rio_A 83 FLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTG 161 (434)
T ss_dssp EEEEEECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTC
T ss_pred eEEEEEecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccC
Confidence 5789999996 59999998632211 13335678999999999999999999999999999996432
Q ss_pred CCceEEEEeecCCcccccccccCC--CCCCccCCCCccCchhhcc-------ccCCCcchHHHHHHHHHHHHh-CCCCCc
Q 039291 150 SGKFVAKIADLGVAKRSRHCKRQK--FDPSMRGTPLYLAPETVVQ-------HMQEAPSDIWALGCVVLEMLS-GRQAWV 219 (362)
Q Consensus 150 ~~~~~~kl~Dfgla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-------~~~~~~~DiwslG~il~~l~~-g~~pf~ 219 (362)
+....+||+|||+++......... ......||+.|+|||++.+ ..++.++|||||||++|+|++ |..||.
T Consensus 162 ~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~ 241 (434)
T 2rio_A 162 AENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFG 241 (434)
T ss_dssp CCSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTC
T ss_pred CCceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCC
Confidence 345689999999998665432111 1234679999999999976 568899999999999999999 999995
Q ss_pred cCCCCCHHHHHHHHcCCCCCCCC----CccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCccCcch
Q 039291 220 VKEDCSIDQLFSIIGDEHSLPEI----PSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGVDE 282 (362)
Q Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~~~~~~ 282 (362)
.... .. ...+......+.. +..++.++++||.+||..||.+|||+.++++||||.....
T Consensus 242 ~~~~--~~--~~i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp~f~~~~~ 304 (434)
T 2rio_A 242 DKYS--RE--SNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFWPKSK 304 (434)
T ss_dssp STTT--HH--HHHHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSCHHH
T ss_pred Cchh--hH--HHHhcCCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhCCccCCcHH
Confidence 4322 11 1222222222221 2345688999999999999999999999999999986543
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-46 Score=332.76 Aligned_cols=247 Identities=15% Similarity=0.238 Sum_probs=203.1
Q ss_pred CCCCceeecceecccCceEEEEEEECCCCCCCCceeeeechh-----hhhhHHHHHHHHHHHHcCCCCcccccccceeee
Q 039291 3 SDGTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAE-----VSASASLQKEKEVFDNLNGCPFVLECFGEEITM 77 (362)
Q Consensus 3 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~-----~~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~ 77 (362)
+.-++|.+.+.||+|+||+||+|++++ ..+++|... ....+.+.+|+.++++++ ||||+++++++...
T Consensus 7 i~~~~y~~~~~lg~G~~g~V~~~~~~~------~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~ 79 (271)
T 3kmu_A 7 IDFKQLNFLTKLNENHSGELWKGRWQG------NDIVVKVLKVRDWSTRKSRDFNEECPRLRIFS-HPNVLPVLGACQSP 79 (271)
T ss_dssp CCGGGCEEEEEEEEETTEEEEEEEETT------EEEEEEEECCTTCCHHHHHHHHHHGGGGCCCS-CTTEECEEEEECTT
T ss_pred CCHHHhHHHHHhcCCCcceEEEEEECC------eeEEEEEecccccCHHHHHHHHHHHHHHHhcC-CCchhheEEEEccC
Confidence 456899999999999999999999863 246666653 234566889999999998 99999999976432
Q ss_pred cCCCceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--ceeCCCCCCCEEEeecCCCceEE
Q 039291 78 GENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSG--YVHCDVKPDNILLVATQSGKFVA 155 (362)
Q Consensus 78 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~--ivH~Dlkp~Nill~~~~~~~~~~ 155 (362)
....+++||||+++++|.+++.......+++..++.++.|++.||.|||++| |+||||||+||++ +.++.+
T Consensus 80 ---~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~----~~~~~~ 152 (271)
T 3kmu_A 80 ---PAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMI----DEDMTA 152 (271)
T ss_dssp ---TSSSCEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEE----CTTSCE
T ss_pred ---CCCCeEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEE----cCCcce
Confidence 1234679999999999999998755556999999999999999999999999 9999999999999 777889
Q ss_pred EEeecCCcccccccccCCCCCCccCCCCccCchhhccccCCC---cchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHH
Q 039291 156 KIADLGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEA---PSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSI 232 (362)
Q Consensus 156 kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~---~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~ 232 (362)
+|+|||++..... ....||+.|+|||++.+..++. ++|||||||++|+|++|..||... ........
T Consensus 153 ~l~~~~~~~~~~~-------~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~---~~~~~~~~ 222 (271)
T 3kmu_A 153 RISMADVKFSFQS-------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADL---SNMEIGMK 222 (271)
T ss_dssp EEEGGGSCCTTSC-------TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTS---CHHHHHHH
T ss_pred eEEeccceeeecc-------cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCcccc---ChHHHHHH
Confidence 9999888643221 3456899999999998765554 799999999999999999999644 33444344
Q ss_pred HcCCCCCCCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhc
Q 039291 233 IGDEHSLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLD 273 (362)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~ 273 (362)
+......+.++..++.++.++|.+||..||++|||+.++++
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 263 (271)
T 3kmu_A 223 VALEGLRPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVP 263 (271)
T ss_dssp HHHSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 44344455677889999999999999999999999999986
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-46 Score=332.49 Aligned_cols=255 Identities=20% Similarity=0.288 Sum_probs=203.0
Q ss_pred CCCCCceeecceecccCceEEEEEEECCCCCCCCceeeeechhh----hhhHHHHHHHHHHHHcCCCCcccccccceeee
Q 039291 2 DSDGTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEV----SASASLQKEKEVFDNLNGCPFVLECFGEEITM 77 (362)
Q Consensus 2 ~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~----~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~ 77 (362)
+...++|.+.+.||+|+||+||+|++...... ...+++|.... ...+.+.+|+.+++.++ ||||+++++++..
T Consensus 8 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~- 84 (281)
T 3cc6_A 8 GIAREDVVLNRILGEGFFGEVYEGVYTNHKGE-KINVAVKTCKKDCTLDNKEKFMSEAVIMKNLD-HPHIVKLIGIIEE- 84 (281)
T ss_dssp SCCGGGEEEEEEEEECSSSEEEEEEEECTTCC-EEEEEEEECCTTSCHHHHHHHHHHHHHHHHHC-CTTBCCEEEEECS-
T ss_pred eecccceEEEEEEEecCCeeEEEeEEcCCCCC-cceEEEEecccccCchHHHHHHHHHHHHHhCC-CCCcceEEEEEcC-
Confidence 45678999999999999999999997654321 23577777543 34567889999999998 9999999986531
Q ss_pred cCCCceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEE
Q 039291 78 GENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKI 157 (362)
Q Consensus 78 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl 157 (362)
. ..++||||+++++|.+++... ...+++..++.++.|++.||.|||++||+||||||+||++ +.++.+||
T Consensus 85 ----~-~~~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~----~~~~~~kl 154 (281)
T 3cc6_A 85 ----E-PTWIIMELYPYGELGHYLERN-KNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILV----ASPECVKL 154 (281)
T ss_dssp ----S-SCEEEEECCTTCBHHHHHHHH-TTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEE----EETTEEEE
T ss_pred ----C-CCEEEEecCCCCCHHHHHHhc-cccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEE----CCCCcEEe
Confidence 1 246999999999999999874 3459999999999999999999999999999999999999 55678999
Q ss_pred eecCCcccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHh-CCCCCccCCCCCHHHHHHHHcCC
Q 039291 158 ADLGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLS-GRQAWVVKEDCSIDQLFSIIGDE 236 (362)
Q Consensus 158 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~ 236 (362)
+|||++......... ......+|+.|+|||++.+..++.++||||||+++|+|++ |+.||.............. .
T Consensus 155 ~Dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~---~ 230 (281)
T 3cc6_A 155 GDFGLSRYIEDEDYY-KASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEK---G 230 (281)
T ss_dssp CCCCGGGCC----------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHH---T
T ss_pred CccCCCccccccccc-ccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhc---C
Confidence 999999765442211 1234557889999999998899999999999999999998 9999975544333333222 2
Q ss_pred CCCCCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhcC
Q 039291 237 HSLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDD 274 (362)
Q Consensus 237 ~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~ 274 (362)
.. +..+..+++.+.++|.+||..||++||++.+++++
T Consensus 231 ~~-~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~ 267 (281)
T 3cc6_A 231 DR-LPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCS 267 (281)
T ss_dssp CC-CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CC-CCCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHH
Confidence 22 23456789999999999999999999999999874
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-46 Score=358.91 Aligned_cols=251 Identities=19% Similarity=0.331 Sum_probs=208.8
Q ss_pred CCCceeecceecccCceEEEEEEECCCCCCCCceeeeechhhh--hhHHHHHHHHHHHHcCCCCcccccccceeeecCCC
Q 039291 4 DGTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVS--ASASLQKEKEVFDNLNGCPFVLECFGEEITMGENG 81 (362)
Q Consensus 4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~~--~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~~ 81 (362)
...+|.+.+.||+|+||.||+|+++.++. .|++|..... ..+.+.+|+.+|++++ ||||+++++++..
T Consensus 218 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~----~vavK~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~----- 287 (495)
T 1opk_A 218 ERTDITMKHKLGGGQYGEVYEGVWKKYSL----TVAVKTLKEDTMEVEEFLKEAAVMKEIK-HPNLVQLLGVCTR----- 287 (495)
T ss_dssp CGGGEEEEEESGGGTTSSEEEEEEGGGTE----EEEEEECCSSSSCHHHHHHHHHHHHHCC-CTTBCCEEEEECS-----
T ss_pred CHHHceeeeEecCCCCeEEEEEEEcCCCe----EEEEEEecCcccchHHHHHHHHHHHhcC-CCCEeeEEEEEec-----
Confidence 45679999999999999999999987653 6788876533 4567899999999998 9999999997643
Q ss_pred ceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEeecC
Q 039291 82 EMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLG 161 (362)
Q Consensus 82 ~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Dfg 161 (362)
...+++||||+++|+|.+++.......+++..+..++.||+.||+|||++||+||||||+|||+ +.++.+||+|||
T Consensus 288 ~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll----~~~~~~kl~DFG 363 (495)
T 1opk_A 288 EPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLV----GENHLVKVADFG 363 (495)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE----CGGGCEEECCTT
T ss_pred CCcEEEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEE----CCCCcEEEeecc
Confidence 2236799999999999999987666679999999999999999999999999999999999999 778899999999
Q ss_pred CcccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHh-CCCCCccCCCCCHHHHHHHHcCCCCCC
Q 039291 162 VAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLS-GRQAWVVKEDCSIDQLFSIIGDEHSLP 240 (362)
Q Consensus 162 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 240 (362)
+++....... .......++..|+|||++.+..++.++|||||||+||||++ |..||...+. .++...+..... .
T Consensus 364 ~a~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~---~~~~~~~~~~~~-~ 438 (495)
T 1opk_A 364 LSRLMTGDTY-TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL---SQVYELLEKDYR-M 438 (495)
T ss_dssp CEECCTTCCE-ECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCG---GGHHHHHHTTCC-C
T ss_pred cceeccCCce-eecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCH---HHHHHHHHcCCC-C
Confidence 9986543221 11234456788999999998899999999999999999999 9999976543 334444443333 3
Q ss_pred CCCccCCHHHHHHHHHHhccCCCCCCCHHHHhc
Q 039291 241 EIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLD 273 (362)
Q Consensus 241 ~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~ 273 (362)
..+..++.++.+||.+||..||++|||+.++++
T Consensus 439 ~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~ 471 (495)
T 1opk_A 439 ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ 471 (495)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHH
Confidence 456789999999999999999999999999876
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=333.79 Aligned_cols=257 Identities=21% Similarity=0.328 Sum_probs=201.2
Q ss_pred CCCCCceeecceecccCceEEEEEEECCCCCCCCceeeeechhh----hhhHHHHHHHHHHHHcCCCCcccccccceeee
Q 039291 2 DSDGTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEV----SASASLQKEKEVFDNLNGCPFVLECFGEEITM 77 (362)
Q Consensus 2 ~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~----~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~ 77 (362)
+....+|.+++.||+|+||+||+|++..++.. ...+++|.... .....+.+|+.++++++ ||||+++++++..
T Consensus 21 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~-~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~- 97 (298)
T 3f66_A 21 GPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGK-KIHCAVKSLNRITDIGEVSQFLTEGIIMKDFS-HPNVLSLLGICLR- 97 (298)
T ss_dssp CGGGEEEEEEEEEEEETTEEEEEEEEC------CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCC-CTTBCCCCEEECC-
T ss_pred CccceehhhcceeeecCCceEEEEEEecCCCc-eeEEEEEecccCCCHHHHHHHHHHHHHHHhCC-CCCEeeeeeEEEc-
Confidence 34567899999999999999999998654421 23466666432 34466889999999998 9999999987542
Q ss_pred cCCCceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEE
Q 039291 78 GENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKI 157 (362)
Q Consensus 78 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl 157 (362)
.....++||||+++++|.+++.. ....+++..++.++.|++.||.|||++||+||||||+||++ +.++.+||
T Consensus 98 ---~~~~~~~v~e~~~~~~L~~~l~~-~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~----~~~~~~kl 169 (298)
T 3f66_A 98 ---SEGSPLVVLPYMKHGDLRNFIRN-ETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCML----DEKFTVKV 169 (298)
T ss_dssp ---SSSCCEEEEECCTTCBHHHHHHC-TTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE----CTTCCEEE
T ss_pred ---CCCceEEEEeCCCCCCHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEE----CCCCCEEE
Confidence 22346699999999999999976 34568999999999999999999999999999999999999 78889999
Q ss_pred eecCCcccccccccC--CCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHh-CCCCCccCCCCCHHHHHHHHc
Q 039291 158 ADLGVAKRSRHCKRQ--KFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLS-GRQAWVVKEDCSIDQLFSIIG 234 (362)
Q Consensus 158 ~Dfgla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~ 234 (362)
+|||+++........ .......||+.|+|||++.+..++.++||||||+++|+|++ |.+||........... +.
T Consensus 170 ~Dfg~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~---~~ 246 (298)
T 3f66_A 170 ADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVY---LL 246 (298)
T ss_dssp CSCGGGCCCSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHH---HH
T ss_pred CcccccccccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHH---Hh
Confidence 999999765432211 12234567889999999999899999999999999999999 6677765544333322 22
Q ss_pred CCCCCCCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhc
Q 039291 235 DEHSLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLD 273 (362)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~ 273 (362)
... .+..+..++.++.++|.+||..||++|||+.++++
T Consensus 247 ~~~-~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 284 (298)
T 3f66_A 247 QGR-RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVS 284 (298)
T ss_dssp TTC-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred cCC-CCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 222 23345678999999999999999999999999986
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-46 Score=340.55 Aligned_cols=253 Identities=25% Similarity=0.380 Sum_probs=204.2
Q ss_pred CCCceeecceecccCceEEEEEEECCCCCCCCceeeeechh----hhhhHHHHHHHHHHHHcCCCCcccccccceeeecC
Q 039291 4 DGTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAE----VSASASLQKEKEVFDNLNGCPFVLECFGEEITMGE 79 (362)
Q Consensus 4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~----~~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~ 79 (362)
..++|.+++.||+|+||.||+|+++.++..+ .+++|... ......+.+|+.+++++.+||||+++++++..
T Consensus 23 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~--~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~--- 97 (327)
T 1fvr_A 23 DWNDIKFQDVIGEGNFGQVLKARIKKDGLRM--DAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEH--- 97 (327)
T ss_dssp CGGGCEEEEEEECGGGCEEEEEEEEETTEEE--EEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEE---
T ss_pred cHHHccceeeeecCCCceEEEEEEccCCccc--ceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeee---
Confidence 4579999999999999999999998776532 23555433 33455688999999999669999999997643
Q ss_pred CCceEEEEEEEecCCCCHHHHHHHhc--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEE
Q 039291 80 NGEMAYNLLLEYAAGGTLGDLIEKCN--------------GNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILL 145 (362)
Q Consensus 80 ~~~~~~~lv~e~~~~~~L~~~l~~~~--------------~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill 145 (362)
...+++||||+++++|.+++.... ...+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus 98 --~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~ 175 (327)
T 1fvr_A 98 --RGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILV 175 (327)
T ss_dssp --TTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE
T ss_pred --CCceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEE
Confidence 234779999999999999998632 2469999999999999999999999999999999999999
Q ss_pred eecCCCceEEEEeecCCcccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHh-CCCCCccCCCC
Q 039291 146 VATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLS-GRQAWVVKEDC 224 (362)
Q Consensus 146 ~~~~~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~ 224 (362)
+.++.+||+|||+++...... ......+++.|+|||++.+..++.++|||||||++|+|++ |..||...
T Consensus 176 ----~~~~~~kL~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~--- 245 (327)
T 1fvr_A 176 ----GENYVAKIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGM--- 245 (327)
T ss_dssp ----CGGGCEEECCTTCEESSCEEC---CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTC---
T ss_pred ----cCCCeEEEcccCcCccccccc---cccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCC---
Confidence 777889999999987443221 1134557889999999998889999999999999999998 99999544
Q ss_pred CHHHHHHHHcCCCCCCCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhcC
Q 039291 225 SIDQLFSIIGDEHSLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDD 274 (362)
Q Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~ 274 (362)
...++...+.... .+..+..++.++.+||.+||..||.+|||+.+++++
T Consensus 246 ~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 294 (327)
T 1fvr_A 246 TCAELYEKLPQGY-RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 294 (327)
T ss_dssp CHHHHHHHGGGTC-CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cHHHHHHHhhcCC-CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 4555555554443 234567789999999999999999999999999874
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-46 Score=355.94 Aligned_cols=250 Identities=23% Similarity=0.379 Sum_probs=206.3
Q ss_pred CCCCceeecceecccCceEEEEEEECCCCCCCCceeeeechhhh--hhHHHHHHHHHHHHcCCCCcccccccceeeecCC
Q 039291 3 SDGTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVS--ASASLQKEKEVFDNLNGCPFVLECFGEEITMGEN 80 (362)
Q Consensus 3 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~~--~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~ 80 (362)
+..++|.+.+.||+|+||+||+|+++.+ ..|++|..... ..+.+.+|+.+|++++ ||||+++++++. .
T Consensus 185 i~~~~~~~~~~lG~G~fg~V~~~~~~~~-----~~vavK~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~l~~~~~----~ 254 (454)
T 1qcf_A 185 IPRESLKLEKKLGAGQFGEVWMATYNKH-----TKVAVKTMKPGSMSVEAFLAEANVMKTLQ-HDKLVKLHAVVT----K 254 (454)
T ss_dssp CCGGGEEEEEEEECCSSEEEEEEEETTT-----EEEEEEEECTTSBCHHHHHHHHHHHTTCC-CTTBCCEEEEEC----S
T ss_pred echHHeEEEEEcccCCceEEEEEEECCc-----cEEEEEEecCCCccHHHHHHHHHHHhhCC-CCCEeeEEEEEe----C
Confidence 4567899999999999999999998753 35788876532 4567899999999998 999999998653 1
Q ss_pred CceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEeec
Q 039291 81 GEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADL 160 (362)
Q Consensus 81 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Df 160 (362)
..+++||||+.+|+|.+++.......+++..+..++.||+.||+|||++||+||||||+|||+ +.++.+||+||
T Consensus 255 --~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill----~~~~~~kl~DF 328 (454)
T 1qcf_A 255 --EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILV----SASLVCKIADF 328 (454)
T ss_dssp --SSCEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEE----CTTCCEEECST
T ss_pred --CccEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEE----CCCCcEEEeeC
Confidence 236799999999999999986544469999999999999999999999999999999999999 77889999999
Q ss_pred CCcccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHh-CCCCCccCCCCCHHHHHHHHcCCCCC
Q 039291 161 GVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLS-GRQAWVVKEDCSIDQLFSIIGDEHSL 239 (362)
Q Consensus 161 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~ 239 (362)
|+++........ ......+|..|+|||++....++.++|||||||+||||++ |+.||.+. ...++...+......
T Consensus 329 G~a~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~---~~~~~~~~i~~~~~~ 404 (454)
T 1qcf_A 329 GLARVIEDNEYT-AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGM---SNPEVIRALERGYRM 404 (454)
T ss_dssp TGGGGBCCHHHH-TTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC---CHHHHHHHHHHTCCC
T ss_pred CCceEcCCCcee-ccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCC---CHHHHHHHHHcCCCC
Confidence 999865432111 1133457788999999998899999999999999999999 99999654 344555555444333
Q ss_pred CCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhc
Q 039291 240 PEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLD 273 (362)
Q Consensus 240 ~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~ 273 (362)
..+..++.++.+||.+||..||++|||+++++.
T Consensus 405 -~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~ 437 (454)
T 1qcf_A 405 -PRPENCPEELYNIMMRCWKNRPEERPTFEYIQS 437 (454)
T ss_dssp -CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHH
Confidence 346779999999999999999999999999875
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-46 Score=333.76 Aligned_cols=251 Identities=23% Similarity=0.341 Sum_probs=207.1
Q ss_pred CCceeecceecccCceEEEEEEECCCCCCCCceeeeechhhhhhHHHHHHHHHHHHcCCCCcccccccceeeecC-----
Q 039291 5 GTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVSASASLQKEKEVFDNLNGCPFVLECFGEEITMGE----- 79 (362)
Q Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~----- 79 (362)
+++|.+++.||+|+||.||+|+++.+++ .+++|..... ...+.+|++++++++ ||||+++++++.....
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~----~vavK~~~~~-~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~~~ 83 (284)
T 2a19_B 10 GMDFKEIELIGSGGFGQVFKAKHRIDGK----TYVIKRVKYN-NEKAEREVKALAKLD-HVNIVHYNGCWDGFDYDPETS 83 (284)
T ss_dssp HHHEEEEEEEECSSSCCEEEEEETTTCC----EEEEEEEECC-SGGGHHHHHHHHHCC-CTTBCCEEEEEEEEEEC----
T ss_pred ccccceeeeeccCCceEEEEEEEcCCCe----EEEEEEeccc-cHHHHHHHHHHHhCC-CCCEEEEeeeEeccccCcccc
Confidence 3689999999999999999999987765 5677776543 345789999999998 9999999987643211
Q ss_pred ------CCceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCce
Q 039291 80 ------NGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKF 153 (362)
Q Consensus 80 ------~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~ 153 (362)
.....+++||||+++++|.+++.......+++..++.++.||+.||.|||++||+||||||+||++ +.++
T Consensus 84 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~----~~~~ 159 (284)
T 2a19_B 84 SKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFL----VDTK 159 (284)
T ss_dssp -----CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE----EETT
T ss_pred cccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEE----cCCC
Confidence 224457899999999999999987655679999999999999999999999999999999999999 5667
Q ss_pred EEEEeecCCcccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHH
Q 039291 154 VAKIADLGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSII 233 (362)
Q Consensus 154 ~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~ 233 (362)
.+||+|||++....... ......||+.|+|||++.+..++.++||||||+++|+|++|..||... ......+
T Consensus 160 ~~kl~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~-----~~~~~~~ 231 (284)
T 2a19_B 160 QVKIGDFGLVTSLKNDG---KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET-----SKFFTDL 231 (284)
T ss_dssp EEEECCCTTCEESSCCS---CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH-----HHHHHHH
T ss_pred CEEECcchhheeccccc---cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH-----HHHHHHh
Confidence 89999999987655422 223567999999999999988999999999999999999999887432 2222333
Q ss_pred cCCCCCCCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCc
Q 039291 234 GDEHSLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFV 277 (362)
Q Consensus 234 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~ 277 (362)
... .++..++.+++++|.+||..||.+|||+.+++++++.
T Consensus 232 ~~~----~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~ 271 (284)
T 2a19_B 232 RDG----IISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTV 271 (284)
T ss_dssp HTT----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred hcc----cccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence 222 2345688999999999999999999999999998765
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-46 Score=346.93 Aligned_cols=255 Identities=21% Similarity=0.345 Sum_probs=194.3
Q ss_pred CCCCceeecceecccCceEEEEEEECCCCCCCCceeeeechhh----hhhHHHHHHHHHHHHcCCCCcccccccceeeec
Q 039291 3 SDGTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEV----SASASLQKEKEVFDNLNGCPFVLECFGEEITMG 78 (362)
Q Consensus 3 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~----~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~ 78 (362)
...++|.+.+.||+|+||+||+|+++..+. ....|++|.... ...+.+.+|+.++++++ ||||+++++++..
T Consensus 42 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~-- 117 (373)
T 2qol_A 42 LDATNISIDKVVGAGEFGEVCSGRLKLPSK-KEISVAIKTLKVGYTEKQRRDFLGEASIMGQFD-HPNIIRLEGVVTK-- 117 (373)
T ss_dssp CCGGGCCCCEEEEECSSSEEEEC-CBCTTS-CBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCC-CTTBCCEEEEECS--
T ss_pred cCHhhceeeeEEeeCCCeEEEEEEEecCCC-CceeEEEEEecCccCHHHHHHHHHHHHHHHhCC-CCCCCeEEEEEee--
Confidence 345789999999999999999998863221 124577777543 34567889999999998 9999999997642
Q ss_pred CCCceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEe
Q 039291 79 ENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIA 158 (362)
Q Consensus 79 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~ 158 (362)
...+++||||+++++|.+++... ...+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+
T Consensus 118 ---~~~~~lv~e~~~~~sL~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll----~~~~~~kl~ 189 (373)
T 2qol_A 118 ---SKPVMIVTEYMENGSLDSFLRKH-DAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILI----NSNLVCKVS 189 (373)
T ss_dssp ---SSSCEEEEECCTTCBHHHHHHTT-TTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE----CTTCCEEEC
T ss_pred ---CCceEEEEeCCCCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEE----cCCCCEEEC
Confidence 23467999999999999999763 3469999999999999999999999999999999999999 788899999
Q ss_pred ecCCcccccccccCC-CCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHh-CCCCCccCCCCCHHHHHHHHcCC
Q 039291 159 DLGVAKRSRHCKRQK-FDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLS-GRQAWVVKEDCSIDQLFSIIGDE 236 (362)
Q Consensus 159 Dfgla~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~ 236 (362)
|||+++......... ......+|+.|+|||++.+..++.++|||||||++|||++ |..||... ...++...+...
T Consensus 190 Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~---~~~~~~~~i~~~ 266 (373)
T 2qol_A 190 DFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEM---SNQDVIKAVDEG 266 (373)
T ss_dssp CC----------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTC---CHHHHHHHHHTT
T ss_pred cCccccccccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCC---CHHHHHHHHHcC
Confidence 999998654322111 1123345788999999999899999999999999999998 99999544 445555555444
Q ss_pred CCCCCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhc
Q 039291 237 HSLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLD 273 (362)
Q Consensus 237 ~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~ 273 (362)
... ..+..++.++.++|.+||..||++||++.++++
T Consensus 267 ~~~-~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~ 302 (373)
T 2qol_A 267 YRL-PPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVS 302 (373)
T ss_dssp EEC-CCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCC-CCCccccHHHHHHHHHHhCcChhhCcCHHHHHH
Confidence 333 235678999999999999999999999999886
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-46 Score=339.95 Aligned_cols=261 Identities=21% Similarity=0.351 Sum_probs=209.1
Q ss_pred CCCceeecceecccCceEEEEEEECCCCCCCCceeeeechhh---hhhHHHHHHHHHHHHcCCCCcccccccceeeecCC
Q 039291 4 DGTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEV---SASASLQKEKEVFDNLNGCPFVLECFGEEITMGEN 80 (362)
Q Consensus 4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~---~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~ 80 (362)
..++|.+++.||+|+||.||+|++...+......|++|.... ...+.+.+|+.++++++ ||||+++++++.. .
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~---~ 96 (327)
T 3lxl_A 21 EERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALH-SDFIVKYRGVSYG---P 96 (327)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCC-CTTBCCEEEEEEC---S
T ss_pred chhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcC-CCceeEEEEEEec---C
Confidence 468999999999999999999996544444446788887643 34456889999999997 9999999986653 2
Q ss_pred CceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEeec
Q 039291 81 GEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADL 160 (362)
Q Consensus 81 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Df 160 (362)
....+++||||+++++|.+++.... ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+||
T Consensus 97 ~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~----~~~~~~kl~Df 171 (327)
T 3lxl_A 97 GRQSLRLVMEYLPSGCLRDFLQRHR-ARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILV----ESEAHVKIADF 171 (327)
T ss_dssp SSCEEEEEEECCTTCBHHHHHHHHG-GGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE----EETTEEEECCG
T ss_pred CCceEEEEEeecCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEE----CCCCCEEEccc
Confidence 3445779999999999999998743 359999999999999999999999999999999999999 66678999999
Q ss_pred CCcccccccccC-CCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHhCCCCCccCCC------------CCHH
Q 039291 161 GVAKRSRHCKRQ-KFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKED------------CSID 227 (362)
Q Consensus 161 gla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~------------~~~~ 227 (362)
|++......... .......||+.|+|||++.+..++.++|||||||++|+|++|..||..... ....
T Consensus 172 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~ 251 (327)
T 3lxl_A 172 GLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALS 251 (327)
T ss_dssp GGCEECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHH
T ss_pred ccceecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHH
Confidence 999865432221 122345688889999999998899999999999999999999999854321 1112
Q ss_pred HHHHHHcCCCCCCCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhcC
Q 039291 228 QLFSIIGDEHSLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDD 274 (362)
Q Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~ 274 (362)
.+...+.... .+..+..+++++.+||.+||..||++|||+.+++++
T Consensus 252 ~~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 297 (327)
T 3lxl_A 252 RLLELLEEGQ-RLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQ 297 (327)
T ss_dssp HHHHHHHTTC-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHhhccc-CCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 3333333333 334567899999999999999999999999999763
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-45 Score=326.52 Aligned_cols=251 Identities=19% Similarity=0.302 Sum_probs=207.1
Q ss_pred CCCCceeecceecccCceEEEEEEECCCCCCCCceeeeechhhh--hhHHHHHHHHHHHHcCCCCcccccccceeeecCC
Q 039291 3 SDGTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVS--ASASLQKEKEVFDNLNGCPFVLECFGEEITMGEN 80 (362)
Q Consensus 3 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~~--~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~ 80 (362)
...++|.+.+.||+|+||.||+|++... ..+++|..... ..+.+.+|+.+++.++ ||||+++++.+..
T Consensus 5 i~~~~y~~~~~lg~G~~g~V~~~~~~~~-----~~vaiK~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~---- 74 (267)
T 3t9t_A 5 IDPSELTFVQEIGSGQFGLVHLGYWLNK-----DKVAIKTIREGAMSEEDFIEEAEVMMKLS-HPKLVQLYGVCLE---- 74 (267)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTT-----EEEEEEEECTTTBCHHHHHHHHHHHHTCC-CTTBCCEEEEECS----
T ss_pred EchhheeeeeEecCCCceeEEEEEecCC-----CeEEEEEccccCCCHHHHHHHHHHHHhCC-CCCEeeEEEEEcc----
Confidence 4678999999999999999999998743 25777776543 3467889999999998 9999999987643
Q ss_pred CceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEeec
Q 039291 81 GEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADL 160 (362)
Q Consensus 81 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Df 160 (362)
...+++||||+++++|.+++... ...+++..+..++.|++.||.|||++||+||||||+||++ +.++.+||+||
T Consensus 75 -~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili----~~~~~~kl~df 148 (267)
T 3t9t_A 75 -QAPICLVTEFMEHGCLSDYLRTQ-RGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLV----GENQVIKVSDF 148 (267)
T ss_dssp -SSSCEEEECCCTTCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEE----CGGGCEEECCT
T ss_pred -CCCeEEEEeCCCCCcHHHHHhhC-cccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEE----CCCCCEEEccc
Confidence 22367999999999999999873 3469999999999999999999999999999999999999 77788999999
Q ss_pred CCcccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHh-CCCCCccCCCCCHHHHHHHHcCCCCC
Q 039291 161 GVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLS-GRQAWVVKEDCSIDQLFSIIGDEHSL 239 (362)
Q Consensus 161 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~ 239 (362)
|++......... ......+|..|+|||++.+..++.++||||||+++|+|++ |..||... ...+....+.....
T Consensus 149 g~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~---~~~~~~~~i~~~~~- 223 (267)
T 3t9t_A 149 GMTRFVLDDQYT-SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENR---SNSEVVEDISTGFR- 223 (267)
T ss_dssp TGGGGBCCHHHH-STTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC---CHHHHHHHHHTTCC-
T ss_pred cccccccccccc-ccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCC---CHHHHHHHHhcCCc-
Confidence 999765432211 1234567889999999998889999999999999999999 89999543 44555555544432
Q ss_pred CCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhcC
Q 039291 240 PEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDD 274 (362)
Q Consensus 240 ~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~ 274 (362)
+..+..++.++.+++.+||..||++||++.+++++
T Consensus 224 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 258 (267)
T 3t9t_A 224 LYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQ 258 (267)
T ss_dssp CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCccCcHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 34466789999999999999999999999999863
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-45 Score=331.73 Aligned_cols=257 Identities=22% Similarity=0.317 Sum_probs=198.9
Q ss_pred CCceeecceecccCceEEEEEEECCCCCCCCceeeeechhh-hhhHHHHHHHHHHHHcCCCCcccccccceeeecCCCce
Q 039291 5 GTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEV-SASASLQKEKEVFDNLNGCPFVLECFGEEITMGENGEM 83 (362)
Q Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~-~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~~~~ 83 (362)
+++|.+++.||+|+||+||+|++..+++ .+++|.... .....+.+|+.+++.+.+++++.. +..+.. ...
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~----~vavK~~~~~~~~~~~~~e~~~l~~l~~~~~i~~-~~~~~~----~~~ 78 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGE----EVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPT-IRWCGA----EGD 78 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTE----EEEEEEEESCSSCCHHHHHHHHHHHHTTSTTCCC-EEEEEE----ETT
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCc----EEEEEEecCCcchhHHHHHHHHHHHhhcCCCCCc-cccccC----CCC
Confidence 5899999999999999999999988775 567776432 233568899999999995555544 433322 223
Q ss_pred EEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEeecCCc
Q 039291 84 AYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVA 163 (362)
Q Consensus 84 ~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Dfgla 163 (362)
.+++||||+ +++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||+..+ +.++.+||+|||++
T Consensus 79 ~~~lv~e~~-~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~-~~~~~~kl~Dfg~~ 155 (296)
T 3uzp_A 79 YNVMVMELL-GPSLEDLFNFC-SRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLG-KKGNLVYIIDFGLA 155 (296)
T ss_dssp EEEEEEECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCG-GGTTCEEECCCTTC
T ss_pred ceEEEEEec-CCCHHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecC-CCCCeEEEeeCCCc
Confidence 567999999 88999999853 3569999999999999999999999999999999999999422 24567999999999
Q ss_pred ccccccccCC-----CCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHHcC---
Q 039291 164 KRSRHCKRQK-----FDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGD--- 235 (362)
Q Consensus 164 ~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~--- 235 (362)
.......... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.........+....+..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 235 (296)
T 3uzp_A 156 KKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKM 235 (296)
T ss_dssp EECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhccccc
Confidence 8655432211 12456799999999999998999999999999999999999999976433222222211111
Q ss_pred CCCCCCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhc
Q 039291 236 EHSLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLD 273 (362)
Q Consensus 236 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~ 273 (362)
....+..+..+++++.++|.+||+.||++|||+.++++
T Consensus 236 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 273 (296)
T 3uzp_A 236 STPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp HSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred CCchHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHH
Confidence 11111233568899999999999999999999999886
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-45 Score=352.50 Aligned_cols=250 Identities=21% Similarity=0.343 Sum_probs=203.1
Q ss_pred CCCCceeecceecccCceEEEEEEECCCCCCCCceeeeechhhh--hhHHHHHHHHHHHHcCCCCcccccccceeeecCC
Q 039291 3 SDGTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVS--ASASLQKEKEVFDNLNGCPFVLECFGEEITMGEN 80 (362)
Q Consensus 3 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~~--~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~ 80 (362)
+..++|.+.+.||+|+||+||+|+++.+. .|++|..... ..+.+.+|+.+|++++ ||||+++++++..
T Consensus 181 i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~-----~vavK~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~---- 250 (452)
T 1fmk_A 181 IPRESLRLEVKLGQGCFGEVWMGTWNGTT-----RVAIKTLKPGTMSPEAFLQEAQVMKKLR-HEKLVQLYAVVSE---- 250 (452)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTE-----EEEEEECCTTSSCHHHHHHHHHHHHHCC-CTTBCCEEEEECS----
T ss_pred cChhHceeeeeecCCCCeEEEEEEECCCc-----eEEEEEeccCCCCHHHHHHHHHHHHhCC-CCCEeeEEEEEcC----
Confidence 45678999999999999999999987642 5788876543 3467899999999998 9999999987532
Q ss_pred CceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEeec
Q 039291 81 GEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADL 160 (362)
Q Consensus 81 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Df 160 (362)
..+++||||+++|+|.+++....+..+++..+..++.||+.||+|||++||+||||||+|||+ +.++.+||+||
T Consensus 251 --~~~~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill----~~~~~~kl~Df 324 (452)
T 1fmk_A 251 --EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILV----GENLVCKVADF 324 (452)
T ss_dssp --SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE----CGGGCEEECCC
T ss_pred --CceEEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEE----CCCCCEEECCC
Confidence 235799999999999999986545569999999999999999999999999999999999999 77888999999
Q ss_pred CCcccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHh-CCCCCccCCCCCHHHHHHHHcCCCCC
Q 039291 161 GVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLS-GRQAWVVKEDCSIDQLFSIIGDEHSL 239 (362)
Q Consensus 161 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~ 239 (362)
|+++...... ........++..|+|||++.+..++.++|||||||++|||++ |..||.+. ...+....+......
T Consensus 325 G~a~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~---~~~~~~~~i~~~~~~ 400 (452)
T 1fmk_A 325 GLARLIEDNE-YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM---VNREVLDQVERGYRM 400 (452)
T ss_dssp CTTC---------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTC---CHHHHHHHHHTTCCC
T ss_pred ccceecCCCc-eecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCC---CHHHHHHHHHcCCCC
Confidence 9997654321 111224457788999999998899999999999999999999 99999644 344555555544433
Q ss_pred CCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhc
Q 039291 240 PEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLD 273 (362)
Q Consensus 240 ~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~ 273 (362)
..+..++.++.+||.+||..||++|||+++++.
T Consensus 401 -~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~ 433 (452)
T 1fmk_A 401 -PCPPECPESLHDLMCQCWRKEPEERPTFEYLQA 433 (452)
T ss_dssp -CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 356789999999999999999999999999876
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-45 Score=330.41 Aligned_cols=253 Identities=26% Similarity=0.418 Sum_probs=196.3
Q ss_pred CCCceeecceecccCceEEEEEEECCCCCCCCceeeeechh------hhhhHHHHHHHHHHHHcCCCCcccccccceeee
Q 039291 4 DGTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAE------VSASASLQKEKEVFDNLNGCPFVLECFGEEITM 77 (362)
Q Consensus 4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~------~~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~ 77 (362)
..++|.+.+.||+|+||.||+|++..++. .+++|... ......+.+|+.++++++ ||||+++++.+..
T Consensus 30 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~----~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~- 103 (310)
T 2wqm_A 30 TLANFRIEKKIGRGQFSEVYRAACLLDGV----PVALKKVQIFDLMDAKARADCIKEIDLLKQLN-HPNVIKYYASFIE- 103 (310)
T ss_dssp SGGGEEEEEEEECC--CEEEEEEETTTCC----EEEEEEECTTSSCCHHHHHHHHHHHHHHHTCC-CTTBCCEEEEEEE-
T ss_pred cccceEEEEeecCCCCceEEEEEEcCCCc----eEEEEeeehhhccCHHHHHHHHHHHHHHHhCC-CCCEeeEEEEEEc-
Confidence 34689999999999999999999988775 56777543 234566889999999998 9999999987653
Q ss_pred cCCCceEEEEEEEecCCCCHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEE
Q 039291 78 GENGEMAYNLLLEYAAGGTLGDLIEKC--NGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVA 155 (362)
Q Consensus 78 ~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~ 155 (362)
...+++||||+++++|.+++... ....+++..++.++.|++.||.|||++||+||||||+||++ +.++.+
T Consensus 104 ----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~----~~~~~~ 175 (310)
T 2wqm_A 104 ----DNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFI----TATGVV 175 (310)
T ss_dssp ----TTEEEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE----CTTSCE
T ss_pred ----CCcEEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEE----cCCCCE
Confidence 22477999999999999999753 24569999999999999999999999999999999999999 777889
Q ss_pred EEeecCCcccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHHcC
Q 039291 156 KIADLGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGD 235 (362)
Q Consensus 156 kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~ 235 (362)
||+|||++....... .......||+.|+|||++.+..++.++||||||+++|+|++|..||..... ....+...+..
T Consensus 176 kl~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~-~~~~~~~~~~~ 252 (310)
T 2wqm_A 176 KLGDLGLGRFFSSKT--TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM-NLYSLCKKIEQ 252 (310)
T ss_dssp EECCC--------------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---C-CHHHHHHHHHT
T ss_pred EEEeccceeeecCCC--ccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccch-hHHHHHHHhhc
Confidence 999999987654322 122346799999999999998999999999999999999999999975432 34455555554
Q ss_pred CCCCCCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhc
Q 039291 236 EHSLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLD 273 (362)
Q Consensus 236 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~ 273 (362)
....+..+..++.++.+||.+||..||++|||+.++++
T Consensus 253 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~ 290 (310)
T 2wqm_A 253 CDYPPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYD 290 (310)
T ss_dssp TCSCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ccCCCCcccccCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 44433334678999999999999999999999999987
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-45 Score=328.79 Aligned_cols=250 Identities=22% Similarity=0.351 Sum_probs=205.8
Q ss_pred CCCCceeecceecccCceEEEEEEECCCCCCCCceeeeechhhh--hhHHHHHHHHHHHHcCCCCcccccccceeeecCC
Q 039291 3 SDGTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVS--ASASLQKEKEVFDNLNGCPFVLECFGEEITMGEN 80 (362)
Q Consensus 3 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~~--~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~ 80 (362)
+..++|.+++.||+|+||+||+|+++.. ..+++|..... ..+.+.+|+++++.++ ||||+++++++. +
T Consensus 10 v~~~~y~~~~~lg~G~~g~Vy~~~~~~~-----~~vavK~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~----~ 79 (279)
T 1qpc_A 10 VPRETLKLVERLGAGQFGEVWMGYYNGH-----TKVAVKSLKQGSMSPDAFLAEANLMKQLQ-HQRLVRLYAVVT----Q 79 (279)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTT-----EEEEEEEECTTSSCHHHHHHHHHHHHHCC-CTTBCCEEEEEC----S
T ss_pred cCHHhhhheeeecCCCCeEEEEEEEcCC-----cEEEEEEecCCcccHHHHHHHHHHHHhCC-CcCcceEEEEEc----C
Confidence 4568999999999999999999998653 25677765433 4567889999999998 999999998653 1
Q ss_pred CceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEeec
Q 039291 81 GEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADL 160 (362)
Q Consensus 81 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Df 160 (362)
. .+++||||+++++|.+++....+..+++..+..++.|++.||.|||++||+||||||+||++ +.++.+||+||
T Consensus 80 -~-~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~----~~~~~~kl~Df 153 (279)
T 1qpc_A 80 -E-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILV----SDTLSCKIADF 153 (279)
T ss_dssp -S-SCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE----CTTSCEEECCC
T ss_pred -C-CcEEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEE----cCCCCEEECCC
Confidence 1 25699999999999999976443469999999999999999999999999999999999999 77888999999
Q ss_pred CCcccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHh-CCCCCccCCCCCHHHHHHHHcCCCCC
Q 039291 161 GVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLS-GRQAWVVKEDCSIDQLFSIIGDEHSL 239 (362)
Q Consensus 161 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~ 239 (362)
|++......... ......++..|+|||++.+..++.++||||||+++|+|++ |..||... ...+....+.....
T Consensus 154 g~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~---~~~~~~~~~~~~~~- 228 (279)
T 1qpc_A 154 GLARLIEDNEYT-AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGM---TNPEVIQNLERGYR- 228 (279)
T ss_dssp TTCEECSSSCEE-CCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTC---CHHHHHHHHHTTCC-
T ss_pred cccccccCcccc-cccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCccc---CHHHHHHHHhcccC-
Confidence 999765532211 2234557889999999998889999999999999999999 99999644 34455555544332
Q ss_pred CCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhc
Q 039291 240 PEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLD 273 (362)
Q Consensus 240 ~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~ 273 (362)
+..+..++.++.++|.+||..||++|||+.++++
T Consensus 229 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 262 (279)
T 1qpc_A 229 MVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRS 262 (279)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCcccccHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 3456678999999999999999999999999876
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-46 Score=345.91 Aligned_cols=257 Identities=17% Similarity=0.166 Sum_probs=198.5
Q ss_pred CCCCceeecceecccCceEEEEEEECCC-CCCCCceeeeechhhhhhHHHHHHHHHHHHcCC--CCcccccccceeeecC
Q 039291 3 SDGTSWFRGRVIGQGSFGCVFIAKPKSN-SSFLPPLMAVKSAEVSASASLQKEKEVFDNLNG--CPFVLECFGEEITMGE 79 (362)
Q Consensus 3 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~-~~~~~~~~~~K~~~~~~~~~~~~E~~il~~l~~--h~~i~~~~~~~~~~~~ 79 (362)
..+++|.+.+.||+|+||+||+|++... .......|++|.........+.+|+.+++.+.+ |+||+.+++.+...
T Consensus 62 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~-- 139 (365)
T 3e7e_A 62 LGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQ-- 139 (365)
T ss_dssp CSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCCHHHHHHHHHHHHHSCGGGGGGBCCEEEEEECS--
T ss_pred ECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCChhHHHHHHHHHHHhhhhhhhhhhhhheeeecC--
Confidence 4578899999999999999999964331 122235789998887777788999999999874 78999998876532
Q ss_pred CCceEEEEEEEecCCCCHHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeec-------C
Q 039291 80 NGEMAYNLLLEYAAGGTLGDLIEKC---NGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVAT-------Q 149 (362)
Q Consensus 80 ~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~-------~ 149 (362)
...++||||++||+|.+++... ....+++..++.++.||+.||+|||++||+||||||+|||+... .
T Consensus 140 ---~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~~~~ 216 (365)
T 3e7e_A 140 ---NGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDED 216 (365)
T ss_dssp ---SCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC----
T ss_pred ---CCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCccccc
Confidence 2367999999999999999764 23569999999999999999999999999999999999999331 1
Q ss_pred CCceEEEEeecCCcccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHH
Q 039291 150 SGKFVAKIADLGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQL 229 (362)
Q Consensus 150 ~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~ 229 (362)
+..+.+||+|||+|+..............+||+.|+|||++.+..++.++|||||||++|+|++|+.||.........
T Consensus 217 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~-- 294 (365)
T 3e7e_A 217 DLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECK-- 294 (365)
T ss_dssp --CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEEE--
T ss_pred cccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCcee--
Confidence 116789999999997654332333334677999999999999999999999999999999999999999654331100
Q ss_pred HHHHcCCCCCCCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhc
Q 039291 230 FSIIGDEHSLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLD 273 (362)
Q Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~ 273 (362)
....+... ..+..+.+++.+||..+|.+|++..+.+.
T Consensus 295 -----~~~~~~~~--~~~~~~~~~~~~~l~~~p~~r~~~~~~l~ 331 (365)
T 3e7e_A 295 -----PEGLFRRL--PHLDMWNEFFHVMLNIPDCHHLPSLDLLR 331 (365)
T ss_dssp -----ECSCCTTC--SSHHHHHHHHHHHHCCCCTTCCCCHHHHH
T ss_pred -----echhcccc--CcHHHHHHHHHHHcCCCCCCcchHHHHHH
Confidence 01111222 24678899999999999999975444333
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-45 Score=335.82 Aligned_cols=257 Identities=21% Similarity=0.354 Sum_probs=204.5
Q ss_pred CCce-eecceecccCceEEEEEEECCCCCCCCceeeeechhhh----hhHHHHHHHHHHHHcCCCCcccccccceeeecC
Q 039291 5 GTSW-FRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVS----ASASLQKEKEVFDNLNGCPFVLECFGEEITMGE 79 (362)
Q Consensus 5 ~~~y-~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~~----~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~ 79 (362)
+++| .+++.||+|+||+||++..+..+......|++|..... ....+.+|+.++++++ ||||+++++++...
T Consensus 29 ~~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~-- 105 (318)
T 3lxp_A 29 HKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLY-HEHIIKYKGCCEDA-- 105 (318)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEEET--
T ss_pred cHHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCC-CcchhhEEEEEecC--
Confidence 3455 99999999999999999876554444567888876543 3566889999999999 99999999977542
Q ss_pred CCceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEee
Q 039291 80 NGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIAD 159 (362)
Q Consensus 80 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~D 159 (362)
....+++||||+++++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+||++ +.++.+||+|
T Consensus 106 -~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~----~~~~~~kl~D 177 (318)
T 3lxp_A 106 -GAASLQLVMEYVPLGSLRDYLPR---HSIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLL----DNDRLVKIGD 177 (318)
T ss_dssp -TTTEEEEEECCCTTCBHHHHGGG---SCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE----CTTCCEEECC
T ss_pred -CCceEEEEEecccCCcHHHHHhh---CCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEE----cCCCCEEECC
Confidence 23457799999999999999976 349999999999999999999999999999999999999 7788899999
Q ss_pred cCCcccccccccC-CCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHhCCCCCccCCCC------------CH
Q 039291 160 LGVAKRSRHCKRQ-KFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDC------------SI 226 (362)
Q Consensus 160 fgla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~------------~~ 226 (362)
||++......... .......||..|+|||++.+..++.++|||||||++|+|++|..||...... ..
T Consensus 178 fg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~ 257 (318)
T 3lxp_A 178 FGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTV 257 (318)
T ss_dssp GGGCEECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHH
T ss_pred ccccccccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhH
Confidence 9999866543211 1223456888899999999888999999999999999999999998643210 01
Q ss_pred HHHHHHHcCCCCCCCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhc
Q 039291 227 DQLFSIIGDEHSLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLD 273 (362)
Q Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~ 273 (362)
..+...+... .....+..++.++.+||.+||..||++|||+.++++
T Consensus 258 ~~~~~~~~~~-~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 303 (318)
T 3lxp_A 258 LRLTELLERG-ERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIP 303 (318)
T ss_dssp HHHHHHHHTT-CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHhcc-cCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 1222233333 234456789999999999999999999999999985
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-45 Score=341.88 Aligned_cols=264 Identities=21% Similarity=0.234 Sum_probs=194.1
Q ss_pred CCCCCceeecceecccCceEEEEEEECCCCCCCCceeeeechhhh--------------hhHHHHHHHHHHHHcCCCCcc
Q 039291 2 DSDGTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVS--------------ASASLQKEKEVFDNLNGCPFV 67 (362)
Q Consensus 2 ~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~~--------------~~~~~~~E~~il~~l~~h~~i 67 (362)
+..+++|.+++.||+|+||+||+|+++.++.. ...+++|..... ....+.+|+.+++.++ ||||
T Consensus 33 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~-~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~-h~ni 110 (345)
T 2v62_A 33 DMEGNQWVLGKKIGSGGFGLIYLAFPTNKPEK-DARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLD-YLGI 110 (345)
T ss_dssp CTTSCEEEEEEEC------CEEEEEESSSCGG-GCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCS-CCCC
T ss_pred cccCceEEEEeeEeecCCeEEEEEEecCCCCc-cceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhcccc-ccCc
Confidence 35678999999999999999999999873221 235666654322 1223556777888887 9999
Q ss_pred cccccceeeecCCCceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEee
Q 039291 68 LECFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVA 147 (362)
Q Consensus 68 ~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~ 147 (362)
+++++.+.... .....+++||||+ |++|.+++.... .+++..++.++.||+.||+|||++||+||||||+|||+..
T Consensus 111 ~~~~~~~~~~~-~~~~~~~lv~e~~-~~~L~~~l~~~~--~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~ 186 (345)
T 2v62_A 111 PLFYGSGLTEF-KGRSYRFMVMERL-GIDLQKISGQNG--TFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGY 186 (345)
T ss_dssp CCEEEEEEEES-SSCEEEEEEEECE-EEEHHHHCBGGG--BCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEES
T ss_pred ceeeccccccc-CCCcEEEEEEecc-CCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEcc
Confidence 99999876533 3345678999999 999999998643 6999999999999999999999999999999999999943
Q ss_pred cCCCceEEEEeecCCcccccccccCC-----CCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHhCCCCCccCC
Q 039291 148 TQSGKFVAKIADLGVAKRSRHCKRQK-----FDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKE 222 (362)
Q Consensus 148 ~~~~~~~~kl~Dfgla~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~ 222 (362)
+ ..+.+||+|||+++......... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||....
T Consensus 187 ~--~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~ 264 (345)
T 2v62_A 187 K--NPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNL 264 (345)
T ss_dssp S--STTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGT
T ss_pred C--CCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccc
Confidence 2 12279999999997654332111 1134579999999999999889999999999999999999999996532
Q ss_pred CCCHHHHHHHHcCCCCCCC------CCccCCHHHHHHHHHHhccCCCCCCCHHHHhc
Q 039291 223 DCSIDQLFSIIGDEHSLPE------IPSRVSKEARDFLRRCFVRKPAFRFTAEMLLD 273 (362)
Q Consensus 223 ~~~~~~~~~~~~~~~~~~~------~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~ 273 (362)
.................+. -...++.++.++|.+||..||++||+++++++
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 321 (345)
T 2v62_A 265 KDPVAVQTAKTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKK 321 (345)
T ss_dssp TCHHHHHHHHHHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred cccHHHHHHHHhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence 2221111111100111110 01168899999999999999999999999886
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-45 Score=337.64 Aligned_cols=260 Identities=21% Similarity=0.369 Sum_probs=182.5
Q ss_pred CCCCCceeecceecccCceEEEEEEECCCCCCCCceeeeechh----hhhhHHHHHHHHHHHHcCCCCcccccccceeee
Q 039291 2 DSDGTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAE----VSASASLQKEKEVFDNLNGCPFVLECFGEEITM 77 (362)
Q Consensus 2 ~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~----~~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~ 77 (362)
+...++|.+++.||+|+||.||+|.++.+++ .|++|... ......+.+|+..+.+..+||||+++++++..
T Consensus 18 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~----~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~- 92 (327)
T 3aln_A 18 DFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQ----IMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFR- 92 (327)
T ss_dssp CCCSCSEEC-CEEEECSSEEEEEEEETTTTE----EEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEEC-
T ss_pred ccCHHHhhehheeccCCCEEEEEEEEcCCCC----EEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEe-
Confidence 3567899999999999999999999988775 55666543 23344566676644444459999999997653
Q ss_pred cCCCceEEEEEEEecCCCCHHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhC-CceeCCCCCCCEEEeecCCCce
Q 039291 78 GENGEMAYNLLLEYAAGGTLGDLIEKC---NGNGLPEKDVRHFTRCILEGIGHIHDS-GYVHCDVKPDNILLVATQSGKF 153 (362)
Q Consensus 78 ~~~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~l~~~~~~~i~~ql~~~l~yLH~~-~ivH~Dlkp~Nill~~~~~~~~ 153 (362)
...+++||||+.+ +|.+++... ....+++..+..++.|++.||.|||+. ||+||||||+||++ +.++
T Consensus 93 ----~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll----~~~~ 163 (327)
T 3aln_A 93 ----EGDCWICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILL----DRSG 163 (327)
T ss_dssp ----SSEEEEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEE----ETTT
T ss_pred ----CCceEEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEE----cCCC
Confidence 2346799999985 888887642 245699999999999999999999999 99999999999999 6778
Q ss_pred EEEEeecCCcccccccccCCCCCCccCCCCccCchhh----ccccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHH
Q 039291 154 VAKIADLGVAKRSRHCKRQKFDPSMRGTPLYLAPETV----VQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQL 229 (362)
Q Consensus 154 ~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~ 229 (362)
.+||+|||+++....... .....||+.|+|||++ .+..++.++|||||||++|+|++|..||..... ..+.
T Consensus 164 ~~kl~Dfg~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~--~~~~ 238 (327)
T 3aln_A 164 NIKLCDFGISGQLVDSIA---KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNS--VFDQ 238 (327)
T ss_dssp EEEECCCSSSCC---------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC--------
T ss_pred CEEEccCCCceecccccc---cccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcch--HHHH
Confidence 899999999976543221 1234799999999998 456789999999999999999999999965322 1111
Q ss_pred HHHHcCCCCCCC----CCccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCccCcc
Q 039291 230 FSIIGDEHSLPE----IPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGVD 281 (362)
Q Consensus 230 ~~~~~~~~~~~~----~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~~~~~ 281 (362)
...+... ..+. ....++.++.+||.+||..||++||++.++++||||....
T Consensus 239 ~~~~~~~-~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~~ 293 (327)
T 3aln_A 239 LTQVVKG-DPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILMYE 293 (327)
T ss_dssp -CCCCCS-CCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHHH
T ss_pred HHHHhcC-CCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHHHHhH
Confidence 1111111 1111 2246899999999999999999999999999999997654
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-45 Score=334.08 Aligned_cols=258 Identities=22% Similarity=0.313 Sum_probs=195.9
Q ss_pred CCCceeecceecccCceEEEEEEECCCCCCCCceeeeechhh-hhhHHHHHHHHHHHHcCCCCcccccccceeeecCCCc
Q 039291 4 DGTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEV-SASASLQKEKEVFDNLNGCPFVLECFGEEITMGENGE 82 (362)
Q Consensus 4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~-~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~~~ 82 (362)
-+++|.+++.||+|+||+||+|++..+++ .+++|.... .....+.+|+.+++.+.+++++. .+..+.. ..
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~----~vavK~~~~~~~~~~~~~e~~~l~~l~~~~~i~-~~~~~~~----~~ 77 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGE----EVAIKLECVKTKHPQLHIESKIYKMMQGGVGIP-TIRWCGA----EG 77 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTTTE----EEEEEEEEC---CCCHHHHHHHHHHHTTSTTCC-CEEEEEE----ET
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCCCc----eEEEEeecccccchHHHHHHHHHHHhcCCCCCC-eeeeecC----CC
Confidence 35899999999999999999999988775 567775332 23456889999999999555554 4433322 22
Q ss_pred eEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEeecCC
Q 039291 83 MAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGV 162 (362)
Q Consensus 83 ~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Dfgl 162 (362)
...++||||+ +++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||+... +..+.+||+|||+
T Consensus 78 ~~~~lv~e~~-~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~-~~~~~~kL~Dfg~ 154 (296)
T 4hgt_A 78 DYNVMVMELL-GPSLEDLFNFC-SRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLG-KKGNLVYIIDFGL 154 (296)
T ss_dssp TEEEEEEECC-CCBHHHHHHHT-TSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCG-GGTTCEEECCCTT
T ss_pred CceEEEEEcc-CCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeecc-CCCCeEEEecCcc
Confidence 3467999999 89999999863 3469999999999999999999999999999999999999422 3456799999999
Q ss_pred cccccccccC-----CCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHHcC--
Q 039291 163 AKRSRHCKRQ-----KFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGD-- 235 (362)
Q Consensus 163 a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~-- 235 (362)
++........ .......||+.|+|||++.+..++.++|||||||++|+|++|+.||.........+....+..
T Consensus 155 a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 234 (296)
T 4hgt_A 155 AKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKK 234 (296)
T ss_dssp CEECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHH
T ss_pred ceeccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhccc
Confidence 9865543221 122356799999999999998999999999999999999999999976543332222221111
Q ss_pred -CCCCCCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhc
Q 039291 236 -EHSLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLD 273 (362)
Q Consensus 236 -~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~ 273 (362)
....+.....+++++.+||.+||..||++|||+.++++
T Consensus 235 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~ 273 (296)
T 4hgt_A 235 MSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp HHSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred ccchhhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHH
Confidence 11111223567899999999999999999999999986
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-46 Score=338.25 Aligned_cols=250 Identities=27% Similarity=0.433 Sum_probs=197.8
Q ss_pred CCCceeecceecccCceEEEEEEECCCCCCCCceeeeechhhh---------hhHHHHHHHHHHHHcC---CCCcccccc
Q 039291 4 DGTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVS---------ASASLQKEKEVFDNLN---GCPFVLECF 71 (362)
Q Consensus 4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~~---------~~~~~~~E~~il~~l~---~h~~i~~~~ 71 (362)
-.++|.+++.||+|+||.||+|+++.++. .+++|..... ....+.+|+.+++++. .||||++++
T Consensus 29 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~----~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~ 104 (312)
T 2iwi_A 29 FEAEYRLGPLLGKGGFGTVFAGHRLTDRL----QVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLL 104 (312)
T ss_dssp ----CEEEEEEEEETTEEEEEEECTTTCC----EEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEE
T ss_pred hhhceEEeeEEEcCCCEEEEEEEEccCCe----EEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEE
Confidence 35789999999999999999999988765 5677765432 2234567999999983 499999999
Q ss_pred cceeeecCCCceEEEEEEEe-cCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCC
Q 039291 72 GEEITMGENGEMAYNLLLEY-AAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQS 150 (362)
Q Consensus 72 ~~~~~~~~~~~~~~~lv~e~-~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~ 150 (362)
+++.. ...+++|||+ +.+++|.+++... ..+++..++.++.||+.||.|||++||+||||||+||++ +
T Consensus 105 ~~~~~-----~~~~~~v~e~~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~----~ 173 (312)
T 2iwi_A 105 DWFET-----QEGFMLVLERPLPAQDLFDYITEK--GPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILI----D 173 (312)
T ss_dssp EEC----------CEEEEECCSSEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEE----E
T ss_pred EEEec-----CCeEEEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEE----e
Confidence 87643 2346799999 7899999999873 459999999999999999999999999999999999999 5
Q ss_pred -CceEEEEeecCCcccccccccCCCCCCccCCCCccCchhhccccCC-CcchHHHHHHHHHHHHhCCCCCccCCCCCHHH
Q 039291 151 -GKFVAKIADLGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQE-APSDIWALGCVVLEMLSGRQAWVVKEDCSIDQ 228 (362)
Q Consensus 151 -~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~ 228 (362)
.++.+||+|||++....... .....||..|+|||++.+..+. .++|||||||++|+|++|+.||... .+
T Consensus 174 ~~~~~~kl~dfg~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~-----~~ 244 (312)
T 2iwi_A 174 LRRGCAKLIDFGSGALLHDEP----YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERD-----QE 244 (312)
T ss_dssp TTTTEEEECCCSSCEECCSSC----BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH-----HH
T ss_pred CCCCeEEEEEcchhhhcccCc----ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCCh-----HH
Confidence 66789999999997654321 2356699999999999876664 5899999999999999999999542 11
Q ss_pred HHHHHcCCCCCCCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCccCcchh
Q 039291 229 LFSIIGDEHSLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGVDEE 283 (362)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~~~~~~~ 283 (362)
. .... ..++..++.++++||.+||..||++|||++++++||||+...+.
T Consensus 245 ~---~~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~~~~~~~~~ 293 (312)
T 2iwi_A 245 I---LEAE---LHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTPAED 293 (312)
T ss_dssp H---HHTC---CCCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHSTTTCC----
T ss_pred H---hhhc---cCCcccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhcCchhc
Confidence 1 1112 23456789999999999999999999999999999999876554
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-45 Score=329.80 Aligned_cols=254 Identities=22% Similarity=0.325 Sum_probs=201.7
Q ss_pred CCceeecceecccCceEEEEEEECCCCCCCCceeeeechhh----hhhHHHHHHHHHHHHcCCCCcccccccceeeecCC
Q 039291 5 GTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEV----SASASLQKEKEVFDNLNGCPFVLECFGEEITMGEN 80 (362)
Q Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~----~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~ 80 (362)
..+|.+++.||+|+||+||+|++..++.. ...+++|.... ...+.+.+|+.+++.++ ||||+++++++..
T Consensus 20 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~-~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~---- 93 (298)
T 3pls_A 20 RVVTHSDRVIGKGHFGVVYHGEYIDQAQN-RIQCAIKSLSRITEMQQVEAFLREGLLMRGLN-HPNVLALIGIMLP---- 93 (298)
T ss_dssp GEEEEEEEEEEEETTEEEEEEEEECSSSC-EEEEEEEEETTCCSHHHHHHHHHHHHHHHTCC-CTTBCCCCEEECC----
T ss_pred ceEEccCceeccCCCceEEEEEEecCCCc-eeeeeeeeccccccHHHHHHHHHHHHHHHhCC-CCCeeeEEEEEec----
Confidence 34677889999999999999998665431 23567776543 34467889999999998 9999999987643
Q ss_pred CceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEeec
Q 039291 81 GEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADL 160 (362)
Q Consensus 81 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Df 160 (362)
.....++||||+.+++|.+++.. ....+++..++.++.|++.||.|||++||+||||||+||++ +.++.+||+||
T Consensus 94 ~~~~~~~v~e~~~~~~L~~~~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili----~~~~~~kl~Df 168 (298)
T 3pls_A 94 PEGLPHVLLPYMCHGDLLQFIRS-PQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCML----DESFTVKVADF 168 (298)
T ss_dssp SSSCCEEEECCCTTCBHHHHHHC-TTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE----CTTCCEEECCT
T ss_pred CCCCcEEEEecccCCCHHHHHhc-cccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEE----cCCCcEEeCcC
Confidence 22334699999999999999976 34569999999999999999999999999999999999999 77888999999
Q ss_pred CCcccccccc--cCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHhCC-CCCccCCCCCHHHHHHHHcCCC
Q 039291 161 GVAKRSRHCK--RQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGR-QAWVVKEDCSIDQLFSIIGDEH 237 (362)
Q Consensus 161 gla~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~-~pf~~~~~~~~~~~~~~~~~~~ 237 (362)
|+++...... .........+|+.|+|||.+.+..++.++|||||||++|+|++|. +||...+ .......+....
T Consensus 169 g~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~---~~~~~~~~~~~~ 245 (298)
T 3pls_A 169 GLARDILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHID---PFDLTHFLAQGR 245 (298)
T ss_dssp TSSCTTTTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSC---GGGHHHHHHTTC
T ss_pred CCcccccCCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCC---HHHHHHHhhcCC
Confidence 9997554322 112223456889999999999989999999999999999999955 4454333 333333333333
Q ss_pred CCCCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhc
Q 039291 238 SLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLD 273 (362)
Q Consensus 238 ~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~ 273 (362)
. +..+..++.++.++|.+||..||.+|||+.++++
T Consensus 246 ~-~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~ 280 (298)
T 3pls_A 246 R-LPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVG 280 (298)
T ss_dssp C-CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred C-CCCCccchHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 2 3346678999999999999999999999999986
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-45 Score=330.26 Aligned_cols=255 Identities=20% Similarity=0.320 Sum_probs=204.3
Q ss_pred CCCCceeecc-eecccCceEEEEEEECCCCCCCCceeeeechhh----hhhHHHHHHHHHHHHcCCCCcccccccceeee
Q 039291 3 SDGTSWFRGR-VIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEV----SASASLQKEKEVFDNLNGCPFVLECFGEEITM 77 (362)
Q Consensus 3 ~~~~~y~~~~-~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~----~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~ 77 (362)
...++|.+.+ .||+|+||.||+|.++..+. ...+++|.... .....+.+|+.+++.++ ||||+++++++.
T Consensus 6 ~~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~--~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~-- 80 (287)
T 1u59_A 6 LKRDNLLIADIELGCGNFGSVRQGVYRMRKK--QIDVAIKVLKQGTEKADTEEMMREAQIMHQLD-NPYIVRLIGVCQ-- 80 (287)
T ss_dssp CCGGGEEEEEEEEECCTTEEEEEEEEC---C--CEEEEEEEECSSCCHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEE--
T ss_pred ccHHHhhhhhccccccCceeEEEeEeccCCC--cceEEEEecCCccchhHHHHHHHHHHHHHhCC-CCCEeEEEEEec--
Confidence 4567788876 99999999999998754322 13567776543 34567889999999997 999999998762
Q ss_pred cCCCceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEE
Q 039291 78 GENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKI 157 (362)
Q Consensus 78 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl 157 (362)
. ..+++||||+++++|.+++.. ....+++..++.++.||+.||.|||++||+||||||+||++ +.++.+||
T Consensus 81 --~--~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili----~~~~~~kl 151 (287)
T 1u59_A 81 --A--EALMLVMEMAGGGPLHKFLVG-KREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLL----VNRHYAKI 151 (287)
T ss_dssp --S--SSEEEEEECCTTEEHHHHHTT-CTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE----EETTEEEE
T ss_pred --C--CCcEEEEEeCCCCCHHHHHHh-CCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEE----cCCCCEEE
Confidence 1 126799999999999999975 34569999999999999999999999999999999999999 56678999
Q ss_pred eecCCcccccccccC-CCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHh-CCCCCccCCCCCHHHHHHHHcC
Q 039291 158 ADLGVAKRSRHCKRQ-KFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLS-GRQAWVVKEDCSIDQLFSIIGD 235 (362)
Q Consensus 158 ~Dfgla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~ 235 (362)
+|||++......... .......||+.|+|||++.+..++.++|||||||++|+|++ |..||.... ..+....+..
T Consensus 152 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~---~~~~~~~i~~ 228 (287)
T 1u59_A 152 SDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMK---GPEVMAFIEQ 228 (287)
T ss_dssp CCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC---THHHHHHHHT
T ss_pred CcccceeeeccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCC---HHHHHHHHhc
Confidence 999999865432221 12234457889999999998889999999999999999998 999996543 2344444443
Q ss_pred CCCCCCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhcCC
Q 039291 236 EHSLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDP 275 (362)
Q Consensus 236 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p 275 (362)
.. .+..+..++.++.++|.+||..||++||++.+++++.
T Consensus 229 ~~-~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l 267 (287)
T 1u59_A 229 GK-RMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRM 267 (287)
T ss_dssp TC-CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHH
T ss_pred CC-cCCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 33 3456778999999999999999999999999999863
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-45 Score=331.12 Aligned_cols=249 Identities=22% Similarity=0.308 Sum_probs=193.5
Q ss_pred CCceeecceecccCceEEEEEEECCCCCCCCceeeeechhhh------hhHHHHHHHHHHHHcCCCCcccccccceeeec
Q 039291 5 GTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVS------ASASLQKEKEVFDNLNGCPFVLECFGEEITMG 78 (362)
Q Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~~------~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~ 78 (362)
-++|.+.+.||+|+||.||+|+++.++. .+++|..... ..+.+.+|+.++++++ ||||+++++++..
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~----~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-hp~iv~~~~~~~~-- 105 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTVRER----IVALKLMSETLSSDPVFRTRMQREARTAGRLQ-EPHVVPIHDFGEI-- 105 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETTTTE----EEEEEECGGGGGGSHHHHHHHHHHHHHHTTCC-CTTBCCEEEEEEE--
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcCCCe----EEEEEecCcccccCHHHHHHHHHHHHHHhhcC-CCCeeEEEEEEee--
Confidence 4789999999999999999999988764 5677765432 2366889999999998 8999999987653
Q ss_pred CCCceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEe
Q 039291 79 ENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIA 158 (362)
Q Consensus 79 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~ 158 (362)
...+++||||++|++|.+++... ..+++..++.++.|++.||.|||++||+||||||+||++ +.++.+||+
T Consensus 106 ---~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~----~~~~~~kl~ 176 (309)
T 2h34_A 106 ---DGQLYVDMRLINGVDLAAMLRRQ--GPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILV----SADDFAYLV 176 (309)
T ss_dssp ---TTEEEEEEECCCCEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE----CTTSCEEEC
T ss_pred ---CCeEEEEEEecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEE----cCCCCEEEe
Confidence 23477999999999999999873 459999999999999999999999999999999999999 777889999
Q ss_pred ecCCcccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHHcCCC-
Q 039291 159 DLGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEH- 237 (362)
Q Consensus 159 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~- 237 (362)
|||++......... ......||+.|+|||++.+..++.++||||||+++|+|++|..||.... ...+...+....
T Consensus 177 Dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~---~~~~~~~~~~~~~ 252 (309)
T 2h34_A 177 DFGIASATTDEKLT-QLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQ---LSVMGAHINQAIP 252 (309)
T ss_dssp SCCC-----------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCH---HHHHHHHHHSCCC
T ss_pred cCccCccccccccc-cccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCch---HHHHHHHhccCCC
Confidence 99998765432211 1235679999999999999899999999999999999999999996543 233333333322
Q ss_pred CCCCCCccCCHHHHHHHHHHhccCCCCCC-CHHHHhc
Q 039291 238 SLPEIPSRVSKEARDFLRRCFVRKPAFRF-TAEMLLD 273 (362)
Q Consensus 238 ~~~~~~~~~~~~~~~li~~~l~~~p~~R~-s~~~~l~ 273 (362)
.....+..++.++.++|.+||..||++|| +++++++
T Consensus 253 ~~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~ 289 (309)
T 2h34_A 253 RPSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSA 289 (309)
T ss_dssp CGGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHH
T ss_pred CccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHH
Confidence 22245567899999999999999999999 8888775
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-45 Score=333.70 Aligned_cols=256 Identities=23% Similarity=0.408 Sum_probs=182.8
Q ss_pred CCCceeecceecccCceEEEEEEECCCCCCCCceeeeechhh----hhhHHHHHHH-HHHHHcCCCCcccccccceeeec
Q 039291 4 DGTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEV----SASASLQKEK-EVFDNLNGCPFVLECFGEEITMG 78 (362)
Q Consensus 4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~----~~~~~~~~E~-~il~~l~~h~~i~~~~~~~~~~~ 78 (362)
.-++|.+++.||+|+||.||+|+++.++. .|++|.... ........|. .+++.++ ||||+++++++..
T Consensus 23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~----~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~-h~~i~~~~~~~~~-- 95 (318)
T 2dyl_A 23 EINDLENLGEMGSGTCGQVWKMRFRKTGH----VIAVKQMRRSGNKEENKRILMDLDVVLKSHD-CPYIVQCFGTFIT-- 95 (318)
T ss_dssp CGGGEEEEEEC------CEEEEEETTTCC----EEEEEEEETTSCHHHHHHHHHHHHHHHHTTT-CTTBCCEEEEEEC--
T ss_pred hhccccccceeeecCCeeEEEEEEecCCe----EEEEEEecccccchHHHHHHHHHHHHHHhcC-CCceeeEEEEEec--
Confidence 34688899999999999999999988775 566665532 2223333444 4555555 9999999997653
Q ss_pred CCCceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC-CceeCCCCCCCEEEeecCCCceEEEE
Q 039291 79 ENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDS-GYVHCDVKPDNILLVATQSGKFVAKI 157 (362)
Q Consensus 79 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~-~ivH~Dlkp~Nill~~~~~~~~~~kl 157 (362)
...+++||||+ ++.+..+... ....+++..++.++.|++.||.|||++ ||+||||||+||++ +.++.+||
T Consensus 96 ---~~~~~lv~e~~-~~~~~~l~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~----~~~~~~kl 166 (318)
T 2dyl_A 96 ---NTDVFIAMELM-GTCAEKLKKR-MQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILL----DERGQIKL 166 (318)
T ss_dssp ---SSEEEEEECCC-SEEHHHHHHH-HTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEE----CTTSCEEE
T ss_pred ---CCcEEEEEecc-CCcHHHHHHH-hccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEE----CCCCCEEE
Confidence 23477999999 5566665554 345699999999999999999999995 99999999999999 77888999
Q ss_pred eecCCcccccccccCCCCCCccCCCCccCchhhc-----cccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHH-
Q 039291 158 ADLGVAKRSRHCKRQKFDPSMRGTPLYLAPETVV-----QHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFS- 231 (362)
Q Consensus 158 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~- 231 (362)
+|||++....... ......||+.|+|||++. ...++.++|||||||++|+|++|+.||.... ...+...
T Consensus 167 ~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~--~~~~~~~~ 241 (318)
T 2dyl_A 167 CDFGISGRLVDDK---AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCK--TDFEVLTK 241 (318)
T ss_dssp CCCTTC-----------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCC--SHHHHHHH
T ss_pred EECCCchhccCCc---cccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCC--ccHHHHHH
Confidence 9999987554322 123457999999999995 4567889999999999999999999996432 2223332
Q ss_pred HHcCCCCCCCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCccCc
Q 039291 232 IIGDEHSLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGV 280 (362)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~~~~ 280 (362)
..............++.++.+||.+||..||.+||+++++++||||+..
T Consensus 242 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 290 (318)
T 2dyl_A 242 VLQEEPPLLPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRY 290 (318)
T ss_dssp HHHSCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHHH
T ss_pred HhccCCCCCCccCCCCHHHHHHHHHHccCChhHCcCHHHHhhCHHHHhc
Confidence 2322222112234589999999999999999999999999999999764
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-45 Score=343.83 Aligned_cols=256 Identities=21% Similarity=0.328 Sum_probs=195.1
Q ss_pred CCCceeecceecccCceEEEEEEECCCCCCCCceeeeechhh----hhhHHHHHHHHHHHHcCCCCcccccccceeeecC
Q 039291 4 DGTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEV----SASASLQKEKEVFDNLNGCPFVLECFGEEITMGE 79 (362)
Q Consensus 4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~----~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~ 79 (362)
...+|.+.+.||+|+||+||+|++..++. ....+++|.... ...+.+.+|+.++++++ ||||+++++++..
T Consensus 87 ~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~~~~~~~~--- 161 (373)
T 3c1x_A 87 SSLIVHFNEVIGRGHFGCVYHGTLLDNDG-KKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFS-HPNVLSLLGICLR--- 161 (373)
T ss_dssp TTEEEEEEEEEECCSSSEEEEEEEEETTT-EEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCC-CTTBCCCCEEECC---
T ss_pred hhceeecCcEeeeCCCeEEEEEEEECCCC-cEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCC-CCCcceEEEEEEc---
Confidence 44568899999999999999999764432 123567776532 34567889999999998 9999999987542
Q ss_pred CCceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEee
Q 039291 80 NGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIAD 159 (362)
Q Consensus 80 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~D 159 (362)
....+++||||+++|+|.+++... ...+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|
T Consensus 162 -~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll----~~~~~~kL~D 235 (373)
T 3c1x_A 162 -SEGSPLVVLPYMKHGDLRNFIRNE-THNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCML----DEKFTVKVAD 235 (373)
T ss_dssp -CSSCCEEEEECCTTCBHHHHHHCT-TCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE----CTTCCEEECC
T ss_pred -CCCCeEEEEECCCCCCHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEE----CCCCCEEEee
Confidence 222356999999999999999763 3458999999999999999999999999999999999999 7788999999
Q ss_pred cCCcccccccccCC--CCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHh-CCCCCccCCCCCHHHHHHHHcCC
Q 039291 160 LGVAKRSRHCKRQK--FDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLS-GRQAWVVKEDCSIDQLFSIIGDE 236 (362)
Q Consensus 160 fgla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~ 236 (362)
||+++......... ......+|+.|+|||++.+..++.++|||||||++|+|++ |.+||......+.... +...
T Consensus 236 FG~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~---~~~~ 312 (373)
T 3c1x_A 236 FGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVY---LLQG 312 (373)
T ss_dssp C---------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHH---HHTT
T ss_pred ccccccccccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHH---HHcC
Confidence 99997554322111 1134457888999999999999999999999999999999 7888876555444332 2222
Q ss_pred CCCCCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhcC
Q 039291 237 HSLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDD 274 (362)
Q Consensus 237 ~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~ 274 (362)
. .+..+..++.++.+++.+||..||++|||+.+++++
T Consensus 313 ~-~~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 349 (373)
T 3c1x_A 313 R-RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR 349 (373)
T ss_dssp C-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred C-CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 2 234466789999999999999999999999999863
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-45 Score=334.82 Aligned_cols=258 Identities=26% Similarity=0.356 Sum_probs=201.7
Q ss_pred CCCCceeecceecccCceEEEEEEECCCCCCCCceeeeech---hhhhhHHHHHHHHHHHHcCCCCcccccccceeeecC
Q 039291 3 SDGTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSA---EVSASASLQKEKEVFDNLNGCPFVLECFGEEITMGE 79 (362)
Q Consensus 3 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~---~~~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~ 79 (362)
+.+++|.+++.||+|+||.||+|+++.+++ .|++|.. .......+.+|+.+++.++ ||||+++++++....
T Consensus 26 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~----~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~- 99 (317)
T 2buj_A 26 IDNKHYLFIQKLGEGGFSYVDLVEGLHDGH----FYALKRILCHEQQDREEAQREADMHRLFN-HPNILRLVAYCLRER- 99 (317)
T ss_dssp ETTEEEEEEEEEEC--CEEEEEEEETTTCC----EEEEEEEEESSHHHHHHHHHHHHHHHTCC-CTTBCCCCEEEEEEE-
T ss_pred ECCeEEEEEEEecCCCCeEEEEEEecCCCc----EEEEEEEecCCHHHHHHHHHHHHHHhhcC-CCCeeeEEEEEEecc-
Confidence 357899999999999999999999988775 5566654 2345567889999999998 999999999776432
Q ss_pred CCceEEEEEEEecCCCCHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEE
Q 039291 80 NGEMAYNLLLEYAAGGTLGDLIEKC--NGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKI 157 (362)
Q Consensus 80 ~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl 157 (362)
.....+++||||+.+++|.+++... .+..+++..++.++.||+.||.|||++||+||||||+||++ +.++.+||
T Consensus 100 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~----~~~~~~kl 175 (317)
T 2buj_A 100 GAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILL----GDEGQPVL 175 (317)
T ss_dssp TTEEEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE----CTTSCEEE
T ss_pred CCCceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEE----cCCCCEEE
Confidence 2345677999999999999999764 24569999999999999999999999999999999999999 77788999
Q ss_pred eecCCcccccccccCC-------CCCCccCCCCccCchhhcccc---CCCcchHHHHHHHHHHHHhCCCCCccCC--CCC
Q 039291 158 ADLGVAKRSRHCKRQK-------FDPSMRGTPLYLAPETVVQHM---QEAPSDIWALGCVVLEMLSGRQAWVVKE--DCS 225 (362)
Q Consensus 158 ~Dfgla~~~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~---~~~~~DiwslG~il~~l~~g~~pf~~~~--~~~ 225 (362)
+|||++.......... ......||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.... ...
T Consensus 176 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~ 255 (317)
T 2buj_A 176 MDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDS 255 (317)
T ss_dssp CCCSSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSC
T ss_pred EecCcchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccch
Confidence 9999987543211110 001345799999999987543 6889999999999999999999996421 112
Q ss_pred HHHHHHHHcCCCCCCCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhcC
Q 039291 226 IDQLFSIIGDEHSLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDD 274 (362)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~ 274 (362)
... .+......+ .+..++.++.++|.+||..||.+|||+.+++++
T Consensus 256 ~~~---~~~~~~~~~-~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 300 (317)
T 2buj_A 256 VAL---AVQNQLSIP-QSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQ 300 (317)
T ss_dssp HHH---HHHCC--CC-CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred hhH---HhhccCCCC-ccccCCHHHHHHHHHHhhcChhhCCCHHHHHHH
Confidence 222 122222222 345689999999999999999999999999874
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-45 Score=329.14 Aligned_cols=247 Identities=20% Similarity=0.322 Sum_probs=198.0
Q ss_pred CCCCceeecceecccCceEEEEEEECCCCCCCCceeeeechhhh-hhHHHHHHHHHHHHcCCCCcccccccceeeecCCC
Q 039291 3 SDGTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVS-ASASLQKEKEVFDNLNGCPFVLECFGEEITMGENG 81 (362)
Q Consensus 3 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~~-~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~~ 81 (362)
...++|.+.+.||+|+||+||+|++++ ..+++|..... ..+.+.+|+.++++++ ||||+++++.+.. .
T Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~~~~~~------~~vavK~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~----~ 86 (278)
T 1byg_A 18 LNMKELKLLQTIGKGEFGDVMLGDYRG------NKVAVKCIKNDATAQAFLAEASVMTQLR-HSNLVQLLGVIVE----E 86 (278)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETT------EEEEEEECCCCC--HHHHHTHHHHTTCC-CTTBCCEEEEECC----C
T ss_pred CChhhceEEeEEecCCCceEEEEEEcC------CEEEEEEecchhHHHHHHHHHHHHHhCC-CCCEeeEEEEEEc----C
Confidence 456799999999999999999998853 36788876543 4566889999999998 9999999986542 2
Q ss_pred ceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEeecC
Q 039291 82 EMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLG 161 (362)
Q Consensus 82 ~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Dfg 161 (362)
...+++||||+++++|.+++.......+++..++.++.|++.||.|||++||+||||||+||++ +.++.+||+|||
T Consensus 87 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~----~~~~~~~l~Dfg 162 (278)
T 1byg_A 87 KGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLV----SEDNVAKVSDFG 162 (278)
T ss_dssp --CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE----CTTSCEEECCCC
T ss_pred CCceEEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEE----eCCCcEEEeecc
Confidence 2346799999999999999987544448999999999999999999999999999999999999 777889999999
Q ss_pred CcccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHh-CCCCCccCCCCCHHHHHHHHcCCCCCC
Q 039291 162 VAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLS-GRQAWVVKEDCSIDQLFSIIGDEHSLP 240 (362)
Q Consensus 162 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 240 (362)
++....... ....+++.|+|||++.+..++.++||||||+++|+|++ |..||..... .+....+.... .+
T Consensus 163 ~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~---~~~~~~~~~~~-~~ 233 (278)
T 1byg_A 163 LTKEASSTQ-----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL---KDVVPRVEKGY-KM 233 (278)
T ss_dssp C-----------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCG---GGHHHHHTTTC-CC
T ss_pred ccccccccc-----cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHHhcCC-CC
Confidence 987544321 23457889999999998889999999999999999998 9999965433 33444443332 34
Q ss_pred CCCccCCHHHHHHHHHHhccCCCCCCCHHHHhc
Q 039291 241 EIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLD 273 (362)
Q Consensus 241 ~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~ 273 (362)
..+..+++++.++|.+||..||++||++.++++
T Consensus 234 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 266 (278)
T 1byg_A 234 DAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLRE 266 (278)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCcccCCHHHHHHHHHHhcCChhhCCCHHHHHH
Confidence 566789999999999999999999999999886
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-45 Score=330.78 Aligned_cols=246 Identities=22% Similarity=0.369 Sum_probs=195.2
Q ss_pred CCCCceeecceecccCceEEEEEEECCCCCCCCceeeeechhhh-hhHHHHHHHHHHHHcCCCCcccccccceeeecCCC
Q 039291 3 SDGTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVS-ASASLQKEKEVFDNLNGCPFVLECFGEEITMGENG 81 (362)
Q Consensus 3 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~~-~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~~ 81 (362)
++.++|.+.+.||+|+||+||+|++++ ..+++|..... ..+.+.+|+.++++++ ||||+++++.+. +
T Consensus 5 i~~~~~~~~~~lg~G~~g~V~~~~~~~------~~vavK~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~----~- 72 (307)
T 2eva_A 5 IDYKEIEVEEVVGRGAFGVVCKAKWRA------KDVAIKQIESESERKAFIVELRQLSRVN-HPNIVKLYGACL----N- 72 (307)
T ss_dssp CCGGGEEEEEEEECCSSSEEEEEEETT------EEEEEEECSSTTHHHHHHHHHHHHHHCC-CTTBCCEEEBCT----T-
T ss_pred CCHhHeeeeeEeecCCCceEEEEEECC------eeEEEEEecChhHHHHHHHHHHHHhcCC-CCCcCeEEEEEc----C-
Confidence 456899999999999999999999863 35788876533 4567889999999998 999999998653 1
Q ss_pred ceEEEEEEEecCCCCHHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHh---CCceeCCCCCCCEEEeecCCCce-EEE
Q 039291 82 EMAYNLLLEYAAGGTLGDLIEKCNG-NGLPEKDVRHFTRCILEGIGHIHD---SGYVHCDVKPDNILLVATQSGKF-VAK 156 (362)
Q Consensus 82 ~~~~~lv~e~~~~~~L~~~l~~~~~-~~l~~~~~~~i~~ql~~~l~yLH~---~~ivH~Dlkp~Nill~~~~~~~~-~~k 156 (362)
.+++||||++|++|.+++..... ..+++..+..++.|++.||.|||+ +||+||||||+|||+ +.++ .+|
T Consensus 73 --~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll----~~~~~~~k 146 (307)
T 2eva_A 73 --PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLL----VAGGTVLK 146 (307)
T ss_dssp --TTEEEEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEE----ETTTTEEE
T ss_pred --CcEEEEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEE----eCCCCEEE
Confidence 15699999999999999986332 237899999999999999999999 899999999999999 4444 489
Q ss_pred EeecCCcccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHHcCC
Q 039291 157 IADLGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDE 236 (362)
Q Consensus 157 l~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 236 (362)
|+|||++...... .....||+.|+|||++.+..++.++|||||||++|+|++|+.||...... .......+..
T Consensus 147 l~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-~~~~~~~~~~- 219 (307)
T 2eva_A 147 ICDFGTACDIQTH-----MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGP-AFRIMWAVHN- 219 (307)
T ss_dssp ECCCCC-----------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSS-HHHHHHHHHT-
T ss_pred Ecccccccccccc-----cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCcc-HHHHHHHHhc-
Confidence 9999998754321 12446999999999999989999999999999999999999999654432 2222222222
Q ss_pred CCCCCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhc
Q 039291 237 HSLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLD 273 (362)
Q Consensus 237 ~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~ 273 (362)
...+..+..++..+.++|.+||..||++|||+.++++
T Consensus 220 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 256 (307)
T 2eva_A 220 GTRPPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVK 256 (307)
T ss_dssp TCCCCCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCCcccccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 2334556779999999999999999999999999987
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=332.07 Aligned_cols=254 Identities=16% Similarity=0.273 Sum_probs=200.6
Q ss_pred CCCCceeecceecccCceEEEEEEECCCCCCCC---ceeeeechhh---hhhHHHHHHHHHHHHcCCCCcccccccceee
Q 039291 3 SDGTSWFRGRVIGQGSFGCVFIAKPKSNSSFLP---PLMAVKSAEV---SASASLQKEKEVFDNLNGCPFVLECFGEEIT 76 (362)
Q Consensus 3 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~---~~~~~K~~~~---~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~ 76 (362)
+..++|.+.+.||+|+||+||+|+++.+++... ..+++|.... ...+.+.+|+.++++++ ||||+++++++..
T Consensus 5 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~ 83 (289)
T 4fvq_A 5 IRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLS-HKHLVLNYGVCVC 83 (289)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSC-CTTBCCEEEEECC
T ss_pred echhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCC-CCCEeEEEEEEEe
Confidence 567899999999999999999999987764321 3577776543 34567889999999998 9999999987653
Q ss_pred ecCCCceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCC----Cc
Q 039291 77 MGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQS----GK 152 (362)
Q Consensus 77 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~----~~ 152 (362)
....++||||++|++|.+++... ...+++..++.++.||+.||.|||++||+||||||+|||+..+.. ..
T Consensus 84 -----~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~ 157 (289)
T 4fvq_A 84 -----GDENILVQEFVKFGSLDTYLKKN-KNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNP 157 (289)
T ss_dssp -----TTCCEEEEECCTTCBHHHHHHHT-GGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBC
T ss_pred -----CCCCEEEEECCCCCCHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCccccccc
Confidence 22356999999999999999873 334999999999999999999999999999999999999954321 11
Q ss_pred eEEEEeecCCcccccccccCCCCCCccCCCCccCchhhcc-ccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHH
Q 039291 153 FVAKIADLGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQ-HMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFS 231 (362)
Q Consensus 153 ~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~ 231 (362)
+.+||+|||++...... ....||+.|+|||++.+ ..++.++|||||||++|+|++|..|+... .+......
T Consensus 158 ~~~kl~Dfg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~--~~~~~~~~ 229 (289)
T 4fvq_A 158 PFIKLSDPGISITVLPK------DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSA--LDSQRKLQ 229 (289)
T ss_dssp CEEEECCCCSCTTTSCH------HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTT--SCHHHHHH
T ss_pred ceeeeccCcccccccCc------cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccc--cchHHHHH
Confidence 23999999998654321 23458999999999987 67899999999999999999955444322 23333333
Q ss_pred HHcCCCCCCCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhcC
Q 039291 232 IIGDEHSLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDD 274 (362)
Q Consensus 232 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~ 274 (362)
...... ..+...+.++.+||.+||..||++|||+.+++++
T Consensus 230 ~~~~~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 269 (289)
T 4fvq_A 230 FYEDRH---QLPAPKAAELANLINNCMDYEPDHRPSFRAIIRD 269 (289)
T ss_dssp HHHTTC---CCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred HhhccC---CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 333332 3445678899999999999999999999999874
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-45 Score=337.74 Aligned_cols=258 Identities=21% Similarity=0.282 Sum_probs=201.1
Q ss_pred CCCCceeecceecccCceEEEEEEECCCCCCCCceeeeechhhh----hhHHHHHHHHHHHHcCCCCcccccccceeeec
Q 039291 3 SDGTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVS----ASASLQKEKEVFDNLNGCPFVLECFGEEITMG 78 (362)
Q Consensus 3 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~~----~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~ 78 (362)
...++|.+.+.||+|+||+||+|++.. + ..|++|..... ....+.+|+.+++.++ ||||+++++++..
T Consensus 27 ~~~~~y~~~~~lg~G~~g~V~~~~~~~-~----~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~-- 98 (326)
T 3uim_A 27 VASDNFSNKNILGRGGFGKVYKGRLAD-G----TLVAVKRLKEERTQGGELQFQTEVEMISMAV-HRNLLRLRGFCMT-- 98 (326)
T ss_dssp TTTTSSCSTTEEECCSSSEEEEECCSS-S----CCEEEEECCC-----CCCHHHHHHHGGGTCC-CTTBCCCCEEECC--
T ss_pred HHhhccccceeEecCCCcEEEEEEecC-C----CEEEEEEeccccCchHHHHHHHHHHHHHhcc-CCCccceEEEEec--
Confidence 457899999999999999999998553 3 35677765432 2336889999999998 9999999997643
Q ss_pred CCCceEEEEEEEecCCCCHHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCCCCEEEeecCCCce
Q 039291 79 ENGEMAYNLLLEYAAGGTLGDLIEKCNG--NGLPEKDVRHFTRCILEGIGHIHDS---GYVHCDVKPDNILLVATQSGKF 153 (362)
Q Consensus 79 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~l~~~~~~~i~~ql~~~l~yLH~~---~ivH~Dlkp~Nill~~~~~~~~ 153 (362)
....++||||+.+|+|.+++..... .++++..+..++.|++.||.|||++ ||+||||||+|||+ +.++
T Consensus 99 ---~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~----~~~~ 171 (326)
T 3uim_A 99 ---PTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILL----DEEF 171 (326)
T ss_dssp ---SSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEE----CTTC
T ss_pred ---CCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEE----CCCC
Confidence 2235699999999999999986432 3499999999999999999999999 99999999999999 7788
Q ss_pred EEEEeecCCcccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHhCCCCCccC-----CCCCHHH
Q 039291 154 VAKIADLGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVK-----EDCSIDQ 228 (362)
Q Consensus 154 ~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~-----~~~~~~~ 228 (362)
.+||+|||++......... ......||+.|+|||++.+..++.++|||||||++|+|++|..||... .......
T Consensus 172 ~~kl~Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~ 250 (326)
T 3uim_A 172 EAVVGDFGLAKLMDYKDTH-VTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLD 250 (326)
T ss_dssp CEEECCCSSCEECCSSSSC-EECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHH
T ss_pred CEEeccCccccccCccccc-ccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHH
Confidence 8999999999865432222 223456999999999999888999999999999999999999999521 1111111
Q ss_pred HHHHHcCCCC---------CCCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCC
Q 039291 229 LFSIIGDEHS---------LPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPF 276 (362)
Q Consensus 229 ~~~~~~~~~~---------~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~ 276 (362)
.......... .+..+...+.++.+++.+||..||.+|||+.++++|..
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~ 307 (326)
T 3uim_A 251 WVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLE 307 (326)
T ss_dssp HHTTTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHH
T ss_pred HHHHHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhc
Confidence 1111111111 11223344578999999999999999999999998643
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=333.05 Aligned_cols=256 Identities=22% Similarity=0.342 Sum_probs=202.2
Q ss_pred CCceeecceecccCceEEEEEEECCCCCCCCceeeeechhhhhhHHHHHHHHHHHHcC-CCCcccccccceeeecCCCce
Q 039291 5 GTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVSASASLQKEKEVFDNLN-GCPFVLECFGEEITMGENGEM 83 (362)
Q Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~~~~~~~~~E~~il~~l~-~h~~i~~~~~~~~~~~~~~~~ 83 (362)
.++|.+++.||+|+||.||+|++++ ..|++|...........+|.+++..+. .||||+++++.+.... ....
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~------~~vavK~~~~~~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~-~~~~ 108 (337)
T 3mdy_A 36 AKQIQMVKQIGKGRYGEVWMGKWRG------EKVAVKVFFTTEEASWFRETEIYQTVLMRHENILGFIAADIKGT-GSWT 108 (337)
T ss_dssp HHHCEEEEEEEEETTEEEEEEEETT------EEEEEEEEEGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESC-GGGC
T ss_pred ccceEEEeEeecCCCeEEEEEEECC------ceEEEEEEeccccchhhhHHHHHHHHhhcCCCeeeEEEEEccCC-CCCC
Confidence 3689999999999999999999862 368888877666667777887777652 5999999998765432 2224
Q ss_pred EEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC--------CceeCCCCCCCEEEeecCCCceEE
Q 039291 84 AYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDS--------GYVHCDVKPDNILLVATQSGKFVA 155 (362)
Q Consensus 84 ~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~--------~ivH~Dlkp~Nill~~~~~~~~~~ 155 (362)
.+++||||+++|+|.++++. ..+++..++.++.|++.||.|||++ ||+||||||+|||+ +.++.+
T Consensus 109 ~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill----~~~~~~ 181 (337)
T 3mdy_A 109 QLYLITDYHENGSLYDYLKS---TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILV----KKNGTC 181 (337)
T ss_dssp EEEEEECCCTTCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEE----CTTSCE
T ss_pred ceEEEEeccCCCcHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEE----CCCCCE
Confidence 57899999999999999976 3599999999999999999999998 99999999999999 778889
Q ss_pred EEeecCCcccccccccCC--CCCCccCCCCccCchhhccccCCCc------chHHHHHHHHHHHHhC----------CCC
Q 039291 156 KIADLGVAKRSRHCKRQK--FDPSMRGTPLYLAPETVVQHMQEAP------SDIWALGCVVLEMLSG----------RQA 217 (362)
Q Consensus 156 kl~Dfgla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~------~DiwslG~il~~l~~g----------~~p 217 (362)
||+|||+++......... ......||+.|+|||++.+...... +|||||||++|||++| ..|
T Consensus 182 kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p 261 (337)
T 3mdy_A 182 CIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLP 261 (337)
T ss_dssp EECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCT
T ss_pred EEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCccccccccccc
Confidence 999999997554322221 1135679999999999988766665 9999999999999999 677
Q ss_pred CccC--CCCCHHHHHHHHcCCCCCCCCCc-----cCCHHHHHHHHHHhccCCCCCCCHHHHhcC
Q 039291 218 WVVK--EDCSIDQLFSIIGDEHSLPEIPS-----RVSKEARDFLRRCFVRKPAFRFTAEMLLDD 274 (362)
Q Consensus 218 f~~~--~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~li~~~l~~~p~~R~s~~~~l~~ 274 (362)
|... ...........+......+..+. .++.++.+||.+||..||++|||+.+++++
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 325 (337)
T 3mdy_A 262 YHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKT 325 (337)
T ss_dssp TTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred HhhhcCCCCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHH
Confidence 7543 22334444444444444444443 466789999999999999999999999874
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-45 Score=335.13 Aligned_cols=256 Identities=20% Similarity=0.308 Sum_probs=186.9
Q ss_pred CCCCceeecceecccCceEEEEEEECCCCCCCCceeeeech---hhhhhHHHHHHHHHHHHcCCCCcccccccceeeec-
Q 039291 3 SDGTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSA---EVSASASLQKEKEVFDNLNGCPFVLECFGEEITMG- 78 (362)
Q Consensus 3 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~---~~~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~- 78 (362)
..+.+|.+++.||+|+||.||+|+++.+++ .+++|.+ .......+.+|+.+++++.+||||+++++.+....
T Consensus 25 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~----~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~ 100 (337)
T 3ll6_A 25 LGELRLRVRRVLAEGGFAFVYEAQDVGSGR----EYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKE 100 (337)
T ss_dssp ETTEEEEEEEEEECCSSEEEEEEEETTTCC----EEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTT
T ss_pred ccCceEEEEEEEccCCceEEEEEEECCCCc----EEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhcccccccccc
Confidence 456799999999999999999999988876 4566654 23345668899999999987999999998775322
Q ss_pred --CCCceEEEEEEEecCCCCHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCC--ceeCCCCCCCEEEeecCCCce
Q 039291 79 --ENGEMAYNLLLEYAAGGTLGDLIEKC-NGNGLPEKDVRHFTRCILEGIGHIHDSG--YVHCDVKPDNILLVATQSGKF 153 (362)
Q Consensus 79 --~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~l~~~~~~~i~~ql~~~l~yLH~~~--ivH~Dlkp~Nill~~~~~~~~ 153 (362)
......++++|||+. |+|.+++... ...++++..++.++.||+.||.|||++| |+||||||+|||+ +.++
T Consensus 101 ~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~----~~~~ 175 (337)
T 3ll6_A 101 ESDTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLL----SNQG 175 (337)
T ss_dssp TSTTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEE----CTTS
T ss_pred ccccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEE----CCCC
Confidence 234556789999996 6999988763 3456999999999999999999999999 9999999999999 7778
Q ss_pred EEEEeecCCcccccccccCC----------CCCCccCCCCccCchhh---ccccCCCcchHHHHHHHHHHHHhCCCCCcc
Q 039291 154 VAKIADLGVAKRSRHCKRQK----------FDPSMRGTPLYLAPETV---VQHMQEAPSDIWALGCVVLEMLSGRQAWVV 220 (362)
Q Consensus 154 ~~kl~Dfgla~~~~~~~~~~----------~~~~~~gt~~y~aPE~~---~~~~~~~~~DiwslG~il~~l~~g~~pf~~ 220 (362)
.+||+|||+++......... ......||+.|+|||++ .+..++.++|||||||++|+|++|..||..
T Consensus 176 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~ 255 (337)
T 3ll6_A 176 TIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFED 255 (337)
T ss_dssp CEEBCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC--
T ss_pred CEEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcc
Confidence 89999999997654322111 11245699999999998 456788899999999999999999999964
Q ss_pred CCCCCHHHHHHHHcCCCCCCCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhcC
Q 039291 221 KEDCSIDQLFSIIGDEHSLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDD 274 (362)
Q Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~ 274 (362)
.... ... ..... ...+...+..+.+||.+||..||++|||+.+++++
T Consensus 256 ~~~~---~~~---~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 302 (337)
T 3ll6_A 256 GAKL---RIV---NGKYS-IPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQ 302 (337)
T ss_dssp ----------------CC-CCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred hhHH---Hhh---cCccc-CCcccccchHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 3221 111 11111 12245567889999999999999999999999986
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-45 Score=355.78 Aligned_cols=250 Identities=21% Similarity=0.343 Sum_probs=207.7
Q ss_pred CCCCceeecceecccCceEEEEEEECCCCCCCCceeeeechhhh--hhHHHHHHHHHHHHcCCCCcccccccceeeecCC
Q 039291 3 SDGTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVS--ASASLQKEKEVFDNLNGCPFVLECFGEEITMGEN 80 (362)
Q Consensus 3 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~~--~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~ 80 (362)
+..++|.+.+.||+|+||+||+|+++.+. .|++|.+... ..+.+.+|+.+|++|+ ||||+++++++..
T Consensus 264 i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~-----~vavK~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~---- 333 (535)
T 2h8h_A 264 IPRESLRLEVKLGQGCFGEVWMGTWNGTT-----RVAIKTLKPGTMSPEAFLQEAQVMKKLR-HEKLVQLYAVVSE---- 333 (535)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTE-----EEEEEEECTTSSCHHHHHHHHHHHHHCC-CTTBCCEEEEECS----
T ss_pred cchhhhhhheecccCCCeEEEEEEECCCc-----eEEEEEeCCCCCCHHHHHHHHHHHHhCC-CCCEeeEEEEEee----
Confidence 45678999999999999999999987642 5788876543 3467899999999998 9999999987532
Q ss_pred CceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEeec
Q 039291 81 GEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADL 160 (362)
Q Consensus 81 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Df 160 (362)
..+++||||+.+|+|.+++....+..+++..+..++.||+.||+|||++||+||||||+|||+ +.++.+||+||
T Consensus 334 --~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll----~~~~~~kl~DF 407 (535)
T 2h8h_A 334 --EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILV----GENLVCKVADF 407 (535)
T ss_dssp --SSCEEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE----CGGGCEEECCT
T ss_pred --ccceEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEE----cCCCcEEEccc
Confidence 236799999999999999986545569999999999999999999999999999999999999 77788999999
Q ss_pred CCcccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHh-CCCCCccCCCCCHHHHHHHHcCCCCC
Q 039291 161 GVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLS-GRQAWVVKEDCSIDQLFSIIGDEHSL 239 (362)
Q Consensus 161 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~ 239 (362)
|+++....... .......++..|+|||++.+..++.++|||||||+||||++ |..||.+. ...++...+......
T Consensus 408 G~a~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~---~~~~~~~~i~~~~~~ 483 (535)
T 2h8h_A 408 GLARLIEDNEY-TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGM---VNREVLDQVERGYRM 483 (535)
T ss_dssp TSTTTCCCHHH-HTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTC---CHHHHHHHHHTTCCC
T ss_pred ccceecCCCce-ecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC---CHHHHHHHHHcCCCC
Confidence 99976543211 11124457888999999998899999999999999999999 99999644 445555555544433
Q ss_pred CCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhc
Q 039291 240 PEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLD 273 (362)
Q Consensus 240 ~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~ 273 (362)
..+..++.++.+||.+||..||++|||++++++
T Consensus 484 -~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~ 516 (535)
T 2h8h_A 484 -PCPPECPESLHDLMCQCWRKEPEERPTFEYLQA 516 (535)
T ss_dssp -CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 356789999999999999999999999999876
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-45 Score=328.34 Aligned_cols=255 Identities=22% Similarity=0.334 Sum_probs=200.0
Q ss_pred CCCCceeecceecccCceEEEEEEECCCCCCCCceeeeechhh------hhhHHHHHHHHHHHHcCCCCcccccccceee
Q 039291 3 SDGTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEV------SASASLQKEKEVFDNLNGCPFVLECFGEEIT 76 (362)
Q Consensus 3 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~------~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~ 76 (362)
...++|.+++.||+|+||+||+|++...+.. ...+++|.... ...+.+.+|+.++++++ ||||+++++++..
T Consensus 15 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~ 92 (291)
T 1u46_A 15 IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGK-TVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLD-HRNLIRLYGVVLT 92 (291)
T ss_dssp CCGGGEEEEEECC----CCCEEEEEECTTSC-EEEEEEEC--------CHHHHHHHHHHHHHHHCC-CTTBCCEEEEECS
T ss_pred cchhHeeeeeeecCCCceeEEEEEeccCCCc-eeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCC-CCCcccEEEEEcc
Confidence 3567999999999999999999987543221 12467777643 24567889999999998 9999999987642
Q ss_pred ecCCCceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEE
Q 039291 77 MGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAK 156 (362)
Q Consensus 77 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~k 156 (362)
.. +++||||+++++|.+++.... ..+++..++.++.|++.||.|||++||+||||||+||++ +.++.+|
T Consensus 93 ----~~--~~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili----~~~~~~k 161 (291)
T 1u46_A 93 ----PP--MKMVTELAPLGSLLDRLRKHQ-GHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLL----ATRDLVK 161 (291)
T ss_dssp ----SS--CEEEEECCTTCBHHHHHHHHG-GGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE----EETTEEE
T ss_pred ----CC--ceeeEecccCCCHHHHHHhcc-CCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEE----cCCCCEE
Confidence 11 569999999999999998743 459999999999999999999999999999999999999 5667899
Q ss_pred EeecCCcccccccccC-CCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHh-CCCCCccCCCCCHHHHHHHHc
Q 039291 157 IADLGVAKRSRHCKRQ-KFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLS-GRQAWVVKEDCSIDQLFSIIG 234 (362)
Q Consensus 157 l~Dfgla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~ 234 (362)
|+|||++......... .......+|..|+|||++.+..++.++||||||+++|+|++ |..||... ...+....+.
T Consensus 162 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~---~~~~~~~~~~ 238 (291)
T 1u46_A 162 IGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGL---NGSQILHKID 238 (291)
T ss_dssp ECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTC---CHHHHHHHHH
T ss_pred EccccccccccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccC---CHHHHHHHHH
Confidence 9999999765433221 12234557888999999998889999999999999999999 99999544 4455555555
Q ss_pred CCCCCCCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhc
Q 039291 235 DEHSLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLD 273 (362)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~ 273 (362)
.....+..+..++.++.++|.+||..||++|||+.++++
T Consensus 239 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 277 (291)
T 1u46_A 239 KEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRD 277 (291)
T ss_dssp TSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ccCCCCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 544444566789999999999999999999999999987
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-45 Score=327.41 Aligned_cols=252 Identities=21% Similarity=0.314 Sum_probs=202.2
Q ss_pred CCCCceeecc-eecccCceEEEEEEECCCCCCCCceeeeechhhh-----hhHHHHHHHHHHHHcCCCCcccccccceee
Q 039291 3 SDGTSWFRGR-VIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVS-----ASASLQKEKEVFDNLNGCPFVLECFGEEIT 76 (362)
Q Consensus 3 ~~~~~y~~~~-~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~~-----~~~~~~~E~~il~~l~~h~~i~~~~~~~~~ 76 (362)
...++|.+.+ .||+|+||+||+|.+.... ....+++|..... ..+.+.+|+.+++.++ ||||+++++++.
T Consensus 13 ~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~- 88 (291)
T 1xbb_A 13 LDRKLLTLEDKELGSGNFGTVKKGYYQMKK--VVKTVAVKILKNEANDPALKDELLAEANVMQQLD-NPYIVRMIGICE- 88 (291)
T ss_dssp CCGGGEEEEEEEEEECSSEEEEEEEEECSS--SEEEEEEEEEC-----CHHHHHHHHHHHHHHTCC-CTTBCCEEEEEE-
T ss_pred ecchhhhhccCccccccCeeeEeeeecCCC--ceeeEEEEeecccccCHHHHHHHHHHHHHHHhCC-CCCEEEEEEEEC-
Confidence 4567899988 9999999999999654321 1246777765432 3567889999999998 999999998762
Q ss_pred ecCCCceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEE
Q 039291 77 MGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAK 156 (362)
Q Consensus 77 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~k 156 (362)
...+++||||+++++|.+++.. ...+++..++.++.||+.||.|||++||+||||||+||++ +.++.+|
T Consensus 89 -----~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~----~~~~~~k 157 (291)
T 1xbb_A 89 -----AESWMLVMEMAELGPLNKYLQQ--NRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLL----VTQHYAK 157 (291)
T ss_dssp -----SSSEEEEEECCTTEEHHHHHHH--CTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE----EETTEEE
T ss_pred -----CCCcEEEEEeCCCCCHHHHHHh--CcCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEE----eCCCcEE
Confidence 1236799999999999999987 4559999999999999999999999999999999999999 5667899
Q ss_pred EeecCCcccccccccC-CCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHh-CCCCCccCCCCCHHHHHHHHc
Q 039291 157 IADLGVAKRSRHCKRQ-KFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLS-GRQAWVVKEDCSIDQLFSIIG 234 (362)
Q Consensus 157 l~Dfgla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~ 234 (362)
|+|||++......... .......+|+.|+|||++.+..++.++||||||+++|+|++ |..||... ...+....+.
T Consensus 158 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~---~~~~~~~~~~ 234 (291)
T 1xbb_A 158 ISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGM---KGSEVTAMLE 234 (291)
T ss_dssp ECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTC---CHHHHHHHHH
T ss_pred EccCCcceeeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCC---CHHHHHHHHH
Confidence 9999999765432221 11123446788999999998889999999999999999999 99999654 3445555544
Q ss_pred CCCCCCCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhc
Q 039291 235 DEHSLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLD 273 (362)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~ 273 (362)
... .+..+..++.++.++|.+||..||++||++.++++
T Consensus 235 ~~~-~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 272 (291)
T 1xbb_A 235 KGE-RMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVEL 272 (291)
T ss_dssp TTC-CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred cCC-CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 433 34567789999999999999999999999999886
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-46 Score=365.30 Aligned_cols=272 Identities=22% Similarity=0.304 Sum_probs=205.8
Q ss_pred CCCceeecceecccCceEEEEEEECCCCCCCCceeeeechh----hhhhHHHHHHHHHHHHcCCCCcccccccceeeec-
Q 039291 4 DGTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAE----VSASASLQKEKEVFDNLNGCPFVLECFGEEITMG- 78 (362)
Q Consensus 4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~----~~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~- 78 (362)
..++|.+++.||+|+||+||+|.++.++. .|++|... ......+.+|+.++++++ ||||+++++++....
T Consensus 12 ~~grY~i~~~LG~G~fG~Vyla~~~~tg~----~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~-HpnIV~l~~v~~~~~~ 86 (676)
T 3qa8_A 12 TCGPWEMKERLGTGGFGYVLRWIHQDTGE----QVAIKQCRQELSPKNRERWCLEIQIMKKLN-HPNVVSAREVPDGLQK 86 (676)
T ss_dssp -----CCCCCCCBCSSSBCCCCCCTTTTC----CEEECCCCSCCCHHHHHHHHHHHHHHHHCC-BTTBCCEEECCTTTCC
T ss_pred CCCCeEEEEEEeeCCCeEEEEEEECCCCc----EEEEEEecccCCHHHHHHHHHHHHHHHhCC-CCCCCceeeeeccccc
Confidence 45899999999999999999999988775 45666543 345567889999999998 999999988654311
Q ss_pred CCCceEEEEEEEecCCCCHHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEE
Q 039291 79 ENGEMAYNLLLEYAAGGTLGDLIEKCNG-NGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKI 157 (362)
Q Consensus 79 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl 157 (362)
......+++||||++||+|.+++..... ..+++..++.++.|++.||.|||+.||+||||||+||++..+ +....+||
T Consensus 87 ~~~~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~-g~~~~vKL 165 (676)
T 3qa8_A 87 LAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPG-PQRLIHKI 165 (676)
T ss_dssp CCTTSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECC-SSSCEEEE
T ss_pred ccCCCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecC-CCceeEEE
Confidence 1123446799999999999999987432 359999999999999999999999999999999999999543 23456999
Q ss_pred eecCCcccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHH--------
Q 039291 158 ADLGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQL-------- 229 (362)
Q Consensus 158 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~-------- 229 (362)
+|||++....... ......||+.|+|||++.+..++.++|||||||++|+|++|..||..... ....
T Consensus 166 ~DFG~a~~~~~~~---~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~--~~~~~~~i~~~~ 240 (676)
T 3qa8_A 166 IDLGYAKELDQGE---LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQ--PVQWHGKVREKS 240 (676)
T ss_dssp CSCCCCCBTTSCC---CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCH--HHHSSTTCC---
T ss_pred ccccccccccccc---ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccc--hhhhhhhhhccc
Confidence 9999997654322 22456899999999999999999999999999999999999999964311 0000
Q ss_pred HHH-H-----cCC-------CCCCCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCccCcchhhhh
Q 039291 230 FSI-I-----GDE-------HSLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGVDEELSR 286 (362)
Q Consensus 230 ~~~-~-----~~~-------~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~~~~~~~~~~ 286 (362)
... . ... .....+...++..+.+||.+||..||++|||+.+++.||||+.+..-+..
T Consensus 241 ~~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~iL~~ 310 (676)
T 3qa8_A 241 NEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSILSL 310 (676)
T ss_dssp ---CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHHHCC
T ss_pred chhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHHHhc
Confidence 000 0 000 01112334577899999999999999999999999999999887655543
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-44 Score=329.46 Aligned_cols=261 Identities=20% Similarity=0.302 Sum_probs=203.6
Q ss_pred CCCCceeecceecccCceEEEEEEECCCCCCCCceeeeechhh---hhhHHHHHHHHHHHHcCCCCcccccccceeeecC
Q 039291 3 SDGTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEV---SASASLQKEKEVFDNLNGCPFVLECFGEEITMGE 79 (362)
Q Consensus 3 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~---~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~ 79 (362)
...++|.+++.||+|+||.||+|++...+......|++|.... ...+.+.+|+.++++++ ||||+++++++...
T Consensus 38 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~-- 114 (326)
T 2w1i_A 38 FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQ-HDNIVKYKGVCYSA-- 114 (326)
T ss_dssp CCGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCC-CTTBCCEEEEECC---
T ss_pred cCHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCC-CCCeeeEEEEEEec--
Confidence 4567899999999999999999996432222335678887643 34457889999999998 99999999866432
Q ss_pred CCceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEee
Q 039291 80 NGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIAD 159 (362)
Q Consensus 80 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~D 159 (362)
....+++||||+++++|.+++... ...+++..++.++.||+.||.|||++||+||||||+||++ +.++.+||+|
T Consensus 115 -~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli----~~~~~~kL~D 188 (326)
T 2w1i_A 115 -GRRNLKLIMEYLPYGSLRDYLQKH-KERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILV----ENENRVKIGD 188 (326)
T ss_dssp ----CCEEEECCCTTCBHHHHHHHS-TTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE----EETTEEEECC
T ss_pred -CCCceEEEEECCCCCCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEE----cCCCcEEEec
Confidence 223467999999999999999873 3459999999999999999999999999999999999999 5667899999
Q ss_pred cCCcccccccccC-CCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHhCCCCCccCC---------CCC----
Q 039291 160 LGVAKRSRHCKRQ-KFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKE---------DCS---- 225 (362)
Q Consensus 160 fgla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~---------~~~---- 225 (362)
||++......... .......++..|+|||++.+..++.++|||||||++|+|++|..||.... ...
T Consensus 189 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~ 268 (326)
T 2w1i_A 189 FGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMI 268 (326)
T ss_dssp CTTCEECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHH
T ss_pred CcchhhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhh
Confidence 9999865543221 11234457788999999998889999999999999999999999885321 000
Q ss_pred HHHHHHHHcCCCCCCCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhc
Q 039291 226 IDQLFSIIGDEHSLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLD 273 (362)
Q Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~ 273 (362)
...+...+..... +..+..++.++.++|.+||..||++|||+.++++
T Consensus 269 ~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~ 315 (326)
T 2w1i_A 269 VFHLIELLKNNGR-LPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 315 (326)
T ss_dssp HHHHHHHHHTTCC-CCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HHHHHHHhhcCCC-CCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 1122233333332 3356779999999999999999999999999986
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-44 Score=326.74 Aligned_cols=240 Identities=22% Similarity=0.368 Sum_probs=188.2
Q ss_pred Cceeec-ceecccCceEEEEEEECCCCCCCCceeeeechhhhhhHHHHHHHHHHHHcCCCCcccccccceeeecCCCceE
Q 039291 6 TSWFRG-RVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVSASASLQKEKEVFDNLNGCPFVLECFGEEITMGENGEMA 84 (362)
Q Consensus 6 ~~y~~~-~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~~~~~ 84 (362)
++|.+. +.||+|+||.||+|.++.+++ .|++|.... ...+.+|+.++.++..||||+++++++.... .....
T Consensus 17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~~----~vaiK~~~~--~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~-~~~~~ 89 (299)
T 3m2w_A 17 DDYKVTSQVLGLGINGKVLQIFNKRTQE----KFALKMLQD--CPKARREVELHWRASQCPHIVRIVDVYENLY-AGRKC 89 (299)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCC----EEEEEEEEC--SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEE-TTEEE
T ss_pred cchhhcCcccccCCCeEEEEEEEcCCCc----EEEEEEecc--cHHHHHHHHHHHHhccCCCchhHHhhhhhhc-CCCce
Confidence 567776 889999999999999988775 678877643 3457789999977767999999999775433 23456
Q ss_pred EEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEeecCCcc
Q 039291 85 YNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAK 164 (362)
Q Consensus 85 ~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Dfgla~ 164 (362)
+++||||++|++|.+++.......+++..++.++.||+.||.|||++||+||||||+||++... ..++.+||+|||++.
T Consensus 90 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~-~~~~~~kl~Dfg~a~ 168 (299)
T 3m2w_A 90 LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSK-RPNAILKLTDFGFAK 168 (299)
T ss_dssp EEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSS-STTCCEEECCCTTCE
T ss_pred EEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecC-CCCCcEEEecccccc
Confidence 7899999999999999988655679999999999999999999999999999999999999321 116789999999985
Q ss_pred cccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHHcCCC--CCCCC
Q 039291 165 RSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEH--SLPEI 242 (362)
Q Consensus 165 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~--~~~~~ 242 (362)
... +..++.++|||||||++|+|++|..||........ ........ .....
T Consensus 169 ~~~------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~---~~~~~~~~~~~~~~~ 221 (299)
T 3m2w_A 169 ETT------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI---SPGMKTRIRMGQYEF 221 (299)
T ss_dssp ECT------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC----------CCSCCSSCTTCCSS
T ss_pred ccc------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhh---hHHHHHHHhhccccC
Confidence 332 23467789999999999999999999965432111 00000010 01112
Q ss_pred C----ccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCccCc
Q 039291 243 P----SRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGV 280 (362)
Q Consensus 243 ~----~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~~~~ 280 (362)
+ ..++.++++||.+||..||++|||+.++++||||+..
T Consensus 222 ~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~ 263 (299)
T 3m2w_A 222 PNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 263 (299)
T ss_dssp CHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTG
T ss_pred CchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhccc
Confidence 2 4589999999999999999999999999999999764
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-44 Score=325.79 Aligned_cols=251 Identities=23% Similarity=0.338 Sum_probs=197.3
Q ss_pred CceeecceecccCceEEEEEEECCCCCCCCceeeeechh-------hhhhHHHHHHHHHHHHcCCCCcccccccceeeec
Q 039291 6 TSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAE-------VSASASLQKEKEVFDNLNGCPFVLECFGEEITMG 78 (362)
Q Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~-------~~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~ 78 (362)
..|..++.||+|+||+||+|++. +. .+++|... ......+.+|+.+++.++ ||||+++++++..
T Consensus 31 ~~~~~~~~lg~G~~g~Vy~~~~~--~~----~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~-- 101 (307)
T 2nru_A 31 PISVGGNKMGEGGFGVVYKGYVN--NT----TVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQ-HENLVELLGFSSD-- 101 (307)
T ss_dssp BTTTTCCEEEECSSEEEEEEESS--SC----EEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCC-CTTBCCEEEEECS--
T ss_pred cccccCCccccCCCeEEEEEEEC--Cc----eEEEEEEecccCcchHHHHHHHHHHHHHHHhcC-CCCeEEEEEEEec--
Confidence 34556799999999999999864 22 46666543 223567889999999998 9999999987642
Q ss_pred CCCceEEEEEEEecCCCCHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEE
Q 039291 79 ENGEMAYNLLLEYAAGGTLGDLIEKCN-GNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKI 157 (362)
Q Consensus 79 ~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl 157 (362)
...+++||||+++++|.+++.... ..++++..++.++.|++.||.|||++||+||||||+||++ +.++.+||
T Consensus 102 ---~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili----~~~~~~kl 174 (307)
T 2nru_A 102 ---GDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILL----DEAFTAKI 174 (307)
T ss_dssp ---SSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE----CTTCCEEE
T ss_pred ---CCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEE----cCCCcEEE
Confidence 223679999999999999997543 3469999999999999999999999999999999999999 77889999
Q ss_pred eecCCcccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCH-HHHHHHHcC-
Q 039291 158 ADLGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSI-DQLFSIIGD- 235 (362)
Q Consensus 158 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~-~~~~~~~~~- 235 (362)
+|||++................||+.|+|||++.+ .++.++||||||+++|+|++|..||........ ..+...+..
T Consensus 175 ~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~ 253 (307)
T 2nru_A 175 SDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDE 253 (307)
T ss_dssp CCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTT
T ss_pred eecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhh
Confidence 99999976554333323345679999999998875 478999999999999999999999976543221 122222111
Q ss_pred --------CCCCCCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhc
Q 039291 236 --------EHSLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLD 273 (362)
Q Consensus 236 --------~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~ 273 (362)
....+..+...+..+.+++.+||..||.+|||+.++++
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~ 299 (307)
T 2nru_A 254 EKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQ 299 (307)
T ss_dssp SCCHHHHSCSSCSCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred hhhhhhhccccccccchHHHHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 11223344556788999999999999999999999986
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-44 Score=330.26 Aligned_cols=255 Identities=23% Similarity=0.328 Sum_probs=205.3
Q ss_pred CceeecceecccCceEEEEEEECCCCCCCCceeeeechhhhhhHHHHHHHHHHHHc-CCCCcccccccceeeecCCCceE
Q 039291 6 TSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVSASASLQKEKEVFDNL-NGCPFVLECFGEEITMGENGEMA 84 (362)
Q Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~~~~~~~~~E~~il~~l-~~h~~i~~~~~~~~~~~~~~~~~ 84 (362)
++|.+++.||+|+||+||+|++. + ..|++|.........+.+|.+++..+ -.||||+++++.+..... ....
T Consensus 42 ~~y~~~~~lg~G~~g~Vy~~~~~--~----~~vavK~~~~~~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~-~~~~ 114 (342)
T 1b6c_B 42 RTIVLQESIGKGRFGEVWRGKWR--G----EEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNG-TWTQ 114 (342)
T ss_dssp HHCEEEEEEEEETTEEEEEEEET--T----EEEEEEEECGGGHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCS-SCCC
T ss_pred ccEEEEeeecCCCCcEEEEEEEc--C----ccEEEEEeCchhHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCC-ccce
Confidence 58999999999999999999984 2 36899988777777888999999984 249999999987654321 1225
Q ss_pred EEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH--------hCCceeCCCCCCCEEEeecCCCceEEE
Q 039291 85 YNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIH--------DSGYVHCDVKPDNILLVATQSGKFVAK 156 (362)
Q Consensus 85 ~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH--------~~~ivH~Dlkp~Nill~~~~~~~~~~k 156 (362)
+++||||+++|+|.+++.. .++++..++.++.|++.||.||| +.||+||||||+|||+ +.++.+|
T Consensus 115 ~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll----~~~~~~k 187 (342)
T 1b6c_B 115 LWLVSDYHEHGSLFDYLNR---YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILV----KKNGTCC 187 (342)
T ss_dssp EEEEECCCTTCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEE----CTTSCEE
T ss_pred eEEEEeecCCCcHHHHHhc---cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEE----CCCCCEE
Confidence 7799999999999999976 35999999999999999999999 8999999999999999 7778899
Q ss_pred EeecCCcccccccccC--CCCCCccCCCCccCchhhcccc------CCCcchHHHHHHHHHHHHhC----------CCCC
Q 039291 157 IADLGVAKRSRHCKRQ--KFDPSMRGTPLYLAPETVVQHM------QEAPSDIWALGCVVLEMLSG----------RQAW 218 (362)
Q Consensus 157 l~Dfgla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~------~~~~~DiwslG~il~~l~~g----------~~pf 218 (362)
|+|||++......... .......||+.|+|||++.+.. ++.++|||||||++|+|++| ..||
T Consensus 188 L~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~ 267 (342)
T 1b6c_B 188 IADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPY 267 (342)
T ss_dssp ECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTT
T ss_pred EEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCc
Confidence 9999999765443211 0224567999999999998652 33689999999999999999 7888
Q ss_pred ccCC--CCCHHHHHHHHcCCCCCCCCCc-----cCCHHHHHHHHHHhccCCCCCCCHHHHhcC
Q 039291 219 VVKE--DCSIDQLFSIIGDEHSLPEIPS-----RVSKEARDFLRRCFVRKPAFRFTAEMLLDD 274 (362)
Q Consensus 219 ~~~~--~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~li~~~l~~~p~~R~s~~~~l~~ 274 (362)
.... ......+...+......+.++. .++..+.+||.+||..||++|||+.+++++
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~ 330 (342)
T 1b6c_B 268 YDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 330 (342)
T ss_dssp TTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHH
T ss_pred cccCcCcccHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHH
Confidence 6542 2345555555555554455543 344689999999999999999999999874
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-44 Score=353.81 Aligned_cols=250 Identities=20% Similarity=0.336 Sum_probs=197.7
Q ss_pred Cceeecc-eecccCceEEEEEEECCCCCCCCceeeeechhh----hhhHHHHHHHHHHHHcCCCCcccccccceeeecCC
Q 039291 6 TSWFRGR-VIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEV----SASASLQKEKEVFDNLNGCPFVLECFGEEITMGEN 80 (362)
Q Consensus 6 ~~y~~~~-~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~----~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~ 80 (362)
+++.+.+ .||+|+||+||+|.++..+. ...||+|.... ...+.+.+|+++|++++ ||||+++++++..
T Consensus 335 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~--~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~-hpniv~l~~~~~~---- 407 (613)
T 2ozo_A 335 DNLLIADIELGCGNFGSVRQGVYRMRKK--QIDVAIKVLKQGTEKADTEEMMREAQIMHQLD-NPYIVRLIGVCQA---- 407 (613)
T ss_dssp TSEEEEEEEEEECSSSEEEEEEEECSSC--EEEEEEEECCCCCSSTTHHHHHHHHHHHTTCC-CTTBCCEEEEEES----
T ss_pred cceeEcCcEEecCCCcEEEEEEEecCCC--cEEEEEEEcCCCCChHHHHHHHHHHHHHHhCC-CCCEeeEEEEecc----
Confidence 3445554 89999999999998864432 13577777643 34567899999999998 9999999997642
Q ss_pred CceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEeec
Q 039291 81 GEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADL 160 (362)
Q Consensus 81 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Df 160 (362)
..+++||||+.+|+|.+++... ...+++..+..++.||+.||+|||++||+||||||+|||+ +.++.+||+||
T Consensus 408 --~~~~lv~E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl----~~~~~vkL~DF 480 (613)
T 2ozo_A 408 --EALMLVMEMAGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLL----VNRHYAKISDF 480 (613)
T ss_dssp --SSEEEEEECCTTCBHHHHHTTC-TTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE----EETTEEEECCC
T ss_pred --CCeEEEEEeCCCCcHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEE----cCCCcEEEeec
Confidence 1267999999999999999753 4569999999999999999999999999999999999999 66678999999
Q ss_pred CCcccccccccC-CCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHh-CCCCCccCCCCCHHHHHHHHcCCCC
Q 039291 161 GVAKRSRHCKRQ-KFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLS-GRQAWVVKEDCSIDQLFSIIGDEHS 238 (362)
Q Consensus 161 gla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~ 238 (362)
|+++........ .......+|+.|+|||++.+..++.++|||||||+||||++ |+.||..... .++...+.....
T Consensus 481 Gla~~~~~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~---~~~~~~i~~~~~ 557 (613)
T 2ozo_A 481 GLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG---PEVMAFIEQGKR 557 (613)
T ss_dssp STTTTCC--------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCS---HHHHHHHHTTCC
T ss_pred cCcccccCCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCH---HHHHHHHHcCCC
Confidence 999865432211 11123346789999999998899999999999999999998 9999965433 344455544443
Q ss_pred CCCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhc
Q 039291 239 LPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLD 273 (362)
Q Consensus 239 ~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~ 273 (362)
...+..++.++.+||.+||..||++||++.++++
T Consensus 558 -~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~ 591 (613)
T 2ozo_A 558 -MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQ 591 (613)
T ss_dssp -CCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHH
T ss_pred -CCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 3456789999999999999999999999999875
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=351.99 Aligned_cols=243 Identities=21% Similarity=0.344 Sum_probs=194.5
Q ss_pred ceecccCceEEEEEEECCCCCCCCceeeeechhhh-----hhHHHHHHHHHHHHcCCCCcccccccceeeecCCCceEEE
Q 039291 12 RVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVS-----ASASLQKEKEVFDNLNGCPFVLECFGEEITMGENGEMAYN 86 (362)
Q Consensus 12 ~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~~-----~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~~~~~~~ 86 (362)
+.||+|+||+||+|.+..... ...||+|..... ..+.+.+|+.+|++|+ ||||+++++++. . . .++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~----~-~-~~~ 445 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKV--VKTVAVKILKNEANDPALKDELLAEANVMQQLD-NPYIVRMIGICE----A-E-SWM 445 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSC--EEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCC-CTTBCCEEEEEE----S-S-SEE
T ss_pred CEeccCCCEEEEEEEEcCCCc--ceEEEEEEeccccCCHHHHHHHHHHHHHHHhCC-CCCEeeEEEEEe----c-C-CEE
Confidence 579999999999996643221 246777776432 3467899999999998 999999999663 1 1 267
Q ss_pred EEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEeecCCcccc
Q 039291 87 LLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRS 166 (362)
Q Consensus 87 lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Dfgla~~~ 166 (362)
+||||+++|+|.+++.. ...+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++..
T Consensus 446 lv~E~~~~g~L~~~l~~--~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl----~~~~~~kL~DFGla~~~ 519 (635)
T 4fl3_A 446 LVMEMAELGPLNKYLQQ--NRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLL----VTQHYAKISDFGLSKAL 519 (635)
T ss_dssp EEEECCTTEEHHHHHHH--CTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE----EETTEEEECCTTHHHHT
T ss_pred EEEEccCCCCHHHHHhh--CCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEE----eCCCCEEEEEcCCcccc
Confidence 99999999999999976 4569999999999999999999999999999999999999 66678999999999865
Q ss_pred cccccC-CCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHh-CCCCCccCCCCCHHHHHHHHcCCCCCCCCCc
Q 039291 167 RHCKRQ-KFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLS-GRQAWVVKEDCSIDQLFSIIGDEHSLPEIPS 244 (362)
Q Consensus 167 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (362)
...... .......+|+.|+|||++.+..++.++|||||||++|||++ |+.||.+. ...+....+..... +..+.
T Consensus 520 ~~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~---~~~~~~~~i~~~~~-~~~p~ 595 (635)
T 4fl3_A 520 RADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGM---KGSEVTAMLEKGER-MGCPA 595 (635)
T ss_dssp TC-------------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTC---CHHHHHHHHHTTCC-CCCCT
T ss_pred ccCccccccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC---CHHHHHHHHHcCCC-CCCCC
Confidence 432221 11223457788999999999899999999999999999998 99999654 34455555544443 34677
Q ss_pred cCCHHHHHHHHHHhccCCCCCCCHHHHhc
Q 039291 245 RVSKEARDFLRRCFVRKPAFRFTAEMLLD 273 (362)
Q Consensus 245 ~~~~~~~~li~~~l~~~p~~R~s~~~~l~ 273 (362)
.++.++.+||.+||..||++||+++++++
T Consensus 596 ~~~~~l~~li~~cl~~dP~~RPs~~~l~~ 624 (635)
T 4fl3_A 596 GCPREMYDLMNLCWTYDVENRPGFAAVEL 624 (635)
T ss_dssp TCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred CCCHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 89999999999999999999999999875
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-45 Score=344.92 Aligned_cols=258 Identities=16% Similarity=0.137 Sum_probs=194.5
Q ss_pred CCceeecceecccCceEEEEEEECCCCCCCCceeeeechh------hhhhHHHHHHHHHHHHcCCCCcccccccc-----
Q 039291 5 GTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAE------VSASASLQKEKEVFDNLNGCPFVLECFGE----- 73 (362)
Q Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~------~~~~~~~~~E~~il~~l~~h~~i~~~~~~----- 73 (362)
...|..++.||+|+||+||+|++..+++ .||+|... ....+.+.+|+.+++.+.++++.......
T Consensus 77 ~~~~~~~~~LG~G~fG~Vy~a~~~~~g~----~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~ 152 (413)
T 3dzo_A 77 PRTLVRGTVLGQEDPYAYLEATDQETGE----SFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIF 152 (413)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEETTTCC----EEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCC
T ss_pred ceeEEEecccccCCCEEEEEEEecCCCC----ceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhccccc
Confidence 3458889999999999999999998876 56777654 12356788999999999854433221111
Q ss_pred ----e------------eeecCCCceEEEEEEEecCCCCHHHHHHHh-----cCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 039291 74 ----E------------ITMGENGEMAYNLLLEYAAGGTLGDLIEKC-----NGNGLPEKDVRHFTRCILEGIGHIHDSG 132 (362)
Q Consensus 74 ----~------------~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-----~~~~l~~~~~~~i~~ql~~~l~yLH~~~ 132 (362)
. ..........++++|+++ +++|.++++.. ....+++..+..++.||+.||+|||++|
T Consensus 153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ 231 (413)
T 3dzo_A 153 PFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG 231 (413)
T ss_dssp CCEEEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred chhhcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 0 000000012356777776 57999999632 2344788899999999999999999999
Q ss_pred ceeCCCCCCCEEEeecCCCceEEEEeecCCcccccccccCCCCCCccCCCCccCchhh----------ccccCCCcchHH
Q 039291 133 YVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMRGTPLYLAPETV----------VQHMQEAPSDIW 202 (362)
Q Consensus 133 ivH~Dlkp~Nill~~~~~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~~~~~Diw 202 (362)
|+||||||+|||+ +.++.+||+|||+++..... ....+| +.|+|||++ .+..++.++|||
T Consensus 232 iiHrDiKp~NILl----~~~~~~kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~Dvw 301 (413)
T 3dzo_A 232 LVHTYLRPVDIVL----DQRGGVFLTGFEHLVRDGAS-----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTW 301 (413)
T ss_dssp EECSCCCGGGEEE----CTTCCEEECCGGGCEETTEE-----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHH
T ss_pred cccCCcccceEEE----ecCCeEEEEeccceeecCCc-----cccCCC-CceeCchhhhccccccccccCcCCCchhhHH
Confidence 9999999999999 77888999999998765442 234567 999999999 555688899999
Q ss_pred HHHHHHHHHHhCCCCCccCCCCCHHHHHHHHcCCCCCCCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCccCcch
Q 039291 203 ALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEHSLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGVDE 282 (362)
Q Consensus 203 slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~~~~~~ 282 (362)
||||++|+|++|+.||........ ...+ + .....++.++++||.+||..||++||++.++++||||+.+.+
T Consensus 302 SlGvil~elltg~~Pf~~~~~~~~---~~~~-----~-~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~~~~~~~~~~ 372 (413)
T 3dzo_A 302 TLGLAIYWIWCADLPNTDDAALGG---SEWI-----F-RSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQLRT 372 (413)
T ss_dssp HHHHHHHHHHHSSCCCCTTGGGSC---SGGG-----G-SSCCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHHHH
T ss_pred HHHHHHHHHHHCCCCCCCcchhhh---HHHH-----H-hhcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHHHHHH
Confidence 999999999999999965432211 1111 1 112357899999999999999999999999999999998876
Q ss_pred hhhh
Q 039291 283 ELSR 286 (362)
Q Consensus 283 ~~~~ 286 (362)
.+..
T Consensus 373 ~~~~ 376 (413)
T 3dzo_A 373 ELSA 376 (413)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 6543
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=352.63 Aligned_cols=253 Identities=17% Similarity=0.278 Sum_probs=202.9
Q ss_pred CCCCceeecceecccCceEEEEEEECCCCCCCCceeeeechhh----hhhHHHHHHHHHHHHcCCCCcccccccceeeec
Q 039291 3 SDGTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEV----SASASLQKEKEVFDNLNGCPFVLECFGEEITMG 78 (362)
Q Consensus 3 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~----~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~ 78 (362)
+..++|.+++.||+|+||+||+|++..++.. ...+++|.... .....+.+|+.++++++ ||||+++++++.
T Consensus 387 i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~--- 461 (656)
T 2j0j_A 387 IQRERIELGRCIGEGQFGDVHQGIYMSPENP-AMAVAIKTCKNCTSDSVREKFLQEALTMRQFD-HPHIVKLIGVIT--- 461 (656)
T ss_dssp CCGGGEEEEEEEECCSSCCEEEEEECCSSSC-CEEEEEEECSSTTCHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEC---
T ss_pred cccccEEEeeEEeeCCCEEEEEEEEecCCCc-cEEEEEEEecccCCHHHHHHHHHHHHHHHhCC-CCCCCeEEEEEe---
Confidence 3457899999999999999999998765432 34677776543 23467889999999998 999999998652
Q ss_pred CCCceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEe
Q 039291 79 ENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIA 158 (362)
Q Consensus 79 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~ 158 (362)
+ ..+++||||+++|+|.++++.. ...+++..++.++.|++.||.|||++||+||||||+|||+ +.++.+||+
T Consensus 462 -~--~~~~lv~E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl----~~~~~vkL~ 533 (656)
T 2j0j_A 462 -E--NPVWIIMELCTLGELRSFLQVR-KFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLV----SSNDCVKLG 533 (656)
T ss_dssp -S--SSCEEEEECCTTCBHHHHHHHT-TTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE----EETTEEEEC
T ss_pred -c--CceEEEEEcCCCCcHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEE----eCCCCEEEE
Confidence 1 1257999999999999999863 3469999999999999999999999999999999999999 666789999
Q ss_pred ecCCcccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHh-CCCCCccCCCCCHHHHHHHHcCCC
Q 039291 159 DLGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLS-GRQAWVVKEDCSIDQLFSIIGDEH 237 (362)
Q Consensus 159 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~ 237 (362)
|||+++........ ......+|+.|+|||++.+..++.++|||||||++|||++ |..||.+. ...+....+....
T Consensus 534 DFG~a~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~---~~~~~~~~i~~~~ 609 (656)
T 2j0j_A 534 DFGLSRYMEDSTYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGV---KNNDVIGRIENGE 609 (656)
T ss_dssp CCCCCCSCCC-----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC---CHHHHHHHHHHTC
T ss_pred ecCCCeecCCCcce-eccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCC---CHHHHHHHHHcCC
Confidence 99999865432211 1234457789999999998899999999999999999997 99999654 3444444443333
Q ss_pred CCCCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhc
Q 039291 238 SLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLD 273 (362)
Q Consensus 238 ~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~ 273 (362)
. +..+..+++++.+||.+||..||++|||+.++++
T Consensus 610 ~-~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~ 644 (656)
T 2j0j_A 610 R-LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKA 644 (656)
T ss_dssp C-CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred C-CCCCccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 2 3456789999999999999999999999999986
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-44 Score=327.82 Aligned_cols=250 Identities=21% Similarity=0.285 Sum_probs=196.8
Q ss_pred CCCCCceeecceecccCceEEEEEEECCCCCCCCceeeeechhh-----hhhHHHHHHHHHHHHcCCCCcccccccceee
Q 039291 2 DSDGTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEV-----SASASLQKEKEVFDNLNGCPFVLECFGEEIT 76 (362)
Q Consensus 2 ~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~-----~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~ 76 (362)
++..++|.+++.||+|+||.||+|+++.. +++|.... ...+.+.+|+.++++++ ||||+++++++..
T Consensus 29 ~i~~~~~~~~~~lg~G~~g~V~~~~~~~~-------~avk~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~ 100 (319)
T 2y4i_B 29 DIPFEQLEIGELIGKGRFGQVYHGRWHGE-------VAIRLIDIERDNEDQLKAFKREVMAYRQTR-HENVVLFMGACMS 100 (319)
T ss_dssp SSCCSCEECCCBCCCSSSSEEEEEEESSS-------EEEEECCCCSCCCCCCCCCCTTGGGGTTCC-CTTBCCCCEEEEC
T ss_pred cCCHHHeEEeeEeccCCceEEEEEEEcCe-------EEEEEeecCCCCHHHHHHHHHHHHHHhcCC-CCCEeEEEEEEec
Confidence 45678999999999999999999998652 45554432 23455778999999998 9999999997653
Q ss_pred ecCCCceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEE
Q 039291 77 MGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAK 156 (362)
Q Consensus 77 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~k 156 (362)
. ..+++||||++|++|.+++... +..+++..++.++.||+.||.|||++||+||||||+||++ + ++.+|
T Consensus 101 ~-----~~~~iv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~----~-~~~~~ 169 (319)
T 2y4i_B 101 P-----PHLAIITSLCKGRTLYSVVRDA-KIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFY----D-NGKVV 169 (319)
T ss_dssp S-----SCEEEECBCCCSEEHHHHTTSS-CCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEE----C---CCE
T ss_pred C-----CceEEEeecccCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEE----e-CCCEE
Confidence 2 2367999999999999999763 3469999999999999999999999999999999999999 4 45799
Q ss_pred EeecCCcccccccc---cCCCCCCccCCCCccCchhhcc---------ccCCCcchHHHHHHHHHHHHhCCCCCccCCCC
Q 039291 157 IADLGVAKRSRHCK---RQKFDPSMRGTPLYLAPETVVQ---------HMQEAPSDIWALGCVVLEMLSGRQAWVVKEDC 224 (362)
Q Consensus 157 l~Dfgla~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~---------~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~ 224 (362)
|+|||++....... .........||+.|+|||++.+ ..++.++|||||||++|+|++|..||...
T Consensus 170 l~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~--- 246 (319)
T 2y4i_B 170 ITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQ--- 246 (319)
T ss_dssp ECCCSCCC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSC---
T ss_pred EeecCCccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCC---
Confidence 99999987543211 1122234568999999999975 34688999999999999999999999543
Q ss_pred CHHHHHHHHcCCCCCCCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhc
Q 039291 225 SIDQLFSIIGDEHSLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLD 273 (362)
Q Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~ 273 (362)
........+.........+..++.++.++|.+||..||++|||+.++++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~ 295 (319)
T 2y4i_B 247 PAEAIIWQMGTGMKPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMD 295 (319)
T ss_dssp CHHHHHHHHHTTCCCCCCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHH
T ss_pred CHHHHHHHhccCCCCCCCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 4455555554444433334468899999999999999999999999987
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-44 Score=331.37 Aligned_cols=250 Identities=14% Similarity=0.111 Sum_probs=185.5
Q ss_pred CCceeecceecccCceEEEEEEECCCCCCCCceeeeechhhh-----------hhHHHHHHHHHHHHcC--------CCC
Q 039291 5 GTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVS-----------ASASLQKEKEVFDNLN--------GCP 65 (362)
Q Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~~-----------~~~~~~~E~~il~~l~--------~h~ 65 (362)
.++|.+++.||+|+||+||+|+++ + ..||+|.+... ..+.+.+|+.+++.|+ .||
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~--~----~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~ 92 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIAD--H----TPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTE 92 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEET--T----EEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCC
T ss_pred cccchheeeecccCceEEEEEEeC--C----ceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCC
Confidence 468999999999999999999983 3 35677765433 2267889999999886 355
Q ss_pred cccccccceeeec-------------------------CCCceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHH
Q 039291 66 FVLECFGEEITMG-------------------------ENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRC 120 (362)
Q Consensus 66 ~i~~~~~~~~~~~-------------------------~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~q 120 (362)
||+++.++....+ ......+|+||||+++|++.+.+.. ..+++..++.++.|
T Consensus 93 niv~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~---~~~~~~~~~~i~~q 169 (336)
T 2vuw_A 93 GFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT---KLSSLATAKSILHQ 169 (336)
T ss_dssp CBCCEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT---TCCCHHHHHHHHHH
T ss_pred chhhhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh---cCCCHHHHHHHHHH
Confidence 5555544332110 0013457899999999977666643 45899999999999
Q ss_pred HHHHHHHHH-hCCceeCCCCCCCEEEeecCC----------------CceEEEEeecCCcccccccccCCCCCCccCCCC
Q 039291 121 ILEGIGHIH-DSGYVHCDVKPDNILLVATQS----------------GKFVAKIADLGVAKRSRHCKRQKFDPSMRGTPL 183 (362)
Q Consensus 121 l~~~l~yLH-~~~ivH~Dlkp~Nill~~~~~----------------~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~ 183 (362)
|+.||+||| ++||+||||||+|||+..++. ....+||+|||+|+.... ...+||+.
T Consensus 170 i~~aL~~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~-------~~~~gt~~ 242 (336)
T 2vuw_A 170 LTASLAVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD-------GIVVFCDV 242 (336)
T ss_dssp HHHHHHHHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET-------TEEECCCC
T ss_pred HHHHHHHHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC-------CcEEEeec
Confidence 999999999 999999999999999965321 123899999999986553 24579999
Q ss_pred ccCchhhccccCCCcchHHHHHHH-HHHHHhCCCCCccCCCCCHHHHHHHHc----CC-CCCCCCCccCCHHHHHHHHHH
Q 039291 184 YLAPETVVQHMQEAPSDIWALGCV-VLEMLSGRQAWVVKEDCSIDQLFSIIG----DE-HSLPEIPSRVSKEARDFLRRC 257 (362)
Q Consensus 184 y~aPE~~~~~~~~~~~DiwslG~i-l~~l~~g~~pf~~~~~~~~~~~~~~~~----~~-~~~~~~~~~~~~~~~~li~~~ 257 (362)
|+|||++.+.. +.++||||+|++ .++++.|..||..... ...+...+. .. ...+..+..+++++++||++|
T Consensus 243 y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~ 319 (336)
T 2vuw_A 243 SMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVLW--LHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTM 319 (336)
T ss_dssp TTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHH--HHHHHHHHHHTCCCSSCCCSHHHHHHHHHHHHHHHHG
T ss_pred ccChhhhcCCC-ccceehhhhhCCCCcccccccCCCcchhh--hhHHHHhhhhhhccCcccchhhhhhcCHHHHHHHHHH
Confidence 99999998766 889999998777 7778889999843100 011222211 11 111122345789999999999
Q ss_pred hccCCCCCCCHHHHh-cCCCcc
Q 039291 258 FVRKPAFRFTAEMLL-DDPFVK 278 (362)
Q Consensus 258 l~~~p~~R~s~~~~l-~~p~~~ 278 (362)
|+.| |+++++ +||||+
T Consensus 320 L~~d-----sa~e~l~~Hp~f~ 336 (336)
T 2vuw_A 320 LNFS-----SATDLLCQHSLFK 336 (336)
T ss_dssp GGSS-----SHHHHHHHCGGGC
T ss_pred hccC-----CHHHHHhcCCCcC
Confidence 9977 999999 999995
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-43 Score=349.83 Aligned_cols=244 Identities=21% Similarity=0.301 Sum_probs=195.7
Q ss_pred CCceeecceecccCceEEEEEEECC-CCCCCCceeeeechhh----hhhHHHHHHHHHHHHcCCCCcccccccceeeecC
Q 039291 5 GTSWFRGRVIGQGSFGCVFIAKPKS-NSSFLPPLMAVKSAEV----SASASLQKEKEVFDNLNGCPFVLECFGEEITMGE 79 (362)
Q Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~-~~~~~~~~~~~K~~~~----~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~ 79 (362)
.++|.+++.||+|+||+||+|.++. ++. .|++|.... .....+.+|+.++++++ ||||+++++++.....
T Consensus 79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~----~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~~ 153 (681)
T 2pzi_A 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGR----PVVLKGLVHSGDAEAQAMAMAERQFLAEVV-HPSIVQIFNFVEHTDR 153 (681)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEEGGGTTE----EEEEEESCSSCCHHHHHHHHHHHGGGGGCC-CTTBCCEEEEEEEECT
T ss_pred CCceEEEEEEeeCCCeEEEEEEEcCCCCc----EEEEEEeCccCCHHHHHHHHHHHHHHHhcC-CCCcCeEeeeEeecCC
Confidence 4799999999999999999999975 443 567776532 34456789999999998 9999999998876554
Q ss_pred CCceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEee
Q 039291 80 NGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIAD 159 (362)
Q Consensus 80 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~D 159 (362)
.....+|+||||++|++|.+++.. .+++..++.++.||+.||.|||++||+||||||+|||+ +.+ .+||+|
T Consensus 154 ~~~~~~~lv~E~~~g~~L~~~~~~----~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll----~~~-~~kl~D 224 (681)
T 2pzi_A 154 HGDPVGYIVMEYVGGQSLKRSKGQ----KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIML----TEE-QLKLID 224 (681)
T ss_dssp TSCEEEEEEEECCCCEECC----C----CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE----CSS-CEEECC
T ss_pred CCCceeEEEEEeCCCCcHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEE----eCC-cEEEEe
Confidence 445556899999999999987753 59999999999999999999999999999999999999 443 699999
Q ss_pred cCCcccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHHcCCCCC
Q 039291 160 LGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEHSL 239 (362)
Q Consensus 160 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 239 (362)
||+++..... ....||+.|+|||++.+. ++.++|||||||++|+|++|.+||....... ...
T Consensus 225 FG~a~~~~~~------~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~g~~~~~~~~~~~-----------~~~ 286 (681)
T 2pzi_A 225 LGAVSRINSF------GYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTLDLPTRNGRYVDG-----------LPE 286 (681)
T ss_dssp CTTCEETTCC------SCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHSCCCEETTEECSS-----------CCT
T ss_pred cccchhcccC------CccCCCccccCHHHHcCC-CCCceehhhhHHHHHHHHhCCCCCccccccc-----------ccc
Confidence 9999765432 356799999999998765 4889999999999999999999886432110 000
Q ss_pred CCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCccCc
Q 039291 240 PEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGV 280 (362)
Q Consensus 240 ~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~~~~ 280 (362)
.......++.+.+||.+||..||++||+..+.+.|+|+...
T Consensus 287 ~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~ 327 (681)
T 2pzi_A 287 DDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVL 327 (681)
T ss_dssp TCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred cccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHH
Confidence 00112356889999999999999999999998888887544
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-41 Score=303.12 Aligned_cols=221 Identities=12% Similarity=0.051 Sum_probs=174.6
Q ss_pred CCceeecceecccCceEEEEEEECCCCCCCCceeeeechhhh------hhHHHHHHHHHHHHcCCCCcccccccceeeec
Q 039291 5 GTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVS------ASASLQKEKEVFDNLNGCPFVLECFGEEITMG 78 (362)
Q Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~~------~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~ 78 (362)
+++|.+.+.||+|+||.||+|++..+++ .|++|..... ....+.+|+.+++.++ ||||+++++++..
T Consensus 30 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~----~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-hp~iv~~~~~~~~-- 102 (286)
T 3uqc_A 30 NGRYRLLIFHGGVPPLQFWQALDTALDR----QVALTFVDPQGVLPDDVLQETLSRTLRLSRID-KPGVARVLDVVHT-- 102 (286)
T ss_dssp TTTEEEEEEEEBSTTCEEEEEEETTTTE----EEEEEESCTTCCSCHHHHHHHHHHHHHHHTCC-CTTBCCEEEEEEE--
T ss_pred cCcEEEEEEEcccCCeEEEEEEecCCCc----eEEEEEECcccccCHHHHHHHHHHHHHHhcCC-CCCcceeeEEEEE--
Confidence 5789999999999999999999988765 6777776433 2367889999999998 9999999997653
Q ss_pred CCCceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEe
Q 039291 79 ENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIA 158 (362)
Q Consensus 79 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~ 158 (362)
...+|+||||++|++|.++++. + ..+.++..++.||+.||+|||++||+||||||+|||+ +.++.+||+
T Consensus 103 ---~~~~~lv~e~~~g~~L~~~l~~---~-~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll----~~~g~~kl~ 171 (286)
T 3uqc_A 103 ---RAGGLVVAEWIRGGSLQEVADT---S-PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRV----SIDGDVVLA 171 (286)
T ss_dssp ---TTEEEEEEECCCEEEHHHHHTT---C-CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEE----ETTSCEEEC
T ss_pred ---CCcEEEEEEecCCCCHHHHHhc---C-CChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEE----cCCCCEEEE
Confidence 2347799999999999999954 2 4667889999999999999999999999999999999 667778887
Q ss_pred ecCCcccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHH-HHHHHcCCC
Q 039291 159 DLGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQ-LFSIIGDEH 237 (362)
Q Consensus 159 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~-~~~~~~~~~ 237 (362)
++| |++ .++.++|||||||++|+|++|+.||...+...... ....+....
T Consensus 172 ~~~----------------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~ 222 (286)
T 3uqc_A 172 YPA----------------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQP 222 (286)
T ss_dssp SCC----------------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCTTSCB
T ss_pred ecc----------------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHhccCC
Confidence 443 333 37889999999999999999999997654322110 000000000
Q ss_pred -CCCCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhc
Q 039291 238 -SLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLD 273 (362)
Q Consensus 238 -~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~ 273 (362)
.....+..++.++.++|.+||+.||++| |+.++++
T Consensus 223 ~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~ 258 (286)
T 3uqc_A 223 IEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLN 258 (286)
T ss_dssp CCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHH
T ss_pred CChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHH
Confidence 0012335689999999999999999999 9999987
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-35 Score=289.46 Aligned_cols=188 Identities=12% Similarity=0.108 Sum_probs=124.7
Q ss_pred ecccCceEEEEEEECCCCCCCCceeeeech---------hhhhhHHHHHHHHHHHHcCCCCcccccccceeeecCCCceE
Q 039291 14 IGQGSFGCVFIAKPKSNSSFLPPLMAVKSA---------EVSASASLQKEKEVFDNLNGCPFVLECFGEEITMGENGEMA 84 (362)
Q Consensus 14 lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~---------~~~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~~~~~ 84 (362)
++.|+.|.+..++..-.++.++.|+..|.. .....+.+.+|+++|+++.+|+||+++++++. + ...
T Consensus 242 ~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~e----d-~~~ 316 (569)
T 4azs_A 242 PYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGE----N-AQS 316 (569)
T ss_dssp -C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEE----C-SSE
T ss_pred cccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEE----E-CCE
Confidence 566777777666655555544444433321 11244568999999999988999999998764 2 334
Q ss_pred EEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEeecCCcc
Q 039291 85 YNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAK 164 (362)
Q Consensus 85 ~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Dfgla~ 164 (362)
+||||||++|++|.++|.. ++++++. .|+.||+.||+|||++|||||||||+|||+ +.++.+||+|||+|+
T Consensus 317 ~yLVMEyv~G~~L~d~i~~--~~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL----~~dg~vKL~DFGlAr 387 (569)
T 4azs_A 317 GWLVMEKLPGRLLSDMLAA--GEEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMV----DARQHARLIDFGSIV 387 (569)
T ss_dssp EEEEEECCCSEEHHHHHHT--TCCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEE----CTTSCEEECCCTTEE
T ss_pred EEEEEecCCCCcHHHHHHh--CCCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEE----CCCCCEEEeecccCe
Confidence 7799999999999999986 4567765 588999999999999999999999999999 778899999999998
Q ss_pred cccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHhCCCCC
Q 039291 165 RSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAW 218 (362)
Q Consensus 165 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf 218 (362)
...... ....+.+||+.|||||++.+. +..++|+||+|+++++|.++..++
T Consensus 388 ~~~~~~--~~~~t~vGTp~YmAPE~l~g~-~~~~~d~~s~g~~~~~l~~~~~~~ 438 (569)
T 4azs_A 388 TTPQDC--SWPTNLVQSFFVFVNELFAEN-KSWNGFWRSAPVHPFNLPQPWSNW 438 (569)
T ss_dssp SCC-----CCSHHHHHHHHHHHHHHC------------------CCCCTTHHHH
T ss_pred eCCCCC--ccccCceechhhccHHHhCCC-CCCcccccccccchhhhccccchh
Confidence 655422 223467899999999999764 667899999999998887665443
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=5.6e-30 Score=249.23 Aligned_cols=182 Identities=15% Similarity=0.169 Sum_probs=134.1
Q ss_pred eecceecccCceEEEEEEECCCCCCCCceeeeec-----hhh------hhhHHHHHHHHHHHHcCCCCcccccccceeee
Q 039291 9 FRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKS-----AEV------SASASLQKEKEVFDNLNGCPFVLECFGEEITM 77 (362)
Q Consensus 9 ~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~-----~~~------~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~ 77 (362)
...+.||+|+||+||+|+.... .+++|. ... ...+.+.+|++++++++ ||||+++..+....
T Consensus 339 ~~~~~LG~G~fg~Vy~~~~~~~------~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~-h~nIv~~~~~~~~~ 411 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDSYLDF------DVIIKERVKKGYRDERLDENIRKSRTAREARYLALVK-DFGIPAPYIFDVDL 411 (540)
T ss_dssp ---------CCEEEEEEECSSC------EEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGG-GGTCCCCCEEEEET
T ss_pred CCCCEEeeCCCEEEEEEEECCC------eEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcC-CCCcCceEEEEEeC
Confidence 4467999999999999954432 233332 111 12345789999999998 99999554433321
Q ss_pred cCCCceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEE
Q 039291 78 GENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKI 157 (362)
Q Consensus 78 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl 157 (362)
. ..++||||++|++|.+++.. +..++.|++.||.|||++||+||||||+|||+ +. .+||
T Consensus 412 ~-----~~~lVmE~~~ggsL~~~l~~----------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl----~~--~~kL 470 (540)
T 3en9_A 412 D-----NKRIMMSYINGKLAKDVIED----------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIF----DK--DLYI 470 (540)
T ss_dssp T-----TTEEEEECCCSEEHHHHSTT----------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEE----SS--SEEE
T ss_pred C-----ccEEEEECCCCCCHHHHHHH----------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEE----CC--eEEE
Confidence 1 23699999999999999865 56899999999999999999999999999999 55 7999
Q ss_pred eecCCcccccccccCC-----CCCCccCCCCccCchhhcc--ccCCCcchHHHHHHHHHHHHhCCCCC
Q 039291 158 ADLGVAKRSRHCKRQK-----FDPSMRGTPLYLAPETVVQ--HMQEAPSDIWALGCVVLEMLSGRQAW 218 (362)
Q Consensus 158 ~Dfgla~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~~l~~g~~pf 218 (362)
+|||+++......... .....+||+.|||||++.. ..|+..+|+||..+-..+.+.++.+|
T Consensus 471 ~DFGla~~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 471 IDFGLGKISNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp CCCTTCEECCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred EECccCEECCCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence 9999998765432211 1135689999999999987 67888899999999888888877665
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=1e-25 Score=201.72 Aligned_cols=144 Identities=20% Similarity=0.150 Sum_probs=111.5
Q ss_pred CCceeecceecccCceEEEEEEECCCCCCCCceeeeechhhh---------------------hhHHHHHHHHHHHHcCC
Q 039291 5 GTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVS---------------------ASASLQKEKEVFDNLNG 63 (362)
Q Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~~---------------------~~~~~~~E~~il~~l~~ 63 (362)
+..|.+++.||+|+||.||+|++ .++. .+++|..... ....+.+|+.++++++
T Consensus 89 ~~~~~~~~~iG~G~~g~Vy~~~~-~~g~----~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~- 162 (282)
T 1zar_A 89 GKVDAIGKLMGEGKESAVFNCYS-EKFG----ECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ- 162 (282)
T ss_dssp TSCSEEEEEEEECSSEEEEEEEE-TTTE----EEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT-
T ss_pred CeEEEecCEeccCCCceEEEEEe-CCCC----EEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc-
Confidence 45566779999999999999999 5554 5677765321 2456889999999999
Q ss_pred CCcccccccceeeecCCCceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCE
Q 039291 64 CPFVLECFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNI 143 (362)
Q Consensus 64 h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Ni 143 (362)
|++ +++.+.. ...++||||++|++|.+ +. . .....++.|++.||.|||++||+||||||+||
T Consensus 163 ~~~---v~~~~~~------~~~~lvmE~~~g~~L~~-l~------~--~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NI 224 (282)
T 1zar_A 163 GLA---VPKVYAW------EGNAVLMELIDAKELYR-VR------V--ENPDEVLDMILEEVAKFYHRGIVHGDLSQYNV 224 (282)
T ss_dssp TSS---SCCEEEE------ETTEEEEECCCCEEGGG-CC------C--SCHHHHHHHHHHHHHHHHHTTEECSCCSTTSE
T ss_pred CCC---cCeEEec------cceEEEEEecCCCcHHH-cc------h--hhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHE
Confidence 444 4443211 22479999999999987 42 1 23557999999999999999999999999999
Q ss_pred EEeecCCCceEEEEeecCCcccccccccCCCCCCccCCCCccCchhhcc
Q 039291 144 LLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQ 192 (362)
Q Consensus 144 ll~~~~~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 192 (362)
|+ + ++.+||+|||+|+ .+..++|||++..
T Consensus 225 Ll----~-~~~vkl~DFG~a~---------------~~~~~~a~e~l~r 253 (282)
T 1zar_A 225 LV----S-EEGIWIIDFPQSV---------------EVGEEGWREILER 253 (282)
T ss_dssp EE----E-TTEEEECCCTTCE---------------ETTSTTHHHHHHH
T ss_pred EE----E-CCcEEEEECCCCe---------------ECCCCCHHHHHHH
Confidence 99 5 6789999999985 3445789998753
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.86 E-value=5.5e-22 Score=175.28 Aligned_cols=139 Identities=25% Similarity=0.237 Sum_probs=102.2
Q ss_pred CCceeecceecccCceEEEEEEECCCCCCCCceeeeechhhh---------------------------hhHHHHHHHHH
Q 039291 5 GTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVS---------------------------ASASLQKEKEV 57 (362)
Q Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~~---------------------------~~~~~~~E~~i 57 (362)
+.-|.+.+.||+|+||.||+|.+..++.. ..+|+|..... ....+.+|+.+
T Consensus 46 ~~~~~i~~~ig~G~~g~Vy~a~~~~~g~~--~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~ 123 (258)
T 1zth_A 46 GYITAMGGVISTGKEANVFYADGVFDGKP--VAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRN 123 (258)
T ss_dssp TSEEEEEEEEEECSSEEEEEEEEEETTEE--EEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHH
T ss_pred CCchhhCCEEeecceEEEEEEEEcCCCcE--eeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHH
Confidence 34578899999999999999998555542 01667653211 11357899999
Q ss_pred HHHcCCCCcc--cccccceeeecCCCceEEEEEEEecCC-C----CHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH-
Q 039291 58 FDNLNGCPFV--LECFGEEITMGENGEMAYNLLLEYAAG-G----TLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIH- 129 (362)
Q Consensus 58 l~~l~~h~~i--~~~~~~~~~~~~~~~~~~~lv~e~~~~-~----~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH- 129 (362)
|++|. |+++ ..++. . ...++||||+.+ | +|.++... .++..+..++.|++.+|.|||
T Consensus 124 l~~l~-~~~i~~p~~~~--~-------~~~~lVmE~~g~~g~~~~~L~~~~~~-----~~~~~~~~i~~qi~~~l~~lH~ 188 (258)
T 1zth_A 124 LERAK-EAGVSVPQPYT--Y-------MKNVLLMEFIGEDELPAPTLVELGRE-----LKELDVEGIFNDVVENVKRLYQ 188 (258)
T ss_dssp HHHHH-HTTCCCCCEEE--E-------ETTEEEEECCEETTEECCBHHHHGGG-----GGGSCHHHHHHHHHHHHHHHHH
T ss_pred HHHHH-hCCCCCCeEEE--c-------CCCEEEEEecCCCCCccccHHHHhhc-----cChHHHHHHHHHHHHHHHHHHH
Confidence 99998 5544 22221 1 124699999942 3 67665432 346678899999999999999
Q ss_pred hCCceeCCCCCCCEEEeecCCCceEEEEeecCCcccc
Q 039291 130 DSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRS 166 (362)
Q Consensus 130 ~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Dfgla~~~ 166 (362)
+.||+||||||+|||+ +. .++|+|||+|...
T Consensus 189 ~~givHrDlkp~NILl----~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 189 EAELVHADLSEYNIMY----ID--KVYFIDMGQAVTL 219 (258)
T ss_dssp TSCEECSSCSTTSEEE----SS--SEEECCCTTCEET
T ss_pred HCCEEeCCCCHHHEEE----cC--cEEEEECcccccC
Confidence 9999999999999999 55 7999999998643
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.74 E-value=1.7e-18 Score=159.33 Aligned_cols=140 Identities=13% Similarity=0.098 Sum_probs=94.0
Q ss_pred CCceeecceecccCceEEEEEEECCCCCCCCceeeeechhhh-----------------hhH--------HHHHHHHHHH
Q 039291 5 GTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVS-----------------ASA--------SLQKEKEVFD 59 (362)
Q Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~~-----------------~~~--------~~~~E~~il~ 59 (362)
+.=|.+++.||+|++|.||+|.+.. |+ .+|+|..... ... ...+|...|.
T Consensus 94 g~iY~I~~~IG~Gk~a~VY~a~d~~-G~----~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~ 168 (397)
T 4gyi_A 94 KDVYSVGSRIGVGKESDIMIVADEK-GK----QKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMK 168 (397)
T ss_dssp TSCSEEEEEEEECSSEEEEEEECTT-CC----EEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHH
T ss_pred CCEEEecCEeeeCCceEEEEEECCC-CC----EEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHH
Confidence 3448999999999999999999864 43 5677753211 001 1235666666
Q ss_pred HcCCCCcccccccceeeecCCCceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCC
Q 039291 60 NLNGCPFVLECFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVK 139 (362)
Q Consensus 60 ~l~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlk 139 (362)
+|. +.++.-...+. .. ..+|||||++|++|.++. ....+..++.||+.+|.|||+.||||||||
T Consensus 169 rL~-~~gv~vp~p~~--~~-----~~~LVME~i~G~~L~~l~--------~~~~~~~l~~qll~~l~~lH~~gIVHrDLK 232 (397)
T 4gyi_A 169 ALY-EEGFPVPEPIA--QS-----RHTIVMSLVDALPMRQVS--------SVPDPASLYADLIALILRLAKHGLIHGDFN 232 (397)
T ss_dssp HHH-HTTCSCCCEEE--EE-----TTEEEEECCSCEEGGGCC--------CCSCHHHHHHHHHHHHHHHHHTTEECSCCS
T ss_pred HHH-hcCCCCCeeee--cc-----CceEEEEecCCccHhhhc--------ccHHHHHHHHHHHHHHHHHHHCCCcCCCCC
Confidence 664 33332111110 01 125999999998886432 223456788999999999999999999999
Q ss_pred CCCEEEeecCCC------ceEEEEeecCCccc
Q 039291 140 PDNILLVATQSG------KFVAKIADLGVAKR 165 (362)
Q Consensus 140 p~Nill~~~~~~------~~~~kl~Dfgla~~ 165 (362)
|.|||+..+.+. ...+.|+||+-+..
T Consensus 233 p~NILl~~dgd~~d~~~~~~~~~iID~~Q~V~ 264 (397)
T 4gyi_A 233 EFNILIREEKDAEDPSSITLTPIIIXFPQMVS 264 (397)
T ss_dssp TTSEEEEEEECSSCTTSEEEEEEECCCTTCEE
T ss_pred HHHEEEeCCCCcccccccccceEEEEeCCccc
Confidence 999999554321 12488999997643
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.39 E-value=1.2e-12 Score=115.44 Aligned_cols=136 Identities=20% Similarity=0.155 Sum_probs=103.0
Q ss_pred ceeecceecccCceEEEEEEECCCCCCCCceeeeechhh---hhhHHHHHHHHHHHHcCCCCcccccccceeeecCCCce
Q 039291 7 SWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEV---SASASLQKEKEVFDNLNGCPFVLECFGEEITMGENGEM 83 (362)
Q Consensus 7 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~---~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~~~~ 83 (362)
.|.+...+|.|+.+.||++...+ ..+++|.... .....+.+|+.+++.|.++..+.++++.... ..
T Consensus 15 ~~~~~~~~~g~s~~~v~~~~~~~------~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~-----~~ 83 (263)
T 3tm0_A 15 KYRCVKDTEGMSPAKVYKLVGEN------ENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERH-----DG 83 (263)
T ss_dssp TSEEEECCSCCSSSEEEEEECSS------CEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEE-----TT
T ss_pred cceeEeeccCCCCCeEEEEECCC------CcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEec-----CC
Confidence 47888899999999999997542 2567777653 3345689999999999766667777765432 22
Q ss_pred EEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---------------------------------
Q 039291 84 AYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHD--------------------------------- 130 (362)
Q Consensus 84 ~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~--------------------------------- 130 (362)
..++||||++|.+|.+.+. +......++.+++.+|..||+
T Consensus 84 ~~~lv~e~i~G~~l~~~~~-------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (263)
T 3tm0_A 84 WSNLLMSEADGVLCSEEYE-------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCE 156 (263)
T ss_dssp EEEEEEECCSSEEHHHHCC-------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGG
T ss_pred ceEEEEEecCCeehhhccC-------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccc
Confidence 3569999999999876531 222345788999999999998
Q ss_pred --------------------------CCceeCCCCCCCEEEeecCCCceEEEEeecCCcc
Q 039291 131 --------------------------SGYVHCDVKPDNILLVATQSGKFVAKIADLGVAK 164 (362)
Q Consensus 131 --------------------------~~ivH~Dlkp~Nill~~~~~~~~~~kl~Dfgla~ 164 (362)
..++|+|++|.|||+ ++...+.|+||+.+.
T Consensus 157 ~~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~----~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 157 NWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFV----KDGKVSGFIDLGRSG 212 (263)
T ss_dssp GGSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEE----ETTEEEEECCCTTCE
T ss_pred cccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEE----ECCcEEEEEEchhcc
Confidence 458999999999999 555667899999763
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.20 E-value=5.1e-11 Score=104.41 Aligned_cols=134 Identities=17% Similarity=0.101 Sum_probs=90.4
Q ss_pred ceeecceecccCceEEEEEEECCCCCCCCceeeeechhhhhhHHHHHHHHHHHHcCCCCc-ccccccceeeecCCCceEE
Q 039291 7 SWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVSASASLQKEKEVFDNLNGCPF-VLECFGEEITMGENGEMAY 85 (362)
Q Consensus 7 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~~~~~~~~~E~~il~~l~~h~~-i~~~~~~~~~~~~~~~~~~ 85 (362)
.|.+....+.|..+.||++.... +. .+++|.........+.+|+.+++.|.++.. +.+++.... .. ...
T Consensus 21 ~~~~~~~~~gg~~~~v~~~~~~~-g~----~~vlK~~~~~~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~----~~-~~~ 90 (264)
T 1nd4_A 21 GYDWAQQTIGCSDAAVFRLSAQG-RP----VLFVKTDLSGALNELQDEAARLSWLATTGVPCAAVLDVVT----EA-GRD 90 (264)
T ss_dssp TCEEEECSCTTSSCEEEEEECTT-SC----CEEEEEECSCTTSCHHHHHHHHHHHHTTTCCBCCEEEEEE----CS-SCE
T ss_pred CCceEecccCCCCceEEEEecCC-CC----eEEEEeCCcccchhhhHHHHHHHHHHhCCCCCCeEEEecc----CC-CCC
Confidence 34444444567779999996532 32 466776544444568899999999986532 444555332 11 235
Q ss_pred EEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---------------------------------
Q 039291 86 NLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSG--------------------------------- 132 (362)
Q Consensus 86 ~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~--------------------------------- 132 (362)
++||||++|.+|. .. . .+ ...++.+++..|..||+..
T Consensus 91 ~~v~e~i~G~~l~--~~---~--~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (264)
T 1nd4_A 91 WLLLGEVPGQDLL--SS---H--LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDE 160 (264)
T ss_dssp EEEEECCSSEETT--TS---C--CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCG
T ss_pred EEEEEecCCcccC--cC---c--CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhh
Confidence 6999999998874 21 1 22 2256677777778887643
Q ss_pred -------------------------ceeCCCCCCCEEEeecCCCceEEEEeecCCcc
Q 039291 133 -------------------------YVHCDVKPDNILLVATQSGKFVAKIADLGVAK 164 (362)
Q Consensus 133 -------------------------ivH~Dlkp~Nill~~~~~~~~~~kl~Dfgla~ 164 (362)
++|+|++|.||++ ++...+.|+|||.+.
T Consensus 161 ~~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~----~~~~~~~liD~~~a~ 213 (264)
T 1nd4_A 161 EHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMV----ENGRFSGFIDCGRLG 213 (264)
T ss_dssp GGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEE----ETTEEEEECCCTTCE
T ss_pred hccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEE----ECCcEEEEEcchhcc
Confidence 9999999999999 555667899999864
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=99.18 E-value=7.6e-11 Score=106.14 Aligned_cols=186 Identities=16% Similarity=0.157 Sum_probs=118.9
Q ss_pred cceecccCceEEEEEEECCCCCCCCceeeeechhhh-hhHHHHHHHHHHHHcCCCCcc--cccccceeeecCCCceEEEE
Q 039291 11 GRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVS-ASASLQKEKEVFDNLNGCPFV--LECFGEEITMGENGEMAYNL 87 (362)
Q Consensus 11 ~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~~-~~~~~~~E~~il~~l~~h~~i--~~~~~~~~~~~~~~~~~~~l 87 (362)
++.++.|....||++. + .+++|..... ....+.+|..+|+.|..+..+ .+++... ...+....-|+
T Consensus 25 i~~~~~G~~n~v~~v~----~-----~~vlR~~~~~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~--~~~~~~~~~~~ 93 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN----R-----DFIFKFPKHSRGSTNLFNEVNILKRIHNKLPLPIPEVVFTG--MPSETYQMSFA 93 (304)
T ss_dssp CCEEEECSSEEEEEST----T-----SEEEEEESSHHHHHHHHHHHHHHHHHTTSSSSCCCCEEEEC--CCCSSCSCSCE
T ss_pred eEecCCCCcceEEEEC----C-----EEEEEecCCcchHHHHHHHHHHHHHHHhcCCCCCCceEeec--CCCCCCCcceE
Confidence 5679999999999873 2 3566654332 456788999999998644333 2222111 01111112258
Q ss_pred EEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh-------------------------------------
Q 039291 88 LLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHD------------------------------------- 130 (362)
Q Consensus 88 v~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~------------------------------------- 130 (362)
||++++|.+|.+.... .++..+...++.|++..|..||+
T Consensus 94 vm~~i~G~~l~~~~~~----~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 169 (304)
T 3sg8_A 94 GFTKIKGVPLTPLLLN----NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQ 169 (304)
T ss_dssp EEECCCCEECCHHHHH----TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHH
T ss_pred EEcccCCeECCccccc----cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCccc
Confidence 8999999988754332 27888888999999999999986
Q ss_pred ---------------------CCceeCCCCCCCEEEeecCCCceEEEEeecCCcccccccccCCCCCCccCCCCc---cC
Q 039291 131 ---------------------SGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMRGTPLY---LA 186 (362)
Q Consensus 131 ---------------------~~ivH~Dlkp~Nill~~~~~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y---~a 186 (362)
..++|+|++|.||++..+ ....+.|+||+.+........-. ....+ ..
T Consensus 170 ~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~--~~~~~~~iD~~~~~~~~~~~Dl~------~~~~~~~~~~ 241 (304)
T 3sg8_A 170 MKKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTE--KNTICGIIDFGDAAISDPDNDFI------SLMEDDEEYG 241 (304)
T ss_dssp HHHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETT--TTEEEEECCCTTCEEECTTHHHH------TTCCTTTSCC
T ss_pred HHHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCC--CCCEEEEEeCCCCccCChHHHHH------HHHhhccccC
Confidence 137999999999999321 15678999999886433211000 01111 23
Q ss_pred chhhcc--ccC------------CCcchHHHHHHHHHHHHhCCCCCc
Q 039291 187 PETVVQ--HMQ------------EAPSDIWALGCVVLEMLSGRQAWV 219 (362)
Q Consensus 187 PE~~~~--~~~------------~~~~DiwslG~il~~l~~g~~pf~ 219 (362)
|+.... ..| ....++|++|.+++.+.+|..+|.
T Consensus 242 ~~~~~~~l~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~~ 288 (304)
T 3sg8_A 242 MEFVSKILNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDWY 288 (304)
T ss_dssp HHHHHHHHHHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHHH
T ss_pred HHHHHHHHHHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHHH
Confidence 332221 011 112589999999999999988873
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.05 E-value=7e-10 Score=102.20 Aligned_cols=143 Identities=16% Similarity=0.171 Sum_probs=98.3
Q ss_pred eecceecccCceEEEEEEECCCCCCCCceeeeechh--h----hhhHHHHHHHHHHHHcCCC-CcccccccceeeecCCC
Q 039291 9 FRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAE--V----SASASLQKEKEVFDNLNGC-PFVLECFGEEITMGENG 81 (362)
Q Consensus 9 ~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~--~----~~~~~~~~E~~il~~l~~h-~~i~~~~~~~~~~~~~~ 81 (362)
...+.|+.|.++.||++...+ + .+++|... . .....+.+|..+++.|... ..+.+++...... +.
T Consensus 41 ~~~~~l~~G~sn~~y~v~~~~-~-----~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~--~~ 112 (359)
T 3dxp_A 41 LSVEQFKGGQSNPTFKLVTPG-Q-----TYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDE--SV 112 (359)
T ss_dssp CEEEECCC-CCSCEEEEECSS-C-----EEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCT--TT
T ss_pred ceEEEcCCcccceEEEEEECC-c-----eEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCC--Cc
Confidence 346789999999999998653 2 45555554 2 1245688999999999842 2355555543221 11
Q ss_pred ceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh-------------------------------
Q 039291 82 EMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHD------------------------------- 130 (362)
Q Consensus 82 ~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~------------------------------- 130 (362)
....++||||++|..+.+.. -..+++.....++.+++..|..||+
T Consensus 113 ~g~~~~vme~v~G~~l~~~~----~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 188 (359)
T 3dxp_A 113 IGRAFYIMEFVSGRVLWDQS----LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKL 188 (359)
T ss_dssp TSSCEEEEECCCCBCCCCTT----CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHH
T ss_pred cCCeEEEEEecCCeecCCCc----cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHh
Confidence 12245899999998775311 1237888889999999999999997
Q ss_pred ---------------------------CCceeCCCCCCCEEEeecCCCceEEEEeecCCccc
Q 039291 131 ---------------------------SGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKR 165 (362)
Q Consensus 131 ---------------------------~~ivH~Dlkp~Nill~~~~~~~~~~kl~Dfgla~~ 165 (362)
.+++|+|+++.|||+..+ +...+.|+||+.+..
T Consensus 189 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~--~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 189 SETESIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPT--EPRVLAVLDWELSTL 248 (359)
T ss_dssp HCCSCCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSS--SSCEEEECCCTTCEE
T ss_pred cCCcCChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCC--CCcEEEEECcccccc
Confidence 368999999999999321 124578999998864
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.61 E-value=3.7e-07 Score=80.23 Aligned_cols=132 Identities=16% Similarity=0.102 Sum_probs=90.9
Q ss_pred ecccCce-EEEEEEECCCCCCCCceeeeechhhhhhHHHHHHHHHHHHcCCCCcccccccceeeecCCCceEEEEEEEec
Q 039291 14 IGQGSFG-CVFIAKPKSNSSFLPPLMAVKSAEVSASASLQKEKEVFDNLNGCPFVLECFGEEITMGENGEMAYNLLLEYA 92 (362)
Q Consensus 14 lG~G~~g-~V~~a~~~~~~~~~~~~~~~K~~~~~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~ 92 (362)
+..|..| .||+......+. .+.+|.........+.+|..+|+.|..+--+.+++..... .. .-++|||++
T Consensus 32 ~~~G~S~~~v~rl~~~~~~~----~~~lk~~~~~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~----~~-~~~lvme~l 102 (272)
T 4gkh_A 32 DNVGQSGATIYRLYGKPNAP----ELFLKHGKGSVANDVTDEMVRLNWLTAFMPLPTIKHFIRT----PD-DAWLLTTAI 102 (272)
T ss_dssp EECSSSSCEEEEEECCTTCC----CEEEEEEETHHHHHHHHHHHHHHHHTTTSCCCCEEEEEEE----TT-EEEEEEECC
T ss_pred ccCCCcCCeEEEEEecCCCe----EEEEEECCCCCHhHHHHHHHHHHHhccCCCcCeEEEEEEE----CC-eEEEEEEee
Confidence 4445555 689887665443 4677776666667788999999999754334455443322 12 345999999
Q ss_pred CCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC-----------------------------------------
Q 039291 93 AGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDS----------------------------------------- 131 (362)
Q Consensus 93 ~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~----------------------------------------- 131 (362)
+|.++.+.... .......+..++...|.-||..
T Consensus 103 ~G~~~~~~~~~------~~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 176 (272)
T 4gkh_A 103 PGKTAFQVLEE------YPDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPV 176 (272)
T ss_dssp CSEEHHHHHHH------CGGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCH
T ss_pred CCccccccccC------CHHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHH
Confidence 99888776543 1223345666777777777752
Q ss_pred -----------------CceeCCCCCCCEEEeecCCCceEEEEeecCCcc
Q 039291 132 -----------------GYVHCDVKPDNILLVATQSGKFVAKIADLGVAK 164 (362)
Q Consensus 132 -----------------~ivH~Dlkp~Nill~~~~~~~~~~kl~Dfgla~ 164 (362)
.++|+|+.+.|||+ +..+.+-|+||+.+.
T Consensus 177 ~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~----~~~~~~~viDwe~a~ 222 (272)
T 4gkh_A 177 EQVWKEMHKLLPFSPDSVVTHGDFSLDNLIF----DEGKLIGCIDVGRVG 222 (272)
T ss_dssp HHHHHHHHTTCCCCCCEEEECSCCCTTSEEE----ETTEEEEECCCTTCE
T ss_pred HHHHHHHHhcccccCCcEEEcCCCCCCeEEE----ECCeEEEEEECcccc
Confidence 27899999999999 666777899999864
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.52 E-value=1.4e-06 Score=78.23 Aligned_cols=139 Identities=18% Similarity=0.190 Sum_probs=88.0
Q ss_pred cceecccCceEEEEEEECCCCCCCCceeeeechhh-hhhHHHHHHHHHHHHcCCCCc--ccccccceeeecCCCceEEEE
Q 039291 11 GRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEV-SASASLQKEKEVFDNLNGCPF--VLECFGEEITMGENGEMAYNL 87 (362)
Q Consensus 11 ~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~-~~~~~~~~E~~il~~l~~h~~--i~~~~~~~~~~~~~~~~~~~l 87 (362)
.+.++.|....||+. .+ .+++|.... .....+.+|..+|+.|.++-. +.+.+.... .. ...-++
T Consensus 24 v~~l~~G~~n~v~~v----g~-----~~VlR~~~~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~---~~-~g~~~~ 90 (306)
T 3tdw_A 24 VESLGEGFRNYAILV----NG-----DWVFRFPKSQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGK---RS-DGNPFV 90 (306)
T ss_dssp EEEEEECSSEEEEEE----TT-----TEEEEEESSHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEE---CT-TSCEEE
T ss_pred eeecCCCcceeEEEE----CC-----EEEEEecCCchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecc---cC-CCceEE
Confidence 466889999999998 12 345555332 245678899999999985422 333332221 11 122359
Q ss_pred EEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC------------------------------------
Q 039291 88 LLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDS------------------------------------ 131 (362)
Q Consensus 88 v~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~------------------------------------ 131 (362)
|||+++|.+|.+..-. .++......++.|+...|..||+.
T Consensus 91 v~e~i~G~~l~~~~~~----~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~ 166 (306)
T 3tdw_A 91 GYRKVQGQILGEDGMA----VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDE 166 (306)
T ss_dssp EEECCCSEECHHHHHT----TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCH
T ss_pred EEeccCCeECchhhhh----hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccch
Confidence 9999999888763211 145555556666666666666542
Q ss_pred ------------------------CceeCCCCCCCEEEeecCCCceEEEEeecCCcccc
Q 039291 132 ------------------------GYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRS 166 (362)
Q Consensus 132 ------------------------~ivH~Dlkp~Nill~~~~~~~~~~kl~Dfgla~~~ 166 (362)
.++|+|+++.||++..+......+.|+||+.+...
T Consensus 167 ~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~g 225 (306)
T 3tdw_A 167 SLRDYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAIS 225 (306)
T ss_dssp HHHHHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEE
T ss_pred hhHHHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCC
Confidence 35999999999999321112445689999987643
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.10 E-value=4e-06 Score=76.73 Aligned_cols=88 Identities=14% Similarity=0.054 Sum_probs=50.0
Q ss_pred eeccee-cccCceEEEEEEEC--CCCCCCCceeeeechhhhh------hHHHHHHHHHHHHcCCC--Ccccccccceeee
Q 039291 9 FRGRVI-GQGSFGCVFIAKPK--SNSSFLPPLMAVKSAEVSA------SASLQKEKEVFDNLNGC--PFVLECFGEEITM 77 (362)
Q Consensus 9 ~~~~~l-G~G~~g~V~~a~~~--~~~~~~~~~~~~K~~~~~~------~~~~~~E~~il~~l~~h--~~i~~~~~~~~~~ 77 (362)
...+.| +.|..+.+|+.... ..+......+++|...... ...+.+|..+++.|..+ -.+.+++.....
T Consensus 23 ~~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~- 101 (357)
T 3ats_A 23 TVESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETT- 101 (357)
T ss_dssp EEEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECS-
T ss_pred EEEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccC-
Confidence 345778 89999999998754 0000001245666544322 25678999999988754 234445443211
Q ss_pred cCCCceEEEEEEEecCCCCHH
Q 039291 78 GENGEMAYNLLLEYAAGGTLG 98 (362)
Q Consensus 78 ~~~~~~~~~lv~e~~~~~~L~ 98 (362)
.+.....++|||+++|..+.
T Consensus 102 -~~~~g~~~~v~e~l~G~~l~ 121 (357)
T 3ats_A 102 -GDVLGTPFFLMDYVEGVVPP 121 (357)
T ss_dssp -STTTSSCEEEEECCCCBCCC
T ss_pred -CCccCCceEEEEecCCCChh
Confidence 11001234899999986643
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.94 E-value=5e-05 Score=68.71 Aligned_cols=30 Identities=23% Similarity=0.227 Sum_probs=26.0
Q ss_pred CCceeCCCCCCCEEEeecCCCceEEEEeecCCcc
Q 039291 131 SGYVHCDVKPDNILLVATQSGKFVAKIADLGVAK 164 (362)
Q Consensus 131 ~~ivH~Dlkp~Nill~~~~~~~~~~kl~Dfgla~ 164 (362)
.+++|+|+++.|||+ +.++.+.|+||+.+.
T Consensus 222 ~~l~HgD~~~~Nil~----~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 222 PNLCHQDYGTGNTLL----GENEQIWVIDLDTVS 251 (346)
T ss_dssp CCEECSSCSTTSEEE----CGGGCEEECCCTTCE
T ss_pred CceecCCCCcccEEE----eCCCcEEEEehhhcc
Confidence 679999999999999 556679999999763
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=97.88 E-value=4.5e-05 Score=70.84 Aligned_cols=75 Identities=17% Similarity=0.166 Sum_probs=44.7
Q ss_pred ecceecccCceEEEEEEECCCCCCCCceeeeechhh----------hhhHHHHHHHHHHHHcCCC-Cc-ccccccceeee
Q 039291 10 RGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEV----------SASASLQKEKEVFDNLNGC-PF-VLECFGEEITM 77 (362)
Q Consensus 10 ~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~----------~~~~~~~~E~~il~~l~~h-~~-i~~~~~~~~~~ 77 (362)
..+.||.|..+.||++.+...+. .+++|.... ....++.+|.++++.+... +. +.+++..
T Consensus 34 ~~~~lg~G~~n~vyrv~~~~~~~----~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~---- 105 (397)
T 2olc_A 34 TCQEIGDGNLNYVFHIYDQEHDR----ALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS---- 105 (397)
T ss_dssp EEEECCSSSSEEEEEEEC----C----EEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE----
T ss_pred EEEECCCCceEEEEEEEECCCCc----EEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE----
Confidence 35789999999999997654333 456664321 1234567899999988643 32 3333321
Q ss_pred cCCCceEEEEEEEecCCC
Q 039291 78 GENGEMAYNLLLEYAAGG 95 (362)
Q Consensus 78 ~~~~~~~~~lv~e~~~~~ 95 (362)
..+ . .++|||+++|.
T Consensus 106 d~~--~-~~lvmE~l~g~ 120 (397)
T 2olc_A 106 DTE--M-AVTVMEDLSHL 120 (397)
T ss_dssp ETT--T-TEEEECCCTTS
T ss_pred cCC--c-cEEEEEeCCCc
Confidence 111 1 25899999874
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=97.82 E-value=0.00018 Score=60.11 Aligned_cols=123 Identities=11% Similarity=0.006 Sum_probs=79.0
Q ss_pred CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH-hCCceeCCCCCCCEEEeecCCCceEEEEeecCCcccccccccCC
Q 039291 95 GTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIH-DSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQK 173 (362)
Q Consensus 95 ~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH-~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Dfgla~~~~~~~~~~ 173 (362)
.+|.++|+.. +.+++|.++|.++.|.+.+|.-+- ...-..+=+.|..|++ ..+|.|.+.+ +.+
T Consensus 33 vSL~eIL~~~-~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l----~~dG~V~f~~-~~s---------- 96 (229)
T 2yle_A 33 LSLEEILRLY-NQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRV----WRDGAVTLAP-AAD---------- 96 (229)
T ss_dssp EEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEE----ETTSCEEECC-C------------
T ss_pred ccHHHHHHHc-CCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEE----ecCCceeccc-ccc----------
Confidence 4799999874 578999999999999999987762 1121233345688888 5556665442 111
Q ss_pred CCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHHcCCCCCCCCCccCCHHHHHH
Q 039291 174 FDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEHSLPEIPSRVSKEARDF 253 (362)
Q Consensus 174 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 253 (362)
......+.|||... ...+.+.=|||||++||.-+--..|- .-+..+|+++.+|
T Consensus 97 ----~~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~e----------------------~eE~eLS~~LE~L 149 (229)
T 2yle_A 97 ----DAGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLKE----------------------NEERELSPPLEQL 149 (229)
T ss_dssp --------------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCCT----------------------TEEECCCHHHHHH
T ss_pred ----cccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCCc----------------------ccchhhCHHHHHH
Confidence 01233466888653 34456778999999999988743321 2245689999999
Q ss_pred HHHHhcc
Q 039291 254 LRRCFVR 260 (362)
Q Consensus 254 i~~~l~~ 260 (362)
|..|...
T Consensus 150 L~~Mt~~ 156 (229)
T 2yle_A 150 IDHMANT 156 (229)
T ss_dssp HHHHTTC
T ss_pred HHHHHhc
Confidence 9999765
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.52 E-value=0.00041 Score=62.12 Aligned_cols=76 Identities=17% Similarity=0.090 Sum_probs=52.5
Q ss_pred cceecccCceEEEEEEECCCCCCCCceeeeechhhhhhHHHHHHHHHHHHcCCC--CcccccccceeeecCCCceEEEEE
Q 039291 11 GRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVSASASLQKEKEVFDNLNGC--PFVLECFGEEITMGENGEMAYNLL 88 (362)
Q Consensus 11 ~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~~~~~~~~~E~~il~~l~~h--~~i~~~~~~~~~~~~~~~~~~~lv 88 (362)
.+.|+.|....+|+.... + ..+.+|.........+.+|...|+.|... ..+.+++.... .. ...++|
T Consensus 41 ~~~l~gG~~n~~y~v~~~--~----~~~vlK~~~~~~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~----~~-g~~~lv 109 (312)
T 3jr1_A 41 KEKLYSGEMNEIWLINDE--V----QTVFVKINERSYRSMFRAEADQLALLAKTNSINVPLVYGIGN----SQ-GHSFLL 109 (312)
T ss_dssp EEEECCSSSSEEEEEESS--S----CEEEEEEEEGGGHHHHHHHHHHHHHHHHTTSSBCCCEEEEEE----CS-SEEEEE
T ss_pred eEEeCCccceeeeEEEEC--C----CeEEEEeCCcccHHHHHHHHHHHHHHHhhCCCCcceEEEEee----cC-CceEEE
Confidence 567999999999999753 2 24667776555566788999999988643 34555554332 11 235699
Q ss_pred EEecCCCCH
Q 039291 89 LEYAAGGTL 97 (362)
Q Consensus 89 ~e~~~~~~L 97 (362)
||+++|..+
T Consensus 110 me~l~G~~~ 118 (312)
T 3jr1_A 110 LEALNKSKN 118 (312)
T ss_dssp EECCCCCCC
T ss_pred EEeccCCCC
Confidence 999998764
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.35 E-value=0.00061 Score=60.55 Aligned_cols=73 Identities=11% Similarity=0.008 Sum_probs=42.5
Q ss_pred eeecceecccCceEEEEEEECCCCCCCCceeeeechhhh--hhHHHHHHHHHHHHcCCCCcccccccceeeecCCCceEE
Q 039291 8 WFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVS--ASASLQKEKEVFDNLNGCPFVLECFGEEITMGENGEMAY 85 (362)
Q Consensus 8 y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~~--~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~~~~~~ 85 (362)
|.-.+.|+.|....+|++ + .+.+|..... ......+|..+++.+..+....+++.. . ....
T Consensus 20 ~~~i~~l~gG~tN~~~~~-----~-----~~vlR~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~~~~----~-~~~~-- 82 (301)
T 3dxq_A 20 YTGPLERLGGLTNLVFRA-----G-----DLCLRIPGKGTEEYINRANEAVAAREAAKAGVSPEVLHV----D-PATG-- 82 (301)
T ss_dssp CCSCEEEESCSSEEEEEE-----T-----TEEEEEECC----CCCHHHHHHHHHHHHHTTSSCCEEEE----C-TTTC--
T ss_pred ccceeEcCCcccccccee-----e-----eEEEECCCCCccceeCHHHHHHHHHHHHHcCCCCceEEE----E-CCCC--
Confidence 444788999999999999 2 3455554322 112245788888887643322333321 1 1111
Q ss_pred EEEEEec-CCCCH
Q 039291 86 NLLLEYA-AGGTL 97 (362)
Q Consensus 86 ~lv~e~~-~~~~L 97 (362)
++++||+ +|.+|
T Consensus 83 ~~v~e~i~~g~~l 95 (301)
T 3dxq_A 83 VMVTRYIAGAQTM 95 (301)
T ss_dssp CEEEECCTTCEEC
T ss_pred EEEEeecCCCccC
Confidence 3799999 66544
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.33 E-value=0.0017 Score=57.15 Aligned_cols=80 Identities=14% Similarity=0.038 Sum_probs=52.8
Q ss_pred CCCceeecceecccCceEEEEEEECCCCCCCCceeeeechhhh---hhHHHHHHHHHHHHcCCCCc--ccccccceeeec
Q 039291 4 DGTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVS---ASASLQKEKEVFDNLNGCPF--VLECFGEEITMG 78 (362)
Q Consensus 4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~~---~~~~~~~E~~il~~l~~h~~--i~~~~~~~~~~~ 78 (362)
.|.+..-++.+|.|..+.||++...+. . .+.+|..... ....+.+|...|+.|..... +.+++.. +
T Consensus 13 ~G~~v~~v~~~g~G~~~~vyrv~l~DG-~----~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~----~ 83 (288)
T 3f7w_A 13 TGREVAAVAERGHSHRWHLYRVELADG-T----PLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGW----D 83 (288)
T ss_dssp HCCCEEEEEEEEEETTEEEEEEEETTS-C----EEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE----E
T ss_pred cCCCeEEEEecCCCCCeEEEEEEECCC-C----EEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEec----c
Confidence 356677788999999999999987653 2 4667764322 23457889999999864322 2333321 1
Q ss_pred CCCceEEEEEEEecCCCCH
Q 039291 79 ENGEMAYNLLLEYAAGGTL 97 (362)
Q Consensus 79 ~~~~~~~~lv~e~~~~~~L 97 (362)
. -++||||++++..
T Consensus 84 ~-----~~lv~e~l~~~~~ 97 (288)
T 3f7w_A 84 D-----RTLAMEWVDERPP 97 (288)
T ss_dssp T-----TEEEEECCCCCCC
T ss_pred C-----ceEEEEeecccCC
Confidence 1 1489999987653
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.32 E-value=0.00078 Score=62.94 Aligned_cols=33 Identities=9% Similarity=0.251 Sum_probs=27.2
Q ss_pred HhCCceeCCCCCCCEEEeecCCCceEEEEeecCCcccc
Q 039291 129 HDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRS 166 (362)
Q Consensus 129 H~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Dfgla~~~ 166 (362)
+...++|+|+++.|||+ +.++ ++|+||+.+...
T Consensus 230 ~~~~liHGDl~~~Nil~----~~~~-~~lID~e~a~~G 262 (420)
T 2pyw_A 230 RAQALIHGDLHTGSVMV----TQDS-TQVIDPEFSFYG 262 (420)
T ss_dssp BCCEEECSCCSGGGEEE----CSSC-EEECCCTTCEEE
T ss_pred CCCeEEecCCCCCcEEE----eCCC-CEEEeCcccccC
Confidence 45789999999999999 5444 899999987643
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.22 E-value=0.0012 Score=59.56 Aligned_cols=37 Identities=27% Similarity=0.367 Sum_probs=26.9
Q ss_pred hCCceeCCCCCCCEEEeecCCCceEEEEeecCCcccc
Q 039291 130 DSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRS 166 (362)
Q Consensus 130 ~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Dfgla~~~ 166 (362)
...++|+|+.+.|||+..+.++...+.|+||+.+...
T Consensus 182 ~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 182 DMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp CCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred CCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 3579999999999999321111256899999987643
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.19 E-value=0.0019 Score=57.76 Aligned_cols=142 Identities=15% Similarity=0.124 Sum_probs=74.7
Q ss_pred ecceecccCceEEEEEEECCCCCCCCceeeeechhh-hhhHHHHHHHHHHHHcCCCCc-ccccccc----eeeecCCCce
Q 039291 10 RGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEV-SASASLQKEKEVFDNLNGCPF-VLECFGE----EITMGENGEM 83 (362)
Q Consensus 10 ~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~-~~~~~~~~E~~il~~l~~h~~-i~~~~~~----~~~~~~~~~~ 83 (362)
-.+.|+.|....+|++...+ + .+++|.... .....+..|..++..|..+.. +.+++.. ..... ..
T Consensus 26 ~~~~i~~G~~n~~~~v~~~~-g-----~~vlk~~~~~~~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~---~g 96 (322)
T 2ppq_A 26 SYKGIAEGVENSNFLLHTTK-D-----PLILTLYEKRVEKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGEL---SG 96 (322)
T ss_dssp EEEEECC---EEEEEEEESS-C-----CEEEEEECC---CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEE---TT
T ss_pred EeeccCCCcccceEEEEeCC-c-----cEEEEEeCCCCCHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEE---CC
Confidence 34667889889999997643 2 355665543 234456778888888764311 2233221 00000 12
Q ss_pred EEEEEEEecCCCCHH-----------HH---HHHhc-CCC------CCHHHHHH---------------HHHHHHHHHHH
Q 039291 84 AYNLLLEYAAGGTLG-----------DL---IEKCN-GNG------LPEKDVRH---------------FTRCILEGIGH 127 (362)
Q Consensus 84 ~~~lv~e~~~~~~L~-----------~~---l~~~~-~~~------l~~~~~~~---------------i~~ql~~~l~y 127 (362)
..+++|++++|..+. .. ++... ... ........ +...+...++.
T Consensus 97 ~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~ 176 (322)
T 2ppq_A 97 RPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDY 176 (322)
T ss_dssp EEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHH
T ss_pred EEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHH
Confidence 346899999986531 11 11110 100 01110000 00113344555
Q ss_pred HHh-------CCceeCCCCCCCEEEeecCCCceEEEEeecCCcc
Q 039291 128 IHD-------SGYVHCDVKPDNILLVATQSGKFVAKIADLGVAK 164 (362)
Q Consensus 128 LH~-------~~ivH~Dlkp~Nill~~~~~~~~~~kl~Dfgla~ 164 (362)
+.. .+++|+|+.+.|||+ +++..+.|+||+.+.
T Consensus 177 l~~~~~~~~~~~liHgDl~~~Nil~----~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 177 LAAHWPKDLPAGVIHADLFQDNVFF----LGDELSGLIDFYFAC 216 (322)
T ss_dssp HHHHCCCSSCEEEECSCCCGGGEEE----ETTEEEEECCCTTCE
T ss_pred HHhhCcccCCcccCCCCCCccCEEE----eCCceEEEecchhcc
Confidence 552 479999999999999 555666899999764
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.90 E-value=0.0018 Score=59.55 Aligned_cols=145 Identities=15% Similarity=0.185 Sum_probs=78.8
Q ss_pred cceecccCceEEEEEEECCC---CCCCCceeeeechhhh--hhHHHHHHHHHHHHcCCCCcccccccceeeecCCCceEE
Q 039291 11 GRVIGQGSFGCVFIAKPKSN---SSFLPPLMAVKSAEVS--ASASLQKEKEVFDNLNGCPFVLECFGEEITMGENGEMAY 85 (362)
Q Consensus 11 ~~~lG~G~~g~V~~a~~~~~---~~~~~~~~~~K~~~~~--~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~~~~~~ 85 (362)
.+.|..|-...+|++..... ...-...+.++..... ....+.+|..+++.|..+....++++.+ .+
T Consensus 55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~----~~----- 125 (379)
T 3feg_A 55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAILQGVDSLVLESVMFAILAERSLGPQLYGVF----PE----- 125 (379)
T ss_dssp CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC---CCHHHHHHHHHHHHHHHHTTSSCCEEEEE----TT-----
T ss_pred EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCccchHHHHHHHHHHHHHHHhcCCCCeEEEEc----CC-----
Confidence 45678888899999986421 0001135666664321 3445678999999887544444444322 11
Q ss_pred EEEEEecCCCCHH--------------HHHHHhcC------CCCC--HHHHHHHHHHHHH-------------------H
Q 039291 86 NLLLEYAAGGTLG--------------DLIEKCNG------NGLP--EKDVRHFTRCILE-------------------G 124 (362)
Q Consensus 86 ~lv~e~~~~~~L~--------------~~l~~~~~------~~l~--~~~~~~i~~ql~~-------------------~ 124 (362)
.+||||++|..|. +.+.+... +... +.++..+..++-. .
T Consensus 126 g~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~ 205 (379)
T 3feg_A 126 GRLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDE 205 (379)
T ss_dssp EEEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHH
T ss_pred ccEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHH
Confidence 1799999985542 12221111 1122 3556666655432 2
Q ss_pred HHHHH----h----CCceeCCCCCCCEEEeecCCCceEEEEeecCCcc
Q 039291 125 IGHIH----D----SGYVHCDVKPDNILLVATQSGKFVAKIADLGVAK 164 (362)
Q Consensus 125 l~yLH----~----~~ivH~Dlkp~Nill~~~~~~~~~~kl~Dfgla~ 164 (362)
+..|. . ..++|+|+.+.||++..+.+..+.+.++||..+.
T Consensus 206 ~~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~ 253 (379)
T 3feg_A 206 MGNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS 253 (379)
T ss_dssp HHHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred HHHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence 33332 2 2599999999999995432223578999999874
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=96.84 E-value=0.0017 Score=60.90 Aligned_cols=77 Identities=16% Similarity=0.114 Sum_probs=46.8
Q ss_pred cceecccCceEEEEEEECCCCC---CCCceeeeechhh-hhhHHHHHHHHHHHHcCCCCcccccccceeeecCCCceEEE
Q 039291 11 GRVIGQGSFGCVFIAKPKSNSS---FLPPLMAVKSAEV-SASASLQKEKEVFDNLNGCPFVLECFGEEITMGENGEMAYN 86 (362)
Q Consensus 11 ~~~lG~G~~g~V~~a~~~~~~~---~~~~~~~~K~~~~-~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~~~~~~~ 86 (362)
.+.|+.|....||++....... .-...+.+|.... .....+.+|..+++.|..+....++++.+ .+ .
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~~~~~li~E~~~l~~L~~~g~~P~l~~~~----~~-----g 148 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPETESHLVAESVIFTLLSERHLGPKLYGIF----SG-----G 148 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCCHHHHHHHHHHHHHHHHTTSSSCEEEEE----TT-----E
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCCcHHHHHHHHHHHHHHHhCCCCCcEEEEe----CC-----C
Confidence 5678899999999998653110 0013566666533 22145668999999887544334554422 11 1
Q ss_pred EEEEecCCCC
Q 039291 87 LLLEYAAGGT 96 (362)
Q Consensus 87 lv~e~~~~~~ 96 (362)
+|+||++|.+
T Consensus 149 ~v~e~l~G~~ 158 (429)
T 1nw1_A 149 RLEEYIPSRP 158 (429)
T ss_dssp EEECCCCEEE
T ss_pred EEEEEeCCcc
Confidence 7899998743
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=96.71 E-value=0.006 Score=54.63 Aligned_cols=76 Identities=11% Similarity=0.014 Sum_probs=43.6
Q ss_pred ceecccCceEEEEEEECCCCCCCCceeeeechhhh--hhHHHHHHHHHHHHcCCCC-cccccccc---eeeecCCCceEE
Q 039291 12 RVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVS--ASASLQKEKEVFDNLNGCP-FVLECFGE---EITMGENGEMAY 85 (362)
Q Consensus 12 ~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~~--~~~~~~~E~~il~~l~~h~-~i~~~~~~---~~~~~~~~~~~~ 85 (362)
+.|+ |....||++...+ ++ .+++|..... ....+..|..+++.|..+. .+.+++.. .... . ....
T Consensus 32 ~~l~-g~~n~~y~v~~~~-g~----~~vlK~~~~~~~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~--~-~g~~ 102 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQDED-RR----RFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLN--H-QGFY 102 (328)
T ss_dssp EEEC-CSSSEEEEECCTT-CC----CEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEE--E-TTEE
T ss_pred Eeec-CcccceEEEEcCC-CC----EEEEEEcCCCCCCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEE--E-CCEE
Confidence 4566 8888999886533 22 3566665422 3456778999888886331 13333321 0000 0 1234
Q ss_pred EEEEEecCCCC
Q 039291 86 NLLLEYAAGGT 96 (362)
Q Consensus 86 ~lv~e~~~~~~ 96 (362)
+++|++++|..
T Consensus 103 ~~l~~~i~G~~ 113 (328)
T 1zyl_A 103 FAVFPSVGGRQ 113 (328)
T ss_dssp EEEEECCCCEE
T ss_pred EEEEEecCCCC
Confidence 68999998754
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.48 E-value=0.0064 Score=57.33 Aligned_cols=75 Identities=15% Similarity=0.095 Sum_probs=44.4
Q ss_pred ecceecccCceEEEEEEECCCCCCCCceeeeechhhhhh--HHHHHHHHHHHHcCCCCcccccccceeeecCCCceEEEE
Q 039291 10 RGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVSAS--ASLQKEKEVFDNLNGCPFVLECFGEEITMGENGEMAYNL 87 (362)
Q Consensus 10 ~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~~~~--~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~~~~~~~l 87 (362)
-.+.|+.|-...+|++.....+ ..+.+|....... -...+|..+++.|..+....++++.+ .+ .+
T Consensus 112 ~i~~lsgG~tN~~y~v~~~~~~----~~~vLRi~g~~~~~~idR~~E~~vl~~L~~~gl~P~ll~~~----~~-----G~ 178 (458)
T 2qg7_A 112 EFQIINGGITNILIKVKDMSKQ----AKYLIRLYGPKTDEIINREREKKISCILYNKNIAKKIYVFF----TN-----GR 178 (458)
T ss_dssp EEEEECC--CEEEEEEEETTTT----EEEEEEEECC-CCSCSCHHHHHHHHHHHTTSSSBCCEEEEE----TT-----EE
T ss_pred EEEEcCCCeEeEEEEEEECCCC----ceEEEEECCCChhhhcCHHHHHHHHHHHHhcCCCCCEEEEe----CC-----eE
Confidence 3567889999999999876522 2455555432211 11268999999998654344555432 11 15
Q ss_pred EEEecCCCCH
Q 039291 88 LLEYAAGGTL 97 (362)
Q Consensus 88 v~e~~~~~~L 97 (362)
||||++|.+|
T Consensus 179 v~e~I~G~~l 188 (458)
T 2qg7_A 179 IEEFMDGYAL 188 (458)
T ss_dssp EEECCCSEEC
T ss_pred EEEeeCCccC
Confidence 9999987443
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.33 E-value=0.0031 Score=57.70 Aligned_cols=77 Identities=13% Similarity=0.086 Sum_probs=41.4
Q ss_pred cceecccCceEEEEEEECCCCC----CCCceeeeechhhhhh--HHHHHHHHHHHHcCCCCcccccccceeeecCCCceE
Q 039291 11 GRVIGQGSFGCVFIAKPKSNSS----FLPPLMAVKSAEVSAS--ASLQKEKEVFDNLNGCPFVLECFGEEITMGENGEMA 84 (362)
Q Consensus 11 ~~~lG~G~~g~V~~a~~~~~~~----~~~~~~~~K~~~~~~~--~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~~~~~ 84 (362)
.+.|+.|....+|++.....+. .....+.+|....... .....|..+++.|..+..+.++++.. . .
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~~~~~~~E~~~l~~L~~~g~~P~~~~~~-----~--~- 109 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDELYNTISEFEVYKTMSKYKIAPQLLNTF-----N--G- 109 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGGTSCHHHHHHHHHHHHHTTSSCCEEEEE-----T--T-
T ss_pred EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccceecHHHHHHHHHHHHhcCCCCceEEec-----C--C-
Confidence 5678889899999998653100 0012456666543211 12468888988887443333444321 1 1
Q ss_pred EEEEEEecCCCC
Q 039291 85 YNLLLEYAAGGT 96 (362)
Q Consensus 85 ~~lv~e~~~~~~ 96 (362)
++||||++|..
T Consensus 110 -~~v~e~i~G~~ 120 (369)
T 3c5i_A 110 -GRIEEWLYGDP 120 (369)
T ss_dssp -EEEEECCCSEE
T ss_pred -cEEEEEecCCc
Confidence 37999998854
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=93.10 E-value=0.29 Score=45.03 Aligned_cols=33 Identities=27% Similarity=0.360 Sum_probs=25.9
Q ss_pred CceeCCCCCCCEEEeecC--CCceEEEEeecCCcc
Q 039291 132 GYVHCDVKPDNILLVATQ--SGKFVAKIADLGVAK 164 (362)
Q Consensus 132 ~ivH~Dlkp~Nill~~~~--~~~~~~kl~Dfgla~ 164 (362)
.++|+|+.+.|||+..++ +....+.++||..|.
T Consensus 245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~ 279 (401)
T 3g15_A 245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSS 279 (401)
T ss_dssp EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCE
T ss_pred eeEEecCCCCeEEEecCcccCcCCeEEEechHhcc
Confidence 367999999999995432 345679999999875
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=92.13 E-value=0.43 Score=44.32 Aligned_cols=78 Identities=14% Similarity=0.108 Sum_probs=46.0
Q ss_pred ecceecccCceEEEEEEECCCCCC---CCceeeeechhhh--hhHHHHHHHHHHHHcCCCCcccccccceeeecCCCceE
Q 039291 10 RGRVIGQGSFGCVFIAKPKSNSSF---LPPLMAVKSAEVS--ASASLQKEKEVFDNLNGCPFVLECFGEEITMGENGEMA 84 (362)
Q Consensus 10 ~~~~lG~G~~g~V~~a~~~~~~~~---~~~~~~~K~~~~~--~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~~~~~ 84 (362)
-++.|..|-...+|++........ ....+.++..... ..-...+|..+++.|.......++++.. .+
T Consensus 74 ~v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~~idR~~E~~~l~~L~~~gi~P~l~~~~----~~---- 145 (424)
T 3mes_A 74 EVKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGKFYDSKVELDVFRYLSNINIAPNIIADF----PE---- 145 (424)
T ss_dssp EEEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-CCCCHHHHHHHHHHHHHTTSSCCEEEEE----TT----
T ss_pred EEEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcchhcCHHHHHHHHHHHHhcCCCCCEEEEc----CC----
Confidence 356778888999999987532100 0134555554322 1122468999998887544444444321 11
Q ss_pred EEEEEEecCCCC
Q 039291 85 YNLLLEYAAGGT 96 (362)
Q Consensus 85 ~~lv~e~~~~~~ 96 (362)
++||||++|..
T Consensus 146 -~~I~efI~G~~ 156 (424)
T 3mes_A 146 -GRIEEFIDGEP 156 (424)
T ss_dssp -EEEEECCCSEE
T ss_pred -CEEEEEeCCcc
Confidence 37999999865
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=89.34 E-value=0.24 Score=44.43 Aligned_cols=33 Identities=18% Similarity=0.193 Sum_probs=26.9
Q ss_pred CCceeCCCCCCCEEEeecCCCceEEEEeecCCccccc
Q 039291 131 SGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSR 167 (362)
Q Consensus 131 ~~ivH~Dlkp~Nill~~~~~~~~~~kl~Dfgla~~~~ 167 (362)
..++|+|+.+.||++ +.++.+.|+||+.+....
T Consensus 206 ~~~~HgD~~~~N~l~----~~~~~~~~iD~e~~~~~~ 238 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLV----GNEESIYIIDWDEPMLAP 238 (339)
T ss_dssp CEEECSCCCGGGEEE----CGGGCEEECCCSSCEEEC
T ss_pred ceeEeCCCCcCCEEE----eCCCeEEEEECCCCeeCC
Confidence 469999999999999 555668999998875433
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 362 | ||||
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 3e-54 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 4e-53 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 2e-52 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 3e-52 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 1e-51 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 2e-51 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 4e-51 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 5e-51 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 2e-49 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 2e-49 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 8e-49 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 2e-48 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 4e-48 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 7e-48 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 5e-47 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 5e-47 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 1e-46 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 1e-46 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 1e-44 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 3e-44 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 3e-43 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 4e-43 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 2e-42 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 2e-42 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 7e-42 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 1e-41 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 2e-41 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 3e-41 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 5e-41 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 6e-41 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 7e-41 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 8e-41 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 2e-40 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 3e-40 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 3e-40 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 4e-40 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 4e-40 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 1e-39 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 2e-39 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 2e-39 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 4e-39 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 5e-39 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 6e-39 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 7e-39 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 1e-38 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 1e-38 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 5e-38 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 8e-38 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 1e-37 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 3e-37 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 6e-37 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 8e-37 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 6e-36 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 3e-35 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 9e-35 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 3e-34 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 4e-34 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 5e-32 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 1e-31 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 4e-31 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 1e-30 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 2e-30 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 9e-12 |
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (452), Expect = 3e-54
Identities = 71/286 (24%), Positives = 125/286 (43%), Gaps = 27/286 (9%)
Query: 11 GRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVSASASLQ---KEKEVFDNLNGCPFV 67
+G G+FG V+ A+ K S L A K + + L+ E ++ + + P +
Sbjct: 17 IGELGDGAFGKVYKAQNKETSV----LAAAKVIDTKSEEELEDYMVEIDILASCD-HPNI 71
Query: 68 LECFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGH 127
++ +L+E+ AGG + ++ + L E ++ + L+ + +
Sbjct: 72 VKLLDAFYYENN-----LWILIEFCAGGAVDAVMLE-LERPLTESQIQVVCKQTLDALNY 125
Query: 128 IHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMRGTPLYLAP 187
+HD+ +H D+K NIL + K+AD GV+ ++ + + S GTP ++AP
Sbjct: 126 LHDNKIIHRDLKAGNILF----TLDGDIKLADFGVSAKNT--RTIQRRDSFIGTPYWMAP 179
Query: 188 ETVVQHMQE-----APSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEHSLPEI 242
E V+ + +D+W+LG ++EM E + L I E
Sbjct: 180 EVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPH--HELNPMRVLLKIAKSEPPTLAQ 237
Query: 243 PSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGVDEELSREL 288
PSR S +DFL++C + R+T LL PFV + REL
Sbjct: 238 PSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTVDSNKPIREL 283
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (443), Expect = 4e-53
Identities = 74/273 (27%), Positives = 124/273 (45%), Gaps = 23/273 (8%)
Query: 11 GRVIGQGSFGCVFIAKPKSNSSFLPPLMAVK----SAEVSASASLQKEKEVFDNLNGCPF 66
+ +G+G++G V +A + +AVK V +++KE + LN
Sbjct: 10 VQTLGEGAYGEVQLAVNRVTEE----AVAVKIVDMKRAVDCPENIKKEICINKMLN-HEN 64
Query: 67 VLECFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIG 126
V++ +G G + Y L LEY +GG L D IE G+PE D + F ++ G+
Sbjct: 65 VVKFYG----HRREGNIQY-LFLEYCSGGELFDRIEP--DIGMPEPDAQRFFHQLMAGVV 117
Query: 127 HIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMRGTPLYLA 186
++H G H D+KP+N+LL + KI+D G+A R+ R++ M GT Y+A
Sbjct: 118 YLHGIGITHRDIKPENLLL----DERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVA 173
Query: 187 PETVV-QHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEHSLPEIPSR 245
PE + + P D+W+ G V+ ML+G W D Q +S ++ + +
Sbjct: 174 PELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSD--SCQEYSDWKEKKTYLNPWKK 231
Query: 246 VSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVK 278
+ L + V P+ R T + D +
Sbjct: 232 IDSAPLALLHKILVENPSARITIPDIKKDRWYN 264
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (443), Expect = 2e-52
Identities = 58/271 (21%), Positives = 106/271 (39%), Gaps = 14/271 (5%)
Query: 11 GRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVSASASLQKEKEVFDNLNGCPFVLEC 70
+V+G G G V K A+K + ++E E+ + CP ++
Sbjct: 17 SQVLGLGINGKVLQIFNKRTQE----KFALK--MLQDCPKARREVELHWRASQCPHIVRI 70
Query: 71 FGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHD 130
+ + +++E GG L I+ E++ + I E I ++H
Sbjct: 71 VDVYENLYAGRKCLL-IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS 129
Query: 131 SGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMRGTPLYLAPETV 190
H DVKP+N+L + + + K+ D G AK + TP Y+APE +
Sbjct: 130 INIAHRDVKPENLLYTSKRPNAIL-KLTDFGFAK---ETTSHNSLTTPCYTPYYVAPEVL 185
Query: 191 VQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSI-DQLFSII--GDEHSLPEIPSRVS 247
+ D+W+LG ++ +L G + +I + + I G S VS
Sbjct: 186 GPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVS 245
Query: 248 KEARDFLRRCFVRKPAFRFTAEMLLDDPFVK 278
+E + +R +P R T ++ P++
Sbjct: 246 EEVKMLIRNLLKTEPTQRMTITEFMNHPWIM 276
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 174 bits (443), Expect = 3e-52
Identities = 57/275 (20%), Positives = 122/275 (44%), Gaps = 22/275 (8%)
Query: 11 GRVIGQGSFGCVFIAKPKSNSSFLPPLMAVK---SAEVSASASLQKEKEVFDNLNGCPFV 67
+G G+FG V ++ + A K + S +++KE + L P +
Sbjct: 31 HEELGTGAFGVVHRVTERATGN----NFAAKFVMTPHESDKETVRKEIQTMSVLR-HPTL 85
Query: 68 LECFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGH 127
+ E+ ++ E+ +GG L + + + + E + + R + +G+ H
Sbjct: 86 VNLHD----AFEDDNEMV-MIYEFMSGGELFEKVADEHN-KMSEDEAVEYMRQVCKGLCH 139
Query: 128 IHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMRGTPLYLAP 187
+H++ YVH D+KP+NI+ +S + K+ D G+ H ++ GT + AP
Sbjct: 140 MHENNYVHLDLKPENIMFTTKRSNE--LKLIDFGLT---AHLDPKQSVKVTTGTAEFAAP 194
Query: 188 ETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEHSLPE-IPSRV 246
E +D+W++G + +LSG + + + L ++ + ++ + S +
Sbjct: 195 EVAEGKPVGYYTDMWSVGVLSYILLSGLSPF--GGENDDETLRNVKSCDWNMDDSAFSGI 252
Query: 247 SKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGVD 281
S++ +DF+R+ + P R T L+ P++ +
Sbjct: 253 SEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGN 287
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 170 bits (433), Expect = 1e-51
Identities = 59/275 (21%), Positives = 111/275 (40%), Gaps = 25/275 (9%)
Query: 11 GRVIGQGSFGCVFIAKPKSNSSFLPPLMAVK-----SAEVSASASLQKEKEVFDNLNGCP 65
IG+GSF V+ + +A S ++E E+ L P
Sbjct: 14 DIEIGRGSFKTVYKGLDTETTV----EVAWCELQDRKLTKSERQRFKEEAEMLKGLQ-HP 68
Query: 66 FVLECFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGI 125
++ + + + + L+ E GTL +++ + K +R + R IL+G+
Sbjct: 69 NIVRFYDSWESTVKGKKCIV-LVTELMTSGTLKTYLKR--FKVMKIKVLRSWCRQILKGL 125
Query: 126 GHIHDSGY--VHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMRGTPL 183
+H +H D+K DNI + KI DLG+A KR F ++ GTP
Sbjct: 126 QFLHTRTPPIIHRDLKCDNIFIT---GPTGSVKIGDLGLATL----KRASFAKAVIGTPE 178
Query: 184 YLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEHSLPEIP 243
++APE + + + D++A G +LEM + + E + Q++ +
Sbjct: 179 FMAPE-MYEEKYDESVDVYAFGMCMLEMATSEYPY--SECQNAAQIYRRVTSGVKPASFD 235
Query: 244 SRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVK 278
E ++ + C + R++ + LL+ F +
Sbjct: 236 KVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ 270
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (435), Expect = 2e-51
Identities = 60/281 (21%), Positives = 119/281 (42%), Gaps = 21/281 (7%)
Query: 11 GRVIGQGSFGCVFIAKPKSNSSFLPPLMAVK--SAEVSASASLQKEKEVFDNLNGCPFVL 68
+G+G FG V S+ K + + ++KE + + +L
Sbjct: 10 AEDLGRGEFGIVHRCVETSSKK----TYMAKFVKVKGTDQVLVKKEISILNIAR-HRNIL 64
Query: 69 ECFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHI 128
+M E ++ E+ +G + + I + L E+++ + + E + +
Sbjct: 65 HLHESFESMEE-----LVMIFEFISGLDIFERINT-SAFELNEREIVSYVHQVCEALQFL 118
Query: 129 HDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMRGTPLYLAPE 188
H H D++P+NI+ +S KI + G A++ + + + P Y APE
Sbjct: 119 HSHNIGHFDIRPENIIYQTRRSSTI--KIIEFGQARQLKPGDNFR---LLFTAPEYYAPE 173
Query: 189 TVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEHSLP-EIPSRVS 247
+ +D+W+LG +V +LSG + + + + +I+ E++ E +S
Sbjct: 174 VHQHDVVSTATDMWSLGTLVYVLLSGINPF--LAETNQQIIENIMNAEYTFDEEAFKEIS 231
Query: 248 KEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGVDEELSREL 288
EA DF+ R V++ R TA L P++K E +S ++
Sbjct: 232 IEAMDFVDRLLVKERKSRMTASEALQHPWLKQKIERVSTKV 272
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 171 bits (435), Expect = 4e-51
Identities = 68/283 (24%), Positives = 124/283 (43%), Gaps = 22/283 (7%)
Query: 11 GRVIGQGSFGCVFIAKPKSNSSFLPPLMAVK---SAEVSASASLQKEKEVFDNLNGCPFV 67
+G G+FG V K+ + K + +++ E + + L+ P +
Sbjct: 34 LEELGSGAFGVVHRCVEKATGR----VFVAKFINTPYPLDKYTVKNEISIMNQLH-HPKL 88
Query: 68 LECFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGH 127
+ E+ L+LE+ +GG L D I + E +V ++ R EG+ H
Sbjct: 89 INLHD----AFEDKYEMV-LILEFLSGGELFDRIAA-EDYKMSEAEVINYMRQACEGLKH 142
Query: 128 IHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMRGTPLYLAP 187
+H+ VH D+KP+NI+ ++ KI D G+A + T + AP
Sbjct: 143 MHEHSIVHLDIKPENIMCETKKASS--VKIIDFGLAT---KLNPDEIVKVTTATAEFAAP 197
Query: 188 ETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEHSLPE-IPSRV 246
E V + +D+WA+G + +LSG + ++D ++ L ++ + E S V
Sbjct: 198 EIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDD--LETLQNVKRCDWEFDEDAFSSV 255
Query: 247 SKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGVDEELSRELE 289
S EA+DF++ ++P R T L+ P++KG L+ +
Sbjct: 256 SPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHSNLTSRIP 298
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (428), Expect = 5e-51
Identities = 68/275 (24%), Positives = 122/275 (44%), Gaps = 31/275 (11%)
Query: 11 GRVIGQGSFGCVFIAKPKSNSSFLPPLMAVK------SAEVSASASLQKEKEVFDNLNGC 64
GR +G+G FG V++A+ K + ++A+K + L++E E+ +L
Sbjct: 11 GRPLGKGKFGNVYLAREKQSKF----ILALKVLFKAQLEKAGVEHQLRREVEIQSHLR-H 65
Query: 65 PFVLECFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEG 124
P +L +G + Y L+LEYA GT+ ++K + E+ + +
Sbjct: 66 PNILRLYG----YFHDATRVY-LILEYAPLGTVYRELQKLSK--FDEQRTATYITELANA 118
Query: 125 IGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMRGTPLY 184
+ + H +H D+KP+N+LL KIAD G + + +R ++ GT Y
Sbjct: 119 LSYCHSKRVIHRDIKPENLLL----GSAGELKIADFGWSVHAPSSRRT----TLCGTLDY 170
Query: 185 LAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEHSLPEIPS 244
L PE + M + D+W+LG + E L G+ + E + + + I P
Sbjct: 171 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPF---EANTYQETYKRISRVE--FTFPD 225
Query: 245 RVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKG 279
V++ ARD + R P+ R +L+ P++
Sbjct: 226 FVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA 260
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (420), Expect = 2e-49
Identities = 67/272 (24%), Positives = 118/272 (43%), Gaps = 24/272 (8%)
Query: 10 RGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVK---SAEVSASASLQKEKEVFDNLNGCPF 66
R IGQG+ G V+ A + +A++ + + E V P
Sbjct: 24 RFEKIGQGASGTVYTAMDVATGQ----EVAIRQMNLQQQPKKELIINEILVMRENK-NPN 78
Query: 67 VLECFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIG 126
++ G+ + +++EY AGG+L D++ + + E + R L+ +
Sbjct: 79 IVNYLD----SYLVGDELW-VVMEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALE 130
Query: 127 HIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMRGTPLYLA 186
+H + +H D+K DNILL K+ D G + + ++ +M GTP ++A
Sbjct: 131 FLHSNQVIHRDIKSDNILL----GMDGSVKLTDFGFCAQITPEQSKRS--TMVGTPYWMA 184
Query: 187 PETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEHSLPEIPSRV 246
PE V + DIW+LG + +EM+ G + + + L+ I + + P ++
Sbjct: 185 PEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPY--LNENPLRALYLIATNGTPELQNPEKL 242
Query: 247 SKEARDFLRRCFVRKPAFRFTAEMLLDDPFVK 278
S RDFL RC R +A+ LL F+K
Sbjct: 243 SAIFRDFLNRCLDMDVEKRGSAKELLQHQFLK 274
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (419), Expect = 2e-49
Identities = 73/291 (25%), Positives = 124/291 (42%), Gaps = 33/291 (11%)
Query: 11 GRVIGQGSFGCVFIAKPKSNSSFLPPLMAVK------SAEVSASASLQKEKEVFDNLNGC 64
G+++G+GSF V +A+ + S A+K + + + +E++V L+
Sbjct: 13 GKILGEGSFSTVVLARELATSR----EYAIKILEKRHIIKENKVPYVTRERDVMSRLD-H 67
Query: 65 PFVLECFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEG 124
PF ++ + ++ E Y L YA G L I K E R +T I+
Sbjct: 68 PFFVKLYF----TFQDDEKLY-FGLSYAKNGELLKYIRKIGS--FDETCTRFYTAEIVSA 120
Query: 125 IGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMRGTPLY 184
+ ++H G +H D+KP+NILL + +I D G AK +Q S GT Y
Sbjct: 121 LEYLHGKGIIHRDLKPENILL----NEDMHIQITDFGTAKVLSPESKQARANSFVGTAQY 176
Query: 185 LAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEHSLPEIPS 244
++PE + + SD+WALGC++ ++++G + + II E + P
Sbjct: 177 VSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF--RAGNEYLIFQKIIKLE---YDFPE 231
Query: 245 RVSKEARDFLRRCFVRKPAFRFTAE------MLLDDPFVKGVDEELSRELE 289
+ +ARD + + V R E L PF + V E +
Sbjct: 232 KFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQT 282
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 163 bits (414), Expect = 8e-49
Identities = 60/290 (20%), Positives = 110/290 (37%), Gaps = 40/290 (13%)
Query: 11 GRVIGQGSFGCVFIAKPKSNSSFLPPLMAVK-----SAEVSASASLQKEKEVFDNLNGCP 65
G+ IG GSFG V+ K + +AVK + + + E V
Sbjct: 13 GQRIGSGSFGTVYKGKWHGD-------VAVKMLNVTAPTPQQLQAFKNEVGVLRKTR-HV 64
Query: 66 FVLECFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGI 125
+L G ++ ++ G +L + + R +G+
Sbjct: 65 NILLFMGYST------APQLAIVTQWCEGSSLYHHLHIIETK-FEMIKLIDIARQTAQGM 117
Query: 126 GHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMRGTPLYL 185
++H +H D+K +NI L KI D G+A + G+ L++
Sbjct: 118 DYLHAKSIIHRDLKSNNIFL----HEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWM 173
Query: 186 APETVVQHMQEAP----SDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEH---S 238
APE V++ + P SD++A G V+ E+++G+ + + DQ+ ++G +
Sbjct: 174 APE-VIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPY--SNINNRDQIIFMVGRGYLSPD 230
Query: 239 LPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGVDEELSREL 288
L ++ S K + + C +K R +L E L+R L
Sbjct: 231 LSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASI------ELLARSL 274
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 163 bits (414), Expect = 2e-48
Identities = 73/276 (26%), Positives = 114/276 (41%), Gaps = 34/276 (12%)
Query: 12 RVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVSASAS------LQKEKEVFDNLNGCP 65
R IG GSFG V+ A+ NS ++A+K S S + KE L P
Sbjct: 21 REIGHGSFGAVYFARDVRNSE----VVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR-HP 75
Query: 66 FVLECFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGI 125
++ G A+ L++EY G L + L E ++ T L+G+
Sbjct: 76 NTIQYRG----CYLREHTAW-LVMEYCLGSASDLLEV--HKKPLQEVEIAAVTHGALQGL 128
Query: 126 GHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMRGTPLYL 185
++H +H DVK NILL S + K+ D G A S GTP ++
Sbjct: 129 AYLHSHNMIHRDVKAGNILL----SEPGLVKLGDFGSASIMAPAN------SFVGTPYWM 178
Query: 186 APETVVQHMQE---APSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEHSLPEI 242
APE ++ + D+W+LG +E+ + ++ L+ I +E S
Sbjct: 179 APEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL--FNMNAMSALYHIAQNE-SPALQ 235
Query: 243 PSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVK 278
S+ R+F+ C + P R T+E+LL FV
Sbjct: 236 SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVL 271
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (409), Expect = 4e-48
Identities = 68/279 (24%), Positives = 112/279 (40%), Gaps = 30/279 (10%)
Query: 11 GRVIGQGSFGCVFIAKPKSNSSFLPPLMAVK-----SAEVSASASLQKEKEVFDNLNGCP 65
IG GS+G + KS+ ++ K S + L E + L P
Sbjct: 9 LYTIGTGSYGRCQKIRRKSDGK----ILVWKELDYGSMTEAEKQMLVSEVNLLRELK-HP 63
Query: 66 FVLECFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNG--LPEKDVRHFTRCILE 123
++ + + + Y +++EY GG L +I K L E+ V +
Sbjct: 64 NIVRYY--DRIIDRTNTTLY-IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTL 120
Query: 124 GIGHIHDSGY-----VHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSM 178
+ H +H D+KP N+ L GK K+ D G+A+ H F +
Sbjct: 121 ALKECHRRSDGGHTVLHRDLKPANVFL----DGKQNVKLGDFGLARILNH--DTSFAKAF 174
Query: 179 RGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEHS 238
GTP Y++PE + + SDIW+LGC++ E+ + + S +L I E
Sbjct: 175 VGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPF---TAFSQKELAGKI-REGK 230
Query: 239 LPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFV 277
IP R S E + + R K R + E +L++P +
Sbjct: 231 FRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI 269
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 161 bits (408), Expect = 7e-48
Identities = 67/287 (23%), Positives = 113/287 (39%), Gaps = 39/287 (13%)
Query: 11 GRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVSASAS------------LQKEKEVF 58
++G+G V K AVK +V+ S KE ++
Sbjct: 8 KEILGRGVSSVVRRCIHKPTCK----EYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63
Query: 59 DNLNGCPFVLECFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFT 118
++G P +++ T + L+ + G L D + + L EK+ R
Sbjct: 64 RKVSGHPNIIQLKDTYET-----NTFFFLVFDLMKKGELFDYLTE--KVTLSEKETRKIM 116
Query: 119 RCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSM 178
R +LE I +H VH D+KP+NILL K+ D G + + ++ + +
Sbjct: 117 RALLEVICALHKLNIVHRDLKPENILL----DDDMNIKLTDFGFSCQLDPGEKLR---EV 169
Query: 179 RGTPLYLAPETVVQHMQEA------PSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSI 232
GTP YLAPE + M + D+W+ G ++ +L+G + + L I
Sbjct: 170 CGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPF--WHRKQMLMLRMI 227
Query: 233 IGDEHSLP-EIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVK 278
+ + S +D + R V +P R+TAE L PF +
Sbjct: 228 MSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQ 274
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (405), Expect = 5e-47
Identities = 78/307 (25%), Positives = 127/307 (41%), Gaps = 34/307 (11%)
Query: 11 GRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVSASAS------LQKEKEVFDNLNGC 64
+++G+GSFG VF+A+ K + A+K+ + EK V
Sbjct: 7 HKMLGKGSFGKVFLAEFKKTNQ----FFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEH 62
Query: 65 PFVLECFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEG 124
PF+ F T ++EY GG L I+ C+ + I+ G
Sbjct: 63 PFLTHMFCTFQTKEN-----LFFVMEYLNGGDLMYHIQSCHK--FDLSRATFYAAEIILG 115
Query: 125 IGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMRGTPLY 184
+ +H G V+ D+K DNIL KIAD G+ K + + GTP Y
Sbjct: 116 LQFLHSKGIVYRDLKLDNIL----LDKDGHIKIADFGMCKE--NMLGDAKTNTFCGTPDY 169
Query: 185 LAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEHSLPEIPS 244
+APE ++ D W+ G ++ EML G+ + ++LF I ++ P P
Sbjct: 170 IAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPF---HGQDEEELFHSIRMDN--PFYPR 224
Query: 245 RVSKEARDFLRRCFVRKPAFRFTAEM-LLDDPFVKGVDEE--LSRELEGDY---SQGEVT 298
+ KEA+D L + FVR+P R + P + ++ E +E++ + +
Sbjct: 225 WLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREINWEELERKEIDPPFRPKVKSPFD 284
Query: 299 LSNADAE 305
SN D E
Sbjct: 285 CSNFDKE 291
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (403), Expect = 5e-47
Identities = 76/287 (26%), Positives = 121/287 (42%), Gaps = 21/287 (7%)
Query: 11 GRVIGQGSFGCVFIAKPKSNSS-----FLPPLMAVKSAEVSASASLQKEKEVFDNLNGCP 65
G +G G F V + KS F+ S + +++E + + P
Sbjct: 15 GEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ-HP 73
Query: 66 FVLECFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGI 125
V+ + EN L+LE AGG L D L E++ F + IL G+
Sbjct: 74 NVITLHE----VYENKTDVI-LILELVAGGELFD--FLAEKESLTEEEATEFLKQILNGV 126
Query: 126 GHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMRGTPLYL 185
++H H D+KP+NI+L+ K KI D G+A + K + GTP ++
Sbjct: 127 YYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN---IFGTPEFV 183
Query: 186 APETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEHSLP-EIPS 244
APE V +D+W++G + +LSG + D + L ++ + E S
Sbjct: 184 APEIVNYEPLGLEADMWSIGVITYILLSGASPF--LGDTKQETLANVSAVNYEFEDEYFS 241
Query: 245 RVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGVDEE--LSRELE 289
S A+DF+RR V+ P R T + L P++K D + LS
Sbjct: 242 NTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQALSSAWS 288
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (403), Expect = 1e-46
Identities = 68/316 (21%), Positives = 127/316 (40%), Gaps = 64/316 (20%)
Query: 12 RVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVSASASLQK----EKEVFDNLNGCPFV 67
+G G+ G VF K + +MA K + +++ E +V N P++
Sbjct: 12 SELGAGNGGVVFKVSHKPSGL----VMARKLIHLEIKPAIRNQIIRELQVLHECN-SPYI 66
Query: 68 LECFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGH 127
+ +G + GE ++ +E+ GG+L +++K +PE+ + + +++G+ +
Sbjct: 67 VGFYGAFYSDGE-----ISICMEHMDGGSLDQVLKK--AGRIPEQILGKVSIAVIKGLTY 119
Query: 128 IHDS-GYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMRGTPLYLA 186
+ + +H DVKP NIL+ + + K+ D GV+ + S GT Y++
Sbjct: 120 LREKHKIMHRDVKPSNILV----NSRGEIKLCDFGVSGQLIDSMAN----SFVGTRSYMS 171
Query: 187 PETVVQHMQEAPSDIWALGCVVLEMLSGRQAW---------------------------- 218
PE + SDIW++G ++EM GR
Sbjct: 172 PERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPR 231
Query: 219 -----------VVKEDCSIDQLFSIIGDEHSLPEIPSRVSKEARDFLRRCFVRKPAFRFT 267
+ +I +L I +E S E +DF+ +C ++ PA R
Sbjct: 232 TPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERAD 291
Query: 268 AEMLLDDPFVKGVDEE 283
+ L+ F+K D E
Sbjct: 292 LKQLMVHAFIKRSDAE 307
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 158 bits (401), Expect = 1e-46
Identities = 72/289 (24%), Positives = 124/289 (42%), Gaps = 24/289 (8%)
Query: 11 GRVIGQGSFGCVFIAKPKSNSSFLPPLMAVK----SAEVSASASLQKEKEVFDNLNGCPF 66
V+G G+F V +A+ K L+A+K A S++ E V + P
Sbjct: 14 RDVLGTGAFSEVILAEDKRTQK----LVAIKCIAKKALEGKEGSMENEIAVLHKIK-HPN 68
Query: 67 VLECFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIG 126
++ + E+G Y L+++ +GG L D I + E+D +L+ +
Sbjct: 69 IVALDD----IYESGGHLY-LIMQLVSGGELFDRIVEKGF--YTERDASRLIFQVLDAVK 121
Query: 127 HIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMRGTPLYLA 186
++HD G VH D+KP+N+L + I+D G++K + GTP Y+A
Sbjct: 122 YLHDLGIVHRDLKPENLLYY-SLDEDSKIMISDFGLSKMEDPGSVLS---TACGTPGYVA 177
Query: 187 PETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEHSLP-EIPSR 245
PE + Q D W++G + +L G + ++ I+ E+
Sbjct: 178 PEVLAQKPYSKAVDCWSIGVIAYILLCGYPPF--YDENDAKLFEQILKAEYEFDSPYWDD 235
Query: 246 VSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGVDEELSRELEGDYSQ 294
+S A+DF+R + P RFT E L P++ G D L + + S+
Sbjct: 236 ISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAG-DTALDKNIHQSVSE 283
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 155 bits (392), Expect = 1e-44
Identities = 69/327 (21%), Positives = 124/327 (37%), Gaps = 40/327 (12%)
Query: 11 GRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVSASASLQKEKEVFD--------NLN 62
R+IG+G FG V+ + + A+K + Q E + +
Sbjct: 9 HRIIGRGGFGEVYGCRKADTGK----MYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG 64
Query: 63 GCPFVLECFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCIL 122
CPF++ T + + +L+ GG L + + E D+R + I+
Sbjct: 65 DCPFIVCMSYAFHTPDK-----LSFILDLMNGGDLHYHLSQHGVF--SEADMRFYAAEII 117
Query: 123 EGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMRGTP 182
G+ H+H+ V+ D+KP NILL +I+DLG+A K GT
Sbjct: 118 LGLEHMHNRFVVYRDLKPANILL----DEHGHVRISDLGLACDFSKKKPHA----SVGTH 169
Query: 183 LYLAPETVVQHMQ-EAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEHSLPE 241
Y+APE + + + ++ +D ++LGC++ ++L G + + ++ + E
Sbjct: 170 GYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMA--VE 227
Query: 242 IPSRVSKEARDFLRRCFVRKPAFRFT-----AEMLLDDPFVKGVDEE--LSRELEGDY-- 292
+P S E R L R R A+ + + PF + +D + ++
Sbjct: 228 LPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQKYPPPLIP 287
Query: 293 -SQGEVTLSNADAESCSPECISFIPLE 318
D S E I L
Sbjct: 288 PRGEVNAADAFDIGSFDEEDTKGIKLL 314
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (385), Expect = 3e-44
Identities = 69/302 (22%), Positives = 120/302 (39%), Gaps = 44/302 (14%)
Query: 11 GRVIGQGSFGCVFIAKPKSNSSFLPPLMAVK-----SAEVSASASLQKEKEVFDNLNGC- 64
IG+G++G VF A+ N +A+K + E S +E V +L
Sbjct: 12 VAEIGEGAYGKVFKARDLKNGG---RFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFE 68
Query: 65 -PFVLECFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILE 123
P V+ F + E L+ E+ ++K G+P + ++ +L
Sbjct: 69 HPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLT-TYLDKVPEPGVPTETIKDMMFQLLR 127
Query: 124 GIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMRGTPL 183
G+ +H VH D+KP NIL+ + K+AD G+A R Q S+ T
Sbjct: 128 GLDFLHSHRVVHRDLKPQNILV----TSSGQIKLADFGLA---RIYSFQMALTSVVVTLW 180
Query: 184 YLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSII---------- 233
Y APE ++Q P D+W++GC+ EM + + + +DQL I+
Sbjct: 181 YRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLF--RGSSDVDQLGKILDVIGLPGEED 238
Query: 234 --------------GDEHSLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKG 279
+ + + + + +D L +C PA R +A L P+ +
Sbjct: 239 WPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQD 298
Query: 280 VD 281
++
Sbjct: 299 LE 300
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (376), Expect = 3e-43
Identities = 51/264 (19%), Positives = 107/264 (40%), Gaps = 24/264 (9%)
Query: 11 GRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVSASA-SLQKEKEVFDNLNGCPFVLE 69
+ IG+G FG V + + N +AVK + A+A + E V L +++
Sbjct: 12 LQTIGKGEFGDVMLGDYRGN------KVAVKCIKNDATAQAFLAEASVMTQLR-HSNLVQ 64
Query: 70 CFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIH 129
G + ++ EY A G+L D + + L + F+ + E + ++
Sbjct: 65 LLGVIVEEKGG----LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE 120
Query: 130 DSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMRGTPLYLAPET 189
+ +VH D+ N+L+ S VAK++D G+ K + + + + + APE
Sbjct: 121 GNNFVHRDLAARNVLV----SEDNVAKVSDFGLTKEASSTQD-----TGKLPVKWTAPEA 171
Query: 190 VVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEHSLPEIPSRVSKE 249
+ + SD+W+ G ++ E+ S + + + + ++ + P
Sbjct: 172 LREKKFSTKSDVWSFGILLWEIYSFGRVP--YPRIPLKDVVPRV-EKGYKMDAPDGCPPA 228
Query: 250 ARDFLRRCFVRKPAFRFTAEMLLD 273
+ ++ C+ A R + L +
Sbjct: 229 VYEVMKNCWHLDAAMRPSFLQLRE 252
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (375), Expect = 4e-43
Identities = 62/277 (22%), Positives = 107/277 (38%), Gaps = 31/277 (11%)
Query: 11 GRVIGQGSFGCVFIAKPKSNSSF-----LPPLMAVKSAEVSASASLQKEKEVFDNLN-GC 64
G ++G G FG V+ S++ + E+ + E + ++ G
Sbjct: 9 GPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGF 68
Query: 65 PFVLECFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEG 124
V+ + L+LE G L E+ R F +LE
Sbjct: 69 SGVIRLLDWFERPDS-----FVLILERPEPVQDLFDFITERG-ALQEELARSFFWQVLEA 122
Query: 125 IGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMRGTPLY 184
+ H H+ G +H D+K +NIL+ + K+ D G + FD GT +Y
Sbjct: 123 VRHCHNCGVLHRDIKDENILIDLN---RGELKLIDFGSGALLKDTVYTDFD----GTRVY 175
Query: 185 LAPETVVQHMQEAPS-DIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEHSLPEIP 243
PE + H S +W+LG ++ +M+ G + E+ Q+F
Sbjct: 176 SPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVF-----------FR 224
Query: 244 SRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGV 280
RVS E + +R C +P+ R T E + + P+++ V
Sbjct: 225 QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV 261
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (375), Expect = 2e-42
Identities = 57/290 (19%), Positives = 107/290 (36%), Gaps = 39/290 (13%)
Query: 11 GRVIGQGSFGCVFIAK-PKSNSSFLPPLMAVK----SAEVSASASLQKEKEVFDNLNGCP 65
G+V+G G+FG V A + + + +AVK A+ S +L E ++ L
Sbjct: 42 GKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHE 101
Query: 66 FVLECFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNG------------------- 106
++ G G L+ EY G L + +
Sbjct: 102 NIVNLLGACTLSGP-----IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 156
Query: 107 --NGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAK 164
N L +D+ F + +G+ + VH D+ N+L+ + V KI D G+A+
Sbjct: 157 DLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLV----THGKVVKICDFGLAR 212
Query: 165 RSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLS-GRQAWVVKED 223
+ R ++APE++ + + SD+W+ G ++ E+ S G +
Sbjct: 213 DIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPY---PG 269
Query: 224 CSIDQLFSIIGDEHSLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLD 273
+D F + + P ++E ++ C+ R + L
Sbjct: 270 IPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTS 319
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (371), Expect = 2e-42
Identities = 56/282 (19%), Positives = 117/282 (41%), Gaps = 29/282 (10%)
Query: 12 RVIGQGSFGCVFIAKPKSNSSFLPPLMAVK-----SAEVSASASLQKEKEVFDNLNGCPF 66
+ +G G+FG V + + +AVK + + + L E V L+ P+
Sbjct: 13 KELGSGNFGTVKKGYYQMKK--VVKTVAVKILKNEANDPALKDELLAEANVMQQLD-NPY 69
Query: 67 VLECFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIG 126
++ G I E+ + L++E A G L + + +K++ + G+
Sbjct: 70 IVRMIG--ICEAES----WMLVMEMAELGPLNKYL--QQNRHVKDKNIIELVHQVSMGMK 121
Query: 127 HIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKR-SRHCKRQKFDPSMRGTPLYL 185
++ +S +VH D+ N+LL + AKI+D G++K K + +
Sbjct: 122 YLEESNFVHRDLAARNVLL----VTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWY 177
Query: 186 APETVVQHMQEAPSDIWALGCVVLEMLS-GRQAWVVKEDCSIDQLFSIIGDEHSLPEIPS 244
APE + + + SD+W+ G ++ E S G++ + ++ +++ ++ P+
Sbjct: 178 APECINYYKFSSKSDVWSFGVLMWEAFSYGQKPY---RGMKGSEVTAML-EKGERMGCPA 233
Query: 245 RVSKEARDFLRRCFVRKPAFRFTA---EMLLDDPFVKGVDEE 283
+E D + C+ R E+ L + + V+E
Sbjct: 234 GCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVNEG 275
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (371), Expect = 7e-42
Identities = 70/311 (22%), Positives = 119/311 (38%), Gaps = 39/311 (12%)
Query: 11 GRVIGQGSFGCVFIAKPKSNSSFLPPLMAVK------SAEVSASASLQKEKEVFDNLNGC 64
+++G+G+FG V + + K+ A+K A E V N
Sbjct: 10 LKLLGKGTFGKVILVREKATGR----YYAMKILRKEVIIAKDEVAHTVTESRVLQNTR-H 64
Query: 65 PFVLECFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEG 124
PF+ T ++EYA GG L + + E+ R + I+
Sbjct: 65 PFLTALKYAFQTHDR-----LCFVMEYANGGELFFHLSRERV--FTEERARFYGAEIVSA 117
Query: 125 IGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMRGTPLY 184
+ ++H V+ D+K +N++L KI D G+ K GTP Y
Sbjct: 118 LEYLHSRDVVYRDIKLENLML----DKDGHIKITDFGLCKEGISDGATMKT--FCGTPEY 171
Query: 185 LAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEHSLPEIPS 244
LAPE + + D W LG V+ EM+ GR + + ++LF +I E P
Sbjct: 172 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF---YNQDHERLFELILMEE--IRFPR 226
Query: 245 RVSKEARDFLRRCFVRKPAFRF-----TAEMLLDDPFVKGVDEE--LSRELEGDYS---Q 294
+S EA+ L + P R A+ +++ F ++ + + ++L +
Sbjct: 227 TLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQKKLLPPFKPQVT 286
Query: 295 GEVTLSNADAE 305
EV D E
Sbjct: 287 SEVDTRYFDDE 297
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (366), Expect = 1e-41
Identities = 52/269 (19%), Positives = 105/269 (39%), Gaps = 19/269 (7%)
Query: 10 RGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVSAS----ASLQKEKEVFDNLNGCP 65
R +VIG G FG V+ K++S +A+K+ + + E + +
Sbjct: 11 RQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFS-HH 69
Query: 66 FVLECFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGI 125
++ G ++ EY G L + + +G + R I G+
Sbjct: 70 NIIRLEGVISKYKP-----MMIITEYMENGALDKFLREKDGE-FSVLQLVGMLRGIAAGM 123
Query: 126 GHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPS-MRGTPLY 184
++ + YVH D+ NIL+ + V K++D G+++ + S + +
Sbjct: 124 KYLANMNYVHRDLAARNILV----NSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRW 179
Query: 185 LAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEHSLPEIPS 244
APE + + SD+W+ G V+ E+++ + + S ++ I D LP P
Sbjct: 180 TAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPY--WELSNHEVMKAINDGFRLP-TPM 236
Query: 245 RVSKEARDFLRRCFVRKPAFRFTAEMLLD 273
+ +C+ ++ A R ++
Sbjct: 237 DCPSAIYQLMMQCWQQERARRPKFADIVS 265
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (365), Expect = 2e-41
Identities = 61/285 (21%), Positives = 121/285 (42%), Gaps = 33/285 (11%)
Query: 11 GRVIGQGSFGCVFIAKPKSNSSFLPP---LMAVKSAEVSAS----ASLQKEKEVFDNLNG 63
G+ +G+G+FG V +A+ P +AVK + A+ + L E E+ +
Sbjct: 18 GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 77
Query: 64 CPFVLECFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNG--------------L 109
++ G + +++EYA+ G L + ++ G L
Sbjct: 78 HKNIINLLGACTQ-----DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 132
Query: 110 PEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHC 169
KD+ + G+ ++ +H D+ N+L+ + V KIAD G+A+ H
Sbjct: 133 SSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLV----TEDNVMKIADFGLARDIHHI 188
Query: 170 KRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQL 229
K + R ++APE + + SD+W+ G ++ E+ + + +++L
Sbjct: 189 DYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPY--PGVPVEEL 246
Query: 230 FSIIGDEHSLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDD 274
F ++ + H + PS + E +R C+ P+ R T + L++D
Sbjct: 247 FKLLKEGH-RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 290
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 144 bits (363), Expect = 3e-41
Identities = 59/272 (21%), Positives = 112/272 (41%), Gaps = 21/272 (7%)
Query: 11 GRVIGQGSFGCVFIAKPKSNSSFLPPLMAVK------SAEVSASASLQKEKEVFDNLNGC 64
G ++G G V +A+ +AVK + + S ++E + LN
Sbjct: 12 GEILGFGGMSEVHLARDLRLHR----DVAVKVLRADLARDPSFYLRFRREAQNAAALN-H 66
Query: 65 PFVLECFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEG 124
P ++ + G + Y +++EY G TL D++ + K +
Sbjct: 67 PAIVAVYDTGEAETPAGPLPY-IVMEYVDGVTLRDIVHTEGP--MTPKRAIEVIADACQA 123
Query: 125 IGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMRGTPLY 184
+ H +G +H DVKP NI++ AT + K + +A + ++ GT Y
Sbjct: 124 LNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTA---AVIGTAQY 180
Query: 185 LAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEHSLP-EIP 243
L+PE +A SD+++LGCV+ E+L+G + D + + + ++ P
Sbjct: 181 LSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPF--TGDSPVSVAYQHVREDPIPPSARH 238
Query: 244 SRVSKEARDFLRRCFVRKPAFRF-TAEMLLDD 274
+S + + + + P R+ TA + D
Sbjct: 239 EGLSADLDAVVLKALAKNPENRYQTAAEMRAD 270
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (361), Expect = 5e-41
Identities = 53/271 (19%), Positives = 108/271 (39%), Gaps = 25/271 (9%)
Query: 11 GRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVSASA--SLQKEKEVFDNLNGCPFVL 68
+G G FG V++ ++ +AVKS + + + + E + L ++
Sbjct: 18 VERLGAGQFGEVWMGYYNGHT-----KVAVKSLKQGSMSPDAFLAEANLMKQLQ-HQRLV 71
Query: 69 ECFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHI 128
+ + ++ EY G+L D ++ +G L + I EG+ I
Sbjct: 72 RLYA----VVTQEP--IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFI 125
Query: 129 HDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMRGTPLYLAPE 188
+ Y+H D++ NIL+ KIAD G+A+ + + + + APE
Sbjct: 126 EERNYIHRDLRAANILVS----DTLSCKIADFGLARLIEDNEYTARE-GAKFPIKWTAPE 180
Query: 189 TVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEHSLPEIPSRVSK 248
+ SD+W+ G ++ E+++ + + ++ + + + P +
Sbjct: 181 AINYGTFTIKSDVWSFGILLTEIVTHGRIP--YPGMTNPEVIQNLERGYRMV-RPDNCPE 237
Query: 249 EARDFLRRCFVRKPAFRFTAEML---LDDPF 276
E +R C+ +P R T + L L+D F
Sbjct: 238 ELYQLMRLCWKERPEDRPTFDYLRSVLEDFF 268
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (363), Expect = 6e-41
Identities = 64/280 (22%), Positives = 113/280 (40%), Gaps = 35/280 (12%)
Query: 11 GRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVSAS----ASLQKEKEVFDNLNGCPF 66
VIG+G+FG V A+ K + + A+K + AS E EV L P
Sbjct: 15 QDVIGEGNFGQVLKARIKKDGLRMD--AAIKRMKEYASKDDHRDFAGELEVLCKLGHHPN 72
Query: 67 VLECFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKC--------------NGNGLPEK 112
++ G G L +EYA G L D + K + L +
Sbjct: 73 IINLLGACEHRGY-----LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQ 127
Query: 113 DVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQ 172
+ HF + G+ ++ ++H D+ NIL+ +VAKIAD G+++ ++
Sbjct: 128 QLLHFAADVARGMDYLSQKQFIHRDLAARNILV----GENYVAKIADFGLSRGQEVYVKK 183
Query: 173 KFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSI 232
R ++A E++ + SD+W+ G ++ E++S + +L+
Sbjct: 184 T---MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP--YCGMTCAELYEK 238
Query: 233 IGDEHSLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLL 272
+ + L P E D +R+C+ KP R + +L
Sbjct: 239 LPQGYRLE-KPLNCDDEVYDLMRQCWREKPYERPSFAQIL 277
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 143 bits (361), Expect = 7e-41
Identities = 48/284 (16%), Positives = 110/284 (38%), Gaps = 24/284 (8%)
Query: 11 GRVIGQGSFGCVFIAKPKSNSSFLPPLMAVK--SAEVSASASLQKEKEVFDNLNGCPFVL 68
+G G +G V+ K S +AVK + KE V + P ++
Sbjct: 22 KHKLGGGQYGEVYEGVWKKYSL----TVAVKTLKEDTMEVEEFLKEAAVMKEIK-HPNLV 76
Query: 69 ECFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHI 128
+ G + ++ E+ G L D + +CN + + + I + ++
Sbjct: 77 QLLGVCTREPP-----FYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYL 131
Query: 129 HDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMRGTPLYLAPE 188
++H D+ N L+ + K+AD G+++ + + APE
Sbjct: 132 EKKNFIHRDLAARNCLV----GENHLVKVADFGLSRLMTGDTYTAHA-GAKFPIKWTAPE 186
Query: 189 TVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEHSLPEIPSRVSK 248
++ + SD+WA G ++ E+ + + + Q++ ++ ++ E P +
Sbjct: 187 SLAYNKFSIKSDVWAFGVLLWEIATYGMSPY--PGIDLSQVYELL-EKDYRMERPEGCPE 243
Query: 249 EARDFLRRCFVRKPAFRFTAEMLLD--DPFVK--GVDEELSREL 288
+ + +R C+ P+ R + + + + + +E+ +EL
Sbjct: 244 KVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEKEL 287
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 143 bits (362), Expect = 8e-41
Identities = 71/310 (22%), Positives = 123/310 (39%), Gaps = 43/310 (13%)
Query: 11 GRVIGQGSFGCVFIAKPKSNSSFLPPLMAVK------SAEVSASASLQKEKEVFDNLNGC 64
R +G GSFG V + + + N A+K + E+ + +
Sbjct: 9 LRTLGTGSFGRVHLIRSRHNGR----YYAMKVLKKEIVVRLKQVEHTNDERLMLSIVT-H 63
Query: 65 PFVLECFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEG 124
PF++ +G ++ + + ++ +Y GG L L+ P + + +
Sbjct: 64 PFIIRMWG----TFQDAQQIFMIM-DYIEGGELFSLL--RKSQRFPNPVAKFYAAEVCLA 116
Query: 125 IGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMRGTPLY 184
+ ++H ++ D+KP+NILL KI D G AK ++ GTP Y
Sbjct: 117 LEYLHSKDIIYRDLKPENILL----DKNGHIKITDFGFAKYVPDVTY-----TLCGTPDY 167
Query: 185 LAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEHSLPEIPS 244
+APE V D W+ G ++ EML+G + + ++ I+ E P
Sbjct: 168 IAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPF--YDSNTMKTYEKILNAE---LRFPP 222
Query: 245 RVSKEARDFLRRCFVRKPAFRF-----TAEMLLDDPFVKGVDEE--LSRELEGDY----S 293
+++ +D L R R + R E + + P+ K V E LSR +E Y
Sbjct: 223 FFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVWEKLLSRNIETPYEPPIQ 282
Query: 294 QGEVTLSNAD 303
QG+ S D
Sbjct: 283 QGQGDTSQFD 292
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (359), Expect = 2e-40
Identities = 58/283 (20%), Positives = 107/283 (37%), Gaps = 32/283 (11%)
Query: 11 GRVIGQGSFGCVFIAK-PKSNSSFLPPLMAVK----SAEVSASASLQKEKEVFDNLNGCP 65
G+ +G G+FG V A S +AVK SA ++ +L E +V L
Sbjct: 28 GKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHM 87
Query: 66 FVLECFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGN----------------GL 109
++ G G ++ EY G L + + + + L
Sbjct: 88 NIVNLLGACTIGGP-----TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142
Query: 110 PEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHC 169
+D+ F+ + +G+ + +H D+ NILL + KI D G+A+ ++
Sbjct: 143 DLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTH----GRITKICDFGLARDIKND 198
Query: 170 KRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQL 229
+ R ++APE++ + SD+W+ G + E+ S + +D
Sbjct: 199 SNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSP--YPGMPVDSK 256
Query: 230 FSIIGDEHSLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLL 272
F + E P E D ++ C+ P R T + ++
Sbjct: 257 FYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIV 299
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 141 bits (356), Expect = 3e-40
Identities = 64/275 (23%), Positives = 112/275 (40%), Gaps = 25/275 (9%)
Query: 11 GRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKS-AEVSASASLQKEKEVFDNLNGCPFV-- 67
GR IG+GSFG +F N+ +A+K S + L+ E + L GC +
Sbjct: 10 GRRIGEGSFGVIFEGTNLLNNQ----QVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPN 65
Query: 68 LECFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGH 127
+ FG+E +N+L+ G +L DL++ C G K V + +L +
Sbjct: 66 VYYFGQEGL--------HNVLVIDLLGPSLEDLLDLC-GRKFSVKTVAMAAKQMLARVQS 116
Query: 128 IHDSGYVHCDVKPDNILL-VATQSGKFVAKIADLGVAKR-----SRHCKRQKFDPSMRGT 181
IH+ V+ D+KPDN L+ + + D G+ K ++ + ++ GT
Sbjct: 117 IHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGT 176
Query: 182 PLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEH---S 238
Y++ T + Q D+ ALG V + L G W + + Q + IG++
Sbjct: 177 ARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTP 236
Query: 239 LPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLD 273
L E+ + +E ++ + L
Sbjct: 237 LRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG 271
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (356), Expect = 3e-40
Identities = 54/290 (18%), Positives = 114/290 (39%), Gaps = 32/290 (11%)
Query: 14 IGQGSFGCVFIAKPKSNSSFLPPLMAVK----SAEVSASASLQKEKEVFDNLNGCPFVLE 69
+G G+FG V + + +A+K E + + + +E ++ L+ P+++
Sbjct: 17 LGCGNFGSVRQGVYRMRKKQID--VAIKVLKQGTEKADTEEMMREAQIMHQLD-NPYIVR 73
Query: 70 CFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIH 129
G L++E A GG L + +P +V + G+ ++
Sbjct: 74 LIGVCQAEA------LMLVMEMAGGGPLHKFLVGKREE-IPVSNVAELLHQVSMGMKYLE 126
Query: 130 DSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKR-SRHCKRQKFDPSMRGTPLYLAPE 188
+ +VH D+ N+LL + AKI+D G++K + + + APE
Sbjct: 127 EKNFVHRDLAARNVLL----VNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPE 182
Query: 189 TVVQHMQEAPSDIWALGCVVLEMLS-GRQAWVVKEDCSIDQLFSIIGDEHSLPEIPSRVS 247
+ + SD+W+ G + E LS G++ + + ++ + I ++ E P
Sbjct: 183 CINFRKFSSRSDVWSYGVTMWEALSYGQKPY---KKMKGPEVMAFI-EQGKRMECPPECP 238
Query: 248 KEARDFLRRCFVRKPAFRFTAEML---LDDPFVKGVDEELSRELEGDYSQ 294
E + C++ K R + + + L+ ++EG +
Sbjct: 239 PELYALMSDCWIYKWEDRPDFLTVEQRMRACY-----YSLASKVEGHHHH 283
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 141 bits (356), Expect = 4e-40
Identities = 57/282 (20%), Positives = 103/282 (36%), Gaps = 28/282 (9%)
Query: 11 GRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEV-SASASLQKEKEVFDNLNGCPFV-- 67
GR IG GSFG +++ + +A+K V + L E +++ + G +
Sbjct: 12 GRKIGSGSFGDIYLGTDIAAGE----EVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPT 67
Query: 68 LECFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGH 127
+ G E +++E + K V ++ I +
Sbjct: 68 IRWCGAE-------GDYNVMVMELLGPSLE--DLFNFCSRKFSLKTVLLLADQMISRIEY 118
Query: 128 IHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMR-----GTP 182
IH ++H DVKPDN L+ + G V I D G+AK+ R + + P GT
Sbjct: 119 IHSKNFIHRDVKPDNFLMGLGKKGNLVYII-DFGLAKKYRDARTHQHIPYRENKNLTGTA 177
Query: 183 LYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEH---SL 239
Y + T + Q D+ +LG V++ G W + + Q + I ++ +
Sbjct: 178 RYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI 237
Query: 240 PEIPSRVSKEARDFLRRCFVRKPAFRFTAEML---LDDPFVK 278
+ E +L C + + L + F +
Sbjct: 238 EVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR 279
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (355), Expect = 4e-40
Identities = 53/272 (19%), Positives = 108/272 (39%), Gaps = 25/272 (9%)
Query: 11 GRVIGQGSFGCVFIAKPKSNSSFLPPLMAVK--SAEVSASASLQKEKEVFDNLNGCPFVL 68
+GQG FG V++ + +A+K + + +E +V L ++
Sbjct: 22 EVKLGQGCFGEVWMGTWNGTT-----RVAIKTLKPGTMSPEAFLQEAQVMKKLR-HEKLV 75
Query: 69 ECFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHI 128
+ + ++ ++ EY + G+L D ++ G L + I G+ ++
Sbjct: 76 QLYAV-VSEEP-----IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYV 129
Query: 129 HDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMRGTPLYLAPE 188
YVH D++ NIL+ V K+AD G+A+ + + + APE
Sbjct: 130 ERMNYVHRDLRAANILV----GENLVCKVADFGLARLIEDNEYTARQ-GAKFPIKWTAPE 184
Query: 189 TVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEHSLPEIPSRVSK 248
+ SD+W+ G ++ E+ + + ++ + + +P P +
Sbjct: 185 AALYGRFTIKSDVWSFGILLTELTTKGRVP--YPGMVNREVLDQVERGYRMP-CPPECPE 241
Query: 249 EARDFLRRCFVRKPAFRFTAEML---LDDPFV 277
D + +C+ ++P R T E L L+D F
Sbjct: 242 SLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 273
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (354), Expect = 1e-39
Identities = 62/296 (20%), Positives = 128/296 (43%), Gaps = 32/296 (10%)
Query: 11 GRVIGQGSFGCVFIAKPKSNSSFLPPLMAVK-------SAEVSASASLQKEKEVFDNLNG 63
+V+G G++G VF+ + S L A+K + + + E++V +++
Sbjct: 29 LKVLGTGAYGKVFLVRKISGHD-TGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQ 87
Query: 64 CPFVLECFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILE 123
PF++ T + +L+L+Y GG L + + E +V+ + I+
Sbjct: 88 SPFLVTLHYAFQTETK-----LHLILDYINGGELFTHLSQRER--FTEHEVQIYVGEIVL 140
Query: 124 GIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMRGTPL 183
+ H+H G ++ D+K +NILL + D G++K + ++ GT
Sbjct: 141 ALEHLHKLGIIYRDIKLENILL----DSNGHVVLTDFGLSKEFVADETERAYD-FCGTIE 195
Query: 184 YLAPETVVQHMQ--EAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSII-GDEHSLP 240
Y+AP+ V + D W+LG ++ E+L+G + D + I S P
Sbjct: 196 YMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPF--TVDGEKNSQAEISRRILKSEP 253
Query: 241 EIPSRVSKEARDFLRRCFVRKPAFRF-----TAEMLLDDPFVKGVDEE--LSRELE 289
P +S A+D ++R ++ P R A+ + + F + ++ + ++++
Sbjct: 254 PYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINWDDLAAKKVP 309
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 140 bits (354), Expect = 2e-39
Identities = 61/307 (19%), Positives = 118/307 (38%), Gaps = 52/307 (16%)
Query: 11 GRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVSASASLQKEKEVFDNLNGCPFVLEC 70
R +G+G + VF A +N+ + VK + +++E ++ +NL G P ++
Sbjct: 40 VRKLGRGKYSEVFEAINITNNE----KVVVKILKPVKKKKIKREIKILENLRGGPNIITL 95
Query: 71 FGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHD 130
+ + L+ E+ L + L + D+R + IL+ + + H
Sbjct: 96 AD---IVKDPVSRTPALVFEHVNNTDFKQLYQT-----LTDYDIRFYMYEILKALDYCHS 147
Query: 131 SGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMRGTPLYLAPETV 190
G +H DVKP N+++ ++ D G+A+ + + + PE +
Sbjct: 148 MGIMHRDVKPHNVMID---HEHRKLRLIDWGLAEFYHPGQEYNV---RVASRYFKGPELL 201
Query: 191 VQHMQ-EAPSDIWALGCVVLEMLSGR-------------------------QAWVVKEDC 224
V + + D+W+LGC++ M+ + ++ K +
Sbjct: 202 VDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNI 261
Query: 225 SIDQLFSIIGDEHSLP--------EIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPF 276
+D F+ I HS E VS EA DFL + R TA ++ P+
Sbjct: 262 ELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPY 321
Query: 277 VKGVDEE 283
V ++
Sbjct: 322 FYTVVKD 328
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (349), Expect = 2e-39
Identities = 48/264 (18%), Positives = 96/264 (36%), Gaps = 22/264 (8%)
Query: 11 GRVIGQGSFGCVFIAKPKSNSSFLPPLMAVK--SAEVSASASLQKEKEVFDNLNGCPFVL 68
+ IG G FG V + + +A+K + +E EV L+ P ++
Sbjct: 10 VQEIGSGQFGLVHLGYWLNKD-----KVAIKTIREGAMSEEDFIEEAEVMMKLS-HPKLV 63
Query: 69 ECFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHI 128
+ +G + L+ E+ G L D + + + + EG+ ++
Sbjct: 64 QLYGVCLEQAP-----ICLVFEFMEHGCLSDYLRTQR-GLFAAETLLGMCLDVCEGMAYL 117
Query: 129 HDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMRGTPLYLAPE 188
++ +H D+ N L+ V K++D G+ + + + + +PE
Sbjct: 118 EEACVIHRDLAARNCLV----GENQVIKVSDFGMTRFVLDDQY-TSSTGTKFPVKWASPE 172
Query: 189 TVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEHSLPEIPSRVSK 248
+ SD+W+ G ++ E+ S + E+ S ++ I L P S
Sbjct: 173 VFSFSRYSSKSDVWSFGVLMWEVFSEGKIP--YENRSNSEVVEDISTGFRLY-KPRLAST 229
Query: 249 EARDFLRRCFVRKPAFRFTAEMLL 272
+ C+ +P R LL
Sbjct: 230 HVYQIMNHCWKERPEDRPAFSRLL 253
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 138 bits (349), Expect = 4e-39
Identities = 61/289 (21%), Positives = 110/289 (38%), Gaps = 40/289 (13%)
Query: 11 GRVIGQGSFGCVFIAKPKSNSSFLPP-LMAVKSAEVSASASLQK----EKEVFDNLNGCP 65
R IG+G+FG VF A+ + P ++AVK + ASA +Q E + +
Sbjct: 18 VRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPN 77
Query: 66 FVLECFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNG----------------- 108
V + G LL EY A G L + + + +
Sbjct: 78 IV-KLLGVCAVGKP-----MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSS 131
Query: 109 -----LPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVA 163
L + R + G+ ++ + +VH D+ N L+ V KIAD G++
Sbjct: 132 PGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLV----GENMVVKIADFGLS 187
Query: 164 KRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKED 223
+ K D + ++ PE++ + SD+WA G V+ E+ S
Sbjct: 188 RNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPY--YG 245
Query: 224 CSIDQLFSIIGDEHSLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLL 272
+ +++ + D + + P E + +R C+ + PA R + +
Sbjct: 246 MAHEEVIYYVRDGN-ILACPENCPLELYNLMRLCWSKLPADRPSFCSIH 293
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (350), Expect = 5e-39
Identities = 51/309 (16%), Positives = 121/309 (39%), Gaps = 24/309 (7%)
Query: 10 RGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVK----SAEVSASASLQKEKEVFDNLNGCP 65
+ +V+G G+FG V+ + +A+K + A+ + E V +++ P
Sbjct: 13 KIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD-NP 71
Query: 66 FVLECFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGI 125
V + + L+ + G L D + + N + + ++ I +G+
Sbjct: 72 HVCRLL----GICLTSTV--QLITQLMPFGCLLDYVREHKDNI-GSQYLLNWCVQIAKGM 124
Query: 126 GHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMRGTPLYL 185
++ D VH D+ N+L+ KI D G+AK +++ + ++
Sbjct: 125 NYLEDRRLVHRDLAARNVLV----KTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 180
Query: 186 APETVVQHMQEAPSDIWALGCVVLEMLS-GRQAWVVKEDCSIDQLFSIIGDEHSLPEIPS 244
A E+++ + SD+W+ G V E+++ G + + + ++ SI+ ++ P
Sbjct: 181 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKPY---DGIPASEISSIL-EKGERLPQPP 236
Query: 245 RVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGVDEELSRELEGDYSQGEVTLSNADA 304
+ + + +C++ R L+ + D + ++GD + L +
Sbjct: 237 ICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDE---RMHLPSPTD 293
Query: 305 ESCSPECIS 313
+ +
Sbjct: 294 SNFYRALMD 302
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (352), Expect = 6e-39
Identities = 71/302 (23%), Positives = 111/302 (36%), Gaps = 43/302 (14%)
Query: 11 GRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVSASASLQKEKEVFDNLNGCPFVLEC 70
+VIG GSFG V+ AK + L+A+K +E ++ L+ ++
Sbjct: 25 TKVIGNGSFGVVYQAKLCDSGE----LVAIKKVL-QDKRFKNRELQIMRKLD-HCNIVRL 78
Query: 71 FGEEITMGENGEMAY-NLLLEYAAGGTLGDLIEKCNGNG-LPEKDVRHFTRCILEGIGHI 128
+ GE + Y NL+L+Y LP V+ + + + +I
Sbjct: 79 RYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYI 138
Query: 129 HDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMRGTPLYLAPE 188
H G H D+KP N+LL V K+ D G A + R + + S + Y APE
Sbjct: 139 HSFGICHRDIKPQNLLL---DPDTAVLKLCDFGSA---KQLVRGEPNVSYICSRYYRAPE 192
Query: 189 TVVQHMQ-EAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIG------------- 234
+ + D+W+ GCV+ E+L G+ + D +DQL II
Sbjct: 193 LIFGATDYTSSIDVWSAGCVLAELLLGQPIF--PGDSGVDQLVEIIKVLGTPTREQIREM 250
Query: 235 ----DEHSLPEIPS---------RVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGVD 281
E P+I + R EA R P R T F +
Sbjct: 251 NPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR 310
Query: 282 EE 283
+
Sbjct: 311 DP 312
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (345), Expect = 7e-39
Identities = 48/267 (17%), Positives = 105/267 (39%), Gaps = 24/267 (8%)
Query: 11 GRVIGQGSFGCVFIAKPKSNSSFLPPLMAVK--SAEVSASASLQKEKEVFDNLNGCPFVL 68
+ +G G FG V K + +A+K + +E +V NL+ ++
Sbjct: 9 LKELGTGQFGVVKYGKWRGQY-----DVAIKMIKEGSMSEDEFIEEAKVMMNLS-HEKLV 62
Query: 69 ECFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHI 128
+ +G ++ EY A G L + + + + + + + E + ++
Sbjct: 63 QLYGVCTKQRP-----IFIITEYMANGCLLNYLREMRHR-FQTQQLLEMCKDVCEAMEYL 116
Query: 129 HDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMRGTPLYLAPE 188
++H D+ N L+ + + V K++D G+++ + + + PE
Sbjct: 117 ESKQFLHRDLAARNCLV----NDQGVVKVSDFGLSRYVLDDEYTSSV-GSKFPVRWSPPE 171
Query: 189 TVVQHMQEAPSDIWALGCVVLEMLS-GRQAWVVKEDCSIDQLFSIIGDEHSLPEIPSRVS 247
++ + SDIWA G ++ E+ S G+ + E + + I + P S
Sbjct: 172 VLMYSKFSSKSDIWAFGVLMWEIYSLGKMPY---ERFTNSETAEHI-AQGLRLYRPHLAS 227
Query: 248 KEARDFLRRCFVRKPAFRFTAEMLLDD 274
++ + C+ K R T ++LL +
Sbjct: 228 EKVYTIMYSCWHEKADERPTFKILLSN 254
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (347), Expect = 1e-38
Identities = 53/269 (19%), Positives = 101/269 (37%), Gaps = 20/269 (7%)
Query: 11 GRVIGQGSFGCVFIAKPKSNSSFLPPLMAVK----SAEVSASASLQKEKEVFDNLNGCPF 66
VIG+G FGCV+ N AVK ++ + E + + + P
Sbjct: 32 NEVIGRGHFGCVYHGTLLDNDG-KKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFS-HPN 89
Query: 67 VLECFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIG 126
VL G + E + ++L Y G L + I + + KD+ F + +G+
Sbjct: 90 VLSLLG----ICLRSEGSPLVVLPYMKHGDLRNFI-RNETHNPTVKDLIGFGLQVAKGMK 144
Query: 127 HIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAK--RSRHCKRQKFDPSMRGTPLY 184
+ +VH D+ N +L KF K+AD G+A+ + + +
Sbjct: 145 FLASKKFVHRDLAARNCML----DEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKW 200
Query: 185 LAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEHSLPEIPS 244
+A E++ SD+W+ G ++ E+++ D + + + L P
Sbjct: 201 MALESLQTQKFTTKSDVWSFGVLLWELMTRGAPP--YPDVNTFDITVYLLQGRRLL-QPE 257
Query: 245 RVSKEARDFLRRCFVRKPAFRFTAEMLLD 273
+ + +C+ K R + L+
Sbjct: 258 YCPDPLYEVMLKCWHPKAEMRPSFSELVS 286
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (344), Expect = 1e-38
Identities = 55/271 (20%), Positives = 102/271 (37%), Gaps = 24/271 (8%)
Query: 11 GRVIGQGSFGCVFIAKPKSNSSFLPPLMAVK------SAEVSASASLQKEKEVFDNLNGC 64
+G GSFG V + + S +AVK ++ A +E +L+
Sbjct: 13 LEKLGDGSFGVVRRGEWDAPSGKTVS-VAVKCLKPDVLSQPEAMDDFIREVNAMHSLD-H 70
Query: 65 PFVLECFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEG 124
++ +G + M ++ E A G+L D + K G+ + + + EG
Sbjct: 71 RNLIRLYG----VVLTPPM--KMVTELAPLGSLLDRLRKHQGH-FLLGTLSRYAVQVAEG 123
Query: 125 IGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMRGTPLY 184
+G++ ++H D+ N+LL + + + KI D G+ + R P
Sbjct: 124 MGYLESKRFIHRDLAARNLLL----ATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFA 179
Query: 185 LAPETVVQHMQ-EAPSDIWALGCVVLEMLS-GRQAWVVKEDCSIDQLFSIIGDEHSLPEI 242
++ SD W G + EM + G++ W + Q+ I E
Sbjct: 180 WCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPW---IGLNGSQILHKIDKEGERLPR 236
Query: 243 PSRVSKEARDFLRRCFVRKPAFRFTAEMLLD 273
P ++ + + +C+ KP R T L D
Sbjct: 237 PEDCPQDIYNVMVQCWAHKPEDRPTFVALRD 267
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (340), Expect = 5e-38
Identities = 48/268 (17%), Positives = 98/268 (36%), Gaps = 21/268 (7%)
Query: 11 GRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVSASASLQK----EKEVFDNLNGCPF 66
GR IG+G FG V S + +A+K+ + S S+++ E + P
Sbjct: 12 GRCIGEGQFGDVHQGIYMSPEN-PALAVAIKTCKNCTSDSVREKFLQEALTMRQFD-HPH 69
Query: 67 VLECFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIG 126
+++ G E +++E G L ++ L + + + +
Sbjct: 70 IVKLIGVIT------ENPVWIIMELCTLGELRSFLQVRKY-SLDLASLILYAYQLSTALA 122
Query: 127 HIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMRGTPLYLA 186
++ +VH D+ N+L+ S K+ D G+++ K + ++A
Sbjct: 123 YLESKRFVHRDIAARNVLV----SSNDCVKLGDFGLSRYMEDSTYYKAS-KGKLPIKWMA 177
Query: 187 PETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEHSLPEIPSRV 246
PE++ + SD+W G + E+L + + + I + LP +P
Sbjct: 178 PESINFRRFTSASDVWMFGVCMWEILMHGVKP--FQGVKNNDVIGRIENGERLP-MPPNC 234
Query: 247 SKEARDFLRRCFVRKPAFRFTAEMLLDD 274
+ +C+ P+ R L
Sbjct: 235 PPTLYSLMTKCWAYDPSRRPRFTELKAQ 262
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 135 bits (340), Expect = 8e-38
Identities = 51/270 (18%), Positives = 98/270 (36%), Gaps = 22/270 (8%)
Query: 11 GRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVSAS----ASLQKEKEVFDNLNGCPF 66
+VIG G FG V K +A+K+ + + E + + P
Sbjct: 31 EQVIGAGEFGEVCSGHLKLPGK-REIFVAIKTLKSGYTEKQRRDFLSEASIMGQFD-HPN 88
Query: 67 VLECFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIG 126
V+ G ++ E+ G+L D + N + R I G+
Sbjct: 89 VIHLEGVVTKSTP-----VMIITEFMENGSL-DSFLRQNDGQFTVIQLVGMLRGIAAGMK 142
Query: 127 HIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAK---RSRHCKRQKFDPSMRGTPL 183
++ D YVH D+ NIL+ + V K++D G+++ +
Sbjct: 143 YLADMNYVHRDLAARNILV----NSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIR 198
Query: 184 YLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEHSLPEIP 243
+ APE + + SD+W+ G V+ E++S + D + + + I ++ LP P
Sbjct: 199 WTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPY--WDMTNQDVINAIEQDYRLP-PP 255
Query: 244 SRVSKEARDFLRRCFVRKPAFRFTAEMLLD 273
+ C+ + R +++
Sbjct: 256 MDCPSALHQLMLDCWQKDRNHRPKFGQIVN 285
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (343), Expect = 1e-37
Identities = 66/302 (21%), Positives = 111/302 (36%), Gaps = 49/302 (16%)
Query: 11 GRVIGQGSFGCVFIAKPKSNSSFLPPLMAVK----SAEVSASASLQKEKEVFDNLNGCPF 66
IG+G++G V A N +A+K + +E ++
Sbjct: 13 LSYIGEGAYGMVCSAYDNVNKV----RVAIKKISPFEHQTYCQRTLREIKILLRFR-HEN 67
Query: 67 VLECFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIG 126
++ I +M L+ + G L L++ L + +F IL G+
Sbjct: 68 IIGINDI-IRAPTIEQMKDVYLVTHLMGADLYKLLKT---QHLSNDHICYFLYQILRGLK 123
Query: 127 HIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRH-CKRQKFDPSMRGTPLYL 185
+IH + +H D+KP N+LL + KI D G+A+ + F T Y
Sbjct: 124 YIHSANVLHRDLKPSNLLL----NTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYR 179
Query: 186 APETVVQHMQEAPS-DIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIG---------- 234
APE ++ S DIW++GC++ EMLS R + K +DQL I+G
Sbjct: 180 APEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHY--LDQLNHILGILGSPSQEDL 237
Query: 235 ------------------DEHSLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPF 276
++ + +A D L + P R E L P+
Sbjct: 238 NCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPY 297
Query: 277 VK 278
++
Sbjct: 298 LE 299
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 135 bits (340), Expect = 3e-37
Identities = 62/294 (21%), Positives = 112/294 (38%), Gaps = 39/294 (13%)
Query: 12 RVIGQGSFGCVFIAKPKSNSSFLPPLMAVK------SAEVSASASLQKEKEVFDNLNGCP 65
+ +G GSFG V + K K + + A+K ++ EK + +N P
Sbjct: 47 KTLGTGSFGRVMLVKHKESGN----HYAMKILDKQKVVKLKQIEHTLNEKRILQAVN-FP 101
Query: 66 FVLECFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGI 125
F+++ +++EY AGG + + E R + I+
Sbjct: 102 FLVKLEFSFKDN-----SNLYMVMEYVAGGEMFSHL--RRIGRFSEPHARFYAAQIVLTF 154
Query: 126 GHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMRGTPLYL 185
++H ++ D+KP+N+L+ + ++ D G AKR + ++ GTP L
Sbjct: 155 EYLHSLDLIYRDLKPENLLI----DQQGYIQVTDFGFAKRVKGRTW-----TLCGTPEAL 205
Query: 186 APETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEHSLPEIPSR 245
APE ++ D WALG ++ EM +G + Q++ I PS
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYEMAAGYPPF---FADQPIQIYEKIVSGK--VRFPSH 260
Query: 246 VSKEARDFLRRCFVRKPAFRF-----TAEMLLDDPFVKGVDEE--LSRELEGDY 292
S + +D LR RF + + + D R++E +
Sbjct: 261 FSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPF 314
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (334), Expect = 6e-37
Identities = 59/301 (19%), Positives = 109/301 (36%), Gaps = 54/301 (17%)
Query: 12 RVIGQGSFGCVFIAKPKSNSSFLPPLMAVK--------SAEVSASASLQKEKEVFDNLNG 63
+G+G F V+ A+ K+ + ++A+K A+ + + +E ++ L+
Sbjct: 4 DFLGEGQFATVYKARDKNTNQ----IVAIKKIKLGHRSEAKDGINRTALREIKLLQELS- 58
Query: 64 CPFVLECFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILE 123
P ++ +L+ ++ + + N L ++ + L+
Sbjct: 59 HPNIIGLLDAFGHKSN-----ISLVFDFMETDLEVIIKD--NSLVLTPSHIKAYMLMTLQ 111
Query: 124 GIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMRGTPL 183
G+ ++H +H D+KP+N+LL V K+AD G+AK + T
Sbjct: 112 GLEYLHQHWILHRDLKPNNLLL----DENGVLKLADFGLAKS--FGSPNRAYTHQVVTRW 165
Query: 184 YLAPETVVQHMQE-APSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSII--------- 233
Y APE + D+WA+GC++ E+L D +DQL I
Sbjct: 166 YRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFL--PGDSDLDQLTRIFETLGTPTEE 223
Query: 234 ----------------GDEHSLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFV 277
L I S + D ++ F+ P R TA L +
Sbjct: 224 QWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYF 283
Query: 278 K 278
Sbjct: 284 S 284
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (333), Expect = 8e-37
Identities = 63/305 (20%), Positives = 120/305 (39%), Gaps = 51/305 (16%)
Query: 12 RVIGQGSFGCVFIAKPKSNSSFLPPLMAVK-----SAEVSASASLQKEKEVFDNLNGCPF 66
IG+G++G V+ A+ K ++A+K + ++ +E + LN P
Sbjct: 8 EKIGEGTYGVVYKARNKLTGE----VVALKKIRLDTETEGVPSTAIREISLLKELN-HPN 62
Query: 67 VLECFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIG 126
+++ T + L+ E+ L ++ G+P ++ + +L+G+
Sbjct: 63 IVKLLDVIHTENK-----LYLVFEFL-HQDLKKFMDASALTGIPLPLIKSYLFQLLQGLA 116
Query: 127 HIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMRGTPLYLA 186
H +H D+KP N+L+ + + K+AD G+A+ + T Y A
Sbjct: 117 FCHSHRVLHRDLKPQNLLI----NTEGAIKLADFGLARA--FGVPVRTYTHEVVTLWYRA 170
Query: 187 PETVVQHMQEAP-SDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSII------------ 233
PE ++ + DIW+LGC+ EM++ R + D IDQLF I
Sbjct: 171 PEILLGCKYYSTAVDIWSLGCIFAEMVTRRALF--PGDSEIDQLFRIFRTLGTPDEVVWP 228
Query: 234 --------------GDEHSLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKG 279
++ + ++ R L + P R +A+ L PF +
Sbjct: 229 GVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQD 288
Query: 280 VDEEL 284
V + +
Sbjct: 289 VTKPV 293
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 130 bits (328), Expect = 6e-36
Identities = 54/296 (18%), Positives = 105/296 (35%), Gaps = 32/296 (10%)
Query: 11 GRVIGQGSFGCVFIAKPKSNSSFLPP-LMAVK----SAEVSASASLQKEKEVFDNLNGCP 65
R +GQGSFG V+ K P +A+K +A + E V N C
Sbjct: 25 SRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFN-CH 83
Query: 66 FVLECFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNG--------LPEKDVRHF 117
V+ G +++E G L + +
Sbjct: 84 HVVRLLGVVSQGQP-----TLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQM 138
Query: 118 TRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPS 177
I +G+ +++ + +VH D+ N ++ + F KI D G+ + +
Sbjct: 139 AGEIADGMAYLNANKFVHRDLAARNCMV----AEDFTVKIGDFGMTRDIYETDYYRKGGK 194
Query: 178 MRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEH 237
+++PE++ + SD+W+ G V+ E+ + + + S +Q+ + E
Sbjct: 195 GLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPY--QGLSNEQVLRFV-MEG 251
Query: 238 SLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLD------DPFVKGVDEELSRE 287
L + P + +R C+ P R + ++ +P + V S E
Sbjct: 252 GLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFREVSFYYSEE 307
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (323), Expect = 3e-35
Identities = 58/282 (20%), Positives = 108/282 (38%), Gaps = 29/282 (10%)
Query: 11 GRVIGQGSFGCVFIAK-PKSNSSFLPPLMAVK----SAEVSASASLQKEKEVFDNLNGCP 65
G+ +G+G+FG V A + + +AVK A S +L E ++ ++
Sbjct: 18 GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 77
Query: 66 FVLECFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNG--------------NGLPE 111
V+ G G +++E+ G L + + L
Sbjct: 78 NVVNLLGACTKPGGP----LMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTL 133
Query: 112 KDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKR 171
+ + ++ + +G+ + +H D+ NILL S K V KI D G+A+
Sbjct: 134 EHLICYSFQVAKGMEFLASRKCIHRDLAARNILL----SEKNVVKICDFGLARDIYKDPD 189
Query: 172 QKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFS 231
R ++APET+ + SD+W+ G ++ E+ S + ID+ F
Sbjct: 190 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP--YPGVKIDEEFC 247
Query: 232 IIGDEHSLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLD 273
E + P + E + C+ +P+ R T L++
Sbjct: 248 RRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVE 289
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (320), Expect = 9e-35
Identities = 56/306 (18%), Positives = 107/306 (34%), Gaps = 51/306 (16%)
Query: 12 RVIGQGSFGCVFIAKPKSNSSFLPPLMAVK-----SAEVSASASLQKEKEVFDNLNGCPF 66
IGQG+FG VF A+ + +A+K + + + +E ++ L
Sbjct: 16 AKIGQGTFGEVFKARHRKTGQ----KVALKKVLMENEKEGFPITALREIKILQLLKHENV 71
Query: 67 V--LECFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEG 124
V +E + + + + L+ ++ G L +++ + +L G
Sbjct: 72 VNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLS--NVLVKFTLSEIKRVMQMLLNG 129
Query: 125 IGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAK--RSRHCKRQKFDPSMRGTP 182
+ +IH + +H D+K N+L+ + V K+AD G+A+ + + T
Sbjct: 130 LYYIHRNKILHRDMKAANVLI----TRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTL 185
Query: 183 LYLAPETVVQHMQ-EAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEHSLPE 241
Y PE ++ P D+W GC++ EM + + + QL I S+
Sbjct: 186 WYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIM--QGNTEQHQLALISQLCGSITP 243
Query: 242 -----------------------------IPSRVSKEARDFLRRCFVRKPAFRFTAEMLL 272
A D + + V PA R ++ L
Sbjct: 244 EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDAL 303
Query: 273 DDPFVK 278
+ F
Sbjct: 304 NHDFFW 309
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 125 bits (314), Expect = 3e-34
Identities = 57/294 (19%), Positives = 107/294 (36%), Gaps = 43/294 (14%)
Query: 12 RVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVSASASLQKEKEVFDNLNGCPFVLECF 71
IG+G++G V+ A+ +F + ++ + ++ +E + L +++ +
Sbjct: 8 EKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELK-HSNIVKLY 66
Query: 72 GEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDS 131
T + L+ E+ L GL + F +L GI + HD
Sbjct: 67 DVIHT-----KKRLVLVFEHLDQDLKKLLDVC--EGGLESVTAKSFLLQLLNGIAYCHDR 119
Query: 132 GYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMRGTPLYLAPETVV 191
+H D+KP N+L+ + + KIAD G+A+ + T Y AP+ ++
Sbjct: 120 RVLHRDLKPQNLLI----NREGELKIADFGLARAFGI--PVRKYTHEIVTLWYRAPDVLM 173
Query: 192 QHMQE-APSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSII----------------- 233
+ DIW++GC+ EM++G + DQL I
Sbjct: 174 GSKKYSTTIDIWSVGCIFAEMVNGTPLF--PGVSEADQLMRIFRILGTPNSKNWPNVTEL 231
Query: 234 ---------GDEHSLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVK 278
+ + + D L + P R TA+ L+ + K
Sbjct: 232 PKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFK 285
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 125 bits (315), Expect = 4e-34
Identities = 60/297 (20%), Positives = 105/297 (35%), Gaps = 48/297 (16%)
Query: 11 GRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVSASASLQKEKEVFDNLN-GCPFVLE 69
IG+G FG V+ K + +AVK S +E E++ + +L
Sbjct: 8 QESIGKGRFGEVWRGKWRGE------EVAVKIFSSREERSWFREAEIYQTVMLRHENILG 61
Query: 70 CFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIH 129
+ + L+ +Y G+L D + + + + + G+ H+H
Sbjct: 62 FIAADNKDNGTWTQLW-LVSDYHEHGSLFDYLNR---YTVTVEGMIKLALSTASGLAHLH 117
Query: 130 DS--------GYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKR--QKFDPSMR 179
H D+K NIL+ IADLG+A R
Sbjct: 118 MEIVGTQGKPAIAHRDLKSKNILV----KKNGTCCIADLGLAVRHDSATDTIDIAPNHRV 173
Query: 180 GTPLYLAPETVVQHMQE------APSDIWALGCVVLEMLSGR------------QAWVVK 221
GT Y+APE + + +DI+A+G V E+ +V
Sbjct: 174 GTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVP 233
Query: 222 EDCSIDQLFSIIGDEHSLPEIPSR-----VSKEARDFLRRCFVRKPAFRFTAEMLLD 273
D S++++ ++ ++ P IP+R + +R C+ A R TA +
Sbjct: 234 SDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKK 290
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 121 bits (303), Expect = 5e-32
Identities = 62/341 (18%), Positives = 120/341 (35%), Gaps = 54/341 (15%)
Query: 12 RVIGQGSFGCVFIAKPKSNSSFLPPLMAVK-----SAEVSASASLQKEKEVFDNLNGCPF 66
+G G++G V A +AVK + + +E + ++
Sbjct: 24 SPVGSGAYGSVCAAFDTKTGL----RVAVKKLSRPFQSIIHAKRTYRELRLLKHMK-HEN 78
Query: 67 VLECFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIG 126
V+ E L+ + G L ++ L + V+ IL G+
Sbjct: 79 VIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNI---VKCQKLTDDHVQFLIYQILRGLK 135
Query: 127 HIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMRGTPLYLA 186
+IH + +H D+KP N+ + KI D G+A+ + T Y A
Sbjct: 136 YIHSADIIHRDLKPSNLA----VNEDCELKILDFGLARHTDDEMT-----GYVATRWYRA 186
Query: 187 PETVVQHMQEAPS-DIWALGCVVLEMLSGRQAWVVKEDCS-IDQLFSIIGD--------- 235
PE ++ M + DIW++GC++ E+L+GR + + + + ++G
Sbjct: 187 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI 246
Query: 236 ----------------EHSLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKG 279
+ + + + A D L + V R TA L +
Sbjct: 247 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 306
Query: 280 V----DEELSRELEGDYSQGEVTLSNADAESCSPECISFIP 316
DE ++ + + ++ + + + E ISF+P
Sbjct: 307 YHDPDDEPVADPYDQSFESRDLLIDEWKSLTYD-EVISFVP 346
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (300), Expect = 1e-31
Identities = 56/304 (18%), Positives = 113/304 (37%), Gaps = 49/304 (16%)
Query: 12 RVIGQGSFGCVFIAKPKSNSSFLPPLMAVK-----SAEVSASASLQKEKEVFDNLNGCPF 66
+ +G G++G V A + +A+K + +E + ++
Sbjct: 24 QPVGSGAYGAVCSAVDGRTGA----KVAIKKLYRPFQSELFAKRAYRELRLLKHMR-HEN 78
Query: 67 VLECFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIG 126
V+ + L+ G LG L++ L E ++ +L+G+
Sbjct: 79 VIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKH---EKLGEDRIQFLVYQMLKGLR 135
Query: 127 HIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMRGTPLYLA 186
+IH +G +H D+KP N+ + + KI D G+A+++ T Y A
Sbjct: 136 YIHAAGIIHRDLKPGNLAV----NEDCELKILDFGLARQADSEMT-----GYVVTRWYRA 186
Query: 187 PETVVQHMQE-APSDIWALGCVVLEMLSGRQAWVVKEDCSIDQ-LFSIIG---------- 234
PE ++ M+ DIW++GC++ EM++G+ + + + + + G
Sbjct: 187 PEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRL 246
Query: 235 ---------------DEHSLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKG 279
++ I + S A + L + V R TA L P+ +
Sbjct: 247 QSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFES 306
Query: 280 VDEE 283
+ +
Sbjct: 307 LHDT 310
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 118 bits (297), Expect = 4e-31
Identities = 68/344 (19%), Positives = 123/344 (35%), Gaps = 67/344 (19%)
Query: 11 GRVIGQGSFGCVFIAKPKSNSSFLPPLMAVK------------SAEVSASASLQKEKEVF 58
R +G G F V++AK N++ +A+K E+ +
Sbjct: 18 VRKLGWGHFSTVWLAKDMVNNT----HVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTK 73
Query: 59 DNLNGCPFVLECFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFT 118
++ G +L+ G NG + +++ G L LI+K G+P V+ +
Sbjct: 74 EDSMGANHILKLLDHFNHKGPNGV--HVVMVFEVLGENLLALIKKYEHRGIPLIYVKQIS 131
Query: 119 RCILEGIGHIH-DSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPS 177
+ +L G+ ++H G +H D+KP+N+L+ + + + +A C + +
Sbjct: 132 KQLLLGLDYMHRRCGIIHTDIKPENVLM---EIVDSPENLIQIKIADLGNACWYDEHYTN 188
Query: 178 MRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCS----IDQLFSII 233
T Y +PE ++ +DIW+ C++ E+++G + E S D + II
Sbjct: 189 SIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQII 248
Query: 234 GDEHSLPE---------------------------------------IPSRVSKEARDFL 254
LP +KE DFL
Sbjct: 249 ELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFL 308
Query: 255 RRCFVRKPAFRFTAEMLLDDPFVKGV--DEELSRELEGDYSQGE 296
P R A L++ P++K EE+ Y G
Sbjct: 309 SPMLQLDPRKRADAGGLVNHPWLKDTLGMEEIRVPDRELYGSGS 352
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 115 bits (289), Expect = 1e-30
Identities = 49/297 (16%), Positives = 100/297 (33%), Gaps = 47/297 (15%)
Query: 12 RVIGQGSFGCVFIAKPKSNSSFLPPLMAVK-----SAEVSASASLQKEKEVFDNLNGCPF 66
IG+G++G VF AK + ++A+K + +S +E + L
Sbjct: 8 EKIGEGTYGTVFKAKNRETHE----IVALKRVRLDDDDEGVPSSALREICLLKELK-HKN 62
Query: 67 VLECFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIG 126
++ + + L+ E+ L + V+ F +L+G+G
Sbjct: 63 IVRLHDVLHS-----DKKLTLVFEFCDQDLKKY--FDSCNGDLDPEIVKSFLFQLLKGLG 115
Query: 127 HIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMRGTPLYLA 186
H +H D+KP N+L+ + K+A+ G+A+ + + +
Sbjct: 116 FCHSRNVLHRDLKPQNLLI----NRNGELKLANFGLARAFGI-PVRCYSAEVVTLWYRPP 170
Query: 187 PETVVQHMQEAPSDIWALGCVVLEMLSGR-------------------------QAWVVK 221
+ D+W+ GC+ E+ + + W
Sbjct: 171 DVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSM 230
Query: 222 EDCSIDQLFSIIGDEHSLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVK 278
+ + + SL + +++ RD L+ P R +AE L P+
Sbjct: 231 TKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFS 287
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 116 bits (292), Expect = 2e-30
Identities = 60/313 (19%), Positives = 109/313 (34%), Gaps = 66/313 (21%)
Query: 12 RVIGQGSFGCVFIAKPKSNSSFLPPLMAVK-----SAEVSASASLQKEKEVFDNLNGCPF 66
+ IG G+ G V A +A+K + + +E + +N
Sbjct: 23 KPIGSGAQGIVCAAYDAVLDR----NVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 78
Query: 67 V--LECFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEG 124
+ L F + T+ E + L++E + + + + + +L G
Sbjct: 79 ISLLNVFTPQKTLEEFQD--VYLVMELMDANLCQVIQMEL-----DHERMSYLLYQMLCG 131
Query: 125 IGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMRGTPLY 184
I H+H +G +H D+KP NI++ KI D G+A+ + T Y
Sbjct: 132 IKHLHSAGIIHRDLKPSNIVV----KSDCTLKILDFGLARTAGTSFMMTP---YVVTRYY 184
Query: 185 LAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEHSLP---- 240
APE ++ + DIW++GC++ EM+ + + IDQ +I +
Sbjct: 185 RAPEVILGMGYKENVDIWSVGCIMGEMVRHKILF--PGRDYIDQWNKVIEQLGTPCPEFM 242
Query: 241 -----------------------------------EIPSRVSKEARDFLRRCFVRKPAFR 265
E + +ARD L + V PA R
Sbjct: 243 KKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKR 302
Query: 266 FTAEMLLDDPFVK 278
+ + L P++
Sbjct: 303 ISVDDALQHPYIN 315
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 61.3 bits (148), Expect = 9e-12
Identities = 27/213 (12%), Positives = 59/213 (27%), Gaps = 39/213 (18%)
Query: 11 GRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVSASASLQKEKEVFDNLNGCPFVLEC 70
G+++G+G VF + VK + F + +
Sbjct: 5 GKLMGEGKESAVFNCYSEKFG-----ECVVKF--------HKVGHTSFKKVKEKRDYGDL 51
Query: 71 FGEEITMGENGEMAYNL----------LLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRC 120
+ + L + + L +LI+ + ++
Sbjct: 52 HFSVLAIRSARNEFRALQKLQGLAVPKVYAWEGNAVLMELIDAKELYRVRVENPDEVLDM 111
Query: 121 ILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMRG 180
ILE + + G VH D+ N+L+ + I D + ++
Sbjct: 112 ILEEVAKFYHRGIVHGDLSQYNVLV-----SEEGIWIIDFPQSVEVGEEGWREI------ 160
Query: 181 TPLYLAPETVVQHMQE---APSDIWALGCVVLE 210
L ++ + DI + +L+
Sbjct: 161 --LERDVRNIITYFSRTYRTEKDINSAIDRILQ 191
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 362 | |||
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.92 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.36 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.93 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.71 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.64 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.36 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.03 |
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-63 Score=438.78 Aligned_cols=256 Identities=29% Similarity=0.465 Sum_probs=212.9
Q ss_pred CceeecceecccCceEEEEEEECCCCCCCCceeeeechh----hhhhHHHHHHHHHHHHcCCCCcccccccceeeecCCC
Q 039291 6 TSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAE----VSASASLQKEKEVFDNLNGCPFVLECFGEEITMGENG 81 (362)
Q Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~----~~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~~ 81 (362)
++|.+++.||+|+||+||+|+++.+++ .||+|.+. .+..+.+.+|+.+|++++ ||||+++++.+..
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~----~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~-HpnIv~~~~~~~~----- 74 (271)
T d1nvra_ 5 EDWDLVQTLGEGAYGEVQLAVNRVTEE----AVAVKIVDMKRAVDCPENIKKEICINKMLN-HENVVKFYGHRRE----- 74 (271)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCC----EEEEEEEECC-------CHHHHHHHHHTCC-CTTBCCEEEEEEE-----
T ss_pred cceEEEEEEecCcCeEEEEEEECCCCC----EEEEEEEehhhcchHHHHHHHHHHHHHhCC-CCCEeeEeeeecc-----
Confidence 579999999999999999999998886 45555542 234456889999999998 9999999997753
Q ss_pred ceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEeecC
Q 039291 82 EMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLG 161 (362)
Q Consensus 82 ~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Dfg 161 (362)
...+|+|||||+||+|.++++. ...+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||
T Consensus 75 ~~~~~ivmEy~~gg~L~~~l~~--~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl----~~~~~~KL~DFG 148 (271)
T d1nvra_ 75 GNIQYLFLEYCSGGELFDRIEP--DIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLL----DERDNLKISDFG 148 (271)
T ss_dssp TTEEEEEEECCTTEEGGGGSBT--TTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE----CTTCCEEECCCT
T ss_pred CceeEEEEeccCCCcHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEE----CCCCCEEEccch
Confidence 2357899999999999999975 4569999999999999999999999999999999999999 777889999999
Q ss_pred CcccccccccCCCCCCccCCCCccCchhhccccC-CCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHHcCCCCCC
Q 039291 162 VAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQ-EAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEHSLP 240 (362)
Q Consensus 162 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 240 (362)
+|+..............+||+.|||||++.+..+ +.++|||||||++|+|++|++||....... .............
T Consensus 149 ~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~--~~~~~~~~~~~~~ 226 (271)
T d1nvra_ 149 LATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC--QEYSDWKEKKTYL 226 (271)
T ss_dssp TCEECEETTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTS--HHHHHHHTTCTTS
T ss_pred hheeeccCCccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHH--HHHHHHhcCCCCC
Confidence 9987655444444456789999999999988776 578999999999999999999997654433 2333333344444
Q ss_pred CCCccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCccC
Q 039291 241 EIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKG 279 (362)
Q Consensus 241 ~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~~~ 279 (362)
..+..+++++++||.+||+.||++|||++++++||||++
T Consensus 227 ~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~ 265 (271)
T d1nvra_ 227 NPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNK 265 (271)
T ss_dssp TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTC
T ss_pred CccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCc
Confidence 445678999999999999999999999999999999974
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-61 Score=430.92 Aligned_cols=253 Identities=26% Similarity=0.434 Sum_probs=213.4
Q ss_pred CceeecceecccCceEEEEEEECCCCCCCCceeeeechhh---hhhHHHHHHHHHHHHcCCCCcccccccceeeecCCCc
Q 039291 6 TSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEV---SASASLQKEKEVFDNLNGCPFVLECFGEEITMGENGE 82 (362)
Q Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~---~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~~~ 82 (362)
++|.+.+.||+|+||+||+|+++.+++ .||+|.+.. ...+.+.+|+.+|++++ ||||+++++++.. .
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~----~vAvK~~~~~~~~~~~~~~~E~~il~~l~-HpnIv~~~~~~~~-----~ 89 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQ----EVAIRQMNLQQQPKKELIINEILVMRENK-NPNIVNYLDSYLV-----G 89 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCC----EEEEEEEEGGGCSCHHHHHHHHHHHHHCC-CTTBCCEEEEEEE-----T
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCC----EEEEEEEecccChHHHHHHHHHHHHHhCC-CCCEeeEeEEEEE-----C
Confidence 589999999999999999999998876 566665432 34466899999999998 8999999997753 2
Q ss_pred eEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEeecCC
Q 039291 83 MAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGV 162 (362)
Q Consensus 83 ~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Dfgl 162 (362)
..+|+|||||+||+|.+++.. +++++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+
T Consensus 90 ~~~~ivmEy~~gg~L~~~~~~---~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl----~~~~~vkl~DFG~ 162 (293)
T d1yhwa1 90 DELWVVMEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILL----GMDGSVKLTDFGF 162 (293)
T ss_dssp TEEEEEEECCTTCBHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE----CTTCCEEECCCTT
T ss_pred CEEEEEEEecCCCcHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEE----CCCCcEeeccchh
Confidence 347899999999999998875 359999999999999999999999999999999999999 7778899999999
Q ss_pred cccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHHcCCCCCCCC
Q 039291 163 AKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEHSLPEI 242 (362)
Q Consensus 163 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 242 (362)
|+...... ......+||+.|+|||++.+..++.++|||||||++|+|++|++||.+.+. ...+...+.........
T Consensus 163 a~~~~~~~--~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~--~~~~~~~~~~~~~~~~~ 238 (293)
T d1yhwa1 163 CAQITPEQ--SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP--LRALYLIATNGTPELQN 238 (293)
T ss_dssp CEECCSTT--CCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH--HHHHHHHHHHCSCCCSS
T ss_pred heeecccc--ccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCH--HHHHHHHHhCCCCCCCC
Confidence 98665422 222467899999999999999999999999999999999999999965432 23333333333333455
Q ss_pred CccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCccC
Q 039291 243 PSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKG 279 (362)
Q Consensus 243 ~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~~~ 279 (362)
+..+++++++||.+||+.||++|||++++++||||+.
T Consensus 239 ~~~~s~~~~~li~~~L~~dP~~R~s~~eil~Hp~~~~ 275 (293)
T d1yhwa1 239 PEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKI 275 (293)
T ss_dssp GGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTCGGGGG
T ss_pred cccCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCC
Confidence 6789999999999999999999999999999999964
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-61 Score=427.54 Aligned_cols=250 Identities=26% Similarity=0.448 Sum_probs=214.2
Q ss_pred CCceeecceecccCceEEEEEEECCCCCCCCceeeeechh------hhhhHHHHHHHHHHHHcCCCCcccccccceeeec
Q 039291 5 GTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAE------VSASASLQKEKEVFDNLNGCPFVLECFGEEITMG 78 (362)
Q Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~------~~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~ 78 (362)
=++|.+++.||+|+||+||+|+++.+++ .||+|.+. ......+.+|+.++++++ ||||+++++++..
T Consensus 5 l~dy~i~~~iG~G~fg~Vy~~~~~~~~~----~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~~~~~~~~-- 77 (263)
T d2j4za1 5 LEDFEIGRPLGKGKFGNVYLAREKQSKF----ILALKVLFKAQLEKAGVEHQLRREVEIQSHLR-HPNILRLYGYFHD-- 77 (263)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCC----EEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCC-CTTBCCEEEEEEC--
T ss_pred hhHeEEEEEEecCCCcEEEEEEECCCCc----EEEEEEEchHHccChHHHHHHHHHHHHHHhcC-CCCCCeEEEEEEE--
Confidence 3679999999999999999999998876 45666543 223456889999999998 9999999997652
Q ss_pred CCCceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEe
Q 039291 79 ENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIA 158 (362)
Q Consensus 79 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~ 158 (362)
...+++|||||+||+|.+++... +++++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+
T Consensus 78 ---~~~~~ivmEy~~~g~L~~~l~~~--~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill----~~~~~~kl~ 148 (263)
T d2j4za1 78 ---ATRVYLILEYAPLGTVYRELQKL--SKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLL----GSAGELKIA 148 (263)
T ss_dssp ---SSEEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE----CTTSCEEEC
T ss_pred ---CCEEEEEEeecCCCcHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeecccccee----cCCCCEeec
Confidence 33477999999999999999874 459999999999999999999999999999999999999 778889999
Q ss_pred ecCCcccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHHcCCCC
Q 039291 159 DLGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEHS 238 (362)
Q Consensus 159 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 238 (362)
|||+|+..... .....+||+.|||||++.+..++.++|||||||+||+|++|+.||.+. +..++...+....
T Consensus 149 DFG~a~~~~~~----~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~---~~~~~~~~i~~~~- 220 (263)
T d2j4za1 149 DFGWSVHAPSS----RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN---TYQETYKRISRVE- 220 (263)
T ss_dssp CCCSCSCCCCC----CCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCS---SHHHHHHHHHTTC-
T ss_pred ccceeeecCCC----cccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCC---CHHHHHHHHHcCC-
Confidence 99999765432 223567999999999999999999999999999999999999999544 4566666654433
Q ss_pred CCCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCccC
Q 039291 239 LPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKG 279 (362)
Q Consensus 239 ~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~~~ 279 (362)
+.+|..+++++++||.+||+.||++|||++++++||||..
T Consensus 221 -~~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~hp~~~~ 260 (263)
T d2j4za1 221 -FTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA 260 (263)
T ss_dssp -CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTCHHHHH
T ss_pred -CCCCccCCHHHHHHHHHHccCCHhHCcCHHHHHcCcCcCC
Confidence 3466789999999999999999999999999999999963
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-61 Score=433.14 Aligned_cols=258 Identities=28% Similarity=0.454 Sum_probs=215.8
Q ss_pred CceeecceecccCceEEEEEEECCCCCCCCceeeeechh------hhhhHHHHHHHHHHHHcCCCCcccccccceeeecC
Q 039291 6 TSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAE------VSASASLQKEKEVFDNLNGCPFVLECFGEEITMGE 79 (362)
Q Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~------~~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~ 79 (362)
++|.+++.||+|+||+||+|+++.+++ .||+|.+. ......+.+|+++|++++ ||||+++++.+..
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~----~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~-HpnIv~l~~~~~~--- 79 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSR----EYAIKILEKRHIIKENKVPYVTRERDVMSRLD-HPFFVKLYFTFQD--- 79 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCC----EEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCC-STTBCCEEEEEEC---
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCC----EEEEEEEehHHccCHHHHHHHHHHHHHHHHcC-CCCeeEEEEEEEE---
Confidence 569999999999999999999998876 56666543 224456889999999998 9999999987642
Q ss_pred CCceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEee
Q 039291 80 NGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIAD 159 (362)
Q Consensus 80 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~D 159 (362)
...+|+|||||+||+|.+++... +.+++..++.++.|++.||+|||++||+||||||+|||+ +.++.+||+|
T Consensus 80 --~~~~~ivmEy~~gg~L~~~~~~~--~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll----~~~~~vkl~D 151 (288)
T d1uu3a_ 80 --DEKLYFGLSYAKNGELLKYIRKI--GSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILL----NEDMHIQITD 151 (288)
T ss_dssp --SSEEEEEECCCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE----CTTSCEEECC
T ss_pred --CCEEEEEEEccCCCCHHHhhhcc--CCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCcccccc----CCCceEEecc
Confidence 34578999999999999999874 459999999999999999999999999999999999999 7888899999
Q ss_pred cCCcccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHHcCCCCC
Q 039291 160 LGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEHSL 239 (362)
Q Consensus 160 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 239 (362)
||+|+..............+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+. +..++...+....
T Consensus 152 FG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~---~~~~~~~~i~~~~-- 226 (288)
T d1uu3a_ 152 FGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAG---NEYLIFQKIIKLE-- 226 (288)
T ss_dssp CTTCEECC----------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCS---SHHHHHHHHHTTC--
T ss_pred cccceecccCCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCc---CHHHHHHHHHcCC--
Confidence 99998765444444445678999999999999999999999999999999999999999654 4556666554433
Q ss_pred CCCCccCCHHHHHHHHHHhccCCCCCCCHHH------HhcCCCccCcchhh
Q 039291 240 PEIPSRVSKEARDFLRRCFVRKPAFRFTAEM------LLDDPFVKGVDEEL 284 (362)
Q Consensus 240 ~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~------~l~~p~~~~~~~~~ 284 (362)
+.+|..+++++++||++||+.||++|||++| +++||||+.+.|+.
T Consensus 227 ~~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~~~i~~Hpff~~i~w~~ 277 (288)
T d1uu3a_ 227 YDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWEN 277 (288)
T ss_dssp CCCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCCTT
T ss_pred CCCCccCCHHHHHHHHHHccCCHhHCcCHHHHcCCHHHHcCCccCCCCHHH
Confidence 3467789999999999999999999999987 58899999987764
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-60 Score=423.35 Aligned_cols=257 Identities=23% Similarity=0.366 Sum_probs=214.6
Q ss_pred CCCce-eecceecccCceEEEEEEECCCCCCCCceeeeech-----hhhhhHHHHHHHHHHHHcCCCCcccccccceeee
Q 039291 4 DGTSW-FRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSA-----EVSASASLQKEKEVFDNLNGCPFVLECFGEEITM 77 (362)
Q Consensus 4 ~~~~y-~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~-----~~~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~ 77 (362)
.++|| ...+.||+|+||+||+|+++.++.. ||+|.+ .....+.+.+|+++|++++ ||||+++++++...
T Consensus 6 ~~gry~~~~~~iG~G~fg~Vy~~~~~~~~~~----va~K~i~~~~~~~~~~~~~~~E~~il~~l~-HpnIv~~~~~~~~~ 80 (270)
T d1t4ha_ 6 NDGRFLKFDIEIGRGSFKTVYKGLDTETTVE----VAWCELQDRKLTKSERQRFKEEAEMLKGLQ-HPNIVRFYDSWEST 80 (270)
T ss_dssp TTSCEEEEEEEEEECSSEEEEEEEETTTCCE----EEEEEEEGGGSCHHHHHHHHHHHHHHTTCC-CTTBCCEEEEEEEE
T ss_pred CCCCEEEeeeEEecCcCcEEEEEEECCCCeE----EEEEEEchhhCCHHHHHHHHHHHHHHHhCC-CCCeeeEEEEEeec
Confidence 34566 6788999999999999999988764 455543 2334566889999999999 99999999977543
Q ss_pred cCCCceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--ceeCCCCCCCEEEeecCCCceEE
Q 039291 78 GENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSG--YVHCDVKPDNILLVATQSGKFVA 155 (362)
Q Consensus 78 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~--ivH~Dlkp~Nill~~~~~~~~~~ 155 (362)
. .....+|+|||||+||+|.+++.+. ..+++..++.++.||+.||+|||+++ |+||||||+|||+. +.++.+
T Consensus 81 ~-~~~~~~~ivmE~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~---~~~~~~ 154 (270)
T d1t4ha_ 81 V-KGKKCIVLVTELMTSGTLKTYLKRF--KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFIT---GPTGSV 154 (270)
T ss_dssp S-SSCEEEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEES---STTSCE
T ss_pred c-ccCCEEEEEEeCCCCCcHHHHHhcc--ccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceee---CCCCCE
Confidence 3 3345678999999999999999874 45999999999999999999999999 99999999999992 245789
Q ss_pred EEeecCCcccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHHcC
Q 039291 156 KIADLGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGD 235 (362)
Q Consensus 156 kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~ 235 (362)
||+|||+|+.... ......+||+.|||||++.+ .++.++|||||||++|||++|+.||... .+..++...+..
T Consensus 155 Kl~DFGla~~~~~----~~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~--~~~~~~~~~i~~ 227 (270)
T d1t4ha_ 155 KIGDLGLATLKRA----SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSEC--QNAAQIYRRVTS 227 (270)
T ss_dssp EECCTTGGGGCCT----TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTC--SSHHHHHHHHTT
T ss_pred EEeecCcceeccC----CccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCc--ccHHHHHHHHHc
Confidence 9999999975432 12235689999999999875 5999999999999999999999999643 356667777776
Q ss_pred CCCCCCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCcc
Q 039291 236 EHSLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVK 278 (362)
Q Consensus 236 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~~ 278 (362)
....+.++..+++++++||.+||+.||++|||++|+++||||+
T Consensus 228 ~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~Hp~fk 270 (270)
T d1t4ha_ 228 GVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ 270 (270)
T ss_dssp TCCCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC
T ss_pred CCCCcccCccCCHHHHHHHHHHccCCHhHCcCHHHHhCCcccC
Confidence 6665566777899999999999999999999999999999996
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-61 Score=439.11 Aligned_cols=265 Identities=24% Similarity=0.450 Sum_probs=213.2
Q ss_pred CCCCCCceeecceecccCceEEEEEEECCCCCCCCceeeeechhhhhhHHHHHHHHHHHHcCCCCcccccccceeeecCC
Q 039291 1 MDSDGTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVSASASLQKEKEVFDNLNGCPFVLECFGEEITMGEN 80 (362)
Q Consensus 1 ~~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~ 80 (362)
|++..++|.+++.||+|+||+||+|+++.+++.++.|+..+.........+.+|+.+|++++ ||||+++++++..
T Consensus 1 ~el~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~---- 75 (322)
T d1s9ja_ 1 MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECN-SPYIVGFYGAFYS---- 75 (322)
T ss_dssp CCCCGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCC-CTTBCCEEEEEEC----
T ss_pred CCCCccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCC-CCCCCcEEEEEEE----
Confidence 56788999999999999999999999998886444433332233344567889999999998 9999999997753
Q ss_pred CceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCceeCCCCCCCEEEeecCCCceEEEEee
Q 039291 81 GEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHD-SGYVHCDVKPDNILLVATQSGKFVAKIAD 159 (362)
Q Consensus 81 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~-~~ivH~Dlkp~Nill~~~~~~~~~~kl~D 159 (362)
...+|+||||++||+|.+++.+. +.+++..++.++.||+.||.|||+ +||+||||||+|||+ +.++.+||+|
T Consensus 76 -~~~~~iVmEy~~gg~L~~~l~~~--~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl----~~~~~vkl~D 148 (322)
T d1s9ja_ 76 -DGEISICMEHMDGGSLDQVLKKA--GRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILV----NSRGEIKLCD 148 (322)
T ss_dssp -SSEEEEEEECCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEE----CTTCCEEECC
T ss_pred -CCEEEEEEEcCCCCcHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeE----CCCCCEEEee
Confidence 23478999999999999999874 459999999999999999999997 599999999999999 7888999999
Q ss_pred cCCcccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHH----------
Q 039291 160 LGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQL---------- 229 (362)
Q Consensus 160 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~---------- 229 (362)
||+|+..... ...+.+||+.|+|||++.+..|+.++||||+||++|||++|+.||.+.+.......
T Consensus 149 FGla~~~~~~----~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~ 224 (322)
T d1s9ja_ 149 FGVSGQLIDS----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAA 224 (322)
T ss_dssp CCCCHHHHHH----TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC---------
T ss_pred CCCccccCCC----ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcc
Confidence 9999865432 22467899999999999999999999999999999999999999976543221111
Q ss_pred -----------------------------HHHHcCCCCCCCCC-ccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCccC
Q 039291 230 -----------------------------FSIIGDEHSLPEIP-SRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKG 279 (362)
Q Consensus 230 -----------------------------~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~~~ 279 (362)
...+... ..+..+ ..++.++++||.+||..||++|||++|+|+||||++
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~ 303 (322)
T d1s9ja_ 225 ETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNE-PPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKR 303 (322)
T ss_dssp ---------------------CCCCHHHHHHHHHTS-CCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHH
T ss_pred cCCcccccccccccccccccccchhHHHHHhhhhcc-CCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCc
Confidence 1111111 112222 236899999999999999999999999999999986
Q ss_pred cch
Q 039291 280 VDE 282 (362)
Q Consensus 280 ~~~ 282 (362)
..+
T Consensus 304 ~~~ 306 (322)
T d1s9ja_ 304 SDA 306 (322)
T ss_dssp HHH
T ss_pred CCc
Confidence 543
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-60 Score=425.94 Aligned_cols=256 Identities=26% Similarity=0.428 Sum_probs=211.8
Q ss_pred CceeecceecccCceEEEEEEECCCCCCCCceeeeechh---hhhhHHHHHHHHHHHHcCCCCcccccccceeeecCCCc
Q 039291 6 TSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAE---VSASASLQKEKEVFDNLNGCPFVLECFGEEITMGENGE 82 (362)
Q Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~---~~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~~~ 82 (362)
+.|.+++.||+|+||+||+|+++.++.. +|+|.+. ....+.+.+|+++|++++ ||||+++++++.. .
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~----vAvK~i~~~~~~~~~~~~~E~~il~~l~-HpnIv~l~~~~~~-----~ 81 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVL----AAAKVIDTKSEEELEDYMVEIDILASCD-HPNIVKLLDAFYY-----E 81 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCE----EEEEEEECSSSGGGGGTHHHHHHHHHCC-CTTBCCEEEEEEE-----T
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeE----EEEEEECcCCHHHHHHHHHHHHHHHhCC-CCCCCeEEEEEee-----C
Confidence 4699999999999999999999998864 5555542 345567889999999998 9999999997753 2
Q ss_pred eEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEeecCC
Q 039291 83 MAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGV 162 (362)
Q Consensus 83 ~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Dfgl 162 (362)
..+++|||||+||+|.+++... .+++++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+
T Consensus 82 ~~~~lvmEy~~~g~L~~~~~~~-~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll----~~~~~~Kl~DFG~ 156 (288)
T d2jfla1 82 NNLWILIEFCAGGAVDAVMLEL-ERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILF----TLDGDIKLADFGV 156 (288)
T ss_dssp TEEEEEEECCTTEEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE----CTTSCEEECCCTT
T ss_pred CeEEEEEecCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeE----CCCCCEEEEechh
Confidence 3477999999999999998763 4569999999999999999999999999999999999999 7788899999999
Q ss_pred cccccccccCCCCCCccCCCCccCchhhc-----cccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHHcCCC
Q 039291 163 AKRSRHCKRQKFDPSMRGTPLYLAPETVV-----QHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEH 237 (362)
Q Consensus 163 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 237 (362)
|+........ ....+||+.|+|||++. +..++.++|||||||++|+|++|++||...+.. ..+........
T Consensus 157 a~~~~~~~~~--~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~--~~~~~i~~~~~ 232 (288)
T d2jfla1 157 SAKNTRTIQR--RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPM--RVLLKIAKSEP 232 (288)
T ss_dssp CEECHHHHHH--HTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGG--GHHHHHHHSCC
T ss_pred hhccCCCccc--ccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHH--HHHHHHHcCCC
Confidence 9755432211 13567999999999985 456789999999999999999999999655432 22333333333
Q ss_pred CCCCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCccCc
Q 039291 238 SLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGV 280 (362)
Q Consensus 238 ~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~~~~ 280 (362)
.....+..+++++++||.+||+.||++|||++++++||||+..
T Consensus 233 ~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~hp~~~~~ 275 (288)
T d2jfla1 233 PTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTVD 275 (288)
T ss_dssp CCCSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGCCC
T ss_pred CCCCccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCC
Confidence 3344567899999999999999999999999999999999753
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.4e-60 Score=430.82 Aligned_cols=259 Identities=25% Similarity=0.371 Sum_probs=221.2
Q ss_pred CCCCceeecceecccCceEEEEEEECCCCCCCCceeeeechh------hhhhHHHHHHHHHHHHcCCCCcccccccceee
Q 039291 3 SDGTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAE------VSASASLQKEKEVFDNLNGCPFVLECFGEEIT 76 (362)
Q Consensus 3 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~------~~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~ 76 (362)
++-++|.+++.||+|+||+||+|+++.+++ .+|+|.+. ....+.+.+|+.+|++++ ||||+++++.+..
T Consensus 2 i~l~dy~~~~~lG~G~fg~V~~~~~~~~~~----~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~-hp~Iv~l~~~~~~ 76 (337)
T d1o6la_ 2 VTMNDFDYLKLLGKGTFGKVILVREKATGR----YYAMKILRKEVIIAKDEVAHTVTESRVLQNTR-HPFLTALKYAFQT 76 (337)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCC----EEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCC-CTTBCCEEEEEEC
T ss_pred CchHhcEEEEEEecCcCeEEEEEEECCCCC----EEEEEEEchhhccCHHHHHHHHHHHHHHHhCC-CCCEEEEEeeecc
Confidence 345789999999999999999999999886 45555543 224466889999999998 9999999987753
Q ss_pred ecCCCceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEE
Q 039291 77 MGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAK 156 (362)
Q Consensus 77 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~k 156 (362)
...+|+|||||+||+|.+++... +.+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+|
T Consensus 77 -----~~~~~iv~ey~~gg~L~~~~~~~--~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl----~~~g~vk 145 (337)
T d1o6la_ 77 -----HDRLCFVMEYANGGELFFHLSRE--RVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLML----DKDGHIK 145 (337)
T ss_dssp -----SSEEEEEEECCTTCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE----CTTSCEE
T ss_pred -----ccccccceeccCCCchhhhhhcc--cCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEe----cCCCCEE
Confidence 34578999999999999999874 459999999999999999999999999999999999999 8888999
Q ss_pred EeecCCcccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHHcCC
Q 039291 157 IADLGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDE 236 (362)
Q Consensus 157 l~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 236 (362)
|+|||+|+...... ......+||+.|+|||++.+..|+.++|||||||++|||++|++||.+. +..++...+...
T Consensus 146 l~DFG~a~~~~~~~--~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~---~~~~~~~~i~~~ 220 (337)
T d1o6la_ 146 ITDFGLCKEGISDG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ---DHERLFELILME 220 (337)
T ss_dssp ECCCTTCBCSCCTT--CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCS---SHHHHHHHHHHC
T ss_pred EeecccccccccCC--cccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCc---CHHHHHHHHhcC
Confidence 99999998654422 2234678999999999999999999999999999999999999999655 445555555443
Q ss_pred CCCCCCCccCCHHHHHHHHHHhccCCCCCCC-----HHHHhcCCCccCcchhh
Q 039291 237 HSLPEIPSRVSKEARDFLRRCFVRKPAFRFT-----AEMLLDDPFVKGVDEEL 284 (362)
Q Consensus 237 ~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s-----~~~~l~~p~~~~~~~~~ 284 (362)
. +.+|..+|+++++||++||+.||.+|++ ++++++||||+++.++.
T Consensus 221 ~--~~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~Hp~f~~i~~~~ 271 (337)
T d1o6la_ 221 E--IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQD 271 (337)
T ss_dssp C--CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTCCHHH
T ss_pred C--CCCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHcCcccccCCHHH
Confidence 3 3567889999999999999999999994 89999999999988764
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.9e-60 Score=428.82 Aligned_cols=256 Identities=26% Similarity=0.404 Sum_probs=198.9
Q ss_pred CCceeecceecccCceEEEEEEECCCCCCCCceeeeechh----hhhhHHHHHHHHHHHHcCCCCcccccccceeeecCC
Q 039291 5 GTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAE----VSASASLQKEKEVFDNLNGCPFVLECFGEEITMGEN 80 (362)
Q Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~----~~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~ 80 (362)
.++|.+++.||+|+||+||+|+++.+++ .||+|.+. ......+.+|+.+|++++ ||||+++++++..
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~----~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~---- 78 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKRTQK----LVAIKCIAKKALEGKEGSMENEIAVLHKIK-HPNIVALDDIYES---- 78 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETTTCC----EEEEEEEEC----------CHHHHHHHTCC-CTTBCCEEEEEEC----
T ss_pred ccceEEEEEEeeccCeEEEEEEECCCCC----EEEEEEEchHHhhhHHHHHHHHHHHHHhCC-CCCCCcEEEEEEE----
Confidence 3679999999999999999999998886 45666543 233456789999999998 9999999997642
Q ss_pred CceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEeec
Q 039291 81 GEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADL 160 (362)
Q Consensus 81 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Df 160 (362)
...+|+|||||+||+|.+++.. .+.+++..++.++.||+.||+|||++||+||||||+|||+... +.++.+||+||
T Consensus 79 -~~~~~lvmE~~~gg~L~~~l~~--~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~-~~~~~vkl~DF 154 (307)
T d1a06a_ 79 -GGHLYLIMQLVSGGELFDRIVE--KGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSL-DEDSKIMISDF 154 (307)
T ss_dssp -SSEEEEEECCCCSCBHHHHHHT--CSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSS-STTCCEEECCC
T ss_pred -CCEEEEEEeccCCCcHHHhhhc--ccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeeccc-CCCceEEEecc
Confidence 3357899999999999999976 4569999999999999999999999999999999999999432 34578999999
Q ss_pred CCcccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHHcCCCCC-
Q 039291 161 GVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEHSL- 239 (362)
Q Consensus 161 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~- 239 (362)
|+|+...... .....+||+.|||||++.+..++.++|||||||++|+|++|++||.+. ...++...+......
T Consensus 155 G~a~~~~~~~---~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~---~~~~~~~~i~~~~~~~ 228 (307)
T d1a06a_ 155 GLSKMEDPGS---VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDE---NDAKLFEQILKAEYEF 228 (307)
T ss_dssp ---------------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCS---SHHHHHHHHHTTCCCC
T ss_pred ceeEEccCCC---eeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCC---CHHHHHHHHhccCCCC
Confidence 9997654322 224578999999999999999999999999999999999999999654 344555544433322
Q ss_pred -CCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCccC
Q 039291 240 -PEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKG 279 (362)
Q Consensus 240 -~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~~~ 279 (362)
...+..+|+++++||.+||+.||++|||++|+++||||++
T Consensus 229 ~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~ 269 (307)
T d1a06a_ 229 DSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAG 269 (307)
T ss_dssp CTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTTS
T ss_pred CCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCC
Confidence 2345679999999999999999999999999999999975
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-60 Score=421.80 Aligned_cols=255 Identities=26% Similarity=0.439 Sum_probs=203.9
Q ss_pred CCceeecceecccCceEEEEEEECCCCCCCCceeeeechh-----hhhhHHHHHHHHHHHHcCCCCcccccccceeeecC
Q 039291 5 GTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAE-----VSASASLQKEKEVFDNLNGCPFVLECFGEEITMGE 79 (362)
Q Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~-----~~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~ 79 (362)
-++|.+++.||+|+||+||+|+++.+++ .||+|.+. ....+.+.+|+++|++++ ||||+++++++..
T Consensus 3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~----~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~-HpnIv~~~~~~~~--- 74 (269)
T d2java1 3 AEDYEVLYTIGTGSYGRCQKIRRKSDGK----ILVWKELDYGSMTEAEKQMLVSEVNLLRELK-HPNIVRYYDRIID--- 74 (269)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCC----EEEEEEECCTTSCHHHHHHHHHHHHHTTSCC-CTTBCCEEEEEEC---
T ss_pred chhCEEeEEEecCCCeEEEEEEECCCCC----EEEEEEEChhhCCHHHHHHHHHHHHHHHHCC-CCCEeeEEEEEEe---
Confidence 3579999999999999999999999886 45666532 234456889999999998 9999999997653
Q ss_pred CCceEEEEEEEecCCCCHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC-----ceeCCCCCCCEEEeecCCCc
Q 039291 80 NGEMAYNLLLEYAAGGTLGDLIEKC--NGNGLPEKDVRHFTRCILEGIGHIHDSG-----YVHCDVKPDNILLVATQSGK 152 (362)
Q Consensus 80 ~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~l~~~~~~~i~~ql~~~l~yLH~~~-----ivH~Dlkp~Nill~~~~~~~ 152 (362)
.....+|+|||||+||+|.+++.+. .+..+++..++.++.||+.||+|||++| |+||||||+|||+ +.+
T Consensus 75 ~~~~~~~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll----~~~ 150 (269)
T d2java1 75 RTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFL----DGK 150 (269)
T ss_dssp ----CEEEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEE----CTT
T ss_pred CCCCEEEEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCc----CCC
Confidence 2233477999999999999999753 3456999999999999999999999976 9999999999999 778
Q ss_pred eEEEEeecCCcccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHH
Q 039291 153 FVAKIADLGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSI 232 (362)
Q Consensus 153 ~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~ 232 (362)
+.+||+|||+|+..... .......+||+.|||||++.+..++.++|||||||++|||++|++||.+. +..++...
T Consensus 151 ~~vkl~DFG~a~~~~~~--~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~---~~~~~~~~ 225 (269)
T d2java1 151 QNVKLGDFGLARILNHD--TSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAF---SQKELAGK 225 (269)
T ss_dssp SCEEECCHHHHHHC-------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCS---SHHHHHHH
T ss_pred CcEEEeeccceeecccC--CCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCC---CHHHHHHH
Confidence 89999999999876542 22234678999999999999999999999999999999999999999654 45555555
Q ss_pred HcCCCCCCCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCc
Q 039291 233 IGDEHSLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFV 277 (362)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~ 277 (362)
+.... .+.++..+|+++++||.+||+.||++|||++++++|||+
T Consensus 226 i~~~~-~~~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~hp~i 269 (269)
T d2java1 226 IREGK-FRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI 269 (269)
T ss_dssp HHHTC-CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred HHcCC-CCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHHhCCcC
Confidence 54333 345677899999999999999999999999999999995
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-59 Score=420.63 Aligned_cols=261 Identities=26% Similarity=0.420 Sum_probs=214.2
Q ss_pred CCceeecceecccCceEEEEEEECCCCCCCCceeeeechhh---------hhhHHHHHHHHHHHHcCCCCccccccccee
Q 039291 5 GTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEV---------SASASLQKEKEVFDNLNGCPFVLECFGEEI 75 (362)
Q Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~---------~~~~~~~~E~~il~~l~~h~~i~~~~~~~~ 75 (362)
+++|.+++.||+|+||+||+|+++.+++. ||+|.+.. ...+.+.+|+.+|++|+ ||||+++++++.
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~----~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~-HpnIv~~~~~~~ 83 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQ----YAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ-HPNVITLHEVYE 83 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCE----EEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCC-CTTBCCEEEEEE
T ss_pred ccCEEEeEEEecCCCeEEEEEEECCCCCE----EEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCC-CCCCCcEEEEEE
Confidence 46899999999999999999999988864 55554321 13467889999999998 999999999764
Q ss_pred eecCCCceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEE
Q 039291 76 TMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVA 155 (362)
Q Consensus 76 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~ 155 (362)
. ...+|+|||||+||+|.+++... +.+++..++.++.|++.||+|||++||+||||||+|||+..++.....+
T Consensus 84 ~-----~~~~~iv~E~~~gg~L~~~i~~~--~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~v 156 (293)
T d1jksa_ 84 N-----KTDVILILELVAGGELFDFLAEK--ESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRI 156 (293)
T ss_dssp C-----SSEEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCE
T ss_pred E-----CCEEEEEEEcCCCccccchhccc--cccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccce
Confidence 3 33578999999999999999874 4599999999999999999999999999999999999996554445579
Q ss_pred EEeecCCcccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHHcC
Q 039291 156 KIADLGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGD 235 (362)
Q Consensus 156 kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~ 235 (362)
||+|||+|+....... .....||+.|+|||++.+..++.++|||||||++|+|++|+.||.+. +..+.+..+..
T Consensus 157 kl~DfG~a~~~~~~~~---~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~---~~~~~~~~i~~ 230 (293)
T d1jksa_ 157 KIIDFGLAHKIDFGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGD---TKQETLANVSA 230 (293)
T ss_dssp EECCCTTCEECTTSCB---CSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS---SHHHHHHHHHT
T ss_pred EecchhhhhhcCCCcc---ccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCC---CHHHHHHHHHh
Confidence 9999999986654322 24567999999999999999999999999999999999999999654 44455555443
Q ss_pred CCC-C-CCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCccCcchh
Q 039291 236 EHS-L-PEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGVDEE 283 (362)
Q Consensus 236 ~~~-~-~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~~~~~~~ 283 (362)
... + +..+..+|.++++||++||..||++|||++++++||||+...+.
T Consensus 231 ~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~~~ 280 (293)
T d1jksa_ 231 VNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQ 280 (293)
T ss_dssp TCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTCC----
T ss_pred cCCCCCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCChh
Confidence 322 1 12335789999999999999999999999999999999876443
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.3e-58 Score=419.57 Aligned_cols=253 Identities=25% Similarity=0.418 Sum_probs=217.5
Q ss_pred CceeecceecccCceEEEEEEECCCCCCCCceeeeechhh------hhhHHHHHHHHHHHHcCCCCcccccccceeeecC
Q 039291 6 TSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEV------SASASLQKEKEVFDNLNGCPFVLECFGEEITMGE 79 (362)
Q Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~------~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~ 79 (362)
+.|.+++.||+|+||+||+|+++.+++ .||+|.+.. ...+.+.+|+.+|++++ ||||+++++++..
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~----~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~-HpnIv~~~~~~~~--- 75 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGR----YYAMKVLKKEIVVRLKQVEHTNDERLMLSIVT-HPFIIRMWGTFQD--- 75 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCC----EEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCC-BTTBCCEEEEEEC---
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCC----EEEEEEEchHHccCHHHHHHHHHHHHHHHhcc-CcChhheeeeEee---
Confidence 579999999999999999999998876 566666432 23466889999999998 9999999997653
Q ss_pred CCceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEee
Q 039291 80 NGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIAD 159 (362)
Q Consensus 80 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~D 159 (362)
...+|+|||||.||+|..++.. ...+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|
T Consensus 76 --~~~~~ivmE~~~gg~l~~~~~~--~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl----~~~g~vkL~D 147 (316)
T d1fota_ 76 --AQQIFMIMDYIEGGELFSLLRK--SQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILL----DKNGHIKITD 147 (316)
T ss_dssp --SSEEEEEECCCCSCBHHHHHHH--TSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEE----CTTSCEEECC
T ss_pred --CCeeeeEeeecCCccccccccc--cccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeE----cCCCCEEEec
Confidence 3357899999999999999987 4569999999999999999999999999999999999999 7888999999
Q ss_pred cCCcccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHHcCCCCC
Q 039291 160 LGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEHSL 239 (362)
Q Consensus 160 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 239 (362)
||+|+..... ....+||+.|||||++.+..++.++|||||||++|+|++|+.||.+. +..++...+....
T Consensus 148 FG~a~~~~~~-----~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~---~~~~~~~~i~~~~-- 217 (316)
T d1fota_ 148 FGFAKYVPDV-----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDS---NTMKTYEKILNAE-- 217 (316)
T ss_dssp CSSCEECSSC-----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCS---SHHHHHHHHHHCC--
T ss_pred CccceEeccc-----cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCc---CHHHHHHHHHcCC--
Confidence 9999865432 23578999999999999999999999999999999999999999654 4555555554332
Q ss_pred CCCCccCCHHHHHHHHHHhccCCCCCC-----CHHHHhcCCCccCcchhh
Q 039291 240 PEIPSRVSKEARDFLRRCFVRKPAFRF-----TAEMLLDDPFVKGVDEEL 284 (362)
Q Consensus 240 ~~~~~~~~~~~~~li~~~l~~~p~~R~-----s~~~~l~~p~~~~~~~~~ 284 (362)
..+|..++++++++|.+||..||.+|+ |++++++||||+++.++.
T Consensus 218 ~~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~Hp~f~~i~~~~ 267 (316)
T d1fota_ 218 LRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKEVVWEK 267 (316)
T ss_dssp CCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSSCCHHH
T ss_pred CCCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcCcccccCCHHH
Confidence 245677999999999999999999996 899999999999998774
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1e-58 Score=418.73 Aligned_cols=249 Identities=28% Similarity=0.405 Sum_probs=207.8
Q ss_pred ceeecceecccCceEEEEEEECCCCCCCCceeeeechh------hhhhHHHHHHHHHHHHcCCCCcccccccceeeecCC
Q 039291 7 SWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAE------VSASASLQKEKEVFDNLNGCPFVLECFGEEITMGEN 80 (362)
Q Consensus 7 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~------~~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~ 80 (362)
+|..++.||+|+||+||+|+++.++. .||+|.+. ....+.+.+|+.+|++|+ ||||+++++++..
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~----~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~~~~~~~~---- 86 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVRNSE----VVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR-HPNTIQYRGCYLR---- 86 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTTE----EEEEEEEECCSSCHHHHHHHHHHHHHHHTTCC-CTTBCCEEEEEEE----
T ss_pred hcEeeEEEecCCCeEEEEEEECCCCc----EEEEEEEchhhccCHHHHHHHHHHHHHHHHCC-CCCEeeEEEEEEE----
Confidence 69999999999999999999998876 45666542 223456889999999998 9999999997753
Q ss_pred CceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEeec
Q 039291 81 GEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADL 160 (362)
Q Consensus 81 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Df 160 (362)
...+|+|||||.||+|..++.. ++++++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+||
T Consensus 87 -~~~~~iv~E~~~~g~l~~~~~~--~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl----~~~~~~Kl~DF 159 (309)
T d1u5ra_ 87 -EHTAWLVMEYCLGSASDLLEVH--KKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILL----SEPGLVKLGDF 159 (309)
T ss_dssp -TTEEEEEEECCSEEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEE----ETTTEEEECCC
T ss_pred -CCEEEEEEEecCCCchHHHHHh--CCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEE----CCCCCEEEeec
Confidence 2347899999999999776665 4569999999999999999999999999999999999999 77789999999
Q ss_pred CCcccccccccCCCCCCccCCCCccCchhhcc---ccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHHcCCC
Q 039291 161 GVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQ---HMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEH 237 (362)
Q Consensus 161 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 237 (362)
|+|+..... ...+||+.|||||++.+ ..|+.++|||||||++|||++|..||... ...+.+..+....
T Consensus 160 G~a~~~~~~------~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~---~~~~~~~~i~~~~ 230 (309)
T d1u5ra_ 160 GSASIMAPA------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM---NAMSALYHIAQNE 230 (309)
T ss_dssp TTCBSSSSB------CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTS---CHHHHHHHHHHSC
T ss_pred ccccccCCC------CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCC---CHHHHHHHHHhCC
Confidence 999754431 35679999999999964 45889999999999999999999999644 3344444443333
Q ss_pred CCCCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCccCc
Q 039291 238 SLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGV 280 (362)
Q Consensus 238 ~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~~~~ 280 (362)
..+..+..+|+++++||.+||+.||++|||++++++||||...
T Consensus 231 ~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~Hp~~~~~ 273 (309)
T d1u5ra_ 231 SPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRE 273 (309)
T ss_dssp CCCCSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHSC
T ss_pred CCCCCCCCCCHHHHHHHHHHCcCChhHCcCHHHHHhCHHhcCC
Confidence 3333456789999999999999999999999999999999653
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=4.8e-58 Score=423.61 Aligned_cols=259 Identities=24% Similarity=0.390 Sum_probs=214.7
Q ss_pred CCceeecceecccCceEEEEEEECCCCCCCCceeeeechhhh------hhHHHHHHH---HHHHHcCCCCccccccccee
Q 039291 5 GTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVS------ASASLQKEK---EVFDNLNGCPFVLECFGEEI 75 (362)
Q Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~~------~~~~~~~E~---~il~~l~~h~~i~~~~~~~~ 75 (362)
=++|.+++.||+|+||+||+|+++.+++ .||+|.+... ....+.+|. .+++.++ ||||+++++++.
T Consensus 3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~----~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~-hpnIv~l~~~~~ 77 (364)
T d1omwa3 3 MNDFSVHRIIGRGGFGEVYGCRKADTGK----MYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD-CPFIVCMSYAFH 77 (364)
T ss_dssp STTEEEEEEEEECSSCEEEEEEETTTCC----EEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSC-CTTBCCEEEEEE
T ss_pred HHhCeeeeEEecCCCeEEEEEEECCCCC----EEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCC-CCcEEEEEEEEE
Confidence 3679999999999999999999998886 5666654321 223344554 4445555 999999998764
Q ss_pred eecCCCceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEE
Q 039291 76 TMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVA 155 (362)
Q Consensus 76 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~ 155 (362)
. ...+|+|||||+||+|.+++... ..+++..++.++.||+.||.|||++|||||||||+|||+ +..+.+
T Consensus 78 ~-----~~~~~ivmE~~~gg~L~~~l~~~--~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl----~~~g~i 146 (364)
T d1omwa3 78 T-----PDKLSFILDLMNGGDLHYHLSQH--GVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILL----DEHGHV 146 (364)
T ss_dssp C-----SSEEEEEECCCCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE----CSSSCE
T ss_pred E-----CCEEEEEEEecCCCcHHHHHHhc--ccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEE----cCCCcE
Confidence 3 23478999999999999999873 459999999999999999999999999999999999999 888899
Q ss_pred EEeecCCcccccccccCCCCCCccCCCCccCchhhcc-ccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHHc
Q 039291 156 KIADLGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQ-HMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIG 234 (362)
Q Consensus 156 kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~ 234 (362)
||+|||+|+..... .....+||+.|+|||++.. ..++.++|||||||+||+|++|+.||......+...+...+.
T Consensus 147 Kl~DFGla~~~~~~----~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~ 222 (364)
T d1omwa3 147 RISDLGLACDFSKK----KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL 222 (364)
T ss_dssp EECCCTTCEECSSS----CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSS
T ss_pred EEeeeceeeecCCC----cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc
Confidence 99999999865432 2245679999999999974 568999999999999999999999998776666666655543
Q ss_pred CCCCCCCCCccCCHHHHHHHHHHhccCCCCCCC-----HHHHhcCCCccCcchhhh
Q 039291 235 DEHSLPEIPSRVSKEARDFLRRCFVRKPAFRFT-----AEMLLDDPFVKGVDEELS 285 (362)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s-----~~~~l~~p~~~~~~~~~~ 285 (362)
. ..+.++..+++++++||.+||+.||++||| ++++++||||+++.|...
T Consensus 223 ~--~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~i~~~~~ 276 (364)
T d1omwa3 223 T--MAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMV 276 (364)
T ss_dssp S--CCCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTSGGGTTCCHHHH
T ss_pred c--CCCCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcCccccCCCHHHH
Confidence 3 334567789999999999999999999999 799999999999987743
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=1.3e-58 Score=425.04 Aligned_cols=257 Identities=21% Similarity=0.367 Sum_probs=213.1
Q ss_pred CceeecceecccCceEEEEEEECCCCCCCCceeeeechh---hhhhHHHHHHHHHHHHcCCCCcccccccceeeecCCCc
Q 039291 6 TSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAE---VSASASLQKEKEVFDNLNGCPFVLECFGEEITMGENGE 82 (362)
Q Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~---~~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~~~ 82 (362)
++|.+++.||+|+||+||+|+++.+++ .||+|.+. ....+.+.+|+.+|++|+ ||||+++++++.. .
T Consensus 26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~g~----~vAvK~i~~~~~~~~~~~~~E~~il~~l~-HpnIv~~~~~~~~-----~ 95 (350)
T d1koaa2 26 DHYDIHEELGTGAFGVVHRVTERATGN----NFAAKFVMTPHESDKETVRKEIQTMSVLR-HPTLVNLHDAFED-----D 95 (350)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTE----EEEEEEECCCSHHHHHHHHHHHHHHHHTC-CTTBCCEEEEEEE-----T
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCC----EEEEEEEcccchhhHHHHHHHHHHHHhCC-CCCCCcEEEEEEE-----C
Confidence 479999999999999999999998876 45666543 234566889999999998 9999999997653 2
Q ss_pred eEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEeecCC
Q 039291 83 MAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGV 162 (362)
Q Consensus 83 ~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Dfgl 162 (362)
..+|+|||||+||+|.+++... .+++++..++.++.||+.||+|||++|||||||||+|||+.. +.++.+||+|||+
T Consensus 96 ~~~~ivmE~~~gg~L~~~l~~~-~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~--~~~~~vkL~DFG~ 172 (350)
T d1koaa2 96 NEMVMIYEFMSGGELFEKVADE-HNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTT--KRSNELKLIDFGL 172 (350)
T ss_dssp TEEEEEECCCCSCBHHHHHTCT-TSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESS--TTSCCEEECCCTT
T ss_pred CEEEEEEEcCCCCCHHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeecc--CCCCeEEEeecch
Confidence 3478999999999999999652 346999999999999999999999999999999999999943 2356799999999
Q ss_pred cccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHHcCCC-C-CC
Q 039291 163 AKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEH-S-LP 240 (362)
Q Consensus 163 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~-~-~~ 240 (362)
|+...... ......||+.|||||++.+..++.++|||||||++|+|++|+.||.+. +..+++..+.... . .+
T Consensus 173 a~~~~~~~---~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~---~~~~~~~~i~~~~~~~~~ 246 (350)
T d1koaa2 173 TAHLDPKQ---SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGE---NDDETLRNVKSCDWNMDD 246 (350)
T ss_dssp CEECCTTS---CEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCS---SHHHHHHHHHHTCCCSCC
T ss_pred heeccccc---ccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCC---CHHHHHHHHHhCCCCCCc
Confidence 98655322 223578999999999999999999999999999999999999999654 3445544443322 2 22
Q ss_pred CCCccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCccCcc
Q 039291 241 EIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGVD 281 (362)
Q Consensus 241 ~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~~~~~ 281 (362)
..+..+++++++||.+||..||++|||++++++||||+...
T Consensus 247 ~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~~~~~~ 287 (350)
T d1koaa2 247 SAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGN 287 (350)
T ss_dssp GGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHSTTTSCTT
T ss_pred ccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCC
Confidence 33457899999999999999999999999999999998653
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1e-57 Score=419.19 Aligned_cols=254 Identities=24% Similarity=0.379 Sum_probs=217.7
Q ss_pred CceeecceecccCceEEEEEEECCCCCCCCceeeeechhh------hhhHHHHHHHHHHHHcCCCCcccccccceeeecC
Q 039291 6 TSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEV------SASASLQKEKEVFDNLNGCPFVLECFGEEITMGE 79 (362)
Q Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~------~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~ 79 (362)
++|.+++.||+|+||+||+|+++.+++ .||+|.+.. .....+.+|+++|+.++ ||||+++++.+..
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~----~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~~~~~~~~--- 112 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGN----HYAMKILDKQKVVKLKQIEHTLNEKRILQAVN-FPFLVKLEFSFKD--- 112 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCC----EEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCC-CTTBCCEEEEEEC---
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCC----EEEEEEEchHHccCHHHHHHHHHHHHHHHHcC-CCcEeeccccccc---
Confidence 689999999999999999999998886 566665432 23456889999999998 9999999987643
Q ss_pred CCceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEee
Q 039291 80 NGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIAD 159 (362)
Q Consensus 80 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~D 159 (362)
...+++||||+.||+|.+++... +.+++..++.++.||+.||.|||++|||||||||+|||+ +.++.+||+|
T Consensus 113 --~~~~~~v~e~~~~g~l~~~l~~~--~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl----~~~g~ikL~D 184 (350)
T d1rdqe_ 113 --NSNLYMVMEYVAGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLI----DQQGYIQVTD 184 (350)
T ss_dssp --SSEEEEEEECCTTCBHHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE----CTTSCEEECC
T ss_pred --ccccccccccccccchhhhHhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHccc----CCCCCEEeee
Confidence 23477999999999999999874 459999999999999999999999999999999999999 7788999999
Q ss_pred cCCcccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHHcCCCCC
Q 039291 160 LGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEHSL 239 (362)
Q Consensus 160 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 239 (362)
||+|+..... .....||+.|||||++.+..++.++|||||||++|+|++|++||.+. +...++..+....
T Consensus 185 FG~a~~~~~~-----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~---~~~~~~~~i~~~~-- 254 (350)
T d1rdqe_ 185 FGFAKRVKGR-----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFAD---QPIQIYEKIVSGK-- 254 (350)
T ss_dssp CTTCEECSSC-----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS---SHHHHHHHHHHCC--
T ss_pred ceeeeecccc-----cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCc---CHHHHHHHHhcCC--
Confidence 9999866432 23568999999999999999999999999999999999999999654 4555555554333
Q ss_pred CCCCccCCHHHHHHHHHHhccCCCCCC-----CHHHHhcCCCccCcchhhh
Q 039291 240 PEIPSRVSKEARDFLRRCFVRKPAFRF-----TAEMLLDDPFVKGVDEELS 285 (362)
Q Consensus 240 ~~~~~~~~~~~~~li~~~l~~~p~~R~-----s~~~~l~~p~~~~~~~~~~ 285 (362)
+..+..+++++.+||++||..||.+|+ |++++++||||+.+.++..
T Consensus 255 ~~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~Hp~f~~~~~~~~ 305 (350)
T d1rdqe_ 255 VRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFATTDWIAI 305 (350)
T ss_dssp CCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTTCCHHHH
T ss_pred CCCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHcCccccCCCHHHH
Confidence 345678999999999999999999995 8999999999999987643
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=1.6e-58 Score=424.64 Aligned_cols=257 Identities=25% Similarity=0.378 Sum_probs=212.5
Q ss_pred CceeecceecccCceEEEEEEECCCCCCCCceeeeechh---hhhhHHHHHHHHHHHHcCCCCcccccccceeeecCCCc
Q 039291 6 TSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAE---VSASASLQKEKEVFDNLNGCPFVLECFGEEITMGENGE 82 (362)
Q Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~---~~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~~~ 82 (362)
++|.+++.||+|+||+||+|+++.+++ .||+|.+. ......+.+|+.+|++|+ ||||+++++++.. .
T Consensus 29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~----~vAiK~i~~~~~~~~~~~~~Ei~il~~l~-HpnIv~~~~~~~~-----~ 98 (352)
T d1koba_ 29 DYYDILEELGSGAFGVVHRCVEKATGR----VFVAKFINTPYPLDKYTVKNEISIMNQLH-HPKLINLHDAFED-----K 98 (352)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCC----EEEEEEEECCSHHHHHHHHHHHHHHTTCC-STTBCCEEEEEEC-----S
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCC----EEEEEEECCcchhHHHHHHHHHHHHHhCC-CCCCCcEEEEEEE-----C
Confidence 469999999999999999999998886 45666543 234456889999999998 9999999997642 3
Q ss_pred eEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEeecCC
Q 039291 83 MAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGV 162 (362)
Q Consensus 83 ~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Dfgl 162 (362)
..+|+|||||+||+|.+++.. .+.++++..++.++.||+.||+|||++||+||||||+|||+.. ...+.+||+|||+
T Consensus 99 ~~~~ivmE~~~gg~L~~~~~~-~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~--~~~~~vkL~DFGl 175 (352)
T d1koba_ 99 YEMVLILEFLSGGELFDRIAA-EDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCET--KKASSVKIIDFGL 175 (352)
T ss_dssp SEEEEEEECCCCCBHHHHTTC-TTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESS--TTCCCEEECCCTT
T ss_pred CEEEEEEEcCCCChHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccc--cCCCeEEEeeccc
Confidence 357899999999999988765 2446999999999999999999999999999999999999932 2457899999999
Q ss_pred cccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHHcC-CCC-CC
Q 039291 163 AKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGD-EHS-LP 240 (362)
Q Consensus 163 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~-~~~-~~ 240 (362)
|+...... ......||+.|+|||++.+..++.++|||||||++|+|++|.+||.+. +..+++..+.. ... .+
T Consensus 176 a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~---~~~~~~~~i~~~~~~~~~ 249 (352)
T d1koba_ 176 ATKLNPDE---IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGE---DDLETLQNVKRCDWEFDE 249 (352)
T ss_dssp CEECCTTS---CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCS---SHHHHHHHHHHCCCCCCS
T ss_pred ceecCCCC---ceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCC---CHHHHHHHHHhCCCCCCc
Confidence 98665422 223567999999999999999999999999999999999999999654 33444444332 222 23
Q ss_pred CCCccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCccCcc
Q 039291 241 EIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGVD 281 (362)
Q Consensus 241 ~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~~~~~ 281 (362)
..+..+++++++||.+||+.||.+|||++++++||||++..
T Consensus 250 ~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~Hp~~~~~~ 290 (352)
T d1koba_ 250 DAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDH 290 (352)
T ss_dssp STTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSCC
T ss_pred ccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCCCc
Confidence 34567999999999999999999999999999999998653
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.8e-58 Score=415.21 Aligned_cols=257 Identities=29% Similarity=0.461 Sum_probs=215.6
Q ss_pred CceeecceecccCceEEEEEEECCCCCCCCceeeeechhh------hhhHHHHHHHHHHHHcCCCCcccccccceeeecC
Q 039291 6 TSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEV------SASASLQKEKEVFDNLNGCPFVLECFGEEITMGE 79 (362)
Q Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~------~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~ 79 (362)
++|.+++.||+|+||+||+|+++.+++ .||+|.+.. .....+.+|..++.+..+||||+++++.+..
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~----~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~--- 74 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQ----FFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQT--- 74 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTE----EEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEEC---
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCC----EEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEcc---
Confidence 469999999999999999999998886 566666532 2334567787777653349999999997653
Q ss_pred CCceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEee
Q 039291 80 NGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIAD 159 (362)
Q Consensus 80 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~D 159 (362)
...+|+|||||+||+|.+++... ..+++..++.++.||+.||+|||++||+||||||+|||+ +..+.+||+|
T Consensus 75 --~~~~yivmEy~~~g~L~~~i~~~--~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~----~~~~~~kl~D 146 (320)
T d1xjda_ 75 --KENLFFVMEYLNGGDLMYHIQSC--HKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILL----DKDGHIKIAD 146 (320)
T ss_dssp --SSEEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE----CTTSCEEECC
T ss_pred --CCceeEEEeecCCCcHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceee----cCCCceeccc
Confidence 23478999999999999999873 459999999999999999999999999999999999999 8888999999
Q ss_pred cCCcccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHHcCCCCC
Q 039291 160 LGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEHSL 239 (362)
Q Consensus 160 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 239 (362)
||+++...... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+. +..++...+... .
T Consensus 147 FG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~---~~~~~~~~i~~~--~ 219 (320)
T d1xjda_ 147 FGMCKENMLGD--AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQ---DEEELFHSIRMD--N 219 (320)
T ss_dssp CTTCBCCCCTT--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCS---SHHHHHHHHHHC--C
T ss_pred cchhhhccccc--ccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCC---CHHHHHHHHHcC--C
Confidence 99998655422 2224578999999999999999999999999999999999999999654 455666555433 2
Q ss_pred CCCCccCCHHHHHHHHHHhccCCCCCCCHH-HHhcCCCccCcchhh
Q 039291 240 PEIPSRVSKEARDFLRRCFVRKPAFRFTAE-MLLDDPFVKGVDEEL 284 (362)
Q Consensus 240 ~~~~~~~~~~~~~li~~~l~~~p~~R~s~~-~~l~~p~~~~~~~~~ 284 (362)
+.+|..+|+++++||.+||..||++||++. ++++||||+++.++.
T Consensus 220 ~~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~hpff~~~~~~~ 265 (320)
T d1xjda_ 220 PFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREINWEE 265 (320)
T ss_dssp CCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTTCCHHH
T ss_pred CCCCccCCHHHHHHHHHhcccCCCCCcCHHHHHHhCchhccCCHHH
Confidence 456778999999999999999999999995 899999999987653
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-57 Score=416.76 Aligned_cols=263 Identities=22% Similarity=0.361 Sum_probs=211.3
Q ss_pred Cceeec-ceecccCceEEEEEEECCCCCCCCceeeeechhhhhhHHHHHHHHHHHHcCCCCcccccccceeeecCCCceE
Q 039291 6 TSWFRG-RVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVSASASLQKEKEVFDNLNGCPFVLECFGEEITMGENGEMA 84 (362)
Q Consensus 6 ~~y~~~-~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~~~~~ 84 (362)
++|.+. +.||+|+||+||+|+++.+++ .||+|.+.. ...+.+|+.++.++.+||||+++++++.... .....
T Consensus 11 ~~y~i~~~~lG~G~fg~Vy~a~~~~~~~----~vAiK~i~~--~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~-~~~~~ 83 (335)
T d2ozaa1 11 DDYKVTSQVLGLGINGKVLQIFNKRTQE----KFALKMLQD--CPKARREVELHWRASQCPHIVRIVDVYENLY-AGRKC 83 (335)
T ss_dssp GTEEEEEEEEEECSSCEEEEEEETTTCC----EEEEEEEEC--SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEE-TTEEE
T ss_pred cCEEEeeEEeeeccCeEEEEEEECCCCC----EEEEEEECC--cHHHHHHHHHHHHhcCCCCCCeEEEEEeecc-cCCCE
Confidence 578876 569999999999999998875 567777643 4557899999887766999999999775432 33456
Q ss_pred EEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEeecCCcc
Q 039291 85 YNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAK 164 (362)
Q Consensus 85 ~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Dfgla~ 164 (362)
+|+|||||+||+|.+++......++++.+++.|+.||+.||+|||++||+||||||+|||+... +..+.+||+|||+|+
T Consensus 84 ~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~-~~~~~~Kl~DFG~a~ 162 (335)
T d2ozaa1 84 LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSK-RPNAILKLTDFGFAK 162 (335)
T ss_dssp EEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCS-STTCCEEECCCTTCE
T ss_pred EEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCccccccccccccccc-cccccccccccceee
Confidence 7899999999999999987555679999999999999999999999999999999999999432 245679999999998
Q ss_pred cccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHH-HHHHHcCCC-CCC-C
Q 039291 165 RSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQ-LFSIIGDEH-SLP-E 241 (362)
Q Consensus 165 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~-~~~~~~~~~-~~~-~ 241 (362)
...... .....+||+.|+|||++.+..++.++|||||||+||+|++|++||.+........ +...+.... .+| .
T Consensus 163 ~~~~~~---~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~~~~~~~ 239 (335)
T d2ozaa1 163 ETTSHN---SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNP 239 (335)
T ss_dssp ECCCCC---CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCSSSCCTT
T ss_pred eccCCC---ccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCc
Confidence 665422 2246789999999999999999999999999999999999999997765443322 222222111 111 1
Q ss_pred CCccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCccC
Q 039291 242 IPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKG 279 (362)
Q Consensus 242 ~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~~~ 279 (362)
.+..+|+++++||.+||+.||++|||+.+++.||||.+
T Consensus 240 ~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~ 277 (335)
T d2ozaa1 240 EWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQ 277 (335)
T ss_dssp HHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHT
T ss_pred ccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHhhC
Confidence 12468999999999999999999999999999999964
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=7e-57 Score=400.73 Aligned_cols=254 Identities=25% Similarity=0.385 Sum_probs=210.8
Q ss_pred CceeecceecccCceEEEEEEECCCCCCCCceeeeechhhh------------hhHHHHHHHHHHHHcCCCCcccccccc
Q 039291 6 TSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVS------------ASASLQKEKEVFDNLNGCPFVLECFGE 73 (362)
Q Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~~------------~~~~~~~E~~il~~l~~h~~i~~~~~~ 73 (362)
++|.+++.||+|+||+||+|+++.+++ .+|+|.+... ..+.+.+|+.++++|..||||++++++
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~----~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~ 78 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCK----EYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDT 78 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTE----EEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEE
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCC----EEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEee
Confidence 689999999999999999999988875 5566654321 234578999999999989999999997
Q ss_pred eeeecCCCceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCce
Q 039291 74 EITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKF 153 (362)
Q Consensus 74 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~ 153 (362)
+.. ...+|+|||||+||+|.++++.. +++++..++.++.||+.||+|||++||+||||||+|||+ +.++
T Consensus 79 ~~~-----~~~~~ivmE~~~~g~L~~~l~~~--~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill----~~~~ 147 (277)
T d1phka_ 79 YET-----NTFFFLVFDLMKKGELFDYLTEK--VTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILL----DDDM 147 (277)
T ss_dssp EEC-----SSEEEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE----CTTC
T ss_pred ccc-----CcceEEEEEcCCCchHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEE----cCCC
Confidence 642 33578999999999999999873 459999999999999999999999999999999999999 8888
Q ss_pred EEEEeecCCcccccccccCCCCCCccCCCCccCchhhcc------ccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHH
Q 039291 154 VAKIADLGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQ------HMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSID 227 (362)
Q Consensus 154 ~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~ 227 (362)
.+||+|||+++....... ....+||+.|+|||++.+ ..++.++||||+||++|+|++|+.||.+.+ ..
T Consensus 148 ~~kl~DFG~a~~~~~~~~---~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~---~~ 221 (277)
T d1phka_ 148 NIKLTDFGFSCQLDPGEK---LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRK---QM 221 (277)
T ss_dssp CEEECCCTTCEECCTTCC---BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS---HH
T ss_pred CeEEccchheeEccCCCc---eeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCC---HH
Confidence 999999999986654222 245779999999999874 246789999999999999999999996543 34
Q ss_pred HHHHHHcCC-CCC-CCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCccCc
Q 039291 228 QLFSIIGDE-HSL-PEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGV 280 (362)
Q Consensus 228 ~~~~~~~~~-~~~-~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~~~~ 280 (362)
.....+... ..+ ......+|+++++||.+||+.||++|||++++++||||++.
T Consensus 222 ~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h~~~~~~ 276 (277)
T d1phka_ 222 LMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQY 276 (277)
T ss_dssp HHHHHHHHTCCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTT
T ss_pred HHHHHHHhCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHHHHh
Confidence 444433322 222 22345799999999999999999999999999999999863
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-56 Score=406.61 Aligned_cols=266 Identities=25% Similarity=0.405 Sum_probs=211.6
Q ss_pred CCceeecceecccCceEEEEEEECCCCCCCCceeeeechhh-----hhhHHHHHHHHHHHHcC--CCCcccccccceeee
Q 039291 5 GTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEV-----SASASLQKEKEVFDNLN--GCPFVLECFGEEITM 77 (362)
Q Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~-----~~~~~~~~E~~il~~l~--~h~~i~~~~~~~~~~ 77 (362)
+++|.+++.||+|+||+||+|+++.++. ..||+|.+.. .....+.+|+.+|+.|. +||||+++++++...
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~---~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~ 82 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGG---RFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVS 82 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTT---EEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEE
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCC---EEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeeccc
Confidence 5799999999999999999999976643 2456665432 23345778999888874 499999999988765
Q ss_pred cCCCceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEE
Q 039291 78 GENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKI 157 (362)
Q Consensus 78 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl 157 (362)
..+....++++|||+.++.+.... ......+++..++.++.|++.||+|||++||+||||||+|||+ +..+.+||
T Consensus 83 ~~~~~~~~~~~~e~~~~~~~~~~~-~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi----~~~~~~kl 157 (305)
T d1blxa_ 83 RTDRETKLTLVFEHVDQDLTTYLD-KVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILV----TSSGQIKL 157 (305)
T ss_dssp ECSSEEEEEEEEECCSCBHHHHHH-HSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE----CTTCCEEE
T ss_pred ccccCceEEEEEEeccCCchhhhh-hccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEE----cCCCCeee
Confidence 555667788999999886655443 3345669999999999999999999999999999999999999 88889999
Q ss_pred eecCCcccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHH-HHHcC-
Q 039291 158 ADLGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLF-SIIGD- 235 (362)
Q Consensus 158 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~-~~~~~- 235 (362)
+|||+++...... ......||+.|+|||++.+..++.++||||+||++|||++|++||.+.+..+....+ .....
T Consensus 158 ~dfg~~~~~~~~~---~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~ 234 (305)
T d1blxa_ 158 ADFGLARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLP 234 (305)
T ss_dssp CSCCSCCCCCGGG---GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred cchhhhhhhcccc---cCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCC
Confidence 9999987554332 224678999999999999999999999999999999999999999755432211111 11110
Q ss_pred --------------------CCCCCCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCccCcc
Q 039291 236 --------------------EHSLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGVD 281 (362)
Q Consensus 236 --------------------~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~~~~~ 281 (362)
....+.++..+++++++||++||+.||++|||++|+|+||||++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~i~ 300 (305)
T d1blxa_ 235 GEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLE 300 (305)
T ss_dssp CGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCC
T ss_pred chhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcCch
Confidence 0111223456889999999999999999999999999999998764
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.6e-57 Score=409.46 Aligned_cols=256 Identities=22% Similarity=0.361 Sum_probs=211.4
Q ss_pred CceeecceecccCceEEEEEEECCCCCCCCceeeeechhhh--hhHHHHHHHHHHHHcCCCCcccccccceeeecCCCce
Q 039291 6 TSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVS--ASASLQKEKEVFDNLNGCPFVLECFGEEITMGENGEM 83 (362)
Q Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~~--~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~~~~ 83 (362)
++|.+++.||+|+||+||+|+++.+++ .+|+|.+... ....+.+|+++|+.++ ||||+++++++.. ..
T Consensus 5 ~rY~i~~~lG~G~fg~Vy~~~~~~~~~----~~AiK~i~~~~~~~~~~~~Ei~il~~l~-HpnIv~~~~~~~~-----~~ 74 (321)
T d1tkia_ 5 EKYMIAEDLGRGEFGIVHRCVETSSKK----TYMAKFVKVKGTDQVLVKKEISILNIAR-HRNILHLHESFES-----ME 74 (321)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTE----EEEEEEECCCTHHHHHHHHHHHHHHHSC-CTTBCCEEEEEEE-----TT
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCc----EEEEEEEcCCcccHHHHHHHHHHHHhCC-CCCCCeEEEEEEE-----CC
Confidence 689999999999999999999998876 4566655432 3345789999999999 9999999997653 23
Q ss_pred EEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEeecCCc
Q 039291 84 AYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVA 163 (362)
Q Consensus 84 ~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Dfgla 163 (362)
.+|+|||||+||+|.+++... +.++++.+++.++.||+.||+|||++||+||||||+|||+.. ++...+||+|||++
T Consensus 75 ~~~lvmE~~~gg~L~~~i~~~-~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~--~~~~~ikl~DFG~~ 151 (321)
T d1tkia_ 75 ELVMIFEFISGLDIFERINTS-AFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQT--RRSSTIKIIEFGQA 151 (321)
T ss_dssp EEEEEECCCCCCBHHHHHTSS-SCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESS--SSCCCEEECCCTTC
T ss_pred EEEEEEecCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecC--CCceEEEEcccchh
Confidence 578999999999999999763 346999999999999999999999999999999999999932 24457999999999
Q ss_pred ccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHHcCCC-CCC-C
Q 039291 164 KRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEH-SLP-E 241 (362)
Q Consensus 164 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~-~~~-~ 241 (362)
+....... .....||+.|+|||.+.+..++.++|||||||++|+|++|..||... +..+++..+.... .++ .
T Consensus 152 ~~~~~~~~---~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~---~~~~~~~~i~~~~~~~~~~ 225 (321)
T d1tkia_ 152 RQLKPGDN---FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAE---TNQQIIENIMNAEYTFDEE 225 (321)
T ss_dssp EECCTTCE---EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCS---SHHHHHHHHHHTCCCCCHH
T ss_pred hccccCCc---ccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCC---CHHHHHHHHHhCCCCCChh
Confidence 76543221 23567999999999999999999999999999999999999999654 3445555443332 222 1
Q ss_pred CCccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCccCc
Q 039291 242 IPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGV 280 (362)
Q Consensus 242 ~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~~~~ 280 (362)
.+..+++++++||.+||..||++|||++++++||||++.
T Consensus 226 ~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~ 264 (321)
T d1tkia_ 226 AFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQK 264 (321)
T ss_dssp HHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred hccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccC
Confidence 224689999999999999999999999999999999753
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8e-57 Score=410.13 Aligned_cols=259 Identities=21% Similarity=0.280 Sum_probs=211.7
Q ss_pred CCCceeecceecccCceEEEEEEECCCCC-CCCceeeeechhh----hhhHHHHHHHHHHHHcCCCCcccccccceeeec
Q 039291 4 DGTSWFRGRVIGQGSFGCVFIAKPKSNSS-FLPPLMAVKSAEV----SASASLQKEKEVFDNLNGCPFVLECFGEEITMG 78 (362)
Q Consensus 4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~-~~~~~~~~K~~~~----~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~ 78 (362)
..++|.+++.||+|+||+||+|+++..++ ..+.+|++|.... .....+.+|+.+|+++.+||||+++++++..
T Consensus 35 ~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~-- 112 (325)
T d1rjba_ 35 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTL-- 112 (325)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECS--
T ss_pred CHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEee--
Confidence 34689999999999999999999876654 3345678887532 3445688999999999669999999997753
Q ss_pred CCCceEEEEEEEecCCCCHHHHHHHhcC---------------------CCCCHHHHHHHHHHHHHHHHHHHhCCceeCC
Q 039291 79 ENGEMAYNLLLEYAAGGTLGDLIEKCNG---------------------NGLPEKDVRHFTRCILEGIGHIHDSGYVHCD 137 (362)
Q Consensus 79 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~---------------------~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~D 137 (362)
...+++|||||+||+|.++++.... ..+++..++.++.|++.||+|||++||||||
T Consensus 113 ---~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRD 189 (325)
T d1rjba_ 113 ---SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRD 189 (325)
T ss_dssp ---SSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETT
T ss_pred ---CCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeecc
Confidence 2236799999999999999976432 3489999999999999999999999999999
Q ss_pred CCCCCEEEeecCCCceEEEEeecCCcccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHh-CCC
Q 039291 138 VKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLS-GRQ 216 (362)
Q Consensus 138 lkp~Nill~~~~~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~ 216 (362)
|||+|||+ +.++.+||+|||+|+...............||+.|||||++.+..++.++|||||||+||||++ |.+
T Consensus 190 lKp~Nill----~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~ 265 (325)
T d1rjba_ 190 LAARNVLV----THGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVN 265 (325)
T ss_dssp CSGGGEEE----ETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCC
T ss_pred Cchhcccc----ccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCC
Confidence 99999999 7788999999999987665443333345678999999999999999999999999999999998 899
Q ss_pred CCccCCCCCHHHHHHHHcCCCCCCCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhcC
Q 039291 217 AWVVKEDCSIDQLFSIIGDEHSLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDD 274 (362)
Q Consensus 217 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~ 274 (362)
||.+.+. ...+...+... ..+..|..+++++++||.+||+.||++|||++++++|
T Consensus 266 Pf~~~~~--~~~~~~~~~~~-~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~ 320 (325)
T d1rjba_ 266 PYPGIPV--DANFYKLIQNG-FKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 320 (325)
T ss_dssp SSTTCCC--SHHHHHHHHTT-CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCCCH--HHHHHHHHhcC-CCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 9965433 22333344333 3345678899999999999999999999999999875
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.7e-57 Score=400.83 Aligned_cols=251 Identities=22% Similarity=0.336 Sum_probs=200.4
Q ss_pred CCCCceeecceecccCceEEEEEEECCCCCCCCceeeeechh-----hhhhHHHHHHHHHHHHcCCCCcccccccceeee
Q 039291 3 SDGTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAE-----VSASASLQKEKEVFDNLNGCPFVLECFGEEITM 77 (362)
Q Consensus 3 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~-----~~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~ 77 (362)
+..++|.+++.||+|+||+||+|+.+. .||+|.+. ....+.+.+|+.+|++++ ||||++++++..
T Consensus 5 i~~~~~~~~~~lG~G~fg~Vy~~~~~~-------~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~-HpnIv~~~~~~~-- 74 (276)
T d1uwha_ 5 IPDGQITVGQRIGSGSFGTVYKGKWHG-------DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTR-HVNILLFMGYST-- 74 (276)
T ss_dssp CCTTCCCCCSEEEECSSCEEEEEESSS-------EEEEEECCCSSCCTTHHHHHHHHHHHHTTCC-CTTBCCEEEEEC--
T ss_pred cccccEEEEEEEeeCCCcEEEEEEECC-------EEEEEEEEcccCCHHHHHHHHHHHHHHHhCC-CCCEeeeeEEEe--
Confidence 456899999999999999999998643 25666643 335567889999999998 999999998642
Q ss_pred cCCCceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEE
Q 039291 78 GENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKI 157 (362)
Q Consensus 78 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl 157 (362)
+ ..+++|||||+||+|.+++... ..++++..+..++.||+.||+|||++|||||||||+|||+ +.++.+||
T Consensus 75 --~--~~~~lv~Ey~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl----~~~~~~Kl 145 (276)
T d1uwha_ 75 --A--PQLAIVTQWCEGSSLYHHLHII-ETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFL----HEDLTVKI 145 (276)
T ss_dssp --S--SSCEEEEECCCEEEHHHHHHTS-CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE----ETTSSEEE
T ss_pred --c--cEEEEEEecCCCCCHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEE----cCCCCEEE
Confidence 1 1257999999999999999763 3569999999999999999999999999999999999999 77788999
Q ss_pred eecCCcccccccccCCCCCCccCCCCccCchhhccc---cCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHHc
Q 039291 158 ADLGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQH---MQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIG 234 (362)
Q Consensus 158 ~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~ 234 (362)
+|||+|+...............||+.|||||++.+. .++.++|||||||+||||++|+.||.... ....+...+.
T Consensus 146 ~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~--~~~~~~~~~~ 223 (276)
T d1uwha_ 146 GDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNIN--NRDQIIFMVG 223 (276)
T ss_dssp CCCCCSCC------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCC--CHHHHHHHHH
T ss_pred ccccceeeccccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCC--hHHHHHHHHh
Confidence 999999866544343344567899999999999743 57889999999999999999999996543 3334444443
Q ss_pred CCCC---CCCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhcC
Q 039291 235 DEHS---LPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDD 274 (362)
Q Consensus 235 ~~~~---~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~ 274 (362)
.... .+.++..+++++.+||.+||..||++|||+++++++
T Consensus 224 ~~~~~p~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~ 266 (276)
T d1uwha_ 224 RGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILAS 266 (276)
T ss_dssp HTSCCCCGGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cCCCCCcchhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 3332 334567789999999999999999999999999875
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.9e-57 Score=400.77 Aligned_cols=248 Identities=25% Similarity=0.406 Sum_probs=203.9
Q ss_pred CCceeecceecccCceEEEEEEECCCCCCCCceeeeechhhh---------hhHHHHHHHHHHHHcC-CCCcccccccce
Q 039291 5 GTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVS---------ASASLQKEKEVFDNLN-GCPFVLECFGEE 74 (362)
Q Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~~---------~~~~~~~E~~il~~l~-~h~~i~~~~~~~ 74 (362)
+++|.+++.||+|+||+||+|+++.++. .||+|.+... ....+.+|+.+|++++ .||||+++++++
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~----~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~ 78 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNL----PVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWF 78 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCC----EEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEE
T ss_pred CCeEEEeEEEeeCCCeEEEEEEECCCCC----EEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEE
Confidence 5789999999999999999999998875 5666654322 2234678999999997 489999999876
Q ss_pred eeecCCCceEEEEEEEecCC-CCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCce
Q 039291 75 ITMGENGEMAYNLLLEYAAG-GTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKF 153 (362)
Q Consensus 75 ~~~~~~~~~~~~lv~e~~~~-~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~ 153 (362)
.. ...+++||||+.+ +++.+++... ..+++..++.++.||+.||+|||++||+||||||+|||+. .+.+
T Consensus 79 ~~-----~~~~~lv~e~~~~~~~l~~~~~~~--~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~---~~~~ 148 (273)
T d1xwsa_ 79 ER-----PDSFVLILERPEPVQDLFDFITER--GALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILID---LNRG 148 (273)
T ss_dssp EC-----SSEEEEEEECCSSEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEE---TTTT
T ss_pred ee-----CCeEEEEEEeccCcchHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEe---cCCC
Confidence 42 3357799999976 6788888763 4599999999999999999999999999999999999993 2346
Q ss_pred EEEEeecCCcccccccccCCCCCCccCCCCccCchhhccccC-CCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHH
Q 039291 154 VAKIADLGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQ-EAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSI 232 (362)
Q Consensus 154 ~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~ 232 (362)
.+||+|||+|+..... ......||+.|+|||++.+..+ +.++|||||||++|+|++|+.||...+ ..
T Consensus 149 ~vkl~DFG~a~~~~~~----~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~-----~i--- 216 (273)
T d1xwsa_ 149 ELKLIDFGSGALLKDT----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE-----EI--- 216 (273)
T ss_dssp EEEECCCTTCEECCSS----CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-----HH---
T ss_pred eEEECccccceecccc----cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch-----HH---
Confidence 8999999999755432 2245789999999999987665 567899999999999999999995431 11
Q ss_pred HcCCCCCCCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCccCcc
Q 039291 233 IGDEHSLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGVD 281 (362)
Q Consensus 233 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~~~~~ 281 (362)
.... ..++..+|+++++||++||..||++|||++|+++||||+++.
T Consensus 217 ~~~~---~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~~ 262 (273)
T d1xwsa_ 217 IRGQ---VFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVL 262 (273)
T ss_dssp HHCC---CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSCC
T ss_pred hhcc---cCCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCCC
Confidence 1122 235667999999999999999999999999999999998864
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-56 Score=402.09 Aligned_cols=253 Identities=22% Similarity=0.324 Sum_probs=199.2
Q ss_pred ecceecccCceEEEEEEECCCCCCCCceeeeechhhh--------hhHHHHHHHHHHHHcCCCCcccccccceeeecCCC
Q 039291 10 RGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVS--------ASASLQKEKEVFDNLNGCPFVLECFGEEITMGENG 81 (362)
Q Consensus 10 ~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~~--------~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~~ 81 (362)
.+++||+|+||+||+|+++.+++ .||+|.+... ....+.+|+.+|++++ ||||+++++++..
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~----~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~~~~~~~~----- 71 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQ----IVAIKKIKLGHRSEAKDGINRTALREIKLLQELS-HPNIIGLLDAFGH----- 71 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCS----EEEEEEC------------CTHHHHHHHHHHHCC-CTTBCCEEEEECC-----
T ss_pred cceEeccCcCeEEEEEEECCCCc----EEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCC-CCCEeEEEeeecc-----
Confidence 46889999999999999998876 5677765322 1345889999999998 9999999997643
Q ss_pred ceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEeecC
Q 039291 82 EMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLG 161 (362)
Q Consensus 82 ~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Dfg 161 (362)
...+|+||||+.|+++..++.. +..+++..++.++.||+.||+|||++||+||||||+|||+ +..+.+||+|||
T Consensus 72 ~~~~~ivmE~~~~~~~~~~~~~--~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli----~~~~~~KL~DFG 145 (299)
T d1ua2a_ 72 KSNISLVFDFMETDLEVIIKDN--SLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLL----DENGVLKLADFG 145 (299)
T ss_dssp TTCCEEEEECCSEEHHHHHTTC--CSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE----CTTCCEEECCCG
T ss_pred CCceeehhhhhcchHHhhhhhc--ccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEe----cCCCccccccCc
Confidence 2236799999998776665543 4569999999999999999999999999999999999999 888899999999
Q ss_pred CcccccccccCCCCCCccCCCCccCchhhcc-ccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHHcCCC---
Q 039291 162 VAKRSRHCKRQKFDPSMRGTPLYLAPETVVQ-HMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEH--- 237 (362)
Q Consensus 162 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~--- 237 (362)
+|+...... ......+||+.|+|||++.+ ..++.++|||||||++|||++|.+||.+..+.+....+.......
T Consensus 146 ~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~ 223 (299)
T d1ua2a_ 146 LAKSFGSPN--RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEE 223 (299)
T ss_dssp GGSTTTSCC--CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTT
T ss_pred cccccCCCc--ccccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChh
Confidence 997655422 22245689999999999875 467999999999999999999999997654322222111111100
Q ss_pred ---------------CCCC-----CCccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCccCc
Q 039291 238 ---------------SLPE-----IPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGV 280 (362)
Q Consensus 238 ---------------~~~~-----~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~~~~ 280 (362)
..+. ....+++++++||.+||+.||++|||++|+|+||||+..
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~ 286 (299)
T d1ua2a_ 224 QWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNR 286 (299)
T ss_dssp TSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSS
T ss_pred hccchhccchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCCC
Confidence 0011 113578999999999999999999999999999999754
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-55 Score=397.26 Aligned_cols=259 Identities=25% Similarity=0.460 Sum_probs=206.4
Q ss_pred CceeecceecccCceEEEEEEECCCCCCCCceeeeechhh-----hhhHHHHHHHHHHHHcCCCCcccccccceeeecCC
Q 039291 6 TSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEV-----SASASLQKEKEVFDNLNGCPFVLECFGEEITMGEN 80 (362)
Q Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~-----~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~ 80 (362)
++|.+++.||+|+||+||+|+++.+++ .||+|.+.. .....+.+|+++|++++ ||||+++++.+..
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~----~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~-Hp~Iv~~~~~~~~---- 72 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGE----VVALKKIRLDTETEGVPSTAIREISLLKELN-HPNIVKLLDVIHT---- 72 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCC----EEEEEEEC-------CCHHHHHHHHHHTTCC-CTTBCCEEEEEEE----
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCC----EEEEEEEehhhcChHHHHHHHHHHHHHHhCC-CCcEEEecccccc----
Confidence 489999999999999999999998876 566666532 23567889999999998 9999999998754
Q ss_pred CceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEeec
Q 039291 81 GEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADL 160 (362)
Q Consensus 81 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Df 160 (362)
...+|+||||+.+ ++.+++.......+++..++.++.||+.||+|||++|||||||||+|||+ +.++.+||+||
T Consensus 73 -~~~~~iv~e~~~~-~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~----~~~~~~kl~DF 146 (298)
T d1gz8a_ 73 -ENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLI----NTEGAIKLADF 146 (298)
T ss_dssp -TTEEEEEEECCSE-EHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE----CTTSCEEECST
T ss_pred -ccceeEEEeecCC-chhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheee----cccCcceeccC
Confidence 2347899999975 56666655556679999999999999999999999999999999999999 77888999999
Q ss_pred CCcccccccccCCCCCCccCCCCccCchhhcccc-CCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHH---cCC
Q 039291 161 GVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHM-QEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSII---GDE 236 (362)
Q Consensus 161 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~---~~~ 236 (362)
|+|+..... ........||+.|+|||++.... ++.++||||+||++|+|++|+.||.+.+. ...+.... ...
T Consensus 147 G~a~~~~~~--~~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~--~~~~~~i~~~~~~~ 222 (298)
T d1gz8a_ 147 GLARAFGVP--VRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSE--IDQLFRIFRTLGTP 222 (298)
T ss_dssp THHHHHCCC--SBCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH--HHHHHHHHHHHCCC
T ss_pred CcceeccCC--cccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCH--HHHHHHHHHhcCCC
Confidence 999866442 22334668999999999987765 57899999999999999999999975532 22222211 110
Q ss_pred C---------------CCCC--------CCccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCccCcchh
Q 039291 237 H---------------SLPE--------IPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGVDEE 283 (362)
Q Consensus 237 ~---------------~~~~--------~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~~~~~~~ 283 (362)
. ..+. ....+++++++||.+||+.||++|||++|+++||||+++...
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~~~p 292 (298)
T d1gz8a_ 223 DEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 292 (298)
T ss_dssp CTTTSTTGGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTCCCC
T ss_pred chhhccccccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccCCCC
Confidence 0 0000 112467899999999999999999999999999999877543
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.3e-56 Score=393.79 Aligned_cols=256 Identities=21% Similarity=0.330 Sum_probs=211.3
Q ss_pred CCCCceeecceecccCceEEEEEEECCCCCCCCceeeeechhhh--hhHHHHHHHHHHHHcCCCCcccccccceeeecCC
Q 039291 3 SDGTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVS--ASASLQKEKEVFDNLNGCPFVLECFGEEITMGEN 80 (362)
Q Consensus 3 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~~--~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~ 80 (362)
+..++|.+++.||+|+||+||+|+++++ ..||+|.+... ..+.+.+|+.++++++ ||||+++++++..
T Consensus 10 i~~~~~~~~~~iG~G~fg~Vy~~~~~~~-----~~vAvK~~~~~~~~~~~~~~E~~~l~~l~-HpnIv~~~g~~~~---- 79 (272)
T d1qpca_ 10 VPRETLKLVERLGAGQFGEVWMGYYNGH-----TKVAVKSLKQGSMSPDAFLAEANLMKQLQ-HQRLVRLYAVVTQ---- 79 (272)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTT-----EEEEEEEECTTSSCHHHHHHHHHHHHHCC-CTTBCCEEEEECS----
T ss_pred cCHHHeEEeEEEecCCCcEEEEEEECCC-----CEEEEEEEccCcCCHHHHHHHHHHHHhCC-CCCEeEEEeeecc----
Confidence 4567999999999999999999998753 25788876432 4567899999999998 9999999986531
Q ss_pred CceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEeec
Q 039291 81 GEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADL 160 (362)
Q Consensus 81 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Df 160 (362)
. .+++||||+++|+|.+++......++++..+..++.||+.||.|||+++|+||||||+|||+ +.++.+||+||
T Consensus 80 -~-~~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll----~~~~~~Kl~DF 153 (272)
T d1qpca_ 80 -E-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILV----SDTLSCKIADF 153 (272)
T ss_dssp -S-SCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE----CTTSCEEECCC
T ss_pred -C-CeEEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheee----ecccceeeccc
Confidence 1 25699999999999998876555569999999999999999999999999999999999999 88889999999
Q ss_pred CCcccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHHcCCCCCC
Q 039291 161 GVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEHSLP 240 (362)
Q Consensus 161 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 240 (362)
|+|+....... .......||+.|+|||++.+..++.++|||||||++|||+||..|+. ......++...+.... .+
T Consensus 154 Gla~~~~~~~~-~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~--~~~~~~~~~~~i~~~~-~~ 229 (272)
T d1qpca_ 154 GLARLIEDNEY-TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPY--PGMTNPEVIQNLERGY-RM 229 (272)
T ss_dssp TTCEECSSSCE-ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSS--TTCCHHHHHHHHHTTC-CC
T ss_pred cceEEccCCcc-ccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCC--CCCCHHHHHHHHHhcC-CC
Confidence 99986654322 22245679999999999998899999999999999999999655443 2234556666665443 34
Q ss_pred CCCccCCHHHHHHHHHHhccCCCCCCCHHHHhc--CCCcc
Q 039291 241 EIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLD--DPFVK 278 (362)
Q Consensus 241 ~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~--~p~~~ 278 (362)
..|..+++++.+||.+||+.||++|||++++++ ++||.
T Consensus 230 ~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ft 269 (272)
T d1qpca_ 230 VRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT 269 (272)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhh
Confidence 467789999999999999999999999999987 56664
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1e-55 Score=395.61 Aligned_cols=252 Identities=19% Similarity=0.315 Sum_probs=211.4
Q ss_pred CCCceeecceecccCceEEEEEEECCCCCCCCceeeeechhhh--hhHHHHHHHHHHHHcCCCCcccccccceeeecCCC
Q 039291 4 DGTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVS--ASASLQKEKEVFDNLNGCPFVLECFGEEITMGENG 81 (362)
Q Consensus 4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~~--~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~~ 81 (362)
..++|.+++.||+|+||+||+|+++.++. .||+|.+... ..+.+.+|+.+|++++ ||||+++++++..
T Consensus 15 ~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~----~vAvK~i~~~~~~~~~~~~E~~il~~l~-HpnIv~~~~~~~~----- 84 (287)
T d1opja_ 15 ERTDITMKHKLGGGQYGEVYEGVWKKYSL----TVAVKTLKEDTMEVEEFLKEAAVMKEIK-HPNLVQLLGVCTR----- 84 (287)
T ss_dssp CGGGEEEEEETTTTTTSSEEEEEEGGGTE----EEEEEECCTTCSCHHHHHHHHHHHHHCC-CTTBCCEEEEECS-----
T ss_pred cHHHeEEeeEEeeCCCeEEEEEEECCCCe----EEEEEEECCccchHHHHHHHHHHHHhCC-CCCEecCCccEee-----
Confidence 45689999999999999999999988775 5677765432 4567899999999998 9999999997743
Q ss_pred ceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEeecC
Q 039291 82 EMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLG 161 (362)
Q Consensus 82 ~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Dfg 161 (362)
...+++|||||++|+|.+++.......+++..+..++.||+.||+|||++||+||||||+|||+ +.++.+||+|||
T Consensus 85 ~~~~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl----~~~~~~Kl~DFG 160 (287)
T d1opja_ 85 EPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLV----GENHLVKVADFG 160 (287)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE----CGGGCEEECCCC
T ss_pred CCeeEEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEE----CCCCcEEEcccc
Confidence 2236799999999999999987666779999999999999999999999999999999999999 788899999999
Q ss_pred CcccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHHcCCCCCCC
Q 039291 162 VAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEHSLPE 241 (362)
Q Consensus 162 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 241 (362)
+|+........ ......||+.|+|||++.+..++.++|||||||++|||++|..||.. ..+..++...+.... .+.
T Consensus 161 ~a~~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~--~~~~~~~~~~i~~~~-~~~ 236 (287)
T d1opja_ 161 LSRLMTGDTYT-AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYP--GIDLSQVYELLEKDY-RME 236 (287)
T ss_dssp CTTTCCSSSSE-EETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSST--TCCHHHHHHHHHTTC-CCC
T ss_pred ceeecCCCCce-eeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCC--cchHHHHHHHHhcCC-CCC
Confidence 99865442222 12345689999999999999999999999999999999997666542 334566666665443 345
Q ss_pred CCccCCHHHHHHHHHHhccCCCCCCCHHHHhc
Q 039291 242 IPSRVSKEARDFLRRCFVRKPAFRFTAEMLLD 273 (362)
Q Consensus 242 ~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~ 273 (362)
.+..+++++++||.+||+.||++|||++++++
T Consensus 237 ~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~ 268 (287)
T d1opja_ 237 RPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ 268 (287)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCccchHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 67889999999999999999999999999975
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.8e-55 Score=394.95 Aligned_cols=256 Identities=19% Similarity=0.310 Sum_probs=199.6
Q ss_pred CCCCceeecceecccCceEEEEEEECCCCCCCCceeeeechh----hhhhHHHHHHHHHHHHcCCCCcccccccceeeec
Q 039291 3 SDGTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAE----VSASASLQKEKEVFDNLNGCPFVLECFGEEITMG 78 (362)
Q Consensus 3 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~----~~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~ 78 (362)
+..++|.+++.||+|+||+||+|+++.+++.. ..|++|... ....+.+.+|+++|++|+ ||||+++++++...
T Consensus 23 i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~-~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-HpnIv~l~g~~~~~- 99 (299)
T d1jpaa_ 23 IDISCVKIEQVIGAGEFGEVCSGHLKLPGKRE-IFVAIKTLKSGYTEKQRRDFLSEASIMGQFD-HPNVIHLEGVVTKS- 99 (299)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEECC---CC-EEEEEEECCSSCCHHHHHHHHHHHHHHTTCC-CTTBCCEEEEECSS-
T ss_pred hChhhcEEeeEEeeCCCeEEEEEEEeCCCCEE-EEEEEEEECcccCHHHHHHHHHHHHHHHhCC-CCCCccEEEEEeeC-
Confidence 34578999999999999999999998766432 346777643 234567899999999998 99999999976432
Q ss_pred CCCceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEe
Q 039291 79 ENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIA 158 (362)
Q Consensus 79 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~ 158 (362)
..+++|||||+||+|.+++... .+.+++.++..++.||+.||+|||++||+||||||+|||+ +.++.+||+
T Consensus 100 ----~~~~iv~Ey~~~g~L~~~~~~~-~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl----~~~~~~Kl~ 170 (299)
T d1jpaa_ 100 ----TPVMIITEFMENGSLDSFLRQN-DGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILV----NSNLVCKVS 170 (299)
T ss_dssp ----SSCEEEEECCTTEEHHHHHHTT-TTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE----CTTCCEEEC
T ss_pred ----CEEEEEEEecCCCcceeeeccc-cCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEE----CCCCcEEEC
Confidence 2367999999999999988763 3469999999999999999999999999999999999999 888899999
Q ss_pred ecCCcccccccccCCC---CCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHh-CCCCCccCCCCCHHHHHHHHc
Q 039291 159 DLGVAKRSRHCKRQKF---DPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLS-GRQAWVVKEDCSIDQLFSIIG 234 (362)
Q Consensus 159 Dfgla~~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~ 234 (362)
|||+|+.......... .....||+.|||||++.+..++.++|||||||+||||+| |.+||... ...++...+.
T Consensus 171 DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~---~~~~~~~~i~ 247 (299)
T d1jpaa_ 171 DFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDM---TNQDVINAIE 247 (299)
T ss_dssp CC-----------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC---CHHHHHHHHH
T ss_pred CcccceEccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCC---CHHHHHHHHH
Confidence 9999986554322211 123457999999999999999999999999999999998 89999544 4556666665
Q ss_pred CCCCCCCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhcC
Q 039291 235 DEHSLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDD 274 (362)
Q Consensus 235 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~ 274 (362)
..... ..+..++.++.+|+.+||+.||++|||+.+++++
T Consensus 248 ~~~~~-~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~ 286 (299)
T d1jpaa_ 248 QDYRL-PPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNT 286 (299)
T ss_dssp TTCCC-CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred cCCCC-CCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 55443 4567899999999999999999999999998863
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-55 Score=386.68 Aligned_cols=250 Identities=19% Similarity=0.289 Sum_probs=198.2
Q ss_pred CCCceeecceecccCceEEEEEEECCCCCCCCceeeeechhh--hhhHHHHHHHHHHHHcCCCCcccccccceeeecCCC
Q 039291 4 DGTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEV--SASASLQKEKEVFDNLNGCPFVLECFGEEITMGENG 81 (362)
Q Consensus 4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~--~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~~ 81 (362)
+.++|.+++.||+|+||+||+|+++++. .||+|.+.. ...+.+.+|++++++++ ||||+++++++...
T Consensus 3 dp~~~~~~~~iG~G~fg~Vy~~~~~~~~-----~vAvK~i~~~~~~~~~~~~E~~~l~~l~-HpnIv~~~g~~~~~---- 72 (263)
T d1sm2a_ 3 DPSELTFVQEIGSGQFGLVHLGYWLNKD-----KVAIKTIREGAMSEEDFIEEAEVMMKLS-HPKLVQLYGVCLEQ---- 72 (263)
T ss_dssp CCSCEEEEEEEECCSSCCEEEEEETTTE-----EEEEEECCSSSSCHHHHHHHHHHHHHCC-CTTBCCEEEEECSS----
T ss_pred ChHHcEEEEEEeeCCCeEEEEEEECCCC-----EEEEEEECCCcCcHHHHHHHHHHHHhcC-CCCcccccceeccC----
Confidence 4578999999999999999999987542 578887643 24567899999999998 99999999987532
Q ss_pred ceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEeecC
Q 039291 82 EMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLG 161 (362)
Q Consensus 82 ~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Dfg 161 (362)
..+++||||+++|+|.+++... ...+++..+..++.|++.||+|||+++|+||||||+|||+ +.++.+||+|||
T Consensus 73 -~~~~lv~E~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill----~~~~~~Kl~DFG 146 (263)
T d1sm2a_ 73 -APICLVFEFMEHGCLSDYLRTQ-RGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLV----GENQVIKVSDFG 146 (263)
T ss_dssp -SSCEEEEECCTTCBHHHHHHTT-TTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEE----CGGGCEEECSCC
T ss_pred -CceEEEEEecCCCcHHHHhhcc-ccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheee----cCCCCeEecccc
Confidence 2367999999999999998763 4569999999999999999999999999999999999999 888899999999
Q ss_pred CcccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHhC-CCCCccCCCCCHHHHHHHHcCCCCCC
Q 039291 162 VAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSG-RQAWVVKEDCSIDQLFSIIGDEHSLP 240 (362)
Q Consensus 162 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g-~~pf~~~~~~~~~~~~~~~~~~~~~~ 240 (362)
+|+........ ......||+.|+|||++.+..++.++|||||||++|||+++ .+||.. ....++...+..... +
T Consensus 147 la~~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~---~~~~~~~~~i~~~~~-~ 221 (263)
T d1sm2a_ 147 MTRFVLDDQYT-SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYEN---RSNSEVVEDISTGFR-L 221 (263)
T ss_dssp -------------------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCS---CCHHHHHHHHHHTCC-C
T ss_pred hheeccCCCce-eecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCC---CCHHHHHHHHHhcCC-C
Confidence 99865543222 22346799999999999999999999999999999999994 666533 345555555544332 3
Q ss_pred CCCccCCHHHHHHHHHHhccCCCCCCCHHHHhcC
Q 039291 241 EIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDD 274 (362)
Q Consensus 241 ~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~ 274 (362)
..|..+++++.+||.+||+.||++|||++++++|
T Consensus 222 ~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~ 255 (263)
T d1sm2a_ 222 YKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQ 255 (263)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCccccCHHHHHHHHHHccCCHhHCcCHHHHHHH
Confidence 4567789999999999999999999999999875
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-55 Score=395.17 Aligned_cols=261 Identities=20% Similarity=0.264 Sum_probs=206.3
Q ss_pred CCCCceeecceecccCceEEEEEEECCCCCC-CCceeeeechhh----hhhHHHHHHHHHHHHcCCCCcccccccceeee
Q 039291 3 SDGTSWFRGRVIGQGSFGCVFIAKPKSNSSF-LPPLMAVKSAEV----SASASLQKEKEVFDNLNGCPFVLECFGEEITM 77 (362)
Q Consensus 3 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~-~~~~~~~K~~~~----~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~ 77 (362)
+..++|.+++.||+|+||+||+|++...+.. ..+.||+|.+.. ...+.+.+|..++.++.+|+||+.+++.+..
T Consensus 10 i~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~- 88 (299)
T d1ywna1 10 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTK- 88 (299)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred ccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeecc-
Confidence 4557899999999999999999998766543 335788888653 2445678899999999889999999876542
Q ss_pred cCCCceEEEEEEEecCCCCHHHHHHHhc--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCE
Q 039291 78 GENGEMAYNLLLEYAAGGTLGDLIEKCN--------------GNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNI 143 (362)
Q Consensus 78 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~--------------~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Ni 143 (362)
....+++|||||++|+|.+++.... ...+++..+..++.||+.||.|||++|||||||||+||
T Consensus 89 ---~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NI 165 (299)
T d1ywna1 89 ---PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNI 165 (299)
T ss_dssp ---TTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGE
T ss_pred ---CCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCccce
Confidence 2234679999999999999997632 23489999999999999999999999999999999999
Q ss_pred EEeecCCCceEEEEeecCCcccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHhC-CCCCccCC
Q 039291 144 LLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSG-RQAWVVKE 222 (362)
Q Consensus 144 ll~~~~~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g-~~pf~~~~ 222 (362)
|+ +.++++||+|||+|+...............||+.|+|||++.+..++.++|||||||++|||++| .+||....
T Consensus 166 Ll----~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~ 241 (299)
T d1ywna1 166 LL----SEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK 241 (299)
T ss_dssp EE----CGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred eE----CCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCC
Confidence 99 88889999999999866554444444567899999999999999999999999999999999986 56775443
Q ss_pred CCCHHHHHHHHcCCCCCCCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhcC
Q 039291 223 DCSIDQLFSIIGDEHSLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDD 274 (362)
Q Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~ 274 (362)
. ...+...+... ..+..+..+++++++||.+||+.||++|||++++++|
T Consensus 242 ~--~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~ 290 (299)
T d1ywna1 242 I--DEEFCRRLKEG-TRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 290 (299)
T ss_dssp C--SHHHHHHHHHT-CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred H--HHHHHHHHhcC-CCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 2 22333333333 3345677899999999999999999999999999986
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8e-55 Score=395.66 Aligned_cols=254 Identities=19% Similarity=0.301 Sum_probs=207.9
Q ss_pred CCceeecceecccCceEEEEEEECCCCCCCCceeeeechhh----hhhHHHHHHHHHHHHcCCCCcccccccceeeecCC
Q 039291 5 GTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEV----SASASLQKEKEVFDNLNGCPFVLECFGEEITMGEN 80 (362)
Q Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~----~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~ 80 (362)
.+.|++++.||+|+||+||+|+++.+++.++.+|++|.+.. ...+.+.+|+.++++++ ||||+++++++...
T Consensus 8 ~~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-HpnIv~l~g~~~~~--- 83 (317)
T d1xkka_ 8 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD-NPHVCRLLGICLTS--- 83 (317)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCC-CTTBCCEEEEEESS---
T ss_pred HHHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCC-CCCEeeEEEEEecC---
Confidence 46799999999999999999999999988888999997643 34567899999999998 99999999987531
Q ss_pred CceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEeec
Q 039291 81 GEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADL 160 (362)
Q Consensus 81 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Df 160 (362)
..+++|||+.+|+|.+++... ...+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+||
T Consensus 84 ---~~~~v~e~~~~~~l~~~~~~~-~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll----~~~~~~kl~DF 155 (317)
T d1xkka_ 84 ---TVQLITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLV----KTPQHVKITDF 155 (317)
T ss_dssp ---SEEEEEECCTTCBHHHHHHHT-SSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE----EETTEEEECCC
T ss_pred ---CeeEEEEeccCCccccccccc-ccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhccee----CCCCCeEeecc
Confidence 256889999999999988763 4569999999999999999999999999999999999999 66778999999
Q ss_pred CCcccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHh-CCCCCccCCCCCHHHHHHHHcCCCCC
Q 039291 161 GVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLS-GRQAWVVKEDCSIDQLFSIIGDEHSL 239 (362)
Q Consensus 161 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~ 239 (362)
|+|+...............||+.|+|||++.+..++.++|||||||++|||+| |.+||.+.... ++...+.....
T Consensus 156 Gla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~---~~~~~i~~~~~- 231 (317)
T d1xkka_ 156 GLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS---EISSILEKGER- 231 (317)
T ss_dssp SHHHHTTTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGG---GHHHHHHHTCC-
T ss_pred ccceecccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHH---HHHHHHHcCCC-
Confidence 99987655444444445679999999999999999999999999999999998 89999665433 33344433332
Q ss_pred CCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhcC
Q 039291 240 PEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDD 274 (362)
Q Consensus 240 ~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~ 274 (362)
+..|..++.++.+|+.+||..||++|||+.+++.|
T Consensus 232 ~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 266 (317)
T d1xkka_ 232 LPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIE 266 (317)
T ss_dssp CCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHH
Confidence 34567899999999999999999999999999987
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-55 Score=390.85 Aligned_cols=252 Identities=21% Similarity=0.334 Sum_probs=203.2
Q ss_pred eeec-ceecccCceEEEEEEECCCCCCCCceeeeechhh-----hhhHHHHHHHHHHHHcCCCCcccccccceeeecCCC
Q 039291 8 WFRG-RVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEV-----SASASLQKEKEVFDNLNGCPFVLECFGEEITMGENG 81 (362)
Q Consensus 8 y~~~-~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~-----~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~~ 81 (362)
+.+. ++||+|+||+||+|.++.++. .+.||+|.+.. ...+.+.+|+++|++++ ||||+++++++..
T Consensus 8 ~~le~k~iG~G~fG~Vy~~~~~~~~~--~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~-HpnIv~~~g~~~~----- 79 (277)
T d1xbba_ 8 LTLEDKELGSGNFGTVKKGYYQMKKV--VKTVAVKILKNEANDPALKDELLAEANVMQQLD-NPYIVRMIGICEA----- 79 (277)
T ss_dssp EEEEEEEEEECSSEEEEEEEEECSSS--EEEEEEEEEC-----CHHHHHHHHHHHHHHTCC-CTTBCCEEEEEES-----
T ss_pred CeecCCCcccCCCeEEEEEEEccCCc--CeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCC-CCCCceEEEEecc-----
Confidence 3443 579999999999998764331 24678876542 23457899999999998 9999999997631
Q ss_pred ceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEeecC
Q 039291 82 EMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLG 161 (362)
Q Consensus 82 ~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Dfg 161 (362)
+ .+++|||||++|+|.+++.. ..++++..+..++.||+.||+|||++||+||||||+|||+ +.++.+||+|||
T Consensus 80 ~-~~~lvmE~~~~g~L~~~l~~--~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill----~~~~~~kl~DFG 152 (277)
T d1xbba_ 80 E-SWMLVMEMAELGPLNKYLQQ--NRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLL----VTQHYAKISDFG 152 (277)
T ss_dssp S-SEEEEEECCTTEEHHHHHHH--CTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE----EETTEEEECCCT
T ss_pred C-CEEEEEEcCCCCcHHHHHhh--ccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcc----cccCcccccchh
Confidence 1 25699999999999999987 4569999999999999999999999999999999999999 677789999999
Q ss_pred CcccccccccC-CCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHh-CCCCCccCCCCCHHHHHHHHcCCCCC
Q 039291 162 VAKRSRHCKRQ-KFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLS-GRQAWVVKEDCSIDQLFSIIGDEHSL 239 (362)
Q Consensus 162 la~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~ 239 (362)
+|+........ .......||+.|+|||++.+..++.++|||||||++|||++ |++||.+. ...++...+.... .
T Consensus 153 la~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~---~~~~~~~~i~~~~-~ 228 (277)
T d1xbba_ 153 LSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGM---KGSEVTAMLEKGE-R 228 (277)
T ss_dssp TCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTC---CHHHHHHHHHTTC-C
T ss_pred hhhhccccccccccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCC---CHHHHHHHHHcCC-C
Confidence 99865433222 22234679999999999999999999999999999999998 89999654 4456666665544 3
Q ss_pred CCCCccCCHHHHHHHHHHhccCCCCCCCHHHHh---cCCCcc
Q 039291 240 PEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLL---DDPFVK 278 (362)
Q Consensus 240 ~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l---~~p~~~ 278 (362)
+..|..+|+++.+||.+||..||++|||+++++ +|+|+.
T Consensus 229 ~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~ 270 (277)
T d1xbba_ 229 MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD 270 (277)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred CCCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHHhh
Confidence 456788999999999999999999999999984 555543
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.1e-55 Score=390.88 Aligned_cols=256 Identities=20% Similarity=0.331 Sum_probs=206.4
Q ss_pred CCCceeecce-ecccCceEEEEEEECCCCCCCCceeeeechh----hhhhHHHHHHHHHHHHcCCCCcccccccceeeec
Q 039291 4 DGTSWFRGRV-IGQGSFGCVFIAKPKSNSSFLPPLMAVKSAE----VSASASLQKEKEVFDNLNGCPFVLECFGEEITMG 78 (362)
Q Consensus 4 ~~~~y~~~~~-lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~----~~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~ 78 (362)
..++|.+.+. ||+|+||+||+|.++.++.. ..||+|.+. ....+.+.+|+++|++++ ||||+++++++..
T Consensus 6 ~~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~--~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~-HpnIv~l~g~~~~-- 80 (285)
T d1u59a_ 6 KRDNLLIADIELGCGNFGSVRQGVYRMRKKQ--IDVAIKVLKQGTEKADTEEMMREAQIMHQLD-NPYIVRLIGVCQA-- 80 (285)
T ss_dssp CGGGEEEEEEEEECCTTEEEEEEEEC---CC--EEEEEEEECSSCCHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEES--
T ss_pred cccCeEECCcEEecccCeEEEEEEEecCCCc--EEEEEEEEChhcCHHHHHHHHHHHHHHHhCC-CCCEeeEeeeecc--
Confidence 4467888885 99999999999988765432 256776643 334567899999999998 9999999997632
Q ss_pred CCCceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEe
Q 039291 79 ENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIA 158 (362)
Q Consensus 79 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~ 158 (362)
+ .+++|||||+||+|.+++... +..+++..+..++.||+.||+|||++||+||||||+|||+ +.++.+||+
T Consensus 81 ---~-~~~lvmE~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill----~~~~~~Kl~ 151 (285)
T d1u59a_ 81 ---E-ALMLVMEMAGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLL----VNRHYAKIS 151 (285)
T ss_dssp ---S-SEEEEEECCTTEEHHHHHTTC-TTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE----EETTEEEEC
T ss_pred ---C-eEEEEEEeCCCCcHHHHhhcc-ccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheee----ccCCceeec
Confidence 1 267999999999999998652 3569999999999999999999999999999999999999 667789999
Q ss_pred ecCCcccccccccC-CCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHh-CCCCCccCCCCCHHHHHHHHcCC
Q 039291 159 DLGVAKRSRHCKRQ-KFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLS-GRQAWVVKEDCSIDQLFSIIGDE 236 (362)
Q Consensus 159 Dfgla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~ 236 (362)
|||+|+........ .......||+.|+|||++.+..++.++|||||||++|||+| |..||.... ..++...+...
T Consensus 152 DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~---~~~~~~~i~~~ 228 (285)
T d1u59a_ 152 DFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMK---GPEVMAFIEQG 228 (285)
T ss_dssp CCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC---THHHHHHHHTT
T ss_pred cchhhhcccccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCC---HHHHHHHHHcC
Confidence 99999866543222 22235678999999999999999999999999999999998 999996543 34455555544
Q ss_pred CCCCCCCccCCHHHHHHHHHHhccCCCCCCCHHHHh---cCCCc
Q 039291 237 HSLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLL---DDPFV 277 (362)
Q Consensus 237 ~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l---~~p~~ 277 (362)
. .+.+|..+++++.+||.+||..||++|||+.+++ +|+|+
T Consensus 229 ~-~~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~ 271 (285)
T d1u59a_ 229 K-RMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYY 271 (285)
T ss_dssp C-CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred C-CCCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence 3 3456788999999999999999999999998874 45554
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-54 Score=399.59 Aligned_cols=266 Identities=23% Similarity=0.300 Sum_probs=206.4
Q ss_pred CCceeecceecccCceEEEEEEECCCCCCCCceeeeechh----hhhhHHHHHHHHHHHHcCCCCcccccccceeeecCC
Q 039291 5 GTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAE----VSASASLQKEKEVFDNLNGCPFVLECFGEEITMGEN 80 (362)
Q Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~----~~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~ 80 (362)
+.||.+++.||+|+||+||+|+++.+++ .||+|.+. ....+.+.+|+.+|++|+ ||||+++++++......
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~----~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~-hp~iv~~~~~~~~~~~~ 81 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKV----RVAIKKISPFEHQTYCQRTLREIKILLRFR-HENIIGINDIIRAPTIE 81 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCS----EEEEEEECCTTCHHHHHHHHHHHHHHHHCC-CTTBCCCCEEECCSSTT
T ss_pred CCCeEEEEEEeeccCeEEEEEEECCCCc----EEEEEEEehhcChHHHHHHHHHHHHHHHcC-CCCCCcEEEEEeecccc
Confidence 5789999999999999999999998886 45666543 234457889999999998 99999999987654333
Q ss_pred CceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEeec
Q 039291 81 GEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADL 160 (362)
Q Consensus 81 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Df 160 (362)
....+|+ ++|+.||+|.++++. .++++..++.++.||+.||+|||++|||||||||+|||+ +.++.+||+||
T Consensus 82 ~~~~~~l-~~~~~~g~L~~~l~~---~~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl----~~~~~~kl~Df 153 (345)
T d1pmea_ 82 QMKDVYL-VTHLMGADLYKLLKT---QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLL----NTTCDLKICDF 153 (345)
T ss_dssp TCCCEEE-EEECCCEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE----CTTCCEEECCC
T ss_pred ccceEEE-EEeecCCchhhhhhc---CCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEE----CCCCCEEEccc
Confidence 3344544 556678999999976 359999999999999999999999999999999999999 78889999999
Q ss_pred CCcccccccccC-CCCCCccCCCCccCchhhcc-ccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHHcCC--
Q 039291 161 GVAKRSRHCKRQ-KFDPSMRGTPLYLAPETVVQ-HMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDE-- 236 (362)
Q Consensus 161 gla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~-- 236 (362)
|+|+........ ......+||+.|+|||++.. ..++.++||||+||++|+|++|+.||...+..+...........
T Consensus 154 G~a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~ 233 (345)
T d1pmea_ 154 GLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPS 233 (345)
T ss_dssp TTCEECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCC
T ss_pred CceeeccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCC
Confidence 999865544322 22356779999999999854 56789999999999999999999999665432222111111100
Q ss_pred -------------------C-----CCCCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCccCcchh
Q 039291 237 -------------------H-----SLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGVDEE 283 (362)
Q Consensus 237 -------------------~-----~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~~~~~~~ 283 (362)
. .+......+++++++||.+||+.||.+|||++++|+||||+.....
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~~~~ 304 (345)
T d1pmea_ 234 QEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDP 304 (345)
T ss_dssp HHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTTCCG
T ss_pred hhhhhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccCCCC
Confidence 0 0011234578899999999999999999999999999999876544
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=9.3e-55 Score=397.54 Aligned_cols=260 Identities=23% Similarity=0.356 Sum_probs=209.4
Q ss_pred CCCceeecceecccCceEEEEEEECCCCCCCCceeeeechhhhhhHHHHHHHHHHHHcCCCCcccccccceeeecCCCce
Q 039291 4 DGTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVSASASLQKEKEVFDNLNGCPFVLECFGEEITMGENGEM 83 (362)
Q Consensus 4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~~~~ 83 (362)
..++|.+++.||+|+||+||+|+++.+++ .||+|.+.....+.+.+|+.+|+.+.+||||+++++.+.. ....
T Consensus 33 ~~d~y~i~~~LG~G~fg~V~~a~~~~~~~----~vAiK~i~~~~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~---~~~~ 105 (328)
T d3bqca1 33 NQDDYQLVRKLGRGKYSEVFEAINITNNE----KVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKD---PVSR 105 (328)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTE----EEEEEEECSSCHHHHHHHHHHHHHHTTSTTBCCEEEEEEC---TTTC
T ss_pred CCcCeEEEEEEecCcCeEEEEEEECCCCC----EEEEEEECHHHHHHHHHHHHHHHhccCCCCCcEEEEEEEe---cCCC
Confidence 34689999999999999999999998875 6788887766777899999999999889999999987653 2233
Q ss_pred EEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEeecCCc
Q 039291 84 AYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVA 163 (362)
Q Consensus 84 ~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Dfgla 163 (362)
.+++|||||.+++|..+. +.+++..++.++.||+.||+|||++||+||||||+|||+. ..+..+||+|||+|
T Consensus 106 ~~~~v~e~~~~~~L~~~~-----~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~---~~~~~vkl~DFG~a 177 (328)
T d3bqca1 106 TPALVFEHVNNTDFKQLY-----QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMID---HEHRKLRLIDWGLA 177 (328)
T ss_dssp SEEEEEECCCSCBGGGTT-----TSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEE---TTTTEEEECCGGGC
T ss_pred ceeEEEeecCCCcHHHHh-----cCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEc---CCCCeeeecccccc
Confidence 577999999999997654 3499999999999999999999999999999999999993 23457999999999
Q ss_pred ccccccccCCCCCCccCCCCccCchhhccc-cCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHH---HHHHc-----
Q 039291 164 KRSRHCKRQKFDPSMRGTPLYLAPETVVQH-MQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQL---FSIIG----- 234 (362)
Q Consensus 164 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~---~~~~~----- 234 (362)
+...... .....+||+.|+|||.+.+. .++.++||||+||++|+|++|..||....+. .... ...+.
T Consensus 178 ~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~-~~~~~~i~~~~g~~~~~ 253 (328)
T d3bqca1 178 EFYHPGQ---EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDN-YDQLVRIAKVLGTEDLY 253 (328)
T ss_dssp EECCTTC---CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSH-HHHHHHHHHHHCHHHHH
T ss_pred eeccCCC---cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchh-HHHHHHHHHHHCCchhh
Confidence 8655422 22467799999999998865 5799999999999999999999999654321 1111 11110
Q ss_pred ------CCC--------------------CCCCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCccCcch
Q 039291 235 ------DEH--------------------SLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGVDE 282 (362)
Q Consensus 235 ------~~~--------------------~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~~~~~~ 282 (362)
... ........+++++++||++||..||++|||++|+|+||||+.+.+
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F~~v~~ 327 (328)
T d3bqca1 254 DYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVVK 327 (328)
T ss_dssp HHHHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTSCC
T ss_pred hhhhhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCCC
Confidence 000 011122457899999999999999999999999999999998765
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-54 Score=399.93 Aligned_cols=264 Identities=25% Similarity=0.355 Sum_probs=203.9
Q ss_pred CceeecceecccCceEEEEEEECCCCCCCCceeeeechhhhhhHHHHHHHHHHHHcCCCCcccccccceeeecC-CCceE
Q 039291 6 TSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVSASASLQKEKEVFDNLNGCPFVLECFGEEITMGE-NGEMA 84 (362)
Q Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~-~~~~~ 84 (362)
-+|..+++||+|+||+||+|+++.+++ .||+|.+... .....+|+.+|++|+ ||||+++++++..... ....+
T Consensus 20 ~~Y~~~k~LG~G~fg~Vy~a~~~~~~~----~vAiK~i~~~-~~~~~~Ei~il~~l~-h~niv~~~~~~~~~~~~~~~~~ 93 (350)
T d1q5ka_ 20 VSYTDTKVIGNGSFGVVYQAKLCDSGE----LVAIKKVLQD-KRFKNRELQIMRKLD-HCNIVRLRYFFYSSGEKKDEVY 93 (350)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCC----EEEEEEEECC-SSSCCHHHHHHHHCC-CTTBCCEEEEEEEC--CCSCCE
T ss_pred CCcEeeeEEeeCcCeEEEEEEECCCCC----EEEEEEECcc-chHHHHHHHHHHhcC-CCCCCcEEEEEEecCccCCceE
Confidence 379999999999999999999998876 5677766433 233458999999998 9999999998765433 33456
Q ss_pred EEEEEEecCCCCHHHHHHH-hcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCc-eEEEEeecCC
Q 039291 85 YNLLLEYAAGGTLGDLIEK-CNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGK-FVAKIADLGV 162 (362)
Q Consensus 85 ~~lv~e~~~~~~L~~~l~~-~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~-~~~kl~Dfgl 162 (362)
+++|||||+++.+..+... .....+++..++.++.||+.||+|||++||+||||||+|||+ +.+ ..+||+|||+
T Consensus 94 ~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl----~~~~~~~kl~DFG~ 169 (350)
T d1q5ka_ 94 LNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLL----DPDTAVLKLCDFGS 169 (350)
T ss_dssp EEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEE----CTTTCCEEECCCTT
T ss_pred EEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEE----ecCCCceeEecccc
Confidence 7899999987544443332 234569999999999999999999999999999999999999 544 4799999999
Q ss_pred cccccccccCCCCCCccCCCCccCchhhcc-ccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHH-HHHHcC-----
Q 039291 163 AKRSRHCKRQKFDPSMRGTPLYLAPETVVQ-HMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQL-FSIIGD----- 235 (362)
Q Consensus 163 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~-~~~~~~----- 235 (362)
++...... .....+||+.|+|||++.+ ..++.++||||+||++|||++|++||...+..+.... ....+.
T Consensus 170 a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~ 246 (350)
T d1q5ka_ 170 AKQLVRGE---PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQ 246 (350)
T ss_dssp CEECCTTS---CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHH
T ss_pred hhhccCCc---ccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHh
Confidence 97654322 2245789999999999875 4789999999999999999999999965543221111 111110
Q ss_pred ---------CCCCC---------CCCccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCccCcch
Q 039291 236 ---------EHSLP---------EIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGVDE 282 (362)
Q Consensus 236 ---------~~~~~---------~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~~~~~~ 282 (362)
....+ .....+++++.+||.+||..||++|||+.|+|+||||+++..
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~ 311 (350)
T d1q5ka_ 247 IREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRD 311 (350)
T ss_dssp HHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGC
T ss_pred hhhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccccC
Confidence 00111 122357899999999999999999999999999999987643
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=1.5e-54 Score=386.79 Aligned_cols=257 Identities=23% Similarity=0.364 Sum_probs=200.5
Q ss_pred CCceeecceecccCceEEEEEEECCCCCCCCceeeeechh------hhhhHHHHHHHHHHHHcCCCCcccccccceeeec
Q 039291 5 GTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAE------VSASASLQKEKEVFDNLNGCPFVLECFGEEITMG 78 (362)
Q Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~------~~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~ 78 (362)
.++|.+++.||+|+||+||+|+++.+++ .||+|.+. ......+.+|+.+++.++ ||||+++++++....
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~----~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~-hpniv~~~~~~~~~~ 80 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHR----DVAVKVLRADLARDPSFYLRFRREAQNAAALN-HPAIVAVYDTGEAET 80 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTE----EEEEEEECSTTTTCHHHHHHHHHHHHHHHTCC-CTTBCCEEEEEEEEC
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCC----EEEEEEEchhhccCHHHHHHHHHHHHHHHhcC-CCCCCcccceeeecc
Confidence 4789999999999999999999998875 56666543 223456889999999998 999999999776543
Q ss_pred CCCceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEe
Q 039291 79 ENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIA 158 (362)
Q Consensus 79 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~ 158 (362)
.....+|+|||||+|++|.+++... +++++.+++.++.||+.||+|||++||+||||||+|||+ +.++.++|+
T Consensus 81 -~~~~~~~lvmE~~~g~~L~~~~~~~--~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll----~~~~~~~l~ 153 (277)
T d1o6ya_ 81 -PAGPLPYIVMEYVDGVTLRDIVHTE--GPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMI----SATNAVKVM 153 (277)
T ss_dssp -SSSEEEEEEEECCCEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE----ETTSCEEEC
T ss_pred -CCCceEEEEEECCCCCEehhhhccc--CCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCccccc----Cccccceee
Confidence 2344577999999999999998773 459999999999999999999999999999999999999 777789999
Q ss_pred ecCCcccccccc-cCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHH-HHHHcCC
Q 039291 159 DLGVAKRSRHCK-RQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQL-FSIIGDE 236 (362)
Q Consensus 159 Dfgla~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~-~~~~~~~ 236 (362)
|||.+....... ........+||+.|+|||++.+..++.++|||||||++|+|++|++||.+. +..+. ...+...
T Consensus 154 d~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~---~~~~~~~~~~~~~ 230 (277)
T d1o6ya_ 154 DFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGD---SPVSVAYQHVRED 230 (277)
T ss_dssp CCTTCEECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCS---SHHHHHHHHHHCC
T ss_pred hhhhhhhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCc---CHHHHHHHHHhcC
Confidence 999987544322 222334678999999999999999999999999999999999999999654 33333 3344433
Q ss_pred CCCC-CCCccCCHHHHHHHHHHhccCCCCCC-CHHHHhcCCCc
Q 039291 237 HSLP-EIPSRVSKEARDFLRRCFVRKPAFRF-TAEMLLDDPFV 277 (362)
Q Consensus 237 ~~~~-~~~~~~~~~~~~li~~~l~~~p~~R~-s~~~~l~~p~~ 277 (362)
...+ ..+..+|+++++||.+||+.||++|| |+++++ |+|.
T Consensus 231 ~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~-~~l~ 272 (277)
T d1o6ya_ 231 PIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMR-ADLV 272 (277)
T ss_dssp CCCGGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHH-HHHH
T ss_pred CCCCchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHH-HHHH
Confidence 3322 34467899999999999999999999 566654 4443
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-54 Score=385.79 Aligned_cols=258 Identities=19% Similarity=0.316 Sum_probs=208.5
Q ss_pred CCCCceeecceecccCceEEEEEEECCCCCCCCceeeeechhhh--hhHHHHHHHHHHHHcCCCCcccccccceeeecCC
Q 039291 3 SDGTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVS--ASASLQKEKEVFDNLNGCPFVLECFGEEITMGEN 80 (362)
Q Consensus 3 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~~--~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~ 80 (362)
+..++|++++.||+|+||+||+|+++++. .||+|.+... ..+.+.+|+.++++++ ||||+++++++. +
T Consensus 14 i~~~~~~i~~~iG~G~fg~Vy~~~~~~~~-----~vAiK~l~~~~~~~~~~~~E~~~l~~l~-h~nIv~~~g~~~----~ 83 (285)
T d1fmka3 14 IPRESLRLEVKLGQGCFGEVWMGTWNGTT-----RVAIKTLKPGTMSPEAFLQEAQVMKKLR-HEKLVQLYAVVS----E 83 (285)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTE-----EEEEEECCTTSSCHHHHHHHHHHHHHCC-CTTBCCEEEEEC----S
T ss_pred cCHHHEEEeeEEeeCCCeEEEEEEECCCC-----EEEEEEECcccCCHHHHHHHHHHHHhcc-cCCEeEEEEEEe----c
Confidence 45678999999999999999999997753 5777776433 3467999999999999 999999999753 1
Q ss_pred CceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEeec
Q 039291 81 GEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADL 160 (362)
Q Consensus 81 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Df 160 (362)
. .+++||||+++|+|..++.......+++..+..++.||+.||+|||++||+||||||+|||+ +.++.+||+||
T Consensus 84 ~--~~~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll----~~~~~~kl~Df 157 (285)
T d1fmka3 84 E--PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILV----GENLVCKVADF 157 (285)
T ss_dssp S--SCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE----CGGGCEEECCC
T ss_pred C--CeEEEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEE----CCCCcEEEccc
Confidence 1 25699999999999999876555669999999999999999999999999999999999999 78889999999
Q ss_pred CCcccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHHcCCCCCC
Q 039291 161 GVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEHSLP 240 (362)
Q Consensus 161 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 240 (362)
|+|+....... .......||+.|+|||++.+..++.++|||||||++|||++|..||.. .....+++..+..... +
T Consensus 158 Gla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~--~~~~~~~~~~i~~~~~-~ 233 (285)
T d1fmka3 158 GLARLIEDNEY-TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYP--GMVNREVLDQVERGYR-M 233 (285)
T ss_dssp CTTC---------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSST--TCCHHHHHHHHHTTCC-C
T ss_pred chhhhccCCCc-eeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCC--CCCHHHHHHHHHhcCC-C
Confidence 99986543222 222456799999999999999999999999999999999996655533 3345666666655443 3
Q ss_pred CCCccCCHHHHHHHHHHhccCCCCCCCHHHHhc--CCCccCc
Q 039291 241 EIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLD--DPFVKGV 280 (362)
Q Consensus 241 ~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~--~p~~~~~ 280 (362)
.++..+++++++||.+||+.||++||+++++++ ++||...
T Consensus 234 ~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~ 275 (285)
T d1fmka3 234 PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST 275 (285)
T ss_dssp CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred CCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCC
Confidence 467889999999999999999999999999987 7777543
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.5e-54 Score=383.07 Aligned_cols=258 Identities=19% Similarity=0.290 Sum_probs=204.4
Q ss_pred CCCCCceeecceecccCceEEEEEEECCCCCCCCceeeeechhh----hhhHHHHHHHHHHHHcCCCCcccccccceeee
Q 039291 2 DSDGTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEV----SASASLQKEKEVFDNLNGCPFVLECFGEEITM 77 (362)
Q Consensus 2 ~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~----~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~ 77 (362)
++..+.|.+.++||+|+||+||+|+++.++......||+|.+.. .....+.+|+.++++++ ||||+++++++..
T Consensus 3 ei~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~-H~nIv~~~g~~~~- 80 (283)
T d1mqba_ 3 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFS-HHNIIRLEGVISK- 80 (283)
T ss_dssp BCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCC-CTTBCCEEEEECS-
T ss_pred cCCHHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcC-CCCEeeeeEEEec-
Confidence 35567899999999999999999999877665556788887643 23456889999999998 9999999997643
Q ss_pred cCCCceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEE
Q 039291 78 GENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKI 157 (362)
Q Consensus 78 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl 157 (362)
...+++||||+.++++.+++... ...+++..+..++.|++.||+|||+++|+||||||+|||+ +.++.+||
T Consensus 81 ----~~~~~~v~e~~~~~~l~~~~~~~-~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl----~~~~~~Kl 151 (283)
T d1mqba_ 81 ----YKPMMIITEYMENGALDKFLREK-DGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILV----NSNLVCKV 151 (283)
T ss_dssp ----SSSEEEEEECCTTEEHHHHHHHT-TTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE----CTTCCEEE
T ss_pred ----CCceEEEEEecccCcchhhhhcc-cccccHHHHHHHHHHHHHhhhhccccccccCccccceEEE----CCCCeEEE
Confidence 22367999999999999988763 4569999999999999999999999999999999999999 88889999
Q ss_pred eecCCcccccccccC-CCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHHcCC
Q 039291 158 ADLGVAKRSRHCKRQ-KFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDE 236 (362)
Q Consensus 158 ~Dfgla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 236 (362)
+|||+|+........ .......||+.|+|||++.+..++.++|||||||++|||++|..||.. .....++...+...
T Consensus 152 ~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~--~~~~~~~~~~i~~~ 229 (283)
T d1mqba_ 152 SDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYW--ELSNHEVMKAINDG 229 (283)
T ss_dssp CCCCC-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTT--TCCHHHHHHHHHTT
T ss_pred cccchhhcccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccc--cCCHHHHHHHHhcc
Confidence 999999865443222 222345689999999999999999999999999999999996555532 23456666666555
Q ss_pred CCCCCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhc
Q 039291 237 HSLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLD 273 (362)
Q Consensus 237 ~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~ 273 (362)
.. +..+..++.++.+||.+||+.||++|||+.++++
T Consensus 230 ~~-~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~ 265 (283)
T d1mqba_ 230 FR-LPTPMDCPSAIYQLMMQCWQQERARRPKFADIVS 265 (283)
T ss_dssp CC-CCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred CC-CCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHH
Confidence 43 4467789999999999999999999999999976
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-54 Score=378.27 Aligned_cols=250 Identities=19% Similarity=0.281 Sum_probs=210.3
Q ss_pred CCCceeecceecccCceEEEEEEECCCCCCCCceeeeechhh--hhhHHHHHHHHHHHHcCCCCcccccccceeeecCCC
Q 039291 4 DGTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEV--SASASLQKEKEVFDNLNGCPFVLECFGEEITMGENG 81 (362)
Q Consensus 4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~--~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~~ 81 (362)
+.++|.+++.||+|+||+||+|++++ + ..||+|.+.. ...+.+.+|+.++++++ ||||+++++++..
T Consensus 2 ~~~~~~~~~~iG~G~fg~Vy~~~~~~-~----~~vAvK~l~~~~~~~~~~~~Ev~~~~~l~-HpnIv~~~g~~~~----- 70 (258)
T d1k2pa_ 2 DPKDLTFLKELGTGQFGVVKYGKWRG-Q----YDVAIKMIKEGSMSEDEFIEEAKVMMNLS-HEKLVQLYGVCTK----- 70 (258)
T ss_dssp CCCCCCCCCCCCEETTEEEEEEEETT-T----EEEEEEEEESSSSCHHHHHHHHHHHHTCC-CTTBCCEEEEECC-----
T ss_pred ChHHCEEeEEEecCCCeEEEEEEECC-C----CEEEEEEECcCcCCHHHHHHHHHHHHhcC-CCceeeEEEEEee-----
Confidence 34789999999999999999999864 3 2567776543 34567899999999998 9999999997643
Q ss_pred ceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEeecC
Q 039291 82 EMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLG 161 (362)
Q Consensus 82 ~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Dfg 161 (362)
...+++||||+++|+|.+++... ...+++..++.++.|++.||.|||++||+||||||+|||+ +.++.+||+|||
T Consensus 71 ~~~~~iv~Ey~~~g~l~~~~~~~-~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill----~~~~~~kl~DfG 145 (258)
T d1k2pa_ 71 QRPIFIITEYMANGCLLNYLREM-RHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLV----NDQGVVKVSDFG 145 (258)
T ss_dssp SSSEEEEEECCTTEEHHHHHHSG-GGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEE----CTTCCEEECCCS
T ss_pred CCceEEEEEccCCCcHHHhhhcc-ccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEE----cCCCcEEECcch
Confidence 23477999999999999997663 3459999999999999999999999999999999999999 888899999999
Q ss_pred CcccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHh-CCCCCccCCCCCHHHHHHHHcCCCCCC
Q 039291 162 VAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLS-GRQAWVVKEDCSIDQLFSIIGDEHSLP 240 (362)
Q Consensus 162 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 240 (362)
+++........ ......||+.|+|||++.+..++.++|||||||++|||+| |+.||... ...++...+..... +
T Consensus 146 ~a~~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~---~~~~~~~~i~~~~~-~ 220 (258)
T d1k2pa_ 146 LSRYVLDDEYT-SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERF---TNSETAEHIAQGLR-L 220 (258)
T ss_dssp SCCBCSSSSCC-CCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTS---CHHHHHHHHHTTCC-C
T ss_pred hheeccCCCce-eecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCC---CHHHHHHHHHhCCC-C
Confidence 99765543222 2345679999999999999999999999999999999998 89999544 45566666655443 4
Q ss_pred CCCccCCHHHHHHHHHHhccCCCCCCCHHHHhcC
Q 039291 241 EIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDD 274 (362)
Q Consensus 241 ~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~ 274 (362)
..|..+++++.+||.+||+.||++|||++++++|
T Consensus 221 ~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 254 (258)
T d1k2pa_ 221 YRPHLASEKVYTIMYSCWHEKADERPTFKILLSN 254 (258)
T ss_dssp CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred CCcccccHHHHHHHHHHccCCHhHCcCHHHHHHH
Confidence 5678899999999999999999999999999986
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.5e-54 Score=394.28 Aligned_cols=260 Identities=21% Similarity=0.361 Sum_probs=203.2
Q ss_pred CCceeecceecccCceEEEEEEECCCCCCCCceeeeechhh-----hhhHHHHHHHHHHHHcCCCCcccccccceeeecC
Q 039291 5 GTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEV-----SASASLQKEKEVFDNLNGCPFVLECFGEEITMGE 79 (362)
Q Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~-----~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~ 79 (362)
.++|.+++.||+|+||+||+|+++.+++ .||+|.+.. ...+.+.+|+.+|+.++ ||||+++++++.....
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~----~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~-hpniv~l~~~~~~~~~ 91 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGA----KVAIKKLYRPFQSELFAKRAYRELRLLKHMR-HENVIGLLDVFTPDET 91 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCC----EEEEEECSSTTSSHHHHHHHHHHHHHHHHCC-BTTBCCCSEEECSCSS
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCC----EEEEEEEchhhcChHHHHHHHHHHHHHHhcC-CCCeeEEEEEeccCcc
Confidence 4799999999999999999999998876 566666532 23456889999999998 9999999998764321
Q ss_pred -CCceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEe
Q 039291 80 -NGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIA 158 (362)
Q Consensus 80 -~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~ 158 (362)
.....+|+||||| +.+|..+++. .++++..++.++.||+.||+|||++||+||||||+|||+ +.++.+|++
T Consensus 92 ~~~~~~~~lv~e~~-~~~l~~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~----~~~~~~kl~ 163 (346)
T d1cm8a_ 92 LDDFTDFYLVMPFM-GTDLGKLMKH---EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAV----NEDCELKIL 163 (346)
T ss_dssp TTTCCCCEEEEECC-SEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE----CTTCCEEEC
T ss_pred ccccceEEEEEecc-cccHHHHHHh---ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhc----ccccccccc
Confidence 1233567999999 6688887764 459999999999999999999999999999999999999 888899999
Q ss_pred ecCCcccccccccCCCCCCccCCCCccCchhhccc-cCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHHc---
Q 039291 159 DLGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQH-MQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIG--- 234 (362)
Q Consensus 159 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~--- 234 (362)
|||+|+..... .....||+.|+|||++.+. .++.++||||+||++|+|++|++||.+.+............
T Consensus 164 Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~ 238 (346)
T d1cm8a_ 164 DFGLARQADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTP 238 (346)
T ss_dssp CCTTCEECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCC
T ss_pred cccceeccCCc-----cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCC
Confidence 99999765432 2456799999999999864 56899999999999999999999997654322211111110
Q ss_pred -----------------------CCCCCCCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCccCcch
Q 039291 235 -----------------------DEHSLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGVDE 282 (362)
Q Consensus 235 -----------------------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~~~~~~ 282 (362)
....++.....+++++++||.+||..||++|||++++|+||||+.+.+
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~~ 309 (346)
T d1cm8a_ 239 PAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHD 309 (346)
T ss_dssp CHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC-
T ss_pred cHHHHhhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCCC
Confidence 111222344568899999999999999999999999999999988654
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=2.7e-54 Score=387.01 Aligned_cols=255 Identities=22% Similarity=0.333 Sum_probs=198.4
Q ss_pred CceeecceecccCceEEEEEEECCCCCCCCceeeeechhh-----hhhHHHHHHHHHHHHcCCCCcccccccceeeecCC
Q 039291 6 TSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEV-----SASASLQKEKEVFDNLNGCPFVLECFGEEITMGEN 80 (362)
Q Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~-----~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~ 80 (362)
+||.+++.||+|+||+||+|+++. ++ .||+|.+.. .....+.+|+.+|++++ ||||+++++.+..
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~-~~----~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~~~~~~~~---- 71 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNY-GE----TFALKKIRLEKEDEGIPSTTIREISILKELK-HSNIVKLYDVIHT---- 71 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETT-SC----EEEEEEECCSSGGGCCCHHHHHHHHGGGGCC-CTTBCCEEEEEEC----
T ss_pred CCceeccEEecCCCcEEEEEEeCC-CC----EEEEEEEehhhcChHHHHHHHHHHHHHHhCC-CCcEEeeeeeccc----
Confidence 599999999999999999999874 43 567776532 23467889999999998 9999999987653
Q ss_pred CceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEeec
Q 039291 81 GEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADL 160 (362)
Q Consensus 81 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Df 160 (362)
...++++||++.++.+..+.+. .+.+++..++.++.||+.||+|||++|||||||||+|||+ +.++.+||+||
T Consensus 72 -~~~~~i~~e~~~~~~~~~~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll----~~~~~~kl~Df 144 (286)
T d1ob3a_ 72 -KKRLVLVFEHLDQDLKKLLDVC--EGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLI----NREGELKIADF 144 (286)
T ss_dssp -SSCEEEEEECCSEEHHHHHHTS--TTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE----CTTSCEEECCT
T ss_pred -CCceeEEEEeehhhhHHHHHhh--cCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeE----cCCCCEEeccc
Confidence 2346799999987666666554 4569999999999999999999999999999999999999 78889999999
Q ss_pred CCcccccccccCCCCCCccCCCCccCchhhccc-cCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHH-HHHHcCC--
Q 039291 161 GVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQH-MQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQL-FSIIGDE-- 236 (362)
Q Consensus 161 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~-~~~~~~~-- 236 (362)
|+|....... .......|++.|+|||.+.+. .++.++|||||||++|||++|++||.+.+..+.... .......
T Consensus 145 G~a~~~~~~~--~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~ 222 (286)
T d1ob3a_ 145 GLARAFGIPV--RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNS 222 (286)
T ss_dssp THHHHHCC-----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCT
T ss_pred ccceecccCc--cccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCCh
Confidence 9997654322 222355799999999999764 568999999999999999999999965432211111 1111100
Q ss_pred ---------------------CCCCCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCccC
Q 039291 237 ---------------------HSLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKG 279 (362)
Q Consensus 237 ---------------------~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~~~ 279 (362)
.........+++++++||++||+.||++|||+.|+++||||++
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f~~ 286 (286)
T d1ob3a_ 223 KNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286 (286)
T ss_dssp TTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred hhccchhhhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCc
Confidence 0011233457899999999999999999999999999999974
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-54 Score=383.58 Aligned_cols=254 Identities=17% Similarity=0.286 Sum_probs=198.4
Q ss_pred CCCCceeecceecccCceEEEEEEECCCCCCCCceeeeechh----hhhhHHHHHHHHHHHHcCCCCcccccccceeeec
Q 039291 3 SDGTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAE----VSASASLQKEKEVFDNLNGCPFVLECFGEEITMG 78 (362)
Q Consensus 3 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~----~~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~ 78 (362)
+..++|.+++.||+|+||+||+|++..+++. ...|++|... ......+.+|+.+|++++ ||||+++++++..
T Consensus 4 i~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~-~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~~-- 79 (273)
T d1mp8a_ 4 IQRERIELGRCIGEGQFGDVHQGIYMSPENP-ALAVAIKTCKNCTSDSVREKFLQEALTMRQFD-HPHIVKLIGVITE-- 79 (273)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEECCC--C-CEEEEEEECTTTTSHHHHHHHHHHHHHHHTCC-CTTBCCEEEEECS--
T ss_pred cCHHHeEEEEEEeeCCCcEEEEEEEecCCce-eEEEEEEEeccccCHHHHHHHHHHHHHHHhCC-CCCEeeEEEEEec--
Confidence 4567999999999999999999998766432 2356777653 234456889999999998 9999999997631
Q ss_pred CCCceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEe
Q 039291 79 ENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIA 158 (362)
Q Consensus 79 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~ 158 (362)
..+++||||+++|+|.+++... ..++++..++.++.||+.||.|||++||+||||||+||++ +.++.+||+
T Consensus 80 ----~~~~iv~E~~~~g~l~~~~~~~-~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll----~~~~~~Kl~ 150 (273)
T d1mp8a_ 80 ----NPVWIIMELCTLGELRSFLQVR-KYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLV----SSNDCVKLG 150 (273)
T ss_dssp ----SSCEEEEECCTTEEHHHHHHHT-TTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE----EETTEEEEC
T ss_pred ----CeEEEEEEeccCCcHHhhhhcc-CCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheee----cCCCcEEEc
Confidence 2367999999999999988763 4569999999999999999999999999999999999999 667789999
Q ss_pred ecCCcccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHh-CCCCCccCCCCCHHHHHHHHcCCC
Q 039291 159 DLGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLS-GRQAWVVKEDCSIDQLFSIIGDEH 237 (362)
Q Consensus 159 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~ 237 (362)
|||+|+....... .......||+.|+|||++.+..++.++|||||||++|||++ |.+||..... .++...+....
T Consensus 151 DfG~a~~~~~~~~-~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~---~~~~~~i~~~~ 226 (273)
T d1mp8a_ 151 DFGLSRYMEDSTY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN---NDVIGRIENGE 226 (273)
T ss_dssp C--------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCG---GGHHHHHHTTC
T ss_pred cchhheeccCCcc-eeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCH---HHHHHHHHcCC
Confidence 9999986543222 22245668999999999999999999999999999999998 8999965543 44444454444
Q ss_pred CCCCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhcC
Q 039291 238 SLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDD 274 (362)
Q Consensus 238 ~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~ 274 (362)
. +.++..+|+++.+||.+||..||++|||+.+++++
T Consensus 227 ~-~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~ 262 (273)
T d1mp8a_ 227 R-LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ 262 (273)
T ss_dssp C-CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred C-CCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 3 35678899999999999999999999999999875
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-53 Score=387.49 Aligned_cols=263 Identities=21% Similarity=0.269 Sum_probs=202.1
Q ss_pred CceeecceecccCceEEEEEEECCCCCCCCceeeeechh-----hhhhHHHHHHHHHHHHcCCCCcccccccceeeecC-
Q 039291 6 TSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAE-----VSASASLQKEKEVFDNLNGCPFVLECFGEEITMGE- 79 (362)
Q Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~-----~~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~- 79 (362)
+||.+++.||+|+||+||+|+++.+++ .||+|.+. ......+.+|+.+|++++ ||||+++++.+.....
T Consensus 10 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~----~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~-h~nii~~~~~~~~~~~~ 84 (318)
T d3blha1 10 SKYEKLAKIGQGTFGEVFKARHRKTGQ----KVALKKVLMENEKEGFPITALREIKILQLLK-HENVVNLIEICRTKASP 84 (318)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCC----EEEEEEC----CTTSSCHHHHHHHHHHHHCC-CTTBCCEEEEEEC----
T ss_pred CCEEEEEEEecCcCeEEEEEEECCCCC----EEEEEEEehhhcchHHHHHHHHHHHHHHHhc-CCCccceEeeeeccccc
Confidence 799999999999999999999998876 56666542 224456889999999998 8999999987754221
Q ss_pred --CCceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEE
Q 039291 80 --NGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKI 157 (362)
Q Consensus 80 --~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl 157 (362)
.....+|+||||+.++.+..+... ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||
T Consensus 85 ~~~~~~~~~iv~e~~~~~~~~~~~~~--~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl----~~~~~~kl 158 (318)
T d3blha1 85 YNRCKGSIYLVFDFCEHDLAGLLSNV--LVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLI----TRDGVLKL 158 (318)
T ss_dssp ------CEEEEEECCCEEHHHHHTCT--TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE----CTTSCEEE
T ss_pred ccccCceEEEEEeccCCCccchhhhc--ccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheee----cCCCcEEe
Confidence 123457899999987665544333 4569999999999999999999999999999999999999 78889999
Q ss_pred eecCCcccccccc--cCCCCCCccCCCCccCchhhccc-cCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHHc
Q 039291 158 ADLGVAKRSRHCK--RQKFDPSMRGTPLYLAPETVVQH-MQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIG 234 (362)
Q Consensus 158 ~Dfgla~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~ 234 (362)
+|||+++...... ........+||+.|+|||++.+. .++.++||||+||++|||++|++||.+.++......+....
T Consensus 159 ~dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~ 238 (318)
T d3blha1 159 ADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLC 238 (318)
T ss_dssp CCCTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHH
T ss_pred eecceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhc
Confidence 9999997554322 12223456799999999999865 68999999999999999999999997654333222222222
Q ss_pred CCCCCCCC------------------C---------ccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCccC
Q 039291 235 DEHSLPEI------------------P---------SRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKG 279 (362)
Q Consensus 235 ~~~~~~~~------------------~---------~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~~~ 279 (362)
........ . ...++++++||.+||+.||++|||++|+++||||+.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~~ 310 (318)
T d3blha1 239 GSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWS 310 (318)
T ss_dssp CCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGSS
T ss_pred CCCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhhcc
Confidence 11110000 0 013678899999999999999999999999999975
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.9e-54 Score=390.09 Aligned_cols=263 Identities=24% Similarity=0.410 Sum_probs=212.8
Q ss_pred CceeecceecccCceEEEEEEECCCCCCCCceeeeechhh-------hhhHHHHHHHHHHHHcCCCCcccccccceeeec
Q 039291 6 TSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEV-------SASASLQKEKEVFDNLNGCPFVLECFGEEITMG 78 (362)
Q Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~-------~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~ 78 (362)
++|.+++.||+|+||+||+|++.... .....||+|.+.. ...+.+.+|++++++++|||||+++++.+..
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~-~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~-- 100 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGH-DTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT-- 100 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSST-TTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEE--
T ss_pred hceEEEEEEecCCCeEEEEEEECccC-CCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeecc--
Confidence 67999999999999999999974421 1123667776532 2345678999999999988999999887643
Q ss_pred CCCceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEe
Q 039291 79 ENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIA 158 (362)
Q Consensus 79 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~ 158 (362)
...++++|||+.||+|.+++... +.+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+
T Consensus 101 ---~~~~~~v~e~~~~~~L~~~i~~~--~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill----~~~~~vkL~ 171 (322)
T d1vzoa_ 101 ---ETKLHLILDYINGGELFTHLSQR--ERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILL----DSNGHVVLT 171 (322)
T ss_dssp ---TTEEEEEECCCCSCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE----CTTSCEEES
T ss_pred ---CCceeeeeecccccHHHHHHHhc--ccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceee----cCCCCEEEe
Confidence 23577999999999999999874 448999999999999999999999999999999999999 778899999
Q ss_pred ecCCcccccccccCCCCCCccCCCCccCchhhccc--cCCCcchHHHHHHHHHHHHhCCCCCccCCCCCH-HHHHHHHcC
Q 039291 159 DLGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQH--MQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSI-DQLFSIIGD 235 (362)
Q Consensus 159 Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~-~~~~~~~~~ 235 (362)
|||+++........ ......|++.|+|||.+.+. .++.++|||||||+||+|++|+.||........ ..+......
T Consensus 172 DFG~a~~~~~~~~~-~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~ 250 (322)
T d1vzoa_ 172 DFGLSKEFVADETE-RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILK 250 (322)
T ss_dssp CSSEEEECCGGGGG-GGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHH
T ss_pred eccchhhhcccccc-cccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhccc
Confidence 99999865443222 22467799999999999764 468899999999999999999999987654443 333333221
Q ss_pred CCCCCCCCccCCHHHHHHHHHHhccCCCCCC-----CHHHHhcCCCccCcchh
Q 039291 236 EHSLPEIPSRVSKEARDFLRRCFVRKPAFRF-----TAEMLLDDPFVKGVDEE 283 (362)
Q Consensus 236 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~-----s~~~~l~~p~~~~~~~~ 283 (362)
..+.++..+++++++||++||+.||++|| |++|+++||||+++.+.
T Consensus 251 --~~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~i~~~ 301 (322)
T d1vzoa_ 251 --SEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINWD 301 (322)
T ss_dssp --CCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCCHH
T ss_pred --CCCCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcCCCHH
Confidence 12346678999999999999999999999 58999999999998765
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-53 Score=376.20 Aligned_cols=254 Identities=22% Similarity=0.337 Sum_probs=202.3
Q ss_pred CCCceeecceecccCceEEEEEEECCCCCCCCceeeeechhh------hhhHHHHHHHHHHHHcCCCCcccccccceeee
Q 039291 4 DGTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEV------SASASLQKEKEVFDNLNGCPFVLECFGEEITM 77 (362)
Q Consensus 4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~------~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~ 77 (362)
..++|.+.+.||+|+||+||+|+.+..... ...||+|.+.. ...+.+.+|+.+|++++ ||||+++++++..
T Consensus 6 ~~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~-~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~-H~nIv~~~g~~~~- 82 (273)
T d1u46a_ 6 GEKDLRLLEKLGDGSFGVVRRGEWDAPSGK-TVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLD-HRNLIRLYGVVLT- 82 (273)
T ss_dssp CGGGEEEEEECC----CCCEEEEEECTTSC-EEEEEEEC--------CHHHHHHHHHHHHHHHCC-CTTBCCEEEEECS-
T ss_pred chHHeEEEEEEecCCCeEEEEEEEECCCCc-EEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCC-CCCEEEEEEEEee-
Confidence 456799999999999999999987654321 13567777542 23467899999999997 9999999997742
Q ss_pred cCCCceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEE
Q 039291 78 GENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKI 157 (362)
Q Consensus 78 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl 157 (362)
. .+++||||+++|+|.+++... .+.+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||
T Consensus 83 ----~-~~~lv~e~~~~~~l~~~~~~~-~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll----~~~~~vkl 152 (273)
T d1u46a_ 83 ----P-PMKMVTELAPLGSLLDRLRKH-QGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLL----ATRDLVKI 152 (273)
T ss_dssp ----S-SCEEEEECCTTCBHHHHHHHH-GGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE----EETTEEEE
T ss_pred ----c-chheeeeeecCcchhhhhhcc-cCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhcc----ccccceee
Confidence 1 256999999999999988764 3459999999999999999999999999999999999999 55678999
Q ss_pred eecCCcccccccccCC-CCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHh-CCCCCccCCCCCHHHHHHHHcC
Q 039291 158 ADLGVAKRSRHCKRQK-FDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLS-GRQAWVVKEDCSIDQLFSIIGD 235 (362)
Q Consensus 158 ~Dfgla~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~ 235 (362)
+|||+++......... ......|+..|+|||++.+..++.++|||||||++|||++ |..||.+. +..+....+..
T Consensus 153 ~DfGl~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~---~~~~~~~~i~~ 229 (273)
T d1u46a_ 153 GDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGL---NGSQILHKIDK 229 (273)
T ss_dssp CCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTC---CHHHHHHHHHT
T ss_pred ccchhhhhcccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCc---CHHHHHHHHHh
Confidence 9999998765433222 2234567889999999999999999999999999999998 89999543 55666666666
Q ss_pred CCCCCCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhc
Q 039291 236 EHSLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLD 273 (362)
Q Consensus 236 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~ 273 (362)
....+..+..+++++++||.+||..||++|||++++++
T Consensus 230 ~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~ 267 (273)
T d1u46a_ 230 EGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRD 267 (273)
T ss_dssp SCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 66566677889999999999999999999999999864
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-53 Score=374.49 Aligned_cols=247 Identities=21% Similarity=0.339 Sum_probs=201.3
Q ss_pred CCCCceeecceecccCceEEEEEEECCCCCCCCceeeeechhhh-hhHHHHHHHHHHHHcCCCCcccccccceeeecCCC
Q 039291 3 SDGTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVS-ASASLQKEKEVFDNLNGCPFVLECFGEEITMGENG 81 (362)
Q Consensus 3 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~~-~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~~ 81 (362)
+.-++|.+++.||+|+||+||+|+++++ +||+|.+..+ ..+.+.+|++++++++ ||||+++++++.. .
T Consensus 4 i~~~~~~~~~~lG~G~fg~Vy~~~~~~~------~vAvK~i~~~~~~~~~~~E~~~l~~l~-HpnIv~~~g~~~~----~ 72 (262)
T d1byga_ 4 LNMKELKLLQTIGKGEFGDVMLGDYRGN------KVAVKCIKNDATAQAFLAEASVMTQLR-HSNLVQLLGVIVE----E 72 (262)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTE------EEEEEECCCCC--HHHHHTHHHHTTCC-CTTBCCEEEEECC----C
T ss_pred cCHHHeEEeEEEecCCCeEEEEEEECCe------EEEEEEECcHHHHHHHHHHHHHHHhCC-CCCEeeEEEEEEe----c
Confidence 3456899999999999999999998642 5788877543 4566899999999998 9999999997653 2
Q ss_pred ceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEeecC
Q 039291 82 EMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLG 161 (362)
Q Consensus 82 ~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Dfg 161 (362)
...+++||||+++|+|.+++.......+++..++.++.||+.||.|||+++|+||||||+|||+ +.++.+||+|||
T Consensus 73 ~~~~~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~----~~~~~~kl~dfg 148 (262)
T d1byga_ 73 KGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLV----SEDNVAKVSDFG 148 (262)
T ss_dssp --CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE----CTTSCEEECCCC
T ss_pred CCcEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhhee----cCCCCEeecccc
Confidence 2336799999999999999977544569999999999999999999999999999999999999 888899999999
Q ss_pred CcccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHh-CCCCCccCCCCCHHHHHHHHcCCCCCC
Q 039291 162 VAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLS-GRQAWVVKEDCSIDQLFSIIGDEHSLP 240 (362)
Q Consensus 162 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~~~~~~~~~~~~~~~~~~~~ 240 (362)
+++..... .....+|..|+|||++.+..++.++|||||||++|||++ |++||... ...++...+... ..+
T Consensus 149 ~s~~~~~~-----~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~---~~~~~~~~i~~~-~~~ 219 (262)
T d1byga_ 149 LTKEASST-----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI---PLKDVVPRVEKG-YKM 219 (262)
T ss_dssp C-----------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTS---CGGGHHHHHTTT-CCC
T ss_pred cceecCCC-----CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCC---CHHHHHHHHHcC-CCC
Confidence 99755432 134568999999999999999999999999999999998 78888654 344455555443 345
Q ss_pred CCCccCCHHHHHHHHHHhccCCCCCCCHHHHhc
Q 039291 241 EIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLD 273 (362)
Q Consensus 241 ~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~ 273 (362)
.++..+++++++||++||+.||++|||+.++++
T Consensus 220 ~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~ 252 (262)
T d1byga_ 220 DAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLRE 252 (262)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCccCCHHHHHHHHHHcccCHhHCcCHHHHHH
Confidence 678889999999999999999999999999987
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-52 Score=378.15 Aligned_cols=258 Identities=22% Similarity=0.389 Sum_probs=211.5
Q ss_pred CCCCceeecceecccCceEEEEEEECCCCCC---CCceeeeechhhh----hhHHHHHHHHHHHHcCCCCccccccccee
Q 039291 3 SDGTSWFRGRVIGQGSFGCVFIAKPKSNSSF---LPPLMAVKSAEVS----ASASLQKEKEVFDNLNGCPFVLECFGEEI 75 (362)
Q Consensus 3 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~---~~~~~~~K~~~~~----~~~~~~~E~~il~~l~~h~~i~~~~~~~~ 75 (362)
+..++|.+++.||+|+||.||+|++..+++. ....||+|.+... ....+.+|...+.++.+||||+++++++.
T Consensus 10 i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~ 89 (299)
T d1fgka_ 10 LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT 89 (299)
T ss_dssp CCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred ccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccc
Confidence 4568999999999999999999998765432 2246888876433 44668889999999977999999999875
Q ss_pred eecCCCceEEEEEEEecCCCCHHHHHHHhc--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCC
Q 039291 76 TMGENGEMAYNLLLEYAAGGTLGDLIEKCN--------------GNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPD 141 (362)
Q Consensus 76 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--------------~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~ 141 (362)
. ...+++|||||++|+|.+++.... ...+++.++..++.||+.||+|||+++||||||||+
T Consensus 90 ~-----~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~ 164 (299)
T d1fgka_ 90 Q-----DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAAR 164 (299)
T ss_dssp S-----SSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG
T ss_pred c-----CCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeeccc
Confidence 3 223679999999999999997643 235899999999999999999999999999999999
Q ss_pred CEEEeecCCCceEEEEeecCCcccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHh-CCCCCcc
Q 039291 142 NILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLS-GRQAWVV 220 (362)
Q Consensus 142 Nill~~~~~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~ 220 (362)
|||+ +.++.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|||++ |.+||..
T Consensus 165 NiLl----~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~ 240 (299)
T d1fgka_ 165 NVLV----TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPG 240 (299)
T ss_dssp GEEE----CTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred ceee----cCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCC
Confidence 9999 8888999999999987766555555566789999999999999999999999999999999998 7888853
Q ss_pred CCCCCHHHHHHHHcCCCCCCCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhc
Q 039291 221 KEDCSIDQLFSIIGDEHSLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLD 273 (362)
Q Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~ 273 (362)
....++...+.... .+..|..+++++++||.+||+.||++|||+.++++
T Consensus 241 ---~~~~~~~~~i~~~~-~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~ 289 (299)
T d1fgka_ 241 ---VPVEELFKLLKEGH-RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 289 (299)
T ss_dssp ---CCHHHHHHHHHTTC-CCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ---CCHHHHHHHHHcCC-CCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHH
Confidence 35566666666544 44568889999999999999999999999999986
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-53 Score=389.06 Aligned_cols=260 Identities=21% Similarity=0.306 Sum_probs=194.8
Q ss_pred CceeecceecccCceEEEEEEECCCCCCCCceeeeechh-----hhhhHHHHHHHHHHHHcCCCCcccccccceeeecC-
Q 039291 6 TSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAE-----VSASASLQKEKEVFDNLNGCPFVLECFGEEITMGE- 79 (362)
Q Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~-----~~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~- 79 (362)
++|.+++.||+|+||+||+|+++.++. .||+|.+. ......+.+|+.++++++ ||||+++++++...+.
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~----~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~~~~~f~~~~~~ 91 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDR----NVAIKKLSRPFQNQTHAKRAYRELVLMKCVN-HKNIISLLNVFTPQKTL 91 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTE----EEEEEEEESTTSSHHHHHHHHHHHHHHHHCC-CTTBCCCSEEECSCCST
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCC----EEEEEEEChhhcCHHHHHHHHHHHHHHHhcC-CCCeeEEEEEEeccccc
Confidence 589999999999999999999998886 45666543 234456889999999998 9999999998764332
Q ss_pred CCceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEee
Q 039291 80 NGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIAD 159 (362)
Q Consensus 80 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~D 159 (362)
+....+|+|||||.+ ++.+.+. ..+++..++.++.||+.||+|||++||+||||||+|||+ +.++.++++|
T Consensus 92 ~~~~~~~iv~Ey~~~-~l~~~~~----~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~----~~~~~~kl~d 162 (355)
T d2b1pa1 92 EEFQDVYLVMELMDA-NLCQVIQ----MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV----KSDCTLKILD 162 (355)
T ss_dssp TTCCEEEEEEECCSE-EHHHHHT----SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE----CTTCCEEECC
T ss_pred ccCceeEEEEeccch-HHHHhhh----cCCCHHHHHHHHHHHHHHHHHhhhcccccccCCcccccc----ccccceeeec
Confidence 234568899999976 4544443 349999999999999999999999999999999999999 7788899999
Q ss_pred cCCcccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHH-HHH-----
Q 039291 160 LGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLF-SII----- 233 (362)
Q Consensus 160 fgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~-~~~----- 233 (362)
||+++...... .....+||+.|+|||++.+..++.++||||+||++++|++|++||.+.+.......+ ...
T Consensus 163 f~~~~~~~~~~---~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~ 239 (355)
T d2b1pa1 163 FGLARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCP 239 (355)
T ss_dssp CCC------------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCH
T ss_pred hhhhhcccccc---ccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCH
Confidence 99987655432 224667999999999999999999999999999999999999999765422211111 111
Q ss_pred --------------cCCCCCCCC-----------------CccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCccCcch
Q 039291 234 --------------GDEHSLPEI-----------------PSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGVDE 282 (362)
Q Consensus 234 --------------~~~~~~~~~-----------------~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~~~~~~ 282 (362)
......... +...++++++||++||..||++|||++|+|+||||+...+
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~~~~~ 319 (355)
T d2b1pa1 240 EFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYD 319 (355)
T ss_dssp HHHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGGCC
T ss_pred HHHHHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCCCC
Confidence 011100000 1124678999999999999999999999999999987544
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.3e-52 Score=373.77 Aligned_cols=255 Identities=21% Similarity=0.350 Sum_probs=206.7
Q ss_pred CceeecceecccCceEEEEEEECCCCCCCCceeeeechh-----hhhhHHHHHHHHHHHHcCCCCcccccccceeeecCC
Q 039291 6 TSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAE-----VSASASLQKEKEVFDNLNGCPFVLECFGEEITMGEN 80 (362)
Q Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~-----~~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~ 80 (362)
+||.+++.||+|+||+||+|+++.+++ .||+|.+. ......+.+|+.+|+.++ ||||+++++.+..
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~----~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~-h~niv~~~~~~~~---- 72 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHE----IVALKRVRLDDDDEGVPSSALREICLLKELK-HKNIVRLHDVLHS---- 72 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCC----EEEEEEEESSCSSTTHHHHHHHHHHHHTTCC-CTTBCCEEEEEEC----
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCc----EEEEEEEehhhCChHHHHHHHHHHHHHHhcC-cCCEEeecccccc----
Confidence 589999999999999999999998876 45666542 234567889999999998 8999999987653
Q ss_pred CceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEeec
Q 039291 81 GEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADL 160 (362)
Q Consensus 81 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Df 160 (362)
...+++++|++.|++|..+++. .+.+++..++.++.|++.||+|||++||+||||||+|||+ +..+.+||+||
T Consensus 73 -~~~~~iv~~~~~~~~l~~~~~~--~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli----~~~~~~kl~DF 145 (292)
T d1unla_ 73 -DKKLTLVFEFCDQDLKKYFDSC--NGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLI----NRNGELKLANF 145 (292)
T ss_dssp -SSEEEEEEECCSEEHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE----CTTCCEEECCC
T ss_pred -ccceeEEeeecccccccccccc--ccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCccccc----ccCCceeeeec
Confidence 2346799999999998888765 4569999999999999999999999999999999999999 77788999999
Q ss_pred CCcccccccccCCCCCCccCCCCccCchhhcccc-CCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHHc---C-
Q 039291 161 GVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHM-QEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIG---D- 235 (362)
Q Consensus 161 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~---~- 235 (362)
|.++....... ......+++.|+|||++.+.. ++.++||||+||++|||++|+.||.... +..+....+. .
T Consensus 146 G~a~~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~--~~~~~~~~~~~~~~~ 221 (292)
T d1unla_ 146 GLARAFGIPVR--CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGN--DVDDQLKRIFRLLGT 221 (292)
T ss_dssp TTCEECCSCCS--CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCS--SHHHHHHHHHHHHCC
T ss_pred chhhcccCCCc--cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCC--CHHHHHHHHHhhcCC
Confidence 99986654322 223556888999999988654 6899999999999999999999975432 3333333221 1
Q ss_pred -----------------------CCCCCCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCccCc
Q 039291 236 -----------------------EHSLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGV 280 (362)
Q Consensus 236 -----------------------~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~~~~ 280 (362)
..........+++++++||++||+.||.+|||++|+|+||||++.
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~~ 289 (292)
T d1unla_ 222 PTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDF 289 (292)
T ss_dssp CCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSSC
T ss_pred CChhhhhhhhhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhhcCC
Confidence 111222345678999999999999999999999999999999864
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-53 Score=389.20 Aligned_cols=259 Identities=21% Similarity=0.323 Sum_probs=202.5
Q ss_pred CceeecceecccCceEEEEEEECCCCCCCCceeeeechhh-----hhhHHHHHHHHHHHHcCCCCcccccccceeeecCC
Q 039291 6 TSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEV-----SASASLQKEKEVFDNLNGCPFVLECFGEEITMGEN 80 (362)
Q Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~-----~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~ 80 (362)
+||.+++.||+|+||+||+|+++.+++ .||+|.+.. .....+.+|+.+|++|+ ||||+++++++......
T Consensus 18 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~----~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~-h~~iv~~~~~~~~~~~~ 92 (348)
T d2gfsa1 18 ERYQNLSPVGSGAYGSVCAAFDTKTGL----RVAVKKLSRPFQSIIHAKRTYRELRLLKHMK-HENVIGLLDVFTPARSL 92 (348)
T ss_dssp TTEEEEEECGGGTTSSEEEEEETTTTE----EEEEEECSCTTSSHHHHHHHHHHHHHHHHCC-CTTBCCCSEEECSCSST
T ss_pred CCeEEEEEEecCCCeEEEEEEECCCCC----EEEEEEECchhcChHHHHHHHHHHHHHHhcC-CCCeeeEEEEEeecccc
Confidence 689999999999999999999998875 567776532 24456889999999998 99999999876543322
Q ss_pred CceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEeec
Q 039291 81 GEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADL 160 (362)
Q Consensus 81 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Df 160 (362)
.....+++|+|+.||+|.+++.. +++++..++.++.||+.||+|||++||+||||||+|||+ +.++.+|++||
T Consensus 93 ~~~~~~~i~~~~~gg~L~~~~~~---~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi----~~~~~~kl~df 165 (348)
T d2gfsa1 93 EEFNDVYLVTHLMGADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV----NEDCELKILDF 165 (348)
T ss_dssp TTCCCCEEEEECCSEEHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE----CTTCCEEECCC
T ss_pred ccCceEEEEEeecCCchhhhccc---ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccc----ccccccccccc
Confidence 22233466788889999999864 459999999999999999999999999999999999999 88889999999
Q ss_pred CCcccccccccCCCCCCccCCCCccCchhhccc-cCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHHcC----
Q 039291 161 GVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQH-MQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGD---- 235 (362)
Q Consensus 161 gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~---- 235 (362)
|++...... .....||+.|+|||++.+. .++.++|||||||++|+|++|++||.+.+.......+.....
T Consensus 166 g~a~~~~~~-----~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~ 240 (348)
T d2gfsa1 166 GLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGA 240 (348)
T ss_dssp ----CCTGG-----GSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCH
T ss_pred chhcccCcc-----cccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCh
Confidence 998755432 1356799999999987765 468899999999999999999999976543222222111110
Q ss_pred -----------------CCCCCC-----CCccCCHHHHHHHHHHhccCCCCCCCHHHHhcCCCccCcc
Q 039291 236 -----------------EHSLPE-----IPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDDPFVKGVD 281 (362)
Q Consensus 236 -----------------~~~~~~-----~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~p~~~~~~ 281 (362)
....+. ....+++++++||++||..||++|||++|+|+||||++..
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~ 308 (348)
T d2gfsa1 241 ELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 308 (348)
T ss_dssp HHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred HHhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCCC
Confidence 011111 1235789999999999999999999999999999998764
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.2e-52 Score=376.91 Aligned_cols=257 Identities=23% Similarity=0.336 Sum_probs=211.1
Q ss_pred CCCCceeecceecccCceEEEEEEECCCC-CCCCceeeeechhhh----hhHHHHHHHHHHHHcCCCCcccccccceeee
Q 039291 3 SDGTSWFRGRVIGQGSFGCVFIAKPKSNS-SFLPPLMAVKSAEVS----ASASLQKEKEVFDNLNGCPFVLECFGEEITM 77 (362)
Q Consensus 3 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~-~~~~~~~~~K~~~~~----~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~ 77 (362)
...++|.+++.||+|+||+||+|+++... ......||+|.+... ....+.+|+.+|++++ ||||+++++.+..
T Consensus 10 ~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~-h~niv~~~~~~~~- 87 (301)
T d1lufa_ 10 YPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFD-NPNIVKLLGVCAV- 87 (301)
T ss_dssp CCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCC-CTTBCCEEEEECS-
T ss_pred CCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcC-CCCcccceeeecc-
Confidence 44578999999999999999999986532 222347888876432 3566899999999998 9999999997643
Q ss_pred cCCCceEEEEEEEecCCCCHHHHHHHhc----------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCcee
Q 039291 78 GENGEMAYNLLLEYAAGGTLGDLIEKCN----------------------GNGLPEKDVRHFTRCILEGIGHIHDSGYVH 135 (362)
Q Consensus 78 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~----------------------~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH 135 (362)
...++++|||+++|+|.+++.... ...+++..+..++.||+.||+|||+++|||
T Consensus 88 ----~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivH 163 (301)
T d1lufa_ 88 ----GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVH 163 (301)
T ss_dssp ----SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred ----CCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEe
Confidence 223669999999999999997532 124889999999999999999999999999
Q ss_pred CCCCCCCEEEeecCCCceEEEEeecCCcccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHhCC
Q 039291 136 CDVKPDNILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGR 215 (362)
Q Consensus 136 ~Dlkp~Nill~~~~~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~ 215 (362)
|||||+|||+ +.++.+||+|||+|+...............||+.|+|||++.+..++.++|||||||++|||++|.
T Consensus 164 rDlKp~NILl----d~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~ 239 (301)
T d1lufa_ 164 RDLATRNCLV----GENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYG 239 (301)
T ss_dssp SCCSGGGEEE----CGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTT
T ss_pred eEEcccceEE----CCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccC
Confidence 9999999999 788899999999998665544444445677999999999999999999999999999999999985
Q ss_pred -CCCccCCCCCHHHHHHHHcCCCCCCCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhc
Q 039291 216 -QAWVVKEDCSIDQLFSIIGDEHSLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLD 273 (362)
Q Consensus 216 -~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~ 273 (362)
+||... +..++...+.... .+.+|..+++++.+||.+||+.||++|||+.++++
T Consensus 240 ~~p~~~~---~~~e~~~~v~~~~-~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~ 294 (301)
T d1lufa_ 240 LQPYYGM---AHEEVIYYVRDGN-ILACPENCPLELYNLMRLCWSKLPADRPSFCSIHR 294 (301)
T ss_dssp CCTTTTS---CHHHHHHHHHTTC-CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCCCC---CHHHHHHHHHcCC-CCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 567433 5566666666554 45678889999999999999999999999999865
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-52 Score=376.84 Aligned_cols=258 Identities=22% Similarity=0.317 Sum_probs=210.2
Q ss_pred CCCceeecceecccCceEEEEEEECCC-CCCCCceeeeechhhh----hhHHHHHHHHHHHHcCCCCcccccccceeeec
Q 039291 4 DGTSWFRGRVIGQGSFGCVFIAKPKSN-SSFLPPLMAVKSAEVS----ASASLQKEKEVFDNLNGCPFVLECFGEEITMG 78 (362)
Q Consensus 4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~-~~~~~~~~~~K~~~~~----~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~ 78 (362)
..++|.+++.||+|+||.||+|+++.. +....+.||+|.+... ....+.+|+.+++++.+||||+++++.+..
T Consensus 21 ~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~-- 98 (311)
T d1t46a_ 21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTI-- 98 (311)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS--
T ss_pred CHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEee--
Confidence 457899999999999999999997542 3344568888876532 445688999999999779999999998743
Q ss_pred CCCceEEEEEEEecCCCCHHHHHHHhc----------------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCC
Q 039291 79 ENGEMAYNLLLEYAAGGTLGDLIEKCN----------------GNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDN 142 (362)
Q Consensus 79 ~~~~~~~~lv~e~~~~~~L~~~l~~~~----------------~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~N 142 (362)
...+++|||||++|+|.+++.... ...+++..+..++.||+.||+|||++|||||||||+|
T Consensus 99 ---~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~N 175 (311)
T d1t46a_ 99 ---GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARN 175 (311)
T ss_dssp ---SSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred ---CCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeeccccccc
Confidence 223679999999999999998632 2258999999999999999999999999999999999
Q ss_pred EEEeecCCCceEEEEeecCCcccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHh-CCCCCccC
Q 039291 143 ILLVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLS-GRQAWVVK 221 (362)
Q Consensus 143 ill~~~~~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~-g~~pf~~~ 221 (362)
|++ +..+.+|++|||+++...............||+.|+|||++.+..++.++|||||||++|||++ |.+||...
T Consensus 176 Il~----~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~ 251 (311)
T d1t46a_ 176 ILL----THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGM 251 (311)
T ss_dssp EEE----ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTC
T ss_pred ccc----cccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCC
Confidence 999 7788999999999987665444444456789999999999999999999999999999999998 56666444
Q ss_pred CCCCHHHHHHHHcCCCCCCCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhc
Q 039291 222 EDCSIDQLFSIIGDEHSLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLD 273 (362)
Q Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~ 273 (362)
... ..+...+. ....+..+..++.++.+||.+||..||++|||++++++
T Consensus 252 ~~~--~~~~~~i~-~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~ 300 (311)
T d1t46a_ 252 PVD--SKFYKMIK-EGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 300 (311)
T ss_dssp CSS--HHHHHHHH-HTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CHH--HHHHHHHh-cCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 322 22222222 33345567789999999999999999999999999986
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-52 Score=376.07 Aligned_cols=254 Identities=24% Similarity=0.376 Sum_probs=208.0
Q ss_pred CCCCceeecceecccCceEEEEEEECCCCCCCCceeeeechh----hhhhHHHHHHHHHHHHcCCCCcccccccceeeec
Q 039291 3 SDGTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAE----VSASASLQKEKEVFDNLNGCPFVLECFGEEITMG 78 (362)
Q Consensus 3 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~----~~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~ 78 (362)
++-++|.+++.||+|+||+||+|+++.++..+ .|++|... ....+.+.+|+++|+++.+||||+++++++..
T Consensus 7 i~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~--~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~-- 82 (309)
T d1fvra_ 7 LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRM--DAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEH-- 82 (309)
T ss_dssp CCGGGCEEEEEEECGGGCEEEEEEEEETTEEE--EEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEE--
T ss_pred cCHHHcEEEEEEeeCCCcEEEEEEECCCCeEE--EEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEec--
Confidence 34578999999999999999999998876532 34555432 23455789999999999669999999998764
Q ss_pred CCCceEEEEEEEecCCCCHHHHHHHh--------------cCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEE
Q 039291 79 ENGEMAYNLLLEYAAGGTLGDLIEKC--------------NGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNIL 144 (362)
Q Consensus 79 ~~~~~~~~lv~e~~~~~~L~~~l~~~--------------~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nil 144 (362)
...+++||||++||+|.++++.. ....+++..+..++.||+.||.|||+++|+||||||+|||
T Consensus 83 ---~~~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL 159 (309)
T d1fvra_ 83 ---RGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNIL 159 (309)
T ss_dssp ---TTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEE
T ss_pred ---CCeeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEE
Confidence 22477999999999999999753 2356999999999999999999999999999999999999
Q ss_pred EeecCCCceEEEEeecCCcccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHhCC-CCCccCCC
Q 039291 145 LVATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGR-QAWVVKED 223 (362)
Q Consensus 145 l~~~~~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~-~pf~~~~~ 223 (362)
+ +..+.+||+|||+|+........ ....||..|+|||.+.+..++.++|||||||++|||++|. +||. .
T Consensus 160 ~----~~~~~~kl~DfG~a~~~~~~~~~---~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~---~ 229 (309)
T d1fvra_ 160 V----GENYVAKIADFGLSRGQEVYVKK---TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYC---G 229 (309)
T ss_dssp E----CGGGCEEECCTTCEESSCEECCC-------CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTT---T
T ss_pred E----cCCCceEEccccccccccccccc---cceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCC---C
Confidence 9 77889999999999755432222 3456999999999999999999999999999999999965 5674 3
Q ss_pred CCHHHHHHHHcCCCCCCCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhcC
Q 039291 224 CSIDQLFSIIGDEHSLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLDD 274 (362)
Q Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~~ 274 (362)
.+..++...+.... .+..+..+++++++||.+||+.||++|||+.+++++
T Consensus 230 ~~~~~~~~~i~~~~-~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 279 (309)
T d1fvra_ 230 MTCAELYEKLPQGY-RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 279 (309)
T ss_dssp CCHHHHHHHGGGTC-CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCHHHHHHHHHhcC-CCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 45677777766544 355678899999999999999999999999999975
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-51 Score=371.43 Aligned_cols=257 Identities=18% Similarity=0.296 Sum_probs=211.8
Q ss_pred CCCCceeecceecccCceEEEEEEECCCCC-CCCceeeeechhhh----hhHHHHHHHHHHHHcCCCCcccccccceeee
Q 039291 3 SDGTSWFRGRVIGQGSFGCVFIAKPKSNSS-FLPPLMAVKSAEVS----ASASLQKEKEVFDNLNGCPFVLECFGEEITM 77 (362)
Q Consensus 3 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~-~~~~~~~~K~~~~~----~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~ 77 (362)
+..++|.+++.||+|+||+||+|.++.... .....||+|.+... ....+.+|+.++++++ ||||+++++++..
T Consensus 17 i~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~-h~nIv~~~~~~~~- 94 (308)
T d1p4oa_ 17 VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFN-CHHVVRLLGVVSQ- 94 (308)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCC-CTTBCCEEEEECS-
T ss_pred ecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcC-CCCEeeeeeEEec-
Confidence 456899999999999999999998864321 11246888876532 3345789999999998 9999999997743
Q ss_pred cCCCceEEEEEEEecCCCCHHHHHHHhc--------CCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecC
Q 039291 78 GENGEMAYNLLLEYAAGGTLGDLIEKCN--------GNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQ 149 (362)
Q Consensus 78 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~--------~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~ 149 (362)
...+++||||+++|+|.+++.... ...+++..+..++.|++.||.|||+++|+||||||+|||+
T Consensus 95 ----~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLl---- 166 (308)
T d1p4oa_ 95 ----GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMV---- 166 (308)
T ss_dssp ----SSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEE----
T ss_pred ----CCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceee----
Confidence 223679999999999999987532 1347899999999999999999999999999999999999
Q ss_pred CCceEEEEeecCCcccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHhCC-CCCccCCCCCHHH
Q 039291 150 SGKFVAKIADLGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGR-QAWVVKEDCSIDQ 228 (362)
Q Consensus 150 ~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~-~pf~~~~~~~~~~ 228 (362)
+.++++||+|||+|+...............||+.|+|||.+.+..++.++|||||||++|||++|. +||.. .+..+
T Consensus 167 d~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~---~~~~~ 243 (308)
T d1p4oa_ 167 AEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQG---LSNEQ 243 (308)
T ss_dssp CTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTT---SCHHH
T ss_pred cCCceEEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCC---CCHHH
Confidence 888999999999998665544433334567999999999999999999999999999999999984 77743 35666
Q ss_pred HHHHHcCCCCCCCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhc
Q 039291 229 LFSIIGDEHSLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLD 273 (362)
Q Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~ 273 (362)
....+..... +..+..+++.+.+||.+||+.||++|||+.++++
T Consensus 244 ~~~~i~~~~~-~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~ 287 (308)
T d1p4oa_ 244 VLRFVMEGGL-LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIIS 287 (308)
T ss_dssp HHHHHHTTCC-CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHhCCC-CCCcccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 6666665543 5567889999999999999999999999999987
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-50 Score=366.65 Aligned_cols=250 Identities=21% Similarity=0.325 Sum_probs=199.1
Q ss_pred cceecccCceEEEEEEECCCCCCCCceeeeechh----hhhhHHHHHHHHHHHHcCCCCcccccccceeeecCCCceEEE
Q 039291 11 GRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAE----VSASASLQKEKEVFDNLNGCPFVLECFGEEITMGENGEMAYN 86 (362)
Q Consensus 11 ~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~----~~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~~~~~~~ 86 (362)
.++||+|+||+||+|++..++.. ...||+|... ....+.+.+|+++|++++ ||||+++++++... +..++
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~-~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~-HpnIv~~~g~~~~~----~~~~~ 105 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGK-KIHCAVKSLNRITDIGEVSQFLTEGIIMKDFS-HPNVLSLLGICLRS----EGSPL 105 (311)
T ss_dssp EEEEEEETTEEEEEEEECC-----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCC-CTTBCCCCEEEEET----TTEEE
T ss_pred ceEEeecCCeEEEEEEEECCCCE-EEEEEEEEECcccCHHHHHHHHHHHHHHHhCC-CCCEeEEeEEEEec----CCceE
Confidence 67899999999999998765421 1245666543 335567999999999998 99999999976532 23467
Q ss_pred EEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEeecCCcccc
Q 039291 87 LLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVAKRS 166 (362)
Q Consensus 87 lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Dfgla~~~ 166 (362)
+|||||++|+|.+++.. ....+++..+..++.|++.||.|||+.+|+||||||+|||+ ++++.+||+|||+++..
T Consensus 106 lv~E~~~~g~l~~~~~~-~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl----~~~~~~kL~DFG~~~~~ 180 (311)
T d1r0pa_ 106 VVLPYMKHGDLRNFIRN-ETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCML----DEKFTVKVADFGLARDM 180 (311)
T ss_dssp EEEECCTTCBHHHHHHC-TTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE----CTTCCEEECSSGGGCCT
T ss_pred EEEEEeecCchhhhhcc-ccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeE----CCCCCEEEecccchhhc
Confidence 99999999999999876 34458899999999999999999999999999999999999 88889999999999865
Q ss_pred cccccC--CCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHHcCCCCCCCCCc
Q 039291 167 RHCKRQ--KFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGDEHSLPEIPS 244 (362)
Q Consensus 167 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (362)
...... .......||+.|+|||++....++.++||||||+++|||++|..||.... +..++...+.... .+..|.
T Consensus 181 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~--~~~~~~~~i~~g~-~~~~p~ 257 (311)
T d1r0pa_ 181 YDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV--NTFDITVYLLQGR-RLLQPE 257 (311)
T ss_dssp TTTTCCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC--------CHHHHHTTC-CCCCCT
T ss_pred cccccccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCC--CHHHHHHHHHcCC-CCCCcc
Confidence 443222 12234578999999999999999999999999999999999877775432 2333334444333 345677
Q ss_pred cCCHHHHHHHHHHhccCCCCCCCHHHHhcC
Q 039291 245 RVSKEARDFLRRCFVRKPAFRFTAEMLLDD 274 (362)
Q Consensus 245 ~~~~~~~~li~~~l~~~p~~R~s~~~~l~~ 274 (362)
.+++++.+||.+||+.||++||++.|+++|
T Consensus 258 ~~~~~l~~li~~cl~~dP~~RPs~~ei~~~ 287 (311)
T d1r0pa_ 258 YCPDPLYEVMLKCWHPKAEMRPSFSELVSR 287 (311)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cCcHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 899999999999999999999999999975
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.1e-50 Score=365.61 Aligned_cols=260 Identities=22% Similarity=0.308 Sum_probs=197.3
Q ss_pred CCceeecceecccCceEEEEEEECCCCCCCCceeeeechhh-hhhHHHHHHHHHHHHcCCCCcccccccceeeecCCCce
Q 039291 5 GTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEV-SASASLQKEKEVFDNLNGCPFVLECFGEEITMGENGEM 83 (362)
Q Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~-~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~~~~ 83 (362)
|++|++++.||+|+||+||+|+++.+++ .||+|.... .....+.+|+++++.+++|++|+.+..... ...
T Consensus 6 g~rY~l~~~iG~G~fG~Vy~a~~~~~~~----~vAvK~~~~~~~~~~~~~E~~i~~~l~~~~~i~~~~~~~~-----~~~ 76 (299)
T d1ckia_ 6 GNRYRLGRKIGSGSFGDIYLGTDIAAGE----EVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGA-----EGD 76 (299)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEETTTTE----EEEEEEEESCTTSCCHHHHHHHHHHSTTSTTCCCEEEEEE-----ETT
T ss_pred CCEEEEeEEEeeCCCcEEEEEEECCCCC----EEEEEEEchhccCHHHHHHHHHHHHccCCCcccEEEEEEe-----cCC
Confidence 5789999999999999999999988875 567776433 234568899999999996666665554332 123
Q ss_pred EEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecCCCceEEEEeecCCc
Q 039291 84 AYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQSGKFVAKIADLGVA 163 (362)
Q Consensus 84 ~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~~~~~~~kl~Dfgla 163 (362)
.+++||||+ +++|.+.+.. ..+.+++..+..++.|++.||+|||++||+||||||+|||+... +.+..++|+|||+|
T Consensus 77 ~~~ivme~~-~~~l~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~-~~~~~vkl~DFG~a 153 (299)
T d1ckia_ 77 YNVMVMELL-GPSLEDLFNF-CSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLG-KKGNLVYIIDFGLA 153 (299)
T ss_dssp EEEEEEECC-CCBHHHHHHH-TTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCG-GGTTCEEECCCSSC
T ss_pred EEEEEEEEc-CCchhhhhhh-ccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhcccccc-CCCceeeeeccCcc
Confidence 467999999 4577776655 34569999999999999999999999999999999999998433 23456999999999
Q ss_pred ccccccccC-----CCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHHcC---
Q 039291 164 KRSRHCKRQ-----KFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIGD--- 235 (362)
Q Consensus 164 ~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~--- 235 (362)
+........ .......||+.|+|||++.+..++.++|||||||++|||++|..||.................
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~ 233 (299)
T d1ckia_ 154 KKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKM 233 (299)
T ss_dssp EECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHH
T ss_pred eeccccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccC
Confidence 866543221 123456899999999999999999999999999999999999999976544333222211111
Q ss_pred CCCCCCCCccCCHHHHHHHHHHhccCCCCCCCHHHH---hcCCC
Q 039291 236 EHSLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEML---LDDPF 276 (362)
Q Consensus 236 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~---l~~p~ 276 (362)
....+..+..+|+++.+||.+||..+|++||++.++ ++|+|
T Consensus 234 ~~~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~ 277 (299)
T d1ckia_ 234 STPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLF 277 (299)
T ss_dssp HSCHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHH
T ss_pred CCChhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHH
Confidence 111223345689999999999999999999998755 55544
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=2.5e-50 Score=361.89 Aligned_cols=261 Identities=24% Similarity=0.354 Sum_probs=209.6
Q ss_pred CCCCCceeecceecccCceEEEEEEECCCCCCCCceeeeechhh-hhhHHHHHHHHHHHHcCCCCcccccccceeeecCC
Q 039291 2 DSDGTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEV-SASASLQKEKEVFDNLNGCPFVLECFGEEITMGEN 80 (362)
Q Consensus 2 ~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~-~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~ 80 (362)
|+-|++|.+++.||+|+||+||+|+++.+++ .||+|.... .....+.+|+++++.|.+|+|++.+++....
T Consensus 1 ~vig~~Y~i~~~iG~G~fG~Vy~a~~~~~~~----~vAvK~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~---- 72 (293)
T d1csna_ 1 NVVGVHYKVGRRIGEGSFGVIFEGTNLLNNQ----QVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQE---- 72 (293)
T ss_dssp CEETTTEEEEEEEEECSSCEEEEEEETTTTE----EEEEEEEECCTTSCCHHHHHHHHHHTTTCTTCCCEEEEEEE----
T ss_pred CCCCCceEEEEEEecCCCeEEEEEEECCCCC----EEEEEEEccccCcHHHHHHHHHHHHhcCCCCCCEEEEEeec----
Confidence 4568999999999999999999999998875 567776532 3445688999999999988999998876542
Q ss_pred CceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEeecC-CCceEEEEee
Q 039291 81 GEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLVATQ-SGKFVAKIAD 159 (362)
Q Consensus 81 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~~~~-~~~~~~kl~D 159 (362)
...+++||||+ |++|.++++.. +..+++.++..++.|++.||+|||++||+||||||+|||+.... ...+.+||+|
T Consensus 73 -~~~~~~vme~~-~~~l~~~~~~~-~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~D 149 (293)
T d1csna_ 73 -GLHNVLVIDLL-GPSLEDLLDLC-GRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVD 149 (293)
T ss_dssp -TTEEEEEEECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECC
T ss_pred -CCccEEEEEec-CCCHHHHHHhh-ccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcc
Confidence 23467999999 67999998763 45699999999999999999999999999999999999995422 2356799999
Q ss_pred cCCcccccccccC-----CCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCHHHHHHHHc
Q 039291 160 LGVAKRSRHCKRQ-----KFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSIDQLFSIIG 234 (362)
Q Consensus 160 fgla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~ 234 (362)
||+|+........ ......+||+.|||||++.+..++.++|||||||++|||++|..||.+............+.
T Consensus 150 FG~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~ 229 (293)
T d1csna_ 150 FGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIG 229 (293)
T ss_dssp CTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHH
T ss_pred cceeEEcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHH
Confidence 9999865432221 12345689999999999999999999999999999999999999998776666555443332
Q ss_pred C---CCCCCCCCccCCHHHHHHHHHHhccCCCCCCCHHHHhc
Q 039291 235 D---EHSLPEIPSRVSKEARDFLRRCFVRKPAFRFTAEMLLD 273 (362)
Q Consensus 235 ~---~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~l~ 273 (362)
. ....+.++..+|+++.+++..|+..+|++||+++.+.+
T Consensus 230 ~~~~~~~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~ 271 (293)
T d1csna_ 230 EKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG 271 (293)
T ss_dssp HHHHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred hccCCCChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence 1 11222344568899999999999999999999877654
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-49 Score=355.47 Aligned_cols=253 Identities=24% Similarity=0.335 Sum_probs=198.9
Q ss_pred CceeecceecccCceEEEEEEECCCCCCCCceeeeechhhhhhHHHHHHHHHHH--HcCCCCcccccccceeeecCCCce
Q 039291 6 TSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVSASASLQKEKEVFD--NLNGCPFVLECFGEEITMGENGEM 83 (362)
Q Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~~~~~~~~~E~~il~--~l~~h~~i~~~~~~~~~~~~~~~~ 83 (362)
.+|.+.+.||+|+||+||+|++++ .+||+|.+.........+|.+++. .++ ||||+++++++.... ....
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~~g------~~vAvK~~~~~~~~~~~~e~ei~~~~~~~-HpnIv~~~~~~~~~~-~~~~ 74 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKWRG------EEVAVKIFSSREERSWFREAEIYQTVMLR-HENILGFIAADNKDN-GTWT 74 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEETT------EEEEEEEECGGGHHHHHHHHHHHTSTTCC-CTTBCCEEEEEEEEC-SSSE
T ss_pred cEEEEEEEEeeCCCeEEEEEEECC------EEEEEEEECccchhHHHHHHHHHHHhhCC-CCcCcceEEEEEeCC-Ccce
Confidence 579999999999999999999743 378899887666666666666554 556 999999999887644 2334
Q ss_pred EEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh--------CCceeCCCCCCCEEEeecCCCceEE
Q 039291 84 AYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHD--------SGYVHCDVKPDNILLVATQSGKFVA 155 (362)
Q Consensus 84 ~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~--------~~ivH~Dlkp~Nill~~~~~~~~~~ 155 (362)
.+++||||+++|+|.+++++ .++++..+..++.|++.||.|||+ +||+||||||+|||+ +.++.+
T Consensus 75 ~~~lv~Ey~~~g~L~~~l~~---~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl----~~~~~~ 147 (303)
T d1vjya_ 75 QLWLVSDYHEHGSLFDYLNR---YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILV----KKNGTC 147 (303)
T ss_dssp EEEEEEECCTTCBHHHHHHH---CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEE----CTTSCE
T ss_pred EEEEEEecccCCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEE----cCCCCe
Confidence 57899999999999999986 359999999999999999999996 699999999999999 888899
Q ss_pred EEeecCCcccccccccC--CCCCCccCCCCccCchhhcccc------CCCcchHHHHHHHHHHHHhCCCCCccCC-----
Q 039291 156 KIADLGVAKRSRHCKRQ--KFDPSMRGTPLYLAPETVVQHM------QEAPSDIWALGCVVLEMLSGRQAWVVKE----- 222 (362)
Q Consensus 156 kl~Dfgla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~------~~~~~DiwslG~il~~l~~g~~pf~~~~----- 222 (362)
||+|||+++........ .......||+.|+|||++.+.. ++.++|||||||+||||++|..||....
T Consensus 148 Kl~DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~ 227 (303)
T d1vjya_ 148 CIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLP 227 (303)
T ss_dssp EECCCTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCT
T ss_pred EEEecCccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccc
Confidence 99999999866543221 1224567999999999987642 5678999999999999999988774322
Q ss_pred -------CCCHHHHHHHHcCCCCCCCCCccC-----CHHHHHHHHHHhccCCCCCCCHHHHhc
Q 039291 223 -------DCSIDQLFSIIGDEHSLPEIPSRV-----SKEARDFLRRCFVRKPAFRFTAEMLLD 273 (362)
Q Consensus 223 -------~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~li~~~l~~~p~~R~s~~~~l~ 273 (362)
......+..........|.++... ...+.+|+.+||+.||++|||+.++++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~ 290 (303)
T d1vjya_ 228 YYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKK 290 (303)
T ss_dssp TTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHH
T ss_pred hhhcccccchHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHH
Confidence 123444545554445445554432 356899999999999999999999976
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=4.8e-47 Score=350.89 Aligned_cols=264 Identities=25% Similarity=0.414 Sum_probs=196.1
Q ss_pred CCceeecceecccCceEEEEEEECCCCCCCCceeeeechhhh--hhHHHHHHHHHHHHcCC----------CCccccccc
Q 039291 5 GTSWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVS--ASASLQKEKEVFDNLNG----------CPFVLECFG 72 (362)
Q Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~~--~~~~~~~E~~il~~l~~----------h~~i~~~~~ 72 (362)
++||.++++||+|+||+||+|+++.+++ .||+|.++.. ..+.+.+|+.+++.+++ |+||+++++
T Consensus 12 ~~rY~i~~~LG~G~fg~Vy~~~~~~~g~----~vAvKvi~~~~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~ 87 (362)
T d1q8ya_ 12 DARYILVRKLGWGHFSTVWLAKDMVNNT----HVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLD 87 (362)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTE----EEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCE
T ss_pred CCcEEEEEEEeeCCCeEEEEEEECCCCC----EEEEEEEeccccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEE
Confidence 4689999999999999999999998876 5677765433 34567889999998862 578999988
Q ss_pred ceeeecCCCceEEEEEEEecCCCC-HHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCceeCCCCCCCEEEeecCC
Q 039291 73 EEITMGENGEMAYNLLLEYAAGGT-LGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHD-SGYVHCDVKPDNILLVATQS 150 (362)
Q Consensus 73 ~~~~~~~~~~~~~~lv~e~~~~~~-L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~-~~ivH~Dlkp~Nill~~~~~ 150 (362)
.+.... ....+++|+++..+. ............+++..++.++.||+.||+|||+ .||+||||||+|||+..++.
T Consensus 88 ~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~ 164 (362)
T d1q8ya_ 88 HFNHKG---PNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDS 164 (362)
T ss_dssp EEEEEE---TTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEET
T ss_pred Eeeecc---ccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCc
Confidence 765432 223445666655444 3344444455679999999999999999999998 89999999999999954322
Q ss_pred --CceEEEEeecCCcccccccccCCCCCCccCCCCccCchhhccccCCCcchHHHHHHHHHHHHhCCCCCccCCCCCH--
Q 039291 151 --GKFVAKIADLGVAKRSRHCKRQKFDPSMRGTPLYLAPETVVQHMQEAPSDIWALGCVVLEMLSGRQAWVVKEDCSI-- 226 (362)
Q Consensus 151 --~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~-- 226 (362)
....++++|||.|..... .....+||+.|+|||++.+..++.++||||+||++++|++|+.||...+....
T Consensus 165 ~~~~~~~kl~dfg~s~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~ 239 (362)
T d1q8ya_ 165 PENLIQIKIADLGNACWYDE-----HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTK 239 (362)
T ss_dssp TTTEEEEEECCCTTCEETTB-----CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------C
T ss_pred ccccceeeEeeccccccccc-----ccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccc
Confidence 224689999999875443 22456799999999999999999999999999999999999999975432111
Q ss_pred --HHH---HHHHcC------------------C---CC---------------CCCCCccCCHHHHHHHHHHhccCCCCC
Q 039291 227 --DQL---FSIIGD------------------E---HS---------------LPEIPSRVSKEARDFLRRCFVRKPAFR 265 (362)
Q Consensus 227 --~~~---~~~~~~------------------~---~~---------------~~~~~~~~~~~~~~li~~~l~~~p~~R 265 (362)
..+ +..++. . .. ....+...++++++||.+||..||.+|
T Consensus 240 ~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R 319 (362)
T d1q8ya_ 240 DDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKR 319 (362)
T ss_dssp HHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTC
T ss_pred hhHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHC
Confidence 111 111110 0 00 011223456889999999999999999
Q ss_pred CCHHHHhcCCCccCc
Q 039291 266 FTAEMLLDDPFVKGV 280 (362)
Q Consensus 266 ~s~~~~l~~p~~~~~ 280 (362)
||++|+|+||||++.
T Consensus 320 pta~e~L~Hp~f~~~ 334 (362)
T d1q8ya_ 320 ADAGGLVNHPWLKDT 334 (362)
T ss_dssp BCHHHHHTCGGGTTC
T ss_pred cCHHHHhcCcccCCC
Confidence 999999999999854
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.92 E-value=1.4e-25 Score=187.37 Aligned_cols=162 Identities=20% Similarity=0.156 Sum_probs=115.1
Q ss_pred eeecceecccCceEEEEEEECCCCCCCCceeeeechhh---------------------hhhHHHHHHHHHHHHcCCCCc
Q 039291 8 WFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEV---------------------SASASLQKEKEVFDNLNGCPF 66 (362)
Q Consensus 8 y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~---------------------~~~~~~~~E~~il~~l~~h~~ 66 (362)
+.+++.||+|+||+||+|++.. ++ .||+|.... .......+|...+.++. +.+
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~~-g~----~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~ 75 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSEK-FG----ECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ-GLA 75 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEETT-TE----EEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT-TSS
T ss_pred chhCCEeeeCcceEEEEEECCC-CC----EEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHcc-CCC
Confidence 5689999999999999999864 43 567764321 11233456888899998 678
Q ss_pred ccccccceeeecCCCceEEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCCCCEEEe
Q 039291 67 VLECFGEEITMGENGEMAYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDSGYVHCDVKPDNILLV 146 (362)
Q Consensus 67 i~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~~ivH~Dlkp~Nill~ 146 (362)
++..++... .+++|||+++..+.+ +++..+..++.|++.+|.|||++||+||||||+|||+
T Consensus 76 v~~~~~~~~---------~~lvme~~~~~~~~~---------l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv- 136 (191)
T d1zara2 76 VPKVYAWEG---------NAVLMELIDAKELYR---------VRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLV- 136 (191)
T ss_dssp SCCEEEEET---------TEEEEECCCCEEGGG---------CCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEE-
T ss_pred cceEEEecC---------CEEEEEeeccccccc---------hhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheee-
Confidence 877664321 258999998865432 5666778899999999999999999999999999999
Q ss_pred ecCCCceEEEEeecCCcccccccccCCCCCCccCCCCccCc--h---hhccccCCCcchHHHHHHHH
Q 039291 147 ATQSGKFVAKIADLGVAKRSRHCKRQKFDPSMRGTPLYLAP--E---TVVQHMQEAPSDIWALGCVV 208 (362)
Q Consensus 147 ~~~~~~~~~kl~Dfgla~~~~~~~~~~~~~~~~gt~~y~aP--E---~~~~~~~~~~~DiwslG~il 208 (362)
++++ ++|+|||+|......... .|... + .+..+.|+.++|+||+.--+
T Consensus 137 ---~~~~-~~liDFG~a~~~~~~~~~----------~~l~rd~~~~~~~f~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 137 ---SEEG-IWIIDFPQSVEVGEEGWR----------EILERDVRNIITYFSRTYRTEKDINSAIDRI 189 (191)
T ss_dssp ---ETTE-EEECCCTTCEETTSTTHH----------HHHHHHHHHHHHHHHHHHCCCCCHHHHHHHH
T ss_pred ---eCCC-EEEEECCCcccCCCCCcH----------HHHHHHHHHHHHHHcCCCCCcccHHHHHHHH
Confidence 4443 889999998654421111 12111 1 11246788999999976443
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.36 E-value=9.9e-07 Score=74.94 Aligned_cols=136 Identities=20% Similarity=0.163 Sum_probs=84.4
Q ss_pred ceeecceecccCceEEEEEEECCCCCCCCceeeeechhhh---hhHHHHHHHHHHHHcCCCCcccccccceeeecCCCce
Q 039291 7 SWFRGRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEVS---ASASLQKEKEVFDNLNGCPFVLECFGEEITMGENGEM 83 (362)
Q Consensus 7 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~~---~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~~~~ 83 (362)
+|...+..+.++-+.||+....+ + .+.+|..... ....+.+|...+..|..+--+.+++.... + ..
T Consensus 15 ~~~~~~~~~G~s~~~v~rv~~~~-~-----~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~----~-~~ 83 (263)
T d1j7la_ 15 KYRCVKDTEGMSPAKVYKLVGEN-E-----NLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFER----H-DG 83 (263)
T ss_dssp TSEEEECSCCCSSSEEEEEECSS-C-----EEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEE----E-TT
T ss_pred ceEEEEcCCCCCCCcEEEEEeCC-C-----eEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEe----c-CC
Confidence 45666665566667899886332 2 3455554322 33457889999988875433444443221 1 12
Q ss_pred EEEEEEEecCCCCHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC--------------------------------
Q 039291 84 AYNLLLEYAAGGTLGDLIEKCNGNGLPEKDVRHFTRCILEGIGHIHDS-------------------------------- 131 (362)
Q Consensus 84 ~~~lv~e~~~~~~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~yLH~~-------------------------------- 131 (362)
..++||++++|.++.+.... ......++.++...+..||+.
T Consensus 84 ~~~lv~~~l~G~~~~~~~~~-------~~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (263)
T d1j7la_ 84 WSNLLMSEADGVLCSEEYED-------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCE 156 (263)
T ss_dssp EEEEEEECCSSEEHHHHTTT-------CSCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGG
T ss_pred ceEEEEEecccccccccccc-------cccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhh
Confidence 35699999999877654321 111223444555555555531
Q ss_pred ---------------------------CceeCCCCCCCEEEeecCCCceEEEEeecCCcc
Q 039291 132 ---------------------------GYVHCDVKPDNILLVATQSGKFVAKIADLGVAK 164 (362)
Q Consensus 132 ---------------------------~ivH~Dlkp~Nill~~~~~~~~~~kl~Dfgla~ 164 (362)
.++|+|+.|.|||+ ++...+.|+||+.+.
T Consensus 157 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~----~~~~~~~lIDwe~a~ 212 (263)
T d1j7la_ 157 NWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFV----KDGKVSGFIDLGRSG 212 (263)
T ss_dssp GGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEE----ETTEEEEECCCTTCE
T ss_pred cccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceee----cCCceEEEeechhcc
Confidence 27899999999999 666667799999764
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.93 E-value=1e-05 Score=68.00 Aligned_cols=74 Identities=20% Similarity=0.140 Sum_probs=46.1
Q ss_pred ecccCc-eEEEEEEECCCCCCCCceeeeechhhhhhHHHHHHHHHHHHcCCCCc-ccccccceeeecCCCceEEEEEEEe
Q 039291 14 IGQGSF-GCVFIAKPKSNSSFLPPLMAVKSAEVSASASLQKEKEVFDNLNGCPF-VLECFGEEITMGENGEMAYNLLLEY 91 (362)
Q Consensus 14 lG~G~~-g~V~~a~~~~~~~~~~~~~~~K~~~~~~~~~~~~E~~il~~l~~h~~-i~~~~~~~~~~~~~~~~~~~lv~e~ 91 (362)
+..|.. +.||+....... .+.+|.........+.+|..+++.|..+.- +.+++.... +. ...++||++
T Consensus 18 ~~~G~s~~~v~r~~~~~~~-----~~vlK~~~~~~~~~l~~E~~~l~~L~~~gvpvP~v~~~~~----~~-~~~~~v~~~ 87 (255)
T d1nd4a_ 18 QTIGCSDAAVFRLSAQGRP-----VLFVKTDLSGALNELQDEAARLSWLATTGVPCAAVLDVVT----EA-GRDWLLLGE 87 (255)
T ss_dssp CSCTTSSCEEEEEECTTSC-----CEEEEEECSCTTSCHHHHHHHHHHHHTTTCCBCCEEEEEE----CS-SCEEEEEEC
T ss_pred cCCcccCCeEEEEEeCCCC-----EEEEEeCCccCHhHHHHHHHHHHHHHhcCCCCCceeeecc----cc-cceEEEEEe
Confidence 344543 678998765432 356677665566668899999988875322 344443221 22 235689999
Q ss_pred cCCCCH
Q 039291 92 AAGGTL 97 (362)
Q Consensus 92 ~~~~~L 97 (362)
++|.++
T Consensus 88 i~G~~~ 93 (255)
T d1nd4a_ 88 VPGQDL 93 (255)
T ss_dssp CSSEET
T ss_pred eecccc
Confidence 988654
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.71 E-value=4e-05 Score=68.89 Aligned_cols=76 Identities=18% Similarity=0.201 Sum_probs=44.3
Q ss_pred cceecccCceEEEEEEECCCCCCCCceeeeechhh----------hhhHHHHHHHHHHHHcCCC-C-cccccccceeeec
Q 039291 11 GRVIGQGSFGCVFIAKPKSNSSFLPPLMAVKSAEV----------SASASLQKEKEVFDNLNGC-P-FVLECFGEEITMG 78 (362)
Q Consensus 11 ~~~lG~G~~g~V~~a~~~~~~~~~~~~~~~K~~~~----------~~~~~~~~E~~il~~l~~h-~-~i~~~~~~~~~~~ 78 (362)
.+.||.|....||++.+..++. .+.+|...+ ....+..+|.++|+.+..+ | .+.+++.+ .
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~----svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~----d 102 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDR----ALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS----D 102 (392)
T ss_dssp EEECCSSSSEEEEEEEC----C----EEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE----E
T ss_pred EEEeCCCceEeEEEEEeCCCCe----EEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE----c
Confidence 5679999999999998766554 344553211 1234567899999887643 2 23333321 1
Q ss_pred CCCceEEEEEEEecCCCCH
Q 039291 79 ENGEMAYNLLLEYAAGGTL 97 (362)
Q Consensus 79 ~~~~~~~~lv~e~~~~~~L 97 (362)
. .. .++|||++.+..+
T Consensus 103 -~-~~-~~lvmE~L~~~~~ 118 (392)
T d2pula1 103 -T-EM-AVTVMEDLSHLKI 118 (392)
T ss_dssp -T-TT-TEEEECCCTTSEE
T ss_pred -C-CC-CEEEEeccCCccc
Confidence 1 12 2489999987543
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.64 E-value=0.0017 Score=57.84 Aligned_cols=78 Identities=17% Similarity=0.120 Sum_probs=48.5
Q ss_pred cceecccCceEEEEEEECCCCCC---CCceeeeechh-hhhhHHHHHHHHHHHHcCCCCcccccccceeeecCCCceEEE
Q 039291 11 GRVIGQGSFGCVFIAKPKSNSSF---LPPLMAVKSAE-VSASASLQKEKEVFDNLNGCPFVLECFGEEITMGENGEMAYN 86 (362)
Q Consensus 11 ~~~lG~G~~g~V~~a~~~~~~~~---~~~~~~~K~~~-~~~~~~~~~E~~il~~l~~h~~i~~~~~~~~~~~~~~~~~~~ 86 (362)
++.|+.|---.+|++........ ....+.+++.. ........+|..+++.+..+.-..++++.+. + .
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~----~-----g 117 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPETESHLVAESVIFTLLSERHLGPKLYGIFS----G-----G 117 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCCHHHHHHHHHHHHHHHHTTSSSCEEEEET----T-----E
T ss_pred EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCcchhhHHHHHHHHHHHHHhCCCCCeEEEEcC----C-----c
Confidence 46789999999999987653211 11344444432 1223345689999999886544456655431 1 3
Q ss_pred EEEEecCCCCH
Q 039291 87 LLLEYAAGGTL 97 (362)
Q Consensus 87 lv~e~~~~~~L 97 (362)
+|+||++|..|
T Consensus 118 ~I~efi~g~~l 128 (395)
T d1nw1a_ 118 RLEEYIPSRPL 128 (395)
T ss_dssp EEECCCCEEEC
T ss_pred eEEEEeccccC
Confidence 79999987543
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.36 E-value=0.0045 Score=53.44 Aligned_cols=69 Identities=14% Similarity=0.144 Sum_probs=39.6
Q ss_pred ceEEEEEEECCCCCCCCceeeeechhhh--hhHHHHHHHHHHHHcCCC--Ccc--cccccceeeecCCCceEEEEEEEec
Q 039291 19 FGCVFIAKPKSNSSFLPPLMAVKSAEVS--ASASLQKEKEVFDNLNGC--PFV--LECFGEEITMGENGEMAYNLLLEYA 92 (362)
Q Consensus 19 ~g~V~~a~~~~~~~~~~~~~~~K~~~~~--~~~~~~~E~~il~~l~~h--~~i--~~~~~~~~~~~~~~~~~~~lv~e~~ 92 (362)
--.||+++..+.. .+++|...+. ..+.+..|...+..|..+ |-. +..-+-... ......+.+++++
T Consensus 35 EN~vy~v~~~dg~-----~~VlK~~rp~~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~---~~~~~~~~l~~~~ 106 (325)
T d1zyla1 35 ENRVYQFQDEDRR-----RFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLL---NHQGFYFAVFPSV 106 (325)
T ss_dssp SSEEEEECCTTCC-----CEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCE---EETTEEEEEEECC
T ss_pred cceeEEEEcCCCC-----EEEEEEeCCCCCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeee---eeeeEEEEEEeec
Confidence 3589999865432 4677776543 456688899998887632 211 111111111 1123456889998
Q ss_pred CCC
Q 039291 93 AGG 95 (362)
Q Consensus 93 ~~~ 95 (362)
.|.
T Consensus 107 ~G~ 109 (325)
T d1zyla1 107 GGR 109 (325)
T ss_dssp CCE
T ss_pred CCc
Confidence 764
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.03 E-value=0.016 Score=49.40 Aligned_cols=30 Identities=27% Similarity=0.469 Sum_probs=26.0
Q ss_pred CCceeCCCCCCCEEEeecCCCceEEEEeecCCcc
Q 039291 131 SGYVHCDVKPDNILLVATQSGKFVAKIADLGVAK 164 (362)
Q Consensus 131 ~~ivH~Dlkp~Nill~~~~~~~~~~kl~Dfgla~ 164 (362)
.|+||+|+.+.||++ +++...-|+||+.+.
T Consensus 183 ~giIHgDl~~dNvl~----~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 183 AGVIHADLFQDNVFF----LGDELSGLIDFYFAC 212 (316)
T ss_dssp EEEECSCCCGGGEEE----ETTEEEEECCCTTCE
T ss_pred cccccCCcchhhhhc----ccccceeEecccccc
Confidence 479999999999999 666777899999864
|